Citrus Sinensis ID: 037267

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200--
Protein Sequence
MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKIK
Secondary Structure (PSIPRED)
cccccccHHcccccccccHHHHHHHHHHHHHHHcccccccccccEEcccccccccccccccEEEEccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHccccccccccccccHHHHHHHHcccccccccccccccHHHHHHHHHHHHHHHHHHHHHcccccccccccHHHHHHHHHHcc
Secondary Structure Prediction (SSPRO)
cccccHHHHHccccccccHHHHHHHHHHHHHHHHHHHcccccccEEcccccHHHEEEcccccEEEccccccEEcccccccEEEEEEEcccccccHHHHHcccccccccHHHHHHHHHHHHcccccccccccccHHHHHHHHHHHHHHHHHHHccHHccccccccccHHHHHHHHHHHHHHHcccHcccccHHHHHHHHHccc
Coil and Loop (DISEMBL)
MPNGSLEKWLYSYNYFFDILERLNIMIDvgsaleyphhghssapiihcdlkptnilldenmvahvsdfgiskllgegedfvTQTMTMATIgymapeygsegivsakcDVYSYGVLLMETftrkrptdemftgemSLRRWVKeslphgltevvdaNLVREEQAFAAKMDCIVSIMDLALDccmespgkrinMTDAAAKLKKIK
Flexible Loop (DISEMBL)
mpngslekWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMEtftrkrptdemftgemslrrWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKIK
Low Complexity Region (SEG)
MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKIK
Disordered region (IsUnstruct)
******EKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLALDCCME*******************
Disordered Region (DISOPRED)
MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLL*************ATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKIK
Disordered Region (DISEMBL)
MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDA********
Disordered Region (DISPRO)
***GSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKIK
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKIK
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	202	2.2.26 [Sep-21-2011]
C0LGP4	1010	Probable LRR receptor-lik	no	no	0.990	0.198	0.419	1e-41
Q9SD62	1025	Putative receptor-like pr	no	no	0.995	0.196	0.396	9e-36
C0LGT6	1031	LRR receptor-like serine/	no	no	0.945	0.185	0.395	2e-33
Q9ZUI0	980	Putative leucine-rich rep	no	no	0.995	0.205	0.366	3e-33
Q9FL28	1173	LRR receptor-like serine/	no	no	0.960	0.165	0.364	2e-30
P93194	1109	Receptor-like protein kin	N/A	no	0.980	0.178	0.367	9e-28
C0LGQ5	1249	LRR receptor-like serine/	no	no	0.960	0.155	0.352	2e-27
C0LGF4	591	LRR receptor-like serine/	no	no	0.891	0.304	0.382	3e-27
Q9LHP4	1141	Receptor-like protein kin	no	no	0.970	0.171	0.364	3e-27
Q9SSL9	1123	Leucine-rich repeat recep	no	no	0.980	0.176	0.334	5e-27

>sp|C0LGP4|Y3475_ARATH Probable LRR receptor-like serine/threonine-protein kinase At3g47570 OS=Arabidopsis thaliana GN=At3g47570 PE=1 SV=1

 Score =  169 bits (428), Expect = 1e-41,   Method: Composition-based stats.
 Identities = 91/217 (41%), Positives = 130/217 (59%), Gaps = 17/217 (7%)

Query: 1   MPNGSLEKWLYSY--------NYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKP 52
           MPNGSL+ WL+          +    +LERLNI IDV S L+Y  H H   PI HCDLKP
Sbjct: 784 MPNGSLDMWLHPEEVEEIHRPSRTLTLLERLNIAIDVASVLDY-LHVHCHEPIAHCDLKP 842

Query: 53  TNILLDENMVAHVSDFGISKLL--GEGEDFVTQTMTMA---TIGYMAPEYGSEGIVSAKC 107
           +N+LLD+++ AHVSDFG+++LL   + E F  Q  +     TIGY APEYG  G  S   
Sbjct: 843 SNVLLDDDLTAHVSDFGLARLLLKFDEESFFNQLSSAGVRGTIGYAAPEYGVGGQPSING 902

Query: 108 DVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVR--EEQAFAA 165
           DVYS+G+LL+E FT KRPT+E+F G  +L  + K +LP  + ++VD +++       F  
Sbjct: 903 DVYSFGILLLEMFTGKRPTNELFGGNFTLNSYTKSALPERILDIVDESILHIGLRVGFPV 962

Query: 166 KMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKIK 202
            ++C+  + ++ L CC ESP  R+  +    +L  I+
Sbjct: 963 -VECLTMVFEVGLRCCEESPMNRLATSIVVKELISIR 998

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q9SD62|Y3471_ARATH Putative receptor-like protein kinase At3g47110 OS=Arabidopsis thaliana GN=At3g47110 PE=3 SV=1

 Score =  149 bits (377), Expect = 9e-36,   Method: Composition-based stats.
 Identities = 86/217 (39%), Positives = 128/217 (58%), Gaps = 16/217 (7%)

Query: 1    MPNGSLEKWLY--------SYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKP 52
            MPNG+L+ WL+        + +    +  RLNI IDV SAL Y  H +   PI HCD+KP
Sbjct: 801  MPNGNLDMWLHPDEIEETGNPSRTLGLFARLNIAIDVASALVY-LHTYCHNPIAHCDIKP 859

Query: 53   TNILLDENMVAHVSDFGISKLL--GEGEDFVTQTMTMA---TIGYMAPEYGSEGIVSAKC 107
            +NILLD+++ AHVSDFG+++LL   + + F  Q  +     TIGY APEYG  G  S   
Sbjct: 860  SNILLDKDLTAHVSDFGLAQLLLKFDRDTFHIQFSSAGVRGTIGYAAPEYGMGGHPSIMG 919

Query: 108  DVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESL-PHGLTEVVDANLVREEQAFAAK 166
            DVYS+G++L+E FT KRPT+++F   ++L  + K +L      ++ D  ++R   A    
Sbjct: 920  DVYSFGIVLLEIFTGKRPTNKLFVDGLTLHSFTKSALQKRQALDITDETILRGAYAQHFN 979

Query: 167  M-DCIVSIMDLALDCCMESPGKRINMTDAAAKLKKIK 202
            M +C+  +  + + C  ESP  RI+M +A +KL  I+
Sbjct: 980  MVECLTLVFRVGVSCSEESPVNRISMAEAISKLVSIR 1016

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGT6|EFR_ARATH LRR receptor-like serine/threonine-protein kinase EFR OS=Arabidopsis thaliana GN=EFR PE=1 SV=1

 Score =  142 bits (357), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 85/215 (39%), Positives = 121/215 (56%), Gaps = 24/215 (11%)

Query: 1   MPNGSLEKWLY--------SYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKP 52
           MP GSL+ WL          ++      E+LNI IDV SALEY H  H   P+ HCD+KP
Sbjct: 794 MPKGSLDMWLQLEDLERVNDHSRSLTPAEKLNIAIDVASALEYLHV-HCHDPVAHCDIKP 852

Query: 53  TNILLDENMVAHVSDFGISKLLG--EGEDFVTQTMTMA---TIGYMAPEYGSEGIVSAKC 107
           +NILLD+++ AHVSDFG+++LL   + E F+ Q  +     TIGY APEYG  G  S + 
Sbjct: 853 SNILLDDDLTAHVSDFGLAQLLYKYDRESFLNQFSSAGVRGTIGYAAPEYGMGGQPSIQG 912

Query: 108 DVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKM 167
           DVYS+G+LL+E F+ K+PTDE F G+ +L  + K S+  G T    +N + E        
Sbjct: 913 DVYSFGILLLEMFSGKKPTDESFAGDYNLHSYTK-SILSGCTSSGGSNAIDEGLRL---- 967

Query: 168 DCIVSIMDLALDCCMESPGKRINMTDAAAKLKKIK 202
                ++ + + C  E P  R+   +A  +L  I+
Sbjct: 968 -----VLQVGIKCSEEYPRDRMRTDEAVRELISIR 997

Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of elongation factor Tu (EF-Tu), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Reduces transformation by Rhizobium radiobacter probably by inducing plant defense during the interaction. Binding to the effector AvrPto1 from P.syringae blocks the downstream plant immune response.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ZUI0|Y2241_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g24130 OS=Arabidopsis thaliana GN=At2g24130 PE=3 SV=1

 Score =  141 bits (355), Expect = 3e-33,   Method: Composition-based stats.
 Identities = 81/221 (36%), Positives = 122/221 (55%), Gaps = 20/221 (9%)

Query: 1   MPNGSLEKWLYSYNYF---FDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILL 57
           MPNGSLE+ LY   Y     D+++ +NI  DV   + Y HH +S   ++HCDLKP+NILL
Sbjct: 738 MPNGSLERHLYPGEYSSKNLDLIQLVNICSDVAEGIAYLHH-YSPVKVVHCDLKPSNILL 796

Query: 58  DENMVAHVSDFGISKLLGEGEDFV----------TQTMTMATIGYMAPEYGSEGIVSAKC 107
           D+ M A V+DFGIS+L+   E+ V          T  +   ++GY+APEYG     S   
Sbjct: 797 DDEMTALVTDFGISRLVQGVEETVSTDDSVSFGSTDGLLCGSVGYIAPEYGMGKRASTHG 856

Query: 108 DVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVR------EEQ 161
           DVYS+GVLL+E  + +RPTD +     SL  ++K   P  L  +++  L R       E+
Sbjct: 857 DVYSFGVLLLEIVSGRRPTDVLVNEGSSLHEFMKSHYPDSLEGIIEQALSRWKPQGKPEK 916

Query: 162 AFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKIK 202
                 + I+ +++L L C   +P  R +M D A ++ ++K
Sbjct: 917 CEKLWREVILEMIELGLVCTQYNPSTRPDMLDVAHEMGRLK 957

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FL28|FLS2_ARATH LRR receptor-like serine/threonine-protein kinase FLS2 OS=Arabidopsis thaliana GN=FLS2 PE=1 SV=1

 Score =  132 bits (331), Expect = 2e-30,   Method: Composition-based stats.
 Identities = 79/217 (36%), Positives = 128/217 (58%), Gaps = 23/217 (10%)

Query: 1    MPNGSLEKWLY-SYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDE 59
            M NG+LE  ++ S      +LE++++ + + S ++Y H G+   PI+HCDLKP NILLD 
Sbjct: 949  MENGNLEDTIHGSAAPIGSLLEKIDLCVHIASGIDYLHSGYG-FPIVHCDLKPANILLDS 1007

Query: 60   NMVAHVSDFGISKLLGEGEDFVTQTMTMA---TIGYMAPEYGSEGIVSAKCDVYSYGVLL 116
            + VAHVSDFG +++LG  ED  T   T A   TIGY+APE+     V+ K DV+S+G+++
Sbjct: 1008 DRVAHVSDFGTARILGFREDGSTTASTSAFEGTIGYLAPEFAYMRKVTTKADVFSFGIIM 1067

Query: 117  METFTRKRPT--DEMFTGEMSLRRWVKESLPH---GLTEVVDANL------VREEQAFAA 165
            ME  T++RPT  ++  + +M+LR+ V++S+ +   G+  V+D  L      +++E+A   
Sbjct: 1068 MELMTKQRPTSLNDEDSQDMTLRQLVEKSIGNGRKGMVRVLDMELGDSIVSLKQEEA--- 1124

Query: 166  KMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKIK 202
                I   + L L C    P  R +M +    L K++
Sbjct: 1125 ----IEDFLKLCLFCTSSRPEDRPDMNEILTHLMKLR 1157

Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of flagellin (flg22), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Flagellin-binding to the receptor is the first step to initiate the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6), resulting in enhanced resistance against pathogens. Binding to the effector AvrPto1 from Pseudomonas syringae blocks the downstream plant immune response.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P93194|RPK1_IPONI Receptor-like protein kinase OS=Ipomoea nil GN=INRPK1 PE=2 SV=2

 Score =  123 bits (308), Expect = 9e-28,   Method: Composition-based stats.
 Identities = 75/204 (36%), Positives = 106/204 (51%), Gaps = 6/204 (2%)

Query: 1    MPNGSLEKWLYSYN--YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLD 58
            M NGSL   L+  N     D   R NI +     L Y H     A I+H D+KP NILLD
Sbjct: 893  MENGSLHDILHETNPPKPLDWSTRHNIAVGTAHGLAYLHFDCDPA-IVHRDIKPMNILLD 951

Query: 59   ENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLME 118
             ++  H+SDFGI+KLL +    +       TIGYMAPE     + S + DVYSYGV+L+E
Sbjct: 952  SDLEPHISDFGIAKLLDQSATSIPSNTVQGTIGYMAPENAFTTVKSRESDVYSYGVVLLE 1011

Query: 119  TFTRKRPTDEMFTGEMSLRRWVKESLPHG--LTEVVDANLVREEQAFAAKMDCIVSIMDL 176
              TRK+  D  F GE  +  WV+        + ++VD +L+ +E   ++ M+ +   + L
Sbjct: 1012 LITRKKALDPSFNGETDIVGWVRSVWTQTGEIQKIVDPSLL-DELIDSSVMEQVTEALSL 1070

Query: 177  ALDCCMESPGKRINMTDAAAKLKK 200
            AL C  +   KR  M D   +L +
Sbjct: 1071 ALRCAEKEVDKRPTMRDVVKQLTR 1094

Possible role in short-day photoperiod floral induction.

Ipomoea nil (taxid: 35883)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1

 Score =  122 bits (306), Expect = 2e-27,   Method: Composition-based stats.
 Identities = 74/210 (35%), Positives = 107/210 (50%), Gaps = 16/210 (7%)

Query: 1    MPNGSLEKWLYS-------YNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPT 53
            M NGS+  WL+             D   RL I + +   +EY HH     PI+H D+K +
Sbjct: 1030 MKNGSIWDWLHEDKPVLEKKKKLLDWEARLRIAVGLAQGVEYLHH-DCVPPIVHRDIKSS 1088

Query: 54   NILLDENMVAHVSDFGISKLLGEGEDFVTQTMT--MATIGYMAPEYGSEGIVSAKCDVYS 111
            N+LLD NM AH+ DFG++K+L E  D  T + T    + GY+APEY      + K DVYS
Sbjct: 1089 NVLLDSNMEAHLGDFGLAKVLTENCDTNTDSNTWFACSYGYIAPEYAYSLKATEKSDVYS 1148

Query: 112  YGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLP---HGLTEVVDANLVREEQAFAAKMD 168
             G++LME  T K PTD +F  EM + RWV+  L        +++D  L   +     + D
Sbjct: 1149 MGIVLMEIVTGKMPTDSVFGAEMDMVRWVETHLEVAGSARDKLIDPKL---KPLLPFEED 1205

Query: 169  CIVSIMDLALDCCMESPGKRINMTDAAAKL 198
                ++++AL C   SP +R +   A   L
Sbjct: 1206 AACQVLEIALQCTKTSPQERPSSRQACDSL 1235

Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGF4|FEI1_ARATH LRR receptor-like serine/threonine-protein kinase FEI 1 OS=Arabidopsis thaliana GN=FEI1 PE=1 SV=1

 Score =  121 bits (304), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 75/196 (38%), Positives = 110/196 (56%), Gaps = 16/196 (8%)

Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           +P GSL++ L+      D   R+NI+I     L Y HH   S  IIH D+K +NILLD N
Sbjct: 382 LPGGSLDEALHERGEQLDWDSRVNIIIGAAKGLSYLHH-DCSPRIIHRDIKSSNILLDGN 440

Query: 61  MVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETF 120
           + A VSDFG++KLL + E  +T T+   T GY+APEY   G  + K DVYS+GVL++E  
Sbjct: 441 LEARVSDFGLAKLLEDEESHIT-TIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVL 499

Query: 121 TRKRPTDEMFTGE-MSLRRWVK----ESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMD 175
           + KRPTD  F  + +++  W+K    E  P    ++VD N          +M+ + +++ 
Sbjct: 500 SGKRPTDASFIEKGLNVVGWLKFLISEKRPR---DIVDPN------CEGMQMESLDALLS 550

Query: 176 LALDCCMESPGKRINM 191
           +A  C   SP +R  M
Sbjct: 551 IATQCVSPSPEERPTM 566

Involved in the signaling pathway that regulates cell wall function, including cellulose biosynthesis, likely via an 1-aminocyclopropane-1-carboxylic acid (ACC)-mediated signal (a precursor of ethylene).

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LHP4|RCH2_ARATH Receptor-like protein kinase 2 OS=Arabidopsis thaliana GN=RCH2 PE=1 SV=1

 Score =  121 bits (304), Expect = 3e-27,   Method: Composition-based stats.
 Identities = 74/203 (36%), Positives = 109/203 (53%), Gaps = 7/203 (3%)

Query: 1    MPNGSLEKWLYSYN-YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDE 59
            MPNGSL   L+       D   R  I++     L Y HH     PI+H D+K  NIL+  
Sbjct: 871  MPNGSLGSLLHERRGSSLDWDLRYRILLGAAQGLAYLHH-DCLPPIVHRDIKANNILIGL 929

Query: 60   NMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMET 119
            +   +++DFG++KL+ EG+          + GY+APEYG    ++ K DVYSYGV+++E 
Sbjct: 930  DFEPYIADFGLAKLVDEGDIGRCSNTVAGSYGYIAPEYGYSMKITEKSDVYSYGVVVLEV 989

Query: 120  FTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLALD 179
             T K+P D      + L  WV+++   G  EV+D+ L    +A A +M   + ++  AL 
Sbjct: 990  LTGKQPIDPTVPEGIHLVDWVRQN--RGSLEVLDSTLRSRTEAEADEM---MQVLGTALL 1044

Query: 180  CCMESPGKRINMTDAAAKLKKIK 202
            C   SP +R  M D AA LK+IK
Sbjct: 1045 CVNSSPDERPTMKDVAAMLKEIK 1067

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SSL9|PEPR1_ARATH Leucine-rich repeat receptor-like protein kinase PEPR1 OS=Arabidopsis thaliana GN=PEPR1 PE=1 SV=1

 Score =  120 bits (302), Expect = 5e-27,   Method: Composition-based stats.
 Identities = 71/212 (33%), Positives = 113/212 (53%), Gaps = 14/212 (6%)

Query: 1    MPNGSLEKWLYSYNYFFDILE---RLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILL 57
            MP GSL   L+  +   ++L+   R N+ + V   L Y H+     PI+H D+KP NIL+
Sbjct: 904  MPKGSLYDVLHGVSPKENVLDWSARYNVALGVAHGLAYLHY-DCHPPIVHRDIKPENILM 962

Query: 58   DENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLM 117
            D ++  H+ DFG+++LL +    V+      T GY+APE   + +   + DVYSYGV+L+
Sbjct: 963  DSDLEPHIGDFGLARLLDDST--VSTATVTGTTGYIAPENAFKTVRGRESDVYSYGVVLL 1020

Query: 118  ETFTRKRPTDEMFTGEMSLRRWVKESLPHG-------LTEVVDANLVREEQAFAAKMDCI 170
            E  TRKR  D+ F     +  WV+ +L          +T +VD  LV +E   ++  + +
Sbjct: 1021 ELVTRKRAVDKSFPESTDIVSWVRSALSSSNNNVEDMVTTIVDPILV-DELLDSSLREQV 1079

Query: 171  VSIMDLALDCCMESPGKRINMTDAAAKLKKIK 202
            + + +LAL C  + P  R  M DA   L+ +K
Sbjct: 1080 MQVTELALSCTQQDPAMRPTMRDAVKLLEDVK 1111

Acts as a receptor for PEP defense peptides. Unlike typical immune receptors, senses an endogenous elicitor that potentiates PAMP-inducible plant responses.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	202
224116832	1061	predicted protein [Populus trichocarpa]	0.990	0.188	0.698	2e-81
224139658	1019	predicted protein [Populus trichocarpa]	0.990	0.196	0.640	1e-73
359485176	1160	PREDICTED: probable LRR receptor-like se	0.990	0.172	0.645	2e-71
359485453	1202	PREDICTED: probable LRR receptor-like se	0.980	0.164	0.628	4e-71
359483677	1229	PREDICTED: LRR receptor-like serine/thre	0.975	0.160	0.636	1e-70
359497186	1140	PREDICTED: LRR receptor-like serine/thre	0.985	0.174	0.640	2e-70
147853795	1420	hypothetical protein VITISV_005816 [Viti	0.980	0.139	0.638	3e-70
147776333	1205	hypothetical protein VITISV_000078 [Viti	0.975	0.163	0.636	5e-70
147769371	1241	hypothetical protein VITISV_010511 [Viti	0.975	0.158	0.626	1e-69
255572272	1089	serine-threonine protein kinase, plant-t	0.990	0.183	0.640	1e-69

>gi|224116832|ref|XP_002317405.1| predicted protein [Populus trichocarpa] gi|222860470|gb|EEE98017.1| predicted protein [Populus trichocarpa]

 Score =  307 bits (786), Expect = 2e-81,   Method: Composition-based stats.
 Identities = 141/202 (69%), Positives = 172/202 (85%), Gaps = 2/202 (0%)

Query: 1    MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
            +P+GSLEKWLYS+NY+ DIL+RLNIMIDV SALEY HHG  + P++HCDLKP+N+L++E+
Sbjct: 847  IPHGSLEKWLYSHNYYLDILQRLNIMIDVASALEYLHHG-CTRPVVHCDLKPSNVLINED 905

Query: 61   MVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETF 120
            MVAHVSDFGIS+LLGEG D VTQT+T+ATIGYMAPEYG EGIVS K DVYSYG+ LMETF
Sbjct: 906  MVAHVSDFGISRLLGEG-DAVTQTLTLATIGYMAPEYGLEGIVSVKGDVYSYGIFLMETF 964

Query: 121  TRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLALDC 180
            TRK+PTD+MF GEMSL+ WVK+SLP  +TEV+DANL+ EE+ F AK DCI SI++LAL+C
Sbjct: 965  TRKKPTDDMFGGEMSLKNWVKQSLPKAITEVIDANLLIEEEHFVAKKDCITSILNLALEC 1024

Query: 181  CMESPGKRINMTDAAAKLKKIK 202
              + PG+RI M D    L+KIK
Sbjct: 1025 SADLPGERICMRDVLPALEKIK 1046

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224139658|ref|XP_002323215.1| predicted protein [Populus trichocarpa] gi|222867845|gb|EEF04976.1| predicted protein [Populus trichocarpa]

 Score =  281 bits (719), Expect = 1e-73,   Method: Composition-based stats.
 Identities = 130/203 (64%), Positives = 163/203 (80%), Gaps = 3/203 (1%)

Query: 1    MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
            MP GSLEKWLYS+NY  DI++R+NIMIDV SALEY HHG+ S P++HCDLKP+N+LLDE+
Sbjct: 807  MPKGSLEKWLYSHNYCLDIIQRVNIMIDVASALEYLHHGYPS-PVVHCDLKPSNVLLDED 865

Query: 61   MVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETF 120
            MVAHV DFGI+KLLGE E F  QT T+ATIGYMAPEYG +G+VS K DVYS+G++LME  
Sbjct: 866  MVAHVCDFGIAKLLGENESF-AQTRTLATIGYMAPEYGLDGLVSTKIDVYSFGIMLMEML 924

Query: 121  TRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMD-CIVSIMDLALD 179
            TRKRPTDEMF GEMSL+R VKESLP  + ++VD+N++     ++ K + C+ SIM+LAL 
Sbjct: 925  TRKRPTDEMFEGEMSLKRLVKESLPDSVIDIVDSNMLNRGDGYSVKKEHCVTSIMELALQ 984

Query: 180  CCMESPGKRINMTDAAAKLKKIK 202
            C  ESPG+R+ M +  A+LK IK
Sbjct: 985  CVNESPGERMAMVEILARLKNIK 1007

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359485176|ref|XP_002280075.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera]

 Score =  274 bits (700), Expect = 2e-71,   Method: Composition-based stats.
 Identities = 131/203 (64%), Positives = 157/203 (77%), Gaps = 3/203 (1%)

Query: 1    MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
            MPNGSLEKWLYS+NY  ++++RLNIMIDV SALEY HH  S  P++HCDLKP N+LLDE 
Sbjct: 954  MPNGSLEKWLYSHNYCLNLVQRLNIMIDVASALEYLHHDFSVNPVVHCDLKPNNVLLDEE 1013

Query: 61   MVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETF 120
            MVA + DFGISKLL E E  + QT T+ TIGYMAPEYGSEGIVS + DVYSYG+++METF
Sbjct: 1014 MVARLGDFGISKLLTETES-MEQTRTLGTIGYMAPEYGSEGIVSTRGDVYSYGIMMMETF 1072

Query: 121  TRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV-REEQAFAAKMDCIVSIMDLALD 179
             RK+PTDEMF GE++LR WV ESL   + EVVD NLV RE+Q F  K  C+ SIM LAL+
Sbjct: 1073 ARKKPTDEMFGGEVTLRSWV-ESLAGRVMEVVDGNLVRREDQHFGIKESCLRSIMALALE 1131

Query: 180  CCMESPGKRINMTDAAAKLKKIK 202
            C  ESP  RI+M +   +LKKI+
Sbjct: 1132 CTTESPRDRIDMKEVVVRLKKIR 1154

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359485453|ref|XP_003633276.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera]

 Score =  273 bits (697), Expect = 4e-71,   Method: Composition-based stats.
 Identities = 127/202 (62%), Positives = 161/202 (79%), Gaps = 4/202 (1%)

Query: 1    MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
            MPNGSLEKWLYS+NY+ D ++RL IMIDV S LEY HH +S+ P++HCDLKP+N+LLD++
Sbjct: 994  MPNGSLEKWLYSHNYYLDFVQRLKIMIDVASGLEYLHHYYSN-PVVHCDLKPSNVLLDDD 1052

Query: 61   MVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETF 120
            MVAH+SDFGI+KLL  G +F+ +T T+ T+GYMAPEYGSEGIVS K D+YSYG+LLMETF
Sbjct: 1053 MVAHISDFGIAKLL-MGSEFMKRTKTLGTVGYMAPEYGSEGIVSTKGDIYSYGILLMETF 1111

Query: 121  TRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREE-QAFAAKMDCIVSIMDLALD 179
             RK+PTDEMF  E++L+ WV ES  + + EV+DANL+ EE ++FA K  C  SIM LALD
Sbjct: 1112 VRKKPTDEMFVEELTLKSWV-ESSTNNIMEVIDANLLTEEDESFALKRACFSSIMTLALD 1170

Query: 180  CCMESPGKRINMTDAAAKLKKI 201
            C +E P KRIN  D   +LKK+
Sbjct: 1171 CTVEPPEKRINTKDVVVRLKKL 1192

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359483677|ref|XP_003633000.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO2-like [Vitis vinifera]

 Score =  271 bits (693), Expect = 1e-70,   Method: Composition-based stats.
 Identities = 128/201 (63%), Positives = 163/201 (81%), Gaps = 4/201 (1%)

Query: 1    MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
            MPNGSLEKWLYS+NYF D+++RLNIMIDV SALEY HH  SS  ++HCDLKP N+LLD++
Sbjct: 1025 MPNGSLEKWLYSHNYFLDLIQRLNIMIDVASALEYLHHDCSSL-VVHCDLKPNNVLLDDD 1083

Query: 61   MVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETF 120
            MVAHV+DFGI+KLL + E  + QT T+ TIGYMAPE+GS+GIVS K DVYSYG+LLME F
Sbjct: 1084 MVAHVADFGITKLLTKTES-MQQTKTLGTIGYMAPEHGSDGIVSTKSDVYSYGILLMEVF 1142

Query: 121  TRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV-REEQAFAAKMDCIVSIMDLALD 179
            +RK+P DEMFTG+++L+ WV ESL + + +VVDANL+ RE++  A K+ C+ SIM LAL 
Sbjct: 1143 SRKKPMDEMFTGDLTLKTWV-ESLSNSVIQVVDANLLRREDEDLATKLSCLSSIMALALA 1201

Query: 180  CCMESPGKRINMTDAAAKLKK 200
            C  +SP +R+NM DA  +LKK
Sbjct: 1202 CTTDSPEERLNMKDAVVELKK 1222

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359497186|ref|XP_003635448.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO1-like [Vitis vinifera]

 Score =  270 bits (691), Expect = 2e-70,   Method: Composition-based stats.
 Identities = 130/203 (64%), Positives = 162/203 (79%), Gaps = 4/203 (1%)

Query: 1    MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
            MPNGSLEKWLYS+NYF D+++RLNIMIDV SALEY HH  SS  ++HCDLKP N+LLD++
Sbjct: 936  MPNGSLEKWLYSHNYFLDLIQRLNIMIDVASALEYLHHDCSSL-VVHCDLKPNNVLLDDD 994

Query: 61   MVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETF 120
            MVAHV+DFGI+KLL + E  + QT T+ TIGYMAPE+GS+GIVS K DVYSYG+LLME F
Sbjct: 995  MVAHVADFGITKLLTKTES-MQQTKTLGTIGYMAPEHGSDGIVSTKSDVYSYGILLMEVF 1053

Query: 121  TRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV-REEQAFAAKMDCIVSIMDLALD 179
            +RK+P DEMFTG ++L+ WV ESL + + +VVDANL+ RE++  A K+ C+ SIM LAL 
Sbjct: 1054 SRKKPMDEMFTGGLTLKTWV-ESLSNSVIQVVDANLLRREDEDLATKLSCLSSIMALALA 1112

Query: 180  CCMESPGKRINMTDAAAKLKKIK 202
            C   SP KR+NM DA  +LKK K
Sbjct: 1113 CTTNSPEKRLNMKDAVVELKKSK 1135

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147853795|emb|CAN81714.1| hypothetical protein VITISV_005816 [Vitis vinifera]

 Score =  270 bits (689), Expect = 3e-70,   Method: Compositional matrix adjust.
 Identities = 129/202 (63%), Positives = 160/202 (79%), Gaps = 4/202 (1%)

Query: 1    MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
            MPN SLEKWLYS+NY  D ++RL IMIDV S LEY HH +S+ P++HCDLKP+N+LLD++
Sbjct: 995  MPNESLEKWLYSHNYCLDFIQRLKIMIDVASGLEYLHHDYSN-PVVHCDLKPSNVLLDDD 1053

Query: 61   MVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETF 120
            MVAH+SDFGI+KLL  G +F+ +T T+ TIGYMAPEYGSEGIVS KCD YSYG++LME F
Sbjct: 1054 MVAHISDFGIAKLL-MGSEFMKRTKTLGTIGYMAPEYGSEGIVSTKCDTYSYGIILMEIF 1112

Query: 121  TRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREE-QAFAAKMDCIVSIMDLALD 179
             RK+PTDEMF  E++L+ WV ES  + + EV+DANL+ EE ++FA K  C  SIM LALD
Sbjct: 1113 VRKKPTDEMFVEELTLKSWV-ESSANNIMEVIDANLLTEEDESFALKQACFSSIMTLALD 1171

Query: 180  CCMESPGKRINMTDAAAKLKKI 201
            C +E P KRINM D  A+LKKI
Sbjct: 1172 CTIEPPEKRINMKDVVARLKKI 1193

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147776333|emb|CAN72034.1| hypothetical protein VITISV_000078 [Vitis vinifera]

 Score =  269 bits (688), Expect = 5e-70,   Method: Composition-based stats.
 Identities = 128/201 (63%), Positives = 161/201 (80%), Gaps = 4/201 (1%)

Query: 1    MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
            MPNGSLEKWLYS+NYF D+++RLNIMIDV SALEY HH  SS  ++HCDLKP+N+LLD++
Sbjct: 1001 MPNGSLEKWLYSHNYFLDLIQRLNIMIDVASALEYLHHDCSSL-VVHCDLKPSNVLLDDD 1059

Query: 61   MVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETF 120
            MVAHV+DFGI+KLL E E  + QT T+ TIGYMAPE+GS GIVS K DVYSYG+LLME F
Sbjct: 1060 MVAHVADFGIAKLLTETES-MQQTKTLGTIGYMAPEHGSAGIVSTKSDVYSYGILLMEVF 1118

Query: 121  TRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV-REEQAFAAKMDCIVSIMDLALD 179
             RK+P DEMFTG+++L+ WV ESL + + +VVD NL+ RE++  A K+ C+ SIM LAL 
Sbjct: 1119 ARKKPMDEMFTGDLTLKTWV-ESLSNSVIQVVDVNLLRREDEDLATKLSCLSSIMALALA 1177

Query: 180  CCMESPGKRINMTDAAAKLKK 200
            C  +SP +RI+M DA  +LKK
Sbjct: 1178 CTTDSPKERIDMKDAVVELKK 1198

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147769371|emb|CAN72496.1| hypothetical protein VITISV_010511 [Vitis vinifera]

 Score =  268 bits (685), Expect = 1e-69,   Method: Composition-based stats.
 Identities = 126/201 (62%), Positives = 162/201 (80%), Gaps = 4/201 (1%)

Query: 1    MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
            MPNGSLEKWLYS+NYF D+++RLNIMIDV SALEY HH  SS  ++HCDLKP+N+LLD+B
Sbjct: 1037 MPNGSLEKWLYSHNYFLDLIQRLNIMIDVASALEYLHHDCSSL-VVHCDLKPSNVLLDDB 1095

Query: 61   MVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETF 120
            MVAHV+DFGI+KLL + E  + QT T+ TIGYMAPE+GS+GIVS K DVYSYG+LLME F
Sbjct: 1096 MVAHVTDFGIAKLLTKTES-MQQTKTLGTIGYMAPEHGSDGIVSTKSDVYSYGILLMEVF 1154

Query: 121  TRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV-REEQAFAAKMDCIVSIMDLALD 179
             RK+P DEMFTG+++L+ WV ESL + + +VVD NL+ RE++  A K+ C+ SIM LAL 
Sbjct: 1155 ARKKPMDEMFTGDLTLKTWV-ESLSNSVIQVVDVNLLRREDEDLATKLSCLSSIMALALA 1213

Query: 180  CCMESPGKRINMTDAAAKLKK 200
            C  +SP +R++M DA  +LKK
Sbjct: 1214 CTNDSPEERLDMKDAVVELKK 1234

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255572272|ref|XP_002527075.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223533580|gb|EEF35319.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis]

 Score =  268 bits (684), Expect = 1e-69,   Method: Composition-based stats.
 Identities = 130/203 (64%), Positives = 162/203 (79%), Gaps = 3/203 (1%)

Query: 1    MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
            MPN SLEKWLYS +YF + L+RLNIM+DV S LEY HHG++  P+ HCD+KP+N+LL+E+
Sbjct: 878  MPNWSLEKWLYSDDYFLNNLQRLNIMLDVASVLEYLHHGYT-IPMAHCDIKPSNVLLNED 936

Query: 61   MVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETF 120
            MVA ++DFGISKLLGE E  V QTMT+ATIGYMAPEYGSEGIVS + DVYSYGVLLMETF
Sbjct: 937  MVAFLADFGISKLLGE-EGSVMQTMTLATIGYMAPEYGSEGIVSVRGDVYSYGVLLMETF 995

Query: 121  TRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVR-EEQAFAAKMDCIVSIMDLALD 179
            T+K+PTD+MFT ++SL+ WV++SL   +T+V+DANL+  EE   AAK DCIVSI+ LAL 
Sbjct: 996  TQKKPTDKMFTEQLSLKSWVEQSLSCEVTQVIDANLLGIEEDHLAAKKDCIVSILKLALQ 1055

Query: 180  CCMESPGKRINMTDAAAKLKKIK 202
            C  + P  RI+M      L+KIK
Sbjct: 1056 CSADLPHDRIDMKHVVTTLQKIK 1078

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	202
TAIR|locus:2075631	1009	AT3G47090 [Arabidopsis thalian	0.990	0.198	0.442	5.8e-40
TAIR|locus:2079142	1010	AT3G47570 [Arabidopsis thalian	0.990	0.198	0.419	1e-37
TAIR|locus:2079157	1011	AT3G47580 [Arabidopsis thalian	0.995	0.198	0.412	1.7e-37
UNIPROTKB|Q40640	1025	Xa21 "Receptor kinase-like pro	0.990	0.195	0.396	4e-35
TAIR|locus:2075661	1025	AT3G47110 [Arabidopsis thalian	0.990	0.195	0.399	5.6e-33
TAIR|locus:2149922	1031	EFR "EF-TU receptor" [Arabidop	0.940	0.184	0.398	6.1e-31
TAIR|locus:2175703	502	AT5G39390 [Arabidopsis thalian	0.935	0.376	0.382	7.4e-30
TAIR|locus:2047525	980	AT2G24130 [Arabidopsis thalian	0.995	0.205	0.371	8.4e-30
TAIR|locus:2170483	1173	FLS2 "FLAGELLIN-SENSITIVE 2" [	0.990	0.170	0.364	3.1e-29
TAIR|locus:2026408	540	RPK1 "receptor-like protein ki	0.851	0.318	0.392	8e-27

TAIR|locus:2075631 AT3G47090 [Arabidopsis thaliana (taxid:3702)]

 Score = 436 (158.5 bits), Expect = 5.8e-40, P = 5.8e-40
 Identities = 96/217 (44%), Positives = 133/217 (61%)

Query:     1 MPNGSLEKWLYSYNY--------FFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKP 52
             MPNGSL+KWL+               +LERLNI IDV S L+Y H  H   PI HCDLKP
Sbjct:   783 MPNGSLDKWLHPEEVEEIHRPSRTLTLLERLNIAIDVASVLDYLHV-HCHEPIAHCDLKP 841

Query:    53 TNILLDENMVAHVSDFGISKLL--GEGEDFVTQTMTMA---TIGYMAPEYGSEGIVSAKC 107
             +NILLD+++ AHVSDFG+++LL   + E F  Q  +     TIGY APEYG  G  S   
Sbjct:   842 SNILLDDDLTAHVSDFGLARLLLKFDQESFFNQLSSAGVRGTIGYAAPEYGMGGQPSIHG 901

Query:   108 DVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVRE--EQAFAA 165
             DVYS+GVL++E FT KRPT+E+F G  +L  + K +LP  + ++ D +++       F  
Sbjct:   902 DVYSFGVLVLEMFTGKRPTNELFGGNFTLNSYTKAALPERVLDIADKSILHSGLRVGFPV 961

Query:   166 KMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKIK 202
              ++C+  I+D+ L CC ESP  R+  ++AA +L  I+
Sbjct:   962 -LECLKGILDVGLRCCEESPLNRLATSEAAKELISIR 997

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009507 "chloroplast" evidence=IDA

TAIR|locus:2079142 AT3G47570 [Arabidopsis thaliana (taxid:3702)]

 Score = 415 (151.1 bits), Expect = 1.0e-37, P = 1.0e-37
 Identities = 91/217 (41%), Positives = 129/217 (59%)

Query:     1 MPNGSLEKWLYSYNY--------FFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKP 52
             MPNGSL+ WL+               +LERLNI IDV S L+Y H  H   PI HCDLKP
Sbjct:   784 MPNGSLDMWLHPEEVEEIHRPSRTLTLLERLNIAIDVASVLDYLHV-HCHEPIAHCDLKP 842

Query:    53 TNILLDENMVAHVSDFGISKLL--GEGEDFVTQTMTMA---TIGYMAPEYGSEGIVSAKC 107
             +N+LLD+++ AHVSDFG+++LL   + E F  Q  +     TIGY APEYG  G  S   
Sbjct:   843 SNVLLDDDLTAHVSDFGLARLLLKFDEESFFNQLSSAGVRGTIGYAAPEYGVGGQPSING 902

Query:   108 DVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVRE--EQAFAA 165
             DVYS+G+LL+E FT KRPT+E+F G  +L  + K +LP  + ++VD +++       F  
Sbjct:   903 DVYSFGILLLEMFTGKRPTNELFGGNFTLNSYTKSALPERILDIVDESILHIGLRVGFPV 962

Query:   166 KMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKIK 202
              ++C+  + ++ L CC ESP  R+  +    +L  I+
Sbjct:   963 -VECLTMVFEVGLRCCEESPMNRLATSIVVKELISIR 998

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

TAIR|locus:2079157 AT3G47580 [Arabidopsis thaliana (taxid:3702)]

 Score = 413 (150.4 bits), Expect = 1.7e-37, P = 1.7e-37
 Identities = 89/216 (41%), Positives = 131/216 (60%)

Query:     1 MPNGSLEKWLYSYNY--------FFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKP 52
             +PNGS++ WL+               +LERLNI+IDV S L+Y H  H   PI HCDLKP
Sbjct:   785 LPNGSVDMWLHPEEVEEIRRPPRTLTLLERLNIVIDVASVLDYLHV-HCHEPIAHCDLKP 843

Query:    53 TNILLDENMVAHVSDFGISKLL--GEGEDFVTQTMTMA---TIGYMAPEYGSEGIVSAKC 107
             +N+LL++++ AHVSDFG+++LL   + E F+ Q  +     TIGY APEYG  G  S   
Sbjct:   844 SNVLLEDDLTAHVSDFGLARLLLKFDKESFLNQLSSAGVRGTIGYAAPEYGMGGQPSIHG 903

Query:   108 DVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKM 167
             DVYS+GVLL+E FT KRPTDE+F G ++L  + K +LP  + E+ D  ++        + 
Sbjct:   904 DVYSFGVLLLEMFTGKRPTDELFGGNLTLHSYTKLALPEKVFEIADKAILHIGLRVGFRT 963

Query:   168 -DCIVSIMDLALDCCMESPGKRINMTDAAAKLKKIK 202
              +C+  ++++ L CC E P  R+  ++ A +L  I+
Sbjct:   964 AECLTLVLEVGLRCCEEYPTNRLATSEVAKELISIR 999

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

UNIPROTKB|Q40640 Xa21 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)]

 Score = 391 (142.7 bits), Expect = 4.0e-35, P = 4.0e-35
 Identities = 88/222 (39%), Positives = 129/222 (58%)

Query:     1 MPNGSLEKWLY------SYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTN 54
             MPNGSLE W++      +     ++  R+ I++DV  AL+Y H  H   P++HCD+K +N
Sbjct:   789 MPNGSLEDWIHPETNDQADQRHLNLHRRVTILLDVACALDYLHR-HGPEPVVHCDIKSSN 847

Query:    55 ILLDENMVAHVSDFGISKLLGEGEDFVTQ-TMTMA---TIGYMAPEYGSEGIVSAKCDVY 110
             +LLD +MVAHV DFG++++L +G   + Q T +M    TIGY APEYG   I S   D+Y
Sbjct:   848 VLLDSDMVAHVGDFGLARILVDGTSLIQQSTSSMGFIGTIGYAAPEYGVGLIASTHGDIY 907

Query:   111 SYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHG-LTEVVDANLVREEQAFAAKM-- 167
             SYG+L++E  T KRPTD  F  ++ LR++V+  L HG +T+VVD  L+ + + +      
Sbjct:   908 SYGILVLEIVTGKRPTDSTFRPDLGLRQYVELGL-HGRVTDVVDTKLILDSENWLNSTNN 966

Query:   168 -------DCIVSIMDLALDCCMESPGKRINMTDAAAKLKKIK 202
                    +CIV ++ L L C  E P  R    D   +L  IK
Sbjct:   967 SPCRRITECIVWLLRLGLSCSQELPSSRTPTGDIIDELNAIK 1008

GO:0005515 "protein binding" evidence=IPI

TAIR|locus:2075661 AT3G47110 [Arabidopsis thaliana (taxid:3702)]

 Score = 371 (135.7 bits), Expect = 5.6e-33, P = 5.6e-33
 Identities = 87/218 (39%), Positives = 130/218 (59%)

Query:     1 MPNGSLEKWLY--------SYNYFFDILERLNIMIDVGSALEYPH-HGHSSAPIIHCDLK 51
             MPNG+L+ WL+        + +    +  RLNI IDV SAL Y H + H+  PI HCD+K
Sbjct:   801 MPNGNLDMWLHPDEIEETGNPSRTLGLFARLNIAIDVASALVYLHTYCHN--PIAHCDIK 858

Query:    52 PTNILLDENMVAHVSDFGISKLL--GEGEDFVTQTMTMA---TIGYMAPEYGSEGIVSAK 106
             P+NILLD+++ AHVSDFG+++LL   + + F  Q  +     TIGY APEYG  G  S  
Sbjct:   859 PSNILLDKDLTAHVSDFGLAQLLLKFDRDTFHIQFSSAGVRGTIGYAAPEYGMGGHPSIM 918

Query:   107 CDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLP-HGLTEVVDANLVREEQAFAA 165
              DVYS+G++L+E FT KRPT+++F   ++L  + K +L      ++ D  ++R   A   
Sbjct:   919 GDVYSFGIVLLEIFTGKRPTNKLFVDGLTLHSFTKSALQKRQALDITDETILRGAYAQHF 978

Query:   166 KM-DCIVSIMDLALDCCMESPGKRINMTDAAAKLKKIK 202
              M +C+  +  + + C  ESP  RI+M +A +KL  I+
Sbjct:   979 NMVECLTLVFRVGVSCSEESPVNRISMAEAISKLVSIR 1016

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2149922 EFR "EF-TU receptor" [Arabidopsis thaliana (taxid:3702)]

 Score = 352 (129.0 bits), Expect = 6.1e-31, P = 6.1e-31
 Identities = 86/216 (39%), Positives = 124/216 (57%)

Query:     1 MPNGSLEKWLY--------SYNYFFDILERLNIMIDVGSALEYPH-HGHSSAPIIHCDLK 51
             MP GSL+ WL          ++      E+LNI IDV SALEY H H H   P+ HCD+K
Sbjct:   794 MPKGSLDMWLQLEDLERVNDHSRSLTPAEKLNIAIDVASALEYLHVHCHD--PVAHCDIK 851

Query:    52 PTNILLDENMVAHVSDFGISKLLG--EGEDFVTQTMTMA---TIGYMAPEYGSEGIVSAK 106
             P+NILLD+++ AHVSDFG+++LL   + E F+ Q  +     TIGY APEYG  G  S +
Sbjct:   852 PSNILLDDDLTAHVSDFGLAQLLYKYDRESFLNQFSSAGVRGTIGYAAPEYGMGGQPSIQ 911

Query:   107 CDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAK 166
              DVYS+G+LL+E F+ K+PTDE F G+ +L  + K S+  G T    +N + E      +
Sbjct:   912 GDVYSFGILLLEMFSGKKPTDESFAGDYNLHSYTK-SILSGCTSSGGSNAIDE----GLR 966

Query:   167 MDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKIK 202
             +     ++ + + C  E P  R+   +A  +L  I+
Sbjct:   967 L-----VLQVGIKCSEEYPRDRMRTDEAVRELISIR 997

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010204 "defense response signaling pathway, resistance gene-independent" evidence=IMP

GO:0016045 "detection of bacterium" evidence=RCA;IDA

GO:0005515 "protein binding" evidence=IPI

GO:0002764 "immune response-regulating signaling pathway" evidence=IMP

GO:0009626 "plant-type hypersensitive response" evidence=IMP

GO:0019199 "transmembrane receptor protein kinase activity" evidence=TAS

GO:0010359 "regulation of anion channel activity" evidence=IMP

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0009581 "detection of external stimulus" evidence=RCA

GO:0009595 "detection of biotic stimulus" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0031347 "regulation of defense response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0042742 "defense response to bacterium" evidence=RCA

GO:0043900 "regulation of multi-organism process" evidence=RCA

GO:0050776 "regulation of immune response" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2175703 AT5G39390 [Arabidopsis thaliana (taxid:3702)]

 Score = 332 (121.9 bits), Expect = 7.4e-30, P = 7.4e-30
 Identities = 83/217 (38%), Positives = 123/217 (56%)

Query:     1 MPNGSLEKWLY--------SYNYFFDILERLNIMIDVGSALEYPH-HGHSSAPIIHCDLK 51
             MP GSL+ WL         +++      E++NI IDV SALEY H + H   P+ HCD+K
Sbjct:   291 MPKGSLDMWLQPEDLESANNHSRSLTFAEKVNIAIDVASALEYLHVYCHD--PVAHCDIK 348

Query:    52 PTNILLDENMVAHVSDFGISKLLGEGED--FVTQTMTMA---TIGYMAPEYGSEGIVSAK 106
             P+N+LLD+++ AHVSDFG+++LL   ++  F+ Q  +     TIGY APEYG     S +
Sbjct:   349 PSNVLLDDDLTAHVSDFGLARLLYNFDEKTFLNQFSSAGVRGTIGYAAPEYGMGSKPSIQ 408

Query:   107 CDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTE-VVDANLVREEQAFAA 165
              DVYS+GVLL+E FT K+PTD  F G  +L         HG T+ V+  +  R  +    
Sbjct:   409 GDVYSFGVLLLEMFTGKKPTDNSFGGGYNL---------HGYTKSVLSCSTSRGGRTMVD 459

Query:   166 KMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKIK 202
             +   +  ++++ + C  E P  R+ M +A  +L  IK
Sbjct:   460 EW--LRLVLEVGIKCSEEYPRDRMGMAEAVRELVSIK 494

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2047525 AT2G24130 [Arabidopsis thaliana (taxid:3702)]

 Score = 341 (125.1 bits), Expect = 8.4e-30, P = 8.4e-30
 Identities = 82/221 (37%), Positives = 123/221 (55%)

Query:     1 MPNGSLEKWLYSYNYF---FDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILL 57
             MPNGSLE+ LY   Y     D+++ +NI  DV   + Y HH +S   ++HCDLKP+NILL
Sbjct:   738 MPNGSLERHLYPGEYSSKNLDLIQLVNICSDVAEGIAYLHH-YSPVKVVHCDLKPSNILL 796

Query:    58 DENMVAHVSDFGISKLLGEGEDFV----------TQTMTMATIGYMAPEYGSEGIVSAKC 107
             D+ M A V+DFGIS+L+   E+ V          T  +   ++GY+APEYG     S   
Sbjct:   797 DDEMTALVTDFGISRLVQGVEETVSTDDSVSFGSTDGLLCGSVGYIAPEYGMGKRASTHG 856

Query:   108 DVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVR-EEQAFAAK 166
             DVYS+GVLL+E  + +RPTD +     SL  ++K   P  L  +++  L R + Q    K
Sbjct:   857 DVYSFGVLLLEIVSGRRPTDVLVNEGSSLHEFMKSHYPDSLEGIIEQALSRWKPQGKPEK 916

Query:   167 MD-----CIVSIMDLALDCCMESPGKRINMTDAAAKLKKIK 202
              +      I+ +++L L C   +P  R +M D A ++ ++K
Sbjct:   917 CEKLWREVILEMIELGLVCTQYNPSTRPDMLDVAHEMGRLK 957

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2170483 FLS2 "FLAGELLIN-SENSITIVE 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 337 (123.7 bits), Expect = 3.1e-29, P = 3.1e-29
 Identities = 77/211 (36%), Positives = 125/211 (59%)

Query:     1 MPNGSLEKWLY-SYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDE 59
             M NG+LE  ++ S      +LE++++ + + S ++Y H G+   PI+HCDLKP NILLD 
Sbjct:   949 MENGNLEDTIHGSAAPIGSLLEKIDLCVHIASGIDYLHSGYGF-PIVHCDLKPANILLDS 1007

Query:    60 NMVAHVSDFGISKLLGEGEDFVTQTMTMA---TIGYMAPEYGSEGIVSAKCDVYSYGVLL 116
             + VAHVSDFG +++LG  ED  T   T A   TIGY+APE+     V+ K DV+S+G+++
Sbjct:  1008 DRVAHVSDFGTARILGFREDGSTTASTSAFEGTIGYLAPEFAYMRKVTTKADVFSFGIIM 1067

Query:   117 METFTRKRPT--DEMFTGEMSLRRWVKESLPHG---LTEVVDANLVREEQAFAAKMDCIV 171
             ME  T++RPT  ++  + +M+LR+ V++S+ +G   +  V+D  L  +      + + I 
Sbjct:  1068 MELMTKQRPTSLNDEDSQDMTLRQLVEKSIGNGRKGMVRVLDMEL-GDSIVSLKQEEAIE 1126

Query:   172 SIMDLALDCCMESPGKRINMTDAAAKLKKIK 202
               + L L C    P  R +M +    L K++
Sbjct:  1127 DFLKLCLFCTSSRPEDRPDMNEILTHLMKLR 1157

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

GO:0016020 "membrane" evidence=ISS;IDA

GO:0016045 "detection of bacterium" evidence=IMP

GO:0005886 "plasma membrane" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0042742 "defense response to bacterium" evidence=RCA;IMP

GO:0052544 "defense response by callose deposition in cell wall" evidence=IMP

GO:0010359 "regulation of anion channel activity" evidence=IMP

GO:0016310 "phosphorylation" evidence=RCA

GO:0005768 "endosome" evidence=IDA

GO:0006898 "receptor-mediated endocytosis" evidence=IDA

TAIR|locus:2026408 RPK1 "receptor-like protein kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 287 (106.1 bits), Expect = 8.0e-27, Sum P(2) = 8.0e-27
 Identities = 71/181 (39%), Positives = 97/181 (53%)

Query:    25 IMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQT 84
             I +DV  AL Y H    S  ++H D+KP+NILLD N  A++SDFG+SKLLG  +  VT T
Sbjct:   362 IALDVARALSYLHE-QCSPKVLHRDIKPSNILLDNNYNAYLSDFGLSKLLGTSQSHVT-T 419

Query:    85 MTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGE---MSLRRWVK 141
                 T GY+APEY     VS K DVYSYG++L+E  + KR  D  F+      ++  W  
Sbjct:   420 GVAGTFGYVAPEYAMTCRVSEKADVYSYGIVLLELISDKRALDPSFSSHENGFNIVSWAH 479

Query:   142 ESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI 201
               L  G  + V    + E        D +V ++ LAL C ++S   R  M  A   LK+I
Sbjct:   480 MMLSQGKAKEVFTTGLWE----TGPPDDLVEVLHLALKCTVDSLSIRPTMKQAVRLLKRI 535

Query:   202 K 202
             +
Sbjct:   536 Q 536

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009737 "response to abscisic acid stimulus" evidence=IEP;RCA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA;IMP

GO:0009942 "longitudinal axis specification" evidence=IMP

GO:0009945 "radial axis specification" evidence=IMP

GO:0048508 "embryonic meristem development" evidence=IMP

GO:0005777 "peroxisome" evidence=IDA

GO:0000165 "MAPK cascade" evidence=RCA

GO:0000303 "response to superoxide" evidence=RCA

GO:0006499 "N-terminal protein myristoylation" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0007154 "cell communication" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0008219 "cell death" evidence=RCA

GO:0009409 "response to cold" evidence=IEP;RCA

GO:0009414 "response to water deprivation" evidence=IEP;RCA

GO:0009611 "response to wounding" evidence=RCA

GO:0009651 "response to salt stress" evidence=IEP;RCA

GO:0009723 "response to ethylene stimulus" evidence=RCA

GO:0009733 "response to auxin stimulus" evidence=RCA

GO:0009743 "response to carbohydrate stimulus" evidence=RCA

GO:0009753 "response to jasmonic acid stimulus" evidence=RCA

GO:0009755 "hormone-mediated signaling pathway" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0009873 "ethylene mediated signaling pathway" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0042538 "hyperosmotic salinity response" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

GO:0004702 "receptor signaling protein serine/threonine kinase activity" evidence=ISS

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	LOW CONFIDENCE prediction!

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	202
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	3e-27
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	5e-24
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	7e-24
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	5e-23
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	4e-22
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	1e-21
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	8e-21
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	7e-20
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	9e-18
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	2e-17
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	3e-16
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	5e-16
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	4e-15
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	1e-14
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	2e-14
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	3e-14
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	4e-14
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	5e-14
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	9e-14
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	1e-13
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	5e-13
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	5e-13
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	6e-13
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	7e-13
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	8e-13
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	1e-12
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	1e-12
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	1e-12
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	1e-12
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	2e-12
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	2e-12
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	2e-12
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	3e-12
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	4e-12
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	5e-12
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	5e-12
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	7e-12
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	8e-12
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	8e-12
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	1e-11
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	1e-11
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	2e-11
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	2e-11
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	2e-11
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	2e-11
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	4e-11
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	4e-11
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	5e-11
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	5e-11
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	5e-11
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	5e-11
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	6e-11
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	6e-11
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	7e-11
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	7e-11
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	8e-11
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	1e-10
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	1e-10
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	1e-10
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	2e-10
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	3e-10
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	3e-10
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	3e-10
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	4e-10
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	7e-10
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	8e-10
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	8e-10
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	9e-10
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	9e-10
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	9e-10
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	1e-09
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	1e-09
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	2e-09
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	2e-09
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	2e-09
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	2e-09
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	2e-09
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	3e-09
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	3e-09
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	3e-09
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	3e-09
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	3e-09
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	3e-09
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	4e-09
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	4e-09
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	4e-09
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	4e-09
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	5e-09
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	6e-09
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	7e-09
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	7e-09
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	7e-09
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	8e-09
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	1e-08
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	1e-08
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	1e-08
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	2e-08
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	2e-08
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	2e-08
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	2e-08
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	3e-08
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	4e-08
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	4e-08
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	4e-08
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	4e-08
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	5e-08
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	5e-08
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	6e-08
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	6e-08
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	6e-08
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	8e-08
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	9e-08
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	9e-08
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	1e-07
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	1e-07
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	1e-07
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	1e-07
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	2e-07
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	2e-07
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	2e-07
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	2e-07
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	3e-07
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	3e-07
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	3e-07
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	3e-07
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	3e-07
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	4e-07
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	4e-07
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	4e-07
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	4e-07
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	5e-07
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	5e-07
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	5e-07
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	5e-07
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	6e-07
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	6e-07
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	7e-07
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	8e-07
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	8e-07
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	8e-07
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	1e-06
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	1e-06
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	1e-06
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	1e-06
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	1e-06
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	1e-06
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	1e-06
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	1e-06
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	2e-06
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	2e-06
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	2e-06
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	2e-06
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	2e-06
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	3e-06
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	3e-06
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	3e-06
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	4e-06
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	4e-06
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	4e-06
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	4e-06
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	4e-06
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	4e-06
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	4e-06
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	5e-06
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	5e-06
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	5e-06
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	6e-06
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	7e-06
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	7e-06
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	7e-06
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	7e-06
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	8e-06
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	8e-06
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	9e-06
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	9e-06
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	9e-06
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	9e-06
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	1e-05
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	1e-05
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	1e-05
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	1e-05
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	1e-05
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	1e-05
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	1e-05
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	2e-05
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	2e-05
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	2e-05
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	2e-05
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	2e-05
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	2e-05
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	2e-05
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	2e-05
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	2e-05
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	2e-05
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	3e-05
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	4e-05
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	4e-05
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	4e-05
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	4e-05
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	5e-05
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	5e-05
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	5e-05
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	5e-05
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	6e-05
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	7e-05
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	7e-05
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	8e-05
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	8e-05
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	8e-05
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	8e-05
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	1e-04
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	1e-04
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	1e-04
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	1e-04
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	1e-04
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	1e-04
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	1e-04
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	1e-04
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	2e-04
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	2e-04
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	2e-04
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	2e-04
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	2e-04
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	2e-04
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	2e-04
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	2e-04
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	2e-04
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	2e-04
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	2e-04
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	2e-04
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	3e-04
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	3e-04
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	3e-04
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	3e-04
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	3e-04
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	3e-04
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	3e-04
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	4e-04
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	4e-04
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	5e-04
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	5e-04
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	6e-04
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	7e-04
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	8e-04
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	8e-04
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	8e-04
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	0.001
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	0.001
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	0.001
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	0.001
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	0.001
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	0.001
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	0.001
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	0.002
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	0.002
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	0.002
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	0.003
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	0.004
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	0.004
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	0.004

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  102 bits (256), Expect = 3e-27
 Identities = 47/120 (39%), Positives = 61/120 (50%), Gaps = 8/120 (6%)

Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDE- 59
              GSL+  L          E L I++ +   LEY H    S  IIH DLKP NILLD  
Sbjct: 73  CEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLH----SNGIIHRDLKPENILLDSD 128

Query: 60  NMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPE-YGSEGIVSAKCDVYSYGVLLME 118
           N    ++DFG+SKLL   +  +     + T  YMAPE    +G  S K D++S GV+L E
Sbjct: 129 NGKVKLADFGLSKLLTSDKSLLKT--IVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYE 186

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score = 95.0 bits (237), Expect = 5e-24
 Identities = 50/128 (39%), Positives = 59/128 (46%), Gaps = 12/128 (9%)

Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
              G L  +L          E   I + +   LEY H    S  IIH DLKP NILLDEN
Sbjct: 80  CEGGDLFDYLSRGGPL-SEDEAKKIALQILRGLEYLH----SNGIIHRDLKPENILLDEN 134

Query: 61  MVAHVSDFGISKLL-GEGEDFVTQTMTMATIGYMAPE--YGSEGIVSAKCDVYSYGVLLM 117
            V  ++DFG++K L        T      T  YMAPE   G  G    K DV+S GV+L 
Sbjct: 135 GVVKIADFGLAKKLLKSSSSLTTFV---GTPWYMAPEVLLGGNGY-GPKVDVWSLGVILY 190

Query: 118 ETFTRKRP 125
           E  T K P
Sbjct: 191 ELLTGKPP 198

Length = 260

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score = 94.5 bits (236), Expect = 7e-24
 Identities = 45/125 (36%), Positives = 58/125 (46%), Gaps = 8/125 (6%)

Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
              G L   L          E    +  + SALEY H    S  I+H DLKP NILLDE+
Sbjct: 79  CEGGDLFDLLKKRG-RLSEDEARFYLRQILSALEYLH----SKGIVHRDLKPENILLDED 133

Query: 61  MVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETF 120
               ++DFG+++ L  GE   T    + T  YMAPE           D++S GV+L E  
Sbjct: 134 GHVKLADFGLARQLDPGEKLTTF---VGTPEYMAPEVLLGKGYGKAVDIWSLGVILYELL 190

Query: 121 TRKRP 125
           T K P
Sbjct: 191 TGKPP 195

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score = 92.6 bits (231), Expect = 5e-23
 Identities = 60/199 (30%), Positives = 87/199 (43%), Gaps = 25/199 (12%)

Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           M  G L  +L        + + L+  + +   +EY      S   IH DL   N L+ EN
Sbjct: 83  MEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLE----SKNFIHRDLAARNCLVGEN 138

Query: 61  MVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETF 120
           +V  +SDFG+S+ L +  D+  +      I +MAPE   EG  ++K DV+S+GVLL E F
Sbjct: 139 LVVKISDFGLSRDLYDD-DYYRKRGGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIF 197

Query: 121 TR-KRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLALD 179
           T  ++P        MS    V E L +G          R  Q      +C   + DL L 
Sbjct: 198 TLGEQPYP-----GMSNEE-VLEYLKNGY---------RLPQP----PNCPPELYDLMLQ 238

Query: 180 CCMESPGKRINMTDAAAKL 198
           C  E P  R   ++    L
Sbjct: 239 CWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score = 89.9 bits (224), Expect = 4e-22
 Identities = 52/199 (26%), Positives = 86/199 (43%), Gaps = 24/199 (12%)

Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           MP G L  +L  +     + + L + + +   +EY      S   +H DL   N L+ EN
Sbjct: 83  MPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLE----SKNFVHRDLAARNCLVTEN 138

Query: 61  MVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETF 120
           +V  +SDFG+S+ + E + +  +      I +MAPE   +G  ++K DV+S+GVLL E F
Sbjct: 139 LVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGKFTSKSDVWSFGVLLWEIF 198

Query: 121 TR-KRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLALD 179
           T  ++P   M                    EV+   L+ +        +C   + +L L 
Sbjct: 199 TLGEQPYPGM-----------------SNEEVL--ELLEDGYRLPRPENCPDELYELMLQ 239

Query: 180 CCMESPGKRINMTDAAAKL 198
           C    P  R   ++    L
Sbjct: 240 CWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score = 88.8 bits (221), Expect = 1e-21
 Identities = 55/200 (27%), Positives = 83/200 (41%), Gaps = 26/200 (13%)

Query: 1   MPNGSLEKWLYSY-NYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDE 59
           MP G L  +L         + + L+  + +   +EY      S   IH DL   N L+ E
Sbjct: 83  MPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE----SKNFIHRDLAARNCLVGE 138

Query: 60  NMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMET 119
           N+V  +SDFG+S+ L +  D+         I +MAPE   EG  ++K DV+S+GVLL E 
Sbjct: 139 NLVVKISDFGLSRDLYDD-DYYKVKGGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEI 197

Query: 120 FTR-KRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLAL 178
           FT  + P   M                    EV+    +++        +C   +  L L
Sbjct: 198 FTLGEEPYPGM-----------------SNAEVL--EYLKKGYRLPKPPNCPPELYKLML 238

Query: 179 DCCMESPGKRINMTDAAAKL 198
            C  E P  R   ++    L
Sbjct: 239 QCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score = 86.4 bits (215), Expect = 8e-21
 Identities = 40/130 (30%), Positives = 64/130 (49%), Gaps = 12/130 (9%)

Query: 1   MPNGSLEKWL--------YSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKP 52
           M  G L  +L                + + L+  I +   +EY      S   +H DL  
Sbjct: 78  MEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA----SKKFVHRDLAA 133

Query: 53  TNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSY 112
            N L+ E++V  +SDFG+S+ + + + +  +T     I +MAPE   +GI ++K DV+S+
Sbjct: 134 RNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSF 193

Query: 113 GVLLMETFTR 122
           GVLL E FT 
Sbjct: 194 GVLLWEIFTL 203

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score = 84.1 bits (209), Expect = 7e-20
 Identities = 41/135 (30%), Positives = 58/135 (42%), Gaps = 25/135 (18%)

Query: 1   MPNGSLEKWLYSY---------NYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLK 51
           +  GSL   L  +          Y   ILE           L Y H    S  I+H D+K
Sbjct: 83  VSGGSLSSLLKKFGKLPEPVIRKYTRQILE----------GLAYLH----SNGIVHRDIK 128

Query: 52  PTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMA-TIGYMAPEYGSEGIVSAKCDVY 110
             NIL+D + V  ++DFG +K LG+ E     T ++  T  +MAPE           D++
Sbjct: 129 GANILVDSDGVVKLADFGCAKRLGDIET-GEGTGSVRGTPYWMAPEVIRGEEYGRAADIW 187

Query: 111 SYGVLLMETFTRKRP 125
           S G  ++E  T K P
Sbjct: 188 SLGCTVIEMATGKPP 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score = 79.8 bits (195), Expect = 9e-18
 Identities = 49/135 (36%), Positives = 64/135 (47%), Gaps = 14/135 (10%)

Query: 1   MPNGSLEKWL--YSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLD 58
           +  GSLE  L            E L I+  + SALEY H    S  IIH D+KP NILLD
Sbjct: 80  VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH----SKGIIHRDIKPENILLD 135

Query: 59  EN-MVAHVSDFGISKLLGEGEDFVTQTMTMA----TIGYMAPEY---GSEGIVSAKCDVY 110
            +  V  + DFG++KLL +     +     +    T GYMAPE     S    S+  D++
Sbjct: 136 RDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIW 195

Query: 111 SYGVLLMETFTRKRP 125
           S G+ L E  T   P
Sbjct: 196 SLGITLYELLTGLPP 210

Length = 384

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 77.2 bits (191), Expect = 2e-17
 Identities = 41/117 (35%), Positives = 58/117 (49%), Gaps = 22/117 (18%)

Query: 23  LNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVT 82
           L+  + +  AL+Y H    S  I+H D+KP NI L  N +  + DFGISK+L    D   
Sbjct: 106 LDWFVQLCLALKYLH----SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDL-A 160

Query: 83  QTMTMATIGYMAPE------YGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGE 133
           +T+   T  Y++PE      Y      + K D++S G +L E  T K P    F GE
Sbjct: 161 KTVV-GTPYYLSPELCQNKPY------NYKSDIWSLGCVLYELCTLKHP----FEGE 206

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 74.3 bits (183), Expect = 3e-16
 Identities = 40/102 (39%), Positives = 51/102 (50%), Gaps = 9/102 (8%)

Query: 25  IMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQT 84
            + ++  ALEY H    S  IIH D+KP NILLDE    H++DF I+  +       T T
Sbjct: 105 WICEIVLALEYLH----SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD----TLT 156

Query: 85  MTMA-TIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRP 125
            + + T GYMAPE       S   D +S GV   E    KRP
Sbjct: 157 TSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRP 198

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 73.7 bits (182), Expect = 5e-16
 Identities = 41/108 (37%), Positives = 53/108 (49%), Gaps = 14/108 (12%)

Query: 28  DVGSALEYPH-HGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMT 86
           ++  ALEY H  G     II+ DLKP NILLD +    ++DFG++K   E     ++T T
Sbjct: 101 EIVLALEYLHSLG-----IIYRDLKPENILLDADGHIKLTDFGLAK---ELSSEGSRTNT 152

Query: 87  MA-TIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGE 133
              T  Y+APE           D +S GVLL E  T K P    F  E
Sbjct: 153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPP----FYAE 196

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 71.5 bits (175), Expect = 4e-15
 Identities = 54/203 (26%), Positives = 95/203 (46%), Gaps = 25/203 (12%)

Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           M NGSL+ +L  ++  F +++ + ++  + S ++Y     S    +H DL   NIL++ N
Sbjct: 87  MENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKY----LSDMGYVHRDLAARNILVNSN 142

Query: 61  MVAHVSDFGISKLLGEGEDFV-TQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMET 119
           +V  VSDFG+S++L +  +   T       I + APE  +    ++  DV+SYG+++ E 
Sbjct: 143 LVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEV 202

Query: 120 FTR-KRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLAL 178
            +  +RP  EM                    +V+ A  + E     A MDC  ++  L L
Sbjct: 203 MSYGERPYWEMSN-----------------QDVIKA--IEEGYRLPAPMDCPAALHQLML 243

Query: 179 DCCMESPGKRINMTDAAAKLKKI 201
           DC  +   +R       + L K+
Sbjct: 244 DCWQKDRNERPKFEQIVSILDKL 266

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 69.6 bits (171), Expect = 1e-14
 Identities = 34/104 (32%), Positives = 50/104 (48%), Gaps = 3/104 (2%)

Query: 23  LNIMIDVGSALEYPHHG-HSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFV 81
             I+  +  AL   H+       ++H DLKP NI LD N    + DFG++K+LG    F 
Sbjct: 108 WRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSF- 166

Query: 82  TQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRP 125
            +T  + T  YM+PE  +      K D++S G L+ E      P
Sbjct: 167 AKTY-VGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPP 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 69.2 bits (169), Expect = 2e-14
 Identities = 53/206 (25%), Positives = 94/206 (45%), Gaps = 31/206 (15%)

Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           M NG+L+K+L  ++  F   + + ++  + + ++Y     S    +H DL   NIL++ N
Sbjct: 88  MENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKY----LSDMNYVHRDLAARNILVNSN 143

Query: 61  MVAHVSDFGISKLLGEGEDFVTQTMTMA----TIGYMAPEYGSEGIVSAKCDVYSYGVLL 116
           +   VSDFG+S++L   ED    T T +     I + APE  +    ++  DV+S+G+++
Sbjct: 144 LECKVSDFGLSRVL---EDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVM 200

Query: 117 METFTR-KRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMD 175
            E  +  +RP  +M                    EV+ A  + +     A MDC  ++  
Sbjct: 201 WEVMSFGERPYWDMSN-----------------HEVMKA--INDGFRLPAPMDCPSAVYQ 241

Query: 176 LALDCCMESPGKRINMTDAAAKLKKI 201
           L L C  +   +R    D    L K+
Sbjct: 242 LMLQCWQQDRARRPRFVDIVNLLDKL 267

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 68.4 bits (167), Expect = 3e-14
 Identities = 59/206 (28%), Positives = 88/206 (42%), Gaps = 38/206 (18%)

Query: 1   MPNGSLEKWLYSYNYFF-DILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDE 59
           M  G+L  +L +       +++ L   +DV   +EY      S  ++H DL   NIL+ E
Sbjct: 80  MSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEY----LESKKLVHRDLAARNILVSE 135

Query: 60  NMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMET 119
           + VA VSDFG++++   G D      +   + + APE       S+K DV+SYGVLL E 
Sbjct: 136 DGVAKVSDFGLARVGSMGVD-----NSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEV 190

Query: 120 FTRKR-PTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMD----CIVSIM 174
           F+  R P  +M   E      VKE +  G                  +M+    C   + 
Sbjct: 191 FSYGRAPYPKMSLKE------VKECVEKGY-----------------RMEPPEGCPADVY 227

Query: 175 DLALDCCMESPGKRINMTDAAAKLKK 200
            L   C    P KR +      KL+K
Sbjct: 228 VLMTSCWETEPKKRPSFHKLREKLEK 253

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 68.5 bits (168), Expect = 4e-14
 Identities = 43/130 (33%), Positives = 60/130 (46%), Gaps = 17/130 (13%)

Query: 1   MPNGSLEKWLYSYNYFF--DILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLD 58
           M  GSL+K L          IL +  I + V   L Y H  H    IIH D+KP+NIL++
Sbjct: 81  MDGGSLDKILKEVQGRIPERILGK--IAVAVLKGLTYLHEKHK---IIHRDVKPSNILVN 135

Query: 59  ENMVAHVSDFGISKLLGEGEDFVTQTMTMATIG---YMAPEYGSEGIVSAKCDVYSYGVL 115
                 + DFG+S  L         ++    +G   YMAPE       S K D++S G+ 
Sbjct: 136 SRGQIKLCDFGVSGQL-------VNSLAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLS 188

Query: 116 LMETFTRKRP 125
           L+E  T + P
Sbjct: 189 LIELATGRFP 198

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 68.2 bits (167), Expect = 5e-14
 Identities = 35/104 (33%), Positives = 53/104 (50%), Gaps = 9/104 (8%)

Query: 21  ERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF 80
           ++L   +DV   +EY          +H DL   N+L+ E++VA VSDFG++K     E  
Sbjct: 103 QQLGFALDVCEGMEY----LEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAK-----EAS 153

Query: 81  VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKR 124
             Q      + + APE   E   S K DV+S+G+LL E ++  R
Sbjct: 154 QGQDSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGR 197

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 67.5 bits (165), Expect = 9e-14
 Identities = 35/90 (38%), Positives = 49/90 (54%), Gaps = 3/90 (3%)

Query: 45  IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVS 104
            IH DL   NIL+ E++V  V+DFG+++L+ E  D    +       + APE  S G  S
Sbjct: 125 SIHRDLAARNILVGEDLVCKVADFGLARLIKE--DVYLSSDKKIPYKWTAPEAASHGTFS 182

Query: 105 AKCDVYSYGVLLMETFTR-KRPTDEMFTGE 133
            K DV+S+G+LL E FT  + P   M   E
Sbjct: 183 TKSDVWSFGILLYEMFTYGQVPYPGMNNHE 212

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 67.0 bits (164), Expect = 1e-13
 Identities = 52/202 (25%), Positives = 94/202 (46%), Gaps = 26/202 (12%)

Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEY-PHHGHSSAPIIHCDLKPTNILLDE 59
           M NGSL+K+L   +  F + + + ++  + S ++Y     +     +H DL   NIL++ 
Sbjct: 87  MENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNY-----VHRDLAARNILVNS 141

Query: 60  NMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMET 119
           N+V  VSDFG+S+ L + E   T       I + APE  +    ++  DV+S+G+++ E 
Sbjct: 142 NLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEV 201

Query: 120 FTR-KRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLAL 178
            +  +RP  +M + +                +V+ A  V +       MDC  ++  L L
Sbjct: 202 MSYGERPYWDM-SNQ----------------DVIKA--VEDGYRLPPPMDCPSALYQLML 242

Query: 179 DCCMESPGKRINMTDAAAKLKK 200
           DC  +   +R   +   + L K
Sbjct: 243 DCWQKDRNERPTFSQIVSTLDK 264

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 65.8 bits (160), Expect = 5e-13
 Identities = 47/177 (26%), Positives = 80/177 (45%), Gaps = 22/177 (12%)

Query: 23  LNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVT 82
           L+I I + + +EY     SS   +H DL   NIL+ E +   +SD G+S+ +   + +  
Sbjct: 127 LHIAIQIAAGMEY----LSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRV 182

Query: 83  QTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKE 142
           Q  ++  I +M PE    G  S+  D++S+GV+L E F+        F+ +         
Sbjct: 183 QPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ--------- 233

Query: 143 SLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLK 199
                  EV++  +VR+ Q      DC   +  L  +C  E P +R    D   +L+
Sbjct: 234 -------EVIE--MVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLR 281

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 65.3 bits (159), Expect = 5e-13
 Identities = 49/205 (23%), Positives = 93/205 (45%), Gaps = 27/205 (13%)

Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           M NG+L+ +L   +  F +++ + ++  + + ++Y     S    +H DL   NIL++ N
Sbjct: 87  MENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKY----LSEMNYVHRDLAARNILVNSN 142

Query: 61  MVAHVSDFGISKLLGEGEDFVTQTMTMA---TIGYMAPEYGSEGIVSAKCDVYSYGVLLM 117
           +V  VSDFG+S+ L +     T T ++     I + APE  +    ++  DV+SYG+++ 
Sbjct: 143 LVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMW 202

Query: 118 ETFTR-KRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDL 176
           E  +  +RP  +M   ++                    N + ++      MDC  ++  L
Sbjct: 203 EVMSYGERPYWDMSNQDV-------------------INAIEQDYRLPPPMDCPTALHQL 243

Query: 177 ALDCCMESPGKRINMTDAAAKLKKI 201
            LDC  +    R       + L K+
Sbjct: 244 MLDCWQKDRNARPKFGQIVSTLDKM 268

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 65.3 bits (160), Expect = 6e-13
 Identities = 41/137 (29%), Positives = 60/137 (43%), Gaps = 30/137 (21%)

Query: 1   MPNGSLEKWLYSYNYFFD-ILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDE 59
           M  GSL   L       + +L  +   I  G  L+Y H       IIH D+KP+N+L++ 
Sbjct: 81  MDGGSLADLLKKVGKIPEPVLAYIARQILKG--LDYLHTKRH---IIHRDIKPSNLLINS 135

Query: 60  NMVAHVSDFGISKLLGEGEDFVTQTMTMA-----TIGYMAPE------YGSEGIVSAKCD 108
                ++DFGISK+L         T+        T+ YM+PE      Y      S   D
Sbjct: 136 KGEVKIADFGISKVL-------ENTLDQCNTFVGTVTYMSPERIQGESY------SYAAD 182

Query: 109 VYSYGVLLMETFTRKRP 125
           ++S G+ L+E    K P
Sbjct: 183 IWSLGLTLLECALGKFP 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 65.3 bits (160), Expect = 7e-13
 Identities = 39/142 (27%), Positives = 60/142 (42%), Gaps = 23/142 (16%)

Query: 2   PNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENM 61
           PNG L +++       D         ++  ALEY H    S  IIH DLKP NILLD++M
Sbjct: 85  PNGELLQYI-RKYGSLDEKCTRFYAAEILLALEYLH----SKGIIHRDLKPENILLDKDM 139

Query: 62  VAHVSDFGISKLLGEGEDFVTQTMTMATIG------------------YMAPEYGSEGIV 103
              ++DFG +K+L       +       I                   Y++PE  +E   
Sbjct: 140 HIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPA 199

Query: 104 SAKCDVYSYGVLLMETFTRKRP 125
               D+++ G ++ +  T K P
Sbjct: 200 GKSSDLWALGCIIYQMLTGKPP 221

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 64.8 bits (158), Expect = 8e-13
 Identities = 47/135 (34%), Positives = 70/135 (51%), Gaps = 11/135 (8%)

Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           +P GS+   L +Y  F + L R      V   L Y H    S  I+H DLK  N+L+D +
Sbjct: 90  VPGGSIGSCLRTYGRFEEQLVR-FFTEQVLEGLAYLH----SKGILHRDLKADNLLVDAD 144

Query: 61  MVAHVSDFGISKLLGEGEDFVTQTMTM-ATIGYMAPE--YGSEGIVSAKCDVYSYGVLLM 117
            +  +SDFGISK   +  D   Q M+M  ++ +MAPE  +      SAK D++S G +++
Sbjct: 145 GICKISDFGISKKSDDIYDND-QNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVL 203

Query: 118 ETFTRKRP--TDEMF 130
           E F  +RP   +E  
Sbjct: 204 EMFAGRRPWSDEEAI 218

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 64.4 bits (157), Expect = 1e-12
 Identities = 41/121 (33%), Positives = 63/121 (52%), Gaps = 4/121 (3%)

Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           +P GSL  +L        + + L + +D  + +EY      S   IH DL   N L+ EN
Sbjct: 74  VPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEY----LESKNCIHRDLAARNCLVGEN 129

Query: 61  MVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETF 120
            V  +SDFG+S+    G   V+  +    I + APE  + G  +++ DV+SYG+LL ETF
Sbjct: 130 NVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETF 189

Query: 121 T 121
           +
Sbjct: 190 S 190

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 64.2 bits (156), Expect = 1e-12
 Identities = 42/135 (31%), Positives = 69/135 (51%), Gaps = 6/135 (4%)

Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           M +G L  +L +    F     L + +DV   + Y      S+ +IH DL   N L+ EN
Sbjct: 81  MEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAY----LESSNVIHRDLAARNCLVGEN 136

Query: 61  MVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETF 120
            V  VSDFG+++ + + + + + T T   + + +PE  S    S+K DV+S+GVL+ E F
Sbjct: 137 QVVKVSDFGMTRFVLD-DQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVF 195

Query: 121 TR-KRPTDEMFTGEM 134
           +  K P +     E+
Sbjct: 196 SEGKTPYENRSNSEV 210

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 64.1 bits (156), Expect = 1e-12
 Identities = 45/130 (34%), Positives = 65/130 (50%), Gaps = 11/130 (8%)

Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           +P GS+   L +Y  F + L R N +  +   L Y H    +  IIH D+K  NIL+D  
Sbjct: 88  VPGGSVAALLNNYGAFEETLVR-NFVRQILKGLNYLH----NRGIIHRDIKGANILVDNK 142

Query: 61  MVAHVSDFGISKLLGEGEDFVTQTMT-----MATIGYMAPEYGSEGIVSAKCDVYSYGVL 115
               +SDFGISK L E     T+T         ++ +MAPE   +   + K D++S G L
Sbjct: 143 GGIKISDFGISKKL-EANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCL 201

Query: 116 LMETFTRKRP 125
           ++E  T K P
Sbjct: 202 VVEMLTGKHP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 64.1 bits (156), Expect = 1e-12
 Identities = 42/129 (32%), Positives = 62/129 (48%), Gaps = 11/129 (8%)

Query: 2   PNGSLEKWLYSYN---YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLD 58
            NG L K L          D + R  I I +G  L + H    S  I+H D+K  N+ LD
Sbjct: 82  ENGDLHKLLKMQRGRPLPEDQVWRFFIQILLG--LAHLH----SKKILHRDIKSLNLFLD 135

Query: 59  ENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLME 118
                 + D G++KLL +  +F   T+ + T  Y++PE   +   + K DV++ GV+L E
Sbjct: 136 AYDNVKIGDLGVAKLLSDNTNF-ANTI-VGTPYYLSPELCEDKPYNEKSDVWALGVVLYE 193

Query: 119 TFTRKRPTD 127
             T K P D
Sbjct: 194 CCTGKHPFD 202

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 63.9 bits (156), Expect = 2e-12
 Identities = 35/104 (33%), Positives = 49/104 (47%), Gaps = 9/104 (8%)

Query: 31  SALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTM--TMA 88
             L Y H    S  I+H D+KP NI LD N V  + DFG +  L      + + +     
Sbjct: 110 EGLAYLH----SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAG 165

Query: 89  TIGYMAPEYGSEGIVSAK---CDVYSYGVLLMETFTRKRPTDEM 129
           T  YMAPE  + G         D++S G +++E  T KRP  E+
Sbjct: 166 TPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSEL 209

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 64.4 bits (157), Expect = 2e-12
 Identities = 45/182 (24%), Positives = 82/182 (45%), Gaps = 22/182 (12%)

Query: 18  DILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEG 77
           D  + L+I I + + +EY     SS   +H DL   N L+ E +   +SDFG+S+ +   
Sbjct: 122 DCSDFLHIAIQIAAGMEY----LSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSA 177

Query: 78  EDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLR 137
           + +  Q+ ++  + +M PE    G  + + D++S+GV+L E F+        F+ +    
Sbjct: 178 DYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ---- 233

Query: 138 RWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAK 197
                       EV+   ++R  Q      DC   +  L ++C  E P +R    D   +
Sbjct: 234 ------------EVI--EMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279

Query: 198 LK 199
           L+
Sbjct: 280 LR 281

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score = 63.8 bits (156), Expect = 2e-12
 Identities = 33/101 (32%), Positives = 49/101 (48%), Gaps = 7/101 (6%)

Query: 25  IMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQT 84
           +  ++   LEY H    S  IIH D+K  NILL  +    + DFG+S  L + +     T
Sbjct: 103 VCKELLKGLEYLH----SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--RNT 156

Query: 85  MTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRP 125
           M + T  +MAPE  +      K D++S G+  +E    K P
Sbjct: 157 M-VGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPP 196

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 63.3 bits (154), Expect = 3e-12
 Identities = 35/127 (27%), Positives = 62/127 (48%), Gaps = 9/127 (7%)

Query: 1   MPNGSLEKWLYSYN-----YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNI 55
           M +G L  +L             +   L  M+D+   +EY     S+   IH DL   N 
Sbjct: 89  MKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEY----LSNRNFIHRDLAARNC 144

Query: 56  LLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVL 115
           +L E+M   V+DFG+SK +  G+ +    +    + ++A E  ++ + ++K DV+++GV 
Sbjct: 145 MLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVT 204

Query: 116 LMETFTR 122
           + E  TR
Sbjct: 205 MWEIATR 211

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 63.3 bits (154), Expect = 4e-12
 Identities = 30/81 (37%), Positives = 48/81 (59%)

Query: 41  SSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSE 100
           +S   IH DL   NILL EN V  + DFG+++ + +  D+V +      + +MAPE   +
Sbjct: 190 ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFD 249

Query: 101 GIVSAKCDVYSYGVLLMETFT 121
            + + + DV+S+GVLL E F+
Sbjct: 250 KVYTTQSDVWSFGVLLWEIFS 270

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 62.8 bits (153), Expect = 5e-12
 Identities = 35/91 (38%), Positives = 43/91 (47%), Gaps = 10/91 (10%)

Query: 29  VGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTM- 87
           V   L Y H    S  IIH D+KP+NILL       + DFG+S     GE   +   T  
Sbjct: 114 VLKGLSYLH----SRKIIHRDIKPSNILLTRKGQVKLCDFGVS-----GELVNSLAGTFT 164

Query: 88  ATIGYMAPEYGSEGIVSAKCDVYSYGVLLME 118
            T  YMAPE       S   DV+S G+ L+E
Sbjct: 165 GTSFYMAPERIQGKPYSITSDVWSLGLTLLE 195

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 62.5 bits (152), Expect = 5e-12
 Identities = 34/84 (40%), Positives = 41/84 (48%), Gaps = 10/84 (11%)

Query: 45  IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIG---YMAPEYGSEG 101
           I+H DLK  NILL  N +  + D GISK+L        + M    IG   YMAPE     
Sbjct: 124 ILHRDLKSANILLVANDLVKIGDLGISKVL-------KKNMAKTQIGTPHYMAPEVWKGR 176

Query: 102 IVSAKCDVYSYGVLLMETFTRKRP 125
             S K D++S G LL E  T   P
Sbjct: 177 PYSYKSDIWSLGCLLYEMATFAPP 200

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 63.3 bits (154), Expect = 7e-12
 Identities = 40/92 (43%), Positives = 49/92 (53%), Gaps = 3/92 (3%)

Query: 37  HHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEG-EDFVTQTMTMATIGYMAP 95
           HH HS   +IH D+K  NILL  N +  + DFG SK+      D V +T    T  Y+AP
Sbjct: 157 HHVHSKH-MIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFC-GTPYYVAP 214

Query: 96  EYGSEGIVSAKCDVYSYGVLLMETFTRKRPTD 127
           E       S K D++S GVLL E  T KRP D
Sbjct: 215 EIWRRKPYSKKADMFSLGVLLYELLTLKRPFD 246

Length = 496

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 61.9 bits (150), Expect = 8e-12
 Identities = 37/102 (36%), Positives = 53/102 (51%), Gaps = 9/102 (8%)

Query: 23  LNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVT 82
           L   +DV  A+EY      +   +H DL   N+L+ E+ VA VSDFG++K     E   T
Sbjct: 105 LKFSLDVCEAMEY----LEANNFVHRDLAARNVLVSEDNVAKVSDFGLTK-----EASST 155

Query: 83  QTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKR 124
           Q      + + APE   E   S K DV+S+G+LL E ++  R
Sbjct: 156 QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGR 197

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 62.1 bits (151), Expect = 8e-12
 Identities = 46/132 (34%), Positives = 68/132 (51%), Gaps = 12/132 (9%)

Query: 18  DILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEG 77
           DIL +  I + +  ALEY H   S   +IH D+KP+N+L++ N    + DFGIS   G  
Sbjct: 103 DILGK--IAVSIVKALEYLH---SKLSVIHRDVKPSNVLINRNGQVKLCDFGIS---GYL 154

Query: 78  EDFVTQTMTMATIGYMAPEY----GSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGE 133
            D V +T+      YMAPE      ++     K DV+S G+ ++E  T + P D   T  
Sbjct: 155 VDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPF 214

Query: 134 MSLRRWVKESLP 145
             L++ V+E  P
Sbjct: 215 QQLKQVVEEPSP 226

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 62.0 bits (151), Expect = 1e-11
 Identities = 37/127 (29%), Positives = 62/127 (48%), Gaps = 5/127 (3%)

Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           +P+GSL  +L  +    ++   L     +   ++Y          IH DL   NIL++  
Sbjct: 90  LPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR----YIHRDLAARNILVESE 145

Query: 61  MVAHVSDFGISKLLGEGEDFVT-QTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMET 119
            +  +SDFG++K+L E +D+   +    + I + APE       S+  DV+S+GV L E 
Sbjct: 146 DLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYEL 205

Query: 120 FTRKRPT 126
           FT   P+
Sbjct: 206 FTYGDPS 212

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 61.6 bits (150), Expect = 1e-11
 Identities = 30/79 (37%), Positives = 47/79 (59%), Gaps = 1/79 (1%)

Query: 46  IHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSA 105
           IH DL   NIL+ EN+V  ++DFG+++L+ + E +  +      I + APE  + G  + 
Sbjct: 125 IHRDLAARNILVGENLVCKIADFGLARLIEDDE-YTAREGAKFPIKWTAPEAANYGRFTI 183

Query: 106 KCDVYSYGVLLMETFTRKR 124
           K DV+S+G+LL E  T  R
Sbjct: 184 KSDVWSFGILLTEIVTYGR 202

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 61.7 bits (150), Expect = 2e-11
 Identities = 43/116 (37%), Positives = 58/116 (50%), Gaps = 10/116 (8%)

Query: 38  HGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTM-ATIGYMAPE 96
           H HS   II+ DLKP NILLDE     ++DFG+SK   E  D   +  +   T+ YMAPE
Sbjct: 113 HLHSLG-IIYRDLKPENILLDEEGHIKLTDFGLSK---ESIDHEKKAYSFCGTVEYMAPE 168

Query: 97  YGSEGIVSAKCDVYSYGVLLMETFTRKRP---TDEMFTGEMSLRRWVKESLPHGLT 149
             +    +   D +S+GVL+ E  T   P    D   T  M L+   K  +P  L+
Sbjct: 169 VVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILK--AKLGMPQFLS 222

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 61.3 bits (149), Expect = 2e-11
 Identities = 48/206 (23%), Positives = 89/206 (43%), Gaps = 14/206 (6%)

Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           +P GSL  +L  +    D  + L     +   +EY      S   +H DL   NIL++  
Sbjct: 89  LPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEY----LGSKRYVHRDLATRNILVESE 144

Query: 61  MVAHVSDFGISKLLGEGEDF-VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMET 119
               + DFG++K+L + +++   +    + I + APE  +E   S   DV+S+GV+L E 
Sbjct: 145 NRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 204

Query: 120 FT---RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDL 176
           FT   +       F   M   +  +  + H +       L++      A   C   I  +
Sbjct: 205 FTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLI------ELLKNNGRLPAPPGCPAEIYAI 258

Query: 177 ALDCCMESPGKRINMTDAAAKLKKIK 202
             +C    P +R + ++ A +++ I+
Sbjct: 259 MKECWNNDPSQRPSFSELALQVEAIR 284

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 61.1 bits (148), Expect = 2e-11
 Identities = 33/100 (33%), Positives = 55/100 (55%), Gaps = 4/100 (4%)

Query: 23  LNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVT 82
           +  MID+ S +EY     SS   IH DL   N +L+ENM   V+DFG+SK +  G+ +  
Sbjct: 116 VRFMIDIASGMEY----LSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQ 171

Query: 83  QTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTR 122
              +   + ++A E  ++ + +   DV+++GV + E  TR
Sbjct: 172 GCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTR 211

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 60.8 bits (147), Expect = 2e-11
 Identities = 50/190 (26%), Positives = 83/190 (43%), Gaps = 26/190 (13%)

Query: 1   MPNGSLEKWLY-SYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDE 59
           M  GSL  +L      +  + + +++   + S + Y    +     +H DL+  NIL+ E
Sbjct: 82  MSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN----YVHRDLRAANILVGE 137

Query: 60  NMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMET 119
           N+V  V+DFG+++L+ E  ++  +      I + APE    G  + K DV+S+G+LL E 
Sbjct: 138 NLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTEL 196

Query: 120 FTRKR-PTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLAL 178
            T+ R P   M                    EV+D   V          +C  S+ DL  
Sbjct: 197 TTKGRVPYPGMVN-----------------REVLDQ--VERGYRMPCPPECPESLHDLMC 237

Query: 179 DCCMESPGKR 188
            C  + P +R
Sbjct: 238 QCWRKEPEER 247

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 59.9 bits (146), Expect = 4e-11
 Identities = 39/108 (36%), Positives = 52/108 (48%), Gaps = 23/108 (21%)

Query: 32  ALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTM-ATI 90
           A EY H+      II+ DLKP N+LLD N    + DFG +K L  G+    +T T   T 
Sbjct: 105 AFEYLHNRG----IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ----KTWTFCGTP 156

Query: 91  GYMAPEYGSEGIVSAK-----CDVYSYGVLLMETFTRKRPTDEMFTGE 133
            Y+APE     I+  K      D +S G+LL E  T + P    F  +
Sbjct: 157 EYVAPE-----IILNKGYDFSVDYWSLGILLYELLTGRPP----FGED 195

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 60.4 bits (146), Expect = 4e-11
 Identities = 50/180 (27%), Positives = 82/180 (45%), Gaps = 27/180 (15%)

Query: 23  LNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVT 82
           L    DV + ++Y     S    IH DL   N+L+ EN+ + ++DFG+S+  GE E +V 
Sbjct: 122 LQFASDVATGMQY----LSEKQFIHRDLAARNVLVGENLASKIADFGLSR--GE-EVYVK 174

Query: 83  QTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTR-KRPTDEMFTGEMSLRRWVK 141
           +TM    + +MA E  +  + + K DV+S+GVLL E  +    P   M   E+       
Sbjct: 175 KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELY------ 228

Query: 142 ESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI 201
           E LP G          R E+      +C   + +L   C  + P +R      + +L ++
Sbjct: 229 EKLPQGY---------RMEKP----RNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRM 275

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 59.8 bits (145), Expect = 5e-11
 Identities = 38/121 (31%), Positives = 59/121 (48%), Gaps = 5/121 (4%)

Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           M NG L  +L            L++  DV  A+EY      S   IH DL   N L+ E+
Sbjct: 81  MANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEY----LESNGFIHRDLAARNCLVGED 136

Query: 61  MVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETF 120
            V  VSDFG+++ + + + + +   T   + +  PE       S+K DV+S+GVL+ E F
Sbjct: 137 NVVKVSDFGLARYVLDDQ-YTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVF 195

Query: 121 T 121
           +
Sbjct: 196 S 196

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 60.2 bits (146), Expect = 5e-11
 Identities = 56/214 (26%), Positives = 89/214 (41%), Gaps = 37/214 (17%)

Query: 1   MPNGSLEKWLYSYNYFFDIL-------------ERLNIMIDVGSALEYPHHGHSSAPIIH 47
           M +G L K+L S+      L             + L I + + S + Y     +S   +H
Sbjct: 90  MEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVY----LASQHFVH 145

Query: 48  CDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKC 107
            DL   N L+  ++V  + DFG+S+ +   + +     TM  I +M PE       + + 
Sbjct: 146 RDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTES 205

Query: 108 DVYSYGVLLMETFTR-KRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAK 166
           DV+S+GV+L E FT  K+P   +   E      V E +  G        L R        
Sbjct: 206 DVWSFGVVLWEIFTYGKQPWYGLSNEE------VIECITQGRL------LQRPR------ 247

Query: 167 MDCIVSIMDLALDCCMESPGKRINMTDAAAKLKK 200
             C   + D+ L C    P +RIN+ D   +L+K
Sbjct: 248 -TCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 60.6 bits (147), Expect = 5e-11
 Identities = 43/168 (25%), Positives = 70/168 (41%), Gaps = 12/168 (7%)

Query: 22  RLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFV 81
           R  I I +  AL +  H   S  ++  +L P  I++D     H+        L       
Sbjct: 782 RRKIAIGIAKALRF-LHCRCSPAVVVGNLSPEKIIIDGKDEPHL-------RLSLPGLLC 833

Query: 82  TQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVK 141
           T T    +  Y+APE      ++ K D+Y +G++L+E  T K P D  F    S+  W +
Sbjct: 834 TDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWAR 893

Query: 142 ESLPH-GLTEVVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKR 188
                  L   +D ++  +    +   + IV +M+LAL C    P  R
Sbjct: 894 YCYSDCHLDMWIDPSIRGD---VSVNQNEIVEVMNLALHCTATDPTAR 938

Length = 968

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 59.7 bits (144), Expect = 5e-11
 Identities = 36/108 (33%), Positives = 58/108 (53%), Gaps = 4/108 (3%)

Query: 46  IHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSA 105
           IH DL+  NIL+ +N+V  ++DFG+++L+ E  ++  +      I + APE    G  + 
Sbjct: 124 IHRDLRAANILVGDNLVCKIADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTI 182

Query: 106 KCDVYSYGVLLMETFTRKR-PTDEMFTGEM--SLRRWVKESLPHGLTE 150
           K DV+S+G+LL E  T+ R P   M   E+   + R  +   P G  E
Sbjct: 183 KSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPE 230

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 60.0 bits (145), Expect = 6e-11
 Identities = 30/81 (37%), Positives = 48/81 (59%)

Query: 41  SSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSE 100
           +S   IH DL   NILL EN V  + DFG+++ + +  D+V +      + +MAPE   +
Sbjct: 191 ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFD 250

Query: 101 GIVSAKCDVYSYGVLLMETFT 121
            + + + DV+S+GVLL E F+
Sbjct: 251 KVYTTQSDVWSFGVLLWEIFS 271

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 59.5 bits (144), Expect = 6e-11
 Identities = 37/131 (28%), Positives = 61/131 (46%), Gaps = 5/131 (3%)

Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           M NG L  +L  +   F   + L +  DV   + Y      S   IH DL   N L+D+ 
Sbjct: 81  MSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAY----LESKQFIHRDLAARNCLVDDQ 136

Query: 61  MVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETF 120
               VSDFG+S+ + + E + +   +   + +  PE       S+K DV+++GVL+ E +
Sbjct: 137 GCVKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVY 195

Query: 121 TRKRPTDEMFT 131
           +  +   E F 
Sbjct: 196 SLGKMPYERFN 206

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 59.7 bits (144), Expect = 7e-11
 Identities = 34/97 (35%), Positives = 54/97 (55%), Gaps = 4/97 (4%)

Query: 26  MIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTM 85
           M D+ S +EY     SS   IH DL   N +L+ENM   V+DFG+SK +  G+ +    +
Sbjct: 118 MTDIASGMEY----LSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRI 173

Query: 86  TMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTR 122
               + ++A E  ++ + + K DV+S+GV + E  TR
Sbjct: 174 AKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATR 210

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 59.6 bits (144), Expect = 7e-11
 Identities = 54/180 (30%), Positives = 81/180 (45%), Gaps = 27/180 (15%)

Query: 23  LNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVT 82
           L+   DV   ++Y     S    IH DL   NIL+ EN VA ++DFG+S+  G+ E +V 
Sbjct: 127 LHFAADVARGMDY----LSQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQ-EVYVK 179

Query: 83  QTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTR-KRPTDEMFTGEMSLRRWVK 141
           +TM    + +MA E  +  + +   DV+SYGVLL E  +    P   M   E+       
Sbjct: 180 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY------ 233

Query: 142 ESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI 201
           E LP G          R E+     ++C   + DL   C  E P +R +       L ++
Sbjct: 234 EKLPQGY---------RLEKP----LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 280

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 59.1 bits (143), Expect = 8e-11
 Identities = 42/128 (32%), Positives = 65/128 (50%), Gaps = 9/128 (7%)

Query: 2   PNGSLEKWLYSY-NYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           P G+L +++    N   D    L+  + +  AL   HH H+   I+H DLK  NILLD++
Sbjct: 82  PGGTLAEYIQKRCNSLLDEDTILHFFVQILLAL---HHVHTKL-ILHRDLKTQNILLDKH 137

Query: 61  -MVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMET 119
            MV  + DFGISK+L       T    + T  Y++PE       + K D+++ G +L E 
Sbjct: 138 KMVVKIGDFGISKILSSKSKAYT---VVGTPCYISPELCEGKPYNQKSDIWALGCVLYEL 194

Query: 120 FTRKRPTD 127
            + KR  +
Sbjct: 195 ASLKRAFE 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 59.9 bits (145), Expect = 1e-10
 Identities = 37/108 (34%), Positives = 53/108 (49%), Gaps = 12/108 (11%)

Query: 25  IMIDVGSALEYPHHGHSSAPIIHCDLKPTNILL---DENMVAHVSDFGISKLLGEGEDFV 81
           +M+ V  AL   H    +  I+H DLKP NI++        A V DFGI  LL    D  
Sbjct: 84  LMLQVLDALACAH----NQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDAD 139

Query: 82  TQTMTMAT--IG---YMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKR 124
             T+T  T  +G   Y APE      V+   D+Y++G++ +E  T +R
Sbjct: 140 VATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQR 187

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 58.5 bits (142), Expect = 1e-10
 Identities = 43/130 (33%), Positives = 60/130 (46%), Gaps = 7/130 (5%)

Query: 2   PNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENM 61
           P G L K+L          +   +   V   + Y    H     +H DL   N+LL    
Sbjct: 78  PLGPLLKYLKKRREIPVS-DLKELAHQVAMGMAYLESKH----FVHRDLAARNVLLVNRH 132

Query: 62  VAHVSDFGISKLLGEGEDFVT-QTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETF 120
            A +SDFG+S+ LG G D+    T     + + APE  + G  S+K DV+SYGV L E F
Sbjct: 133 QAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAF 192

Query: 121 TR-KRPTDEM 129
           +   +P  EM
Sbjct: 193 SYGAKPYGEM 202

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 58.5 bits (141), Expect = 1e-10
 Identities = 35/118 (29%), Positives = 58/118 (49%), Gaps = 4/118 (3%)

Query: 4   GSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVA 63
           G    +L +      + E + ++ +  + +EY    H     IH DL   N L+ E  V 
Sbjct: 78  GDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHC----IHRDLAARNCLVTEKNVL 133

Query: 64  HVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT 121
            +SDFG+S+   +G    T  M    + + APE  + G  S++ DV+S+G+LL E F+
Sbjct: 134 KISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFS 191

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 58.1 bits (141), Expect = 2e-10
 Identities = 35/88 (39%), Positives = 46/88 (52%), Gaps = 8/88 (9%)

Query: 45  IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPE----YGSE 100
           IIH D+KP+NILLD N    + DFGIS   G+  D + +T       YMAPE       +
Sbjct: 129 IIHRDVKPSNILLDRNGNIKLCDFGIS---GQLVDSIAKTRDAGCRPYMAPERIDPSARD 185

Query: 101 GIVSAKCDVYSYGVLLMETFTRKRPTDE 128
           G    + DV+S G+ L E  T K P  +
Sbjct: 186 G-YDVRSDVWSLGITLYEVATGKFPYPK 212

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 57.7 bits (139), Expect = 3e-10
 Identities = 42/144 (29%), Positives = 67/144 (46%), Gaps = 21/144 (14%)

Query: 46  IHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSA 105
           IH DL+  NIL+ + +V  ++DFG+++L+ E  ++  +      I + APE    G  + 
Sbjct: 124 IHRDLRSANILVGDGLVCKIADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTI 182

Query: 106 KCDVYSYGVLLMETFTRKR-PTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFA 164
           K DV+S+G+LL E  T+ R P   M        R V E +  G                 
Sbjct: 183 KSDVWSFGILLTELVTKGRVPYPGMNN------REVLEQVERGYR-------------MP 223

Query: 165 AKMDCIVSIMDLALDCCMESPGKR 188
              DC +S+ +L L C  + P +R
Sbjct: 224 CPQDCPISLHELMLQCWKKDPEER 247

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 57.6 bits (140), Expect = 3e-10
 Identities = 33/134 (24%), Positives = 54/134 (40%), Gaps = 25/134 (18%)

Query: 1   MPNGSLEKWLYSYN---------YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLK 51
             NGSL + +  +          Y + +L+           L Y H       +IH D+K
Sbjct: 81  AENGSLRQIIKKFGPFPESLVAVYVYQVLQ----------GLAYLH----EQGVIHRDIK 126

Query: 52  PTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYS 111
             NIL  ++ V  ++DFG++  L +          + T  +MAPE       S   D++S
Sbjct: 127 AANILTTKDGVVKLADFGVATKLNDVSK--DDASVVGTPYWMAPEVIEMSGASTASDIWS 184

Query: 112 YGVLLMETFTRKRP 125
            G  ++E  T   P
Sbjct: 185 LGCTVIELLTGNPP 198

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 58.1 bits (140), Expect = 3e-10
 Identities = 30/81 (37%), Positives = 48/81 (59%)

Query: 41  SSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSE 100
           +S   IH DL   NILL EN V  + DFG+++ + +  D+V +      + +MAPE   +
Sbjct: 196 ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD 255

Query: 101 GIVSAKCDVYSYGVLLMETFT 121
            + + + DV+S+GVLL E F+
Sbjct: 256 RVYTIQSDVWSFGVLLWEIFS 276

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 57.3 bits (139), Expect = 4e-10
 Identities = 40/133 (30%), Positives = 61/133 (45%), Gaps = 23/133 (17%)

Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPH-HGHSSAPIIHCDLKPTNILLDE 59
           +P G L   L +     + + R   + ++  ALEY H +G     IIH DLKP NIL+D 
Sbjct: 75  LPGGDLASLLENVGSLDEDVAR-IYIAEIVLALEYLHSNG-----IIHRDLKPDNILIDS 128

Query: 60  NMVAHVSDFGISKL------LGEGEDFVTQTMTMATIGYMAPEYGSEGIV-----SAKCD 108
           N    ++DFG+SK+      +   +D       + T  Y+APE     ++     S   D
Sbjct: 129 NGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPE-----VILGQGHSKTVD 183

Query: 109 VYSYGVLLMETFT 121
            +S G +L E   
Sbjct: 184 WWSLGCILYEFLV 196

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 56.7 bits (137), Expect = 7e-10
 Identities = 28/92 (30%), Positives = 44/92 (47%), Gaps = 1/92 (1%)

Query: 45  IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVS 104
           ++H DL   N+L+       ++DFG++KLL   E           I +MA E     I +
Sbjct: 130 LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYT 189

Query: 105 AKCDVYSYGVLLMETFT-RKRPTDEMFTGEMS 135
            K DV+SYGV + E  T   +P + +   E+ 
Sbjct: 190 HKSDVWSYGVTVWELMTFGAKPYEGIPAVEIP 221

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 57.0 bits (138), Expect = 8e-10
 Identities = 34/98 (34%), Positives = 49/98 (50%), Gaps = 19/98 (19%)

Query: 33  LEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGY 92
           L+Y H    SA ++H DLKP+N+LL+ N    + DFG+++   E  DF+T+   + T  Y
Sbjct: 121 LKYIH----SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTE--YVVTRWY 174

Query: 93  MAPE-------YGSEGIVSAKCDVYSYGVLLMETFTRK 123
            APE       Y          DV+S G +  E   RK
Sbjct: 175 RAPELLLNCSEYT------TAIDVWSVGCIFAELLGRK 206

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 56.4 bits (136), Expect = 8e-10
 Identities = 28/79 (35%), Positives = 46/79 (58%), Gaps = 1/79 (1%)

Query: 46  IHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSA 105
           IH DL+  NIL+ E +   ++DFG+++L+ E  ++  +      I + APE  + G  + 
Sbjct: 124 IHRDLRAANILVSETLCCKIADFGLARLI-EDNEYTAREGAKFPIKWTAPEAINYGTFTI 182

Query: 106 KCDVYSYGVLLMETFTRKR 124
           K DV+S+G+LL E  T  R
Sbjct: 183 KSDVWSFGILLTEIVTYGR 201

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 56.3 bits (136), Expect = 9e-10
 Identities = 24/76 (31%), Positives = 42/76 (55%)

Query: 46  IHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSA 105
           IH DL   N+LL    +  + DFG+++ +    ++V +      + +MAPE     + + 
Sbjct: 163 IHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTF 222

Query: 106 KCDVYSYGVLLMETFT 121
           + DV+SYG+LL E F+
Sbjct: 223 ESDVWSYGILLWEIFS 238

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 56.3 bits (136), Expect = 9e-10
 Identities = 41/144 (28%), Positives = 61/144 (42%), Gaps = 21/144 (14%)

Query: 46  IHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSA 105
           IH DL   N+L+ EN +  V+DFG+++++ E + +  +      I + APE       S 
Sbjct: 125 IHRDLAARNVLVGENNICKVADFGLARVIKE-DIYEAREGAKFPIKWTAPEAALYNRFSI 183

Query: 106 KCDVYSYGVLLMETFTRKR-PTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFA 164
           K DV+S+G+LL E  T  R P   M   E      V + +  G                 
Sbjct: 184 KSDVWSFGILLTEIVTYGRMPYPGMTNAE------VLQQVDQGYRMPCPPG--------- 228

Query: 165 AKMDCIVSIMDLALDCCMESPGKR 188
               C   + D+ LDC  E P  R
Sbjct: 229 ----CPKELYDIMLDCWKEDPDDR 248

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 56.2 bits (135), Expect = 9e-10
 Identities = 53/175 (30%), Positives = 79/175 (45%), Gaps = 27/175 (15%)

Query: 28  DVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTM 87
           DV   ++Y     S    IH DL   NIL+ EN VA ++DFG+S+  G+ E +V +TM  
Sbjct: 120 DVARGMDY----LSQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQ-EVYVKKTMGR 172

Query: 88  ATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTR-KRPTDEMFTGEMSLRRWVKESLPH 146
             + +MA E  +  + +   DV+SYGVLL E  +    P   M   E+       E LP 
Sbjct: 173 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY------EKLPQ 226

Query: 147 GLTEVVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI 201
           G          R E+     ++C   + DL   C  E P +R +       L ++
Sbjct: 227 GY---------RLEKP----LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 268

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 56.1 bits (135), Expect = 1e-09
 Identities = 40/157 (25%), Positives = 71/157 (45%), Gaps = 18/157 (11%)

Query: 45  IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVS 104
           ++H DL   N+L+ E     +SDFG+S+ + E + +V ++     + +MA E   + I +
Sbjct: 148 LVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYT 207

Query: 105 AKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFA 164
            + DV+S+GVLL E  T        + G    R +               NL++      
Sbjct: 208 TQSDVWSFGVLLWEIVTLG---GNPYPGIAPERLF---------------NLLKTGYRME 249

Query: 165 AKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI 201
              +C   + +L L C  + P KR    D + +L+K+
Sbjct: 250 RPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKM 286

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 55.9 bits (135), Expect = 1e-09
 Identities = 42/151 (27%), Positives = 59/151 (39%), Gaps = 30/151 (19%)

Query: 45  IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED-FVTQTMTMATIGYMAPEYGSEGIV 103
            IH DL   NILL  +    + DFG+ + L + ED +V +        + APE       
Sbjct: 118 FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTF 177

Query: 104 SAKCDVYSYGVLLMETFTRKRPTDEMFT-GEMSLRRWVKESLPHGLT-----EVVDANLV 157
           S   DV+ +GV L           EMFT GE     W       GL+     + +D    
Sbjct: 178 SHASDVWMFGVTLW----------EMFTYGEEP---WA------GLSGSQILKKIDKEGE 218

Query: 158 REEQAFAAKMDCIVSIMDLALDCCMESPGKR 188
           R E+       C   I ++ L C   +P  R
Sbjct: 219 RLERP----EACPQDIYNVMLQCWAHNPADR 245

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 55.5 bits (134), Expect = 2e-09
 Identities = 42/131 (32%), Positives = 62/131 (47%), Gaps = 21/131 (16%)

Query: 2   PNGSLEKWLYSYNYFFDILERL---NIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLD 58
           P GSL K L  Y  F + + RL    I+      LEY H  +     +H D+K  NIL+D
Sbjct: 85  PGGSLAKLLKKYGSFPEPVIRLYTRQIL----LGLEYLHDRN----TVHRDIKGANILVD 136

Query: 59  ENMVAHVSDFGISKLLGEGEDFVTQTMTMATIG---YMAPEY-GSEGIVSAKCDVYSYGV 114
            N V  ++DFG++K +      V  +   +  G   +MAPE    +G      D++S G 
Sbjct: 137 TNGVVKLADFGMAKQV------VEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGC 190

Query: 115 LLMETFTRKRP 125
            ++E  T K P
Sbjct: 191 TVLEMATGKPP 201

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 55.6 bits (134), Expect = 2e-09
 Identities = 39/122 (31%), Positives = 60/122 (49%), Gaps = 6/122 (4%)

Query: 1   MPNGSLEKWLYSYN-YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDE 59
           M  G+L  +L   N    + +  L +   + SA+EY    +     IH DL   N L+ E
Sbjct: 84  MTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN----FIHRDLAARNCLVGE 139

Query: 60  NMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMET 119
           N +  V+DFG+S+L+  G+ +         I + APE  +    S K DV+++GVLL E 
Sbjct: 140 NHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 198

Query: 120 FT 121
            T
Sbjct: 199 AT 200

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 55.2 bits (133), Expect = 2e-09
 Identities = 43/143 (30%), Positives = 57/143 (39%), Gaps = 40/143 (27%)

Query: 1   MPNGSLEKWLYSY---------NYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLK 51
           MP GS++  L +Y          Y   ILE           +EY H       I+H D+K
Sbjct: 86  MPGGSVKDQLKAYGALTETVTRKYTRQILE----------GVEYLHSNM----IVHRDIK 131

Query: 52  PTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIG---------YMAPEYGSEGI 102
             NIL D      + DFG SK L        QT+  +  G         +M+PE  S   
Sbjct: 132 GANILRDSAGNVKLGDFGASKRL--------QTICSSGTGMKSVTGTPYWMSPEVISGEG 183

Query: 103 VSAKCDVYSYGVLLMETFTRKRP 125
              K DV+S G  ++E  T K P
Sbjct: 184 YGRKADVWSVGCTVVEMLTEKPP 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 55.2 bits (133), Expect = 2e-09
 Identities = 43/126 (34%), Positives = 58/126 (46%), Gaps = 12/126 (9%)

Query: 4   GSLEKWLYSYNYFFDILERLNIMI-DVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMV 62
           G L   LY   +F      + + I ++  AL++ H       II+ D+K  NILLD    
Sbjct: 90  GELFTHLYQREHF--TESEVRVYIAEIVLALDHLHQ----LGIIYRDIKLENILLDSEGH 143

Query: 63  AHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEY---GSEGIVSAKCDVYSYGVLLMET 119
             ++DFG+SK     E+    +    TI YMAPE    GS G   A  D +S GVL  E 
Sbjct: 144 VVLTDFGLSKEFLAEEEERAYSFC-GTIEYMAPEVIRGGSGGHDKA-VDWWSLGVLTFEL 201

Query: 120 FTRKRP 125
            T   P
Sbjct: 202 LTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 55.2 bits (133), Expect = 2e-09
 Identities = 31/96 (32%), Positives = 47/96 (48%), Gaps = 10/96 (10%)

Query: 33  LEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGY 92
           L   H       I+H D+KP+NIL++      + DFG+S   GE  + +  T  + T  Y
Sbjct: 119 LYNVHR------IMHRDIKPSNILVNSRGQIKLCDFGVS---GELINSIADTF-VGTSTY 168

Query: 93  MAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDE 128
           M+PE    G  + K DV+S G+ ++E    K P   
Sbjct: 169 MSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAF 204

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 55.0 bits (132), Expect = 3e-09
 Identities = 44/174 (25%), Positives = 74/174 (42%), Gaps = 24/174 (13%)

Query: 21  ERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF 80
           + L+I   + S + Y    H     +H DL   N L+  N++  + DFG+S+ +   + +
Sbjct: 124 QMLHIASQIASGMVYLASQH----FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYY 179

Query: 81  VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTR-KRPTDEMFTGEMSLRRW 139
                TM  I +M PE       + + DV+S+GV+L E FT  K+P             W
Sbjct: 180 RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP-------------W 226

Query: 140 VKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTD 193
            + S    + E +    V E         C   + D+ L C    P +R+N+ +
Sbjct: 227 FQLS-NTEVIECITQGRVLERPRV-----CPKEVYDIMLGCWQREPQQRLNIKE 274

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 55.2 bits (134), Expect = 3e-09
 Identities = 35/101 (34%), Positives = 52/101 (51%), Gaps = 20/101 (19%)

Query: 32  ALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMT--MAT 89
            L+Y H    SA +IH DLKP+NIL++ N    + DFG+++ +   ED     +T  + T
Sbjct: 115 GLKYLH----SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGF-LTEYVVT 169

Query: 90  IGYMAPE-------YGSEGIVSAKCDVYSYGVLLMETFTRK 123
             Y APE       Y ++ I     D++S G +  E  TRK
Sbjct: 170 RWYRAPELLLSSSRY-TKAI-----DIWSVGCIFAELLTRK 204

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 54.9 bits (133), Expect = 3e-09
 Identities = 31/93 (33%), Positives = 47/93 (50%), Gaps = 21/93 (22%)

Query: 32  ALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTM-ATI 90
           ALEY H       I++ DLKP N+LLD +    ++DFG +K +         T T+  T 
Sbjct: 113 ALEYLHSLD----IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR------TYTLCGTP 162

Query: 91  GYMAPEYGSEGIVSAK-----CDVYSYGVLLME 118
            Y+APE     I+ +K      D ++ G+L+ E
Sbjct: 163 EYLAPE-----IILSKGYGKAVDWWALGILIYE 190

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 55.0 bits (132), Expect = 3e-09
 Identities = 39/177 (22%), Positives = 80/177 (45%), Gaps = 22/177 (12%)

Query: 23  LNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVT 82
           ++I+  + + +E+     SS  ++H DL   N+L+ + +   +SD G+ + +   + +  
Sbjct: 127 VHIVTQIAAGMEF----LSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKL 182

Query: 83  QTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKE 142
              ++  I +M+PE    G  S   D++SYGV+L E F+                  ++ 
Sbjct: 183 MGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYG----------------LQP 226

Query: 143 SLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLK 199
              +   +V++  ++R  Q      DC   +  L L+C  E P +R    D  ++L+
Sbjct: 227 YCGYSNQDVIE--MIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLR 281

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 54.6 bits (131), Expect = 3e-09
 Identities = 31/76 (40%), Positives = 46/76 (60%), Gaps = 1/76 (1%)

Query: 46  IHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSA 105
           IH DL   N L+ EN V  +SDFG+S+   +G  + +  +    I + APE  + G  S+
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSRQEDDGI-YSSSGLKQIPIKWTAPEALNYGRYSS 173

Query: 106 KCDVYSYGVLLMETFT 121
           + DV+SYG+LL ETF+
Sbjct: 174 ESDVWSYGILLWETFS 189

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 55.1 bits (133), Expect = 3e-09
 Identities = 35/105 (33%), Positives = 52/105 (49%), Gaps = 11/105 (10%)

Query: 32  ALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMT--MAT 89
            L+Y H    SA ++H DLKP N+L++ +    + DFG+++   E        MT  +AT
Sbjct: 117 GLKYIH----SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVAT 172

Query: 90  IGYMAPEYG-SEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGE 133
             Y APE   S    +   DV+S G +L E   RK     +F G+
Sbjct: 173 RWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK----PVFKGK 213

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 54.8 bits (132), Expect = 4e-09
 Identities = 40/141 (28%), Positives = 64/141 (45%), Gaps = 38/141 (26%)

Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           M  GSLE    +   F   + R      + S + Y H  H    I+H D+KP+N+L++  
Sbjct: 154 MDGGSLEGTHIADEQFLADVAR-----QILSGIAYLHRRH----IVHRDIKPSNLLINSA 204

Query: 61  MVAHVSDFGISKLLGEGEDFVTQTM-----TMATIGYMAPEY-----------GSEGIVS 104
               ++DFG+S++L        QTM     ++ TI YM+PE            G  G   
Sbjct: 205 KNVKIADFGVSRILA-------QTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAG--- 254

Query: 105 AKCDVYSYGVLLMETFTRKRP 125
              D++S GV ++E +  + P
Sbjct: 255 ---DIWSLGVSILEFYLGRFP 272

Length = 353

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 54.6 bits (131), Expect = 4e-09
 Identities = 36/114 (31%), Positives = 62/114 (54%), Gaps = 8/114 (7%)

Query: 46  IHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSA 105
           IH DL+  NIL+  ++V  ++DFG+++++ E  ++  +      I + APE  + G  + 
Sbjct: 124 IHRDLRAANILVSASLVCKIADFGLARVI-EDNEYTAREGAKFPIKWTAPEAINFGSFTI 182

Query: 106 KCDVYSYGVLLMETFTRKR-PTDEMFTGEM--SLRRWVK----ESLPHGLTEVV 152
           K DV+S+G+LLME  T  R P   M   E+  +L R  +    E+ P  L  ++
Sbjct: 183 KSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIM 236

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 54.4 bits (131), Expect = 4e-09
 Identities = 40/131 (30%), Positives = 61/131 (46%), Gaps = 9/131 (6%)

Query: 21  ERL-NIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED 79
           ER+ NI + +  AL Y H       I+H DL P NI+L E+    ++DFG++K       
Sbjct: 113 ERIWNIFVQMVLALRYLH---KEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESK 169

Query: 80  FVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRP--TDEMFTGEMSLR 137
               T  + TI Y  PE         K DV+++G +L +  T + P  +  M +    + 
Sbjct: 170 L---TSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIV 226

Query: 138 RWVKESLPHGL 148
             V E LP G+
Sbjct: 227 EAVYEPLPEGM 237

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 54.3 bits (131), Expect = 4e-09
 Identities = 34/99 (34%), Positives = 51/99 (51%), Gaps = 11/99 (11%)

Query: 32  ALEYPH-HGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATI 90
            LEY H +G      IH D+K  NILL E+    ++DFG+S  L +G D  T+ +    +
Sbjct: 114 GLEYLHSNGQ-----IHRDIKAGNILLGEDGSVKIADFGVSASLADGGD-RTRKVRKTFV 167

Query: 91  G---YMAPEYGSEGI-VSAKCDVYSYGVLLMETFTRKRP 125
           G   +MAPE   +      K D++S+G+  +E  T   P
Sbjct: 168 GTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAP 206

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 54.3 bits (131), Expect = 5e-09
 Identities = 39/119 (32%), Positives = 54/119 (45%), Gaps = 10/119 (8%)

Query: 31  SALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATI 90
            AL Y    H    +IH D+KP+NILLD +    + DFGIS   G   D   +T +    
Sbjct: 125 KALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGIS---GRLVDSKAKTRSAGCA 178

Query: 91  GYMAPEY----GSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLP 145
            YMAPE             + DV+S G+ L+E  T + P     T    L + ++E  P
Sbjct: 179 AYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPP 237

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 54.0 bits (130), Expect = 6e-09
 Identities = 33/99 (33%), Positives = 51/99 (51%), Gaps = 6/99 (6%)

Query: 26  MIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTM 85
           +  + SA+ Y H     A I+H D+K  NI L +  +  + DFGISK+L  G ++     
Sbjct: 107 LFQIVSAVSYIH----KAGILHRDIKTLNIFLTKAGLIKLGDFGISKIL--GSEYSMAET 160

Query: 86  TMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKR 124
            + T  YM+PE       + K D+++ G +L E  T KR
Sbjct: 161 VVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKR 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 53.8 bits (129), Expect = 7e-09
 Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 2/92 (2%)

Query: 46  IHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFV-TQTMTMATIGYMAPEYGSEGIVS 104
           +H DL   N+LL     A +SDFG+SK LG  E++   +T     + + APE  +    S
Sbjct: 117 VHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFS 176

Query: 105 AKCDVYSYGVLLMETFTR-KRPTDEMFTGEMS 135
           +K DV+S+GVL+ E F+  ++P   M   E++
Sbjct: 177 SKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVT 208

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 53.9 bits (130), Expect = 7e-09
 Identities = 34/103 (33%), Positives = 53/103 (51%), Gaps = 11/103 (10%)

Query: 33  LEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMT--MATI 90
           L+Y H    SA +IH DLKP+N+L++E+    + DFG+++ L          MT  +AT 
Sbjct: 120 LKYIH----SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATR 175

Query: 91  GYMAPEYG-SEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTG 132
            Y APE   S    +   D++S G +  E   R+    ++F G
Sbjct: 176 WYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRR----QLFPG 214

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 54.3 bits (130), Expect = 7e-09
 Identities = 29/103 (28%), Positives = 55/103 (53%), Gaps = 4/103 (3%)

Query: 19  ILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGE 78
            L+ L+    V   +E+     +S   +H DL   N+LL +  +  + DFG+++ +    
Sbjct: 236 TLDLLSFTYQVARGMEF----LASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDS 291

Query: 79  DFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT 121
           ++V++  T   + +MAPE   + + +   DV+SYG+LL E F+
Sbjct: 292 NYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 53.5 bits (129), Expect = 8e-09
 Identities = 30/102 (29%), Positives = 50/102 (49%), Gaps = 9/102 (8%)

Query: 24  NIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQ 83
           + +  +   L + H    S  I+H DLKP N+L++   V  ++DFG+++    G      
Sbjct: 102 SYLYQLLQGLAFCH----SHGILHRDLKPENLLINTEGVLKLADFGLARSF--GSPVRPY 155

Query: 84  TMTMATIGYMAPE--YGSEGIVSAKCDVYSYGVLLMETFTRK 123
           T  + T  Y APE   G +G  S   D++S G +  E  +R+
Sbjct: 156 THYVVTRWYRAPELLLGDKG-YSTPVDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 53.0 bits (128), Expect = 1e-08
 Identities = 34/93 (36%), Positives = 47/93 (50%), Gaps = 6/93 (6%)

Query: 33  LEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGY 92
           LEY H    S   IH D+K  NILL+E   A ++DFG+S  L         T+ + T  +
Sbjct: 112 LEYLH----SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQL-TDTMAKRNTV-IGTPFW 165

Query: 93  MAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRP 125
           MAPE   E   + K D++S G+  +E    K P
Sbjct: 166 MAPEVIQEIGYNNKADIWSLGITAIEMAEGKPP 198

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 53.5 bits (129), Expect = 1e-08
 Identities = 34/96 (35%), Positives = 53/96 (55%), Gaps = 10/96 (10%)

Query: 32  ALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMT--MAT 89
            L+Y H    SA ++H DLKP+N+LL+ N    + DFG++++     D  T  +T  +AT
Sbjct: 118 GLKYIH----SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDH-TGFLTEYVAT 172

Query: 90  IGYMAPE--YGSEGIVSAKCDVYSYGVLLMETFTRK 123
             Y APE    S+G   A  D++S G +L E  + +
Sbjct: 173 RWYRAPEIMLNSKGYTKA-IDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 53.1 bits (128), Expect = 1e-08
 Identities = 23/77 (29%), Positives = 44/77 (57%)

Query: 45  IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVS 104
            +H DL   N ++ E++   + DFG+++ + E + +      +  + +MAPE   +G+ +
Sbjct: 140 FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFT 199

Query: 105 AKCDVYSYGVLLMETFT 121
            K DV+S+GV+L E  T
Sbjct: 200 TKSDVWSFGVVLWEMAT 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 52.9 bits (127), Expect = 2e-08
 Identities = 40/114 (35%), Positives = 54/114 (47%), Gaps = 15/114 (13%)

Query: 32  ALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIG 91
           ALE+ H       II+ DLKP NILLD      ++DFG+ K     E  VT T    TI 
Sbjct: 112 ALEHLHQ----QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIH-EGTVTHTFC-GTIE 165

Query: 92  YMAPEYGSEGIVSAKCDVYSYGVLLMETFT---------RKRPTDEMFTGEMSL 136
           YMAPE           D +S G L+ +  T         RK+  D++  G+++L
Sbjct: 166 YMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNL 219

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 53.0 bits (127), Expect = 2e-08
 Identities = 26/81 (32%), Positives = 44/81 (54%)

Query: 41  SSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSE 100
           +S   IH DL   NILL    +  + DFG+++ +    ++V +      + +MAPE    
Sbjct: 231 ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFN 290

Query: 101 GIVSAKCDVYSYGVLLMETFT 121
            + + + DV+SYG+LL E F+
Sbjct: 291 CVYTFESDVWSYGILLWEIFS 311

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 52.4 bits (126), Expect = 2e-08
 Identities = 27/80 (33%), Positives = 46/80 (57%)

Query: 42  SAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEG 101
           S   IH DL   N+L+ E+ V  ++DFG+++ +   + +   T     + +MAPE   + 
Sbjct: 150 SKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDR 209

Query: 102 IVSAKCDVYSYGVLLMETFT 121
           + + + DV+S+GVLL E FT
Sbjct: 210 VYTHQSDVWSFGVLLWEIFT 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 52.1 bits (125), Expect = 2e-08
 Identities = 33/106 (31%), Positives = 51/106 (48%), Gaps = 7/106 (6%)

Query: 19  ILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLD---ENMVAHVSDFGISKLLG 75
           + + L    DV    +Y    H     IH D+   N LL       VA ++DFG+++ + 
Sbjct: 115 MKDLLFCARDVAKGCKYLEENH----FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIY 170

Query: 76  EGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT 121
               +      M  I +M PE   +GI ++K DV+S+GVLL E F+
Sbjct: 171 RASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 52.2 bits (126), Expect = 3e-08
 Identities = 30/95 (31%), Positives = 45/95 (47%), Gaps = 11/95 (11%)

Query: 32  ALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGE-GEDFVTQTMTMATI 90
            LEY H    S  I+H DLKP N+L+  + V  ++DFG+++  G        Q   + T 
Sbjct: 114 GLEYLH----SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQ---VVTR 166

Query: 91  GYMAPE--YGSEGIVSAKCDVYSYGVLLMETFTRK 123
            Y APE  +G+        D++S G +  E   R 
Sbjct: 167 WYRAPELLFGARHYGVG-VDMWSVGCIFAELLLRV 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 51.7 bits (124), Expect = 4e-08
 Identities = 26/81 (32%), Positives = 39/81 (48%), Gaps = 3/81 (3%)

Query: 45  IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVS 104
           I++ DLKP N+LLD++    +SD G++  L  G+          T GYMAPE     +  
Sbjct: 116 IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKGRAGTPGYMAPEVLQGEVYD 172

Query: 105 AKCDVYSYGVLLMETFTRKRP 125
              D ++ G  L E    + P
Sbjct: 173 FSVDWFALGCTLYEMIAGRSP 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 51.7 bits (124), Expect = 4e-08
 Identities = 27/83 (32%), Positives = 40/83 (48%), Gaps = 10/83 (12%)

Query: 45  IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPE--YGSEGI 102
           IIH D+KP N+L+D+     ++DFG+S+   E + FV       T  Y+APE   G    
Sbjct: 118 IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFV------GTPDYLAPETILGVGDD 171

Query: 103 VSAKCDVYSYGVLLMETFTRKRP 125
                D +S G ++ E      P
Sbjct: 172 --KMSDWWSLGCVIFEFLFGYPP 192

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 51.6 bits (123), Expect = 4e-08
 Identities = 28/81 (34%), Positives = 47/81 (58%)

Query: 41  SSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSE 100
           +S   IH DL   N+L+ E+ V  ++DFG+++ +   + +   T     + +MAPE   +
Sbjct: 157 ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD 216

Query: 101 GIVSAKCDVYSYGVLLMETFT 121
            I + + DV+S+GVLL E FT
Sbjct: 217 RIYTHQSDVWSFGVLLWEIFT 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 51.6 bits (123), Expect = 4e-08
 Identities = 25/76 (32%), Positives = 47/76 (61%), Gaps = 1/76 (1%)

Query: 46  IHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSA 105
           IH DL+  N+L+ E+++  ++DFG+++++ E  ++  +      I + APE  + G  + 
Sbjct: 125 IHRDLRAANVLVSESLMCKIADFGLARVI-EDNEYTAREGAKFPIKWTAPEAINFGSFTI 183

Query: 106 KCDVYSYGVLLMETFT 121
           K DV+S+G+LL E  T
Sbjct: 184 KSDVWSFGILLYEIVT 199

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 51.5 bits (123), Expect = 5e-08
 Identities = 31/120 (25%), Positives = 62/120 (51%), Gaps = 9/120 (7%)

Query: 41  SSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSE 100
           +S   +H DL   N+L+ E  +  + DFG+++ +    +++++  T   + +MAPE    
Sbjct: 256 ASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFN 315

Query: 101 GIVSAKCDVYSYGVLLMETFT------RKRPTDEMFTGEMSLRRWVKESLP-HGLTEVVD 153
            + +   DV+S+G+LL E FT       + P +E F    +++R  + + P H   E+ +
Sbjct: 316 NLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYN--AIKRGYRMAKPAHASDEIYE 373

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 51.6 bits (123), Expect = 5e-08
 Identities = 27/81 (33%), Positives = 47/81 (58%)

Query: 41  SSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSE 100
           +S   IH DL   N+L+ EN V  ++DFG+++ +   + +   T     + +MAPE   +
Sbjct: 154 ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFD 213

Query: 101 GIVSAKCDVYSYGVLLMETFT 121
            + + + DV+S+GVL+ E FT
Sbjct: 214 RVYTHQSDVWSFGVLMWEIFT 234

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 51.0 bits (122), Expect = 6e-08
 Identities = 34/88 (38%), Positives = 50/88 (56%), Gaps = 5/88 (5%)

Query: 45  IIHCDLKPTNILLDE-NMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGI- 102
           I+H D+K  N+L++  + V  +SDFG SK L  G +  T+T T  T+ YMAPE   +G  
Sbjct: 129 IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA-GINPCTETFT-GTLQYMAPEVIDKGPR 186

Query: 103 -VSAKCDVYSYGVLLMETFTRKRPTDEM 129
              A  D++S G  ++E  T K P  E+
Sbjct: 187 GYGAPADIWSLGCTIVEMATGKPPFIEL 214

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 51.2 bits (122), Expect = 6e-08
 Identities = 30/93 (32%), Positives = 51/93 (54%), Gaps = 4/93 (4%)

Query: 29  VGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMA 88
           V   +EY     +S   IH DL   N+L+ E+ V  ++DFG+++ +   + +   T    
Sbjct: 143 VARGMEY----LASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRL 198

Query: 89  TIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT 121
            + +MAPE   + + + + DV+S+GVLL E FT
Sbjct: 199 PVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 51.0 bits (122), Expect = 6e-08
 Identities = 36/102 (35%), Positives = 45/102 (44%), Gaps = 13/102 (12%)

Query: 31  SALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATI 90
             L Y H    S   IH D+K  NILL E     ++DFG + L+     FV       T 
Sbjct: 126 QGLAYLH----SHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV------GTP 175

Query: 91  GYMAPEY---GSEGIVSAKCDVYSYGVLLMETFTRKRPTDEM 129
            +MAPE      EG    K DV+S G+  +E   RK P   M
Sbjct: 176 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 217

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 51.0 bits (122), Expect = 8e-08
 Identities = 25/76 (32%), Positives = 45/76 (59%)

Query: 46  IHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSA 105
           IH D+   N+LL +  VA + DFG+++ +    ++V +      + +MAPE   + + + 
Sbjct: 234 IHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTV 293

Query: 106 KCDVYSYGVLLMETFT 121
           + DV+SYG+LL E F+
Sbjct: 294 QSDVWSYGILLWEIFS 309

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 50.7 bits (121), Expect = 9e-08
 Identities = 37/124 (29%), Positives = 57/124 (45%), Gaps = 9/124 (7%)

Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           +P GSL  +L  +    ++ + L     +   + Y H  H     IH DL   N+LLD +
Sbjct: 90  VPLGSLRDYLPKHK--LNLAQLLLFAQQICEGMAYLHSQH----YIHRDLAARNVLLDND 143

Query: 61  MVAHVSDFGISKLLGEGEDF--VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLME 118
            +  + DFG++K + EG ++  V +        Y A E   E   S   DV+S+GV L E
Sbjct: 144 RLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-AVECLKENKFSYASDVWSFGVTLYE 202

Query: 119 TFTR 122
             T 
Sbjct: 203 LLTH 206

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 50.5 bits (121), Expect = 9e-08
 Identities = 30/87 (34%), Positives = 46/87 (52%), Gaps = 2/87 (2%)

Query: 41  SSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMAT--IGYMAPEYG 98
           +S   +H DL   N +LDE+    V+DFG+++ + + E +     T A   + +MA E  
Sbjct: 115 ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESL 174

Query: 99  SEGIVSAKCDVYSYGVLLMETFTRKRP 125
                + K DV+S+GVLL E  TR  P
Sbjct: 175 QTQKFTTKSDVWSFGVLLWELMTRGAP 201

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 50.7 bits (122), Expect = 1e-07
 Identities = 43/128 (33%), Positives = 67/128 (52%), Gaps = 27/128 (21%)

Query: 18  DILERLN---IMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLL 74
           +ILE ++   IM  +  AL+Y H    S  +IH DLKP+NILL+ +    ++DFG+++ L
Sbjct: 102 NILEDVHKRYIMYQLLKALKYIH----SGNVIHRDLKPSNILLNSDCRVKLADFGLARSL 157

Query: 75  GEGEDFVT-QTMT--MATIGYMAPE-------YGSEGIVSAKCDVYSYGVLLMETFTRKR 124
            E E+      +T  +AT  Y APE       Y ++G+     D++S G +L E    K 
Sbjct: 158 SELEENPENPVLTDYVATRWYRAPEILLGSTRY-TKGV-----DMWSVGCILGEMLLGK- 210

Query: 125 PTDEMFTG 132
               +F G
Sbjct: 211 ---PLFPG 215

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 50.2 bits (120), Expect = 1e-07
 Identities = 38/126 (30%), Positives = 60/126 (47%), Gaps = 9/126 (7%)

Query: 1   MPNGSLEKWLYSYNYFF--DILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLD 58
           M NG L  +L         D+L  L++  DV   +EY          IH DL   N L+ 
Sbjct: 81  MENGCLLNYLRQRQGKLSKDML--LSMCQDVCEGMEYLERNS----FIHRDLAARNCLVS 134

Query: 59  ENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLME 118
              V  VSDFG+++ + + E + + +     + +  PE  +    S+K DV+S+GVL+ E
Sbjct: 135 STGVVKVSDFGMTRYVLDDE-YTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWE 193

Query: 119 TFTRKR 124
            FT  +
Sbjct: 194 VFTEGK 199

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 49.9 bits (119), Expect = 1e-07
 Identities = 43/137 (31%), Positives = 60/137 (43%), Gaps = 26/137 (18%)

Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           M  GS+   L  Y  F + +  +N    +   L Y H       IIH D+K  N+L+D  
Sbjct: 85  MAGGSVSHLLSKYGAFKEAVI-INYTEQLLRGLSYLHENQ----IIHRDVKGANLLIDST 139

Query: 61  -MVAHVSDFGI-----SKLLGEGEDFVTQTMTMATIGYMAPE------YGSEGIVSAKCD 108
                ++DFG      +K  G GE    Q   + TI +MAPE      YG        CD
Sbjct: 140 GQRLRIADFGAAARLAAKGTGAGE---FQGQLLGTIAFMAPEVLRGEQYGRS------CD 190

Query: 109 VYSYGVLLMETFTRKRP 125
           V+S G +++E  T K P
Sbjct: 191 VWSVGCVIIEMATAKPP 207

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 50.0 bits (120), Expect = 1e-07
 Identities = 32/103 (31%), Positives = 54/103 (52%), Gaps = 17/103 (16%)

Query: 37  HHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPE 96
            + H++  I+H DLKP N+L+  + V  ++DFG+++L  E E  +  +  +AT  Y APE
Sbjct: 113 AYMHANG-IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRL-YSHQVATRWYRAPE 170

Query: 97  --YGS----EGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGE 133
             YG+     G+     D+++ G +  E      P   +F GE
Sbjct: 171 LLYGARKYDPGV-----DLWAVGCIFAELL-NGSP---LFPGE 204

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 50.0 bits (119), Expect = 2e-07
 Identities = 30/82 (36%), Positives = 45/82 (54%), Gaps = 3/82 (3%)

Query: 45  IIHCDLKPTNILLDEN-MVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIV 103
           I+H D+K  NI L +N MVA + DFGI++ L +  +    T  + T  Y++PE       
Sbjct: 122 ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMEL-AYT-CVGTPYYLSPEICQNRPY 179

Query: 104 SAKCDVYSYGVLLMETFTRKRP 125
           + K D++S G +L E  T K P
Sbjct: 180 NNKTDIWSLGCVLYELCTLKHP 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 49.6 bits (118), Expect = 2e-07
 Identities = 31/97 (31%), Positives = 47/97 (48%), Gaps = 6/97 (6%)

Query: 27  IDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMT 86
           + +  AL+Y H  H    I+H DLK  N+ L    +  V D GI+++L    D    +  
Sbjct: 109 VQIAMALQYLHEKH----ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMA--STL 162

Query: 87  MATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRK 123
           + T  YM+PE  S    + K DV++ G  + E  T K
Sbjct: 163 IGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLK 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 49.9 bits (120), Expect = 2e-07
 Identities = 30/101 (29%), Positives = 50/101 (49%), Gaps = 20/101 (19%)

Query: 25  IMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQT 84
           +  +V   LEY H    S  +IH D+K  NILL ++    ++DFG +  L +     ++ 
Sbjct: 121 VCREVLQGLEYLH----SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE---KSKR 173

Query: 85  MTM-ATIGYMAPE------YGSEGIVSAKCDVYSYGVLLME 118
            ++  T  +MAPE      YG       K D++S G++ +E
Sbjct: 174 NSVVGTPYWMAPEVIKRKDYG------PKVDIWSLGIMCIE 208

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 49.7 bits (119), Expect = 2e-07
 Identities = 33/103 (32%), Positives = 50/103 (48%), Gaps = 9/103 (8%)

Query: 25  IMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQT 84
           I+ +V  AL+Y H       +IH D+K  NIL+       + DFG++ LL +     ++ 
Sbjct: 106 IIREVLVALKYIHK----VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS---SKR 158

Query: 85  MTMATIGY-MAPEYGSEGIV-SAKCDVYSYGVLLMETFTRKRP 125
            T     Y MAPE  +EG     K D++S G+ + E  T   P
Sbjct: 159 STFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPP 201

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 49.2 bits (117), Expect = 3e-07
 Identities = 43/160 (26%), Positives = 70/160 (43%), Gaps = 27/160 (16%)

Query: 45  IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVS 104
           I++ DLKP NILLD+     +SD G++  + EGE   T    + T+GYMAPE  +    +
Sbjct: 123 IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE---TVRGRVGTVGYMAPEVINNEKYT 179

Query: 105 AKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFA 164
              D +  G L+           EM  G+   R+  KE +     E VD  +  +++ ++
Sbjct: 180 FSPDWWGLGCLIY----------EMIQGQSPFRKR-KERVKR---EEVDRRVKEDQEEYS 225

Query: 165 AKMDCIVSIMDLALDCC----MESPGKRINMTDAAAKLKK 200
            K        + A   C     ++P +R+      A   K
Sbjct: 226 EKFS------EDAKSICRMLLTKNPKERLGCRGNGAAGVK 259

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 49.4 bits (118), Expect = 3e-07
 Identities = 33/93 (35%), Positives = 51/93 (54%), Gaps = 8/93 (8%)

Query: 33  LEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGY 92
           L+Y H    SA I+H D+KP N+L++ N V  + DFG+++ + E ++    T  + T  Y
Sbjct: 116 LKYLH----SAGILHRDIKPGNLLVNSNCVLKICDFGLAR-VEEPDESKHMTQEVVTQYY 170

Query: 93  MAPE--YGSEGIVSAKCDVYSYGVLLMETFTRK 123
            APE   GS    SA  D++S G +  E   R+
Sbjct: 171 RAPEILMGSRHYTSA-VDIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 49.1 bits (118), Expect = 3e-07
 Identities = 29/100 (29%), Positives = 47/100 (47%), Gaps = 18/100 (18%)

Query: 31  SALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATI 90
             L+Y H       I+H D+K +NIL++ + V  ++DFG+++      +    T  + T+
Sbjct: 111 EGLQYLHSNG----ILHRDIKGSNILINNDGVLKLADFGLARPY-TKRNSADYTNRVITL 165

Query: 91  GYMAPE-------YGSEGIVSAKCDVYSYGVLLMETFTRK 123
            Y  PE       YG E       D++S G +L E F  K
Sbjct: 166 WYRPPELLLGATRYGPE------VDMWSVGCILAELFLGK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 49.2 bits (117), Expect = 3e-07
 Identities = 43/126 (34%), Positives = 60/126 (47%), Gaps = 22/126 (17%)

Query: 32  ALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMA--- 88
           ALE+ H       II+ D+K  NILLD N    ++DFG+SK      +F    +  A   
Sbjct: 117 ALEHLH----KLGIIYRDIKLENILLDSNGHVVLTDFGLSK------EFHEDEVERAYSF 166

Query: 89  --TIGYMAPEY--GSEGIVSAKCDVYSYGVLLMETFTRKRP----TDEMFTGEMSLRRWV 140
             TI YMAP+   G +G      D +S GVL+ E  T   P     ++    E+S RR +
Sbjct: 167 CGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEIS-RRIL 225

Query: 141 KESLPH 146
           K   P+
Sbjct: 226 KSEPPY 231

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 48.9 bits (117), Expect = 3e-07
 Identities = 28/91 (30%), Positives = 46/91 (50%), Gaps = 2/91 (2%)

Query: 41  SSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSE 100
            S   +H DL   N L+ +N    ++DFG+S+ L   + +  Q      I +MA E    
Sbjct: 147 ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLL 206

Query: 101 GIVSAKCDVYSYGVLLMETFT--RKRPTDEM 129
           G  + K DV+++GV L E  T  R++P + +
Sbjct: 207 GKFTTKSDVWAFGVTLWEILTLCREQPYEHL 237

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 48.9 bits (116), Expect = 4e-07
 Identities = 29/81 (35%), Positives = 44/81 (54%), Gaps = 3/81 (3%)

Query: 45  IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVS 104
           I++ DLKP NILLD++    +SD G++  + EG+   T    + T+GYMAPE       +
Sbjct: 123 IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---TIKGRVGTVGYMAPEVVKNERYT 179

Query: 105 AKCDVYSYGVLLMETFTRKRP 125
              D ++ G LL E    + P
Sbjct: 180 FSPDWWALGCLLYEMIAGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 49.0 bits (117), Expect = 4e-07
 Identities = 34/119 (28%), Positives = 50/119 (42%), Gaps = 20/119 (16%)

Query: 23  LNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF-- 80
           L+I   + + +EY H    S  ++H DLKP NILL       + D+G +      E+   
Sbjct: 116 LSIFHKICATIEYVH----SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLL 171

Query: 81  ---------VTQTMT-----MATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRP 125
                       +MT     + T  YMAPE       S   D+Y+ GV+L +  T   P
Sbjct: 172 DIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230

Length = 932

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 48.4 bits (115), Expect = 4e-07
 Identities = 31/88 (35%), Positives = 45/88 (51%), Gaps = 4/88 (4%)

Query: 38  HGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEY 97
           H HS   I++ D+KP N+LLD+     +SD G++  L +G+   T T    T GYMAPE 
Sbjct: 110 HLHS-MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQRAGTNGYMAPEI 165

Query: 98  GSEGIVSAKCDVYSYGVLLMETFTRKRP 125
             E   S   D ++ G  + E    + P
Sbjct: 166 LKEEPYSYPVDWFAMGCSIYEMVAGRTP 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 48.5 bits (115), Expect = 4e-07
 Identities = 48/215 (22%), Positives = 86/215 (40%), Gaps = 38/215 (17%)

Query: 1   MPNGSLEKWLYSYNYFFDILER--------------LNIMIDVGSALEYPHHGHSSAPII 46
           M +G L ++L S+     IL                L I   + S + Y    H     +
Sbjct: 89  MRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH----FV 144

Query: 47  HCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAK 106
           H DL   N L+ + +V  + DFG+S+ +   + +     TM  I +M PE       + +
Sbjct: 145 HRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTE 204

Query: 107 CDVYSYGVLLMETFTR-KRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAA 165
            D++S+GV+L E FT  K+P             W + S     TE ++   + + +    
Sbjct: 205 SDIWSFGVVLWEIFTYGKQP-------------WYQLS----NTEAIEC--ITQGRELER 245

Query: 166 KMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKK 200
              C   +  +   C    P +R+ + D  ++L+ 
Sbjct: 246 PRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 48.5 bits (115), Expect = 5e-07
 Identities = 30/113 (26%), Positives = 56/113 (49%), Gaps = 6/113 (5%)

Query: 17  FDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGE 76
           FD  +   ++ ++   L+Y H    S   IH D+K  N+LL E     ++DFG++  L +
Sbjct: 98  FDEFQIATMLKEILKGLDYLH----SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD 153

Query: 77  GEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEM 129
            +  + +   + T  +MAPE   +    +K D++S G+  +E    + P  +M
Sbjct: 154 TQ--IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDM 204

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 48.5 bits (115), Expect = 5e-07
 Identities = 30/95 (31%), Positives = 50/95 (52%), Gaps = 1/95 (1%)

Query: 41  SSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSE 100
           +S   +H DL   N L+ EN++  + DFG+S+ +   + +     TM  I +M PE    
Sbjct: 137 ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY 196

Query: 101 GIVSAKCDVYSYGVLLMETFTR-KRPTDEMFTGEM 134
              + + DV+S GV+L E FT  K+P  ++   E+
Sbjct: 197 RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV 231

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 48.4 bits (115), Expect = 5e-07
 Identities = 35/120 (29%), Positives = 60/120 (50%), Gaps = 13/120 (10%)

Query: 23  LNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVT 82
           L + + + S ++Y     +S   +H DL   N L+  +    ++DFG+S+ L  G+ +  
Sbjct: 132 LYMAVQIASGMKY----LASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRI 187

Query: 83  QTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT--RKRP----TDEMF---TGE 133
           Q   +  I +MA E    G  +   DV+++GV L E FT  +++P    +DE     TGE
Sbjct: 188 QGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGE 247

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 48.0 bits (114), Expect = 5e-07
 Identities = 26/77 (33%), Positives = 43/77 (55%), Gaps = 1/77 (1%)

Query: 46  IHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVT-QTMTMATIGYMAPEYGSEGIVS 104
           +H DL   N+LL     A +SDFG+SK LG  + +   ++     + + APE  +    S
Sbjct: 117 VHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFS 176

Query: 105 AKCDVYSYGVLLMETFT 121
           ++ DV+SYG+ + E F+
Sbjct: 177 SRSDVWSYGITMWEAFS 193

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 48.4 bits (115), Expect = 6e-07
 Identities = 30/74 (40%), Positives = 41/74 (55%), Gaps = 3/74 (4%)

Query: 45  IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVS 104
           I+H DLK  NI L  N++  + DFG+S+LL    D  T T T  T  YM+PE        
Sbjct: 127 ILHRDLKAKNIFLKNNLL-KIGDFGVSRLLMGSCDLAT-TFT-GTPYYMSPEALKHQGYD 183

Query: 105 AKCDVYSYGVLLME 118
           +K D++S G +L E
Sbjct: 184 SKSDIWSLGCILYE 197

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 48.1 bits (114), Expect = 6e-07
 Identities = 42/137 (30%), Positives = 59/137 (43%), Gaps = 22/137 (16%)

Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           MP GS++  L +Y    + + R      +   + Y H    S  I+H D+K  NIL D  
Sbjct: 88  MPGGSVKDQLKAYGALTESVTR-KYTRQILEGMSYLH----SNMIVHRDIKGANILRDSA 142

Query: 61  MVAHVSDFGISKLLGEGEDFVTQTMTMATIG---------YMAPEYGSEGIVSAKCDVYS 111
               + DFG SK L        QT+ M+  G         +M+PE  S      K DV+S
Sbjct: 143 GNVKLGDFGASKRL--------QTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWS 194

Query: 112 YGVLLMETFTRKRPTDE 128
            G  ++E  T K P  E
Sbjct: 195 LGCTVVEMLTEKPPWAE 211

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 47.9 bits (114), Expect = 7e-07
 Identities = 28/88 (31%), Positives = 45/88 (51%), Gaps = 8/88 (9%)

Query: 38  HGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPE- 96
           H H    ++H DLKP N+L++      ++DFG+++    G    T T  + T+ Y APE 
Sbjct: 117 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEI 171

Query: 97  -YGSEGIVSAKCDVYSYGVLLMETFTRK 123
             G +   S   D++S G +  E  TR+
Sbjct: 172 LLGCK-YYSTAVDIWSLGCIFAEMVTRR 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 48.0 bits (114), Expect = 8e-07
 Identities = 37/122 (30%), Positives = 58/122 (47%), Gaps = 17/122 (13%)

Query: 45  IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVS 104
            ++ DLKP NILLD+     +SD G++  + EGE    +   + T+GYMAPE  +    +
Sbjct: 123 TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGR---VGTVGYMAPEVLNNQRYT 179

Query: 105 AKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFA 164
              D +  G L+ E    + P    F G        KE +     E VD  ++  E+ ++
Sbjct: 180 LSPDYWGLGCLIYEMIEGQSP----FRGR-------KEKVKR---EEVDRRVLETEEVYS 225

Query: 165 AK 166
           AK
Sbjct: 226 AK 227

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 47.9 bits (114), Expect = 8e-07
 Identities = 30/81 (37%), Positives = 42/81 (51%), Gaps = 3/81 (3%)

Query: 45  IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVS 104
           I++ DLKP NILLD+     +SD G++  + EGE   T    + T+GYMAPE       +
Sbjct: 123 IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE---TIRGRVGTVGYMAPEVVKNERYT 179

Query: 105 AKCDVYSYGVLLMETFTRKRP 125
              D +  G L+ E    K P
Sbjct: 180 FSPDWWGLGCLIYEMIEGKSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 48.1 bits (114), Expect = 8e-07
 Identities = 29/84 (34%), Positives = 39/84 (46%)

Query: 42  SAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEG 101
           S  ++H DLK  NI L    +  + DFG SK   +       +    T  Y+APE     
Sbjct: 187 SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERK 246

Query: 102 IVSAKCDVYSYGVLLMETFTRKRP 125
             S K D++S GV+L E  T  RP
Sbjct: 247 RYSKKADMWSLGVILYELLTLHRP 270

Length = 478

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 47.6 bits (114), Expect = 1e-06
 Identities = 33/110 (30%), Positives = 49/110 (44%), Gaps = 18/110 (16%)

Query: 25  IMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQT 84
           I+ +V   LEY H        IH D+K  NILL E     ++DFG+S   G+    +++ 
Sbjct: 103 ILREVLLGLEYLH----EEGKIHRDIKAANILLSEEGDVKLADFGVS---GQLTSTMSKR 155

Query: 85  MTMA-TIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGE 133
            T   T  +MAPE   +     K D++S G+             E+  GE
Sbjct: 156 NTFVGTPFWMAPEVIKQSGYDEKADIWSLGI----------TAIELAKGE 195

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 47.3 bits (112), Expect = 1e-06
 Identities = 44/134 (32%), Positives = 59/134 (44%), Gaps = 16/134 (11%)

Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           MP GS++  L SY    + + R          LE   + HS+  I+H D+K  NIL D  
Sbjct: 88  MPGGSIKDQLKSYGALTENVTRKYTR----QILEGVSYLHSNM-IVHRDIKGANILRDSV 142

Query: 61  MVAHVSDFGISKLL------GEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGV 114
               + DFG SK L      G G   VT      T  +M+PE  S      K D++S G 
Sbjct: 143 GNVKLGDFGASKRLQTICLSGTGMKSVT-----GTPYWMSPEVISGEGYGRKADIWSVGC 197

Query: 115 LLMETFTRKRPTDE 128
            ++E  T K P  E
Sbjct: 198 TVVEMLTEKPPWAE 211

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 47.3 bits (112), Expect = 1e-06
 Identities = 39/137 (28%), Positives = 60/137 (43%), Gaps = 23/137 (16%)

Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           MPNG   + + SY Y             +  A+ + H       I+H D+KP N+L+  N
Sbjct: 93  MPNGVPPEKVRSYIY------------QLIKAIHWCHKND----IVHRDIKPENLLISHN 136

Query: 61  MVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLME-- 118
            V  + DFG ++ L EG +    T  +AT  Y +PE           D++S G +L E  
Sbjct: 137 DVLKLCDFGFARNLSEGSN-ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELS 195

Query: 119 ----TFTRKRPTDEMFT 131
                F  +   D++FT
Sbjct: 196 DGQPLFPGESEIDQLFT 212

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 47.3 bits (112), Expect = 1e-06
 Identities = 24/92 (26%), Positives = 47/92 (51%)

Query: 46  IHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSA 105
           +H DL   N ++ E+    + DFG+++ + E + +      +  + +M+PE   +G+ + 
Sbjct: 141 VHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTT 200

Query: 106 KCDVYSYGVLLMETFTRKRPTDEMFTGEMSLR 137
             DV+S+GV+L E  T      +  + E  LR
Sbjct: 201 YSDVWSFGVVLWEIATLAEQPYQGMSNEQVLR 232

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 47.5 bits (113), Expect = 1e-06
 Identities = 36/98 (36%), Positives = 51/98 (52%), Gaps = 12/98 (12%)

Query: 31  SALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMA-T 89
           S LE+ H       II+ DLKP N+LLD +    +SD G++  L +G+   ++T   A T
Sbjct: 108 SGLEHLHQRR----IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ---SKTKGYAGT 160

Query: 90  IGYMAPEY--GSEGIVSAKCDVYSYGVLLMETFTRKRP 125
            G+MAPE   G E   S   D ++ GV L E    + P
Sbjct: 161 PGFMAPELLQGEEYDFSV--DYFALGVTLYEMIAARGP 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 47.7 bits (113), Expect = 1e-06
 Identities = 23/76 (30%), Positives = 46/76 (60%)

Query: 46  IHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSA 105
           IH DL   N+L+ E+ V  ++DFG+++ + + + +   +     + +MAPE   + + + 
Sbjct: 156 IHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTH 215

Query: 106 KCDVYSYGVLLMETFT 121
           + DV+S+G+L+ E FT
Sbjct: 216 QSDVWSFGILMWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 47.0 bits (112), Expect = 1e-06
 Identities = 36/97 (37%), Positives = 50/97 (51%), Gaps = 13/97 (13%)

Query: 31  SALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTM-AT 89
            ALEY H    S  I++ DLKP NILLD+     ++DFG +K L        +T T+  T
Sbjct: 112 CALEYLH----SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKL------RDRTWTLCGT 161

Query: 90  IGYMAPE-YGSEGIVSAKCDVYSYGVLLMETFTRKRP 125
             Y+APE   S+G   A  D ++ G+L+ E      P
Sbjct: 162 PEYLAPEVIQSKGHNKA-VDWWALGILIYEMLVGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 47.1 bits (112), Expect = 1e-06
 Identities = 30/102 (29%), Positives = 49/102 (48%), Gaps = 4/102 (3%)

Query: 20  LERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED 79
            E+L I   V + + Y          +H DL   N L+ ENMV  ++DFG+S+ +   + 
Sbjct: 130 TEQLCIAKQVAAGMAYLSERK----FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY 185

Query: 80  FVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT 121
           +         I +M PE       + + DV++YGV+L E F+
Sbjct: 186 YKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 46.7 bits (111), Expect = 2e-06
 Identities = 37/118 (31%), Positives = 55/118 (46%), Gaps = 19/118 (16%)

Query: 24  NIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQ 83
              + + SALE+ H    S  I+H D+KP N+ +    V  + D      LG G  F ++
Sbjct: 110 KYFVQLCSALEHMH----SKRIMHRDIKPANVFITATGVVKLGD------LGLGRFFSSK 159

Query: 84  TMT----MATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGE-MSL 136
           T      + T  YM+PE   E   + K D++S G LL E    + P    F G+ M+L
Sbjct: 160 TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP----FYGDKMNL 213

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 47.0 bits (112), Expect = 2e-06
 Identities = 31/103 (30%), Positives = 51/103 (49%), Gaps = 13/103 (12%)

Query: 25  IMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQT 84
           +M+ +   L+Y H       IIH DLK +N+LL +     ++DFG+++  G       + 
Sbjct: 113 LMLQLLRGLQYLHENF----IIHRDLKVSNLLLTDKGCLKIADFGLARTYG----LPAKP 164

Query: 85  MT--MATIGYMAPE--YGSEGIVSAKCDVYSYGVLLMETFTRK 123
           MT  + T+ Y APE   G     +A  D+++ G +L E    K
Sbjct: 165 MTPKVVTLWYRAPELLLGCTTYTTA-IDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 46.7 bits (111), Expect = 2e-06
 Identities = 40/122 (32%), Positives = 56/122 (45%), Gaps = 22/122 (18%)

Query: 32  ALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTM-ATI 90
           A EY H    S  II+ DLKP N+LLD      V+DFG +K + +      +T T+  T 
Sbjct: 130 AFEYLH----SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD------RTFTLCGTP 179

Query: 91  GYMAPEY-GSEGIVSAKCDVYSYGVLLMETF---------TRKRPTDEMFTGEMSLRRWV 140
            Y+APE   S+G   A  D ++ GVLL E           T  R  +++  G +    W 
Sbjct: 180 EYLAPEVIQSKGHGKA-VDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWF 238

Query: 141 KE 142
             
Sbjct: 239 DG 240

Length = 329

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 46.8 bits (111), Expect = 2e-06
 Identities = 32/102 (31%), Positives = 52/102 (50%), Gaps = 9/102 (8%)

Query: 41  SSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSE 100
           SS   +H DL   N L+ +N    ++DFG+S+ L  G+ +  Q   +  I +M+ E    
Sbjct: 147 SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILL 206

Query: 101 GIVSAKCDVYSYGVLLMETFT--RKRP----TDEMF---TGE 133
           G  +   DV+++GV L E  T  +++P    +DE     TGE
Sbjct: 207 GKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTGE 248

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 46.6 bits (110), Expect = 2e-06
 Identities = 29/105 (27%), Positives = 54/105 (51%), Gaps = 6/105 (5%)

Query: 25  IMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQT 84
           I+ ++   L+Y H    S   IH D+K  N+LL E+    ++DFG++  L + +  + + 
Sbjct: 106 ILREILKGLDYLH----SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--IKRN 159

Query: 85  MTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEM 129
             + T  +MAPE   +    +K D++S G+  +E    + P  E+
Sbjct: 160 TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSEL 204

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 46.2 bits (110), Expect = 3e-06
 Identities = 30/91 (32%), Positives = 42/91 (46%), Gaps = 17/91 (18%)

Query: 38  HGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPE- 96
           H H+   IIH D+KP NIL+ E+ V  + DFG ++ L         T  +AT  Y APE 
Sbjct: 117 HSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARPA-SPLTDYVATRWYRAPEL 172

Query: 97  ------YGSEGIVSAKCDVYSYGVLLMETFT 121
                 YG         DV++ G ++ E   
Sbjct: 173 LVGDTNYGKP------VDVWAIGCIMAELLD 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 46.1 bits (109), Expect = 3e-06
 Identities = 27/75 (36%), Positives = 42/75 (56%), Gaps = 9/75 (12%)

Query: 45  IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQT--MTMATIGYMAPEYGSEGI 102
           +++ DLKP NILLDE+    +SD G++       DF  +    ++ T GYMAPE   +G+
Sbjct: 118 VVYRDLKPANILLDEHGHVRISDLGLAC------DFSKKKPHASVGTHGYMAPEVLQKGV 171

Query: 103 V-SAKCDVYSYGVLL 116
              +  D +S G +L
Sbjct: 172 AYDSSADWFSLGCML 186

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 46.2 bits (109), Expect = 3e-06
 Identities = 33/95 (34%), Positives = 45/95 (47%), Gaps = 12/95 (12%)

Query: 38  HGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEY 97
           H H+   +IH D+K  NILL E  +  + DFG + ++     FV       T  +MAPE 
Sbjct: 132 HSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV------GTPYWMAPEV 182

Query: 98  ---GSEGIVSAKCDVYSYGVLLMETFTRKRPTDEM 129
                EG    K DV+S G+  +E   RK P   M
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 217

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 45.9 bits (108), Expect = 4e-06
 Identities = 33/95 (34%), Positives = 44/95 (46%), Gaps = 12/95 (12%)

Query: 38  HGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEY 97
           H H+   +IH D+K  NILL E     ++DFG + +      FV       T  +MAPE 
Sbjct: 142 HSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV------GTPYWMAPEV 192

Query: 98  ---GSEGIVSAKCDVYSYGVLLMETFTRKRPTDEM 129
                EG    K DV+S G+  +E   RK P   M
Sbjct: 193 ILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 227

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 45.9 bits (109), Expect = 4e-06
 Identities = 33/105 (31%), Positives = 50/105 (47%), Gaps = 21/105 (20%)

Query: 25  IMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLL-GEGEDFVTQ 83
            +  +   +E+ H    S  IIH D+KP NIL+ ++ V  + DFG ++ L   GE +   
Sbjct: 105 YLFQILRGIEFCH----SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY--- 157

Query: 84  TMTMATIGYMAPE-------YGSEGIVSAKCDVYSYGVLLMETFT 121
           T  +AT  Y APE       YG         D+++ G L+ E  T
Sbjct: 158 TDYVATRWYRAPELLVGDTKYGR------AVDIWAVGCLVTEMLT 196

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 45.6 bits (108), Expect = 4e-06
 Identities = 35/132 (26%), Positives = 59/132 (44%), Gaps = 15/132 (11%)

Query: 1   MPNGSLEKWLYS------YNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTN 54
           M  G L  +L              + E L+I +DV     Y    H     IH DL   N
Sbjct: 81  MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH----FIHRDLAARN 136

Query: 55  ILLDE-----NMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDV 109
            L+ E     + V  + DFG+++ + + + +  +   +  + +MAPE   +G  + + DV
Sbjct: 137 CLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDV 196

Query: 110 YSYGVLLMETFT 121
           +S+GVL+ E  T
Sbjct: 197 WSFGVLMWEILT 208

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 45.8 bits (109), Expect = 4e-06
 Identities = 31/92 (33%), Positives = 43/92 (46%), Gaps = 8/92 (8%)

Query: 28  DVGSALEYPH-HGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMT 86
           ++   L++ H  G     II+ DLK  N+LLD      ++DFG+ K  G      T T  
Sbjct: 104 EIVLGLQFLHERG-----IIYRDLKLDNVLLDSEGHIKIADFGMCK-EGILGGVTTSTFC 157

Query: 87  MATIGYMAPEYGSEGIVSAKCDVYSYGVLLME 118
             T  Y+APE  S        D ++ GVLL E
Sbjct: 158 -GTPDYIAPEILSYQPYGPAVDWWALGVLLYE 188

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 45.8 bits (108), Expect = 4e-06
 Identities = 36/125 (28%), Positives = 55/125 (44%), Gaps = 5/125 (4%)

Query: 23  LNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVT 82
           LN  + +   + Y         ++H DL   N+L+       ++DFG++KLLG  E    
Sbjct: 112 LNWCVQIAKGMNYLEERR----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYH 167

Query: 83  QTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVK 141
                  I +MA E     I + + DV+SYGV + E  T   +P D +   E+S      
Sbjct: 168 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG 227

Query: 142 ESLPH 146
           E LP 
Sbjct: 228 ERLPQ 232

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 45.7 bits (109), Expect = 4e-06
 Identities = 32/96 (33%), Positives = 45/96 (46%), Gaps = 23/96 (23%)

Query: 33  LEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMAT--- 89
           L Y H        IH D+K  NILL E+    ++DFG+S  L         T T+A    
Sbjct: 114 LAYLHETG----KIHRDIKGANILLTEDGDVKLADFGVSAQL---------TATIAKRKS 160

Query: 90  -IG---YMAPEYGSE---GIVSAKCDVYSYGVLLME 118
            IG   +MAPE  +    G    KCD+++ G+  +E
Sbjct: 161 FIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIE 196

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 45.5 bits (108), Expect = 4e-06
 Identities = 33/119 (27%), Positives = 52/119 (43%), Gaps = 9/119 (7%)

Query: 41  SSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSE 100
           S+A  +H DL   N L+       VS   +SK +   E +  +   +  + ++APE   E
Sbjct: 134 SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRN-ALIPLRWLAPEAVQE 192

Query: 101 GIVSAKCDVYSYGVLLMETFTR------KRPTDEMFTG--EMSLRRWVKESLPHGLTEV 151
              S K DV+S+GVL+ E FT+          +E+        L   V E  P  L ++
Sbjct: 193 DDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVPEGCPSRLYKL 251

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 45.8 bits (108), Expect = 5e-06
 Identities = 28/102 (27%), Positives = 53/102 (51%), Gaps = 8/102 (7%)

Query: 24  NIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQ 83
           ++M  +   L++ H    S  ++H DLKP NIL+  +    ++DFG++++       +  
Sbjct: 114 DMMFQLLRGLDFLH----SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ---MAL 166

Query: 84  TMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRP 125
           T  + T+ Y APE   +   +   D++S G +  E F R++P
Sbjct: 167 TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF-RRKP 207

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 45.7 bits (108), Expect = 5e-06
 Identities = 39/123 (31%), Positives = 56/123 (45%), Gaps = 7/123 (5%)

Query: 4   GSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVA 63
           G +   LY  + F +   R     ++  ALE+ H       I++ D+K  NILLD     
Sbjct: 90  GEMFTHLYQRDNFSEDEVRFYSG-EIILALEHLH----KLGIVYRDIKLENILLDSEGHV 144

Query: 64  HVSDFGISKLLGEGEDFVTQTMTMATIGYMAPE-YGSEGIVSAKCDVYSYGVLLMETFTR 122
            ++DFG+SK     E   T +    TI YMAPE    +G      D +S G+L+ E  T 
Sbjct: 145 VLTDFGLSKEFLSEEKERTYSFC-GTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTG 203

Query: 123 KRP 125
             P
Sbjct: 204 ASP 206

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 45.3 bits (107), Expect = 5e-06
 Identities = 29/95 (30%), Positives = 44/95 (46%), Gaps = 4/95 (4%)

Query: 42  SAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEG 101
           S  I+H D+KP+N+L++      + DFG+S  L            + T  YMAPE  S  
Sbjct: 113 SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS----IAKTYVGTNAYMAPERISGE 168

Query: 102 IVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSL 136
                 DV+S G+  ME    + P  ++   + SL
Sbjct: 169 QYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSL 203

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 45.3 bits (107), Expect = 6e-06
 Identities = 42/212 (19%), Positives = 84/212 (39%), Gaps = 29/212 (13%)

Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           +P+GSL+++L       ++ ++L   + +   ++Y      S   +H DL   N+L++  
Sbjct: 90  LPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDY----LGSRQYVHRDLAARNVLVESE 145

Query: 61  MVAHVSDFGISKLLGEGEDFVTQTMTM-ATIGYMAPEYGSEGIVSAKCDVYSYGVLLMET 119
               + DFG++K +   +++ T    + + + + APE   +       DV+S+GV L E 
Sbjct: 146 HQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYEL 205

Query: 120 FT----RKRPTDEMFT------GEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDC 169
            T       P            G+M++ R V+              ++ E +      +C
Sbjct: 206 LTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR--------------VLEEGKRLPRPPNC 251

Query: 170 IVSIMDLALDCCMESPGKRINMTDAAAKLKKI 201
              +  L   C    P KR    +     + I
Sbjct: 252 PEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 45.3 bits (107), Expect = 7e-06
 Identities = 33/88 (37%), Positives = 44/88 (50%), Gaps = 7/88 (7%)

Query: 32  ALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIG 91
           ALE+ H       I++ DLKP NILLD      + DFG+SK     ++  T T    T  
Sbjct: 108 ALEHLHKYD----IVYRDLKPENILLDATGHIALCDFGLSK-ANLTDNKTTNTFC-GTTE 161

Query: 92  YMAPE-YGSEGIVSAKCDVYSYGVLLME 118
           Y+APE    E   +   D +S GVL+ E
Sbjct: 162 YLAPEVLLDEKGYTKHVDFWSLGVLVFE 189

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 45.2 bits (107), Expect = 7e-06
 Identities = 33/100 (33%), Positives = 50/100 (50%), Gaps = 26/100 (26%)

Query: 33  LEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMT--MATI 90
           L+Y H    SA ++H DLKP+NIL++EN    + DFG++++    +D     MT  ++T 
Sbjct: 121 LKYVH----SAGVVHRDLKPSNILINENCDLKICDFGLARI----QD---PQMTGYVSTR 169

Query: 91  GYMAPE-------YGSEGIVSAKCDVYSYGVLLMETFTRK 123
            Y APE       Y  E       D++S G +  E    K
Sbjct: 170 YYRAPEIMLTWQKYDVE------VDIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 45.2 bits (107), Expect = 7e-06
 Identities = 28/69 (40%), Positives = 36/69 (52%), Gaps = 6/69 (8%)

Query: 28  DVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTM 87
           ++ SAL Y H    S  II+ DLKP NILLD      ++DFG+ K   E     T +   
Sbjct: 104 EIASALGYLH----SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK--TTSTFC 157

Query: 88  ATIGYMAPE 96
            T  Y+APE
Sbjct: 158 GTPEYLAPE 166

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 44.9 bits (107), Expect = 7e-06
 Identities = 28/106 (26%), Positives = 50/106 (47%), Gaps = 19/106 (17%)

Query: 24  NIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQ 83
           ++M  +   +++ H    S  I+H DLKP NIL+  +    ++DFG++++          
Sbjct: 111 DLMRQLLRGVDFLH----SHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMAL--- 163

Query: 84  TMTMATIGYMAPE------YGSEGIVSAKCDVYSYGVLLMETFTRK 123
           T  + T+ Y APE      Y +        D++S G +  E F R+
Sbjct: 164 TSVVVTLWYRAPEVLLQSSYAT------PVDMWSVGCIFAELFRRR 203

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 45.0 bits (106), Expect = 8e-06
 Identities = 25/79 (31%), Positives = 41/79 (51%), Gaps = 3/79 (3%)

Query: 45  IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVS 104
           I+H DLKP NIL+       ++DFG++++       +  T  + T+ Y APE   +   +
Sbjct: 129 IVHRDLKPENILVTSGGQVKLADFGLARIYSCQ---MALTPVVVTLWYRAPEVLLQSTYA 185

Query: 105 AKCDVYSYGVLLMETFTRK 123
              D++S G +  E F RK
Sbjct: 186 TPVDMWSVGCIFAEMFRRK 204

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 45.0 bits (106), Expect = 8e-06
 Identities = 40/131 (30%), Positives = 60/131 (45%), Gaps = 15/131 (11%)

Query: 1   MPNGSLEKWLYSYNYFFDILERLN--IMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLD 58
           MP G L   + +Y    D+ E+       +V  AL+  H    S  +IH D+KP N+LLD
Sbjct: 125 MPGGDLVNLMSNY----DVPEKWAKFYTAEVVLALDAIH----SMGLIHRDVKPDNMLLD 176

Query: 59  ENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEY----GSEGIVSAKCDVYSYGV 114
           ++    ++DFG    + E    V     + T  Y++PE     G +G    +CD +S GV
Sbjct: 177 KHGHLKLADFGTCMKMDE-TGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGV 235

Query: 115 LLMETFTRKRP 125
            L E      P
Sbjct: 236 FLFEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 44.6 bits (105), Expect = 9e-06
 Identities = 40/137 (29%), Positives = 58/137 (42%), Gaps = 22/137 (16%)

Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           MP GS++  L +Y    + + R      +   + Y H    S  I+H D+K  NIL D  
Sbjct: 88  MPGGSIKDQLKAYGALTENVTR-RYTRQILQGVSYLH----SNMIVHRDIKGANILRDSA 142

Query: 61  MVAHVSDFGISKLLGEGEDFVTQTMTMATIG---------YMAPEYGSEGIVSAKCDVYS 111
               + DFG SK +        QT+ M+  G         +M+PE  S      K DV+S
Sbjct: 143 GNVKLGDFGASKRI--------QTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWS 194

Query: 112 YGVLLMETFTRKRPTDE 128
               ++E  T K P  E
Sbjct: 195 VACTVVEMLTEKPPWAE 211

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 45.0 bits (107), Expect = 9e-06
 Identities = 33/101 (32%), Positives = 49/101 (48%), Gaps = 26/101 (25%)

Query: 32  ALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMT--MAT 89
            L+Y H    SA IIH DLKP+NI ++E+    + DFG+++   +        MT  +AT
Sbjct: 130 GLKYIH----SAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDD-------EMTGYVAT 178

Query: 90  IGYMAPE-------YGSEGIVSAKCDVYSYGVLLMETFTRK 123
             Y APE       Y      +   D++S G ++ E  T K
Sbjct: 179 RWYRAPEIMLNWMHY------NQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 44.6 bits (105), Expect = 9e-06
 Identities = 28/84 (33%), Positives = 43/84 (51%), Gaps = 9/84 (10%)

Query: 45  IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQT--MTMATIGYMAPEYGSEGI 102
           +++ DLKP NILLDE+    +SD G++       DF  +    ++ T GYMAPE   +G 
Sbjct: 118 VVYRDLKPANILLDEHGHVRISDLGLAC------DFSKKKPHASVGTHGYMAPEVLQKGT 171

Query: 103 V-SAKCDVYSYGVLLMETFTRKRP 125
              +  D +S G +L +      P
Sbjct: 172 AYDSSADWFSLGCMLFKLLRGHSP 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 44.9 bits (106), Expect = 9e-06
 Identities = 34/112 (30%), Positives = 58/112 (51%), Gaps = 10/112 (8%)

Query: 23  LNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVT 82
           L++ + + S ++Y     SS   +H DL   N L+ EN+   ++DFG+S+ L  G+ +  
Sbjct: 141 LHVALQIASGMKY----LSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRI 196

Query: 83  QTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT--RKRP----TDE 128
           Q   +  I +MA E    G  +   DV+++GV L E     +++P    TDE
Sbjct: 197 QGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDE 248

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 44.9 bits (106), Expect = 1e-05
 Identities = 44/122 (36%), Positives = 57/122 (46%), Gaps = 11/122 (9%)

Query: 32  ALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIG 91
           ALE  H       +I+ DLKP NILLD      + DFG+ KL  + +D  T T    T  
Sbjct: 105 ALENLH----KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD-KTNTFC-GTPE 158

Query: 92  YMAPEYGSEGIVSAKC-DVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESL--PHGL 148
           Y+APE    G    K  D ++ GVLL E  T   P  +    EM  R+ ++E L  P G 
Sbjct: 159 YLAPELLL-GHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEM-YRKILQEPLRFPDGF 216

Query: 149 TE 150
             
Sbjct: 217 DR 218

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 44.6 bits (106), Expect = 1e-05
 Identities = 45/156 (28%), Positives = 63/156 (40%), Gaps = 54/156 (34%)

Query: 1   MPNGSLEKWLYSYNYFFDILERLNI--MIDVGSALEYPHH-GHSSAPIIHCDLKPTNILL 57
           MP G L   L   + F +   R  I  ++    AL+  H  G      IH D+KP NIL+
Sbjct: 83  MPGGDLMNLLIRKDVFPEETARFYIAELV---LALDSVHKLGF-----IHRDIKPDNILI 134

Query: 58  DENMVAHV--SDFGISKLLGEGEDFV----------------------TQTMTMA--TIG 91
           D +   H+  +DFG+ K + + +D                         Q    A  T+G
Sbjct: 135 DAD--GHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVG 192

Query: 92  ---YMAPE------YGSEGIVSAKCDVYSYGVLLME 118
              Y+APE      YG E      CD +S GV+L E
Sbjct: 193 TPDYIAPEVLRGTPYGLE------CDWWSLGVILYE 222

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 44.6 bits (105), Expect = 1e-05
 Identities = 37/113 (32%), Positives = 50/113 (44%), Gaps = 10/113 (8%)

Query: 20  LERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED 79
           L+ + I      AL+   + HS   +IH D+K  NILL E     ++DFG +        
Sbjct: 118 LQEVEIAAITHGALQGLAYLHSHN-MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANS 176

Query: 80  FVTQTMTMATIGYMAPEY---GSEGIVSAKCDVYSYGVLLMETFTRKRPTDEM 129
           FV       T  +MAPE      EG    K DV+S G+  +E   RK P   M
Sbjct: 177 FV------GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 223

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 44.8 bits (106), Expect = 1e-05
 Identities = 36/109 (33%), Positives = 50/109 (45%), Gaps = 13/109 (11%)

Query: 28  DVGSALEYPH-HGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMT 86
           +V  AL + H HG     +I+ DLK  NILLD      ++DFG+ K  G      T T  
Sbjct: 104 EVTLALMFLHRHG-----VIYRDLKLDNILLDAEGHCKLADFGMCK-EGILNGVTTTTFC 157

Query: 87  MATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRP-----TDEMF 130
             T  Y+APE   E       D ++ GVL+ E    + P      D++F
Sbjct: 158 -GTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLF 205

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 44.5 bits (106), Expect = 1e-05
 Identities = 33/121 (27%), Positives = 56/121 (46%), Gaps = 17/121 (14%)

Query: 17  FDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGE 76
           F   E   +M+ + S + + H       I+H DLK +N+LL+   +  + DFG+++  G 
Sbjct: 103 FLQSEVKCLMLQLLSGVAHLHDNW----ILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158

Query: 77  GEDFVTQTMT--MATIGYMAPE--YGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTG 132
                 +  T  + T+ Y APE   G     S   D++S G +  E    K+P   +F G
Sbjct: 159 ----PLKPYTQLVVTLWYRAPELLLG-AKEYSTAIDMWSVGCIFAE-LLTKKP---LFPG 209

Query: 133 E 133
           +
Sbjct: 210 K 210

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 44.6 bits (105), Expect = 1e-05
 Identities = 40/131 (30%), Positives = 60/131 (45%), Gaps = 15/131 (11%)

Query: 1   MPNGSLEKWLYSYNYFFDILERLN--IMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLD 58
           MP G L   + +Y    D+ E+       +V  AL+  H    S   IH D+KP N+LLD
Sbjct: 125 MPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIH----SMGFIHRDVKPDNMLLD 176

Query: 59  ENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEY----GSEGIVSAKCDVYSYGV 114
           ++    ++DFG    + + E  V     + T  Y++PE     G +G    +CD +S GV
Sbjct: 177 KSGHLKLADFGTCMKMNK-EGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGV 235

Query: 115 LLMETFTRKRP 125
            L E      P
Sbjct: 236 FLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 44.6 bits (105), Expect = 1e-05
 Identities = 33/91 (36%), Positives = 45/91 (49%), Gaps = 6/91 (6%)

Query: 28  DVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTM 87
           +V SA+ Y H    S  II+ DLKP NILLD      ++DFG+ K   E E+  T +   
Sbjct: 104 EVASAIGYLH----SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE--TTSTFC 157

Query: 88  ATIGYMAPEYGSEGIVSAKCDVYSYGVLLME 118
            T  Y+APE   +       D +  G +L E
Sbjct: 158 GTPEYLAPEVLRKEPYDRTVDWWCLGAVLYE 188

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 44.2 bits (104), Expect = 2e-05
 Identities = 32/122 (26%), Positives = 54/122 (44%), Gaps = 6/122 (4%)

Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEY-PHHGHSSAPIIHCDLKPTNILLDE 59
            P GSL   +  +    D    LN  + +   + Y   H      ++H +L   NILL  
Sbjct: 90  SPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR-----MVHRNLAARNILLKS 144

Query: 60  NMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMET 119
           + +  ++DFG++ LL   +     +     I +MA E    G  + + DV+SYGV + E 
Sbjct: 145 DSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEM 204

Query: 120 FT 121
            +
Sbjct: 205 MS 206

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 44.2 bits (104), Expect = 2e-05
 Identities = 19/76 (25%), Positives = 41/76 (53%)

Query: 46  IHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSA 105
           +H DL   N ++  +    + DFG+++ + E + +      +  + +MAPE   +G+ + 
Sbjct: 141 VHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTT 200

Query: 106 KCDVYSYGVLLMETFT 121
             D++S+GV+L E  +
Sbjct: 201 SSDMWSFGVVLWEITS 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 43.9 bits (103), Expect = 2e-05
 Identities = 30/103 (29%), Positives = 49/103 (47%), Gaps = 14/103 (13%)

Query: 27  IDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMT 86
           + + SALE+ H    S  ++H D+KP N+ +    V  + D G+ +       F ++T  
Sbjct: 113 VQLCSALEHMH----SRRVMHRDIKPANVFITATGVVKLGDLGLGRF------FSSKTTA 162

Query: 87  ----MATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRP 125
               + T  YM+PE   E   + K D++S G LL E    + P
Sbjct: 163 AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 44.1 bits (104), Expect = 2e-05
 Identities = 35/109 (32%), Positives = 51/109 (46%), Gaps = 13/109 (11%)

Query: 28  DVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEG-EDFVTQTMT 86
           ++ SAL + H       II+ DLK  N+LLD      ++DFG+ K   EG  +  T +  
Sbjct: 104 EITSALMFLH----DKGIIYRDLKLDNVLLDHEGHCKLADFGMCK---EGIFNGKTTSTF 156

Query: 87  MATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRP-----TDEMF 130
             T  Y+APE   E +     D ++ GVLL E      P      D++F
Sbjct: 157 CGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLF 205

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 44.0 bits (104), Expect = 2e-05
 Identities = 30/108 (27%), Positives = 49/108 (45%), Gaps = 19/108 (17%)

Query: 45  IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQT----------MT--MATIGY 92
            +H DL P NI ++   +  ++DFG+++  G      T +          MT  + T+ Y
Sbjct: 140 FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWY 199

Query: 93  MAPE--YGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRR 138
            APE   G+E    A  D++S G +  E  T K     +F GE  + +
Sbjct: 200 RAPELLMGAEKYHFA-VDMWSVGCIFAELLTGK----PLFPGENEIDQ 242

Length = 335

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 44.0 bits (104), Expect = 2e-05
 Identities = 33/105 (31%), Positives = 49/105 (46%), Gaps = 11/105 (10%)

Query: 31  SALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATI 90
             L++ H       II+ DLK  N+LLD++    ++DFG+ K    GE     +    T 
Sbjct: 107 CGLQFLH----KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEG--KASTFCGTP 160

Query: 91  GYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRP-----TDEMF 130
            Y+APE       +   D +S+GVLL E    + P      DE+F
Sbjct: 161 DYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELF 205

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 43.7 bits (103), Expect = 2e-05
 Identities = 28/83 (33%), Positives = 42/83 (50%), Gaps = 16/83 (19%)

Query: 45  IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIG---YMAPEYGSEG 101
           IIH D+KPTN+L++ N    + DFG+S  L         ++    IG   YMAPE    G
Sbjct: 124 IIHRDVKPTNVLVNGNGQVKLCDFGVSGNL-------VASLAKTNIGCQSYMAPERIKSG 176

Query: 102 IVSA------KCDVYSYGVLLME 118
             +       + DV+S G+ ++E
Sbjct: 177 GPNQNPTYTVQSDVWSLGLSILE 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 43.6 bits (103), Expect = 2e-05
 Identities = 28/81 (34%), Positives = 43/81 (53%), Gaps = 5/81 (6%)

Query: 45  IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPE--YGSEGI 102
           ++H DLKP N+L+D   V  ++DFG+++    G      T  + T+ Y APE   GS   
Sbjct: 122 VLHRDLKPQNLLIDNKGVIKLADFGLARAF--GIPVRVYTHEVVTLWYRAPEVLLGSP-R 178

Query: 103 VSAKCDVYSYGVLLMETFTRK 123
            S   D++S G +  E  T+K
Sbjct: 179 YSTPVDIWSIGTIFAEMATKK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 43.5 bits (102), Expect = 2e-05
 Identities = 38/126 (30%), Positives = 63/126 (50%), Gaps = 10/126 (7%)

Query: 1   MPNGSLEKWLYSYNYF-FDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDE 59
           M  GSL++ L        +IL +++I +  G  L Y    H    I+H D+KP+NIL++ 
Sbjct: 85  MDGGSLDQVLKEAKRIPEEILGKVSIAVLRG--LAYLREKHQ---IMHRDVKPSNILVNS 139

Query: 60  NMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMET 119
                + DFG+S   G+  D +  +  + T  YM+PE       S + D++S G+ L+E 
Sbjct: 140 RGEIKLCDFGVS---GQLIDSMANSF-VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEL 195

Query: 120 FTRKRP 125
              + P
Sbjct: 196 AIGRYP 201

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 43.2 bits (103), Expect = 2e-05
 Identities = 28/86 (32%), Positives = 41/86 (47%), Gaps = 16/86 (18%)

Query: 31  SALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMT--MA 88
             L Y H    S  I+H DLKP NIL++ + V  ++DFG+++  G       +T T  + 
Sbjct: 109 RGLAYCH----SHRILHRDLKPQNILINRDGVLKLADFGLARAFG----IPLRTYTHEVV 160

Query: 89  TIGYMAPEYGSEGIVSAKCDVYSYGV 114
           T+ Y APE      +      YS  V
Sbjct: 161 TLWYRAPE------ILLGSKHYSTAV 180

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 43.1 bits (101), Expect = 3e-05
 Identities = 28/105 (26%), Positives = 52/105 (49%), Gaps = 6/105 (5%)

Query: 25  IMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQT 84
           I+ ++   L+Y H    S   IH D+K  N+LL E     ++DFG++  L + +  + + 
Sbjct: 106 ILREILKGLDYLH----SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--IKRN 159

Query: 85  MTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEM 129
             + T  +MAPE   +     K D++S G+  +E    + P  ++
Sbjct: 160 TFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDL 204

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 43.1 bits (101), Expect = 4e-05
 Identities = 31/99 (31%), Positives = 49/99 (49%), Gaps = 8/99 (8%)

Query: 28  DVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEG-EDFVTQTMT 86
           ++ SAL+Y H G     I++ DLK  N++LD++    ++DFG+ K   EG  D  T    
Sbjct: 103 EIVSALDYLHSGK----IVYRDLKLENLMLDKDGHIKITDFGLCK---EGITDAATMKTF 155

Query: 87  MATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRP 125
             T  Y+APE   +       D +  GV++ E    + P
Sbjct: 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 42.8 bits (101), Expect = 4e-05
 Identities = 39/136 (28%), Positives = 59/136 (43%), Gaps = 30/136 (22%)

Query: 45  IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIG---YMAPEYGSEG 101
            IH DLKP N L+D +    ++DFG+SK        VT   ++  +G   YMAPE     
Sbjct: 122 YIHRDLKPENFLIDASGHIKLTDFGLSK------GIVTYANSV--VGSPDYMAPE----- 168

Query: 102 IVSAK-----CDVYSYGVLLMETFTRKRP-----TDEMFTGEMSLRRWVKESLPHGLTEV 151
           ++  K      D +S G +L E      P      +E +    +L+ W KE+L   + + 
Sbjct: 169 VLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWE---NLKYW-KETLQRPVYDD 224

Query: 152 VDANLVREEQAFAAKM 167
              NL  E      K+
Sbjct: 225 PRFNLSDEAWDLITKL 240

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 42.7 bits (100), Expect = 4e-05
 Identities = 28/86 (32%), Positives = 45/86 (52%), Gaps = 8/86 (9%)

Query: 46  IHCDLKPTNILLDENMVAHVSDFGIS-KLLGEGEDFVTQTMTMATIGYMAPEY-----GS 99
           +H D+KP NIL+D N    ++DFG   KL+ +G   V  ++ + T  Y++PE        
Sbjct: 124 VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT--VQSSVAVGTPDYISPEILQAMEDG 181

Query: 100 EGIVSAKCDVYSYGVLLMETFTRKRP 125
           +G    +CD +S GV + E    + P
Sbjct: 182 KGKYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 42.7 bits (100), Expect = 4e-05
 Identities = 31/109 (28%), Positives = 52/109 (47%), Gaps = 16/109 (14%)

Query: 27  IDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMT 86
           + + SA+E+ H    S  ++H D+KP N+ +    V  + D G+ +       F ++T  
Sbjct: 113 VQLCSAVEHMH----SRRVMHRDIKPANVFITATGVVKLGDLGLGRF------FSSKTTA 162

Query: 87  ----MATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRP--TDEM 129
               + T  YM+PE   E   + K D++S G LL E    + P   D+M
Sbjct: 163 AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM 211

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 42.9 bits (101), Expect = 5e-05
 Identities = 29/107 (27%), Positives = 49/107 (45%), Gaps = 12/107 (11%)

Query: 46  IHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEY------GS 99
           +H D+KP N+L+D      ++DFG +  L      V   + + T  Y+APE         
Sbjct: 124 VHRDIKPENVLIDRTGHIKLADFGSAARL-TANKMVNSKLPVGTPDYIAPEVLTTMNGDG 182

Query: 100 EGIVSAKCDVYSYGVLLMETFTRKRPTDE-----MFTGEMSLRRWVK 141
           +G    +CD +S GV+  E    + P  E      +   M+ +R++K
Sbjct: 183 KGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLK 229

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 42.7 bits (100), Expect = 5e-05
 Identities = 38/126 (30%), Positives = 63/126 (50%), Gaps = 10/126 (7%)

Query: 1   MPNGSLEKWLYSYNYFFD-ILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDE 59
           M  GSL++ L       + IL +++I +  G  L Y    H    I+H D+KP+NIL++ 
Sbjct: 85  MDGGSLDQVLKKAGRIPEQILGKVSIAVIKG--LTYLREKHK---IMHRDVKPSNILVNS 139

Query: 60  NMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMET 119
                + DFG+S   G+  D +  +  + T  YM+PE       S + D++S G+ L+E 
Sbjct: 140 RGEIKLCDFGVS---GQLIDSMANSF-VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEM 195

Query: 120 FTRKRP 125
              + P
Sbjct: 196 AIGRYP 201

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 42.5 bits (100), Expect = 5e-05
 Identities = 32/93 (34%), Positives = 48/93 (51%), Gaps = 8/93 (8%)

Query: 33  LEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGY 92
           L Y H  +     +H D+K +NILL+      ++DFG+++L    E+    T  + T+ Y
Sbjct: 129 LNYCHKKN----FLHRDIKCSNILLNNKGQIKLADFGLARLY-NSEESRPYTNKVITLWY 183

Query: 93  MAPE--YGSEGIVSAKCDVYSYGVLLMETFTRK 123
             PE   G E    A  DV+S G +L E FT+K
Sbjct: 184 RPPELLLGEERYGPA-IDVWSCGCILGELFTKK 215

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 42.9 bits (101), Expect = 5e-05
 Identities = 27/74 (36%), Positives = 41/74 (55%), Gaps = 7/74 (9%)

Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPH-HGHSSAPIIHCDLKPTNILLDE 59
           +  G ++  L+ Y YF + +    I  +V  AL+Y H HG     IIH DLKP N+L+  
Sbjct: 86  LIGGDVKSLLHIYGYFDEEMAVKYIS-EVALALDYLHRHG-----IIHRDLKPDNMLISN 139

Query: 60  NMVAHVSDFGISKL 73
                ++DFG+SK+
Sbjct: 140 EGHIKLTDFGLSKV 153

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 42.5 bits (100), Expect = 6e-05
 Identities = 39/124 (31%), Positives = 57/124 (45%), Gaps = 15/124 (12%)

Query: 1   MPNGSLEKWLYSYNYFFDILERLNIM--IDVGSALEYPHHGHSSAPIIHCDLKPTNILLD 58
           MP G L   + +Y    DI E+       +V  AL+  H    S   IH D+KP N+LLD
Sbjct: 125 MPGGDLVNLMSNY----DIPEKWARFYTAEVVLALDAIH----SMGFIHRDVKPDNMLLD 176

Query: 59  ENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEY----GSEGIVSAKCDVYSYGV 114
           ++    ++DFG    +      V     + T  Y++PE     G +G    +CD +S GV
Sbjct: 177 KSGHLKLADFGTCMKMDA-NGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGV 235

Query: 115 LLME 118
            L E
Sbjct: 236 FLYE 239

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 42.0 bits (99), Expect = 7e-05
 Identities = 33/103 (32%), Positives = 56/103 (54%), Gaps = 13/103 (12%)

Query: 18  DILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEG 77
           +IL +++I +  G  L Y    H    I+H D+KP+NIL++      + DFG+S   G+ 
Sbjct: 99  NILGKISIAVLRG--LTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVS---GQL 150

Query: 78  EDFVTQTMTMATIGYMAPE--YGSEGIVSAKCDVYSYGVLLME 118
            D +  +  + T  YM+PE   G+   V +  D++S G+ L+E
Sbjct: 151 IDSMANSF-VGTRSYMSPERLQGTHYTVQS--DIWSLGLSLVE 190

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 42.5 bits (100), Expect = 7e-05
 Identities = 31/95 (32%), Positives = 48/95 (50%), Gaps = 7/95 (7%)

Query: 32  ALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKL-LGEGEDFVTQTMTMATI 90
           AL+Y H    +A + H DLKP NIL + +    + DFG++++   +    +  T  +AT 
Sbjct: 115 ALKYIH----TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170

Query: 91  GYMAPEY-GS-EGIVSAKCDVYSYGVLLMETFTRK 123
            Y APE  GS     +   D++S G +  E  T K
Sbjct: 171 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 42.1 bits (99), Expect = 8e-05
 Identities = 31/97 (31%), Positives = 45/97 (46%), Gaps = 11/97 (11%)

Query: 45  IIHCDLKPTNILLDENMVAHVSDFGISKLLGEG--EDFVTQTMTMATIGYMAPEYGSEGI 102
           II+ DLK  N++LD      ++DFG+ K   E       T+T    T  Y+APE  +   
Sbjct: 122 IIYRDLKLDNVMLDAEGHIKIADFGMCK---ENIFGGKTTRTFC-GTPDYIAPEIIAYQP 177

Query: 103 VSAKCDVYSYGVLLMETFTRKRP-----TDEMFTGEM 134
                D +++GVLL E    + P      DE+F   M
Sbjct: 178 YGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIM 214

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 42.0 bits (99), Expect = 8e-05
 Identities = 29/115 (25%), Positives = 52/115 (45%), Gaps = 19/115 (16%)

Query: 17  FDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISK--LL 74
           F + E   +M  + + L Y H       I+H D+K  NIL+ ++ +  ++DFG+++   L
Sbjct: 116 FTLSEIKKVMKMLLNGLYYIH----RNKILHRDMKAANILITKDGILKLADFGLARAFSL 171

Query: 75  GEGEDFVTQTMTMATIGYMAPE-------YGSEGIVSAKCDVYSYGVLLMETFTR 122
            +       T  + T+ Y  PE       YG         D++  G ++ E +TR
Sbjct: 172 SKNSKPNRYTNRVVTLWYRPPELLLGERDYGP------PIDMWGAGCIMAEMWTR 220

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 42.0 bits (99), Expect = 8e-05
 Identities = 27/83 (32%), Positives = 38/83 (45%), Gaps = 15/83 (18%)

Query: 46  IHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPE-------YG 98
           IH D+KP NIL+ +     + DFG +++L    D  T    +AT  Y APE       YG
Sbjct: 122 IHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTD--YVATRWYRAPELLVGDTQYG 179

Query: 99  SEGIVSAKCDVYSYGVLLMETFT 121
                    DV++ G +  E  T
Sbjct: 180 P------PVDVWAIGCVFAELLT 196

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 41.7 bits (98), Expect = 8e-05
 Identities = 25/82 (30%), Positives = 41/82 (50%), Gaps = 8/82 (9%)

Query: 45  IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIG---YMAPEYGSEG 101
           I+H D+K  NI L ++    + DFGI+++L       T  +    IG   Y++PE     
Sbjct: 122 ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNS-----TVELARTCIGTPYYLSPEICENR 176

Query: 102 IVSAKCDVYSYGVLLMETFTRK 123
             + K D+++ G +L E  T K
Sbjct: 177 PYNNKSDIWALGCVLYEMCTLK 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 41.6 bits (98), Expect = 1e-04
 Identities = 30/89 (33%), Positives = 45/89 (50%), Gaps = 10/89 (11%)

Query: 32  ALEYPH-HGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTM-AT 89
            L+Y H +      I++ DLK  N+LLD      ++DFG+ K   EG  F  +T T   T
Sbjct: 113 GLQYLHENK-----IVYRDLKLDNLLLDTEGFVKIADFGLCK---EGMGFGDRTSTFCGT 164

Query: 90  IGYMAPEYGSEGIVSAKCDVYSYGVLLME 118
             ++APE  +E   +   D +  GVL+ E
Sbjct: 165 PEFLAPEVLTETSYTRAVDWWGLGVLIYE 193

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 41.5 bits (98), Expect = 1e-04
 Identities = 29/88 (32%), Positives = 44/88 (50%), Gaps = 8/88 (9%)

Query: 38  HGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPE- 96
           H H    ++H DLKP N+L+D      ++DFG+++    G    T T  + T+ Y APE 
Sbjct: 116 HSHR---VLHRDLKPQNLLIDREGALKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEI 170

Query: 97  -YGSEGIVSAKCDVYSYGVLLMETFTRK 123
             GS    S   D++S G +  E   R+
Sbjct: 171 LLGSR-QYSTPVDIWSIGCIFAEMVNRR 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 41.5 bits (97), Expect = 1e-04
 Identities = 33/92 (35%), Positives = 44/92 (47%), Gaps = 8/92 (8%)

Query: 28  DVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTM 87
           ++ SAL Y H    S  I++ DLKP NILLD      ++DFG+ K   EG      T T 
Sbjct: 104 EIASALGYLH----SINIVYRDLKPENILLDSQGHVVLTDFGLCK---EGIAQSDTTTTF 156

Query: 88  -ATIGYMAPEYGSEGIVSAKCDVYSYGVLLME 118
             T  Y+APE   +       D +  G +L E
Sbjct: 157 CGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYE 188

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 41.5 bits (97), Expect = 1e-04
 Identities = 22/48 (45%), Positives = 30/48 (62%), Gaps = 6/48 (12%)

Query: 24  NIMIDVGSALEYPH-HGHSSAPIIHCDLKPTNILLDENMVAHVSDFGI 70
           NIM D+ + LEY H HG     I H D+KP NI++D N   ++ D+GI
Sbjct: 130 NIMKDMLTTLEYIHEHG-----ISHGDIKPENIMVDGNNRGYIIDYGI 172

Length = 294

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 41.5 bits (97), Expect = 1e-04
 Identities = 30/99 (30%), Positives = 50/99 (50%), Gaps = 7/99 (7%)

Query: 28  DVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEG-EDFVTQTMT 86
           ++ SAL+Y H   S   +++ DLK  N++LD++    ++DFG+ K   EG +D  T    
Sbjct: 103 EIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK---EGIKDGATMKTF 156

Query: 87  MATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRP 125
             T  Y+APE   +       D +  GV++ E    + P
Sbjct: 157 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 41.5 bits (97), Expect = 1e-04
 Identities = 30/102 (29%), Positives = 51/102 (50%), Gaps = 14/102 (13%)

Query: 28  DVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTM 87
           ++ SALEY H    S  +++ D+K  N++LD++    ++DFG+ K   EG   ++   TM
Sbjct: 103 EIVSALEYLH----SRDVVYRDIKLENLMLDKDGHIKITDFGLCK---EG---ISDGATM 152

Query: 88  ATI----GYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRP 125
            T      Y+APE   +       D +  GV++ E    + P
Sbjct: 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 41.3 bits (97), Expect = 1e-04
 Identities = 31/120 (25%), Positives = 62/120 (51%), Gaps = 17/120 (14%)

Query: 33  LEYPHHGHSSAPIIHCDLKPTNILLD-ENMVAHVSDFGISKLLG---EGEDFVTQTMTMA 88
           L+Y H    SA ++H DLKP N+ ++ E++V  + DFG+++++      + ++++ +   
Sbjct: 127 LKYIH----SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLV-- 180

Query: 89  TIGYMAPEYG-SEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTG--EMSLRRWVKESLP 145
           T  Y +P    S    +   D+++ G +  E  T K     +F G  E+   + + ES+P
Sbjct: 181 TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK----PLFAGAHELEQMQLILESVP 236

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 41.3 bits (97), Expect = 1e-04
 Identities = 26/93 (27%), Positives = 46/93 (49%), Gaps = 18/93 (19%)

Query: 32  ALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIG 91
           AL + H    +  +IH D+K  +ILL  +    +SDFG    +   ++   +   + T  
Sbjct: 127 ALSFLH----AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQV--SKEVPRRKSLVGTPY 180

Query: 92  YMAPE------YGSEGIVSAKCDVYSYGVLLME 118
           +MAPE      YG+E       D++S G++++E
Sbjct: 181 WMAPEVISRLPYGTE------VDIWSLGIMVIE 207

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 40.9 bits (96), Expect = 2e-04
 Identities = 28/86 (32%), Positives = 45/86 (52%), Gaps = 8/86 (9%)

Query: 46  IHCDLKPTNILLDENMVAHVSDFGIS-KLLGEGEDFVTQTMTMATIGYMAPEY-----GS 99
           +H D+KP N+LLD+N    ++DFG   +LL +G   V   + + T  Y++PE        
Sbjct: 124 VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT--VQSNVAVGTPDYISPEILQAMEDG 181

Query: 100 EGIVSAKCDVYSYGVLLMETFTRKRP 125
           +G    +CD +S GV + E    + P
Sbjct: 182 KGRYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 41.2 bits (96), Expect = 2e-04
 Identities = 29/91 (31%), Positives = 47/91 (51%), Gaps = 10/91 (10%)

Query: 32  ALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIG 91
            L+Y H    SA IIH DLKP+N+ ++E+    + DFG+++   +       T  +AT  
Sbjct: 132 GLKYIH----SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVATRW 182

Query: 92  YMAPEYGSEGI-VSAKCDVYSYGVLLMETFT 121
           Y APE     +  +   D++S G ++ E  T
Sbjct: 183 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 213

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 41.2 bits (96), Expect = 2e-04
 Identities = 32/104 (30%), Positives = 48/104 (46%), Gaps = 8/104 (7%)

Query: 38  HGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEY 97
           H HS A IIH DLKP+NI++  +    + DFG+++  G        T  + T  Y APE 
Sbjct: 134 HLHS-AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPYVVTRYYRAPEV 189

Query: 98  GSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVK 141
                     D++S G ++ E    K     +F G   + +W K
Sbjct: 190 ILGMGYKENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQWNK 229

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 41.0 bits (96), Expect = 2e-04
 Identities = 25/87 (28%), Positives = 43/87 (49%), Gaps = 6/87 (6%)

Query: 32  ALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIG 91
           ALE+ H       +IH D+K  NILL  +    ++DFG    +   +    ++  + T  
Sbjct: 127 ALEFLHSNQ----VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPY 180

Query: 92  YMAPEYGSEGIVSAKCDVYSYGVLLME 118
           +MAPE  +      K D++S G++ +E
Sbjct: 181 WMAPEVVTRKAYGPKVDIWSLGIMAIE 207

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 40.8 bits (95), Expect = 2e-04
 Identities = 39/158 (24%), Positives = 66/158 (41%), Gaps = 5/158 (3%)

Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           MP+G L  +++ +         LN  + +   + Y         ++H DL   N+L+   
Sbjct: 90  MPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR----LVHRDLAARNVLVKSP 145

Query: 61  MVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETF 120
               ++DFG+++LL   E           I +MA E       + + DV+SYGV + E  
Sbjct: 146 NHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELM 205

Query: 121 T-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV 157
           T   +P D + T E+       E LP      +D  +V
Sbjct: 206 TFGGKPYDGIPTREIPDLLEKGERLPQPPICTIDVYMV 243

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 40.8 bits (95), Expect = 2e-04
 Identities = 40/158 (25%), Positives = 73/158 (46%), Gaps = 22/158 (13%)

Query: 25  IMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQT 84
           + + V  AL Y H    +  +IH D+K  +ILL  +    +SDFG    +   ++   + 
Sbjct: 123 VCLSVLRALSYLH----NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQV--SKEVPKRK 176

Query: 85  MTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLR--RWVKE 142
             + T  +MAPE  S      + D++S G++++E    + P    +  E  L+  R +++
Sbjct: 177 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPP----YFNEPPLQAMRRIRD 232

Query: 143 SLP------HGLTEV----VDANLVREEQAFAAKMDCI 170
           +LP      H ++ V    +D  LVRE    A   + +
Sbjct: 233 NLPPRVKDSHKVSSVLRGFLDLMLVREPSQRATAQELL 270

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 40.8 bits (95), Expect = 2e-04
 Identities = 32/95 (33%), Positives = 44/95 (46%), Gaps = 7/95 (7%)

Query: 45  IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVS 104
           II+ DLK  N++LD      ++DFG+ K      D VT      T  Y+APE  +     
Sbjct: 122 IIYRDLKLDNVMLDSEGHIKIADFGMCK--EHMVDGVTTRTFCGTPDYIAPEIIAYQPYG 179

Query: 105 AKCDVYSYGVLLMETFTRKRP-----TDEMFTGEM 134
              D ++YGVLL E    + P      DE+F   M
Sbjct: 180 KSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIM 214

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 40.8 bits (95), Expect = 2e-04
 Identities = 35/107 (32%), Positives = 47/107 (43%), Gaps = 6/107 (5%)

Query: 28  DVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTM 87
           ++ SAL Y H    S  I++ DLKP NILLD      ++DFG+ K     E   T +   
Sbjct: 104 EIASALGYLH----SLNIVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNGTTSTFC 157

Query: 88  ATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEM 134
            T  Y+APE   +       D +  G +L E      P     T EM
Sbjct: 158 GTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM 204

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 40.9 bits (96), Expect = 2e-04
 Identities = 29/83 (34%), Positives = 42/83 (50%), Gaps = 8/83 (9%)

Query: 38  HGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMT--MATIGYMAP 95
           H HS A IIH DLKP+NI++  +    + DFG+++    G  F    MT  + T  Y AP
Sbjct: 133 HLHS-AGIIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSF---MMTPYVVTRYYRAP 186

Query: 96  EYGSEGIVSAKCDVYSYGVLLME 118
           E           D++S G ++ E
Sbjct: 187 EVILGMGYKENVDIWSVGCIMGE 209

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 40.7 bits (95), Expect = 2e-04
 Identities = 31/86 (36%), Positives = 45/86 (52%), Gaps = 6/86 (6%)

Query: 42  SAPIIHCDLKPTNILLDENMVAHVSDFGISK--LLGEGEDFVTQTMTMATIGYMAPEYGS 99
           S  I++ DLK  NILLD +    ++DFG+ K  +LG+ +   T T    T  Y+APE   
Sbjct: 114 SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK---TCTFC-GTPDYIAPEILL 169

Query: 100 EGIVSAKCDVYSYGVLLMETFTRKRP 125
               +   D +S+GVLL E    + P
Sbjct: 170 GQKYNTSVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 40.5 bits (94), Expect = 2e-04
 Identities = 27/94 (28%), Positives = 46/94 (48%), Gaps = 6/94 (6%)

Query: 32  ALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIG 91
           ALE+ H    S  +IH D+K  NILL  +    ++DFG    +   +    ++  + T  
Sbjct: 128 ALEFLH----SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPY 181

Query: 92  YMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRP 125
           +MAPE  +      K D++S G++ +E    + P
Sbjct: 182 WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 40.7 bits (95), Expect = 2e-04
 Identities = 37/115 (32%), Positives = 55/115 (47%), Gaps = 18/115 (15%)

Query: 42  SAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEG 101
           S  II+ DLK  N++LD +    ++DFG+ K    G++    +    T  Y+APE     
Sbjct: 114 SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN--RASTFCGTPDYIAPEILQGL 171

Query: 102 IVSAKCDVYSYGVLLMETFTRKRP-----TDEMFTGEMSLR-------RWV-KES 143
             +   D +S+GVLL E    + P      DE+F    S+R       RW+ KES
Sbjct: 172 KYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFE---SIRVDTPHYPRWITKES 223

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 40.6 bits (95), Expect = 3e-04
 Identities = 32/129 (24%), Positives = 54/129 (41%), Gaps = 37/129 (28%)

Query: 38  HGHSSAPIIHCDLKPTNILLD-ENMVAHVSDFGISKLLGEGEDFV----TQTMTMATIGY 92
           H H    ++H DLKP N+L+D +  +  ++D G+ +       F     + T  + T+ Y
Sbjct: 127 HKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGR------AFSIPVKSYTHEIVTLWY 177

Query: 93  MAPE--YGSEGIVSAKCDVYSYGVLLMETFTRK--------------------RPTDEMF 130
            APE   GS    S   D++S G +  E   ++                     PT++++
Sbjct: 178 RAPEVLLGSTH-YSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVW 236

Query: 131 TGEMSLRRW 139
            G   LR W
Sbjct: 237 PGVSKLRDW 245

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 40.4 bits (94), Expect = 3e-04
 Identities = 27/86 (31%), Positives = 43/86 (50%), Gaps = 8/86 (9%)

Query: 46  IHCDLKPTNILLDENMVAHVSDFGIS-KLLGEGEDFVTQTMTMATIGYMAPEY-----GS 99
           +H D+KP N+LLD N    ++DFG   K+  +G   V  ++ + T  Y++PE        
Sbjct: 124 VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT--VQSSVAVGTPDYISPEILQAMEDG 181

Query: 100 EGIVSAKCDVYSYGVLLMETFTRKRP 125
            G    +CD +S GV + E    + P
Sbjct: 182 MGKYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 40.3 bits (95), Expect = 3e-04
 Identities = 35/108 (32%), Positives = 46/108 (42%), Gaps = 21/108 (19%)

Query: 32  ALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVS--DFGISKLLGEGEDFVTQTMTMAT 89
            L Y H       +IH D+K  NILL +N  A V   DFG+S  L       T       
Sbjct: 125 GLAYLHENK----VIHRDIKGQNILLTKN--AEVKLVDFGVSAQLDS-----TLGRRNTF 173

Query: 90  IG---YMAPE-----YGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEM 129
           IG   +MAPE        +    A+ DV+S G+  +E    K P  +M
Sbjct: 174 IGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDM 221

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 40.4 bits (94), Expect = 3e-04
 Identities = 33/106 (31%), Positives = 48/106 (45%), Gaps = 12/106 (11%)

Query: 31  SALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATI 90
            AL    H H++  IIH D+K  NILL       + DFG+S  L      + +  ++ T 
Sbjct: 136 GALLGLQHLHNNR-IIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTR--LRRNTSVGTP 192

Query: 91  GYMAPE-------YGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEM 129
            +MAPE       Y       A+CDV+S G+  +E      P  +M
Sbjct: 193 FWMAPEVIACEQQYDYS--YDARCDVWSLGITAIELGDGDPPLFDM 236

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 40.0 bits (93), Expect = 3e-04
 Identities = 29/97 (29%), Positives = 47/97 (48%), Gaps = 6/97 (6%)

Query: 29  VGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMA 88
           V  AL Y H    S  +IH D+K  +ILL  +    +SDFG    + +  D   +   + 
Sbjct: 126 VLQALCYLH----SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISK--DVPKRKSLVG 179

Query: 89  TIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRP 125
           T  +MAPE  S      + D++S G++++E    + P
Sbjct: 180 TPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPP 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 40.0 bits (93), Expect = 3e-04
 Identities = 25/81 (30%), Positives = 39/81 (48%), Gaps = 2/81 (2%)

Query: 45  IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVS 104
           ++H D+K  NI L +N    + DFG ++LL     +      + T  Y+ PE       +
Sbjct: 121 VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYA--CTYVGTPYYVPPEIWENMPYN 178

Query: 105 AKCDVYSYGVLLMETFTRKRP 125
            K D++S G +L E  T K P
Sbjct: 179 NKSDIWSLGCILYELCTLKHP 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 40.0 bits (93), Expect = 3e-04
 Identities = 32/98 (32%), Positives = 45/98 (45%), Gaps = 7/98 (7%)

Query: 42  SAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEG 101
           S  II+ DLK  N++LD      ++DFG+ K      D VT      T  Y+APE  +  
Sbjct: 119 SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENMWDGVTTKTFCGTPDYIAPEIIAYQ 176

Query: 102 IVSAKCDVYSYGVLLMETFTRKRP-----TDEMFTGEM 134
                 D +++GVLL E    + P      DE+F   M
Sbjct: 177 PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM 214

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 40.1 bits (94), Expect = 4e-04
 Identities = 32/125 (25%), Positives = 54/125 (43%), Gaps = 6/125 (4%)

Query: 2   PNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENM 61
           P G L  +L    Y  D+   +     + +AL Y      S   +H D+   N+L+    
Sbjct: 89  PLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE----SKRFVHRDIAARNVLVSSPD 144

Query: 62  VAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT 121
              + DFG+S+ L E E +   +     I +MAPE  +    ++  DV+ +GV + E   
Sbjct: 145 CVKLGDFGLSRYL-EDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILM 203

Query: 122 R-KRP 125
              +P
Sbjct: 204 LGVKP 208

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 39.8 bits (93), Expect = 4e-04
 Identities = 29/96 (30%), Positives = 45/96 (46%), Gaps = 8/96 (8%)

Query: 31  SALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTM-AT 89
           SAL Y H    S  +++ DLK  N++LD++    ++DFG+ K   EG        T   T
Sbjct: 106 SALGYLH----SCDVVYRDLKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCGT 158

Query: 90  IGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRP 125
             Y+APE   +       D +  GV++ E    + P
Sbjct: 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 40.0 bits (93), Expect = 5e-04
 Identities = 31/104 (29%), Positives = 47/104 (45%), Gaps = 8/104 (7%)

Query: 38  HGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEY 97
           H HS A IIH DLKP+NI++  +    + DFG+++  G        T  + T  Y APE 
Sbjct: 141 HLHS-AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPYVVTRYYRAPEV 196

Query: 98  GSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVK 141
                     D++S G ++ E          +F G   + +W K
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMIKGGV----LFPGTDHIDQWNK 236

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 39.3 bits (91), Expect = 5e-04
 Identities = 26/94 (27%), Positives = 46/94 (48%), Gaps = 6/94 (6%)

Query: 32  ALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIG 91
           AL++ H    S  +IH D+K  NILL  +    ++DFG    +   +    ++  + T  
Sbjct: 127 ALDFLH----SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPY 180

Query: 92  YMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRP 125
           +MAPE  +      K D++S G++ +E    + P
Sbjct: 181 WMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 39.1 bits (91), Expect = 6e-04
 Identities = 25/89 (28%), Positives = 43/89 (48%), Gaps = 4/89 (4%)

Query: 45  IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIG----YMAPEYGSE 100
           ++H D+K  N++L  N +  + DFG ++ L       T +  + ++     +MAPE  +E
Sbjct: 123 VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINE 182

Query: 101 GIVSAKCDVYSYGVLLMETFTRKRPTDEM 129
                K D++S G  + E  T K P   M
Sbjct: 183 SGYGRKSDIWSIGCTVFEMATGKPPLASM 211

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 39.2 bits (91), Expect = 7e-04
 Identities = 34/107 (31%), Positives = 50/107 (46%), Gaps = 19/107 (17%)

Query: 32  ALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGIS----KLLGEGEDFVTQTMTM 87
           AL+Y H    S  IIH DLK  N+LL  +    ++DFG+S    K L   + F+      
Sbjct: 122 ALQYLH----SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI------ 171

Query: 88  ATIGYMAPEY-----GSEGIVSAKCDVYSYGVLLMETFTRKRPTDEM 129
            T  +MAPE        +     K D++S G+ L+E    + P  E+
Sbjct: 172 GTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL 218

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 39.1 bits (91), Expect = 8e-04
 Identities = 30/94 (31%), Positives = 41/94 (43%), Gaps = 4/94 (4%)

Query: 32  ALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIG 91
           AL Y H       IIH D+K  NI LDE   A + DFG +  L    D         T+ 
Sbjct: 197 ALAYLH----GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLE 252

Query: 92  YMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRP 125
             +PE  +     AK D++S G++L E   +   
Sbjct: 253 TNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVT 286

Length = 392

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 39.3 bits (91), Expect = 8e-04
 Identities = 29/92 (31%), Positives = 47/92 (51%), Gaps = 10/92 (10%)

Query: 33  LEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGY 92
           L+Y H    SA IIH DLKP+N+ ++E+    + DFG+++   +       T  +AT  Y
Sbjct: 131 LKYIH----SAGIIHRDLKPSNVAVNEDCELRILDFGLARQADD-----EMTGYVATRWY 181

Query: 93  MAPEYGSEGI-VSAKCDVYSYGVLLMETFTRK 123
            APE     +  +   D++S G ++ E    K
Sbjct: 182 RAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 39.3 bits (92), Expect = 8e-04
 Identities = 29/109 (26%), Positives = 44/109 (40%), Gaps = 36/109 (33%)

Query: 46  IHCDLKPTNILLDENMVAHVSDFGISK-----------------LLGEGEDFVTQTM--- 85
           IH D+KP N+LLD      +SDFG+                   L     DF+++ M   
Sbjct: 123 IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSK 182

Query: 86  ----------------TMATIGYMAPEYGSEGIVSAKCDVYSYGVLLME 118
                           T+ T  Y+APE   +   + +CD +S GV++ E
Sbjct: 183 RKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYE 231

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 38.7 bits (91), Expect = 0.001
 Identities = 36/124 (29%), Positives = 53/124 (42%), Gaps = 23/124 (18%)

Query: 24  NIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMV-AHVSDFGISKLLGEGEDFVT 82
            I+  +  AL   H  +    IIH D+K  N+L D      ++ D+G+ K++G      T
Sbjct: 113 KIIRQLVEALNDLHKHN----IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG------T 162

Query: 83  QTMTMATIGYMAPEYGSEGIVSAKCDV----YSYGVLLMETFTRKRP----TDEMFTGEM 134
            +    T+ Y +P    E I     DV    ++ GVL  E  T K P     DE    E 
Sbjct: 163 PSCYDGTLDYFSP----EKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLES 218

Query: 135 SLRR 138
            L+R
Sbjct: 219 LLKR 222

Length = 267

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 38.6 bits (90), Expect = 0.001
 Identities = 30/89 (33%), Positives = 45/89 (50%), Gaps = 9/89 (10%)

Query: 38  HGHSSAPIIHCDLKPTNILLDENMVA-HVSDFGISKLLGEGEDFVTQTMTMATIGYMAPE 96
           H H    ++H DLKP N+L+D    A  ++DFG+++    G    T T  + T+ Y APE
Sbjct: 119 HSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAF--GIPVRTFTHEVVTLWYRAPE 173

Query: 97  --YGSEGIVSAKCDVYSYGVLLMETFTRK 123
              GS    S   D++S G +  E   +K
Sbjct: 174 ILLGSRH-YSTPVDIWSVGCIFAEMVNQK 201

Length = 294

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 38.8 bits (90), Expect = 0.001
 Identities = 22/56 (39%), Positives = 35/56 (62%), Gaps = 7/56 (12%)

Query: 42  SAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTM-ATIGYMAPE 96
           S  I++ DLKP N+LLD++    ++DFG +K++       T+T T+  T  Y+APE
Sbjct: 149 SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD------TRTYTLCGTPEYIAPE 198

Length = 340

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 38.6 bits (90), Expect = 0.001
 Identities = 32/111 (28%), Positives = 50/111 (45%), Gaps = 13/111 (11%)

Query: 25  IMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGIS-KLLGEGEDFVTQ 83
           +   +  AL + H    S  +IH DLK  NILL  +    ++DFG+S K     +   T 
Sbjct: 108 VCRQMLEALNFLH----SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT- 162

Query: 84  TMTMATIGYMAPEY-----GSEGIVSAKCDVYSYGVLLMETFTRKRPTDEM 129
              + T  +MAPE        +     K D++S G+ L+E    + P  E+
Sbjct: 163 --FIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHEL 211

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 38.5 bits (89), Expect = 0.001
 Identities = 28/84 (33%), Positives = 42/84 (50%), Gaps = 4/84 (4%)

Query: 45  IIHCDLKPTNILLDENMVAHVSDFGISKL-LGEGEDFVTQTMTMATIGYMAPEYGSEGIV 103
           II+ DLK  N+LLD +    ++D+G+ K  LG G+   T +    T  Y+APE       
Sbjct: 117 IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD---TTSTFCGTPNYIAPEILRGEEY 173

Query: 104 SAKCDVYSYGVLLMETFTRKRPTD 127
               D ++ GVL+ E    + P D
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 38.4 bits (90), Expect = 0.001
 Identities = 22/47 (46%), Positives = 27/47 (57%), Gaps = 10/47 (21%)

Query: 32  ALEYPH-HGHSSAPIIHCDLKPTNILLDENMVAHV--SDFGISKLLG 75
           ALEY H  G     I++ DLKP NILL E+   H+  SDF +SK   
Sbjct: 115 ALEYLHLLG-----IVYRDLKPENILLHES--GHIMLSDFDLSKQSD 154

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 38.2 bits (88), Expect = 0.001
 Identities = 25/94 (26%), Positives = 45/94 (47%), Gaps = 6/94 (6%)

Query: 32  ALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIG 91
           ALE+ H       +IH D+K  N+LL  +    ++DFG    +   +    ++  + T  
Sbjct: 127 ALEFLHANQ----VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPY 180

Query: 92  YMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRP 125
           +MAPE  +      K D++S G++ +E    + P
Sbjct: 181 WMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 38.1 bits (88), Expect = 0.002
 Identities = 30/106 (28%), Positives = 42/106 (39%), Gaps = 33/106 (31%)

Query: 46  IHCDLKPTNILLDENMVAHVSDFGISKLLGEGE--------------DFVTQTM------ 85
           IH D+KP N+LLD      +SDFG+   L +                DF  Q M      
Sbjct: 123 IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKA 182

Query: 86  -------------TMATIGYMAPEYGSEGIVSAKCDVYSYGVLLME 118
                        T+ T  Y+APE   +   +  CD +S GV++ E
Sbjct: 183 ETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYE 228

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 37.8 bits (88), Expect = 0.002
 Identities = 27/103 (26%), Positives = 45/103 (43%), Gaps = 20/103 (19%)

Query: 27  IDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISK--------LLGEGE 78
           I +   + Y H       +IH D+   N ++DE +   ++D  +S+         LG+ E
Sbjct: 124 IQIACGMSYLH----KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNE 179

Query: 79  DFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT 121
           +          + +MA E       S+  DV+S+GVLL E  T
Sbjct: 180 N--------RPVKWMALESLVNKEYSSASDVWSFGVLLWELMT 214

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 37.3 bits (86), Expect = 0.002
 Identities = 22/76 (28%), Positives = 40/76 (52%), Gaps = 5/76 (6%)

Query: 46  IHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGS---EGI 102
           +H D+K  NILL +N    ++DFG+S  +        +   + T  +MAPE  +   +G 
Sbjct: 128 MHRDIKGANILLTDNGHVKLADFGVSAQI--TATIAKRKSFIGTPYWMAPEVAAVERKGG 185

Query: 103 VSAKCDVYSYGVLLME 118
            +  CD+++ G+  +E
Sbjct: 186 YNQLCDIWAVGITAIE 201

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 37.5 bits (87), Expect = 0.003
 Identities = 24/110 (21%), Positives = 44/110 (40%), Gaps = 15/110 (13%)

Query: 38  HGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEY 97
           H      IIH D+K  NI +++     + D G ++       F+    T+ T    APE 
Sbjct: 174 HAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGTVET---NAPEV 227

Query: 98  GSEGIVSAKCDVYSYGVLLMETFTRKR---------PTDEMFTGEMSLRR 138
            +    ++K D++S G++L E               P + + +    L +
Sbjct: 228 LARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLK 277

Length = 357

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 37.0 bits (86), Expect = 0.004
 Identities = 33/153 (21%), Positives = 65/153 (42%), Gaps = 27/153 (17%)

Query: 22  RLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFV 81
           +L++ ID    L Y  + +++ P  + +L   + L+ EN           K++  G + +
Sbjct: 124 KLDMAIDCCKGL-YNLYKYTNKP--YKNLTSVSFLVTEN--------YKLKIICHGLEKI 172

Query: 82  TQTMTMATIGYMAPEYGSEGIVS-------AKCDVYSYGVLLMETFTRKRPTDEMFTGE- 133
             +     + +M   Y S  +++        K D+YS GV+L E FT K P + + T E 
Sbjct: 173 LSSPPFKNVNFMV--YFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEI 230

Query: 134 --MSLRRWVKESL----PHGLTEVVDANLVREE 160
             + + +     L    P  +  +V+A    + 
Sbjct: 231 YDLIINKNNSLKLPLDCPLEIKCIVEACTSHDS 263

Length = 283

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 36.9 bits (85), Expect = 0.004
 Identities = 30/106 (28%), Positives = 42/106 (39%), Gaps = 33/106 (31%)

Query: 46  IHCDLKPTNILLDENMVAHVSDFGISKLLGEGE--------------DFVTQTM------ 85
           IH D+KP N+LLD      +SDFG+   L +                DF  Q M      
Sbjct: 123 IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKA 182

Query: 86  -------------TMATIGYMAPEYGSEGIVSAKCDVYSYGVLLME 118
                        T+ T  Y+APE   +   +  CD +S GV++ E
Sbjct: 183 ETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYE 228

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 36.7 bits (85), Expect = 0.004
 Identities = 33/107 (30%), Positives = 50/107 (46%), Gaps = 31/107 (28%)

Query: 32  ALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKL--------LGEG------ 77
           ALEY H    +  I+H DLKP N+L+       ++DFG+SK+        L EG      
Sbjct: 113 ALEYLH----NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDT 168

Query: 78  EDFVTQTMTMATIGYMAPE------YGSEGIVSAKCDVYSYGVLLME 118
            +F+ + +   T  Y+APE      YG         D ++ G++L E
Sbjct: 169 REFLDKQVC-GTPEYIAPEVILRQGYGK------PVDWWAMGIILYE 208

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	202
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	99.98
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	99.98
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	99.98
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	99.98
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	99.98
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	99.98
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	99.98
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	99.98
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	99.98
KOG4721	904	consensus Serine/threonine protein kinase, contain	99.98
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	99.98
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	99.98
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	99.98
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	99.98
PTZ00283	496	serine/threonine protein kinase; Provisional	99.98
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	99.98
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	99.98
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	99.98
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	99.98
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	99.98
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	99.98
KOG0201	467	consensus Serine/threonine protein kinase [Signal	99.97
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	99.97
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	99.97
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	99.97
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	99.97
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	99.97
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	99.97
PTZ00267	478	NIMA-related protein kinase; Provisional	99.97
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	99.97
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	99.97
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	99.97
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	99.97
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	99.97
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	99.97
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	99.97
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	99.97
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	99.97
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	99.97
KOG0589	426	consensus Serine/threonine protein kinase [General	99.97
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	99.97
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	99.97
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	99.97
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	99.97
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	99.97
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	99.97
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	99.97
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.97
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	99.97
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.97
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	99.97
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	99.97
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	99.97
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	99.97
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	99.97
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	99.97
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	99.97
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	99.97
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	99.97
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	99.97
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	99.97
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	99.97
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	99.97
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	99.97
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	99.97
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	99.97
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	99.97
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	99.97
PHA02882	294	putative serine/threonine kinase; Provisional	99.97
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	99.97
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	99.97
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	99.97
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	99.97
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	99.97
PHA03212	391	serine/threonine kinase US3; Provisional	99.97
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	99.97
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	99.97
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	99.97
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	99.97
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	99.97
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	99.97
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	99.97
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	99.97
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	99.97
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	99.97
KOG1989	738	consensus ARK protein kinase family [Signal transd	99.97
PTZ00284	467	protein kinase; Provisional	99.97
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	99.97
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	99.97
PTZ00036	440	glycogen synthase kinase; Provisional	99.97
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	99.97
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	99.97
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	99.97
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	99.97
PTZ00263	329	protein kinase A catalytic subunit; Provisional	99.97
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	99.97
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	99.97
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	99.97
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	99.97
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	99.97
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	99.97
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	99.97
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	99.97
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	99.97
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	99.97
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	99.97
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	99.97
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	99.97
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	99.97
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	99.97
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	99.97
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	99.97
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	99.97
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	99.97
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	99.97
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	99.97
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	99.97
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	99.97
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	99.97
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	99.97
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	99.97
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	99.97
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	99.97
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	99.97
PHA03207	392	serine/threonine kinase US3; Provisional	99.97
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	99.97
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	99.97
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	99.97
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	99.97
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	99.97
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	99.97
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	99.97
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	99.97
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	99.97
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	99.97
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	99.97
PHA03211	461	serine/threonine kinase US3; Provisional	99.97
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	99.97
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	99.97
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	99.97
PHA03209	357	serine/threonine kinase US3; Provisional	99.97
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	99.97
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	99.97
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	99.97
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	99.97
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	99.97
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	99.97
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	99.97
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	99.97
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	99.97
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	99.97
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	99.97
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	99.97
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	99.97
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	99.97
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	99.97
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	99.97
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	99.96
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	99.96
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	99.96
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	99.96
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	99.96
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	99.96
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	99.96
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	99.96
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	99.96
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	99.96
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	99.96
PLN00034	353	mitogen-activated protein kinase kinase; Provision	99.96
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	99.96
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	99.96
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	99.96
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	99.96
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	99.96
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	99.96
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	99.96
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	99.96
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	99.96
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	99.96
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	99.96
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	99.96
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	99.96
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	99.96
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	99.96
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	99.96
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	99.96
KOG0694	694	consensus Serine/threonine protein kinase [Signal	99.96
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.96
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	99.96
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	99.96
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	99.96
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	99.96
KOG0584	632	consensus Serine/threonine protein kinase [General	99.96
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.96
KOG4717	864	consensus Serine/threonine protein kinase [Signal	99.96
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	99.96
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	99.96
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	99.96
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	99.96
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	99.96
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.96
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	99.96
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	99.96
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	99.96
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	99.96
KOG0605	550	consensus NDR and related serine/threonine kinases	99.96
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	99.96
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	99.96
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	99.96
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	99.96
KOG0596	677	consensus Dual specificity; serine/threonine and t	99.96
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	99.96
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	99.96
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	99.96
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.96
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	99.96
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	99.96
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	99.96
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	99.96
KOG0610	459	consensus Putative serine/threonine protein kinase	99.96
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	99.96
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	99.96
PLN00181	793	protein SPA1-RELATED; Provisional	99.96
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	99.96
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	99.96
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	99.96
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	99.96
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	99.96
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	99.96
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	99.96
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	99.96
KOG3653	534	consensus Transforming growth factor beta/activin	99.96
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	99.96
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	99.96
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	99.96
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	99.96
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	99.96
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	99.96
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.96
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	99.96
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	99.96
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	99.96
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	99.96
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	99.96
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	99.96
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	99.96
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	99.96
PHA03210	501	serine/threonine kinase US3; Provisional	99.96
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	99.96
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	99.96
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	99.96
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.96
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	99.96
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	99.96
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	99.96
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	99.96
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	99.96
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	99.96
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	99.96
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	99.96
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	99.96
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	99.96
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	99.96
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.95
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	99.95
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	99.95
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	99.95
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	99.95
KOG0611	668	consensus Predicted serine/threonine protein kinas	99.95
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	99.95
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	99.95
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.95
PTZ00266	1021	NIMA-related protein kinase; Provisional	99.95
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	99.95
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	99.95
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	99.95
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.95
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	99.95
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	99.95
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	99.95
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	99.95
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	99.95
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	99.95
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	99.95
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	99.95
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	99.95
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	99.95
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	99.95
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	99.95
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	99.95
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	99.95
KOG2052	513	consensus Activin A type IB receptor, serine/threo	99.95
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	99.95
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	99.95
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	99.95
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.95
KOG0577	948	consensus Serine/threonine protein kinase [Signal	99.95
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.95
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	99.95
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	99.95
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	99.95
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	99.95
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	99.95
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	99.95
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	99.95
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.95
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	99.95
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	99.95
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	99.95
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	99.95
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	99.95
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.95
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.95
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.95
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	99.95
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	99.95
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	99.95
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	99.95
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	99.95
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.95
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.95
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.95
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.95
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	99.94
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	99.94
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.94
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	99.94
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	99.94
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.94
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.94
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.94
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.94
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.94
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.94
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.94
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.94
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.94
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.94
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.94
PLN00009	294	cyclin-dependent kinase A; Provisional	99.94
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.94
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.94
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.93
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.93
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.93
KOG0586	596	consensus Serine/threonine protein kinase [General	99.93
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	99.93
KOG0690	516	consensus Serine/threonine protein kinase [Signal	99.93
KOG0607	463	consensus MAP kinase-interacting kinase and relate	99.93
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.93
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.93
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.92
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.92
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.92
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.92
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.91
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.91
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.91
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.9
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.9
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.9
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.9
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.9
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.89
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.89
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.88
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.87
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.87
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.86
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.85
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.83
KOG1152	772	consensus Signal transduction serine/threonine kin	99.83
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.83
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.82
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.79
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.77
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.77
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.76
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.75
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.75
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.71
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.69
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.68
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.65
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.61
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.47
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.42
PRK09188	365	serine/threonine protein kinase; Provisional	99.39
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.34
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.3
PRK12274	218	serine/threonine protein kinase; Provisional	99.28
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.25
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.2
smart00090	237	RIO RIO-like kinase.	99.11
PRK10345	210	hypothetical protein; Provisional	99.09
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.02
PRK14879	211	serine/threonine protein kinase; Provisional	98.99
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	98.96
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.96
COG4248	637	Uncharacterized protein with protein kinase and he	98.96
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	98.94
PRK09605	535	bifunctional UGMP family protein/serine/threonine	98.92
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	98.75
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.73
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.72
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.55
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	98.53
KOG1243	690	consensus Protein kinase [General function predict	98.37
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	98.33
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.31
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.3
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	98.26
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	98.24
KOG3087	229	consensus Serine/threonine protein kinase [General	98.17
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	98.09
PRK09902	216	hypothetical protein; Provisional	98.09
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	97.68
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	97.54
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	97.21
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	97.05
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	97.04
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	96.73
COG0478	304	RIO-like serine/threonine protein kinase fused to	96.69
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	96.65
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	95.49
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	95.47
PRK05231	319	homoserine kinase; Provisional	95.04
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	94.88
PF01636	239	APH: Phosphotransferase enzyme family This family	94.59
COG0661	517	AarF Predicted unusual protein kinase [General fun	94.54
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	94.44
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	94.44
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	94.32
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	94.25
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	94.2
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	94.1
KOG1093	725	consensus Predicted protein kinase (contains TBC a	94.09
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	93.85
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	93.48
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	93.43
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	93.43
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	93.42
COG0510	269	ycfN Thiamine kinase and related kinases [Coenzyme	93.41
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	93.25
PRK10271	188	thiK thiamine kinase; Provisional	93.23
PF05445	434	Pox_ser-thr_kin: Poxvirus serine/threonine protein	92.89
KOG1235	538	consensus Predicted unusual protein kinase [Genera	92.67
PLN02236	344	choline kinase	92.37
COG2334	331	Putative homoserine kinase type II (protein kinase	92.27
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	92.1
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	92.02
KOG0576	829	consensus Mitogen-activated protein kinase kinase	91.75
smart00587	196	CHK ZnF_C4 abd HLH domain containing kinases domai	91.41
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	91.08
KOG2268	465	consensus Serine/threonine protein kinase [Signal	90.25
PRK06148	1013	hypothetical protein; Provisional	88.89
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	87.92
PRK11768	325	serine/threonine protein kinase; Provisional	86.36
PHA03111	444	Ser/Thr kinase; Provisional	86.18
PRK06149	972	hypothetical protein; Provisional	85.36
PRK09550	401	mtnK methylthioribose kinase; Reviewed	84.92
PF02958	294	EcKinase: Ecdysteroid kinase; InterPro: IPR004119	82.92

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-39  Score=243.33  Aligned_cols=175  Identities=24%  Similarity=0.289  Sum_probs=143.3

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |-+|||.+++.... .+++...-+++.++++||.|||+   +++|+|||+||+|+|++..|.+||+|||++......   
T Consensus       160 MDgGSLd~~~k~~g-~i~E~~L~~ia~~VL~GL~YLh~---~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS---  232 (364)
T KOG0581|consen  160 MDGGSLDDILKRVG-RIPEPVLGKIARAVLRGLSYLHE---ERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS---  232 (364)
T ss_pred             cCCCCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHhh---ccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh---
Confidence            67999999998754 48999999999999999999995   589999999999999999999999999999987765   


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhH
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREE  160 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (202)
                       ...++.||..|++||.+.+..|+.++||||||+.++|+.+|+.||...........            ++.......+.
T Consensus       233 -~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~------------~Ll~~Iv~~pp  299 (364)
T KOG0581|consen  233 -IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIF------------ELLCAIVDEPP  299 (364)
T ss_pred             -hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHH------------HHHHHHhcCCC
Confidence             23457899999999999999999999999999999999999999977522222222            22222222221


Q ss_pred             HHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          161 QAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       161 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                      ...+. ..+++++.+++..||++||.+|||+.|+++
T Consensus       300 P~lP~-~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~  334 (364)
T KOG0581|consen  300 PRLPE-GEFSPEFRSFVSCCLRKDPSERPSAKQLLQ  334 (364)
T ss_pred             CCCCc-ccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            11111 158889999999999999999999999874

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-39  Score=248.81  Aligned_cols=177  Identities=29%  Similarity=0.424  Sum_probs=145.4

Q ss_pred             CCCCcHHHHHhh-cCCCCCHHHHHHHHHHHHHhhhcccCCCCCCC-eeecCCCCCceeeCCCC-ceEEcccccceeccCC
Q 037267            1 MPNGSLEKWLYS-YNYFFDILERLNIMIDVGSALEYPHHGHSSAP-IIHCDLKPTNILLDENM-VAHVSDFGISKLLGEG   77 (202)
Q Consensus         1 ~~~gsL~~~l~~-~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~-i~h~dlk~~nil~~~~~-~~~l~d~g~~~~~~~~   77 (202)
                      |++|||.+++.. ....+++..+++++.||+.|+.|||    +.+ |+|||||++|+|++.++ .+||+|||+++.....
T Consensus       122 ~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH----~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~  197 (362)
T KOG0192|consen  122 MPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLH----SEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVIS  197 (362)
T ss_pred             CCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh----cCCCeeecccChhhEEEcCCCCEEEECCCccceeeccc
Confidence            689999999987 3667999999999999999999999    788 99999999999999997 9999999999876643


Q ss_pred             CccccccCCCCCccccCCCCCC--CCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhh
Q 037267           78 EDFVTQTMTMATIGYMAPEYGS--EGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDAN  155 (202)
Q Consensus        78 ~~~~~~~~~~~~~~~~~pe~~~--~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (202)
                      ...  -+...||..|+|||++.  ...++.++|+||||+++||+++|..||..... .......+..             
T Consensus       198 ~~~--~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-~~~~~~v~~~-------------  261 (362)
T KOG0192|consen  198 KTS--MTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-VQVASAVVVG-------------  261 (362)
T ss_pred             ccc--ccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-HHHHHHHHhc-------------
Confidence            211  12256899999999999  55899999999999999999999999988654 2212211111             


Q ss_pred             hhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          156 LVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                          ..+...+..|++.+..+|..||..||++||++.+++..|+.+
T Consensus       262 ----~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~  303 (362)
T KOG0192|consen  262 ----GLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESI  303 (362)
T ss_pred             ----CCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHH
Confidence                111222334778899999999999999999999999999865

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.3e-39  Score=248.56  Aligned_cols=177  Identities=30%  Similarity=0.514  Sum_probs=149.4

Q ss_pred             CCCCcHHHHHhh-cCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCc
Q 037267            1 MPNGSLEKWLYS-YNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED   79 (202)
Q Consensus         1 ~~~gsL~~~l~~-~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~   79 (202)
                      |++|||.+||+. ....+...+-+.++.|||+|++||+    ++++|||||-..|||++++..+||+|||+++...+. .
T Consensus       283 m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLe----s~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~-~  357 (468)
T KOG0197|consen  283 MPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLE----SKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDD-E  357 (468)
T ss_pred             cccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHH----hCCccchhhhhhheeeccCceEEEcccccccccCCC-c
Confidence            689999999997 4556899999999999999999999    999999999999999999999999999999944333 3


Q ss_pred             cccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhh
Q 037267           80 FVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVR  158 (202)
Q Consensus        80 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (202)
                      +........+..|.|||.+....++.++|+||||+++||++| |+.||..+...+.                 +  +...
T Consensus       358 Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev-----------------~--~~le  418 (468)
T KOG0197|consen  358 YTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEV-----------------L--ELLE  418 (468)
T ss_pred             eeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHH-----------------H--HHHh
Confidence            333344456788999999999999999999999999999998 9999877654331                 1  1122


Q ss_pred             hHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          159 EEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       159 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                      .+.+.+.|..|+++++++|..||+.+|++|||+..+...|+.+
T Consensus       419 ~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~  461 (468)
T KOG0197|consen  419 RGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDF  461 (468)
T ss_pred             ccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHh
Confidence            3445667788999999999999999999999999999888764

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-36  Score=233.33  Aligned_cols=195  Identities=41%  Similarity=0.640  Sum_probs=152.4

Q ss_pred             CCCCcHHHHHhhcCC-CCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccC-CC
Q 037267            1 MPNGSLEKWLYSYNY-FFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGE-GE   78 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~-~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~-~~   78 (202)
                      |+||||+++|..... .++|..|++|+.++|.||.|||+.. ...|+|||+|++|||+|+++.+||+|||+++.... ..
T Consensus       154 m~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~-~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~~~  232 (361)
T KOG1187|consen  154 MPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGC-PPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEGDT  232 (361)
T ss_pred             cCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCC-CCCEecCCCCHHHeeECCCCCEEccCccCcccCCcccc
Confidence            689999999997665 7999999999999999999999643 33699999999999999999999999999965443 22


Q ss_pred             ccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCccc-ccchhhHHHHHHhCCC-Chhhhhhhhh
Q 037267           79 DFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMF-TGEMSLRRWVKESLPH-GLTEVVDANL  156 (202)
Q Consensus        79 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~  156 (202)
                      .....  ..||..|++||+...+..+.++|+||||++++|+++|+.+.+... .....+..|....... ...+++++.+
T Consensus       233 ~~~~~--~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l  310 (361)
T KOG1187|consen  233 SVSTT--VMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRL  310 (361)
T ss_pred             ceeee--cCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCCc
Confidence            11111  168999999999988889999999999999999999998887543 3333456665443332 4666666665


Q ss_pred             hhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          157 VREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                      .......   ......+..+...|++.+|++||+|.||++.|+.+
T Consensus       311 ~~~~~~~---~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~  352 (361)
T KOG1187|consen  311 KEGEYPD---EKEVKKLAELALRCLRPDPKERPTMSQVVKELEGI  352 (361)
T ss_pred             cCCCCCh---HHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhh
Confidence            4211110   14556689999999999999999999999998654

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.2e-36  Score=237.20  Aligned_cols=169  Identities=23%  Similarity=0.308  Sum_probs=139.0

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |++|||..+++. .+++++.+++.+++||+.||.|||    +.+|+|||||..|++++++..+||+|||+|........ 
T Consensus       100 C~~~sL~el~Kr-rk~ltEpEary~l~QIv~GlkYLH----~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~E-  173 (592)
T KOG0575|consen  100 CHRGSLMELLKR-RKPLTEPEARYFLRQIVEGLKYLH----SLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGE-  173 (592)
T ss_pred             cCCccHHHHHHh-cCCCCcHHHHHHHHHHHHHHHHHH----hcCceecccchhheeecCcCcEEecccceeeeecCccc-
Confidence            789999999984 556999999999999999999999    99999999999999999999999999999998764422 


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhH
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREE  160 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (202)
                       ...+..||+-|.|||++.....+..+||||+||++|.++.|++||+.-.-.+.                 .......  
T Consensus       174 -rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vket-----------------y~~Ik~~--  233 (592)
T KOG0575|consen  174 -RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKET-----------------YNKIKLN--  233 (592)
T ss_pred             -ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHH-----------------HHHHHhc--
Confidence             12345799999999999988889999999999999999999999976421111                 1000000  


Q ss_pred             HHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          161 QAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       161 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                       ....|...+.+..+||.++|+.||.+|||+++|+.
T Consensus       234 -~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~  268 (592)
T KOG0575|consen  234 -EYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD  268 (592)
T ss_pred             -CcccccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence             11223356677899999999999999999999974

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-36  Score=226.86  Aligned_cols=175  Identities=28%  Similarity=0.351  Sum_probs=136.2

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCC-CCceEEcccccceeccCCCc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDE-NMVAHVSDFGISKLLGEGED   79 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~-~~~~~l~d~g~~~~~~~~~~   79 (202)
                      +++|||.+++.+....|++..+..+++|+++||.|||    +++|+||||||+|||++. ++.+||+|||++........
T Consensus        98 ~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylH----s~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~  173 (313)
T KOG0198|consen   98 APGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLH----SKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGT  173 (313)
T ss_pred             cCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH----hCCEeccCcccceEEEeCCCCeEEeccCccccccccccc
Confidence            5899999999987656999999999999999999999    999999999999999999 79999999999887653111


Q ss_pred             c-ccccCCCCCccccCCCCCCC-CCcCcchhhhhHHHHHHHHHhCCCCCCcc-cccchhhHHHHHHhCCCChhhhhhhhh
Q 037267           80 F-VTQTMTMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKRPTDEM-FTGEMSLRRWVKESLPHGLTEVVDANL  156 (202)
Q Consensus        80 ~-~~~~~~~~~~~~~~pe~~~~-~~~~~~~di~s~G~~~~~~~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (202)
                      . .......||+.|+|||+..+ ......+|+||+||++.||++|..||... ......+........            
T Consensus       174 ~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~------------  241 (313)
T KOG0198|consen  174 KSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSL------------  241 (313)
T ss_pred             cccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCC------------
Confidence            1 11233578999999998884 33345899999999999999999999874 111111111111000            


Q ss_pred             hhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 037267          157 VREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAK  197 (202)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~  197 (202)
                            ...+...+++..+++.+|+.+||++||||+++++-
T Consensus       242 ------P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~h  276 (313)
T KOG0198|consen  242 ------PEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEH  276 (313)
T ss_pred             ------CCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhC
Confidence                  02233466778999999999999999999999863

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=8.1e-36  Score=232.19  Aligned_cols=171  Identities=26%  Similarity=0.381  Sum_probs=139.9

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      ++||+|.++|++.+. |++.++..++.+|+.||+|||    +.|||||||||+|||+++++.++|.|||.+..+.+....
T Consensus       156 A~nGdll~~i~K~Gs-fde~caR~YAAeIldAleylH----~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~  230 (604)
T KOG0592|consen  156 APNGDLLDLIKKYGS-FDETCARFYAAEILDALEYLH----SNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKS  230 (604)
T ss_pred             cCCCcHHHHHHHhCc-chHHHHHHHHHHHHHHHHHHH----hcCceeccCChhheeEcCCCcEEEeeccccccCChhhcc
Confidence            589999999998765 999999999999999999999    999999999999999999999999999999987654221


Q ss_pred             -----------ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChh
Q 037267           81 -----------VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLT  149 (202)
Q Consensus        81 -----------~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  149 (202)
                                 .....+.||..|.+||++.+...+..+|+|+|||++|+|+.|.+||....  +....+-+..-      
T Consensus       231 ~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~N--eyliFqkI~~l------  302 (604)
T KOG0592|consen  231 QENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAAN--EYLIFQKIQAL------  302 (604)
T ss_pred             ccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcccc--HHHHHHHHHHh------
Confidence                       11244789999999999999999999999999999999999999996632  21111111100      


Q ss_pred             hhhhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          150 EVVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                                  ..+.+...++.+.+|+.+.|..||.+|+++.++.+
T Consensus       303 ------------~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~  337 (604)
T KOG0592|consen  303 ------------DYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKA  337 (604)
T ss_pred             ------------cccCCCCCCHHHHHHHHHHHccCccccccHHHHhh
Confidence                        11223345567899999999999999999988754

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.7e-35  Score=214.51  Aligned_cols=178  Identities=21%  Similarity=0.289  Sum_probs=139.3

Q ss_pred             CCCCcHHHHHh---hcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCC
Q 037267            1 MPNGSLEKWLY---SYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEG   77 (202)
Q Consensus         1 ~~~gsL~~~l~---~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~   77 (202)
                      |.+|+|.+.++   +....+++..+++++.|++.||..+|.-.-...++||||||.||.++.+|++|++|||+++.+...
T Consensus       102 c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s~  181 (375)
T KOG0591|consen  102 CDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLSSK  181 (375)
T ss_pred             hcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhcch
Confidence            67999999987   345679999999999999999999993100234999999999999999999999999999987654


Q ss_pred             CccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhh
Q 037267           78 EDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV  157 (202)
Q Consensus        78 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (202)
                      ..  -.++..|||.|++||.+.+.+|+.++|+||+||++|||..-+.||.+-  .-..+..-+.+.              
T Consensus       182 ~t--fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~--n~~~L~~KI~qg--------------  243 (375)
T KOG0591|consen  182 TT--FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD--NLLSLCKKIEQG--------------  243 (375)
T ss_pred             hH--HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc--cHHHHHHHHHcC--------------
Confidence            43  245678999999999999999999999999999999999999999763  111122111111              


Q ss_pred             hhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 037267          158 REEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKL  198 (202)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l  198 (202)
                        ....-+....+.++..|+..|+..||+.||+...++..+
T Consensus       244 --d~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di  282 (375)
T KOG0591|consen  244 --DYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDI  282 (375)
T ss_pred             --CCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHH
Confidence              111111246777899999999999999999854444444

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=1.3e-34  Score=225.25  Aligned_cols=164  Identities=26%  Similarity=0.402  Sum_probs=127.0

Q ss_pred             CCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCccccccCCCCCccccCC
Q 037267           16 FFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAP   95 (202)
Q Consensus        16 ~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~p   95 (202)
                      .+++..+..++.|++.||.|||    +.+|+||||||.||+++.++.++++|||+++...............++..|+||
T Consensus       170 ~l~~~~~~~~~~qi~~aL~~LH----~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aP  245 (338)
T cd05102         170 PLTMEDLICYSFQVARGMEFLA----SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAP  245 (338)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHH----HCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCc
Confidence            3788899999999999999999    899999999999999999999999999999765433222222233456789999


Q ss_pred             CCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhHHHHHHhHHHHHHHH
Q 037267           96 EYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIM  174 (202)
Q Consensus        96 e~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  174 (202)
                      |.+.+..++.++|+||+|+++|++++ |..||........... .......                 ...+..+++++.
T Consensus       246 E~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~-~~~~~~~-----------------~~~~~~~~~~l~  307 (338)
T cd05102         246 ESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQ-RLKDGTR-----------------MRAPENATPEIY  307 (338)
T ss_pred             HHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHH-HHhcCCC-----------------CCCCCCCCHHHH
Confidence            99888889999999999999999997 9999976433221111 1111000                 001123456689


Q ss_pred             HHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          175 DLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       175 ~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                      +++.+||+.||++|||+.++++.|+.+
T Consensus       308 ~li~~cl~~dp~~RPs~~el~~~l~~~  334 (338)
T cd05102         308 RIMLACWQGDPKERPTFSALVEILGDL  334 (338)
T ss_pred             HHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.5e-36  Score=225.45  Aligned_cols=173  Identities=25%  Similarity=0.332  Sum_probs=137.0

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCC---CceEEcccccceeccCC
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN---MVAHVSDFGISKLLGEG   77 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~---~~~~l~d~g~~~~~~~~   77 (202)
                      +.||.|.+++-.+.. +.+..-..++.|++.||.|||    +.||+||||||+|||+..+   ..+||.|||+++..+..
T Consensus       258 v~GGeLfd~vv~nk~-l~ed~~K~~f~Qll~avkYLH----~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g~~  332 (475)
T KOG0615|consen  258 VEGGELFDKVVANKY-LREDLGKLLFKQLLTAVKYLH----SQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVSGEG  332 (475)
T ss_pred             ecCccHHHHHHhccc-cccchhHHHHHHHHHHHHHHH----HcCcccccCCcceEEeccCCcceEEEecccchhhccccc
Confidence            579999999987554 888889999999999999999    9999999999999999865   77899999999987744


Q ss_pred             CccccccCCCCCccccCCCCCCCCC---cCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhh
Q 037267           78 EDFVTQTMTMATIGYMAPEYGSEGI---VSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDA  154 (202)
Q Consensus        78 ~~~~~~~~~~~~~~~~~pe~~~~~~---~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (202)
                      ...   .+..||+.|.|||++.+..   +..++|+||+||++|-+++|.+||.+..... .+.+.+..+           
T Consensus       333 sfm---~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~-sl~eQI~~G-----------  397 (475)
T KOG0615|consen  333 SFM---KTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP-SLKEQILKG-----------  397 (475)
T ss_pred             eeh---hhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc-cHHHHHhcC-----------
Confidence            332   2357999999999877654   3347899999999999999999998754332 122222111           


Q ss_pred             hhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          155 NLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                      ....   ..+.+...+++..+|+..||..||++|||++|++.
T Consensus       398 ~y~f---~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~  436 (475)
T KOG0615|consen  398 RYAF---GPLQWDRISEEALDLINWMLVVDPENRPSADEALN  436 (475)
T ss_pred             cccc---cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence            1111   11334578888999999999999999999999874

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=6.1e-35  Score=222.00  Aligned_cols=175  Identities=22%  Similarity=0.269  Sum_probs=137.8

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |++|+|.+++.+.. .+++..+..++.|++.||.|||.   ..+++||||||+||+++.++.+|++|||++.......  
T Consensus       104 ~~~g~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lH~---~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~--  177 (283)
T PHA02988        104 CTRGYLREVLDKEK-DLSFKTKLDMAIDCCKGLYNLYK---YTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP--  177 (283)
T ss_pred             CCCCcHHHHHhhCC-CCChhHHHHHHHHHHHHHHHHHh---cCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc--
Confidence            58999999998654 58999999999999999999993   2488999999999999999999999999987654322  


Q ss_pred             ccccCCCCCccccCCCCCCC--CCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhh
Q 037267           81 VTQTMTMATIGYMAPEYGSE--GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVR  158 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~--~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (202)
                         ....++..|+|||...+  ..++.++|+||+|+++|++++|..||.......  ....+....              
T Consensus       178 ---~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~--~~~~i~~~~--------------  238 (283)
T PHA02988        178 ---FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKE--IYDLIINKN--------------  238 (283)
T ss_pred             ---ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHhcC--------------
Confidence               12357889999998765  578999999999999999999999997643221  111111000              


Q ss_pred             hHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhcC
Q 037267          159 EEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKIK  202 (202)
Q Consensus       159 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l~  202 (202)
                        .....+..++.++.+++.+||+.||++|||++++++.|+.++
T Consensus       239 --~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~  280 (283)
T PHA02988        239 --NSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK  280 (283)
T ss_pred             --CCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence              000111245677999999999999999999999999998864

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-34  Score=219.66  Aligned_cols=188  Identities=21%  Similarity=0.201  Sum_probs=143.0

Q ss_pred             CCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCccc
Q 037267            2 PNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFV   81 (202)
Q Consensus         2 ~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~~   81 (202)
                      ..-+|.+.++..+..|++..+..|+.||++||+|+|    .+|+.|||+||+|||+..+..+||+|||+|+.......  
T Consensus        92 Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hiH----k~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~SkpP--  165 (538)
T KOG0661|consen   92 MDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIH----KHGFFHRDLKPENILISGNDVIKIADFGLAREVRSKPP--  165 (538)
T ss_pred             hhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHH----hcCcccccCChhheEecccceeEecccccccccccCCC--
Confidence            345788999877888999999999999999999999    89999999999999999999999999999998776554  


Q ss_pred             cccCCCCCccccCCCC-CCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhh-
Q 037267           82 TQTMTMATIGYMAPEY-GSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVRE-  159 (202)
Q Consensus        82 ~~~~~~~~~~~~~pe~-~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  159 (202)
                       .+...+|++|+|||+ +....|+.+.|+||+||+++|+.+-++-|.+..+-+..++-.-.-+.|..........+... 
T Consensus       166 -YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~m  244 (538)
T KOG0661|consen  166 -YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAM  244 (538)
T ss_pred             -cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHh
Confidence             345679999999995 45677999999999999999999999988876554443332211122211111110111100 


Q ss_pred             --------H-HHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          160 --------E-QAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       160 --------~-~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                              + .....-..++.+..+++.+|+..||.+||+|+++++
T Consensus       245 nf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~  290 (538)
T KOG0661|consen  245 NFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQ  290 (538)
T ss_pred             ccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhc
Confidence                    0 001112237888999999999999999999999875

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-34  Score=223.46  Aligned_cols=169  Identities=22%  Similarity=0.298  Sum_probs=140.4

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |+||+|.|.+...  .+++.++..+++++++||.|||    ..+|+|||||++|||++.+|.+||+|||+|........ 
T Consensus       352 m~ggsLTDvVt~~--~~~E~qIA~Icre~l~aL~fLH----~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-  424 (550)
T KOG0578|consen  352 MEGGSLTDVVTKT--RMTEGQIAAICREILQGLKFLH----ARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-  424 (550)
T ss_pred             cCCCchhhhhhcc--cccHHHHHHHHHHHHHHHHHHH----hcceeeeccccceeEeccCCcEEEeeeeeeeccccccC-
Confidence            6899999999753  3899999999999999999999    99999999999999999999999999999988765543 


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHH--HHHhCCCChhhhhhhhhhh
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRW--VKESLPHGLTEVVDANLVR  158 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~  158 (202)
                       .+.+..||+.|+|||+.....|+.++||||||++..||+.|.+||-.    +..++.+  +...-.+            
T Consensus       425 -KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYln----E~PlrAlyLIa~ng~P------------  487 (550)
T KOG0578|consen  425 -KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLN----ENPLRALYLIATNGTP------------  487 (550)
T ss_pred             -ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccC----CChHHHHHHHhhcCCC------------
Confidence             35567899999999999999999999999999999999999999965    2222222  1111100            


Q ss_pred             hHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          159 EEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       159 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                         ....+...+.++.+++.+||..|+++|++|.|+++
T Consensus       488 ---~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~  522 (550)
T KOG0578|consen  488 ---KLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLE  522 (550)
T ss_pred             ---CcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence               01223456778999999999999999999999985

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-34  Score=217.99  Aligned_cols=182  Identities=25%  Similarity=0.293  Sum_probs=143.0

Q ss_pred             CCCCcHHHHHhh-cCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCc
Q 037267            1 MPNGSLEKWLYS-YNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED   79 (202)
Q Consensus         1 ~~~gsL~~~l~~-~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~   79 (202)
                      |.+||+.+.++. .+..+++..+..++++++.||.|||    ..|.+|||+|+.|||++.+|.+|++|||++..+..++.
T Consensus       106 Ma~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH----~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~  181 (516)
T KOG0582|consen  106 MAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLH----QNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGD  181 (516)
T ss_pred             hcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHH----hcCceecccccccEEEcCCCcEEEcCceeeeeecccCc
Confidence            689999999985 3556999999999999999999999    89999999999999999999999999999887766542


Q ss_pred             c-ccc-cCCCCCccccCCCCCCC--CCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhh
Q 037267           80 F-VTQ-TMTMATIGYMAPEYGSE--GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDAN  155 (202)
Q Consensus        80 ~-~~~-~~~~~~~~~~~pe~~~~--~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (202)
                      - ..+ ....|+++|+|||++..  ..|+.|+||||||+...|+.+|..||.....-...+..+.  +.++...      
T Consensus       182 R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLq--n~pp~~~------  253 (516)
T KOG0582|consen  182 RQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQ--NDPPTLL------  253 (516)
T ss_pred             eeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhc--CCCCCcc------
Confidence            2 222 55689999999997433  4689999999999999999999999987654443333222  1111111      


Q ss_pred             hhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          156 LVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                        ......+.....+..+..++..||.+||.+|||++++++
T Consensus       254 --t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk  292 (516)
T KOG0582|consen  254 --TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK  292 (516)
T ss_pred             --cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence              001112334556668999999999999999999999875

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-34  Score=226.59  Aligned_cols=182  Identities=23%  Similarity=0.344  Sum_probs=142.6

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |+|.||..+|+.....|.....+.|++|+++|+.|||    .++|+|||||+.||++.+++++||+|||++..-....-.
T Consensus       469 CeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLH----AK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~  544 (678)
T KOG0193|consen  469 CEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLH----AKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGE  544 (678)
T ss_pred             ccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhh----hhhhhhhhccccceEEccCCcEEEecccceeeeeeeccc
Confidence            7899999999976666999999999999999999999    999999999999999999999999999998754322211


Q ss_pred             ccccCCCCCccccCCCCCC---CCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhh
Q 037267           81 VTQTMTMATIGYMAPEYGS---EGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV  157 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~---~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (202)
                      .......+...|+|||++.   ..+|+..+|+||||+++|||++|..||.....+...+.      +-..+         
T Consensus       545 ~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifm------VGrG~---------  609 (678)
T KOG0193|consen  545 QQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFM------VGRGY---------  609 (678)
T ss_pred             cccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEE------ecccc---------
Confidence            2233456788999999765   34789999999999999999999999984322221111      10010         


Q ss_pred             hhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          158 REEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                      ...+.......|+.++.+|+..||.+++++||.+.+++..|+.+
T Consensus       610 l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l  653 (678)
T KOG0193|consen  610 LMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEEL  653 (678)
T ss_pred             cCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHh
Confidence            00111222346888899999999999999999999999988764

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-34  Score=221.91  Aligned_cols=167  Identities=27%  Similarity=0.315  Sum_probs=135.1

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCC-CceEEcccccceecc-CCC
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN-MVAHVSDFGISKLLG-EGE   78 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~-~~~~l~d~g~~~~~~-~~~   78 (202)
                      |.||+|.+++.+ ...+++.++.++++|+++||+|||    +++|+||||||+|++++.+ +.+||+|||++.... ...
T Consensus       102 ~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H----~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~~~~  176 (370)
T KOG0583|consen  102 CSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCH----SRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISPGEDG  176 (370)
T ss_pred             cCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHH----hCCEeeCCCCHHHEEecCCCCCEEEeccccccccCCCCC
Confidence            578999999998 556999999999999999999999    9999999999999999998 999999999999873 222


Q ss_pred             ccccccCCCCCccccCCCCCCCCC-cC-cchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhh
Q 037267           79 DFVTQTMTMATIGYMAPEYGSEGI-VS-AKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANL  156 (202)
Q Consensus        79 ~~~~~~~~~~~~~~~~pe~~~~~~-~~-~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (202)
                      .   .....|++.|+|||++.+.. |+ .++|+||+|+++|.|++|..||++.........  +..+             
T Consensus       177 ~---l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~k--i~~~-------------  238 (370)
T KOG0583|consen  177 L---LKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRK--IRKG-------------  238 (370)
T ss_pred             c---ccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHH--HhcC-------------
Confidence            2   23457999999999998877 75 679999999999999999999987322111111  1100             


Q ss_pred             hhhHHHHHHhHHH-HHHHHHHHhhhcCCCCCCCCCHHHHH
Q 037267          157 VREEQAFAAKMDC-IVSIMDLALDCCMESPGKRINMTDAA  195 (202)
Q Consensus       157 ~~~~~~~~~~~~~-~~~~~~l~~~cl~~~p~~Rps~~~~~  195 (202)
                           ....+..+ +.++.+|+.+|+..||.+|+++.+++
T Consensus       239 -----~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~  273 (370)
T KOG0583|consen  239 -----EFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL  273 (370)
T ss_pred             -----CccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence                 01112223 66789999999999999999999998

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=1.1e-33  Score=214.62  Aligned_cols=178  Identities=22%  Similarity=0.343  Sum_probs=139.1

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      +++|||.+++......+++..+..++.|++.||.|||    +.+++|+||||+||+++.++.++++|||+++........
T Consensus        90 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~~  165 (279)
T cd05111          90 SPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLE----EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKK  165 (279)
T ss_pred             CCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH----HCCEeccccCcceEEEcCCCcEEEcCCccceeccCCCcc
Confidence            4799999999876667899999999999999999999    899999999999999999999999999999876443222


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhh
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVRE  159 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (202)
                      .......++..|++||...+..++.++|+||+|+++|++++ |..||.......  ....+.....              
T Consensus       166 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~--~~~~~~~~~~--------------  229 (279)
T cd05111         166 YFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE--VPDLLEKGER--------------  229 (279)
T ss_pred             cccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHHHCCCc--------------
Confidence            11222345678999999888889999999999999999998 999986643221  1111111110              


Q ss_pred             HHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          160 EQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       160 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                         ...+..++..+.+++.+||..+|++|||+.|+++.|..+
T Consensus       230 ---~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~  268 (279)
T cd05111         230 ---LAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRM  268 (279)
T ss_pred             ---CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence               001112445578999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=1.4e-34  Score=235.44  Aligned_cols=178  Identities=28%  Similarity=0.494  Sum_probs=151.6

Q ss_pred             CCCCcHHHHHhhcC-------------CCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcc
Q 037267            1 MPNGSLEKWLYSYN-------------YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSD   67 (202)
Q Consensus         1 ~~~gsL~~~l~~~~-------------~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d   67 (202)
                      |.+|||.+||+.+.             .+|+..+.+.|+.|||.|+.||-    ++.+|||||-..|+||++...+||+|
T Consensus       571 m~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs----~~~FVHRDLATRNCLVge~l~VKIsD  646 (774)
T KOG1026|consen  571 MDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS----SHHFVHRDLATRNCLVGENLVVKISD  646 (774)
T ss_pred             cccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH----hCcccccchhhhhceeccceEEEecc
Confidence            67999999998542             12889999999999999999999    89999999999999999999999999


Q ss_pred             cccceeccCCCccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhCCC
Q 037267           68 FGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPH  146 (202)
Q Consensus        68 ~g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~  146 (202)
                      ||+++-....+-++..+...-+.+|+|||.+..+++++++||||||+++||+++ |..||.+....+.            
T Consensus       647 fGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EV------------  714 (774)
T KOG1026|consen  647 FGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEV------------  714 (774)
T ss_pred             cccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHH------------
Confidence            999998777666665555567889999999999999999999999999999998 9999988755441            


Q ss_pred             ChhhhhhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          147 GLTEVVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                           +.- + ..+..++.+..|+.++++||..||++.|++||+++||-.+|+..
T Consensus       715 -----Ie~-i-~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~  762 (774)
T KOG1026|consen  715 -----IEC-I-RAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAW  762 (774)
T ss_pred             -----HHH-H-HcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHH
Confidence                 111 1 11222566778999999999999999999999999999999863

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5e-34  Score=226.76  Aligned_cols=168  Identities=26%  Similarity=0.345  Sum_probs=140.1

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      ++||-|+++|...+. |++.++.+++.||..|+.|+|    ..+|+||||||+|+|++..+.+||+|||+|....+... 
T Consensus        94 v~gGELFdylv~kG~-l~e~eaa~ff~QIi~gv~yCH----~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gkl-  167 (786)
T KOG0588|consen   94 VPGGELFDYLVRKGP-LPEREAAHFFRQILDGVSYCH----AFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKL-  167 (786)
T ss_pred             cCCchhHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHh----hhcceeccCCchhhhhhcccCEeeeccceeecccCCcc-
Confidence            589999999987554 899999999999999999999    88999999999999999888899999999987665543 


Q ss_pred             ccccCCCCCccccCCCCCCCCCcC-cchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhh
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVS-AKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVRE  159 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~-~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (202)
                        ..+..|.+.|++||++.|.+|. .++|+||+|+|+|.+++|+.||++-     .++.+...               ..
T Consensus       168 --LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDd-----Nir~LLlK---------------V~  225 (786)
T KOG0588|consen  168 --LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDD-----NIRVLLLK---------------VQ  225 (786)
T ss_pred             --ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCc-----cHHHHHHH---------------HH
Confidence              3446799999999999999885 5699999999999999999999741     12222111               11


Q ss_pred             HHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          160 EQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       160 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                      ...+..+..++.+.-+|+.+|+..||+.|+|+.||++
T Consensus       226 ~G~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~k  262 (786)
T KOG0588|consen  226 RGVFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILK  262 (786)
T ss_pred             cCcccCCCcCCHHHHHHHHHHhccCccccccHHHHhh
Confidence            2224555678888999999999999999999999986

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-34  Score=241.20  Aligned_cols=178  Identities=26%  Similarity=0.428  Sum_probs=150.1

Q ss_pred             CCCCcHHHHHhhc------CCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceec
Q 037267            1 MPNGSLEKWLYSY------NYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLL   74 (202)
Q Consensus         1 ~~~gsL~~~l~~~------~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~   74 (202)
                      |+||+|..||++.      +..++..+-+.+++|||.|+.||+    ++.+|||||...|+|++....+||+|||+++-.
T Consensus       777 M~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe----~~~fvHRDLAaRNCLL~~~r~VKIaDFGlArDi  852 (1025)
T KOG1095|consen  777 MEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLE----SKHFVHRDLAARNCLLDERRVVKIADFGLARDI  852 (1025)
T ss_pred             cccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHH----hCCCcCcchhhhheeecccCcEEEcccchhHhh
Confidence            7899999999987      667999999999999999999999    899999999999999999999999999999955


Q ss_pred             cCCCccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhCCCChhhhhh
Q 037267           75 GEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVD  153 (202)
Q Consensus        75 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (202)
                      ....-+.......-+..|+|||.+..+.++.++|+||||+++||+++ |..||....+.+.... +.             
T Consensus       853 y~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~-~~-------------  918 (1025)
T KOG1095|consen  853 YDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLD-VL-------------  918 (1025)
T ss_pred             hhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHH-HH-------------
Confidence            55444443333456789999999999999999999999999999998 8899977543331111 11             


Q ss_pred             hhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          154 ANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                          . ..+++.+..|+..++++|.+||+.+|++||++..+++++.++
T Consensus       919 ----~-ggRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i  961 (1025)
T KOG1095|consen  919 ----E-GGRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAI  961 (1025)
T ss_pred             ----h-CCccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhh
Confidence                1 114566678999999999999999999999999999988764

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=1.8e-33  Score=217.00  Aligned_cols=178  Identities=23%  Similarity=0.376  Sum_probs=138.8

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      +++|+|.+++......+++..++.++.|++.||.|||    +.+++||||||+||+++.++.++|+|||++.........
T Consensus        90 ~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH----~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  165 (316)
T cd05108          90 MPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE----ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKE  165 (316)
T ss_pred             CCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHH----hcCeeccccchhheEecCCCcEEEccccccccccCCCcc
Confidence            5789999999876666899999999999999999999    899999999999999999999999999999876543322


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhh
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVRE  159 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (202)
                      ........+..|++||...+..++.++|+||+|+++|++++ |..||.......  +........               
T Consensus       166 ~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~--~~~~~~~~~---------------  228 (316)
T cd05108         166 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISSILEKGE---------------  228 (316)
T ss_pred             eeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHHhCCC---------------
Confidence            22222234567999999888889999999999999999997 999986532211  111111100               


Q ss_pred             HHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          160 EQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       160 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                        ..+.+..++.++.+++.+||..+|++||++.+++..|..+
T Consensus       229 --~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~  268 (316)
T cd05108         229 --RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM  268 (316)
T ss_pred             --CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence              0011123455688999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=3.1e-33  Score=212.37  Aligned_cols=178  Identities=25%  Similarity=0.466  Sum_probs=139.2

Q ss_pred             CCCCcHHHHHhhcC---------------CCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEE
Q 037267            1 MPNGSLEKWLYSYN---------------YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHV   65 (202)
Q Consensus         1 ~~~gsL~~~l~~~~---------------~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l   65 (202)
                      +++|+|.+++....               ..+++..++.++.|++.||.|||    +.+++|+||||+||+++.++.+++
T Consensus        90 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH----~~~i~H~dlkp~Nil~~~~~~~~L  165 (283)
T cd05048          90 LAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS----SHHFVHRDLAARNCLVGEGLTVKI  165 (283)
T ss_pred             CCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH----hCCeeccccccceEEEcCCCcEEE
Confidence            47899999997542               34788999999999999999999    899999999999999999999999


Q ss_pred             cccccceeccCCCccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhC
Q 037267           66 SDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESL  144 (202)
Q Consensus        66 ~d~g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~  144 (202)
                      +|||++................++..|+|||...+..++.++|+||+||++|++++ |..||......+  ....+....
T Consensus       166 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~--~~~~i~~~~  243 (283)
T cd05048         166 SDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE--VIEMIRSRQ  243 (283)
T ss_pred             CCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHHHcCC
Confidence            99999876543322222223346778999998888888999999999999999997 999987643221  111111110


Q ss_pred             CCChhhhhhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          145 PHGLTEVVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                      .                 ...+..++.++.+++.+||+.||.+||++.++++.|+.+
T Consensus       244 ~-----------------~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~  283 (283)
T cd05048         244 L-----------------LPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW  283 (283)
T ss_pred             c-----------------CCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence            0                 011234677899999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=3.5e-33  Score=211.76  Aligned_cols=178  Identities=21%  Similarity=0.351  Sum_probs=138.3

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      +++|+|.++++.....+++..++.++.|++.||.|||    +.+++||||||+||+++.++.++++|||++.........
T Consensus        90 ~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH----~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~~  165 (279)
T cd05109          90 MPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLE----EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETE  165 (279)
T ss_pred             CCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH----HCCeeccccccceEEEcCCCcEEECCCCceeecccccce
Confidence            4789999999876666899999999999999999999    899999999999999999999999999999876543222


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhh
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVRE  159 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (202)
                      .......++..|++||...+..++.++|+||+||++|++++ |..||.......  ....+.....              
T Consensus       166 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~~~~~~~~~--------------  229 (279)
T cd05109         166 YHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE--IPDLLEKGER--------------  229 (279)
T ss_pred             eecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHHHCCCc--------------
Confidence            11112234567999998888888999999999999999998 888986532211  1111111100              


Q ss_pred             HHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          160 EQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       160 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                         .+.+..++.++.+++.+||..||++||++.++++.|+.+
T Consensus       230 ---~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~  268 (279)
T cd05109         230 ---LPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRM  268 (279)
T ss_pred             ---CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence               001123456689999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=1.7e-33  Score=205.97  Aligned_cols=186  Identities=21%  Similarity=0.197  Sum_probs=139.8

Q ss_pred             cHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcccccc
Q 037267            5 SLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQT   84 (202)
Q Consensus         5 sL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~   84 (202)
                      ++.+-|..++..++...+.+++.|++.|+.|+|    +++++|||+||+|||+..++.+|++|||+|+....+..  ..+
T Consensus        86 TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cH----k~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd--~YT  159 (396)
T KOG0593|consen   86 TVLHELERYPNGVPSELVKKYLYQLLKAIHFCH----KNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGD--NYT  159 (396)
T ss_pred             HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhh----hcCeecccCChhheEEecCCcEEeccchhhHhhcCCcc--hhh
Confidence            344556666667999999999999999999999    89999999999999999999999999999998774332  234


Q ss_pred             CCCCCccccCCCCCCC-CCcCcchhhhhHHHHHHHHHhCCCCCCcccccch-hhHHHHHHhCCCChhhhhhhhhhhhH--
Q 037267           85 MTMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEM-SLRRWVKESLPHGLTEVVDANLVREE--  160 (202)
Q Consensus        85 ~~~~~~~~~~pe~~~~-~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~--  160 (202)
                      ....|++|.|||.+.| .+|+.++||||+||++.||++|.+-|.+..+-+. .........+.+...++...+....+  
T Consensus       160 DYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~  239 (396)
T KOG0593|consen  160 DYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVR  239 (396)
T ss_pred             hhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeee
Confidence            4578999999998877 6899999999999999999999999987544332 22223333333333333332221111  


Q ss_pred             --------HHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          161 --------QAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       161 --------~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                              .........+.-+++++..|++.||.+|++-+|++.
T Consensus       240 lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  240 LPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             cCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence                    111222345557899999999999999999998863

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=8.5e-34  Score=212.15  Aligned_cols=163  Identities=29%  Similarity=0.275  Sum_probs=132.1

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      +.||.|.-.|+++.. +++..+.-++.+|+.||.|||    +++|+||||||+|||++..|.++++|||+++....... 
T Consensus       107 ~~GGeLf~hL~~eg~-F~E~~arfYlaEi~lAL~~LH----~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~-  180 (357)
T KOG0598|consen  107 LNGGELFYHLQREGR-FSEDRARFYLAEIVLALGYLH----SKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGD-  180 (357)
T ss_pred             cCCccHHHHHHhcCC-cchhHHHHHHHHHHHHHHHHH----hCCeeeccCCHHHeeecCCCcEEEeccccchhcccCCC-
Confidence            478999999987665 899999999999999999999    99999999999999999999999999999986543322 


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhH
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREE  160 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (202)
                       ...+..||+.|+|||++.+..++..+|.||+|+++|+|++|..||.........             ..+.....    
T Consensus       181 -~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~-------------~~I~~~k~----  242 (357)
T KOG0598|consen  181 -ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMY-------------DKILKGKL----  242 (357)
T ss_pred             -ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHH-------------HHHhcCcC----
Confidence             233468999999999999999999999999999999999999999775432211             11111110    


Q ss_pred             HHHHHhHHHHHHHHHHHhhhcCCCCCCCC
Q 037267          161 QAFAAKMDCIVSIMDLALDCCMESPGKRI  189 (202)
Q Consensus       161 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rp  189 (202)
                        ...+.-.+.+..+++.+.+.+||++|.
T Consensus       243 --~~~p~~ls~~ardll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  243 --PLPPGYLSEEARDLLKKLLKRDPRQRL  269 (357)
T ss_pred             --CCCCccCCHHHHHHHHHHhccCHHHhc
Confidence              111123556689999999999999996

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2.1e-33  Score=203.25  Aligned_cols=172  Identities=32%  Similarity=0.393  Sum_probs=137.2

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |+.|-|.|||.+ .-.+++....++++|+..|+.|||    ..+||||||||+|||++.+..++++|||+++...++...
T Consensus       105 ~prGELFDyLts-~VtlSEK~tR~iMrqlfegVeylH----a~~IVHRDLKpENILlddn~~i~isDFGFa~~l~~GekL  179 (411)
T KOG0599|consen  105 MPRGELFDYLTS-KVTLSEKETRRIMRQLFEGVEYLH----ARNIVHRDLKPENILLDDNMNIKISDFGFACQLEPGEKL  179 (411)
T ss_pred             cccchHHHHhhh-heeecHHHHHHHHHHHHHHHHHHH----HhhhhhcccChhheeeccccceEEeccceeeccCCchhH
Confidence            689999999975 345999999999999999999999    999999999999999999999999999999987766543


Q ss_pred             ccccCCCCCccccCCCCCCC------CCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhh
Q 037267           81 VTQTMTMATIGYMAPEYGSE------GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDA  154 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~------~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (202)
                      .   ...||+.|+|||.+.-      ..|+..+|+|++|+++|.++.|.+||-..  .....-.++..+.          
T Consensus       180 r---elCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHR--kQmlMLR~ImeGk----------  244 (411)
T KOG0599|consen  180 R---ELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHR--KQMLMLRMIMEGK----------  244 (411)
T ss_pred             H---HhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHH--HHHHHHHHHHhcc----------
Confidence            2   2469999999996542      35788899999999999999999998431  1111111221111          


Q ss_pred             hhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          155 NLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                        ..  ..-+...+.+.+..+|+.+||+.||.+|.|+.|++.
T Consensus       245 --yq--F~speWadis~~~KdLIsrlLqVdp~~Ritake~La  282 (411)
T KOG0599|consen  245 --YQ--FRSPEWADISATVKDLISRLLQVDPTKRITAKEALA  282 (411)
T ss_pred             --cc--cCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence              00  112344677888999999999999999999999874

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=3.2e-33  Score=201.00  Aligned_cols=187  Identities=21%  Similarity=0.238  Sum_probs=140.3

Q ss_pred             CcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCccccc
Q 037267            4 GSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQ   83 (202)
Q Consensus         4 gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~   83 (202)
                      -+|+..++.....++..++..++.+++.||+|||    ++.|+|||+||.|+|++.+|.+|++|||+++.+..+......
T Consensus        85 tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H----~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~~  160 (318)
T KOG0659|consen   85 TDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCH----SKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQTH  160 (318)
T ss_pred             ccHHHHhcccccccCHHHHHHHHHHHHHHHHHHH----hhhhhcccCCccceEEcCCCcEEeecccchhccCCCCccccc
Confidence            5789999988888999999999999999999999    999999999999999999999999999999988765543322


Q ss_pred             cCCCCCccccCCCCCCCC-CcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCC-----CChhhhhhhhhh
Q 037267           84 TMTMATIGYMAPEYGSEG-IVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLP-----HGLTEVVDANLV  157 (202)
Q Consensus        84 ~~~~~~~~~~~pe~~~~~-~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~  157 (202)
                        ...|.+|.|||.+.|. .|+...||||.||++.|++-|.+.|.+..+-+..-.-+..-+.|     +.+..+.+....
T Consensus       161 --~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~  238 (318)
T KOG0659|consen  161 --QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKI  238 (318)
T ss_pred             --ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHH
Confidence              2678999999977764 68899999999999999999987776544332211111111111     122222222111


Q ss_pred             h--h-HHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          158 R--E-EQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       158 ~--~-~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                      .  + .........++.++++|+.++|.+||.+|+++.|+++
T Consensus       239 ~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~  280 (318)
T KOG0659|consen  239 QQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALK  280 (318)
T ss_pred             hcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhc
Confidence            1  0 0001123456777899999999999999999999875

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-33  Score=212.26  Aligned_cols=125  Identities=32%  Similarity=0.456  Sum_probs=111.0

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCC------CceEEcccccceec
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN------MVAHVSDFGISKLL   74 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~------~~~~l~d~g~~~~~   74 (202)
                      |.||+|.+||++.+. +++.++..++.||++||++||    +++|+||||||+|||+...      -.+||+|||+++..
T Consensus        91 C~gGDLs~yi~~~~~-l~e~t~r~Fm~QLA~alq~L~----~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L  165 (429)
T KOG0595|consen   91 CNGGDLSDYIRRRGR-LPEATARHFMQQLASALQFLH----ENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFL  165 (429)
T ss_pred             CCCCCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH----HCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhC
Confidence            789999999998664 899999999999999999999    9999999999999999864      45799999999987


Q ss_pred             cCCCccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccc
Q 037267           75 GEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGE  133 (202)
Q Consensus        75 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~  133 (202)
                      .+...   ..+..|++.|+|||+....+|+.|+|+||+|+++|++++|..||+..+..+
T Consensus       166 ~~~~~---a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~e  221 (429)
T KOG0595|consen  166 QPGSM---AETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKE  221 (429)
T ss_pred             CchhH---HHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHH
Confidence            75432   344679999999999999999999999999999999999999998765444

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=3.7e-33  Score=219.80  Aligned_cols=164  Identities=23%  Similarity=0.381  Sum_probs=125.9

Q ss_pred             CCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCccccccCCCCCccccCC
Q 037267           16 FFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAP   95 (202)
Q Consensus        16 ~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~p   95 (202)
                      .+++..+++++.|++.||.|||    +.+++||||||+||+++.++.++|+|||++................++..|+||
T Consensus       208 ~l~~~~~~~i~~qi~~aL~yLH----~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aP  283 (374)
T cd05106         208 PLDLDDLLRFSSQVAQGMDFLA----SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAP  283 (374)
T ss_pred             CcCHHHHHHHHHHHHHHHHHHH----HCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCCccceeCH
Confidence            3788899999999999999999    899999999999999999999999999998765433221112222345679999


Q ss_pred             CCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhHHHHHHhHHHHHHHH
Q 037267           96 EYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIM  174 (202)
Q Consensus        96 e~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  174 (202)
                      |...+..++.++|+||+|+++|++++ |..||........ ...........                 ..+...+.++.
T Consensus       284 E~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~-~~~~~~~~~~~-----------------~~~~~~~~~l~  345 (374)
T cd05106         284 ESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK-FYKMVKRGYQM-----------------SRPDFAPPEIY  345 (374)
T ss_pred             HHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH-HHHHHHcccCc-----------------cCCCCCCHHHH
Confidence            98888889999999999999999997 9999976543221 11111111100                 00112345689


Q ss_pred             HHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          175 DLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       175 ~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                      +++.+||..||++|||+.++++.|+++
T Consensus       346 ~li~~cl~~dp~~RPs~~~l~~~l~~~  372 (374)
T cd05106         346 SIMKMCWNLEPTERPTFSQISQLIQRQ  372 (374)
T ss_pred             HHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=3.5e-32  Score=207.54  Aligned_cols=178  Identities=26%  Similarity=0.413  Sum_probs=137.9

Q ss_pred             CCCCcHHHHHhhcC---------------CCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEE
Q 037267            1 MPNGSLEKWLYSYN---------------YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHV   65 (202)
Q Consensus         1 ~~~gsL~~~l~~~~---------------~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l   65 (202)
                      +++|+|.+++..+.               ..+++..++.++.|++.||.|||    +++++||||||.||+++.++.+++
T Consensus        89 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH----~~~i~H~dlkp~Nil~~~~~~~~l  164 (291)
T cd05094          89 MKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA----SQHFVHRDLATRNCLVGANLLVKI  164 (291)
T ss_pred             CCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH----hCCeeecccCcceEEEccCCcEEE
Confidence            47899999997542               23789999999999999999999    899999999999999999999999


Q ss_pred             cccccceeccCCCccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhC
Q 037267           66 SDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESL  144 (202)
Q Consensus        66 ~d~g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~  144 (202)
                      +|||++................++..|+|||...+..++.++|+||+|+++|++++ |..||.......  .........
T Consensus       165 ~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--~~~~~~~~~  242 (291)
T cd05094         165 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE--VIECITQGR  242 (291)
T ss_pred             CCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHhCCC
Confidence            99999876543322111222345678999999888888999999999999999998 999986543221  111111110


Q ss_pred             CCChhhhhhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          145 PHGLTEVVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                      ..                 ..+..++..+.+++.+||..+|++|||+.++++.|+++
T Consensus       243 ~~-----------------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~  282 (291)
T cd05094         243 VL-----------------ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHAL  282 (291)
T ss_pred             CC-----------------CCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence            00                 01123456689999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=1.4e-32  Score=216.66  Aligned_cols=164  Identities=23%  Similarity=0.376  Sum_probs=125.8

Q ss_pred             CCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCccccccCCCCCccccCC
Q 037267           16 FFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAP   95 (202)
Q Consensus        16 ~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~p   95 (202)
                      .+++..+..++.|++.||.|||    +.+++||||||.||+++.++.++++|||++................++..|+||
T Consensus       210 ~l~~~~~~~~~~qi~~~l~~lH----~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aP  285 (375)
T cd05104         210 ALDTEDLLSFSYQVAKGMSFLA----SKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAP  285 (375)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHH----HCCeeccCCchhhEEEECCCcEEEecCccceeccCcccccccCCCCCCcceeCh
Confidence            4788899999999999999999    899999999999999999999999999999865443222112223345679999


Q ss_pred             CCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhHHHHHHhHHHHHHHH
Q 037267           96 EYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIM  174 (202)
Q Consensus        96 e~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  174 (202)
                      |...+..++.++|+||+|+++|++++ |..||....... .+...+......                 ..+...+.++.
T Consensus       286 E~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~-~~~~~~~~~~~~-----------------~~~~~~~~~l~  347 (375)
T cd05104         286 ESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS-KFYKMIKEGYRM-----------------LSPECAPSEMY  347 (375)
T ss_pred             hHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH-HHHHHHHhCccC-----------------CCCCCCCHHHH
Confidence            99888889999999999999999997 888886643222 111122111100                 00112345689


Q ss_pred             HHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          175 DLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       175 ~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                      +++.+||..||++|||+.++++.|++.
T Consensus       348 ~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         348 DIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             HHHHHHccCChhHCcCHHHHHHHHHhh
Confidence            999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=9.3e-33  Score=210.41  Aligned_cols=178  Identities=26%  Similarity=0.425  Sum_probs=137.1

Q ss_pred             CCCCcHHHHHhhcC------------CCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEccc
Q 037267            1 MPNGSLEKWLYSYN------------YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDF   68 (202)
Q Consensus         1 ~~~gsL~~~l~~~~------------~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~   68 (202)
                      +++|+|.+++..+.            ..+++..++.++.|++.||.|||    +.+++|||+||+||+++.++.++++||
T Consensus        89 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH----~~~i~H~dlkp~Nili~~~~~~kl~df  164 (288)
T cd05093          89 MKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA----SQHFVHRDLATRNCLVGENLLVKIGDF  164 (288)
T ss_pred             CCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH----hCCeeecccCcceEEEccCCcEEeccC
Confidence            47899999997543            24899999999999999999999    899999999999999999999999999


Q ss_pred             ccceeccCCCccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhCCCC
Q 037267           69 GISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHG  147 (202)
Q Consensus        69 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~  147 (202)
                      |++................++..|+|||.+.+..++.++|+||+|+++|++++ |..||.......  ....+.....  
T Consensus       165 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~--~~~~i~~~~~--  240 (288)
T cd05093         165 GMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE--VIECITQGRV--  240 (288)
T ss_pred             CccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcCCc--
Confidence            99876543222111222334678999999888888999999999999999998 888986543221  1111111100  


Q ss_pred             hhhhhhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          148 LTEVVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                                     ...+..++.++.+++.+||+.||++|||+.++.+.|+.+
T Consensus       241 ---------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~  279 (288)
T cd05093         241 ---------------LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNL  279 (288)
T ss_pred             ---------------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence                           000112445689999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=1.3e-32  Score=207.75  Aligned_cols=178  Identities=25%  Similarity=0.444  Sum_probs=136.8

Q ss_pred             CCCCcHHHHHhh-----cCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceecc
Q 037267            1 MPNGSLEKWLYS-----YNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLG   75 (202)
Q Consensus         1 ~~~gsL~~~l~~-----~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~   75 (202)
                      |++|+|.+++..     ....+++..+..++.|++.||.|||    +++|+||||||+||+++.++.++++|||++....
T Consensus        88 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  163 (272)
T cd05075          88 MKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLS----SKSFIHRDLAARNCMLNENMNVCVADFGLSKKIY  163 (272)
T ss_pred             CCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHH----HCCeeccccchhheEEcCCCCEEECCCCcccccC
Confidence            478999998852     2234899999999999999999999    8999999999999999999999999999998765


Q ss_pred             CCCccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhCCCChhhhhhh
Q 037267           76 EGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDA  154 (202)
Q Consensus        76 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (202)
                      ............+++.|++||...+..++.++|+||+|+++|++++ |..||......  .....+.....         
T Consensus       164 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~~~~~~~~~~---------  232 (272)
T cd05075         164 NGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS--EIYDYLRQGNR---------  232 (272)
T ss_pred             cccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHHcCCC---------
Confidence            4332222222345678999999888888999999999999999998 78888653221  11111111100         


Q ss_pred             hhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          155 NLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                              ...+..++..+.+++.+||..||++|||+.++++.|+++
T Consensus       233 --------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         233 --------LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             --------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                    001123455689999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=99.98  E-value=5.9e-32  Score=210.33  Aligned_cols=164  Identities=27%  Similarity=0.424  Sum_probs=127.0

Q ss_pred             CCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCccccccCCCCCccccCC
Q 037267           16 FFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAP   95 (202)
Q Consensus        16 ~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~p   95 (202)
                      .+++..+.+++.|++.||.|||    +.+|+||||||.||+++.++.++|+|||++................++..|+||
T Consensus       169 ~l~~~~~~~~~~qi~~aL~~lH----~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aP  244 (337)
T cd05054         169 PLTLEDLISYSFQVARGMEFLA----SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP  244 (337)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCc
Confidence            5789999999999999999999    899999999999999999999999999999875433222222233456789999


Q ss_pred             CCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhHHHHHHhHHHHHHHH
Q 037267           96 EYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIM  174 (202)
Q Consensus        96 e~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  174 (202)
                      |.+.+..++.++|+||+||++|++++ |..||......+. +.........    .             ..+..++.++.
T Consensus       245 E~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~-~~~~~~~~~~----~-------------~~~~~~~~~~~  306 (337)
T cd05054         245 ESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE-FCRRLKEGTR----M-------------RAPEYATPEIY  306 (337)
T ss_pred             HHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH-HHHHHhccCC----C-------------CCCccCCHHHH
Confidence            99888889999999999999999997 9999865332221 1111111100    0             00123445689


Q ss_pred             HHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          175 DLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       175 ~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                      +++.+||..+|++||++.++++.|+.+
T Consensus       307 ~l~~~cl~~~p~~RPs~~ell~~l~~~  333 (337)
T cd05054         307 SIMLDCWHNNPEDRPTFSELVEILGDL  333 (337)
T ss_pred             HHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=8.3e-33  Score=206.29  Aligned_cols=186  Identities=25%  Similarity=0.209  Sum_probs=135.3

Q ss_pred             CCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcccc
Q 037267            3 NGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVT   82 (202)
Q Consensus         3 ~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~   82 (202)
                      +-+|.+.++++. .|+...+..++.|++.||+|+|    +.+++||||||+|++++.+..+|++|||+++..... ....
T Consensus       109 etDL~~iik~~~-~L~d~H~q~f~YQiLrgLKyiH----SAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~-~~~~  182 (359)
T KOG0660|consen  109 ETDLHQIIKSQQ-DLTDDHAQYFLYQILRGLKYIH----SANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKF-FEDG  182 (359)
T ss_pred             hhHHHHHHHcCc-cccHHHHHHHHHHHHHhcchhh----cccccccccchhheeeccCCCEEeccccceeecccc-Cccc
Confidence            457888887644 3899999999999999999999    999999999999999999999999999999987543 1111


Q ss_pred             -ccCCCCCccccCCCC-CCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhh--------
Q 037267           83 -QTMTMATIGYMAPEY-GSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVV--------  152 (202)
Q Consensus        83 -~~~~~~~~~~~~pe~-~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--------  152 (202)
                       -+....|.+|.|||+ +....|+...||||+|||+.||++|+.-|.+...-..  -..+....+..-.+.+        
T Consensus       183 ~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Q--l~lI~~~lGtP~~e~l~~i~s~~a  260 (359)
T KOG0660|consen  183 FMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQ--LQLILELLGTPSEEDLQKIRSEKA  260 (359)
T ss_pred             chhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHH--HHHHHHhcCCCCHHHHHHhccHHH
Confidence             133567999999995 4556899999999999999999999998876432211  1111111111111111        


Q ss_pred             ----hhhhhhhHH-HHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          153 ----DANLVREEQ-AFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       153 ----~~~~~~~~~-~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                          ......++. .........+..++|+.+||..||.+|+|++|+++
T Consensus       261 r~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~  309 (359)
T KOG0660|consen  261 RPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA  309 (359)
T ss_pred             HHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence                100001111 11223466778999999999999999999999875

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=99.98  E-value=3.1e-32  Score=209.06  Aligned_cols=184  Identities=26%  Similarity=0.383  Sum_probs=135.0

Q ss_pred             CCCCcHHHHHhhcC------------------CCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCc
Q 037267            1 MPNGSLEKWLYSYN------------------YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMV   62 (202)
Q Consensus         1 ~~~gsL~~~l~~~~------------------~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~   62 (202)
                      |++|+|.+++....                  ..+++..+.+++.|++.||.|||    +.+++||||||+||+++.++.
T Consensus       101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH----~~~ivH~dlkp~Nill~~~~~  176 (304)
T cd05096         101 MENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS----SLNFVHRDLATRNCLVGENLT  176 (304)
T ss_pred             CCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH----HCCccccCcchhheEEcCCcc
Confidence            57899999986432                  23678899999999999999999    899999999999999999999


Q ss_pred             eEEcccccceeccCCCccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh--CCCCCCcccccchhhHHHH
Q 037267           63 AHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT--RKRPTDEMFTGEMSLRRWV  140 (202)
Q Consensus        63 ~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~--g~~p~~~~~~~~~~~~~~~  140 (202)
                      +|++|||++................++..|+|||...+..++.++|+||+|+++|++++  +..||.......  ....+
T Consensus       177 ~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~--~~~~~  254 (304)
T cd05096         177 IKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQ--VIENA  254 (304)
T ss_pred             EEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCCcCCHHH--HHHHH
Confidence            99999999986544332222223345778999998888889999999999999999986  556776543221  11111


Q ss_pred             HHhCCCChhhhhhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhh
Q 037267          141 KESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKK  200 (202)
Q Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~  200 (202)
                      ...........          ....+..++..+.+++.+||+.||++|||+.++.+.|+.
T Consensus       255 ~~~~~~~~~~~----------~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~  304 (304)
T cd05096         255 GEFFRDQGRQV----------YLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE  304 (304)
T ss_pred             HHHhhhccccc----------cccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence            10000000000          001122456679999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=99.98  E-value=2.5e-32  Score=205.68  Aligned_cols=178  Identities=28%  Similarity=0.480  Sum_probs=138.8

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      +++|+|.+++......+++..+..++.|++.||.|||    +.+++|+|+||.||+++.++.++++|||++.........
T Consensus        87 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh----~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~  162 (266)
T cd05033          87 MENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLS----EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEAT  162 (266)
T ss_pred             CCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCCcceEEEcCCCCEEECccchhhcccccccc
Confidence            4789999999876667899999999999999999999    899999999999999999999999999999876522211


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhh
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVRE  159 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (202)
                      .......++..|++||...+..++.++|+||+|+++|++++ |..||.......  ....+.....              
T Consensus       163 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~--~~~~~~~~~~--------------  226 (266)
T cd05033         163 YTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD--VIKAVEDGYR--------------  226 (266)
T ss_pred             eeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH--HHHHHHcCCC--------------
Confidence            11112234567999999888888999999999999999987 999986543221  1111111100              


Q ss_pred             HHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          160 EQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       160 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                         .+.+..++..+.+++.+||+.+|++||++.++++.|+++
T Consensus       227 ---~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         227 ---LPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             ---CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence               011123456689999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=99.98  E-value=1.6e-33  Score=211.68  Aligned_cols=175  Identities=34%  Similarity=0.532  Sum_probs=132.6

Q ss_pred             CCCCcHHHHHhhc-CCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCc
Q 037267            1 MPNGSLEKWLYSY-NYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED   79 (202)
Q Consensus         1 ~~~gsL~~~l~~~-~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~   79 (202)
                      |++|+|.++|... ...+++..+..++.|++.||.|||    +.+++|++|++.||+++.++.+||+|||++........
T Consensus        83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh----~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~  158 (259)
T PF07714_consen   83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLH----SNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK  158 (259)
T ss_dssp             -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHH----HTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred             cccccccccccccccccccccccccccccccccccccc----cccccccccccccccccccccccccccccccccccccc
Confidence            5789999999976 456999999999999999999999    88999999999999999999999999999987633222


Q ss_pred             cccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhh
Q 037267           80 FVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVR  158 (202)
Q Consensus        80 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (202)
                      ............|.|||.+.+..++.++||||||+++||+++ |..||.......  +...+....              
T Consensus       159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~--~~~~~~~~~--------------  222 (259)
T PF07714_consen  159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEE--IIEKLKQGQ--------------  222 (259)
T ss_dssp             EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHH--HHHHHHTTE--------------
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccc--ccccccccc--------------
Confidence            222233346778999998888888999999999999999999 678886652221  111111110              


Q ss_pred             hHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 037267          159 EEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKL  198 (202)
Q Consensus       159 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l  198 (202)
                         ..+.+..++..+.+++..||+.+|++|||+.+++++|
T Consensus       223 ---~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  223 ---RLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             ---ETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             ---cceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence               0111234566789999999999999999999999986

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=99.98  E-value=1.8e-32  Score=205.73  Aligned_cols=178  Identities=24%  Similarity=0.430  Sum_probs=138.3

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      +++|+|.+++......+++..++.++.|++.||.|||    +.+++|+||||+||+++.++.++++|||++.........
T Consensus        76 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~  151 (257)
T cd05115          76 ASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLE----GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSY  151 (257)
T ss_pred             CCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH----hcCeeecccchheEEEcCCCcEEeccCCccccccCCccc
Confidence            4799999999865666999999999999999999999    899999999999999999999999999998765433221


Q ss_pred             -ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhh
Q 037267           81 -VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVR  158 (202)
Q Consensus        81 -~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (202)
                       .......++..|+|||...+..++.++|+||+|+++|++++ |..||.......  ....+.....             
T Consensus       152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~~~~~~~~-------------  216 (257)
T cd05115         152 YKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE--VMSFIEQGKR-------------  216 (257)
T ss_pred             eeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH--HHHHHHCCCC-------------
Confidence             11111223567999998877788899999999999999996 999997653221  1111111110             


Q ss_pred             hHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          159 EEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       159 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                          ...+..++.++.+++.+||..+|++||++.++.+.|+.+
T Consensus       217 ----~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         217 ----LDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             ----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence                011123567789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.98  E-value=1.9e-32  Score=211.92  Aligned_cols=188  Identities=23%  Similarity=0.234  Sum_probs=143.8

Q ss_pred             CcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCccccc
Q 037267            4 GSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQ   83 (202)
Q Consensus         4 gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~   83 (202)
                      .+|..++.+..-.|++.++..++.||++||.|||    +.+++|||||.+||||+.+|.+||+|||+++++...... ..
T Consensus       202 hDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH----~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~-~~  276 (560)
T KOG0600|consen  202 HDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCH----SRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSA-PY  276 (560)
T ss_pred             chhhhhhcCCCcccChHHHHHHHHHHHHHHHHHh----hcCeeeccccccceEEcCCCCEEeccccceeeccCCCCc-cc
Confidence            4677777765556999999999999999999999    999999999999999999999999999999987665432 24


Q ss_pred             cCCCCCccccCCCCCCCC-CcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCC--hh--hh-----hh
Q 037267           84 TMTMATIGYMAPEYGSEG-IVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHG--LT--EV-----VD  153 (202)
Q Consensus        84 ~~~~~~~~~~~pe~~~~~-~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~--~~-----~~  153 (202)
                      +...-|.+|.|||.+.|. .|+...|+||+|||+.||+.|++.|++.++-+..-.-+..-+-|..  +.  .+     ..
T Consensus       277 T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~k  356 (560)
T KOG0600|consen  277 TSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIFK  356 (560)
T ss_pred             ccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcccccC
Confidence            556779999999988775 6899999999999999999999999887655443222222222211  11  01     11


Q ss_pred             hhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          154 ANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                      +.........+.....+...++|+..+|..||.+|.||.++++
T Consensus       357 p~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  357 PQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             CCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence            1111122223345567778999999999999999999999874

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=99.98  E-value=2.3e-32  Score=205.02  Aligned_cols=177  Identities=25%  Similarity=0.391  Sum_probs=137.5

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      +++|+|.+++.... .+++..+..++.|++.||.|||    +.+++|+|+||.||+++.++.++++|||++.........
T Consensus        77 ~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH----~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~  151 (257)
T cd05116          77 AELGPLNKFLQKNK-HVTEKNITELVHQVSMGMKYLE----ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENY  151 (257)
T ss_pred             CCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCe
Confidence            46899999997644 4899999999999999999999    899999999999999999999999999999876543321


Q ss_pred             c-cccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhh
Q 037267           81 V-TQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVR  158 (202)
Q Consensus        81 ~-~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (202)
                      . ......++..|+|||......++.++|+||+|+++|++++ |..||......  .....+.....             
T Consensus       152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~i~~~~~-------------  216 (257)
T cd05116         152 YKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN--EVTQMIESGER-------------  216 (257)
T ss_pred             eeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHCCCC-------------
Confidence            1 1111233568999998877778889999999999999998 99999764322  12222211110             


Q ss_pred             hHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          159 EEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       159 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                          .+.+..++.++.+++.+||..||++||++++|.+.|+.+
T Consensus       217 ----~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~  255 (257)
T cd05116         217 ----MECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY  255 (257)
T ss_pred             ----CCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence                011123566789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=99.98  E-value=3.8e-32  Score=203.12  Aligned_cols=177  Identities=25%  Similarity=0.398  Sum_probs=135.0

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      +++++|.+++......+++..+..++.|+++||.|||    +.+++|+|+||.||+++.++.++++|||++.........
T Consensus        75 ~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH----~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~  150 (252)
T cd05084          75 VQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLE----SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYA  150 (252)
T ss_pred             ccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH----hCCccccccchheEEEcCCCcEEECccccCccccccccc
Confidence            4789999999866556899999999999999999999    899999999999999999999999999998754432211


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhh
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVRE  159 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (202)
                      ........+..|+|||.+.+..++.++|+||+|+++|++++ |..||.......  ..........              
T Consensus       151 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~--~~~~~~~~~~--------------  214 (252)
T cd05084         151 STGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ--TREAIEQGVR--------------  214 (252)
T ss_pred             ccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH--HHHHHHcCCC--------------
Confidence            11111123456999999888888999999999999999997 888886543211  1111111000              


Q ss_pred             HHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhh
Q 037267          160 EQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKK  200 (202)
Q Consensus       160 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~  200 (202)
                         ...+..++.++.+++.+||..+|++|||+.++++.|++
T Consensus       215 ---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~  252 (252)
T cd05084         215 ---LPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQS  252 (252)
T ss_pred             ---CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhC
Confidence               01112345678999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=99.98  E-value=3.5e-33  Score=219.20  Aligned_cols=174  Identities=25%  Similarity=0.322  Sum_probs=146.6

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |+.|-|...|+... .++....+.|.-+|+.|+.|||    .+.|+|||||+.||||..+..+||+|||-++...+..+.
T Consensus       194 Ca~GqL~~VLka~~-~itp~llv~Wsk~IA~GM~YLH----~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STk  268 (904)
T KOG4721|consen  194 CAQGQLYEVLKAGR-PITPSLLVDWSKGIAGGMNYLH----LHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTK  268 (904)
T ss_pred             cccccHHHHHhccC-ccCHHHHHHHHHHhhhhhHHHH----HhhHhhhccCCCceEeeccceEEeccccchHhhhhhhhh
Confidence            78999999998654 4899999999999999999999    899999999999999999999999999999887665332


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhH
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREE  160 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (202)
                         -.+.||..|+|||++...+.+.++||||||+++|||+||..||.+.+.....+      ++            ...-
T Consensus       269 ---MSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIw------GV------------GsNs  327 (904)
T KOG4721|consen  269 ---MSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIW------GV------------GSNS  327 (904)
T ss_pred             ---hhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEE------ec------------cCCc
Confidence               34679999999999999999999999999999999999999998754332111      11            1111


Q ss_pred             HHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhh
Q 037267          161 QAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKK  200 (202)
Q Consensus       161 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~  200 (202)
                      -.++.+..|++.+.=|+++||.-.|..|||+.+++.-|+.
T Consensus       328 L~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldI  367 (904)
T KOG4721|consen  328 LHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDI  367 (904)
T ss_pred             ccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence            2245567899999999999999999999999999987764

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=99.98  E-value=2.8e-32  Score=206.99  Aligned_cols=177  Identities=24%  Similarity=0.403  Sum_probs=136.3

Q ss_pred             CCCCcHHHHHhhcC--------------CCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEc
Q 037267            1 MPNGSLEKWLYSYN--------------YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVS   66 (202)
Q Consensus         1 ~~~gsL~~~l~~~~--------------~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~   66 (202)
                      +++|+|.+++....              ..+++..++.++.|++.||.|||    +.+++|+||||+||+++.++.++++
T Consensus        89 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH----~~~i~H~dlkp~nil~~~~~~~kL~  164 (280)
T cd05092          89 MRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA----SLHFVHRDLATRNCLVGQGLVVKIG  164 (280)
T ss_pred             CCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH----HCCeecccccHhhEEEcCCCCEEEC
Confidence            47899999997643              24889999999999999999999    8999999999999999999999999


Q ss_pred             ccccceeccCCCccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhCC
Q 037267           67 DFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLP  145 (202)
Q Consensus        67 d~g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~  145 (202)
                      |||++................++..|+|||...+..++.++|+||+||++|++++ |..||........  ........+
T Consensus       165 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~--~~~~~~~~~  242 (280)
T cd05092         165 DFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA--IECITQGRE  242 (280)
T ss_pred             CCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHH--HHHHHcCcc
Confidence            9999876543322211222334678999999888889999999999999999998 8999865432211  111111000


Q ss_pred             CChhhhhhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhh
Q 037267          146 HGLTEVVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKK  200 (202)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~  200 (202)
                                       ...+..++..+.+++.+||+.||++||++.++++.|+.
T Consensus       243 -----------------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~  280 (280)
T cd05092         243 -----------------LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA  280 (280)
T ss_pred             -----------------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence                             01112355668999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=99.98  E-value=4.5e-32  Score=204.74  Aligned_cols=178  Identities=25%  Similarity=0.438  Sum_probs=138.1

Q ss_pred             CCCCcHHHHHhhc-----CCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceecc
Q 037267            1 MPNGSLEKWLYSY-----NYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLG   75 (202)
Q Consensus         1 ~~~gsL~~~l~~~-----~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~   75 (202)
                      +++|+|.+++...     ...+++..+..++.|++.||.|||    +.+++|+|+||+||+++.++.++++|||+++...
T Consensus        89 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH----~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  164 (273)
T cd05035          89 MKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLS----NRNFIHRDLAARNCMLREDMTVCVADFGLSKKIY  164 (273)
T ss_pred             cCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHH----hCCeeccccchheEEECCCCeEEECCccceeecc
Confidence            4789999998643     235899999999999999999999    8999999999999999999999999999998765


Q ss_pred             CCCccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhCCCChhhhhhh
Q 037267           76 EGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDA  154 (202)
Q Consensus        76 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (202)
                      .............+..|++||...+..++.++|+||+||++|++++ |..||.......  ....+.....         
T Consensus       165 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~--~~~~~~~~~~---------  233 (273)
T cd05035         165 SGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE--IYDYLRHGNR---------  233 (273)
T ss_pred             ccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcCCC---------
Confidence            4433222222334667999999888888999999999999999998 888886533211  1111111100         


Q ss_pred             hhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          155 NLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                              ...+..++.++.+++.+||..||++|||+.++++.|+.+
T Consensus       234 --------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         234 --------LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             --------CCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                    001123566799999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=99.98  E-value=2.5e-32  Score=208.36  Aligned_cols=178  Identities=25%  Similarity=0.426  Sum_probs=136.2

Q ss_pred             CCCCcHHHHHhhc---------------CCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEE
Q 037267            1 MPNGSLEKWLYSY---------------NYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHV   65 (202)
Q Consensus         1 ~~~gsL~~~l~~~---------------~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l   65 (202)
                      +++|+|.+++...               ...+++..++.++.|++.||.|||    +.+++|+||||.||+++.++.+++
T Consensus        98 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH----~~~ivH~dlkp~Nil~~~~~~~kL  173 (293)
T cd05053          98 AAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA----SKKCIHRDLAARNVLVTEDHVMKI  173 (293)
T ss_pred             CCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH----HCCccccccceeeEEEcCCCeEEe
Confidence            4789999999642               235899999999999999999999    899999999999999999999999


Q ss_pred             cccccceeccCCCccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhC
Q 037267           66 SDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESL  144 (202)
Q Consensus        66 ~d~g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~  144 (202)
                      +|||++................++..|+|||...+..++.++|+||+||++|++++ |..||.......  .........
T Consensus       174 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~~~~~~~~~  251 (293)
T cd05053         174 ADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE--LFKLLKEGY  251 (293)
T ss_pred             CccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH--HHHHHHcCC
Confidence            99999987554332211222234567999998888888999999999999999997 888886532211  111111100


Q ss_pred             CCChhhhhhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          145 PHGLTEVVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                      .                 ...+..++..+.+++.+||..+|++|||+.++++.|+.+
T Consensus       252 ~-----------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~  291 (293)
T cd05053         252 R-----------------MEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM  291 (293)
T ss_pred             c-----------------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence            0                 001123455689999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=99.98  E-value=4.8e-32  Score=205.42  Aligned_cols=177  Identities=28%  Similarity=0.451  Sum_probs=136.5

Q ss_pred             CCCCcHHHHHhhcC-------------CCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcc
Q 037267            1 MPNGSLEKWLYSYN-------------YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSD   67 (202)
Q Consensus         1 ~~~gsL~~~l~~~~-------------~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d   67 (202)
                      +++|+|.++++...             ..+++..+..++.|++.||.|||    +.+++|+||||+||+++.++.++++|
T Consensus        90 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH----~~~i~h~dlkp~nili~~~~~~kl~d  165 (280)
T cd05049          90 MEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA----SQHFVHRDLATRNCLVGYDLVVKIGD  165 (280)
T ss_pred             CCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh----hCCeeccccccceEEEcCCCeEEECC
Confidence            57999999997542             24788999999999999999999    89999999999999999999999999


Q ss_pred             cccceeccCCCccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhCCC
Q 037267           68 FGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPH  146 (202)
Q Consensus        68 ~g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~  146 (202)
                      ||++................++..|+|||.+.+..++.++|+||+|+++|++++ |..||.......  ....+..... 
T Consensus       166 ~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~--~~~~~~~~~~-  242 (280)
T cd05049         166 FGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE--VIECITQGRL-  242 (280)
T ss_pred             cccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH--HHHHHHcCCc-
Confidence            999876433222111222345678999999888889999999999999999998 999986543222  1111111000 


Q ss_pred             ChhhhhhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhh
Q 037267          147 GLTEVVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKK  200 (202)
Q Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~  200 (202)
                                      ...+..++..+.+++.+||..||++||++.|+++.|++
T Consensus       243 ----------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~  280 (280)
T cd05049         243 ----------------LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK  280 (280)
T ss_pred             ----------------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence                            00112345668999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=99.98  E-value=2.2e-32  Score=221.99  Aligned_cols=173  Identities=28%  Similarity=0.274  Sum_probs=135.2

Q ss_pred             CCCCcHHHHHhhc---CCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCC
Q 037267            1 MPNGSLEKWLYSY---NYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEG   77 (202)
Q Consensus         1 ~~~gsL~~~l~~~---~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~   77 (202)
                      +++|+|.+++...   ...+++..+..++.|++.||.|||    +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus       121 ~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH----~~~IiHrDLKP~NILl~~~~~vkL~DFGls~~~~~~  196 (496)
T PTZ00283        121 ANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVH----SKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAAT  196 (496)
T ss_pred             CCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH----hCCEecCCCCHHHEEEeCCCCEEEEecccCeecccc
Confidence            4789999999743   345899999999999999999999    899999999999999999999999999999875433


Q ss_pred             CccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhh
Q 037267           78 EDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV  157 (202)
Q Consensus        78 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (202)
                      ..........|++.|+|||.+.+..++.++|+||+|+++|++++|..||.......     ..........         
T Consensus       197 ~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~-----~~~~~~~~~~---------  262 (496)
T PTZ00283        197 VSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEE-----VMHKTLAGRY---------  262 (496)
T ss_pred             ccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH-----HHHHHhcCCC---------
Confidence            22112233468899999999988889999999999999999999999996532111     1111000000         


Q ss_pred             hhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          158 REEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                           .+.+..+++++.+++.+||..||++||++.++++
T Consensus       263 -----~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~  296 (496)
T PTZ00283        263 -----DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLN  296 (496)
T ss_pred             -----CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHh
Confidence                 0112235567899999999999999999999875

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=99.98  E-value=2.3e-32  Score=194.90  Aligned_cols=180  Identities=22%  Similarity=0.269  Sum_probs=137.0

Q ss_pred             CCCcHHHHHhhc---CCCCCHHHHHHHHHHHHHhhhcccCCCCCCC--eeecCCCCCceeeCCCCceEEcccccceeccC
Q 037267            2 PNGSLEKWLYSY---NYFFDILERLNIMIDVGSALEYPHHGHSSAP--IIHCDLKPTNILLDENMVAHVSDFGISKLLGE   76 (202)
Q Consensus         2 ~~gsL~~~l~~~---~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~--i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~   76 (202)
                      ..|||.|.++..   +..+++.+++.++.++++||++||    +..  +.|||+||.||++..++.+++.|||.++....
T Consensus       106 ~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH----~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i  181 (302)
T KOG2345|consen  106 KRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALH----EKEPPYAHRDIKPANILLSDSGLPVLMDLGSATQAPI  181 (302)
T ss_pred             ccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHh----ccCCcccccCCCcceeEecCCCceEEEeccCccccce
Confidence            479999998742   346999999999999999999999    555  99999999999999999999999999886553


Q ss_pred             CCcccc-------ccCCCCCccccCCCCCCC---CCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCC
Q 037267           77 GEDFVT-------QTMTMATIGYMAPEYGSE---GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPH  146 (202)
Q Consensus        77 ~~~~~~-------~~~~~~~~~~~~pe~~~~---~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~  146 (202)
                      ......       -.....|..|+|||.+.-   ...+.++||||+||++|.++.|..||+......+++.-        
T Consensus       182 ~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaL--------  253 (302)
T KOG2345|consen  182 QIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLAL--------  253 (302)
T ss_pred             EeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEE--------
Confidence            321111       112357889999997643   34678999999999999999999999765443322221        


Q ss_pred             ChhhhhhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          147 GLTEVVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                         .+....+..     +.....++.+.+++..|++.||.+||++.+++..++.+
T Consensus       254 ---Av~n~q~s~-----P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L  300 (302)
T KOG2345|consen  254 ---AVQNAQISI-----PNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL  300 (302)
T ss_pred             ---eeecccccc-----CCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence               111111111     11122567799999999999999999999999999865

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=99.98  E-value=3.3e-32  Score=205.21  Aligned_cols=177  Identities=21%  Similarity=0.344  Sum_probs=137.0

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      +++|+|.+++......+++..++.++.|++.||.|||    +.+++|||+||+||+++.++.++++|||...........
T Consensus        88 ~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH----~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~~~  163 (266)
T cd05064          88 MSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLS----EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIY  163 (266)
T ss_pred             CCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH----HCCEeeccccHhhEEEcCCCcEEECCCcccccccccchh
Confidence            5789999999876666899999999999999999999    899999999999999999999999999987653322111


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhh
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVRE  159 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (202)
                       ......++..|+|||...+..++.++|+||+||++|++++ |..||.......  ....+....               
T Consensus       164 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~--~~~~~~~~~---------------  225 (266)
T cd05064         164 -TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD--VIKAVEDGF---------------  225 (266)
T ss_pred             -cccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH--HHHHHHCCC---------------
Confidence             1111234568999998888889999999999999999775 999996643221  111111110               


Q ss_pred             HHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          160 EQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       160 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                        ..+.+..++..+.+++.+||+.+|++||++.++++.|+++
T Consensus       226 --~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         226 --RLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             --CCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence              0011234566789999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.98  E-value=4e-32  Score=206.37  Aligned_cols=193  Identities=23%  Similarity=0.374  Sum_probs=137.9

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      +++|+|.+++......+++..+..++.|++.||.|||    +.+++|+||||+||+++.++.++++|||++.........
T Consensus        89 ~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH----~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~  164 (284)
T cd05081          89 LPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLG----SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEY  164 (284)
T ss_pred             cCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHH----HCCceeccCCHhhEEECCCCeEEECCCcccccccCCCcc
Confidence            4789999999865556899999999999999999999    899999999999999999999999999999876443221


Q ss_pred             c-cccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCC--CChhhhhhhhhh
Q 037267           81 V-TQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLP--HGLTEVVDANLV  157 (202)
Q Consensus        81 ~-~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~  157 (202)
                      . ......++..|++||...+..++.++|+||+|+++|++++|..++......   +.........  ....... .. .
T Consensus       165 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~-~~-~  239 (284)
T cd05081         165 YKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE---FMRMMGNDKQGQMIVYHLI-EL-L  239 (284)
T ss_pred             eeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh---hhhhcccccccccchHHHH-HH-H
Confidence            1 111122344689999988888899999999999999999987665432111   0000000000  0000000 00 0


Q ss_pred             hhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhcC
Q 037267          158 REEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKIK  202 (202)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l~  202 (202)
                      ......+.+..++.++.+++.+||..+|++|||+.++++.|++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~~  284 (284)
T cd05081         240 KNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR  284 (284)
T ss_pred             hcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhcC
Confidence            000111122345667999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=99.98  E-value=4.1e-32  Score=208.35  Aligned_cols=178  Identities=22%  Similarity=0.361  Sum_probs=137.9

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      +++|+|.+++......+++..+..++.|++.||.|||    +.+++|+||||.||+++.++.+|++|||++.........
T Consensus        90 ~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH----~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~  165 (303)
T cd05110          90 MPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLE----ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKE  165 (303)
T ss_pred             cCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHh----hcCeeccccccceeeecCCCceEEccccccccccCcccc
Confidence            4789999999876666899999999999999999999    899999999999999999999999999999865433221


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhh
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVRE  159 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (202)
                      .......++..|++||...+..++.++|+||+|+++|++++ |..||.......  ...+......              
T Consensus       166 ~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~--~~~~~~~~~~--------------  229 (303)
T cd05110         166 YNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE--IPDLLEKGER--------------  229 (303)
T ss_pred             cccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHCCCC--------------
Confidence            11222335678999999888888999999999999999997 889986542111  1111111100              


Q ss_pred             HHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          160 EQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       160 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                         .+.+..++..+.+++..||..+|++||++.++++.|+++
T Consensus       230 ---~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~  268 (303)
T cd05110         230 ---LPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRM  268 (303)
T ss_pred             ---CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence               001122445688999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=99.98  E-value=4.5e-32  Score=203.36  Aligned_cols=177  Identities=28%  Similarity=0.451  Sum_probs=138.2

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      +++|+|.+++.... .+++..+..++.|++.||.|||    +.+++|+||||+||+++.++.++++|||.+.........
T Consensus        77 ~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lh----~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~  151 (257)
T cd05060          77 APLGPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLE----SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDY  151 (257)
T ss_pred             CCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHh----hcCeeccCcccceEEEcCCCcEEeccccccceeecCCcc
Confidence            46899999998655 5899999999999999999999    899999999999999999999999999998865443322


Q ss_pred             cc-ccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhh
Q 037267           81 VT-QTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVR  158 (202)
Q Consensus        81 ~~-~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (202)
                      .. .....++..|++||...+..++.++|+||+|+++|++++ |..||.......  +...+.....             
T Consensus       152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~--~~~~~~~~~~-------------  216 (257)
T cd05060         152 YRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE--VIAMLESGER-------------  216 (257)
T ss_pred             cccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHH--HHHHHHcCCc-------------
Confidence            11 111223457999998888888999999999999999997 999987643221  1222111110             


Q ss_pred             hHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          159 EEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       159 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                          .+.+..++..+.+++.+||..+|++|||+.++++.|+.+
T Consensus       217 ----~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~  255 (257)
T cd05060         217 ----LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD  255 (257)
T ss_pred             ----CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence                011223556789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=99.98  E-value=5.4e-32  Score=205.99  Aligned_cols=173  Identities=23%  Similarity=0.291  Sum_probs=133.3

Q ss_pred             CCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCc
Q 037267            1 MPNGSLEKWLYSYN-YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED   79 (202)
Q Consensus         1 ~~~gsL~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~   79 (202)
                      |++|+|.+++.... ..+++..+..++.|++.||.|||    +.+|+||||||+||+++.++.++++|||++........
T Consensus        82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~  157 (285)
T cd05631          82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ----RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET  157 (285)
T ss_pred             cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH----hCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe
Confidence            57999999886433 35899999999999999999999    89999999999999999999999999999987543222


Q ss_pred             cccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhh
Q 037267           80 FVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVRE  159 (202)
Q Consensus        80 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (202)
                         .....++..|+|||.+.+..++.++|+||+||++|++++|..||........  ...+....            ...
T Consensus       158 ---~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~--~~~~~~~~------------~~~  220 (285)
T cd05631         158 ---VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK--REEVDRRV------------KED  220 (285)
T ss_pred             ---ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh--HHHHHHHh------------hcc
Confidence               1224578999999999888899999999999999999999999976432211  00000000            000


Q ss_pred             HHHHHHhHHHHHHHHHHHhhhcCCCCCCCCC-----HHHHHH
Q 037267          160 EQAFAAKMDCIVSIMDLALDCCMESPGKRIN-----MTDAAA  196 (202)
Q Consensus       160 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps-----~~~~~~  196 (202)
                        ....+...+.++.+|+.+||..||++||+     ++++++
T Consensus       221 --~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  260 (285)
T cd05631         221 --QEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ  260 (285)
T ss_pred             --cccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence              00112234567899999999999999997     777765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=6.3e-33  Score=211.30  Aligned_cols=170  Identities=26%  Similarity=0.326  Sum_probs=140.0

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |.|||+.+.|+..+ .+++..+.-++++++.|+.|||    +.+.+|||+|+.||++..+|.+|++|||++........ 
T Consensus        93 ~~gGsv~~lL~~~~-~~~E~~i~~ilre~l~~l~ylH----~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~-  166 (467)
T KOG0201|consen   93 CGGGSVLDLLKSGN-ILDEFEIAVILREVLKGLDYLH----SEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK-  166 (467)
T ss_pred             hcCcchhhhhccCC-CCccceeeeehHHHHHHhhhhh----hcceecccccccceeEeccCcEEEEecceeeeeechhh-
Confidence            57999999997544 3688899999999999999999    89999999999999999999999999999987665332 


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhH
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREE  160 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (202)
                       .+.++.||+.|+|||++.+..|+.++||||+|++.+||.+|.+|+...+....  .-.+....|+.+            
T Consensus       167 -rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrv--lflIpk~~PP~L------------  231 (467)
T KOG0201|consen  167 -RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRV--LFLIPKSAPPRL------------  231 (467)
T ss_pred             -ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceE--EEeccCCCCCcc------------
Confidence             23567899999999999988999999999999999999999999988765221  111111111111            


Q ss_pred             HHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          161 QAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       161 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                           ...+++.+.+++..||.+||+.||||.++++
T Consensus       232 -----~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK  262 (467)
T KOG0201|consen  232 -----DGDFSPPFKEFVEACLDKNPEFRPSAKELLK  262 (467)
T ss_pred             -----ccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence                 1246667899999999999999999999986

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.97  E-value=5.9e-32  Score=205.42  Aligned_cols=191  Identities=23%  Similarity=0.320  Sum_probs=138.4

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      +++|+|.+++...  .+++..+..++.|++.||.|||    +.+++|+||||+||+++.++.++++|||++.........
T Consensus        90 ~~~~~l~~~~~~~--~l~~~~~~~i~~~l~~~l~~lH----~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~  163 (283)
T cd05080          90 VPLGSLRDYLPKH--KLNLAQLLLFAQQICEGMAYLH----SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEY  163 (283)
T ss_pred             CCCCCHHHHHHHc--CCCHHHHHHHHHHHHHHHHHHH----HCCeeccccChheEEEcCCCcEEEeecccccccCCcchh
Confidence            4789999999764  3899999999999999999999    899999999999999999999999999998865433221


Q ss_pred             c-cccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhC-CCChhhhhhhhhhh
Q 037267           81 V-TQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESL-PHGLTEVVDANLVR  158 (202)
Q Consensus        81 ~-~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~  158 (202)
                      . ......++..|++||...+..++.++|+||+|+++|++++|..||.................. .....+.....   
T Consensus       164 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---  240 (283)
T cd05080         164 YRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERG---  240 (283)
T ss_pred             hccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcC---
Confidence            1 112223456799999888888899999999999999999999998653321111000000000 00000000000   


Q ss_pred             hHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhcC
Q 037267          159 EEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKIK  202 (202)
Q Consensus       159 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l~  202 (202)
                        ...+.+..++.++.+++.+||..+|++|||++++++.|++++
T Consensus       241 --~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         241 --MRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             --CCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence              001112345677999999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=99.97  E-value=1.7e-32  Score=212.28  Aligned_cols=169  Identities=20%  Similarity=0.188  Sum_probs=132.1

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |++|+|.+++.... .+++..+..++.|++.||.|||    +.+|+||||||+||+++.++.++|+|||++.........
T Consensus        77 ~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~lH----~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~  151 (323)
T cd05571          77 ANGGELFFHLSRER-VFSEDRARFYGAEIVSALGYLH----SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGAT  151 (323)
T ss_pred             CCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----hCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCc
Confidence            57999999997644 4899999999999999999999    899999999999999999999999999998753222111


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhH
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREE  160 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (202)
                        .....|++.|+|||.+.+..++.++|+||+||++|++++|..||.......  ....+....                
T Consensus       152 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~--~~~~~~~~~----------------  211 (323)
T cd05571         152 --MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK--LFELILMEE----------------  211 (323)
T ss_pred             --ccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHH--HHHHHHcCC----------------
Confidence              122458999999999988889999999999999999999999996532111  111110000                


Q ss_pred             HHHHHhHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHH
Q 037267          161 QAFAAKMDCIVSIMDLALDCCMESPGKRI-----NMTDAAA  196 (202)
Q Consensus       161 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rp-----s~~~~~~  196 (202)
                        ...+...+.++.+++.+||..||++||     ++.++++
T Consensus       212 --~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  250 (323)
T cd05571         212 --IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME  250 (323)
T ss_pred             --CCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence              001123456689999999999999999     7888764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=99.97  E-value=7.5e-32  Score=202.85  Aligned_cols=177  Identities=25%  Similarity=0.370  Sum_probs=136.7

Q ss_pred             CCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCc
Q 037267            1 MPNGSLEKWLYSYN-YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED   79 (202)
Q Consensus         1 ~~~gsL~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~   79 (202)
                      +++|+|.+++.... ..+++..++.++.|++.||.|||    +.+++|+||||+||+++.++.++++|||++........
T Consensus        84 ~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH----~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~  159 (263)
T cd05052          84 MTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE----KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY  159 (263)
T ss_pred             CCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH----hCCEeecccCcceEEEcCCCcEEeCCCcccccccccee
Confidence            47899999997543 45899999999999999999999    89999999999999999999999999999876543321


Q ss_pred             cccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhh
Q 037267           80 FVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVR  158 (202)
Q Consensus        80 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (202)
                      . .......+..|++||...+..++.++|+||+|+++|++++ |..||.......  ..........             
T Consensus       160 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~--~~~~~~~~~~-------------  223 (263)
T cd05052         160 T-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--VYELLEKGYR-------------  223 (263)
T ss_pred             e-ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHHHCCCC-------------
Confidence            1 1111223567999998888888999999999999999998 888986532211  1111111000             


Q ss_pred             hHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          159 EEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       159 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                          ...+..++.++.+++.+||..+|++||++.++++.|+++
T Consensus       224 ----~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         224 ----MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             ----CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence                011123566799999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=99.97  E-value=7.5e-32  Score=206.83  Aligned_cols=179  Identities=24%  Similarity=0.375  Sum_probs=137.3

Q ss_pred             CCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCc
Q 037267            1 MPNGSLEKWLYSYN-YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED   79 (202)
Q Consensus         1 ~~~gsL~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~   79 (202)
                      +++|+|.++++... ..+++.++..++.|++.||.|||    +.+++|+|+||+||+++.++.++++|||++........
T Consensus       121 ~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH----~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~  196 (302)
T cd05055         121 CCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLA----SKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSN  196 (302)
T ss_pred             CCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH----HCCeehhhhccceEEEcCCCeEEECCCcccccccCCCc
Confidence            47899999997543 34899999999999999999999    89999999999999999999999999999876543322


Q ss_pred             cccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhh
Q 037267           80 FVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVR  158 (202)
Q Consensus        80 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (202)
                      ........++..|+|||...+..++.++|+||+|+++|++++ |..||........ +..........            
T Consensus       197 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~-~~~~~~~~~~~------------  263 (302)
T cd05055         197 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK-FYKLIKEGYRM------------  263 (302)
T ss_pred             eeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH-HHHHHHcCCcC------------
Confidence            111222345678999998888888999999999999999998 9999876432211 11111111000            


Q ss_pred             hHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          159 EEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       159 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                           ..+...+.++.+++.+||..+|++|||+.|+++.|+++
T Consensus       264 -----~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         264 -----AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             -----CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence                 00112345689999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=99.97  E-value=7e-32  Score=202.16  Aligned_cols=177  Identities=25%  Similarity=0.370  Sum_probs=137.3

Q ss_pred             CCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCc
Q 037267            1 MPNGSLEKWLYSYN-YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED   79 (202)
Q Consensus         1 ~~~gsL~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~   79 (202)
                      +++|+|.+++.+.. ..+++..+..++.|++.||.|||    +.+++|+||+|+||+++.++.++++|||++........
T Consensus        77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH----~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~  152 (257)
T cd05040          77 APLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE----SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNED  152 (257)
T ss_pred             cCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHH----hCCccccccCcccEEEecCCEEEecccccccccccccc
Confidence            46899999998755 46899999999999999999999    89999999999999999999999999999887654221


Q ss_pred             c-ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhh
Q 037267           80 F-VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV  157 (202)
Q Consensus        80 ~-~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (202)
                      . .......++..|++||...+..++.++|+||+|+++|++++ |..||......+.  ...+....             
T Consensus       153 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~--~~~~~~~~-------------  217 (257)
T cd05040         153 HYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQI--LKKIDKEG-------------  217 (257)
T ss_pred             ceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHH--HHHHHhcC-------------
Confidence            1 11222346678999999888888999999999999999998 9999865432221  11110000             


Q ss_pred             hhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHh
Q 037267          158 REEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLK  199 (202)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~  199 (202)
                         .....+...+..+.+++.+||..+|++|||+.++++.|.
T Consensus       218 ---~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         218 ---ERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             ---CcCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence               000111234566899999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=99.97  E-value=6.5e-32  Score=204.86  Aligned_cols=178  Identities=21%  Similarity=0.325  Sum_probs=137.7

Q ss_pred             CCCCcHHHHHhhcC-------CCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEccccccee
Q 037267            1 MPNGSLEKWLYSYN-------YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKL   73 (202)
Q Consensus         1 ~~~gsL~~~l~~~~-------~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~   73 (202)
                      +++|+|.+++....       ..+++..+..++.|++.||.|||    +.+++|+|+||+||+++.++.++++|||+++.
T Consensus        91 ~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH----~~~i~H~di~p~nil~~~~~~~kl~d~g~~~~  166 (280)
T cd05043          91 MNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH----KRGVIHKDIAARNCVIDEELQVKITDNALSRD  166 (280)
T ss_pred             CCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH----HCCEeecccCHhhEEEcCCCcEEECCCCCccc
Confidence            36899999997532       35899999999999999999999    89999999999999999999999999999976


Q ss_pred             ccCCCccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhCCCChhhhh
Q 037267           74 LGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVV  152 (202)
Q Consensus        74 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  152 (202)
                      ..............++..|+|||...+..++.++|+||+|+++|++++ |..||......  .+.........       
T Consensus       167 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~~~~~~~-------  237 (280)
T cd05043         167 LFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPF--EMAAYLKDGYR-------  237 (280)
T ss_pred             ccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHH--HHHHHHHcCCC-------
Confidence            544332211222335667999998888888999999999999999998 99998654221  11111111110       


Q ss_pred             hhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          153 DANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                                ...+..++.++.+++.+||..||++|||+.++++.|+.+
T Consensus       238 ----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~  276 (280)
T cd05043         238 ----------LAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDF  276 (280)
T ss_pred             ----------CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence                      001123456689999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=99.97  E-value=6.7e-32  Score=218.74  Aligned_cols=173  Identities=24%  Similarity=0.232  Sum_probs=134.4

Q ss_pred             CCCCcHHHHHhhc---CCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCC
Q 037267            1 MPNGSLEKWLYSY---NYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEG   77 (202)
Q Consensus         1 ~~~gsL~~~l~~~---~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~   77 (202)
                      |+||+|.+++...   ...+++..+..++.|++.||.|||    +.+|+||||||+||+++.++.+||+|||++......
T Consensus       147 ~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH----~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~  222 (478)
T PTZ00267        147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH----SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS  222 (478)
T ss_pred             CCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH----hCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCc
Confidence            5799999988642   345899999999999999999999    899999999999999999999999999999876543


Q ss_pred             CccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhh
Q 037267           78 EDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV  157 (202)
Q Consensus        78 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (202)
                      ..........|++.|+|||...+..++.++|+||+||++|++++|..||.......  ....+.....            
T Consensus       223 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~--~~~~~~~~~~------------  288 (478)
T PTZ00267        223 VSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQRE--IMQQVLYGKY------------  288 (478)
T ss_pred             cccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhCCC------------
Confidence            22212233458999999999888889999999999999999999999996532211  1111100000            


Q ss_pred             hhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          158 REEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                           .+.+..++.++.+++.+||..||++||++.+++.
T Consensus       289 -----~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        289 -----DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             -----CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence                 0011234566899999999999999999999864

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=99.97  E-value=1.6e-33  Score=227.28  Aligned_cols=177  Identities=28%  Similarity=0.523  Sum_probs=150.4

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |+||+|..||+.+...|++.+.+.++++|++|++||-    +.++|||||-..|||++.+-.+||+|||+++...+....
T Consensus       712 MENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLs----dm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~  787 (996)
T KOG0196|consen  712 MENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLS----DMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA  787 (996)
T ss_pred             hhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHh----hcCchhhhhhhhheeeccceEEEeccccceeecccCCCc
Confidence            7999999999988888999999999999999999999    999999999999999999999999999999977544311


Q ss_pred             ccccCC--CCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhh
Q 037267           81 VTQTMT--MATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV  157 (202)
Q Consensus        81 ~~~~~~--~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (202)
                       ..++.  .=+.+|+|||.+...+++.++|+||||+++||.++ |..||=++.+.+                 +++.  .
T Consensus       788 -~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQd-----------------VIka--I  847 (996)
T KOG0196|consen  788 -AYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD-----------------VIKA--I  847 (996)
T ss_pred             -cccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHH-----------------HHHH--H
Confidence             11111  22468999999999999999999999999999886 999986654322                 2211  2


Q ss_pred             hhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          158 REEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                      .+..+++.+++|+..+.+||..||++|-..||.++|++..|.++
T Consensus       848 e~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDkl  891 (996)
T KOG0196|consen  848 EQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKL  891 (996)
T ss_pred             HhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHH
Confidence            34456788899999999999999999999999999999999875

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=1.9e-32  Score=210.98  Aligned_cols=166  Identities=27%  Similarity=0.286  Sum_probs=129.2

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |++|+|.+++.... .+++..+..++.|++.||.|||    +.+|+||||||+||+++.++.++++|||++........ 
T Consensus        75 ~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH----~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-  148 (312)
T cd05585          75 INGGELFHHLQREG-RFDLSRARFYTAELLCALENLH----KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD-  148 (312)
T ss_pred             CCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----hCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC-
Confidence            57999999998654 4899999999999999999999    89999999999999999999999999999875332221 


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhH
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREE  160 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (202)
                       ......|++.|+|||.+.+..++.++|+||+||++|++++|..||.......     ......        ...     
T Consensus       149 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~-----~~~~~~--------~~~-----  209 (312)
T cd05585         149 -KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNE-----MYRKIL--------QEP-----  209 (312)
T ss_pred             -ccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHH-----HHHHHH--------cCC-----
Confidence             1223458899999999888889999999999999999999999997532211     111100        000     


Q ss_pred             HHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHH
Q 037267          161 QAFAAKMDCIVSIMDLALDCCMESPGKRINMTD  193 (202)
Q Consensus       161 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~  193 (202)
                        ...+...+.++.+++.+||..||++||++.+
T Consensus       210 --~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~  240 (312)
T cd05585         210 --LRFPDGFDRDAKDLLIGLLSRDPTRRLGYNG  240 (312)
T ss_pred             --CCCCCcCCHHHHHHHHHHcCCCHHHcCCCCC
Confidence              0111234566899999999999999986433

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=99.97  E-value=2.9e-31  Score=199.38  Aligned_cols=178  Identities=24%  Similarity=0.401  Sum_probs=133.7

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      +++|+|.+++......+++..++.++.|++.||.|||    +.+++||||||+||+++.++.++++|||++.........
T Consensus        79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~  154 (262)
T cd05058          79 MKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLA----SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY  154 (262)
T ss_pred             CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----hCCccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence            4789999999865555788889999999999999999    899999999999999999999999999998765432211


Q ss_pred             c--cccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhC-CCCCCcccccchhhHHHHHHhCCCChhhhhhhhhh
Q 037267           81 V--TQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTR-KRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV  157 (202)
Q Consensus        81 ~--~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (202)
                      .  ......++..|+|||...+..++.++|+||+|+++|++++| ..||.......  ....+.....            
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~--~~~~~~~~~~------------  220 (262)
T cd05058         155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFD--ITVYLLQGRR------------  220 (262)
T ss_pred             eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHHhcCCC------------
Confidence            1  11122346689999988778889999999999999999995 55554422111  1111111000            


Q ss_pred             hhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          158 REEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                           ...+..++..+.+++.+||..+|++||++.++++.|+++
T Consensus       221 -----~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~  259 (262)
T cd05058         221 -----LLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI  259 (262)
T ss_pred             -----CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence                 001112345689999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=99.97  E-value=1.2e-31  Score=204.44  Aligned_cols=186  Identities=23%  Similarity=0.273  Sum_probs=133.4

Q ss_pred             CCcHHHHHhhcC-CCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCccc
Q 037267            3 NGSLEKWLYSYN-YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFV   81 (202)
Q Consensus         3 ~gsL~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~~   81 (202)
                      +|+|.+++.... ..+++..+..++.|++.||.|||    +.+++||||||+||+++.++.++++|||++.......   
T Consensus        92 ~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH----~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---  164 (290)
T cd07862          92 DQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH----SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM---  164 (290)
T ss_pred             CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH----HCCeeeCCCCHHHEEEcCCCCEEEccccceEeccCCc---
Confidence            478999987543 35899999999999999999999    8999999999999999999999999999998654332   


Q ss_pred             cccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHh-CCC--Chhhh---hhhh
Q 037267           82 TQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKES-LPH--GLTEV---VDAN  155 (202)
Q Consensus        82 ~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~-~~~--~~~~~---~~~~  155 (202)
                      ......++..|+|||...+..++.++|+||+||++|++++|..||......+. +...+... .+.  .....   ....
T Consensus       165 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~~  243 (290)
T cd07862         165 ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ-LGKILDVIGLPGEEDWPRDVALPRQA  243 (290)
T ss_pred             ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHH-HHHHHHHhCCCChhhchhhhcccchh
Confidence            12234578899999988888889999999999999999999999976433221 11111100 000  00000   0000


Q ss_pred             hh--hhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          156 LV--REEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       156 ~~--~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                      ..  ............+..+.+++.+||+.||++|||+.++++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         244 FHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             ccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence            00  000000111235567889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=99.97  E-value=4.1e-32  Score=206.23  Aligned_cols=177  Identities=21%  Similarity=0.395  Sum_probs=135.2

Q ss_pred             CCCCcHHHHHhhc---------------CCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEE
Q 037267            1 MPNGSLEKWLYSY---------------NYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHV   65 (202)
Q Consensus         1 ~~~gsL~~~l~~~---------------~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l   65 (202)
                      +++++|.+++...               ...+++..+..++.|++.||.|||    +.+++||||||.||+++.++.+++
T Consensus        90 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH----~~gi~H~dlkp~Nil~~~~~~~kl  165 (283)
T cd05091          90 CSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS----SHHVVHKDLATRNVLVFDKLNVKI  165 (283)
T ss_pred             CCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH----HcCccccccchhheEecCCCceEe
Confidence            4678999998522               124788899999999999999999    899999999999999999999999


Q ss_pred             cccccceeccCCCccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhC
Q 037267           66 SDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESL  144 (202)
Q Consensus        66 ~d~g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~  144 (202)
                      +|||+++...............+++.|+|||...+..++.++|+||+||++|++++ |..||.......  ....+....
T Consensus       166 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~--~~~~i~~~~  243 (283)
T cd05091         166 SDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD--VIEMIRNRQ  243 (283)
T ss_pred             cccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHHHcCC
Confidence            99999876544332222223345678999998877788999999999999999998 888886543211  111111110


Q ss_pred             CCChhhhhhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhh
Q 037267          145 PHGLTEVVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKK  200 (202)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~  200 (202)
                      .                 .+.+..++..+.+++.+||+.+|.+||++++++..|+.
T Consensus       244 ~-----------------~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         244 V-----------------LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             c-----------------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence            0                 01123466778999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=99.97  E-value=9.3e-32  Score=201.47  Aligned_cols=176  Identities=28%  Similarity=0.486  Sum_probs=138.6

Q ss_pred             CCCCcHHHHHhhc--------CCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccce
Q 037267            1 MPNGSLEKWLYSY--------NYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISK   72 (202)
Q Consensus         1 ~~~gsL~~~l~~~--------~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~   72 (202)
                      +++|+|.+++...        ...+++..+..++.|++.||.|||    +.+++|+|++|+||+++.++.++++|||.+.
T Consensus        78 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH----~~~i~H~di~p~nili~~~~~~~l~dfg~~~  153 (262)
T cd00192          78 MEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA----SKKFVHRDLAARNCLVGEDLVVKISDFGLSR  153 (262)
T ss_pred             ccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH----cCCcccCccCcceEEECCCCcEEEccccccc
Confidence            4689999999875        356899999999999999999999    8999999999999999999999999999998


Q ss_pred             eccCCCccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhCCCChhhh
Q 037267           73 LLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEV  151 (202)
Q Consensus        73 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (202)
                      ...............++..|+|||......++.++|+||+|+++|++++ |..||.......  +.......        
T Consensus       154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~~~~~~~--------  223 (262)
T cd00192         154 DVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE--VLEYLRKG--------  223 (262)
T ss_pred             ccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHH--HHHHHHcC--------
Confidence            7654432222223446788999998887788999999999999999998 689987652211  11111100        


Q ss_pred             hhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHh
Q 037267          152 VDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLK  199 (202)
Q Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~  199 (202)
                               .....+..++.++.+++.+||..+|++|||+.|+++.|+
T Consensus       224 ---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         224 ---------YRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             ---------CCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence                     001112334667999999999999999999999999874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.97  E-value=6.1e-33  Score=218.49  Aligned_cols=177  Identities=29%  Similarity=0.425  Sum_probs=142.7

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |.||||.++|++.+..++..+++.++.+.+.||+|||    +++++||||-..|||+..++.+||+|||+++.-..-.  
T Consensus       243 ~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh----~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~~--  316 (474)
T KOG0194|consen  243 CNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLH----SKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQYV--  316 (474)
T ss_pred             cCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHH----HCCCcchhHhHHHheecCCCeEEeCccccccCCccee--
Confidence            7899999999988777999999999999999999999    9999999999999999999999999999987643111  


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhh
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVRE  159 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (202)
                      .......-+..|+|||.+....++.++|+||||+++||+++ |..||.+.....  ...++                ...
T Consensus       317 ~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~--v~~kI----------------~~~  378 (474)
T KOG0194|consen  317 MKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYE--VKAKI----------------VKN  378 (474)
T ss_pred             eccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHH--HHHHH----------------Hhc
Confidence            11111235689999999998899999999999999999998 888997764332  22222                111


Q ss_pred             HHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          160 EQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       160 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                      ..+.+.+...+..+..++.+||..+|++||+|.++.++|+.+
T Consensus       379 ~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~  420 (474)
T KOG0194|consen  379 GYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEAL  420 (474)
T ss_pred             CccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHH
Confidence            112222335667789999999999999999999999999875

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=99.97  E-value=1.5e-31  Score=207.66  Aligned_cols=185  Identities=22%  Similarity=0.282  Sum_probs=133.4

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |++|+|.+++.... .+++..+..++.|++.||.|||+   ..+|+||||||+||+++.++.++++|||++.......  
T Consensus        85 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--  158 (331)
T cd06649          85 MDGGSLDQVLKEAK-RIPEEILGKVSIAVLRGLAYLRE---KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--  158 (331)
T ss_pred             CCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhh---cCCEEcCCCChhhEEEcCCCcEEEccCcccccccccc--
Confidence            57899999997644 48999999999999999999993   2469999999999999999999999999987654322  


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCC-------------
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHG-------------  147 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~-------------  147 (202)
                        .....++..|+|||.+.+..++.++|+||+||++|++++|..||......+.  ...........             
T Consensus       159 --~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  234 (331)
T cd06649         159 --ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKEL--EAIFGRPVVDGEEGEPHSISPRPR  234 (331)
T ss_pred             --cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHhcccccccccCCccccCcccc
Confidence              1224578899999998888899999999999999999999999965432211  11100000000             


Q ss_pred             ------------------hhhhhhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          148 ------------------LTEVVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       148 ------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                                        ..+......... .........+.++.+++.+||..||++|||+.++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~  300 (331)
T cd06649         235 PPGRPVSGHGMDSRPAMAIFELLDYIVNEP-PPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMN  300 (331)
T ss_pred             cccccccccccccccchhHHHHHHHHHhCC-CcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhc
Confidence                              000000000000 000001135667999999999999999999999975

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=99.97  E-value=1.2e-31  Score=205.74  Aligned_cols=178  Identities=25%  Similarity=0.414  Sum_probs=136.2

Q ss_pred             CCCCcHHHHHhhcC---------------CCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEE
Q 037267            1 MPNGSLEKWLYSYN---------------YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHV   65 (202)
Q Consensus         1 ~~~gsL~~~l~~~~---------------~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l   65 (202)
                      +++|+|.+++....               ..+++..++.++.|++.||.|||    +.+++||||||+||+++.++.+++
T Consensus       103 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH----~~givH~dlkp~Nili~~~~~~kl  178 (304)
T cd05101         103 ASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA----SQKCIHRDLAARNVLVTENNVMKI  178 (304)
T ss_pred             CCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH----HCCeeecccccceEEEcCCCcEEE
Confidence            46899999997532               24788899999999999999999    899999999999999999999999


Q ss_pred             cccccceeccCCCccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhC
Q 037267           66 SDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESL  144 (202)
Q Consensus        66 ~d~g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~  144 (202)
                      +|||++................++..|+|||...+..++.++|+||+|+++|++++ |..||.......  +...+....
T Consensus       179 ~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~~~~~~~  256 (304)
T cd05101         179 ADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--LFKLLKEGH  256 (304)
T ss_pred             CCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH--HHHHHHcCC
Confidence            99999987643322211222335678999998888888999999999999999998 778875432111  111111100


Q ss_pred             CCChhhhhhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          145 PHGLTEVVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                                       ....+..++.++.+++.+||..+|++|||+.++++.|+++
T Consensus       257 -----------------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~  296 (304)
T cd05101         257 -----------------RMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRI  296 (304)
T ss_pred             -----------------cCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHH
Confidence                             0011124566789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=99.97  E-value=9.4e-32  Score=201.98  Aligned_cols=177  Identities=23%  Similarity=0.380  Sum_probs=137.1

Q ss_pred             CCCCcHHHHHhhc-CCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCc
Q 037267            1 MPNGSLEKWLYSY-NYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED   79 (202)
Q Consensus         1 ~~~gsL~~~l~~~-~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~   79 (202)
                      +++|+|.+++... ...+++..+..++.|++.||.|||    +.+++|+|+||.||+++.++.++++|||++........
T Consensus        83 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH----~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~  158 (261)
T cd05072          83 MAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE----RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY  158 (261)
T ss_pred             CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCeeccccchhhEEecCCCcEEECCCccceecCCCce
Confidence            5789999999754 345889999999999999999999    89999999999999999999999999999987654322


Q ss_pred             cccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhh
Q 037267           80 FVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVR  158 (202)
Q Consensus        80 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (202)
                      . ......++..|+|||...+..++.++|+||+|+++|++++ |..||.......  ....+.....             
T Consensus       159 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~--~~~~~~~~~~-------------  222 (261)
T cd05072         159 T-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD--VMSALQRGYR-------------  222 (261)
T ss_pred             e-ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH--HHHHHHcCCC-------------
Confidence            1 1122335667999998888888889999999999999998 999986532211  1111111100             


Q ss_pred             hHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          159 EEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       159 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                          .+....++.++.+++.+||..+|++||+++++.+.|+.+
T Consensus       223 ----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  261 (261)
T cd05072         223 ----MPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF  261 (261)
T ss_pred             ----CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence                011123456689999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.97  E-value=2.5e-32  Score=211.56  Aligned_cols=172  Identities=22%  Similarity=0.263  Sum_probs=144.0

Q ss_pred             CCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCc
Q 037267            1 MPNGSLEKWLYSYN-YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED   79 (202)
Q Consensus         1 ~~~gsL~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~   79 (202)
                      |+||+|.+.|.... ..++++.+.+|+.|++.|+.|||    +..|+|||||..||++.+++.++++|||+++.+.....
T Consensus        86 ~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH----~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~  161 (426)
T KOG0589|consen   86 CEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLH----ENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDS  161 (426)
T ss_pred             cCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH----hhhhhcccchhhhhhccccCceeecchhhhhhcCCchh
Confidence            78999999998665 57999999999999999999999    89999999999999999999999999999998876542


Q ss_pred             cccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhh
Q 037267           80 FVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVRE  159 (202)
Q Consensus        80 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (202)
                        ...+..||+.|++||+..+.+|+.++||||+||++||+.+-+.+|........     +.            ......
T Consensus       162 --~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~L-----i~------------ki~~~~  222 (426)
T KOG0589|consen  162 --LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSEL-----IL------------KINRGL  222 (426)
T ss_pred             --hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHH-----HH------------HHhhcc
Confidence              23456799999999999999999999999999999999999999976532221     11            111110


Q ss_pred             HHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 037267          160 EQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAK  197 (202)
Q Consensus       160 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~  197 (202)
                        ..+.+...+.++..++..|+..+|+.||++.+++..
T Consensus       223 --~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  223 --YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             --CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence              122344567779999999999999999999999864

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=99.97  E-value=2e-31  Score=200.27  Aligned_cols=177  Identities=28%  Similarity=0.425  Sum_probs=136.8

Q ss_pred             CCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCc
Q 037267            1 MPNGSLEKWLYSYN-YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED   79 (202)
Q Consensus         1 ~~~gsL~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~   79 (202)
                      +++++|.+++.... ..+++..+..++.|++.||.|||    +.+++|+||||+||+++.++.++++|||++........
T Consensus        83 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~  158 (261)
T cd05068          83 MKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE----AQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY  158 (261)
T ss_pred             ccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHH----hCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence            36899999997644 45899999999999999999999    89999999999999999999999999999987653221


Q ss_pred             cccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhh
Q 037267           80 FVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVR  158 (202)
Q Consensus        80 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (202)
                      . .......+..|++||...+..++.++|+||+|+++|++++ |..||.......  ....+.....             
T Consensus       159 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~~~~~~~~~-------------  222 (261)
T cd05068         159 E-AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE--VLQQVDQGYR-------------  222 (261)
T ss_pred             c-ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH--HHHHHHcCCC-------------
Confidence            1 1111123457999999888888999999999999999998 999986543211  1111111000             


Q ss_pred             hHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          159 EEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       159 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                          .+.+..++..+.+++.+||..+|++||++.++.+.|+.+
T Consensus       223 ----~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~  261 (261)
T cd05068         223 ----MPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF  261 (261)
T ss_pred             ----CCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence                001123456689999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=99.97  E-value=9.7e-32  Score=203.66  Aligned_cols=177  Identities=21%  Similarity=0.400  Sum_probs=134.2

Q ss_pred             CCCCcHHHHHhhcC---------CCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccc
Q 037267            1 MPNGSLEKWLYSYN---------YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGIS   71 (202)
Q Consensus         1 ~~~gsL~~~l~~~~---------~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~   71 (202)
                      +++|+|.+++.+..         ..+++..+..++.|++.||.|||    +.+++|+||||+||+++.++.++++|||++
T Consensus        91 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH----~~~~vH~dlkp~Nil~~~~~~~~l~dfg~~  166 (277)
T cd05062          91 MTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN----ANKFVHRDLAARNCMVAEDFTVKIGDFGMT  166 (277)
T ss_pred             CCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCcchheEEEcCCCCEEECCCCCc
Confidence            57899999997532         23578889999999999999999    899999999999999999999999999998


Q ss_pred             eeccCCCccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhCCCChhh
Q 037267           72 KLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTE  150 (202)
Q Consensus        72 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  150 (202)
                      ................++..|+|||...+..++.++|+||+|+++|++++ |..||.......  ....+.....     
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~--~~~~~~~~~~-----  239 (277)
T cd05062         167 RDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ--VLRFVMEGGL-----  239 (277)
T ss_pred             cccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHHHcCCc-----
Confidence            76543322211222345678999999888888999999999999999998 688886543211  1111111000     


Q ss_pred             hhhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhh
Q 037267          151 VVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKK  200 (202)
Q Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~  200 (202)
                                  ...+..++..+.+++.+||+.+|++|||+.|+++.|++
T Consensus       240 ------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~  277 (277)
T cd05062         240 ------------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE  277 (277)
T ss_pred             ------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence                        00112345568999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=99.97  E-value=8.3e-32  Score=200.95  Aligned_cols=187  Identities=23%  Similarity=0.237  Sum_probs=136.8

Q ss_pred             CcHHHHHhhcC---CCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            4 GSLEKWLYSYN---YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         4 gsL~~~l~~~~---~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      -+|.+++...+   ..++...+..++.||+.||+|||    +++|+||||||+|++++++|.+|++|||+++....+...
T Consensus       101 ~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H----~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~ip~~~  176 (323)
T KOG0594|consen  101 RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLH----SHGILHRDLKPQNLLISSSGVLKLADFGLARAFSIPMRT  176 (323)
T ss_pred             ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHH----hCCeecccCCcceEEECCCCcEeeeccchHHHhcCCccc
Confidence            46788887655   35788899999999999999999    999999999999999999999999999999976644332


Q ss_pred             ccccCCCCCccccCCCCCCCC-CcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCC-----CChhhhhhh
Q 037267           81 VTQTMTMATIGYMAPEYGSEG-IVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLP-----HGLTEVVDA  154 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~-~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~  154 (202)
                        .+....|.+|.|||++.|. .|+...||||+||++.||++++.-|.+..+-+....-+..-+.|     +......+.
T Consensus       177 --yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~  254 (323)
T KOG0594|consen  177 --YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDY  254 (323)
T ss_pred             --ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCccccccc
Confidence              3445788899999988876 68999999999999999999998887755433222222222222     111111122


Q ss_pred             hhhhhHHH-----HHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          155 NLVREEQA-----FAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       155 ~~~~~~~~-----~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                      ......+.     ............+++.+|++++|.+|.|+..+++
T Consensus       255 k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~  301 (323)
T KOG0594|consen  255 KAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALT  301 (323)
T ss_pred             cccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhc
Confidence            11111111     1111122246899999999999999999998876

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=99.97  E-value=1.6e-31  Score=201.72  Aligned_cols=177  Identities=23%  Similarity=0.392  Sum_probs=138.7

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      +++|+|.+++......+++..+..++.|++.||.|||    +.+++|+||||+||+++.++.++++|||++.........
T Consensus        88 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH----~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~  163 (270)
T cd05056          88 APLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE----SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYY  163 (270)
T ss_pred             CCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH----hCCeeccccChheEEEecCCCeEEccCceeeecccccce
Confidence            5789999999875556899999999999999999999    899999999999999999999999999998765443222


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhh
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVRE  159 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (202)
                      . .....++..|+|||......++.++|+||+|++++++++ |..||.........  ..+....               
T Consensus       164 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~--~~~~~~~---------------  225 (270)
T cd05056         164 K-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVI--GRIENGE---------------  225 (270)
T ss_pred             e-cCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHH--HHHHcCC---------------
Confidence            1 112234567999998888888999999999999999886 99999765432211  1111000               


Q ss_pred             HHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          160 EQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       160 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                        ....+..++.++.+++.+||..+|.+|||+.++++.|+++
T Consensus       226 --~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~  265 (270)
T cd05056         226 --RLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDI  265 (270)
T ss_pred             --cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence              0011224566799999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=99.97  E-value=1.5e-31  Score=202.74  Aligned_cols=178  Identities=22%  Similarity=0.349  Sum_probs=138.3

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      +++|+|.+++......+++..+..++.|++.||.|||    +.+++|+|+||.||+++.++.++++|||.+.........
T Consensus        90 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH----~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~~~  165 (279)
T cd05057          90 MPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLE----EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKE  165 (279)
T ss_pred             CCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH----hCCEEecccCcceEEEcCCCeEEECCCcccccccCcccc
Confidence            4789999999876666999999999999999999999    899999999999999999999999999999876533322


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhh
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVRE  159 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (202)
                      .......++..|++||......++.++|+||+|+++|++++ |..||......+  +...+.....              
T Consensus       166 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~~~~~~~~--------------  229 (279)
T cd05057         166 YHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE--IPDLLEKGER--------------  229 (279)
T ss_pred             eecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH--HHHHHhCCCC--------------
Confidence            11112223567999998877788899999999999999998 999987643221  1111111100              


Q ss_pred             HHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          160 EQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       160 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                         .+.+..++..+.+++.+||..+|++||++.++++.|..+
T Consensus       230 ---~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~  268 (279)
T cd05057         230 ---LPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKM  268 (279)
T ss_pred             ---CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence               011122445688999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=99.97  E-value=2.3e-31  Score=204.13  Aligned_cols=188  Identities=18%  Similarity=0.169  Sum_probs=131.9

Q ss_pred             CCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcccc
Q 037267            3 NGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVT   82 (202)
Q Consensus         3 ~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~   82 (202)
                      +++|.+++......++...+..++.|++.||.|||    +.+|+||||||+||+++.++.+|++|||++........  .
T Consensus        86 ~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH----~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~  159 (303)
T cd07869          86 HTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIH----QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSH--T  159 (303)
T ss_pred             CcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCc--c
Confidence            57889998876666899999999999999999999    89999999999999999999999999999875432221  1


Q ss_pred             ccCCCCCccccCCCCCCC-CCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCCh------hhh---h
Q 037267           83 QTMTMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGL------TEV---V  152 (202)
Q Consensus        83 ~~~~~~~~~~~~pe~~~~-~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~------~~~---~  152 (202)
                      .....+++.|+|||.+.+ ..++.++|+||+||++|++++|..||.........+............      ...   .
T Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (303)
T cd07869         160 YSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFK  239 (303)
T ss_pred             CCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccc
Confidence            223457889999997654 457888999999999999999999998654322222221111000000      000   0


Q ss_pred             hhhh--hhhHH--HHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          153 DANL--VREEQ--AFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       153 ~~~~--~~~~~--~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                      ....  .....  ........+..+.+++.+||+.||++|||+.|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         240 PERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             cccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence            0000  00000  00001123356789999999999999999999975

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=99.97  E-value=5.8e-31  Score=198.22  Aligned_cols=180  Identities=20%  Similarity=0.267  Sum_probs=138.4

Q ss_pred             CCCCcHHHHHhh---cCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCC
Q 037267            1 MPNGSLEKWLYS---YNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEG   77 (202)
Q Consensus         1 ~~~gsL~~~l~~---~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~   77 (202)
                      +++|+|.+++..   ....++...+..++.|++.||.|||    +.+++|+||||+||+++.++.++++|||.+......
T Consensus        84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH----~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~  159 (267)
T cd08228          84 ADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH----SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK  159 (267)
T ss_pred             cCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHh----hCCeeCCCCCHHHEEEcCCCCEEECccccceeccch
Confidence            468899998863   2335889999999999999999999    899999999999999999999999999998875433


Q ss_pred             CccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhh
Q 037267           78 EDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV  157 (202)
Q Consensus        78 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (202)
                      ..  ......++..|+|||...+..++.++|+||+|+++|++++|..||.........+...+.....        +.  
T Consensus       160 ~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~--------~~--  227 (267)
T cd08228         160 TT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDY--------PP--  227 (267)
T ss_pred             hH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCC--------CC--
Confidence            21  1122357788999998888788889999999999999999999986533222111111111000        00  


Q ss_pred             hhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhcC
Q 037267          158 REEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKIK  202 (202)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l~  202 (202)
                            ......+..+.+++.+||..+|++|||+.++++.|++++
T Consensus       228 ------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~  266 (267)
T cd08228         228 ------LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH  266 (267)
T ss_pred             ------CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence                  001234566899999999999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.97  E-value=9.9e-31  Score=185.58  Aligned_cols=166  Identities=20%  Similarity=0.153  Sum_probs=127.1

Q ss_pred             CcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCccccc
Q 037267            4 GSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQ   83 (202)
Q Consensus         4 gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~   83 (202)
                      |||.+++.+.+..+++.++..++.|++.||.|||    +.+      ||+||+++.++.+++  ||.+.......     
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH----~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~-----   63 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELH----RQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ-----   63 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH----hcC------CcccEeEcCccceee--ccceEeecccc-----
Confidence            8999999876667999999999999999999999    555      999999999999998  99987654321     


Q ss_pred             cCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhHHHH
Q 037267           84 TMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAF  163 (202)
Q Consensus        84 ~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (202)
                        ..+++.|+|||.+.+..++.++||||+||++|++++|..||.........+........+.....            .
T Consensus        64 --~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~------------~  129 (176)
T smart00750       64 --SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRD------------R  129 (176)
T ss_pred             --CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccc------------c
Confidence              24789999999999989999999999999999999999999654332222222222111100000            0


Q ss_pred             HHhHHHH--HHHHHHHhhhcCCCCCCCCCHHHHHHHHhh
Q 037267          164 AAKMDCI--VSIMDLALDCCMESPGKRINMTDAAAKLKK  200 (202)
Q Consensus       164 ~~~~~~~--~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~  200 (202)
                      ..+....  .++.+++.+||..+|.+||++.++++.+..
T Consensus       130 ~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~  168 (176)
T smart00750      130 SNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRA  168 (176)
T ss_pred             ccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHH
Confidence            0011222  258999999999999999999999987754

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=99.97  E-value=1.3e-31  Score=205.85  Aligned_cols=178  Identities=25%  Similarity=0.408  Sum_probs=135.0

Q ss_pred             CCCCcHHHHHhhcC---------------CCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEE
Q 037267            1 MPNGSLEKWLYSYN---------------YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHV   65 (202)
Q Consensus         1 ~~~gsL~~~l~~~~---------------~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l   65 (202)
                      |++|+|.+++....               ..+++.+++.++.|++.||.|||    +.+++|+||||+||+++.++.+++
T Consensus       106 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH----~~gi~H~dlkp~Nill~~~~~~kL  181 (307)
T cd05098         106 ASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA----SKKCIHRDLAARNVLVTEDNVMKI  181 (307)
T ss_pred             CCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH----HCCcccccccHHheEEcCCCcEEE
Confidence            57899999997532               24889999999999999999999    899999999999999999999999


Q ss_pred             cccccceeccCCCccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhC
Q 037267           66 SDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESL  144 (202)
Q Consensus        66 ~d~g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~  144 (202)
                      +|||.+................++..|+|||...+..++.++|+||+|+++|++++ |..||......  .+...+....
T Consensus       182 ~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~--~~~~~~~~~~  259 (307)
T cd05098         182 ADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE--ELFKLLKEGH  259 (307)
T ss_pred             CCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH--HHHHHHHcCC
Confidence            99999876543221111111224467999998888888999999999999999998 88888543211  1111111000


Q ss_pred             CCChhhhhhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          145 PHGLTEVVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                                       ....+..++.++.+++.+||..+|++|||+.++++.|+++
T Consensus       260 -----------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~  299 (307)
T cd05098         260 -----------------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI  299 (307)
T ss_pred             -----------------CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence                             0011223556789999999999999999999999999765

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.97  E-value=1.3e-31  Score=195.80  Aligned_cols=177  Identities=24%  Similarity=0.288  Sum_probs=142.7

Q ss_pred             CCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeC---CCCceEEcccccceeccC
Q 037267            1 MPNGSLEKWLYSYN-YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLD---ENMVAHVSDFGISKLLGE   76 (202)
Q Consensus         1 ~~~gsL~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~---~~~~~~l~d~g~~~~~~~   76 (202)
                      |+||.|...++..+ ..|++.++..|+.||+.|+.|||    +.+|.|||+||+|+|..   .+..+|++|||+++.-..
T Consensus       141 meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH----~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~  216 (400)
T KOG0604|consen  141 MEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLH----SMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQE  216 (400)
T ss_pred             ccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHH----hcchhhccCChhheeeecCCCCcceEecccccccccCC
Confidence            68999999998654 46999999999999999999999    99999999999999986   456789999999987543


Q ss_pred             CCccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhh
Q 037267           77 GEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANL  156 (202)
Q Consensus        77 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (202)
                      ...   ..++..|+.|.|||++-..+|+...|+||+|+++|-++.|.+||...+...          +++.+...+.-..
T Consensus       217 ~~~---L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a----------ispgMk~rI~~gq  283 (400)
T KOG0604|consen  217 PGD---LMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA----------ISPGMKRRIRTGQ  283 (400)
T ss_pred             Ccc---ccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc----------CChhHHhHhhccC
Confidence            322   234567899999999988899999999999999999999999998866532          1222222222211


Q ss_pred             hhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          157 VREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                      ..  ...+.+.+.++...+++..+|..+|.+|.++.++++
T Consensus       284 y~--FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~  321 (400)
T KOG0604|consen  284 YE--FPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD  321 (400)
T ss_pred             cc--CCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence            11  123456788899999999999999999999999874

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=99.97  E-value=1.9e-31  Score=199.86  Aligned_cols=175  Identities=25%  Similarity=0.338  Sum_probs=134.0

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      +++|+|.+++......+++..+..++.|++.||.|||    +.+++|+|+||+||+++.++.++++|||.+.........
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~  156 (256)
T cd05114          81 MENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE----RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT  156 (256)
T ss_pred             CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH----HCCccccccCcceEEEcCCCeEEECCCCCccccCCCcee
Confidence            4789999999865556899999999999999999999    899999999999999999999999999998765432221


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhh
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVRE  159 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (202)
                       ......++..|+|||...+..++.++|+||+|+++|++++ |..||.......  ....+......             
T Consensus       157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~--~~~~i~~~~~~-------------  220 (256)
T cd05114         157 -SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYE--VVEMISRGFRL-------------  220 (256)
T ss_pred             -ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHHHCCCCC-------------
Confidence             1111234567999999888888999999999999999999 899986543211  11111111000             


Q ss_pred             HHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHh
Q 037267          160 EQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLK  199 (202)
Q Consensus       160 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~  199 (202)
                          ..+...+.++.+++.+||..+|.+|||++++++.|.
T Consensus       221 ----~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~  256 (256)
T cd05114         221 ----YRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT  256 (256)
T ss_pred             ----CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence                001113346899999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=99.97  E-value=1e-31  Score=204.78  Aligned_cols=178  Identities=25%  Similarity=0.415  Sum_probs=136.3

Q ss_pred             CCCCcHHHHHhhcC-----------------------CCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceee
Q 037267            1 MPNGSLEKWLYSYN-----------------------YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILL   57 (202)
Q Consensus         1 ~~~gsL~~~l~~~~-----------------------~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~   57 (202)
                      +++|+|.+++....                       ..+++..++.++.|++.||.|||    +.+++||||||+||++
T Consensus        85 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH----~~~ivH~dikp~nill  160 (290)
T cd05045          85 AKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA----EMKLVHRDLAARNVLV  160 (290)
T ss_pred             cCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH----HCCeehhhhhhheEEE
Confidence            46899999986421                       24788999999999999999999    8999999999999999


Q ss_pred             CCCCceEEcccccceeccCCCccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhh
Q 037267           58 DENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSL  136 (202)
Q Consensus        58 ~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~  136 (202)
                      +.++.++++|||++................++..|++||...+..++.++|+||+|++++++++ |..||.......  +
T Consensus       161 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~  238 (290)
T cd05045         161 AEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER--L  238 (290)
T ss_pred             cCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH--H
Confidence            9999999999999876543332222222335668999998877788999999999999999998 999986543211  1


Q ss_pred             HHHHHHhCCCChhhhhhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          137 RRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       137 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                      .........                 .+.+..++.++.+++..||+.+|++||++.++++.|+++
T Consensus       239 ~~~~~~~~~-----------------~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~  286 (290)
T cd05045         239 FNLLKTGYR-----------------MERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKM  286 (290)
T ss_pred             HHHHhCCCC-----------------CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHH
Confidence            111111100                 011123456689999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=99.97  E-value=1.4e-31  Score=200.68  Aligned_cols=175  Identities=27%  Similarity=0.366  Sum_probs=135.0

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      +++++|.+++......+++..+..++.|++.||.|||    +.+++|+|+||+||+++.++.++++|||.++........
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~  156 (256)
T cd05059          81 MANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE----SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT  156 (256)
T ss_pred             CCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH----HCCcccccccHhhEEECCCCcEEECCcccceeccccccc
Confidence            4789999999876556899999999999999999999    899999999999999999999999999998765432211


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhh
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVRE  159 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (202)
                       ......++..|+|||...+..++.++|+||+|+++|++++ |..||......+  ....+....               
T Consensus       157 -~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~~~~~~~~---------------  218 (256)
T cd05059         157 -SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE--VVESVSAGY---------------  218 (256)
T ss_pred             -ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH--HHHHHHcCC---------------
Confidence             1111123457999998888888999999999999999998 888986543221  111111000               


Q ss_pred             HHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHh
Q 037267          160 EQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLK  199 (202)
Q Consensus       160 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~  199 (202)
                        ....+..++.++.+++.+||..+|++|||+.++++.|.
T Consensus       219 --~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~  256 (256)
T cd05059         219 --RLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT  256 (256)
T ss_pred             --cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence              00111235667999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=99.97  E-value=4e-31  Score=199.33  Aligned_cols=177  Identities=25%  Similarity=0.427  Sum_probs=135.6

Q ss_pred             CCCCcHHHHHhhc------CCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCC-----ceEEcccc
Q 037267            1 MPNGSLEKWLYSY------NYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENM-----VAHVSDFG   69 (202)
Q Consensus         1 ~~~gsL~~~l~~~------~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~-----~~~l~d~g   69 (202)
                      +++|+|.+++.+.      ...+++.+++.++.|++.||.|||    +.+++|+|++|+||+++.++     .++++|||
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH----~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg  156 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE----QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFG  156 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHH----hCCcccCCCChheEEEecCCCCCCcceEECCcc
Confidence            4789999999742      234788999999999999999999    89999999999999999877     89999999


Q ss_pred             cceeccCCCccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhCCCCh
Q 037267           70 ISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGL  148 (202)
Q Consensus        70 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~  148 (202)
                      ++................++..|++||...+..++.++|+||+|+++|++++ |..||.......  ....+...     
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~--~~~~~~~~-----  229 (269)
T cd05044         157 LARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE--VLQHVTAG-----  229 (269)
T ss_pred             cccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH--HHHHHhcC-----
Confidence            9876543322222223345678999998888888999999999999999998 999986533211  11111000     


Q ss_pred             hhhhhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhh
Q 037267          149 TEVVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKK  200 (202)
Q Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~  200 (202)
                                  .....+..++..+.+++.+||..+|++||++.++++.|++
T Consensus       230 ------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  269 (269)
T cd05044         230 ------------GRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN  269 (269)
T ss_pred             ------------CccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence                        0001122355678999999999999999999999999864

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=99.97  E-value=7.6e-31  Score=196.56  Aligned_cols=173  Identities=28%  Similarity=0.399  Sum_probs=135.0

Q ss_pred             CCCCcHHHHHhhcCC-CCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCc
Q 037267            1 MPNGSLEKWLYSYNY-FFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED   79 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~-~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~   79 (202)
                      +++|+|.+++.+... .+++..++.++.|++.||.|||    +.+++|+||||+||+++.++.++++|||++....... 
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-  156 (256)
T cd05082          82 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE----ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-  156 (256)
T ss_pred             CCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH----hCCEeccccchheEEEcCCCcEEecCCccceeccccC-
Confidence            478999999986443 4889999999999999999999    8999999999999999999999999999987643322 


Q ss_pred             cccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhh
Q 037267           80 FVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVR  158 (202)
Q Consensus        80 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (202)
                          .....+..|+|||...+..++.++|+||+||++|++++ |..||.......  ....+......            
T Consensus       157 ----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~--~~~~~~~~~~~------------  218 (256)
T cd05082         157 ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VVPRVEKGYKM------------  218 (256)
T ss_pred             ----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHhcCCCC------------
Confidence                12234567999998888888999999999999999997 998886432111  11111111000            


Q ss_pred             hHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          159 EEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       159 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                           ..+..++..+.+++.+||..+|++|||++++++.|+.+
T Consensus       219 -----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         219 -----DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             -----CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence                 01123566789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=99.97  E-value=1.5e-31  Score=200.74  Aligned_cols=176  Identities=28%  Similarity=0.469  Sum_probs=137.7

Q ss_pred             CCCCcHHHHHhhc-CCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCc
Q 037267            1 MPNGSLEKWLYSY-NYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED   79 (202)
Q Consensus         1 ~~~gsL~~~l~~~-~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~   79 (202)
                      +++|+|.+++.+. +..+++..+..++.|++.||.|||    +.+++|+|++|+||+++.++.++++|||.+........
T Consensus        84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH----~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~  159 (261)
T cd05148          84 MEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE----EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY  159 (261)
T ss_pred             cccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH----HCCeeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence            4789999999864 345899999999999999999999    89999999999999999999999999999876543322


Q ss_pred             cccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhh
Q 037267           80 FVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVR  158 (202)
Q Consensus        80 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (202)
                      ..  ....++..|++||...+..++.++|+||+|+++|++++ |..||....... .+. .+....              
T Consensus       160 ~~--~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~-~~~-~~~~~~--------------  221 (261)
T cd05148         160 LS--SDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE-VYD-QITAGY--------------  221 (261)
T ss_pred             cc--cCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH-HHH-HHHhCC--------------
Confidence            11  12235667999998877788899999999999999998 899986543211 111 111110              


Q ss_pred             hHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          159 EEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       159 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                         ..+.+..++..+.+++.+||..||.+|||+.++++.|+.+
T Consensus       222 ---~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~  261 (261)
T cd05148         222 ---RMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI  261 (261)
T ss_pred             ---cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence               0111234566789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=99.97  E-value=2.6e-31  Score=202.57  Aligned_cols=187  Identities=18%  Similarity=0.199  Sum_probs=132.1

Q ss_pred             CCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcccc
Q 037267            3 NGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVT   82 (202)
Q Consensus         3 ~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~   82 (202)
                      .|+|.+++......+++..+..++.|++.||.|||    +.+|+||||||+||+++.++.+|++|||++.........  
T Consensus        86 ~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH----~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~--  159 (288)
T cd07871          86 DSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCH----KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKT--  159 (288)
T ss_pred             CcCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCcc--
Confidence            46899999876666899999999999999999999    899999999999999999999999999998764332211  


Q ss_pred             ccCCCCCccccCCCCCCC-CCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCC--Chhhh--------
Q 037267           83 QTMTMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPH--GLTEV--------  151 (202)
Q Consensus        83 ~~~~~~~~~~~~pe~~~~-~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~--------  151 (202)
                      .....++..|+|||.+.+ ..++.++|+||+||++|++++|..||......+...........+.  .+...        
T Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (288)
T cd07871         160 YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRS  239 (288)
T ss_pred             ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhc
Confidence            122356889999997765 4678899999999999999999999976433221111110000000  00000        


Q ss_pred             -hhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          152 -VDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       152 -~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                       ..+...... ........+.+..+++.+||..||++|||+.|+++
T Consensus       240 ~~~~~~~~~~-~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         240 YLFPQYRAQP-LINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             cccCccCCCc-hHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence             000000000 00111234567899999999999999999999874

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=99.97  E-value=2.7e-31  Score=202.94  Aligned_cols=184  Identities=23%  Similarity=0.353  Sum_probs=136.1

Q ss_pred             CCCCcHHHHHhhcC----------CCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEccccc
Q 037267            1 MPNGSLEKWLYSYN----------YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGI   70 (202)
Q Consensus         1 ~~~gsL~~~l~~~~----------~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~   70 (202)
                      +++++|.+++....          ..+++..++.++.|++.||.|||    +.+++|+||||+||+++.++.++++|||+
T Consensus       101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH----~~~i~H~dlkp~Nili~~~~~~~l~dfg~  176 (296)
T cd05051         101 MENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE----SLNFVHRDLATRNCLVGKNYTIKIADFGM  176 (296)
T ss_pred             CCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH----HcCccccccchhceeecCCCceEEccccc
Confidence            46899999997543          25899999999999999999999    89999999999999999999999999999


Q ss_pred             ceeccCCCccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh--CCCCCCcccccchhhHHHHHHhCCCCh
Q 037267           71 SKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT--RKRPTDEMFTGEMSLRRWVKESLPHGL  148 (202)
Q Consensus        71 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~--g~~p~~~~~~~~~~~~~~~~~~~~~~~  148 (202)
                      +................++..|+|||...+..++.++|+||+|+++|++++  +..||....... .+. ..........
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~-~~~-~~~~~~~~~~  254 (296)
T cd05051         177 SRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQ-VIE-NAGHFFRDDG  254 (296)
T ss_pred             eeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHH-HHH-HHHhcccccc
Confidence            886544332222333446778999998877788999999999999999987  667775432211 111 1111000000


Q ss_pred             hhhhhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhh
Q 037267          149 TEVVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKK  200 (202)
Q Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~  200 (202)
                      ..          ...+.+..++.++.+++.+||+.||++|||+.++++.|++
T Consensus       255 ~~----------~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~  296 (296)
T cd05051         255 RQ----------IYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR  296 (296)
T ss_pred             cc----------ccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence            00          0001112345679999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=99.97  E-value=1.3e-31  Score=202.85  Aligned_cols=177  Identities=22%  Similarity=0.414  Sum_probs=135.4

Q ss_pred             CCCCcHHHHHhhcC---------CCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccc
Q 037267            1 MPNGSLEKWLYSYN---------YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGIS   71 (202)
Q Consensus         1 ~~~gsL~~~l~~~~---------~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~   71 (202)
                      +++|+|.+++....         ..+++..++.++.|++.||.|||    +.+++|+||||+||+++.++.++++|||++
T Consensus        91 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~di~p~nill~~~~~~kl~dfg~~  166 (277)
T cd05032          91 MAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA----AKKFVHRDLAARNCMVAEDLTVKIGDFGMT  166 (277)
T ss_pred             CCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH----hCCccccccChheEEEcCCCCEEECCcccc
Confidence            46899999997432         13688899999999999999999    899999999999999999999999999998


Q ss_pred             eeccCCCccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhCCCChhh
Q 037267           72 KLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTE  150 (202)
Q Consensus        72 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  150 (202)
                      +...............++..|.|||...+..++.++|+||+|+++|++++ |..||.......  .........      
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--~~~~~~~~~------  238 (277)
T cd05032         167 RDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE--VLKFVIDGG------  238 (277)
T ss_pred             hhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH--HHHHHhcCC------
Confidence            76544332222223345678999998887788999999999999999998 888886533211  111111100      


Q ss_pred             hhhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhh
Q 037267          151 VVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKK  200 (202)
Q Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~  200 (202)
                                 ....+..++.++.+++.+||..+|++|||+.++++.|+.
T Consensus       239 -----------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  277 (277)
T cd05032         239 -----------HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD  277 (277)
T ss_pred             -----------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence                       000112245668999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=99.97  E-value=2.5e-31  Score=203.37  Aligned_cols=175  Identities=25%  Similarity=0.390  Sum_probs=132.7

Q ss_pred             CCCCcHHHHHhhcC---------------CCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEE
Q 037267            1 MPNGSLEKWLYSYN---------------YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHV   65 (202)
Q Consensus         1 ~~~gsL~~~l~~~~---------------~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l   65 (202)
                      +++|+|.+++....               ..+++..+..++.|++.||+|||    +.+++||||||+||+++.++.+++
T Consensus        85 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH----~~~ivH~dlkp~Nill~~~~~~kl  160 (297)
T cd05089          85 APYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS----EKQFIHRDLAARNVLVGENLASKI  160 (297)
T ss_pred             cCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH----HCCcccCcCCcceEEECCCCeEEE
Confidence            47899999997532               24888999999999999999999    899999999999999999999999


Q ss_pred             cccccceeccCCCccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhC
Q 037267           66 SDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESL  144 (202)
Q Consensus        66 ~d~g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~  144 (202)
                      +|||++.......   .......+..|++||...+..++.++|+||+|+++|++++ |..||.......  .........
T Consensus       161 ~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~--~~~~~~~~~  235 (297)
T cd05089         161 ADFGLSRGEEVYV---KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE--LYEKLPQGY  235 (297)
T ss_pred             CCcCCCcccccee---ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHHhcCC
Confidence            9999986422111   1111123456999998888888999999999999999997 999996543221  111110000


Q ss_pred             CCChhhhhhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          145 PHGLTEVVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                                       ....+..++..+.+++.+||..+|.+||+++++++.|..+
T Consensus       236 -----------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  275 (297)
T cd05089         236 -----------------RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRM  275 (297)
T ss_pred             -----------------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence                             0011123556689999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=99.97  E-value=1.9e-31  Score=202.17  Aligned_cols=177  Identities=25%  Similarity=0.392  Sum_probs=133.7

Q ss_pred             CCCCcHHHHHhhcC------CCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCC---ceEEcccccc
Q 037267            1 MPNGSLEKWLYSYN------YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENM---VAHVSDFGIS   71 (202)
Q Consensus         1 ~~~gsL~~~l~~~~------~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~---~~~l~d~g~~   71 (202)
                      +++|+|.+++....      ..+++..++.++.|++.||.|||    +.+++|+||||+||+++.++   .++++|||++
T Consensus        91 ~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH----~~~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~  166 (277)
T cd05036          91 MAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE----ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMA  166 (277)
T ss_pred             CCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH----HCCEeecccchheEEEeccCCCcceEeccCccc
Confidence            46899999997543      24899999999999999999999    89999999999999998654   5899999998


Q ss_pred             eeccCCCccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhCCCChhh
Q 037267           72 KLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTE  150 (202)
Q Consensus        72 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  150 (202)
                      .................+..|+|||...+..++.++|+||+||++|++++ |..||.......  ....+.....     
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~--~~~~~~~~~~-----  239 (277)
T cd05036         167 RDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE--VMEFVTGGGR-----  239 (277)
T ss_pred             cccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHHHcCCc-----
Confidence            86533222111112233567999999888889999999999999999996 999987543222  1111111000     


Q ss_pred             hhhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhh
Q 037267          151 VVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKK  200 (202)
Q Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~  200 (202)
                                  ...+..++..+.+++.+||..+|++|||+.++++.|+.
T Consensus       240 ------------~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~  277 (277)
T cd05036         240 ------------LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY  277 (277)
T ss_pred             ------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence                        00122345678999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=99.97  E-value=1.6e-31  Score=203.33  Aligned_cols=190  Identities=19%  Similarity=0.159  Sum_probs=132.5

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |+++++..+. ..+..+++..+..++.|++.||.|||    +.+++||||||+||+++.++.++++|||++.........
T Consensus        82 ~~~~~l~~~~-~~~~~~~~~~~~~~~~qi~~~L~~lH----~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  156 (287)
T cd07848          82 VEKNMLELLE-EMPNGVPPEKVRSYIYQLIKAIHWCH----KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNA  156 (287)
T ss_pred             CCCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccccc
Confidence            3566665444 33445899999999999999999999    899999999999999999999999999999875432211


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhH-HHHHHhCCCChhhhh-------
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLR-RWVKESLPHGLTEVV-------  152 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~-------  152 (202)
                       ......++..|+|||...+..++.++|+||+||++|++++|..||........... .......+.......       
T Consensus       157 -~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (287)
T cd07848         157 -NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFH  235 (287)
T ss_pred             -cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhc
Confidence             11224578899999988888889999999999999999999999976432221111 000000110000000       


Q ss_pred             ---hhhhh-hhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          153 ---DANLV-REEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       153 ---~~~~~-~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                         .+... ...........++.++.+++.+||+.||++|||++++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         236 GLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             ccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence               00000 000001112346677999999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=99.97  E-value=6.1e-31  Score=208.49  Aligned_cols=164  Identities=23%  Similarity=0.419  Sum_probs=127.1

Q ss_pred             CCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCccccccCCCCCccccCC
Q 037267           16 FFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAP   95 (202)
Q Consensus        16 ~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~p   95 (202)
                      .+++..++.++.|++.||.|||    +.+++|+||||.||+++.++.++++|||++................++..|+||
T Consensus       233 ~l~~~~~~~~~~qi~~aL~~LH----~~~ivH~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aP  308 (400)
T cd05105         233 GLTTLDLLSFTYQVARGMEFLA----SKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAP  308 (400)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHH----hCCeeCCCCChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceECh
Confidence            3788889999999999999999    899999999999999999999999999998865433222222233466789999


Q ss_pred             CCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhHHHHHHhHHHHHHHH
Q 037267           96 EYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIM  174 (202)
Q Consensus        96 e~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  174 (202)
                      |.+.+..++.++|+||+|+++|++++ |..||........... .+....                 ....+..++.++.
T Consensus       309 E~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~-~~~~~~-----------------~~~~~~~~~~~l~  370 (400)
T cd05105         309 ESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYN-KIKSGY-----------------RMAKPDHATQEVY  370 (400)
T ss_pred             hhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHH-HHhcCC-----------------CCCCCccCCHHHH
Confidence            99888888999999999999999997 8899876433221111 111110                 0011224566789


Q ss_pred             HHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          175 DLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       175 ~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                      +++.+||..+|++||++.++.+.|+++
T Consensus       371 ~li~~cl~~dP~~RPt~~~l~~~l~~l  397 (400)
T cd05105         371 DIMVKCWNSEPEKRPSFLHLSDIVESL  397 (400)
T ss_pred             HHHHHHCccCHhHCcCHHHHHHHHHHH
Confidence            999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=99.97  E-value=2.4e-31  Score=205.05  Aligned_cols=178  Identities=23%  Similarity=0.404  Sum_probs=135.1

Q ss_pred             CCCCcHHHHHhhcC---------------CCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEE
Q 037267            1 MPNGSLEKWLYSYN---------------YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHV   65 (202)
Q Consensus         1 ~~~gsL~~~l~~~~---------------~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l   65 (202)
                      +++|+|.+++....               ..+++.++++++.|++.||.|||    +.+++|+||||.||+++.++.+++
T Consensus       100 ~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH----~~gi~H~dlkp~Nill~~~~~~kL  175 (314)
T cd05099         100 AAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE----SRRCIHRDLAARNVLVTEDNVMKI  175 (314)
T ss_pred             CCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH----HCCeeeccccceeEEEcCCCcEEE
Confidence            47899999997532               24889999999999999999999    899999999999999999999999


Q ss_pred             cccccceeccCCCccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhC
Q 037267           66 SDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESL  144 (202)
Q Consensus        66 ~d~g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~  144 (202)
                      +|||++................++..|++||...+..++.++|+||+|+++|++++ |..||.......  +........
T Consensus       176 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~--~~~~~~~~~  253 (314)
T cd05099         176 ADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE--LFKLLREGH  253 (314)
T ss_pred             ccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcCC
Confidence            99999976543222111111223457999998888888999999999999999998 888886532211  111111100


Q ss_pred             CCChhhhhhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          145 PHGLTEVVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                      .                 ...+..++.++.+++.+||..+|++|||+.++++.|+++
T Consensus       254 ~-----------------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~  293 (314)
T cd05099         254 R-----------------MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKV  293 (314)
T ss_pred             C-----------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence            0                 001123456688999999999999999999999999765

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.97  E-value=8.7e-31  Score=196.29  Aligned_cols=168  Identities=21%  Similarity=0.326  Sum_probs=130.1

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCC-------ceEEccccccee
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENM-------VAHVSDFGISKL   73 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~-------~~~l~d~g~~~~   73 (202)
                      |++|+|.+++......+++..+..++.|++.||.|||    +.+++|+||||+||+++.++       .++++|||++..
T Consensus        82 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH----~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~  157 (259)
T cd05037          82 VKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLE----DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPIT  157 (259)
T ss_pred             CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHh----hCCeecccCccceEEEecCccccCCceeEEeCCCCcccc
Confidence            5789999999876656899999999999999999999    89999999999999999877       799999999876


Q ss_pred             ccCCCccccccCCCCCccccCCCCCCCC--CcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhCCCChhh
Q 037267           74 LGEGEDFVTQTMTMATIGYMAPEYGSEG--IVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTE  150 (202)
Q Consensus        74 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~--~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  150 (202)
                      ....      ....++..|++||.+.+.  .++.++|+||+|+++|++++ |..||.......  .........   .  
T Consensus       158 ~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~--~~~~~~~~~---~--  224 (259)
T cd05037         158 VLSR------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE--KERFYQDQH---R--  224 (259)
T ss_pred             cccc------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh--HHHHHhcCC---C--
Confidence            5431      122456779999987766  67889999999999999998 577776543211  111111000   0  


Q ss_pred             hhhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHh
Q 037267          151 VVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLK  199 (202)
Q Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~  199 (202)
                            ..        ......+.+++.+||..+|.+|||+.++++.|+
T Consensus       225 ------~~--------~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         225 ------LP--------MPDCAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             ------CC--------CCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence                  00        000145889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.97  E-value=2.3e-31  Score=202.39  Aligned_cols=192  Identities=20%  Similarity=0.361  Sum_probs=137.1

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      ++||+|.+++......+++..+..++.|++.||.|||    +.+++||||||+||+++.++.++++|||++.........
T Consensus        90 ~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH----~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~  165 (284)
T cd05079          90 LPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG----SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEY  165 (284)
T ss_pred             cCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH----HCCeeecccchheEEEcCCCCEEECCCccccccccCccc
Confidence            4799999999766556899999999999999999999    899999999999999999999999999998865433221


Q ss_pred             -ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCC-hhhhhhhhhhh
Q 037267           81 -VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHG-LTEVVDANLVR  158 (202)
Q Consensus        81 -~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  158 (202)
                       .......++..|+|||...+..++.++|+||+|+++|+++++..|+........   .......... ...... . ..
T Consensus       166 ~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~-~-~~  240 (284)
T cd05079         166 YTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFL---KMIGPTHGQMTVTRLVR-V-LE  240 (284)
T ss_pred             eeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhh---hhcccccccccHHHHHH-H-HH
Confidence             111223456679999988877888999999999999999997765432111000   0000000000 000000 0 00


Q ss_pred             hHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          159 EEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       159 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                      .....+.+..++..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus       241 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         241 EGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             cCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            0001111234567799999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=99.97  E-value=1.1e-31  Score=207.23  Aligned_cols=168  Identities=26%  Similarity=0.279  Sum_probs=130.8

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |+||+|.+++.... .+++..+..++.|++.||.|||    +.+|+||||||+||+++.++.++|+|||++........ 
T Consensus        78 ~~gg~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~LH----~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~-  151 (316)
T cd05592          78 LNGGDLMFHIQSSG-RFDEARARFYAAEIICGLQFLH----KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEG-  151 (316)
T ss_pred             CCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCC-
Confidence            57999999997654 4899999999999999999999    89999999999999999999999999999876432221 


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhH
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREE  160 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (202)
                       ......|++.|+|||.+.+..++.++|+||+||++|++++|..||.......  ....+....+               
T Consensus       152 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~--~~~~i~~~~~---------------  213 (316)
T cd05592         152 -KASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE--LFDSILNDRP---------------  213 (316)
T ss_pred             -ccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHH--HHHHHHcCCC---------------
Confidence             1223458899999999888889999999999999999999999997643211  1111110000               


Q ss_pred             HHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHH-HHH
Q 037267          161 QAFAAKMDCIVSIMDLALDCCMESPGKRINMT-DAA  195 (202)
Q Consensus       161 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~-~~~  195 (202)
                         ..+..++.++.+++.+||+.||++||++. +++
T Consensus       214 ---~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05592         214 ---HFPRWISKEAKDCLSKLFERDPTKRLGVDGDIR  246 (316)
T ss_pred             ---CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence               01122455688999999999999999875 443

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=9.8e-32  Score=205.16  Aligned_cols=166  Identities=25%  Similarity=0.275  Sum_probs=130.9

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |++|+|.+++.+.. .+++..+..++.|++.||.|||    +.+++||||||+||+++.++.++++|||++.......  
T Consensus        83 ~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~--  155 (291)
T cd05612          83 VPGGELFSYLRNSG-RFSNSTGLFYASEIVCALEYLH----SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT--  155 (291)
T ss_pred             CCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeeecCCCHHHeEECCCCCEEEEecCcchhccCCc--
Confidence            57899999998654 4899999999999999999999    8999999999999999999999999999987654321  


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhH
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREE  160 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (202)
                         ....+++.|+|||.+.+..++.++|+||+||++|++++|..||.......  ....+....                
T Consensus       156 ---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~--~~~~i~~~~----------------  214 (291)
T cd05612         156 ---WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG--IYEKILAGK----------------  214 (291)
T ss_pred             ---ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhCC----------------
Confidence               12357889999999888888999999999999999999999996543211  111111000                


Q ss_pred             HHHHHhHHHHHHHHHHHhhhcCCCCCCCCC-----HHHHHH
Q 037267          161 QAFAAKMDCIVSIMDLALDCCMESPGKRIN-----MTDAAA  196 (202)
Q Consensus       161 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps-----~~~~~~  196 (202)
                        ...+...+..+.+++.+||..||.+||+     ++++++
T Consensus       215 --~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  253 (291)
T cd05612         215 --LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN  253 (291)
T ss_pred             --cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence              0011223456889999999999999995     777653

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.97  E-value=5e-31  Score=201.53  Aligned_cols=178  Identities=17%  Similarity=0.152  Sum_probs=131.1

Q ss_pred             cHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCccc---
Q 037267            5 SLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFV---   81 (202)
Q Consensus         5 sL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~~---   81 (202)
                      ++.+.+.... ..++..+..++.|++.||.|||    +.+++||||||+||+++.++.++++|||+++.........   
T Consensus       112 ~~~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH----~~~iiHrDiKp~Nill~~~~~~~l~DFGla~~~~~~~~~~~~~  186 (294)
T PHA02882        112 NTKEIFKRIK-CKNKKLIKNIMKDMLTTLEYIH----EHGISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYS  186 (294)
T ss_pred             CHHHHHHhhc-cCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEEcCCCcEEEEEcCCceeeccCCcccccc
Confidence            5555554322 3578888999999999999999    8999999999999999999999999999998764322111   


Q ss_pred             --cccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhh
Q 037267           82 --TQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVRE  159 (202)
Q Consensus        82 --~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (202)
                        ......+++.|+|||...+..++.++|+||+||+++++++|..||...............+..    ..+....    
T Consensus       187 ~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~~~~----~~~~~~~----  258 (294)
T PHA02882        187 KEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKCDFI----KRLHEGK----  258 (294)
T ss_pred             cccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHHHHH----HHhhhhh----
Confidence              112235889999999988888999999999999999999999999875332221111111000    0000000    


Q ss_pred             HHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHh
Q 037267          160 EQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLK  199 (202)
Q Consensus       160 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~  199 (202)
                          .....++..+.+++..||..+|++||+++++++.|.
T Consensus       259 ----~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~  294 (294)
T PHA02882        259 ----IKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD  294 (294)
T ss_pred             ----hccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence                011235677999999999999999999999998763

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=99.97  E-value=2.9e-31  Score=200.06  Aligned_cols=178  Identities=26%  Similarity=0.466  Sum_probs=136.9

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      +++|+|.+++......+++..+..++.|++.||.|||    +.+++|+|+||.||+++.++.++++|||++.........
T Consensus        88 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH----~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~  163 (268)
T cd05063          88 MENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLS----DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEG  163 (268)
T ss_pred             CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCeeccccchhhEEEcCCCcEEECCCccceeccccccc
Confidence            4789999999876666899999999999999999999    899999999999999999999999999998765433211


Q ss_pred             cc-ccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhh
Q 037267           81 VT-QTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVR  158 (202)
Q Consensus        81 ~~-~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (202)
                      .. ......+..|++||...+..++.++|+||+|+++|++++ |..||.......  ....+....              
T Consensus       164 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~--~~~~i~~~~--------------  227 (268)
T cd05063         164 TYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE--VMKAINDGF--------------  227 (268)
T ss_pred             ceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH--HHHHHhcCC--------------
Confidence            11 111123457999998887788899999999999999987 999986533211  111111100              


Q ss_pred             hHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          159 EEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       159 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                         ..+....++.++.+++.+||..+|++||++.++++.|+++
T Consensus       228 ---~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         228 ---RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             ---CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence               0011123556689999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=99.97  E-value=1.4e-31  Score=207.13  Aligned_cols=169  Identities=21%  Similarity=0.224  Sum_probs=131.6

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |++|+|.+++.... .+++..+..++.|++.||.|||    +.+++||||||+||+++.++.++|+|||++........ 
T Consensus        77 ~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH----~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~-  150 (323)
T cd05595          77 ANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLH----SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-  150 (323)
T ss_pred             CCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC-
Confidence            57999999997654 4899999999999999999999    89999999999999999999999999999875322211 


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhH
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREE  160 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (202)
                       ......+++.|+|||.+.+..++.++|+||+||++|++++|..||........ .......            ..    
T Consensus       151 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~-~~~~~~~------------~~----  212 (323)
T cd05595         151 -TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL-FELILME------------EI----  212 (323)
T ss_pred             -ccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHH-HHHHhcC------------CC----
Confidence             11234588999999999888899999999999999999999999965432111 0000000            00    


Q ss_pred             HHHHHhHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHH
Q 037267          161 QAFAAKMDCIVSIMDLALDCCMESPGKRI-----NMTDAAA  196 (202)
Q Consensus       161 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rp-----s~~~~~~  196 (202)
                         ..+..+++++.+++.+||..||++||     ++.++++
T Consensus       213 ---~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~  250 (323)
T cd05595         213 ---RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  250 (323)
T ss_pred             ---CCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence               01123456689999999999999998     7777764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=99.97  E-value=1.4e-31  Score=207.54  Aligned_cols=169  Identities=22%  Similarity=0.238  Sum_probs=131.5

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |++|+|.+++.... .+++..+..++.|++.||.|||    +.+|+||||||+||+++.++.+||+|||++........ 
T Consensus        77 ~~~g~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH----~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~-  150 (328)
T cd05593          77 VNGGELFFHLSRER-VFSEDRTRFYGAEIVSALDYLH----SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA-  150 (328)
T ss_pred             CCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----hCCeEecccCHHHeEECCCCcEEEecCcCCccCCCccc-
Confidence            57999999997644 4899999999999999999999    89999999999999999999999999999875322111 


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhH
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREE  160 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (202)
                       ......+++.|+|||.+.+..++.++|+||+||++|++++|..||.......  ....+...           .     
T Consensus       151 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~--~~~~~~~~-----------~-----  211 (328)
T cd05593         151 -TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK--LFELILME-----------D-----  211 (328)
T ss_pred             -ccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHH--HHHHhccC-----------C-----
Confidence             1122458899999999888888999999999999999999999996532211  11110000           0     


Q ss_pred             HHHHHhHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHH
Q 037267          161 QAFAAKMDCIVSIMDLALDCCMESPGKRI-----NMTDAAA  196 (202)
Q Consensus       161 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rp-----s~~~~~~  196 (202)
                        ...+...+.++.+++.+||..||++|+     ++.++++
T Consensus       212 --~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~  250 (328)
T cd05593         212 --IKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMR  250 (328)
T ss_pred             --ccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhc
Confidence              001123456688999999999999997     7888764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=99.97  E-value=5.1e-31  Score=198.00  Aligned_cols=177  Identities=25%  Similarity=0.430  Sum_probs=136.7

Q ss_pred             CCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCc
Q 037267            1 MPNGSLEKWLYSYN-YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED   79 (202)
Q Consensus         1 ~~~gsL~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~   79 (202)
                      +++|+|.+++.... ..+++..+..++.|++.||.|||    +.+++|+||+|.||+++.++.++++|||.+........
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH----~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~  157 (260)
T cd05069          82 MGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE----RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY  157 (260)
T ss_pred             CCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH----hCCEeecccCcceEEEcCCCeEEECCCccceEccCCcc
Confidence            46889999997543 35899999999999999999999    89999999999999999999999999999976543221


Q ss_pred             cccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhh
Q 037267           80 FVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVR  158 (202)
Q Consensus        80 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (202)
                      . ......++..|++||...+..++.++|+||+|+++|++++ |..||.......  ...........            
T Consensus       158 ~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~~~~~~~~~~------------  222 (260)
T cd05069         158 T-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE--VLEQVERGYRM------------  222 (260)
T ss_pred             c-ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcCCCC------------
Confidence            1 1112235667999998888888999999999999999998 899987643221  11111111000            


Q ss_pred             hHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          159 EEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       159 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                           +.+...+..+.+++.+||..||++||+++++++.|+.+
T Consensus       223 -----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  260 (260)
T cd05069         223 -----PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLEDY  260 (260)
T ss_pred             -----CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence                 01123456689999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=99.97  E-value=3.8e-31  Score=198.65  Aligned_cols=177  Identities=27%  Similarity=0.447  Sum_probs=136.5

Q ss_pred             CCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCc
Q 037267            1 MPNGSLEKWLYSYN-YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED   79 (202)
Q Consensus         1 ~~~gsL~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~   79 (202)
                      +++|+|.+++.... ..+++..+..++.|++.||.|||    +.+++|+|+||+||+++.++.++++|||++........
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH----~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~  157 (260)
T cd05070          82 MSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE----RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY  157 (260)
T ss_pred             cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCccceEEEeCCceEEeCCceeeeeccCccc
Confidence            46899999997643 35899999999999999999999    89999999999999999999999999999987544322


Q ss_pred             cccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhh
Q 037267           80 FVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVR  158 (202)
Q Consensus        80 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (202)
                      .. .....++..|+|||...+..++.++|+||+|+++|++++ |..||......+  ..........             
T Consensus       158 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~--~~~~~~~~~~-------------  221 (260)
T cd05070         158 TA-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE--VLEQVERGYR-------------  221 (260)
T ss_pred             cc-ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH--HHHHHHcCCC-------------
Confidence            11 112234567999998887888899999999999999998 888986543211  1111111000             


Q ss_pred             hHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          159 EEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       159 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                          .+.+...+..+.+++.+||..+|++|||++++.+.|+.+
T Consensus       222 ----~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  260 (260)
T cd05070         222 ----MPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLEDY  260 (260)
T ss_pred             ----CCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhcC
Confidence                011223456689999999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>PHA03212 serine/threonine kinase US3; Provisional

Probab=99.97  E-value=1.9e-30  Score=205.31  Aligned_cols=188  Identities=19%  Similarity=0.167  Sum_probs=131.8

Q ss_pred             CCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcccc
Q 037267            3 NGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVT   82 (202)
Q Consensus         3 ~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~   82 (202)
                      +++|.+++.... .+++.+++.++.|++.||.|||    +.+|+||||||+||+++.++.++|+|||++......... .
T Consensus       166 ~~~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~ylH----~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~-~  239 (391)
T PHA03212        166 KTDLYCYLAAKR-NIAICDILAIERSVLRAIQYLH----ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN-K  239 (391)
T ss_pred             CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCChHhEEEcCCCCEEEEeCCccccccccccc-c
Confidence            578888887543 4899999999999999999999    899999999999999999999999999998653321111 1


Q ss_pred             ccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccc------hhhHHHHHHh------CCCChhh
Q 037267           83 QTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGE------MSLRRWVKES------LPHGLTE  150 (202)
Q Consensus        83 ~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~------~~~~~~~~~~------~~~~~~~  150 (202)
                      .....|++.|+|||++.+..++.++|+||+||++|++++|..||.......      ..+...+...      .+.....
T Consensus       240 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~  319 (391)
T PHA03212        240 YYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQA  319 (391)
T ss_pred             cccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhH
Confidence            123468999999999888889999999999999999999998875432111      1111111100      0000000


Q ss_pred             hhhhhh-------h---hhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          151 VVDANL-------V---REEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       151 ~~~~~~-------~---~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                      ......       .   ............+.++.+|+.+||+.||++|||+.|+++
T Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~  375 (391)
T PHA03212        320 NLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD  375 (391)
T ss_pred             HHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence            000000       0   000001111245667899999999999999999999984

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=99.97  E-value=1.5e-30  Score=195.05  Aligned_cols=175  Identities=25%  Similarity=0.347  Sum_probs=134.9

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      +++|+|.+++......+++..++.++.|++.||.|||    +.+++|+||||.||+++.++.++++|||.+.........
T Consensus        81 ~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~  156 (256)
T cd05113          81 MSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE----SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT  156 (256)
T ss_pred             CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----hCCeeccccCcceEEEcCCCCEEECCCccceecCCCcee
Confidence            4689999999875556899999999999999999999    899999999999999999999999999998765443221


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhh
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVRE  159 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (202)
                       ......++..|++||...+..++.++|+||+|+++|++++ |..||.......  ....+......             
T Consensus       157 -~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~--~~~~~~~~~~~-------------  220 (256)
T cd05113         157 -SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE--TVEKVSQGLRL-------------  220 (256)
T ss_pred             -ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH--HHHHHhcCCCC-------------
Confidence             1112234567999998887788899999999999999998 999986543221  11111111100             


Q ss_pred             HHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHh
Q 037267          160 EQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLK  199 (202)
Q Consensus       160 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~  199 (202)
                          ..+...+..+.+++.+||+.+|.+||++.++++.|+
T Consensus       221 ----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         221 ----YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             ----CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence                001123456899999999999999999999998774

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=99.97  E-value=4.3e-31  Score=200.71  Aligned_cols=177  Identities=26%  Similarity=0.449  Sum_probs=135.2

Q ss_pred             CCCCcHHHHHhhc----------------CCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceE
Q 037267            1 MPNGSLEKWLYSY----------------NYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAH   64 (202)
Q Consensus         1 ~~~gsL~~~l~~~----------------~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~   64 (202)
                      +++|+|.+++...                ...+++..++.++.|++.||.|||    +.+++|+|+||+||+++.++.++
T Consensus        89 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH----~~~i~H~dlkp~nili~~~~~~k  164 (283)
T cd05090          89 LNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS----SHFFVHKDLAARNILIGEQLHVK  164 (283)
T ss_pred             CCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH----hcCeehhccccceEEEcCCCcEE
Confidence            4689999998532                124788999999999999999999    89999999999999999999999


Q ss_pred             EcccccceeccCCCccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHh
Q 037267           65 VSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKES  143 (202)
Q Consensus        65 l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~  143 (202)
                      ++|||++................++..|++||...+..++.++|+||+|+++|++++ |..||......  .....+...
T Consensus       165 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~--~~~~~~~~~  242 (283)
T cd05090         165 ISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ--EVIEMVRKR  242 (283)
T ss_pred             eccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHHcC
Confidence            999999987644332222222345667999998888888999999999999999998 88888653211  111111111


Q ss_pred             CCCChhhhhhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhh
Q 037267          144 LPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKK  200 (202)
Q Consensus       144 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~  200 (202)
                      ..                 .+.+..++..+.+++.+||..||++||++.++.+.|..
T Consensus       243 ~~-----------------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         243 QL-----------------LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             Cc-----------------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence            00                 01112345668999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=99.97  E-value=1.6e-31  Score=206.58  Aligned_cols=164  Identities=24%  Similarity=0.248  Sum_probs=128.9

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |++|+|.+++.... .+++..+..++.|++.||.|||    +.+++||||||+||+++.++.++|+|||++........ 
T Consensus        78 ~~~g~L~~~i~~~~-~l~~~~~~~~~~ql~~~L~~lH----~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~-  151 (320)
T cd05590          78 VNGGDLMFHIQKSR-RFDEARARFYAAEITSALMFLH----DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK-  151 (320)
T ss_pred             CCCchHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC-
Confidence            57899999997654 4899999999999999999999    89999999999999999999999999999875432211 


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhH
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREE  160 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (202)
                       ......|++.|+|||.+.+..++.++|+||+||++|++++|..||.......  ....+....           .    
T Consensus       152 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~--~~~~i~~~~-----------~----  213 (320)
T cd05590         152 -TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDD--LFEAILNDE-----------V----  213 (320)
T ss_pred             -cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH--HHHHHhcCC-----------C----
Confidence             1223458899999999888888999999999999999999999997543221  111111000           0    


Q ss_pred             HHHHHhHHHHHHHHHHHhhhcCCCCCCCCCH
Q 037267          161 QAFAAKMDCIVSIMDLALDCCMESPGKRINM  191 (202)
Q Consensus       161 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~  191 (202)
                         ..+...+.++.+++.+||+.||++||++
T Consensus       214 ---~~~~~~~~~~~~li~~~L~~dP~~R~~~  241 (320)
T cd05590         214 ---VYPTWLSQDAVDILKAFMTKNPTMRLGS  241 (320)
T ss_pred             ---CCCCCCCHHHHHHHHHHcccCHHHCCCC
Confidence               0011245568899999999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=99.97  E-value=4.8e-31  Score=201.71  Aligned_cols=184  Identities=23%  Similarity=0.342  Sum_probs=134.3

Q ss_pred             CCCCcHHHHHhhcC----------CCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEccccc
Q 037267            1 MPNGSLEKWLYSYN----------YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGI   70 (202)
Q Consensus         1 ~~~gsL~~~l~~~~----------~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~   70 (202)
                      +++|+|.+++.+..          ..+++..+..++.|++.||.|||    +.+++|+||||+||+++.++.++++|||+
T Consensus       101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH----~~~i~H~dlkp~Nili~~~~~~~l~dfg~  176 (296)
T cd05095         101 MENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS----SLNFVHRDLATRNCLVGKNYTIKIADFGM  176 (296)
T ss_pred             CCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH----HCCeecccCChheEEEcCCCCEEeccCcc
Confidence            46899999997542          23677899999999999999999    89999999999999999999999999999


Q ss_pred             ceeccCCCccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh--CCCCCCcccccchhhHHHHHHhCCCCh
Q 037267           71 SKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT--RKRPTDEMFTGEMSLRRWVKESLPHGL  148 (202)
Q Consensus        71 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~--g~~p~~~~~~~~~~~~~~~~~~~~~~~  148 (202)
                      +............+....+..|++||...+..++.++|+||+||++|++++  |..||......... . ..........
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~-~-~~~~~~~~~~  254 (296)
T cd05095         177 SRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVI-E-NTGEFFRDQG  254 (296)
T ss_pred             cccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHHHH-H-HHHHHHhhcc
Confidence            876543322111222334677999997777788999999999999999998  67788654322211 0 0000000000


Q ss_pred             hhhhhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhh
Q 037267          149 TEVVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKK  200 (202)
Q Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~  200 (202)
                      ..          ...+.+..++..+.+++.+||+.||.+||++.++++.|++
T Consensus       255 ~~----------~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  296 (296)
T cd05095         255 RQ----------VYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE  296 (296)
T ss_pred             cc----------ccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            00          0001122355678999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=99.97  E-value=5.9e-31  Score=196.50  Aligned_cols=177  Identities=30%  Similarity=0.450  Sum_probs=135.5

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      +++++|.+++......++...+..++.+++.||.|||    +.+++|||++|+||+++.++.++++|||.+.........
T Consensus        74 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH----~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~  149 (251)
T cd05041          74 VPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLE----SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYT  149 (251)
T ss_pred             CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----hCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcce
Confidence            4689999999865556899999999999999999999    899999999999999999999999999998765422211


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhh
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVRE  159 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (202)
                      ........+..|+|||.+.+..++.++|+||+|+++|++++ |..||.......  ....+....               
T Consensus       150 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~--~~~~~~~~~---------------  212 (251)
T cd05041         150 VSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ--TRERIESGY---------------  212 (251)
T ss_pred             eccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH--HHHHHhcCC---------------
Confidence            11112223556999998888888999999999999999998 788886543211  111111100               


Q ss_pred             HHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhh
Q 037267          160 EQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKK  200 (202)
Q Consensus       160 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~  200 (202)
                        ....+..++.++.+++.+||..+|.+||++.|+++.|+.
T Consensus       213 --~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~  251 (251)
T cd05041         213 --RMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQI  251 (251)
T ss_pred             --CCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence              001122345679999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=99.97  E-value=1.1e-30  Score=203.02  Aligned_cols=187  Identities=20%  Similarity=0.200  Sum_probs=130.5

Q ss_pred             CCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc-c
Q 037267            3 NGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF-V   81 (202)
Q Consensus         3 ~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~-~   81 (202)
                      +++|.+++.... .+++..+..++.|++.||.|||    +.+|+||||||+||+++.++.++|+|||++......... .
T Consensus        87 ~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH----~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~  161 (338)
T cd07859          87 ESDLHQVIKAND-DLTPEHHQFFLYQLLRALKYIH----TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAI  161 (338)
T ss_pred             CCCHHHHHHhcc-cCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHeEECCCCcEEEccCccccccccccCccc
Confidence            578999987644 4899999999999999999999    899999999999999999999999999998754322111 1


Q ss_pred             cccCCCCCccccCCCCCCC--CCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhh----hh
Q 037267           82 TQTMTMATIGYMAPEYGSE--GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVD----AN  155 (202)
Q Consensus        82 ~~~~~~~~~~~~~pe~~~~--~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~  155 (202)
                      ......++..|+|||...+  ..++.++|+||+||++|++++|+.||........  ...+.............    ..
T Consensus       162 ~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~i~~~~  239 (338)
T cd07859         162 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQ--LDLITDLLGTPSPETISRVRNEK  239 (338)
T ss_pred             cccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHH--HHHHHHHhCCCCHHHHHHhhhhh
Confidence            1123468899999997654  5678899999999999999999999975432111  01111100000000000    00


Q ss_pred             h-------h-hhH-HHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          156 L-------V-REE-QAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       156 ~-------~-~~~-~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                      .       . ... .........+..+.+++.+||..||++|||+.|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~  289 (338)
T cd07859         240 ARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA  289 (338)
T ss_pred             HHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence            0       0 000 000011124566889999999999999999999874

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=99.97  E-value=3.4e-31  Score=200.01  Aligned_cols=175  Identities=29%  Similarity=0.428  Sum_probs=132.4

Q ss_pred             CCCCcHHHHHhhcC---------------CCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEE
Q 037267            1 MPNGSLEKWLYSYN---------------YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHV   65 (202)
Q Consensus         1 ~~~gsL~~~l~~~~---------------~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l   65 (202)
                      +++|+|.+++....               ..+++..+..++.|++.||+|||    +.+++|+||||+||+++.++.+++
T Consensus        78 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH----~~~i~H~dikp~nili~~~~~~kl  153 (270)
T cd05047          78 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS----QKQFIHRDLAARNILVGENYVAKI  153 (270)
T ss_pred             CCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH----HCCEeecccccceEEEcCCCeEEE
Confidence            47899999997532               24789999999999999999999    899999999999999999999999


Q ss_pred             cccccceeccCCCccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhC
Q 037267           66 SDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESL  144 (202)
Q Consensus        66 ~d~g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~  144 (202)
                      +|||++......   ........+..|+|||+..+..++.++|+||+|+++|++++ |..||.......  ....+....
T Consensus       154 ~dfgl~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~--~~~~~~~~~  228 (270)
T cd05047         154 ADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE--LYEKLPQGY  228 (270)
T ss_pred             CCCCCccccchh---hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH--HHHHHhCCC
Confidence            999997532211   11111223557999998888888999999999999999997 999986532111  111111000


Q ss_pred             CCChhhhhhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          145 PHGLTEVVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                                       ..+.+..++.++.+++.+||..+|.+|||+.++++.|..+
T Consensus       229 -----------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~  268 (270)
T cd05047         229 -----------------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  268 (270)
T ss_pred             -----------------CCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence                             0001123445689999999999999999999999999765

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=1.3e-31  Score=208.18  Aligned_cols=174  Identities=21%  Similarity=0.227  Sum_probs=133.6

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |+||+|.+++.... .+++..+..++.|++.||.|||    +.+++||||||+||+++.++.++|+|||++.....    
T Consensus        83 ~~g~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH----~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~----  153 (333)
T cd05600          83 VPGGDFRTLLNNLG-VLSEDHARFYMAEMFEAVDALH----ELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT----  153 (333)
T ss_pred             CCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCccccCCCHHHEEECCCCCEEEEeCcCCccccc----
Confidence            57999999997644 4899999999999999999999    89999999999999999999999999999876443    


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhH
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREE  160 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (202)
                       ......+++.|+|||.+.+..++.++|+||+||++|++++|..||......+. .. .+.....     ........  
T Consensus       154 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~-~~-~i~~~~~-----~~~~~~~~--  223 (333)
T cd05600         154 -YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNET-WE-NLKYWKE-----TLQRPVYD--  223 (333)
T ss_pred             -ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHH-HH-HHHhccc-----cccCCCCC--
Confidence             11234688999999998888899999999999999999999999975432211 11 1110000     00000000  


Q ss_pred             HHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          161 QAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       161 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                         .....++.++.+++.+||..+|.+||++.++++
T Consensus       224 ---~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~  256 (333)
T cd05600         224 ---DPRFNLSDEAWDLITKLINDPSRRFGSLEDIKN  256 (333)
T ss_pred             ---ccccccCHHHHHHHHHHhhChhhhcCCHHHHHh
Confidence               000234667899999999999999999999885

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=99.97  E-value=1.5e-30  Score=202.86  Aligned_cols=163  Identities=27%  Similarity=0.424  Sum_probs=123.7

Q ss_pred             CCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCccccccCCCCCccccCCC
Q 037267           17 FDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPE   96 (202)
Q Consensus        17 l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~pe   96 (202)
                      +++..+..++.|++.||.|||    +.+++||||||.||+++.++.++++|||++................++..|++||
T Consensus       176 ~~~~~~~~~~~qi~~al~~lH----~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE  251 (343)
T cd05103         176 LTLEDLICYSFQVAKGMEFLA----SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE  251 (343)
T ss_pred             CCHHHHHHHHHHHHHHHHHHH----hCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCcceECcH
Confidence            678889999999999999999    8999999999999999999999999999987654332222222233456799999


Q ss_pred             CCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhHHHHHHhHHHHHHHHH
Q 037267           97 YGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMD  175 (202)
Q Consensus        97 ~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  175 (202)
                      ...+..++.++|+||+|+++|++++ |..||........ +.........                 ...+...++++.+
T Consensus       252 ~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~-~~~~~~~~~~-----------------~~~~~~~~~~~~~  313 (343)
T cd05103         252 TIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-FCRRLKEGTR-----------------MRAPDYTTPEMYQ  313 (343)
T ss_pred             HhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH-HHHHHhccCC-----------------CCCCCCCCHHHHH
Confidence            8888888999999999999999996 8899865432211 1111111100                 0001113346899


Q ss_pred             HHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          176 LALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       176 l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                      ++..||..+|++|||+.++++.|+.+
T Consensus       314 ~~~~cl~~~p~~Rps~~eil~~l~~~  339 (343)
T cd05103         314 TMLDCWHGEPSQRPTFSELVEHLGNL  339 (343)
T ss_pred             HHHHHccCChhhCcCHHHHHHHHHHH
Confidence            99999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=99.97  E-value=8.2e-31  Score=197.18  Aligned_cols=177  Identities=28%  Similarity=0.447  Sum_probs=136.7

Q ss_pred             CCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCc
Q 037267            1 MPNGSLEKWLYSYN-YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED   79 (202)
Q Consensus         1 ~~~gsL~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~   79 (202)
                      +++|+|.+++.... ..+++..+..++.|++.||.|||    +.+++|+|+||.||+++.++.++++|||.+........
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH----~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~  157 (262)
T cd05071          82 MSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE----RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY  157 (262)
T ss_pred             CCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHH----HCCccccccCcccEEEcCCCcEEeccCCceeecccccc
Confidence            47899999998643 35899999999999999999999    89999999999999999999999999999976543322


Q ss_pred             cccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhh
Q 037267           80 FVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVR  158 (202)
Q Consensus        80 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (202)
                      . ......++..|++||...+..++.++|+||+|+++|++++ |..||........  ...+....              
T Consensus       158 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~--~~~~~~~~--------------  220 (262)
T cd05071         158 T-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV--LDQVERGY--------------  220 (262)
T ss_pred             c-cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHH--HHHHhcCC--------------
Confidence            1 1122335667999998888888999999999999999999 8888865432211  00000000              


Q ss_pred             hHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          159 EEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       159 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                         ..+....++..+.+++.+||..+|++||+++++++.|+.+
T Consensus       221 ---~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         221 ---RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             ---CCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence               0011123566789999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=99.97  E-value=2.6e-31  Score=216.95  Aligned_cols=177  Identities=24%  Similarity=0.296  Sum_probs=136.9

Q ss_pred             CCCCcHHHHHhhc-CCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCc
Q 037267            1 MPNGSLEKWLYSY-NYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED   79 (202)
Q Consensus         1 ~~~gsL~~~l~~~-~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~   79 (202)
                      |+||+|-|++.+. ...|++.++++|+.|+|+||.+||..  ...|+|||||.+|+|+..++..||||||.+........
T Consensus       124 C~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~--~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~~~~~  201 (738)
T KOG1989|consen  124 CKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL--KPPIIHRDLKIENVLLSADGNYKLCDFGSATTKILSPT  201 (738)
T ss_pred             ccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC--CCccchhhhhhhheEEcCCCCEEeCcccccccccCCCc
Confidence            7899999999843 22399999999999999999999943  34599999999999999999999999999875332221


Q ss_pred             ------cccccC-CCCCccccCCCC---CCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChh
Q 037267           80 ------FVTQTM-TMATIGYMAPEY---GSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLT  149 (202)
Q Consensus        80 ------~~~~~~-~~~~~~~~~pe~---~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  149 (202)
                            ...... ..-|+.|++||+   ..+..++.|+|||++||++|.+.....||+..-.                 .
T Consensus       202 ~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~-----------------l  264 (738)
T KOG1989|consen  202 SAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK-----------------L  264 (738)
T ss_pred             cHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc-----------------e
Confidence                  001111 235889999995   4567899999999999999999999999976311                 1


Q ss_pred             hhhhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          150 EVVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                      .++..+     ...+.....+..+.+||..||+.||.+||++.++++.+.++
T Consensus       265 aIlng~-----Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l  311 (738)
T KOG1989|consen  265 AILNGN-----YSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFEL  311 (738)
T ss_pred             eEEecc-----ccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHH
Confidence            111111     11222245677799999999999999999999999988765

>PTZ00284 protein kinase; Provisional

Probab=99.97  E-value=7.6e-31  Score=212.23  Aligned_cols=184  Identities=22%  Similarity=0.228  Sum_probs=128.7

Q ss_pred             CCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCC-CCeeecCCCCCceeeCCCC----------------ceEE
Q 037267            3 NGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSS-APIIHCDLKPTNILLDENM----------------VAHV   65 (202)
Q Consensus         3 ~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~-~~i~h~dlk~~nil~~~~~----------------~~~l   65 (202)
                      +++|.+++.+.. .+++..+..++.|++.||.|||    + .+|+||||||+|||++.++                .+||
T Consensus       215 g~~l~~~l~~~~-~l~~~~~~~i~~qi~~aL~yLH----~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~vkl  289 (467)
T PTZ00284        215 GPCLLDWIMKHG-PFSHRHLAQIIFQTGVALDYFH----TELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRI  289 (467)
T ss_pred             CCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----hcCCeecCCCCHHHEEEecCCcccccccccccCCCCceEEE
Confidence            688999997654 4899999999999999999999    6 5999999999999998655                4899


Q ss_pred             cccccceeccCCCccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchh-hHHHHHHhC
Q 037267           66 SDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMS-LRRWVKESL  144 (202)
Q Consensus        66 ~d~g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~-~~~~~~~~~  144 (202)
                      +|||.+......     .....+++.|+|||++.+..++.++|+||+||++|+|++|+.||......+.. .........
T Consensus       290 ~DfG~~~~~~~~-----~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~  364 (467)
T PTZ00284        290 CDLGGCCDERHS-----RTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRL  364 (467)
T ss_pred             CCCCccccCccc-----cccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCC
Confidence            999987543221     22346899999999999889999999999999999999999999764322110 000000001


Q ss_pred             CCChh---------hhhh----------hhhhhh-HH-HHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          145 PHGLT---------EVVD----------ANLVRE-EQ-AFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       145 ~~~~~---------~~~~----------~~~~~~-~~-~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                      +..+.         .+..          ...... .. ...........+.+|+.+||.+||++|||+.|+++
T Consensus       365 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~  437 (467)
T PTZ00284        365 PSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTT  437 (467)
T ss_pred             CHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhc
Confidence            10000         0000          000000 00 00000112355789999999999999999999986

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=99.97  E-value=1.7e-31  Score=207.31  Aligned_cols=172  Identities=25%  Similarity=0.206  Sum_probs=129.9

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |++|+|.+++.... .+++..+..++.|++.||.|||    +.+|+||||||+||+++.++.++|+|||++.........
T Consensus        87 ~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH----~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~~  161 (332)
T cd05614          87 VSGGEMFTHLYQRD-NFSEDEVRFYSGEIILALEHLH----KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKE  161 (332)
T ss_pred             CCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccCCC
Confidence            57899999997644 4899999999999999999999    899999999999999999999999999998765432221


Q ss_pred             ccccCCCCCccccCCCCCCCC-CcCcchhhhhHHHHHHHHHhCCCCCCcccccch--hhHHHHHHhCCCChhhhhhhhhh
Q 037267           81 VTQTMTMATIGYMAPEYGSEG-IVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEM--SLRRWVKESLPHGLTEVVDANLV  157 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~-~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  157 (202)
                      . .....|+..|+|||.+.+. .++.++|+||+||++|++++|..||........  .+...+....             
T Consensus       162 ~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~-------------  227 (332)
T cd05614         162 R-TYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCD-------------  227 (332)
T ss_pred             c-cccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCC-------------
Confidence            1 1224588999999987764 467889999999999999999999965322211  0111000000             


Q ss_pred             hhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHH
Q 037267          158 REEQAFAAKMDCIVSIMDLALDCCMESPGKRI-----NMTDAAA  196 (202)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rp-----s~~~~~~  196 (202)
                           ...+...+..+.+++.+||..||++||     ++.++++
T Consensus       228 -----~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  266 (332)
T cd05614         228 -----PPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE  266 (332)
T ss_pred             -----CCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence                 001123455688999999999999999     6666653

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=99.97  E-value=8.7e-32  Score=201.17  Aligned_cols=185  Identities=24%  Similarity=0.225  Sum_probs=136.0

Q ss_pred             CcHHHHHhh---cCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCC-CceEEcccccceeccCCCc
Q 037267            4 GSLEKWLYS---YNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN-MVAHVSDFGISKLLGEGED   79 (202)
Q Consensus         4 gsL~~~l~~---~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~-~~~~l~d~g~~~~~~~~~~   79 (202)
                      .+|.++++.   .+..++...+.-++.||++||.|||    +++|+||||||+|+|+|.+ |.+||+|||.|+.......
T Consensus       106 ~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh----~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~ep  181 (364)
T KOG0658|consen  106 ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLH----SHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEP  181 (364)
T ss_pred             HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHH----hcCcccCCCChheEEEcCCCCeEEeccCCcceeeccCCC
Confidence            367777773   2456888999999999999999999    8999999999999999955 8999999999998876654


Q ss_pred             cccccCCCCCccccCCCCCCCC-CcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHH-HHhCCCC---------h
Q 037267           80 FVTQTMTMATIGYMAPEYGSEG-IVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWV-KESLPHG---------L  148 (202)
Q Consensus        80 ~~~~~~~~~~~~~~~pe~~~~~-~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~---------~  148 (202)
                      .   .....++.|+|||.+.|. .|+.+.|+||.||++.||+.|++.|.+....+. +...+ .-+.|..         .
T Consensus       182 n---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQ-L~eIik~lG~Pt~e~I~~mn~~y  257 (364)
T KOG0658|consen  182 N---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQ-LVEIIKVLGTPTREDIKSMNPNY  257 (364)
T ss_pred             c---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHH-HHHHHHHhCCCCHHHHhhcCccc
Confidence            3   335688999999977764 689999999999999999999999987433222 22111 1111110         0


Q ss_pred             hhhhhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          149 TEVVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                      .+...+.+....+..-.....+++..+++.+++.++|.+|.++.|++.
T Consensus       258 ~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~  305 (364)
T KOG0658|consen  258 TEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA  305 (364)
T ss_pred             ccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence            011111111111111233467778999999999999999999998874

>PTZ00036 glycogen synthase kinase; Provisional

Probab=99.97  E-value=6.1e-31  Score=211.09  Aligned_cols=186  Identities=20%  Similarity=0.193  Sum_probs=130.0

Q ss_pred             CCcHHHHHhh---cCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCC-ceEEcccccceeccCCC
Q 037267            3 NGSLEKWLYS---YNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENM-VAHVSDFGISKLLGEGE   78 (202)
Q Consensus         3 ~gsL~~~l~~---~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~-~~~l~d~g~~~~~~~~~   78 (202)
                      .|+|.+++..   ....+++..+..++.|++.||.|||    +.+|+||||||+||+++.++ .+||+|||+++......
T Consensus       150 ~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH----~~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~  225 (440)
T PTZ00036        150 PQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH----SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQ  225 (440)
T ss_pred             CccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCEecCCcCHHHEEEcCCCCceeeeccccchhccCCC
Confidence            3577777753   3446899999999999999999999    89999999999999999654 69999999998654322


Q ss_pred             ccccccCCCCCccccCCCCCCC-CCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhh-------
Q 037267           79 DFVTQTMTMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTE-------  150 (202)
Q Consensus        79 ~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-------  150 (202)
                      .   .....+++.|+|||.+.+ ..++.++|+||+||++|+|++|..||......... ...+...-.+....       
T Consensus       226 ~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~-~~i~~~~~~p~~~~~~~~~~~  301 (440)
T PTZ00036        226 R---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQL-VRIIQVLGTPTEDQLKEMNPN  301 (440)
T ss_pred             C---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHHHHhCCCCHHHHHHhchh
Confidence            2   122457889999998765 36889999999999999999999999764332211 11111000000000       


Q ss_pred             ---hhhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          151 ---VVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       151 ---~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                         ...+...........+...+.++.+|+.+||.+||++|||+.|+++
T Consensus       302 ~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~  350 (440)
T PTZ00036        302 YADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA  350 (440)
T ss_pred             hhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence               0000001111111122345678999999999999999999999873

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=99.97  E-value=4.2e-31  Score=203.87  Aligned_cols=168  Identities=23%  Similarity=0.282  Sum_probs=130.0

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |++|+|.+++.... .+++..+..++.|++.||.|||    +.+|+||||||+||+++.++.++++|||++........ 
T Consensus        78 ~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~~l~~lH----~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-  151 (316)
T cd05620          78 LNGGDLMFHIQDKG-RFDLYRATFYAAEIVCGLQFLH----SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN-  151 (316)
T ss_pred             CCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCC-
Confidence            57899999997644 4899999999999999999999    89999999999999999999999999999875322111 


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhH
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREE  160 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (202)
                       ......|+..|+|||.+.+..++.++|+||+||++|++++|..||.......  ....+....+               
T Consensus       152 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~--~~~~~~~~~~---------------  213 (316)
T cd05620         152 -RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDE--LFESIRVDTP---------------  213 (316)
T ss_pred             -ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH--HHHHHHhCCC---------------
Confidence             1123457899999999888889999999999999999999999996543211  1111111100               


Q ss_pred             HHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHH-HHH
Q 037267          161 QAFAAKMDCIVSIMDLALDCCMESPGKRINMT-DAA  195 (202)
Q Consensus       161 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~-~~~  195 (202)
                         ..+..++.++.+++.+||+.||++||++. +++
T Consensus       214 ---~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         214 ---HYPRWITKESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             ---CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence               00112445688999999999999999974 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=99.97  E-value=2e-30  Score=195.29  Aligned_cols=179  Identities=22%  Similarity=0.269  Sum_probs=137.0

Q ss_pred             CCCCcHHHHHhh---cCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCC
Q 037267            1 MPNGSLEKWLYS---YNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEG   77 (202)
Q Consensus         1 ~~~gsL~~~l~~---~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~   77 (202)
                      +++++|.+++..   ....+++..+..++.|++.||.|||    +.+++|+||||.||+++.++.++++|||.+......
T Consensus        84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH----~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd08229          84 ADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH----SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK  159 (267)
T ss_pred             cCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHEEEcCCCCEEECcchhhhccccC
Confidence            468999999874   2345899999999999999999999    899999999999999999999999999998765433


Q ss_pred             CccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhh
Q 037267           78 EDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV  157 (202)
Q Consensus        78 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (202)
                      ...  .....++..|+|||...+..++.++|+||+|+++|++++|..||.............+....        ...  
T Consensus       160 ~~~--~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--------~~~--  227 (267)
T cd08229         160 TTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCD--------YPP--  227 (267)
T ss_pred             Ccc--cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCC--------CCC--
Confidence            221  12235778899999888888888999999999999999999998643222111111110000        000  


Q ss_pred             hhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          158 REEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                            ......+.++.+++.+||..+|++|||+.+|++.++++
T Consensus       228 ------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~  265 (267)
T cd08229         228 ------LPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM  265 (267)
T ss_pred             ------CCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence                  00123556799999999999999999999999998765

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=99.97  E-value=7e-31  Score=204.08  Aligned_cols=178  Identities=24%  Similarity=0.408  Sum_probs=135.6

Q ss_pred             CCCCcHHHHHhhcC---------------CCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEE
Q 037267            1 MPNGSLEKWLYSYN---------------YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHV   65 (202)
Q Consensus         1 ~~~gsL~~~l~~~~---------------~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l   65 (202)
                      +++|+|.+++....               ..+++..++.++.|++.||.|||    +.+++||||||+||+++.++.+++
T Consensus       100 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH----~~givH~dlkp~Nill~~~~~~kL  175 (334)
T cd05100         100 ASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA----SQKCIHRDLAARNVLVTEDNVMKI  175 (334)
T ss_pred             CCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH----HCCeeccccccceEEEcCCCcEEE
Confidence            47899999997532               24788999999999999999999    899999999999999999999999


Q ss_pred             cccccceeccCCCccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhC
Q 037267           66 SDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESL  144 (202)
Q Consensus        66 ~d~g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~  144 (202)
                      +|||+++...............++..|+|||...+..++.++|+||+|+++|++++ |..||.......  +...+....
T Consensus       176 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~~~~~~~~~  253 (334)
T cd05100         176 ADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE--LFKLLKEGH  253 (334)
T ss_pred             CCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHH--HHHHHHcCC
Confidence            99999876543322211222234567999999888888999999999999999998 888886542211  111111100


Q ss_pred             CCChhhhhhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          145 PHGLTEVVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                      .                 .+.+..++.++.+++.+||+.+|++|||+.++++.|+++
T Consensus       254 ~-----------------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~  293 (334)
T cd05100         254 R-----------------MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRV  293 (334)
T ss_pred             C-----------------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence            0                 011123455689999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=99.97  E-value=2.4e-31  Score=205.42  Aligned_cols=169  Identities=24%  Similarity=0.220  Sum_probs=131.7

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |+||+|.+++.+.. .+++..+..++.|++.||.|||    +.+++||||||.||+++.++.++++|||++.........
T Consensus        78 ~~~~~L~~~~~~~~-~l~~~~~~~~~~qi~~~l~~LH----~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  152 (318)
T cd05570          78 VNGGDLMFHIQRSG-RFDEPRARFYAAEIVLGLQFLH----ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT  152 (318)
T ss_pred             CCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----hCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCc
Confidence            57999999997654 4899999999999999999999    899999999999999999999999999998653222111


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhH
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREE  160 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (202)
                        .....++..|+|||.+.+..++.++|+||+||++|++++|..||.......  ....+....           .    
T Consensus       153 --~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~--~~~~i~~~~-----------~----  213 (318)
T cd05570         153 --TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDE--LFQSILEDE-----------V----  213 (318)
T ss_pred             --ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHH--HHHHHHcCC-----------C----
Confidence              122357889999999988889999999999999999999999996543211  111111000           0    


Q ss_pred             HHHHHhHHHHHHHHHHHhhhcCCCCCCCCCH-----HHHHH
Q 037267          161 QAFAAKMDCIVSIMDLALDCCMESPGKRINM-----TDAAA  196 (202)
Q Consensus       161 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~-----~~~~~  196 (202)
                         ..+..++.++.+++.+||..||++|||+     .++++
T Consensus       214 ---~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~  251 (318)
T cd05570         214 ---RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG  251 (318)
T ss_pred             ---CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence               0112345668999999999999999999     77654

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=99.97  E-value=1.6e-31  Score=207.32  Aligned_cols=165  Identities=25%  Similarity=0.208  Sum_probs=129.6

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |++|+|.+++.+.. .+++..+..++.|++.||.|||    +.+|+||||||+||+++.++.++|+|||++.......  
T Consensus       100 ~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH----~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--  172 (329)
T PTZ00263        100 VVGGELFTHLRKAG-RFPNDVAKFYHAELVLAFEYLH----SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT--  172 (329)
T ss_pred             CCCChHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc--
Confidence            57899999998654 4899999999999999999999    8999999999999999999999999999998754322  


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhH
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREE  160 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (202)
                         ....+++.|+|||.+.+..++.++|+||+||++|++++|..||.......  ....+....           .    
T Consensus       173 ---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~--~~~~i~~~~-----------~----  232 (329)
T PTZ00263        173 ---FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFR--IYEKILAGR-----------L----  232 (329)
T ss_pred             ---ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHH--HHHHHhcCC-----------c----
Confidence               12357899999999888888999999999999999999999996532111  111111000           0    


Q ss_pred             HHHHHhHHHHHHHHHHHhhhcCCCCCCCCC-----HHHHH
Q 037267          161 QAFAAKMDCIVSIMDLALDCCMESPGKRIN-----MTDAA  195 (202)
Q Consensus       161 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps-----~~~~~  195 (202)
                         ..+...+..+.+++.+||..||++||+     +.+++
T Consensus       233 ---~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll  269 (329)
T PTZ00263        233 ---KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVK  269 (329)
T ss_pred             ---CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHh
Confidence               001123455789999999999999997     56665

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.97  E-value=1.8e-31  Score=190.44  Aligned_cols=171  Identities=24%  Similarity=0.300  Sum_probs=134.4

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeC---CCCceEEcccccceeccCC
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLD---ENMVAHVSDFGISKLLGEG   77 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~---~~~~~~l~d~g~~~~~~~~   77 (202)
                      |+||+|..-|-.. ..+++..+.+.++||+.+|.|+|    ..+|||||+||.|+++.   +...+|++|||++..+..+
T Consensus        92 m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH----~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g  166 (355)
T KOG0033|consen   92 VTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCH----SNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDG  166 (355)
T ss_pred             ccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHH----hcCceeccCChhheeeeeccCCCceeecccceEEEeCCc
Confidence            4677776666543 34789999999999999999999    99999999999999986   3446899999999988743


Q ss_pred             CccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhh
Q 037267           78 EDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV  157 (202)
Q Consensus        78 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (202)
                      .-   ...+.|+|.|++||++...+++.++|||+.|+++|-++.|..||.+.+...  +.+.+..+.             
T Consensus       167 ~~---~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~r--lye~I~~g~-------------  228 (355)
T KOG0033|consen  167 EA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR--LYEQIKAGA-------------  228 (355)
T ss_pred             cc---cccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHH--HHHHHhccc-------------
Confidence            32   334679999999999999999999999999999999999999997643222  111221111             


Q ss_pred             hhHH-HHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          158 REEQ-AFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       158 ~~~~-~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                        .. ..+.....+++..+|+.+||..||++|+|+.|+++
T Consensus       229 --yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~  266 (355)
T KOG0033|consen  229 --YDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK  266 (355)
T ss_pred             --cCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence              11 11233567778999999999999999999999864

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=99.97  E-value=7.9e-31  Score=203.72  Aligned_cols=121  Identities=28%  Similarity=0.348  Sum_probs=103.5

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |++|+|.+++.... .+++..+..++.|++.||.|||.   ..+++|+||||+||+++.++.++++|||++.......  
T Consensus        85 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~lH~---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~--  158 (333)
T cd06650          85 MDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLRE---KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--  158 (333)
T ss_pred             CCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHh---cCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc--
Confidence            57899999998644 48999999999999999999993   2479999999999999999999999999987543321  


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcc
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEM  129 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~  129 (202)
                        .....++..|+|||...+..++.++|+||+||++|++++|..||...
T Consensus       159 --~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~  205 (333)
T cd06650         159 --ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP  205 (333)
T ss_pred             --cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence              12235788999999988888899999999999999999999999754

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=99.97  E-value=7e-31  Score=197.95  Aligned_cols=178  Identities=28%  Similarity=0.491  Sum_probs=138.2

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      +++|+|.+++......+++.++..++.|++.||.|||    +.+++|+|+||+||+++.++.++++|||++.........
T Consensus        87 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH----~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~  162 (267)
T cd05066          87 MENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLS----DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA  162 (267)
T ss_pred             CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCEeehhhchhcEEECCCCeEEeCCCCcccccccccce
Confidence            4789999999876666899999999999999999999    899999999999999999999999999999876543221


Q ss_pred             cc-ccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhh
Q 037267           81 VT-QTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVR  158 (202)
Q Consensus        81 ~~-~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (202)
                      .. ......+..|++||...+..++.++|+||+|+++|++++ |..||......+  ....+....              
T Consensus       163 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~--~~~~~~~~~--------------  226 (267)
T cd05066         163 AYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD--VIKAIEEGY--------------  226 (267)
T ss_pred             eeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH--HHHHHhCCC--------------
Confidence            11 111223457999999888888999999999999999886 999986643221  111111100              


Q ss_pred             hHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          159 EEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       159 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                         ..+.+..++..+.+++.+||.++|++||++.++++.|+++
T Consensus       227 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         227 ---RLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             ---cCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence               0011123456688999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=99.97  E-value=2.3e-31  Score=205.73  Aligned_cols=169  Identities=22%  Similarity=0.206  Sum_probs=131.1

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |++|+|.+++.... .+++..+..++.|++.||.|||    +.+|+||||||+||+++.++.++|+|||++.........
T Consensus        78 ~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH----~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~  152 (321)
T cd05591          78 VNGGDLMFQIQRSR-KFDEPRSRFYAAEVTLALMFLH----RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT  152 (321)
T ss_pred             CCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeeccCCCHHHeEECCCCCEEEeecccceecccCCcc
Confidence            57899999997654 4899999999999999999999    899999999999999999999999999998754322211


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhH
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREE  160 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (202)
                        .....+++.|+|||.+.+..++.++|+||+||++|++++|..||....... ... .+...           ..    
T Consensus       153 --~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~-~~~-~i~~~-----------~~----  213 (321)
T cd05591         153 --TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD-LFE-SILHD-----------DV----  213 (321)
T ss_pred             --ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHH-HHH-HHHcC-----------CC----
Confidence              123457899999999888888999999999999999999999997543211 111 11000           00    


Q ss_pred             HHHHHhHHHHHHHHHHHhhhcCCCCCCCC-------CHHHHHH
Q 037267          161 QAFAAKMDCIVSIMDLALDCCMESPGKRI-------NMTDAAA  196 (202)
Q Consensus       161 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rp-------s~~~~~~  196 (202)
                         ..+..++.++.+++.+||..||++||       ++.++++
T Consensus       214 ---~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~  253 (321)
T cd05591         214 ---LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ  253 (321)
T ss_pred             ---CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence               00112345688999999999999999       6777653

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.97  E-value=4.4e-31  Score=200.37  Aligned_cols=194  Identities=24%  Similarity=0.353  Sum_probs=140.3

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      +++|+|.+++......+++..+..++.|++.||.|||    +.+++|+|+||.||+++.++.++++|||.+.........
T Consensus        90 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH----~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~  165 (284)
T cd05038          90 LPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLG----SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDY  165 (284)
T ss_pred             CCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHhEEEcCCCCEEEcccccccccccCCcc
Confidence            4689999999876656899999999999999999999    899999999999999999999999999999876533221


Q ss_pred             c-cccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhh
Q 037267           81 V-TQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVRE  159 (202)
Q Consensus        81 ~-~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (202)
                      . ......++..|.+||...+..++.++|+||+|++++++++|..|+.............   .............+.. 
T Consensus       166 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~-  241 (284)
T cd05038         166 YYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGI---AQGQMIVTRLLELLKE-  241 (284)
T ss_pred             eeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcccccc---ccccccHHHHHHHHHc-
Confidence            1 1111234556899998877788899999999999999999999876533221110000   0000000000000000 


Q ss_pred             HHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhcC
Q 037267          160 EQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKIK  202 (202)
Q Consensus       160 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l~  202 (202)
                      ....+.+..++.++.+++.+||..+|++|||+.|+++.|+++.
T Consensus       242 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i~  284 (284)
T cd05038         242 GERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR  284 (284)
T ss_pred             CCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhcC
Confidence            0011112345677999999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=99.97  E-value=6.7e-31  Score=194.55  Aligned_cols=187  Identities=22%  Similarity=0.230  Sum_probs=138.4

Q ss_pred             CcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCccccc
Q 037267            4 GSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQ   83 (202)
Q Consensus         4 gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~   83 (202)
                      .+|...+.+.+.+|+..++..++.|+++|++|||    ...|+|||||++|+|+...|.+||+|||+|+.++.+..  ..
T Consensus       161 hDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH----~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k--~~  234 (419)
T KOG0663|consen  161 HDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLH----DNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLK--PY  234 (419)
T ss_pred             hhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHh----hceeEecccchhheeeccCCcEEecccchhhhhcCCcc--cC
Confidence            4677788887878999999999999999999999    99999999999999999999999999999999876533  22


Q ss_pred             cCCCCCccccCCCCCCCC-CcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCC-----Chhhhhhhh-h
Q 037267           84 TMTMATIGYMAPEYGSEG-IVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPH-----GLTEVVDAN-L  156 (202)
Q Consensus        84 ~~~~~~~~~~~pe~~~~~-~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~-~  156 (202)
                      +...-|.+|.|||.+.+. .|+++.||||+|||+.|++.+.+-|.+..+-+..-.-+..-+.|.     +...+...+ .
T Consensus       235 T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~  314 (419)
T KOG0663|consen  235 TPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKM  314 (419)
T ss_pred             cceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhcc
Confidence            334568899999987775 589999999999999999999988877554333222222222221     111111100 0


Q ss_pred             --hh-hH-HHHHHhH--HHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          157 --VR-EE-QAFAAKM--DCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       157 --~~-~~-~~~~~~~--~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                        .. +. .......  ..++..++|+..++.+||++|.||.|.++
T Consensus       315 ~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~  360 (419)
T KOG0663|consen  315 TFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK  360 (419)
T ss_pred             ccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence              00 00 0001111  14577899999999999999999999874

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=99.97  E-value=3e-31  Score=205.40  Aligned_cols=164  Identities=23%  Similarity=0.267  Sum_probs=127.8

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |+||+|.+++.... .+++..+..++.|++.||.|||    +.+|+||||||+||+++.++.++++|||++........ 
T Consensus        83 ~~~g~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~lH----~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~-  156 (324)
T cd05587          83 VNGGDLMYHIQQVG-KFKEPHAVFYAAEIAIGLFFLH----SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK-  156 (324)
T ss_pred             CCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCC-
Confidence            57999999997654 4899999999999999999999    89999999999999999999999999999875322111 


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhH
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREE  160 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (202)
                       ......|++.|+|||++.+..++.++|+||+||++|++++|..||........  ...+....           .    
T Consensus       157 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~--~~~i~~~~-----------~----  218 (324)
T cd05587         157 -TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL--FQSIMEHN-----------V----  218 (324)
T ss_pred             -ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH--HHHHHcCC-----------C----
Confidence             11223578999999999888889999999999999999999999975432111  11111000           0    


Q ss_pred             HHHHHhHHHHHHHHHHHhhhcCCCCCCCCCH
Q 037267          161 QAFAAKMDCIVSIMDLALDCCMESPGKRINM  191 (202)
Q Consensus       161 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~  191 (202)
                         ..+...+.++.+++.+||..||++|+++
T Consensus       219 ---~~~~~~~~~~~~li~~~l~~~P~~R~~~  246 (324)
T cd05587         219 ---SYPKSLSKEAVSICKGLLTKHPAKRLGC  246 (324)
T ss_pred             ---CCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence               0012245568899999999999999976

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=99.97  E-value=1.9e-30  Score=195.76  Aligned_cols=180  Identities=22%  Similarity=0.304  Sum_probs=129.4

Q ss_pred             CCCCcHHHHHhhcC----CCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccC
Q 037267            1 MPNGSLEKWLYSYN----YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGE   76 (202)
Q Consensus         1 ~~~gsL~~~l~~~~----~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~   76 (202)
                      |++|+|.+++....    ...++..+..++.|++.||.|||    +.+++|+|+||.||+++.++.++++|||.+.....
T Consensus        77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH----~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~  152 (269)
T cd05087          77 CPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH----KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYK  152 (269)
T ss_pred             CCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH----HCCEeccccCcceEEEcCCCcEEECCccccccccC
Confidence            57899999997532    23567788899999999999999    89999999999999999999999999999875443


Q ss_pred             CCccccccCCCCCccccCCCCCCCC-------CcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhCCCCh
Q 037267           77 GEDFVTQTMTMATIGYMAPEYGSEG-------IVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGL  148 (202)
Q Consensus        77 ~~~~~~~~~~~~~~~~~~pe~~~~~-------~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~  148 (202)
                      ...........++..|+|||+..+.       .++.++|+||+|+++|++++ |..||......+. ....+....    
T Consensus       153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~-~~~~~~~~~----  227 (269)
T cd05087         153 EDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV-LTYTVREQQ----  227 (269)
T ss_pred             cceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH-HHHHhhccc----
Confidence            3222222233467789999976432       35778999999999999996 9999976543221 111111000    


Q ss_pred             hhhhhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHh
Q 037267          149 TEVVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLK  199 (202)
Q Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~  199 (202)
                      .....+..         ....+..+.+++..|| .+|++|||+++|+..|+
T Consensus       228 ~~~~~~~~---------~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         228 LKLPKPRL---------KLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             CCCCCCcc---------CCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            00000000         0123445788999999 68999999999999875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=99.97  E-value=3.8e-31  Score=204.74  Aligned_cols=169  Identities=24%  Similarity=0.267  Sum_probs=130.8

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |++|+|.+++.... .+++..+..++.|++.||.|||    +.+|+||||||+||+++.++.++|+|||++.........
T Consensus        82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH----~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  156 (323)
T cd05584          82 LSGGELFMHLEREG-IFMEDTACFYLSEISLALEHLH----QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTV  156 (323)
T ss_pred             CCCchHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCc
Confidence            57899999997654 4788999999999999999999    899999999999999999999999999998754322211


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhH
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREE  160 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (202)
                        .....+++.|+|||.+.+..++.++|+||+|+++|++++|..||....... .... +.           ...     
T Consensus       157 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~-~~~~-~~-----------~~~-----  216 (323)
T cd05584         157 --THTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKK-TIDK-IL-----------KGK-----  216 (323)
T ss_pred             --ccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHH-HHHH-HH-----------cCC-----
Confidence              122458899999999888888899999999999999999999996532211 0110 00           000     


Q ss_pred             HHHHHhHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHH
Q 037267          161 QAFAAKMDCIVSIMDLALDCCMESPGKRI-----NMTDAAA  196 (202)
Q Consensus       161 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rp-----s~~~~~~  196 (202)
                        ...+..++.++.+++.+||..||++||     ++.++++
T Consensus       217 --~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         217 --LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             --CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence              001122455688999999999999999     6777654

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=99.97  E-value=9.4e-31  Score=197.41  Aligned_cols=178  Identities=26%  Similarity=0.478  Sum_probs=136.3

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      +++|+|.+++......+++..++.++.|++.||.|||    +.+++|+|+||+||+++.++.++++|||++.........
T Consensus        87 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH----~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~  162 (269)
T cd05065          87 MENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLS----EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSD  162 (269)
T ss_pred             CCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH----HCCEeecccChheEEEcCCCcEEECCCccccccccCccc
Confidence            4689999999876666899999999999999999999    899999999999999999999999999998765432211


Q ss_pred             ccccC---CCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhCCCChhhhhhhhh
Q 037267           81 VTQTM---TMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANL  156 (202)
Q Consensus        81 ~~~~~---~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (202)
                      .....   ...+..|++||...+..++.++|+||+|+++|++++ |..||.......  ....+....            
T Consensus       163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~--~~~~i~~~~------------  228 (269)
T cd05065         163 PTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD--VINAIEQDY------------  228 (269)
T ss_pred             cccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH--HHHHHHcCC------------
Confidence            11111   112346999999888888999999999999999886 999986543211  111111000            


Q ss_pred             hhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          157 VREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                           ..+.+..++..+.+++.+||..+|.+||++.+++..|+++
T Consensus       229 -----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         229 -----RLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             -----cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                 0111224556788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=99.97  E-value=7.4e-31  Score=199.26  Aligned_cols=174  Identities=24%  Similarity=0.261  Sum_probs=132.2

Q ss_pred             CCCCcHHHHHhh---cCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCC
Q 037267            1 MPNGSLEKWLYS---YNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEG   77 (202)
Q Consensus         1 ~~~gsL~~~l~~---~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~   77 (202)
                      |++|+|.+++..   .+..+++..+..++.|++.||.|||    +.+++||||||+||+++.++.++++|||.+......
T Consensus        75 ~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH----~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~  150 (280)
T cd05608          75 MNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH----QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDG  150 (280)
T ss_pred             CCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEEECCCCCEEEeeCccceecCCC
Confidence            579999998853   2345899999999999999999999    899999999999999999999999999998765443


Q ss_pred             CccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhh
Q 037267           78 EDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV  157 (202)
Q Consensus        78 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (202)
                      ...  .....+++.|+|||.+.+..++.++|+||+|+++|++++|..||........ .........        ...  
T Consensus       151 ~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~-~~~~~~~~~--------~~~--  217 (280)
T cd05608         151 QSK--TKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE-NKELKQRIL--------NDS--  217 (280)
T ss_pred             Ccc--ccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh-HHHHHHhhc--------ccC--
Confidence            221  1224578899999999888899999999999999999999999975332111 111111000        000  


Q ss_pred             hhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHH
Q 037267          158 REEQAFAAKMDCIVSIMDLALDCCMESPGKRI-----NMTDAAA  196 (202)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rp-----s~~~~~~  196 (202)
                           ...+..++.++.+++.+||..||++||     +++++++
T Consensus       218 -----~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~  256 (280)
T cd05608         218 -----VTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT  256 (280)
T ss_pred             -----CCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence                 011123556789999999999999999     5666653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=99.97  E-value=3.2e-31  Score=205.14  Aligned_cols=164  Identities=24%  Similarity=0.261  Sum_probs=128.9

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |++|+|.+++.... .+++..+..++.|++.||.|||    +.+|+||||||+||+++.++.++|+|||++........ 
T Consensus        83 ~~~g~L~~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH----~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~-  156 (323)
T cd05616          83 VNGGDLMYQIQQVG-RFKEPHAVFYAAEIAIGLFFLH----SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV-  156 (323)
T ss_pred             CCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCC-
Confidence            57899999997654 4899999999999999999999    89999999999999999999999999999875432211 


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhH
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREE  160 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (202)
                       ......|++.|+|||++.+..++.++|+||+||++|++++|..||.......  ....+....           .    
T Consensus       157 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~--~~~~i~~~~-----------~----  218 (323)
T cd05616         157 -TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE--LFQSIMEHN-----------V----  218 (323)
T ss_pred             -ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHH--HHHHHHhCC-----------C----
Confidence             1223458899999999988889999999999999999999999997543211  111111100           0    


Q ss_pred             HHHHHhHHHHHHHHHHHhhhcCCCCCCCCCH
Q 037267          161 QAFAAKMDCIVSIMDLALDCCMESPGKRINM  191 (202)
Q Consensus       161 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~  191 (202)
                         ..+...+.++.+++.+||+.||++|++.
T Consensus       219 ---~~p~~~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         219 ---AYPKSMSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             ---CCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence               0112345668999999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=99.97  E-value=1.2e-30  Score=194.77  Aligned_cols=175  Identities=26%  Similarity=0.409  Sum_probs=135.2

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      +++|+|.+++......+++..++.++.|++.+|.|+|    +.+++|+|++|+||+++.++.++++|||++.........
T Consensus        74 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH----~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~  149 (250)
T cd05085          74 VPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLE----SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS  149 (250)
T ss_pred             CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----hCCeeecccChheEEEcCCCeEEECCCccceeccccccc
Confidence            4789999999865556899999999999999999999    899999999999999999999999999998764432211


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhh
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVRE  159 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (202)
                       ......++..|+|||+..+..++.++|+||+|+++|++++ |..||.......  ....+.....              
T Consensus       150 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~--~~~~~~~~~~--------------  212 (250)
T cd05085         150 -SSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ--AREQVEKGYR--------------  212 (250)
T ss_pred             -cCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH--HHHHHHcCCC--------------
Confidence             1111234567999998888888999999999999999998 999986543221  1111111100              


Q ss_pred             HHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHh
Q 037267          160 EQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLK  199 (202)
Q Consensus       160 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~  199 (202)
                         ...+..++..+.+++.+||..+|++||++.++.+.|.
T Consensus       213 ---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         213 ---MSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             ---CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence               0001224566899999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=99.97  E-value=2.4e-31  Score=208.62  Aligned_cols=167  Identities=26%  Similarity=0.341  Sum_probs=136.4

Q ss_pred             CCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcccc
Q 037267            3 NGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVT   82 (202)
Q Consensus         3 ~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~   82 (202)
                      -|+|..+|..... ++++.+..++.|+++||.|||    +.+|.|||+||.|||+++.+.+|++|||+++.+.....  .
T Consensus        84 ~g~L~~il~~d~~-lpEe~v~~~a~~LVsaL~yLh----s~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~--v  156 (808)
T KOG0597|consen   84 VGDLFTILEQDGK-LPEEQVRAIAYDLVSALYYLH----SNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTS--V  156 (808)
T ss_pred             hhhHHHHHHhccC-CCHHHHHHHHHHHHHHHHHHH----hcCcccccCCcceeeecCCCceeechhhhhhhcccCce--e
Confidence            3699999987555 999999999999999999999    99999999999999999999999999999998776432  2


Q ss_pred             ccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhHHH
Q 037267           83 QTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQA  162 (202)
Q Consensus        83 ~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (202)
                      .....||+.|+|||...+.+|+..+|+||+||++||+++|++||....     +.+++            ......+   
T Consensus       157 ltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s-----i~~Lv------------~~I~~d~---  216 (808)
T KOG0597|consen  157 LTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS-----ITQLV------------KSILKDP---  216 (808)
T ss_pred             eeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH-----HHHHH------------HHHhcCC---
Confidence            334569999999999999999999999999999999999999995421     11121            1111111   


Q ss_pred             HHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          163 FAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       163 ~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                      ...+...+..+..++...+.+||.+|.+..+++.
T Consensus       217 v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~  250 (808)
T KOG0597|consen  217 VKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG  250 (808)
T ss_pred             CCCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence            1112355666899999999999999999998864

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=99.97  E-value=4.5e-30  Score=193.24  Aligned_cols=179  Identities=22%  Similarity=0.293  Sum_probs=137.0

Q ss_pred             CCCCcHHHHHhhc---CCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCC
Q 037267            1 MPNGSLEKWLYSY---NYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEG   77 (202)
Q Consensus         1 ~~~gsL~~~l~~~---~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~   77 (202)
                      +++|+|.+++...   ...++...+..++.|++.||.|||    +.+++|+||+|+||+++.++.++++|||++......
T Consensus        84 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh----~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~  159 (267)
T cd08224          84 ADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH----SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK  159 (267)
T ss_pred             CCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHH----hCCEecCCcChhhEEECCCCcEEEeccceeeeccCC
Confidence            4789999998642   345899999999999999999999    899999999999999999999999999998765433


Q ss_pred             CccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhh
Q 037267           78 EDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV  157 (202)
Q Consensus        78 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (202)
                      ...  .....++..|.|||...+..++.++|+||+|+++|++++|..||......   ...............       
T Consensus       160 ~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~~-------  227 (267)
T cd08224         160 TTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN---LYSLCKKIEKCDYPP-------  227 (267)
T ss_pred             Ccc--cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc---HHHHHhhhhcCCCCC-------
Confidence            211  12235778899999888888899999999999999999999998643211   111111000000000       


Q ss_pred             hhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          158 REEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                            ......+..+.+++.+||..+|++|||+.++++.|+.+
T Consensus       228 ------~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~  265 (267)
T cd08224         228 ------LPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM  265 (267)
T ss_pred             ------CChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence                  00113455689999999999999999999999999876

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=99.97  E-value=5.1e-31  Score=203.43  Aligned_cols=168  Identities=25%  Similarity=0.310  Sum_probs=130.1

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |+||+|.+++.... .+++.++..++.|++.||.|||    +.+++||||||+||+++.++.++++|||++........ 
T Consensus        78 ~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~LH----~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-  151 (316)
T cd05619          78 LNGGDLMFHIQSCH-KFDLPRATFYAAEIICGLQFLH----SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA-  151 (316)
T ss_pred             CCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----hCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC-
Confidence            57999999998643 4899999999999999999999    89999999999999999999999999999875322211 


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhH
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREE  160 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (202)
                       ......++..|+|||.+.+..++.++|+||+||++|++++|..||.......  ....+....+               
T Consensus       152 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~--~~~~i~~~~~---------------  213 (316)
T cd05619         152 -KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE--LFQSIRMDNP---------------  213 (316)
T ss_pred             -ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhCCC---------------
Confidence             1122357899999999888889999999999999999999999997543211  1111110000               


Q ss_pred             HHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHH-HHH
Q 037267          161 QAFAAKMDCIVSIMDLALDCCMESPGKRINMT-DAA  195 (202)
Q Consensus       161 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~-~~~  195 (202)
                         ..+..++.++.+++.+||..||++||++. +++
T Consensus       214 ---~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05619         214 ---CYPRWLTREAKDILVKLFVREPERRLGVKGDIR  246 (316)
T ss_pred             ---CCCccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence               00112445688999999999999999996 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=99.97  E-value=1.1e-31  Score=207.80  Aligned_cols=169  Identities=20%  Similarity=0.192  Sum_probs=131.0

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCC-CCeeecCCCCCceeeCCCCceEEcccccceeccCCCc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSS-APIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED   79 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~-~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~   79 (202)
                      |+||+|.+++.... .+++..+..++.|++.||.|||    + .+|+||||||+||+++.++.++|+|||++........
T Consensus        77 ~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH----~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~  151 (325)
T cd05594          77 ANGGELFFHLSRER-VFSEDRARFYGAEIVSALDYLH----SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA  151 (325)
T ss_pred             CCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----hcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc
Confidence            57999999997644 4899999999999999999999    6 7999999999999999999999999999875432211


Q ss_pred             cccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhh
Q 037267           80 FVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVRE  159 (202)
Q Consensus        80 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (202)
                      .  .....+++.|+|||.+.+..++.++|+||+||++|++++|..||.......  ....+....               
T Consensus       152 ~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~--~~~~i~~~~---------------  212 (325)
T cd05594         152 T--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK--LFELILMEE---------------  212 (325)
T ss_pred             c--cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHH--HHHHHhcCC---------------
Confidence            1  122458899999999888888999999999999999999999996532211  111110000               


Q ss_pred             HHHHHHhHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHH
Q 037267          160 EQAFAAKMDCIVSIMDLALDCCMESPGKRI-----NMTDAAA  196 (202)
Q Consensus       160 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rp-----s~~~~~~  196 (202)
                         ...+...+.++.+++.+||..||++|+     ++.++++
T Consensus       213 ---~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~  251 (325)
T cd05594         213 ---IRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ  251 (325)
T ss_pred             ---CCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence               000122455688999999999999997     8888764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=99.97  E-value=6.9e-31  Score=199.13  Aligned_cols=176  Identities=21%  Similarity=0.300  Sum_probs=133.2

Q ss_pred             CCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCc
Q 037267            1 MPNGSLEKWLYSYN-YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED   79 (202)
Q Consensus         1 ~~~gsL~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~   79 (202)
                      ++||+|.+++.... ..+++..+..++.|++.||.|||    +.+++||||||+||+++.++.++++|||++........
T Consensus        75 ~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH----~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~  150 (277)
T cd05607          75 MNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLH----SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT  150 (277)
T ss_pred             CCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH----HCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCce
Confidence            47899999986543 35889999999999999999999    89999999999999999999999999999876544322


Q ss_pred             cccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhh
Q 037267           80 FVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVRE  159 (202)
Q Consensus        80 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (202)
                      .   ....++..|+|||...+..++.++|+||+||++|++++|..||......... ...........        ..  
T Consensus       151 ~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~-~~~~~~~~~~~--------~~--  216 (277)
T cd05607         151 I---TQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAK-EELKRRTLEDE--------VK--  216 (277)
T ss_pred             e---eccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhH-HHHHHHhhccc--------cc--
Confidence            1   2235788999999988888999999999999999999999999754322111 11111100000        00  


Q ss_pred             HHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 037267          160 EQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKL  198 (202)
Q Consensus       160 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l  198 (202)
                          ......+.++.+++.+||..||++||++.|+++.+
T Consensus       217 ----~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~  251 (277)
T cd05607         217 ----FEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDP  251 (277)
T ss_pred             ----cccccCCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence                00113456689999999999999999997766443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=99.97  E-value=6.7e-31  Score=200.12  Aligned_cols=177  Identities=25%  Similarity=0.434  Sum_probs=133.8

Q ss_pred             CCCCcHHHHHhhcC---------------------CCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCC
Q 037267            1 MPNGSLEKWLYSYN---------------------YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDE   59 (202)
Q Consensus         1 ~~~gsL~~~l~~~~---------------------~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~   59 (202)
                      +++|+|.+++....                     ..+++..++.++.|++.||.|||    +.+++||||||+||+++.
T Consensus        90 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH----~~~i~H~dl~p~nil~~~  165 (288)
T cd05050          90 MAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS----ERKFVHRDLATRNCLVGE  165 (288)
T ss_pred             CCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH----hCCeecccccHhheEecC
Confidence            47899999997431                     23788899999999999999999    899999999999999999


Q ss_pred             CCceEEcccccceeccCCCccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHH
Q 037267           60 NMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRR  138 (202)
Q Consensus        60 ~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~  138 (202)
                      ++.++++|||++.................+..|+|||...+..++.++|+||+|+++|++++ |..||......+  ...
T Consensus       166 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~--~~~  243 (288)
T cd05050         166 NMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE--VIY  243 (288)
T ss_pred             CCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHH
Confidence            99999999999876543322211222234567999998888888999999999999999997 888886533221  111


Q ss_pred             HHHHhCCCChhhhhhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhh
Q 037267          139 WVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKK  200 (202)
Q Consensus       139 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~  200 (202)
                      .+...           ..      ...+..++.++.+++.+||..+|++|||+.|+++.|++
T Consensus       244 ~~~~~-----------~~------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         244 YVRDG-----------NV------LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             HHhcC-----------CC------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence            11100           00      00112345678999999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=99.97  E-value=3.9e-31  Score=192.87  Aligned_cols=159  Identities=26%  Similarity=0.289  Sum_probs=130.8

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      .+||-|..++++... |++..+.-++.||+.||+|||    +.+|++|||||+|||++.+|.+||+|||+++.....   
T Consensus       126 v~GGElFS~Lrk~~r-F~e~~arFYAAeivlAleylH----~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r---  197 (355)
T KOG0616|consen  126 VPGGELFSYLRKSGR-FSEPHARFYAAEIVLALEYLH----SLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR---  197 (355)
T ss_pred             cCCccHHHHHHhcCC-CCchhHHHHHHHHHHHHHHHH----hcCeeeccCChHHeeeccCCcEEEEeccceEEecCc---
Confidence            379999999997665 999999999999999999999    999999999999999999999999999999986653   


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhH
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREE  160 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (202)
                        ..+..||+.|+|||++....++.++|.||||+++|||+.|..||.......  .-           ..++...+..  
T Consensus       198 --T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~--iY-----------~KI~~~~v~f--  260 (355)
T KOG0616|consen  198 --TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQ--IY-----------EKILEGKVKF--  260 (355)
T ss_pred             --EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHH--HH-----------HHHHhCcccC--
Confidence              223579999999999999999999999999999999999999997754311  11           1111121111  


Q ss_pred             HHHHHhHHHHHHHHHHHhhhcCCCCCCCC
Q 037267          161 QAFAAKMDCIVSIMDLALDCCMESPGKRI  189 (202)
Q Consensus       161 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rp  189 (202)
                           |...+.++.+|+...++.|-.+|.
T Consensus       261 -----P~~fs~~~kdLl~~LL~vD~t~R~  284 (355)
T KOG0616|consen  261 -----PSYFSSDAKDLLKKLLQVDLTKRF  284 (355)
T ss_pred             -----CcccCHHHHHHHHHHHhhhhHhhh
Confidence                 234556688999999999988884

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=99.97  E-value=4.3e-30  Score=196.38  Aligned_cols=184  Identities=23%  Similarity=0.360  Sum_probs=133.8

Q ss_pred             CCCCcHHHHHhhcC-----------CCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccc
Q 037267            1 MPNGSLEKWLYSYN-----------YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFG   69 (202)
Q Consensus         1 ~~~gsL~~~l~~~~-----------~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g   69 (202)
                      |++++|.+++....           ..+++..++.++.|++.||.|||    +.+++|+|+||+||+++.++.++++|||
T Consensus        99 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH----~~~i~H~dlkp~Nill~~~~~~kl~dfg  174 (295)
T cd05097          99 MENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA----SLNFVHRDLATRNCLVGNHYTIKIADFG  174 (295)
T ss_pred             CCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH----hcCeeccccChhhEEEcCCCcEEecccc
Confidence            57899999996432           13688999999999999999999    8999999999999999999999999999


Q ss_pred             cceeccCCCccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh--CCCCCCcccccchhhHHHHHHhCCCC
Q 037267           70 ISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT--RKRPTDEMFTGEMSLRRWVKESLPHG  147 (202)
Q Consensus        70 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~--g~~p~~~~~~~~~~~~~~~~~~~~~~  147 (202)
                      ++................++..|+|||...+..++.++|+||+|+++|++++  +..||....... ... .........
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~-~~~-~~~~~~~~~  252 (295)
T cd05097         175 MSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ-VIE-NTGEFFRNQ  252 (295)
T ss_pred             cccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH-HHH-HHHHhhhhc
Confidence            9876543322222222345678999998888888999999999999999988  566776543221 111 100000000


Q ss_pred             hhhhhhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhh
Q 037267          148 LTEVVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKK  200 (202)
Q Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~  200 (202)
                      .....          ...+..++..+.+++.+||+.||++|||++++++.|++
T Consensus       253 ~~~~~----------~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~  295 (295)
T cd05097         253 GRQIY----------LSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE  295 (295)
T ss_pred             ccccc----------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence            00000          00011245569999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=99.97  E-value=4.6e-31  Score=204.74  Aligned_cols=169  Identities=20%  Similarity=0.241  Sum_probs=127.8

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |++|+|.+++.... .+++..+..++.|++.||.|||    +.+++||||||+||+++.++.++|+|||++........ 
T Consensus        78 ~~~g~L~~~~~~~~-~l~~~~~~~~~~qi~~~l~~lH----~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~-  151 (329)
T cd05588          78 VSGGDLMFHMQRQR-KLPEEHARFYSAEISLALNFLH----ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD-  151 (329)
T ss_pred             CCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeEecCCCHHHeEECCCCCEEECcCccccccccCCC-
Confidence            58999999997654 4899999999999999999999    89999999999999999999999999999864322111 


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccc---hhhHHHHHHhCCCChhhhhhhhhh
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGE---MSLRRWVKESLPHGLTEVVDANLV  157 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~  157 (202)
                       ......|+..|+|||.+.+..++.++|+||+||++|++++|..||.......   .....+....            +.
T Consensus       152 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~------------~~  218 (329)
T cd05588         152 -TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQV------------IL  218 (329)
T ss_pred             -ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHH------------HH
Confidence             1123457899999999888888999999999999999999999996432111   1111111000            00


Q ss_pred             hhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCC
Q 037267          158 REEQAFAAKMDCIVSIMDLALDCCMESPGKRIN  190 (202)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps  190 (202)
                      ...  ...+..++.++.+++.+||..||++|++
T Consensus       219 ~~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~  249 (329)
T cd05588         219 EKQ--IRIPRSLSVKASSVLKGFLNKDPKERLG  249 (329)
T ss_pred             cCC--CCCCCCCCHHHHHHHHHHhccCHHHcCC
Confidence            000  0111234566899999999999999998

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=99.97  E-value=2e-30  Score=197.34  Aligned_cols=186  Identities=23%  Similarity=0.256  Sum_probs=131.9

Q ss_pred             CCcHHHHHhhcC-CCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCccc
Q 037267            3 NGSLEKWLYSYN-YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFV   81 (202)
Q Consensus         3 ~gsL~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~~   81 (202)
                      .++|.+++.... ..+++..+..++.|++.||.|||    +.+++|||+||+||+++.++.++++|||++........  
T Consensus        90 ~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH----~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~~~~--  163 (288)
T cd07863          90 DQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH----ANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMA--  163 (288)
T ss_pred             ccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEECCCCCEEECccCccccccCccc--
Confidence            357888887543 34899999999999999999999    89999999999999999999999999999876543221  


Q ss_pred             cccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHH-hCCCC--hhhhh---hhh
Q 037267           82 TQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKE-SLPHG--LTEVV---DAN  155 (202)
Q Consensus        82 ~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~--~~~~~---~~~  155 (202)
                       .....++..|+|||.+.+..++.++|+||+||++|++++|..||....... .+...... ..+..  +....   ...
T Consensus       164 -~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (288)
T cd07863         164 -LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD-QLGKIFDLIGLPPEDDWPRDVTLPRGA  241 (288)
T ss_pred             -CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHH-HHHHHHHHhCCCChhhCcccccccccc
Confidence             122357889999999888889999999999999999999999986543221 11111110 00000  00000   000


Q ss_pred             hh--hhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          156 LV--REEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       156 ~~--~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                      ..  ...........++.++.+++.+||+.||++|||+.|++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         242 FSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             cCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            00  000001111235567899999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=99.97  E-value=8.8e-31  Score=203.14  Aligned_cols=170  Identities=21%  Similarity=0.248  Sum_probs=128.5

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |++|+|.+++.... .+++..+..++.|++.||.|||    +.+|+||||||+||+++.++.++|+|||++........ 
T Consensus        78 ~~~~~L~~~~~~~~-~l~~~~~~~i~~qi~~~l~~lH----~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~-  151 (329)
T cd05618          78 VNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYLH----ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-  151 (329)
T ss_pred             CCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC-
Confidence            57999999987654 4899999999999999999999    89999999999999999999999999999875322111 


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccc---hhhHHHHHHhCCCChhhhhhhhhh
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGE---MSLRRWVKESLPHGLTEVVDANLV  157 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~  157 (202)
                       ......|+..|+|||++.+..++.++|+||+||++|++++|..||.......   .....+.....            .
T Consensus       152 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i------------~  218 (329)
T cd05618         152 -TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI------------L  218 (329)
T ss_pred             -ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHH------------h
Confidence             1123458899999999888888999999999999999999999996432111   11111111000            0


Q ss_pred             hhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCH
Q 037267          158 REEQAFAAKMDCIVSIMDLALDCCMESPGKRINM  191 (202)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~  191 (202)
                      ...  ...+...+.++.+++.+||..||++||++
T Consensus       219 ~~~--~~~p~~~~~~~~~ll~~~L~~dP~~R~~~  250 (329)
T cd05618         219 EKQ--IRIPRSLSVKAASVLKSFLNKDPKERLGC  250 (329)
T ss_pred             cCC--CCCCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence            000  01122345668899999999999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=99.97  E-value=5.7e-31  Score=202.00  Aligned_cols=175  Identities=28%  Similarity=0.418  Sum_probs=132.4

Q ss_pred             CCCCcHHHHHhhcC---------------CCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEE
Q 037267            1 MPNGSLEKWLYSYN---------------YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHV   65 (202)
Q Consensus         1 ~~~gsL~~~l~~~~---------------~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l   65 (202)
                      +++|+|.+++....               ..+++..++.++.|++.||.|||    +.+++||||||+||+++.++.+++
T Consensus        90 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH----~~gi~H~dlkp~Nili~~~~~~kl  165 (303)
T cd05088          90 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS----QKQFIHRDLAARNILVGENYVAKI  165 (303)
T ss_pred             CCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH----hCCccccccchheEEecCCCcEEe
Confidence            47899999997532               24789999999999999999999    899999999999999999999999


Q ss_pred             cccccceeccCCCccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhC
Q 037267           66 SDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESL  144 (202)
Q Consensus        66 ~d~g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~  144 (202)
                      +|||++.......   .......+..|++||...+..++.++|+||+|+++|++++ |..||.......  .........
T Consensus       166 ~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~~~~~~~  240 (303)
T cd05088         166 ADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE--LYEKLPQGY  240 (303)
T ss_pred             CccccCcccchhh---hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH--HHHHHhcCC
Confidence            9999986422111   1111223567999998877778899999999999999998 999986533211  111111000


Q ss_pred             CCChhhhhhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          145 PHGLTEVVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                                       ....+..++.++.+++.+||+.+|++||++.+++..|..+
T Consensus       241 -----------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~  280 (303)
T cd05088         241 -----------------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  280 (303)
T ss_pred             -----------------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence                             0001112455689999999999999999999999988653

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=1.6e-31  Score=208.76  Aligned_cols=174  Identities=25%  Similarity=0.320  Sum_probs=133.3

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCC--
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGE--   78 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~--   78 (202)
                      |++|+|.+++.+. ..+++..+..++.|++.||.|||    +.+++||||||+||+++.++.++|+|||++.......  
T Consensus        83 ~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH----~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~  157 (350)
T cd05573          83 MPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVH----KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDR  157 (350)
T ss_pred             CCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH----HCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcc
Confidence            5799999999875 45899999999999999999999    8999999999999999999999999999987654332  


Q ss_pred             -------------------------ccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccc
Q 037267           79 -------------------------DFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGE  133 (202)
Q Consensus        79 -------------------------~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~  133 (202)
                                               .........+++.|+|||.+.+..++.++|+||+||++|++++|..||.......
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~  237 (350)
T cd05573         158 EYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQE  237 (350)
T ss_pred             cccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHH
Confidence                                     0011223458899999999888889999999999999999999999997643211


Q ss_pred             hhhHHHHHHhCCCChhhhhhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCC-HHHHHH
Q 037267          134 MSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRIN-MTDAAA  196 (202)
Q Consensus       134 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps-~~~~~~  196 (202)
                      . .. .+....    ...          ..+....+++++.+++.+|+. ||.+||+ +.++++
T Consensus       238 ~-~~-~i~~~~----~~~----------~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~  284 (350)
T cd05573         238 T-YN-KIINWK----ESL----------RFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKS  284 (350)
T ss_pred             H-HH-HHhccC----Ccc----------cCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhc
Confidence            1 00 000000    000          000011145678999999997 9999999 999875

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=99.97  E-value=4.9e-31  Score=204.42  Aligned_cols=171  Identities=20%  Similarity=0.218  Sum_probs=129.1

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |++|+|.+++.... .+++..+..++.|++.||.|||    +.+++||||||+||+++.++.++|+|||++........ 
T Consensus        78 ~~~~~L~~~~~~~~-~l~~~~~~~~~~qi~~al~~lH----~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-  151 (327)
T cd05617          78 VNGGDLMFHMQRQR-KLPEEHARFYAAEICIALNFLH----ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD-  151 (327)
T ss_pred             CCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC-
Confidence            57999999987644 4899999999999999999999    89999999999999999999999999999875332211 


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccch-hhHHHHHHhCCCChhhhhhhhhhhh
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEM-SLRRWVKESLPHGLTEVVDANLVRE  159 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  159 (202)
                       ......|++.|+|||.+.+..++.++|+||+|+++|++++|..||........ .........            ....
T Consensus       152 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~------------~~~~  218 (327)
T cd05617         152 -TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQV------------ILEK  218 (327)
T ss_pred             -ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHH------------HHhC
Confidence             11234588999999998888899999999999999999999999965332211 111111000            0000


Q ss_pred             HHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHH
Q 037267          160 EQAFAAKMDCIVSIMDLALDCCMESPGKRINMT  192 (202)
Q Consensus       160 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~  192 (202)
                      .  ...+...+..+.+++.+||..||++|+++.
T Consensus       219 ~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~  249 (327)
T cd05617         219 P--IRIPRFLSVKASHVLKGFLNKDPKERLGCQ  249 (327)
T ss_pred             C--CCCCCCCCHHHHHHHHHHhccCHHHcCCCC
Confidence            0  011123445688999999999999999853

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.97  E-value=1.5e-30  Score=195.36  Aligned_cols=168  Identities=20%  Similarity=0.280  Sum_probs=127.0

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCc--------eEEcccccce
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMV--------AHVSDFGISK   72 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~--------~~l~d~g~~~   72 (202)
                      |++|+|.+++......+++..++.++.|++.||.|||    +++++||||||+||+++.++.        ++++|||++.
T Consensus        81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~  156 (258)
T cd05078          81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLE----DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI  156 (258)
T ss_pred             CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence            5789999999876656899999999999999999999    899999999999999986654        6899999876


Q ss_pred             eccCCCccccccCCCCCccccCCCCCCC-CCcCcchhhhhHHHHHHHHHhCC-CCCCcccccchhhHHHHHHhCCCChhh
Q 037267           73 LLGEGEDFVTQTMTMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRK-RPTDEMFTGEMSLRRWVKESLPHGLTE  150 (202)
Q Consensus        73 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~di~s~G~~~~~~~~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~  150 (202)
                      .....      ....++..|+|||...+ ..++.++|+||+|+++|++++|. .||........  .......       
T Consensus       157 ~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~--~~~~~~~-------  221 (258)
T cd05078         157 TVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK--LQFYEDR-------  221 (258)
T ss_pred             ccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH--HHHHHcc-------
Confidence            54322      12346778999998776 34788899999999999999985 55543221110  0000000       


Q ss_pred             hhhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHh
Q 037267          151 VVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLK  199 (202)
Q Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~  199 (202)
                                  ...+.....++.+++.+||+.+|++|||++++++.|+
T Consensus       222 ------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         222 ------------HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             ------------ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence                        0011122345889999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=99.97  E-value=1.6e-30  Score=195.23  Aligned_cols=177  Identities=25%  Similarity=0.414  Sum_probs=137.0

Q ss_pred             CCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCc
Q 037267            1 MPNGSLEKWLYSYN-YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED   79 (202)
Q Consensus         1 ~~~gsL~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~   79 (202)
                      +++|+|.+++.... ..+++..+..++.|++.||.|||    +.+++|+|+||+||+++.++.++++|||++........
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH----~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~  157 (260)
T cd05067          82 MENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE----RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY  157 (260)
T ss_pred             CCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHh----cCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCc
Confidence            47899999997543 45899999999999999999999    89999999999999999999999999999876543221


Q ss_pred             cccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhh
Q 037267           80 FVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVR  158 (202)
Q Consensus        80 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (202)
                      . ......++..|++||...+..++.++|+||+|+++|++++ |..||.......  ..........             
T Consensus       158 ~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~~~~~~~~-------------  221 (260)
T cd05067         158 T-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE--VIQNLERGYR-------------  221 (260)
T ss_pred             c-cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH--HHHHHHcCCC-------------
Confidence            1 1222335678999998888888899999999999999998 999997543221  1111111100             


Q ss_pred             hHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          159 EEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       159 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                          .+.+...+.++.+++.+||..+|++||+++++++.|+.+
T Consensus       222 ----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  260 (260)
T cd05067         222 ----MPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLEDF  260 (260)
T ss_pred             ----CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhcC
Confidence                001122455699999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>PHA03207 serine/threonine kinase US3; Provisional

Probab=99.97  E-value=2.5e-30  Score=205.05  Aligned_cols=189  Identities=21%  Similarity=0.175  Sum_probs=133.6

Q ss_pred             CCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcccc
Q 037267            3 NGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVT   82 (202)
Q Consensus         3 ~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~   82 (202)
                      +++|.+++.. ...+++.+++.++.|++.||.|||    +.+|+||||||+||+++.++.++|+|||++...........
T Consensus       169 ~~~l~~~l~~-~~~l~~~~~~~i~~ql~~aL~~LH----~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~  243 (392)
T PHA03207        169 KCDLFTYVDR-SGPLPLEQAITIQRRLLEALAYLH----GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQ  243 (392)
T ss_pred             CCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH----HCCccccCCCHHHEEEcCCCCEEEccCccccccCccccccc
Confidence            5788999854 345899999999999999999999    89999999999999999999999999999876554332222


Q ss_pred             ccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccc--hhhHHHHHHh------CCCCh-hhhhh
Q 037267           83 QTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGE--MSLRRWVKES------LPHGL-TEVVD  153 (202)
Q Consensus        83 ~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~--~~~~~~~~~~------~~~~~-~~~~~  153 (202)
                      .....++..|+|||++.+..++.++|+||+||++|++++|..||.......  ..+...+...      ++... .....
T Consensus       244 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~  323 (392)
T PHA03207        244 CYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCK  323 (392)
T ss_pred             ccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHH
Confidence            223468999999999988889999999999999999999999997643321  1111111100      00000 00000


Q ss_pred             h---hhhhhH--HHH---HHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          154 A---NLVREE--QAF---AAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       154 ~---~~~~~~--~~~---~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                      .   ......  ...   ......+.++.+++.+||..||++|||+.|++.
T Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~  374 (392)
T PHA03207        324 HFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILS  374 (392)
T ss_pred             HHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhh
Confidence            0   000000  000   000123456789999999999999999999875

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=99.97  E-value=1.5e-30  Score=194.92  Aligned_cols=173  Identities=29%  Similarity=0.484  Sum_probs=135.7

Q ss_pred             CCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCc
Q 037267            1 MPNGSLEKWLYSYN-YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED   79 (202)
Q Consensus         1 ~~~gsL~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~   79 (202)
                      +++++|.+++.... ..+++..+..++.|++.||.|||    +.+++|+||||.||+++.++.++++|||.+........
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh----~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~  157 (256)
T cd05039          82 MAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE----EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD  157 (256)
T ss_pred             cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH----hCCccchhcccceEEEeCCCCEEEcccccccccccccc
Confidence            46899999998644 25899999999999999999999    89999999999999999999999999999887633221


Q ss_pred             cccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhh
Q 037267           80 FVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVR  158 (202)
Q Consensus        80 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (202)
                           ....+..|++||......++.++|+||+|++++++++ |..||.......  +...+.....             
T Consensus       158 -----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~~~~~~~~~-------------  217 (256)
T cd05039         158 -----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VVPHVEKGYR-------------  217 (256)
T ss_pred             -----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH--HHHHHhcCCC-------------
Confidence                 1234567999998887888889999999999999997 999986542211  1111111000             


Q ss_pred             hHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          159 EEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       159 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                          ...+..+++++.+++.+||..+|++|||+.++++.|+++
T Consensus       218 ----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  256 (256)
T cd05039         218 ----MEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI  256 (256)
T ss_pred             ----CCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence                001123456789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.97  E-value=2.8e-30  Score=194.35  Aligned_cols=167  Identities=20%  Similarity=0.274  Sum_probs=126.7

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCc-------eEEccccccee
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMV-------AHVSDFGISKL   73 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~-------~~l~d~g~~~~   73 (202)
                      |++|+|..++......+++..++.++.|++.||.|||    +.+++||||||.||+++.++.       ++++|||++..
T Consensus        86 ~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~~  161 (262)
T cd05077          86 VEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLE----DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPIT  161 (262)
T ss_pred             ccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhh----hCCeECCCCCcccEEEecCCccCCCCceeEeCCCCCCcc
Confidence            4689999999866566899999999999999999999    899999999999999986553       89999998865


Q ss_pred             ccCCCccccccCCCCCccccCCCCCC-CCCcCcchhhhhHHHHHHHHH-hCCCCCCcccccchhhHHHHHHhCCCChhhh
Q 037267           74 LGEGEDFVTQTMTMATIGYMAPEYGS-EGIVSAKCDVYSYGVLLMETF-TRKRPTDEMFTGEMSLRRWVKESLPHGLTEV  151 (202)
Q Consensus        74 ~~~~~~~~~~~~~~~~~~~~~pe~~~-~~~~~~~~di~s~G~~~~~~~-~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (202)
                      ....      ....++..|+|||... +..++.++|+||+|+++|+++ .|..||......+.  ........     . 
T Consensus       162 ~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~--~~~~~~~~-----~-  227 (262)
T cd05077         162 VLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK--ERFYEGQC-----M-  227 (262)
T ss_pred             ccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH--HHHHhcCc-----c-
Confidence            4321      1234677899999775 456888999999999999997 58888754321110  00000000     0 


Q ss_pred             hhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 037267          152 VDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKL  198 (202)
Q Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l  198 (202)
                                   .......++.+++.+||+.||.+||++.++++.+
T Consensus       228 -------------~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~  261 (262)
T cd05077         228 -------------LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI  261 (262)
T ss_pred             -------------CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence                         0011234588999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=99.97  E-value=1.4e-30  Score=206.45  Aligned_cols=164  Identities=21%  Similarity=0.376  Sum_probs=124.9

Q ss_pred             CCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCccccccCCCCCccccCC
Q 037267           16 FFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAP   95 (202)
Q Consensus        16 ~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~p   95 (202)
                      .+++..+++++.|++.||.|||    +.+++||||||.||+++.++.++++|||++................++..|++|
T Consensus       235 ~l~~~~~~~~~~qi~~aL~~LH----~~~ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aP  310 (401)
T cd05107         235 ALSYMDLVGFSYQVANGMEFLA----SKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAP  310 (401)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHh----cCCcCcccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeCh
Confidence            3677888999999999999999    899999999999999999999999999999764332211111223467789999


Q ss_pred             CCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhHHHHHHhHHHHHHHH
Q 037267           96 EYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIM  174 (202)
Q Consensus        96 e~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  174 (202)
                      |.+.+..++.++|+||+|+++|++++ |..||......+. ....+.....                 ...+..++.++.
T Consensus       311 E~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~-~~~~~~~~~~-----------------~~~p~~~~~~l~  372 (401)
T cd05107         311 ESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ-FYNAIKRGYR-----------------MAKPAHASDEIY  372 (401)
T ss_pred             HHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHH-HHHHHHcCCC-----------------CCCCCCCCHHHH
Confidence            98888888999999999999999998 8889865432211 1111111100                 011123456789


Q ss_pred             HHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          175 DLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       175 ~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                      +++.+||..+|++||+++++++.|+.+
T Consensus       373 ~li~~cl~~~P~~RPs~~ell~~L~~~  399 (401)
T cd05107         373 EIMQKCWEEKFEIRPDFSQLVHLVGDL  399 (401)
T ss_pred             HHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=99.97  E-value=5.2e-30  Score=195.31  Aligned_cols=177  Identities=20%  Similarity=0.401  Sum_probs=133.8

Q ss_pred             CCCCcHHHHHhhcC---------CCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccc
Q 037267            1 MPNGSLEKWLYSYN---------YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGIS   71 (202)
Q Consensus         1 ~~~gsL~~~l~~~~---------~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~   71 (202)
                      |++|+|.+++++..         ..++...+..++.|++.||.|||    +++++|||+||+||+++.++.++++|||++
T Consensus        91 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH----~~~i~H~dikp~nili~~~~~~~L~Dfg~~  166 (288)
T cd05061          91 MAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN----AKKFVHRDLAARNCMVAHDFTVKIGDFGMT  166 (288)
T ss_pred             CCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH----hCCCcCCCCChheEEEcCCCcEEECcCCcc
Confidence            57899999997521         23567889999999999999999    899999999999999999999999999998


Q ss_pred             eeccCCCccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhCCCChhh
Q 037267           72 KLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTE  150 (202)
Q Consensus        72 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  150 (202)
                      +...............++..|++||...+..++.++|+||+||++|++++ |..||......+  ....+....   .  
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~--~~~~~~~~~---~--  239 (288)
T cd05061         167 RDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ--VLKFVMDGG---Y--  239 (288)
T ss_pred             ccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcCC---C--
Confidence            76543322211122234667999999888888999999999999999998 788886533221  111111000   0  


Q ss_pred             hhhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhh
Q 037267          151 VVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKK  200 (202)
Q Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~  200 (202)
                                  ...+..++..+.+++.+||+.||++|||+.++++.|++
T Consensus       240 ------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~  277 (288)
T cd05061         240 ------------LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKD  277 (288)
T ss_pred             ------------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence                        00012345669999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=99.97  E-value=2.7e-31  Score=205.53  Aligned_cols=165  Identities=28%  Similarity=0.257  Sum_probs=128.4

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |++|+|.+++.... .+++..+..++.|++.||.|||    +.+|+||||||+||+++.++.++++|||++........ 
T Consensus        78 ~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH----~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~-  151 (323)
T cd05575          78 VNGGELFFHLQRER-SFPEPRARFYAAEIASALGYLH----SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK-  151 (323)
T ss_pred             CCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC-
Confidence            57999999998644 4899999999999999999999    89999999999999999999999999999875322211 


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhH
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREE  160 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (202)
                       ......+++.|+|||.+.+..++.++|+||+||++|++++|..||.......     ......        ....    
T Consensus       152 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~-----~~~~i~--------~~~~----  213 (323)
T cd05575         152 -TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAE-----MYDNIL--------NKPL----  213 (323)
T ss_pred             -ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHH-----HHHHHH--------cCCC----
Confidence             1223457899999999888889999999999999999999999996542211     111100        0000    


Q ss_pred             HHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHH
Q 037267          161 QAFAAKMDCIVSIMDLALDCCMESPGKRINMT  192 (202)
Q Consensus       161 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~  192 (202)
                         ......+.++.+++.+||+.||++||++.
T Consensus       214 ---~~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         214 ---RLKPNISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             ---CCCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence               00112355688999999999999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=99.97  E-value=3e-31  Score=205.46  Aligned_cols=169  Identities=27%  Similarity=0.243  Sum_probs=130.6

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |++|+|.+++.+.. .++...+..++.|++.||.|||    +.+|+||||||+||+++.++.++|+|||++........ 
T Consensus        78 ~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~L~~lH----~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~-  151 (325)
T cd05602          78 INGGELFYHLQRER-CFLEPRARFYAAEIASALGYLH----SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG-  151 (325)
T ss_pred             CCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC-
Confidence            57899999998654 4788899999999999999999    89999999999999999999999999999875332211 


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhH
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREE  160 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (202)
                       ......|++.|+|||.+.+..++.++|+||+||++|++++|..||........  ...+..           ...    
T Consensus       152 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~i~~-----------~~~----  213 (325)
T cd05602         152 -TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM--YDNILN-----------KPL----  213 (325)
T ss_pred             -CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHH--HHHHHh-----------CCc----
Confidence             12234588999999998888899999999999999999999999975332110  001000           000    


Q ss_pred             HHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          161 QAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       161 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                         ......+..+.+++.+||+.||.+||++.+.+.
T Consensus       214 ---~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~  246 (325)
T cd05602         214 ---QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFM  246 (325)
T ss_pred             ---CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHH
Confidence               001134556889999999999999999875443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=99.97  E-value=7e-30  Score=191.06  Aligned_cols=171  Identities=25%  Similarity=0.306  Sum_probs=134.1

Q ss_pred             CCCCcHHHHHhhc-CCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCc
Q 037267            1 MPNGSLEKWLYSY-NYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED   79 (202)
Q Consensus         1 ~~~gsL~~~l~~~-~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~   79 (202)
                      ++|++|.+++... ...++...+..++.|++.||.|||    +.+++|+|++|+||+++.++.++++|||++........
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH----~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~  156 (256)
T cd08529          81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH----SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN  156 (256)
T ss_pred             CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence            4789999999864 346899999999999999999999    89999999999999999999999999999886654332


Q ss_pred             cccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhh
Q 037267           80 FVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVRE  159 (202)
Q Consensus        80 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (202)
                      .  .....++..|+|||+..+..++.++|+||+|++++++++|..||.......  ....+.....              
T Consensus       157 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~~--------------  218 (256)
T cd08529         157 F--ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA--LILKIIRGVF--------------  218 (256)
T ss_pred             h--hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHcCCC--------------
Confidence            2  122356788999999888888899999999999999999999996543111  1111110000              


Q ss_pred             HHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          160 EQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       160 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                         ...+...+.++.+++.+||..+|++||++.++++
T Consensus       219 ---~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  252 (256)
T cd08529         219 ---PPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLR  252 (256)
T ss_pred             ---CCCccccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence               0001134556899999999999999999999976

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=1.7e-30  Score=195.23  Aligned_cols=173  Identities=25%  Similarity=0.231  Sum_probs=132.3

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      +++++|.+++.... .++...+..++.|++.||.|||    +.+++|+||+|.||+++.++.++++|||++.........
T Consensus        86 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lH----~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~  160 (263)
T cd06625          86 MPGGSVKDQLKAYG-ALTETVTRKYTRQILEGVEYLH----SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSS  160 (263)
T ss_pred             CCCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEEcCCCCEEEeecccceeccccccc
Confidence            47899999997654 4899999999999999999999    899999999999999999999999999998765332111


Q ss_pred             cc-ccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhh
Q 037267           81 VT-QTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVRE  159 (202)
Q Consensus        81 ~~-~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (202)
                      .. .....++..|+|||...+..++.++|+||+|+++|++++|..||......... .......                
T Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-~~~~~~~----------------  223 (263)
T cd06625         161 GTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAI-FKIATQP----------------  223 (263)
T ss_pred             cccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHH-HHHhccC----------------
Confidence            00 12234678899999988888899999999999999999999998653221110 0000000                


Q ss_pred             HHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          160 EQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       160 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                       .....+..++..+.+++.+||..+|++||++.++++
T Consensus       224 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  259 (263)
T cd06625         224 -TNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLR  259 (263)
T ss_pred             -CCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhh
Confidence             000111234556889999999999999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=99.97  E-value=1.8e-31  Score=207.00  Aligned_cols=174  Identities=22%  Similarity=0.322  Sum_probs=132.2

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |++|+|.+++......+++..+..++.|++.||.|||    +.+|+||||||+||+++.++.++|+|||++.........
T Consensus        83 ~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH----~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~  158 (330)
T cd05601          83 QPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVH----QMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV  158 (330)
T ss_pred             CCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH----HCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCce
Confidence            5799999999876566999999999999999999999    899999999999999999999999999999876543322


Q ss_pred             ccccCCCCCccccCCCCCC------CCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhh
Q 037267           81 VTQTMTMATIGYMAPEYGS------EGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDA  154 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~------~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (202)
                       ......+++.|+|||++.      +..++.++|+||+||++|++++|..||........ +... ....         .
T Consensus       159 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~-~~~i-~~~~---------~  226 (330)
T cd05601         159 -NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKT-YNNI-MNFQ---------R  226 (330)
T ss_pred             -eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHH-HHHH-HcCC---------C
Confidence             122245789999999865      44567889999999999999999999965432111 1100 0000         0


Q ss_pred             hhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          155 NLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                      ...     .+.....+.++.+|+..||. +|.+||++.+++.
T Consensus       227 ~~~-----~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~  262 (330)
T cd05601         227 FLK-----FPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC  262 (330)
T ss_pred             ccC-----CCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence            000     00111245568899999997 9999999999874

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=99.97  E-value=1.1e-30  Score=202.21  Aligned_cols=168  Identities=21%  Similarity=0.227  Sum_probs=129.2

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |++|+|..++..  ..+++..+..++.|++.||.|||    +.+++||||||+||+++.++.+||+|||++........ 
T Consensus        84 ~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~al~~lH----~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~-  156 (324)
T cd05589          84 AAGGDLMMHIHT--DVFSEPRAVFYAACVVLGLQYLH----ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGD-  156 (324)
T ss_pred             CCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHH----hCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCC-
Confidence            578999998864  34899999999999999999999    89999999999999999999999999999865322111 


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhH
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREE  160 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (202)
                       ......+++.|+|||...+..++.++|+||+||++|++++|..||........ ... +....           .    
T Consensus       157 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~-~~~-i~~~~-----------~----  218 (324)
T cd05589         157 -RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEV-FDS-IVNDE-----------V----  218 (324)
T ss_pred             -cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHH-HHH-HHhCC-----------C----
Confidence             12234688999999998888889999999999999999999999965432110 111 10000           0    


Q ss_pred             HHHHHhHHHHHHHHHHHhhhcCCCCCCCCC-----HHHHHH
Q 037267          161 QAFAAKMDCIVSIMDLALDCCMESPGKRIN-----MTDAAA  196 (202)
Q Consensus       161 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps-----~~~~~~  196 (202)
                         ..+..++..+.+++.+||..||++||+     +.++++
T Consensus       219 ---~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~  256 (324)
T cd05589         219 ---RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK  256 (324)
T ss_pred             ---CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence               011234566889999999999999994     555543

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=99.97  E-value=2.8e-30  Score=194.87  Aligned_cols=180  Identities=21%  Similarity=0.307  Sum_probs=128.1

Q ss_pred             CCCCcHHHHHhhcCC----CCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccC
Q 037267            1 MPNGSLEKWLYSYNY----FFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGE   76 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~----~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~   76 (202)
                      +++|+|.+++.....    ..++.....++.|++.||.|||    +.+++||||||.||+++.++.++++|||++.....
T Consensus        77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~  152 (269)
T cd05042          77 CPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH----QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYP  152 (269)
T ss_pred             CCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHH----hcCEecccccHhheEecCCCcEEEecccccccccc
Confidence            578999999986432    2467788999999999999999    89999999999999999999999999999865433


Q ss_pred             CCccccccCCCCCccccCCCCCC-------CCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhCCCCh
Q 037267           77 GEDFVTQTMTMATIGYMAPEYGS-------EGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGL  148 (202)
Q Consensus        77 ~~~~~~~~~~~~~~~~~~pe~~~-------~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~  148 (202)
                      ...........++..|+|||+..       ...++.++|+||+||++|++++ |..||....... .+........    
T Consensus       153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-~~~~~~~~~~----  227 (269)
T cd05042         153 EDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ-VLKQVVREQD----  227 (269)
T ss_pred             chheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH-HHHHHhhccC----
Confidence            22211122233566799999643       2356778999999999999998 778886543221 1111111100    


Q ss_pred             hhhhhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHh
Q 037267          149 TEVVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLK  199 (202)
Q Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~  199 (202)
                      .....+         ..+..++..+.+++..|| .||++|||+++|++.|+
T Consensus       228 ~~~~~~---------~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         228 IKLPKP---------QLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             ccCCCC---------cccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            000000         011234555788999999 59999999999999875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>PHA03211 serine/threonine kinase US3; Provisional

Probab=99.97  E-value=2.2e-30  Score=207.95  Aligned_cols=190  Identities=16%  Similarity=0.182  Sum_probs=132.6

Q ss_pred             CCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcccc
Q 037267            3 NGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVT   82 (202)
Q Consensus         3 ~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~   82 (202)
                      +|+|.+++......+++..++.++.|++.||.|||    +.+|+||||||+||+++.++.++|+|||+++..........
T Consensus       243 ~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH----~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~  318 (461)
T PHA03211        243 RSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIH----GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPF  318 (461)
T ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCEEECcCCHHHEEECCCCCEEEcccCCceeccccccccc
Confidence            57899998766556999999999999999999999    89999999999999999999999999999986543221111


Q ss_pred             ccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccc------hhhHHHHHHh------CCCChhh
Q 037267           83 QTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGE------MSLRRWVKES------LPHGLTE  150 (202)
Q Consensus        83 ~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~------~~~~~~~~~~------~~~~~~~  150 (202)
                      .....|+..|++||++.+..++.++|+||+||++|++++|..++.......      ..+...+...      ++.....
T Consensus       319 ~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~  398 (461)
T PHA03211        319 HYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGS  398 (461)
T ss_pred             ccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcch
Confidence            223458999999999988889999999999999999999876654322110      1111111111      1110000


Q ss_pred             hhhhhhhh-------h---HHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          151 VVDANLVR-------E---EQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       151 ~~~~~~~~-------~---~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                      ........       .   .............+.+|+.+||+.||++|||+.|+++
T Consensus       399 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~  454 (461)
T PHA03211        399 RLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLR  454 (461)
T ss_pred             HHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhh
Confidence            00000000       0   0000011123446889999999999999999999986

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=99.97  E-value=1.6e-30  Score=195.25  Aligned_cols=177  Identities=28%  Similarity=0.444  Sum_probs=136.1

Q ss_pred             CCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCc
Q 037267            1 MPNGSLEKWLYSYN-YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED   79 (202)
Q Consensus         1 ~~~gsL~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~   79 (202)
                      +++++|.+++.... ..+++..+..++.|++.||.|||    +.+++|+|+||+||+++.++.++++|||.+........
T Consensus        83 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh----~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~  158 (261)
T cd05034          83 MSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE----SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEY  158 (261)
T ss_pred             cCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHH----hCCcccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence            47899999998644 45899999999999999999999    89999999999999999999999999999876543221


Q ss_pred             cccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhh
Q 037267           80 FVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVR  158 (202)
Q Consensus        80 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (202)
                      . .......+..|++||...+..++.++|+||+|++++++++ |..||....... ..... .....             
T Consensus       159 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~-~~~~~-~~~~~-------------  222 (261)
T cd05034         159 T-AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE-VLEQV-ERGYR-------------  222 (261)
T ss_pred             h-hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHH-HcCCC-------------
Confidence            1 1112234567999998888888999999999999999998 999986532211 11111 10000             


Q ss_pred             hHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          159 EEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       159 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                          .+.+..++.++.+++.+||..+|++||+++++.+.|+.+
T Consensus       223 ----~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~~  261 (261)
T cd05034         223 ----MPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLEDY  261 (261)
T ss_pred             ----CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhcC
Confidence                001122355689999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=99.97  E-value=6.9e-31  Score=204.50  Aligned_cols=166  Identities=19%  Similarity=0.172  Sum_probs=130.7

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |++|+|.+++.... .+++..+..++.|++.||.|||    +.+|+||||||+||+++.++.++++|||++.......  
T Consensus       113 ~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~aL~~LH----~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~~--  185 (340)
T PTZ00426        113 VIGGEFFTFLRRNK-RFPNDVGCFYAAQIVLIFEYLQ----SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRT--  185 (340)
T ss_pred             CCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCCc--
Confidence            57999999998654 4899999999999999999999    8999999999999999999999999999997654321  


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhH
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREE  160 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (202)
                         ....|++.|+|||.+.+..++.++|+||+||++|++++|..||.......  ....+....           .    
T Consensus       186 ---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~--~~~~i~~~~-----------~----  245 (340)
T PTZ00426        186 ---YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLL--IYQKILEGI-----------I----  245 (340)
T ss_pred             ---ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHH--HHHHHhcCC-----------C----
Confidence               12358899999999888888999999999999999999999997532211  111111000           0    


Q ss_pred             HHHHHhHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHH
Q 037267          161 QAFAAKMDCIVSIMDLALDCCMESPGKRI-----NMTDAAA  196 (202)
Q Consensus       161 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rp-----s~~~~~~  196 (202)
                         ..+...+..+.+++.+||+.||++|+     ++.++++
T Consensus       246 ---~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~  283 (340)
T PTZ00426        246 ---YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE  283 (340)
T ss_pred             ---CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence               00112345578999999999999996     7887764

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=99.97  E-value=2.6e-30  Score=193.48  Aligned_cols=172  Identities=31%  Similarity=0.500  Sum_probs=134.3

Q ss_pred             CCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCc
Q 037267            1 MPNGSLEKWLYSYN-YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED   79 (202)
Q Consensus         1 ~~~gsL~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~   79 (202)
                      +++|+|.+++.... ..+++..+..++.|++.||.|||    +.+++|||+||+||+++.++.++++|||.+....... 
T Consensus        80 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH----~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~-  154 (254)
T cd05083          80 MSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE----SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV-  154 (254)
T ss_pred             CCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH----hCCeeccccCcceEEEcCCCcEEECCCccceeccccC-
Confidence            57899999998644 34899999999999999999999    8999999999999999999999999999987643221 


Q ss_pred             cccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhh
Q 037267           80 FVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVR  158 (202)
Q Consensus        80 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (202)
                          .....+..|++||.+.+..++.++|+||+|+++|++++ |..||.......  ....+....              
T Consensus       155 ----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~--~~~~~~~~~--------------  214 (254)
T cd05083         155 ----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE--VKECVEKGY--------------  214 (254)
T ss_pred             ----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH--HHHHHhCCC--------------
Confidence                11234567999998888888999999999999999997 899986543211  111111110              


Q ss_pred             hHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhh
Q 037267          159 EEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKK  200 (202)
Q Consensus       159 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~  200 (202)
                         ....+..++..+.+++.+||..+|++||+++++++.|++
T Consensus       215 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         215 ---RMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             ---CCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence               000112345678999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>PHA03209 serine/threonine kinase US3; Provisional

Probab=99.97  E-value=3.1e-30  Score=202.12  Aligned_cols=187  Identities=17%  Similarity=0.184  Sum_probs=129.6

Q ss_pred             CCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcccc
Q 037267            3 NGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVT   82 (202)
Q Consensus         3 ~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~   82 (202)
                      .|+|.+++......+++..+..++.|++.||.|||    +.+|+||||||.||+++.++.++|+|||++........   
T Consensus       140 ~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH----~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~---  212 (357)
T PHA03209        140 SSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLH----AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPA---  212 (357)
T ss_pred             CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHEEECCCCCEEEecCccccccccCcc---
Confidence            57899999876667999999999999999999999    89999999999999999999999999999875332211   


Q ss_pred             ccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCC-Ccccccc-h-------hhHHHHHH------hCCCC
Q 037267           83 QTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPT-DEMFTGE-M-------SLRRWVKE------SLPHG  147 (202)
Q Consensus        83 ~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~-~~~~~~~-~-------~~~~~~~~------~~~~~  147 (202)
                      .....++..|+|||.+.+..++.++|+||+||++|+++++..++ ....... .       .+...+..      .++..
T Consensus       213 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  292 (357)
T PHA03209        213 FLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRD  292 (357)
T ss_pred             cccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCC
Confidence            12235789999999998888999999999999999999855544 3321110 0       01111100      00000


Q ss_pred             hhh-hhhhhhh--------hhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          148 LTE-VVDANLV--------REEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       148 ~~~-~~~~~~~--------~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                      ... .......        ...........++.++.+++.+||..||++|||+.|+++
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~  350 (357)
T PHA03209        293 PGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILN  350 (357)
T ss_pred             CccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhc
Confidence            000 0000000        000001111234556778999999999999999999875

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.97  E-value=1e-29  Score=192.45  Aligned_cols=168  Identities=21%  Similarity=0.270  Sum_probs=127.1

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCC-------ceEEccccccee
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENM-------VAHVSDFGISKL   73 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~-------~~~l~d~g~~~~   73 (202)
                      |++|+|.+++......+++..++.++.|++.||.|||    +.+++||||||.||+++..+       .++++|||.+..
T Consensus        98 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~  173 (274)
T cd05076          98 VEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLE----DKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFT  173 (274)
T ss_pred             CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----cCCccCCCCCcccEEEeccCcccCccceeeecCCccccc
Confidence            5799999999866566899999999999999999999    89999999999999997543       379999998754


Q ss_pred             ccCCCccccccCCCCCccccCCCCCCC-CCcCcchhhhhHHHHHHHHH-hCCCCCCcccccchhhHHHHHHhCCCChhhh
Q 037267           74 LGEGEDFVTQTMTMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETF-TRKRPTDEMFTGEMSLRRWVKESLPHGLTEV  151 (202)
Q Consensus        74 ~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~di~s~G~~~~~~~-~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (202)
                      ....      ....++..|++||.+.+ ..++.++|+||+|+++|+++ +|..||........  ........       
T Consensus       174 ~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~--~~~~~~~~-------  238 (274)
T cd05076         174 ALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK--ERFYEKKH-------  238 (274)
T ss_pred             cccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH--HHHHHhcc-------
Confidence            3221      11246778999997765 45788999999999999985 68888865432221  11111000       


Q ss_pred             hhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHh
Q 037267          152 VDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLK  199 (202)
Q Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~  199 (202)
                           .       .+......+.+++.+||..+|++|||+.++++.|+
T Consensus       239 -----~-------~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         239 -----R-------LPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             -----C-------CCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence                 0       00012235889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=99.97  E-value=2.7e-30  Score=195.22  Aligned_cols=178  Identities=25%  Similarity=0.446  Sum_probs=134.6

Q ss_pred             CCCCcHHHHHhhc-----CCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceecc
Q 037267            1 MPNGSLEKWLYSY-----NYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLG   75 (202)
Q Consensus         1 ~~~gsL~~~l~~~-----~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~   75 (202)
                      +++|+|.+++...     ...++...+..++.|++.||.|||    +.+++|+|+||+||+++.++.++++|||+++...
T Consensus        89 ~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH----~~~i~H~dikp~nili~~~~~~kl~dfg~~~~~~  164 (273)
T cd05074          89 MKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS----SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIY  164 (273)
T ss_pred             CCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH----hCCEeecccchhhEEEcCCCCEEECccccccccc
Confidence            3578999887532     124788999999999999999999    8999999999999999999999999999988654


Q ss_pred             CCCccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhCCCChhhhhhh
Q 037267           76 EGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDA  154 (202)
Q Consensus        76 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (202)
                      ............++..|++||...+..++.++|+||+|+++|++++ |..||......  .....+.....         
T Consensus       165 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~--~~~~~~~~~~~---------  233 (273)
T cd05074         165 SGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS--EIYNYLIKGNR---------  233 (273)
T ss_pred             CCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH--HHHHHHHcCCc---------
Confidence            3322211122234567899998877788889999999999999998 88888653221  11111111100         


Q ss_pred             hhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          155 NLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                              ...+..++..+.+++.+||..+|++|||+.++++.|+++
T Consensus       234 --------~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         234 --------LKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             --------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                    000112445689999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=99.97  E-value=3.5e-30  Score=193.46  Aligned_cols=177  Identities=24%  Similarity=0.408  Sum_probs=136.3

Q ss_pred             CCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCc
Q 037267            1 MPNGSLEKWLYSYN-YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED   79 (202)
Q Consensus         1 ~~~gsL~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~   79 (202)
                      +++|+|.+++.+.. ..+++..++.++.|++.||.|||    +.+++|+||+|+||+++.++.++++|||.+........
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH----~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  157 (260)
T cd05073          82 MAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE----QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY  157 (260)
T ss_pred             CCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHH----hCCccccccCcceEEEcCCCcEEECCCcceeeccCCCc
Confidence            47899999998643 35788999999999999999999    89999999999999999999999999999876543221


Q ss_pred             cccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhh
Q 037267           80 FVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVR  158 (202)
Q Consensus        80 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (202)
                      . ......++..|++||...+..++.++|+||+|+++|++++ |..||.......  ....+.....             
T Consensus       158 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~--~~~~~~~~~~-------------  221 (260)
T cd05073         158 T-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE--VIRALERGYR-------------  221 (260)
T ss_pred             c-cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH--HHHHHhCCCC-------------
Confidence            1 1122234567999999888888889999999999999998 899986543211  1111111100             


Q ss_pred             hHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          159 EEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       159 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                          .+.....+.++.+++.+||..+|++||++.++++.|+.+
T Consensus       222 ----~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~~  260 (260)
T cd05073         222 ----MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF  260 (260)
T ss_pred             ----CCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhcC
Confidence                011123455689999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=99.97  E-value=1.6e-30  Score=196.26  Aligned_cols=172  Identities=19%  Similarity=0.226  Sum_probs=130.1

Q ss_pred             CCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCc
Q 037267            1 MPNGSLEKWLYSYN-YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED   79 (202)
Q Consensus         1 ~~~gsL~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~   79 (202)
                      |++|+|.+++.... ..+++..+..++.|++.||.|||    +.+++|+|+||.||+++.++.++++|||++........
T Consensus        91 ~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH----~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~~~  166 (272)
T cd06637          91 CGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH----QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG  166 (272)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH----HCCCccCCCCHHHEEECCCCCEEEccCCCceecccccc
Confidence            57899999998643 45899999999999999999999    89999999999999999999999999999876433211


Q ss_pred             cccccCCCCCccccCCCCCC-----CCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhh
Q 037267           80 FVTQTMTMATIGYMAPEYGS-----EGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDA  154 (202)
Q Consensus        80 ~~~~~~~~~~~~~~~pe~~~-----~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (202)
                        ......++..|+|||++.     +..++.++|+||+|+++|++++|..||...........  ....   ....    
T Consensus       167 --~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~--~~~~---~~~~----  235 (272)
T cd06637         167 --RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFL--IPRN---PAPR----  235 (272)
T ss_pred             --cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHH--HhcC---CCCC----
Confidence              122345788899999765     33577889999999999999999999865332111100  0000   0000    


Q ss_pred             hhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          155 NLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                               .....++.++.+++.+||..+|.+|||+.++++
T Consensus       236 ---------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         236 ---------LKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             ---------CCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence                     001124456899999999999999999999875

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=99.97  E-value=3.8e-30  Score=195.41  Aligned_cols=173  Identities=23%  Similarity=0.251  Sum_probs=130.6

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      +++|+|.+++.+....+++..+..++.|++.||.|||    +.+++|+||||+||+++.++.++++|||++........ 
T Consensus        84 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH----~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~-  158 (282)
T cd06643          84 CAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLH----ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-  158 (282)
T ss_pred             cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCeeecCCCcccEEEccCCCEEEcccccccccccccc-
Confidence            4789999988765556899999999999999999999    89999999999999999999999999999876433211 


Q ss_pred             ccccCCCCCccccCCCCCC-----CCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhh
Q 037267           81 VTQTMTMATIGYMAPEYGS-----EGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDAN  155 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~-----~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (202)
                       ......++..|++||.+.     +..++.++|+||+||++|++++|..||......... ..... ..+..        
T Consensus       159 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~-~~~~~-~~~~~--------  227 (282)
T cd06643         159 -RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVL-LKIAK-SEPPT--------  227 (282)
T ss_pred             -ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHH-HHHhh-cCCCC--------
Confidence             112235788999999763     345677899999999999999999998654321111 11100 00000        


Q ss_pred             hhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          156 LVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                             ...+..++.++.+++.+||..+|.+||++.++++
T Consensus       228 -------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  261 (282)
T cd06643         228 -------LAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ  261 (282)
T ss_pred             -------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                   0011234566899999999999999999999875

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=99.97  E-value=1.4e-31  Score=206.68  Aligned_cols=166  Identities=27%  Similarity=0.280  Sum_probs=129.5

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |++|+|.+++.+.. .+++..+..++.|++.||.|||    +.+++||||||+||+++.++.++|+|||++........ 
T Consensus        80 ~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH----~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~-  153 (318)
T cd05582          80 LRGGDLFTRLSKEV-MFTEEDVKFYLAELALALDHLH----SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK-  153 (318)
T ss_pred             CCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC-
Confidence            57899999997644 4899999999999999999999    89999999999999999999999999999876543211 


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhH
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREE  160 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (202)
                       ......++..|+|||...+..++.++|+||+||++|++++|..||.......  ....+....                
T Consensus       154 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~--~~~~i~~~~----------------  214 (318)
T cd05582         154 -KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKE--TMTMILKAK----------------  214 (318)
T ss_pred             -ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHH--HHHHHHcCC----------------
Confidence             1122457889999999888888899999999999999999999997543211  111110000                


Q ss_pred             HHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHH
Q 037267          161 QAFAAKMDCIVSIMDLALDCCMESPGKRINMTD  193 (202)
Q Consensus       161 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~  193 (202)
                        ...+...+.++.+++.+||+.||++||++.+
T Consensus       215 --~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         215 --LGMPQFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             --CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence              0011234556889999999999999999655

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=99.97  E-value=4.4e-30  Score=198.14  Aligned_cols=124  Identities=19%  Similarity=0.226  Sum_probs=99.6

Q ss_pred             CCCcHHHHHhhc--------CCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceee----CCCCceEEcccc
Q 037267            2 PNGSLEKWLYSY--------NYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILL----DENMVAHVSDFG   69 (202)
Q Consensus         2 ~~gsL~~~l~~~--------~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~----~~~~~~~l~d~g   69 (202)
                      .+++|.+++...        ...+++..+..++.|++.||.|||    +.+|+||||||+||++    +.++.+|++|||
T Consensus        82 ~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH----~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG  157 (317)
T cd07868          82 AEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH----ANWVLHRDLKPANILVMGEGPERGRVKIADMG  157 (317)
T ss_pred             cCCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHH----hCCEEcCCCCHHHEEEecCCCCcCcEEEeecC
Confidence            356788887532        124889999999999999999999    8999999999999999    456789999999


Q ss_pred             cceeccCCCcc-ccccCCCCCccccCCCCCCC-CCcCcchhhhhHHHHHHHHHhCCCCCCcc
Q 037267           70 ISKLLGEGEDF-VTQTMTMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKRPTDEM  129 (202)
Q Consensus        70 ~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~-~~~~~~~di~s~G~~~~~~~~g~~p~~~~  129 (202)
                      ++......... .......+++.|+|||.+.+ ..++.++|+||+||++|++++|..||...
T Consensus       158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~  219 (317)
T cd07868         158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             ceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence            99865432211 11223467889999998766 45788999999999999999999999754

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=99.97  E-value=6.7e-31  Score=208.20  Aligned_cols=177  Identities=21%  Similarity=0.373  Sum_probs=151.4

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      ++-|-|..||+.+...|+......++.||+.||.|||    ++.+|||||-..|||+.++.-+|++|||+++.+.+..-+
T Consensus       472 ~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLe----SkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yY  547 (974)
T KOG4257|consen  472 APLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLE----SKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYY  547 (974)
T ss_pred             ccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHH----hhchhhhhhhhhheeecCcceeeecccchhhhccccchh
Confidence            4678999999988888999999999999999999999    999999999999999999999999999999988776544


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhh
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVRE  159 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (202)
                      . .+...-+..|++||.+....++.++|+|-||+++||++. |..||....+.+.                 +-  ....
T Consensus       548 k-aS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDV-----------------I~--~iEn  607 (974)
T KOG4257|consen  548 K-ASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDV-----------------IG--HIEN  607 (974)
T ss_pred             h-ccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccce-----------------EE--EecC
Confidence            3 333456788999999999999999999999999999986 9999987654431                 11  1223


Q ss_pred             HHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          160 EQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       160 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                      +.+.+.+..|++.++.||.+||.++|.+||.+.++...|+.+
T Consensus       608 GeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv  649 (974)
T KOG4257|consen  608 GERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDV  649 (974)
T ss_pred             CCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHH
Confidence            445667789999999999999999999999999999888653

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.3e-30  Score=206.91  Aligned_cols=177  Identities=26%  Similarity=0.371  Sum_probs=146.4

Q ss_pred             CCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCc
Q 037267            1 MPNGSLEKWLYSYN-YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED   79 (202)
Q Consensus         1 ~~~gsL~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~   79 (202)
                      |..|+|.|||+..+ ..++....+.++-||.+|++||.    .++++||||-..|+|+.++..+||+|||+++.+.... 
T Consensus       345 M~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLE----kknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDT-  419 (1157)
T KOG4278|consen  345 MCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLE----KKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDT-  419 (1157)
T ss_pred             ccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHH----HhhhhhhhhhhhhccccccceEEeeccchhhhhcCCc-
Confidence            68999999999554 45777788889999999999999    8999999999999999999999999999999886543 


Q ss_pred             cccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhh
Q 037267           80 FVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVR  158 (202)
Q Consensus        80 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (202)
                      +..+....-++.|+|||.+....++.++|+|+||+++||+.+ |-.||.+.+-.                   .-..+..
T Consensus       420 YTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlS-------------------qVY~LLE  480 (1157)
T KOG4278|consen  420 YTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-------------------QVYGLLE  480 (1157)
T ss_pred             eecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHH-------------------HHHHHHh
Confidence            222333445788999999999999999999999999999987 88898764311                   1122233


Q ss_pred             hHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          159 EEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       159 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                      ...+.+.+..|++.++.||..||...|++||+++|+-+.++.+
T Consensus       481 kgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtm  523 (1157)
T KOG4278|consen  481 KGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETM  523 (1157)
T ss_pred             ccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHH
Confidence            3444566778999999999999999999999999999988753

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=99.97  E-value=1.4e-29  Score=197.49  Aligned_cols=183  Identities=22%  Similarity=0.234  Sum_probs=129.0

Q ss_pred             CCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCccc
Q 037267            2 PNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFV   81 (202)
Q Consensus         2 ~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~~   81 (202)
                      .+++|.+++...  .+++..+..++.|++.||.|||    +.+|+||||||+||+++.++.+|++|||++.......   
T Consensus       102 ~~~~l~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH----~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~---  172 (343)
T cd07878         102 MGADLNNIVKCQ--KLSDEHVQFLIYQLLRGLKYIH----SAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEM---  172 (343)
T ss_pred             CCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH----HCCeecccCChhhEEECCCCCEEEcCCccceecCCCc---
Confidence            478898888643  4899999999999999999999    8999999999999999999999999999988654321   


Q ss_pred             cccCCCCCccccCCCCCCC-CCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHh-CC-CChhhhhhhhhh-
Q 037267           82 TQTMTMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKES-LP-HGLTEVVDANLV-  157 (202)
Q Consensus        82 ~~~~~~~~~~~~~pe~~~~-~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~-~~-~~~~~~~~~~~~-  157 (202)
                        ....++..|+|||.+.+ ..++.++|+||+||++|++++|..||....... .+....... .+ ......+..... 
T Consensus       173 --~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (343)
T cd07878         173 --TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYID-QLKRIMEVVGTPSPEVLKKISSEHAR  249 (343)
T ss_pred             --CCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHHhCCCCHHHHHhcchhhHH
Confidence              22457889999998766 467889999999999999999999996533211 111111100 00 000000000000 


Q ss_pred             -------h--hHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          158 -------R--EEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       158 -------~--~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                             .  ............+.+.+++.+||..||++|||+.|+++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~  297 (343)
T cd07878         250 KYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA  297 (343)
T ss_pred             HHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                   0  00000001123445789999999999999999999984

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=99.97  E-value=1.5e-29  Score=198.47  Aligned_cols=182  Identities=20%  Similarity=0.183  Sum_probs=127.9

Q ss_pred             CCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcccc
Q 037267            3 NGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVT   82 (202)
Q Consensus         3 ~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~   82 (202)
                      +++|.+.+..   .++...+..++.|++.||.|||    +.+|+||||||+||+++.++.++|+|||++........   
T Consensus       109 ~~~l~~~~~~---~~~~~~~~~~~~qi~~~L~~LH----~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~---  178 (359)
T cd07876         109 DANLCQVIHM---ELDHERMSYLLYQMLCGIKHLH----SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFM---  178 (359)
T ss_pred             CcCHHHHHhc---cCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCCHHHEEECCCCCEEEecCCCccccccCcc---
Confidence            3566666642   3788999999999999999999    89999999999999999999999999999875432211   


Q ss_pred             ccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhh---hhh--
Q 037267           83 QTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDA---NLV--  157 (202)
Q Consensus        83 ~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~--  157 (202)
                      .....++..|+|||.+.+..++.++|+||+||++|++++|..||....... .+.... .............   ...  
T Consensus       179 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~-~~~~~~-~~~~~~~~~~~~~~~~~~~~~  256 (359)
T cd07876         179 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHID-QWNKVI-EQLGTPSAEFMNRLQPTVRNY  256 (359)
T ss_pred             CCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHH-HhcCCCcHHHHHHHHHHHHHH
Confidence            122457889999999988889999999999999999999999997643211 111111 1110000000000   000  


Q ss_pred             ------hh---------HHH----HHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          158 ------RE---------EQA----FAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       158 ------~~---------~~~----~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                            ..         .+.    .......+.++.+++.+||..||++|||+.|+++
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  314 (359)
T cd07876         257 VENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR  314 (359)
T ss_pred             HhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhc
Confidence                  00         000    0011123456899999999999999999999986

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=99.97  E-value=2.2e-30  Score=187.54  Aligned_cols=168  Identities=27%  Similarity=0.298  Sum_probs=133.8

Q ss_pred             HHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCccccccCC
Q 037267            7 EKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMT   86 (202)
Q Consensus         7 ~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~   86 (202)
                      +..++....++++...-++...+..||.||-+   .++|+|||+||+|||+|..|++|++|||++.++.++...   +..
T Consensus       178 ekLlkrik~piPE~ilGk~tva~v~AL~YLKe---KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAh---trs  251 (391)
T KOG0983|consen  178 EKLLKRIKGPIPERILGKMTVAIVKALYYLKE---KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAH---TRS  251 (391)
T ss_pred             HHHHHHhcCCchHHhhhhhHHHHHHHHHHHHH---hcceeecccCccceEEccCCCEEeecccccceeeccccc---ccc
Confidence            34444444568999999999999999999997   789999999999999999999999999999988876543   334


Q ss_pred             CCCccccCCCCCCCC---CcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhHHHH
Q 037267           87 MATIGYMAPEYGSEG---IVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAF  163 (202)
Q Consensus        87 ~~~~~~~~pe~~~~~---~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (202)
                      .|.+.|+|||.+...   .|..++|+||||+.++|+.||+.||.....+...+....+ ..|+.               +
T Consensus       252 AGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln-~ePP~---------------L  315 (391)
T KOG0983|consen  252 AGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN-EEPPL---------------L  315 (391)
T ss_pred             cCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh-cCCCC---------------C
Confidence            689999999976543   6788999999999999999999999887665544443322 22111               1


Q ss_pred             HHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          164 AAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       164 ~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                      +.....++.+.+++..||.+|+.+||...++++
T Consensus       316 ~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~  348 (391)
T KOG0983|consen  316 PGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLE  348 (391)
T ss_pred             CcccCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence            111235677899999999999999999998875

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=99.97  E-value=7.2e-30  Score=192.35  Aligned_cols=174  Identities=22%  Similarity=0.244  Sum_probs=130.2

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |++|+|.+++.... .+++.++..++.|++.||.|||    +.+++|+||||+||+++.++.++++|||++........ 
T Consensus        88 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~-  161 (267)
T cd06645          88 CGGGSLQDIYHVTG-PLSESQIAYVSRETLQGLYYLH----SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIA-  161 (267)
T ss_pred             cCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHEEECCCCCEEECcceeeeEccCccc-
Confidence            47899999997644 4899999999999999999999    89999999999999999999999999999876543221 


Q ss_pred             ccccCCCCCccccCCCCCC---CCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhh
Q 037267           81 VTQTMTMATIGYMAPEYGS---EGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV  157 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~---~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (202)
                       ......++..|+|||.+.   ...++.++|+||+||++|++++|..||..................+....        
T Consensus       162 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~--------  232 (267)
T cd06645         162 -KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLK--------  232 (267)
T ss_pred             -ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCccc--------
Confidence             122345788999999763   34578899999999999999999999865432221111000000000000        


Q ss_pred             hhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          158 REEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                             ....++..+.+++.+||..+|++||+++++++
T Consensus       233 -------~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         233 -------DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             -------ccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence                   00123455889999999999999999999874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=99.97  E-value=7.9e-30  Score=196.16  Aligned_cols=188  Identities=15%  Similarity=0.209  Sum_probs=132.1

Q ss_pred             CCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcccc
Q 037267            3 NGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVT   82 (202)
Q Consensus         3 ~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~   82 (202)
                      .++|.+++......++...+..++.|++.||.|||    +.+|+||||||+||+++.++.++++|||++.........  
T Consensus        87 ~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH----~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~--  160 (309)
T cd07872          87 DKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCH----RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKT--  160 (309)
T ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHEEECCCCCEEECccccceecCCCccc--
Confidence            36888888766666899999999999999999999    899999999999999999999999999998764332211  


Q ss_pred             ccCCCCCccccCCCCCCC-CCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCC--Chhhhh------h
Q 037267           83 QTMTMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPH--GLTEVV------D  153 (202)
Q Consensus        83 ~~~~~~~~~~~~pe~~~~-~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~------~  153 (202)
                      .....++..|+|||...+ ..++.++|+||+|+++|++++|..||......+...........+.  .+....      .
T Consensus       161 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (309)
T cd07872         161 YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKN  240 (309)
T ss_pred             cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhh
Confidence            122356889999997654 4578899999999999999999999976543221111100000000  000000      0


Q ss_pred             hhhh--hhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          154 ANLV--REEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       154 ~~~~--~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                      ....  ...........++.++.+++.+||..||.+|||+.|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         241 YNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             hhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence            0000  000001111235667899999999999999999999886

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=99.97  E-value=2.6e-29  Score=189.63  Aligned_cols=180  Identities=20%  Similarity=0.298  Sum_probs=126.2

Q ss_pred             CCCCcHHHHHhhcC---CCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCC
Q 037267            1 MPNGSLEKWLYSYN---YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEG   77 (202)
Q Consensus         1 ~~~gsL~~~l~~~~---~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~   77 (202)
                      |++|+|.+++....   ..++...+..++.|++.||.|||    +.+++|+||||+||+++.++.++++|||++......
T Consensus        77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH----~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~  152 (268)
T cd05086          77 CELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH----KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKE  152 (268)
T ss_pred             CCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH----HCCeeccCCccceEEEcCCccEEecccccccccCcc
Confidence            57899999998542   23677788899999999999999    899999999999999999999999999987543221


Q ss_pred             CccccccCCCCCccccCCCCCCC-------CCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhCCCChh
Q 037267           78 EDFVTQTMTMATIGYMAPEYGSE-------GIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLT  149 (202)
Q Consensus        78 ~~~~~~~~~~~~~~~~~pe~~~~-------~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  149 (202)
                      ..........++..|++||+...       ..++.++|+||+|+++|++++ |..||......+ .+.........    
T Consensus       153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-~~~~~~~~~~~----  227 (268)
T cd05086         153 DYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDRE-VLNHVIKDQQV----  227 (268)
T ss_pred             hhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHHhhccc----
Confidence            11111223456788999997532       234678999999999999997 566775533221 11111111110    


Q ss_pred             hhhhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHh
Q 037267          150 EVVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLK  199 (202)
Q Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~  199 (202)
                      ....+..         ....++.+.+++..|| .+|.+||++.++++.|.
T Consensus       228 ~~~~~~~---------~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         228 KLFKPQL---------ELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             ccCCCcc---------CCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            0000000         0113445788999999 67999999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=99.97  E-value=2.4e-30  Score=193.92  Aligned_cols=176  Identities=30%  Similarity=0.375  Sum_probs=131.2

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |++++|.+++.... .++...+..++.|++.||.+||    +.+++|+||||+||+++.++.++++|||.+.......  
T Consensus        80 ~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~Lh----~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~--  152 (260)
T PF00069_consen   80 CPGGSLQDYLQKNK-PLSEEEILKIAYQILEALAYLH----SKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENN--  152 (260)
T ss_dssp             ETTEBHHHHHHHHS-SBBHHHHHHHHHHHHHHHHHHH----HTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTT--
T ss_pred             cccccccccccccc-cccccccccccccccccccccc----ccccccccccccccccccccccccccccccccccccc--
Confidence            36779999998433 4899999999999999999999    8999999999999999999999999999997642111  


Q ss_pred             ccccCCCCCccccCCCCCC-CCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhh
Q 037267           81 VTQTMTMATIGYMAPEYGS-EGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVRE  159 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~-~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (202)
                      .......++..|.|||... +..++.++|+||+|++++++++|..||.......  ........        ........
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~--~~~~~~~~--------~~~~~~~~  222 (260)
T PF00069_consen  153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDD--QLEIIEKI--------LKRPLPSS  222 (260)
T ss_dssp             SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHH--HHHHHHHH--------HHTHHHHH
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccchh--hhhhhhhc--------cccccccc
Confidence            1223346788999999877 7788999999999999999999999997651111  00000000        00000000


Q ss_pred             HHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          160 EQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       160 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                      .   ........++.+++.+||+.||++|||+.++++
T Consensus       223 ~---~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  223 S---QQSREKSEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             T---TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             c---cccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0   000011267999999999999999999999875

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=99.96  E-value=5.2e-30  Score=191.79  Aligned_cols=173  Identities=24%  Similarity=0.298  Sum_probs=134.3

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      +++++|.+++......+++..+..++.|++.||.|||    +.+++|+|++|.||+++.++.++++|||++........ 
T Consensus        80 ~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh----~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-  154 (256)
T cd06612          80 CGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLH----SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-  154 (256)
T ss_pred             CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCcceEEECCCCcEEEcccccchhcccCcc-
Confidence            4789999999876667899999999999999999999    89999999999999999999999999999876543321 


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhH
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREE  160 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (202)
                       ......++..|++||...+..++.++|+||+|+++|++++|..||...........  .....    .           
T Consensus       155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~--~~~~~----~-----------  216 (256)
T cd06612         155 -KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFM--IPNKP----P-----------  216 (256)
T ss_pred             -ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhh--hccCC----C-----------
Confidence             11223467889999998888889999999999999999999999875432211000  00000    0           


Q ss_pred             HHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          161 QAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       161 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                      .....+...+..+.+++.+||+.+|++|||+.|+++
T Consensus       217 ~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         217 PTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             CCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence            000111234556899999999999999999999975

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=99.96  E-value=1e-30  Score=202.16  Aligned_cols=165  Identities=26%  Similarity=0.252  Sum_probs=127.5

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |++|+|.+++.... .+++..+..++.|++.||.|||    +.+|+||||||+||+++.++.+||+|||++........ 
T Consensus        78 ~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~lH----~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~-  151 (321)
T cd05603          78 VNGGELFFHLQRER-CFLEPRARFYAAEVASAIGYLH----SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE-  151 (321)
T ss_pred             CCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC-
Confidence            57999999987644 4889999999999999999999    89999999999999999999999999999875322211 


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhH
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREE  160 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (202)
                       ......+++.|+|||.+.+..++.++|+||+||++|++++|..||.......     ......        ...     
T Consensus       152 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-----~~~~i~--------~~~-----  212 (321)
T cd05603         152 -TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQ-----MYDNIL--------HKP-----  212 (321)
T ss_pred             -ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHH-----HHHHHh--------cCC-----
Confidence             1223457899999999888888999999999999999999999996542111     111100        000     


Q ss_pred             HHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHH
Q 037267          161 QAFAAKMDCIVSIMDLALDCCMESPGKRINMT  192 (202)
Q Consensus       161 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~  192 (202)
                        ...+...+.++.+++.+||+.||.+||++.
T Consensus       213 --~~~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         213 --LQLPGGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             --CCCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence              001112345588999999999999999864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=99.96  E-value=5.2e-30  Score=191.90  Aligned_cols=175  Identities=28%  Similarity=0.403  Sum_probs=133.8

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      +++|+|.+++......+++..+..++.|++.||.|||    +.+++|+|+||+||+++.++.++++|||.+........ 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH----~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-  155 (256)
T cd05112          81 MEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLE----SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY-  155 (256)
T ss_pred             CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH----HCCccccccccceEEEcCCCeEEECCCcceeecccCcc-
Confidence            4789999999876556899999999999999999999    89999999999999999999999999999876543221 


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhh
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVRE  159 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (202)
                      ........+..|++||...+..++.++|+||+|+++|++++ |..||.......  .........    . ..       
T Consensus       156 ~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~--~~~~~~~~~----~-~~-------  221 (256)
T cd05112         156 TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE--VVETINAGF----R-LY-------  221 (256)
T ss_pred             cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH--HHHHHhCCC----C-CC-------
Confidence            11112234568999998888888899999999999999998 899986533211  111111000    0 00       


Q ss_pred             HHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHh
Q 037267          160 EQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLK  199 (202)
Q Consensus       160 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~  199 (202)
                           .+...+..+.+++.+||..+|++|||+.++++.|+
T Consensus       222 -----~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~  256 (256)
T cd05112         222 -----KPRLASQSVYELMQHCWKERPEDRPSFSLLLHQLA  256 (256)
T ss_pred             -----CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence                 01113456899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=99.96  E-value=8.9e-30  Score=194.80  Aligned_cols=171  Identities=22%  Similarity=0.270  Sum_probs=131.4

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      +++|+|.+++...  .+++.++..++.|++.||.|||    +.+++|+||||+||+++.++.++++|||++.........
T Consensus        99 ~~~~~L~~~~~~~--~~~~~~~~~i~~ql~~aL~~LH----~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~  172 (296)
T cd06654          99 LAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH----SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK  172 (296)
T ss_pred             cCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEEEcCCCCEEECccccchhccccccc
Confidence            4789999999753  3789999999999999999999    899999999999999999999999999998764432211


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhH
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREE  160 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (202)
                        .....+++.|+|||...+..++.++|+||+|+++|++++|..||........ +........+    ..         
T Consensus       173 --~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~-~~~~~~~~~~----~~---------  236 (296)
T cd06654         173 --RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-LYLIATNGTP----EL---------  236 (296)
T ss_pred             --cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh-HHHHhcCCCC----CC---------
Confidence              1223577899999988888888999999999999999999999965432111 1111100000    00         


Q ss_pred             HHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          161 QAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       161 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                         ..+...+..+.+++.+||..+|++||++.++++
T Consensus       237 ---~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~  269 (296)
T cd06654         237 ---QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (296)
T ss_pred             ---CCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence               001234456889999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=99.96  E-value=2.5e-30  Score=200.11  Aligned_cols=164  Identities=23%  Similarity=0.264  Sum_probs=128.1

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |+||+|.+++.... .+++.++..++.|++.||.|||    +.+++||||||+||+++.++.++|+|||++........ 
T Consensus        83 ~~~g~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~lH----~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~-  156 (323)
T cd05615          83 VNGGDLMYHIQQVG-KFKEPQAVFYAAEISVGLFFLH----RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV-  156 (323)
T ss_pred             CCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCc-
Confidence            57999999997644 4899999999999999999999    89999999999999999999999999999875432221 


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhH
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREE  160 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (202)
                       ......|++.|+|||.+.+..++.++|+||+|+++|++++|..||.......  ....+....           .    
T Consensus       157 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~--~~~~i~~~~-----------~----  218 (323)
T cd05615         157 -TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE--LFQSIMEHN-----------V----  218 (323)
T ss_pred             -cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHH--HHHHHHhCC-----------C----
Confidence             1122357899999999888888999999999999999999999997643211  111111000           0    


Q ss_pred             HHHHHhHHHHHHHHHHHhhhcCCCCCCCCCH
Q 037267          161 QAFAAKMDCIVSIMDLALDCCMESPGKRINM  191 (202)
Q Consensus       161 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~  191 (202)
                         ..+...+.++.+++.+||..+|++|++.
T Consensus       219 ---~~p~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         219 ---SYPKSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             ---CCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence               0112345568899999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=99.96  E-value=1.3e-29  Score=189.74  Aligned_cols=171  Identities=23%  Similarity=0.282  Sum_probs=133.2

Q ss_pred             CCCCcHHHHHhhc-CCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCc
Q 037267            1 MPNGSLEKWLYSY-NYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED   79 (202)
Q Consensus         1 ~~~gsL~~~l~~~-~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~   79 (202)
                      |++++|.+++... ...+++.++..++.|++.||.|||    +.+++|+||+|+||+++.++.++++|||++........
T Consensus        82 ~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH----~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~  157 (257)
T cd08223          82 CEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH----EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD  157 (257)
T ss_pred             cCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----hCCeeccCCCchhEEEecCCcEEEecccceEEecccCC
Confidence            5789999999864 345899999999999999999999    89999999999999999999999999999886643222


Q ss_pred             cccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhh
Q 037267           80 FVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVRE  159 (202)
Q Consensus        80 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (202)
                        ......++..|+|||...+..++.++|+||+|++++++++|..||........ .... .....              
T Consensus       158 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~-~~~~-~~~~~--------------  219 (257)
T cd08223         158 --MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSL-VYRI-IEGKL--------------  219 (257)
T ss_pred             --ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHH-HHHH-HhcCC--------------
Confidence              12234578889999998888888999999999999999999999864321111 0111 11000              


Q ss_pred             HHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          160 EQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       160 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                         ...+...+.++.+++.+||..+|++||++.++++
T Consensus       220 ---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  253 (257)
T cd08223         220 ---PPMPKDYSPELGELIATMLSKRPEKRPSVKSILR  253 (257)
T ss_pred             ---CCCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence               0011234566899999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=99.96  E-value=7.7e-31  Score=203.15  Aligned_cols=168  Identities=24%  Similarity=0.243  Sum_probs=129.2

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |+||+|.+++.+.. .+++..+..++.|++.||.|||    +.+++||||||.||+++.++.++|+|||++........ 
T Consensus        78 ~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH----~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-  151 (325)
T cd05604          78 VNGGELFFHLQRER-SFPEPRARFYAAEIASALGYLH----SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD-  151 (325)
T ss_pred             CCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC-
Confidence            57999999997644 4899999999999999999999    89999999999999999999999999999875322111 


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhH
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREE  160 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (202)
                       ......++..|+|||.+.+..++.++|+||+||++|+|++|..||........ ......            ...    
T Consensus       152 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~-~~~~~~------------~~~----  213 (325)
T cd05604         152 -TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEM-YDNILH------------KPL----  213 (325)
T ss_pred             -CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHH-HHHHHc------------CCc----
Confidence             12234588999999999888889999999999999999999999965322110 111000            000    


Q ss_pred             HHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHH
Q 037267          161 QAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAA  195 (202)
Q Consensus       161 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~  195 (202)
                         ......+..+.+++.+|+..+|++||++.+.+
T Consensus       214 ---~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~  245 (325)
T cd05604         214 ---VLRPGASLTAWSILEELLEKDRQRRLGAKEDF  245 (325)
T ss_pred             ---cCCCCCCHHHHHHHHHHhccCHHhcCCCCCCH
Confidence               00012345578999999999999999886433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=2.2e-29  Score=188.94  Aligned_cols=175  Identities=23%  Similarity=0.290  Sum_probs=132.9

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      +++++|.+++......++...+..++.|++.||.|||    +.+++|+||+|+||+++.++.++++|||.+........ 
T Consensus        82 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh----~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-  156 (262)
T cd06613          82 CGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLH----ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA-  156 (262)
T ss_pred             CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH----hCCceecCCChhhEEECCCCCEEECccccchhhhhhhh-
Confidence            4678999999876456899999999999999999999    89999999999999999999999999999876443211 


Q ss_pred             ccccCCCCCccccCCCCCCCC---CcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhh
Q 037267           81 VTQTMTMATIGYMAPEYGSEG---IVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV  157 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~---~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (202)
                       ......++..|++||...+.   .++.++|+||+|+++|++++|..||........... ........       .   
T Consensus       157 -~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~-~~~~~~~~-------~---  224 (262)
T cd06613         157 -KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFL-ISKSNFPP-------P---  224 (262)
T ss_pred             -ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHhccCCC-------c---
Confidence             11223567789999987766   788899999999999999999999976442221111 10000000       0   


Q ss_pred             hhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          158 REEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                          ........+.++.+++.+||..+|.+|||+.+++.
T Consensus       225 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         225 ----KLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             ----cccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                00011234566899999999999999999999874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=99.96  E-value=4.2e-30  Score=193.62  Aligned_cols=175  Identities=21%  Similarity=0.263  Sum_probs=129.9

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      +++|+|.+++.... .+++..+..++.|++.||.|||    +.+++|+|++|.||+++.++.++++|||++........ 
T Consensus        88 ~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~-  161 (267)
T cd06646          88 CGGGSLQDIYHVTG-PLSELQIAYVCRETLQGLAYLH----SKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA-  161 (267)
T ss_pred             CCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCccccCCCHHHEEECCCCCEEECcCccceeeccccc-
Confidence            47899999997544 4899999999999999999999    89999999999999999999999999999986543221 


Q ss_pred             ccccCCCCCccccCCCCCC---CCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhh
Q 037267           81 VTQTMTMATIGYMAPEYGS---EGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV  157 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~---~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (202)
                       ......++..|+|||...   ...++.++|+||+|+++|++++|..||........... ......       ..... 
T Consensus       162 -~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~-~~~~~~-------~~~~~-  231 (267)
T cd06646         162 -KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFL-MSKSNF-------QPPKL-  231 (267)
T ss_pred             -ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhee-eecCCC-------CCCCC-
Confidence             112235778899999764   33467789999999999999999999865432111000 000000       00000 


Q ss_pred             hhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 037267          158 REEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAK  197 (202)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~  197 (202)
                            ......+..+.+++.+||..+|++||+++++++-
T Consensus       232 ------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  265 (267)
T cd06646         232 ------KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTH  265 (267)
T ss_pred             ------ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcC
Confidence                  0011244568999999999999999999998864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=7.7e-30  Score=194.14  Aligned_cols=173  Identities=25%  Similarity=0.311  Sum_probs=132.7

Q ss_pred             CCCCcHHHHHhhc-CCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCc
Q 037267            1 MPNGSLEKWLYSY-NYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED   79 (202)
Q Consensus         1 ~~~gsL~~~l~~~-~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~   79 (202)
                      |++|+|.+++... ...+++..+..++.|++.||.|||    +.+++|+||||.||+++.++.++++|||++........
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  157 (285)
T cd05605          82 MNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH----RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET  157 (285)
T ss_pred             cCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH----HCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc
Confidence            5789999998754 345899999999999999999999    89999999999999999999999999999877543222


Q ss_pred             cccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhh
Q 037267           80 FVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVRE  159 (202)
Q Consensus        80 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (202)
                         .....++..|++||.+.+..++.++|+||+|+++|++++|..||........ .. .+....            .. 
T Consensus       158 ---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~-~~-~~~~~~------------~~-  219 (285)
T cd05605         158 ---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVK-RE-EVERRV------------KE-  219 (285)
T ss_pred             ---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhH-HH-HHHHHh------------hh-
Confidence               1223578899999998888889999999999999999999999975332110 00 000000            00 


Q ss_pred             HHHHHHhHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHH
Q 037267          160 EQAFAAKMDCIVSIMDLALDCCMESPGKRI-----NMTDAAA  196 (202)
Q Consensus       160 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rp-----s~~~~~~  196 (202)
                       .....+...+..+.+++.+||..||++||     ++.++++
T Consensus       220 -~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05605         220 -DQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA  260 (285)
T ss_pred             -cccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence             00011123556689999999999999999     7888754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=99.96  E-value=1.3e-29  Score=190.53  Aligned_cols=175  Identities=25%  Similarity=0.275  Sum_probs=133.9

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCC-CCeeecCCCCCceeeCCCCceEEcccccceeccCCCc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSS-APIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED   79 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~-~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~   79 (202)
                      +++++|.+++......++...+..++.|++.||.|||    + .+++|+||+|+||+++.++.++++|||.+........
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH----~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~  156 (265)
T cd06605          81 MDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLH----EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA  156 (265)
T ss_pred             cCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHc----CCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh
Confidence            4679999999876566899999999999999999999    7 9999999999999999999999999998865432211


Q ss_pred             cccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhh
Q 037267           80 FVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVRE  159 (202)
Q Consensus        80 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (202)
                          ....++..|++||...+..++.++|+||+|++++++++|..||...................            ..
T Consensus       157 ----~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------------~~  220 (265)
T cd06605         157 ----KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVN------------EP  220 (265)
T ss_pred             ----hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhc------------CC
Confidence                11457788999999888888999999999999999999999997653222111111111100            00


Q ss_pred             HHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          160 EQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       160 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                      ... .....++.++.+++.+||..+|++|||+.+++.
T Consensus       221 ~~~-~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  256 (265)
T cd06605         221 PPR-LPSGKFSPDFQDFVNLCLIKDPRERPSYKELLE  256 (265)
T ss_pred             CCC-CChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence            000 000115566899999999999999999999875

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=99.96  E-value=6e-30  Score=200.27  Aligned_cols=169  Identities=24%  Similarity=0.334  Sum_probs=122.6

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |++|+|.+..     ..++..+..++.|++.||.|||    +.+++||||||+||+++.++.++|+|||++.........
T Consensus       154 ~~~~~L~~~~-----~~~~~~~~~i~~qi~~aL~~LH----~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~  224 (353)
T PLN00034        154 MDGGSLEGTH-----IADEQFLADVARQILSGIAYLH----RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP  224 (353)
T ss_pred             CCCCcccccc-----cCCHHHHHHHHHHHHHHHHHHH----HCCEeecCCCHHHEEEcCCCCEEEcccccceeccccccc
Confidence            4567765432     2467788899999999999999    899999999999999999999999999998865432211


Q ss_pred             ccccCCCCCccccCCCCCCC-----CCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhh
Q 037267           81 VTQTMTMATIGYMAPEYGSE-----GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDAN  155 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~-----~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (202)
                        .....++..|++||.+..     ...+.++|+|||||++|++++|..||.......  +........           
T Consensus       225 --~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~--~~~~~~~~~-----------  289 (353)
T PLN00034        225 --CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD--WASLMCAIC-----------  289 (353)
T ss_pred             --ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc--HHHHHHHHh-----------
Confidence              123468899999997643     223458999999999999999999997322221  111110000           


Q ss_pred             hhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          156 LVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                       ..  .....+..++.++.+++.+||..||++||++.|+++
T Consensus       290 -~~--~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~  327 (353)
T PLN00034        290 -MS--QPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQ  327 (353)
T ss_pred             -cc--CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence             00  000111235567899999999999999999999975

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=99.96  E-value=1.9e-29  Score=191.52  Aligned_cols=170  Identities=22%  Similarity=0.260  Sum_probs=130.8

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |++|+|.+++.... .+++..+..++.|++.||.|||    +.+++|+||||+||+++.++.++++|||++........ 
T Consensus        79 ~~~~~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~lH----~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~-  152 (279)
T cd05633          79 MNGGDLHYHLSQHG-VFSEKEMRFYATEIILGLEHMH----NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-  152 (279)
T ss_pred             CCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccCc-
Confidence            57899999997654 4899999999999999999999    89999999999999999999999999999875443221 


Q ss_pred             ccccCCCCCccccCCCCCC-CCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhh
Q 037267           81 VTQTMTMATIGYMAPEYGS-EGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVRE  159 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~-~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (202)
                         ....++..|+|||... +..++.++|+||+||++|++++|..||..................               
T Consensus       153 ---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~---------------  214 (279)
T cd05633         153 ---HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTV---------------  214 (279)
T ss_pred             ---cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcC---------------
Confidence               2235788999999765 455788999999999999999999999764332211000000000               


Q ss_pred             HHHHHHhHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHH
Q 037267          160 EQAFAAKMDCIVSIMDLALDCCMESPGKRI-----NMTDAAA  196 (202)
Q Consensus       160 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rp-----s~~~~~~  196 (202)
                        ....+..++.++.+++.+||..||++||     |+.++++
T Consensus       215 --~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~  254 (279)
T cd05633         215 --NVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKE  254 (279)
T ss_pred             --CcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHh
Confidence              0011223556789999999999999999     5888865

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=99.96  E-value=4.6e-30  Score=192.18  Aligned_cols=172  Identities=20%  Similarity=0.232  Sum_probs=133.3

Q ss_pred             CCCCcHHHHHhhc-CCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCc
Q 037267            1 MPNGSLEKWLYSY-NYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED   79 (202)
Q Consensus         1 ~~~gsL~~~l~~~-~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~   79 (202)
                      +++|+|.+++... ...++...+..++.|++.||.|||    +.+++|+||||.||+++.++.++++|||.+........
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH----~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~  155 (255)
T cd08219          80 CDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIH----EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA  155 (255)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHh----hCCcccCCCCcceEEECCCCcEEEcccCcceeeccccc
Confidence            4789999998753 345899999999999999999999    89999999999999999999999999999876654322


Q ss_pred             cccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhh
Q 037267           80 FVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVRE  159 (202)
Q Consensus        80 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (202)
                      .  .....++..|+|||...+..++.++|+||+|+++|++++|..||........  ...+.....   .          
T Consensus       156 ~--~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~--~~~~~~~~~---~----------  218 (255)
T cd08219         156 Y--ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNL--ILKVCQGSY---K----------  218 (255)
T ss_pred             c--cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHH--HHHHhcCCC---C----------
Confidence            1  1223577889999998888889999999999999999999999965321111  001100000   0          


Q ss_pred             HHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 037267          160 EQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAK  197 (202)
Q Consensus       160 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~  197 (202)
                          +.+..++..+.+++.+||..||++||++.+++.+
T Consensus       219 ----~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         219 ----PLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             ----CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence                0112344568899999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=99.96  E-value=4e-29  Score=187.02  Aligned_cols=174  Identities=30%  Similarity=0.501  Sum_probs=134.2

Q ss_pred             CCCCcHHHHHhhcCCC-CCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCc
Q 037267            1 MPNGSLEKWLYSYNYF-FDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED   79 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~-l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~   79 (202)
                      +++++|.+++...... +++..+..++.|++.||.|||    +.+++|+|++|+||+++.++.++++|||++........
T Consensus        83 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh----~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~  158 (258)
T smart00219       83 MEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE----SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY  158 (258)
T ss_pred             cCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHh----cCCeeecccccceEEEccCCeEEEcccCCceecccccc
Confidence            4789999999865443 899999999999999999999    89999999999999999999999999999987655432


Q ss_pred             cccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhh
Q 037267           80 FVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVR  158 (202)
Q Consensus        80 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (202)
                      .... ...++..|++||...+..++.++|+||+|++++++++ |..||.......  ....+.....             
T Consensus       159 ~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~--~~~~~~~~~~-------------  222 (258)
T smart00219      159 YKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEE--VLEYLKKGYR-------------  222 (258)
T ss_pred             cccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHhcCCC-------------
Confidence            2211 1235678999998877788999999999999999998 788876522111  1111111000             


Q ss_pred             hHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 037267          159 EEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKL  198 (202)
Q Consensus       159 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l  198 (202)
                          ...+..++.++.+++.+||..+|++|||+.|+++.|
T Consensus       223 ----~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      223 ----LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             ----CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence                001112556689999999999999999999998864

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=99.96  E-value=1.2e-29  Score=199.79  Aligned_cols=186  Identities=24%  Similarity=0.301  Sum_probs=130.2

Q ss_pred             CCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcccc
Q 037267            3 NGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVT   82 (202)
Q Consensus         3 ~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~   82 (202)
                      +++|.+++... ..+++..+..++.|++.||.|||    +.+++||||||+||+++.++.++|+|||++......... .
T Consensus        87 ~~~l~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH----~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~~-~  160 (372)
T cd07853          87 QSDLHKIIVSP-QPLSSDHVKVFLYQILRGLKYLH----SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESK-H  160 (372)
T ss_pred             ccCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH----hCCeeCCCCChHHEEECCCCCEEeccccceeecccCccc-c
Confidence            46788888653 35899999999999999999999    899999999999999999999999999999865432211 1


Q ss_pred             ccCCCCCccccCCCCCCCC-CcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCC-CChhhhhhh------
Q 037267           83 QTMTMATIGYMAPEYGSEG-IVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLP-HGLTEVVDA------  154 (202)
Q Consensus        83 ~~~~~~~~~~~~pe~~~~~-~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~------  154 (202)
                      .....++..|+|||.+.+. .++.++|+||+||++|++++|+.||........ + ..+..... +........      
T Consensus       161 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~-~~i~~~~g~~~~~~~~~~~~~~~~  238 (372)
T cd07853         161 MTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQ-L-DLITDLLGTPSLEAMRSACEGARA  238 (372)
T ss_pred             CCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHH-H-HHHHHHcCCCCHHHHHHhhHHHHH
Confidence            1223568889999987664 478889999999999999999999976432211 1 11111110 000000000      


Q ss_pred             hh----hhh---HHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          155 NL----VRE---EQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       155 ~~----~~~---~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                      .+    ...   ..........++++.+++.+||..||++|||+.|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  287 (372)
T cd07853         239 HILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA  287 (372)
T ss_pred             HHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence            00    000   0000111234567899999999999999999999875

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=99.96  E-value=1.8e-29  Score=191.74  Aligned_cols=188  Identities=21%  Similarity=0.242  Sum_probs=130.9

Q ss_pred             CCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcccc
Q 037267            3 NGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVT   82 (202)
Q Consensus         3 ~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~   82 (202)
                      +++|.+++.+....+++..+..++.|++.||.|||    +.+++|+||||+||+++.++.++++|||++.........  
T Consensus        82 ~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH----~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~--  155 (284)
T cd07839          82 DQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH----SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRC--  155 (284)
T ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCC--
Confidence            46888888765566999999999999999999999    899999999999999999999999999998765432211  


Q ss_pred             ccCCCCCccccCCCCCCCC-CcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCC------hhhhhhhh
Q 037267           83 QTMTMATIGYMAPEYGSEG-IVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHG------LTEVVDAN  155 (202)
Q Consensus        83 ~~~~~~~~~~~~pe~~~~~-~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~  155 (202)
                      .....++..|+|||.+.+. .++.++|+||+|+++|++++|..|+.........+...........      ........
T Consensus       156 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (284)
T cd07839         156 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYK  235 (284)
T ss_pred             cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccccc
Confidence            1223567889999976654 4688999999999999999999886543322221111111000000      00000000


Q ss_pred             h----hhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          156 L----VREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       156 ~----~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                      .    .............+.++.+++.+||..||.+|||++++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         236 PYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             ccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence            0    0000001111235677899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=99.96  E-value=3.3e-30  Score=202.89  Aligned_cols=173  Identities=22%  Similarity=0.282  Sum_probs=130.2

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |+||+|.+++.+.  .+++..+..++.|++.||.|||    +.+|+||||||+||+++.++.++|+|||++.........
T Consensus       125 ~~gg~L~~~l~~~--~l~~~~~~~~~~qi~~aL~~LH----~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~  198 (370)
T cd05596         125 MPGGDLVNLMSNY--DIPEKWARFYTAEVVLALDAIH----SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMV  198 (370)
T ss_pred             CCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH----HCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCcc
Confidence            5799999999754  3789999999999999999999    899999999999999999999999999999865433211


Q ss_pred             ccccCCCCCccccCCCCCCCC----CcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhh
Q 037267           81 VTQTMTMATIGYMAPEYGSEG----IVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANL  156 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~----~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (202)
                       ......|++.|+|||.+.+.    .++.++|+||+||++|++++|..||....... .... +.....    .      
T Consensus       199 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~-~~~~-i~~~~~----~------  265 (370)
T cd05596         199 -RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG-TYSK-IMDHKN----S------  265 (370)
T ss_pred             -cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHH-HHHH-HHcCCC----c------
Confidence             12234689999999976543    37789999999999999999999997533211 0110 100000    0      


Q ss_pred             hhhHHHHHHhHHHHHHHHHHHhhhcCCCCCC--CCCHHHHHH
Q 037267          157 VREEQAFAAKMDCIVSIMDLALDCCMESPGK--RINMTDAAA  196 (202)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~--Rps~~~~~~  196 (202)
                          ...+.....+.++.+++.+||..+|.+  |+|+.++++
T Consensus       266 ----~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~  303 (370)
T cd05596         266 ----LTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKS  303 (370)
T ss_pred             ----CCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhc
Confidence                000111134567899999999999988  999999864

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=99.96  E-value=1e-29  Score=199.06  Aligned_cols=183  Identities=21%  Similarity=0.214  Sum_probs=128.0

Q ss_pred             CCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcccc
Q 037267            3 NGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVT   82 (202)
Q Consensus         3 ~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~   82 (202)
                      .++|.+++..   .++...+..++.|++.||.|||    +.+|+||||||+||+++.++.++++|||++........   
T Consensus       105 ~~~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH----~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~~~---  174 (355)
T cd07874         105 DANLCQVIQM---ELDHERMSYLLYQMLCGIKHLH----SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---  174 (355)
T ss_pred             cccHHHHHhh---cCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCChHHEEECCCCCEEEeeCcccccCCCccc---
Confidence            3566666642   3788999999999999999999    89999999999999999999999999999976543221   


Q ss_pred             ccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhC-C---------CChhhhh
Q 037267           83 QTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESL-P---------HGLTEVV  152 (202)
Q Consensus        83 ~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~-~---------~~~~~~~  152 (202)
                      .....++..|+|||.+.+..++.++|+||+||++|++++|..||........ +...+.... +         .......
T Consensus       175 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (355)
T cd07874         175 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ-WNKVIEQLGTPCPEFMKKLQPTVRNYV  253 (355)
T ss_pred             cCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCCHHHHHhhcHHHHHHH
Confidence            1224578899999998888899999999999999999999999975432111 111110000 0         0000000


Q ss_pred             hh----------hhhhhH---HHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          153 DA----------NLVREE---QAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       153 ~~----------~~~~~~---~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                      ..          ......   ...........++.+++.+||..||++|||+.|+++
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~  310 (355)
T cd07874         254 ENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQ  310 (355)
T ss_pred             hcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhc
Confidence            00          000000   000011123456899999999999999999999986

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=99.96  E-value=1.7e-29  Score=190.55  Aligned_cols=169  Identities=22%  Similarity=0.263  Sum_probs=133.1

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCC-ceEEcccccceeccCCCc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENM-VAHVSDFGISKLLGEGED   79 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~-~~~l~d~g~~~~~~~~~~   79 (202)
                      +++|+|.+++.... .+++.++..++.|++.||.|||    +.+++|+||||.||+++.++ .++++|||.+....... 
T Consensus        91 ~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH----~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~-  164 (267)
T PHA03390         91 IKDGDLFDLLKKEG-KLSEAEVKKIIRQLVEALNDLH----KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPS-  164 (267)
T ss_pred             CCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----hCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCCc-
Confidence            57999999998654 5899999999999999999999    89999999999999999888 99999999987654322 


Q ss_pred             cccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhh
Q 037267           80 FVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVRE  159 (202)
Q Consensus        80 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (202)
                           ...++..|+|||...+..++.++|+||+|+++|++++|..||............+.....         .     
T Consensus       165 -----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~---------~-----  225 (267)
T PHA03390        165 -----CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQ---------K-----  225 (267)
T ss_pred             -----cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhc---------c-----
Confidence                 234788999999988888899999999999999999999999754333322222211110         0     


Q ss_pred             HHHHHHhHHHHHHHHHHHhhhcCCCCCCCCC-HHHHHH
Q 037267          160 EQAFAAKMDCIVSIMDLALDCCMESPGKRIN-MTDAAA  196 (202)
Q Consensus       160 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps-~~~~~~  196 (202)
                        ........+..+.+++.+||+.+|.+||+ ++++++
T Consensus       226 --~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        226 --KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             --cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence              00111245667899999999999999996 588874

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=99.96  E-value=1.1e-29  Score=193.39  Aligned_cols=173  Identities=24%  Similarity=0.287  Sum_probs=132.7

Q ss_pred             CCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCc
Q 037267            1 MPNGSLEKWLYSYN-YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED   79 (202)
Q Consensus         1 ~~~gsL~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~   79 (202)
                      ++||+|.+++.... ..+++..++.++.|++.||.|||    +.+++||||||.||+++.++.++++|||++........
T Consensus        82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH----~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  157 (285)
T cd05630          82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH----QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT  157 (285)
T ss_pred             cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH----hCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc
Confidence            47899999996543 35899999999999999999999    89999999999999999999999999999876543222


Q ss_pred             cccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhh
Q 037267           80 FVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVRE  159 (202)
Q Consensus        80 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (202)
                      .   ....++..|+|||...+..++.++|+||+|+++|++++|..||........ .. .....        ...     
T Consensus       158 ~---~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~-~~-~~~~~--------~~~-----  219 (285)
T cd05630         158 I---KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK-RE-EVERL--------VKE-----  219 (285)
T ss_pred             c---cCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccch-HH-HHHhh--------hhh-----
Confidence            1   123578899999998888899999999999999999999999976432110 00 00000        000     


Q ss_pred             HHHHHHhHHHHHHHHHHHhhhcCCCCCCCCC-----HHHHHH
Q 037267          160 EQAFAAKMDCIVSIMDLALDCCMESPGKRIN-----MTDAAA  196 (202)
Q Consensus       160 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps-----~~~~~~  196 (202)
                       .....+..++.++.+++.+||..||++|||     +.|+++
T Consensus       220 -~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         220 -VQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             -hhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence             000112235566899999999999999999     788875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=99.96  E-value=2e-29  Score=192.40  Aligned_cols=173  Identities=24%  Similarity=0.280  Sum_probs=130.0

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      +++|+|..++.+....+++..+..++.|++.+|.|||    +.+++|+|+||+||+++.++.++|+|||.+........ 
T Consensus        91 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH----~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~-  165 (292)
T cd06644          91 CPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLH----SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQ-  165 (292)
T ss_pred             CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh----cCCeeecCCCcceEEEcCCCCEEEccCccceecccccc-
Confidence            4789999988765566899999999999999999999    89999999999999999999999999998865432211 


Q ss_pred             ccccCCCCCccccCCCCCC-----CCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhh
Q 037267           81 VTQTMTMATIGYMAPEYGS-----EGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDAN  155 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~-----~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (202)
                       ......++..|++||.+.     ...++.++|+||+|+++|++++|..||........ ...... ..++         
T Consensus       166 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~-~~~~~~-~~~~---------  233 (292)
T cd06644         166 -RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV-LLKIAK-SEPP---------  233 (292)
T ss_pred             -ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHH-HHHHhc-CCCc---------
Confidence             112235678899999764     34467789999999999999999999865432111 111100 0000         


Q ss_pred             hhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          156 LVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                            ....+..++.++.+++.+||..+|++||++.++++
T Consensus       234 ------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         234 ------TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             ------cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence                  00011234556889999999999999999999975

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=99.96  E-value=2.3e-29  Score=189.80  Aligned_cols=175  Identities=23%  Similarity=0.322  Sum_probs=134.2

Q ss_pred             CCCCcHHHHHhh---cCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCC
Q 037267            1 MPNGSLEKWLYS---YNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEG   77 (202)
Q Consensus         1 ~~~gsL~~~l~~---~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~   77 (202)
                      ++|++|.+++..   ....+++..++.++.|++.||.|||.   ..+++|+|++|.||+++.++.++++|||.+......
T Consensus        91 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~  167 (269)
T cd08528          91 IEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHK---EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPE  167 (269)
T ss_pred             CCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhcc---CCceeecCCCHHHEEECCCCcEEEecccceeecccc
Confidence            478999998853   34468999999999999999999993   368999999999999999999999999999765443


Q ss_pred             CccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhh
Q 037267           78 EDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV  157 (202)
Q Consensus        78 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (202)
                      .   ......++..|++||...+..++.++|+||+|+++|++++|..||.......  ....+....   ...       
T Consensus       168 ~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~--~~~~~~~~~---~~~-------  232 (269)
T cd08528         168 S---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLS--LATKIVEAV---YEP-------  232 (269)
T ss_pred             c---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHH--HHHHHhhcc---CCc-------
Confidence            2   1223457888999999888888999999999999999999999986432111  111111000   000       


Q ss_pred             hhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHh
Q 037267          158 REEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLK  199 (202)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~  199 (202)
                            ......+.++.+++.+||+.||++||++.|+.+.++
T Consensus       233 ------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         233 ------LPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             ------CCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence                  001124456899999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=99.96  E-value=9.1e-30  Score=197.31  Aligned_cols=191  Identities=17%  Similarity=0.186  Sum_probs=130.4

Q ss_pred             CCCCcHHHHHhhc-CCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCc
Q 037267            1 MPNGSLEKWLYSY-NYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED   79 (202)
Q Consensus         1 ~~~gsL~~~l~~~-~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~   79 (202)
                      |++|+|.+++..+ ...+++..++.++.|++.||.|||    +.+++||||||+||+++.++.+++.||+..........
T Consensus        81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH----~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~  156 (327)
T cd08227          81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIH----HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ  156 (327)
T ss_pred             cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH----HCCEecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence            5789999999754 335899999999999999999999    89999999999999999999999999976543322111


Q ss_pred             cc-----cccCCCCCccccCCCCCCC--CCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhh-
Q 037267           80 FV-----TQTMTMATIGYMAPEYGSE--GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEV-  151 (202)
Q Consensus        80 ~~-----~~~~~~~~~~~~~pe~~~~--~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-  151 (202)
                      ..     ......++..|+|||++.+  ..++.++|+||+||++|++++|..||......... ........+...... 
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~  235 (327)
T cd08227         157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML-LEKLNGTVPCLLDTTT  235 (327)
T ss_pred             cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHH-HHHhcCCccccccccc
Confidence            00     0111235667999998765  35788999999999999999999999754322211 111111111000000 


Q ss_pred             -hh-----------------h-hh-------hhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          152 -VD-----------------A-NL-------VREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       152 -~~-----------------~-~~-------~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                       ..                 . ..       .......+.....++++.+++.+||+.||++|||++++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~  306 (327)
T cd08227         236 IPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN  306 (327)
T ss_pred             hhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence             00                 0 00       0000001112345667899999999999999999999986

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=2.4e-30  Score=207.40  Aligned_cols=173  Identities=24%  Similarity=0.291  Sum_probs=138.2

Q ss_pred             CCCCcHHHHHhhcCCCC--CHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeC-CCCceEEcccccceeccCC
Q 037267            1 MPNGSLEKWLYSYNYFF--DILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLD-ENMVAHVSDFGISKLLGEG   77 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l--~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~-~~~~~~l~d~g~~~~~~~~   77 (202)
                      .|||||.+.|++.=+++  .+.+.--+..||++||.|||    ...|||||||.+|+|++ -.|.+||.|||-++....-
T Consensus       654 VPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLH----en~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi  729 (1226)
T KOG4279|consen  654 VPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLH----ENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI  729 (1226)
T ss_pred             CCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhh----hcceeeccccCCcEEEeeccceEEecccccchhhccC
Confidence            48999999999765556  67788888999999999999    89999999999999998 5789999999998875432


Q ss_pred             CccccccCCCCCccccCCCCCCCC--CcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhh
Q 037267           78 EDFVTQTMTMATIGYMAPEYGSEG--IVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDAN  155 (202)
Q Consensus        78 ~~~~~~~~~~~~~~~~~pe~~~~~--~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (202)
                      .  ....++.||..|+|||++..+  .|+.++|||||||.+.||.||++||.............  ..+           
T Consensus       730 n--P~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkV--Gmy-----------  794 (1226)
T KOG4279|consen  730 N--PCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKV--GMY-----------  794 (1226)
T ss_pred             C--ccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhh--cce-----------
Confidence            2  134567899999999987654  58889999999999999999999997764443211110  000           


Q ss_pred             hhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          156 LVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                          ....+.+.+.+.+...++.+|+..||.+||||.++++
T Consensus       795 ----KvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  795 ----KVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             ----ecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence                0112345567788899999999999999999999875

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=99.96  E-value=9.2e-30  Score=191.69  Aligned_cols=172  Identities=26%  Similarity=0.318  Sum_probs=132.1

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      +++++|.+++.... .++...+..++.|++.||.|||    +.+++|+||+|+||+++.++.++++|||.+.........
T Consensus        88 ~~~~~L~~~l~~~~-~l~~~~~~~~~~~l~~~l~~lH----~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~  162 (267)
T cd06628          88 VPGGSVAALLNNYG-AFEETLVRNFVRQILKGLNYLH----NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLS  162 (267)
T ss_pred             cCCCCHHHHHHhcc-CccHHHHHHHHHHHHHHHHHHH----hcCcccccCCHHHEEEcCCCCEEecccCCCccccccccc
Confidence            47899999997654 4899999999999999999999    899999999999999999999999999998765422110


Q ss_pred             ----ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhh
Q 037267           81 ----VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANL  156 (202)
Q Consensus        81 ----~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (202)
                          .......++..|++||...+..++.++|+||+|+++|++++|..||........ .... ....            
T Consensus       163 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~~-~~~~------------  228 (267)
T cd06628         163 TKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQA-IFKI-GENA------------  228 (267)
T ss_pred             CCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHH-HHHH-hccC------------
Confidence                011123467889999988888888899999999999999999999976432111 1100 0000            


Q ss_pred             hhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          157 VREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                           ....+...+..+.+++.+||+.||.+||++.++++
T Consensus       229 -----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         229 -----SPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             -----CCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence                 00111234566899999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=99.96  E-value=1e-29  Score=199.76  Aligned_cols=182  Identities=20%  Similarity=0.188  Sum_probs=128.8

Q ss_pred             CCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcccc
Q 037267            3 NGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVT   82 (202)
Q Consensus         3 ~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~   82 (202)
                      .++|.+++..   .++...+..++.|++.||.|||    +.+|+||||||+||+++.++.++|+|||++........   
T Consensus       112 ~~~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH----~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~---  181 (364)
T cd07875         112 DANLCQVIQM---ELDHERMSYLLYQMLCGIKHLH----SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---  181 (364)
T ss_pred             CCCHHHHHHh---cCCHHHHHHHHHHHHHHHHHHh----hCCeecCCCCHHHEEECCCCcEEEEeCCCccccCCCCc---
Confidence            3567777753   3788999999999999999999    89999999999999999999999999999976543221   


Q ss_pred             ccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhh---hhhhhh--
Q 037267           83 QTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEV---VDANLV--  157 (202)
Q Consensus        83 ~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~--  157 (202)
                      .....++..|+|||.+.+..++.++|+||+||++|++++|..||........ +.... ..........   ......  
T Consensus       182 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~-~~~~~-~~~~~~~~~~~~~~~~~~~~~  259 (364)
T cd07875         182 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQ-WNKVI-EQLGTPCPEFMKKLQPTVRTY  259 (364)
T ss_pred             ccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHH-HHHHH-HhcCCCCHHHHHhhhHHHHHH
Confidence            1224578899999998888899999999999999999999999976432211 11111 1110000000   000000  


Q ss_pred             --hh-----------------HHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          158 --RE-----------------EQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       158 --~~-----------------~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                        ..                 ............++.+++.+||..||++|||+.|+++
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~  317 (364)
T cd07875         260 VENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ  317 (364)
T ss_pred             HhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence              00                 0000011123456889999999999999999999875

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=3.7e-30  Score=199.73  Aligned_cols=170  Identities=24%  Similarity=0.198  Sum_probs=127.2

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |++|+|.+++.... .+++..+..++.|++.||.|||    +.+|+||||||+||+++.++.++|+|||++.........
T Consensus        78 ~~~g~L~~~l~~~~-~~~~~~~~~~~~qil~al~~LH----~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~  152 (330)
T cd05586          78 MSGGELFWHLQKEG-RFSEDRAKFYIAELVLALEHLH----KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT  152 (330)
T ss_pred             CCCChHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCC
Confidence            57899999997644 4899999999999999999999    899999999999999999999999999998753322211


Q ss_pred             ccccCCCCCccccCCCCCCCC-CcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhh
Q 037267           81 VTQTMTMATIGYMAPEYGSEG-IVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVRE  159 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~-~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (202)
                        .....|+..|+|||.+.+. .++.++|+||+||++|+|++|..||.......  ....+....    ...        
T Consensus       153 --~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~--~~~~i~~~~----~~~--------  216 (330)
T cd05586         153 --TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ--MYRNIAFGK----VRF--------  216 (330)
T ss_pred             --ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHH--HHHHHHcCC----CCC--------
Confidence              1234588999999987654 47889999999999999999999996532211  000000000    000        


Q ss_pred             HHHHHHhHHHHHHHHHHHhhhcCCCCCCCCC----HHHHHH
Q 037267          160 EQAFAAKMDCIVSIMDLALDCCMESPGKRIN----MTDAAA  196 (202)
Q Consensus       160 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps----~~~~~~  196 (202)
                           .....+.++.+++.+||..||.+||+    +.++++
T Consensus       217 -----~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~  252 (330)
T cd05586         217 -----PKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE  252 (330)
T ss_pred             -----CCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence                 00123456789999999999999995    555543

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=99.96  E-value=1.2e-29  Score=192.00  Aligned_cols=177  Identities=21%  Similarity=0.321  Sum_probs=133.7

Q ss_pred             CCCCcHHHHHhhcC--------CCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccce
Q 037267            1 MPNGSLEKWLYSYN--------YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISK   72 (202)
Q Consensus         1 ~~~gsL~~~l~~~~--------~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~   72 (202)
                      +++|+|.+++....        ..+++..+..++.|++.||.|||    +.+++|+||||.||+++.++.++++|||++.
T Consensus        90 ~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH----~~~i~H~dlkp~Nili~~~~~~~l~~~~~~~  165 (275)
T cd05046          90 TDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS----NARFVHRDLAARNCLVSSQREVKVSLLSLSK  165 (275)
T ss_pred             cCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh----hcCcccCcCccceEEEeCCCcEEEccccccc
Confidence            47899999998544        14899999999999999999999    8999999999999999999999999999986


Q ss_pred             eccCCCccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhCCCChhhh
Q 037267           73 LLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEV  151 (202)
Q Consensus        73 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (202)
                      ........ ......++..|++||...+..++.++|+||+|+++|++++ |..||.......  ...........     
T Consensus       166 ~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~--~~~~~~~~~~~-----  237 (275)
T cd05046         166 DVYNSEYY-KLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE--VLNRLQAGKLE-----  237 (275)
T ss_pred             ccCccccc-ccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH--HHHHHHcCCcC-----
Confidence            54322211 1122245667999998877778889999999999999998 788886533211  11111100000     


Q ss_pred             hhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhh
Q 037267          152 VDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKK  200 (202)
Q Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~  200 (202)
                                 ...+..++..+.+++.+||..+|++|||+.++++.|++
T Consensus       238 -----------~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~  275 (275)
T cd05046         238 -----------LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE  275 (275)
T ss_pred             -----------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence                       00012345668999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=2.8e-30  Score=206.16  Aligned_cols=162  Identities=23%  Similarity=0.224  Sum_probs=129.0

Q ss_pred             CCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCccc
Q 037267            2 PNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFV   81 (202)
Q Consensus         2 ~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~~   81 (202)
                      .||++..+++  ...|++..+.-++..++.||.|||    .++|+|||||.+|||+|..|.+||+|||+++..-...  .
T Consensus       452 ~Ggdm~~~~~--~~~F~e~rarfyaAev~l~L~fLH----~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g--~  523 (694)
T KOG0694|consen  452 AGGDLMHHIH--TDVFSEPRARFYAAEVVLGLQFLH----ENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQG--D  523 (694)
T ss_pred             CCCcEEEEEe--cccccHHHHHHHHHHHHHHHHHHH----hcCceeeecchhheEEcccCcEEecccccccccCCCC--C
Confidence            5677333332  345999999999999999999999    9999999999999999999999999999998643222  1


Q ss_pred             cccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhHH
Q 037267           82 TQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQ  161 (202)
Q Consensus        82 ~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (202)
                      ...+..||+.|+|||++.+..|+..+|.||||+++|+|+.|+.||.+-++++  +.+.+                ..+..
T Consensus       524 ~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee--~FdsI----------------~~d~~  585 (694)
T KOG0694|consen  524 RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEE--VFDSI----------------VNDEV  585 (694)
T ss_pred             ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHH--HHHHH----------------hcCCC
Confidence            3556889999999999999999999999999999999999999997644332  11111                11111


Q ss_pred             HHHHhHHHHHHHHHHHhhhcCCCCCCCCCH
Q 037267          162 AFAAKMDCIVSIMDLALDCCMESPGKRINM  191 (202)
Q Consensus       162 ~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~  191 (202)
                        ..|.-++.+..++|.+++.++|++|..+
T Consensus       586 --~yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  586 --RYPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             --CCCCcccHHHHHHHHHHhccCcccccCC
Confidence              1123466778999999999999999965

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.96  E-value=3.1e-30  Score=193.71  Aligned_cols=186  Identities=23%  Similarity=0.276  Sum_probs=140.9

Q ss_pred             CCCcHHHHHhhcCC-CCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCC--------------------C
Q 037267            2 PNGSLEKWLYSYNY-FFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDE--------------------N   60 (202)
Q Consensus         2 ~~gsL~~~l~~~~~-~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~--------------------~   60 (202)
                      .|-|+.|+|..++. +++...+..++.|++.+++|||    +.+++|.||||+|||+.+                    +
T Consensus       173 lG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh----~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ks  248 (415)
T KOG0671|consen  173 LGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLH----DLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLKS  248 (415)
T ss_pred             cChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHH----hcceeecCCChheEEEeccceEEEeccCCccceeccCCC
Confidence            45699999997653 6999999999999999999999    999999999999999842                    1


Q ss_pred             CceEEcccccceeccCCCccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccc-hhhHHH
Q 037267           61 MVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGE-MSLRRW  139 (202)
Q Consensus        61 ~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~-~~~~~~  139 (202)
                      -.++++|||.++......     .....|..|.|||++.+..++.++|+||+|||+.|+.+|...|+.+.+.+ ....+.
T Consensus       249 ~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMer  323 (415)
T KOG0671|consen  249 TAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMMER  323 (415)
T ss_pred             cceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHHHHHH
Confidence            247899999998754332     23467899999999999999999999999999999999999999876544 234444


Q ss_pred             HHHhCCCChhhhh-h-----------hhhhhhH-------------HHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHH
Q 037267          140 VKESLPHGLTEVV-D-----------ANLVREE-------------QAFAAKMDCIVSIMDLALDCCMESPGKRINMTDA  194 (202)
Q Consensus       140 ~~~~~~~~~~~~~-~-----------~~~~~~~-------------~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~  194 (202)
                      +.+..|..+.... .           ++....+             ......+....+++||+.+||.+||.+|+|+.|+
T Consensus       324 IlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EA  403 (415)
T KOG0671|consen  324 ILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREA  403 (415)
T ss_pred             hhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHH
Confidence            4444444433222 0           0000000             0011234455669999999999999999999998


Q ss_pred             HH
Q 037267          195 AA  196 (202)
Q Consensus       195 ~~  196 (202)
                      +.
T Consensus       404 L~  405 (415)
T KOG0671|consen  404 LS  405 (415)
T ss_pred             hc
Confidence            74

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.96  E-value=1.6e-30  Score=219.09  Aligned_cols=173  Identities=25%  Similarity=0.267  Sum_probs=136.3

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |.+|||++.++... -.++.....+..|++.|+.|||    ++||||||+||.||+++.+|.+|++|||.+.........
T Consensus      1316 C~~GsLa~ll~~gr-i~dE~vt~vyt~qll~gla~LH----~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~ 1390 (1509)
T KOG4645|consen 1316 CEGGSLASLLEHGR-IEDEMVTRVYTKQLLEGLAYLH----EHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQT 1390 (1509)
T ss_pred             hccCcHHHHHHhcc-hhhhhHHHHHHHHHHHHHHHHH----hcCceecCCCccceeeecCCcEEeecccceeEecCchhc
Confidence            78999999997543 3677778888999999999999    899999999999999999999999999999877654311


Q ss_pred             c--cccCCCCCccccCCCCCCCCC---cCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhh
Q 037267           81 V--TQTMTMATIGYMAPEYGSEGI---VSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDAN  155 (202)
Q Consensus        81 ~--~~~~~~~~~~~~~pe~~~~~~---~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (202)
                      .  .-....||+.|+|||++.+..   -..++||||+||++.||+||+.||...+............+.|          
T Consensus      1391 ~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~P---------- 1460 (1509)
T KOG4645|consen 1391 MPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKP---------- 1460 (1509)
T ss_pred             CCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCC----------
Confidence            1  122357999999999877643   3567999999999999999999998876554333222222221          


Q ss_pred             hhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          156 LVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                              +.|...+.+..+++..||..||++|.++.|+++
T Consensus      1461 --------q~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1461 --------QIPERLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred             --------CCchhhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence                    112235666889999999999999999998876

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=99.96  E-value=4.9e-30  Score=202.69  Aligned_cols=175  Identities=24%  Similarity=0.308  Sum_probs=127.9

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCc-
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED-   79 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~-   79 (202)
                      |+||+|.+++.+.. .+++..+..++.|++.||.|||    +.+|+||||||+||+++.++.++++|||++........ 
T Consensus        83 ~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~aL~~LH----~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~  157 (381)
T cd05626          83 IPGGDMMSLLIRME-VFPEVLARFYIAELTLAIESVH----KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNS  157 (381)
T ss_pred             CCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----hCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccc
Confidence            57999999998654 4899999999999999999999    89999999999999999999999999998753211000 


Q ss_pred             --------------------------------------------cccccCCCCCccccCCCCCCCCCcCcchhhhhHHHH
Q 037267           80 --------------------------------------------FVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVL  115 (202)
Q Consensus        80 --------------------------------------------~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~  115 (202)
                                                                  ........||..|+|||.+.+..++.++|+||+||+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~i  237 (381)
T cd05626         158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI  237 (381)
T ss_pred             ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhH
Confidence                                                        000112358899999999888888999999999999


Q ss_pred             HHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhHHHHHHhHHHHHHHHHHHhh--hcCCCCCCCCCHHH
Q 037267          116 LMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLALD--CCMESPGKRINMTD  193 (202)
Q Consensus       116 ~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~--cl~~~p~~Rps~~~  193 (202)
                      +|++++|..||...........  +....  .  ..          ..+....++.++.+++.+  |+..++..||++.+
T Consensus       238 l~elltG~~Pf~~~~~~~~~~~--i~~~~--~--~~----------~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~  301 (381)
T cd05626         238 LFEMLVGQPPFLAPTPTETQLK--VINWE--N--TL----------HIPPQVKLSPEAVDLITKLCCSAEERLGRNGADD  301 (381)
T ss_pred             HHHHHhCCCCCcCCCHHHHHHH--HHccc--c--cc----------CCCCCCCCCHHHHHHHHHHccCcccccCCCCHHH
Confidence            9999999999976432221110  00000  0  00          000111245567888887  55566777999999


Q ss_pred             HHH
Q 037267          194 AAA  196 (202)
Q Consensus       194 ~~~  196 (202)
                      ++.
T Consensus       302 ~l~  304 (381)
T cd05626         302 IKA  304 (381)
T ss_pred             Hhc
Confidence            875

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=3e-30  Score=202.67  Aligned_cols=174  Identities=24%  Similarity=0.306  Sum_probs=129.9

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |+||+|.+++.+.. .+++..+..++.|++.||.|||    +.+|+||||||+||+++.++.++++|||++.........
T Consensus        83 ~~~g~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH----~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~  157 (364)
T cd05599          83 LPGGDMMTLLMKKD-TFTEEETRFYIAETILAIDSIH----KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRT  157 (364)
T ss_pred             CCCcHHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeEeccCCHHHeEECCCCCEEEeecccceeccccccc
Confidence            57999999998654 4899999999999999999999    899999999999999999999999999998754321100


Q ss_pred             c------------------------------------cccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCC
Q 037267           81 V------------------------------------TQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKR  124 (202)
Q Consensus        81 ~------------------------------------~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~  124 (202)
                      .                                    ......||+.|+|||++.+..++.++|+||+||++|++++|..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~  237 (364)
T cd05599         158 EFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYP  237 (364)
T ss_pred             cccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCC
Confidence            0                                    0011348899999999888889999999999999999999999


Q ss_pred             CCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCC---HHHHHH
Q 037267          125 PTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRIN---MTDAAA  196 (202)
Q Consensus       125 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps---~~~~~~  196 (202)
                      ||........  ...+....    ...     .     .+.....++++.+++.+|+. +|.+|++   +.++++
T Consensus       238 Pf~~~~~~~~--~~~i~~~~----~~~-----~-----~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~  295 (364)
T cd05599         238 PFCSDNPQET--YRKIINWK----ETL-----Q-----FPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS  295 (364)
T ss_pred             CCCCCCHHHH--HHHHHcCC----Ccc-----C-----CCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence            9976432111  01110000    000     0     00011245568899999996 9999998   888764

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=99.96  E-value=1.2e-29  Score=193.81  Aligned_cols=172  Identities=20%  Similarity=0.287  Sum_probs=130.8

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      +++++|.+++...  .+++..+..++.|++.||.|||    +.+++||||||.||+++.++.++++|||++........ 
T Consensus       101 ~~~~~L~~~~~~~--~l~~~~~~~~~~qi~~~l~~LH----~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-  173 (292)
T cd06658         101 LEGGALTDIVTHT--RMNEEQIATVCLSVLRALSYLH----NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-  173 (292)
T ss_pred             CCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH----HCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-
Confidence            5789999998643  4899999999999999999999    89999999999999999999999999999875433221 


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhH
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREE  160 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (202)
                       ......++..|+|||...+..++.++|+||+|+++|++++|..||....... ... .+....+...            
T Consensus       174 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~-~~~-~~~~~~~~~~------------  238 (292)
T cd06658         174 -KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ-AMR-RIRDNLPPRV------------  238 (292)
T ss_pred             -cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHH-HHHhcCCCcc------------
Confidence             1122357889999999888888899999999999999999999986532111 011 1111110000            


Q ss_pred             HHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 037267          161 QAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAK  197 (202)
Q Consensus       161 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~  197 (202)
                         ......+..+.+++.+||..||++|||+.++++.
T Consensus       239 ---~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         239 ---KDSHKVSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             ---ccccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence               0011234558899999999999999999999863

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.96  E-value=8.3e-30  Score=201.68  Aligned_cols=170  Identities=22%  Similarity=0.335  Sum_probs=138.7

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeC-CCCceEEcccccceeccCCCc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLD-ENMVAHVSDFGISKLLGEGED   79 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~-~~~~~~l~d~g~~~~~~~~~~   79 (202)
                      |+.|+|..|++++.. +......+|++||+.||.|||+.  ...|+|||||=+||+|+ .-|.+||+|+|+|.....+- 
T Consensus       125 ~TSGtLr~Y~kk~~~-vn~kaik~W~RQILkGL~yLHs~--~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~-  200 (632)
T KOG0584|consen  125 FTSGTLREYRKKHRR-VNIKAIKSWCRQILKGLVYLHSQ--DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH-  200 (632)
T ss_pred             ccCCcHHHHHHHhcc-CCHHHHHHHHHHHHHHhhhhhcC--CCCccccccccceEEEcCCcCceeecchhHHHHhhccc-
Confidence            578999999998765 89999999999999999999965  57999999999999998 56899999999998765432 


Q ss_pred             cccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhh
Q 037267           80 FVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVRE  159 (202)
Q Consensus        80 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (202)
                         ....+|||.|+|||+.. ..|+..+||||||++++||+|+..||..+...-...+..+-+..|.....+        
T Consensus       201 ---aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV--------  268 (632)
T KOG0584|consen  201 ---AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKV--------  268 (632)
T ss_pred             ---cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhcc--------
Confidence               22358999999999865 789999999999999999999999999887665444433322222222222        


Q ss_pred             HHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          160 EQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       160 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                               -.+++.++|.+|+.. .++|||+.|+++
T Consensus       269 ---------~dPevr~fIekCl~~-~~~R~sa~eLL~  295 (632)
T KOG0584|consen  269 ---------KDPEVREFIEKCLAT-KSERLSAKELLK  295 (632)
T ss_pred             ---------CCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence                     234589999999999 999999999985

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.96  E-value=1.5e-29  Score=209.42  Aligned_cols=178  Identities=25%  Similarity=0.424  Sum_probs=144.8

Q ss_pred             CCCCcHHHHHhhcC---------------CCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEE
Q 037267            1 MPNGSLEKWLYSYN---------------YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHV   65 (202)
Q Consensus         1 ~~~gsL~~~l~~~~---------------~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l   65 (202)
                      |++|+|.+||+...               ..++..+.+.++.||+.|++||+    +..++||||-..|||+..+..+|+
T Consensus       384 ~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~----~~~~vHRDLAaRNVLi~~~~~~kI  459 (609)
T KOG0200|consen  384 AEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA----SVPCVHRDLAARNVLITKNKVIKI  459 (609)
T ss_pred             ccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh----hCCccchhhhhhhEEecCCCEEEE
Confidence            57899999999765               34899999999999999999999    899999999999999999999999


Q ss_pred             cccccceeccCCCcccccc-CCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHh
Q 037267           66 SDFGISKLLGEGEDFVTQT-MTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKES  143 (202)
Q Consensus        66 ~d~g~~~~~~~~~~~~~~~-~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~  143 (202)
                      +|||+++.......+.... ...-+..|+|||.+....++.++|+||||+++||+++ |..||.+....... .++    
T Consensus       460 aDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l-~~~----  534 (609)
T KOG0200|consen  460 ADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEEL-LEF----  534 (609)
T ss_pred             ccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHH-HHH----
Confidence            9999999766555443221 1113567999999999999999999999999999998 88999763211111 112    


Q ss_pred             CCCChhhhhhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhh
Q 037267          144 LPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKK  200 (202)
Q Consensus       144 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~  200 (202)
                                   ...+.+.+.|..|..+++++|+.||+.+|++||+++++.+.++.
T Consensus       535 -------------l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~  578 (609)
T KOG0200|consen  535 -------------LKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEK  578 (609)
T ss_pred             -------------HhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHH
Confidence                         22233345567789999999999999999999999999999875

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.6e-29  Score=196.90  Aligned_cols=168  Identities=22%  Similarity=0.345  Sum_probs=138.5

Q ss_pred             CCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceee-CCCCceEEcccccceeccCCCcc
Q 037267            2 PNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILL-DENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         2 ~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~-~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      -+|+|+|||.++...+.+..+.++++||+.||.|+|    ...+|||||||+|+.+ .+-|-+|+.|||++..+.++.. 
T Consensus       100 D~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCH----qLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~k-  174 (864)
T KOG4717|consen  100 DGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCH----QLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKK-  174 (864)
T ss_pred             CCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHh----hhhhhcccCCcceeEEeeecCceEeeeccccccCCCcch-
Confidence            378999999999888999999999999999999999    6779999999999986 4788999999999988776653 


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCc-chhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhh
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSA-KCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVRE  159 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~-~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (202)
                        ..+..|+..|-|||++.|..|.. ++||||+|+|+|.++.|+.||+...+.+..             ..+.+=.    
T Consensus       175 --L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETL-------------TmImDCK----  235 (864)
T KOG4717|consen  175 --LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETL-------------TMIMDCK----  235 (864)
T ss_pred             --hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhh-------------hhhhccc----
Confidence              33467899999999999988865 579999999999999999999876544321             1111110    


Q ss_pred             HHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          160 EQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       160 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                         ...+...+.+-.+||..||.+||++|.|.+++..
T Consensus       236 ---YtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s  269 (864)
T KOG4717|consen  236 ---YTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS  269 (864)
T ss_pred             ---ccCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence               1223456777899999999999999999999864

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=99.96  E-value=3.6e-29  Score=187.35  Aligned_cols=172  Identities=25%  Similarity=0.320  Sum_probs=134.4

Q ss_pred             CCCCcHHHHHhhc-CCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCc
Q 037267            1 MPNGSLEKWLYSY-NYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED   79 (202)
Q Consensus         1 ~~~gsL~~~l~~~-~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~   79 (202)
                      |++|+|.+++... ...+++..+..++.|++.||.|||    +.+++|+||+|+||+++.++.++++|||.+........
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh----~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~  156 (256)
T cd08221          81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH----KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS  156 (256)
T ss_pred             cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH----hCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence            5789999999865 345899999999999999999999    89999999999999999999999999999876544331


Q ss_pred             cccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhh
Q 037267           80 FVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVRE  159 (202)
Q Consensus        80 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (202)
                        ......++..|.+||...+..++.++|+||+|++++++++|..||........  ...+...           ...  
T Consensus       157 --~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~--~~~~~~~-----------~~~--  219 (256)
T cd08221         157 --MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNL--VVKIVQG-----------NYT--  219 (256)
T ss_pred             --cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHHcC-----------CCC--
Confidence              12234578899999988887788899999999999999999999865322110  0000000           000  


Q ss_pred             HHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 037267          160 EQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAK  197 (202)
Q Consensus       160 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~  197 (202)
                          +....++.++.+++.+||..+|.+||++.++++.
T Consensus       220 ----~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~  253 (256)
T cd08221         220 ----PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ  253 (256)
T ss_pred             ----CCccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence                0012345668999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=99.96  E-value=1.7e-29  Score=194.71  Aligned_cols=123  Identities=20%  Similarity=0.236  Sum_probs=98.7

Q ss_pred             CCcHHHHHhhc--------CCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceee----CCCCceEEccccc
Q 037267            3 NGSLEKWLYSY--------NYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILL----DENMVAHVSDFGI   70 (202)
Q Consensus         3 ~gsL~~~l~~~--------~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~----~~~~~~~l~d~g~   70 (202)
                      +++|.+++...        ...+++..+..++.|++.||.|||    +.+++||||||+||++    +.++.++|+|||+
T Consensus        83 ~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH----~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~  158 (317)
T cd07867          83 EHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH----ANWVLHRDLKPANILVMGEGPERGRVKIADMGF  158 (317)
T ss_pred             CCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH----hCCEEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence            46787877522        124888999999999999999999    8999999999999999    4567899999999


Q ss_pred             ceeccCCCcc-ccccCCCCCccccCCCCCCC-CCcCcchhhhhHHHHHHHHHhCCCCCCcc
Q 037267           71 SKLLGEGEDF-VTQTMTMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKRPTDEM  129 (202)
Q Consensus        71 ~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~-~~~~~~~di~s~G~~~~~~~~g~~p~~~~  129 (202)
                      ++........ .......++..|+|||.+.+ ..++.++|+||+||++|++++|..||...
T Consensus       159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~  219 (317)
T cd07867         159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             eeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence            9875443221 11223457889999998766 45788999999999999999999999753

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=99.96  E-value=4.5e-29  Score=190.93  Aligned_cols=171  Identities=20%  Similarity=0.249  Sum_probs=131.9

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      +++|+|.+++...  .+++.++..++.|++.||.|||    +.+++|+||+|+||+++.++.++++|||++.........
T Consensus        98 ~~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH----~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~  171 (296)
T cd06655          98 LAGGSLTDVVTET--CMDEAQIAAVCRECLQALEFLH----ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK  171 (296)
T ss_pred             cCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEEECCCCCEEEccCccchhccccccc
Confidence            4789999999753  4899999999999999999999    899999999999999999999999999998765433211


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhH
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREE  160 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (202)
                        .....++..|++||...+..++.++|+||+|+++|++++|..||......... ........+ .             
T Consensus       172 --~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~-~~~~~~~~~-~-------------  234 (296)
T cd06655         172 --RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL-YLIATNGTP-E-------------  234 (296)
T ss_pred             --CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHhcCCc-c-------------
Confidence              12234678899999988888889999999999999999999999664322111 101000000 0             


Q ss_pred             HHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          161 QAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       161 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                        ...+..++..+.+++.+||..||++||++.++++
T Consensus       235 --~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~  268 (296)
T cd06655         235 --LQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ  268 (296)
T ss_pred             --cCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence              0011234556889999999999999999999874

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=99.96  E-value=2e-29  Score=189.89  Aligned_cols=172  Identities=24%  Similarity=0.235  Sum_probs=128.1

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      +++++|.+++.+.. .+++..+..++.|++.||.|||    +.+++|+|++|+||+++.++.++++|||++.........
T Consensus        88 ~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~LH----~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~  162 (266)
T cd06651          88 MPGGSVKDQLKAYG-ALTESVTRKYTRQILEGMSYLH----SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMS  162 (266)
T ss_pred             CCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----hCCeeeCCCCHHHEEECCCCCEEEccCCCcccccccccc
Confidence            46899999998654 4899999999999999999999    899999999999999999999999999998754321111


Q ss_pred             -ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhh
Q 037267           81 -VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVRE  159 (202)
Q Consensus        81 -~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (202)
                       .......++..|+|||...+..++.++|+||+|+++|++++|..||........ .........    .          
T Consensus       163 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~-~~~~~~~~~----~----------  227 (266)
T cd06651         163 GTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAA-IFKIATQPT----N----------  227 (266)
T ss_pred             CCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHH-HHHHhcCCC----C----------
Confidence             111123467889999998888889999999999999999999999975422111 110000000    0          


Q ss_pred             HHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          160 EQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       160 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                         ...+....+.+.+++ .||..+|++||++.|+++
T Consensus       228 ---~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         228 ---PQLPSHISEHARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             ---CCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence               000122344466777 788899999999999974

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=7e-29  Score=187.68  Aligned_cols=170  Identities=24%  Similarity=0.269  Sum_probs=132.8

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      +++++|.+++...  .+++..+..++.|++.||.|||    +.+++|+|++|+||+++.++.++++|||++........ 
T Consensus        81 ~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh----~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-  153 (274)
T cd06609          81 CGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLH----EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS-  153 (274)
T ss_pred             eCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCCHHHEEECCCCCEEEcccccceeeccccc-
Confidence            4789999999864  5899999999999999999999    89999999999999999999999999999987654321 


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhH
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREE  160 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (202)
                       ......++..|++||...+..++.++|+||+|+++|++++|..||.......  ....+....++...           
T Consensus       154 -~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~--~~~~~~~~~~~~~~-----------  219 (274)
T cd06609         154 -KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR--VLFLIPKNNPPSLE-----------  219 (274)
T ss_pred             -ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH--HHHHhhhcCCCCCc-----------
Confidence             1223457788999999888889999999999999999999999996543211  11111111000000           


Q ss_pred             HHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          161 QAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       161 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                           ...++.++.+++.+||..+|++||++.++++
T Consensus       220 -----~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~  250 (274)
T cd06609         220 -----GNKFSKPFKDFVSLCLNKDPKERPSAKELLK  250 (274)
T ss_pred             -----ccccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence                 0014556889999999999999999999975

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.96  E-value=7.9e-29  Score=190.89  Aligned_cols=190  Identities=22%  Similarity=0.233  Sum_probs=133.1

Q ss_pred             CCCCcHHHHHhhc-CCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCc
Q 037267            1 MPNGSLEKWLYSY-NYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED   79 (202)
Q Consensus         1 ~~~gsL~~~l~~~-~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~   79 (202)
                      |++|+|.+++... +..+++..+..++.|++.||.|||    +.+|+|+||||+||+++.++.++++||+.+........
T Consensus        81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH----~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~  156 (314)
T cd08216          81 MAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIH----SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGK  156 (314)
T ss_pred             cCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCcceEEEecCCceEEecCccceeeccccc
Confidence            5789999999854 345899999999999999999999    89999999999999999999999999998875532211


Q ss_pred             c-----ccccCCCCCccccCCCCCCC--CCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCC-----
Q 037267           80 F-----VTQTMTMATIGYMAPEYGSE--GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHG-----  147 (202)
Q Consensus        80 ~-----~~~~~~~~~~~~~~pe~~~~--~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~-----  147 (202)
                      .     .......++..|++||.+..  ..++.++|+||+|++++++++|..||............ .....+..     
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~  235 (314)
T cd08216         157 RQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEK-VRGTVPCLLDKST  235 (314)
T ss_pred             cccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-HhccCccccccCc
Confidence            0     00112345678999998755  34788899999999999999999999764332221111 11000000     


Q ss_pred             -------hhh----hhhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          148 -------LTE----VVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       148 -------~~~----~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                             ...    ..... .............+.++.+++.+||..||++|||+.++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~  294 (314)
T cd08216         236 YPLYEDSMSQSRSSNEHPN-NRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN  294 (314)
T ss_pred             hhhhcCCcCcccccccccc-hhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence                   000    00000 0001111222345567899999999999999999999875

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=99.96  E-value=1e-29  Score=199.69  Aligned_cols=124  Identities=27%  Similarity=0.351  Sum_probs=105.3

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |+||+|.+++.... .+++..+..++.|++.||.|||    +.+|+||||||+||+++.++.++|+|||++.........
T Consensus        83 ~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH----~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~  157 (363)
T cd05628          83 LPGGDMMTLLMKKD-TLTEEETQFYIAETVLAIDSIH----QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRT  157 (363)
T ss_pred             CCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----hCCeEecCCCHHHeEECCCCCEEEeeccCcccccccccc
Confidence            58999999998654 4899999999999999999999    899999999999999999999999999998754321000


Q ss_pred             ---------------------------------ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCC
Q 037267           81 ---------------------------------VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTD  127 (202)
Q Consensus        81 ---------------------------------~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~  127 (202)
                                                       .......||+.|+|||.+.+..++.++|+||+||++|+|++|..||.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~  237 (363)
T cd05628         158 EFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC  237 (363)
T ss_pred             cccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCC
Confidence                                             00012358999999999888889999999999999999999999997


Q ss_pred             cc
Q 037267          128 EM  129 (202)
Q Consensus       128 ~~  129 (202)
                      ..
T Consensus       238 ~~  239 (363)
T cd05628         238 SE  239 (363)
T ss_pred             CC
Confidence            54

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=99.96  E-value=5.6e-29  Score=187.29  Aligned_cols=174  Identities=21%  Similarity=0.220  Sum_probs=131.4

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCc-
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED-   79 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~-   79 (202)
                      +++|+|.+++.+.. .+++..+..++.|++.||.|||    +.+++|+||+|.||+++.++.++++|||.+........ 
T Consensus        84 ~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~  158 (265)
T cd06631          84 VPGGSISSILNRFG-PLPEPVFCKYTKQILDGVAYLH----NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLH  158 (265)
T ss_pred             CCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----hCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcccc
Confidence            57899999997654 4789999999999999999999    89999999999999999999999999999875432110 


Q ss_pred             ---cccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhh
Q 037267           80 ---FVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANL  156 (202)
Q Consensus        80 ---~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (202)
                         ........++..|+|||...+..++.++|+||+|+++|++++|..||......... . ......  ...       
T Consensus       159 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~-~-~~~~~~--~~~-------  227 (265)
T cd06631         159 GTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAM-F-YIGAHR--GLM-------  227 (265)
T ss_pred             ccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHH-H-Hhhhcc--CCC-------
Confidence               00111234678899999988888889999999999999999999999653221110 0 000000  000       


Q ss_pred             hhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          157 VREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                            ...+...+.++.+++.+||..+|++||++.+++.
T Consensus       228 ------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         228 ------PRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             ------CCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                  0011234566899999999999999999999874

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=99.96  E-value=4.9e-29  Score=189.42  Aligned_cols=188  Identities=24%  Similarity=0.296  Sum_probs=130.4

Q ss_pred             CCcHHHHHhhcC--CCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            3 NGSLEKWLYSYN--YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         3 ~gsL~~~l~~~~--~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      .++|.+++....  ..+++..+..++.|++.||.|||    +.+++|+|++|+||+++.++.++++|||++........ 
T Consensus        82 ~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH----~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-  156 (285)
T cd07861          82 SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH----SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR-  156 (285)
T ss_pred             CCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHH----hCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc-
Confidence            368888887533  45899999999999999999999    89999999999999999999999999999876543221 


Q ss_pred             ccccCCCCCccccCCCCCCCC-CcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCC-----CChhhhhhh
Q 037267           81 VTQTMTMATIGYMAPEYGSEG-IVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLP-----HGLTEVVDA  154 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~-~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~  154 (202)
                       ......++..|+|||...+. .++.++|+||+|++++++++|..||..................+     .......+.
T Consensus       157 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (285)
T cd07861         157 -VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDY  235 (285)
T ss_pred             -cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHH
Confidence             12223567889999976543 46888999999999999999999997543221111110000000     000000000


Q ss_pred             hhh----hhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          155 NLV----REEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       155 ~~~----~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                      ...    ...........++.++.+++.+||..||++|||+.++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         236 KNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             HhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence            000    000001112235677899999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=99.96  E-value=1.1e-28  Score=186.11  Aligned_cols=173  Identities=26%  Similarity=0.308  Sum_probs=128.7

Q ss_pred             CCCCcHHHHHhhcCCCC--CHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCC-CCceEEcccccceeccCC
Q 037267            1 MPNGSLEKWLYSYNYFF--DILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDE-NMVAHVSDFGISKLLGEG   77 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l--~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~-~~~~~l~d~g~~~~~~~~   77 (202)
                      +++++|.+++......+  +...+..++.|++.||.|||    +.+++|+|+||.||+++. ++.++++|||.+......
T Consensus        87 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH----~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~  162 (268)
T cd06624          87 VPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLH----DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGI  162 (268)
T ss_pred             CCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHH----HCCEeecCCCHHHEEEcCCCCeEEEecchhheecccC
Confidence            47899999998654445  78889999999999999999    899999999999999986 678999999998765322


Q ss_pred             CccccccCCCCCccccCCCCCCCC--CcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhh
Q 037267           78 EDFVTQTMTMATIGYMAPEYGSEG--IVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDAN  155 (202)
Q Consensus        78 ~~~~~~~~~~~~~~~~~pe~~~~~--~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (202)
                      ...  .....++..|++||.....  .++.++|+||+|+++|++++|..||...........  .....           
T Consensus       163 ~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~--~~~~~-----------  227 (268)
T cd06624         163 NPC--TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMF--KVGMF-----------  227 (268)
T ss_pred             CCc--cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHh--hhhhh-----------
Confidence            211  1123468899999986553  367889999999999999999999865432211110  00000           


Q ss_pred             hhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          156 LVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                        .  .....+..+.+++.+++.+||+.+|++|||+.++++
T Consensus       228 --~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  264 (268)
T cd06624         228 --K--IHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ  264 (268)
T ss_pred             --c--cCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence              0  000112234566889999999999999999999875

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=99.96  E-value=8.4e-30  Score=198.49  Aligned_cols=166  Identities=24%  Similarity=0.308  Sum_probs=130.1

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccC----
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGE----   76 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~----   76 (202)
                      +|||++.-.|.+.+. |++..+.-++.+++.||.-+|    ..|++||||||+|+|||..|.+||.|||++.....    
T Consensus       223 lPGGD~mTLL~~~~~-L~e~~arfYiaE~vlAI~~iH----~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~  297 (550)
T KOG0605|consen  223 LPGGDMMTLLMRKDT-LTEDWARFYIAETVLAIESIH----QLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRI  297 (550)
T ss_pred             cCCccHHHHHHhcCc-CchHHHHHHHHHHHHHHHHHH----HcCcccccCChhheeecCCCCEeeccccccchhhhhhhh
Confidence            589999999987554 999999999999999999999    89999999999999999999999999999863211    


Q ss_pred             ------------------CCccc----c-------------------ccCCCCCccccCCCCCCCCCcCcchhhhhHHHH
Q 037267           77 ------------------GEDFV----T-------------------QTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVL  115 (202)
Q Consensus        77 ------------------~~~~~----~-------------------~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~  115 (202)
                                        .....    .                   .-...|||-|+|||++.+..|+..+|.||+|||
T Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~I  377 (550)
T KOG0605|consen  298 ESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCI  377 (550)
T ss_pred             hhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHH
Confidence                              00000    0                   001358999999999999999999999999999


Q ss_pred             HHHHHhCCCCCCcccccch--hhHHHHHHhCCCChhhhhhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCC
Q 037267          116 LMETFTRKRPTDEMFTGEM--SLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRIN  190 (202)
Q Consensus       116 ~~~~~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps  190 (202)
                      +|||+.|.+||...+..+.  .+..|...                  ...+....++.+..|||.+|+. ||++|..
T Consensus       378 myEmLvGyPPF~s~tp~~T~rkI~nwr~~------------------l~fP~~~~~s~eA~DLI~rll~-d~~~RLG  435 (550)
T KOG0605|consen  378 MYEMLVGYPPFCSETPQETYRKIVNWRET------------------LKFPEEVDLSDEAKDLITRLLC-DPENRLG  435 (550)
T ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHHHhhh------------------ccCCCcCcccHHHHHHHHHHhc-CHHHhcC
Confidence            9999999999987543321  11111110                  1122233455789999999999 9999986

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.96  E-value=8e-30  Score=196.30  Aligned_cols=157  Identities=29%  Similarity=0.391  Sum_probs=119.8

Q ss_pred             CCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCc---cccccCCCCCcccc
Q 037267           17 FDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED---FVTQTMTMATIGYM   93 (202)
Q Consensus        17 l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~---~~~~~~~~~~~~~~   93 (202)
                      +++.++++++++++.||+|||    ..+|+||||||+|+|++.+|.+||+|||++........   ........||+.|+
T Consensus       207 ls~~~Ar~ylrDvv~GLEYLH----~QgiiHRDIKPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~  282 (576)
T KOG0585|consen  207 LSEQQARKYLRDVVLGLEYLH----YQGIIHRDIKPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFF  282 (576)
T ss_pred             ccHHHHHHHHHHHHHHHHHHH----hcCeeccccchhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCcccc
Confidence            899999999999999999999    99999999999999999999999999999987632211   11122247999999


Q ss_pred             CCCCCCCCC----cCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhHHHHHHhHHH
Q 037267           94 APEYGSEGI----VSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDC  169 (202)
Q Consensus        94 ~pe~~~~~~----~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  169 (202)
                      |||...++.    .+.+.||||+|+.+|.++.|+.||.+...-+  +.           ..++     ...-..+...+.
T Consensus       283 APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~--l~-----------~KIv-----n~pL~fP~~pe~  344 (576)
T KOG0585|consen  283 APELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELE--LF-----------DKIV-----NDPLEFPENPEI  344 (576)
T ss_pred             chHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHH--HH-----------HHHh-----cCcccCCCcccc
Confidence            999765532    3567899999999999999999996532111  11           1111     111111222356


Q ss_pred             HHHHHHHHhhhcCCCCCCCCCHHHHH
Q 037267          170 IVSIMDLALDCCMESPGKRINMTDAA  195 (202)
Q Consensus       170 ~~~~~~l~~~cl~~~p~~Rps~~~~~  195 (202)
                      .+.+.+|+.++|.+||++|++..+|.
T Consensus       345 ~e~~kDli~~lL~KdP~~Ri~l~~ik  370 (576)
T KOG0585|consen  345 NEDLKDLIKRLLEKDPEQRITLPDIK  370 (576)
T ss_pred             cHHHHHHHHHHhhcChhheeehhhhe
Confidence            67799999999999999999998875

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=99.96  E-value=3.3e-29  Score=190.65  Aligned_cols=173  Identities=23%  Similarity=0.262  Sum_probs=131.3

Q ss_pred             CCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCc
Q 037267            1 MPNGSLEKWLYSYN-YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED   79 (202)
Q Consensus         1 ~~~gsL~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~   79 (202)
                      +++|+|.+++.... ..+++..+..++.|++.||.|||    +.+|+|||+||.||+++.++.++++|||++........
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH----~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~  157 (285)
T cd05632          82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH----RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES  157 (285)
T ss_pred             ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----hCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCc
Confidence            47899999987543 35899999999999999999999    89999999999999999999999999999876543221


Q ss_pred             cccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhh
Q 037267           80 FVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVRE  159 (202)
Q Consensus        80 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (202)
                         .....++..|+|||...+..++.++|+||+|+++|++++|..||......... . ..........           
T Consensus       158 ---~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~-~-~~~~~~~~~~-----------  221 (285)
T cd05632         158 ---IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKR-E-EVDRRVLETE-----------  221 (285)
T ss_pred             ---ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHH-H-HHHHhhhccc-----------
Confidence               12245789999999988888899999999999999999999999754321110 0 0100000000           


Q ss_pred             HHHHHHhHHHHHHHHHHHhhhcCCCCCCCCC-----HHHHHH
Q 037267          160 EQAFAAKMDCIVSIMDLALDCCMESPGKRIN-----MTDAAA  196 (202)
Q Consensus       160 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps-----~~~~~~  196 (202)
                         .......+.++.+++..||+.||++||+     +.+++.
T Consensus       222 ---~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05632         222 ---EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR  260 (285)
T ss_pred             ---cccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence               0011234556889999999999999999     566654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=2.1e-29  Score=191.15  Aligned_cols=173  Identities=23%  Similarity=0.296  Sum_probs=131.1

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      +++|+|.+++.+....+++..+..++.|++.||.|||    +.+++|+|++|.||+++.++.++++|||++........ 
T Consensus        84 ~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh----~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-  158 (280)
T cd06611          84 CDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH----SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ-  158 (280)
T ss_pred             cCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCChhhEEECCCCCEEEccCccchhhccccc-
Confidence            4789999999876666999999999999999999999    89999999999999999999999999998765433211 


Q ss_pred             ccccCCCCCccccCCCCCC-----CCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhh
Q 037267           81 VTQTMTMATIGYMAPEYGS-----EGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDAN  155 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~-----~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (202)
                       ......++..|.+||...     +..++.++|+||+|+++|++++|..||........ .... ....+.         
T Consensus       159 -~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~-~~~~-~~~~~~---------  226 (280)
T cd06611         159 -KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRV-LLKI-LKSEPP---------  226 (280)
T ss_pred             -ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHH-HHHH-hcCCCC---------
Confidence             112235788899999753     34567789999999999999999999865432111 1111 000000         


Q ss_pred             hhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          156 LVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                            ....+..++.++.+++.+||..+|.+||++.++++
T Consensus       227 ------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (280)
T cd06611         227 ------TLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLK  261 (280)
T ss_pred             ------CcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhc
Confidence                  00111234556889999999999999999999875

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=99.96  E-value=2.6e-29  Score=192.99  Aligned_cols=177  Identities=20%  Similarity=0.190  Sum_probs=130.4

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      ++||+|.+++.+.. .+++..+..++.|++.||.|||    +.+++|+|+||.||+++.++.++++|||+++........
T Consensus        83 ~~g~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~  157 (305)
T cd05609          83 VEGGDCATLLKNIG-ALPVDMARMYFAETVLALEYLH----NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTT  157 (305)
T ss_pred             CCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCccccCCchHHEEECCCCCEEEeeCCCccccCcCccc
Confidence            47899999997654 4899999999999999999999    899999999999999999999999999988642111000


Q ss_pred             -------------ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCC
Q 037267           81 -------------VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHG  147 (202)
Q Consensus        81 -------------~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~  147 (202)
                                   .......++..|++||.+.+..++.++|+||+|+++|++++|..||....... ..........   
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~-~~~~~~~~~~---  233 (305)
T cd05609         158 NLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE-LFGQVISDDI---  233 (305)
T ss_pred             cccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhccc---
Confidence                         00112346778999999888888999999999999999999999986432111 0111100000   


Q ss_pred             hhhhhhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHh
Q 037267          148 LTEVVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLK  199 (202)
Q Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~  199 (202)
                               ..    ......++.++.+++.+||+.+|++||++.++.+.|+
T Consensus       234 ---------~~----~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~  272 (305)
T cd05609         234 ---------EW----PEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQ  272 (305)
T ss_pred             ---------CC----CCccccCCHHHHHHHHHHhccChhhccCccCHHHHHh
Confidence                     00    0001135566899999999999999999766665554

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=1.1e-29  Score=198.51  Aligned_cols=172  Identities=23%  Similarity=0.286  Sum_probs=126.9

Q ss_pred             CCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcccc
Q 037267            3 NGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVT   82 (202)
Q Consensus         3 ~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~   82 (202)
                      .-+|..+|++...-+..-.++.++.|++.++.++|    .+||||.||||.|+|+.. |.+||+|||.+.......+...
T Consensus       443 d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH----~~gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DTTsI~  517 (677)
T KOG0596|consen  443 DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIH----QHGIVHSDLKPANFLLVK-GRLKLIDFGIANAIQPDTTSIV  517 (677)
T ss_pred             cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHH----HhceeecCCCcccEEEEe-eeEEeeeechhcccCcccccee
Confidence            45788999865543443478899999999999999    999999999999999865 5799999999998776665555


Q ss_pred             ccCCCCCccccCCCCCCCC-----------CcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhh
Q 037267           83 QTMTMATIGYMAPEYGSEG-----------IVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEV  151 (202)
Q Consensus        83 ~~~~~~~~~~~~pe~~~~~-----------~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (202)
                      ...-.||+-|++||.+...           +.+.++||||+|||+|+|+.|+.||.........+.            .+
T Consensus       518 kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~------------aI  585 (677)
T KOG0596|consen  518 KDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLH------------AI  585 (677)
T ss_pred             eccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHH------------hh
Confidence            5556899999999954432           256789999999999999999999976422111111            11


Q ss_pred             hhhhhh-hhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          152 VDANLV-REEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       152 ~~~~~~-~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                      .+++.. ..+.     ..-..++.++|+.||.+||.+|||..++++
T Consensus       586 ~~P~~~Iefp~-----~~~~~~li~~mK~CL~rdPkkR~si~eLLq  626 (677)
T KOG0596|consen  586 TDPNHEIEFPD-----IPENDELIDVMKCCLARDPKKRWSIPELLQ  626 (677)
T ss_pred             cCCCccccccC-----CCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence            111000 0000     001112889999999999999999999875

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=99.96  E-value=1.7e-29  Score=191.84  Aligned_cols=172  Identities=19%  Similarity=0.223  Sum_probs=129.2

Q ss_pred             CCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCc
Q 037267            1 MPNGSLEKWLYSYN-YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED   79 (202)
Q Consensus         1 ~~~gsL~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~   79 (202)
                      |++|+|.+++.... ..+++..+..++.|++.||.|||    +.+++|+|++|.||+++.++.++++|||++........
T Consensus       101 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH----~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~~~~  176 (282)
T cd06636         101 CGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLH----AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG  176 (282)
T ss_pred             CCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEEECCCCCEEEeeCcchhhhhcccc
Confidence            47889999997543 35888999999999999999999    89999999999999999999999999999875432211


Q ss_pred             cccccCCCCCccccCCCCCC-----CCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhh
Q 037267           80 FVTQTMTMATIGYMAPEYGS-----EGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDA  154 (202)
Q Consensus        80 ~~~~~~~~~~~~~~~pe~~~-----~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (202)
                        ......++..|+|||.+.     ...++.++|+||+|+++|++++|..||...........  +....        ..
T Consensus       177 --~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~--~~~~~--------~~  244 (282)
T cd06636         177 --RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFL--IPRNP--------PP  244 (282)
T ss_pred             --CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhh--HhhCC--------CC
Confidence              112245788899999764     34577789999999999999999999965432111100  00000        00


Q ss_pred             hhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          155 NLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                      .        .....++.++.+++.+||+.||.+||++.|+++
T Consensus       245 ~--------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         245 K--------LKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             C--------CcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence            0        001234567999999999999999999999874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=99.96  E-value=2e-29  Score=193.23  Aligned_cols=186  Identities=17%  Similarity=0.194  Sum_probs=131.5

Q ss_pred             CCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcccc
Q 037267            3 NGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVT   82 (202)
Q Consensus         3 ~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~   82 (202)
                      .++|.+++......+++..+..++.|++.||.|||    +.+++|+||||+||+++.++.++++|||++.........  
T Consensus        87 ~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH----~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~--  160 (301)
T cd07873          87 DKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCH----RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT--  160 (301)
T ss_pred             ccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----hCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCc--
Confidence            46899998876666899999999999999999999    899999999999999999999999999998764332211  


Q ss_pred             ccCCCCCccccCCCCCCC-CCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCC----Chhhhhhhhh-
Q 037267           83 QTMTMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPH----GLTEVVDANL-  156 (202)
Q Consensus        83 ~~~~~~~~~~~~pe~~~~-~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~-  156 (202)
                      .....++..|+|||...+ ..++.++|+||+|+++|++++|..||......+..  ..+......    .+........ 
T Consensus       161 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  238 (301)
T cd07873         161 YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQL--HFIFRILGTPTEETWPGILSNEEF  238 (301)
T ss_pred             ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHHHcCCCChhhchhhhccccc
Confidence            122346788999997654 34678899999999999999999999764332211  111111110    0000000000 


Q ss_pred             -----hh--hHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          157 -----VR--EEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       157 -----~~--~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                           ..  ..........++..+.+++.+||..||.+|||++|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         239 KSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             cccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence                 00  00000111235567899999999999999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=99.96  E-value=3.8e-29  Score=190.71  Aligned_cols=173  Identities=24%  Similarity=0.246  Sum_probs=128.8

Q ss_pred             CCCCcHHHHHhh---cCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCC
Q 037267            1 MPNGSLEKWLYS---YNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEG   77 (202)
Q Consensus         1 ~~~gsL~~~l~~---~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~   77 (202)
                      +++|+|.++++.   ....+++..+..++.|++.||.|||    +.+++|+||||+||+++.++.++++|||++......
T Consensus       106 ~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH----~~~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~~  181 (291)
T cd06639         106 CNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH----NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTST  181 (291)
T ss_pred             CCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH----hCCeeccCCCHHHEEEcCCCCEEEeecccchhcccc
Confidence            468999999863   2345899999999999999999999    899999999999999999999999999998765432


Q ss_pred             CccccccCCCCCccccCCCCCCCC-----CcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhh
Q 037267           78 EDFVTQTMTMATIGYMAPEYGSEG-----IVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVV  152 (202)
Q Consensus        78 ~~~~~~~~~~~~~~~~~pe~~~~~-----~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  152 (202)
                      ...  .....++..|++||.+...     .++.++|+||+|+++|++++|..||........ ...... ..+...    
T Consensus       182 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~-~~~~~~-~~~~~~----  253 (291)
T cd06639         182 RLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT-LFKIPR-NPPPTL----  253 (291)
T ss_pred             ccc--ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH-HHHHhc-CCCCCC----
Confidence            211  1223567889999976543     357889999999999999999999876432211 111100 000000    


Q ss_pred             hhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          153 DANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                                 ..+......+.+++.+||..+|++||++.++++
T Consensus       254 -----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  286 (291)
T cd06639         254 -----------LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE  286 (291)
T ss_pred             -----------CcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence                       001123345899999999999999999999875

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.96  E-value=9.8e-29  Score=187.45  Aligned_cols=170  Identities=23%  Similarity=0.287  Sum_probs=131.1

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |+||+|.+++.... .+++..+..++.|++.||.|||    +.+++|+|+||.||+++.++.++++|||++.......  
T Consensus        79 ~~g~~L~~~l~~~~-~l~~~~~~~~~~ql~~~l~~lH----~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--  151 (278)
T cd05606          79 MNGGDLHYHLSQHG-VFSEAEMRFYAAEIILGLEHMH----NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--  151 (278)
T ss_pred             CCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC--
Confidence            57999999997644 5899999999999999999999    8999999999999999999999999999987543221  


Q ss_pred             ccccCCCCCccccCCCCCCCC-CcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhh
Q 037267           81 VTQTMTMATIGYMAPEYGSEG-IVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVRE  159 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~-~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (202)
                        .....++..|++||...+. .++.++|+||+|+++|++++|..||..................               
T Consensus       152 --~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~---------------  214 (278)
T cd05606         152 --PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM---------------  214 (278)
T ss_pred             --CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhcc---------------
Confidence              1234578899999987643 5788899999999999999999999765322211110000000               


Q ss_pred             HHHHHHhHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHH
Q 037267          160 EQAFAAKMDCIVSIMDLALDCCMESPGKRI-----NMTDAAA  196 (202)
Q Consensus       160 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rp-----s~~~~~~  196 (202)
                        ....+..++.++.+++.+||..+|++||     ++.++++
T Consensus       215 --~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  254 (278)
T cd05606         215 --AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  254 (278)
T ss_pred             --CCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence              0011123456789999999999999999     8998874

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=99.96  E-value=5.5e-29  Score=191.44  Aligned_cols=185  Identities=23%  Similarity=0.292  Sum_probs=132.3

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCC-CCeeecCCCCCceeeCCCCceEEcccccceeccCCCc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSS-APIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED   79 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~-~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~   79 (202)
                      +++|+|.+++.+.. .+++..+..++.|++.||.|||    + .+++|+|+||.||+++.++.++++|||++....... 
T Consensus        81 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH----~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-  154 (308)
T cd06615          81 MDGGSLDQVLKKAG-RIPENILGKISIAVLRGLTYLR----EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-  154 (308)
T ss_pred             cCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----hhCCEEECCCChHHEEEecCCcEEEccCCCcccccccc-
Confidence            47899999998654 4899999999999999999999    5 589999999999999999999999999986543321 


Q ss_pred             cccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCC------------
Q 037267           80 FVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHG------------  147 (202)
Q Consensus        80 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~------------  147 (202)
                         .....++..|++||...+..++.++|+||+|+++|++++|..||.......  ............            
T Consensus       155 ---~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  229 (308)
T cd06615         155 ---ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE--LEAMFGRPVSEGEAKESHRPVSGH  229 (308)
T ss_pred             ---cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhh--HHHhhcCccccccccCCcccccCC
Confidence               123457889999998888788889999999999999999999986433111  111110000000            


Q ss_pred             ---------hhhhhhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 037267          148 ---------LTEVVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAK  197 (202)
Q Consensus       148 ---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~  197 (202)
                               ............. ........+.++.+++.+||..+|++||++.++++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  287 (308)
T cd06615         230 PPDSPRPMAIFELLDYIVNEPP-PKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH  287 (308)
T ss_pred             CCCccchhhHHHHHHHHhcCCC-ccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                     0000000000000 000011245678999999999999999999998753

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=3.6e-29  Score=188.90  Aligned_cols=173  Identities=23%  Similarity=0.281  Sum_probs=130.2

Q ss_pred             CCCCcHHHHHhhc---CCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCC
Q 037267            1 MPNGSLEKWLYSY---NYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEG   77 (202)
Q Consensus         1 ~~~gsL~~~l~~~---~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~   77 (202)
                      |++++|.+++...   +..+++..+..++.|++.||.|||    +.+++|+||+|+||+++.++.++++|||.+......
T Consensus        91 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH----~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~  166 (275)
T cd06608          91 CGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH----ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDST  166 (275)
T ss_pred             CCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHh----cCCcccCCCCHHHEEEccCCeEEECCCccceecccc
Confidence            4788999998743   356899999999999999999999    899999999999999999999999999998765432


Q ss_pred             CccccccCCCCCccccCCCCCCC-----CCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhh
Q 037267           78 EDFVTQTMTMATIGYMAPEYGSE-----GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVV  152 (202)
Q Consensus        78 ~~~~~~~~~~~~~~~~~pe~~~~-----~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  152 (202)
                      ..  ......++..|+|||.+..     ..++.++|+||+|+++|++++|..||........ ...... ....      
T Consensus       167 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~-~~~~------  236 (275)
T cd06608         167 LG--RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRA-LFKIPR-NPPP------  236 (275)
T ss_pred             hh--hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHH-HHHhhc-cCCC------
Confidence            21  1223457888999997543     3467789999999999999999999965322111 111110 0000      


Q ss_pred             hhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          153 DANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                        .       ...+..++.++.+++.+||..||++|||+.++++
T Consensus       237 --~-------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         237 --T-------LKSPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             --C-------CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence              0       0111234566889999999999999999999875

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=99.96  E-value=9.6e-30  Score=201.09  Aligned_cols=174  Identities=24%  Similarity=0.314  Sum_probs=126.3

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCc-
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED-   79 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~-   79 (202)
                      |++|+|.+++.+.. .+++..+..++.|++.||.|||    +.+|+||||||+||+++.++.++|+|||++........ 
T Consensus        83 ~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~al~~lH----~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~  157 (382)
T cd05625          83 IPGGDMMSLLIRMG-IFPEDLARFYIAELTCAVESVH----KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS  157 (382)
T ss_pred             CCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccc
Confidence            57999999997654 4889999999999999999999    89999999999999999999999999999753210000 


Q ss_pred             --------------------------------------------cccccCCCCCccccCCCCCCCCCcCcchhhhhHHHH
Q 037267           80 --------------------------------------------FVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVL  115 (202)
Q Consensus        80 --------------------------------------------~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~  115 (202)
                                                                  ........|++.|+|||++.+..++.++|+||+||+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvi  237 (382)
T cd05625         158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI  237 (382)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHH
Confidence                                                        000012357899999999888889999999999999


Q ss_pred             HHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCC---HH
Q 037267          116 LMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRIN---MT  192 (202)
Q Consensus       116 ~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps---~~  192 (202)
                      +|+|++|..||......... .. +.....    .          ...+.....++++.+++.+++ .+|++|++   +.
T Consensus       238 l~elltG~~Pf~~~~~~~~~-~~-i~~~~~----~----------~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~  300 (382)
T cd05625         238 LYEMLVGQPPFLAQTPLETQ-MK-VINWQT----S----------LHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGAD  300 (382)
T ss_pred             HHHHHhCCCCCCCCCHHHHH-HH-HHccCC----C----------cCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHH
Confidence            99999999999764322110 00 000000    0          000011224456788888876 59999997   77


Q ss_pred             HHHH
Q 037267          193 DAAA  196 (202)
Q Consensus       193 ~~~~  196 (202)
                      +++.
T Consensus       301 ei~~  304 (382)
T cd05625         301 EIKA  304 (382)
T ss_pred             HHhc
Confidence            7653

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=99.96  E-value=2.3e-29  Score=200.18  Aligned_cols=119  Identities=28%  Similarity=0.277  Sum_probs=102.6

Q ss_pred             CCcHHHHHhhcC-CCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCC--CCceEEcccccceeccCCCc
Q 037267            3 NGSLEKWLYSYN-YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDE--NMVAHVSDFGISKLLGEGED   79 (202)
Q Consensus         3 ~gsL~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~--~~~~~l~d~g~~~~~~~~~~   79 (202)
                      .-+|.++|+.++ ..|+...+..++.||+.||.+||    +.+|+|+||||+|||+..  ...+||+|||.+........
T Consensus       271 ~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~----~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q~vy  346 (586)
T KOG0667|consen  271 STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLH----ELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQRVY  346 (586)
T ss_pred             hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH----hCCeeeccCChhheeeccCCcCceeEEecccccccCCcce
Confidence            357999998655 35999999999999999999999    899999999999999974  44789999999987654321


Q ss_pred             cccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCccc
Q 037267           80 FVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMF  130 (202)
Q Consensus        80 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~  130 (202)
                           ..+-++.|+|||++.|.+|+.+-||||||||+.||.+|.+-|.+..
T Consensus       347 -----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~n  392 (586)
T KOG0667|consen  347 -----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDN  392 (586)
T ss_pred             -----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCC
Confidence                 3456789999999999999999999999999999999987776543

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=99.96  E-value=4e-29  Score=189.52  Aligned_cols=173  Identities=24%  Similarity=0.264  Sum_probs=135.0

Q ss_pred             CCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCC--
Q 037267            1 MPNGSLEKWLYSYN-YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEG--   77 (202)
Q Consensus         1 ~~~gsL~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~--   77 (202)
                      |+||+|.-.+++++ ..|++..+.-++.+++.||+|||    -.|||+|||||+|||+-++|.+.+.||.++......  
T Consensus       159 CpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLH----mlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt  234 (459)
T KOG0610|consen  159 CPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLH----MLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPT  234 (459)
T ss_pred             CCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHH----hhceeeccCCcceeEEecCCcEEeeeccccccCCCCCe
Confidence            89999999999765 46999999999999999999999    899999999999999999999999999887532100  


Q ss_pred             ------------------------------Cccc----------------------cccCCCCCccccCCCCCCCCCcCc
Q 037267           78 ------------------------------EDFV----------------------TQTMTMATIGYMAPEYGSEGIVSA  105 (202)
Q Consensus        78 ------------------------------~~~~----------------------~~~~~~~~~~~~~pe~~~~~~~~~  105 (202)
                                                    ....                      ....+.||-.|.|||++.|..-+.
T Consensus       235 ~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgs  314 (459)
T KOG0610|consen  235 LVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGS  314 (459)
T ss_pred             eeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCc
Confidence                                          0000                      011245788999999999999999


Q ss_pred             chhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCC
Q 037267          106 KCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLALDCCMESP  185 (202)
Q Consensus       106 ~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p  185 (202)
                      ++|.|+||+++|||+.|..||.+....+. +            .+++.+....     +.....+..+.|||.+.|.+||
T Consensus       315 AVDWWtfGIflYEmLyG~TPFKG~~~~~T-l------------~NIv~~~l~F-----p~~~~vs~~akDLIr~LLvKdP  376 (459)
T KOG0610|consen  315 AVDWWTFGIFLYEMLYGTTPFKGSNNKET-L------------RNIVGQPLKF-----PEEPEVSSAAKDLIRKLLVKDP  376 (459)
T ss_pred             hhhHHHHHHHHHHHHhCCCCcCCCCchhh-H------------HHHhcCCCcC-----CCCCcchhHHHHHHHHHhccCh
Confidence            99999999999999999999987544331 1            1222221111     1112455668999999999999


Q ss_pred             CCCCC----HHHHH
Q 037267          186 GKRIN----MTDAA  195 (202)
Q Consensus       186 ~~Rps----~~~~~  195 (202)
                      ++|..    |+||.
T Consensus       377 ~kRlg~~rGA~eIK  390 (459)
T KOG0610|consen  377 SKRLGSKRGAAEIK  390 (459)
T ss_pred             hhhhccccchHHhh
Confidence            99997    77764

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=99.96  E-value=4.9e-29  Score=185.57  Aligned_cols=172  Identities=26%  Similarity=0.321  Sum_probs=133.5

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      +++++|.+++......+++..+..++.|++.||.|||    +.+++|+|++|.||+++.++.++|+|||.+........ 
T Consensus        79 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh----~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-  153 (253)
T cd05122          79 CSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLH----SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-  153 (253)
T ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhh----cCCEecCCCCHHHEEEccCCeEEEeecccccccccccc-
Confidence            4689999999876556899999999999999999999    89999999999999999999999999999877654331 


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhH
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREE  160 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (202)
                        .....++..|++||...+..++.++|+||+|++++++++|..||...........  ......   ..          
T Consensus       154 --~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~--~~~~~~---~~----------  216 (253)
T cd05122         154 --RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFK--IATNGP---PG----------  216 (253)
T ss_pred             --ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHH--HHhcCC---CC----------
Confidence              1223577889999988877788899999999999999999999875432111110  000000   00          


Q ss_pred             HHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          161 QAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       161 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                        ......++..+.+++.+||..||++|||+.++++
T Consensus       217 --~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~  250 (253)
T cd05122         217 --LRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK  250 (253)
T ss_pred             --cCcccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence              0011123556899999999999999999999875

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=99.96  E-value=9.6e-29  Score=187.81  Aligned_cols=187  Identities=22%  Similarity=0.234  Sum_probs=132.1

Q ss_pred             CCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcccc
Q 037267            3 NGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVT   82 (202)
Q Consensus         3 ~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~   82 (202)
                      +++|.+++......+++..+..++.|++.||.|||    +.+++|+||||+||+++.++.++++|||.+........ ..
T Consensus        82 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-~~  156 (286)
T cd07832          82 PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMH----ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-RL  156 (286)
T ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-Cc
Confidence            89999999876667999999999999999999999    89999999999999999999999999999876544321 11


Q ss_pred             ccCCCCCccccCCCCCCCC-CcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChh-------hhhh-
Q 037267           83 QTMTMATIGYMAPEYGSEG-IVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLT-------EVVD-  153 (202)
Q Consensus        83 ~~~~~~~~~~~~pe~~~~~-~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~-  153 (202)
                      .....++..|+|||...+. .++.++|+||+|++++++++|..+|....... .+. .+.........       +..+ 
T Consensus       157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~-~~~-~~~~~~~~~~~~~~~~~~~~~~~  234 (286)
T cd07832         157 YSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIE-QLA-IVFRTLGTPNEETWPGLTSLPDY  234 (286)
T ss_pred             cccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHH-HHH-HHHHHcCCCChHHHhhccCcchh
Confidence            1223578889999987544 45789999999999999999987775433211 111 11111100000       0000 


Q ss_pred             hhhhh---hH-HHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          154 ANLVR---EE-QAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       154 ~~~~~---~~-~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                      ..+..   .. .........+..+.+++.+||..+|++||++++++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~  281 (286)
T cd07832         235 NKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR  281 (286)
T ss_pred             hcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            00000   00 000111234577999999999999999999999875

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.96  E-value=3.7e-29  Score=213.51  Aligned_cols=170  Identities=19%  Similarity=0.271  Sum_probs=121.5

Q ss_pred             CCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCC-------------------CCc
Q 037267            2 PNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDE-------------------NMV   62 (202)
Q Consensus         2 ~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~-------------------~~~   62 (202)
                      .+++|.++|......+++.+++.++.||+.||.|||    +.+|+||||||+|||++.                   ++.
T Consensus        62 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH----~~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~  137 (793)
T PLN00181         62 EDVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAH----SQGIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDAT  137 (793)
T ss_pred             CCccHHHHHhcccccccHHHHHHHHHHHHHHHHHHH----hCCeeeccCCchhEEEcccCcEEEeeccccCcccccccCc
Confidence            478999999865556999999999999999999999    899999999999999954                   345


Q ss_pred             eEEcccccceeccCCC--------c------cccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCc
Q 037267           63 AHVSDFGISKLLGEGE--------D------FVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDE  128 (202)
Q Consensus        63 ~~l~d~g~~~~~~~~~--------~------~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~  128 (202)
                      +|++|||+++......        .      ........+|+.|+|||++.+..++.++||||+||++|||++|..|+..
T Consensus       138 ~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~  217 (793)
T PLN00181        138 TKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREE  217 (793)
T ss_pred             ccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhh
Confidence            5666666665321100        0      0001123578889999999888899999999999999999998877643


Q ss_pred             ccccchhhHHHHHHhCCCChhhhhhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          129 MFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       129 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                      ..   ..+........+                  +..........+++..||..+|.+||++.|+++
T Consensus       218 ~~---~~~~~~~~~~~~------------------~~~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~  264 (793)
T PLN00181        218 KS---RTMSSLRHRVLP------------------PQILLNWPKEASFCLWLLHPEPSCRPSMSELLQ  264 (793)
T ss_pred             HH---HHHHHHHHhhcC------------------hhhhhcCHHHHHHHHHhCCCChhhCcChHHHhh
Confidence            11   011111110000                  000111233568889999999999999999974

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=99.96  E-value=7.9e-29  Score=187.76  Aligned_cols=169  Identities=22%  Similarity=0.306  Sum_probs=132.3

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      ++||+|.+++...  .++...+..++.|++.||.|||    +.+++|+||+|+||+++.++.++++|||++.........
T Consensus        84 ~~~~~L~~~i~~~--~l~~~~~~~~~~~l~~~l~~lh----~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~  157 (277)
T cd06640          84 LGGGSALDLLRAG--PFDEFQIATMLKEILKGLDYLH----SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK  157 (277)
T ss_pred             CCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH----hCCccCcCCChhhEEEcCCCCEEEcccccceeccCCccc
Confidence            4789999999753  3789999999999999999999    899999999999999999999999999998765443211


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhH
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREE  160 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (202)
                        .....++..|.|||...+..++.++|+||+|+++|++++|..||.........  ..+....+               
T Consensus       158 --~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~--~~~~~~~~---------------  218 (277)
T cd06640         158 --RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVL--FLIPKNNP---------------  218 (277)
T ss_pred             --cccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHh--hhhhcCCC---------------
Confidence              12234677899999888888899999999999999999999998754322110  00000000               


Q ss_pred             HHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          161 QAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       161 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                        ......++..+.+++.+||..+|++||++.+++.
T Consensus       219 --~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  252 (277)
T cd06640         219 --PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLK  252 (277)
T ss_pred             --CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHh
Confidence              0111235667899999999999999999999965

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=99.96  E-value=8.5e-29  Score=188.11  Aligned_cols=188  Identities=19%  Similarity=0.158  Sum_probs=130.8

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |++++|..++.... .+++..+..++.|++.||.|||    +.+++|+||||.||+++.++.++++|||++.........
T Consensus        82 ~~~~~l~~~~~~~~-~~~~~~~~~~~~ql~~~l~~LH----~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~  156 (286)
T cd07847          82 CDHTVLNELEKNPR-GVPEHLIKKIIWQTLQAVNFCH----KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDD  156 (286)
T ss_pred             cCccHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHH----HCCceecCCChhhEEEcCCCcEEECccccceecCCCccc
Confidence            46777777765433 4899999999999999999999    899999999999999999999999999999876443211


Q ss_pred             ccccCCCCCccccCCCCCCC-CCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHH--hCCCChhhhhh----
Q 037267           81 VTQTMTMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKE--SLPHGLTEVVD----  153 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~-~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~----  153 (202)
                        .....++..|++||.+.+ ..++.++|+||+|+++|++++|..||......+... .....  ...........    
T Consensus       157 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  233 (286)
T cd07847         157 --YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLY-LIRKTLGDLIPRHQQIFSTNQF  233 (286)
T ss_pred             --ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHH-HHHHHhCCCChHHhhhcccccc
Confidence              122346788999998665 457789999999999999999999997644322111 11000  00000000000    


Q ss_pred             ------hhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          154 ------ANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       154 ------~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                            +...............+..+.+++.+||..+|++||++.+++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         234 FKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             cccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence                  0000000000111234667899999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=99.96  E-value=5.1e-29  Score=190.71  Aligned_cols=171  Identities=20%  Similarity=0.255  Sum_probs=131.7

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      ++|++|.+++.+.  .+++..+..++.|++.||.|||    +.+++|+||||+||+++.++.++++|||++.........
T Consensus        98 ~~~~~L~~~~~~~--~~~~~~~~~~~~~l~~~L~~LH----~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~  171 (297)
T cd06656          98 LAGGSLTDVVTET--CMDEGQIAAVCRECLQALDFLH----SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK  171 (297)
T ss_pred             cCCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEEECCCCCEEECcCccceEccCCccC
Confidence            4789999999753  3789999999999999999999    899999999999999999999999999998765433221


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhH
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREE  160 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (202)
                        .....++..|++||...+..++.++|+||+|+++|++++|..||........... ......+.              
T Consensus       172 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~-~~~~~~~~--------------  234 (297)
T cd06656         172 --RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL-IATNGTPE--------------  234 (297)
T ss_pred             --cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee-eccCCCCC--------------
Confidence              1223577889999988888888999999999999999999999965332111000 00000000              


Q ss_pred             HHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          161 QAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       161 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                        ...+...+..+.+++.+||..+|++||++.++++
T Consensus       235 --~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (297)
T cd06656         235 --LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ  268 (297)
T ss_pred             --CCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence              0011234455889999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=99.96  E-value=5.6e-29  Score=187.19  Aligned_cols=178  Identities=27%  Similarity=0.315  Sum_probs=133.9

Q ss_pred             CCCCcHHHHHhhcC--CCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCC
Q 037267            1 MPNGSLEKWLYSYN--YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGE   78 (202)
Q Consensus         1 ~~~gsL~~~l~~~~--~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~   78 (202)
                      |++++|.++++...  ..+++..+..++.|++.||.|||    +.+++|+|++|.||+++.++.++++|||++.......
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh----~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~  156 (267)
T cd06610          81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH----SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGG  156 (267)
T ss_pred             cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence            57899999998542  35899999999999999999999    8999999999999999999999999999987665433


Q ss_pred             ccc--cccCCCCCccccCCCCCCCC-CcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhh
Q 037267           79 DFV--TQTMTMATIGYMAPEYGSEG-IVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDAN  155 (202)
Q Consensus        79 ~~~--~~~~~~~~~~~~~pe~~~~~-~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (202)
                      ...  ......++..|++||.+... .++.++|+||+|++++++++|..||........ +....... +......    
T Consensus       157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~-~~~~~~~~-~~~~~~~----  230 (267)
T cd06610         157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV-LMLTLQND-PPSLETG----  230 (267)
T ss_pred             cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh-HHHHhcCC-CCCcCCc----
Confidence            221  11223577889999987665 678899999999999999999999975433211 11111100 0000000    


Q ss_pred             hhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          156 LVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                              ......+.++.+++.+||..||++||++.++++
T Consensus       231 --------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         231 --------ADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             --------cccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence                    001245567899999999999999999999875

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=99.96  E-value=4.6e-30  Score=202.52  Aligned_cols=174  Identities=24%  Similarity=0.303  Sum_probs=127.6

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCC--
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGE--   78 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~--   78 (202)
                      |++|+|.+++.+.. .+++..+..++.|++.||.|||    +.+|+||||||+||+++.++.++|+|||++.......  
T Consensus        83 ~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~al~~lH----~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~  157 (376)
T cd05598          83 IPGGDMMSLLIRLG-IFEEDLARFYIAELTCAIESVH----KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS  157 (376)
T ss_pred             CCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccc
Confidence            57999999998654 4889999999999999999999    8999999999999999999999999999975321000  


Q ss_pred             ---------------------------------------ccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHH
Q 037267           79 ---------------------------------------DFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMET  119 (202)
Q Consensus        79 ---------------------------------------~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~  119 (202)
                                                             .........|++.|+|||++.+..++.++|+||+||++|++
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyel  237 (376)
T cd05598         158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM  237 (376)
T ss_pred             cccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeeh
Confidence                                                   00001123588999999998888899999999999999999


Q ss_pred             HhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCC---CHHHHHH
Q 037267          120 FTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRI---NMTDAAA  196 (202)
Q Consensus       120 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rp---s~~~~~~  196 (202)
                      ++|..||......+...  .+..... .   .          ..+....++.++.+++.+|+ .+|++|+   ++.++++
T Consensus       238 l~G~~Pf~~~~~~~~~~--~i~~~~~-~---~----------~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~  300 (376)
T cd05598         238 LVGQPPFLADTPAETQL--KVINWET-T---L----------HIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKA  300 (376)
T ss_pred             hhCCCCCCCCCHHHHHH--HHhccCc-c---c----------cCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhC
Confidence            99999997643221100  0100000 0   0          00001124455778888876 5999999   8888764

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=99.96  E-value=1.3e-28  Score=188.42  Aligned_cols=186  Identities=24%  Similarity=0.237  Sum_probs=131.1

Q ss_pred             CCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcccc
Q 037267            3 NGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVT   82 (202)
Q Consensus         3 ~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~   82 (202)
                      +|+|.+++......+++..++.++.|++.||.|||    +++++|+||+|+||+++.++.++++|||++.........  
T Consensus        85 ~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH----~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~--  158 (298)
T cd07841          85 ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLH----SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRK--  158 (298)
T ss_pred             CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH----hCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCcc--
Confidence            78999999865546899999999999999999999    899999999999999999999999999999876543221  


Q ss_pred             ccCCCCCccccCCCCCCC-CCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCC-hh---------hh
Q 037267           83 QTMTMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHG-LT---------EV  151 (202)
Q Consensus        83 ~~~~~~~~~~~~pe~~~~-~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~---------~~  151 (202)
                      .....++..|.|||.+.+ ..++.++|+||+||++|++++|..||....... .+.... ...... ..         ..
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~-~~~~~~-~~~~~~~~~~~~~~~~~~~~  236 (298)
T cd07841         159 MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDID-QLGKIF-EALGTPTEENWPGVTSLPDY  236 (298)
T ss_pred             ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHH-HHHHHH-HHcCCCchhhhhhccccccc
Confidence            112245678999997654 456888999999999999999977776433211 111111 100000 00         00


Q ss_pred             hhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          152 VDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                      ..................+.++.+++.+||..+|++|||+.|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~  281 (298)
T cd07841         237 VEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE  281 (298)
T ss_pred             ccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence            000000000001112345677899999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=99.96  E-value=1.2e-28  Score=187.51  Aligned_cols=174  Identities=22%  Similarity=0.233  Sum_probs=129.8

Q ss_pred             CCCCcHHHHHhh---cCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCC
Q 037267            1 MPNGSLEKWLYS---YNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEG   77 (202)
Q Consensus         1 ~~~gsL~~~l~~---~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~   77 (202)
                      |++|+|.+++..   ....+++..+..++.|++.||.|||    +.+++|||+||+||+++.++.++++|||++......
T Consensus       102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~  177 (286)
T cd06638         102 CNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH----VNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTST  177 (286)
T ss_pred             cCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHH----hCCccccCCCHHhEEECCCCCEEEccCCceeecccC
Confidence            578999999863   2345889999999999999999999    899999999999999999999999999998765432


Q ss_pred             CccccccCCCCCccccCCCCCCC-----CCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhh
Q 037267           78 EDFVTQTMTMATIGYMAPEYGSE-----GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVV  152 (202)
Q Consensus        78 ~~~~~~~~~~~~~~~~~pe~~~~-----~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  152 (202)
                      ...  .....++..|+|||.+..     ..++.++|+||+|+++|++++|..||........ ..... ...+       
T Consensus       178 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~-~~~~~-~~~~-------  246 (286)
T cd06638         178 RLR--RNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA-LFKIP-RNPP-------  246 (286)
T ss_pred             CCc--cccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH-Hhhcc-ccCC-------
Confidence            211  122357889999997643     3467889999999999999999999865432111 00000 0000       


Q ss_pred             hhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 037267          153 DANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAK  197 (202)
Q Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~  197 (202)
                       ..       ...+..++.++.+++.+||+.||++|||+.|+++.
T Consensus       247 -~~-------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  283 (286)
T cd06638         247 -PT-------LHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH  283 (286)
T ss_pred             -Cc-------ccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence             00       00011234568899999999999999999999864

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=99.96  E-value=4.6e-29  Score=189.91  Aligned_cols=171  Identities=19%  Similarity=0.287  Sum_probs=131.1

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      +++++|.+++..  ..++...+..++.|++.||.|||    +.+++||||+|+||+++.++.++++|||.+........ 
T Consensus        98 ~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH----~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-  170 (285)
T cd06648          98 LEGGALTDIVTH--TRMNEEQIATVCLAVLKALSFLH----AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-  170 (285)
T ss_pred             cCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc-
Confidence            468999999986  34899999999999999999999    89999999999999999999999999998765433221 


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhH
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREE  160 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (202)
                       ......++..|++||...+..++.++|+||+|+++|++++|..||....... .. .......+...            
T Consensus       171 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~-~~-~~~~~~~~~~~------------  235 (285)
T cd06648         171 -RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQ-AM-KRIRDNLPPKL------------  235 (285)
T ss_pred             -ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHH-HH-HHHHhcCCCCC------------
Confidence             1122457889999999888888899999999999999999999986532111 01 11110000000            


Q ss_pred             HHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          161 QAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       161 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                         .....++..+.+++.+||..+|++||++.++++
T Consensus       236 ---~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         236 ---KNLHKVSPRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             ---cccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence               001124556899999999999999999999885

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=99.96  E-value=7.4e-29  Score=190.76  Aligned_cols=197  Identities=23%  Similarity=0.311  Sum_probs=137.4

Q ss_pred             CCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCC-----CCCCeeecCCCCCceeeCCCCceEEcccccceeccC
Q 037267            2 PNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGH-----SSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGE   76 (202)
Q Consensus         2 ~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~-----~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~   76 (202)
                      ++|||.+||..+.  ++|....+++..++.||+|||+-.     -..+|+|||+|+.|||+.+|.++.|+|||++..+.+
T Consensus       291 ~kGsL~dyL~~nt--isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p  368 (534)
T KOG3653|consen  291 PKGSLCDYLKANT--ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEP  368 (534)
T ss_pred             cCCcHHHHHHhcc--ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEecC
Confidence            6899999998654  799999999999999999999821     156899999999999999999999999999998886


Q ss_pred             CCccccccCCCCCccccCCCCCCCCCc------CcchhhhhHHHHHHHHHhCCCCCCc-ccccc-hhhHHHHHHhCC--C
Q 037267           77 GEDFVTQTMTMATIGYMAPEYGSEGIV------SAKCDVYSYGVLLMETFTRKRPTDE-MFTGE-MSLRRWVKESLP--H  146 (202)
Q Consensus        77 ~~~~~~~~~~~~~~~~~~pe~~~~~~~------~~~~di~s~G~~~~~~~~g~~p~~~-~~~~~-~~~~~~~~~~~~--~  146 (202)
                      ...........||.+|+|||++.+...      -.+.||||+|.++||++++-..++. ...+. ..+..-+ ...|  .
T Consensus       369 ~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~ev-G~hPt~e  447 (534)
T KOG3653|consen  369 GKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEV-GNHPTLE  447 (534)
T ss_pred             CCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHh-cCCCCHH
Confidence            655444445689999999998776532      1358999999999999997654321 11111 1111111 0011  0


Q ss_pred             ChhhhhhhhhhhhHHHHHH-hHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          147 GLTEVVDANLVREEQAFAA-KMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       147 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                      .++..+-.....+...... ...-...+.+.+..||+.||+.|.|+.=+-+++.++
T Consensus       448 ~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l  503 (534)
T KOG3653|consen  448 EMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAEL  503 (534)
T ss_pred             HHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHH
Confidence            1111111111111000000 012334488999999999999999999998888765

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=9.4e-30  Score=200.80  Aligned_cols=174  Identities=25%  Similarity=0.311  Sum_probs=127.4

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCc-
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED-   79 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~-   79 (202)
                      |+||+|.+++.... .+++..+..++.|++.||.|||    +.+|+||||||+||+++.++.++++|||+++....... 
T Consensus        83 ~~gg~L~~~l~~~~-~~~~~~~~~~~~ql~~aL~~LH----~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  157 (377)
T cd05629          83 LPGGDLMTMLIKYD-TFSEDVTRFYMAECVLAIEAVH----KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDS  157 (377)
T ss_pred             CCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----hCCeeccCCCHHHEEECCCCCEEEeeccccccccccccc
Confidence            57999999997644 4899999999999999999999    89999999999999999999999999999863321000 


Q ss_pred             -----------cc---------------------------------cccCCCCCccccCCCCCCCCCcCcchhhhhHHHH
Q 037267           80 -----------FV---------------------------------TQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVL  115 (202)
Q Consensus        80 -----------~~---------------------------------~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~  115 (202)
                                 ..                                 ......|++.|+|||.+.+..++.++|+||+||+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi  237 (377)
T cd05629         158 AYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAI  237 (377)
T ss_pred             ccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchh
Confidence                       00                                 0001358889999999888889999999999999


Q ss_pred             HHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCC---CCHH
Q 037267          116 LMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKR---INMT  192 (202)
Q Consensus       116 ~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~R---ps~~  192 (202)
                      +|++++|..||........ +.. +....    ...     .     .+.....+.++.+++.+|+. +|.+|   +++.
T Consensus       238 l~elltG~~Pf~~~~~~~~-~~~-i~~~~----~~~-----~-----~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~  300 (377)
T cd05629         238 MFECLIGWPPFCSENSHET-YRK-IINWR----ETL-----Y-----FPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAH  300 (377)
T ss_pred             hhhhhcCCCCCCCCCHHHH-HHH-HHccC----Ccc-----C-----CCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHH
Confidence            9999999999965432111 111 10000    000     0     00011245568899999997 77775   5888


Q ss_pred             HHHH
Q 037267          193 DAAA  196 (202)
Q Consensus       193 ~~~~  196 (202)
                      +++.
T Consensus       301 ~~l~  304 (377)
T cd05629         301 EIKS  304 (377)
T ss_pred             HHhc
Confidence            8765

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=99.96  E-value=1.1e-28  Score=186.27  Aligned_cols=177  Identities=26%  Similarity=0.333  Sum_probs=130.6

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      +++|+|.++++... .++...+..++.|++.||.|||    +.+++|+|++|.||+++.++.++++|||++.........
T Consensus        90 ~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH----~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~  164 (272)
T cd06629          90 VPGGSIGSCLRTYG-RFEEQLVRFFTEQVLEGLAYLH----SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDN  164 (272)
T ss_pred             CCCCcHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHh----hCCeeecCCChhhEEEcCCCeEEEeeccccccccccccc
Confidence            47899999998764 5899999999999999999999    899999999999999999999999999998764322111


Q ss_pred             ccccCCCCCccccCCCCCCCCC--cCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhh
Q 037267           81 VTQTMTMATIGYMAPEYGSEGI--VSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVR  158 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~--~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (202)
                      .......++..|++||......  ++.++|+||+|++++++++|..||........ ..........    ....     
T Consensus       165 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~----~~~~-----  234 (272)
T cd06629         165 DQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAA-MFKLGNKRSA----PPIP-----  234 (272)
T ss_pred             cccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHH-HHHhhccccC----CcCC-----
Confidence            1112234678899999766543  78889999999999999999999864322110 0000000000    0000     


Q ss_pred             hHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          159 EEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       159 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                          ......++.++.+++.+||..+|.+|||+.++++
T Consensus       235 ----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (272)
T cd06629         235 ----PDVSMNLSPVALDFLNACFTINPDNRPTARELLQ  268 (272)
T ss_pred             ----ccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence                0011235667899999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=99.96  E-value=1.9e-29  Score=198.49  Aligned_cols=173  Identities=22%  Similarity=0.281  Sum_probs=127.7

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |++|+|.+++...  .+++..+..++.|++.||.|||    +.+|+||||||+||+++.++.+||+|||++.........
T Consensus       125 ~~gg~L~~~l~~~--~~~~~~~~~~~~qil~aL~~LH----~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~  198 (370)
T cd05621         125 MPGGDLVNLMSNY--DVPEKWAKFYTAEVVLALDAIH----SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMV  198 (370)
T ss_pred             CCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH----HCCeEecCCCHHHEEECCCCCEEEEecccceecccCCce
Confidence            5799999999754  3789999999999999999999    899999999999999999999999999999876433221


Q ss_pred             ccccCCCCCccccCCCCCCCC----CcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhh
Q 037267           81 VTQTMTMATIGYMAPEYGSEG----IVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANL  156 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~----~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (202)
                       ......|++.|+|||.+.+.    .++.++|+||+||++|++++|..||....... ..........     ..     
T Consensus       199 -~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~-~~~~i~~~~~-----~~-----  266 (370)
T cd05621         199 -RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVG-TYSKIMDHKN-----SL-----  266 (370)
T ss_pred             -ecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHH-HHHHHHhCCc-----cc-----
Confidence             12234689999999976543    36789999999999999999999996532211 1111100000     00     


Q ss_pred             hhhHHHHHHhHHHHHHHHHHHhhhcCCCCCC--CCCHHHHHH
Q 037267          157 VREEQAFAAKMDCIVSIMDLALDCCMESPGK--RINMTDAAA  196 (202)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~--Rps~~~~~~  196 (202)
                           ..+.....+..+.+++..|+..++..  |+++.|+++
T Consensus       267 -----~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~  303 (370)
T cd05621         267 -----NFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQ  303 (370)
T ss_pred             -----CCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhc
Confidence                 00111234556789999999865543  889999875

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=99.96  E-value=6.2e-29  Score=188.30  Aligned_cols=169  Identities=21%  Similarity=0.281  Sum_probs=131.8

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |++|+|.+++..  ..+++..+..++.|++.||.|||    +.+++|+||+|+||+++.++.++++|||++........ 
T Consensus        84 ~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH----~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-  156 (277)
T cd06642          84 LGGGSALDLLKP--GPLEETYIATILREILKGLDYLH----SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-  156 (277)
T ss_pred             cCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHh----cCCeeccCCChheEEEeCCCCEEEccccccccccCcch-
Confidence            578999999864  34799999999999999999999    89999999999999999999999999999876543221 


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhH
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREE  160 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (202)
                       ......++..|++||...+..++.++|+||+|++++++++|..||.........  .......+.              
T Consensus       157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~--~~~~~~~~~--------------  219 (277)
T cd06642         157 -KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVL--FLIPKNSPP--------------  219 (277)
T ss_pred             -hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHH--hhhhcCCCC--------------
Confidence             112235678899999988888889999999999999999999998654322211  011100000              


Q ss_pred             HHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          161 QAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       161 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                         .....++.++.+++.+||..+|.+||++.++++
T Consensus       220 ---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  252 (277)
T cd06642         220 ---TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLK  252 (277)
T ss_pred             ---CCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence               001134556889999999999999999999987

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=99.96  E-value=4.9e-29  Score=189.12  Aligned_cols=170  Identities=24%  Similarity=0.278  Sum_probs=127.0

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      +++|+|..+.     .+++..+..++.|++.||.|||    +.+++|+||||+||+++.++.++++|||++.......  
T Consensus        81 ~~~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~--  149 (279)
T cd06619          81 MDGGSLDVYR-----KIPEHVLGRIAVAVVKGLTYLW----SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI--  149 (279)
T ss_pred             CCCCChHHhh-----cCCHHHHHHHHHHHHHHHHHHH----HCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc--
Confidence            4677876553     2688889999999999999999    8999999999999999999999999999987654322  


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhh--HHHHHHhCCCChhhhhhhhhhh
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSL--RRWVKESLPHGLTEVVDANLVR  158 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  158 (202)
                        .....++..|+|||...+..++.++|+||+|+++|++++|..||..........  ..........     ....   
T Consensus       150 --~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-----~~~~---  219 (279)
T cd06619         150 --AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDE-----DPPV---  219 (279)
T ss_pred             --ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhcc-----CCCC---
Confidence              222457889999999888888999999999999999999999997643222110  0000000000     0000   


Q ss_pred             hHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          159 EEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       159 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                           ......+.++.+++.+||..+|++||++.++++
T Consensus       220 -----~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~  252 (279)
T cd06619         220 -----LPVGQFSEKFVHFITQCMRKQPKERPAPENLMD  252 (279)
T ss_pred             -----CCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence                 001123456889999999999999999999875

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=99.96  E-value=1.3e-28  Score=186.82  Aligned_cols=184  Identities=19%  Similarity=0.195  Sum_probs=130.8

Q ss_pred             CCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcccc
Q 037267            3 NGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVT   82 (202)
Q Consensus         3 ~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~   82 (202)
                      .|+|.+++......+++..+..++.|++.||.|||    +.+++|+||+|.||+++. +.++++|||++.........  
T Consensus        83 ~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH----~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~--  155 (282)
T cd07831          83 DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH----RNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPY--  155 (282)
T ss_pred             CccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH----HCCceecccCHHHEEEcC-CCeEEEecccccccccCCCc--
Confidence            47888888865556899999999999999999999    899999999999999999 99999999998765433221  


Q ss_pred             ccCCCCCccccCCCCCC-CCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhh---hhhh-hh
Q 037267           83 QTMTMATIGYMAPEYGS-EGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEV---VDAN-LV  157 (202)
Q Consensus        83 ~~~~~~~~~~~~pe~~~-~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~-~~  157 (202)
                       ....++..|++||... +..++.++|+||+||++|++++|..||......+.  ...............   .... ..
T Consensus       156 -~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~  232 (282)
T cd07831         156 -TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQ--IAKIHDVLGTPDAEVLKKFRKSRHM  232 (282)
T ss_pred             -CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHH--HHHHHHHcCCCCHHHHHhhcccccc
Confidence             1234678899999653 34567889999999999999999999966432211  111111111000000   0000 00


Q ss_pred             -------hhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          158 -------REEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       158 -------~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                             ............+.++.+++.+||.++|++||++.++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         233 NYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             cccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence                   000001112345788999999999999999999999875

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.96  E-value=2.4e-28  Score=212.83  Aligned_cols=186  Identities=25%  Similarity=0.440  Sum_probs=137.9

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |++|+|.++++.    +++..+.+++.|++.||.|||..+ +.+++|||+||+||+++.++..++. ++.......    
T Consensus       765 ~~~g~L~~~l~~----l~~~~~~~i~~~ia~~L~yLH~~~-~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~----  834 (968)
T PLN00113        765 IEGKNLSEVLRN----LSWERRRKIAIGIAKALRFLHCRC-SPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT----  834 (968)
T ss_pred             CCCCcHHHHHhc----CCHHHHHHHHHHHHHHHHHhccCC-CCCeecCCCCHHhEEECCCCceEEE-ecccccccc----
Confidence            589999999963    799999999999999999999544 5699999999999999988877764 544332211    


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCC-Chhhhhhhhhhhh
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPH-GLTEVVDANLVRE  159 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~  159 (202)
                        .....++..|+|||+..+..++.++|+||+|+++||+++|+.||+...........|....... .....+++.....
T Consensus       835 --~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  912 (968)
T PLN00113        835 --DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGD  912 (968)
T ss_pred             --CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCC
Confidence              1123567899999999888899999999999999999999999975544444444454333221 1122222222111


Q ss_pred             HHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          160 EQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       160 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                         ...+.....++.+++.+||+.||++|||+.|+++.|+++
T Consensus       913 ---~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~  951 (968)
T PLN00113        913 ---VSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESA  951 (968)
T ss_pred             ---CCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHh
Confidence               011223455788999999999999999999999999875

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=99.96  E-value=5.5e-29  Score=189.27  Aligned_cols=182  Identities=24%  Similarity=0.284  Sum_probs=133.2

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      +++|+|.+++.... .+++..+..++.+++.||.|||+   ..+++|+|++|+||+++.++.++++|||++.......  
T Consensus        85 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~LH~---~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~--  158 (284)
T cd06620          85 MDCGSLDRIYKKGG-PIPVEILGKIAVAVVEGLTYLYN---VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI--  158 (284)
T ss_pred             CCCCCHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHH---hcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc--
Confidence            47899999987643 48999999999999999999993   3689999999999999999999999999986543221  


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhH
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREE  160 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (202)
                        .....++..|++||.+.+..++.++|+||+||++|++++|..||...........      .+...............
T Consensus       159 --~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~  230 (284)
T cd06620         159 --ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQD------DPMGILDLLQQIVQEPP  230 (284)
T ss_pred             --cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhh------hhhHHHHHHHHHhhccC
Confidence              1224578899999988777888999999999999999999999986543211000      00000001100000000


Q ss_pred             HHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 037267          161 QAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAK  197 (202)
Q Consensus       161 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~  197 (202)
                      . ......++.++.+++.+||..||++|||+.|+++.
T Consensus       231 ~-~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~  266 (284)
T cd06620         231 P-RLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAM  266 (284)
T ss_pred             C-CCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            0 00011255678999999999999999999999864

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=99.96  E-value=6.3e-29  Score=209.42  Aligned_cols=179  Identities=23%  Similarity=0.283  Sum_probs=132.2

Q ss_pred             CCCCcHHHHHhhc----------CCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEccccc
Q 037267            1 MPNGSLEKWLYSY----------NYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGI   70 (202)
Q Consensus         1 ~~~gsL~~~l~~~----------~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~   70 (202)
                      |+||+|.+++.+.          ...+++..++.++.|++.||.|||    +.+|+||||||+||+++.++.++++|||+
T Consensus        84 ~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH----s~GIIHRDLKPeNILLd~dg~vKLiDFGL  159 (932)
T PRK13184         84 IEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH----SKGVLHRDLKPDNILLGLFGEVVILDWGA  159 (932)
T ss_pred             CCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH----HCCccccCCchheEEEcCCCCEEEEecCc
Confidence            5799999998642          123567788999999999999999    89999999999999999999999999999


Q ss_pred             ceeccCCCc----------------cccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccch
Q 037267           71 SKLLGEGED----------------FVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEM  134 (202)
Q Consensus        71 ~~~~~~~~~----------------~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~  134 (202)
                      +........                ........|++.|+|||...+..++.++|+||+||++|++++|..||........
T Consensus       160 Ak~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki  239 (932)
T PRK13184        160 AIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKI  239 (932)
T ss_pred             ceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhh
Confidence            986521100                0001123589999999998888899999999999999999999999966322211


Q ss_pred             hhHHHHHHhCCCChhhhhhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCC-CHHHHHHHHhh
Q 037267          135 SLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRI-NMTDAAAKLKK  200 (202)
Q Consensus       135 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rp-s~~~~~~~l~~  200 (202)
                      ......           ..      ..........+..+.+++.+||..||++|| ++.++.+.|+.
T Consensus       240 ~~~~~i-----------~~------P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~  289 (932)
T PRK13184        240 SYRDVI-----------LS------PIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEP  289 (932)
T ss_pred             hhhhhc-----------cC------hhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            111000           00      000001124556688999999999999997 46677776654

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=99.96  E-value=5e-29  Score=190.76  Aligned_cols=171  Identities=21%  Similarity=0.275  Sum_probs=130.6

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      +++++|.+++..  ..+++..+..++.|++.||.|||    +.+++|+||+|.||+++.++.++++|||++........ 
T Consensus       100 ~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH----~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~-  172 (297)
T cd06659         100 LQGGALTDIVSQ--TRLNEEQIATVCESVLQALCYLH----SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-  172 (297)
T ss_pred             CCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccc-
Confidence            478999998864  34899999999999999999999    89999999999999999999999999999865433221 


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhH
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREE  160 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (202)
                       ......++..|+|||.+.+..++.++|+||+|+++|++++|..||....... ... .+........            
T Consensus       173 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-~~~-~~~~~~~~~~------------  237 (297)
T cd06659         173 -KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQ-AMK-RLRDSPPPKL------------  237 (297)
T ss_pred             -cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHH-HHhccCCCCc------------
Confidence             1122457889999999888888999999999999999999999986532211 111 1110000000            


Q ss_pred             HHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          161 QAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       161 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                         ......+..+.+++.+||..+|++||++.++++
T Consensus       238 ---~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~  270 (297)
T cd06659         238 ---KNAHKISPVLRDFLERMLTREPQERATAQELLD  270 (297)
T ss_pred             ---cccCCCCHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence               001123455889999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.96  E-value=2.2e-29  Score=201.66  Aligned_cols=175  Identities=24%  Similarity=0.379  Sum_probs=144.7

Q ss_pred             CCCCcHHHHHhhc-CCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCc
Q 037267            1 MPNGSLEKWLYSY-NYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED   79 (202)
Q Consensus         1 ~~~gsL~~~l~~~-~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~   79 (202)
                      ++.|||.|.|++. ...|-....-.++.||+.|+.||.    ++.+|||||-..|+++.....+||+|||+.+.++....
T Consensus       192 aplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLe----skrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned  267 (1039)
T KOG0199|consen  192 APLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLE----SKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENED  267 (1039)
T ss_pred             cccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHh----hhhhhhhhhhhhhheecccceeeeecccceeccCCCCc
Confidence            5789999999973 345778888899999999999999    99999999999999999999999999999998776544


Q ss_pred             c-ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhh
Q 037267           80 F-VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV  157 (202)
Q Consensus        80 ~-~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (202)
                      . .......-+..|+|||.+....++.++|+|+||+.+|||++ |..||-+...-.              +...+     
T Consensus       268 ~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~q--------------IL~~i-----  328 (1039)
T KOG0199|consen  268 MYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQ--------------ILKNI-----  328 (1039)
T ss_pred             ceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHH--------------HHHhc-----
Confidence            3 22333445778999999999999999999999999999998 889997653221              11111     


Q ss_pred             hhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 037267          158 REEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKL  198 (202)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l  198 (202)
                      ..+.+++.+..|++.++++|+.||..+|++||++..+.+.+
T Consensus       329 D~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~  369 (1039)
T KOG0199|consen  329 DAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL  369 (1039)
T ss_pred             cccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence            13455667788999999999999999999999999998654

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=99.96  E-value=9.8e-29  Score=186.03  Aligned_cols=172  Identities=23%  Similarity=0.194  Sum_probs=129.2

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      ++||+|.+++.+.. .+++..+..++.|++.||.|||    +.+++|+||+|.||+++.++.++++|||.+.........
T Consensus        88 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~lH----~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~  162 (265)
T cd06652          88 MPGGSIKDQLKSYG-ALTENVTRKYTRQILEGVSYLH----SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLS  162 (265)
T ss_pred             cCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----hCCEecCCCCHHHEEecCCCCEEECcCcccccccccccc
Confidence            47899999998654 4789999999999999999999    899999999999999999999999999998764322111


Q ss_pred             c-cccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhh
Q 037267           81 V-TQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVRE  159 (202)
Q Consensus        81 ~-~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (202)
                      . ......++..|+|||...+..++.++|+||+|+++|++++|..||........ ........    .           
T Consensus       163 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~-~~~~~~~~----~-----------  226 (265)
T cd06652         163 GTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAA-IFKIATQP----T-----------  226 (265)
T ss_pred             ccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHH-HHHHhcCC----C-----------
Confidence            0 11123467889999988887888999999999999999999999965421111 11110000    0           


Q ss_pred             HHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          160 EQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       160 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                        ....+...+..+.+++.+||. +|++||+++++++
T Consensus       227 --~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~  260 (265)
T cd06652         227 --NPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR  260 (265)
T ss_pred             --CCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence              000112344567889999995 9999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=5.4e-29  Score=186.87  Aligned_cols=171  Identities=20%  Similarity=0.184  Sum_probs=130.4

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |++|+|.+++.... .+++..+..++.|++.||.|||    +.+++|+||+|.||+++.++.++++|||++......   
T Consensus        79 ~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH----~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~---  150 (260)
T cd05611          79 LNGGDCASLIKTLG-GLPEDWAKQYIAEVVLGVEDLH----QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN---  150 (260)
T ss_pred             cCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHeEECCCCcEEEeecccceecccc---
Confidence            57899999997644 4899999999999999999999    899999999999999999999999999988764331   


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhH
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREE  160 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (202)
                         ....++..|++||...+..++.++|+||+|+++|++++|..||....... .+... ....           ..   
T Consensus       151 ---~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~-~~~~-----------~~---  211 (260)
T cd05611         151 ---KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA-VFDNI-LSRR-----------IN---  211 (260)
T ss_pred             ---ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH-HHHHH-Hhcc-----------cC---
Confidence               12346788999998887778899999999999999999999996533211 11110 0000           00   


Q ss_pred             HHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 037267          161 QAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKL  198 (202)
Q Consensus       161 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l  198 (202)
                      ........++..+.+++.+||..+|++||++.++.+.|
T Consensus       212 ~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l  249 (260)
T cd05611         212 WPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIK  249 (260)
T ss_pred             CCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence            00001123566789999999999999999876554443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=99.96  E-value=3.9e-29  Score=196.82  Aligned_cols=173  Identities=22%  Similarity=0.261  Sum_probs=126.8

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |+||+|.+++...  .++...+..++.|++.||.|||    +.+|+||||||+||+++.++.++|+|||++.........
T Consensus       125 ~~gg~L~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH----~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~~  198 (371)
T cd05622         125 MPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIH----SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV  198 (371)
T ss_pred             CCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH----HCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCcc
Confidence            5799999999754  3789999999999999999999    899999999999999999999999999999876433221


Q ss_pred             ccccCCCCCccccCCCCCCCC----CcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhh
Q 037267           81 VTQTMTMATIGYMAPEYGSEG----IVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANL  156 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~----~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (202)
                       ......|++.|+|||++.+.    .++.++|+||+||++|+|++|..||....... ...... ....           
T Consensus       199 -~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~-~~~~i~-~~~~-----------  264 (371)
T cd05622         199 -RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG-TYSKIM-NHKN-----------  264 (371)
T ss_pred             -cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHH-HHHHHH-cCCC-----------
Confidence             12234689999999986543    37789999999999999999999997532111 111110 0000           


Q ss_pred             hhhHHHHHHhHHHHHHHHHHHhhhcCCCCCC--CCCHHHHHH
Q 037267          157 VREEQAFAAKMDCIVSIMDLALDCCMESPGK--RINMTDAAA  196 (202)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~--Rps~~~~~~  196 (202)
                         ....+.....+..+.+++..|+..++.+  |+++.++++
T Consensus       265 ---~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~  303 (371)
T cd05622         265 ---SLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKR  303 (371)
T ss_pred             ---cccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhc
Confidence               0000111235566889999999844332  678888775

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.96  E-value=5.5e-29  Score=194.36  Aligned_cols=171  Identities=25%  Similarity=0.300  Sum_probs=138.7

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCC----CceEEcccccceeccC
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN----MVAHVSDFGISKLLGE   76 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~----~~~~l~d~g~~~~~~~   76 (202)
                      |.||.|.|.+... . +++..+..++.|++.++.|||    +.+++|||+||+|+++...    +.++++|||++.....
T Consensus       118 ~~GGeLfd~i~~~-~-~sE~da~~~~~~il~av~~lH----~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~  191 (382)
T KOG0032|consen  118 CEGGELFDRIVKK-H-YSERDAAGIIRQILEAVKYLH----SLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP  191 (382)
T ss_pred             cCCchHHHHHHHc-c-CCHHHHHHHHHHHHHHHHHHH----hCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC
Confidence            5799999999876 3 899999999999999999999    8999999999999999733    4799999999998776


Q ss_pred             CCccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhh
Q 037267           77 GEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANL  156 (202)
Q Consensus        77 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (202)
                      ..   ......||+.|+|||.+.+..|+..+|+||+|+++|.|+.|..||...........  +           .....
T Consensus       192 ~~---~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~--i-----------~~~~~  255 (382)
T KOG0032|consen  192 GE---RLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLA--I-----------LRGDF  255 (382)
T ss_pred             Cc---eEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHH--H-----------HcCCC
Confidence            22   22345799999999999989999999999999999999999999987554332221  1           11100


Q ss_pred             hhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          157 VREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                         ....+.....+..+.+++..|+..||.+|+|+.++++
T Consensus       256 ---~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~  292 (382)
T KOG0032|consen  256 ---DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ  292 (382)
T ss_pred             ---CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence               1111233456778999999999999999999999886

>PHA03210 serine/threonine kinase US3; Provisional

Probab=99.96  E-value=3.3e-28  Score=198.10  Aligned_cols=189  Identities=17%  Similarity=0.172  Sum_probs=127.0

Q ss_pred             CCcHHHHHhhcC----CCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCC
Q 037267            3 NGSLEKWLYSYN----YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGE   78 (202)
Q Consensus         3 ~gsL~~~l~~~~----~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~   78 (202)
                      +++|.+++....    .......+..++.|++.||.|||    +.+|+||||||+||+++.++.+||+|||++.......
T Consensus       246 ~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH----~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~  321 (501)
T PHA03210        246 DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH----DKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKER  321 (501)
T ss_pred             ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEECCCCCEEEEeCCCceecCccc
Confidence            456777765322    12345678889999999999999    8999999999999999999999999999998765432


Q ss_pred             ccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCC-CCCcccccc-hhhHHHHH------HhCCCChhh
Q 037267           79 DFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKR-PTDEMFTGE-MSLRRWVK------ESLPHGLTE  150 (202)
Q Consensus        79 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~-p~~~~~~~~-~~~~~~~~------~~~~~~~~~  150 (202)
                      ... .....|+..|++||.+.+..++.++|+||+||++|++++|.. ||....... ..+...+.      ..++.....
T Consensus       322 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~  400 (501)
T PHA03210        322 EAF-DYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCK  400 (501)
T ss_pred             ccc-cccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHHhcccChhhcCCcHHH
Confidence            211 122468999999999988889999999999999999999875 444322211 11111111      001110000


Q ss_pred             hhhhh----hhhh---HHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          151 VVDAN----LVRE---EQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       151 ~~~~~----~~~~---~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                      ..+..    ....   ....-.....+.++.+++.+||..||++|||+.|++.
T Consensus       401 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~  453 (501)
T PHA03210        401 LFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA  453 (501)
T ss_pred             HHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence            00000    0000   0000111224456788999999999999999999985

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=99.96  E-value=9.1e-29  Score=185.87  Aligned_cols=172  Identities=27%  Similarity=0.291  Sum_probs=132.4

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      +++|+|.+++.+.. .++...+..++.|++.||.|||    +.+++|+|++|.||+++.++.++++|||++........ 
T Consensus        75 ~~~~~L~~~l~~~~-~l~~~~~~~~~~~i~~~l~~lH----~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~-  148 (262)
T cd05572          75 CLGGELWTILRDRG-LFDEYTARFYIACVVLAFEYLH----NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQK-  148 (262)
T ss_pred             CCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHh----hCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccc-
Confidence            37899999998654 4899999999999999999999    89999999999999999999999999999887654321 


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhH
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREE  160 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (202)
                        .....++..|++||...+..++.++|+||+|+++|++++|..||.....+.......+...                .
T Consensus       149 --~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~----------------~  210 (262)
T cd05572         149 --TWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKG----------------N  210 (262)
T ss_pred             --cccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhcc----------------C
Confidence              1223567889999988777888999999999999999999999976543211111111000                0


Q ss_pred             HHHHHhHHHHHHHHHHHhhhcCCCCCCCCC-----HHHHHH
Q 037267          161 QAFAAKMDCIVSIMDLALDCCMESPGKRIN-----MTDAAA  196 (202)
Q Consensus       161 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps-----~~~~~~  196 (202)
                      .....+...+.++.+++.+||..+|++||+     +.|+++
T Consensus       211 ~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         211 GKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             CCCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence            000111223567899999999999999999     777765

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=99.96  E-value=4.2e-28  Score=184.73  Aligned_cols=177  Identities=25%  Similarity=0.246  Sum_probs=131.7

Q ss_pred             CCCCcHHHHHhh---cCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCC
Q 037267            1 MPNGSLEKWLYS---YNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEG   77 (202)
Q Consensus         1 ~~~gsL~~~l~~---~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~   77 (202)
                      +++|+|.+++..   ....++...+..++.|++.||.|||    +.+++|+|++|.||+++.++.++++|||++......
T Consensus        83 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH----~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~  158 (287)
T cd06621          83 CEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH----SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS  158 (287)
T ss_pred             cCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEEEecCCeEEEeecccccccccc
Confidence            478999998753   2345889999999999999999999    899999999999999999999999999998754432


Q ss_pred             CccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccc---hhhHHHHHHhCCCChhhhhhh
Q 037267           78 EDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGE---MSLRRWVKESLPHGLTEVVDA  154 (202)
Q Consensus        78 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~  154 (202)
                      ..    ....++..|++||...+..++.++|+||+|+++|++++|..||.......   .....+............   
T Consensus       159 ~~----~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---  231 (287)
T cd06621         159 LA----GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDE---  231 (287)
T ss_pred             cc----ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccC---
Confidence            21    12346778999998888888999999999999999999999997653211   111111111000000000   


Q ss_pred             hhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          155 NLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                              .......+..+.+++.+||..+|++|||+.|+++
T Consensus       232 --------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~  265 (287)
T cd06621         232 --------PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE  265 (287)
T ss_pred             --------CCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence                    0000123456899999999999999999999986

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=99.96  E-value=2.5e-28  Score=185.76  Aligned_cols=173  Identities=24%  Similarity=0.302  Sum_probs=129.2

Q ss_pred             CCCCcHHHHHhhc--CCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCC
Q 037267            1 MPNGSLEKWLYSY--NYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGE   78 (202)
Q Consensus         1 ~~~gsL~~~l~~~--~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~   78 (202)
                      |++++|.+++...  ...+++..+..++.|++.||.|||+   +.+++|+||||+||+++.++.++++|||.+.......
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  157 (286)
T cd06622          81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE---EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL  157 (286)
T ss_pred             cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh---cCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc
Confidence            5789999998753  2358999999999999999999993   3699999999999999999999999999987653322


Q ss_pred             ccccccCCCCCccccCCCCCCCCC------cCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhh
Q 037267           79 DFVTQTMTMATIGYMAPEYGSEGI------VSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVV  152 (202)
Q Consensus        79 ~~~~~~~~~~~~~~~~pe~~~~~~------~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  152 (202)
                      .    ....++..|++||...+..      ++.++|+||+||++|++++|..||........ ... ...        ..
T Consensus       158 ~----~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-~~~-~~~--------~~  223 (286)
T cd06622         158 A----KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANI-FAQ-LSA--------IV  223 (286)
T ss_pred             c----ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhH-HHH-HHH--------Hh
Confidence            1    2234677899999875443      47789999999999999999999965322111 000 000        00


Q ss_pred             hhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          153 DANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                      ..    .  ....+..++.++.+++.+||..+|++||++.+++.
T Consensus       224 ~~----~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  261 (286)
T cd06622         224 DG----D--PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE  261 (286)
T ss_pred             hc----C--CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence            00    0  00111235667899999999999999999999876

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.96  E-value=5.1e-29  Score=197.70  Aligned_cols=163  Identities=26%  Similarity=0.296  Sum_probs=127.8

Q ss_pred             CCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceee-CCCCceEEcccccceeccCCCcc
Q 037267            2 PNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILL-DENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         2 ~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~-~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      .||=|.+.++.... +. .++..|+++|+.|+.|||    ++|++||||||+|||+ +.++.++++|||.+........ 
T Consensus       399 ~g~ell~ri~~~~~-~~-~e~~~w~~~lv~Av~~LH----~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~~~-  471 (612)
T KOG0603|consen  399 DGGELLRRIRSKPE-FC-SEASQWAAELVSAVDYLH----EQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERSCD-  471 (612)
T ss_pred             cccHHHHHHHhcch-hH-HHHHHHHHHHHHHHHHHH----hcCeeecCCChhheeecCCCCcEEEEEechhhhCchhhc-
Confidence            45556666665443 33 888899999999999999    9999999999999999 6999999999999987665411 


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhH
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREE  160 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (202)
                          ...-|..|.|||++....++.++|+||+|+++|+|++|+.||.....+. .+...+.                .. 
T Consensus       472 ----tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~-ei~~~i~----------------~~-  529 (612)
T KOG0603|consen  472 ----TPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGI-EIHTRIQ----------------MP-  529 (612)
T ss_pred             ----ccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchH-HHHHhhc----------------CC-
Confidence                1234678999999998899999999999999999999999997754431 1111110                00 


Q ss_pred             HHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          161 QAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       161 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                         ......+.+..+|+.+||+.||.+|++++++..
T Consensus       530 ---~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~  562 (612)
T KOG0603|consen  530 ---KFSECVSDEAKDLLQQLLQVDPALRLGADEIGA  562 (612)
T ss_pred             ---ccccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence               011456777999999999999999999999864

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=99.96  E-value=1.7e-28  Score=186.76  Aligned_cols=173  Identities=23%  Similarity=0.300  Sum_probs=132.8

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      +++++|.+++......+++..+..++.|++.||.|||    +.+++|+|++|.||+++.++.++++|||++........ 
T Consensus        97 ~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH----~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-  171 (286)
T cd06614          97 MDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLH----SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS-  171 (286)
T ss_pred             cCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH----hCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh-
Confidence            4689999999876546899999999999999999999    89999999999999999999999999998765433221 


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhH
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREE  160 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (202)
                       ......++..|++||...+..++.++|+||+|+++|++++|..||........ .........+               
T Consensus       172 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~-~~~~~~~~~~---------------  234 (286)
T cd06614         172 -KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRA-LFLITTKGIP---------------  234 (286)
T ss_pred             -hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhcCCC---------------
Confidence             11223467789999988888889999999999999999999999865322111 1100000000               


Q ss_pred             HHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          161 QAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       161 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                       .......++..+.+++.+||+.+|.+||++.++++
T Consensus       235 -~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  269 (286)
T cd06614         235 -PLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ  269 (286)
T ss_pred             -CCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence             00111224566899999999999999999999975

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=99.96  E-value=1.7e-28  Score=190.21  Aligned_cols=192  Identities=20%  Similarity=0.236  Sum_probs=130.4

Q ss_pred             CCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCc
Q 037267            1 MPNGSLEKWLYSYN-YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED   79 (202)
Q Consensus         1 ~~~gsL~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~   79 (202)
                      +++|+|.+++.... ..+++..+..++.|++.||.|||    +.+++||||||+||+++.++.+++.||+..........
T Consensus        81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH----~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~  156 (328)
T cd08226          81 MAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLH----QNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQ  156 (328)
T ss_pred             ccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCc
Confidence            46789999998643 35899999999999999999999    89999999999999999999999999976433221110


Q ss_pred             c-----ccccCCCCCccccCCCCCCCC--CcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCCh----
Q 037267           80 F-----VTQTMTMATIGYMAPEYGSEG--IVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGL----  148 (202)
Q Consensus        80 ~-----~~~~~~~~~~~~~~pe~~~~~--~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~----  148 (202)
                      .     .......++..|++||.+.+.  .++.++|+||+||++|++++|..||...................+..    
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (328)
T cd08226         157 KAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTF  236 (328)
T ss_pred             cccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCcccccc
Confidence            0     000111245679999987653  46789999999999999999999997654332211111100000000    


Q ss_pred             ----hh---------------hhhh----hhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          149 ----TE---------------VVDA----NLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       149 ----~~---------------~~~~----~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                          ..               ....    .........+....++.++.+++.+||..||++|||++++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~  307 (328)
T cd08226         237 PCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS  307 (328)
T ss_pred             chhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence                00               0000    000000111223457788999999999999999999999974

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=99.96  E-value=5.4e-28  Score=181.45  Aligned_cols=175  Identities=23%  Similarity=0.311  Sum_probs=133.9

Q ss_pred             CCCCcHHHHHhhc---CCCCCHHHHHHHHHHHHHhhhcccCCC-CCCCeeecCCCCCceeeCCCCceEEcccccceeccC
Q 037267            1 MPNGSLEKWLYSY---NYFFDILERLNIMIDVGSALEYPHHGH-SSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGE   76 (202)
Q Consensus         1 ~~~gsL~~~l~~~---~~~l~~~~~~~~~~~l~~~l~~lH~~~-~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~   76 (202)
                      +++++|.+++...   ...+++..++.++.|++.||.|||... .+.+++|+|++|+||+++.++.++++|||++.....
T Consensus        83 ~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~  162 (265)
T cd08217          83 CEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGH  162 (265)
T ss_pred             ccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccccC
Confidence            4789999999753   346899999999999999999999320 035799999999999999999999999999887654


Q ss_pred             CCccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhh
Q 037267           77 GEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANL  156 (202)
Q Consensus        77 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (202)
                      ....  .....++..|++||...+..++.++|+||+|++++++++|..||.....  ......+......          
T Consensus       163 ~~~~--~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~~~~~----------  228 (265)
T cd08217         163 DSSF--AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ--LQLASKIKEGKFR----------  228 (265)
T ss_pred             Cccc--ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH--HHHHHHHhcCCCC----------
Confidence            3321  1223578899999998888888999999999999999999999976431  1111111111100          


Q ss_pred             hhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          157 VREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                             ..+...+..+.+++.+||..+|++||++.++++
T Consensus       229 -------~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~  261 (265)
T cd08217         229 -------RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ  261 (265)
T ss_pred             -------CCccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence                   111234566899999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=99.96  E-value=1.1e-29  Score=199.21  Aligned_cols=169  Identities=25%  Similarity=0.323  Sum_probs=124.6

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |+||+|.+++.+.. .+++..+..++.|++.||.|||    +.+|+||||||+||+++.++.++|+|||++.........
T Consensus        83 ~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~~L~~lH----~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~  157 (360)
T cd05627          83 LPGGDMMTLLMKKD-TLSEEATQFYIAETVLAIDAIH----QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRT  157 (360)
T ss_pred             CCCccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeEccCCCHHHEEECCCCCEEEeeccCCccccccccc
Confidence            58999999997654 4899999999999999999999    899999999999999999999999999998654221100


Q ss_pred             ---------------------------------ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCC
Q 037267           81 ---------------------------------VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTD  127 (202)
Q Consensus        81 ---------------------------------~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~  127 (202)
                                                       .......|++.|+|||++.+..++.++|+||+||++|+|++|..||.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~  237 (360)
T cd05627         158 EFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC  237 (360)
T ss_pred             ccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCC
Confidence                                             00012358899999999888889999999999999999999999997


Q ss_pred             cccccchhhHHHHHHhCCCChhhhhhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCH
Q 037267          128 EMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINM  191 (202)
Q Consensus       128 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~  191 (202)
                      ....... .. .+....         ...     ..+.....+.++.+++.+++. ||++|++.
T Consensus       238 ~~~~~~~-~~-~i~~~~---------~~~-----~~p~~~~~s~~~~~li~~l~~-~p~~R~~~  284 (360)
T cd05627         238 SETPQET-YR-KVMNWK---------ETL-----VFPPEVPISEKAKDLILRFCT-DSENRIGS  284 (360)
T ss_pred             CCCHHHH-HH-HHHcCC---------Cce-----ecCCCCCCCHHHHHHHHHhcc-ChhhcCCC
Confidence            6432211 00 010000         000     000011244567888888774 99999964

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=99.96  E-value=3.2e-28  Score=185.60  Aligned_cols=188  Identities=19%  Similarity=0.189  Sum_probs=128.5

Q ss_pred             CCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcccc
Q 037267            3 NGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVT   82 (202)
Q Consensus         3 ~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~   82 (202)
                      +++|.+++......+++..+..++.|++.||.|||    +.+++|+||||+||+++.++.++++|||++.........  
T Consensus        86 ~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH----~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~--  159 (291)
T cd07870          86 HTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIH----GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQT--  159 (291)
T ss_pred             cCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCC--
Confidence            46788887665556888899999999999999999    899999999999999999999999999998754332211  


Q ss_pred             ccCCCCCccccCCCCCCCC-CcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHH-HHhCCCC------------h
Q 037267           83 QTMTMATIGYMAPEYGSEG-IVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWV-KESLPHG------------L  148 (202)
Q Consensus        83 ~~~~~~~~~~~~pe~~~~~-~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~------------~  148 (202)
                      .....++..|+|||...+. .++.++|+||+|+++|++++|..||.........+.... ....+..            .
T Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (291)
T cd07870         160 YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYK  239 (291)
T ss_pred             CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhccccc
Confidence            1223467889999987653 467889999999999999999999976443221111110 0001100            0


Q ss_pred             hhhhhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          149 TEVVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                      .....................+.++.+++.+|+..||++|||+.|++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         240 PEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             chhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence            000000000000000000112456889999999999999999999874

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=99.96  E-value=3.7e-28  Score=184.39  Aligned_cols=170  Identities=28%  Similarity=0.357  Sum_probs=127.3

Q ss_pred             CCcHHHHHhh---cCCCCCHHHHHHHHHHHHHhhhcccCCCCCC-CeeecCCCCCceeeCCCCceEEcccccceeccCCC
Q 037267            3 NGSLEKWLYS---YNYFFDILERLNIMIDVGSALEYPHHGHSSA-PIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGE   78 (202)
Q Consensus         3 ~gsL~~~l~~---~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~-~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~   78 (202)
                      .|+|.+++..   ....+++..+..++.|++.||.|||    +. +++||||||+||+++.++.++++|||++.......
T Consensus        83 ~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~  158 (283)
T cd06617          83 DTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH----SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV  158 (283)
T ss_pred             cccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh----hcCCeecCCCCHHHEEECCCCCEEEeeccccccccccc
Confidence            4788888764   2345899999999999999999999    66 99999999999999999999999999987653321


Q ss_pred             ccccccCCCCCccccCCCCCCC----CCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhh
Q 037267           79 DFVTQTMTMATIGYMAPEYGSE----GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDA  154 (202)
Q Consensus        79 ~~~~~~~~~~~~~~~~pe~~~~----~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (202)
                      .   .....++..|++||.+.+    ..++.++|+||+|+++|++++|..||..................+.        
T Consensus       159 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--------  227 (283)
T cd06617         159 A---KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQ--------  227 (283)
T ss_pred             c---cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCC--------
Confidence            1   122356788999997754    3457889999999999999999999865332221111111100000        


Q ss_pred             hhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          155 NLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                               .....++.++.+++.+||..+|.+||++.++++
T Consensus       228 ---------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         228 ---------LPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             ---------CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                     001124567899999999999999999999985

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=8.5e-29  Score=190.92  Aligned_cols=174  Identities=27%  Similarity=0.282  Sum_probs=131.0

Q ss_pred             CCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCc
Q 037267            1 MPNGSLEKWLYSYN-YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED   79 (202)
Q Consensus         1 ~~~gsL~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~   79 (202)
                      +++++|.+++.... ..+++..+..++.|++.||.|||    +.+++|+||||+||+++.++.++++|||++........
T Consensus        83 ~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH----~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~  158 (316)
T cd05574          83 CPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH----LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPP  158 (316)
T ss_pred             cCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHH----HCCeeccCCChHHeEEcCCCCEEEeecchhhccccccc
Confidence            46899999998543 45899999999999999999999    89999999999999999999999999999875432111


Q ss_pred             cc---------------------------cccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCccccc
Q 037267           80 FV---------------------------TQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTG  132 (202)
Q Consensus        80 ~~---------------------------~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~  132 (202)
                      ..                           ......++..|++||...+..++.++|+||+|+++|++++|..||......
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~  238 (316)
T cd05574         159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRD  238 (316)
T ss_pred             ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchH
Confidence            00                           011235678899999988888899999999999999999999999754322


Q ss_pred             chhhHHHHHHhCCCChhhhhhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCC----HHHHHH
Q 037267          133 EMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRIN----MTDAAA  196 (202)
Q Consensus       133 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps----~~~~~~  196 (202)
                      .. +.....            ....     .+.....+.++.+++.+||..||++|||    +.+++.
T Consensus       239 ~~-~~~~~~------------~~~~-----~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~  288 (316)
T cd05574         239 ET-FSNILK------------KEVT-----FPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ  288 (316)
T ss_pred             HH-HHHHhc------------CCcc-----CCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence            11 111100            0000     0001114567999999999999999999    777665

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=99.96  E-value=2.3e-28  Score=182.89  Aligned_cols=170  Identities=26%  Similarity=0.359  Sum_probs=130.8

Q ss_pred             CCCCcHHHHHhhc-CCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCC-CceEEcccccceeccCCC
Q 037267            1 MPNGSLEKWLYSY-NYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN-MVAHVSDFGISKLLGEGE   78 (202)
Q Consensus         1 ~~~gsL~~~l~~~-~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~-~~~~l~d~g~~~~~~~~~   78 (202)
                      +++++|.+++... ...+++..+..++.|++.+|.|||    +.+++|+|++|.||+++.+ +.++++|||.+.......
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh----~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~  156 (256)
T cd08220          81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH----TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS  156 (256)
T ss_pred             CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence            4789999999864 345899999999999999999999    8999999999999999854 467999999998765432


Q ss_pred             ccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhh
Q 037267           79 DFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVR  158 (202)
Q Consensus        79 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (202)
                      .   .....++..|+|||...+..++.++|+||+|++++++++|..||........  ...+.....             
T Consensus       157 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~--~~~~~~~~~-------------  218 (256)
T cd08220         157 K---AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPAL--VLKIMSGTF-------------  218 (256)
T ss_pred             c---ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHH--HHHHHhcCC-------------
Confidence            1   1223567889999998888888999999999999999999999865432111  101000000             


Q ss_pred             hHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          159 EEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       159 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                          .+.+..++.++.+++.+||..+|++|||+.|++.
T Consensus       219 ----~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~  252 (256)
T cd08220         219 ----APISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA  252 (256)
T ss_pred             ----CCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence                0011124566899999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=99.96  E-value=5e-29  Score=193.59  Aligned_cols=176  Identities=21%  Similarity=0.226  Sum_probs=127.8

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |++|+|.+++.+....+++..+..++.|++.||.|||    +.+|+||||||+||+++.++.++|+|||++.........
T Consensus        83 ~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH----~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~  158 (332)
T cd05623          83 YVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVH----QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV  158 (332)
T ss_pred             cCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH----HCCeEecCCCHHHEEECCCCCEEEeecchheecccCCcc
Confidence            5799999999875556899999999999999999999    899999999999999999999999999998764332221


Q ss_pred             ccccCCCCCccccCCCCCC-----CCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhh
Q 037267           81 VTQTMTMATIGYMAPEYGS-----EGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDAN  155 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~-----~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (202)
                       ......|++.|+|||++.     ...++.++|+||+||++|++++|..||........ .. .+....    .     .
T Consensus       159 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~-~~-~i~~~~----~-----~  226 (332)
T cd05623         159 -QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET-YG-KIMNHK----E-----R  226 (332)
T ss_pred             -eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHH-HH-HHhCCC----c-----c
Confidence             122346899999999765     24578899999999999999999999965321110 00 000000    0     0


Q ss_pred             hhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCC--CCCHHHHHH
Q 037267          156 LVREEQAFAAKMDCIVSIMDLALDCCMESPGK--RINMTDAAA  196 (202)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~--Rps~~~~~~  196 (202)
                      ..    .......++.++.+++.+|+..++..  |+++.++++
T Consensus       227 ~~----~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~  265 (332)
T cd05623         227 FQ----FPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQ  265 (332)
T ss_pred             cc----CCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhC
Confidence            00    00001235667889999988664443  678888764

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=99.96  E-value=7.9e-28  Score=182.47  Aligned_cols=186  Identities=22%  Similarity=0.205  Sum_probs=133.3

Q ss_pred             CCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcccc
Q 037267            3 NGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVT   82 (202)
Q Consensus         3 ~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~   82 (202)
                      .++|.+++......+++..+..++.|++.||.|||    +.+++|+||+|+||+++.++.++++|||.+........  .
T Consensus        81 ~~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH----~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~--~  154 (283)
T cd05118          81 DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH----SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR--P  154 (283)
T ss_pred             CCCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHH----HCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc--c
Confidence            46888888875556899999999999999999999    89999999999999999999999999999877654331  1


Q ss_pred             ccCCCCCccccCCCCCCCC-CcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCCh----hhhhh----
Q 037267           83 QTMTMATIGYMAPEYGSEG-IVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGL----TEVVD----  153 (202)
Q Consensus        83 ~~~~~~~~~~~~pe~~~~~-~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~----~~~~~----  153 (202)
                      .....++..|.+||...+. .++.++|+||+|+++|++++|+.||......+. ... +........    .....    
T Consensus       155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~-~~~-~~~~~~~~~~~~~~~~~~~~~~  232 (283)
T cd05118         155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQ-LFK-IFRTLGTPDPEVWPKFTSLARN  232 (283)
T ss_pred             ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHH-HHHHcCCCchHhcccchhhhhh
Confidence            1223467789999987665 678899999999999999999999865432111 111 111000000    00000    


Q ss_pred             hhhhh----hHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          154 ANLVR----EEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       154 ~~~~~----~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                      .....    ...........+.++.+++.+||..||.+||++.+++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         233 YKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             hhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence            00000    00001122346778999999999999999999999875

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=99.96  E-value=4e-29  Score=196.73  Aligned_cols=185  Identities=23%  Similarity=0.361  Sum_probs=149.7

Q ss_pred             CCCCcHHHHHhhcCCC-CCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCc
Q 037267            1 MPNGSLEKWLYSYNYF-FDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED   79 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~-l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~   79 (202)
                      |++|+|.+|+..+..+ +....-++++.||++|++||.    +.++||||+.+.|||+++++++||+|||.++.+.....
T Consensus       617 mEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLe----s~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~y  692 (807)
T KOG1094|consen  617 MENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLE----SLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDY  692 (807)
T ss_pred             HhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHH----hhchhhccccccceeecCcccEEecCcccccccccCCc
Confidence            5899999999976432 455677789999999999999    99999999999999999999999999999998877777


Q ss_pred             cccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh--CCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhh
Q 037267           80 FVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT--RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV  157 (202)
Q Consensus        80 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (202)
                      +..++...-+.+|+|+|.+.-+++++++|+|+||+.+||+++  ...||...+++....  -....++.+          
T Consensus       693 y~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vve--n~~~~~~~~----------  760 (807)
T KOG1094|consen  693 YRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVE--NAGEFFRDQ----------  760 (807)
T ss_pred             eeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHH--hhhhhcCCC----------
Confidence            777777788899999998888899999999999999999875  778998765443210  000011000          


Q ss_pred             hhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          158 REEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                      ........+..|+.+++++|.+||.++-++|||++++..-|+..
T Consensus       761 ~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  761 GRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             CcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence            01112345677999999999999999999999999999988753

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.95  E-value=7.2e-28  Score=183.02  Aligned_cols=186  Identities=20%  Similarity=0.233  Sum_probs=132.5

Q ss_pred             CCcHHHHHhhcC-CCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCccc
Q 037267            3 NGSLEKWLYSYN-YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFV   81 (202)
Q Consensus         3 ~gsL~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~~   81 (202)
                      +++|.+++.... ..+++..+..++.|++.||.|||    +.+++|+|++|+||+++.++.++++|||.+......... 
T Consensus        89 ~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH----~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~~~~-  163 (287)
T cd07838          89 DQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLH----SHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMAL-  163 (287)
T ss_pred             ccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH----HCCeeeccCChhhEEEccCCCEEEeccCcceeccCCccc-
Confidence            468889887643 35899999999999999999999    899999999999999999999999999998776433221 


Q ss_pred             cccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhh------hhh
Q 037267           82 TQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVV------DAN  155 (202)
Q Consensus        82 ~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~  155 (202)
                        ....++..|++||...+..++.++|+||+|+++|++++|..||......+ ..................      ...
T Consensus       164 --~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (287)
T cd07838         164 --TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEAD-QLDKIFDVIGLPSEEEWPRNVSLPRSS  240 (287)
T ss_pred             --ccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHH-HHHHHHHHcCCCChHhcCCCcccchhh
Confidence              11236778999999888888999999999999999999999987643322 111111111000000000      000


Q ss_pred             hhh--hHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          156 LVR--EEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       156 ~~~--~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                      ...  ...........+..+.+++.+||..||.+||++.+++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         241 FPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             cccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence            000  00001112245677899999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=99.95  E-value=2.6e-28  Score=183.37  Aligned_cols=175  Identities=26%  Similarity=0.314  Sum_probs=131.7

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      +++++|.+++.... .+++..+..++.|++.||.|||    +.+++|+||+|.||+++.++.++++|||++.........
T Consensus        81 ~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lh----~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~  155 (264)
T cd06626          81 CSGGTLEELLEHGR-ILDEHVIRVYTLQLLEGLAYLH----SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT  155 (264)
T ss_pred             CCCCcHHHHHhhcC-CCChHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCc
Confidence            47899999998643 4789999999999999999999    899999999999999999999999999998876543321


Q ss_pred             cc--ccCCCCCccccCCCCCCCCC---cCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhh
Q 037267           81 VT--QTMTMATIGYMAPEYGSEGI---VSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDAN  155 (202)
Q Consensus        81 ~~--~~~~~~~~~~~~pe~~~~~~---~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (202)
                      ..  .....++..|++||.+.+..   ++.++|+||+|++++++++|..||........... .+.......        
T Consensus       156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~-~~~~~~~~~--------  226 (264)
T cd06626         156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMF-HVGAGHKPP--------  226 (264)
T ss_pred             ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHH-HHhcCCCCC--------
Confidence            11  11234678899999877665   78889999999999999999999975432211110 011000000        


Q ss_pred             hhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          156 LVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                             .+....++..+.+++.+||+.+|++||++.+++.
T Consensus       227 -------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         227 -------IPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             -------CCcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence                   0011123556789999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=99.95  E-value=5.2e-28  Score=181.65  Aligned_cols=172  Identities=26%  Similarity=0.321  Sum_probs=134.2

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCC-CCeeecCCCCCceeeCCCCceEEcccccceeccCCCc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSS-APIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED   79 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~-~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~   79 (202)
                      +++++|.+++... ..++...+..++.|++.||.|||    + .+++|+|++|+||+++.++.++++|||.+........
T Consensus        81 ~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh----~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~  155 (264)
T cd06623          81 MDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLH----TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD  155 (264)
T ss_pred             cCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHh----ccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCC
Confidence            4789999999865 45899999999999999999999    8 9999999999999999999999999999886643322


Q ss_pred             cccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccc-cchhhHHHHHHhCCCChhhhhhhhhhh
Q 037267           80 FVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFT-GEMSLRRWVKESLPHGLTEVVDANLVR  158 (202)
Q Consensus        80 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (202)
                      ..  ....++..|.+||...+..++.++|+||+|+++|++++|..||..... ........+......            
T Consensus       156 ~~--~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~------------  221 (264)
T cd06623         156 QC--NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPP------------  221 (264)
T ss_pred             cc--cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCC------------
Confidence            11  123467889999998888888999999999999999999999976542 111111111110000            


Q ss_pred             hHHHHHHhHH-HHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          159 EEQAFAAKMD-CIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       159 ~~~~~~~~~~-~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                           ..+.. ++..+.+++.+||..+|++||++.++++
T Consensus       222 -----~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~  255 (264)
T cd06623         222 -----SLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQ  255 (264)
T ss_pred             -----CCCcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence                 00112 5567899999999999999999999986

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=99.95  E-value=2.4e-28  Score=184.05  Aligned_cols=176  Identities=26%  Similarity=0.311  Sum_probs=131.2

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCC-ceEEcccccceeccCCCc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENM-VAHVSDFGISKLLGEGED   79 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~-~~~l~d~g~~~~~~~~~~   79 (202)
                      +++++|.+++.... .+++..+..++.|++.||.|||    +.+++|+||+|.||+++.++ .++++|||.+........
T Consensus        85 ~~~~~L~~~l~~~~-~~~~~~~~~~~~ql~~al~~LH----~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~  159 (268)
T cd06630          85 MAGGSVSHLLSKYG-AFKEAVIINYTEQLLRGLSYLH----ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGT  159 (268)
T ss_pred             cCCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEEcCCCCEEEEcccccccccccccc
Confidence            47899999997644 4899999999999999999999    89999999999999998765 689999999876654321


Q ss_pred             cc--cccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhh
Q 037267           80 FV--TQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV  157 (202)
Q Consensus        80 ~~--~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (202)
                      ..  ......++..|+|||...+..++.++|+||+|++++++++|..||......... ........             
T Consensus       160 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~-~~~~~~~~-------------  225 (268)
T cd06630         160 GAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHL-ALIFKIAS-------------  225 (268)
T ss_pred             cCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchH-HHHHHHhc-------------
Confidence            11  112234678899999888888889999999999999999999998643221110 00000000             


Q ss_pred             hhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          158 REEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                       .......+...+.++.+++.+||..+|.+||++.++++
T Consensus       226 -~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         226 -ATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             -cCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence             00000112235566889999999999999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=99.95  E-value=3.9e-28  Score=181.74  Aligned_cols=170  Identities=25%  Similarity=0.276  Sum_probs=130.8

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      +++++|.+++.+.. .+++..+..++.|++.||.|||    +.+++|+||+|+||+++.++.++++|||++.......  
T Consensus        84 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~--  156 (258)
T cd06632          84 VPGGSLAKLLKKYG-SFPEPVIRLYTRQILLGLEYLH----DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS--  156 (258)
T ss_pred             cCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEEECCCCCEEEccCccceeccccc--
Confidence            47899999998654 4899999999999999999999    8999999999999999999999999999987654332  


Q ss_pred             ccccCCCCCccccCCCCCCCCC-cCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhh
Q 037267           81 VTQTMTMATIGYMAPEYGSEGI-VSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVRE  159 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~-~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (202)
                       ......++..|++||...... ++.++|+||+|+++|++++|..||........... . ....  .            
T Consensus       157 -~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~-~-~~~~--~------------  219 (258)
T cd06632         157 -FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFK-I-GRSK--E------------  219 (258)
T ss_pred             -cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHH-H-Hhcc--c------------
Confidence             112345778899999776655 78899999999999999999999976542111100 0 0000  0            


Q ss_pred             HHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          160 EQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       160 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                        ....+..++..+.+++.+||..+|++||++.+++.
T Consensus       220 --~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         220 --LPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             --CCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence              00011234556889999999999999999999874

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=99.95  E-value=1.5e-28  Score=186.83  Aligned_cols=166  Identities=24%  Similarity=0.293  Sum_probs=133.6

Q ss_pred             CCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCccc
Q 037267            2 PNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFV   81 (202)
Q Consensus         2 ~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~~   81 (202)
                      .+|.|.||+.... .|++.++.++++||++|+.|+|    ..+++|||||.+|||++.++++||+|||++..+.....  
T Consensus       136 S~GeLYDYiSer~-~LsErEaRhfFRQIvSAVhYCH----knrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~kf--  208 (668)
T KOG0611|consen  136 SGGELYDYISERG-SLSEREARHFFRQIVSAVHYCH----KNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKKF--  208 (668)
T ss_pred             CCccHHHHHHHhc-cccHHHHHHHHHHHHHHHHHHh----hccceecccchhheeecCCCCeeeeccchhhhhccccH--
Confidence            5899999997644 4999999999999999999999    89999999999999999999999999999988776554  


Q ss_pred             cccCCCCCccccCCCCCCCCCcCc-chhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhH
Q 037267           82 TQTMTMATIGYMAPEYGSEGIVSA-KCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREE  160 (202)
Q Consensus        82 ~~~~~~~~~~~~~pe~~~~~~~~~-~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (202)
                       .+++.|++-|++||+..|.+|.. .+|.||+|+++|.++.|..||++.+....  ...+..+.                
T Consensus       209 -LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~l--vrQIs~Ga----------------  269 (668)
T KOG0611|consen  209 -LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRL--VRQISRGA----------------  269 (668)
T ss_pred             -HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHH--HHHhhccc----------------
Confidence             34578999999999999988854 58999999999999999999987643221  11111000                


Q ss_pred             HHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          161 QAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       161 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                      .+   ....+....-||..||..+|+.|.|+.++..
T Consensus       270 Yr---EP~~PSdA~gLIRwmLmVNP~RRATieDiAs  302 (668)
T KOG0611|consen  270 YR---EPETPSDASGLIRWMLMVNPERRATIEDIAS  302 (668)
T ss_pred             cc---CCCCCchHHHHHHHHHhcCcccchhHHHHhh
Confidence            00   0112333668999999999999999998753

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=99.95  E-value=1.7e-28  Score=183.79  Aligned_cols=171  Identities=20%  Similarity=0.310  Sum_probs=132.2

Q ss_pred             CCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCc
Q 037267            1 MPNGSLEKWLYSYN-YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED   79 (202)
Q Consensus         1 ~~~gsL~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~   79 (202)
                      +++++|.+++.... ..+++..+..++.|++.||.|||    +.+++|+|++|+||+++.++.++++|||.+........
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh----~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~  156 (256)
T cd08218          81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVH----DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE  156 (256)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH----hCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence            47899999997543 35789999999999999999999    89999999999999999999999999999876543321


Q ss_pred             cccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhh
Q 037267           80 FVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVRE  159 (202)
Q Consensus        80 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (202)
                      .  .....++..|.|||...+..++.++|+||+|++++++++|..||........ .........               
T Consensus       157 ~--~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~-~~~~~~~~~---------------  218 (256)
T cd08218         157 L--ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNL-VLKIIRGSY---------------  218 (256)
T ss_pred             h--hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHH-HHHHhcCCC---------------
Confidence            1  1123467789999988888888899999999999999999999864321111 000000000               


Q ss_pred             HHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          160 EQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       160 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                         ...+..++.++.+++.+||+.+|.+||++.++++
T Consensus       219 ---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~  252 (256)
T cd08218         219 ---PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE  252 (256)
T ss_pred             ---CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence               0012234566899999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=99.95  E-value=4.9e-28  Score=184.78  Aligned_cols=187  Identities=23%  Similarity=0.206  Sum_probs=130.8

Q ss_pred             CCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcccc
Q 037267            3 NGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVT   82 (202)
Q Consensus         3 ~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~   82 (202)
                      .++|.+++......+++..+..++.|++.||.|||    +.+++|+||||+||+++.++.++++|||++........  .
T Consensus        89 ~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH----~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~--~  162 (293)
T cd07843          89 EHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLH----DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK--P  162 (293)
T ss_pred             CcCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH----HCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCcc--c
Confidence            46899998866656899999999999999999999    89999999999999999999999999999887654321  1


Q ss_pred             ccCCCCCccccCCCCCCCC-CcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCC---hh---hhhhhh
Q 037267           83 QTMTMATIGYMAPEYGSEG-IVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHG---LT---EVVDAN  155 (202)
Q Consensus        83 ~~~~~~~~~~~~pe~~~~~-~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~---~~~~~~  155 (202)
                      .....++..|+|||.+.+. .++.++|+||+|++++++++|..||........ ..........+.   +.   .+....
T Consensus       163 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (293)
T cd07843         163 YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQ-LNKIFKLLGTPTEKIWPGFSELPGAK  241 (293)
T ss_pred             cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCchHHHHHhhccchhc
Confidence            1223467889999987654 357889999999999999999999975432211 111110000000   00   000000


Q ss_pred             ------hhhhHHHHHHhHH-HHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          156 ------LVREEQAFAAKMD-CIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       156 ------~~~~~~~~~~~~~-~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                            ..........+.. .++.+.+++.+||+.+|++|||+.|+++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         242 KKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             ccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence                  0000000000111 3667899999999999999999999875

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.95  E-value=1.4e-28  Score=182.53  Aligned_cols=157  Identities=21%  Similarity=0.195  Sum_probs=123.2

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      ++||+|.+++.... .+++..+..++.|++.||.|||    +.+++|||+||+||+++.++.++++|||.+........ 
T Consensus        67 ~~~~~L~~~l~~~~-~l~~~~~~~~~~ql~~~l~~lH----~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~~-  140 (237)
T cd05576          67 AEGGKLWSHISKFL-NIPEECVKRWAAEMVVALDALH----REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCD-  140 (237)
T ss_pred             CCCCCHHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHH----hCCeeccCCCHHHEEEcCCCCEEEecccchhccccccc-
Confidence            57899999997654 4899999999999999999999    89999999999999999999999999998765443211 


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhH
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREE  160 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (202)
                          ...++..|++||...+..++.++|+||+|+++|++++|..|+.......               .....       
T Consensus       141 ----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~---------------~~~~~-------  194 (237)
T cd05576         141 ----GEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI---------------NTHTT-------  194 (237)
T ss_pred             ----cCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc---------------ccccc-------
Confidence                1234667999998887778889999999999999999998764321100               00000       


Q ss_pred             HHHHHhHHHHHHHHHHHhhhcCCCCCCCCCH
Q 037267          161 QAFAAKMDCIVSIMDLALDCCMESPGKRINM  191 (202)
Q Consensus       161 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~  191 (202)
                        ...+..++..+.+++.+||+.||++||++
T Consensus       195 --~~~~~~~~~~~~~li~~~l~~dp~~R~~~  223 (237)
T cd05576         195 --LNIPEWVSEEARSLLQQLLQFNPTERLGA  223 (237)
T ss_pred             --cCCcccCCHHHHHHHHHHccCCHHHhcCC
Confidence              00112345568899999999999999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=99.95  E-value=1.3e-28  Score=208.49  Aligned_cols=174  Identities=21%  Similarity=0.237  Sum_probs=126.9

Q ss_pred             CCCCcHHHHHhhc---CCCCCHHHHHHHHHHHHHhhhcccCCC---CCCCeeecCCCCCceeeCC---------------
Q 037267            1 MPNGSLEKWLYSY---NYFFDILERLNIMIDVGSALEYPHHGH---SSAPIIHCDLKPTNILLDE---------------   59 (202)
Q Consensus         1 ~~~gsL~~~l~~~---~~~l~~~~~~~~~~~l~~~l~~lH~~~---~~~~i~h~dlk~~nil~~~---------------   59 (202)
                      |++|+|.++|...   ...+++..++.++.||+.||.|||...   ...+|+||||||+|||++.               
T Consensus        96 ~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~  175 (1021)
T PTZ00266         96 CDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNL  175 (1021)
T ss_pred             CCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccccccccc
Confidence            5789999999752   245899999999999999999999311   0145999999999999964               


Q ss_pred             --CCceEEcccccceeccCCCccccccCCCCCccccCCCCCCC--CCcCcchhhhhHHHHHHHHHhCCCCCCcccccchh
Q 037267           60 --NMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSE--GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMS  135 (202)
Q Consensus        60 --~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~--~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~  135 (202)
                        ...++|+|||++........   .....+++.|+|||++.+  ..++.++|+|||||++|+|++|..||.........
T Consensus       176 ng~~iVKLsDFGlAr~l~~~s~---~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~ql  252 (1021)
T PTZ00266        176 NGRPIAKIGDFGLSKNIGIESM---AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQL  252 (1021)
T ss_pred             CCCCceEEccCCcccccccccc---ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHHHH
Confidence              23489999999976543221   123468999999997754  45788999999999999999999999653221111


Q ss_pred             hHHHHHHhCCCChhhhhhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          136 LRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       136 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                      +..... . +         .        ......+.++.+|+..||..+|.+||++.|++.
T Consensus       253 i~~lk~-~-p---------~--------lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~  294 (1021)
T PTZ00266        253 ISELKR-G-P---------D--------LPIKGKSKELNILIKNLLNLSAKERPSALQCLG  294 (1021)
T ss_pred             HHHHhc-C-C---------C--------CCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence            111000 0 0         0        000123456899999999999999999999983

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=99.95  E-value=5.8e-29  Score=190.76  Aligned_cols=167  Identities=27%  Similarity=0.336  Sum_probs=137.3

Q ss_pred             CCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCc
Q 037267            1 MPNGSLEKWLYSYN-YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED   79 (202)
Q Consensus         1 ~~~gsL~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~   79 (202)
                      |-||+|.-.|.+.+ ..|++.+++-++.+|+-||++||    +..||+||+||+|||+|.+|.+.|+|+|++..+..+..
T Consensus       267 MNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH----~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~  342 (591)
T KOG0986|consen  267 MNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLH----RRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKP  342 (591)
T ss_pred             ecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHH----hcceeeccCChhheeeccCCCeEeeccceEEecCCCCc
Confidence            56899988888765 35999999999999999999999    89999999999999999999999999999998877664


Q ss_pred             cccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhh
Q 037267           80 FVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVRE  159 (202)
Q Consensus        80 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (202)
                      ..   ...||..|+|||++....|+..+|.||+||++|+|+.|+.||....+...              .+.++..+...
T Consensus       343 ~~---~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk--------------~eEvdrr~~~~  405 (591)
T KOG0986|consen  343 IR---GRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVK--------------REEVDRRTLED  405 (591)
T ss_pred             cc---cccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhh--------------HHHHHHHHhcc
Confidence            32   34799999999999999999999999999999999999999966432210              11223333332


Q ss_pred             HHHHHHhHHHHHHHHHHHhhhcCCCCCCCCC
Q 037267          160 EQAFAAKMDCIVSIMDLALDCCMESPGKRIN  190 (202)
Q Consensus       160 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps  190 (202)
                      ..  ..+...+++..++....|.+||++|..
T Consensus       406 ~~--ey~~kFS~eakslc~~LL~Kdp~~RLG  434 (591)
T KOG0986|consen  406 PE--EYSDKFSEEAKSLCEGLLTKDPEKRLG  434 (591)
T ss_pred             hh--hcccccCHHHHHHHHHHHccCHHHhcc
Confidence            22  223567888999999999999999974

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=99.95  E-value=4.5e-28  Score=186.39  Aligned_cols=186  Identities=22%  Similarity=0.183  Sum_probs=130.4

Q ss_pred             CCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcccc
Q 037267            3 NGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVT   82 (202)
Q Consensus         3 ~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~   82 (202)
                      +++|.+++......+++..+..++.|++.||.|||    +.+++|+||||+||+++.++.++++|||.+.........  
T Consensus        91 ~~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH----~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~~--  164 (309)
T cd07845          91 EQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLH----ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKP--  164 (309)
T ss_pred             CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEECCCCCEEECccceeeecCCccCC--
Confidence            46888888865566899999999999999999999    899999999999999999999999999999876543211  


Q ss_pred             ccCCCCCccccCCCCCCC-CCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhh-------hh-
Q 037267           83 QTMTMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEV-------VD-  153 (202)
Q Consensus        83 ~~~~~~~~~~~~pe~~~~-~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~-  153 (202)
                      .....++..|+|||.+.+ ..++.++|+||+|+++|++++|..||........ +. .+...........       .. 
T Consensus       165 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~~~~  242 (309)
T cd07845         165 MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQ-LD-LIIQLLGTPNESIWPGFSDLPLV  242 (309)
T ss_pred             CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HH-HHHHhcCCCChhhchhhhccccc
Confidence            111234678999998755 4578899999999999999999999975432211 11 1111110000000       00 


Q ss_pred             --hhhh--hhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          154 --ANLV--REEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       154 --~~~~--~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                        ....  ............++++.+++.+||..||++|||+.+++.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~  289 (309)
T cd07845         243 GKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE  289 (309)
T ss_pred             ccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence              0000  000000011124667889999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=99.95  E-value=5.9e-28  Score=183.66  Aligned_cols=188  Identities=23%  Similarity=0.201  Sum_probs=130.6

Q ss_pred             CCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCccc
Q 037267            2 PNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFV   81 (202)
Q Consensus         2 ~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~~   81 (202)
                      +++++..+..+ ...+++..+..++.|++.||.|||    ..+++|+|++|.||+++.++.++++|||++......... 
T Consensus        83 ~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH----~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~-  156 (288)
T cd07833          83 ERTLLELLEAS-PGGLPPDAVRSYIWQLLQAIAYCH----SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPAS-  156 (288)
T ss_pred             CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCccc-
Confidence            45555555544 445899999999999999999999    899999999999999999999999999998765543321 


Q ss_pred             cccCCCCCccccCCCCCCCC-CcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHH--HhCCCChhhhhhh----
Q 037267           82 TQTMTMATIGYMAPEYGSEG-IVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVK--ESLPHGLTEVVDA----  154 (202)
Q Consensus        82 ~~~~~~~~~~~~~pe~~~~~-~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~----  154 (202)
                      ......++..|+|||...+. .++.++|+||+|+++|++++|..||......+. +.....  ...+.........    
T Consensus       157 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  235 (288)
T cd07833         157 PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQ-LYLIQKCLGPLPPSHQELFSSNPRF  235 (288)
T ss_pred             cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCCHHHhhhcccCccc
Confidence            11224567889999988777 788899999999999999999999875432211 111100  0000000000000    


Q ss_pred             ------hhh-hhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          155 ------NLV-REEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       155 ------~~~-~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                            ... ........+..++.++.+++.+||..+|++|||++++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         236 AGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             cccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence                  000 000000112234778999999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.95  E-value=4.7e-28  Score=185.20  Aligned_cols=172  Identities=26%  Similarity=0.279  Sum_probs=126.6

Q ss_pred             CCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcccc
Q 037267            3 NGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVT   82 (202)
Q Consensus         3 ~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~   82 (202)
                      +++|.+.+......+++..+..++.|++.||.|||.   ..+++|+||+|+||+++.++.++|+|||.+.........  
T Consensus        97 ~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~---~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~~--  171 (296)
T cd06618          97 STCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKE---KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK--  171 (296)
T ss_pred             CcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---hCCEecCCCcHHHEEEcCCCCEEECccccchhccCCCcc--
Confidence            456777776545568999999999999999999993   259999999999999999999999999998765432211  


Q ss_pred             ccCCCCCccccCCCCCCCCC----cCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhh
Q 037267           83 QTMTMATIGYMAPEYGSEGI----VSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVR  158 (202)
Q Consensus        83 ~~~~~~~~~~~~pe~~~~~~----~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (202)
                       ....++..|++||.+.+..    ++.++|+||+|+++|++++|..||.........+........+ ..          
T Consensus       172 -~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~-~~----------  239 (296)
T cd06618         172 -TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPP-SL----------  239 (296)
T ss_pred             -cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCC-CC----------
Confidence             1224667899999876543    6788999999999999999999996532221111111111000 00          


Q ss_pred             hHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          159 EEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       159 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                           +....++.++.+++.+||..||++||++.+++.
T Consensus       240 -----~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  272 (296)
T cd06618         240 -----PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQ  272 (296)
T ss_pred             -----CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence                 000124556899999999999999999999875

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=2.3e-28  Score=185.02  Aligned_cols=170  Identities=24%  Similarity=0.314  Sum_probs=129.8

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      +++++|.++++..  .+++..+..++.|++.||.|||    +.+++|+||+|+||+++.++.++++|||++.........
T Consensus        84 ~~~~~L~~~~~~~--~l~~~~~~~i~~~i~~~l~~lh----~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~  157 (277)
T cd06917          84 AEGGSVRTLMKAG--PIAEKYISVIIREVLVALKYIH----KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSK  157 (277)
T ss_pred             CCCCcHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHH----hCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCccc
Confidence            4689999999753  5899999999999999999999    899999999999999999999999999998876543321


Q ss_pred             ccccCCCCCccccCCCCCCC-CCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhh
Q 037267           81 VTQTMTMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVRE  159 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~-~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (202)
                        .....++..|+|||...+ ..++.++|+||+|+++|++++|..||........  ........+        +...  
T Consensus       158 --~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~--~~~~~~~~~--------~~~~--  223 (277)
T cd06917         158 --RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA--MMLIPKSKP--------PRLE--  223 (277)
T ss_pred             --cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhh--hhccccCCC--------CCCC--
Confidence              222357888999997654 4468899999999999999999999965422110  000000000        0000  


Q ss_pred             HHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          160 EQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       160 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                            ....+.++.+++.+||..||++||++.+++.
T Consensus       224 ------~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~  254 (277)
T cd06917         224 ------DNGYSKLLREFVAACLDEEPKERLSAEELLK  254 (277)
T ss_pred             ------cccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence                  0114456899999999999999999999875

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=99.95  E-value=3.1e-28  Score=186.01  Aligned_cols=171  Identities=21%  Similarity=0.255  Sum_probs=131.4

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      +++|+|.+++.+.  .+++..+..++.|++.||.|||    +.+++|+|++|.||+++.++.++++|||++.........
T Consensus        98 ~~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH----~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~  171 (293)
T cd06647          98 LAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH----SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK  171 (293)
T ss_pred             CCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH----hCCEeeccCCHHHEEEcCCCCEEEccCcceecccccccc
Confidence            4789999999753  3789999999999999999999    899999999999999999999999999988765443221


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhH
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREE  160 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (202)
                        .....++..|++||...+..++.++|+||+|+++|++++|..||........... ......+               
T Consensus       172 --~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~-~~~~~~~---------------  233 (293)
T cd06647         172 --RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL-IATNGTP---------------  233 (293)
T ss_pred             --cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheee-hhcCCCC---------------
Confidence              1223577889999988777888999999999999999999999975432211000 0000000               


Q ss_pred             HHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          161 QAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       161 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                       ....+...+..+.+++.+||..+|++||++.+++.
T Consensus       234 -~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  268 (293)
T cd06647         234 -ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ  268 (293)
T ss_pred             -CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence             00111234556889999999999999999999875

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=99.95  E-value=6.7e-28  Score=183.15  Aligned_cols=188  Identities=22%  Similarity=0.233  Sum_probs=129.2

Q ss_pred             CCcHHHHHhhc-CCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCccc
Q 037267            3 NGSLEKWLYSY-NYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFV   81 (202)
Q Consensus         3 ~gsL~~~l~~~-~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~~   81 (202)
                      +++|.+++... ...+++..+..++.|++.||.|||    +.+++|+|++|.||+++.++.++++|||++........  
T Consensus        82 ~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh----~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~--  155 (284)
T cd07860          82 HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH----SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--  155 (284)
T ss_pred             ccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc--
Confidence            36788888653 345899999999999999999999    89999999999999999999999999999876543221  


Q ss_pred             cccCCCCCccccCCCCCCCCC-cCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCCh-----hhhhhhh
Q 037267           82 TQTMTMATIGYMAPEYGSEGI-VSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGL-----TEVVDAN  155 (202)
Q Consensus        82 ~~~~~~~~~~~~~pe~~~~~~-~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~  155 (202)
                      ......++..|+|||...+.. ++.++|+||+|+++|++++|..||..................+...     .......
T Consensus       156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (284)
T cd07860         156 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYK  235 (284)
T ss_pred             ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHH
Confidence            112234577899999766543 5778999999999999999999997543222111111111111000     0000000


Q ss_pred             hhhh----HHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          156 LVRE----EQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       156 ~~~~----~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                      ....    ..........+.++.+++.+||+.||++||++.++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         236 PSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             hhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence            0000    0000111234567889999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.95  E-value=2.3e-28  Score=173.58  Aligned_cols=167  Identities=25%  Similarity=0.290  Sum_probs=137.0

Q ss_pred             CCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            2 PNGSLEKWLYSYN-YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         2 ~~gsL~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      ++|+|...|+... ..+++.....+..|++.|+.|+|    .++++|||+||+|+|++..+.+|++|||.+.....    
T Consensus       105 ~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h----~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~----  176 (281)
T KOG0580|consen  105 PRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCH----LKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS----  176 (281)
T ss_pred             CCchHHHHHHhcccccccccchhHHHHHHHHHHHHhc----cCCcccCCCCHHHhccCCCCCeeccCCCceeecCC----
Confidence            6899999998433 35899999999999999999999    99999999999999999999999999999876432    


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhH
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREE  160 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (202)
                      ..+.+..||..|.+||+..+...+..+|+|++|++.||++.|..||.....++. .++..                 .  
T Consensus       177 ~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~et-YkrI~-----------------k--  236 (281)
T KOG0580|consen  177 NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSET-YKRIR-----------------K--  236 (281)
T ss_pred             CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHH-HHHHH-----------------H--
Confidence            234556799999999999999999999999999999999999999987542221 11111                 0  


Q ss_pred             HHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          161 QAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       161 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                      .....+...+.+..|++.+|+.++|.+|.+..|+++
T Consensus       237 ~~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~  272 (281)
T KOG0580|consen  237 VDLKFPSTISGGAADLISRLLVKNPIERLALTEVMD  272 (281)
T ss_pred             ccccCCcccChhHHHHHHHHhccCccccccHHHHhh
Confidence            011122456677899999999999999999999875

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=99.95  E-value=2.6e-28  Score=185.77  Aligned_cols=162  Identities=26%  Similarity=0.275  Sum_probs=120.2

Q ss_pred             CCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCccccccCCCCCccccC
Q 037267           15 YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMA   94 (202)
Q Consensus        15 ~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~   94 (202)
                      ..+++..+..++.|++.||+|||+   +.+++||||||+||+++.++.++++|||++........   .....++..|++
T Consensus       102 ~~l~~~~~~~i~~~i~~~l~~lh~---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~a  175 (288)
T cd06616         102 SVIPEEILGKIAVATVKALNYLKE---ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIA---KTRDAGCRPYMA  175 (288)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHhh---cCCeeccCCCHHHEEEccCCcEEEeecchhHHhccCCc---cccccCccCccC
Confidence            458999999999999999999993   35999999999999999999999999999876543221   122346788999


Q ss_pred             CCCCCCC---CcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhHHHHHHhHHHHH
Q 037267           95 PEYGSEG---IVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIV  171 (202)
Q Consensus        95 pe~~~~~---~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (202)
                      ||.+.+.   .++.++|+||+|+++|++++|..||......    ........... .    +...     ......++.
T Consensus       176 PE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~----~~~~~~~~~~~-~----~~~~-----~~~~~~~~~  241 (288)
T cd06616         176 PERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSV----FDQLTQVVKGD-P----PILS-----NSEEREFSP  241 (288)
T ss_pred             HHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchH----HHHHhhhcCCC-C----CcCC-----CcCCCccCH
Confidence            9987665   5788999999999999999999998654311    11111000000 0    0000     000123566


Q ss_pred             HHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          172 SIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       172 ~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                      ++.+++.+||..+|++|||+.++++
T Consensus       242 ~l~~li~~~l~~~p~~Rpt~~~i~~  266 (288)
T cd06616         242 SFVNFINLCLIKDESKRPKYKELLE  266 (288)
T ss_pred             HHHHHHHHHccCChhhCcCHHHHhc
Confidence            7899999999999999999999876

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=99.95  E-value=4.4e-28  Score=184.24  Aligned_cols=189  Identities=21%  Similarity=0.203  Sum_probs=130.0

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      +++++|.++.... ..+++..+..++.|++.||.|||    +.+++|+|++|+||+++.++.++++|||++.........
T Consensus        82 ~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH----~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~  156 (286)
T cd07846          82 VDHTVLDDLEKYP-NGLDESRVRKYLFQILRGIEFCH----SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV  156 (286)
T ss_pred             CCccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH----HCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccc
Confidence            4677787776543 34899999999999999999999    899999999999999999999999999998765433211


Q ss_pred             ccccCCCCCccccCCCCCCC-CCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHH-HHHhCCCChhhhhh-----
Q 037267           81 VTQTMTMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRW-VKESLPHGLTEVVD-----  153 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~-~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~-----  153 (202)
                        .....++..|++||+..+ ..++.++|+||+|+++|++++|..||......+...... ..............     
T Consensus       157 --~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (286)
T cd07846         157 --YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLF  234 (286)
T ss_pred             --cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHh
Confidence              122356788999998765 346778999999999999999999886533211100000 00000000000000     


Q ss_pred             -----hhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          154 -----ANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       154 -----~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                           +..............++..+.+++.+||..+|++||++.++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         235 AGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             hccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence                 0000000011112345677999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=99.95  E-value=5.5e-28  Score=189.20  Aligned_cols=182  Identities=21%  Similarity=0.189  Sum_probs=129.1

Q ss_pred             CCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcccc
Q 037267            3 NGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVT   82 (202)
Q Consensus         3 ~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~   82 (202)
                      .++|.+++...   ++...+..++.|++.||.|||    +.+++||||||+||+++.++.++++|||++........   
T Consensus       104 ~~~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH----~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~---  173 (353)
T cd07850         104 DANLCQVIQMD---LDHERMSYLLYQMLCGIKHLH----SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---  173 (353)
T ss_pred             CCCHHHHHhhc---CCHHHHHHHHHHHHHHHHHHH----hCCeeeCCCCHHHEEECCCCCEEEccCccceeCCCCCC---
Confidence            46788877532   789999999999999999999    89999999999999999999999999999986543221   


Q ss_pred             ccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCCh-----------hhh
Q 037267           83 QTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGL-----------TEV  151 (202)
Q Consensus        83 ~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-----------~~~  151 (202)
                      .....++..|+|||...+..++.++|+||+||++|++++|..||....... .+... ........           ...
T Consensus       174 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~-~~~~~-~~~~~~~~~~~~~~~~~~~~~~  251 (353)
T cd07850         174 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHID-QWNKI-IEQLGTPSDEFMSRLQPTVRNY  251 (353)
T ss_pred             CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHH-HHHHH-HHhcCCCCHHHHHHhhhhhhHH
Confidence            122346788999999888889999999999999999999999997543211 11111 00000000           000


Q ss_pred             hhhhhhh--------------hHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          152 VDANLVR--------------EEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       152 ~~~~~~~--------------~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                      .......              ...........+.++.+++.+||..||++|||+.|+++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~  310 (353)
T cd07850         252 VENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ  310 (353)
T ss_pred             hhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            0000000              00000001234567899999999999999999999974

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=99.95  E-value=8.3e-28  Score=179.65  Aligned_cols=174  Identities=25%  Similarity=0.263  Sum_probs=134.8

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      +++++|.+++.+.. .+++..+..++.|++.||.|||    +.+++|+|++|+||+++.++.++++|||.+.........
T Consensus        83 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh----~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~  157 (260)
T cd06606          83 VSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLH----SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG  157 (260)
T ss_pred             cCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccc
Confidence            36899999998765 5899999999999999999999    899999999999999999999999999998876554321


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhH
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREE  160 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (202)
                      .......++..|.+||...+...+.++|+||+|++++++++|..||...............                 ..
T Consensus       158 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-----------------~~  220 (260)
T cd06606         158 EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGS-----------------SG  220 (260)
T ss_pred             ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccc-----------------cC
Confidence            1112245778999999988887899999999999999999999999765411111100000                 00


Q ss_pred             HHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          161 QAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       161 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                      .....+...+..+.+++.+||..+|.+||++.+++.
T Consensus       221 ~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         221 EPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             CCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence            000112233566899999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=99.95  E-value=8.9e-29  Score=192.10  Aligned_cols=176  Identities=19%  Similarity=0.228  Sum_probs=127.6

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |+||+|.+++......+++..+..++.|++.||.|||    +.+|+||||||.||+++.++.++++|||++.........
T Consensus        83 ~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH----~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  158 (331)
T cd05624          83 YVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIH----QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV  158 (331)
T ss_pred             CCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH----HCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCce
Confidence            5799999999875556899999999999999999999    899999999999999999999999999998765433221


Q ss_pred             ccccCCCCCccccCCCCCCC-----CCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhh
Q 037267           81 VTQTMTMATIGYMAPEYGSE-----GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDAN  155 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~-----~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (202)
                       ......|++.|+|||.+.+     ..++.++|+||+|+++|++++|..||....... .... +....         ..
T Consensus       159 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~-~~~~-i~~~~---------~~  226 (331)
T cd05624         159 -QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE-TYGK-IMNHE---------ER  226 (331)
T ss_pred             -eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHH-HHHH-HHcCC---------Cc
Confidence             1122458899999997654     456788999999999999999999996532111 0000 00000         00


Q ss_pred             hhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCC--CCCHHHHHH
Q 037267          156 LVREEQAFAAKMDCIVSIMDLALDCCMESPGK--RINMTDAAA  196 (202)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~--Rps~~~~~~  196 (202)
                      ...    .......+.++.+++.+|+..++.+  |+++.++++
T Consensus       227 ~~~----p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~  265 (331)
T cd05624         227 FQF----PSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKK  265 (331)
T ss_pred             ccC----CCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence            000    0001124566889999999866544  457777653

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=99.95  E-value=1.7e-28  Score=184.24  Aligned_cols=175  Identities=26%  Similarity=0.310  Sum_probs=131.2

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      +++++|.+++.+.. .+++..+..++.|++.||.|||    +.+++|+||+|.||+++.++.++++|||++.........
T Consensus        75 ~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~L~~lH----~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~  149 (265)
T cd05579          75 LPGGDLASLLENVG-SLDEDVARIYIAEIVLALEYLH----SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQI  149 (265)
T ss_pred             CCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccc
Confidence            46889999998755 5899999999999999999999    899999999999999999999999999998754332110


Q ss_pred             ------ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhh
Q 037267           81 ------VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDA  154 (202)
Q Consensus        81 ------~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (202)
                            .......++..|++||.......+.++|+||+|++++++++|..||........  ........          
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~--~~~~~~~~----------  217 (265)
T cd05579         150 NLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEI--FQNILNGK----------  217 (265)
T ss_pred             ccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHhcCC----------
Confidence                  012223467789999988777788899999999999999999999965432111  10110000          


Q ss_pred             hhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 037267          155 NLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKL  198 (202)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l  198 (202)
                       ..     .+.....+..+.+++.+||+.+|.+||++.++.+.|
T Consensus       218 -~~-----~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l  255 (265)
T cd05579         218 -IE-----WPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIK  255 (265)
T ss_pred             -cC-----CCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence             00     000001256689999999999999999995555544

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=2.8e-28  Score=189.27  Aligned_cols=176  Identities=20%  Similarity=0.202  Sum_probs=126.4

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |+||+|.+++......+++..+..++.|++.||.|||    +.+++||||||.||+++.++.++|+|||++.........
T Consensus        83 ~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  158 (331)
T cd05597          83 YVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVH----QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV  158 (331)
T ss_pred             CCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH----hCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCc
Confidence            5799999999865556899999999999999999999    899999999999999999999999999998765433221


Q ss_pred             ccccCCCCCccccCCCCCCC-----CCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhh
Q 037267           81 VTQTMTMATIGYMAPEYGSE-----GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDAN  155 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~-----~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (202)
                      . .....+++.|+|||.+..     ..++.++|+||+||++|++++|..||........ .. .+....  .....    
T Consensus       159 ~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~-~~-~i~~~~--~~~~~----  229 (331)
T cd05597         159 Q-SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET-YG-KIMNHK--EHFQF----  229 (331)
T ss_pred             c-ccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHH-HH-HHHcCC--CcccC----
Confidence            1 122357899999997652     3467789999999999999999999965321110 00 000000  00000    


Q ss_pred             hhhhHHHHHHhHHHHHHHHHHHhhhcCCCC--CCCCCHHHHHH
Q 037267          156 LVREEQAFAAKMDCIVSIMDLALDCCMESP--GKRINMTDAAA  196 (202)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p--~~Rps~~~~~~  196 (202)
                             ......++.++.+++.+|+..++  ..|+++.++++
T Consensus       230 -------~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~  265 (331)
T cd05597         230 -------PPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKD  265 (331)
T ss_pred             -------CCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhc
Confidence                   00011245668889998776533  33778888764

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=99.95  E-value=7.6e-28  Score=184.85  Aligned_cols=190  Identities=21%  Similarity=0.224  Sum_probs=129.0

Q ss_pred             CCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc--
Q 037267            3 NGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF--   80 (202)
Q Consensus         3 ~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~--   80 (202)
                      +++|.+++...+..+++.++..++.|++.||.|||    +.+++|+||||+||+++.++.++++|||++.........  
T Consensus       102 ~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH----~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~  177 (310)
T cd07865         102 EHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIH----RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKP  177 (310)
T ss_pred             CcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH----HCCeeccCCCHHHEEECCCCcEEECcCCCcccccCCcccCC
Confidence            46888888766556899999999999999999999    899999999999999999999999999998765432211  


Q ss_pred             ccccCCCCCccccCCCCCCCC-CcCcchhhhhHHHHHHHHHhCCCCCCcccccch-hhHHHHHHhCCCChhhhh------
Q 037267           81 VTQTMTMATIGYMAPEYGSEG-IVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEM-SLRRWVKESLPHGLTEVV------  152 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~-~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~------  152 (202)
                      .......++..|+|||...+. .++.++|+||+|+++|++++|..||........ ..........+.......      
T Consensus       178 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (310)
T cd07865         178 NRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELF  257 (310)
T ss_pred             CCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccchhhh
Confidence            111223467789999976654 367889999999999999999999865432111 000111111110000000      


Q ss_pred             hh-hhhhh---HH-HHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          153 DA-NLVRE---EQ-AFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       153 ~~-~~~~~---~~-~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                      .. .....   .. ..-........+.+++.+||..||++|||++++++
T Consensus       258 ~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~  306 (310)
T cd07865         258 KKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN  306 (310)
T ss_pred             hhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence            00 00000   00 00000112345789999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=99.95  E-value=1.1e-27  Score=182.58  Aligned_cols=188  Identities=18%  Similarity=0.194  Sum_probs=128.8

Q ss_pred             CCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcccc
Q 037267            3 NGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVT   82 (202)
Q Consensus         3 ~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~   82 (202)
                      .++|.+++......+++..+..++.|++.||.|||    +.+++|+||||.||+++.++.++++|||++.........  
T Consensus        86 ~~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH----~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~--  159 (291)
T cd07844          86 DTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCH----QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKT--  159 (291)
T ss_pred             CCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH----hCCeecccCCHHHEEEcCCCCEEECccccccccCCCCcc--
Confidence            36899999876667899999999999999999999    899999999999999999999999999998754322111  


Q ss_pred             ccCCCCCccccCCCCCCC-CCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCC---CChhhhhh-----
Q 037267           83 QTMTMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLP---HGLTEVVD-----  153 (202)
Q Consensus        83 ~~~~~~~~~~~~pe~~~~-~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~-----  153 (202)
                      .....++..|+|||...+ ..++.++|+||+|+++|++++|..||.........+.........   ..+.....     
T Consensus       160 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (291)
T cd07844         160 YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFK  239 (291)
T ss_pred             ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccc
Confidence            112235778999998765 457888999999999999999999997544221111111100000   00000000     


Q ss_pred             -hh--hhhhHHHHHHhHHHH--HHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          154 -AN--LVREEQAFAAKMDCI--VSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       154 -~~--~~~~~~~~~~~~~~~--~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                       ..  ...............  .++.+++.+||..+|++|||+.+++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         240 PYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             cccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence             00  000000000001122  56789999999999999999999874

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=99.95  E-value=3.6e-28  Score=185.36  Aligned_cols=165  Identities=25%  Similarity=0.235  Sum_probs=129.2

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      +++|+|.+++.... .++...+..++.|++.||.|||    +.+++|+||+|.||+++.++.++++|||++......   
T Consensus        83 ~~~~~L~~~~~~~~-~l~~~~~~~~~~qil~~l~~lH----~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~---  154 (290)
T cd05580          83 VPGGELFSHLRKSG-RFPEPVARFYAAQVVLALEYLH----SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR---  154 (290)
T ss_pred             CCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC---
Confidence            46899999998654 4899999999999999999999    899999999999999999999999999998765443   


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhH
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREE  160 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (202)
                        .....+++.|++||...+...+.++|+||+|+++|++++|..||.......  ....+....                
T Consensus       155 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~----------------  214 (290)
T cd05580         155 --TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQ--IYEKILEGK----------------  214 (290)
T ss_pred             --CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHhcCC----------------
Confidence              122357888999998887778889999999999999999999986543111  111110000                


Q ss_pred             HHHHHhHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHH
Q 037267          161 QAFAAKMDCIVSIMDLALDCCMESPGKRI-----NMTDAA  195 (202)
Q Consensus       161 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rp-----s~~~~~  195 (202)
                        ...+...+..+.+++.+||..||.+|+     +++|++
T Consensus       215 --~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~  252 (290)
T cd05580         215 --VRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK  252 (290)
T ss_pred             --ccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence              001112345688999999999999999     666665

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=6.7e-28  Score=184.36  Aligned_cols=190  Identities=24%  Similarity=0.355  Sum_probs=142.0

Q ss_pred             CCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccC---CC-CCCCeeecCCCCCceeeCCCCceEEcccccceeccCC
Q 037267            2 PNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHH---GH-SSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEG   77 (202)
Q Consensus         2 ~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~---~~-~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~   77 (202)
                      |+|||.|||..  ..++....++++..+++||++||.   .+ ....|.|||||+.|||+.+++.+.|+|+|++......
T Consensus       292 e~GSL~DyL~r--~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~  369 (513)
T KOG2052|consen  292 EHGSLYDYLNR--NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSD  369 (513)
T ss_pred             cCCcHHHHHhh--ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEeccc
Confidence            78999999986  348999999999999999999996   11 1457999999999999999999999999999876543


Q ss_pred             Cccc--cccCCCCCccccCCCCCCCCC------cCcchhhhhHHHHHHHHHhC----------CCCCCcccccchhhHHH
Q 037267           78 EDFV--TQTMTMATIGYMAPEYGSEGI------VSAKCDVYSYGVLLMETFTR----------KRPTDEMFTGEMSLRRW  139 (202)
Q Consensus        78 ~~~~--~~~~~~~~~~~~~pe~~~~~~------~~~~~di~s~G~~~~~~~~g----------~~p~~~~~~~~~~~~~~  139 (202)
                      ....  ......||.+|+|||++....      --..+||||||+++||+.-+          +.||.+....+..+.++
T Consensus       370 t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~eeM  449 (513)
T KOG2052|consen  370 TDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFEEM  449 (513)
T ss_pred             CCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHHHH
Confidence            2221  233457999999999865431      12358999999999998652          26888877777666665


Q ss_pred             HHHhCCCChhhhhhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          140 VKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       140 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                      .+-.........+......        ..+-..+.++|+.||..+|.-|.||-.+.+.|.++
T Consensus       450 rkVVCv~~~RP~ipnrW~s--------~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l  503 (513)
T KOG2052|consen  450 RKVVCVQKLRPNIPNRWKS--------DPALRVMAKLMKECWYANPAARLTALRIKKTLAKL  503 (513)
T ss_pred             hcceeecccCCCCCccccc--------CHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHH
Confidence            4322222222222222111        23445588999999999999999999999998765

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=99.95  E-value=1.4e-27  Score=185.68  Aligned_cols=186  Identities=23%  Similarity=0.234  Sum_probs=128.1

Q ss_pred             CCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCccc-
Q 037267            3 NGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFV-   81 (202)
Q Consensus         3 ~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~~-   81 (202)
                      .++|.+++..  ..+++..+..++.|++.||.|||    +.+++||||||+||+++.++.++++|||++.......... 
T Consensus        91 ~~~l~~~~~~--~~l~~~~~~~i~~ql~~aL~~LH----~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~  164 (336)
T cd07849          91 ETDLYKLIKT--QHLSNDHIQYFLYQILRGLKYIH----SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTG  164 (336)
T ss_pred             ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH----hCCeeccCCCHHHEEECCCCCEEECcccceeeccccccccC
Confidence            3577777754  34899999999999999999999    8999999999999999999999999999987654322211 


Q ss_pred             cccCCCCCccccCCCCCCC-CCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCC----hhhhhhhhh
Q 037267           82 TQTMTMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHG----LTEVVDANL  156 (202)
Q Consensus        82 ~~~~~~~~~~~~~pe~~~~-~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~  156 (202)
                      ......++..|+|||...+ ..++.++|+||+|+++|++++|..||.......  ........+...    ...+.....
T Consensus       165 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~  242 (336)
T cd07849         165 FLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH--QLNLILGVLGTPSQEDLNCIISLRA  242 (336)
T ss_pred             CcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHcCCCCHHHHHHhhchhh
Confidence            1122357888999997544 457889999999999999999999996532111  111111111100    010000000


Q ss_pred             hh--------hHHH-HHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          157 VR--------EEQA-FAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       157 ~~--------~~~~-~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                      ..        .... .......+.++.+++.+||+.+|++|||+.++++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~  291 (336)
T cd07849         243 RNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALA  291 (336)
T ss_pred             hhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            00        0000 0011234567899999999999999999999886

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=99.95  E-value=9.7e-28  Score=184.40  Aligned_cols=166  Identities=27%  Similarity=0.278  Sum_probs=126.8

Q ss_pred             CCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcccc
Q 037267            3 NGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVT   82 (202)
Q Consensus         3 ~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~   82 (202)
                      .|+|.+++......+++..+..++.|++.||.|||    +.+++|+||+|.||+++.++.++++|||++.......    
T Consensus        98 ~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH----~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~~----  169 (307)
T cd06607          98 LGSASDILEVHKKPLQEVEIAAICHGALQGLAYLH----SHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPAN----  169 (307)
T ss_pred             CCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHH----HCCceecCCCcccEEECCCCCEEEeecCcceecCCCC----
Confidence            46788887755556899999999999999999999    8999999999999999999999999999987643321    


Q ss_pred             ccCCCCCccccCCCCCC---CCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhh
Q 037267           83 QTMTMATIGYMAPEYGS---EGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVRE  159 (202)
Q Consensus        83 ~~~~~~~~~~~~pe~~~---~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (202)
                        ...++..|+|||...   ...++.++|+||+|+++|++++|..||........ .. ......+        ..    
T Consensus       170 --~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~-~~-~~~~~~~--------~~----  233 (307)
T cd06607         170 --SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-LY-HIAQNDS--------PT----  233 (307)
T ss_pred             --CccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH-HH-HHhcCCC--------CC----
Confidence              235677899999763   34578899999999999999999999865321110 00 0000000        00    


Q ss_pred             HHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          160 EQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       160 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                          .....++.++.+++.+||..+|++||++.+++.
T Consensus       234 ----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  266 (307)
T cd06607         234 ----LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLK  266 (307)
T ss_pred             ----CCchhhCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence                001235567899999999999999999999975

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=99.95  E-value=1.4e-27  Score=182.29  Aligned_cols=187  Identities=20%  Similarity=0.207  Sum_probs=127.8

Q ss_pred             CcHHHHHhhc----CCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCC-CCceEEcccccceeccCCC
Q 037267            4 GSLEKWLYSY----NYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDE-NMVAHVSDFGISKLLGEGE   78 (202)
Q Consensus         4 gsL~~~l~~~----~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~-~~~~~l~d~g~~~~~~~~~   78 (202)
                      ++|.+++...    ...+++..+..++.|++.||.|||    +.+++|||++|+||+++. ++.++++|||.+.......
T Consensus        90 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH----~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~~~~~  165 (295)
T cd07837          90 SDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH----KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPV  165 (295)
T ss_pred             cCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHH----HCCeeecCCChHHEEEecCCCeEEEeecccceecCCCc
Confidence            5888888643    235899999999999999999999    899999999999999998 8899999999987654322


Q ss_pred             ccccccCCCCCccccCCCCCCC-CCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCC-----hhhhh
Q 037267           79 DFVTQTMTMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHG-----LTEVV  152 (202)
Q Consensus        79 ~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~-----~~~~~  152 (202)
                      ..  .....+++.|.|||...+ ..++.++|+||+|+++|++++|..||..................+..     .....
T Consensus       166 ~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (295)
T cd07837         166 KS--YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLR  243 (295)
T ss_pred             cc--cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchhhcc
Confidence            11  112245778999997654 45688999999999999999999999754322111110000000000     00000


Q ss_pred             h---hhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          153 D---ANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       153 ~---~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                      .   ................+.++.+++.+||..||++||++.|++.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         244 DWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             chhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            0   0000000001111245677999999999999999999999874

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.95  E-value=2.1e-27  Score=184.47  Aligned_cols=188  Identities=23%  Similarity=0.215  Sum_probs=130.0

Q ss_pred             CCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCccc
Q 037267            2 PNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFV   81 (202)
Q Consensus         2 ~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~~   81 (202)
                      .+++|.+++.... .+++..+..++.|++.||.|||    +.+++||||||+||+++.++.++|+|||++..........
T Consensus        88 ~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH----~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~  162 (332)
T cd07857          88 MEADLHQIIRSGQ-PLTDAHFQSFIYQILCGLKYIH----SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGEN  162 (332)
T ss_pred             ccCCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCCHHHeEEcCCCCEEeCcCCCceecccccccc
Confidence            3578999986543 4899999999999999999999    8999999999999999999999999999998654322111


Q ss_pred             --cccCCCCCccccCCCCCCC-CCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhh----h
Q 037267           82 --TQTMTMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVD----A  154 (202)
Q Consensus        82 --~~~~~~~~~~~~~pe~~~~-~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~  154 (202)
                        ......++..|++||...+ ..++.++|+||+|+++|++++|..||....... .+. ...........+...    .
T Consensus       163 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~-~~~-~~~~~~~~~~~~~~~~~~~~  240 (332)
T cd07857         163 AGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVD-QLN-QILQVLGTPDEETLSRIGSP  240 (332)
T ss_pred             cccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHH-HHH-HHHHHhCCCCHHHHHhhhhh
Confidence              1122357888999997654 457889999999999999999999986533211 111 111110000000000    0


Q ss_pred             hh--------hhh-HHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          155 NL--------VRE-EQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       155 ~~--------~~~-~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                      ..        ... ..........+..+.+++.+||+.||++|||+.++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~  291 (332)
T cd07857         241 KAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE  291 (332)
T ss_pred             hHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            00        000 0000011123567899999999999999999999864

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1.6e-28  Score=193.97  Aligned_cols=165  Identities=25%  Similarity=0.274  Sum_probs=134.5

Q ss_pred             CcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCccccc
Q 037267            4 GSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQ   83 (202)
Q Consensus         4 gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~   83 (202)
                      ||-.|.+..+.+++.+.++..|+++.+.||.|||    +++.+|||||..|||+..+|.+|++|||.+....+      .
T Consensus       110 GSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLH----S~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P------A  179 (948)
T KOG0577|consen  110 GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH----SHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP------A  179 (948)
T ss_pred             ccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHH----HhhHHhhhccccceEecCCCeeeeccccchhhcCc------h
Confidence            7888999888888999999999999999999999    99999999999999999999999999999877654      3


Q ss_pred             cCCCCCccccCCCCCC---CCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhH
Q 037267           84 TMTMATIGYMAPEYGS---EGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREE  160 (202)
Q Consensus        84 ~~~~~~~~~~~pe~~~---~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (202)
                      ..++|||.|+|||++.   .+.|+.++||||+|+.+-++..+++|+..+..-  ..-.-+...-++        .     
T Consensus       180 nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAM--SALYHIAQNesP--------t-----  244 (948)
T KOG0577|consen  180 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--SALYHIAQNESP--------T-----  244 (948)
T ss_pred             hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHH--HHHHHHHhcCCC--------C-----
Confidence            4578999999999754   357999999999999999999999998765321  111111111111        1     


Q ss_pred             HHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          161 QAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       161 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                         ....+++..+..++..||++-|++|||.++++.
T Consensus       245 ---Lqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~  277 (948)
T KOG0577|consen  245 ---LQSNEWSDYFRNFVDSCLQKIPQERPTSEELLK  277 (948)
T ss_pred             ---CCCchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence               112456777999999999999999999998875

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.95  E-value=1.9e-28  Score=199.21  Aligned_cols=178  Identities=22%  Similarity=0.376  Sum_probs=151.3

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      ||.|+|.||++.+...+....-+.|+.||++|+.|||    ....+||||-..|+|+.+...+|+.|||+++........
T Consensus       779 mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe----~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~e  854 (1177)
T KOG1025|consen  779 MPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLE----EQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKE  854 (1177)
T ss_pred             cccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH----hcchhhhhhhhhheeecCCCeEEEEecchhhccCccccc
Confidence            6999999999988888999999999999999999999    899999999999999999999999999999987765544


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhh
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVRE  159 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (202)
                      .......-.+.|+|-|.+....++.++|+||||+++||++| |..|++.....+.                   +.+...
T Consensus       855 y~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI-------------------~dlle~  915 (1177)
T KOG1025|consen  855 YSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEI-------------------PDLLEK  915 (1177)
T ss_pred             ccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHh-------------------hHHHhc
Confidence            33343445678999999999999999999999999999998 9999987643331                   111223


Q ss_pred             HHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          160 EQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       160 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                      +.+++.+..|+.+++-+|.+||..|+..||.++++.+++.+.
T Consensus       916 geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~  957 (1177)
T KOG1025|consen  916 GERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRM  957 (1177)
T ss_pred             cccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHH
Confidence            344566778999999999999999999999999999988653

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=99.95  E-value=5.4e-28  Score=183.22  Aligned_cols=173  Identities=23%  Similarity=0.282  Sum_probs=130.3

Q ss_pred             CCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCc
Q 037267            1 MPNGSLEKWLYSYN-YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED   79 (202)
Q Consensus         1 ~~~gsL~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~   79 (202)
                      +++|+|.+++.+.. ..+++..+..++.|++.||.|||    +.+++|+||+|.||+++.++.++++|||.+........
T Consensus        75 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH----~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~  150 (277)
T cd05577          75 MNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLH----QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK  150 (277)
T ss_pred             CCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCc
Confidence            46899999998644 35899999999999999999999    89999999999999999999999999998875433211


Q ss_pred             cccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhh
Q 037267           80 FVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVRE  159 (202)
Q Consensus        80 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (202)
                         .....++..|++||...+..++.++|+||+|++++++++|..||........ ...... ..            .. 
T Consensus       151 ---~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~-~~------------~~-  212 (277)
T cd05577         151 ---IKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVE-KEELKR-RT------------LE-  212 (277)
T ss_pred             ---cccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccccc-HHHHHh-cc------------cc-
Confidence               1223467789999988877788899999999999999999999965432110 000000 00            00 


Q ss_pred             HHHHHHhHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHH
Q 037267          160 EQAFAAKMDCIVSIMDLALDCCMESPGKRI-----NMTDAAA  196 (202)
Q Consensus       160 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rp-----s~~~~~~  196 (202)
                       .....+...++.+.+++.+||+.+|++||     ++.+++.
T Consensus       213 -~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  253 (277)
T cd05577         213 -MAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE  253 (277)
T ss_pred             -ccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence             00011223466689999999999999999     6666653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=4.9e-28  Score=192.72  Aligned_cols=173  Identities=23%  Similarity=0.258  Sum_probs=137.7

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |+||.....+-.-+.+|++.++.-++.|++.||.|||    +.+|+|||||..|||+.-+|.++++|||++-....  ..
T Consensus       111 C~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LH----s~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~--t~  184 (1187)
T KOG0579|consen  111 CGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLH----SQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS--TR  184 (1187)
T ss_pred             cCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHh----hcchhhhhccccceEEEecCcEeeecccccccchh--HH
Confidence            7888888887765667999999999999999999999    99999999999999999999999999999865332  12


Q ss_pred             ccccCCCCCccccCCCC-----CCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhh
Q 037267           81 VTQTMTMATIGYMAPEY-----GSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDAN  155 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~-----~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (202)
                      ..+..++||+.|+|||+     +.+.+|..++||||||+.+.+|..+.+|-.....-.    .++.-             
T Consensus       185 qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMR----VllKi-------------  247 (1187)
T KOG0579|consen  185 QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMR----VLLKI-------------  247 (1187)
T ss_pred             hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHH----HHHHH-------------
Confidence            23567899999999995     566789999999999999999999999865432211    11110             


Q ss_pred             hhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          156 LVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                      ....+..+..+..++..+.|++.+||.+||..||+++++++
T Consensus       248 aKSePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~  288 (1187)
T KOG0579|consen  248 AKSEPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK  288 (1187)
T ss_pred             hhcCCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence            01111122334567777999999999999999999999975

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=99.95  E-value=1.2e-27  Score=185.91  Aligned_cols=187  Identities=22%  Similarity=0.261  Sum_probs=130.3

Q ss_pred             CCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcccc
Q 037267            3 NGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVT   82 (202)
Q Consensus         3 ~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~   82 (202)
                      +|+|.+++.... .+++..+..++.|++.||.|||    +.+++||||||+||+++.++.++++|||++...........
T Consensus        91 ~~~l~~~~~~~~-~~~~~~~~~i~~qi~~aL~~LH----~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~  165 (334)
T cd07855          91 ESDLHHIIHSDQ-PLTEEHIRYFLYQLLRGLKYIH----SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHK  165 (334)
T ss_pred             hhhHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHEEEcCCCcEEecccccceeecccCcCCC
Confidence            468888887544 4899999999999999999999    89999999999999999999999999999876543221111


Q ss_pred             --ccCCCCCccccCCCCCCC-CCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhC--C-CCh-hhh----
Q 037267           83 --QTMTMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESL--P-HGL-TEV----  151 (202)
Q Consensus        83 --~~~~~~~~~~~~pe~~~~-~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~--~-~~~-~~~----  151 (202)
                        .....++..|.+||.+.+ ..++.++|+||+|+++|++++|..||........ + ..+....  + ... ...    
T Consensus       166 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~-~-~~~~~~~g~~~~~~~~~~~~~~  243 (334)
T cd07855         166 YFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQ-L-KLILSVLGSPSEEVLNRIGSDR  243 (334)
T ss_pred             cccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHH-H-HHHHHHhCCChhHhhhhhchhh
Confidence              122357888999997654 4578899999999999999999999965432111 0 1111100  0 000 000    


Q ss_pred             hhhhhh----hhHH-HHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          152 VDANLV----REEQ-AFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       152 ~~~~~~----~~~~-~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                      +.....    .... ........+.++.+++.+||+.+|.+||++++++.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  293 (334)
T cd07855         244 VRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ  293 (334)
T ss_pred             HHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            000000    0000 00111234677999999999999999999999875

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=99.95  E-value=4.4e-28  Score=203.52  Aligned_cols=174  Identities=26%  Similarity=0.315  Sum_probs=128.6

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceecc-----
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLG-----   75 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~-----   75 (202)
                      |+.-+|.++++.+...-.....++++++|+.||.|+|    +.||+||||||.||+++.+..+||+|||+++...     
T Consensus       678 CE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH----~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~  753 (1351)
T KOG1035|consen  678 CEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIH----DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLES  753 (1351)
T ss_pred             hhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHH----hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhh
Confidence            6677788888765532257889999999999999999    8999999999999999999999999999998621     


Q ss_pred             -C----------CCccccccCCCCCccccCCCCCCCC---CcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHH
Q 037267           76 -E----------GEDFVTQTMTMATIGYMAPEYGSEG---IVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVK  141 (202)
Q Consensus        76 -~----------~~~~~~~~~~~~~~~~~~pe~~~~~---~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~  141 (202)
                       +          +......+..+||.-|+|||.+.+.   .|+.|.||||+|++++||+.   ||....++-..+..+..
T Consensus       754 ~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~  830 (1351)
T KOG1035|consen  754 IDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRK  830 (1351)
T ss_pred             HhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhccc
Confidence             0          0111134556899999999987665   49999999999999999965   46554444333333332


Q ss_pred             HhCCCChhhhhhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          142 ESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                      ..+|.. .++.              ...-+.-.+++..+++.||.+||||.|++.
T Consensus       831 g~iP~~-~~f~--------------~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  831 GSIPEP-ADFF--------------DPEHPEEASLIRWLLSHDPSKRPTATELLN  870 (1351)
T ss_pred             CCCCCC-cccc--------------cccchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence            222222 1111              111223568999999999999999999985

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=99.95  E-value=1.4e-27  Score=181.36  Aligned_cols=187  Identities=23%  Similarity=0.252  Sum_probs=129.5

Q ss_pred             CCcHHHHHhhcC-CCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCccc
Q 037267            3 NGSLEKWLYSYN-YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFV   81 (202)
Q Consensus         3 ~gsL~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~~   81 (202)
                      +++|.+++.... ..+++..++.++.|++.||.|||    +.+++|+|++|.||+++.++.++++|||.+......... 
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH----~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~-  155 (283)
T cd07835          81 DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH----SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT-  155 (283)
T ss_pred             CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH----HCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc-
Confidence            468999987654 35899999999999999999999    899999999999999999999999999998754332211 


Q ss_pred             cccCCCCCccccCCCCCCCC-CcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHh-CCCCh-----hhhhhh
Q 037267           82 TQTMTMATIGYMAPEYGSEG-IVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKES-LPHGL-----TEVVDA  154 (202)
Q Consensus        82 ~~~~~~~~~~~~~pe~~~~~-~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~-----~~~~~~  154 (202)
                       .....++..|+|||.+.+. .++.++|+||+|+++|++++|..||........ ........ .+...     ......
T Consensus       156 -~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  233 (283)
T cd07835         156 -YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQ-LFRIFRTLGTPDEDVWPGVTSLPDY  233 (283)
T ss_pred             -cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCChHHhhhhhhchhh
Confidence             1222457789999976654 468889999999999999999999965432111 11111110 00000     000000


Q ss_pred             h--hhhh--HHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          155 N--LVRE--EQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       155 ~--~~~~--~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                      .  ....  ..........+..+.+++.+||+.||++||++.|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         234 KPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             hhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            0  0000  0000111234467889999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=99.95  E-value=4.8e-28  Score=181.52  Aligned_cols=170  Identities=29%  Similarity=0.285  Sum_probs=131.7

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      ++|++|.+++... ..++...+..++.|++.||.|||    +.+++|+||+|.||+++.++.++++|||.+........ 
T Consensus        82 ~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh----~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~-  155 (258)
T cd05578          82 LLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLH----SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL-  155 (258)
T ss_pred             CCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHH----hCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCcc-
Confidence            5789999999865 35899999999999999999999    89999999999999999999999999999876544321 


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhH
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREE  160 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (202)
                        .....++..|.+||...+..++.++|+||+|+++|++++|..||.......  ...... ....              
T Consensus       156 --~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~~~~~~-~~~~--------------  216 (258)
T cd05578         156 --TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI--RDQIRA-KQET--------------  216 (258)
T ss_pred             --ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH--HHHHHH-Hhcc--------------
Confidence              122457788999998887778999999999999999999999997654321  111110 0000              


Q ss_pred             HHHHHhHHHHHHHHHHHhhhcCCCCCCCCCH--HHHH
Q 037267          161 QAFAAKMDCIVSIMDLALDCCMESPGKRINM--TDAA  195 (202)
Q Consensus       161 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~--~~~~  195 (202)
                      .....+...+..+.+++.+||..||.+||++  .|++
T Consensus       217 ~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         217 ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence            0001112345678999999999999999999  5554

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=99.95  E-value=8.9e-28  Score=183.47  Aligned_cols=171  Identities=20%  Similarity=0.264  Sum_probs=130.3

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      +++++|.+++...  .+++..+..++.|++.||.|||    +.+++|+|++|.||+++.++.++++|||++........ 
T Consensus        99 ~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH----~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-  171 (292)
T cd06657          99 LEGGALTDIVTHT--RMNEEQIAAVCLAVLKALSVLH----AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-  171 (292)
T ss_pred             CCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHEEECCCCCEEEcccccceecccccc-
Confidence            4789999988643  3799999999999999999999    89999999999999999999999999998876543221 


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhH
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREE  160 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (202)
                       ......++..|++||...+..++.++|+||+|+++|++++|..||......  ..........+....           
T Consensus       172 -~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~~-----------  237 (292)
T cd06657         172 -RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL--KAMKMIRDNLPPKLK-----------  237 (292)
T ss_pred             -cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhhCCcccC-----------
Confidence             112235678899999887778889999999999999999999998653211  111111111111100           


Q ss_pred             HHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          161 QAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       161 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                          .....+..+.+++.+||..+|.+||++.++++
T Consensus       238 ----~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~  269 (292)
T cd06657         238 ----NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  269 (292)
T ss_pred             ----CcccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence                01123455789999999999999999999886

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.95  E-value=3.3e-28  Score=199.71  Aligned_cols=188  Identities=20%  Similarity=0.233  Sum_probs=118.6

Q ss_pred             CCCCcHHHHHhhcCCCC-------------------CHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCC-C
Q 037267            1 MPNGSLEKWLYSYNYFF-------------------DILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDE-N   60 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l-------------------~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~-~   60 (202)
                      +++|+|.+++.......                   ....+..++.|++.||.|||    +.+|+||||||+|||++. +
T Consensus       217 ~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH----~~gIiHRDLKP~NILl~~~~  292 (566)
T PLN03225        217 EGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH----STGIVHRDVKPQNIIFSEGS  292 (566)
T ss_pred             cCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH----HCCEEeCcCCHHHEEEeCCC
Confidence            36789999987543211                   12345679999999999999    899999999999999985 5


Q ss_pred             CceEEcccccceeccCCCccccccCCCCCccccCCCCCCCC----------------------CcCcchhhhhHHHHHHH
Q 037267           61 MVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEG----------------------IVSAKCDVYSYGVLLME  118 (202)
Q Consensus        61 ~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~----------------------~~~~~~di~s~G~~~~~  118 (202)
                      +.+||+|||++.......... .....+++.|+|||.+...                      .++.++|+||+||++|+
T Consensus       293 ~~~KL~DFGlA~~l~~~~~~~-~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~e  371 (566)
T PLN03225        293 GSFKIIDLGAAADLRVGINYI-PKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQ  371 (566)
T ss_pred             CcEEEEeCCCccccccccccC-CcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHHHHHH
Confidence            789999999997654332221 2234678899999943211                      23345699999999999


Q ss_pred             HHhCCCCCCcccccchhhHHHHHH-hCC-CChhhhhhhhhhhh-HHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHH
Q 037267          119 TFTRKRPTDEMFTGEMSLRRWVKE-SLP-HGLTEVVDANLVRE-EQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAA  195 (202)
Q Consensus       119 ~~~g~~p~~~~~~~~~~~~~~~~~-~~~-~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~  195 (202)
                      ++++..+++...   ..+...... ... ..+........... .......+......++|+.+||.+||++|||+.+++
T Consensus       372 l~~~~~~~~~~~---~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta~e~L  448 (566)
T PLN03225        372 MAFPNLRSDSNL---IQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISAKAAL  448 (566)
T ss_pred             HHhCcCCCchHH---HHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCCCHHHHh
Confidence            998776643211   111111100 000 00000111100000 000111112233467999999999999999999997


Q ss_pred             H
Q 037267          196 A  196 (202)
Q Consensus       196 ~  196 (202)
                      +
T Consensus       449 ~  449 (566)
T PLN03225        449 A  449 (566)
T ss_pred             C
Confidence            5

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=99.95  E-value=7.2e-28  Score=187.44  Aligned_cols=185  Identities=25%  Similarity=0.282  Sum_probs=130.4

Q ss_pred             CCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcccc
Q 037267            3 NGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVT   82 (202)
Q Consensus         3 ~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~   82 (202)
                      +++|.+++.... .+++..+..++.|++.||.|||    +.+++|+||||+||+++.++.++++|||++.........  
T Consensus        92 ~~~L~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH----~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~--  164 (337)
T cd07858          92 DTDLHQIIRSSQ-TLSDDHCQYFLYQLLRGLKYIH----SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDF--  164 (337)
T ss_pred             CCCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH----hCCEecCCCCHHHEEEcCCCCEEECcCccccccCCCccc--
Confidence            468888887543 5899999999999999999999    899999999999999999999999999998765433211  


Q ss_pred             ccCCCCCccccCCCCCCC-CCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhC----CCChhhhhhhhhh
Q 037267           83 QTMTMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESL----PHGLTEVVDANLV  157 (202)
Q Consensus        83 ~~~~~~~~~~~~pe~~~~-~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~  157 (202)
                      .....++..|+|||.... ..++.++|+||+|+++|++++|..||....... .. ..+....    +............
T Consensus       165 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~~~~~  242 (337)
T cd07858         165 MTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVH-QL-KLITELLGSPSEEDLGFIRNEKAR  242 (337)
T ss_pred             ccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHH-HH-HHHHHHhCCCChHHhhhcCchhhh
Confidence            122356788999996543 457889999999999999999999996532111 00 0000000    0000000000000


Q ss_pred             -------h--hHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          158 -------R--EEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       158 -------~--~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                             .  ..........++.++.+++.+||..+|++|||+.++++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~  290 (337)
T cd07858         243 RYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALA  290 (337)
T ss_pred             HHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHc
Confidence                   0  00001112346777899999999999999999999885

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=99.95  E-value=1.3e-27  Score=184.45  Aligned_cols=168  Identities=26%  Similarity=0.284  Sum_probs=128.6

Q ss_pred             CCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcccc
Q 037267            3 NGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVT   82 (202)
Q Consensus         3 ~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~   82 (202)
                      .|+|.+.+......+++..+..++.|++.||.|||    +.+++|+||+|.||+++.++.++++|||++......     
T Consensus       108 ~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH----~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~-----  178 (317)
T cd06635         108 LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH----SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA-----  178 (317)
T ss_pred             CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCcccEEECCCCCEEEecCCCccccCCc-----
Confidence            46888888766666899999999999999999999    899999999999999999999999999988654321     


Q ss_pred             ccCCCCCccccCCCCCC---CCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhh
Q 037267           83 QTMTMATIGYMAPEYGS---EGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVRE  159 (202)
Q Consensus        83 ~~~~~~~~~~~~pe~~~---~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (202)
                       ....++..|++||...   ...++.++|+||+|+++|++++|..||........ .........+.             
T Consensus       179 -~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~-~~~~~~~~~~~-------------  243 (317)
T cd06635         179 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-LYHIAQNESPT-------------  243 (317)
T ss_pred             -ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH-HHHHHhccCCC-------------
Confidence             1235778899999763   34578889999999999999999999865321111 11111111100             


Q ss_pred             HHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 037267          160 EQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKL  198 (202)
Q Consensus       160 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l  198 (202)
                          .....++..+.+++.+||+.+|++||++.++++.+
T Consensus       244 ----~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~  278 (317)
T cd06635         244 ----LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHM  278 (317)
T ss_pred             ----CCCccccHHHHHHHHHHccCCcccCcCHHHHHhCh
Confidence                00123455689999999999999999999998743

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=99.95  E-value=2.4e-27  Score=180.05  Aligned_cols=188  Identities=23%  Similarity=0.237  Sum_probs=131.6

Q ss_pred             CCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcccc
Q 037267            3 NGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVT   82 (202)
Q Consensus         3 ~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~   82 (202)
                      .++|.+++......+++..+..++.|++.||.|||    +.+++|+|++|.||+++.++.++++|||.+......... .
T Consensus        83 ~~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH----~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~-~  157 (287)
T cd07840          83 DHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLH----SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSA-D  157 (287)
T ss_pred             cccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH----HCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcc-c
Confidence            35888888765456899999999999999999999    899999999999999999999999999999876543311 1


Q ss_pred             ccCCCCCccccCCCCCCC-CCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhC-C--CC---hhhh----
Q 037267           83 QTMTMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESL-P--HG---LTEV----  151 (202)
Q Consensus        83 ~~~~~~~~~~~~pe~~~~-~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~-~--~~---~~~~----  151 (202)
                      .....++..|++||...+ ..++.++|+||+|+++|++++|..||....... .......... +  ..   ....    
T Consensus       158 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (287)
T cd07840         158 YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELE-QLEKIFELCGSPTDENWPGVSKLPWFE  236 (287)
T ss_pred             ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCchhhccccccchhhh
Confidence            122345778999997654 357889999999999999999999997644221 1111111000 0  00   0000    


Q ss_pred             -hhhhhhhhHHHHHHhHH-HHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          152 -VDANLVREEQAFAAKMD-CIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       152 -~~~~~~~~~~~~~~~~~-~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                       ................. ++..+.+++.+||..+|.+||++.++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         237 NLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             hccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence             00000000001111112 3778999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=99.95  E-value=2.9e-27  Score=176.71  Aligned_cols=171  Identities=26%  Similarity=0.336  Sum_probs=133.2

Q ss_pred             CCCCcHHHHHhhc---CCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCC
Q 037267            1 MPNGSLEKWLYSY---NYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEG   77 (202)
Q Consensus         1 ~~~gsL~~~l~~~---~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~   77 (202)
                      +++++|.+++...   +..+++..+..++.+++.||.|||    +.+++|+|++|+||+++.++.++++|||.+......
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh----~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~  156 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH----SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST  156 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHH----hCCEecccCChHHeEEcCCCcEEECCccceeecccC
Confidence            4688999999865   356999999999999999999999    889999999999999999999999999998775543


Q ss_pred             CccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhh
Q 037267           78 EDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV  157 (202)
Q Consensus        78 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (202)
                      ..  ......+++.|++||...+..++.++|+||+|++++++++|..||.......  ........   ...        
T Consensus       157 ~~--~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~--~~~~~~~~---~~~--------  221 (258)
T cd08215         157 VD--LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE--LALKILKG---QYP--------  221 (258)
T ss_pred             cc--eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHH--HHHHHhcC---CCC--------
Confidence            21  1122357788999998888888899999999999999999999986533111  11110000   000        


Q ss_pred             hhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          158 REEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                            +.+..++..+.+++.+||..+|.+||++.++++
T Consensus       222 ------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  254 (258)
T cd08215         222 ------PIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ  254 (258)
T ss_pred             ------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence                  001134566899999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=99.95  E-value=1.2e-27  Score=178.80  Aligned_cols=169  Identities=28%  Similarity=0.288  Sum_probs=132.3

Q ss_pred             CCCCcHHHHHhhc---CCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCC
Q 037267            1 MPNGSLEKWLYSY---NYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEG   77 (202)
Q Consensus         1 ~~~gsL~~~l~~~---~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~   77 (202)
                      +++++|.+++...   ...+++..+..++.|++.||.|||    +.+++|+|++|.||+++.++.++++|||++......
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh----~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~  156 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH----EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN  156 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh----hCCcccCCCCcceEEEecCCcEEEeeccchhhhccC
Confidence            3689999998752   245899999999999999999999    899999999999999999999999999998776543


Q ss_pred             CccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhh
Q 037267           78 EDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV  157 (202)
Q Consensus        78 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (202)
                      .    .....++..|++||...+..++.++|+||+|++++++++|..||.......  +...+.....            
T Consensus       157 ~----~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~--~~~~~~~~~~------------  218 (256)
T cd08530         157 M----AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD--LRYKVQRGKY------------  218 (256)
T ss_pred             C----cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHhcCCC------------
Confidence            1    112346788999998888888889999999999999999999996543211  1111111000            


Q ss_pred             hhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          158 REEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                           ...+...+.++.+++.+||..+|++||++.++++
T Consensus       219 -----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  252 (256)
T cd08530         219 -----PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA  252 (256)
T ss_pred             -----CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence                 0011235566899999999999999999999875

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.95  E-value=1.9e-27  Score=182.68  Aligned_cols=188  Identities=19%  Similarity=0.163  Sum_probs=128.4

Q ss_pred             CCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcccc
Q 037267            3 NGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVT   82 (202)
Q Consensus         3 ~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~   82 (202)
                      .++|.+.+......+++..+..++.|+++||.|||    +.+++|+|+||.||+++.++.++++|||++...........
T Consensus        98 ~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH----~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~  173 (311)
T cd07866          98 DHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLH----ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPK  173 (311)
T ss_pred             CcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEECCCCCEEECcCccchhccCCCcccc
Confidence            35677777665556999999999999999999999    89999999999999999999999999999876543221111


Q ss_pred             ---------ccCCCCCccccCCCCCCCC-CcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCC--h--
Q 037267           83 ---------QTMTMATIGYMAPEYGSEG-IVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHG--L--  148 (202)
Q Consensus        83 ---------~~~~~~~~~~~~pe~~~~~-~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~--  148 (202)
                               .....++..|+|||...+. .++.++|+||+|+++|++++|..||............+.....+..  +  
T Consensus       174 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (311)
T cd07866         174 GGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPG  253 (311)
T ss_pred             cCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhchh
Confidence                     1122456789999976543 4788899999999999999999998754332111100000000000  0  


Q ss_pred             -h---h----hhhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          149 -T---E----VVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       149 -~---~----~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                       .   .    .....  ...............+.+++.+||..||++|||+.+++.
T Consensus       254 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         254 WRSLPGCEGVHSFTN--YPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             hhhcccccccccCCC--CCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence             0   0    00000  000001111223466899999999999999999999874

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.95  E-value=1e-27  Score=184.42  Aligned_cols=167  Identities=25%  Similarity=0.268  Sum_probs=127.4

Q ss_pred             CCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcccc
Q 037267            3 NGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVT   82 (202)
Q Consensus         3 ~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~   82 (202)
                      .|+|.+++......++...+..++.|++.||.|||    +.+++|+||+|.||+++.++.++++|||++......     
T Consensus        98 ~~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH----~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~-----  168 (308)
T cd06634          98 LGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH----SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-----  168 (308)
T ss_pred             CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCCHHhEEECCCCcEEECCcccceeecCc-----
Confidence            46888888765666899999999999999999999    899999999999999999999999999998765432     


Q ss_pred             ccCCCCCccccCCCCCC---CCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhh
Q 037267           83 QTMTMATIGYMAPEYGS---EGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVRE  159 (202)
Q Consensus        83 ~~~~~~~~~~~~pe~~~---~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (202)
                       ....++..|+|||...   ...++.++|+||+|+++|++++|..||........ .........+              
T Consensus       169 -~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~~~~~~~--------------  232 (308)
T cd06634         169 -NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-LYHIAQNESP--------------  232 (308)
T ss_pred             -ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHH-HHHHhhcCCC--------------
Confidence             1234678899999753   34567889999999999999999999865322111 0111100000              


Q ss_pred             HHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 037267          160 EQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAK  197 (202)
Q Consensus       160 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~  197 (202)
                         ......++..+.+++.+||..+|++||++.++++-
T Consensus       233 ---~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~  267 (308)
T cd06634         233 ---ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  267 (308)
T ss_pred             ---CcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence               00012345668899999999999999999998753

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.95  E-value=2.6e-27  Score=183.67  Aligned_cols=187  Identities=25%  Similarity=0.227  Sum_probs=133.7

Q ss_pred             CCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc-c
Q 037267            3 NGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF-V   81 (202)
Q Consensus         3 ~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~-~   81 (202)
                      +++|.+++.+.. .+++..+..++.|++.||.|||    +.+++|+||||.||+++.++.++++|||.+......... .
T Consensus        87 ~~~l~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH----~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~~~  161 (330)
T cd07834          87 ETDLHKVIKSPQ-PLTDDHIQYFLYQILRGLKYLH----SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKG  161 (330)
T ss_pred             hhhHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEEcCCCCEEEcccCceEeecccccccc
Confidence            357888887544 5899999999999999999999    899999999999999999999999999999876543210 1


Q ss_pred             cccCCCCCccccCCCCCCCC-CcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCC------------h
Q 037267           82 TQTMTMATIGYMAPEYGSEG-IVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHG------------L  148 (202)
Q Consensus        82 ~~~~~~~~~~~~~pe~~~~~-~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~------------~  148 (202)
                      ......++..|++||.+.+. .++.++|+||+|+++|++++|..||.........  ..+.......            .
T Consensus       162 ~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~--~~i~~~~~~~~~~~~~~~~~~~~  239 (330)
T cd07834         162 FLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQL--NLIVEVLGTPSEEDLKFITSEKA  239 (330)
T ss_pred             cccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHH--HHHHHhcCCCChhHhhhccccch
Confidence            12223567889999988777 7888999999999999999999999765432211  1111111000            0


Q ss_pred             hhhhhhhhhh-hHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          149 TEVVDANLVR-EEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       149 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                      ...+...... ...........+.++.+++.+||+.+|.+||++.+++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~  288 (330)
T cd07834         240 RNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALA  288 (330)
T ss_pred             hhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence            0000000000 00001112235677899999999999999999999986

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=99.95  E-value=5.6e-27  Score=177.64  Aligned_cols=169  Identities=22%  Similarity=0.311  Sum_probs=131.2

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      +++|+|.+++...  .+++..+..++.|++.++.|||    +.+++|+|++|.||+++.++.++++|||++........ 
T Consensus        84 ~~~~~l~~~i~~~--~~~~~~~~~~~~~l~~~l~~lh----~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~-  156 (277)
T cd06641          84 LGGGSALDLLEPG--PLDETQIATILREILKGLDYLH----SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-  156 (277)
T ss_pred             CCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHc----cCCeecCCCCHHhEEECCCCCEEEeecccceecccchh-
Confidence            4789999999753  4799999999999999999999    89999999999999999999999999999876543221 


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhH
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREE  160 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (202)
                       ......++..|++||...+..++.++|+||+|+++|++++|..||........  ...+......              
T Consensus       157 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~--~~~~~~~~~~--------------  219 (277)
T cd06641         157 -KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKV--LFLIPKNNPP--------------  219 (277)
T ss_pred             -hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHH--HHHHhcCCCC--------------
Confidence             12223567789999988877888899999999999999999999865332110  1111100000              


Q ss_pred             HHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          161 QAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       161 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                         .....++.++.+++.+||..+|++||++.++++
T Consensus       220 ---~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  252 (277)
T cd06641         220 ---TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLK  252 (277)
T ss_pred             ---CCCcccCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence               001234566889999999999999999999987

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=99.95  E-value=1.3e-27  Score=184.13  Aligned_cols=190  Identities=18%  Similarity=0.162  Sum_probs=128.3

Q ss_pred             CCcHHHHHhhc----CCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCC----CCceEEcccccceec
Q 037267            3 NGSLEKWLYSY----NYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDE----NMVAHVSDFGISKLL   74 (202)
Q Consensus         3 ~gsL~~~l~~~----~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~----~~~~~l~d~g~~~~~   74 (202)
                      +++|.+++...    ...+++..+..++.|++.||.|||    +.+++||||||+||+++.    ++.++++|||++...
T Consensus        87 ~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~  162 (316)
T cd07842          87 EHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH----SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLF  162 (316)
T ss_pred             CcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHH----hCCEeeCCCCHHHEEEcCCCCccceEEECCCcccccc
Confidence            45777776532    225889999999999999999999    899999999999999999    899999999998865


Q ss_pred             cCCCc-cccccCCCCCccccCCCCCCC-CCcCcchhhhhHHHHHHHHHhCCCCCCcccccch--------hhHHHHHHhC
Q 037267           75 GEGED-FVTQTMTMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEM--------SLRRWVKESL  144 (202)
Q Consensus        75 ~~~~~-~~~~~~~~~~~~~~~pe~~~~-~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~--------~~~~~~~~~~  144 (202)
                      ..... ........++..|+|||...+ ..++.++|+||+|++++++++|..||........        .+...+...-
T Consensus       163 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  242 (316)
T cd07842         163 NAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLG  242 (316)
T ss_pred             CCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHHhC
Confidence            43322 111122346788999997655 3578889999999999999999999976543320        0010000000


Q ss_pred             C------------CChhhh---hh-hhhh--hhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          145 P------------HGLTEV---VD-ANLV--REEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       145 ~------------~~~~~~---~~-~~~~--~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                      .            +.....   .. ....  ............+.++.+++.+||+.||++|||+.|+++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~  312 (316)
T cd07842         243 TPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE  312 (316)
T ss_pred             CCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            0            000000   00 0000  000000111145567899999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=99.95  E-value=1.9e-27  Score=184.98  Aligned_cols=186  Identities=25%  Similarity=0.291  Sum_probs=129.8

Q ss_pred             CCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc--
Q 037267            3 NGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF--   80 (202)
Q Consensus         3 ~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~--   80 (202)
                      +++|.+++...  .+++..+..++.|++.||.|||    +.+++|+||+|.||+++.++.++++|||++.........  
T Consensus        92 ~~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH----~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~~~  165 (337)
T cd07852          92 ETDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIH----SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPE  165 (337)
T ss_pred             ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHEEEcCCCcEEEeeccchhcccccccccc
Confidence            36888888754  5789999999999999999999    899999999999999999999999999998765433211  


Q ss_pred             -ccccCCCCCccccCCCCCCC-CCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHH-hCCCC----------
Q 037267           81 -VTQTMTMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKE-SLPHG----------  147 (202)
Q Consensus        81 -~~~~~~~~~~~~~~pe~~~~-~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~----------  147 (202)
                       .......++..|++||.+.+ ..++.++|+||+|+++|++++|..||......... ...... ..+..          
T Consensus       166 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  244 (337)
T cd07852         166 NPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQL-EKIIEVIGPPSAEDIESIKSPF  244 (337)
T ss_pred             CcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHHHHhCCCCHHHHHHHHhhh
Confidence             11122357888999997654 45678899999999999999999999654332211 111100 00000          


Q ss_pred             hhhhhhhhhhhh--HHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          148 LTEVVDANLVRE--EQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       148 ~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                      ...... .....  .........++.++.+++.+||+.+|++|||+.++++
T Consensus       245 ~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~  294 (337)
T cd07852         245 AATMLD-SLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALE  294 (337)
T ss_pred             HHHhhh-hcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhh
Confidence            000000 00000  0001111225677999999999999999999999985

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=99.95  E-value=1e-27  Score=179.51  Aligned_cols=171  Identities=24%  Similarity=0.312  Sum_probs=130.5

Q ss_pred             CCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCC-ceEEcccccceeccCCC
Q 037267            1 MPNGSLEKWLYSYN-YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENM-VAHVSDFGISKLLGEGE   78 (202)
Q Consensus         1 ~~~gsL~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~-~~~l~d~g~~~~~~~~~   78 (202)
                      +++++|.+++.... ..+++..+..++.|++.||.|||    +.+++|+|++|.||+++.++ .++++|||.+.......
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh----~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~  156 (257)
T cd08225          81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH----DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM  156 (257)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH----HCCcccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence            47899999997544 35899999999999999999999    89999999999999999775 46999999987654432


Q ss_pred             ccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhh
Q 037267           79 DFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVR  158 (202)
Q Consensus        79 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (202)
                      ..  .....++..|+|||...+..++.++|+||+|++++++++|..||.......     .+.........         
T Consensus       157 ~~--~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-----~~~~~~~~~~~---------  220 (257)
T cd08225         157 EL--AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQ-----LVLKICQGYFA---------  220 (257)
T ss_pred             cc--ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH-----HHHHHhcccCC---------
Confidence            21  112347788999998877788899999999999999999999986532211     11111000000         


Q ss_pred             hHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          159 EEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       159 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                           ......+.++.+++.+||..+|++|||+.++++
T Consensus       221 -----~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  253 (257)
T cd08225         221 -----PISPNFSRDLRSLISQLFKVSPRDRPSITSILK  253 (257)
T ss_pred             -----CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence                 001123456899999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=4.4e-27  Score=175.56  Aligned_cols=170  Identities=24%  Similarity=0.304  Sum_probs=132.0

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      +++++|.+++.... .+++..+..++.|++.||.|||    +.+++|+|++|.||+++.++.++++|||.+.........
T Consensus        81 ~~~~~L~~~~~~~~-~l~~~~~~~~~~~i~~~l~~lH----~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~  155 (254)
T cd06627          81 AENGSLRQIIKKFG-PFPESLVAVYVYQVLQGLAYLH----EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD  155 (254)
T ss_pred             CCCCcHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHh----hCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc
Confidence            36889999998653 4899999999999999999999    899999999999999999999999999999876543321


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhH
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREE  160 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (202)
                        .....++..|.+||...+..++.++|+||+|++++++++|..||........ .........                
T Consensus       156 --~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~----------------  216 (254)
T cd06627         156 --DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAA-LFRIVQDDH----------------  216 (254)
T ss_pred             --ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHH-HHHHhccCC----------------
Confidence              1223567889999988777788899999999999999999999865431111 000000000                


Q ss_pred             HHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          161 QAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       161 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                        ...+...+..+.+++.+||..+|++|||+.+++.
T Consensus       217 --~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         217 --PPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             --CCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence              0011234556889999999999999999999874

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.95  E-value=1.6e-27  Score=181.59  Aligned_cols=177  Identities=27%  Similarity=0.254  Sum_probs=131.2

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      +++|+|.+++.... .+++..+..++.|++.+|.|||    +.+++|+|++|.||+++.++.++++|||++.........
T Consensus        87 ~~~~~L~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lH----~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~  161 (288)
T cd05583          87 VNGGELFTHLYQRE-HFTESEVRVYIAEIVLALDHLH----QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEE  161 (288)
T ss_pred             CCCCcHHHHHhhcC-CcCHHHHHHHHHHHHHHHHHHH----HCCeeccCCCHHHeEECCCCCEEEEECcccccccccccc
Confidence            46899999997644 4899999999999999999999    899999999999999999999999999998765433211


Q ss_pred             ccccCCCCCccccCCCCCCCCC--cCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhh
Q 037267           81 VTQTMTMATIGYMAPEYGSEGI--VSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVR  158 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~--~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (202)
                       ......++..|++||...+..  .+.++|+||+|+++|++++|..||....... ..........             .
T Consensus       162 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~-~~~~~~~~~~-------------~  226 (288)
T cd05583         162 -RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN-SQSEISRRIL-------------K  226 (288)
T ss_pred             -ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc-hHHHHHHHHH-------------c
Confidence             112234678899999876554  6778999999999999999999986422111 1111111000             0


Q ss_pred             hHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHh
Q 037267          159 EEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLK  199 (202)
Q Consensus       159 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~  199 (202)
                      .  ..+.+..++..+.+++.+||+.||++|||+.++.+.|+
T Consensus       227 ~--~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~  265 (288)
T cd05583         227 S--KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKN  265 (288)
T ss_pred             c--CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhc
Confidence            0  00111224456889999999999999999888877664

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.95  E-value=6.7e-27  Score=177.28  Aligned_cols=185  Identities=25%  Similarity=0.248  Sum_probs=130.6

Q ss_pred             CCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcccc
Q 037267            3 NGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVT   82 (202)
Q Consensus         3 ~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~   82 (202)
                      +++|.+++......+++..+..++.|++.||.|||    +.+++|+|++|+||+++.++.++++|||.+........  .
T Consensus        81 ~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH----~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~--~  154 (282)
T cd07829          81 DMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH----SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR--T  154 (282)
T ss_pred             CcCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc--c
Confidence            46899999876456999999999999999999999    89999999999999999999999999999876543321  1


Q ss_pred             ccCCCCCccccCCCCCCCC-CcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCC----h---hhh---
Q 037267           83 QTMTMATIGYMAPEYGSEG-IVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHG----L---TEV---  151 (202)
Q Consensus        83 ~~~~~~~~~~~~pe~~~~~-~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~---~~~---  151 (202)
                      ......+..|+|||...+. .++.++|+||+|++++++++|..||...........  +.......    +   .+.   
T Consensus       155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  232 (282)
T cd07829         155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFK--IFQILGTPTEESWPGVTKLPDY  232 (282)
T ss_pred             cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHH--HHHHhCCCcHHHHHhhcccccc
Confidence            1123356779999977655 778899999999999999999999865432211100  00000000    0   000   


Q ss_pred             --hhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          152 --VDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       152 --~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                        ..+...... ........+..+.+++.+||..||++||++.+++.
T Consensus       233 ~~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         233 KPTFPKFPPKD-LEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             cccccccCccc-hHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence              000000000 00111123567999999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.95  E-value=3.7e-27  Score=178.41  Aligned_cols=171  Identities=26%  Similarity=0.362  Sum_probs=131.3

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      +++++|.+++.+.+ .+++..+..++.|++.||.|||    +.+++|+|++|.||+++.++.++++|||++.........
T Consensus        84 ~~~~~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~Lh----~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~  158 (280)
T cd05581          84 APNGELLQYIRKYG-SLDEKCTRFYAAEILLALEYLH----SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSP  158 (280)
T ss_pred             CCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeeecCCCHHHeEECCCCCEEecCCccccccCCcccc
Confidence            46899999998755 4999999999999999999999    899999999999999999999999999998765432210


Q ss_pred             ------------------ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHH
Q 037267           81 ------------------VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKE  142 (202)
Q Consensus        81 ------------------~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~  142 (202)
                                        .......++..|.+||......++.++|+||+|++++++++|..||....... .+... ..
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~~~-~~  236 (280)
T cd05581         159 ESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL-TFQKI-LK  236 (280)
T ss_pred             ccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHH-HHHHH-Hh
Confidence                              11122346788999998877778889999999999999999999997643111 11110 00


Q ss_pred             hCCCChhhhhhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCH----HHHHH
Q 037267          143 SLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINM----TDAAA  196 (202)
Q Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~----~~~~~  196 (202)
                      ..                  ...+...++.+.+++.+||..+|++||++    .++++
T Consensus       237 ~~------------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         237 LE------------------YSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             cC------------------CCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence            00                  00112235568999999999999999999    66653

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1.1e-27  Score=186.08  Aligned_cols=164  Identities=26%  Similarity=0.315  Sum_probs=135.3

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |.||.|.-.|+..+. |+..++.-++..+++|++|||    +++|++|||||+|++++.+|.+|+.|||+++....+.. 
T Consensus       502 ClGGElWTiLrdRg~-Fdd~tarF~~acv~EAfeYLH----~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~K-  575 (732)
T KOG0614|consen  502 CLGGELWTILRDRGS-FDDYTARFYVACVLEAFEYLH----RKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRK-  575 (732)
T ss_pred             hcCchhhhhhhhcCC-cccchhhhhHHHHHHHHHHHH----hcCceeccCChhheeeccCCceEEeehhhHHHhccCCc-
Confidence            679999999987554 899999999999999999999    99999999999999999999999999999998876654 


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhH
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREE  160 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (202)
                        .+++.||+.|.|||++.......++|.||+|+++||+++|.+||...+.-.  ....+..++                
T Consensus       576 --TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmk--tYn~ILkGi----------------  635 (732)
T KOG0614|consen  576 --TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMK--TYNLILKGI----------------  635 (732)
T ss_pred             --eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHH--HHHHHHhhh----------------
Confidence              456789999999999888888899999999999999999999997743221  111111111                


Q ss_pred             HHHHHhHHHHHHHHHHHhhhcCCCCCCCCC
Q 037267          161 QAFAAKMDCIVSIMDLALDCCMESPGKRIN  190 (202)
Q Consensus       161 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps  190 (202)
                      .....|..+.....+|+.+.+..+|.+|..
T Consensus       636 d~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG  665 (732)
T KOG0614|consen  636 DKIEFPRRITKTATDLIKKLCRDNPTERLG  665 (732)
T ss_pred             hhhhcccccchhHHHHHHHHHhcCcHhhhc
Confidence            112334456667889999999999999985

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=99.94  E-value=5.6e-29  Score=182.79  Aligned_cols=173  Identities=22%  Similarity=0.317  Sum_probs=143.1

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |-.||..|.++..+++|++.++..++++-+.||.|||    ...-+|||+|..|||++.+|..|++|||++..+.+... 
T Consensus       110 CGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH----~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA-  184 (502)
T KOG0574|consen  110 CGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLH----DLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA-  184 (502)
T ss_pred             cCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHH----HHHHHHhhcccccEEEcccchhhhhhccccchhhhhHH-
Confidence            5579999999988889999999999999999999999    77889999999999999999999999999988765432 


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhH
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREE  160 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (202)
                       .+.+.+||+.|+|||++..-.|+.++||||+|+...||..|++||.+.+.-...+.      .|     ...      +
T Consensus       185 -KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFM------IP-----T~P------P  246 (502)
T KOG0574|consen  185 -KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFM------IP-----TKP------P  246 (502)
T ss_pred             -hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEe------cc-----CCC------C
Confidence             34557899999999998877899999999999999999999999987654332111      11     000      1


Q ss_pred             HHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          161 QAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       161 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                      ..+..+..++.++.|++.+||.++|++|-++.++++
T Consensus       247 PTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~  282 (502)
T KOG0574|consen  247 PTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCE  282 (502)
T ss_pred             CCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence            111223567788999999999999999999998875

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=99.94  E-value=5.9e-27  Score=179.42  Aligned_cols=188  Identities=23%  Similarity=0.210  Sum_probs=129.5

Q ss_pred             CCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcccc
Q 037267            3 NGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVT   82 (202)
Q Consensus         3 ~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~   82 (202)
                      .|+|.+++.+....+++..+..++.|++.||.|||    +.+++|+|++|.||+++.++.++++|||++......... .
T Consensus        99 ~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH----~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~-~  173 (302)
T cd07864          99 DHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCH----KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESR-P  173 (302)
T ss_pred             CccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEECCCCcEEeCcccccccccCCccc-c
Confidence            35777887765556899999999999999999999    899999999999999999999999999998765433211 1


Q ss_pred             ccCCCCCccccCCCCCCC-CCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHH---hCCCChhhhhhh----
Q 037267           83 QTMTMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKE---SLPHGLTEVVDA----  154 (202)
Q Consensus        83 ~~~~~~~~~~~~pe~~~~-~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~----  154 (202)
                      .....++..|++||...+ ..++.++|+||+|++++++++|+.||....... .+......   ..+.........    
T Consensus       174 ~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (302)
T cd07864         174 YTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELA-QLELISRLCGSPCPAVWPDVIKLPYFN  252 (302)
T ss_pred             cccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCChhhccccccccccc
Confidence            112235678999997654 346788999999999999999999997532211 11111110   000000000000    


Q ss_pred             ----hhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          155 ----NLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       155 ----~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                          ...............+..+.+++.+||..||.+||++.+++.
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         253 TMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             ccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence                000000011112235677999999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.94  E-value=7e-27  Score=182.46  Aligned_cols=183  Identities=22%  Similarity=0.246  Sum_probs=127.4

Q ss_pred             CCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCccc
Q 037267            2 PNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFV   81 (202)
Q Consensus         2 ~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~~   81 (202)
                      .+++|.++++..  .+++..+..++.|++.||.|||    +.+++|||+||.||+++.++.++++|||++.......   
T Consensus       104 ~~~~L~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH----~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~~~---  174 (345)
T cd07877         104 MGADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---  174 (345)
T ss_pred             cccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH----HCCeeecCCChHHEEEcCCCCEEEecccccccccccc---
Confidence            468888888643  3899999999999999999999    8999999999999999999999999999987643221   


Q ss_pred             cccCCCCCccccCCCCCCC-CCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHH-HhCC-CChhhhhhhh---
Q 037267           82 TQTMTMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVK-ESLP-HGLTEVVDAN---  155 (202)
Q Consensus        82 ~~~~~~~~~~~~~pe~~~~-~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~-~~~~-~~~~~~~~~~---  155 (202)
                        ....++..|+|||...+ ..++.++|+||+||++|++++|..||....... ....... ...+ ......+...   
T Consensus       175 --~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (345)
T cd07877         175 --TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID-QLKLILRLVGTPGAELLKKISSESAR  251 (345)
T ss_pred             --cccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHHHHhhcccHhHH
Confidence              12356788999997655 457888999999999999999999996533221 1111110 0000 0000000000   


Q ss_pred             -hhh------hHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          156 -LVR------EEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       156 -~~~------~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                       ...      ...........+.++.+++.+|+..||.+||++.+++.
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  299 (345)
T cd07877         252 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  299 (345)
T ss_pred             HHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhc
Confidence             000      00000000123566899999999999999999999874

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=99.94  E-value=1.1e-26  Score=176.38  Aligned_cols=186  Identities=18%  Similarity=0.211  Sum_probs=130.1

Q ss_pred             CcHHHHHhhcC--CCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCccc
Q 037267            4 GSLEKWLYSYN--YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFV   81 (202)
Q Consensus         4 gsL~~~l~~~~--~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~~   81 (202)
                      |+|.+++....  ..+++..+..++.|++.||.|||    +.+++|+|++|.||+++.++.++++|||++........  
T Consensus        82 ~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~--  155 (284)
T cd07836          82 KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH----ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN--  155 (284)
T ss_pred             ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHH----HCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc--
Confidence            58889887544  45899999999999999999999    89999999999999999999999999999875543221  


Q ss_pred             cccCCCCCccccCCCCCCCC-CcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCC---hhhhhh----
Q 037267           82 TQTMTMATIGYMAPEYGSEG-IVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHG---LTEVVD----  153 (202)
Q Consensus        82 ~~~~~~~~~~~~~pe~~~~~-~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~----  153 (202)
                      ......++..|++||.+.+. .++.++|+||+|+++|++++|..||......+. ..........+.   +.....    
T Consensus       156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd07836         156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQ-LLKIFRIMGTPTESTWPGISQLPEY  234 (284)
T ss_pred             ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHHHHHhCCCChhhHHHHhcCchh
Confidence            11223457789999976553 467889999999999999999999976443221 111111100000   000000    


Q ss_pred             -hhhh--hhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          154 -ANLV--REEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       154 -~~~~--~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                       ....  ............+..+.+++.+||+.||.+||++.++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         235 KPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             cccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence             0000  000011112245677899999999999999999999874

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=8.7e-27  Score=175.37  Aligned_cols=172  Identities=22%  Similarity=0.181  Sum_probs=130.0

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      +++++|.+++.+... +++..+..++.|++.||.|||    +.+++|+|+||+||+++.++.++++|||++.........
T Consensus        88 ~~~~~L~~~~~~~~~-l~~~~~~~~~~~i~~al~~LH----~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~  162 (264)
T cd06653          88 MPGGSIKDQLKAYGA-LTENVTRRYTRQILQGVSYLH----SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMS  162 (264)
T ss_pred             CCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH----hCCEecCCCCHHHEEEcCCCCEEECcccccccccccccc
Confidence            478999999986443 889999999999999999999    899999999999999999999999999998764321110


Q ss_pred             -ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhh
Q 037267           81 -VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVRE  159 (202)
Q Consensus        81 -~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (202)
                       .......++..|+|||...+..++.++|+||+|++++++++|..||........ ........                
T Consensus       163 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~----------------  225 (264)
T cd06653         163 GTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAA-IFKIATQP----------------  225 (264)
T ss_pred             CccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHH-HHHHHcCC----------------
Confidence             011223578889999998888888999999999999999999999975322111 11110000                


Q ss_pred             HHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          160 EQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       160 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                       .....+...++++.+++.+||. +|..||++.+++.
T Consensus       226 -~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         226 -TKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             -CCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence             0001123355668999999999 5799999998764

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.94  E-value=1.6e-26  Score=175.37  Aligned_cols=185  Identities=19%  Similarity=0.211  Sum_probs=130.1

Q ss_pred             CCcHHHHHhhcC-CCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCccc
Q 037267            3 NGSLEKWLYSYN-YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFV   81 (202)
Q Consensus         3 ~gsL~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~~   81 (202)
                      +|+|.+++.... ..+++..+..++.|++.+|.|||    +.+++|+||+|.||+++.++.++++|||.+......... 
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh----~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~-  155 (283)
T cd07830          81 EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH----KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY-  155 (283)
T ss_pred             CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCCc-
Confidence            789999987654 45899999999999999999999    899999999999999999999999999998765443221 


Q ss_pred             cccCCCCCccccCCCCCC-CCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChh----------h
Q 037267           82 TQTMTMATIGYMAPEYGS-EGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLT----------E  150 (202)
Q Consensus        82 ~~~~~~~~~~~~~pe~~~-~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~----------~  150 (202)
                        ....++..|+|||... ...++.++|+||+|++++++++|..||......... .... ........          .
T Consensus       156 --~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~~  231 (283)
T cd07830         156 --TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQL-YKIC-SVLGTPTKQDWPEGYKLAS  231 (283)
T ss_pred             --CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHH-HHHH-HhcCCCChhhhhhHhhhhc
Confidence              2234678899999764 345788999999999999999999998654322211 1000 00000000          0


Q ss_pred             hhhhhhhh--hHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          151 VVDANLVR--EEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       151 ~~~~~~~~--~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                      ........  ...........+..+.+++.+||..+|++||++.|++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  279 (283)
T cd07830         232 KLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ  279 (283)
T ss_pred             cccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence            00000000  00000111112466899999999999999999999875

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.94  E-value=1.3e-27  Score=171.50  Aligned_cols=189  Identities=19%  Similarity=0.246  Sum_probs=133.9

Q ss_pred             CcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc--c
Q 037267            4 GSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF--V   81 (202)
Q Consensus         4 gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~--~   81 (202)
                      .+|...|.+....++..++.+++.++..||.|+|    ...|+|||+|+.|+||+.++.+|++|||+++.+......  .
T Consensus       108 hDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iH----r~kilHRDmKaaNvLIt~dgilklADFGlar~fs~~~n~~kp  183 (376)
T KOG0669|consen  108 HDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIH----RNKILHRDMKAANVLITKDGILKLADFGLARAFSTSKNVVKP  183 (376)
T ss_pred             hhHHHHhcCccccccHHHHHHHHHHHHHHHHHHH----HhhHHhhcccHhhEEEcCCceEEeeccccccceecccccCCC
Confidence            3677777665567999999999999999999999    899999999999999999999999999999876544322  2


Q ss_pred             cccCCCCCccccCCCCCCCC-CcCcchhhhhHHHHHHHHHhCCCCCCcccccch-h-hHHHHHHhCCCChhhhhhhhhh-
Q 037267           82 TQTMTMATIGYMAPEYGSEG-IVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEM-S-LRRWVKESLPHGLTEVVDANLV-  157 (202)
Q Consensus        82 ~~~~~~~~~~~~~pe~~~~~-~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~-~-~~~~~~~~~~~~~~~~~~~~~~-  157 (202)
                      ..+...-|.+|.+||.+.|. .|+++.|+|+.||++.+|++|++.+++.++... . +..+.....+.-+.......+. 
T Consensus       184 rytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~  263 (376)
T KOG0669|consen  184 RYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQ  263 (376)
T ss_pred             CcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCcccchHHH
Confidence            24455668899999977664 688899999999999999999998887654332 1 1222211111111111110000 


Q ss_pred             --------hhH-HHH---HHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          158 --------REE-QAF---AAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       158 --------~~~-~~~---~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                              ... ...   ..+-.-.++.++|+.+++..||.+|+++++++.
T Consensus       264 sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln  314 (376)
T KOG0669|consen  264 SIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN  314 (376)
T ss_pred             hccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence                    000 000   000011235789999999999999999999874

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.94  E-value=9.4e-27  Score=180.96  Aligned_cols=189  Identities=18%  Similarity=0.160  Sum_probs=129.8

Q ss_pred             CCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCc---
Q 037267            3 NGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED---   79 (202)
Q Consensus         3 ~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~---   79 (202)
                      .|+|.+++.... .+++..+..++.|++.||.|||    +.+++|+||+|.||+++.++.++++|||.+........   
T Consensus       103 ~~~l~~~l~~~~-~~~~~~~~~~~~ql~~aL~~LH----~~~i~H~dl~~~nill~~~~~~kl~dfg~~~~~~~~~~~~~  177 (335)
T PTZ00024        103 ASDLKKVVDRKI-RLTESQVKCILLQILNGLNVLH----KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDT  177 (335)
T ss_pred             ccCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----hCCeecccccHHHeEECCCCCEEECCccceeeccccccccc
Confidence            478999997543 4899999999999999999999    89999999999999999999999999999876552110   


Q ss_pred             ---------cccccCCCCCccccCCCCCCCC-CcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhH--HHHHHhCCCC
Q 037267           80 ---------FVTQTMTMATIGYMAPEYGSEG-IVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLR--RWVKESLPHG  147 (202)
Q Consensus        80 ---------~~~~~~~~~~~~~~~pe~~~~~-~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~--~~~~~~~~~~  147 (202)
                               ........++..|++||.+.+. .++.++|+||+|+++|++++|..||......+....  ..........
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i~~~~~~~~~~~  257 (335)
T PTZ00024        178 LSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELLGTPNEDN  257 (335)
T ss_pred             ccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCchhh
Confidence                     0011122356789999987654 468889999999999999999999976433221100  0000000000


Q ss_pred             hhhhh-----hhh-hhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          148 LTEVV-----DAN-LVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       148 ~~~~~-----~~~-~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                      +....     ... .............++.++.+++.+||+.+|++|||++|++.
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  312 (335)
T PTZ00024        258 WPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK  312 (335)
T ss_pred             CcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence            00000     000 00001111112334667899999999999999999999875

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.94  E-value=1.3e-26  Score=178.65  Aligned_cols=166  Identities=26%  Similarity=0.255  Sum_probs=126.3

Q ss_pred             CCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcccc
Q 037267            3 NGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVT   82 (202)
Q Consensus         3 ~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~   82 (202)
                      .|+|.+++......+++.++..++.|++.||.|||    +.+++|+|++|.||+++.++.++++|||++......     
T Consensus       104 ~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH----~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~-----  174 (313)
T cd06633         104 LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH----SHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPA-----  174 (313)
T ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCChhhEEECCCCCEEEeecCCCcccCCC-----
Confidence            46888888766666899999999999999999999    899999999999999999999999999987643221     


Q ss_pred             ccCCCCCccccCCCCCC---CCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhh
Q 037267           83 QTMTMATIGYMAPEYGS---EGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVRE  159 (202)
Q Consensus        83 ~~~~~~~~~~~~pe~~~---~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (202)
                       ....++..|++||.+.   ...++.++|+||+|+++|++++|..||.......... .......+..            
T Consensus       175 -~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~-~~~~~~~~~~------------  240 (313)
T cd06633         175 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-HIAQNDSPTL------------  240 (313)
T ss_pred             -CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH-HHHhcCCCCC------------
Confidence             1235778899999863   3557888999999999999999999986643211111 1110000000            


Q ss_pred             HHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          160 EQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       160 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                           .....+..+.+++.+||+.+|++||++.+++.
T Consensus       241 -----~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~  272 (313)
T cd06633         241 -----QSNEWTDSFRGFVDYCLQKIPQERPASAELLR  272 (313)
T ss_pred             -----CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                 01123345889999999999999999999875

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.94  E-value=7.6e-27  Score=175.22  Aligned_cols=170  Identities=21%  Similarity=0.205  Sum_probs=129.2

Q ss_pred             CCCCcHHHHHhh---cCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCC
Q 037267            1 MPNGSLEKWLYS---YNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEG   77 (202)
Q Consensus         1 ~~~gsL~~~l~~---~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~   77 (202)
                      +++++|.+++..   ....+++..++.++.|++.||.|||    +.+++|+|++|+||+++. +.++++|||++......
T Consensus        84 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH----~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~  158 (260)
T cd08222          84 CEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH----QRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGS  158 (260)
T ss_pred             CCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHH----HcCccccCCChhheEeec-CCEeecccCceeecCCC
Confidence            478999998864   2345899999999999999999999    899999999999999975 56999999998775443


Q ss_pred             CccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhh
Q 037267           78 EDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV  157 (202)
Q Consensus        78 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (202)
                      ...  .....++..|++||...+..++.++|+||+|+++|++++|..||.......  .........             
T Consensus       159 ~~~--~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~--~~~~~~~~~-------------  221 (260)
T cd08222         159 CDL--ATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLS--VVLRIVEGP-------------  221 (260)
T ss_pred             ccc--ccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH--HHHHHHcCC-------------
Confidence            221  122346788999998877778889999999999999999999985422111  000000000             


Q ss_pred             hhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          158 REEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                          ....+..++.++.+++.+||..+|++||++.++++
T Consensus       222 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         222 ----TPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             ----CCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence                00012245567899999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.94  E-value=1.4e-27  Score=180.47  Aligned_cols=175  Identities=22%  Similarity=0.326  Sum_probs=143.1

Q ss_pred             CcHHHHHh-----hc--CCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccC
Q 037267            4 GSLEKWLY-----SY--NYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGE   76 (202)
Q Consensus         4 gsL~~~l~-----~~--~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~   76 (202)
                      |+|..||.     ..  ...++..+.+.++.|++.|++|||    +++++|.||-..|++|+..-.+|++|=.+++-..+
T Consensus       373 gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh----~~~ViHkDiAaRNCvIdd~LqVkltDsaLSRDLFP  448 (563)
T KOG1024|consen  373 GNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLH----NHGVIHKDIAARNCVIDDQLQVKLTDSALSRDLFP  448 (563)
T ss_pred             chHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHH----hcCcccchhhhhcceehhheeEEeccchhccccCc
Confidence            78888987     21  235788899999999999999999    99999999999999999999999999999887666


Q ss_pred             CCccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhCCCChhhhhhhh
Q 037267           77 GEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDAN  155 (202)
Q Consensus        77 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (202)
                      ..-..-......+..|+++|.+....|+..+|+||||+++||+++ |+.|+.+.+.-++  ..+.               
T Consensus       449 ~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm--~~yl---------------  511 (563)
T KOG1024|consen  449 GDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEM--EHYL---------------  511 (563)
T ss_pred             ccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHH--HHHH---------------
Confidence            554333334456788999999988999999999999999999998 9999876543331  1111               


Q ss_pred             hhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          156 LVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                        .++.+...|-+|+++++.+|..||..+|++||+.+|+..-|+.+
T Consensus       512 --kdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF  555 (563)
T KOG1024|consen  512 --KDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEF  555 (563)
T ss_pred             --hccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence              22334455678999999999999999999999999999988754

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.94  E-value=1.4e-26  Score=180.67  Aligned_cols=181  Identities=24%  Similarity=0.256  Sum_probs=128.9

Q ss_pred             CCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCccc
Q 037267            2 PNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFV   81 (202)
Q Consensus         2 ~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~~   81 (202)
                      .+++|.+++..  ..+++..+..++.|++.||.|||    +.+++|+|++|+||+++.++.++++|||++.......   
T Consensus       102 ~~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH----~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~---  172 (343)
T cd07851         102 MGADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIH----SAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEM---  172 (343)
T ss_pred             CCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHeEECCCCCEEEccccccccccccc---
Confidence            36789999875  34899999999999999999999    8999999999999999999999999999987654321   


Q ss_pred             cccCCCCCccccCCCCCCC-CCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhh-
Q 037267           82 TQTMTMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVRE-  159 (202)
Q Consensus        82 ~~~~~~~~~~~~~pe~~~~-~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  159 (202)
                        ....++..|++||...+ ..++.++|+||+|+++|++++|..||....... .+.. +............. ..... 
T Consensus       173 --~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~-~~~~-i~~~~~~~~~~~~~-~~~~~~  247 (343)
T cd07851         173 --TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHID-QLKR-IMNLVGTPDEELLQ-KISSES  247 (343)
T ss_pred             --cCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH-HHHH-HHHhcCCCCHHHHh-hccchh
Confidence              12346778999997644 356788999999999999999999996533211 1111 11111100000000 00000 


Q ss_pred             -------------HHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          160 -------------EQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       160 -------------~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                                   ..........+.++.+++.+||..+|++|||+.++++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~  297 (343)
T cd07851         248 ARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA  297 (343)
T ss_pred             HHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence                         0000111234677999999999999999999999875

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.94  E-value=1.2e-26  Score=180.90  Aligned_cols=186  Identities=19%  Similarity=0.219  Sum_probs=125.8

Q ss_pred             CCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeC-CCCceEEcccccceeccCCCccc
Q 037267            3 NGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLD-ENMVAHVSDFGISKLLGEGEDFV   81 (202)
Q Consensus         3 ~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~-~~~~~~l~d~g~~~~~~~~~~~~   81 (202)
                      +++|.+++...  .+++..+..++.|++.||.|||    +.+++||||||+||+++ .++.++++|||.+..........
T Consensus        99 ~~~L~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH----~~givH~dikp~Nili~~~~~~~kl~dfg~~~~~~~~~~~~  172 (342)
T cd07854          99 ETDLANVLEQG--PLSEEHARLFMYQLLRGLKYIH----SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHK  172 (342)
T ss_pred             cccHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCCHHHEEEcCCCceEEECCcccceecCCccccc
Confidence            46788888642  4899999999999999999999    89999999999999998 45678999999987653321111


Q ss_pred             c-ccCCCCCccccCCCCCCC-CCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhh-------h
Q 037267           82 T-QTMTMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEV-------V  152 (202)
Q Consensus        82 ~-~~~~~~~~~~~~pe~~~~-~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-------~  152 (202)
                      . .....++..|+|||...+ ..++.++|+||+||++|++++|..||......... .. .....+......       .
T Consensus       173 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~  250 (342)
T cd07854         173 GYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQM-QL-ILESVPVVREEDRNELLNVI  250 (342)
T ss_pred             cccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HH-HHHhcCCCChHHhhhhhhhh
Confidence            1 112346778999996543 45778899999999999999999999754322111 11 111111000000       0


Q ss_pred             hhhhh----hhH-HHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          153 DANLV----REE-QAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       153 ~~~~~----~~~-~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                      .....    ... .........+.++.+++.+||..||++|||+.+++.
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  299 (342)
T cd07854         251 PSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM  299 (342)
T ss_pred             hhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence            00000    000 000111235567889999999999999999999873

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.94  E-value=9.1e-27  Score=177.53  Aligned_cols=174  Identities=28%  Similarity=0.247  Sum_probs=127.4

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      +++|+|.+++.... .++...+..++.|++.||.|||    +.+++||||+|.||+++.++.++++|||++.........
T Consensus        87 ~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~al~~lH----~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~  161 (290)
T cd05613          87 INGGELFTHLSQRE-RFKEQEVQIYSGEIVLALEHLH----KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVE  161 (290)
T ss_pred             CCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----hCCeeccCCCHHHeEECCCCCEEEeeCccceeccccccc
Confidence            57899999998654 4889999999999999999999    899999999999999999999999999998765432211


Q ss_pred             ccccCCCCCccccCCCCCCCC--CcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhh
Q 037267           81 VTQTMTMATIGYMAPEYGSEG--IVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVR  158 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~--~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (202)
                       ......++..|++||.....  .++.++|+||+|+++|++++|..||..... .............            .
T Consensus       162 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~-~~~~~~~~~~~~~------------~  227 (290)
T cd05613         162 -RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGE-KNSQAEISRRILK------------S  227 (290)
T ss_pred             -ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCc-cccHHHHHHHhhc------------c
Confidence             11224578889999987542  356789999999999999999999864211 1111111110000            0


Q ss_pred             hHHHHHHhHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHH
Q 037267          159 EEQAFAAKMDCIVSIMDLALDCCMESPGKRI-----NMTDAAA  196 (202)
Q Consensus       159 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rp-----s~~~~~~  196 (202)
                         ..+.+..++..+.+++.+||..||++||     ++.++++
T Consensus       228 ---~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~  267 (290)
T cd05613         228 ---EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK  267 (290)
T ss_pred             ---CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence               0001123455688999999999999997     5666553

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.94  E-value=3.4e-26  Score=170.52  Aligned_cols=166  Identities=29%  Similarity=0.276  Sum_probs=128.1

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      +++++|.+++.... .+++..+..++.|++.||.|||    +.+++|+|++|.||+++.++.++++|||.+........ 
T Consensus        75 ~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lh----~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~-  148 (250)
T cd05123          75 APGGELFSHLSKEG-RFSEERARFYAAEIVLALEYLH----SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS-  148 (250)
T ss_pred             CCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCceecCCCcceEEEcCCCcEEEeecCcceecccCCC-
Confidence            36899999998654 4899999999999999999999    89999999999999999999999999999877544321 


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhH
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREE  160 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (202)
                       ......++..|++||...+...+.++|+||+|+++|++++|..||.......  ....+...           .     
T Consensus       149 -~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~--~~~~~~~~-----------~-----  209 (250)
T cd05123         149 -RTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKE--IYEKILKD-----------P-----  209 (250)
T ss_pred             -cccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHhcC-----------C-----
Confidence             1122356778999998887778889999999999999999999996543211  11111000           0     


Q ss_pred             HHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHH
Q 037267          161 QAFAAKMDCIVSIMDLALDCCMESPGKRINMTD  193 (202)
Q Consensus       161 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~  193 (202)
                        ...+...+..+.+++.+||..||++||++.+
T Consensus       210 --~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         210 --LRFPEFLSPEARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             --CCCCCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence              0111122456889999999999999999943

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.94  E-value=1.5e-26  Score=180.42  Aligned_cols=181  Identities=21%  Similarity=0.206  Sum_probs=127.7

Q ss_pred             CCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcccc
Q 037267            3 NGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVT   82 (202)
Q Consensus         3 ~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~   82 (202)
                      +++|.+++..  ..+++..+..++.|++.||.|||    +.+|+||||||+||+++.++.++++|||++.......    
T Consensus       103 ~~~l~~~~~~--~~l~~~~~~~i~~qi~~al~~LH----~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~----  172 (343)
T cd07880         103 GTDLGKLMKH--EKLSEDRIQFLVYQMLKGLKYIH----AAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEM----  172 (343)
T ss_pred             CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEEcCCCCEEEeecccccccccCc----
Confidence            6788888864  34899999999999999999999    8999999999999999999999999999987643221    


Q ss_pred             ccCCCCCccccCCCCCCC-CCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhC--CCChhhhhh-h---h
Q 037267           83 QTMTMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESL--PHGLTEVVD-A---N  155 (202)
Q Consensus        83 ~~~~~~~~~~~~pe~~~~-~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~-~---~  155 (202)
                       ....++..|++||...+ ..++.++|+||+|+++|++++|..||........ .........  +......+. .   .
T Consensus       173 -~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (343)
T cd07880         173 -TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQ-LMEIMKVTGTPSKEFVQKLQSEDAKN  250 (343)
T ss_pred             -cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcCCCCHHHHHhhcchhHHH
Confidence             22346788999997655 3578889999999999999999999975432211 111111000  000000000 0   0


Q ss_pred             ----hh--hhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHH
Q 037267          156 ----LV--REEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAA  195 (202)
Q Consensus       156 ----~~--~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~  195 (202)
                          ..  ...........++.++.+++.+|+..||++|||+.+++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l  296 (343)
T cd07880         251 YVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEAL  296 (343)
T ss_pred             HHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHh
Confidence                00  00000111234566789999999999999999999988

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=99.94  E-value=2.1e-26  Score=175.89  Aligned_cols=188  Identities=22%  Similarity=0.213  Sum_probs=125.9

Q ss_pred             CCcHHHHHhhcCC-CCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCC-CCceEEcccccceeccCCCcc
Q 037267            3 NGSLEKWLYSYNY-FFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDE-NMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         3 ~gsL~~~l~~~~~-~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~-~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      +++|.+++..... .+++..+..++.|++.||.|||    +.+++|+||+|+||+++. ++.++++|||++........ 
T Consensus        84 ~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH----~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~-  158 (294)
T PLN00009         84 DLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH----SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR-  158 (294)
T ss_pred             cccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHH----hCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCcc-
Confidence            4678888764433 3678888999999999999999    899999999999999984 56789999999876543211 


Q ss_pred             ccccCCCCCccccCCCCCCC-CCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCC--Ch---hhhhhh
Q 037267           81 VTQTMTMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPH--GL---TEVVDA  154 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~-~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~---~~~~~~  154 (202)
                       ......++..|++||...+ ..++.++|+||+|+++|++++|..||......+...........+.  .+   ..+.+.
T Consensus       159 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (294)
T PLN00009        159 -TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDY  237 (294)
T ss_pred             -ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhh
Confidence             1122346788999997655 3568889999999999999999999976433221111110000000  00   000000


Q ss_pred             hhh----hhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          155 NLV----REEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       155 ~~~----~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                      ...    ............+.++.+++.+|+..+|++||++.++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        238 KSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             hhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence            000    000000111234566899999999999999999999875

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.94  E-value=2.2e-26  Score=179.41  Aligned_cols=178  Identities=22%  Similarity=0.206  Sum_probs=122.3

Q ss_pred             cHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcccccc
Q 037267            5 SLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQT   84 (202)
Q Consensus         5 sL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~   84 (202)
                      +|.+++   ...+++..+..++.|++.||.|||    +.+++||||||+||+++.++.++++|||++......     ..
T Consensus       105 ~l~~~~---~~~~~~~~~~~~~~qi~~aL~~LH----~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~-----~~  172 (342)
T cd07879         105 DLQKIM---GHPLSEDKVQYLVYQMLCGLKYIH----SAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAE-----MT  172 (342)
T ss_pred             CHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCCC-----CC
Confidence            455444   224889999999999999999999    899999999999999999999999999998754321     11


Q ss_pred             CCCCCccccCCCCCCC-CCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhh-------hhh
Q 037267           85 MTMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVD-------ANL  156 (202)
Q Consensus        85 ~~~~~~~~~~pe~~~~-~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~  156 (202)
                      ...++..|+|||.+.+ ..++.++|+||+|+++|++++|+.||....... .+.. +.............       ...
T Consensus       173 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  250 (342)
T cd07879         173 GYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-QLTQ-ILKVTGVPGPEFVQKLEDKAAKSY  250 (342)
T ss_pred             CceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHH-HHHhcCCCCHHHHHHhcccchHHH
Confidence            2346778999998765 457889999999999999999999997532111 1111 11100000000000       000


Q ss_pred             ------hhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          157 ------VREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       157 ------~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                            .............+.++.+++.+||..||++||++.+++.
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~  296 (342)
T cd07879         251 IKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALE  296 (342)
T ss_pred             HhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence                  0000000011134566889999999999999999999983

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.94  E-value=7.9e-26  Score=175.40  Aligned_cols=182  Identities=25%  Similarity=0.287  Sum_probs=127.0

Q ss_pred             CCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCccc
Q 037267            2 PNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFV   81 (202)
Q Consensus         2 ~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~~   81 (202)
                      .+++|.+++...  .++...+..++.|++.||.|||    +.+++|+|++|.||+++.++.++++|||.+.......   
T Consensus        92 ~~~~L~~~~~~~--~~~~~~~~~~~~ql~~aL~~LH----~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~~---  162 (328)
T cd07856          92 LGTDLHRLLTSR--PLEKQFIQYFLYQILRGLKYVH----SAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQM---  162 (328)
T ss_pred             hccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCCHHHEeECCCCCEEeCccccccccCCCc---
Confidence            367888888643  3788889999999999999999    8999999999999999999999999999987543211   


Q ss_pred             cccCCCCCccccCCCCCCC-CCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhh----hhh-
Q 037267           82 TQTMTMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVV----DAN-  155 (202)
Q Consensus        82 ~~~~~~~~~~~~~pe~~~~-~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~-  155 (202)
                        ....++..|++||...+ ..++.++|+||+|+++|++++|..||....... ... .+.+.......+..    ... 
T Consensus       163 --~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~-~~~-~~~~~~~~~~~~~~~~~~~~~~  238 (328)
T cd07856         163 --TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVN-QFS-IITDLLGTPPDDVINTICSENT  238 (328)
T ss_pred             --CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHH-HHHHHhCCCCHHHHHhccchhh
Confidence              12346778999997655 567889999999999999999999996543211 010 01111000000000    000 


Q ss_pred             ------hhh-hH-HHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          156 ------LVR-EE-QAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       156 ------~~~-~~-~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                            ... .. ........++.++.+++.+||..+|++||++.+++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~  287 (328)
T cd07856         239 LRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALA  287 (328)
T ss_pred             HHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                  000 00 000111234577999999999999999999999875

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.93  E-value=1e-25  Score=166.61  Aligned_cols=171  Identities=32%  Similarity=0.313  Sum_probs=131.3

Q ss_pred             CCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCccc
Q 037267            2 PNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFV   81 (202)
Q Consensus         2 ~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~~   81 (202)
                      ++++|.+++..... ++...+..++.+++.++.|||    +.+++|+|++|.||+++.++.++++|||.+........  
T Consensus        70 ~~~~L~~~~~~~~~-~~~~~~~~~~~~l~~~l~~lh----~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~--  142 (244)
T smart00220       70 DGGDLFDLLKKRGR-LSEDEARFYARQILSALEYLH----SNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGL--  142 (244)
T ss_pred             CCCCHHHHHHhccC-CCHHHHHHHHHHHHHHHHHHH----HcCeecCCcCHHHeEECCCCcEEEccccceeeeccccc--
Confidence            56799999976544 899999999999999999999    88999999999999999999999999999887654321  


Q ss_pred             cccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhHH
Q 037267           82 TQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQ  161 (202)
Q Consensus        82 ~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (202)
                       .....++..|.+||...+..++.++|+||+|++++++++|..||........ ............              
T Consensus       143 -~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~-~~~~~~~~~~~~--------------  206 (244)
T smart00220      143 -LTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLE-LFKKIGKPKPPF--------------  206 (244)
T ss_pred             -cccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHHHhccCCCC--------------
Confidence             1223467789999988777788899999999999999999999865322211 111111110000              


Q ss_pred             HHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          162 AFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       162 ~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                       ......++.++.+++.+||..+|++||++.++++
T Consensus       207 -~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      207 -PPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             -ccccccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence             0000014456899999999999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.93  E-value=2.9e-26  Score=168.92  Aligned_cols=189  Identities=20%  Similarity=0.165  Sum_probs=128.1

Q ss_pred             CcHHHHHhhcC----CCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCC----CceEEcccccceecc
Q 037267            4 GSLEKWLYSYN----YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN----MVAHVSDFGISKLLG   75 (202)
Q Consensus         4 gsL~~~l~~~~----~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~----~~~~l~d~g~~~~~~   75 (202)
                      .+|.+.|+-+.    ..++...+.+++-||+.|+.|||    +.=++||||||.||++..+    |.+||+|+|+++.+.
T Consensus       112 hDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH----~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGlaR~~~  187 (438)
T KOG0666|consen  112 HDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLH----SNWVLHRDLKPANILVMGDGPERGRVKIADLGLARLFN  187 (438)
T ss_pred             hhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHh----hhheeeccCCcceEEEeccCCccCeeEeecccHHHHhh
Confidence            46777776332    34888999999999999999999    8889999999999999876    899999999999877


Q ss_pred             CCCccc-cccCCCCCccccCCCCCCCC-CcCcchhhhhHHHHHHHHHhCCCCCCcccccc---hhhH--HHH----HHhC
Q 037267           76 EGEDFV-TQTMTMATIGYMAPEYGSEG-IVSAKCDVYSYGVLLMETFTRKRPTDEMFTGE---MSLR--RWV----KESL  144 (202)
Q Consensus        76 ~~~~~~-~~~~~~~~~~~~~pe~~~~~-~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~---~~~~--~~~----~~~~  144 (202)
                      .+.... ......-|.+|.|||.+.|. .|+.+.|+||+|||+.|+++-.+.|.......   ..+.  ++.    .-+.
T Consensus       188 ~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~  267 (438)
T KOG0666|consen  188 NPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIFEVLGT  267 (438)
T ss_pred             ccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHHHHcCC
Confidence            654322 22223568899999988775 58888999999999999999888776422110   0111  100    0011


Q ss_pred             C------------CChhhhhhhh-hhhhHH----HHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          145 P------------HGLTEVVDAN-LVREEQ----AFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       145 ~------------~~~~~~~~~~-~~~~~~----~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                      |            +.-..+-+-. -..+..    -......-++..++|+.++|.+||-+|+|+.++++
T Consensus       268 Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAle  336 (438)
T KOG0666|consen  268 PTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALE  336 (438)
T ss_pred             CccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhc
Confidence            1            1100000000 000000    00111122334889999999999999999999875

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.93  E-value=5.7e-26  Score=173.17  Aligned_cols=163  Identities=24%  Similarity=0.282  Sum_probs=132.2

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      +.||+|--.++.-+. +.+..++-++.+|+.||-+||    +++|++||||.+|++++..|.+||+|||+++.-..... 
T Consensus       432 vnGGDLMyhiQQ~Gk-FKEp~AvFYAaEiaigLFFLh----~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~~-  505 (683)
T KOG0696|consen  432 VNGGDLMYHIQQVGK-FKEPVAVFYAAEIAIGLFFLH----SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDGV-  505 (683)
T ss_pred             ecCchhhhHHHHhcc-cCCchhhhhhHHHHHHhhhhh----cCCeeeeeccccceEeccCCceEeeecccccccccCCc-
Confidence            358888888876555 788899999999999999999    99999999999999999999999999999986433222 


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhH
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREE  160 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (202)
                       +..++.||+-|.|||++.+.+|+.++|.||+|+++|||+.|+.||++.++++  +.+           .+.+.+..   
T Consensus       506 -TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~e--lF~-----------aI~ehnvs---  568 (683)
T KOG0696|consen  506 -TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE--LFQ-----------AIMEHNVS---  568 (683)
T ss_pred             -ceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHH--HHH-----------HHHHccCc---
Confidence             2334689999999999999999999999999999999999999998865443  111           11122222   


Q ss_pred             HHHHHhHHHHHHHHHHHhhhcCCCCCCCCC
Q 037267          161 QAFAAKMDCIVSIMDLALDCCMESPGKRIN  190 (202)
Q Consensus       161 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps  190 (202)
                          .+...+.+..++....+.+.|.+|..
T Consensus       569 ----yPKslSkEAv~ickg~ltK~P~kRLG  594 (683)
T KOG0696|consen  569 ----YPKSLSKEAVAICKGLLTKHPGKRLG  594 (683)
T ss_pred             ----CcccccHHHHHHHHHHhhcCCccccC
Confidence                23456777889999999999999974

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.93  E-value=1.6e-26  Score=182.81  Aligned_cols=168  Identities=27%  Similarity=0.314  Sum_probs=132.3

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      +.+|.+++|+.+++. +.+..+..++.|+++|++|||    +++|+|||||.+|++++.+.++||+|||++..+..... 
T Consensus       137 a~~ge~~~yl~~~gr-~~e~~ar~~F~q~vsaveYcH----~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~~-  210 (596)
T KOG0586|consen  137 ASGGELFDYLVKHGR-MKEKEARAKFRQIVSAVEYCH----SKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGLM-  210 (596)
T ss_pred             ccCchhHHHHHhccc-chhhhhhhhhHHHHHHHHHHh----hcceeccccchhhcccccccceeeeccccceeeccccc-
Confidence            358999999998765 667999999999999999999    99999999999999999999999999999998764332 


Q ss_pred             ccccCCCCCccccCCCCCCCCCc-CcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhh
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIV-SAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVRE  159 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~-~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (202)
                        ..+..|++.|+|||++.+..+ .+.+|+||+|+++|.++.|..||++..-.+                  ..++....
T Consensus       211 --lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~------------------Lr~rvl~g  270 (596)
T KOG0586|consen  211 --LQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKE------------------LRPRVLRG  270 (596)
T ss_pred             --ccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccc------------------ccchheee
Confidence              334679999999999988776 456999999999999999999998642111                  01111111


Q ss_pred             HHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          160 EQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       160 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                      ..+.+.  -.+.+..+++.+++..+|.+|++.+++.+
T Consensus       271 k~rIp~--~ms~dce~lLrk~lvl~Pskr~~~dqim~  305 (596)
T KOG0586|consen  271 KYRIPF--YMSCDCEDLLRKFLVLNPSKRGPCDQIMK  305 (596)
T ss_pred             eecccc--eeechhHHHHHHhhccCccccCCHHHhhh
Confidence            111111  12334578999999999999999999875

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=99.93  E-value=5.9e-26  Score=182.17  Aligned_cols=193  Identities=25%  Similarity=0.256  Sum_probs=136.4

Q ss_pred             CCCCcHHHHHhhc--CCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeC--CCC--ceEEcccccceec
Q 037267            1 MPNGSLEKWLYSY--NYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLD--ENM--VAHVSDFGISKLL   74 (202)
Q Consensus         1 ~~~gsL~~~l~~~--~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~--~~~--~~~l~d~g~~~~~   74 (202)
                      |+||||+..|++.  ...|++.+.+.++.+++.||.|||    ..+|+||||||.||++-  ++|  ..|++|||.|+..
T Consensus        99 C~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~Lr----En~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel  174 (732)
T KOG4250|consen   99 CSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLR----ENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAREL  174 (732)
T ss_pred             cCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHH----HcCceeccCCCCcEEEeecCCCceEEeeecccccccC
Confidence            7999999999843  346999999999999999999999    89999999999999973  444  4699999999987


Q ss_pred             cCCCccccccCCCCCccccCCCCCC-CCCcCcchhhhhHHHHHHHHHhCCCCCCcccccch-hhHHHH-HHhCCCChhhh
Q 037267           75 GEGEDFVTQTMTMATIGYMAPEYGS-EGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEM-SLRRWV-KESLPHGLTEV  151 (202)
Q Consensus        75 ~~~~~~~~~~~~~~~~~~~~pe~~~-~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~-~~~~~~-~~~~~~~~~~~  151 (202)
                      .+...   -....||..|.+||... ...|+..+|.|||||++|+++||..||-.+..+.. .-..|. ....+......
T Consensus       175 ~d~s~---~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~  251 (732)
T KOG4250|consen  175 DDNSL---FTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIG  251 (732)
T ss_pred             CCCCe---eeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEe
Confidence            76553   23467999999999877 47788899999999999999999999987654431 111111 11111111111


Q ss_pred             hhhhhhh---hHH----HHHHhHHHHHHHHHHHhhhcCCCCCCCC--CHHHHHHHHhh
Q 037267          152 VDANLVR---EEQ----AFAAKMDCIVSIMDLALDCCMESPGKRI--NMTDAAAKLKK  200 (202)
Q Consensus       152 ~~~~~~~---~~~----~~~~~~~~~~~~~~l~~~cl~~~p~~Rp--s~~~~~~~l~~  200 (202)
                      ..+..+.   +..    ...........+-.++..+|..+|++|-  ...+...++..
T Consensus       252 ~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~d  309 (732)
T KOG4250|consen  252 AQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDD  309 (732)
T ss_pred             eecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHH
Confidence            1111110   000    0111123334467788888899999998  66666666543

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.93  E-value=3.7e-26  Score=169.50  Aligned_cols=169  Identities=24%  Similarity=0.223  Sum_probs=130.9

Q ss_pred             CCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcccc
Q 037267            3 NGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVT   82 (202)
Q Consensus         3 ~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~   82 (202)
                      ||.|.-.|... ..+++..+.-+-..|++||.|||    +.+||+||+|.+|.+++++|.+||.|||+|+.--....  .
T Consensus       252 GGeLf~HLsre-r~FsE~RtRFYGaEIvsAL~YLH----s~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g~--t  324 (516)
T KOG0690|consen  252 GGELFFHLSRE-RVFSEDRTRFYGAEIVSALGYLH----SRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYGD--T  324 (516)
T ss_pred             CceEeeehhhh-hcccchhhhhhhHHHHHHhhhhh----hCCeeeeechhhhheeccCCceEeeecccchhcccccc--e
Confidence            56666666543 35899999999999999999999    89999999999999999999999999999986432221  2


Q ss_pred             ccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhHHH
Q 037267           83 QTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQA  162 (202)
Q Consensus        83 ~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (202)
                      ..++.||+.|+|||++.+..|+..+|.|.+|+++|||+.|+.||...+.+.  +.+++.-.      +            
T Consensus       325 ~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~k--LFeLIl~e------d------------  384 (516)
T KOG0690|consen  325 TKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEK--LFELILME------D------------  384 (516)
T ss_pred             eccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhH--HHHHHHhh------h------------
Confidence            345789999999999999999999999999999999999999997643322  22222100      0            


Q ss_pred             HHHhHHHHHHHHHHHhhhcCCCCCCCCC--HHHHHHHH
Q 037267          163 FAAKMDCIVSIMDLALDCCMESPGKRIN--MTDAAAKL  198 (202)
Q Consensus       163 ~~~~~~~~~~~~~l~~~cl~~~p~~Rps--~~~~~~~l  198 (202)
                      ...+...+++...|+...|.+||.+|..  .+++.+..
T Consensus       385 ~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~  422 (516)
T KOG0690|consen  385 LKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIM  422 (516)
T ss_pred             ccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHH
Confidence            1112345667889999999999999983  44544443

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.93  E-value=1.1e-25  Score=166.50  Aligned_cols=188  Identities=20%  Similarity=0.290  Sum_probs=134.8

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCC---ceEEcccccceeccCC
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENM---VAHVSDFGISKLLGEG   77 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~---~~~l~d~g~~~~~~~~   77 (202)
                      |.||+|...|.+... |++.++..+..+|++||.|||    .+||.|||+||+|||-....   .+||+||.+.......
T Consensus       158 m~GGplLshI~~~~~-F~E~EAs~vvkdia~aLdFlH----~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~  232 (463)
T KOG0607|consen  158 MRGGPLLSHIQKRKH-FNEREASRVVKDIASALDFLH----TKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLN  232 (463)
T ss_pred             ccCchHHHHHHHhhh-ccHHHHHHHHHHHHHHHHHHh----hcCcccccCCccceeecCCCCcCceeeeccccccccccC
Confidence            568999999987554 899999999999999999999    99999999999999987544   4699999876543221


Q ss_pred             Cc-----cccccCCCCCccccCCCCCC---C--CCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCC
Q 037267           78 ED-----FVTQTMTMATIGYMAPEYGS---E--GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHG  147 (202)
Q Consensus        78 ~~-----~~~~~~~~~~~~~~~pe~~~---~--~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~  147 (202)
                      ..     .....++.|+..|+|||+..   +  ..|..+.|.||+|+|+|-|++|..||.++-+.+=.   |-....=+.
T Consensus       233 ~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCG---WdrGe~Cr~  309 (463)
T KOG0607|consen  233 NDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCG---WDRGEVCRV  309 (463)
T ss_pred             CCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCC---ccCCCccHH
Confidence            11     11233467888999999532   2  35788999999999999999999999876543211   100000011


Q ss_pred             hhhhhhhhhhhhHH--HHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          148 LTEVVDANLVREEQ--AFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       148 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                      .++.+-+.+.....  ....+..++.+..+++...+.+|+.+|.++.+++.
T Consensus       310 CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  310 CQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             HHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence            11222222222211  12345678889999999999999999999998765

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.93  E-value=2.7e-25  Score=152.56  Aligned_cols=187  Identities=21%  Similarity=0.212  Sum_probs=133.3

Q ss_pred             CcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCccccc
Q 037267            4 GSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQ   83 (202)
Q Consensus         4 gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~   83 (202)
                      .+|..|..+-+..++.+.+.+++.|++.||.++|    ++++.|||+||+|.+|+.+|.+|++|||+++.++.+..+  .
T Consensus        85 qdlkkyfdslng~~d~~~~rsfmlqllrgl~fch----shnvlhrdlkpqnllin~ngelkladfglarafgipvrc--y  158 (292)
T KOG0662|consen   85 QDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCH----SHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRC--Y  158 (292)
T ss_pred             HHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhh----hhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEe--e
Confidence            3566666665667999999999999999999999    999999999999999999999999999999988765432  3


Q ss_pred             cCCCCCccccCCCCCCCCC-cCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhCC-----CChhhhhhhhh
Q 037267           84 TMTMATIGYMAPEYGSEGI-VSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLP-----HGLTEVVDANL  156 (202)
Q Consensus        84 ~~~~~~~~~~~pe~~~~~~-~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~  156 (202)
                      ....-|.+|.+|.++.|.+ |++.-|+||.||++.|+.. |.+.|.+.+..+...+-+..-+.+     +.+..+.+...
T Consensus       159 saevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~  238 (292)
T KOG0662|consen  159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKP  238 (292)
T ss_pred             eceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcc
Confidence            4456789999999887764 7888999999999999987 666666655444322222211211     11222222111


Q ss_pred             hhhHHH----HHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          157 VREEQA----FAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       157 ~~~~~~----~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                      ......    ...-......-.+++++.+.-+|.+|+|++..++
T Consensus       239 yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq  282 (292)
T KOG0662|consen  239 YPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ  282 (292)
T ss_pred             cCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence            110000    0111223334689999999999999999998764

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.93  E-value=1.3e-26  Score=188.54  Aligned_cols=170  Identities=27%  Similarity=0.375  Sum_probs=126.7

Q ss_pred             CcHHHHHhhcCC--CCCH-HHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCC---CC--ceEEcccccceecc
Q 037267            4 GSLEKWLYSYNY--FFDI-LERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDE---NM--VAHVSDFGISKLLG   75 (202)
Q Consensus         4 gsL~~~l~~~~~--~l~~-~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~---~~--~~~l~d~g~~~~~~   75 (202)
                      -||+|++..+..  .... ...+..+.|+++||.+||    +.+||||||||+||||..   ++  .++|+|||+++.+.
T Consensus       587 ~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLH----sl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~  662 (903)
T KOG1027|consen  587 CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLH----SLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA  662 (903)
T ss_pred             hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHH----hcccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence            478999987411  1111 456788999999999999    899999999999999986   33  57899999999887


Q ss_pred             CCCcc-ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhCCCChhhhhh
Q 037267           76 EGEDF-VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVD  153 (202)
Q Consensus        76 ~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (202)
                      ..... .......||-.|.|||.+....-+.++||+|+||++|+.++ |..||++....+..+..        ....+. 
T Consensus       663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~--------~~~~L~-  733 (903)
T KOG1027|consen  663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILT--------GNYTLV-  733 (903)
T ss_pred             CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhc--------Ccccee-
Confidence            55433 33455678999999999988888889999999999999887 58899876544321110        000110 


Q ss_pred             hhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          154 ANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                              ......++  +..+||.+|+..+|..||+|.+|+.
T Consensus       734 --------~L~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~  766 (903)
T KOG1027|consen  734 --------HLEPLPDC--EAKDLISRMLNPDPQLRPSATDVLN  766 (903)
T ss_pred             --------eeccCchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence                    01111222  6889999999999999999999873

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.92  E-value=5.7e-26  Score=174.62  Aligned_cols=178  Identities=25%  Similarity=0.345  Sum_probs=133.9

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeC---CCCceEEcccccceeccCC
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLD---ENMVAHVSDFGISKLLGEG   77 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~---~~~~~~l~d~g~~~~~~~~   77 (202)
                      |+|.+|.-||+.+ ..+++.++..|..||+.||.||.+.  +..|+|.||||.|||+.   ..|.+||.|||+++.+.+.
T Consensus       550 ceGNDLDFYLKQh-klmSEKEARSIiMQiVnAL~YLNEi--kpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMddd  626 (775)
T KOG1151|consen  550 CEGNDLDFYLKQH-KLMSEKEARSIIMQIVNALKYLNEI--KPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDD  626 (775)
T ss_pred             cCCCchhHHHHhh-hhhhHHHHHHHHHHHHHHHHHHhcc--CCCeeeeccCCccEEEecCcccceeEeeecchhhhccCC
Confidence            7899999999764 4599999999999999999999965  67899999999999985   4578999999999987654


Q ss_pred             Ccccc-----ccCCCCCccccCCCCCCCC----CcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCCh
Q 037267           78 EDFVT-----QTMTMATIGYMAPEYGSEG----IVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGL  148 (202)
Q Consensus        78 ~~~~~-----~~~~~~~~~~~~pe~~~~~----~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  148 (202)
                      ..-..     .....||.+|++||.+.-+    +++.++|+||+|+|+|.++.|+.||.........+.+-..       
T Consensus       627 Sy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTI-------  699 (775)
T KOG1151|consen  627 SYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTI-------  699 (775)
T ss_pred             ccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhch-------
Confidence            32111     2235689999999965433    5788999999999999999999999875433322221110       


Q ss_pred             hhhhhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHH
Q 037267          149 TEVVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAA  195 (202)
Q Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~  195 (202)
                         +.    .....++.-...+.+..++|.+||.+.-++|.+..++.
T Consensus       700 ---lk----AtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA  739 (775)
T KOG1151|consen  700 ---LK----ATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA  739 (775)
T ss_pred             ---hc----ceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence               00    01111222234566688999999999999999887763

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.92  E-value=2e-25  Score=164.70  Aligned_cols=179  Identities=23%  Similarity=0.254  Sum_probs=124.6

Q ss_pred             CcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCccccc
Q 037267            4 GSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQ   83 (202)
Q Consensus         4 gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~   83 (202)
                      ++|.+.+.   ..++=.+...++.|++.|++|||    +.+|+||||||+||++..+..+||.|||+++.....   ..-
T Consensus       105 ~nl~~vi~---~elDH~tis~i~yq~~~~ik~lh----s~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~---~~m  174 (369)
T KOG0665|consen  105 ANLCQVIL---MELDHETISYILYQMLCGIKHLH----SAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD---FMM  174 (369)
T ss_pred             hHHHHHHH---HhcchHHHHHHHHHHHHHHHHHH----hcceeecccCcccceecchhheeeccchhhcccCcc---ccc
Confidence            44555544   12566788999999999999999    999999999999999999999999999999865433   112


Q ss_pred             cCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHH--hC----CCChhhhhh----
Q 037267           84 TMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKE--SL----PHGLTEVVD----  153 (202)
Q Consensus        84 ~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~--~~----~~~~~~~~~----  153 (202)
                      +-...+..|.|||.+.+..+...+||||+||++.||+.|..-|.+.    ..+.+|.+-  ..    ++.+.++..    
T Consensus       175 tpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~----d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~  250 (369)
T KOG0665|consen  175 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGK----DHIDQWNKIIEQLGTPDPSFMKQLQPTVRN  250 (369)
T ss_pred             CchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCc----hHHHHHHHHHHHhcCCCHHHHHHhhHHHHH
Confidence            2345788999999998888999999999999999999999887642    222222100  00    000111000    


Q ss_pred             -------------hhhhhh---HHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          154 -------------ANLVRE---EQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       154 -------------~~~~~~---~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                                   .....+   ......+.-....+.+++.+||..+|++|.|+.+++.
T Consensus       251 yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~  309 (369)
T KOG0665|consen  251 YVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR  309 (369)
T ss_pred             HhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence                         000000   0001111123345789999999999999999999874

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.92  E-value=3.1e-25  Score=185.48  Aligned_cols=172  Identities=23%  Similarity=0.319  Sum_probs=130.7

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      ||||+|-..+.+.. .+++..+.-++..++.||.-||    +.|+||||+||+|||++..|.++++|||.|-.+...+.-
T Consensus       157 ~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH----~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~V  231 (1317)
T KOG0612|consen  157 MPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLH----SMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTV  231 (1317)
T ss_pred             ccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHH----hccceeccCCcceeEecccCcEeeccchhHHhcCCCCcE
Confidence            69999999999877 6999999999999999999999    899999999999999999999999999999887754432


Q ss_pred             ccccCCCCCccccCCCCC----CC-CCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhh
Q 037267           81 VTQTMTMATIGYMAPEYG----SE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDAN  155 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~----~~-~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (202)
                       .-....|||-|.+||++    .+ +.|+..+|.||+|+++|||+.|..||..-.-             ...+..+....
T Consensus       232 -~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadsl-------------veTY~KIm~hk  297 (1317)
T KOG0612|consen  232 -RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSL-------------VETYGKIMNHK  297 (1317)
T ss_pred             -EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHH-------------HHHHHHHhchh
Confidence             23456899999999953    23 5688899999999999999999999965210             00111111110


Q ss_pred             hhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCC---HHHHH
Q 037267          156 LVREEQAFAAKMDCIVSIMDLALDCCMESPGKRIN---MTDAA  195 (202)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps---~~~~~  195 (202)
                         ....+|.....+++..+||...+. +|+.|..   +.++.
T Consensus       298 ---~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik  336 (1317)
T KOG0612|consen  298 ---ESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIK  336 (1317)
T ss_pred             ---hhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHH
Confidence               000111223477778888887664 6667776   66553

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.92  E-value=2.2e-26  Score=166.20  Aligned_cols=163  Identities=26%  Similarity=0.269  Sum_probs=124.4

Q ss_pred             CCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCccccccCCCCCccccC
Q 037267           15 YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMA   94 (202)
Q Consensus        15 ~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~   94 (202)
                      ..+++...-+++.-.+.||.||-+   ...|+|||+||+|||++..|.+|++|||.+..+.++-.   .+.-.|...|+|
T Consensus       162 ~~ipE~Ilg~ItvatV~AL~yLK~---~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiA---kT~daGCrpYmA  235 (361)
T KOG1006|consen  162 SRIPENILGHITVATVDALDYLKE---ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIA---KTVDAGCRPYMA  235 (361)
T ss_pred             ccCcHhhhhheeeeehhHHHHHHH---HhhhhhccCChhheEEecCCCEeeecccchHhHHHHHH---hhhccCCccccC
Confidence            458888888899999999999997   78999999999999999999999999999977654422   223458899999


Q ss_pred             CCCCCCC--CcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhHHHHHHhHHHHHH
Q 037267           95 PEYGSEG--IVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVS  172 (202)
Q Consensus        95 pe~~~~~--~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (202)
                      ||.+...  .|..++|+||+|+.+||+.+|..||..+..-...+...+....|...         ..    ....+.+..
T Consensus       236 PERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~---------~~----~~~~~~s~~  302 (361)
T KOG1006|consen  236 PERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILL---------FD----KECVHYSFS  302 (361)
T ss_pred             hhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeec---------Cc----ccccccCHH
Confidence            9976543  47889999999999999999999998765533333322222211110         00    011235566


Q ss_pred             HHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          173 IMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       173 ~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                      +..++..|+.+|-+.||...++.+
T Consensus       303 ~~~fintCl~Kd~~~Rpky~~Lk~  326 (361)
T KOG1006|consen  303 MVRFINTCLIKDRSDRPKYDDLKK  326 (361)
T ss_pred             HHHHHHHHhhcccccCcchhhhhc
Confidence            899999999999999999998864

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.91  E-value=7.9e-25  Score=152.93  Aligned_cols=133  Identities=32%  Similarity=0.358  Sum_probs=108.1

Q ss_pred             cHHHHHh---hcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCccc
Q 037267            5 SLEKWLY---SYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFV   81 (202)
Q Consensus         5 sL~~~l~---~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~~   81 (202)
                      ||..+.+   +.+..+++...-+|+..+..||.|||+   ...++|||+||+|||++.+|.+|++|||.+..+.++... 
T Consensus       130 Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~---kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiAk-  205 (282)
T KOG0984|consen  130 SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS---KLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIAK-  205 (282)
T ss_pred             hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH---HhhhhhccCCcceEEEccCCcEEEcccccceeehhhhHH-
Confidence            4444443   345568899999999999999999996   679999999999999999999999999999887765422 


Q ss_pred             cccCCCCCccccCCCCCCCC----CcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHh
Q 037267           82 TQTMTMATIGYMAPEYGSEG----IVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKES  143 (202)
Q Consensus        82 ~~~~~~~~~~~~~pe~~~~~----~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~  143 (202)
                        +.-.|...|+|||.+..+    .|+.++|+||+|+.+.|+.+++.||+....+...+.+.+...
T Consensus       206 --t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep  269 (282)
T KOG0984|consen  206 --TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEP  269 (282)
T ss_pred             --HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCC
Confidence              223578899999976543    588899999999999999999999998877766666555433

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.91  E-value=2e-24  Score=181.07  Aligned_cols=67  Identities=36%  Similarity=0.612  Sum_probs=61.6

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccce
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISK   72 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~   72 (202)
                      |+||+|.+++.... .+++..++.++.||+.||.|||    ..+|+||||||+||+++.++.++|+|||+++
T Consensus        86 ~~g~~L~~li~~~~-~l~~~~~~~i~~qil~aL~yLH----~~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          86 LIGGDVKSLLHIYG-YFDEEMAVKYISEVALALDYLH----RHGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             CCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----hCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            57999999997654 4889999999999999999999    8999999999999999999999999999875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.91  E-value=6.3e-24  Score=171.26  Aligned_cols=184  Identities=22%  Similarity=0.206  Sum_probs=120.8

Q ss_pred             CCCCcHHHHHhhcC-----------------------CCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceee
Q 037267            1 MPNGSLEKWLYSYN-----------------------YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILL   57 (202)
Q Consensus         1 ~~~gsL~~~l~~~~-----------------------~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~   57 (202)
                      +++|+|.+++....                       ..+++..+..++.|++.+|.|||    +.+++||||||.||++
T Consensus       267 ~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~~~~~~i~~ql~~aL~~lH----~~~ivHrDLKp~NILl  342 (507)
T PLN03224        267 ESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDINVIKGVMRQVLTGLRKLH----RIGIVHRDIKPENLLV  342 (507)
T ss_pred             CCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCchHhEEE
Confidence            46888888886421                       12456788899999999999999    8999999999999999


Q ss_pred             CCCCceEEcccccceeccCCCccccccCCCCCccccCCCCCCCCC--------------------c--CcchhhhhHHHH
Q 037267           58 DENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGI--------------------V--SAKCDVYSYGVL  115 (202)
Q Consensus        58 ~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~--------------------~--~~~~di~s~G~~  115 (202)
                      +.++.++++|||++.......... ......++.|++||.+....                    +  ..+.|+||+||+
T Consensus       343 ~~~~~~kL~DFGla~~~~~~~~~~-~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvi  421 (507)
T PLN03224        343 TVDGQVKIIDFGAAVDMCTGINFN-PLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVL  421 (507)
T ss_pred             CCCCcEEEEeCcCccccccCCccC-ccccCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHH
Confidence            999999999999987544322111 11123478999999754321                    1  123699999999


Q ss_pred             HHHHHhCCC-CCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCC---CCCCCH
Q 037267          116 LMETFTRKR-PTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLALDCCMESP---GKRINM  191 (202)
Q Consensus       116 ~~~~~~g~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p---~~Rps~  191 (202)
                      +++|+++.. ||.....-......+-. .. ..+...     .......+.....+...++++.+++.++|   .+|+|+
T Consensus       422 l~em~~~~l~p~~~~~~f~~~~~~~~~-~~-~~~r~~-----~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa  494 (507)
T PLN03224        422 LMQMCVPELRPVANIRLFNTELRQYDN-DL-NRWRMY-----KGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSV  494 (507)
T ss_pred             HHHHHhCCCCCccchhhhhhHHhhccc-hH-HHHHhh-----cccCCCcccccccChHHHHHHHHHhccCCCCcccCCCH
Confidence            999999875 66432111100000000 00 000000     00001111233456778999999999876   689999


Q ss_pred             HHHHH
Q 037267          192 TDAAA  196 (202)
Q Consensus       192 ~~~~~  196 (202)
                      +|+++
T Consensus       495 ~eaL~  499 (507)
T PLN03224        495 GQALS  499 (507)
T ss_pred             HHHhC
Confidence            99874

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.90  E-value=7.4e-25  Score=159.29  Aligned_cols=175  Identities=23%  Similarity=0.266  Sum_probs=121.4

Q ss_pred             CCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCC-ccccccCCCCCccc
Q 037267           14 NYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGE-DFVTQTMTMATIGY   92 (202)
Q Consensus        14 ~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~~~~~~   92 (202)
                      +..++...+.-++.||+.||+|||    +.+|.||||||.|.|++++-.+||+|||+++...... ..+++  ..-|..|
T Consensus       150 PQ~Ls~DHvKVFlYQILRGLKYLH----sA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~hMTq--EVVTQYY  223 (449)
T KOG0664|consen  150 PQALTPDHVKVFVYQILRGLKYLH----TANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLNMTH--EVVTQYY  223 (449)
T ss_pred             CCCCCcchhhhhHHHHHhhhHHHh----hcchhhccCCCccEEeccCceEEecccccccccchhhhhhhHH--HHHHHHh
Confidence            556889999999999999999999    9999999999999999999999999999998754322 12222  2457889


Q ss_pred             cCCCCCCCC-CcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCC-CChhhh-----------hhhhhhhh
Q 037267           93 MAPEYGSEG-IVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLP-HGLTEV-----------VDANLVRE  159 (202)
Q Consensus        93 ~~pe~~~~~-~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~-----------~~~~~~~~  159 (202)
                      .+||++.|. .|+...||||.|||+.|++.++.-|+....-.  --+++.+-+. +.++..           ........
T Consensus       224 RAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~Piq--QL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~P  301 (449)
T KOG0664|consen  224 RAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIE--QLQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLRAP  301 (449)
T ss_pred             ccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHH--HHHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCCCC
Confidence            999988875 68999999999999999999988776532211  0111111111 000000           00000000


Q ss_pred             ----HHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          160 ----EQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       160 ----~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                          ......+..-..+..++..+++..||.+|.+..+.+.
T Consensus       302 s~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~  342 (449)
T KOG0664|consen  302 DTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQ  342 (449)
T ss_pred             CccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcc
Confidence                0001122233445778999999999999999888764

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.90  E-value=4.8e-24  Score=174.57  Aligned_cols=173  Identities=19%  Similarity=0.198  Sum_probs=139.3

Q ss_pred             CCCCcHHHHHhhc-CCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCc
Q 037267            1 MPNGSLEKWLYSY-NYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED   79 (202)
Q Consensus         1 ~~~gsL~~~l~~~-~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~   79 (202)
                      |.|||..|..++- +..+.+..+..|++.++.|+.+||    ...++|||+|..|||+..++.+|++|||++....... 
T Consensus       103 C~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH----~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQldsT~-  177 (953)
T KOG0587|consen  103 CGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLH----NNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDSTV-  177 (953)
T ss_pred             cCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHh----hcceeeecccCceEEEeccCcEEEeeeeeeeeeeccc-
Confidence            7899999999853 346899999999999999999999    8999999999999999999999999999987754322 


Q ss_pred             cccccCCCCCccccCCCCCCCC-----CcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhh
Q 037267           80 FVTQTMTMATIGYMAPEYGSEG-----IVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDA  154 (202)
Q Consensus        80 ~~~~~~~~~~~~~~~pe~~~~~-----~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (202)
                       ..+.+.+||+.|+|||++...     .|+.++|+||+|++..|+..|.+|+.+++.-...+.                 
T Consensus       178 -grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~-----------------  239 (953)
T KOG0587|consen  178 -GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFL-----------------  239 (953)
T ss_pred             -ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhcc-----------------
Confidence             235567899999999976543     467789999999999999999999988764331111                 


Q ss_pred             hhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          155 NLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                      ....++-.+..+.....++.+++..||.+|.++||++.++++
T Consensus       240 IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  240 IPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             CCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence            001111223345677888999999999999999999998874

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.90  E-value=1.9e-23  Score=161.78  Aligned_cols=109  Identities=15%  Similarity=0.028  Sum_probs=74.1

Q ss_pred             CCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHH-------hCCC-------Chhhhhh
Q 037267           88 ATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKE-------SLPH-------GLTEVVD  153 (202)
Q Consensus        88 ~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~-------~~~~-------~~~~~~~  153 (202)
                      -|..|++||++.|..|+..+||||++|+.+|++||...|+..........+....       .+|.       ...+++.
T Consensus       413 QTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFn  492 (590)
T KOG1290|consen  413 QTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFFN  492 (590)
T ss_pred             hhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhhc
Confidence            3678999999999999999999999999999999999988765544322221110       0110       0111111


Q ss_pred             hhh--------hhh------HHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          154 ANL--------VRE------EQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       154 ~~~--------~~~------~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                      ...        ...      ..-...+.+...++.+++.-||+.+|++||||+++++
T Consensus       493 r~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl~  549 (590)
T KOG1290|consen  493 RRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCLK  549 (590)
T ss_pred             cccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHhc
Confidence            000        000      0112345677788999999999999999999999874

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.90  E-value=3.9e-25  Score=173.00  Aligned_cols=168  Identities=24%  Similarity=0.299  Sum_probs=130.8

Q ss_pred             CCc-HHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCC---CceEEcccccceeccCCC
Q 037267            3 NGS-LEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN---MVAHVSDFGISKLLGEGE   78 (202)
Q Consensus         3 ~gs-L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~---~~~~l~d~g~~~~~~~~~   78 (202)
                      +|+ |+..|.++...|++....-+..||+.||+|||    -++|+|+||||+|+|+...   -.+|++|||+++..+.+.
T Consensus       646 ~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH----~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks  721 (888)
T KOG4236|consen  646 HGDMLEMILSSEKGRLPERITKFLVTQILVALRYLH----FKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS  721 (888)
T ss_pred             cchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhh----hcceeeccCCchheeeccCCCCCceeeccccceeecchhh
Confidence            344 45556666678999999999999999999999    8999999999999999743   358999999999988765


Q ss_pred             ccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhh
Q 037267           79 DFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVR  158 (202)
Q Consensus        79 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (202)
                      .   +....||+.|+|||++....|+..-||||.|+|+|.-++|..||..-   +. +.+.+           ....   
T Consensus       722 F---RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd---Ed-IndQI-----------QNAa---  780 (888)
T KOG4236|consen  722 F---RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED---ED-INDQI-----------QNAA---  780 (888)
T ss_pred             h---hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCc---cc-hhHHh-----------hccc---
Confidence            4   23457999999999999999999999999999999999999998542   21 11111           1000   


Q ss_pred             hHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHH
Q 037267          159 EEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAA  195 (202)
Q Consensus       159 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~  195 (202)
                      .-.....+.+.+.+..+||...|+..-.+|.|.+..+
T Consensus       781 FMyPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~l  817 (888)
T KOG4236|consen  781 FMYPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSL  817 (888)
T ss_pred             cccCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence            0111123456777899999999999999999988765

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.90  E-value=2.3e-24  Score=168.23  Aligned_cols=185  Identities=22%  Similarity=0.241  Sum_probs=133.0

Q ss_pred             CcHHHHHhhcCC--CCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCC-CceEEcccccceeccCCCcc
Q 037267            4 GSLEKWLYSYNY--FFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN-MVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         4 gsL~~~l~~~~~--~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~-~~~~l~d~g~~~~~~~~~~~   80 (202)
                      -+|.+.|++.+.  .|....+..++.|+..||..|-    ..+++|.||||+|||+++. ..+||||||.|.........
T Consensus       518 lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK----~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~eneit  593 (752)
T KOG0670|consen  518 LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLK----KCGVLHADIKPDNILVNESKNILKLCDFGSASFASENEIT  593 (752)
T ss_pred             chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHH----hcCeeecccCccceEeccCcceeeeccCcccccccccccc
Confidence            468888886653  5777899999999999999999    8999999999999999954 56799999999876554321


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchh-hH-H--------------HHHHhC
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMS-LR-R--------------WVKESL  144 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~-~~-~--------------~~~~~~  144 (202)
                          -..-+..|.|||++.|..|+..-|+||+||++||+.+|+..|.+.++..+. +. +              ++..++
T Consensus       594 ----PYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHF  669 (752)
T KOG0670|consen  594 ----PYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQHF  669 (752)
T ss_pred             ----HHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhhc
Confidence                123466899999999999999999999999999999999999876654432 11 1              111111


Q ss_pred             CCC-------hhhhhh-------hhhhh----------hHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          145 PHG-------LTEVVD-------ANLVR----------EEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       145 ~~~-------~~~~~~-------~~~~~----------~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                      ...       ...+..       .++..          .............++.+|+.+|+..||++|.|.+++++
T Consensus       670 D~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~  745 (752)
T KOG0670|consen  670 DQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALK  745 (752)
T ss_pred             ccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhc
Confidence            100       000000       00000          00011233456677999999999999999999999874

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.89  E-value=2.2e-23  Score=148.01  Aligned_cols=172  Identities=19%  Similarity=0.279  Sum_probs=124.0

Q ss_pred             CCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeC-CCCceEEcccccceeccCCCccccccCCCCCccccCC
Q 037267           17 FDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLD-ENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAP   95 (202)
Q Consensus        17 l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~-~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~p   95 (202)
                      |+--++.-.+.+++.||.|+|    +.||+|||+||.|++|+ +..+++++|+|++.+..+...+..   ...+..|--|
T Consensus       129 l~d~dIryY~~elLkALdyCH----S~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eYnV---RVASRyfKGP  201 (338)
T KOG0668|consen  129 LTDYDIRYYIYELLKALDYCH----SMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV---RVASRYFKGP  201 (338)
T ss_pred             hchhhHHHHHHHHHHHHhHHH----hcCcccccCCcceeeechhhceeeeeecchHhhcCCCceeee---eeehhhcCCc
Confidence            666788899999999999999    99999999999999999 677899999999999888776543   3456677789


Q ss_pred             CCCCCC-CcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHH------------HHHH---hCCCChhhhhhhhhhhh
Q 037267           96 EYGSEG-IVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRR------------WVKE---SLPHGLTEVVDANLVRE  159 (202)
Q Consensus        96 e~~~~~-~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~------------~~~~---~~~~~~~~~~~~~~~~~  159 (202)
                      |.+.+. .|.-+-|+||+||++..|+..+.||....+....+-.            ++..   .+++...++...-.. .
T Consensus       202 ELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~r-k  280 (338)
T KOG0668|consen  202 ELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSR-K  280 (338)
T ss_pred             hheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhcccc-c
Confidence            976554 4677889999999999999999998765443322211            1111   122222222211111 0


Q ss_pred             HHH---HHHhH-HHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          160 EQA---FAAKM-DCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       160 ~~~---~~~~~-~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                      .+.   .+... -.+++..|++.+.|.+|.++|+|+.|+++
T Consensus       281 ~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~  321 (338)
T KOG0668|consen  281 PWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA  321 (338)
T ss_pred             cHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence            111   11112 23478999999999999999999999864

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.89  E-value=1.9e-23  Score=155.91  Aligned_cols=168  Identities=21%  Similarity=0.230  Sum_probs=127.1

Q ss_pred             CCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCccc
Q 037267            2 PNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFV   81 (202)
Q Consensus         2 ~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~~   81 (202)
                      +||+|--.++.+.+ ++++.+.-+...|+.||.|||    +.||++||||.+|+|++..|.+|+.|+|.++.--.+..  
T Consensus       334 ~ggdlmfhmqrqrk-lpeeharfys~ei~lal~flh----~rgiiyrdlkldnvlldaeghikltdygmcke~l~~gd--  406 (593)
T KOG0695|consen  334 NGGDLMFHMQRQRK-LPEEHARFYSAEICLALNFLH----ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPGD--  406 (593)
T ss_pred             cCcceeeehhhhhc-CcHHHhhhhhHHHHHHHHHHh----hcCeeeeeccccceEEccCCceeecccchhhcCCCCCc--
Confidence            57777666666555 899999999999999999999    99999999999999999999999999999986433322  


Q ss_pred             cccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcc--cccchhhHHHHHHhCCCChhhhhhhhhhhh
Q 037267           82 TQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEM--FTGEMSLRRWVKESLPHGLTEVVDANLVRE  159 (202)
Q Consensus        82 ~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (202)
                      ...++.||+-|.|||++.|..|...+|.|++|++++||+.|+.||+-.  .+++.....+            +-+.+...
T Consensus       407 ~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedy------------lfqvilek  474 (593)
T KOG0695|consen  407 TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDY------------LFQVILEK  474 (593)
T ss_pred             ccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHH------------HHHHHhhh
Confidence            245678999999999999999999999999999999999999999842  2222211111            11111111


Q ss_pred             HHHHHHhHHHHHHHHHHHhhhcCCCCCCCCC
Q 037267          160 EQAFAAKMDCIVSIMDLALDCCMESPGKRIN  190 (202)
Q Consensus       160 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps  190 (202)
                      ..  ..+...+.....+++..+.+||.+|..
T Consensus       475 qi--riprslsvkas~vlkgflnkdp~erlg  503 (593)
T KOG0695|consen  475 QI--RIPRSLSVKASHVLKGFLNKDPKERLG  503 (593)
T ss_pred             cc--cccceeehhhHHHHHHhhcCCcHHhcC
Confidence            00  011223344667889999999999863

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.88  E-value=3.8e-22  Score=144.15  Aligned_cols=140  Identities=37%  Similarity=0.481  Sum_probs=118.6

Q ss_pred             CCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCC-CCceEEcccccceeccCCCcc
Q 037267            2 PNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDE-NMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         2 ~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~-~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      ++++|.+++......++...+..++.+++.++.+||    +.+++|+|++|.||+++. ++.++++||+.+........ 
T Consensus        74 ~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh----~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-  148 (215)
T cd00180          74 EGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLH----SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-  148 (215)
T ss_pred             CCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH----hCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-
Confidence            568999999865345899999999999999999999    889999999999999998 89999999999987654321 


Q ss_pred             ccccCCCCCccccCCCCCCCC-CcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhh
Q 037267           81 VTQTMTMATIGYMAPEYGSEG-IVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVRE  159 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~-~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (202)
                       ......+...|.+||..... ..+.+.|+|++|++++++                                        
T Consensus       149 -~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------------  187 (215)
T cd00180         149 -LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------------  187 (215)
T ss_pred             -hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------
Confidence             11223467789999987766 778889999999999998                                        


Q ss_pred             HHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 037267          160 EQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKL  198 (202)
Q Consensus       160 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l  198 (202)
                                 ..+.+++.+|+..+|++||++.++++.+
T Consensus       188 -----------~~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         188 -----------PELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             -----------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence                       3378999999999999999999998653

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.87  E-value=2.1e-22  Score=160.75  Aligned_cols=128  Identities=27%  Similarity=0.413  Sum_probs=107.7

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceecc---CC
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLG---EG   77 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~---~~   77 (202)
                      .|||++-..|-+.+- |.+..+.-++.++.-|+++.|    ..|++||||||+|||||.+|.+||.|||+|..+.   +.
T Consensus       711 IPGGDmMSLLIrmgI-FeE~LARFYIAEltcAiesVH----kmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHds  785 (1034)
T KOG0608|consen  711 IPGGDMMSLLIRMGI-FEEDLARFYIAELTCAIESVH----KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS  785 (1034)
T ss_pred             cCCccHHHHHHHhcc-CHHHHHHHHHHHHHHHHHHHH----hccceecccCccceEEccCCceeeeeccccccceecccc
Confidence            489999999887665 889999999999999999999    8999999999999999999999999999997431   00


Q ss_pred             C-----c--------------------------------cccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHH
Q 037267           78 E-----D--------------------------------FVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETF  120 (202)
Q Consensus        78 ~-----~--------------------------------~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~  120 (202)
                      .     .                                ........||+-|.|||++....+++.+|.||.|+|+|+|+
T Consensus       786 kYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~  865 (1034)
T KOG0608|consen  786 KYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEML  865 (1034)
T ss_pred             ccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHh
Confidence            0     0                                00122346899999999999989999999999999999999


Q ss_pred             hCCCCCCcccccc
Q 037267          121 TRKRPTDEMFTGE  133 (202)
Q Consensus       121 ~g~~p~~~~~~~~  133 (202)
                      .|+.||-..+..+
T Consensus       866 ~g~~pf~~~tp~~  878 (1034)
T KOG0608|consen  866 VGQPPFLADTPGE  878 (1034)
T ss_pred             hCCCCccCCCCCc
Confidence            9999998765544

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.87  E-value=3.2e-22  Score=164.52  Aligned_cols=179  Identities=19%  Similarity=0.154  Sum_probs=137.0

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |++ +|..++... ..++..++-.++.|+..||+|+|    +.|+.|||+|++|+++..++.+|++|||.+..+......
T Consensus       403 ~~~-Dlf~~~~~~-~~~~~~e~~c~fKqL~~Gv~y~h----~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~  476 (601)
T KOG0590|consen  403 CPY-DLFSLVMSN-GKLTPLEADCFFKQLLRGVKYLH----SMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEK  476 (601)
T ss_pred             ccH-HHHHHHhcc-cccchhhhhHHHHHHHHHHHHHH----hcCceeccCccccEEEecCCceEEeecCcceeeccCcch
Confidence            566 888888754 34899999999999999999999    999999999999999999999999999998866543322


Q ss_pred             --ccccCCCCCccccCCCCCCCCCcCcc-hhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhh
Q 037267           81 --VTQTMTMATIGYMAPEYGSEGIVSAK-CDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV  157 (202)
Q Consensus        81 --~~~~~~~~~~~~~~pe~~~~~~~~~~-~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (202)
                        .......|+..|.|||...+..|.+. .|+||.|+++..|++|+.||......+..+...           .......
T Consensus       477 ~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~-----------~~~~~~~  545 (601)
T KOG0590|consen  477 NIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTN-----------NYSDQRN  545 (601)
T ss_pred             hhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhh-----------ccccccc
Confidence              23444678899999999998888765 799999999999999999998765544332100           0000000


Q ss_pred             hhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          158 REEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                      ............+..-..+|.++|+.+|.+|.+++++++
T Consensus       546 ~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  546 IFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             cccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence            111111223445666789999999999999999999985

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.86  E-value=6.6e-22  Score=156.71  Aligned_cols=187  Identities=26%  Similarity=0.337  Sum_probs=136.1

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |..|||+|.+......+++.....+.++++.||.|+|+   +....|+.+++.|++++....+|+.|||+..........
T Consensus        29 c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~---s~i~~hg~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~  105 (484)
T KOG1023|consen   29 CSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHN---SPIGYHGALKSSNCLVDSRWVLKLTDFGLNSLLEETAEP  105 (484)
T ss_pred             ecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhc---CcceeeeeeccccceeeeeEEEEechhhhcccccccccc
Confidence            68999999999877779999999999999999999995   444499999999999999999999999998776431111


Q ss_pred             ccccCCCCCccccCCCCCCCCC-------cCcchhhhhHHHHHHHHHhCCCCCCcccccchh--hHHHHHHhCCCChhhh
Q 037267           81 VTQTMTMATIGYMAPEYGSEGI-------VSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMS--LRRWVKESLPHGLTEV  151 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~-------~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~  151 (202)
                      .......-..-|.|||.+.+..       .++++|+||+|++++|+++.+.||+........  +...+.+...    ..
T Consensus       106 ~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~~~~~~~~~eii~~~~~~~~----~~  181 (484)
T KOG1023|consen  106 EAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDLRNLVEDPDEIILRVKKGGS----NP  181 (484)
T ss_pred             cccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCccccccccCChHHHHHHHHhcCC----CC
Confidence            1111112345689999776631       466799999999999999999999875443322  1112222010    00


Q ss_pred             hhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          152 VDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                      ..+.+       ....+..+++..++..||..+|++||++.++...++.+
T Consensus       182 ~rP~i-------~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~  224 (484)
T KOG1023|consen  182 FRPSI-------ELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTI  224 (484)
T ss_pred             cCcch-------hhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhh
Confidence            11100       00114555799999999999999999999999887653

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.85  E-value=1e-21  Score=142.60  Aligned_cols=166  Identities=19%  Similarity=0.272  Sum_probs=115.1

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeC--CCCceEEcccccceeccCCC
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLD--ENMVAHVSDFGISKLLGEGE   78 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~--~~~~~~l~d~g~~~~~~~~~   78 (202)
                      +|.|||..-+...  .+.+....+++.|+++||.|+|    ++++||||||.+||||-  ....+|++|||..+..+..-
T Consensus       104 aP~gdL~snv~~~--GigE~~~K~v~~ql~SAi~fMH----sknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV  177 (378)
T KOG1345|consen  104 APRGDLRSNVEAA--GIGEANTKKVFAQLLSAIEFMH----SKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTV  177 (378)
T ss_pred             CccchhhhhcCcc--cccHHHHHHHHHHHHHHHHHhh----ccchhhcccccceEEEecCCccEEEeeecccccccCcee
Confidence            5788998888653  3789999999999999999999    99999999999999985  34579999999987654322


Q ss_pred             ccccccCCCCCccccCCCCC---CCC--CcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhh
Q 037267           79 DFVTQTMTMATIGYMAPEYG---SEG--IVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVD  153 (202)
Q Consensus        79 ~~~~~~~~~~~~~~~~pe~~---~~~--~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (202)
                      ....     -+..|.+||..   ..+  ...+..|+|.||++++.+++|..||+.....+....+|..... ..+-.+  
T Consensus       178 ~~~~-----~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~-rk~~~~--  249 (378)
T KOG1345|consen  178 KYLE-----YVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLK-RKNPAL--  249 (378)
T ss_pred             hhhh-----hhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhc-ccCccC--
Confidence            2111     23456777732   222  3456789999999999999999999864443333332221110 000000  


Q ss_pred             hhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCC
Q 037267          154 ANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRI  189 (202)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rp  189 (202)
                               .......++.+..++++-+..+|++|-
T Consensus       250 ---------P~~F~~fs~~a~r~Fkk~lt~~~~drc  276 (378)
T KOG1345|consen  250 ---------PKKFNPFSEKALRLFKKSLTPRFKDRC  276 (378)
T ss_pred             ---------chhhcccCHHHHHHHHHhcCCcccccc
Confidence                     011123455578899999999999983

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.83  E-value=6.9e-21  Score=145.14  Aligned_cols=187  Identities=22%  Similarity=0.286  Sum_probs=124.4

Q ss_pred             CCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeC-CCCceEEcccccceec------
Q 037267            2 PNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLD-ENMVAHVSDFGISKLL------   74 (202)
Q Consensus         2 ~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~-~~~~~~l~d~g~~~~~------   74 (202)
                      ++-+..++++.    ++..++..+++.+..||.++|    ..||+|||+||+|++.+ .-+.-.|+|||++...      
T Consensus       118 ~H~~f~~l~~~----l~~~~i~~Yl~~ll~Al~~~h----~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~  189 (418)
T KOG1167|consen  118 EHDRFRDLYRS----LSLAEIRWYLRNLLKALAHLH----KNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQT  189 (418)
T ss_pred             CccCHHHHHhc----CCHHHHHHHHHHHHHHhhhhh----ccCccccCCCccccccccccCCceEEechhHHHHHhhhhh
Confidence            45555666653    678999999999999999999    89999999999999998 4466789999998721      


Q ss_pred             -----------cC-CC----------------ccc--------cccCCCCCccccCCCCCCCC-CcCcchhhhhHHHHHH
Q 037267           75 -----------GE-GE----------------DFV--------TQTMTMATIGYMAPEYGSEG-IVSAKCDVYSYGVLLM  117 (202)
Q Consensus        75 -----------~~-~~----------------~~~--------~~~~~~~~~~~~~pe~~~~~-~~~~~~di~s~G~~~~  117 (202)
                                 .. .+                ...        ......||+.|.|||++... .-+++.|+||.|+|++
T Consensus       190 ~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~L  269 (418)
T KOG1167|consen  190 EHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILL  269 (418)
T ss_pred             hhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceee
Confidence                       00 00                000        01224589999999976543 4577899999999999


Q ss_pred             HHHhCCCCCCcccccchhhHHHHH----------HhCCCC--hhh----------hhh------hhhhh-hH---HHHHH
Q 037267          118 ETFTRKRPTDEMFTGEMSLRRWVK----------ESLPHG--LTE----------VVD------ANLVR-EE---QAFAA  165 (202)
Q Consensus       118 ~~~~g~~p~~~~~~~~~~~~~~~~----------~~~~~~--~~~----------~~~------~~~~~-~~---~~~~~  165 (202)
                      .++++..||.....+-..+.+.+-          ...+..  +.+          .+.      +.... +.   .....
T Consensus       270 slls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~  349 (418)
T KOG1167|consen  270 SLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIG  349 (418)
T ss_pred             hhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeeccc
Confidence            999999999866554443332210          000000  000          000      00000 00   11112


Q ss_pred             hHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          166 KMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       166 ~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                      .+..+..+++++.+|++.||.+|+|++++++
T Consensus       350 ~d~~~~~~~dlLdk~le~np~kRitAEeALk  380 (418)
T KOG1167|consen  350 SDVFPALLLDLLDKCLELNPQKRITAEDALK  380 (418)
T ss_pred             cccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence            2233447899999999999999999999875

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.83  E-value=3.6e-21  Score=152.06  Aligned_cols=118  Identities=23%  Similarity=0.305  Sum_probs=102.8

Q ss_pred             CCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCccc
Q 037267            2 PNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFV   81 (202)
Q Consensus         2 ~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~~   81 (202)
                      +|-+|+|+|.-.+. +++.++..|+.|++.|+++||    +.+|+|||||-+|++++.+|-+|++|||.+.-...+.   
T Consensus       653 ~gIDLFd~IE~kp~-m~E~eAk~IFkQV~agi~hlh----~~~ivhrdikdenvivd~~g~~klidfgsaa~~ksgp---  724 (772)
T KOG1152|consen  653 EGIDLFDFIEFKPR-MDEPEAKLIFKQVVAGIKHLH----DQGIVHRDIKDENVIVDSNGFVKLIDFGSAAYTKSGP---  724 (772)
T ss_pred             CCcchhhhhhccCc-cchHHHHHHHHHHHhcccccc----ccCceecccccccEEEecCCeEEEeeccchhhhcCCC---
Confidence            56799999986554 999999999999999999999    9999999999999999999999999999886533322   


Q ss_pred             cccCCCCCccccCCCCCCCCCcC-cchhhhhHHHHHHHHHhCCCCCCc
Q 037267           82 TQTMTMATIGYMAPEYGSEGIVS-AKCDVYSYGVLLMETFTRKRPTDE  128 (202)
Q Consensus        82 ~~~~~~~~~~~~~pe~~~~~~~~-~~~di~s~G~~~~~~~~g~~p~~~  128 (202)
                       ...+.||..|+|||++.|.+|- ...|||++|+++|.++....||.+
T Consensus       725 -fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  725 -FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             -cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence             2346799999999999998874 458999999999999999999864

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.83  E-value=3.4e-20  Score=141.29  Aligned_cols=171  Identities=24%  Similarity=0.231  Sum_probs=121.7

Q ss_pred             CcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeC--CCC--ceEEcccccceeccCCCc
Q 037267            4 GSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLD--ENM--VAHVSDFGISKLLGEGED   79 (202)
Q Consensus         4 gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~--~~~--~~~l~d~g~~~~~~~~~~   79 (202)
                      .||++|+...+  .+...+.-++.|+++|+.|||    .+|+.|||+|++|||+.  .++  .++++|||.+---.....
T Consensus       327 ~tLr~yl~~~~--~s~r~~~~~laQlLEav~hL~----~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGl  400 (598)
T KOG4158|consen  327 QTLREYLWTRH--RSYRTGRVILAQLLEAVTHLH----KHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGL  400 (598)
T ss_pred             hhHHHHHhcCC--CchHHHHHHHHHHHHHHHHHH----HccchhhcccccceEEEecCCCCcEEEEcccceeeecccccc
Confidence            47899998755  478888999999999999999    89999999999999985  333  568999998764332211


Q ss_pred             cc----cccCCCCCccccCCCCCCCCC------cCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChh
Q 037267           80 FV----TQTMTMATIGYMAPEYGSEGI------VSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLT  149 (202)
Q Consensus        80 ~~----~~~~~~~~~~~~~pe~~~~~~------~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  149 (202)
                      ..    ..-...|+...+|||+....+      .-.++|.|+.|.+.||+++...||...-+-....+.+.         
T Consensus       401 qlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yq---------  471 (598)
T KOG4158|consen  401 QLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQ---------  471 (598)
T ss_pred             ccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhh---------
Confidence            11    111234677889999765432      23479999999999999999999976221111111111         


Q ss_pred             hhhhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 037267          150 EVVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKL  198 (202)
Q Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l  198 (202)
                               +......+..+++.+.+++...|++||++|+|..-.-..|
T Consensus       472 ---------e~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl  511 (598)
T KOG4158|consen  472 ---------ESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVL  511 (598)
T ss_pred             ---------hhhCCCCcccCChHHHHHHHHHhcCCccccCCccHHHhHH
Confidence                     1122234456778899999999999999999976444433

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.82  E-value=9.4e-21  Score=151.71  Aligned_cols=174  Identities=21%  Similarity=0.237  Sum_probs=131.8

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |-||||+|..+... ++++.++...++..+.|++|||    +.+-+|||+|..||++...+.+|+.|||.+-..+...  
T Consensus        94 cgggslQdiy~~Tg-plselqiayvcRetl~gl~ylh----s~gk~hRdiKGanilltd~gDvklaDfgvsaqitati--  166 (829)
T KOG0576|consen   94 CGGGSLQDIYHVTG-PLSELQIAYVCRETLQGLKYLH----SQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATI--  166 (829)
T ss_pred             cCCCcccceeeecc-cchhHHHHHHHhhhhccchhhh----cCCcccccccccceeecccCceeecccCchhhhhhhh--
Confidence            56899999887544 4999999999999999999999    8999999999999999999999999999987655432  


Q ss_pred             ccccCCCCCccccCCCCC---CCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhh
Q 037267           81 VTQTMTMATIGYMAPEYG---SEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV  157 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~---~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (202)
                      ..+..++||+.|+|||+.   ..+.|++.+|+|++|+..-|+..-+.|..+.+.-...+-.-+-...++.          
T Consensus       167 ~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~----------  236 (829)
T KOG0576|consen  167 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPT----------  236 (829)
T ss_pred             hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCc----------
Confidence            234557899999999953   4457899999999999988988888875543322211111111111111          


Q ss_pred             hhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          158 REEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                           +......++.+.++++.|+.++|++||++..++.
T Consensus       237 -----lkDk~kws~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  237 -----LKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             -----ccCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence                 1112345566889999999999999999987653

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.79  E-value=6.4e-19  Score=129.02  Aligned_cols=123  Identities=28%  Similarity=0.349  Sum_probs=102.1

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      +++++|.+++......+++..+..++.+++.++.+||    +.+++|+|+++.|++++.++.++++|||.+.........
T Consensus        79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh----~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~  154 (225)
T smart00221       79 CEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLH----SLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA  154 (225)
T ss_pred             cCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc
Confidence            3577999999865433789999999999999999999    889999999999999999999999999998876543200


Q ss_pred             ccccCCCCCccccCCCCC-CCCCcCcchhhhhHHHHHHHHHhCCCCCCc
Q 037267           81 VTQTMTMATIGYMAPEYG-SEGIVSAKCDVYSYGVLLMETFTRKRPTDE  128 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~-~~~~~~~~~di~s~G~~~~~~~~g~~p~~~  128 (202)
                       ......+...|++||.. ....++.++|+|++|++++++++|..||..
T Consensus       155 -~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      155 -LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             -cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence             11123466789999987 556677799999999999999999999965

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.77  E-value=4.3e-18  Score=131.75  Aligned_cols=180  Identities=18%  Similarity=0.094  Sum_probs=131.0

Q ss_pred             CCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCC-----CceEEcccccce--e
Q 037267            2 PNGSLEKWLYSYN-YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN-----MVAHVSDFGISK--L   73 (202)
Q Consensus         2 ~~gsL~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~-----~~~~l~d~g~~~--~   73 (202)
                      -|-||.+..+..+ ..++..+++.++.|++.+|+++|    +.|++|||+||+|++++..     ..+.++|||+++  .
T Consensus       103 ~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH----~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~~  178 (322)
T KOG1164|consen  103 LGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLH----SKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRFK  178 (322)
T ss_pred             cCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHH----hcCcccCCcCHHHeeecCCCCcccceEEEEecCCCcccc
Confidence            4789999887555 67999999999999999999999    9999999999999999854     468999999998  3


Q ss_pred             ccCCCc---ccc---ccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCC
Q 037267           74 LGEGED---FVT---QTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHG  147 (202)
Q Consensus        74 ~~~~~~---~~~---~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~  147 (202)
                      ......   ...   .....||..|+++....+...+.+.|+||++.++.++..|..||........ ............
T Consensus       179 ~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~-~~~~~~~~~~~~  257 (322)
T KOG1164|consen  179 YVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL-KSKFEKDPRKLL  257 (322)
T ss_pred             ccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch-HHHHHHHhhhhc
Confidence            222211   011   1234589999999998888899999999999999999999999976543321 111100000000


Q ss_pred             hhhhhhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhh
Q 037267          148 LTEVVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKK  200 (202)
Q Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~  200 (202)
                      ...              .....+.++.+++..+-..+..++|....+...|+.
T Consensus       258 ~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~  296 (322)
T KOG1164|consen  258 TDR--------------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKD  296 (322)
T ss_pred             ccc--------------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHH
Confidence            000              112234556777777777899999999988887654

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.77  E-value=1.2e-17  Score=124.77  Aligned_cols=179  Identities=16%  Similarity=0.096  Sum_probs=134.2

Q ss_pred             CCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCC-----ceEEcccccceeccC
Q 037267            2 PNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENM-----VAHVSDFGISKLLGE   76 (202)
Q Consensus         2 ~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~-----~~~l~d~g~~~~~~~   76 (202)
                      -|-||+|...--+..|+..+++.++.|+..-++|+|    ++.+|+||+||+|+||...+     .+.++|||+++...+
T Consensus       106 LGPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH----~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrD  181 (449)
T KOG1165|consen  106 LGPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVH----EKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRD  181 (449)
T ss_pred             hCcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHH----hcceeecccCccceeecCCCCCCCceEEEEeccchhhhcC
Confidence            367899988755667999999999999999999999    99999999999999998543     578999999998877


Q ss_pred             CCc-----cccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCC--Chh
Q 037267           77 GED-----FVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPH--GLT  149 (202)
Q Consensus        77 ~~~-----~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~  149 (202)
                      +.+     +.......||.+|++--...|..-+.+.|+-|+|-++++.+-|+.||++...+....+.-.+.....  .+.
T Consensus       182 p~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i~  261 (449)
T KOG1165|consen  182 PKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTPIE  261 (449)
T ss_pred             ccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCCHH
Confidence            654     2334455789999999888888889999999999999999999999998765543333222222110  011


Q ss_pred             hhhhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 037267          150 EVVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKL  198 (202)
Q Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l  198 (202)
                      .+              -...+.++...+...-..+-.+-|+.+-+..-+
T Consensus       262 ~L--------------c~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf  296 (449)
T KOG1165|consen  262 VL--------------CEGFPEEFATYLRYVRRLDFFETPDYDYLRKLF  296 (449)
T ss_pred             HH--------------HhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHH
Confidence            11              123555666666666677777777766555444

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.76  E-value=1e-18  Score=146.86  Aligned_cols=170  Identities=22%  Similarity=0.225  Sum_probs=117.5

Q ss_pred             CcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCc-c--
Q 037267            4 GSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED-F--   80 (202)
Q Consensus         4 gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~-~--   80 (202)
                      .+|.|+|...+ .+...+++.|+-|++.||..+|    ..||+|+|||.+|||+..=+.+.+.||..-+....+.+ .  
T Consensus       105 hnLyDRlSTRP-FL~~iEKkWiaFQLL~al~qcH----~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPad  179 (1431)
T KOG1240|consen  105 HNLYDRLSTRP-FLVLIEKKWIAFQLLKALSQCH----KLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPAD  179 (1431)
T ss_pred             hhhhhhhccch-HHHHHHHHHHHHHHHHHHHHHH----HcCccccccccceEEEeeechhhhhcccccCCccCCCCCccc
Confidence            57888886644 4888999999999999999999    89999999999999999999999999977653321111 0  


Q ss_pred             --ccccCCCCCccccCCCCCCCC----------C-cCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhCCC
Q 037267           81 --VTQTMTMATIGYMAPEYGSEG----------I-VSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPH  146 (202)
Q Consensus        81 --~~~~~~~~~~~~~~pe~~~~~----------~-~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~  146 (202)
                        --..+.....+|.|||.+...          . .+++-||+|+||++.|++. |+++|.-.     .+..+.... ..
T Consensus       180 f~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS-----QL~aYr~~~-~~  253 (1431)
T KOG1240|consen  180 FTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS-----QLLAYRSGN-AD  253 (1431)
T ss_pred             ceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH-----HHHhHhccC-cc
Confidence              001122234589999965431          1 4567899999999999986 78777421     011111110 00


Q ss_pred             ChhhhhhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 037267          147 GLTEVVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAK  197 (202)
Q Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~  197 (202)
                      .......             .-....+..++..|+++||++|.||++.++.
T Consensus       254 ~~e~~Le-------------~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  254 DPEQLLE-------------KIEDVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             CHHHHHH-------------hCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence            0000000             0011237899999999999999999999886

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.75  E-value=1.1e-18  Score=127.26  Aligned_cols=172  Identities=23%  Similarity=0.299  Sum_probs=121.7

Q ss_pred             CCCCcHHHHHhhcCC-CCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEc--ccccceeccCC
Q 037267            1 MPNGSLEKWLYSYNY-FFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVS--DFGISKLLGEG   77 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~-~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~--d~g~~~~~~~~   77 (202)
                      ||-|||...|+.... ..+-.++++++.+++.|+.|||+.  ..-|...-|++.+++++++.+.++.  |-.++-.    
T Consensus       269 mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhsl--ep~ipr~~lns~hvmidedltarismad~kfsfq----  342 (448)
T KOG0195|consen  269 MPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL--EPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ----  342 (448)
T ss_pred             ccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc--chhhhhhhcccceEEecchhhhheecccceeeee----
Confidence            688999999986543 578889999999999999999964  3345555788899999998776653  3222211    


Q ss_pred             CccccccCCCCCccccCCCCCCCCC---cCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhh
Q 037267           78 EDFVTQTMTMATIGYMAPEYGSEGI---VSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDA  154 (202)
Q Consensus        78 ~~~~~~~~~~~~~~~~~pe~~~~~~---~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (202)
                           .....-.+.|++||.+...+   .-.++|+|||++++||+.++..||.+...-+-..+--.     +.+.     
T Consensus       343 -----e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkial-----eglr-----  407 (448)
T KOG0195|consen  343 -----EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIAL-----EGLR-----  407 (448)
T ss_pred             -----ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhh-----cccc-----
Confidence                 11223467899999665433   23468999999999999999999987654332111000     0111     


Q ss_pred             hhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          155 NLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                              ...+...+....+||.-|+..||.+||.++.++-.|++.
T Consensus       408 --------v~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm  446 (448)
T KOG0195|consen  408 --------VHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM  446 (448)
T ss_pred             --------ccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence                    111223445578999999999999999999998888764

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.75  E-value=8.3e-19  Score=137.57  Aligned_cols=164  Identities=24%  Similarity=0.352  Sum_probs=118.3

Q ss_pred             CCCCcHHHHHhhc--CCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCC
Q 037267            1 MPNGSLEKWLYSY--NYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGE   78 (202)
Q Consensus         1 ~~~gsL~~~l~~~--~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~   78 (202)
                      |+.++|+|||...  ....++...+.++.|++.|++|       ++.+|+|+||.||....+..+||.|||+........
T Consensus       338 c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y-------k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~~~~~  410 (516)
T KOG1033|consen  338 CEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY-------KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQDKDE  410 (516)
T ss_pred             hhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh-------ccchhhhccccccccccchhhhhhhhhheeecccCC
Confidence            5678999999633  2346788899999999999997       478999999999999999899999999987655433


Q ss_pred             ----ccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhCCCChhhhhh
Q 037267           79 ----DFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVD  153 (202)
Q Consensus        79 ----~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (202)
                          .....+.-.++.+|++||.+.+..|+.++||||+|++++|++. =...+..    ...+.......+|        
T Consensus       411 ~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er----~~t~~d~r~g~ip--------  478 (516)
T KOG1033|consen  411 TVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER----IATLTDIRDGIIP--------  478 (516)
T ss_pred             cccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH----HHhhhhhhcCCCC--------
Confidence                1112334578999999999999999999999999999999987 2222211    1111111110010        


Q ss_pred             hhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHH
Q 037267          154 ANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTD  193 (202)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~  193 (202)
                                +....-.++-+.++.+++...|.+||++.+
T Consensus       479 ----------~~~~~d~p~e~~ll~~lls~~p~~RP~~~~  508 (516)
T KOG1033|consen  479 ----------PEFLQDYPEEYTLLQQLLSPSPEERPSAIE  508 (516)
T ss_pred             ----------hHHhhcCcHHHHHHHHhcCCCcccCchHHH
Confidence                      001112233568999999999999995544

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.71  E-value=2.8e-16  Score=120.54  Aligned_cols=183  Identities=30%  Similarity=0.353  Sum_probs=129.9

Q ss_pred             CCCCcHHHHHhhcC--CCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCC-ceEEcccccceeccCC
Q 037267            1 MPNGSLEKWLYSYN--YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENM-VAHVSDFGISKLLGEG   77 (202)
Q Consensus         1 ~~~gsL~~~l~~~~--~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~-~~~l~d~g~~~~~~~~   77 (202)
                      +.++++.+++....  ..++......++.|++.++.|+|    +.+++|||+||+|++++... .++++|||.+......
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H----~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~  155 (384)
T COG0515          80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH----SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP  155 (384)
T ss_pred             CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHH----hCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence            46788887777554  25899999999999999999999    89999999999999999888 7999999999865543


Q ss_pred             Cccc----cccCCCCCccccCCCCCCC---CCcCcchhhhhHHHHHHHHHhCCCCCCccccc--chhhHHHHHHhCCCCh
Q 037267           78 EDFV----TQTMTMATIGYMAPEYGSE---GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTG--EMSLRRWVKESLPHGL  148 (202)
Q Consensus        78 ~~~~----~~~~~~~~~~~~~pe~~~~---~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~  148 (202)
                      ....    ......++..|.+||...+   ...+...|+||+|+++++++.|..||......  .......+........
T Consensus       156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~  235 (384)
T COG0515         156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSL  235 (384)
T ss_pred             CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCccc
Confidence            3211    1234568999999998776   56788899999999999999999997654431  1111111111110000


Q ss_pred             hhhhhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          149 TEVVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                      .........         ......+.+++..|+..+|..|.+..+...
T Consensus       236 ~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~  274 (384)
T COG0515         236 ASPLSPSNP---------ELISKAASDLLKKLLAKDPKNRLSSSSDLS  274 (384)
T ss_pred             ccccCcccc---------chhhHHHHHHHHHHHhcCchhcCCHHHHhh
Confidence            000000000         122345789999999999999999877654

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.69  E-value=5.1e-17  Score=116.58  Aligned_cols=183  Identities=16%  Similarity=0.113  Sum_probs=129.5

Q ss_pred             CCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCC---CCceEEcccccceeccCCC
Q 037267            2 PNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDE---NMVAHVSDFGISKLLGEGE   78 (202)
Q Consensus         2 ~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~---~~~~~l~d~g~~~~~~~~~   78 (202)
                      -|-||++.+.--...++..+++.++-|++.-++|+|    .++++||||||+|+|..-   ...+.++|||+++...+..
T Consensus        93 LGPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH----~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~  168 (341)
T KOG1163|consen   93 LGPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVH----LRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIR  168 (341)
T ss_pred             cCccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHH----hhccccccCCccceeeccccccceEEEEeccchhhhcccc
Confidence            367899988744556899999999999999999999    899999999999999873   3467899999998776543


Q ss_pred             c-----cccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhh
Q 037267           79 D-----FVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVD  153 (202)
Q Consensus        79 ~-----~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (202)
                      +     +.......||..|++-....+..-+.+.|+-|+|.++.++--|..||++.......-..          +.+..
T Consensus       169 t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKy----------EkI~E  238 (341)
T KOG1163|consen  169 TRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKY----------EKISE  238 (341)
T ss_pred             ccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHH----------HHHHH
Confidence            2     22233346888888776666666678899999999999999999999986543211110          11111


Q ss_pred             hhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhh
Q 037267          154 ANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKK  200 (202)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~  200 (202)
                      .........+  =...|.++.-.+..|-...-++-|+..-+.+.+..
T Consensus       239 kK~s~~ie~L--C~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFri  283 (341)
T KOG1163|consen  239 KKMSTPIEVL--CKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRI  283 (341)
T ss_pred             hhcCCCHHHH--hCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHH
Confidence            1111111110  02345667788888888888888887766665543

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.68  E-value=1.4e-17  Score=124.81  Aligned_cols=153  Identities=19%  Similarity=0.229  Sum_probs=99.8

Q ss_pred             CCcHHHHHh---hcCC---CCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccC
Q 037267            3 NGSLEKWLY---SYNY---FFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGE   76 (202)
Q Consensus         3 ~gsL~~~l~---~~~~---~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~   76 (202)
                      -+||.+.+.   ....   .+....++.+..|+...+++||    +.|++|+|++|+|++++.+|.+.++||+.....+.
T Consensus       122 ~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh----~~GlVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~  197 (288)
T PF14531_consen  122 QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLH----SYGLVHGDIKPENFLLDQDGGVFLGDFSSLVRAGT  197 (288)
T ss_dssp             SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH----HTTEEEST-SGGGEEE-TTS-EEE--GGGEEETTE
T ss_pred             hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHh----hcceEecccceeeEEEcCCCCEEEcChHHHeecCc
Confidence            356666644   2222   2445667778899999999999    99999999999999999999999999987766443


Q ss_pred             CCccccccCCCCCccccCCCCCCC--------CCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCCh
Q 037267           77 GEDFVTQTMTMATIGYMAPEYGSE--------GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGL  148 (202)
Q Consensus        77 ~~~~~~~~~~~~~~~~~~pe~~~~--------~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  148 (202)
                      ....     ...+..|.|||....        ..++.+.|.|++|+++|.++.+..||+..........           
T Consensus       198 ~~~~-----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~-----------  261 (288)
T PF14531_consen  198 RYRC-----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADPEW-----------  261 (288)
T ss_dssp             EEEG-----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSGG-----------
T ss_pred             eeec-----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCccccccc-----------
Confidence            2211     123466788884322        2467789999999999999999999986543321110           


Q ss_pred             hhhhhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCC
Q 037267          149 TEVVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKR  188 (202)
Q Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~R  188 (202)
                        ...          ... +.++.+.+|+..+|+++|++|
T Consensus       262 --~f~----------~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  262 --DFS----------RCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             --GGT----------TSS----HHHHHHHHHHT-SSGGGS
T ss_pred             --cch----------hcC-CcCHHHHHHHHHHccCCcccC
Confidence              000          001 456678999999999999988

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.65  E-value=6.8e-17  Score=135.67  Aligned_cols=143  Identities=24%  Similarity=0.215  Sum_probs=106.7

Q ss_pred             HHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCccc-------------cccCCCCCccccC
Q 037267           28 DVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFV-------------TQTMTMATIGYMA   94 (202)
Q Consensus        28 ~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~~-------------~~~~~~~~~~~~~   94 (202)
                      +++.+++|||    +.+|+|||+||+|.+|..-|.+|+.|||+.+........+             ......+|+.|.|
T Consensus       151 dmvla~Eylh----~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyia  226 (1205)
T KOG0606|consen  151 DMVLAVEYLH----SYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIA  226 (1205)
T ss_pred             hhhHHhHhhc----cCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccC
Confidence            4488999999    9999999999999999999999999999987532211100             0112368999999


Q ss_pred             CCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhHHHHHHhHHHHHHHH
Q 037267           95 PEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIM  174 (202)
Q Consensus        95 pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  174 (202)
                      ||++.-..|+..+|.|++|+|+|+.+.|..||++-+.++ .+...+.+..            .    ..+.+...+.++.
T Consensus       227 PeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpee-lfg~visd~i------------~----wpE~dea~p~Ea~  289 (1205)
T KOG0606|consen  227 PEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE-LFGQVISDDI------------E----WPEEDEALPPEAQ  289 (1205)
T ss_pred             hhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHH-HHhhhhhhhc------------c----ccccCcCCCHHHH
Confidence            999988899999999999999999999999997743332 2222222111            0    0111234566788


Q ss_pred             HHHhhhcCCCCCCCCCH
Q 037267          175 DLALDCCMESPGKRINM  191 (202)
Q Consensus       175 ~l~~~cl~~~p~~Rps~  191 (202)
                      +++.+.|+.+|..|--.
T Consensus       290 dli~~LL~qnp~~Rlgt  306 (1205)
T KOG0606|consen  290 DLIEQLLRQNPLCRLGT  306 (1205)
T ss_pred             HHHHHHHHhChHhhccc
Confidence            99999999999999743

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.61  E-value=3.9e-16  Score=124.93  Aligned_cols=152  Identities=24%  Similarity=0.257  Sum_probs=117.5

Q ss_pred             CCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcccc
Q 037267            3 NGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVT   82 (202)
Q Consensus         3 ~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~   82 (202)
                      ||.|.-.+.+... +++.....+...++.+++++|    ..+|+|||+|++||+++.+|.+++.|||+++.......   
T Consensus        81 gg~lft~l~~~~~-f~~~~~~~~~aelaLald~lh----~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~---  152 (612)
T KOG0603|consen   81 GGDLFTRLSKEVM-FDELDVAFYLAELALALDHLH----KLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI---  152 (612)
T ss_pred             cchhhhccccCCc-hHHHHHHHHHHHHHHHHhhcc----hhHHHHhcccccceeecccCccccCCchhhhHhHhhhh---
Confidence            4555555554443 778888889999999999999    89999999999999999999999999999987655432   


Q ss_pred             ccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhHHH
Q 037267           83 QTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQA  162 (202)
Q Consensus        83 ~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (202)
                         ..|+..|+|||++.  .....+|.||+|++.+++++|..||..    +  ..           ..+....       
T Consensus       153 ---~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~--~~-----------~~Il~~~-------  203 (612)
T KOG0603|consen  153 ---ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----D--TM-----------KRILKAE-------  203 (612)
T ss_pred             ---cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----H--HH-----------HHHhhhc-------
Confidence               25899999999987  345778999999999999999999966    1  00           1111111       


Q ss_pred             HHHhHHHHHHHHHHHhhhcCCCCCCCCCH
Q 037267          163 FAAKMDCIVSIMDLALDCCMESPGKRINM  191 (202)
Q Consensus       163 ~~~~~~~~~~~~~l~~~cl~~~p~~Rps~  191 (202)
                      ...+......+.+++..+..++|..|...
T Consensus       204 ~~~p~~l~~~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  204 LEMPRELSAEARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             cCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence            12334556667888889999999988855

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.47  E-value=3e-13  Score=115.10  Aligned_cols=117  Identities=21%  Similarity=0.145  Sum_probs=96.1

Q ss_pred             CCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCC-------CCceEEcccccceec
Q 037267            2 PNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDE-------NMVAHVSDFGISKLL   74 (202)
Q Consensus         2 ~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~-------~~~~~l~d~g~~~~~   74 (202)
                      +-|||.|++. ..+.+++..++.+..|++.-|+.||    ..+|||+||||+|+++..       ...++|+|||.+.-+
T Consensus       777 ~~Gtlld~~N-~~~~m~e~lv~~~~~qml~ive~lH----~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm  851 (974)
T KOG1166|consen  777 PYGTLLDLIN-TNKVMDEYLVMFFSCQMLRIVEHLH----AMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDM  851 (974)
T ss_pred             ccccHHHhhc-cCCCCCchhhhHHHHHHHHHHHHHH----hcceecccCCcceeEeecccCCCCcccceEEEecccceee
Confidence            4599999997 4456999999999999999999999    999999999999999953       346899999998754


Q ss_pred             cCCCccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCC
Q 037267           75 GEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRK  123 (202)
Q Consensus        75 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~  123 (202)
                      ..............+-.+-++|+..|.+++.+.|.|.++.+++.|+.|+
T Consensus       852 ~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~  900 (974)
T KOG1166|consen  852 KLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGK  900 (974)
T ss_pred             eEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHH
Confidence            3222111122234567788999999999999999999999999999887

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.42  E-value=4.3e-14  Score=116.87  Aligned_cols=176  Identities=22%  Similarity=0.221  Sum_probs=130.5

Q ss_pred             CCCcHHHHH-hhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCC-ceEEcccccceeccC-CC
Q 037267            2 PNGSLEKWL-YSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENM-VAHVSDFGISKLLGE-GE   78 (202)
Q Consensus         2 ~~gsL~~~l-~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~-~~~l~d~g~~~~~~~-~~   78 (202)
                      .||++.+.+ ..+....+...+-.++.|+..++.|+|.   ..++.|+|+||+|.+++..+ ..++.|||++..... ..
T Consensus       104 ~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~---~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~g  180 (601)
T KOG0590|consen  104 DGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHP---ENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNKNG  180 (601)
T ss_pred             cccccccccccCCccCCCCcchhhhhhhhccCccccCc---ccccccCCCCCccchhccCCCcccCCCchhhccccccCC
Confidence            467777777 4333256778889999999999999995   67899999999999999998 999999999988776 33


Q ss_pred             ccccccCCCC-CccccCCCCCCCC-CcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhh
Q 037267           79 DFVTQTMTMA-TIGYMAPEYGSEG-IVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANL  156 (202)
Q Consensus        79 ~~~~~~~~~~-~~~~~~pe~~~~~-~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (202)
                      .........| ++.|.+||...+. ......|+||.|+++..+++|..||............|+.....           
T Consensus       181 ~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~-----------  249 (601)
T KOG0590|consen  181 AERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGR-----------  249 (601)
T ss_pred             cceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccc-----------
Confidence            3333333456 9999999987774 34567899999999999999999998766555443333322100           


Q ss_pred             hhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHH
Q 037267          157 VREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAA  195 (202)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~  195 (202)
                          ..............++..+++..+|+.|.+..++.
T Consensus       250 ----~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~  284 (601)
T KOG0590|consen  250 ----FTQLPWNSISDQAHDLLHKILKENPSNRLSIEELK  284 (601)
T ss_pred             ----cccCccccCChhhhhcccccccCCchhcccccccc
Confidence                00011123344578899999999999999988764

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.39  E-value=4.7e-13  Score=104.39  Aligned_cols=88  Identities=22%  Similarity=0.184  Sum_probs=64.7

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCC-CCCceeeCCCCceEEcccccceeccCCCc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDL-KPTNILLDENMVAHVSDFGISKLLGEGED   79 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dl-k~~nil~~~~~~~~l~d~g~~~~~~~~~~   79 (202)
                      |+|++|.. +.  .  ..   ...++.+++.+|.|||    +.+|+|||| ||+||+++.++.++|+|||++........
T Consensus       100 ~~G~~L~~-~~--~--~~---~~~~~~~i~~aL~~lH----~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~~~  167 (365)
T PRK09188        100 TEGVPLHL-AR--P--HG---DPAWFRSAHRALRDLH----RAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRRGA  167 (365)
T ss_pred             cCCCCHHH-hC--c--cc---hHHHHHHHHHHHHHHH----HCCCeeCCCCCcceEEEcCCCCEEEEECccceecccCcc
Confidence            57888863 21  1  11   2467899999999999    899999999 99999999889999999999987654331


Q ss_pred             ccc------ccCCCCCccccCCCCCCC
Q 037267           80 FVT------QTMTMATIGYMAPEYGSE  100 (202)
Q Consensus        80 ~~~------~~~~~~~~~~~~pe~~~~  100 (202)
                      ...      -....+++.|.+||....
T Consensus       168 ~~~~~~~~d~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        168 LYRIAAYEDLRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             hhhhhhhhhhhhhhccCccCCcccCCh
Confidence            111      122346777889986544

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.34  E-value=1.3e-12  Score=93.65  Aligned_cols=68  Identities=12%  Similarity=0.093  Sum_probs=55.9

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcc-cCCCCCCCeeecCCCCCceeeCCCCceEEcccccceec
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYP-HHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLL   74 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~l-H~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~   74 (202)
                      ++|+++...+.. ...++...+..++.|++.+|.++ |    +.+|+|||+||.||+++ ++.++++|||++...
T Consensus        99 i~g~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~l~H----~~giiHrDlkP~NIli~-~~~v~LiDFG~a~~~  167 (190)
T cd05147          99 IGDDGWAAPRLK-DAPLSESKARELYLQVIQIMRILYQ----DCRLVHADLSEYNLLYH-DGKLYIIDVSQSVEH  167 (190)
T ss_pred             eCCCCCcchhhh-cCCCCHHHHHHHHHHHHHHHHHHHH----hCCcccCCCCHHHEEEE-CCcEEEEEccccccC
Confidence            356666555333 23589999999999999999999 7    88999999999999998 478999999998653

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.30  E-value=3.7e-12  Score=91.44  Aligned_cols=67  Identities=18%  Similarity=0.095  Sum_probs=55.4

Q ss_pred             CCCcHHHH-HhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCC-CCeeecCCCCCceeeCCCCceEEcccccceecc
Q 037267            2 PNGSLEKW-LYSYNYFFDILERLNIMIDVGSALEYPHHGHSS-APIIHCDLKPTNILLDENMVAHVSDFGISKLLG   75 (202)
Q Consensus         2 ~~gsL~~~-l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~-~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~   75 (202)
                      +|+++... +..  ..++...+..++.|++.++.++|    . .+++|||+||.||+++ ++.++++|||++....
T Consensus       100 ~g~~~~~~~l~~--~~~~~~~~~~i~~~l~~~l~~lH----~~~givHrDlkP~NIll~-~~~~~liDFG~a~~~~  168 (190)
T cd05145         100 GDDGSPAPRLKD--VPLEEEEAEELYEQVVEQMRRLY----QEAGLVHGDLSEYNILYH-DGKPYIIDVSQAVELD  168 (190)
T ss_pred             cCCCchhhhhhh--ccCCHHHHHHHHHHHHHHHHHHH----HhCCEecCCCChhhEEEE-CCCEEEEEcccceecC
Confidence            45544333 432  34788899999999999999999    7 9999999999999999 7899999999987643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.28  E-value=5.8e-12  Score=90.47  Aligned_cols=100  Identities=19%  Similarity=0.149  Sum_probs=70.0

Q ss_pred             HHHHHHHHHhhhcccCCCCCCCeeecCC-CCCceeeCCCCceEEcccccceeccCCCcc----c-c------ccCCCCCc
Q 037267           23 LNIMIDVGSALEYPHHGHSSAPIIHCDL-KPTNILLDENMVAHVSDFGISKLLGEGEDF----V-T------QTMTMATI   90 (202)
Q Consensus        23 ~~~~~~l~~~l~~lH~~~~~~~i~h~dl-k~~nil~~~~~~~~l~d~g~~~~~~~~~~~----~-~------~~~~~~~~   90 (202)
                      ..++.|++.+|.++|    +.||+|||| ||.||+++.++.++|+|||++.........    . .      ......++
T Consensus        94 ~~~~~qi~~~L~~lH----~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~  169 (218)
T PRK12274         94 LAYFRAARRLLQQLH----RCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCP  169 (218)
T ss_pred             HHHHHHHHHHHHHHH----HCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCC
Confidence            457889999999999    999999999 799999999999999999999865433210    0 0      00011344


Q ss_pred             cccCCCCCCCC-CcC-cchhhhhHHHHHHHHHhCCCCC
Q 037267           91 GYMAPEYGSEG-IVS-AKCDVYSYGVLLMETFTRKRPT  126 (202)
Q Consensus        91 ~~~~pe~~~~~-~~~-~~~di~s~G~~~~~~~~g~~p~  126 (202)
                      .++.|+...-. ..+ ...+.++.|+-+|.++|+..+.
T Consensus       170 ~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~  207 (218)
T PRK12274        170 AALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLH  207 (218)
T ss_pred             CCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCc
Confidence            45555421111 223 3456677899999999988774

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.25  E-value=2.7e-11  Score=91.13  Aligned_cols=171  Identities=18%  Similarity=0.256  Sum_probs=111.4

Q ss_pred             CCCCcHHHHHhhc---CCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceec--c
Q 037267            1 MPNGSLEKWLYSY---NYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLL--G   75 (202)
Q Consensus         1 ~~~gsL~~~l~~~---~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~--~   75 (202)
                      |.-|||..+|+..   ...+....-.+|+-||.+||.|||+.  ...|+|+++.-..+.+..++-+|+..-.-....  .
T Consensus       154 mssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~--~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~  231 (458)
T KOG1266|consen  154 MSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC--DPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSV  231 (458)
T ss_pred             ccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc--CCccccCCcchhheeecCCceEEecccCccccchhh
Confidence            4678999999843   34577788899999999999999976  678999999999999998887776532211110  0


Q ss_pred             CCCccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhh
Q 037267           76 EGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDAN  155 (202)
Q Consensus        76 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (202)
                      ............+-+.|.+|++......+.++|||++|...+++..+..--..... .....+        .....+.. 
T Consensus       232 ~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq~tnseS-~~~~ee--------~ia~~i~~-  301 (458)
T KOG1266|consen  232 NSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQSTNSES-KVEVEE--------NIANVIIG-  301 (458)
T ss_pred             hhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHheeccCCCcc-eeehhh--------hhhhheee-
Confidence            11111112223466788999987777778899999999999998776642111100 000000        00000000 


Q ss_pred             hhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHH
Q 037267          156 LVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAA  195 (202)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~  195 (202)
                       ...+  +         =.+++.+|+.-.|+.||+|.+++
T Consensus       302 -len~--l---------qr~~i~kcl~~eP~~rp~ar~ll  329 (458)
T KOG1266|consen  302 -LENG--L---------QRGSITKCLEGEPNGRPDARLLL  329 (458)
T ss_pred             -ccCc--c---------ccCcCcccccCCCCCCcchhhhh
Confidence             0000  0         24789999999999999998875

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.20  E-value=3.9e-12  Score=92.96  Aligned_cols=91  Identities=12%  Similarity=0.146  Sum_probs=64.6

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      ++|.+|.++..     ++.    ....+++.+|..+|    ..|++|||++|+|++++.++ ++++|||...........
T Consensus       125 i~G~tL~~~~~-----~~~----~~~~~i~~~l~~lH----~~gi~H~Dikp~Nili~~~g-i~liDfg~~~~~~e~~a~  190 (232)
T PRK10359        125 IEGVELNDMPE-----ISE----DVKAKIKASIESLH----QHGMVSGDPHKGNFIVSKNG-LRIIDLSGKRCTAQRKAK  190 (232)
T ss_pred             ECCccHHHhhh-----ccH----HHHHHHHHHHHHHH----HcCCccCCCChHHEEEeCCC-EEEEECCCcccccchhhH
Confidence            35677777632     222    34669999999999    99999999999999999888 999999987654221110


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHH
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMET  119 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~  119 (202)
                       .             .+.....+..++|+|++|+.+..+
T Consensus       191 -d-------------~~vler~y~~~~di~~lg~~~~~~  215 (232)
T PRK10359        191 -D-------------RIDLERHYGIKNEIKDLGYYLLIY  215 (232)
T ss_pred             -H-------------HHHHHhHhcccccccceeEeehHH
Confidence             0             012223345689999999987654

>smart00090 RIO RIO-like kinase

Probab=99.11  E-value=6.3e-11  Score=87.82  Aligned_cols=67  Identities=18%  Similarity=0.087  Sum_probs=54.8

Q ss_pred             CCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCC-eeecCCCCCceeeCCCCceEEcccccceec
Q 037267            2 PNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAP-IIHCDLKPTNILLDENMVAHVSDFGISKLL   74 (202)
Q Consensus         2 ~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~-i~h~dlk~~nil~~~~~~~~l~d~g~~~~~   74 (202)
                      +|++|..+.... ..++......++.|++.+|.+||    ..+ ++|+|+||.||+++ ++.++++|||.+...
T Consensus       131 ~g~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH----~~g~iiH~Dikp~NIli~-~~~i~LiDFg~a~~~  198 (237)
T smart00090      131 GGDGLPAPRLKD-VEPEEEEEFELYDDILEEMRKLY----KEGELVHGDLSEYNILVH-DGKVVIIDVSQSVEL  198 (237)
T ss_pred             cCCccccccccc-CCcchHHHHHHHHHHHHHHHHHH----hcCCEEeCCCChhhEEEE-CCCEEEEEChhhhcc
Confidence            556666654332 23566677899999999999999    889 99999999999999 788999999987653

>PRK10345 hypothetical protein; Provisional

Probab=99.09  E-value=1.4e-10  Score=84.23  Aligned_cols=63  Identities=21%  Similarity=0.250  Sum_probs=49.8

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhh-hcccCCCCCCCeeecCCCCCceeeCC----CCceEEcccccc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSAL-EYPHHGHSSAPIIHCDLKPTNILLDE----NMVAHVSDFGIS   71 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l-~~lH~~~~~~~i~h~dlk~~nil~~~----~~~~~l~d~g~~   71 (202)
                      +++|||.+++.+.  .+++.  ..++.+++.++ +|||    +.+|+||||||+||+++.    +..++|+|++.+
T Consensus        89 ~~~~tL~~~l~~~--~~~e~--~~~~~~~L~~l~~yLh----~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~  156 (210)
T PRK10345         89 KPSITLTEFAEQC--RYEED--VAQLRQLLKKLKRYLL----DNRIVTMELKPQNILCQRISESEVIPVVCDNIGE  156 (210)
T ss_pred             CcchhHHHHHHcc--cccHh--HHHHHHHHHHHHHHHH----HCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence            3578999999753  25555  46688888887 8999    999999999999999973    347999995443

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.02  E-value=4.8e-10  Score=83.23  Aligned_cols=62  Identities=26%  Similarity=0.267  Sum_probs=51.8

Q ss_pred             CC-CcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEccccccee
Q 037267            2 PN-GSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKL   73 (202)
Q Consensus         2 ~~-gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~   73 (202)
                      +| .+|.+++...  .++..    .+.+++.+|.+||    ..||+|+|+||.||+++.++.++++|||.+..
T Consensus       129 ~G~~~L~~~l~~~--~l~~~----~~~~i~~~l~~lH----~~GI~HrDlkp~NILv~~~~~v~LIDfg~~~~  191 (239)
T PRK01723        129 EGARDLVALLQEA--PLSEE----QWQAIGQLIARFH----DAGVYHADLNAHNILLDPDGKFWLIDFDRGEL  191 (239)
T ss_pred             CCCCCHHHHHhcC--CCCHH----HHHHHHHHHHHHH----HCCCCCCCCCchhEEEcCCCCEEEEECCCccc
Confidence            55 6898888643  24543    3678999999999    99999999999999999888999999998765

>PRK14879 serine/threonine protein kinase; Provisional

Probab=98.99  E-value=6.1e-10  Score=81.08  Aligned_cols=63  Identities=29%  Similarity=0.478  Sum_probs=55.2

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEccccccee
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKL   73 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~   73 (202)
                      ++|++|.+++....    . .+..++.+++.+|.++|    +.+++|+|++|.||+++ ++.++++|||.+..
T Consensus        81 ~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH----~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSNG----M-EELELSREIGRLVGKLH----SAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHH----hCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            47889999986432    2 78899999999999999    89999999999999999 78899999998754

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=98.96  E-value=6.1e-10  Score=80.44  Aligned_cols=51  Identities=20%  Similarity=0.214  Sum_probs=46.0

Q ss_pred             HHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceecc
Q 037267           21 ERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLG   75 (202)
Q Consensus        21 ~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~   75 (202)
                      ....++.+++.++.++|    ..+++|+|++|.||+++.++.++++|||.+....
T Consensus       126 ~~~~~~~~i~~~l~~lh----~~gi~H~Dl~p~Nill~~~~~~~liDfg~~~~~~  176 (198)
T cd05144         126 DPEEVLDEILEEIVKAY----KHGIIHGDLSEFNILVDDDEKIYIIDWPQMVSTD  176 (198)
T ss_pred             cHHHHHHHHHHHHHHHH----HCCCCcCCCCcccEEEcCCCcEEEEECCccccCC
Confidence            35678899999999999    8999999999999999999999999999986544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.96  E-value=2.9e-10  Score=92.89  Aligned_cols=157  Identities=15%  Similarity=0.160  Sum_probs=105.3

Q ss_pred             HHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcccc--cc-----CCCCCccc
Q 037267           20 LERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVT--QT-----MTMATIGY   92 (202)
Q Consensus        20 ~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~--~~-----~~~~~~~~   92 (202)
                      +....=+.+++.|+.|+|.   +.++||+++.|.+|.++..+..|+..|+.+........+..  ..     .......|
T Consensus        99 e~~f~nl~~v~dgl~flh~---sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f  175 (700)
T KOG2137|consen   99 EDGFANLGNVADGLAFLHR---SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNF  175 (700)
T ss_pred             cHhhhhhhcccchhhhhcc---CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCccc
Confidence            3444456677789999997   78999999999999999999999999988765433211100  00     01123468


Q ss_pred             cCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhHHHHHHhHHHHH
Q 037267           93 MAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIV  171 (202)
Q Consensus        93 ~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (202)
                      .+||++.+...+.++|++|+|+.+|.+.. |+.-+.........-.+....                .....-.....+.
T Consensus       176 ~apE~~~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~----------------~~~~~~~s~~~p~  239 (700)
T KOG2137|consen  176 LAPEYLLGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLL----------------NAGAFGYSNNLPS  239 (700)
T ss_pred             ccchhhccccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhccc----------------ccccccccccCcH
Confidence            99999888778889999999999998884 554433221111100000000                0011112256778


Q ss_pred             HHHHHHhhhcCCCCCCCCCHHHHH
Q 037267          172 SIMDLALDCCMESPGKRINMTDAA  195 (202)
Q Consensus       172 ~~~~l~~~cl~~~p~~Rps~~~~~  195 (202)
                      ++.+=+.+++..++..||++..+.
T Consensus       240 el~~~l~k~l~~~~~~rp~~~~l~  263 (700)
T KOG2137|consen  240 ELRESLKKLLNGDSAVRPTLDLLL  263 (700)
T ss_pred             HHHHHHHHHhcCCcccCcchhhhh
Confidence            899999999999999999777654

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.96  E-value=6.7e-09  Score=81.13  Aligned_cols=177  Identities=12%  Similarity=0.065  Sum_probs=115.9

Q ss_pred             CCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCccccccCCCCCccccCC
Q 037267           16 FFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAP   95 (202)
Q Consensus        16 ~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~p   95 (202)
                      ...|...++.++.++++-.-||    .+|.+-+|++++|+|++.++.+.+.|-..-.......   ......+...|++|
T Consensus       113 ~~~w~fllrvaRnlA~aFA~lH----~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~~ng~---~~~cpVg~~eftPP  185 (637)
T COG4248         113 HCAWDFLLRVARNLASAFATLH----EHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQINANGT---LHLCPVGVSEFTPP  185 (637)
T ss_pred             ccccHHHHHHHHHHHHHHHHHH----hcCCcccccCccceeeecCceEEEEcccceeeccCCc---eEecccCccccCCH
Confidence            4789999999999999999999    8999999999999999999999988744332222222   23345788899999


Q ss_pred             CCCC-----CCCcCcchhhhhHHHHHHHHHhC-CCCCCcccccc---hhhHHHHHHhCCCChhhhhhhhhhhhHHHHHHh
Q 037267           96 EYGS-----EGIVSAKCDVYSYGVLLMETFTR-KRPTDEMFTGE---MSLRRWVKESLPHGLTEVVDANLVREEQAFAAK  166 (202)
Q Consensus        96 e~~~-----~~~~~~~~di~s~G~~~~~~~~g-~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (202)
                      |.-.     +...+...|.|.+|+++++++.| ..||.+..-..   ......+..+.-  .............-.....
T Consensus       186 ElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f--~ya~~~~~g~~p~P~~~P~  263 (637)
T COG4248         186 ELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRF--AYASDQRRGLKPPPRSIPL  263 (637)
T ss_pred             HHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhccee--eechhccCCCCCCCCCCCh
Confidence            9533     33445668999999999998764 88998643111   111111111100  0000000000000000112


Q ss_pred             HHHHHHHHHHHhhhcCCC--CCCCCCHHHHHHHHhhc
Q 037267          167 MDCIVSIMDLALDCCMES--PGKRINMTDAAAKLKKI  201 (202)
Q Consensus       167 ~~~~~~~~~l~~~cl~~~--p~~Rps~~~~~~~l~~l  201 (202)
                      ...++.+-.|+.+|+...  +.-|||+..++..|..+
T Consensus       264 ~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al  300 (637)
T COG4248         264 SMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDAL  300 (637)
T ss_pred             hhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHH
Confidence            345667889999999874  56899999998888654

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=98.94  E-value=9.5e-10  Score=79.38  Aligned_cols=60  Identities=25%  Similarity=0.407  Sum_probs=51.6

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEccccccee
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKL   73 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~   73 (202)
                      ++|++|.+++.....        .++.+++.+|.++|    +.+++|+|++|.||+++ ++.++++|||.+..
T Consensus        79 ~~g~~l~~~~~~~~~--------~~~~~i~~~l~~lH----~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        79 IEGKPLKDVIEEGND--------ELLREIGRLVGKLH----KAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             ECCccHHHHHhhcHH--------HHHHHHHHHHHHHH----HCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            478888888754221        88999999999999    89999999999999999 78899999998754

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=98.92  E-value=1.1e-09  Score=90.60  Aligned_cols=59  Identities=25%  Similarity=0.392  Sum_probs=51.8

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEccccccee
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKL   73 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~   73 (202)
                      ++|++|.+++.         ....++.+++.+|.+||    +.+++|||+||.||++ .++.++++|||+++.
T Consensus       418 ~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH----~~giiHrDlkp~NILl-~~~~~~liDFGla~~  476 (535)
T PRK09605        418 IGGKDLKDVLE---------GNPELVRKVGEIVAKLH----KAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY  476 (535)
T ss_pred             cCCCcHHHHHH---------HHHHHHHHHHHHHHHHH----hCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence            46788888875         35678999999999999    8999999999999999 677899999999865

>cd05119 RIO RIO kinase family, catalytic domain

Probab=98.75  E-value=9.7e-09  Score=73.32  Aligned_cols=51  Identities=18%  Similarity=0.154  Sum_probs=46.3

Q ss_pred             HHHHHHHHHHHHhhhcccCCCCC-CCeeecCCCCCceeeCCCCceEEcccccceecc
Q 037267           20 LERLNIMIDVGSALEYPHHGHSS-APIIHCDLKPTNILLDENMVAHVSDFGISKLLG   75 (202)
Q Consensus        20 ~~~~~~~~~l~~~l~~lH~~~~~-~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~   75 (202)
                      ..+..++.+++.++.++|    . .+++|+|+||.||+++ ++.++++|||.+....
T Consensus       114 ~~~~~~~~~~~~~l~~lh----~~~~ivH~Dl~p~Nili~-~~~~~liDfg~a~~~~  165 (187)
T cd05119         114 EDPEELYDQILELMRKLY----REAGLVHGDLSEYNILVD-DGKVYIIDVPQAVEID  165 (187)
T ss_pred             ccHHHHHHHHHHHHHHHh----hccCcCcCCCChhhEEEE-CCcEEEEECccccccc
Confidence            567889999999999999    7 9999999999999999 8899999999986543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.73  E-value=5.5e-08  Score=78.46  Aligned_cols=169  Identities=21%  Similarity=0.216  Sum_probs=118.2

Q ss_pred             CCCcHHHHHhhcCCCCCHHHHHHHHHHHHH----hhhcccCCCCCCCeeecCCCCCceeeCCC-CceEEcccccceeccC
Q 037267            2 PNGSLEKWLYSYNYFFDILERLNIMIDVGS----ALEYPHHGHSSAPIIHCDLKPTNILLDEN-MVAHVSDFGISKLLGE   76 (202)
Q Consensus         2 ~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~----~l~~lH~~~~~~~i~h~dlk~~nil~~~~-~~~~l~d~g~~~~~~~   76 (202)
                      .+.+|..+...-...++.......+.+..+    ||.++|    +.+++|-|+||.|+....+ ..++++||++...+.+
T Consensus       200 ~~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~h----s~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i~~  275 (524)
T KOG0601|consen  200 CGESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLH----SNNIVHDDLKPANIFTTSDWTSCKLTDFGLVSKISD  275 (524)
T ss_pred             ccchhHHhhhcccccCCchhhhhHHhhhhhcccccccccC----CCcccccccchhheecccccceeecCCcceeEEccC
Confidence            467788887765555788888889999999    999999    8999999999999999998 8899999999988776


Q ss_pred             CCcccccc---CCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccc-hhhHHHHHHhCCCChhhhh
Q 037267           77 GEDFVTQT---MTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGE-MSLRRWVKESLPHGLTEVV  152 (202)
Q Consensus        77 ~~~~~~~~---~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~  152 (202)
                      ........   ...+...|++||...+ .++..+|++++|.++.+...+........... ..++.+.           +
T Consensus       276 ~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~-----------i  343 (524)
T KOG0601|consen  276 GNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY-----------I  343 (524)
T ss_pred             CccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc-----------C
Confidence            55322211   1246678999997655 45778999999999999888775433221111 0011000           1


Q ss_pred             hhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHH
Q 037267          153 DANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAA  195 (202)
Q Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~  195 (202)
                      .......         -..++...+.++++.+|-.|+++..+.
T Consensus       344 p~e~~~~---------~s~~l~~~~~~~~d~~~~~~~~~q~~~  377 (524)
T KOG0601|consen  344 PLEFCEG---------GSSSLRSVTSQMLDEDPRLRLTAQILT  377 (524)
T ss_pred             chhhhcC---------cchhhhhHHHHhcCcchhhhhHHHHHh
Confidence            1111111         112244588899999999999887654

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.72  E-value=1e-08  Score=87.54  Aligned_cols=168  Identities=21%  Similarity=0.219  Sum_probs=116.0

Q ss_pred             CCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCC-----
Q 037267            3 NGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEG-----   77 (202)
Q Consensus         3 ~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~-----   77 (202)
                      ||+|..-|++.+. .+.+-+......+..+++|||    +..+.|+|++|.|.++..++..++.+|+.....+.-     
T Consensus       888 ~~~~~Skl~~~~~-~saepaRs~i~~~vqs~e~L~----s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~  962 (1205)
T KOG0606|consen  888 GGDLPSKLHNSGC-LSAEPARSPILERVQSLESLH----SSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTD  962 (1205)
T ss_pred             cCCchhhhhcCCC-cccccccchhHHHHhhhhccc----cchhhcccccccchhhcccCCcccCccccccccccccCcCC
Confidence            4566666665442 566667777888889999999    777999999999999999999999998733221100     


Q ss_pred             ------------------------CccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccc
Q 037267           78 ------------------------EDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGE  133 (202)
Q Consensus        78 ------------------------~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~  133 (202)
                                              ..........+++.|.+||...+......+|.|+.|+++++.++|..||.......
T Consensus       963 ~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~ 1042 (1205)
T KOG0606|consen  963 LSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQQ 1042 (1205)
T ss_pred             cccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchhh
Confidence                                    00011223457899999999999888889999999999999999999997644322


Q ss_pred             hhhHHHHHHhCCCChhhhhhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHH
Q 037267          134 MSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMT  192 (202)
Q Consensus       134 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~  192 (202)
                      . + +.+.+..           +..    ...+...+.+..+++...+..+|.+|..+.
T Consensus      1043 ~-f-~ni~~~~-----------~~~----p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1043 I-F-ENILNRD-----------IPW----PEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             h-h-hccccCC-----------CCC----CCCccccChhhhhhhhhhhccCchhccCcc
Confidence            1 1 1111110           000    011123444567888889999999998765

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.55  E-value=6.1e-08  Score=78.19  Aligned_cols=164  Identities=18%  Similarity=0.196  Sum_probs=107.2

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCC-CceEEcccccceeccCCCc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN-MVAHVSDFGISKLLGEGED   79 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~-~~~~l~d~g~~~~~~~~~~   79 (202)
                      |+++|+...+.. ..-+++..++++..|++.++.++|    ++.++|.|++|+||++..+ +..++.||+.+..+.-...
T Consensus       348 ~~~~s~~l~~~~-~~~~d~~~~~~~~~q~~~~l~~i~----s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~~  422 (524)
T KOG0601|consen  348 CEGGSSSLRSVT-SQMLDEDPRLRLTAQILTALNVIH----SKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSSG  422 (524)
T ss_pred             hcCcchhhhhHH-HHhcCcchhhhhHHHHHhcccccc----chhhhcccccccceeeccchhhhhccccccccccceecc
Confidence            466777766632 223788899999999999999999    8999999999999999986 7778999998864221111


Q ss_pred             cccccCCCCCccc-cCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhh
Q 037267           80 FVTQTMTMATIGY-MAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVR  158 (202)
Q Consensus        80 ~~~~~~~~~~~~~-~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (202)
                      .    .......| .++.......+..++|++|+|.-+.+.+++...-.....-.                .+ ..+   
T Consensus       423 ~----~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~----------------~i-~~~---  478 (524)
T KOG0601|consen  423 V----FHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQSL----------------TI-RSG---  478 (524)
T ss_pred             c----ccccccccccchhhccccccccccccccccccccccccCcccCcccccce----------------ee-ecc---
Confidence            0    01122333 34555556677889999999999999888775321111000                00 000   


Q ss_pred             hHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          159 EEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       159 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                         ..+.......++..+.+.+...++..||++-++..
T Consensus       479 ---~~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~  513 (524)
T KOG0601|consen  479 ---DTPNLPGLKLQLQVLLKVMINPDRKRRPSAVELSL  513 (524)
T ss_pred             ---cccCCCchHHhhhhhhhhhcCCccccchhhhhhcc
Confidence               00000111134667788888899999998776543

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=98.53  E-value=1.4e-07  Score=64.48  Aligned_cols=55  Identities=24%  Similarity=0.303  Sum_probs=46.8

Q ss_pred             CHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEccccccee
Q 037267           18 DILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKL   73 (202)
Q Consensus        18 ~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~   73 (202)
                      +......++.+++.++.++|..+ ..+++|+|++|.|++++..+.++++||+.+..
T Consensus        84 ~~~~~~~~~~~~~~~l~~lh~~~-~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          84 SEEEKEDIAEQLAELLAKLHQLP-LLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             CHHHHHHHHHHHHHHHHHHhCCC-ceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            44677888999999999999533 25799999999999999988999999998754

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=98.37  E-value=4.4e-06  Score=68.83  Aligned_cols=98  Identities=12%  Similarity=0.129  Sum_probs=70.0

Q ss_pred             HHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCccccccCCCCCccccCCCCC
Q 037267           19 ILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYG   98 (202)
Q Consensus        19 ~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~   98 (202)
                      ...+..-+.||+.||.|||.   ..+++|+++.-+.+.++..|..|+++|.++........  ..........|..|+..
T Consensus       103 ~~~v~~Gl~qIl~AL~FL~~---d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~  177 (690)
T KOG1243|consen  103 KEEVCLGLFQILAALSFLND---DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEI  177 (690)
T ss_pred             HHHHHHHHHHHHHHHHHHhc---cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhc
Confidence            44555668999999999986   78999999999999999999999999988765332111  11111222344555533


Q ss_pred             CCCCcCcchhhhhHHHHHHHHHhCC
Q 037267           99 SEGIVSAKCDVYSYGVLLMETFTRK  123 (202)
Q Consensus        99 ~~~~~~~~~di~s~G~~~~~~~~g~  123 (202)
                      ....  -..|.|-|||++++++.|.
T Consensus       178 ~~s~--~s~D~~~Lg~li~el~ng~  200 (690)
T KOG1243|consen  178 DPSE--WSIDSWGLGCLIEELFNGS  200 (690)
T ss_pred             Cccc--cchhhhhHHHHHHHHhCcc
Confidence            2221  2359999999999999994

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=98.33  E-value=5.6e-07  Score=72.61  Aligned_cols=69  Identities=22%  Similarity=0.210  Sum_probs=51.6

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHH-hhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccC
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGS-ALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGE   76 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~-~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~   76 (202)
                      ++|++|.++........   .+..++..++. .+..+|    ..|++|+|++|.||+++.++.++++|||++.....
T Consensus       240 i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~----~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       240 IDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVL----RDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             ECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHH----hCCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence            46788887765322112   23456666655 367788    88999999999999999999999999999877543

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.31  E-value=1.3e-06  Score=65.89  Aligned_cols=65  Identities=22%  Similarity=0.193  Sum_probs=53.5

Q ss_pred             cHHHHHhhc-CCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCC-------CCceEEccccccee
Q 037267            5 SLEKWLYSY-NYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDE-------NMVAHVSDFGISKL   73 (202)
Q Consensus         5 sL~~~l~~~-~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~-------~~~~~l~d~g~~~~   73 (202)
                      ||.+++... ....+...+..++.+++..+.-||    ..|++|+|+++.||+++.       +..+.++||+.+..
T Consensus       122 sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH----~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~  194 (268)
T PRK15123        122 SLEDYCADWATNPPDPRLKRMLIKRVATMVRDMH----AAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI  194 (268)
T ss_pred             cHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH----HCcCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence            788887531 223566778899999999999999    999999999999999975       46789999997743

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.30  E-value=1.2e-06  Score=63.71  Aligned_cols=65  Identities=25%  Similarity=0.361  Sum_probs=55.9

Q ss_pred             CcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCC---ceEEccccccee
Q 037267            4 GSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENM---VAHVSDFGISKL   73 (202)
Q Consensus         4 gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~---~~~l~d~g~~~~   73 (202)
                      -+|.+++..... .+......++.+++..+.-||    ..|++|+|+++.|||++.+.   .+.++||+.+..
T Consensus       103 ~~L~~~~~~~~~-~~~~~~~~ll~~l~~~i~~lH----~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  103 QDLRDLLQQWEQ-LDPSQRRELLRALARLIAKLH----DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             ccHHHHHHhhcc-cchhhHHHHHHHHHHHHHHHH----HCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            368888875333 567788999999999999999    99999999999999999776   789999987765

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=98.26  E-value=1.3e-06  Score=62.73  Aligned_cols=53  Identities=21%  Similarity=0.149  Sum_probs=44.9

Q ss_pred             CCHHHHHHHHHHHHHhhhcc-cCCCCCCCeeecCCCCCceeeCCCCceEEcccccceec
Q 037267           17 FDILERLNIMIDVGSALEYP-HHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLL   74 (202)
Q Consensus        17 l~~~~~~~~~~~l~~~l~~l-H~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~   74 (202)
                      ++......+..+++.+|..+ |    ..+++|+||++.||++. ++.+.++||+.+...
T Consensus       121 ~~~~~~~~i~~~i~~~l~~l~H----~~glVHGDLs~~NIL~~-~~~v~iIDF~qav~~  174 (197)
T cd05146         121 LNDEEMKNAYYQVLSMMKQLYK----ECNLVHADLSEYNMLWH-DGKVWFIDVSQSVEP  174 (197)
T ss_pred             cCHHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEEE-CCcEEEEECCCceeC
Confidence            45556677889999999988 7    88999999999999997 467899999987654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=98.24  E-value=1.9e-06  Score=60.55  Aligned_cols=59  Identities=29%  Similarity=0.428  Sum_probs=47.2

Q ss_pred             CCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEccccccee
Q 037267            2 PNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKL   73 (202)
Q Consensus         2 ~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~   73 (202)
                      +|-.|.|++...        ...++..+..-+.-||    ..+|+|+||.++|+++...+ +.++|||++..
T Consensus        82 ~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH----~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          82 EGELLKDALEEA--------RPDLLREVGRLVGKLH----KAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             CChhHHHHHHhc--------chHHHHHHHHHHHHHH----hcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence            345566666543        2567788888888899    89999999999999998775 88999999864

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=98.17  E-value=5e-06  Score=58.48  Aligned_cols=65  Identities=25%  Similarity=0.310  Sum_probs=50.7

Q ss_pred             cHHHHHhhcCCCCCHH-HHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCC---ceEEccccccee
Q 037267            5 SLEKWLYSYNYFFDIL-ERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENM---VAHVSDFGISKL   73 (202)
Q Consensus         5 sL~~~l~~~~~~l~~~-~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~---~~~l~d~g~~~~   73 (202)
                      ++.+++...-..-+.. ....++..+.+.|.-||    ..+|+|+||..+||++..++   .+.++|||++..
T Consensus        97 ~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH----~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   97 TVKDFILSTMEDESEDEGLAELARRIGELIGKLH----DNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             HHHHHHHHHccCcccchhHHHHHHHHHHHHHHhh----hCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence            7888887543322333 33788999999999999    99999999999999997554   457999999765

>cd05151 ChoK Choline Kinase (ChoK)

Probab=98.09  E-value=4e-06  Score=58.69  Aligned_cols=45  Identities=29%  Similarity=0.366  Sum_probs=38.4

Q ss_pred             HHHHHHHHHhhhcccCCCCCCC-----eeecCCCCCceeeCCCCceEEcccccce
Q 037267           23 LNIMIDVGSALEYPHHGHSSAP-----IIHCDLKPTNILLDENMVAHVSDFGISK   72 (202)
Q Consensus        23 ~~~~~~l~~~l~~lH~~~~~~~-----i~h~dlk~~nil~~~~~~~~l~d~g~~~   72 (202)
                      ...+.+++.+|..||    +.+     ++|+|+++.||+++ ++.++++||+.+.
T Consensus        86 ~~~~~~l~~~l~~LH----~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~  135 (170)
T cd05151          86 PENLEKIAKLLKKLH----SSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG  135 (170)
T ss_pred             HHHHHHHHHHHHHHh----CCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence            456789999999999    565     59999999999999 5678999999764

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PRK09902 hypothetical protein; Provisional

Probab=98.09  E-value=6.6e-06  Score=59.43  Aligned_cols=66  Identities=18%  Similarity=0.091  Sum_probs=55.7

Q ss_pred             CcHHHHHhhcC-CCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCc--eEEccccccee
Q 037267            4 GSLEKWLYSYN-YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMV--AHVSDFGISKL   73 (202)
Q Consensus         4 gsL~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~--~~l~d~g~~~~   73 (202)
                      -||.+++.+.. ...+...+..++.+++..|.-||    ..|+.|+|+.+.||+++..+.  +.++||..++.
T Consensus       111 ~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH----~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        111 ISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMH----SVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             ccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHH----HCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            47888886533 24678888999999999999999    999999999999999986666  89999987654

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=97.68  E-value=0.00011  Score=52.44  Aligned_cols=51  Identities=27%  Similarity=0.343  Sum_probs=37.6

Q ss_pred             HHHHHHHHHHHHhhhc-ccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceecc
Q 037267           20 LERLNIMIDVGSALEY-PHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLG   75 (202)
Q Consensus        20 ~~~~~~~~~l~~~l~~-lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~   75 (202)
                      .....++.+++..+.. +|    ..|++|+||.+.||+++.+ .+.++|||.+....
T Consensus       106 ~~~~~~~~~il~~~~~~~~----~~givHGDLs~~NIlv~~~-~~~iIDf~qav~~~  157 (188)
T PF01163_consen  106 EEPKELLEEILEEIIKMLH----KAGIVHGDLSEYNILVDDG-KVYIIDFGQAVDSS  157 (188)
T ss_dssp             STHHHHHHHHHHHHHHHHH----CTTEEESS-STTSEEEETT-CEEE--GTTEEETT
T ss_pred             hhHHHHHHHHHHHHHHHHH----hcCceecCCChhhEEeecc-eEEEEecCcceecC
Confidence            3456677777775544 57    8999999999999999987 89999999876543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=97.54  E-value=0.00016  Score=59.81  Aligned_cols=35  Identities=29%  Similarity=0.434  Sum_probs=31.1

Q ss_pred             CCCeeecCCCCCceeeCCCC----ceEEcccccceeccC
Q 037267           42 SAPIIHCDLKPTNILLDENM----VAHVSDFGISKLLGE   76 (202)
Q Consensus        42 ~~~i~h~dlk~~nil~~~~~----~~~l~d~g~~~~~~~   76 (202)
                      ..|++|+|++|.||+++.++    .++++|||+......
T Consensus       278 ~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        278 RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence            56899999999999999887    899999999987654

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=97.21  E-value=0.00052  Score=50.00  Aligned_cols=32  Identities=25%  Similarity=0.440  Sum_probs=27.1

Q ss_pred             CCCeeecCCCCCceeeCC--CCceEEccccccee
Q 037267           42 SAPIIHCDLKPTNILLDE--NMVAHVSDFGISKL   73 (202)
Q Consensus        42 ~~~i~h~dlk~~nil~~~--~~~~~l~d~g~~~~   73 (202)
                      ...++|+|+.+.||+++.  ++.+.++||+.+..
T Consensus       173 ~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         173 RPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             CcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence            467899999999999998  66788999987643

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=97.05  E-value=0.00057  Score=49.83  Aligned_cols=43  Identities=21%  Similarity=0.257  Sum_probs=36.2

Q ss_pred             HHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccce
Q 037267           25 IMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISK   72 (202)
Q Consensus        25 ~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~   72 (202)
                      +...+.+++.-+|    ..|++|+|..|.|+++..++ ++++|++..+
T Consensus       140 ~~~ki~~~ikqlH----~~G~~HGD~hpgNFlv~~~~-i~iID~~~k~  182 (229)
T PF06176_consen  140 LAEKIVEAIKQLH----KHGFYHGDPHPGNFLVSNNG-IRIIDTQGKR  182 (229)
T ss_pred             HHHHHHHHHHHHH----HcCCccCCCCcCcEEEECCc-EEEEECcccc
Confidence            4566778899999    99999999999999998655 8899997644

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=97.04  E-value=0.012  Score=48.06  Aligned_cols=85  Identities=22%  Similarity=0.198  Sum_probs=66.0

Q ss_pred             CCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCccccccCCCCCccccCC
Q 037267           16 FFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAP   95 (202)
Q Consensus        16 ~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~p   95 (202)
                      ..++...+.++.|+..||.++|    +.|..-+-|.+.+|++..+..+++...|.........              .+|
T Consensus       389 ~~~e~~lW~y~~QLtaaL~sIH----ssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~--------------~~~  450 (655)
T KOG3741|consen  389 KAPEEVLWSYISQLTAALYSIH----SSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQEDP--------------TEP  450 (655)
T ss_pred             CchHHHHHHHHHHHHHHHHHHH----hcCceeecccHhHeEeeCcceEEEecccceeeecCCC--------------Ccc
Confidence            3678899999999999999999    8899999999999999988888887776654432211              011


Q ss_pred             CCCCCCCcCcchhhhhHHHHHHHHHhCC
Q 037267           96 EYGSEGIVSAKCDVYSYGVLLMETFTRK  123 (202)
Q Consensus        96 e~~~~~~~~~~~di~s~G~~~~~~~~g~  123 (202)
                        +   .--++-|.-.+|.++..+.+|.
T Consensus       451 --l---e~~Qq~D~~~lG~ll~aLAt~~  473 (655)
T KOG3741|consen  451 --L---ESQQQNDLRDLGLLLLALATGT  473 (655)
T ss_pred             --h---hHHhhhhHHHHHHHHHHHhhcc
Confidence              1   1124578999999999999985

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=96.73  E-value=0.0029  Score=45.29  Aligned_cols=56  Identities=20%  Similarity=0.229  Sum_probs=48.7

Q ss_pred             CCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEccccccee
Q 037267           17 FDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKL   73 (202)
Q Consensus        17 l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~   73 (202)
                      -+|..+.+++.+++..+.++++... ..+.-.|++++|+.++.++.+|++|......
T Consensus        56 ~~w~~R~~iA~~lL~~l~~l~~~~~-~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~  111 (188)
T PF12260_consen   56 SPWEQRAKIALQLLELLEELDHGPL-GFFYLCDVSPDNFGVNDDGRLKLIDLDDVFV  111 (188)
T ss_pred             cCHHHHHHHHHHHHHHHHHHhcCCC-CcEEEeecchHHeEEeCCCcEEEEechhcch
Confidence            4899999999999999999996542 3488899999999999999999999976544

Proteins in this uncharacterised family are described as transmembrane proteins.

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=96.69  E-value=0.0016  Score=48.88  Aligned_cols=49  Identities=22%  Similarity=0.208  Sum_probs=37.3

Q ss_pred             HHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccc
Q 037267           19 ILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGIS   71 (202)
Q Consensus        19 ~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~   71 (202)
                      ....-.++..|+.-+.-.-    ..|++|+|+++-||+++++|.+.++||--+
T Consensus       201 ~en~~~il~~il~~~~~~~----~~GiVHGDlSefNIlV~~dg~~~vIDwPQ~  249 (304)
T COG0478         201 VENPDEILDKILEEVRKAY----RRGIVHGDLSEFNILVTEDGDIVVIDWPQA  249 (304)
T ss_pred             ccCHHHHHHHHHHHHHHHH----HcCccccCCchheEEEecCCCEEEEeCccc
Confidence            4445555666655555444    578999999999999999999999999543

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=96.65  E-value=0.0084  Score=53.35  Aligned_cols=157  Identities=19%  Similarity=0.170  Sum_probs=91.6

Q ss_pred             CCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCC---ceeeCCCCceEEc--ccccceeccCC
Q 037267            3 NGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPT---NILLDENMVAHVS--DFGISKLLGEG   77 (202)
Q Consensus         3 ~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~---nil~~~~~~~~l~--d~g~~~~~~~~   77 (202)
                      .-++...+.+- ...+..+.+.+..++..|+.|+|    +....|.-+..+   +...+..+.....  ||+......+.
T Consensus       270 ~~~~~~~~q~v-~~i~~~~~r~~~~~~~~GL~~~h----~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~  344 (1351)
T KOG1035|consen  270 KVELRSLLQSV-GSIPLETLRILHQKLLEGLAYLH----SLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDN  344 (1351)
T ss_pred             ccchHHHHhhc-cccCHHHHHHHHHHHhhhHHHHH----HhccceeEEecccccccccCccceeecchhhhcccccCCCc
Confidence            34455555432 34788899999999999999999    554444434333   2223334444444  66665554432


Q ss_pred             CccccccCCCCCccccCCCCCCCCCc--CcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhh
Q 037267           78 EDFVTQTMTMATIGYMAPEYGSEGIV--SAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDAN  155 (202)
Q Consensus        78 ~~~~~~~~~~~~~~~~~pe~~~~~~~--~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (202)
                      ...   .....+..+.+++......+  +...|+|.+|.....+..|..+-....                ....+.   
T Consensus       345 ~~~---~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~~~i~~~~~----------------~~~~~l---  402 (1351)
T KOG1035|consen  345 EKS---FSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQGEDISEKSA----------------VPVSLL---  402 (1351)
T ss_pred             ccc---hhhcCccccccccccccccchhhhhhHHHHHHHHHhhhhhcCccccccc----------------chhhhh---
Confidence            211   11123344555654443333  334699999999998887764321100                000000   


Q ss_pred             hhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          156 LVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                                +..+.....+...+|+..++++|+++.+++.
T Consensus       403 ----------~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~  433 (1351)
T KOG1035|consen  403 ----------DVLSTSELLDALPKCLDEDSEERLSALELLT  433 (1351)
T ss_pred             ----------ccccchhhhhhhhhhcchhhhhccchhhhhh
Confidence                      0111114778999999999999999999875

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=95.49  E-value=0.02  Score=42.62  Aligned_cols=52  Identities=21%  Similarity=0.210  Sum_probs=43.2

Q ss_pred             CHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEccccccee
Q 037267           18 DILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKL   73 (202)
Q Consensus        18 ~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~   73 (202)
                      +..+...+..+++..+.-|-.   ..++||+||+.=|||+. ++.+.++|++-+..
T Consensus       164 e~~e~~~~~~~~v~~~~~l~~---~a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~  215 (268)
T COG1718         164 ELEEAEGLYEDVVEYMRRLYK---EAGLVHGDLSEYNILVH-DGEPYIIDVSQAVT  215 (268)
T ss_pred             CchhHHHHHHHHHHHHHHHHH---hcCcccccchhhheEEE-CCeEEEEECccccc
Confidence            344678888888888887763   58999999999999999 88899999987654

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=95.47  E-value=0.05  Score=40.26  Aligned_cols=31  Identities=32%  Similarity=0.531  Sum_probs=26.6

Q ss_pred             CCCeeecCCCCCceeeCCCCceEEcccccce
Q 037267           42 SAPIIHCDLKPTNILLDENMVAHVSDFGISK   72 (202)
Q Consensus        42 ~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~   72 (202)
                      ..+++|+|+.+.|++++..+...|+||+.+.
T Consensus       163 ~~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~  193 (235)
T cd05155         163 PPVWFHGDLAPGNLLVQDGRLSAVIDFGCLG  193 (235)
T ss_pred             CceEEeCCCCCCcEEEECCCEEEEEeCcccC
Confidence            5679999999999999977667899998764

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PRK05231 homoserine kinase; Provisional

Probab=95.04  E-value=0.017  Score=44.86  Aligned_cols=31  Identities=26%  Similarity=0.414  Sum_probs=26.6

Q ss_pred             CCCeeecCCCCCceeeCCCCceEEcccccce
Q 037267           42 SAPIIHCDLKPTNILLDENMVAHVSDFGISK   72 (202)
Q Consensus        42 ~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~   72 (202)
                      ..+++|+|+.+.||+++.+....++||+.+.
T Consensus       186 p~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        186 PRGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             CcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence            4589999999999999977666899998764

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=94.88  E-value=0.065  Score=39.52  Aligned_cols=31  Identities=23%  Similarity=0.314  Sum_probs=26.8

Q ss_pred             CCCeeecCCCCCceeeCC-CCceEEcccccce
Q 037267           42 SAPIIHCDLKPTNILLDE-NMVAHVSDFGISK   72 (202)
Q Consensus        42 ~~~i~h~dlk~~nil~~~-~~~~~l~d~g~~~   72 (202)
                      ...++|+|+.+.||+++. ++.+.++||..+.
T Consensus       169 ~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~  200 (235)
T cd05157         169 PIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG  200 (235)
T ss_pred             CEEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence            457999999999999997 5789999998664

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=94.59  E-value=0.058  Score=39.37  Aligned_cols=32  Identities=34%  Similarity=0.482  Sum_probs=22.2

Q ss_pred             CCCeeecCCCCCceeeC-CCCceEEccccccee
Q 037267           42 SAPIIHCDLKPTNILLD-ENMVAHVSDFGISKL   73 (202)
Q Consensus        42 ~~~i~h~dlk~~nil~~-~~~~~~l~d~g~~~~   73 (202)
                      ...++|+|+.+.||+++ .++.+.++||+.+..
T Consensus       165 ~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~  197 (239)
T PF01636_consen  165 PPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW  197 (239)
T ss_dssp             CEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred             CcEEEEeccccccceeeeccceeEEEecccceE
Confidence            67899999999999999 556668999986543

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=94.54  E-value=0.064  Score=44.48  Aligned_cols=35  Identities=31%  Similarity=0.426  Sum_probs=31.5

Q ss_pred             CCCeeecCCCCCceeeCCCCceEEcccccceeccC
Q 037267           42 SAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGE   76 (202)
Q Consensus        42 ~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~   76 (202)
                      ..|++|.|..|.||++..++.+.+.|||......+
T Consensus       283 ~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         283 RDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             hcCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence            56899999999999999999999999999876554

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=94.44  E-value=0.075  Score=41.04  Aligned_cols=31  Identities=39%  Similarity=0.566  Sum_probs=27.4

Q ss_pred             CCCeeecCCCCCceeeCCCCceEEcccccce
Q 037267           42 SAPIIHCDLKPTNILLDENMVAHVSDFGISK   72 (202)
Q Consensus        42 ~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~   72 (202)
                      ..+++|+|+.+.|++++.++.+.++||+.+.
T Consensus       186 ~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       186 PRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             CCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence            5789999999999999988877899998764

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=94.44  E-value=0.081  Score=41.88  Aligned_cols=56  Identities=27%  Similarity=0.267  Sum_probs=47.6

Q ss_pred             CCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccC
Q 037267           17 FDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGE   76 (202)
Q Consensus        17 l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~   76 (202)
                      -.++++++++.++++-+.-+.+   ....=|||+.-.||+|+ .|.+.++||-+++....
T Consensus       318 ~~~~e~lsff~s~~sil~~lek---kf~fehrnlt~~niLId-~GnvtLIDfklsRl~~~  373 (488)
T COG5072         318 DRSEEELSFFWSCISILDILEK---KFPFEHRNLTLDNILID-EGNVTLIDFKLSRLSYS  373 (488)
T ss_pred             ccHHHHHHHHHHHHHHHhhhhh---cCCcccccccccceeee-cCceEEEEeeeeecccC
Confidence            4577899999999888777775   66889999999999999 89999999999985433

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=94.32  E-value=0.078  Score=39.40  Aligned_cols=31  Identities=23%  Similarity=0.259  Sum_probs=27.2

Q ss_pred             CCCeeecCCCCCceeeCCCCceEEcccccce
Q 037267           42 SAPIIHCDLKPTNILLDENMVAHVSDFGISK   72 (202)
Q Consensus        42 ~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~   72 (202)
                      ...++|+|+.+.|++++++....|+||+.+.
T Consensus       162 ~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         162 DLVVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             ceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence            5679999999999999998778899998653

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=94.25  E-value=0.043  Score=42.23  Aligned_cols=31  Identities=29%  Similarity=0.306  Sum_probs=27.2

Q ss_pred             CCCeeecCCCCCceeeCCC----CceEEcccccce
Q 037267           42 SAPIIHCDLKPTNILLDEN----MVAHVSDFGISK   72 (202)
Q Consensus        42 ~~~i~h~dlk~~nil~~~~----~~~~l~d~g~~~   72 (202)
                      ...++|+|+.+.||+++.+    +.+.++||..+.
T Consensus       178 ~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~  212 (302)
T cd05156         178 PVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS  212 (302)
T ss_pred             CceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence            5689999999999999974    789999998764

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=94.20  E-value=0.037  Score=40.73  Aligned_cols=37  Identities=24%  Similarity=0.191  Sum_probs=29.8

Q ss_pred             hhhcccCCCCCCCeeecCCCCCceeeCCCCceEEccccc
Q 037267           32 ALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGI   70 (202)
Q Consensus        32 ~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~   70 (202)
                      +|.-.|+.  +.+.+|+|.+|+||+-++.|.+|+.|-+.
T Consensus       153 ~L~~fH~~--~~~~lHGD~np~NiM~D~~G~lKlVDP~~  189 (308)
T PF07387_consen  153 DLMDFHSE--NQHCLHGDCNPDNIMCDKFGYLKLVDPVC  189 (308)
T ss_pred             HHHHhhcc--CCCeecCCCChhheeecCCCCEEecChhh
Confidence            34455632  56899999999999999999999998653

The function of this family is unknown.

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=94.10  E-value=0.037  Score=42.36  Aligned_cols=31  Identities=32%  Similarity=0.468  Sum_probs=26.9

Q ss_pred             CCCeeecCCCCCceeeCCCCceEEcccccce
Q 037267           42 SAPIIHCDLKPTNILLDENMVAHVSDFGISK   72 (202)
Q Consensus        42 ~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~   72 (202)
                      ..+++|+|+.|.|++++.++.+.|+||+.+.
T Consensus       174 ~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         174 PRGVIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             CCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence            3579999999999999998778899998764

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=94.09  E-value=0.067  Score=44.16  Aligned_cols=84  Identities=15%  Similarity=0.080  Sum_probs=49.8

Q ss_pred             CcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCC
Q 037267          104 SAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLALDCCME  183 (202)
Q Consensus       104 ~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~  183 (202)
                      .+++|+||+|.++.++..|..-+......+....-..- .......    .....+   .....++...++++...|+-.
T Consensus       109 ~pKsdVwsl~~i~~el~L~~~l~~~~~~s~~l~~i~k~-~~~d~~~----~~~a~e---~~~~~~~d~~~~~~~~~c~~~  180 (725)
T KOG1093|consen  109 GPKSDVWSLGFIILELYLGISLEAELTESEYLEILLKY-YTDDQEL----LSTAME---HLIQLLADKKRLPLLKKCLWL  180 (725)
T ss_pred             CcchhhhhHHHHHHHHHHhhHHHHHHHHHHHHHHHHHh-ccCchhH----HHHHHH---HHHHHhhhHhHHHHhccCCcc
Confidence            35899999999999998887655443322211110000 0000000    000111   133456778899999999999


Q ss_pred             CCCCCCCHHHHH
Q 037267          184 SPGKRINMTDAA  195 (202)
Q Consensus       184 ~p~~Rps~~~~~  195 (202)
                      .|..||...++.
T Consensus       181 ~~~ir~l~~~~~  192 (725)
T KOG1093|consen  181 EPIIRPLPMELS  192 (725)
T ss_pred             ccccccchhHHh
Confidence            999999766554

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=93.85  E-value=0.011  Score=54.59  Aligned_cols=122  Identities=11%  Similarity=-0.029  Sum_probs=80.6

Q ss_pred             CCCcHHHHHhhcCC---CCCHHHHHHHHHHH-HHhhhcccCCCC-CCCeeecCCCCCceeeCCCCceEEcccccceeccC
Q 037267            2 PNGSLEKWLYSYNY---FFDILERLNIMIDV-GSALEYPHHGHS-SAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGE   76 (202)
Q Consensus         2 ~~gsL~~~l~~~~~---~l~~~~~~~~~~~l-~~~l~~lH~~~~-~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~   76 (202)
                      .+|.+.+.|-+...   .+.. ......+++ ..+..-+|..++ +.--+|+++|+.|.+|..+..+++.++|+.+...+
T Consensus      1314 ~~g~~f~iIikg~ee~~~ld~-~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp 1392 (2724)
T KOG1826|consen 1314 EFGKLFSIIIKGLEESPDLDR-SPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNP 1392 (2724)
T ss_pred             HHhHHHHHHHhccccCCcchh-chHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccccccccccccCc
Confidence            45677777664322   1222 223333333 556565554322 44578999999999999999999999999984333


Q ss_pred             CCccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCC
Q 037267           77 GEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPT  126 (202)
Q Consensus        77 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~  126 (202)
                      ...  ..+...+++.|..++....-.++.++|+|..|+-+|..-.|..+|
T Consensus      1393 ~~s--f~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1393 VLS--FFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNAYF 1440 (2724)
T ss_pred             hHh--hhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccHHH
Confidence            222  233456777777777666666777899999999988876666543

>TIGR02721 ycfN_thiK thiamine kinase

Probab=93.48  E-value=0.065  Score=40.20  Aligned_cols=30  Identities=13%  Similarity=0.275  Sum_probs=25.6

Q ss_pred             CCCeeecCCCCCceeeCCCCceEEcccccce
Q 037267           42 SAPIIHCDLKPTNILLDENMVAHVSDFGISK   72 (202)
Q Consensus        42 ~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~   72 (202)
                      ...++|+|+.+.||+++.++ +.++||..+.
T Consensus       145 ~~~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~  174 (256)
T TIGR02721       145 PLAPLHMDVHAYNLVVTPQG-LKLIDWEYAS  174 (256)
T ss_pred             CCeeecCCCCcCcEEEeCCC-CEEEeccccC
Confidence            34789999999999999876 7899998764

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=93.43  E-value=0.15  Score=39.32  Aligned_cols=29  Identities=31%  Similarity=0.300  Sum_probs=25.0

Q ss_pred             CCCeeecCCCCCceeeCCCCceEEcccccc
Q 037267           42 SAPIIHCDLKPTNILLDENMVAHVSDFGIS   71 (202)
Q Consensus        42 ~~~i~h~dlk~~nil~~~~~~~~l~d~g~~   71 (202)
                      ..+++|+|+.+.|++++. +.+.++||+.+
T Consensus       186 ~~~liHgD~~~~Nil~~~-~~i~lIDfd~~  214 (313)
T TIGR02906       186 IRGFCHQDYAYHNILLKD-NEVYVIDFDYC  214 (313)
T ss_pred             cCceEcCCCCcccEEEeC-CcEEEEECccc
Confidence            468999999999999987 56789999854

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=93.43  E-value=0.068  Score=38.85  Aligned_cols=32  Identities=28%  Similarity=0.451  Sum_probs=22.5

Q ss_pred             CCCeeecCCCCCceee-CCCCceEEccccccee
Q 037267           42 SAPIIHCDLKPTNILL-DENMVAHVSDFGISKL   73 (202)
Q Consensus        42 ~~~i~h~dlk~~nil~-~~~~~~~l~d~g~~~~   73 (202)
                      ...++|.|+.+.||++ ..++.++++||..+..
T Consensus       142 ~~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  142 PLVFCHNDLNPGNILINNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             GEEEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred             CceEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence            4578999999999999 7889999999988754

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=93.42  E-value=0.076  Score=39.20  Aligned_cols=30  Identities=17%  Similarity=0.197  Sum_probs=25.9

Q ss_pred             CCCeeecCCCCCceeeCCCCceEEcccccce
Q 037267           42 SAPIIHCDLKPTNILLDENMVAHVSDFGISK   72 (202)
Q Consensus        42 ~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~   72 (202)
                      ...++|+|+.|.|++++..+ +.++||+.+.
T Consensus       152 ~~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       152 TSTCLHGDFQIGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             CCceEecCCCCCcEEEcCCC-cEEEechhcC
Confidence            45679999999999999877 8999998764

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism]

Probab=93.41  E-value=0.19  Score=38.14  Aligned_cols=51  Identities=24%  Similarity=0.220  Sum_probs=39.2

Q ss_pred             HHHHHHHHHHHHhhhcccCCCCC-CCeeecCCCCCceeeCCCCceEEccccccee
Q 037267           20 LERLNIMIDVGSALEYPHHGHSS-APIIHCDLKPTNILLDENMVAHVSDFGISKL   73 (202)
Q Consensus        20 ~~~~~~~~~l~~~l~~lH~~~~~-~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~   73 (202)
                      ....+.+..+-.++.-.+.   . .-.+|.|+.+.|++.+..+.+.++||..+..
T Consensus       132 ~~~~~~~~~l~~~l~~~~~---~~~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg~  183 (269)
T COG0510         132 HLLRKKLKELRRALEEVPK---DDLVPCHNDLNPGNLLLTDKGGLFLIDWEYAGL  183 (269)
T ss_pred             HHHHHHHHHHHHHhhhcCC---CceeeecCCCCccceEEcCCCcEEEEecccCCC
Confidence            3444466666667776663   3 4799999999999999999999999987643

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=93.25  E-value=0.27  Score=35.52  Aligned_cols=54  Identities=22%  Similarity=0.222  Sum_probs=37.3

Q ss_pred             CcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCC--C--ceEEcc
Q 037267            4 GSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN--M--VAHVSD   67 (202)
Q Consensus         4 gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~--~--~~~l~d   67 (202)
                      -||.++++...  ++. .....+.++..-|.       ...|+.+|++|.||++...  +  .+.++|
T Consensus       108 ~TL~~~l~~~~--~~~-~~~~~L~~f~~~l~-------~~~Iv~~dl~~~NIv~~~~~~~~~~lvlID  165 (199)
T PF10707_consen  108 PTLEDYLKEGG--LTE-ELRQALDEFKRYLL-------DHHIVIRDLNPHNIVVQRRDSGEFRLVLID  165 (199)
T ss_pred             ccHHHHHHcCC--ccH-HHHHHHHHHHHHHH-------HcCCeecCCCcccEEEEecCCCceEEEEEe
Confidence            47888886433  555 55566666655544       6679999999999999632  2  466776

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PRK10271 thiK thiamine kinase; Provisional

Probab=93.23  E-value=0.077  Score=37.91  Aligned_cols=31  Identities=13%  Similarity=0.186  Sum_probs=25.9

Q ss_pred             CCCeeecCCCCCceeeCCCCceEEccccccee
Q 037267           42 SAPIIHCDLKPTNILLDENMVAHVSDFGISKL   73 (202)
Q Consensus        42 ~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~   73 (202)
                      ....+|+|+.|.|+++..++ ++++||+.+..
T Consensus        76 ~~~p~H~D~~~~N~~~~~~~-~~lIDwe~a~~  106 (188)
T PRK10271         76 RLAPLHMDVHAGNLVHSASG-LRLIDWEYAGD  106 (188)
T ss_pred             CeeeecCCCCCccEEEECCC-EEEEeCCcccC
Confidence            34679999999999998777 88999987743

>PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly

Probab=92.89  E-value=0.18  Score=39.55  Aligned_cols=38  Identities=24%  Similarity=0.215  Sum_probs=24.1

Q ss_pred             HHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeC
Q 037267           21 ERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLD   58 (202)
Q Consensus        21 ~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~   58 (202)
                      -+..+..|++.-.--+.+.....+.+|-||||+|||+=
T Consensus       276 YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiF  313 (434)
T PF05445_consen  276 YVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIF  313 (434)
T ss_pred             HHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEe
Confidence            34456777754321132222255799999999999984

; GO: 0004672 protein kinase activity, 0005524 ATP binding

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=92.67  E-value=0.24  Score=41.28  Aligned_cols=54  Identities=19%  Similarity=0.301  Sum_probs=38.1

Q ss_pred             CCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCC----CCceEEcccccceeccC
Q 037267           17 FDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDE----NMVAHVSDFGISKLLGE   76 (202)
Q Consensus        17 l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~----~~~~~l~d~g~~~~~~~   76 (202)
                      ++...+..-+.++..-.-+      ..|++|+|-.|.||++..    ++.+.+.|+|+......
T Consensus       300 i~~~~i~~~l~~~~~~qIf------~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  300 ISPHDILNKLVEAYLEQIF------KTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             CCHHHHHHHHHHHHHHHHH------hcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence            5665555555555443333      347999999999999983    56789999999876443

>PLN02236 choline kinase

Probab=92.37  E-value=0.33  Score=38.26  Aligned_cols=32  Identities=25%  Similarity=0.399  Sum_probs=27.2

Q ss_pred             CCCeeecCCCCCceeeCC-CCceEEccccccee
Q 037267           42 SAPIIHCDLKPTNILLDE-NMVAHVSDFGISKL   73 (202)
Q Consensus        42 ~~~i~h~dlk~~nil~~~-~~~~~l~d~g~~~~   73 (202)
                      ...++|+|+++.||+++. ++.+.++||..+..
T Consensus       199 ~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        199 EIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             CceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence            568999999999999985 56799999987653

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=92.27  E-value=0.38  Score=37.73  Aligned_cols=28  Identities=43%  Similarity=0.717  Sum_probs=24.6

Q ss_pred             eeecCCCCCceeeCCCC-ceEEcccccce
Q 037267           45 IIHCDLKPTNILLDENM-VAHVSDFGISK   72 (202)
Q Consensus        45 i~h~dlk~~nil~~~~~-~~~l~d~g~~~   72 (202)
                      ++|+|+.+.||+++.+. .+.++||+-+.
T Consensus       199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         199 IIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             eeecCCCccceeEcCCCCeeeEEEccccc
Confidence            99999999999999876 48899998653

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=92.10  E-value=0.13  Score=39.19  Aligned_cols=32  Identities=31%  Similarity=0.562  Sum_probs=26.1

Q ss_pred             CCCeeecCCCCCceeeCCCCc-eEEccccccee
Q 037267           42 SAPIIHCDLKPTNILLDENMV-AHVSDFGISKL   73 (202)
Q Consensus        42 ~~~i~h~dlk~~nil~~~~~~-~~l~d~g~~~~   73 (202)
                      ...++|+|+.+.|++++.++. ..|+||+.+..
T Consensus       184 ~~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         184 HTVLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             CCeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            457999999999999997444 57999987654

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=92.02  E-value=0.092  Score=40.64  Aligned_cols=32  Identities=19%  Similarity=0.297  Sum_probs=27.9

Q ss_pred             CCCeeecCCCCCceeeCCCCceEEccccccee
Q 037267           42 SAPIIHCDLKPTNILLDENMVAHVSDFGISKL   73 (202)
Q Consensus        42 ~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~   73 (202)
                      ..+++|+|+.++|++++.++.+.++||..+..
T Consensus       195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            45899999999999999988899999976643

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=91.75  E-value=0.14  Score=43.35  Aligned_cols=95  Identities=22%  Similarity=0.164  Sum_probs=67.5

Q ss_pred             HHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCccccccCCCCCccccCCCCCC
Q 037267           20 LERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGS   99 (202)
Q Consensus        20 ~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~   99 (202)
                      -....+++.-..+++|+|    +..-+|+|    ||+..+ +..+..+|+....+....   ......+++.+++||...
T Consensus       336 ~~~~~~~r~et~~l~~l~----~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~---~~~t~~~~~~~~~pev~~  403 (829)
T KOG0576|consen  336 YQFAYPLRKETRPLAELH----SSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM---KPRTAIGTPEPLAPEVIQ  403 (829)
T ss_pred             hhhhhhhhhhcccccccc----cccccCcc----cccccc-cccccccccCCcccCccc---ccccCCCCCCCCCchhhc
Confidence            344556677778899999    55457877    665554 567888998876655432   233457899999999887


Q ss_pred             CCCcCcchhhhhHHHHHHHHHhCCCCC
Q 037267          100 EGIVSAKCDVYSYGVLLMETFTRKRPT  126 (202)
Q Consensus       100 ~~~~~~~~di~s~G~~~~~~~~g~~p~  126 (202)
                      ...+....|.|+.|.---++.-|..|-
T Consensus       404 ~~~~~~~p~~~~~~~~~~~~ap~~pPr  430 (829)
T KOG0576|consen  404 ENTIDGCPDSGSLAVSAIQMAPGLPPR  430 (829)
T ss_pred             ccccccCCCccCCCcchhhcCCCCCCC
Confidence            778888899999987555555566553

>smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain

Probab=91.41  E-value=0.19  Score=36.17  Aligned_cols=31  Identities=26%  Similarity=0.296  Sum_probs=25.1

Q ss_pred             CCCeeecCCCCCceeeCCCC-----ceEEcccccce
Q 037267           42 SAPIIHCDLKPTNILLDENM-----VAHVSDFGISK   72 (202)
Q Consensus        42 ~~~i~h~dlk~~nil~~~~~-----~~~l~d~g~~~   72 (202)
                      ...++|+|+.+.|+++..++     .+.++||..+.
T Consensus       119 ~~vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~  154 (196)
T smart00587      119 FNVLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSH  154 (196)
T ss_pred             ceEEeeCCCCccceeeccCCCCCccceEEEecccCC
Confidence            46899999999999997543     57899997653

subfamily of choline kinases

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=91.08  E-value=0.64  Score=36.23  Aligned_cols=33  Identities=24%  Similarity=0.482  Sum_probs=29.5

Q ss_pred             CCCeeecCCCCCceeeCCCCceEEcccccceec
Q 037267           42 SAPIIHCDLKPTNILLDENMVAHVSDFGISKLL   74 (202)
Q Consensus        42 ~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~   74 (202)
                      ...++|+|..+.|++++..+.+-|+||+.+..-
T Consensus       197 ~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG  229 (321)
T COG3173         197 PPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG  229 (321)
T ss_pred             CceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence            668999999999999998888999999988653

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=90.25  E-value=0.36  Score=37.86  Aligned_cols=29  Identities=28%  Similarity=0.394  Sum_probs=27.0

Q ss_pred             CCCeeecCCCCCceeeCCCCceEEccccc
Q 037267           42 SAPIIHCDLKPTNILLDENMVAHVSDFGI   70 (202)
Q Consensus        42 ~~~i~h~dlk~~nil~~~~~~~~l~d~g~   70 (202)
                      .+|++|+|.+--||++..+..++++||--
T Consensus       220 ~~GlIHgDFNEFNimv~dd~~i~vIDFPQ  248 (465)
T KOG2268|consen  220 NHGLIHGDFNEFNIMVKDDDKIVVIDFPQ  248 (465)
T ss_pred             HcCceecccchheeEEecCCCEEEeechH
Confidence            78999999999999999999999999954

>PRK06148 hypothetical protein; Provisional

Probab=88.89  E-value=0.86  Score=41.37  Aligned_cols=32  Identities=34%  Similarity=0.500  Sum_probs=26.2

Q ss_pred             CCCeeecCCCCCceeeCCCC---ceEEccccccee
Q 037267           42 SAPIIHCDLKPTNILLDENM---VAHVSDFGISKL   73 (202)
Q Consensus        42 ~~~i~h~dlk~~nil~~~~~---~~~l~d~g~~~~   73 (202)
                      ..+++|.|+++.||+++.+.   ...|+|||-+..
T Consensus       202 p~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        202 PAQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             CcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            45799999999999999764   346999997654

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=87.92  E-value=1.3  Score=34.63  Aligned_cols=31  Identities=23%  Similarity=0.305  Sum_probs=26.3

Q ss_pred             CCeeecCCCCCceeeC-CCCceEEccccccee
Q 037267           43 APIIHCDLKPTNILLD-ENMVAHVSDFGISKL   73 (202)
Q Consensus        43 ~~i~h~dlk~~nil~~-~~~~~~l~d~g~~~~   73 (202)
                      ...+|.|+.+.||+++ .++.++++||..+..
T Consensus       182 ~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        182 VVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             eEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence            4689999999999997 457899999988754

>PRK11768 serine/threonine protein kinase; Provisional

Probab=86.36  E-value=0.47  Score=37.10  Aligned_cols=30  Identities=27%  Similarity=0.398  Sum_probs=24.7

Q ss_pred             CCCeeecCCCCCceeeCCCCceEEccccccee
Q 037267           42 SAPIIHCDLKPTNILLDENMVAHVSDFGISKL   73 (202)
Q Consensus        42 ~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~   73 (202)
                      ..+++|+|+.+.||+++ + .+.++||+-+..
T Consensus       195 ~~~liHgD~h~~NvL~~-d-~~~iIDFDd~~~  224 (325)
T PRK11768        195 RLLRLHGDCHPGNILWR-D-GPHFVDLDDARM  224 (325)
T ss_pred             CccceecCCCchhcccc-C-CcEEEeCCCCCC
Confidence            46799999999999995 4 578999987653

>PHA03111 Ser/Thr kinase; Provisional

Probab=86.18  E-value=2.1  Score=33.77  Aligned_cols=38  Identities=24%  Similarity=0.204  Sum_probs=25.3

Q ss_pred             HHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeC
Q 037267           21 ERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLD   58 (202)
Q Consensus        21 ~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~   58 (202)
                      -+..++.|++.-.-.+.+..-..+.+|-||||+|||+-
T Consensus       280 YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiF  317 (444)
T PHA03111        280 YIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIF  317 (444)
T ss_pred             HHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEe
Confidence            45556788866443332222145799999999999984

>PRK06149 hypothetical protein; Provisional

Probab=85.36  E-value=0.6  Score=42.15  Aligned_cols=31  Identities=23%  Similarity=0.305  Sum_probs=25.3

Q ss_pred             CCCeeecCCCCCceeeCCCC-----ceEEcccccce
Q 037267           42 SAPIIHCDLKPTNILLDENM-----VAHVSDFGISK   72 (202)
Q Consensus        42 ~~~i~h~dlk~~nil~~~~~-----~~~l~d~g~~~   72 (202)
                      ..+++|.|+++.||+++.+.     ...|+|||-+.
T Consensus       207 ~~g~IH~Dl~~~Nilv~~~~~~~~~v~giIDFgD~~  242 (972)
T PRK06149        207 PLQAVHLDITDDNVVGSRDADGRWQPDGVIDFGDLV  242 (972)
T ss_pred             cccccCCCCCcccEEEcCCCCCCcceeEEEEcccch
Confidence            56899999999999998652     24799998764

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=84.92  E-value=0.86  Score=36.75  Aligned_cols=31  Identities=23%  Similarity=0.349  Sum_probs=26.3

Q ss_pred             CCCeeecCCCCCceeeCCCCceEEccccccee
Q 037267           42 SAPIIHCDLKPTNILLDENMVAHVSDFGISKL   73 (202)
Q Consensus        42 ~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~   73 (202)
                      ...++|+|+.+.||++..+ .++++|+..+..
T Consensus       222 ~~~l~HgDl~~gni~~~~~-~~~viD~E~a~~  252 (401)
T PRK09550        222 AEALLHGDLHTGSIFVTEE-ETKVIDPEFAFY  252 (401)
T ss_pred             CCceeeccCCcccEEeeCC-CcEEEecccccc
Confidence            6689999999999999776 588999987653

>PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function

Probab=82.92  E-value=0.79  Score=35.06  Aligned_cols=30  Identities=23%  Similarity=0.276  Sum_probs=24.0

Q ss_pred             CCCeeecCCCCCceeeCCC--C---ceEEcccccc
Q 037267           42 SAPIIHCDLKPTNILLDEN--M---VAHVSDFGIS   71 (202)
Q Consensus        42 ~~~i~h~dlk~~nil~~~~--~---~~~l~d~g~~   71 (202)
                      -.-++|+|+...||++..+  +   .++++||..+
T Consensus       214 ~~vl~HGD~w~nNilf~~~~~g~~~~~~liDfQ~~  248 (294)
T PF02958_consen  214 FNVLCHGDFWTNNILFKYDDDGKPIDVVLIDFQLA  248 (294)
T ss_pred             ceEEEcCccCHHhEeEccccccccccceeeccccc
Confidence            3469999999999999754  2   5788899765

All known members of this group are proteins from drosophila and Caenorhabditis elegans.

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	202
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		5e-21
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		1e-20
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		1e-17
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		5e-17
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-13
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-13
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		4e-13
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		7e-13
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		9e-13
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		9e-13
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-12
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		1e-12
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-12
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		1e-12
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		1e-12
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		1e-12
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		1e-12
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		1e-12
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		1e-12
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		1e-12
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		2e-12
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		2e-12
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		2e-12
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		2e-12
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		2e-12
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-12
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		2e-12
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		2e-12
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		3e-12
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		5e-12
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		6e-12
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		6e-12
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		6e-12
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		7e-12
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		7e-12
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		7e-12
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		1e-11
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		1e-11
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		2e-11
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		2e-11
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		2e-11
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		3e-11
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		8e-11
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		1e-10
1fvr_A	327	Tie2 Kinase Domain Length = 327		1e-10
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		1e-10
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		1e-10
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		1e-10
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		1e-10
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		1e-10
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		2e-10
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		3e-10
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		3e-10
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		3e-10
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		3e-10
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		3e-10
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		3e-10
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		3e-10
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		3e-10
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		3e-10
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		3e-10
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		3e-10
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		3e-10
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		3e-10
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		3e-10
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		4e-10
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		4e-10
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		4e-10
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		4e-10
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		5e-10
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		5e-10
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		5e-10
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		5e-10
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		6e-10
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		6e-10
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		9e-10
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		1e-09
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		1e-09
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		1e-09
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		1e-09
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-09
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		1e-09
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		1e-09
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		1e-09
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		1e-09
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-09
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-09
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		1e-09
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-09
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		1e-09
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		1e-09
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		1e-09
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		1e-09
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		1e-09
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		1e-09
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		1e-09
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		1e-09
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		2e-09
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		2e-09
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		2e-09
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		2e-09
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		2e-09
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		2e-09
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		2e-09
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		2e-09
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		2e-09
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		2e-09
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		2e-09
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		2e-09
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		2e-09
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		2e-09
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		3e-09
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		3e-09
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		3e-09
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-09
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		4e-09
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		4e-09
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		4e-09
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-09
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		4e-09
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-09
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		4e-09
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-09
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		4e-09
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		4e-09
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		4e-09
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		4e-09
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		4e-09
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		5e-09
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		5e-09
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		5e-09
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		5e-09
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		6e-09
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		6e-09
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		6e-09
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		7e-09
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		7e-09
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		8e-09
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-09
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		8e-09
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-09
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		9e-09
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		9e-09
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		1e-08
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		1e-08
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-08
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		1e-08
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		1e-08
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		1e-08
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		1e-08
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		1e-08
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		1e-08
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		1e-08
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		1e-08
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		1e-08
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		1e-08
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		1e-08
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		1e-08
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-08
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		2e-08
2pl0_A	289	Lck Bound To Imatinib Length = 289		2e-08
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		2e-08
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		2e-08
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-08
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		2e-08
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-08
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		2e-08
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		2e-08
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		2e-08
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		2e-08
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		2e-08
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		2e-08
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-08
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		2e-08
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		2e-08
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		2e-08
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-08
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		2e-08
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		2e-08
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		2e-08
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		2e-08
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-08
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		2e-08
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		2e-08
3b2t_A	311	Structure Of Phosphotransferase Length = 311		2e-08
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-08
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		2e-08
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-08
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		2e-08
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		2e-08
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		2e-08
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		2e-08
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		2e-08
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		2e-08
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		2e-08
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		3e-08
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		3e-08
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		3e-08
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		3e-08
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		3e-08
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		3e-08
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		3e-08
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		3e-08
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		3e-08
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		3e-08
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		3e-08
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		3e-08
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		3e-08
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		3e-08
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		3e-08
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		3e-08
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-08
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		3e-08
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		3e-08
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		3e-08
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		3e-08
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		3e-08
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		3e-08
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		3e-08
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		3e-08
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		3e-08
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		3e-08
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		3e-08
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		3e-08
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		3e-08
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		3e-08
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		4e-08
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		4e-08
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		4e-08
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		4e-08
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		4e-08
4fl3_A	635	Structural And Biophysical Characterization Of The		4e-08
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		4e-08
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		4e-08
4fl2_A	636	Structural And Biophysical Characterization Of The		4e-08
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		4e-08
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		4e-08
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		4e-08
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		4e-08
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		4e-08
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		4e-08
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		5e-08
3a4o_X	286	Lyn Kinase Domain Length = 286		5e-08
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		5e-08
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		5e-08
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		5e-08
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		5e-08
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		5e-08
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		5e-08
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		5e-08
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		5e-08
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		5e-08
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		5e-08
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		6e-08
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		6e-08
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		6e-08
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		6e-08
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		6e-08
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		6e-08
3g51_A	325	Structural Diversity Of The Active Conformation Of		7e-08
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		7e-08
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		7e-08
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		8e-08
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		8e-08
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		8e-08
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		8e-08
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		8e-08
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		8e-08
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		9e-08
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		9e-08
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		9e-08
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		9e-08
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		9e-08
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		9e-08
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		9e-08
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		9e-08
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		9e-08
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		9e-08
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-07
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		1e-07
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		1e-07
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-07
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		1e-07
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		1e-07
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		1e-07
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		1e-07
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-07
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		1e-07
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		1e-07
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		1e-07
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		2e-07
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		2e-07
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		2e-07
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		2e-07
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		2e-07
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		2e-07
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		2e-07
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		2e-07
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		2e-07
4h58_A	275	Braf In Complex With Compound 3 Length = 275		2e-07
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		2e-07
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		2e-07
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		2e-07
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		2e-07
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		2e-07
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		2e-07
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		3e-07
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		3e-07
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		3e-07
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		3e-07
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		3e-07
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		3e-07
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		3e-07
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		4e-07
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		5e-07
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		5e-07
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		5e-07
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		5e-07
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		7e-07
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		7e-07
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		7e-07
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		8e-07
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		8e-07
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		8e-07
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		1e-06
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		1e-06
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		1e-06
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		1e-06
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-06
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-06
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-06
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		1e-06
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		1e-06
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		1e-06
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		1e-06
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-06
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		2e-06
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		2e-06
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		2e-06
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		2e-06
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		2e-06
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		2e-06
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		2e-06
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		2e-06
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		2e-06
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		3e-06
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		3e-06
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		3e-06
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		3e-06
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		3e-06
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		3e-06
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		3e-06
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		3e-06
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		3e-06
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		3e-06
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		3e-06
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		3e-06
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		3e-06
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		3e-06
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-06
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		3e-06
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		3e-06
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		3e-06
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		3e-06
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-06
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		3e-06
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		3e-06
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		3e-06
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		3e-06
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-06
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		3e-06
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		3e-06
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		3e-06
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		3e-06
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		3e-06
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		3e-06
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		3e-06
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		3e-06
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		3e-06
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-06
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		3e-06
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-06
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		3e-06
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		3e-06
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		4e-06
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		4e-06
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		4e-06
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		4e-06
3a7f_A	303	Human Mst3 Kinase Length = 303		4e-06
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		4e-06
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		4e-06
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		4e-06
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		4e-06
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		4e-06
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		5e-06
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		5e-06
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		5e-06
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		5e-06
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		5e-06
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		5e-06
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		5e-06
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		5e-06
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		5e-06
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		5e-06
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		5e-06
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		6e-06
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		6e-06
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		6e-06
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		6e-06
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		6e-06
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		7e-06
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		7e-06
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		7e-06
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		7e-06
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		7e-06
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		8e-06
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		8e-06
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		9e-06
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		9e-06
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		9e-06
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		9e-06
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		9e-06
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		9e-06
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		1e-05
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-05
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		1e-05
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		1e-05
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		1e-05
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		1e-05
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		1e-05
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		1e-05
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		1e-05
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		1e-05
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		1e-05
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		1e-05
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		1e-05
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		1e-05
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		1e-05
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		1e-05
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		1e-05
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		1e-05
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		1e-05
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		1e-05
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		1e-05
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-05
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		1e-05
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		1e-05
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		1e-05
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		1e-05
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		1e-05
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		1e-05
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		1e-05
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-05
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-05
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-05
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-05
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		2e-05
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		2e-05
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-05
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		2e-05
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		2e-05
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		2e-05
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		2e-05
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		2e-05
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		2e-05
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		2e-05
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		2e-05
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		2e-05
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		2e-05
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		2e-05
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		2e-05
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		2e-05
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		2e-05
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		2e-05
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		2e-05
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		2e-05
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		2e-05
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		3e-05
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		3e-05
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		3e-05
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		3e-05
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		3e-05
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		3e-05
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		3e-05
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		3e-05
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		3e-05
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		3e-05
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		3e-05
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		3e-05
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		3e-05
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		3e-05
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		3e-05
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		3e-05
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		3e-05
2oza_A	356	Structure Of P38alpha Complex Length = 356		3e-05
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		3e-05
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		3e-05
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		3e-05
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		3e-05
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		3e-05
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		3e-05
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		3e-05
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		3e-05
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		3e-05
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		3e-05
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		3e-05
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		3e-05
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		3e-05
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		3e-05
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		3e-05
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-05
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		3e-05
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		3e-05
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-05
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		3e-05
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		3e-05
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-05
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		3e-05
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		3e-05
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		4e-05
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		4e-05
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		4e-05
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		4e-05
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		4e-05
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		4e-05
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		4e-05
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		4e-05
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		4e-05
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		4e-05
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		4e-05
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		4e-05
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		4e-05
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		4e-05
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		4e-05
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		4e-05
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		4e-05
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		4e-05
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		4e-05
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		4e-05
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		4e-05
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		4e-05
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		4e-05
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		4e-05
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		4e-05
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		4e-05
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		4e-05
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		4e-05
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		4e-05
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		4e-05
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		4e-05
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		5e-05
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		5e-05
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		5e-05
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		5e-05
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		5e-05
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		5e-05
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		5e-05
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		5e-05
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		5e-05
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		5e-05
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		5e-05
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		5e-05
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		5e-05
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		5e-05
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		5e-05
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		5e-05
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		5e-05
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		5e-05
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		5e-05
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		5e-05
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		5e-05
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-05
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		5e-05
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		5e-05
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		6e-05
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		6e-05
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		6e-05
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		6e-05
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		6e-05
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-05
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-05
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		6e-05
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		6e-05
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		6e-05
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		6e-05
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		6e-05
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		7e-05
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		7e-05
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		7e-05
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		7e-05
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-05
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		7e-05
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		7e-05
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		8e-05
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		8e-05
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		8e-05
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		8e-05
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		8e-05
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		8e-05
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		8e-05
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		8e-05
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		9e-05
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		9e-05
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		9e-05
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		9e-05
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		9e-05
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		1e-04
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		1e-04
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		1e-04
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		1e-04
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		1e-04
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		1e-04
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		1e-04
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		1e-04
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		1e-04
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		1e-04
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		1e-04
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		1e-04
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		1e-04
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-04
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		1e-04
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		1e-04
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		1e-04
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		1e-04
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-04
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		1e-04
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		1e-04
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		1e-04
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		1e-04
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-04
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-04
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		1e-04
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		1e-04
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		1e-04
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		1e-04
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		1e-04
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		1e-04
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		1e-04
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-04
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-04
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-04
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		1e-04
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		1e-04
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		1e-04
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		1e-04
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		2e-04
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		2e-04
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		2e-04
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		2e-04
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		2e-04
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		2e-04
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		2e-04
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		2e-04
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		2e-04
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		2e-04
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-04
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		2e-04
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		2e-04
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-04
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		2e-04
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		2e-04
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		2e-04
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		2e-04
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-04
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		2e-04
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-04
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		2e-04
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-04
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-04
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-04
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-04
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		2e-04
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-04
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		2e-04
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		2e-04
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		2e-04
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		2e-04
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		2e-04
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		2e-04
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		2e-04
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		2e-04
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		2e-04
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		2e-04
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		2e-04
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		2e-04
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		2e-04
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		3e-04
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		3e-04
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		3e-04
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		3e-04
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		3e-04
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		3e-04
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		3e-04
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		3e-04
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		3e-04
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		3e-04
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		3e-04
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		3e-04
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		3e-04
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		3e-04
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		3e-04
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		3e-04
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		3e-04
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		3e-04
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		3e-04
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		3e-04
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		3e-04
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		3e-04
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		3e-04
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		3e-04
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		3e-04
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		3e-04
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		3e-04
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		3e-04
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		3e-04
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		3e-04
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		3e-04
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-04
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		3e-04
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		3e-04
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		4e-04
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		4e-04
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		4e-04
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		4e-04
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		4e-04
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		4e-04
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		4e-04
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		4e-04
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		4e-04
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		4e-04
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		4e-04
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		4e-04
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		4e-04
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		4e-04
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		4e-04
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		4e-04
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		4e-04
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		4e-04
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		4e-04
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		4e-04
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		4e-04
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		4e-04
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		4e-04
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		4e-04
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		4e-04
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		4e-04
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		4e-04
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		4e-04
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		4e-04
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		4e-04
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		4e-04
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		4e-04
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		5e-04
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		5e-04
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		5e-04
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		5e-04
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		5e-04
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		5e-04
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		5e-04
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		5e-04
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		5e-04
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		6e-04
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		6e-04
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		6e-04
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		6e-04
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		6e-04
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		6e-04
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		6e-04
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		6e-04
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		6e-04
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		6e-04
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		6e-04
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		6e-04
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		6e-04
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		6e-04
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		6e-04
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		6e-04
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		6e-04
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		6e-04
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		6e-04
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		6e-04
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		6e-04
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		6e-04
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		6e-04
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		6e-04
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		6e-04
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		6e-04
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-04
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		6e-04
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		6e-04
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		6e-04
3hec_A	348	P38 In Complex With Imatinib Length = 348		6e-04
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		6e-04
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		6e-04
2oza_B	366	Structure Of P38alpha Complex Length = 366		6e-04
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		6e-04
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		6e-04
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		6e-04
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		6e-04
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		7e-04
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		7e-04
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		7e-04
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		7e-04
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		7e-04
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		7e-04
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		7e-04
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		7e-04
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		7e-04
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		7e-04
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		7e-04
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		7e-04
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		7e-04
4ae6_A	343	Structure And Function Of The Human Sperm-specific		7e-04
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		7e-04
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		7e-04
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		7e-04
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		8e-04
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		8e-04
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		8e-04
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		8e-04
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		8e-04
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		8e-04
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		8e-04
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		8e-04
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		8e-04
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		8e-04
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		8e-04
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		8e-04
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		8e-04
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		8e-04
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		8e-04
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		8e-04
4ae9_A	343	Structure And Function Of The Human Sperm-specific		8e-04
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		8e-04
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		8e-04
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		8e-04
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		8e-04
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		8e-04
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		9e-04
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		9e-04
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		9e-04
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		9e-04
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		9e-04
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		9e-04

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 97.1 bits (240), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 71/204 (34%), Positives = 101/204 (49%), Gaps = 14/204 (6%)
Query: 1   MPNGSLEKWLYSYNY---FFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILL 57
           M NG+L++ LY  +         +RL I I     L Y H    +  IIH D+K  NILL
Sbjct: 117 MENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH----TRAIIHRDVKSINILL 172
Query: 58  DENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLM 117
           DEN V  ++DFGISK   E +      +   T+GY+ PEY  +G ++ K DVYS+GV+L 
Sbjct: 173 DENFVPKITDFGISKKGTELDQTHLXXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLF 232
Query: 118 ETFTRKRPTDEMFTGEM-SLRRWVKESLPHG-LTEVVDANLVREEQAFAAKMDCIVSIMD 175
           E    +    +    EM +L  W  ES  +G L ++VD NL     A   + + +    D
Sbjct: 233 EVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNL-----ADKIRPESLRKFGD 287
Query: 176 LALDCCMESPGKRINMTDAAAKLK 199
            A+ C   S   R +M D   KL+
Sbjct: 288 TAVKCLALSSEDRPSMGDVLWKLE 311

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 95.9 bits (237), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 71/204 (34%), Positives = 100/204 (49%), Gaps = 14/204 (6%)
Query: 1   MPNGSLEKWLYSYNY---FFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILL 57
           M NG+L++ LY  +         +RL I I     L Y H    +  IIH D+K  NILL
Sbjct: 117 MENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH----TRAIIHRDVKSINILL 172
Query: 58  DENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLM 117
           DEN V  ++DFGISK   E        +   T+GY+ PEY  +G ++ K DVYS+GV+L 
Sbjct: 173 DENFVPKITDFGISKKGTELGQTHLXXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLF 232
Query: 118 ETFTRKRPTDEMFTGEM-SLRRWVKESLPHG-LTEVVDANLVREEQAFAAKMDCIVSIMD 175
           E    +    +    EM +L  W  ES  +G L ++VD NL     A   + + +    D
Sbjct: 233 EVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNL-----ADKIRPESLRKFGD 287
Query: 176 LALDCCMESPGKRINMTDAAAKLK 199
            A+ C   S   R +M D   KL+
Sbjct: 288 TAVKCLALSSEDRPSMGDVLWKLE 311

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score = 85.9 bits (211), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 65/187 (34%), Positives = 92/187 (49%), Gaps = 11/187 (5%)
Query: 17  FDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGE 76
            D  +R  I +     L Y H  H    IIH D+K  NILLDE   A V DFG++KL+ +
Sbjct: 136 LDWPKRQRIALGSARGLAYLHD-HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM-D 193
Query: 77  GEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTG---E 133
            +D         TIG++APEY S G  S K DV+ YGV+L+E  T +R  D        +
Sbjct: 194 YKDXHVXXAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDD 253
Query: 134 MSLRRWVKESLPH-GLTEVVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMT 192
           + L  WVK  L    L  +VD +L         K + +  ++ +AL C   SP +R  M+
Sbjct: 254 VMLLDWVKGLLKEKKLEALVDVDL-----QGNYKDEEVEQLIQVALLCTQSSPMERPKMS 308
Query: 193 DAAAKLK 199
           +    L+
Sbjct: 309 EVVRMLE 315

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score = 84.0 bits (206), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 64/187 (34%), Positives = 91/187 (48%), Gaps = 11/187 (5%)
Query: 17  FDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGE 76
            D  +R  I +     L Y H  H    IIH D+K  NILLDE   A V DFG++KL+ +
Sbjct: 128 LDWPKRQRIALGSARGLAYLHD-HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM-D 185
Query: 77  GEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTG---E 133
            +D          IG++APEY S G  S K DV+ YGV+L+E  T +R  D        +
Sbjct: 186 YKDXHVXXAVRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDD 245
Query: 134 MSLRRWVKESLPH-GLTEVVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMT 192
           + L  WVK  L    L  +VD +L         K + +  ++ +AL C   SP +R  M+
Sbjct: 246 VMLLDWVKGLLKEKKLEALVDVDL-----QGNYKDEEVEQLIQVALLCTQSSPMERPKMS 300
Query: 193 DAAAKLK 199
           +    L+
Sbjct: 301 EVVRMLE 307

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/193 (29%), Positives = 97/193 (50%), Gaps = 17/193 (8%)
Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           M NGSL+ +L +++  F I++ + ++  VG+ + Y     S    +H DL   N+L+D N
Sbjct: 132 MENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRY----LSDLGYVHRDLAARNVLVDSN 187
Query: 61  MVAHVSDFGISKLLGEGEDFV-TQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMET 119
           +V  VSDFG+S++L +  D   T T     I + APE  +    S+  DV+S+GV++ E 
Sbjct: 188 LVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEV 247
Query: 120 FTR-KRP------TDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVS 172
               +RP       D + + E   R       PH L +++  +   +++A   +   IVS
Sbjct: 248 LAYGERPYWNMTNRDVISSVEEGYRLPAPMGCPHALHQLM-LDCWHKDRAQRPRFSQIVS 306
Query: 173 IMDLALDCCMESP 185
           +    LD  + SP
Sbjct: 307 V----LDALIRSP 315

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/193 (29%), Positives = 97/193 (50%), Gaps = 17/193 (8%)
Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           M NGSL+ +L +++  F I++ + ++  VG+ + Y     S    +H DL   N+L+D N
Sbjct: 132 MENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRY----LSDLGYVHRDLAARNVLVDSN 187
Query: 61  MVAHVSDFGISKLLGEGEDFV-TQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMET 119
           +V  VSDFG+S++L +  D   T T     I + APE  +    S+  DV+S+GV++ E 
Sbjct: 188 LVCKVSDFGLSRVLEDDPDAAXTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEV 247
Query: 120 FTR-KRP------TDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVS 172
               +RP       D + + E   R       PH L +++  +   +++A   +   IVS
Sbjct: 248 LAYGERPYWNMTNRDVISSVEEGYRLPAPMGCPHALHQLM-LDCWHKDRAQRPRFSQIVS 306
Query: 173 IMDLALDCCMESP 185
           +    LD  + SP
Sbjct: 307 V----LDALIRSP 315

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 70.9 bits (172), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 39/109 (35%), Positives = 59/109 (54%), Gaps = 4/109 (3%)
Query: 17  FDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGE 76
            D   RL++  DV   + Y H+   + PI+H DLK  N+L+D+     V DFG+S+L  +
Sbjct: 134 LDERRRLSMAYDVAKGMNYLHN--RNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--K 189
Query: 77  GEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRP 125
              F+       T  +MAPE   +   + K DVYS+GV+L E  T ++P
Sbjct: 190 ASXFLXSKXAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQP 238

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 70.1 bits (170), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 93/203 (45%), Gaps = 25/203 (12%)
Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           M NGSL+ +L  ++  F +++ + ++  + S ++Y     S    +H DL   NIL++ N
Sbjct: 128 MENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKY----LSDMGFVHRDLAARNILINSN 183
Query: 61  MVAHVSDFGISKLL-GEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMET 119
           +V  VSDFG+S++L  + E   T       I + +PE  +    ++  DV+SYG++L E 
Sbjct: 184 LVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEV 243
Query: 120 FTR-KRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLAL 178
            +  +RP  EM                    +V+ A  V E       MDC  ++  L L
Sbjct: 244 MSYGERPYWEMSN-----------------QDVIKA--VDEGYRLPPPMDCPAALYQLML 284
Query: 179 DCCMESPGKRINMTDAAAKLKKI 201
           DC  +    R       + L K+
Sbjct: 285 DCWQKDRNNRPKFEQIVSILDKL 307

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 69.7 bits (169), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 93/203 (45%), Gaps = 25/203 (12%)
Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           M NGSL+ +L  ++  F +++ + ++  + S ++Y     S    +H DL   NIL++ N
Sbjct: 128 MENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKY----LSDMGYVHRDLAARNILINSN 183
Query: 61  MVAHVSDFGISKLL-GEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMET 119
           +V  VSDFG+S++L  + E   T       I + +PE  +    ++  DV+SYG++L E 
Sbjct: 184 LVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEV 243
Query: 120 FTR-KRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLAL 178
            +  +RP  EM                    +V+ A  V E       MDC  ++  L L
Sbjct: 244 MSYGERPYWEMSN-----------------QDVIKA--VDEGYRLPPPMDCPAALYQLML 284
Query: 179 DCCMESPGKRINMTDAAAKLKKI 201
           DC  +    R       + L K+
Sbjct: 285 DCWQKDRNNRPKFEQIVSILDKL 307

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 69.7 bits (169), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 93/203 (45%), Gaps = 25/203 (12%)
Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           M NGSL+ +L  ++  F +++ + ++  + S ++Y     S    +H DL   NIL++ N
Sbjct: 128 MENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKY----LSDMGYVHRDLAARNILINSN 183
Query: 61  MVAHVSDFGISKLL-GEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMET 119
           +V  VSDFG+S++L  + E   T       I + +PE  +    ++  DV+SYG++L E 
Sbjct: 184 LVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEV 243
Query: 120 FTR-KRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLAL 178
            +  +RP  EM                    +V+ A  V E       MDC  ++  L L
Sbjct: 244 MSYGERPYWEMSN-----------------QDVIKA--VDEGYRLPPPMDCPAALYQLML 284
Query: 179 DCCMESPGKRINMTDAAAKLKKI 201
           DC  +    R       + L K+
Sbjct: 285 DCWQKDRNNRPKFEQIVSILDKL 307

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 93/203 (45%), Gaps = 25/203 (12%)
Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           M NGSL+ +L  ++  F +++ + ++  + S ++Y     S    +H DL   NIL++ N
Sbjct: 128 MENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKY----LSDMGAVHRDLAARNILINSN 183
Query: 61  MVAHVSDFGISKLL-GEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMET 119
           +V  VSDFG+S++L  + E   T       I + +PE  +    ++  DV+SYG++L E 
Sbjct: 184 LVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEV 243
Query: 120 FTR-KRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLAL 178
            +  +RP  EM                    +V+ A  V E       MDC  ++  L L
Sbjct: 244 MSYGERPYWEMSN-----------------QDVIKA--VDEGYRLPPPMDCPAALYQLML 284
Query: 179 DCCMESPGKRINMTDAAAKLKKI 201
           DC  +    R       + L K+
Sbjct: 285 DCWQKDRNNRPKFEQIVSILDKL 307

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 93/203 (45%), Gaps = 25/203 (12%)
Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           M NGSL+ +L  ++  F +++ + ++  + S ++Y     S    +H DL   NIL++ N
Sbjct: 128 MENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKY----LSDMGYVHRDLAARNILINSN 183
Query: 61  MVAHVSDFGISKLL-GEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMET 119
           +V  VSDFG+S++L  + E   T       I + +PE  +    ++  DV+SYG++L E 
Sbjct: 184 LVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEV 243
Query: 120 FTR-KRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLAL 178
            +  +RP  EM                    +V+ A  V E       MDC  ++  L L
Sbjct: 244 MSYGERPYWEMSN-----------------QDVIKA--VDEGYRLPPPMDCPAALYQLML 284
Query: 179 DCCMESPGKRINMTDAAAKLKKI 201
           DC  +    R       + L K+
Sbjct: 285 DCWQKDRNNRPKFEQIVSILDKL 307

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 93/203 (45%), Gaps = 25/203 (12%)
Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           M NGSL+ +L  ++  F +++ + ++  + S ++Y     S    +H DL   NIL++ N
Sbjct: 128 MENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKY----LSDMGYVHRDLAARNILINSN 183
Query: 61  MVAHVSDFGISKLL-GEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMET 119
           +V  VSDFG+S++L  + E   T       I + +PE  +    ++  DV+SYG++L E 
Sbjct: 184 LVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEV 243
Query: 120 FTR-KRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLAL 178
            +  +RP  EM                    +V+ A  V E       MDC  ++  L L
Sbjct: 244 MSYGERPYWEMSN-----------------QDVIKA--VDEGYRLPPPMDCPAALYQLML 284
Query: 179 DCCMESPGKRINMTDAAAKLKKI 201
           DC  +    R       + L K+
Sbjct: 285 DCWQKDRNNRPKFEQIVSILDKL 307

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 93/203 (45%), Gaps = 25/203 (12%)
Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           M NGSL+ +L  ++  F +++ + ++  + S ++Y     S    +H DL   NIL++ N
Sbjct: 126 MENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKY----LSDMGYVHRDLAARNILINSN 181
Query: 61  MVAHVSDFGISKLL-GEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMET 119
           +V  VSDFG+S++L  + E   T       I + +PE  +    ++  DV+SYG++L E 
Sbjct: 182 LVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEV 241
Query: 120 FTR-KRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLAL 178
            +  +RP  EM                    +V+ A  V E       MDC  ++  L L
Sbjct: 242 MSYGERPYWEMSN-----------------QDVIKA--VDEGYRLPPPMDCPAALYQLML 282
Query: 179 DCCMESPGKRINMTDAAAKLKKI 201
           DC  +    R       + L K+
Sbjct: 283 DCWQKDRNNRPKFEQIVSILDKL 305

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 93/203 (45%), Gaps = 25/203 (12%)
Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           M NGSL+ +L  ++  F +++ + ++  + S ++Y     S    +H DL   NIL++ N
Sbjct: 128 MENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKY----LSDMGYVHRDLAARNILINSN 183
Query: 61  MVAHVSDFGISKLL-GEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMET 119
           +V  VSDFG+S++L  + E   T       I + +PE  +    ++  DV+SYG++L E 
Sbjct: 184 LVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEV 243
Query: 120 FTR-KRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLAL 178
            +  +RP  EM                    +V+ A  V E       MDC  ++  L L
Sbjct: 244 MSYGERPYWEMSN-----------------QDVIKA--VDEGYRLPPPMDCPAALYQLML 284
Query: 179 DCCMESPGKRINMTDAAAKLKKI 201
           DC  +    R       + L K+
Sbjct: 285 DCWQKDRNNRPKFEQIVSILDKL 307

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 38/109 (34%), Positives = 60/109 (55%), Gaps = 4/109 (3%)
Query: 17  FDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGE 76
            D   RL++  DV   + Y H+   + PI+H +LK  N+L+D+     V DFG+S+L  +
Sbjct: 134 LDERRRLSMAYDVAKGMNYLHN--RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL--K 189
Query: 77  GEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRP 125
              F++      T  +MAPE   +   + K DVYS+GV+L E  T ++P
Sbjct: 190 ASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQP 238

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 93/203 (45%), Gaps = 25/203 (12%)
Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           M NGSL+ +L  ++  F +++ + ++  + S ++Y     S    +H DL   NIL++ N
Sbjct: 99  MENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKY----LSDMGYVHRDLAARNILINSN 154
Query: 61  MVAHVSDFGISKLL-GEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMET 119
           +V  VSDFG+S++L  + E   T       I + +PE  +    ++  DV+SYG++L E 
Sbjct: 155 LVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEV 214
Query: 120 FTR-KRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLAL 178
            +  +RP  EM                    +V+ A  V E       MDC  ++  L L
Sbjct: 215 MSYGERPYWEMSN-----------------QDVIKA--VDEGYRLPPPMDCPAALYQLML 255
Query: 179 DCCMESPGKRINMTDAAAKLKKI 201
           DC  +    R       + L K+
Sbjct: 256 DCWQKDRNNRPKFEQIVSILDKL 278

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 93/203 (45%), Gaps = 25/203 (12%)
Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           M NGSL+ +L  ++  F +++ + ++  + S ++Y     S    +H DL   NIL++ N
Sbjct: 99  MENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKY----LSDMGYVHRDLAARNILINSN 154
Query: 61  MVAHVSDFGISKLL-GEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMET 119
           +V  VSDFG+S++L  + E   T       I + +PE  +    ++  DV+SYG++L E 
Sbjct: 155 LVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEV 214
Query: 120 FTR-KRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLAL 178
            +  +RP  EM                    +V+ A  V E       MDC  ++  L L
Sbjct: 215 MSYGERPYWEMSN-----------------QDVIKA--VDEGYRLPPPMDCPAALYQLML 255
Query: 179 DCCMESPGKRINMTDAAAKLKKI 201
           DC  +    R       + L K+
Sbjct: 256 DCWQKDRNNRPKFEQIVSILDKL 278

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 93/203 (45%), Gaps = 25/203 (12%)
Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           M NGSL+ +L  ++  F +++ + ++  + S ++Y     S    +H DL   NIL++ N
Sbjct: 116 MENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKY----LSDMGYVHRDLAARNILINSN 171
Query: 61  MVAHVSDFGISKLL-GEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMET 119
           +V  VSDFG+S++L  + E   T       I + +PE  +    ++  DV+SYG++L E 
Sbjct: 172 LVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEV 231
Query: 120 FTR-KRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLAL 178
            +  +RP  EM                    +V+ A  V E       MDC  ++  L L
Sbjct: 232 MSYGERPYWEMSN-----------------QDVIKA--VDEGYRLPPPMDCPAALYQLML 272
Query: 179 DCCMESPGKRINMTDAAAKLKKI 201
           DC  +    R       + L K+
Sbjct: 273 DCWQKDRNNRPKFEQIVSILDKL 295

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 46/130 (35%), Positives = 66/130 (50%), Gaps = 7/130 (5%)
Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSA--LEYPHHGHSSAPIIHCDLKPTNILLD 58
           MPNGSL   L   +    +   +   I  G+A  + + H  H     IH D+K  NILLD
Sbjct: 112 MPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH----IHRDIKSANILLD 167
Query: 59  ENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLME 118
           E   A +SDFG+++   +    V  +  + T  YMAPE    G ++ K D+YS+GV+L+E
Sbjct: 168 EAFTAKISDFGLARASEKFAQTVMXSRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLE 226
Query: 119 TFTRKRPTDE 128
             T     DE
Sbjct: 227 IITGLPAVDE 236

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 96/203 (47%), Gaps = 25/203 (12%)
Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           M NG+L+K+L   +  F +L+ + ++  + + ++Y     ++   +H DL   NIL++ N
Sbjct: 128 MENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKY----LANMNYVHRDLAARNILVNSN 183
Query: 61  MVAHVSDFGISKLL-GEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMET 119
           +V  VSDFG+S++L  + E   T +     I + APE  S    ++  DV+S+G+++ E 
Sbjct: 184 LVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEV 243
Query: 120 FTR-KRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLAL 178
            T  +RP  E+   E      V +++  G                   MDC  +I  L +
Sbjct: 244 MTYGERPYWELSNHE------VMKAINDGFR-------------LPTPMDCPSAIYQLMM 284
Query: 179 DCCMESPGKRINMTDAAAKLKKI 201
            C  +   +R    D  + L K+
Sbjct: 285 QCWQQERARRPKFADIVSILDKL 307

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 94/201 (46%), Gaps = 31/201 (15%)
Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           M NGSL+ +L   +  F +++ + ++  +GS ++Y     S    +H DL   NIL++ N
Sbjct: 97  MENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKY----LSDMSYVHRDLAARNILVNSN 152
Query: 61  MVAHVSDFGISKLL-GEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMET 119
           +V  VSDFG+S++L  + E   T       I + APE  +    ++  DV+SYG+++ E 
Sbjct: 153 LVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEV 212
Query: 120 FTR-KRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLAL 178
            +  +RP  +M                    +V+ A  + E       MDC +++  L L
Sbjct: 213 MSYGERPYWDMSN-----------------QDVIKA--IEEGYRLPPPMDCPIALHQLML 253
Query: 179 DCCMESPGKR------INMTD 193
           DC  +    R      +NM D
Sbjct: 254 DCWQKERSDRPKFGQIVNMLD 274

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 94/201 (46%), Gaps = 31/201 (15%)
Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           M NGSL+ +L   +  F +++ + ++  +GS ++Y     S    +H DL   NIL++ N
Sbjct: 91  MENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKY----LSDMSYVHRDLAARNILVNSN 146
Query: 61  MVAHVSDFGISKLL-GEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMET 119
           +V  VSDFG+S++L  + E   T       I + APE  +    ++  DV+SYG+++ E 
Sbjct: 147 LVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEV 206
Query: 120 FTR-KRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLAL 178
            +  +RP  +M                    +V+ A  + E       MDC +++  L L
Sbjct: 207 MSYGERPYWDMSN-----------------QDVIKA--IEEGYRLPPPMDCPIALHQLML 247
Query: 179 DCCMESPGKR------INMTD 193
           DC  +    R      +NM D
Sbjct: 248 DCWQKERSDRPKFGQIVNMLD 268

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 46/130 (35%), Positives = 65/130 (50%), Gaps = 7/130 (5%)
Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSA--LEYPHHGHSSAPIIHCDLKPTNILLD 58
           MPNGSL   L   +    +   +   I  G+A  + + H  H     IH D+K  NILLD
Sbjct: 106 MPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH----IHRDIKSANILLD 161
Query: 59  ENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLME 118
           E   A +SDFG+++   +    V     + T  YMAPE    G ++ K D+YS+GV+L+E
Sbjct: 162 EAFTAKISDFGLARASEKFAQXVMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLE 220
Query: 119 TFTRKRPTDE 128
             T     DE
Sbjct: 221 IITGLPAVDE 230

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 94/201 (46%), Gaps = 31/201 (15%)
Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           M NGSL+ +L   +  F +++ + ++  +GS ++Y     S    +H DL   NIL++ N
Sbjct: 112 MENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKY----LSDMSAVHRDLAARNILVNSN 167
Query: 61  MVAHVSDFGISKLL-GEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMET 119
           +V  VSDFG+S++L  + E   T       I + APE  +    ++  DV+SYG+++ E 
Sbjct: 168 LVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEV 227
Query: 120 FTR-KRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLAL 178
            +  +RP  +M                    +V+ A  + E       MDC +++  L L
Sbjct: 228 MSYGERPYWDMSN-----------------QDVIKA--IEEGYRLPPPMDCPIALHQLML 268
Query: 179 DCCMESPGKR------INMTD 193
           DC  +    R      +NM D
Sbjct: 269 DCWQKERSDRPKFGQIVNMLD 289

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 93/203 (45%), Gaps = 25/203 (12%)
Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           M NGSL+ +L  ++  F +++ + ++  + S ++Y     S    +H DL   NIL++ N
Sbjct: 128 MENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKY----LSDMGYVHRDLAARNILINSN 183
Query: 61  MVAHVSDFGISKLL-GEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMET 119
           +V  VSDFG++++L  + E   T       I + +PE  +    ++  DV+SYG++L E 
Sbjct: 184 LVCKVSDFGLARVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEV 243
Query: 120 FTR-KRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLAL 178
            +  +RP  EM                    +V+ A  V E       MDC  ++  L L
Sbjct: 244 MSYGERPYWEMSN-----------------QDVIKA--VDEGYRLPPPMDCPAALYQLML 284
Query: 179 DCCMESPGKRINMTDAAAKLKKI 201
           DC  +    R       + L K+
Sbjct: 285 DCWQKDRNNRPKFEQIVSILDKL 307

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 36/81 (44%), Positives = 49/81 (60%)
Query: 41  SSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSE 100
           SS   IH DL   NILL EN V  + DFG+++ + +  D+V +  T   + +MAPE   +
Sbjct: 216 SSRKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRLPLKWMAPESIFD 275
Query: 101 GIVSAKCDVYSYGVLLMETFT 121
            I S K DV+SYGVLL E F+
Sbjct: 276 KIYSTKSDVWSYGVLLWEIFS 296

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 46/130 (35%), Positives = 65/130 (50%), Gaps = 7/130 (5%)
Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSA--LEYPHHGHSSAPIIHCDLKPTNILLD 58
           MPNGSL   L   +    +   +   I  G+A  + + H  H     IH D+K  NILLD
Sbjct: 112 MPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH----IHRDIKSANILLD 167
Query: 59  ENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLME 118
           E   A +SDFG+++   +    V     + T  YMAPE    G ++ K D+YS+GV+L+E
Sbjct: 168 EAFTAKISDFGLARASEKFAQTVMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLE 226
Query: 119 TFTRKRPTDE 128
             T     DE
Sbjct: 227 IITGLPAVDE 236

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 68.2 bits (165), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 92/203 (45%), Gaps = 25/203 (12%)
Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           M NGSL+ +L  ++  F +++ + ++  + S ++Y     S    +H DL   NIL++ N
Sbjct: 128 MENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKY----LSDMGYVHRDLAARNILINSN 183
Query: 61  MVAHVSDFGISKLL-GEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMET 119
           +V  VSDFG+ ++L  + E   T       I + +PE  +    ++  DV+SYG++L E 
Sbjct: 184 LVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEV 243
Query: 120 FTR-KRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLAL 178
            +  +RP  EM                    +V+ A  V E       MDC  ++  L L
Sbjct: 244 MSYGERPYWEMSN-----------------QDVIKA--VDEGYRLPPPMDCPAALYQLML 284
Query: 179 DCCMESPGKRINMTDAAAKLKKI 201
           DC  +    R       + L K+
Sbjct: 285 DCWQKDRNNRPKFEQIVSILDKL 307

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 67.4 bits (163), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 39/112 (34%), Positives = 58/112 (51%), Gaps = 9/112 (8%)
Query: 23  LNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVT 82
           + ++ D   AL + H       IIH D+KP NI++       V DFGI++ + +  + VT
Sbjct: 119 IEVIADACQALNFSHQNG----IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVT 174
Query: 83  QTMT-MATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGE 133
           QT   + T  Y++PE      V A+ DVYS G +L E  T + P    FTG+
Sbjct: 175 QTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP----FTGD 222

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 67.4 bits (163), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 39/112 (34%), Positives = 58/112 (51%), Gaps = 9/112 (8%)
Query: 23  LNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVT 82
           + ++ D   AL + H       IIH D+KP NI++       V DFGI++ + +  + VT
Sbjct: 119 IEVIADACQALNFSHQNG----IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVT 174
Query: 83  QTMT-MATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGE 133
           QT   + T  Y++PE      V A+ DVYS G +L E  T + P    FTG+
Sbjct: 175 QTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP----FTGD 222

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 67.4 bits (163), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 39/112 (34%), Positives = 58/112 (51%), Gaps = 9/112 (8%)
Query: 23  LNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVT 82
           + ++ D   AL + H       IIH D+KP NI++       V DFGI++ + +  + VT
Sbjct: 119 IEVIADACQALNFSHQNG----IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVT 174
Query: 83  QTMT-MATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGE 133
           QT   + T  Y++PE      V A+ DVYS G +L E  T + P    FTG+
Sbjct: 175 QTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP----FTGD 222

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 67.4 bits (163), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 39/112 (34%), Positives = 58/112 (51%), Gaps = 9/112 (8%)
Query: 23  LNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVT 82
           + ++ D   AL + H       IIH D+KP NI++       V DFGI++ + +  + VT
Sbjct: 119 IEVIADACQALNFSHQNG----IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVT 174
Query: 83  QTMT-MATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGE 133
           QT   + T  Y++PE      V A+ DVYS G +L E  T + P    FTG+
Sbjct: 175 QTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP----FTGD 222

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 67.0 bits (162), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 93/203 (45%), Gaps = 25/203 (12%)
Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           M NGSL+ +L   +  F +++ + ++  + + ++Y     S    +H DL   NIL++ N
Sbjct: 105 MENGSLDTFLKKNDGQFTVIQLVGMLRGISAGMKY----LSDMGYVHRDLAARNILINSN 160
Query: 61  MVAHVSDFGISKLL-GEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMET 119
           +V  VSDFG+S++L  + E   T       I + APE  +    ++  DV+SYG+++ E 
Sbjct: 161 LVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAFRKFTSASDVWSYGIVMWEV 220
Query: 120 FTR-KRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLAL 178
            +  +RP  EM                    +V+ A  V E     + MDC  ++  L L
Sbjct: 221 VSYGERPYWEMTN-----------------QDVIKA--VEEGYRLPSPMDCPAALYQLML 261
Query: 179 DCCMESPGKRINMTDAAAKLKKI 201
           DC  +    R    +    L K+
Sbjct: 262 DCWQKERNSRPKFDEIVNMLDKL 284

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 67.0 bits (162), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 49/205 (23%), Positives = 91/205 (44%), Gaps = 27/205 (13%)
Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           M NG+L+ +L   +  F +++ + ++  + S + Y     +    +H DL   NIL++ N
Sbjct: 99  MENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRY----LAEMSYVHRDLAARNILVNSN 154
Query: 61  MVAHVSDFGISKLLGEGEDFVTQTMTMA---TIGYMAPEYGSEGIVSAKCDVYSYGVLLM 117
           +V  VSDFG+S+ L E     T+T ++     I + APE  +    ++  D +SYG+++ 
Sbjct: 155 LVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMW 214
Query: 118 ETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDL 176
           E  +  +RP  +M   ++                    N + ++       DC  S+  L
Sbjct: 215 EVMSFGERPYWDMSNQDV-------------------INAIEQDYRLPPPPDCPTSLHQL 255
Query: 177 ALDCCMESPGKRINMTDAAAKLKKI 201
            LDC  +    R       + L K+
Sbjct: 256 MLDCWQKDRNARPRFPQVVSALDKM 280

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 67.0 bits (162), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 39/112 (34%), Positives = 58/112 (51%), Gaps = 9/112 (8%)
Query: 23  LNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVT 82
           + ++ D   AL + H       IIH D+KP NI++       V DFGI++ + +  + VT
Sbjct: 136 IEVIADACQALNFSHQNG----IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVT 191
Query: 83  QTMT-MATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGE 133
           QT   + T  Y++PE      V A+ DVYS G +L E  T + P    FTG+
Sbjct: 192 QTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP----FTGD 239

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 39/112 (34%), Positives = 57/112 (50%), Gaps = 9/112 (8%)
Query: 23  LNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVT 82
           + ++ D   AL + H       IIH D+KP NIL+       V DFGI++ + +  + V 
Sbjct: 119 IEVIADACQALNFSHQNG----IIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVX 174
Query: 83  QTMT-MATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGE 133
           QT   + T  Y++PE      V A+ DVYS G +L E  T + P    FTG+
Sbjct: 175 QTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP----FTGD 222

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 93/203 (45%), Gaps = 25/203 (12%)
Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           M NG+L+ +L  ++  F +++ + ++  + + + Y     +    +H DL   NIL++ N
Sbjct: 126 MENGALDAFLRKHDGQFTVIQLVGMLRGIAAGMRY----LADMGYVHRDLAARNILVNSN 181
Query: 61  MVAHVSDFGISKLLGEGEDFV-TQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMET 119
           +V  VSDFG+S+++ +  + V T T     + + APE       ++  DV+SYG+++ E 
Sbjct: 182 LVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVRWTAPEAIQYRKFTSASDVWSYGIVMWEV 241
Query: 120 FTR-KRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLAL 178
            +  +RP  +M                    +V+ A  + E     A MDC   +  L L
Sbjct: 242 MSYGERPYWDMSN-----------------QDVIKA--IEEGYRLPAPMDCPAGLHQLML 282
Query: 179 DCCMESPGKRINMTDAAAKLKKI 201
           DC  +   +R         L K+
Sbjct: 283 DCWQKERAERPKFEQIVGILDKM 305

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/205 (23%), Positives = 90/205 (43%), Gaps = 27/205 (13%)
Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           M NG+L+ +L   +  F +++ + ++  + S + Y     +    +H DL   NIL++ N
Sbjct: 97  MENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRY----LAEMSYVHRDLAARNILVNSN 152
Query: 61  MVAHVSDFGISKLLGEGEDFVTQTMTMA---TIGYMAPEYGSEGIVSAKCDVYSYGVLLM 117
           +V  VSDFG+S+ L E     T T ++     I + APE  +    ++  D +SYG+++ 
Sbjct: 153 LVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMW 212
Query: 118 ETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDL 176
           E  +  +RP  +M   ++                    N + ++       DC  S+  L
Sbjct: 213 EVMSFGERPYWDMSNQDV-------------------INAIEQDYRLPPPPDCPTSLHQL 253
Query: 177 ALDCCMESPGKRINMTDAAAKLKKI 201
            LDC  +    R       + L K+
Sbjct: 254 MLDCWQKDRNARPRFPQVVSALDKM 278

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 42/119 (35%), Positives = 68/119 (57%), Gaps = 13/119 (10%)
Query: 38  HGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQT-MTMATIGYMAPE 96
           H H    I+H D+KP NIL+D N    + DFGI+K L E    +TQT   + T+ Y +PE
Sbjct: 126 HAHD-MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS--LTQTNHVLGTVQYFSPE 182
Query: 97  YGSEGIVSAKC-DVYSYGVLLMETFTRKRPTDEMFTGEMSLR---RWVKESLPHGLTEV 151
             ++G  + +C D+YS G++L E    + P    F GE ++    + +++S+P+  T+V
Sbjct: 183 Q-AKGEATDECTDIYSIGIVLYEMLVGEPP----FNGETAVSIAIKHIQDSVPNVTTDV 236

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/205 (23%), Positives = 90/205 (43%), Gaps = 27/205 (13%)
Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           M NGSL+ +L   +  F +++ + ++  + + ++Y     +    +H DL   NIL++ N
Sbjct: 116 MENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKY----LADMNYVHRDLAARNILVNSN 171
Query: 61  MVAHVSDFGISKLLGEGEDFVTQTMTMA---TIGYMAPEYGSEGIVSAKCDVYSYGVLLM 117
           +V  VSDFG+S+ L +     T T  +     I + APE       ++  DV+SYG+++ 
Sbjct: 172 LVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMW 231
Query: 118 ETFTR-KRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDL 176
           E  +  +RP  +M   ++                    N + ++      MDC  ++  L
Sbjct: 232 EVMSYGERPYWDMTNQDV-------------------INAIEQDYRLPPPMDCPSALHQL 272
Query: 177 ALDCCMESPGKRINMTDAAAKLKKI 201
            LDC  +    R         L K+
Sbjct: 273 MLDCWQKDRNHRPKFGQIVNTLDKM 297

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 65.1 bits (157), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 37/107 (34%), Positives = 54/107 (50%), Gaps = 5/107 (4%)
Query: 22  RLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFV 81
           R  I     + + + H  H     IH D+K  NILLDE   A +SDFG+++   +    V
Sbjct: 126 RCKIAQGAANGINFLHENHH----IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXV 181
Query: 82  TQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDE 128
             +  + T  Y APE    G ++ K D+YS+GV+L+E  T     DE
Sbjct: 182 XXSRIVGTTAYXAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDE 227

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 63.5 bits (153), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 39/124 (31%), Positives = 64/124 (51%), Gaps = 5/124 (4%)
Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           M +G L  +L +    F     L + +DV   + Y       A +IH DL   N L+ EN
Sbjct: 84  MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE----ASVIHRDLAARNCLVGEN 139
Query: 61  MVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETF 120
            V  VSDFG+++ + + + + + T T   + + +PE  S    S+K DV+S+GVL+ E F
Sbjct: 140 QVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVF 198
Query: 121 TRKR 124
           +  +
Sbjct: 199 SEGK 202

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 78/180 (43%), Gaps = 27/180 (15%)
Query: 23  LNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVT 82
           L+   DV   ++Y     S    IH DL   NIL+ EN VA ++DFG+S+  G+ E +V 
Sbjct: 135 LHFAADVARGMDYL----SQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQ-EVYVK 187
Query: 83  QTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVK 141
           +TM    + +MA E  +  + +   DV+SYGVLL E  +    P   M   E+       
Sbjct: 188 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY------ 241
Query: 142 ESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI 201
           E LP G                   ++C   + DL   C  E P +R +       L ++
Sbjct: 242 EKLPQGYR-------------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 288

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/180 (30%), Positives = 81/180 (45%), Gaps = 27/180 (15%)
Query: 23  LNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVT 82
           L+   DV   ++Y     S    IH DL   NIL+ EN VA ++DFG+S+  G+ E +V 
Sbjct: 145 LHFAADVARGMDYL----SQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQ-EVYVK 197
Query: 83  QTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVK 141
           +TM    + +MA E  +  + +   DV+SYGVLL E  +    P   M   E+       
Sbjct: 198 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY------ 251
Query: 142 ESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI 201
           E LP G          R E+     ++C   + DL   C  E P +R +       L ++
Sbjct: 252 EKLPQG---------YRLEKP----LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 298

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 39/124 (31%), Positives = 64/124 (51%), Gaps = 5/124 (4%)
Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           M +G L  +L +    F     L + +DV   + Y       A +IH DL   N L+ EN
Sbjct: 84  MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE----ACVIHRDLAARNCLVGEN 139
Query: 61  MVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETF 120
            V  VSDFG+++ + + + + + T T   + + +PE  S    S+K DV+S+GVL+ E F
Sbjct: 140 QVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVF 198
Query: 121 TRKR 124
           +  +
Sbjct: 199 SEGK 202

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 39/124 (31%), Positives = 64/124 (51%), Gaps = 5/124 (4%)
Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           M +G L  +L +    F     L + +DV   + Y       A +IH DL   N L+ EN
Sbjct: 85  MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE----ACVIHRDLAARNCLVGEN 140
Query: 61  MVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETF 120
            V  VSDFG+++ + + + + + T T   + + +PE  S    S+K DV+S+GVL+ E F
Sbjct: 141 QVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVF 199
Query: 121 TRKR 124
           +  +
Sbjct: 200 SEGK 203

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 39/124 (31%), Positives = 64/124 (51%), Gaps = 5/124 (4%)
Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           M +G L  +L +    F     L + +DV   + Y       A +IH DL   N L+ EN
Sbjct: 87  MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE----ACVIHRDLAARNCLVGEN 142
Query: 61  MVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETF 120
            V  VSDFG+++ + + + + + T T   + + +PE  S    S+K DV+S+GVL+ E F
Sbjct: 143 QVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVF 201
Query: 121 TRKR 124
           +  +
Sbjct: 202 SEGK 205

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 39/124 (31%), Positives = 64/124 (51%), Gaps = 5/124 (4%)
Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           M +G L  +L +    F     L + +DV   + Y       A +IH DL   N L+ EN
Sbjct: 82  MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE----ACVIHRDLAARNCLVGEN 137
Query: 61  MVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETF 120
            V  VSDFG+++ + + + + + T T   + + +PE  S    S+K DV+S+GVL+ E F
Sbjct: 138 QVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVF 196
Query: 121 TRKR 124
           +  +
Sbjct: 197 SEGK 200

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 39/124 (31%), Positives = 64/124 (51%), Gaps = 5/124 (4%)
Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           M +G L  +L +    F     L + +DV   + Y       A +IH DL   N L+ EN
Sbjct: 104 MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE----ACVIHRDLAARNCLVGEN 159
Query: 61  MVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETF 120
            V  VSDFG+++ + + + + + T T   + + +PE  S    S+K DV+S+GVL+ E F
Sbjct: 160 QVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVF 218
Query: 121 TRKR 124
           +  +
Sbjct: 219 SEGK 222

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/205 (23%), Positives = 89/205 (43%), Gaps = 27/205 (13%)
Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           M NGSL+ +L   +  F +++ + ++  + + ++Y     +    +H  L   NIL++ N
Sbjct: 90  MENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKY----LADMNYVHRALAARNILVNSN 145
Query: 61  MVAHVSDFGISKLLGEGEDFVTQTMTMA---TIGYMAPEYGSEGIVSAKCDVYSYGVLLM 117
           +V  VSDFG+S+ L +     T T  +     I + APE       ++  DV+SYG+++ 
Sbjct: 146 LVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMW 205
Query: 118 ETFTR-KRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDL 176
           E  +  +RP  +M   ++                    N + ++      MDC  ++  L
Sbjct: 206 EVMSYGERPYWDMTNQDV-------------------INAIEQDYRLPPPMDCPSALHQL 246
Query: 177 ALDCCMESPGKRINMTDAAAKLKKI 201
            LDC  +    R         L K+
Sbjct: 247 MLDCWQKDRNHRPKFGQIVNTLDKM 271

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 61.6 bits (148), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 31/79 (39%), Positives = 47/79 (59%), Gaps = 1/79 (1%)
Query: 46  IHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSA 105
           +H DL+  NIL+ EN+V  V+DFG+++L+ + E    Q      I + APE    G  + 
Sbjct: 126 VHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFP-IKWTAPEAALYGRFTI 184
Query: 106 KCDVYSYGVLLMETFTRKR 124
           K DV+S+G+LL E  T+ R
Sbjct: 185 KSDVWSFGILLTELTTKGR 203

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 61.6 bits (148), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/180 (29%), Positives = 81/180 (45%), Gaps = 27/180 (15%)
Query: 23  LNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVT 82
           L+   DV   ++Y     S    IH +L   NIL+ EN VA ++DFG+S+  G+ E +V 
Sbjct: 142 LHFAADVARGMDYL----SQKQFIHRNLAARNILVGENYVAKIADFGLSR--GQ-EVYVK 194
Query: 83  QTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVK 141
           +TM    + +MA E  +  + +   DV+SYGVLL E  +    P   M   E+       
Sbjct: 195 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY------ 248
Query: 142 ESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI 201
           E LP G          R E+     ++C   + DL   C  E P +R +       L ++
Sbjct: 249 EKLPQG---------YRLEKP----LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 295

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 61.6 bits (148), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 30/79 (37%), Positives = 48/79 (60%), Gaps = 1/79 (1%)
Query: 46  IHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSA 105
           +H DL+  NIL+ EN+V  V+DFG+++L+ E  ++  +      I + APE    G  + 
Sbjct: 385 VHRDLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTI 443
Query: 106 KCDVYSYGVLLMETFTRKR 124
           K DV+S+G+LL E  T+ R
Sbjct: 444 KSDVWSFGILLTELTTKGR 462

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 61.6 bits (148), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 30/79 (37%), Positives = 48/79 (60%), Gaps = 1/79 (1%)
Query: 46  IHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSA 105
           +H DL+  NIL+ EN+V  V+DFG+++L+ E  ++  +      I + APE    G  + 
Sbjct: 127 VHRDLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTI 185
Query: 106 KCDVYSYGVLLMETFTRKR 124
           K DV+S+G+LL E  T+ R
Sbjct: 186 KSDVWSFGILLTELTTKGR 204

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 30/79 (37%), Positives = 48/79 (60%), Gaps = 1/79 (1%)
Query: 46  IHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSA 105
           +H DL+  NIL+ EN+V  V+DFG+++L+ E  ++  +      I + APE    G  + 
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTI 360
Query: 106 KCDVYSYGVLLMETFTRKR 124
           K DV+S+G+LL E  T+ R
Sbjct: 361 KSDVWSFGILLTELTTKGR 379

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 30/79 (37%), Positives = 48/79 (60%), Gaps = 1/79 (1%)
Query: 46  IHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSA 105
           +H DL+  NIL+ EN+V  V+DFG+++L+ E  ++  +      I + APE    G  + 
Sbjct: 129 VHRDLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTI 187
Query: 106 KCDVYSYGVLLMETFTRKR 124
           K DV+S+G+LL E  T+ R
Sbjct: 188 KSDVWSFGILLTELTTKGR 206

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 30/79 (37%), Positives = 48/79 (60%), Gaps = 1/79 (1%)
Query: 46  IHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSA 105
           +H DL+  NIL+ EN+V  V+DFG+++L+ E  ++  +      I + APE    G  + 
Sbjct: 125 VHRDLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTI 183
Query: 106 KCDVYSYGVLLMETFTRKR 124
           K DV+S+G+LL E  T+ R
Sbjct: 184 KSDVWSFGILLTELTTKGR 202

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 30/79 (37%), Positives = 48/79 (60%), Gaps = 1/79 (1%)
Query: 46  IHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSA 105
           +H DL+  NIL+ EN+V  V+DFG+++L+ E  ++  +      I + APE    G  + 
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTI 360
Query: 106 KCDVYSYGVLLMETFTRKR 124
           K DV+S+G+LL E  T+ R
Sbjct: 361 KSDVWSFGILLTELTTKGR 379

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 31/79 (39%), Positives = 47/79 (59%), Gaps = 1/79 (1%)
Query: 46  IHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSA 105
           +H DL+  NIL+ EN+V  V+DFG+++L+ + E    Q      I + APE    G  + 
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFP-IKWTAPEAALYGRFTI 194
Query: 106 KCDVYSYGVLLMETFTRKR 124
           K DV+S+G+LL E  T+ R
Sbjct: 195 KSDVWSFGILLTELTTKGR 213

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 30/79 (37%), Positives = 48/79 (60%), Gaps = 1/79 (1%)
Query: 46  IHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSA 105
           +H DL+  NIL+ EN+V  V+DFG+++L+ E  ++  +      I + APE    G  + 
Sbjct: 133 VHRDLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTI 191
Query: 106 KCDVYSYGVLLMETFTRKR 124
           K DV+S+G+LL E  T+ R
Sbjct: 192 KSDVWSFGILLTELTTKGR 210

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 30/79 (37%), Positives = 48/79 (60%), Gaps = 1/79 (1%)
Query: 46  IHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSA 105
           +H DL+  NIL+ EN+V  V+DFG+++L+ E  ++  +      I + APE    G  + 
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTI 194
Query: 106 KCDVYSYGVLLMETFTRKR 124
           K DV+S+G+LL E  T+ R
Sbjct: 195 KSDVWSFGILLTELTTKGR 213

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 30/79 (37%), Positives = 48/79 (60%), Gaps = 1/79 (1%)
Query: 46  IHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSA 105
           +H DL+  NIL+ EN+V  V+DFG+++L+ E  ++  +      I + APE    G  + 
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTI 194
Query: 106 KCDVYSYGVLLMETFTRKR 124
           K DV+S+G+LL E  T+ R
Sbjct: 195 KSDVWSFGILLTELTTKGR 213

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 30/79 (37%), Positives = 48/79 (60%), Gaps = 1/79 (1%)
Query: 46  IHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSA 105
           +H DL+  NIL+ EN+V  V+DFG+++L+ E  ++  +      I + APE    G  + 
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTI 360
Query: 106 KCDVYSYGVLLMETFTRKR 124
           K DV+S+G+LL E  T+ R
Sbjct: 361 KSDVWSFGILLTELTTKGR 379

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 30/79 (37%), Positives = 48/79 (60%), Gaps = 1/79 (1%)
Query: 46  IHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSA 105
           +H DL+  NIL+ EN+V  V+DFG+++L+ E  ++  +      I + APE    G  + 
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTI 194
Query: 106 KCDVYSYGVLLMETFTRKR 124
           K DV+S+G+LL E  T+ R
Sbjct: 195 KSDVWSFGILLTELTTKGR 213

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 61.2 bits (147), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 30/79 (37%), Positives = 48/79 (60%), Gaps = 1/79 (1%)
Query: 46  IHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSA 105
           +H DL+  NIL+ EN+V  V+DFG+++L+ E  ++  +      I + APE    G  + 
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTI 194
Query: 106 KCDVYSYGVLLMETFTRKR 124
           K DV+S+G+LL E  T+ R
Sbjct: 195 KSDVWSFGILLTELTTKGR 213

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 61.2 bits (147), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 30/79 (37%), Positives = 48/79 (60%), Gaps = 1/79 (1%)
Query: 46  IHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSA 105
           +H DL+  NIL+ EN+V  V+DFG+++L+ E  ++  +      I + APE    G  + 
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTI 194
Query: 106 KCDVYSYGVLLMETFTRKR 124
           K DV+S+G+LL E  T+ R
Sbjct: 195 KSDVWSFGILLTELTTKGR 213

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 61.2 bits (147), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 30/79 (37%), Positives = 48/79 (60%), Gaps = 1/79 (1%)
Query: 46  IHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSA 105
           +H DL+  NIL+ EN+V  V+DFG+++L+ E  ++  +      I + APE    G  + 
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTI 194
Query: 106 KCDVYSYGVLLMETFTRKR 124
           K DV+S+G+LL E  T+ R
Sbjct: 195 KSDVWSFGILLTELTTKGR 213

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 61.2 bits (147), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 30/79 (37%), Positives = 48/79 (60%), Gaps = 1/79 (1%)
Query: 46  IHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSA 105
           +H DL+  NIL+ EN+V  V+DFG+++L+ E  ++  +      I + APE    G  + 
Sbjct: 133 VHRDLRAANILVGENLVCKVADFGLARLI-EDNEWTARQGAKFPIKWTAPEAALYGRFTI 191
Query: 106 KCDVYSYGVLLMETFTRKR 124
           K DV+S+G+LL E  T+ R
Sbjct: 192 KSDVWSFGILLTELTTKGR 210

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 60.8 bits (146), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 39/122 (31%), Positives = 62/122 (50%), Gaps = 5/122 (4%)
Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           +P+G L  +L  +    D    L     +   +EY      S   +H DL   NIL++  
Sbjct: 95  LPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEY----LGSRRCVHRDLAARNILVESE 150
Query: 61  MVAHVSDFGISKLLGEGEDF-VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMET 119
               ++DFG++KLL   +D+ V +    + I + APE  S+ I S + DV+S+GV+L E 
Sbjct: 151 AHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYEL 210
Query: 120 FT 121
           FT
Sbjct: 211 FT 212

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 60.8 bits (146), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 39/122 (31%), Positives = 62/122 (50%), Gaps = 5/122 (4%)
Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           +P+G L  +L  +    D    L     +   +EY      S   +H DL   NIL++  
Sbjct: 96  LPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEY----LGSRRCVHRDLAARNILVESE 151
Query: 61  MVAHVSDFGISKLLGEGEDF-VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMET 119
               ++DFG++KLL   +D+ V +    + I + APE  S+ I S + DV+S+GV+L E 
Sbjct: 152 AHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYEL 211
Query: 120 FT 121
           FT
Sbjct: 212 FT 213

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 60.8 bits (146), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 30/79 (37%), Positives = 47/79 (59%), Gaps = 1/79 (1%)
Query: 46  IHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSA 105
           +H DL+  NIL+ EN+V  V+DFG+ +L+ E  ++  +      I + APE    G  + 
Sbjct: 303 VHRDLRAANILVGENLVCKVADFGLGRLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTI 361
Query: 106 KCDVYSYGVLLMETFTRKR 124
           K DV+S+G+LL E  T+ R
Sbjct: 362 KSDVWSFGILLTELTTKGR 380

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 60.8 bits (146), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 39/122 (31%), Positives = 62/122 (50%), Gaps = 5/122 (4%)
Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           +P+G L  +L  +    D    L     +   +EY      S   +H DL   NIL++  
Sbjct: 108 LPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEY----LGSRRCVHRDLAARNILVESE 163
Query: 61  MVAHVSDFGISKLLGEGEDF-VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMET 119
               ++DFG++KLL   +D+ V +    + I + APE  S+ I S + DV+S+GV+L E 
Sbjct: 164 AHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYEL 223
Query: 120 FT 121
           FT
Sbjct: 224 FT 225

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 60.5 bits (145), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 38/116 (32%), Positives = 59/116 (50%), Gaps = 5/116 (4%)
Query: 3   NGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMV 62
           NG L K++     F +   R     ++ SALEY H       IIH DLKP NILL+E+M 
Sbjct: 116 NGCLLKYIRKIGSFDETCTRF-YTAEIVSALEYLH----GKGIIHRDLKPENILLNEDMH 170
Query: 63  AHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLME 118
             ++DFG +K+L            + T  Y++PE  +E   S   D+++ G ++ +
Sbjct: 171 IQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSASKSSDLWALGCIIYQ 226

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 60.5 bits (145), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 37/102 (36%), Positives = 53/102 (51%), Gaps = 9/102 (8%)
Query: 23  LNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVT 82
           L   +DV  A+EY    +     +H DL   N+L+ E+ VA VSDFG++K     E   T
Sbjct: 111 LKFSLDVCEAMEYLEGNN----FVHRDLAARNVLVSEDNVAKVSDFGLTK-----EASST 161
Query: 83  QTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKR 124
           Q      + + APE   E   S K DV+S+G+LL E ++  R
Sbjct: 162 QDTGKLPVKWTAPEALREAAFSTKSDVWSFGILLWEIYSFGR 203

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 60.1 bits (144), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 30/79 (37%), Positives = 47/79 (59%), Gaps = 1/79 (1%)
Query: 46  IHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSA 105
           +H DL   NIL+ EN+V  V+DFG+++L+ E  ++  +      I + APE    G  + 
Sbjct: 136 VHRDLAAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTI 194
Query: 106 KCDVYSYGVLLMETFTRKR 124
           K DV+S+G+LL E  T+ R
Sbjct: 195 KSDVWSFGILLTELTTKGR 213

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 65/144 (45%), Gaps = 21/144 (14%)
Query: 46  IHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSA 105
           IH DL+  NIL+   ++  ++DFG+++L+ + E    Q      I + APE    G  + 
Sbjct: 127 IHRDLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFP-IKWTAPEAALYGRFTI 185
Query: 106 KCDVYSYGVLLMETFTRKR-PTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFA 164
           K DV+S+G+LL E  T+ R P   M   E      V E +  G                 
Sbjct: 186 KSDVWSFGILLTELVTKGRVPYPGMNNRE------VLEQVERGYR-------------MP 226
Query: 165 AKMDCIVSIMDLALDCCMESPGKR 188
              DC +S+ +L + C  + P +R
Sbjct: 227 CPQDCPISLHELMIHCWKKDPEER 250

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 37/116 (31%), Positives = 58/116 (50%), Gaps = 5/116 (4%)
Query: 3   NGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMV 62
           NG L K++     F +   R     ++ SALEY H       IIH DLKP NILL+E+M 
Sbjct: 116 NGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH----GKGIIHRDLKPENILLNEDMH 170
Query: 63  AHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLME 118
             ++DFG +K+L            + T  Y++PE  +E       D+++ G ++ +
Sbjct: 171 IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAXKSSDLWALGCIIYQ 226

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 39/122 (31%), Positives = 61/122 (50%), Gaps = 5/122 (4%)
Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           +P+G L  +L  +    D    L     +   +EY      S   +H DL   NIL++  
Sbjct: 92  LPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEY----LGSRRCVHRDLAARNILVESE 147
Query: 61  MVAHVSDFGISKLLGEGEDF-VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMET 119
               ++DFG++KLL   +D  V +    + I + APE  S+ I S + DV+S+GV+L E 
Sbjct: 148 AHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYEL 207
Query: 120 FT 121
           FT
Sbjct: 208 FT 209

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 37/102 (36%), Positives = 53/102 (51%), Gaps = 9/102 (8%)
Query: 23  LNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVT 82
           L   +DV  A+EY    +     +H DL   N+L+ E+ VA VSDFG++K     E   T
Sbjct: 105 LKFSLDVCEAMEYLEGNN----FVHRDLAARNVLVSEDNVAKVSDFGLTK-----EASST 155
Query: 83  QTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKR 124
           Q      + + APE   E   S K DV+S+G+LL E ++  R
Sbjct: 156 QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGR 197

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 37/116 (31%), Positives = 58/116 (50%), Gaps = 5/116 (4%)
Query: 3   NGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMV 62
           NG L K++     F +   R     ++ SALEY H       IIH DLKP NILL+E+M 
Sbjct: 93  NGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH----GKGIIHRDLKPENILLNEDMH 147
Query: 63  AHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLME 118
             ++DFG +K+L            + T  Y++PE  +E       D+++ G ++ +
Sbjct: 148 IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQ 203

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 37/116 (31%), Positives = 58/116 (50%), Gaps = 5/116 (4%)
Query: 3   NGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMV 62
           NG L K++     F +   R     ++ SALEY H       IIH DLKP NILL+E+M 
Sbjct: 94  NGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH----GKGIIHRDLKPENILLNEDMH 148
Query: 63  AHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLME 118
             ++DFG +K+L            + T  Y++PE  +E       D+++ G ++ +
Sbjct: 149 IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQ 204

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 37/102 (36%), Positives = 53/102 (51%), Gaps = 9/102 (8%)
Query: 23  LNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVT 82
           L   +DV  A+EY    +     +H DL   N+L+ E+ VA VSDFG++K     E   T
Sbjct: 120 LKFSLDVCEAMEYLEGNN----FVHRDLAARNVLVSEDNVAKVSDFGLTK-----EASST 170
Query: 83  QTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKR 124
           Q      + + APE   E   S K DV+S+G+LL E ++  R
Sbjct: 171 QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGR 212

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 37/116 (31%), Positives = 58/116 (50%), Gaps = 5/116 (4%)
Query: 3   NGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMV 62
           NG L K++     F +   R     ++ SALEY H       IIH DLKP NILL+E+M 
Sbjct: 92  NGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH----GKGIIHRDLKPENILLNEDMH 146
Query: 63  AHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLME 118
             ++DFG +K+L            + T  Y++PE  +E       D+++ G ++ +
Sbjct: 147 IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQ 202

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 37/116 (31%), Positives = 58/116 (50%), Gaps = 5/116 (4%)
Query: 3   NGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMV 62
           NG L K++     F +   R     ++ SALEY H       IIH DLKP NILL+E+M 
Sbjct: 116 NGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH----GKGIIHRDLKPENILLNEDMH 170
Query: 63  AHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLME 118
             ++DFG +K+L            + T  Y++PE  +E       D+++ G ++ +
Sbjct: 171 IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQ 226

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 37/116 (31%), Positives = 58/116 (50%), Gaps = 5/116 (4%)
Query: 3   NGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMV 62
           NG L K++     F +   R     ++ SALEY H       IIH DLKP NILL+E+M 
Sbjct: 114 NGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH----GKGIIHRDLKPENILLNEDMH 168
Query: 63  AHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLME 118
             ++DFG +K+L            + T  Y++PE  +E       D+++ G ++ +
Sbjct: 169 IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQ 224

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 37/116 (31%), Positives = 58/116 (50%), Gaps = 5/116 (4%)
Query: 3   NGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMV 62
           NG L K++     F +   R     ++ SALEY H       IIH DLKP NILL+E+M 
Sbjct: 114 NGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH----GKGIIHRDLKPENILLNEDMH 168
Query: 63  AHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLME 118
             ++DFG +K+L            + T  Y++PE  +E       D+++ G ++ +
Sbjct: 169 IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQ 224

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 37/116 (31%), Positives = 58/116 (50%), Gaps = 5/116 (4%)
Query: 3   NGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMV 62
           NG L K++     F +   R     ++ SALEY H       IIH DLKP NILL+E+M 
Sbjct: 91  NGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH----GKGIIHRDLKPENILLNEDMH 145
Query: 63  AHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLME 118
             ++DFG +K+L            + T  Y++PE  +E       D+++ G ++ +
Sbjct: 146 IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQ 201

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 37/116 (31%), Positives = 58/116 (50%), Gaps = 5/116 (4%)
Query: 3   NGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMV 62
           NG L K++     F +   R     ++ SALEY H       IIH DLKP NILL+E+M 
Sbjct: 114 NGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH----GKGIIHRDLKPENILLNEDMH 168
Query: 63  AHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLME 118
             ++DFG +K+L            + T  Y++PE  +E       D+++ G ++ +
Sbjct: 169 IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQ 224

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 37/116 (31%), Positives = 58/116 (50%), Gaps = 5/116 (4%)
Query: 3   NGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMV 62
           NG L K++     F +   R     ++ SALEY H       IIH DLKP NILL+E+M 
Sbjct: 116 NGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH----GKGIIHRDLKPENILLNEDMH 170
Query: 63  AHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLME 118
             ++DFG +K+L            + T  Y++PE  +E       D+++ G ++ +
Sbjct: 171 IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQ 226

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 37/116 (31%), Positives = 58/116 (50%), Gaps = 5/116 (4%)
Query: 3   NGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMV 62
           NG L K++     F +   R     ++ SALEY H       IIH DLKP NILL+E+M 
Sbjct: 121 NGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH----GKGIIHRDLKPENILLNEDMH 175
Query: 63  AHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLME 118
             ++DFG +K+L            + T  Y++PE  +E       D+++ G ++ +
Sbjct: 176 IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQ 231

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 37/116 (31%), Positives = 58/116 (50%), Gaps = 5/116 (4%)
Query: 3   NGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMV 62
           NG L K++     F +   R     ++ SALEY H       IIH DLKP NILL+E+M 
Sbjct: 114 NGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH----GKGIIHRDLKPENILLNEDMH 168
Query: 63  AHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLME 118
             ++DFG +K+L            + T  Y++PE  +E       D+++ G ++ +
Sbjct: 169 IQITDFGTAKVLSPESKQARANAFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQ 224

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 37/116 (31%), Positives = 58/116 (50%), Gaps = 5/116 (4%)
Query: 3   NGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMV 62
           NG L K++     F +   R     ++ SALEY H       IIH DLKP NILL+E+M 
Sbjct: 117 NGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH----GKGIIHRDLKPENILLNEDMH 171
Query: 63  AHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLME 118
             ++DFG +K+L            + T  Y++PE  +E       D+++ G ++ +
Sbjct: 172 IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQ 227

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 37/116 (31%), Positives = 58/116 (50%), Gaps = 5/116 (4%)
Query: 3   NGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMV 62
           NG L K++     F +   R     ++ SALEY H       IIH DLKP NILL+E+M 
Sbjct: 98  NGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH----GKGIIHRDLKPENILLNEDMH 152
Query: 63  AHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLME 118
             ++DFG +K+L            + T  Y++PE  +E       D+++ G ++ +
Sbjct: 153 IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQ 208

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 37/116 (31%), Positives = 58/116 (50%), Gaps = 5/116 (4%)
Query: 3   NGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMV 62
           NG L K++     F +   R     ++ SALEY H       IIH DLKP NILL+E+M 
Sbjct: 119 NGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH----GKGIIHRDLKPENILLNEDMH 173
Query: 63  AHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLME 118
             ++DFG +K+L            + T  Y++PE  +E       D+++ G ++ +
Sbjct: 174 IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQ 229

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 37/116 (31%), Positives = 58/116 (50%), Gaps = 5/116 (4%)
Query: 3   NGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMV 62
           NG L K++     F +   R     ++ SALEY H       IIH DLKP NILL+E+M 
Sbjct: 116 NGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH----GKGIIHRDLKPENILLNEDMH 170
Query: 63  AHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLME 118
             ++DFG +K+L            + T  Y++PE  +E       D+++ G ++ +
Sbjct: 171 IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQ 226

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 37/116 (31%), Positives = 58/116 (50%), Gaps = 5/116 (4%)
Query: 3   NGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMV 62
           NG L K++     F +   R     ++ SALEY H       IIH DLKP NILL+E+M 
Sbjct: 116 NGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH----GKGIIHRDLKPENILLNEDMH 170
Query: 63  AHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLME 118
             ++DFG +K+L            + T  Y++PE  +E       D+++ G ++ +
Sbjct: 171 IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQ 226

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/144 (31%), Positives = 70/144 (48%), Gaps = 12/144 (8%)
Query: 18  DILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEG 77
           DIL +  I + +  ALE   H HS   +IH D+KP+N+L++      + DFGIS  L   
Sbjct: 153 DILGK--IAVSIVKALE---HLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL--- 204
Query: 78  EDFVTQTMTMATIGYMAPEYGSEGI----VSAKCDVYSYGVLLMETFTRKRPTDEMFTGE 133
            D V +T+      YMAPE  +  +     S K D++S G+ ++E    + P D   T  
Sbjct: 205 VDSVAKTIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPF 264
Query: 134 MSLRRWVKESLPHGLTEVVDANLV 157
             L++ V+E  P    +   A  V
Sbjct: 265 QQLKQVVEEPSPQLPADKFSAEFV 288

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 37/116 (31%), Positives = 58/116 (50%), Gaps = 5/116 (4%)
Query: 3   NGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMV 62
           NG L K++     F +   R     ++ SALEY H       IIH DLKP NILL+E+M 
Sbjct: 117 NGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH----GKGIIHRDLKPENILLNEDMH 171
Query: 63  AHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLME 118
             ++DFG +K+L            + T  Y++PE  +E       D+++ G ++ +
Sbjct: 172 IQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQ 227

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 37/102 (36%), Positives = 53/102 (51%), Gaps = 9/102 (8%)
Query: 23  LNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVT 82
           L   +DV  A+EY    +     +H DL   N+L+ E+ VA VSDFG++K     E   T
Sbjct: 292 LKFSLDVCEAMEYLEGNN----FVHRDLAARNVLVSEDNVAKVSDFGLTK-----EASST 342
Query: 83  QTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKR 124
           Q      + + APE   E   S K DV+S+G+LL E ++  R
Sbjct: 343 QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGR 384

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 37/94 (39%), Positives = 50/94 (53%), Gaps = 10/94 (10%)
Query: 40  HSSAP--IIHCDLKPTNILL-DENMVAHVSDFGISKLLGEGEDFVTQ-TMTMATIGYMAP 95
           HS  P  +IH DLKP N+LL     V  + DFG +       D  T  T    +  +MAP
Sbjct: 119 HSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC------DIQTHMTNNKGSAAWMAP 172
Query: 96  EYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEM 129
           E       S KCDV+S+G++L E  TR++P DE+
Sbjct: 173 EVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEI 206

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 56/99 (56%), Gaps = 8/99 (8%)
Query: 31  SALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATI 90
           SA+EY H       I+H DLKP N+LLDE++   ++DFG+S ++ +G    T   +  + 
Sbjct: 123 SAVEYCHR----HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKT---SCGSP 175
Query: 91  GYMAPEYGSEGIVSA-KCDVYSYGVLLMETFTRKRPTDE 128
            Y APE  S  + +  + DV+S GV+L     R+ P D+
Sbjct: 176 NYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDD 214

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 56/99 (56%), Gaps = 8/99 (8%)
Query: 31  SALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATI 90
           SA+EY H       I+H DLKP N+LLDE++   ++DFG+S ++ +G    T   +  + 
Sbjct: 124 SAVEYCHR----HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKT---SCGSP 176
Query: 91  GYMAPEYGSEGIVSA-KCDVYSYGVLLMETFTRKRPTDE 128
            Y APE  S  + +  + DV+S GV+L     R+ P D+
Sbjct: 177 NYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDD 215

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 37/94 (39%), Positives = 50/94 (53%), Gaps = 10/94 (10%)
Query: 40  HSSAP--IIHCDLKPTNILL-DENMVAHVSDFGISKLLGEGEDFVTQ-TMTMATIGYMAP 95
           HS  P  +IH DLKP N+LL     V  + DFG +       D  T  T    +  +MAP
Sbjct: 120 HSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC------DIQTHMTNNKGSAAWMAP 173
Query: 96  EYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEM 129
           E       S KCDV+S+G++L E  TR++P DE+
Sbjct: 174 EVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEI 207

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 37/116 (31%), Positives = 58/116 (50%), Gaps = 5/116 (4%)
Query: 3   NGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMV 62
           NG L K++     F +   R     ++ SALEY H       IIH DLKP NILL+E+M 
Sbjct: 113 NGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH----GKGIIHRDLKPENILLNEDMH 167
Query: 63  AHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLME 118
             ++DFG +K+L            + T  Y++PE  +E       D+++ G ++ +
Sbjct: 168 IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQ 223

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 40/177 (22%), Positives = 80/177 (45%), Gaps = 22/177 (12%)
Query: 23  LNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVT 82
           ++++  + + +EY     SS  ++H DL   N+L+ + +   +SD G+ + +   + +  
Sbjct: 131 VHLVAQIAAGMEY----LSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKL 186
Query: 83  QTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKE 142
              ++  I +MAPE    G  S   D++SYGV+L E F+                  ++ 
Sbjct: 187 LGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYG----------------LQP 230
Query: 143 SLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLK 199
              +   +VV+  ++R  Q      DC   +  L ++C  E P +R    D  ++L+
Sbjct: 231 YCGYSNQDVVE--MIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLR 285

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/183 (24%), Positives = 78/183 (42%), Gaps = 30/183 (16%)
Query: 29  VGSALEYPHHGH------------SSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGE 76
           V SALE P   H            SS  ++H DL   N+L+ + +   +SD G+ + +  
Sbjct: 138 VKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYA 197
Query: 77  GEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSL 136
            + +     ++  I +MAPE    G  S   D++SYGV+L E F+               
Sbjct: 198 ADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYG------------- 244
Query: 137 RRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA 196
              ++    +   +VV+  ++R  Q      DC   +  L ++C  E P +R    D  +
Sbjct: 245 ---LQPYCGYSNQDVVE--MIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHS 299
Query: 197 KLK 199
           +L+
Sbjct: 300 RLR 302

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 56/99 (56%), Gaps = 8/99 (8%)
Query: 31  SALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATI 90
           SA+EY H       I+H DLKP N+LLDE++   ++DFG+S ++ +G    T   +  + 
Sbjct: 114 SAVEYCHRHK----IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKT---SCGSP 166
Query: 91  GYMAPEYGSEGIVSA-KCDVYSYGVLLMETFTRKRPTDE 128
            Y APE  S  + +  + DV+S GV+L     R+ P D+
Sbjct: 167 NYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDD 205

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 56/99 (56%), Gaps = 8/99 (8%)
Query: 31  SALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATI 90
           SA+EY H       I+H DLKP N+LLDE++   ++DFG+S ++ +G    T   +  + 
Sbjct: 118 SAVEYCHR----HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKT---SCGSP 170
Query: 91  GYMAPEYGSEGIVSA-KCDVYSYGVLLMETFTRKRPTDE 128
            Y APE  S  + +  + DV+S GV+L     R+ P D+
Sbjct: 171 NYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDD 209

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 37/122 (30%), Positives = 61/122 (50%), Gaps = 5/122 (4%)
Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           +P GSL  +L  +    D ++ L     +   +EY      +   IH DL   NIL++  
Sbjct: 95  LPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEY----LGTKRYIHRDLATRNILVENE 150
Query: 61  MVAHVSDFGISKLLGEGEDFV-TQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMET 119
               + DFG++K+L + ++F   +    + I + APE  +E   S   DV+S+GV+L E 
Sbjct: 151 NRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 210
Query: 120 FT 121
           FT
Sbjct: 211 FT 212

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 37/116 (31%), Positives = 58/116 (50%), Gaps = 5/116 (4%)
Query: 3   NGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMV 62
           NG L K++     F +   R     ++ SALEY H       IIH DLKP NILL+E+M 
Sbjct: 113 NGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH----GKGIIHRDLKPENILLNEDMH 167
Query: 63  AHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLME 118
             ++DFG +K+L            + T  Y++PE  +E       D+++ G ++ +
Sbjct: 168 IQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQ 223

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 29/81 (35%), Positives = 47/81 (58%)
Query: 41  SSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSE 100
           +S   IH DL   NILL E  V  + DFG+++ + +  D+V +      + +MAPE   +
Sbjct: 161 ASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD 220
Query: 101 GIVSAKCDVYSYGVLLMETFT 121
            + + + DV+S+GVLL E F+
Sbjct: 221 RVYTIQSDVWSFGVLLWEIFS 241

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 27/76 (35%), Positives = 44/76 (57%)
Query: 46  IHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSA 105
           +H DL   N+L+    V  + DFG+++ +    ++V +      + +MAPE   EGI + 
Sbjct: 194 VHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTI 253
Query: 106 KCDVYSYGVLLMETFT 121
           K DV+SYG+LL E F+
Sbjct: 254 KSDVWSYGILLWEIFS 269

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 38/132 (28%), Positives = 65/132 (49%), Gaps = 5/132 (3%)
Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           M NG L  +L    + F   + L +  DV  A+EY      S   +H DL   N L+++ 
Sbjct: 85  MANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE----SKQFLHRDLAARNCLVNDQ 140
Query: 61  MVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETF 120
            V  VSDFG+S+ + + E + +   +   + +  PE       S+K D++++GVL+ E +
Sbjct: 141 GVVKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIY 199
Query: 121 TRKRPTDEMFTG 132
           +  +   E FT 
Sbjct: 200 SLGKMPYERFTN 211

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 29/81 (35%), Positives = 47/81 (58%)
Query: 41  SSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSE 100
           +S   IH DL   NILL E  V  + DFG+++ + +  D+V +      + +MAPE   +
Sbjct: 156 ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD 215
Query: 101 GIVSAKCDVYSYGVLLMETFT 121
            + + + DV+S+GVLL E F+
Sbjct: 216 RVYTIQSDVWSFGVLLWEIFS 236

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 38/132 (28%), Positives = 65/132 (49%), Gaps = 5/132 (3%)
Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           M NG L  +L    + F   + L +  DV  A+EY      S   +H DL   N L+++ 
Sbjct: 81  MANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE----SKQFLHRDLAARNCLVNDQ 136
Query: 61  MVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETF 120
            V  VSDFG+S+ + + E + +   +   + +  PE       S+K D++++GVL+ E +
Sbjct: 137 GVVKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIY 195
Query: 121 TRKRPTDEMFTG 132
           +  +   E FT 
Sbjct: 196 SLGKMPYERFTN 207

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 29/81 (35%), Positives = 47/81 (58%)
Query: 41  SSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSE 100
           +S   IH DL   NILL E  V  + DFG+++ + +  D+V +      + +MAPE   +
Sbjct: 161 ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD 220
Query: 101 GIVSAKCDVYSYGVLLMETFT 121
            + + + DV+S+GVLL E F+
Sbjct: 221 RVYTIQSDVWSFGVLLWEIFS 241

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 29/81 (35%), Positives = 47/81 (58%)
Query: 41  SSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSE 100
           +S   IH DL   NILL E  V  + DFG+++ + +  D+V +      + +MAPE   +
Sbjct: 210 ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD 269
Query: 101 GIVSAKCDVYSYGVLLMETFT 121
            + + + DV+S+GVLL E F+
Sbjct: 270 RVYTIQSDVWSFGVLLWEIFS 290

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 29/81 (35%), Positives = 47/81 (58%)
Query: 41  SSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSE 100
           +S   IH DL   NILL E  V  + DFG+++ + +  D+V +      + +MAPE   +
Sbjct: 165 ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD 224
Query: 101 GIVSAKCDVYSYGVLLMETFT 121
            + + + DV+S+GVLL E F+
Sbjct: 225 RVYTIQSDVWSFGVLLWEIFS 245

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 29/81 (35%), Positives = 47/81 (58%)
Query: 41  SSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSE 100
           +S   IH DL   NILL E  V  + DFG+++ + +  D+V +      + +MAPE   +
Sbjct: 208 ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD 267
Query: 101 GIVSAKCDVYSYGVLLMETFT 121
            + + + DV+S+GVLL E F+
Sbjct: 268 RVYTIQSDVWSFGVLLWEIFS 288

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 29/81 (35%), Positives = 47/81 (58%)
Query: 41  SSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSE 100
           +S   IH DL   NILL E  V  + DFG+++ + +  D+V +      + +MAPE   +
Sbjct: 156 ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD 215
Query: 101 GIVSAKCDVYSYGVLLMETFT 121
            + + + DV+S+GVLL E F+
Sbjct: 216 RVYTIQSDVWSFGVLLWEIFS 236

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 29/81 (35%), Positives = 47/81 (58%)
Query: 41  SSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSE 100
           +S   IH DL   NILL E  V  + DFG+++ + +  D+V +      + +MAPE   +
Sbjct: 215 ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD 274
Query: 101 GIVSAKCDVYSYGVLLMETFT 121
            + + + DV+S+GVLL E F+
Sbjct: 275 RVYTIQSDVWSFGVLLWEIFS 295

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 29/81 (35%), Positives = 47/81 (58%)
Query: 41  SSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSE 100
           +S   IH DL   NILL E  V  + DFG+++ + +  D+V +      + +MAPE   +
Sbjct: 217 ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD 276
Query: 101 GIVSAKCDVYSYGVLLMETFT 121
            + + + DV+S+GVLL E F+
Sbjct: 277 RVYTIQSDVWSFGVLLWEIFS 297

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 38/132 (28%), Positives = 65/132 (49%), Gaps = 5/132 (3%)
Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           M NG L  +L    + F   + L +  DV  A+EY      S   +H DL   N L+++ 
Sbjct: 86  MANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE----SKQFLHRDLAARNCLVNDQ 141
Query: 61  MVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETF 120
            V  VSDFG+S+ + + E + +   +   + +  PE       S+K D++++GVL+ E +
Sbjct: 142 GVVKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIY 200
Query: 121 TRKRPTDEMFTG 132
           +  +   E FT 
Sbjct: 201 SLGKMPYERFTN 212

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 29/81 (35%), Positives = 47/81 (58%)
Query: 41  SSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSE 100
           +S   IH DL   NILL E  V  + DFG+++ + +  D+V +      + +MAPE   +
Sbjct: 167 ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD 226
Query: 101 GIVSAKCDVYSYGVLLMETFT 121
            + + + DV+S+GVLL E F+
Sbjct: 227 RVYTIQSDVWSFGVLLWEIFS 247

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 53/99 (53%), Gaps = 4/99 (4%)
Query: 23  LNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVT 82
           L ++ D  + +EY      S   IH DL   N L+ E  V  +SDFG+S+   +G    +
Sbjct: 216 LQMVGDAAAGMEY----LESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAAS 271
Query: 83  QTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT 121
             +    + + APE  + G  S++ DV+S+G+LL ETF+
Sbjct: 272 GGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFS 310

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 38/131 (29%), Positives = 65/131 (49%), Gaps = 5/131 (3%)
Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           M NG L  +L    + F   + L +  DV  A+EY      S   +H DL   N L+++ 
Sbjct: 86  MANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE----SKQFLHRDLAARNCLVNDQ 141
Query: 61  MVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETF 120
            V  VSDFG+S+ + + E + +   +   + +  PE       S+K D++++GVL+ E +
Sbjct: 142 GVVKVSDFGLSRYVLDDE-YTSSRGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIY 200
Query: 121 TRKRPTDEMFT 131
           +  +   E FT
Sbjct: 201 SLGKMPYERFT 211

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 38/131 (29%), Positives = 65/131 (49%), Gaps = 5/131 (3%)
Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           M NG L  +L    + F   + L +  DV  A+EY      S   +H DL   N L+++ 
Sbjct: 101 MANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE----SKQFLHRDLAARNCLVNDQ 156
Query: 61  MVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETF 120
            V  VSDFG+S+ + + E + +   +   + +  PE       S+K D++++GVL+ E +
Sbjct: 157 GVVKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIY 215
Query: 121 TRKRPTDEMFT 131
           +  +   E FT
Sbjct: 216 SLGKMPYERFT 226

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 57.8 bits (138), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 38/131 (29%), Positives = 65/131 (49%), Gaps = 5/131 (3%)
Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           M NG L  +L    + F   + L +  DV  A+EY      S   +H DL   N L+++ 
Sbjct: 92  MANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE----SKQFLHRDLAARNCLVNDQ 147
Query: 61  MVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETF 120
            V  VSDFG+S+ + + E + +   +   + +  PE       S+K D++++GVL+ E +
Sbjct: 148 GVVKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIY 206
Query: 121 TRKRPTDEMFT 131
           +  +   E FT
Sbjct: 207 SLGKMPYERFT 217

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 57.4 bits (137), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 29/81 (35%), Positives = 47/81 (58%)
Query: 41  SSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSE 100
           +S   IH DL   NILL E  V  + DFG+++ + +  D+V +      + +MAPE   +
Sbjct: 202 ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD 261
Query: 101 GIVSAKCDVYSYGVLLMETFT 121
            + + + DV+S+GVLL E F+
Sbjct: 262 RVYTIQSDVWSFGVLLWEIFS 282

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 57.4 bits (137), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 34/100 (34%), Positives = 53/100 (53%), Gaps = 9/100 (9%)
Query: 23  LNIMIDVGSALEYPHH----GHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGE 78
           L +M  +  AL+  H     GH+   ++H DLKP N+ LD      + DFG++++L   E
Sbjct: 114 LRVMTQLTLALKECHRRSDGGHT---VLHRDLKPANVFLDGKQNVKLGDFGLARILNHDE 170
Query: 79  DFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLME 118
           DF  +   + T  YM+PE  +    + K D++S G LL E
Sbjct: 171 DFAKE--FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYE 208

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 57.4 bits (137), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 28/79 (35%), Positives = 48/79 (60%), Gaps = 1/79 (1%)
Query: 46  IHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSA 105
           IH DL+  NIL+  ++V  ++DFG+++++ E  ++  +      I + APE  + G  + 
Sbjct: 133 IHRDLRAANILVSASLVCKIADFGLARVI-EDNEYTAREGAKFPIKWTAPEAINFGSFTI 191
Query: 106 KCDVYSYGVLLMETFTRKR 124
           K DV+S+G+LLME  T  R
Sbjct: 192 KSDVWSFGILLMEIVTYGR 210

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 57.4 bits (137), Expect = 6e-09,   Method: Composition-based stats.
 Identities = 36/104 (34%), Positives = 53/104 (50%), Gaps = 10/104 (9%)
Query: 25  IMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLD---ENMVAHVSDFGISKLLGEGEDFV 81
           ++ D+ SAL Y H       IIH DLKP NI+L    + ++  + D G +K L +GE   
Sbjct: 127 LLSDISSALRYLHENR----IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE--- 179
Query: 82  TQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRP 125
             T  + T+ Y+APE   +   +   D +S+G L  E  T  RP
Sbjct: 180 LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRP 223

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 57.4 bits (137), Expect = 6e-09,   Method: Composition-based stats.
 Identities = 36/104 (34%), Positives = 53/104 (50%), Gaps = 10/104 (9%)
Query: 25  IMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLD---ENMVAHVSDFGISKLLGEGEDFV 81
           ++ D+ SAL Y H       IIH DLKP NI+L    + ++  + D G +K L +GE   
Sbjct: 126 LLSDISSALRYLHENR----IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE--- 178
Query: 82  TQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRP 125
             T  + T+ Y+APE   +   +   D +S+G L  E  T  RP
Sbjct: 179 LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRP 222

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 38/131 (29%), Positives = 65/131 (49%), Gaps = 5/131 (3%)
Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           M NG L  +L    + F   + L +  DV  A+EY      S   +H DL   N L+++ 
Sbjct: 101 MANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE----SKQFLHRDLAARNCLVNDQ 156
Query: 61  MVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETF 120
            V  VSDFG+S+ + + E+  +   +   + +  PE       S+K D++++GVL+ E +
Sbjct: 157 GVVKVSDFGLSRYVLDDEE-TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIY 215
Query: 121 TRKRPTDEMFT 131
           +  +   E FT
Sbjct: 216 SLGKMPYERFT 226

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 57.0 bits (136), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 28/79 (35%), Positives = 48/79 (60%), Gaps = 1/79 (1%)
Query: 46  IHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSA 105
           IH DL+  NIL+  ++V  ++DFG+++++ E  ++  +      I + APE  + G  + 
Sbjct: 306 IHRDLRAANILVSASLVCKIADFGLARVI-EDNEYTAREGAKFPIKWTAPEAINFGSFTI 364
Query: 106 KCDVYSYGVLLMETFTRKR 124
           K DV+S+G+LLME  T  R
Sbjct: 365 KSDVWSFGILLMEIVTYGR 383

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 57.0 bits (136), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 53/99 (53%), Gaps = 4/99 (4%)
Query: 23  LNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVT 82
           L ++ D  + +EY      S   IH DL   N L+ E  V  +SDFG+S+   +G    +
Sbjct: 216 LQMVGDAAAGMEY----LESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAAS 271
Query: 83  QTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT 121
             +    + + APE  + G  S++ DV+S+G+LL ETF+
Sbjct: 272 GGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFS 310

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 57.0 bits (136), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 33/109 (30%), Positives = 54/109 (49%), Gaps = 4/109 (3%)
Query: 13  YNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISK 72
           Y  F  +   +     V   +E+     +S   IH DL   NILL E  V  + DFG+++
Sbjct: 141 YKDFLTLEHLIXYSFQVAKGMEF----LASRKXIHRDLAARNILLSEKNVVKICDFGLAR 196
Query: 73  LLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT 121
            + +  D V +      + +MAPE   + + + + DV+S+GVLL E F+
Sbjct: 197 DIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 56.6 bits (135), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 29/81 (35%), Positives = 46/81 (56%)
Query: 41  SSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSE 100
           +S   IH DL   NILL E  V  + DFG+++ + +  D V +      + +MAPE   +
Sbjct: 156 ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFD 215
Query: 101 GIVSAKCDVYSYGVLLMETFT 121
            + + + DV+S+GVLL E F+
Sbjct: 216 RVYTIQSDVWSFGVLLWEIFS 236

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 56.6 bits (135), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 29/81 (35%), Positives = 46/81 (56%)
Query: 41  SSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSE 100
           +S   IH DL   NILL E  V  + DFG+++ + +  D V +      + +MAPE   +
Sbjct: 165 ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFD 224
Query: 101 GIVSAKCDVYSYGVLLMETFT 121
            + + + DV+S+GVLL E F+
Sbjct: 225 RVYTIQSDVWSFGVLLWEIFS 245

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 56.6 bits (135), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 29/81 (35%), Positives = 46/81 (56%)
Query: 41  SSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSE 100
           +S   IH DL   NILL E  V  + DFG+++ + +  D V +      + +MAPE   +
Sbjct: 156 ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFD 215
Query: 101 GIVSAKCDVYSYGVLLMETFT 121
            + + + DV+S+GVLL E F+
Sbjct: 216 RVYTIQSDVWSFGVLLWEIFS 236

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 56.6 bits (135), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 29/81 (35%), Positives = 46/81 (56%)
Query: 41  SSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSE 100
           +S   IH DL   NILL E  V  + DFG+++ + +  D V +      + +MAPE   +
Sbjct: 165 ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFD 224
Query: 101 GIVSAKCDVYSYGVLLMETFT 121
            + + + DV+S+GVLL E F+
Sbjct: 225 RVYTIQSDVWSFGVLLWEIFS 245

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 56.6 bits (135), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 44/174 (25%), Positives = 78/174 (44%), Gaps = 24/174 (13%)
Query: 21  ERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF 80
           + L+I   + S + Y     +S   +H DL   N L+  N++  + DFG+S+ +   + +
Sbjct: 134 QMLHIASQIASGMVYL----ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYY 189
Query: 81  VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTR-KRPTDEMFTGEMSLRRW 139
                TM  I +M PE       + + DV+S+GV+L E FT  K+P             W
Sbjct: 190 RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP-------------W 236
Query: 140 VKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTD 193
            + S     TEV++   + + +       C   + D+ L C    P +R+N+ +
Sbjct: 237 FQLS----NTEVIEC--ITQGRVLERPRVCPKEVYDVMLGCWQREPQQRLNIKE 284

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 37/122 (30%), Positives = 60/122 (49%), Gaps = 5/122 (4%)
Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           +P GSL ++L  +    D ++ L     +   +EY      +   IH DL   NIL++  
Sbjct: 98  LPYGSLREYLQKHKERIDHIKLLQYTSQICKGMEY----LGTKRYIHRDLATRNILVENE 153
Query: 61  MVAHVSDFGISKLLGE-GEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMET 119
               + DFG++K+L +  E    +    + I + APE  +E   S   DV+S+GV+L E 
Sbjct: 154 NRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 213
Query: 120 FT 121
           FT
Sbjct: 214 FT 215

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/131 (32%), Positives = 63/131 (48%), Gaps = 17/131 (12%)
Query: 4   GSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDE---- 59
           G L + L       DIL  +N  + +   + Y  H  +  PIIH DLK +NIL+ +    
Sbjct: 91  GPLNRVLSGKRIPPDIL--VNWAVQIARGMNY-LHDEAIVPIIHRDLKSSNILILQKVEN 147
Query: 60  ----NMVAHVSDFGISKLLGEGEDFVTQTMTMA-TIGYMAPEYGSEGIVSAKCDVYSYGV 114
               N +  ++DFG+++     E   T  M+ A    +MAPE     + S   DV+SYGV
Sbjct: 148 GDLSNKILKITDFGLAR-----EWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGV 202
Query: 115 LLMETFTRKRP 125
           LL E  T + P
Sbjct: 203 LLWELLTGEVP 213

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 51/99 (51%), Gaps = 5/99 (5%)
Query: 23  LNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVT 82
           L +   + SA+EY    +     IH DL   N L+ EN +  V+DFG+S+L+  G+ F  
Sbjct: 112 LYMATQISSAMEYLEKKN----FIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTFTA 166
Query: 83  QTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT 121
                  I + APE  +    S K DV+++GVLL E  T
Sbjct: 167 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 205

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 70/148 (47%), Gaps = 23/148 (15%)
Query: 22  RLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILL---DEN--MVAHVSDFGISKLLGE 76
           +L +M+D+   +EY  +   + PI+H DL+  NI L   DEN  + A V+DFG+S+    
Sbjct: 124 KLRLMLDIALGIEYMQN--QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ---- 177
Query: 77  GEDFVTQTMTMATIGYMAPEY--GSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTG-- 132
            +   + +  +    +MAPE     E   + K D YS+ ++L    T + P DE   G  
Sbjct: 178 -QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI 236
Query: 133 -------EMSLRRWVKESLPHGLTEVVD 153
                  E  LR  + E  P  L  V++
Sbjct: 237 KFINMIREEGLRPTIPEDCPPRLRNVIE 264

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/163 (25%), Positives = 69/163 (42%), Gaps = 30/163 (18%)
Query: 45  IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVS 104
           ++H DL   NIL+ E     +SDFG+S+ + E + +V ++     + +MA E   + I +
Sbjct: 171 LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYT 230
Query: 105 AKCDVYSYGVLLMETFTRKR------PTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVR 158
            + DV+S+GVLL E  T         P + +F                        NL++
Sbjct: 231 TQSDVWSFGVLLWEIVTLGGNPYPGIPPERLF------------------------NLLK 266
Query: 159 EEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI 201
                    +C   +  L L C  + P KR    D +  L+K+
Sbjct: 267 TGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKM 309

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 29/81 (35%), Positives = 46/81 (56%)
Query: 41  SSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSE 100
           +S   IH DL   NILL E  V  + DFG+++ + +  D V +      + +MAPE   +
Sbjct: 165 ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGDARLPLKWMAPETIFD 224
Query: 101 GIVSAKCDVYSYGVLLMETFT 121
            + + + DV+S+GVLL E F+
Sbjct: 225 RVYTIQSDVWSFGVLLWEIFS 245

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/144 (31%), Positives = 69/144 (47%), Gaps = 12/144 (8%)
Query: 18  DILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEG 77
           DIL +  I + +  ALE   H HS   +IH D+KP+N+L++      + DFGIS  L   
Sbjct: 109 DILGK--IAVSIVKALE---HLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL--- 160
Query: 78  EDFVTQTMTMATIGYMAPEYGSEGI----VSAKCDVYSYGVLLMETFTRKRPTDEMFTGE 133
            D V + +      YMAPE  +  +     S K D++S G+ ++E    + P D   T  
Sbjct: 161 VDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPF 220
Query: 134 MSLRRWVKESLPHGLTEVVDANLV 157
             L++ V+E  P    +   A  V
Sbjct: 221 QQLKQVVEEPSPQLPADKFSAEFV 244

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 38/89 (42%), Positives = 48/89 (53%), Gaps = 5/89 (5%)
Query: 38  HGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTM-ATIGYMAPE 96
           H HS   II+ DLKP NILLDE     ++DFG+SK   E  D   +  +   T+ YMAPE
Sbjct: 145 HLHSLG-IIYRDLKPENILLDEEGHIKLTDFGLSK---EAIDHEKKAYSFCGTVEYMAPE 200
Query: 97  YGSEGIVSAKCDVYSYGVLLMETFTRKRP 125
             +    S   D +SYGVL+ E  T   P
Sbjct: 201 VVNRQGHSHSADWWSYGVLMFEMLTGSLP 229

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 51/99 (51%), Gaps = 5/99 (5%)
Query: 23  LNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVT 82
           L +   + SA+EY    +     IH DL   N L+ EN V  V+DFG+S+L+  G+ +  
Sbjct: 133 LYMATQISSAMEYLEKKN----FIHRDLAARNCLVGENHVVKVADFGLSRLM-TGDTYTA 187
Query: 83  QTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT 121
                  I + APE  +    S K DV+++GVLL E  T
Sbjct: 188 HAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIAT 226

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 37/117 (31%), Positives = 60/117 (51%), Gaps = 10/117 (8%)
Query: 11  YSYNYFFDILERLN------IMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAH 64
           YSYN   +  E+L+          V   +EY     +S   IH DL   N+L+ E+ V  
Sbjct: 124 YSYNPSHNPEEQLSSKDLVSCAYQVARGMEY----LASKKCIHRDLAARNVLVTEDNVMK 179
Query: 65  VSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT 121
           ++DFG+++ +   + +   T     + +MAPE   + I + + DV+S+GVLL E FT
Sbjct: 180 IADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 236

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 37/117 (31%), Positives = 60/117 (51%), Gaps = 10/117 (8%)
Query: 11  YSYNYFFDILERLN------IMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAH 64
           YSYN   +  E+L+          V   +EY     +S   IH DL   N+L+ E+ V  
Sbjct: 127 YSYNPSHNPEEQLSSKDLVSCAYQVARGMEY----LASKKCIHRDLAARNVLVTEDNVMK 182
Query: 65  VSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT 121
           ++DFG+++ +   + +   T     + +MAPE   + I + + DV+S+GVLL E FT
Sbjct: 183 IADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 239

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/124 (29%), Positives = 64/124 (51%), Gaps = 4/124 (3%)
Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           M NGSL  +L + +    I   +N ++D+ + +            IH DL+  NIL+ + 
Sbjct: 89  MENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDT 145
Query: 61  MVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETF 120
           +   ++DFG+++L+ E  ++  +      I + APE  + G  + K DV+S+G+LL E  
Sbjct: 146 LSCKIADFGLARLI-EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIV 204
Query: 121 TRKR 124
           T  R
Sbjct: 205 THGR 208

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 27/79 (34%), Positives = 46/79 (58%), Gaps = 1/79 (1%)
Query: 46  IHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSA 105
           IH DL+  NIL+ + +   ++DFG+++L+ E  ++  +      I + APE  + G  + 
Sbjct: 137 IHRDLRAANILVSDTLSCKIADFGLARLI-EDNEYTAREGAKFPIKWTAPEAINYGTFTI 195
Query: 106 KCDVYSYGVLLMETFTRKR 124
           K DV+S+G+LL E  T  R
Sbjct: 196 KSDVWSFGILLTEIVTHGR 214

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 27/79 (34%), Positives = 46/79 (58%), Gaps = 1/79 (1%)
Query: 46  IHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSA 105
           IH DL+  NIL+ + +   ++DFG+++L+ E  ++  +      I + APE  + G  + 
Sbjct: 136 IHRDLRAANILVSDTLSCKIADFGLARLI-EDNEYTAREGAKFPIKWTAPEAINYGTFTI 194
Query: 106 KCDVYSYGVLLMETFTRKR 124
           K DV+S+G+LL E  T  R
Sbjct: 195 KSDVWSFGILLTEIVTHGR 213

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/124 (29%), Positives = 64/124 (51%), Gaps = 4/124 (3%)
Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           M NGSL  +L + +    I   +N ++D+ + +            IH DL+  NIL+ + 
Sbjct: 84  MENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDT 140
Query: 61  MVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETF 120
           +   ++DFG+++L+ E  ++  +      I + APE  + G  + K DV+S+G+LL E  
Sbjct: 141 LSCKIADFGLARLI-EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIV 199
Query: 121 TRKR 124
           T  R
Sbjct: 200 THGR 203

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 37/117 (31%), Positives = 60/117 (51%), Gaps = 10/117 (8%)
Query: 11  YSYNYFFDILERLN------IMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAH 64
           YSYN   +  E+L+          V   +EY     +S   IH DL   N+L+ E+ V  
Sbjct: 128 YSYNPSHNPEEQLSSKDLVSCAYQVARGMEY----LASKKCIHRDLAARNVLVTEDNVMK 183
Query: 65  VSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT 121
           ++DFG+++ +   + +   T     + +MAPE   + I + + DV+S+GVLL E FT
Sbjct: 184 IADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 240

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 37/117 (31%), Positives = 60/117 (51%), Gaps = 10/117 (8%)
Query: 11  YSYNYFFDILERLN------IMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAH 64
           YSYN   +  E+L+          V   +EY     +S   IH DL   N+L+ E+ V  
Sbjct: 135 YSYNPSHNPEEQLSSKDLVSCAYQVARGMEY----LASKKCIHRDLAARNVLVTEDNVMK 190
Query: 65  VSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT 121
           ++DFG+++ +   + +   T     + +MAPE   + I + + DV+S+GVLL E FT
Sbjct: 191 IADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 27/79 (34%), Positives = 46/79 (58%), Gaps = 1/79 (1%)
Query: 46  IHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSA 105
           IH DL+  NIL+ + +   ++DFG+++L+ E  ++  +      I + APE  + G  + 
Sbjct: 141 IHRDLRAANILVSDTLSCKIADFGLARLI-EDNEYTAREGAKFPIKWTAPEAINYGTFTI 199
Query: 106 KCDVYSYGVLLMETFTRKR 124
           K DV+S+G+LL E  T  R
Sbjct: 200 KSDVWSFGILLTEIVTHGR 218

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 37/122 (30%), Positives = 59/122 (48%), Gaps = 5/122 (4%)
Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           +P GSL  +L  +    D ++ L     +   +EY      +   IH DL   NIL++  
Sbjct: 94  LPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEY----LGTKRYIHRDLATRNILVENE 149
Query: 61  MVAHVSDFGISKLLGE-GEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMET 119
               + DFG++K+L +  E    +    + I + APE  +E   S   DV+S+GV+L E 
Sbjct: 150 NRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 209
Query: 120 FT 121
           FT
Sbjct: 210 FT 211

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 37/117 (31%), Positives = 60/117 (51%), Gaps = 10/117 (8%)
Query: 11  YSYNYFFDILERLN------IMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAH 64
           YSYN   +  E+L+          V   +EY     +S   IH DL   N+L+ E+ V  
Sbjct: 135 YSYNPSHNPEEQLSSKDLVSCAYQVARGMEY----LASKKCIHRDLAARNVLVTEDNVMK 190
Query: 65  VSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT 121
           ++DFG+++ +   + +   T     + +MAPE   + I + + DV+S+GVLL E FT
Sbjct: 191 IADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 27/81 (33%), Positives = 47/81 (58%)
Query: 41  SSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSE 100
           +S   IH DL   N+L+ EN V  ++DFG+++ +   + +   T     + +MAPE   +
Sbjct: 174 ASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD 233
Query: 101 GIVSAKCDVYSYGVLLMETFT 121
            + + + DV+S+GVL+ E FT
Sbjct: 234 RVYTHQSDVWSFGVLMWEIFT 254

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 37/122 (30%), Positives = 59/122 (48%), Gaps = 5/122 (4%)
Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           +P GSL  +L  +    D ++ L     +   +EY      +   IH DL   NIL++  
Sbjct: 95  LPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEY----LGTKRYIHRDLATRNILVENE 150
Query: 61  MVAHVSDFGISKLLGE-GEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMET 119
               + DFG++K+L +  E    +    + I + APE  +E   S   DV+S+GV+L E 
Sbjct: 151 NRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 210
Query: 120 FT 121
           FT
Sbjct: 211 FT 212

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 27/81 (33%), Positives = 47/81 (58%)
Query: 41  SSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSE 100
           +S   IH DL   N+L+ EN V  ++DFG+++ +   + +   T     + +MAPE   +
Sbjct: 174 ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTTNGRLPVKWMAPEALFD 233
Query: 101 GIVSAKCDVYSYGVLLMETFT 121
            + + + DV+S+GVL+ E FT
Sbjct: 234 RVYTHQSDVWSFGVLMWEIFT 254

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 37/122 (30%), Positives = 59/122 (48%), Gaps = 5/122 (4%)
Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           +P GSL  +L  +    D ++ L     +   +EY      +   IH DL   NIL++  
Sbjct: 99  LPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEY----LGTKRYIHRDLATRNILVENE 154
Query: 61  MVAHVSDFGISKLLGE-GEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMET 119
               + DFG++K+L +  E    +    + I + APE  +E   S   DV+S+GV+L E 
Sbjct: 155 NRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 214
Query: 120 FT 121
           FT
Sbjct: 215 FT 216

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 37/122 (30%), Positives = 59/122 (48%), Gaps = 5/122 (4%)
Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           +P GSL  +L  +    D ++ L     +   +EY      +   IH DL   NIL++  
Sbjct: 93  LPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEY----LGTKRYIHRDLATRNILVENE 148
Query: 61  MVAHVSDFGISKLLGE-GEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMET 119
               + DFG++K+L +  E    +    + I + APE  +E   S   DV+S+GV+L E 
Sbjct: 149 NRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 208
Query: 120 FT 121
           FT
Sbjct: 209 FT 210

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 37/122 (30%), Positives = 59/122 (48%), Gaps = 5/122 (4%)
Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           +P GSL  +L  +    D ++ L     +   +EY      +   IH DL   NIL++  
Sbjct: 95  LPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEY----LGTKRYIHRDLATRNILVENE 150
Query: 61  MVAHVSDFGISKLLGE-GEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMET 119
               + DFG++K+L +  E    +    + I + APE  +E   S   DV+S+GV+L E 
Sbjct: 151 NRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 210
Query: 120 FT 121
           FT
Sbjct: 211 FT 212

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 37/122 (30%), Positives = 59/122 (48%), Gaps = 5/122 (4%)
Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           +P GSL  +L  +    D ++ L     +   +EY      +   IH DL   NIL++  
Sbjct: 98  LPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEY----LGTKRYIHRDLATRNILVENE 153
Query: 61  MVAHVSDFGISKLLGE-GEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMET 119
               + DFG++K+L +  E    +    + I + APE  +E   S   DV+S+GV+L E 
Sbjct: 154 NRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 213
Query: 120 FT 121
           FT
Sbjct: 214 FT 215

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 37/122 (30%), Positives = 59/122 (48%), Gaps = 5/122 (4%)
Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           +P GSL  +L  +    D ++ L     +   +EY      +   IH DL   NIL++  
Sbjct: 101 LPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEY----LGTKRYIHRDLATRNILVENE 156
Query: 61  MVAHVSDFGISKLLGE-GEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMET 119
               + DFG++K+L +  E    +    + I + APE  +E   S   DV+S+GV+L E 
Sbjct: 157 NRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 216
Query: 120 FT 121
           FT
Sbjct: 217 FT 218

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/117 (29%), Positives = 60/117 (51%), Gaps = 10/117 (8%)
Query: 4   GSLEKWLYSYN-YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMV 62
           G+LE+W+        D +  L +   +   ++Y H    S  +IH DLKP+NI L +   
Sbjct: 119 GTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIH----SKKLIHRDLKPSNIFLVDTKQ 174
Query: 63  AHVSDFG-ISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLME 118
             + DFG ++ L  +G+    +T +  T+ YM+PE  S      + D+Y+ G++L E
Sbjct: 175 VKIGDFGLVTSLKNDGK----RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAE 227

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 27/81 (33%), Positives = 47/81 (58%)
Query: 41  SSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSE 100
           +S   IH DL   N+L+ EN V  ++DFG+++ +   + +   T     + +MAPE   +
Sbjct: 174 ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD 233
Query: 101 GIVSAKCDVYSYGVLLMETFT 121
            + + + DV+S+GVL+ E FT
Sbjct: 234 RVYTHQSDVWSFGVLMWEIFT 254

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 37/122 (30%), Positives = 59/122 (48%), Gaps = 5/122 (4%)
Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           +P GSL  +L  +    D ++ L     +   +EY      +   IH DL   NIL++  
Sbjct: 100 LPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEY----LGTKRYIHRDLATRNILVENE 155
Query: 61  MVAHVSDFGISKLLGE-GEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMET 119
               + DFG++K+L +  E    +    + I + APE  +E   S   DV+S+GV+L E 
Sbjct: 156 NRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 215
Query: 120 FT 121
           FT
Sbjct: 216 FT 217

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 37/122 (30%), Positives = 59/122 (48%), Gaps = 5/122 (4%)
Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           +P GSL  +L  +    D ++ L     +   +EY      +   IH DL   NIL++  
Sbjct: 102 LPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEY----LGTKRYIHRDLATRNILVENE 157
Query: 61  MVAHVSDFGISKLLGE-GEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMET 119
               + DFG++K+L +  E    +    + I + APE  +E   S   DV+S+GV+L E 
Sbjct: 158 NRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 217
Query: 120 FT 121
           FT
Sbjct: 218 FT 219

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 25/81 (30%), Positives = 46/81 (56%)
Query: 41  SSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSE 100
           +S   IH D+   N+LL    VA + DFG+++ +    +++ +      + +MAPE   +
Sbjct: 177 ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFD 236
Query: 101 GIVSAKCDVYSYGVLLMETFT 121
            + + + DV+SYG+LL E F+
Sbjct: 237 CVYTVQSDVWSYGILLWEIFS 257

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 27/81 (33%), Positives = 47/81 (58%)
Query: 41  SSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSE 100
           +S   IH DL   N+L+ EN V  ++DFG+++ +   + +   T     + +MAPE   +
Sbjct: 174 ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD 233
Query: 101 GIVSAKCDVYSYGVLLMETFT 121
            + + + DV+S+GVL+ E FT
Sbjct: 234 RVYTHQSDVWSFGVLMWEIFT 254

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 37/122 (30%), Positives = 59/122 (48%), Gaps = 5/122 (4%)
Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           +P GSL  +L  +    D ++ L     +   +EY      +   IH DL   NIL++  
Sbjct: 113 LPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL----GTKRYIHRDLATRNILVENE 168
Query: 61  MVAHVSDFGISKLLGE-GEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMET 119
               + DFG++K+L +  E    +    + I + APE  +E   S   DV+S+GV+L E 
Sbjct: 169 NRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 228
Query: 120 FT 121
           FT
Sbjct: 229 FT 230

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 27/81 (33%), Positives = 47/81 (58%)
Query: 41  SSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSE 100
           +S   IH DL   N+L+ EN V  ++DFG+++ +   + +   T     + +MAPE   +
Sbjct: 220 ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD 279
Query: 101 GIVSAKCDVYSYGVLLMETFT 121
            + + + DV+S+GVL+ E FT
Sbjct: 280 RVYTHQSDVWSFGVLMWEIFT 300

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 37/122 (30%), Positives = 59/122 (48%), Gaps = 5/122 (4%)
Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           +P GSL  +L  +    D ++ L     +   +EY      +   IH DL   NIL++  
Sbjct: 126 LPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEY----LGTKRYIHRDLATRNILVENE 181
Query: 61  MVAHVSDFGISKLLGE-GEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMET 119
               + DFG++K+L +  E    +    + I + APE  +E   S   DV+S+GV+L E 
Sbjct: 182 NRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 241
Query: 120 FT 121
           FT
Sbjct: 242 FT 243

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 37/122 (30%), Positives = 59/122 (48%), Gaps = 5/122 (4%)
Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           +P GSL  +L  +    D ++ L     +   +EY      +   IH DL   NIL++  
Sbjct: 113 LPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL----GTKRYIHRDLATRNILVENE 168
Query: 61  MVAHVSDFGISKLLGE-GEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMET 119
               + DFG++K+L +  E    +    + I + APE  +E   S   DV+S+GV+L E 
Sbjct: 169 NRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 228
Query: 120 FT 121
           FT
Sbjct: 229 FT 230

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 27/81 (33%), Positives = 47/81 (58%)
Query: 41  SSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSE 100
           +S   IH DL   N+L+ EN V  ++DFG+++ +   + +   T     + +MAPE   +
Sbjct: 174 ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD 233
Query: 101 GIVSAKCDVYSYGVLLMETFT 121
            + + + DV+S+GVL+ E FT
Sbjct: 234 RVYTHQSDVWSFGVLMWEIFT 254

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 27/81 (33%), Positives = 47/81 (58%)
Query: 41  SSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSE 100
           +S   IH DL   N+L+ EN V  ++DFG+++ +   + +   T     + +MAPE   +
Sbjct: 163 ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD 222
Query: 101 GIVSAKCDVYSYGVLLMETFT 121
            + + + DV+S+GVL+ E FT
Sbjct: 223 RVYTHQSDVWSFGVLMWEIFT 243

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 37/122 (30%), Positives = 60/122 (49%), Gaps = 5/122 (4%)
Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           +P GSL  +L ++    D ++ L     +   +EY      +   IH DL   NIL++  
Sbjct: 98  LPYGSLRDYLQAHAERIDHIKLLQYTSQICKGMEY----LGTKRYIHRDLATRNILVENE 153
Query: 61  MVAHVSDFGISKLLGE-GEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMET 119
               + DFG++K+L +  E    +    + I + APE  +E   S   DV+S+GV+L E 
Sbjct: 154 NRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 213
Query: 120 FT 121
           FT
Sbjct: 214 FT 215

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 27/81 (33%), Positives = 47/81 (58%)
Query: 41  SSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSE 100
           +S   IH DL   N+L+ EN V  ++DFG+++ +   + +   T     + +MAPE   +
Sbjct: 161 ASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD 220
Query: 101 GIVSAKCDVYSYGVLLMETFT 121
            + + + DV+S+GVL+ E FT
Sbjct: 221 RVYTHQSDVWSFGVLMWEIFT 241

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 27/81 (33%), Positives = 47/81 (58%)
Query: 41  SSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSE 100
           +S   IH DL   N+L+ EN V  ++DFG+++ +   + +   T     + +MAPE   +
Sbjct: 174 ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD 233
Query: 101 GIVSAKCDVYSYGVLLMETFT 121
            + + + DV+S+GVL+ E FT
Sbjct: 234 RVYTHQSDVWSFGVLMWEIFT 254

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 69/148 (46%), Gaps = 23/148 (15%)
Query: 22  RLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILL---DEN--MVAHVSDFGISKLLGE 76
           +L +M+D+   +EY  +   + PI+H DL+  NI L   DEN  + A V+DFG S+    
Sbjct: 124 KLRLMLDIALGIEYMQN--QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ---- 177
Query: 77  GEDFVTQTMTMATIGYMAPEY--GSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTG-- 132
            +   + +  +    +MAPE     E   + K D YS+ ++L    T + P DE   G  
Sbjct: 178 -QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI 236
Query: 133 -------EMSLRRWVKESLPHGLTEVVD 153
                  E  LR  + E  P  L  V++
Sbjct: 237 KFINMIREEGLRPTIPEDCPPRLRNVIE 264

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 27/81 (33%), Positives = 47/81 (58%)
Query: 41  SSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSE 100
           +S   IH DL   N+L+ EN V  ++DFG+++ +   + +   T     + +MAPE   +
Sbjct: 174 ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD 233
Query: 101 GIVSAKCDVYSYGVLLMETFT 121
            + + + DV+S+GVL+ E FT
Sbjct: 234 RVYTHQSDVWSFGVLMWEIFT 254

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/122 (28%), Positives = 61/122 (50%), Gaps = 5/122 (4%)
Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           +P GSL  +L  +    D ++ L     +   +EY      +   IH +L   NIL++  
Sbjct: 96  LPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL----GTKRYIHRNLATRNILVENE 151
Query: 61  MVAHVSDFGISKLLGEGEDFV-TQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMET 119
               + DFG++K+L + +++   +    + I + APE  +E   S   DV+S+GV+L E 
Sbjct: 152 NRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 211
Query: 120 FT 121
           FT
Sbjct: 212 FT 213

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 27/81 (33%), Positives = 47/81 (58%)
Query: 41  SSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSE 100
           +S   IH DL   N+L+ EN V  ++DFG+++ +   + +   T     + +MAPE   +
Sbjct: 166 ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD 225
Query: 101 GIVSAKCDVYSYGVLLMETFT 121
            + + + DV+S+GVL+ E FT
Sbjct: 226 RVYTHQSDVWSFGVLMWEIFT 246

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 25/81 (30%), Positives = 46/81 (56%)
Query: 41  SSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSE 100
           +S   IH D+   N+LL    VA + DFG+++ +    +++ +      + +MAPE   +
Sbjct: 181 ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFD 240
Query: 101 GIVSAKCDVYSYGVLLMETFT 121
            + + + DV+SYG+LL E F+
Sbjct: 241 CVYTVQSDVWSYGILLWEIFS 261

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 25/81 (30%), Positives = 46/81 (56%)
Query: 41  SSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSE 100
           +S   IH D+   N+LL    VA + DFG+++ +    +++ +      + +MAPE   +
Sbjct: 181 ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFD 240
Query: 101 GIVSAKCDVYSYGVLLMETFT 121
            + + + DV+SYG+LL E F+
Sbjct: 241 CVYTVQSDVWSYGILLWEIFS 261

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 25/81 (30%), Positives = 46/81 (56%)
Query: 41  SSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSE 100
           +S   IH D+   N+LL    VA + DFG+++ +    +++ +      + +MAPE   +
Sbjct: 169 ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFD 228
Query: 101 GIVSAKCDVYSYGVLLMETFT 121
            + + + DV+SYG+LL E F+
Sbjct: 229 CVYTVQSDVWSYGILLWEIFS 249

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 25/81 (30%), Positives = 46/81 (56%)
Query: 41  SSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSE 100
           +S   IH D+   N+LL    VA + DFG+++ +    +++ +      + +MAPE   +
Sbjct: 183 ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFD 242
Query: 101 GIVSAKCDVYSYGVLLMETFT 121
            + + + DV+SYG+LL E F+
Sbjct: 243 CVYTVQSDVWSYGILLWEIFS 263

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 39/138 (28%), Positives = 69/138 (50%), Gaps = 6/138 (4%)
Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           + NG L  +L S+    +  + L +  DV   + +      S   IH DL   N L+D +
Sbjct: 85  ISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFL----ESHQFIHRDLAARNCLVDRD 140
Query: 61  MVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETF 120
           +   VSDFG+++ + + + +V+   T   + + APE       S+K DV+++G+L+ E F
Sbjct: 141 LCVKVSDFGMTRYVLD-DQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVF 199
Query: 121 TR-KRPTDEMFTGEMSLR 137
           +  K P D     E+ L+
Sbjct: 200 SLGKMPYDLYTNSEVVLK 217

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 55/100 (55%), Gaps = 8/100 (8%)
Query: 32  ALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIG 91
           A+EY H       I+H DLKP N+LLD+N+   ++DFG+S ++ +G    T   +  +  
Sbjct: 120 AIEYCHRHK----IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKT---SCGSPN 172
Query: 92  YMAPEYGSEGIVSA-KCDVYSYGVLLMETFTRKRPTDEMF 130
           Y APE  +  + +  + DV+S G++L      + P D+ F
Sbjct: 173 YAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEF 212

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 51/99 (51%), Gaps = 5/99 (5%)
Query: 23  LNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVT 82
           L +   + SA+EY    +     IH DL   N L+ EN +  V+DFG+S+L+  G+ +  
Sbjct: 114 LYMATQISSAMEYLEKKN----FIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTA 168
Query: 83  QTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT 121
                  I + APE  +    S K DV+++GVLL E  T
Sbjct: 169 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 37/117 (31%), Positives = 60/117 (51%), Gaps = 10/117 (8%)
Query: 11  YSYNYFFDILERLN------IMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAH 64
           YSYN   +  E+L+          V   +EY     +S   IH DL   N+L+ E+ V  
Sbjct: 176 YSYNPSHNPEEQLSSKDLVSCAYQVARGMEY----LASKKCIHRDLAARNVLVTEDNVMK 231
Query: 65  VSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT 121
           ++DFG+++ +   + +   T     + +MAPE   + I + + DV+S+GVLL E FT
Sbjct: 232 IADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 51/99 (51%), Gaps = 5/99 (5%)
Query: 23  LNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVT 82
           L +   + SA+EY    +     IH DL   N L+ EN +  V+DFG+S+L+  G+ +  
Sbjct: 119 LYMATQISSAMEYLEKKN----FIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTA 173
Query: 83  QTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT 121
                  I + APE  +    S K DV+++GVLL E  T
Sbjct: 174 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 25/81 (30%), Positives = 46/81 (56%)
Query: 41  SSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSE 100
           +S   IH D+   N+LL    VA + DFG+++ +    +++ +      + +MAPE   +
Sbjct: 175 ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFD 234
Query: 101 GIVSAKCDVYSYGVLLMETFT 121
            + + + DV+SYG+LL E F+
Sbjct: 235 CVYTVQSDVWSYGILLWEIFS 255

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 51/99 (51%), Gaps = 5/99 (5%)
Query: 23  LNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVT 82
           L +   + SA+EY    +     IH DL   N L+ EN +  V+DFG+S+L+  G+ +  
Sbjct: 119 LYMATQISSAMEYLEKKN----FIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTA 173
Query: 83  QTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT 121
                  I + APE  +    S K DV+++GVLL E  T
Sbjct: 174 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 51/99 (51%), Gaps = 5/99 (5%)
Query: 23  LNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVT 82
           L +   + SA+EY    +     IH DL   N L+ EN +  V+DFG+S+L+  G+ +  
Sbjct: 116 LYMATQISSAMEYLEKKN----FIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTA 170
Query: 83  QTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT 121
                  I + APE  +    S K DV+++GVLL E  T
Sbjct: 171 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 209

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 51/93 (54%), Gaps = 2/93 (2%)
Query: 45  IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFV-TQTMTMATIGYMAPEYGSEGIV 103
            +H DL   N+LL     A +SDFG+SK L   E++   QT     + + APE  +    
Sbjct: 128 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF 187
Query: 104 SAKCDVYSYGVLLMETFTR-KRPTDEMFTGEMS 135
           S+K DV+S+GVL+ E F+  ++P   M   E++
Sbjct: 188 SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT 220

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 51/99 (51%), Gaps = 5/99 (5%)
Query: 23  LNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVT 82
           L +   + SA+EY    +     IH DL   N L+ EN +  V+DFG+S+L+  G+ +  
Sbjct: 119 LYMATQISSAMEYLEKKN----FIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTA 173
Query: 83  QTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT 121
                  I + APE  +    S K DV+++GVLL E  T
Sbjct: 174 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 36/124 (29%), Positives = 63/124 (50%), Gaps = 4/124 (3%)
Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           M NGSL  +L + +    I   +N ++D+ + +            IH DL+  NIL+ + 
Sbjct: 89  MENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDT 145
Query: 61  MVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETF 120
           +   ++DFG+++L+ + E    +      I + APE  + G  + K DV+S+G+LL E  
Sbjct: 146 LSCKIADFGLARLIEDNEXTAREGAKFP-IKWTAPEAINYGTFTIKSDVWSFGILLTEIV 204
Query: 121 TRKR 124
           T  R
Sbjct: 205 THGR 208

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 51/99 (51%), Gaps = 5/99 (5%)
Query: 23  LNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVT 82
           L +   + SA+EY    +     IH DL   N L+ EN +  V+DFG+S+L+  G+ +  
Sbjct: 119 LYMATQISSAMEYLEKKN----FIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTA 173
Query: 83  QTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT 121
                  I + APE  +    S K DV+++GVLL E  T
Sbjct: 174 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 27/79 (34%), Positives = 45/79 (56%), Gaps = 1/79 (1%)
Query: 46  IHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSA 105
           IH DL+  NIL+ + +   ++DFG+++L+ + E    +      I + APE  + G  + 
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFP-IKWTAPEAINYGTFTI 189
Query: 106 KCDVYSYGVLLMETFTRKR 124
           K DV+S+G+LL E  T  R
Sbjct: 190 KSDVWSFGILLTEIVTHGR 208

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 51/93 (54%), Gaps = 2/93 (2%)
Query: 45  IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFV-TQTMTMATIGYMAPEYGSEGIV 103
            +H DL   N+LL     A +SDFG+SK L   E++   QT     + + APE  +    
Sbjct: 146 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF 205
Query: 104 SAKCDVYSYGVLLMETFTR-KRPTDEMFTGEMS 135
           S+K DV+S+GVL+ E F+  ++P   M   E++
Sbjct: 206 SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT 238

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 51/99 (51%), Gaps = 5/99 (5%)
Query: 23  LNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVT 82
           L +   + SA+EY    +     IH DL   N L+ EN +  V+DFG+S+L+  G+ +  
Sbjct: 114 LYMATQISSAMEYLEKKN----FIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTA 168
Query: 83  QTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT 121
                  I + APE  +    S K DV+++GVLL E  T
Sbjct: 169 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 51/99 (51%), Gaps = 5/99 (5%)
Query: 23  LNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVT 82
           L +   + SA+EY    +     IH DL   N L+ EN +  V+DFG+S+L+  G+ +  
Sbjct: 114 LYMATQISSAMEYLEKKN----FIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTA 168
Query: 83  QTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT 121
                  I + APE  +    S K DV+++GVLL E  T
Sbjct: 169 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 51/99 (51%), Gaps = 5/99 (5%)
Query: 23  LNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVT 82
           L +   + SA+EY    +     IH DL   N L+ EN +  V+DFG+S+L+  G+ +  
Sbjct: 114 LYMATQISSAMEYLEKKN----FIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTA 168
Query: 83  QTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT 121
                  I + APE  +    S K DV+++GVLL E  T
Sbjct: 169 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 51/99 (51%), Gaps = 5/99 (5%)
Query: 23  LNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVT 82
           L +   + SA+EY    +     IH DL   N L+ EN +  V+DFG+S+L+  G+ +  
Sbjct: 116 LYMATQISSAMEYLEKKN----FIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTA 170
Query: 83  QTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT 121
                  I + APE  +    S K DV+++GVLL E  T
Sbjct: 171 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 209

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 51/99 (51%), Gaps = 5/99 (5%)
Query: 23  LNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVT 82
           L +   + SA+EY    +     IH DL   N L+ EN +  V+DFG+S+L+  G+ +  
Sbjct: 114 LYMATQISSAMEYLEKKN----FIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTA 168
Query: 83  QTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT 121
                  I + APE  +    S K DV+++GVLL E  T
Sbjct: 169 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 51/99 (51%), Gaps = 5/99 (5%)
Query: 23  LNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVT 82
           L +   + SA+EY    +     IH DL   N L+ EN +  V+DFG+S+L+  G+ +  
Sbjct: 114 LYMATQISSAMEYLEKKN----FIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTA 168
Query: 83  QTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT 121
                  I + APE  +    S K DV+++GVLL E  T
Sbjct: 169 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 51/99 (51%), Gaps = 5/99 (5%)
Query: 23  LNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVT 82
           L +   + SA+EY    +     IH DL   N L+ EN +  V+DFG+S+L+  G+ +  
Sbjct: 127 LYMATQISSAMEYLEKKN----FIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTA 181
Query: 83  QTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT 121
                  I + APE  +    S K DV+++GVLL E  T
Sbjct: 182 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 220

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 35/110 (31%), Positives = 59/110 (53%), Gaps = 8/110 (7%)
Query: 20  LERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED 79
           +E   +   + SA++Y H       ++H DLKP N+LLD +M A ++DFG+S ++ +GE 
Sbjct: 111 MEARRLFQQILSAVDYCH----RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF 166
Query: 80  FVTQTMTMATIGYMAPEYGSEGIVSA-KCDVYSYGVLLMETFTRKRPTDE 128
             T   +  +  Y APE  S  + +  + D++S GV+L        P D+
Sbjct: 167 LRT---SCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDD 213

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 36/124 (29%), Positives = 63/124 (50%), Gaps = 4/124 (3%)
Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           M NGSL  +L + +    I   +N ++D+ + +            IH DL+  NIL+ + 
Sbjct: 90  MENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDT 146
Query: 61  MVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETF 120
           +   ++DFG+++L+ + E    +      I + APE  + G  + K DV+S+G+LL E  
Sbjct: 147 LSCKIADFGLARLIEDNEXTAREGAKFP-IKWTAPEAINYGTFTIKSDVWSFGILLTEIV 205
Query: 121 TRKR 124
           T  R
Sbjct: 206 THGR 209

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 51/93 (54%), Gaps = 2/93 (2%)
Query: 45  IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFV-TQTMTMATIGYMAPEYGSEGIV 103
            +H DL   N+LL     A +SDFG+SK L   E++   QT     + + APE  +    
Sbjct: 132 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF 191
Query: 104 SAKCDVYSYGVLLMETFTR-KRPTDEMFTGEMS 135
           S+K DV+S+GVL+ E F+  ++P   M   E++
Sbjct: 192 SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT 224

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 51/99 (51%), Gaps = 5/99 (5%)
Query: 23  LNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVT 82
           L +   + SA+EY    +     IH DL   N L+ EN +  V+DFG+S+L+  G+ +  
Sbjct: 118 LYMATQISSAMEYLEKKN----FIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTA 172
Query: 83  QTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT 121
                  I + APE  +    S K DV+++GVLL E  T
Sbjct: 173 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 211

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 51/93 (54%), Gaps = 2/93 (2%)
Query: 45  IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFV-TQTMTMATIGYMAPEYGSEGIV 103
            +H DL   N+LL     A +SDFG+SK L   E++   QT     + + APE  +    
Sbjct: 138 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF 197
Query: 104 SAKCDVYSYGVLLMETFTR-KRPTDEMFTGEMS 135
           S+K DV+S+GVL+ E F+  ++P   M   E++
Sbjct: 198 SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT 230

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 27/79 (34%), Positives = 45/79 (56%), Gaps = 1/79 (1%)
Query: 46  IHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSA 105
           IH DL+  NIL+ + +   ++DFG+++L+ + E    +      I + APE  + G  + 
Sbjct: 133 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFP-IKWTAPEAINYGTFTI 191
Query: 106 KCDVYSYGVLLMETFTRKR 124
           K DV+S+G+LL E  T  R
Sbjct: 192 KSDVWSFGILLTEIVTHGR 210

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 27/79 (34%), Positives = 45/79 (56%), Gaps = 1/79 (1%)
Query: 46  IHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSA 105
           IH DL+  NIL+ + +   ++DFG+++L+ + E    +      I + APE  + G  + 
Sbjct: 137 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFP-IKWTAPEAINYGTFTI 195
Query: 106 KCDVYSYGVLLMETFTRKR 124
           K DV+S+G+LL E  T  R
Sbjct: 196 KSDVWSFGILLTEIVTHGR 214

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 27/79 (34%), Positives = 45/79 (56%), Gaps = 1/79 (1%)
Query: 46  IHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSA 105
           IH DL+  NIL+ + +   ++DFG+++L+ + E    +      I + APE  + G  + 
Sbjct: 139 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFP-IKWTAPEAINYGTFTI 197
Query: 106 KCDVYSYGVLLMETFTRKR 124
           K DV+S+G+LL E  T  R
Sbjct: 198 KSDVWSFGILLTEIVTHGR 216

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 51/93 (54%), Gaps = 2/93 (2%)
Query: 45  IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFV-TQTMTMATIGYMAPEYGSEGIV 103
            +H DL   N+LL     A +SDFG+SK L   E++   QT     + + APE  +    
Sbjct: 126 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF 185
Query: 104 SAKCDVYSYGVLLMETFTR-KRPTDEMFTGEMS 135
           S+K DV+S+GVL+ E F+  ++P   M   E++
Sbjct: 186 SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT 218

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 27/79 (34%), Positives = 45/79 (56%), Gaps = 1/79 (1%)
Query: 46  IHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSA 105
           IH DL+  NIL+ + +   ++DFG+++L+ + E    +      I + APE  + G  + 
Sbjct: 140 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFP-IKWTAPEAINYGTFTI 198
Query: 106 KCDVYSYGVLLMETFTRKR 124
           K DV+S+G+LL E  T  R
Sbjct: 199 KSDVWSFGILLTEIVTHGR 217

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 27/79 (34%), Positives = 45/79 (56%), Gaps = 1/79 (1%)
Query: 46  IHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSA 105
           IH DL+  NIL+ + +   ++DFG+++L+ + E    +      I + APE  + G  + 
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFP-IKWTAPEAINYGTFTI 189
Query: 106 KCDVYSYGVLLMETFTRKR 124
           K DV+S+G+LL E  T  R
Sbjct: 190 KSDVWSFGILLTEIVTHGR 208

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 30/78 (38%), Positives = 44/78 (56%), Gaps = 1/78 (1%)
Query: 45  IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFV-TQTMTMATIGYMAPEYGSEGIV 103
            +H DL   N+LL     A +SDFG+SK L   E++   QT     + + APE  +    
Sbjct: 148 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF 207
Query: 104 SAKCDVYSYGVLLMETFT 121
           S+K DV+S+GVL+ E F+
Sbjct: 208 SSKSDVWSFGVLMWEAFS 225

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 37/85 (43%), Positives = 45/85 (52%), Gaps = 8/85 (9%)
Query: 45  IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMA-TIGYMAPEYGSE--- 100
           IIH D+KP NILLDE+   H++DF I+ +L       TQ  TMA T  YMAPE  S    
Sbjct: 136 IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE----TQITTMAGTKPYMAPEMFSSRKG 191
Query: 101 GIVSAKCDVYSYGVLLMETFTRKRP 125
              S   D +S GV   E    +RP
Sbjct: 192 AGYSFAVDWWSLGVTAYELLRGRRP 216

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 30/78 (38%), Positives = 44/78 (56%), Gaps = 1/78 (1%)
Query: 45  IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFV-TQTMTMATIGYMAPEYGSEGIV 103
            +H DL   N+LL     A +SDFG+SK L   E++   QT     + + APE  +    
Sbjct: 148 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF 207
Query: 104 SAKCDVYSYGVLLMETFT 121
           S+K DV+S+GVL+ E F+
Sbjct: 208 SSKSDVWSFGVLMWEAFS 225

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 29/100 (29%), Positives = 53/100 (53%), Gaps = 4/100 (4%)
Query: 23  LNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVT 82
           +  M+D+   +EY     SS   IH DL   N +L E+M   V+DFG+S+ +  G+ +  
Sbjct: 140 VRFMVDIACGMEY----LSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQ 195
Query: 83  QTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTR 122
              +   + ++A E  ++ + +   DV+++GV + E  TR
Sbjct: 196 GCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTR 235

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 35/124 (28%), Positives = 56/124 (45%), Gaps = 7/124 (5%)
Query: 5   SLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAH 64
           SL K L+     F + + ++I       ++Y H    +  IIH D+K  NI L E +   
Sbjct: 117 SLYKHLHVQETKFQMFQLIDIARQTAQGMDYLH----AKNIIHRDMKSNNIFLHEGLTVK 172
Query: 65  VSDFGISKLLGEGEDFVTQTMTMATIGYMAPEY---GSEGIVSAKCDVYSYGVLLMETFT 121
           + DFG++ +               ++ +MAPE          S + DVYSYG++L E  T
Sbjct: 173 IGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMT 232
Query: 122 RKRP 125
            + P
Sbjct: 233 GELP 236

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 30/78 (38%), Positives = 44/78 (56%), Gaps = 1/78 (1%)
Query: 45  IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFV-TQTMTMATIGYMAPEYGSEGIV 103
            +H DL   N+LL     A +SDFG+SK L   E++   QT     + + APE  +    
Sbjct: 490 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF 549
Query: 104 SAKCDVYSYGVLLMETFT 121
           S+K DV+S+GVL+ E F+
Sbjct: 550 SSKSDVWSFGVLMWEAFS 567

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 28/81 (34%), Positives = 47/81 (58%)
Query: 41  SSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSE 100
           +S   IH DL   N+L+ E+ V  ++DFG+++ +   + +   T     + +MAPE   +
Sbjct: 152 ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD 211
Query: 101 GIVSAKCDVYSYGVLLMETFT 121
            I + + DV+S+GVLL E FT
Sbjct: 212 RIYTHQSDVWSFGVLLWEIFT 232

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 41/163 (25%), Positives = 68/163 (41%), Gaps = 30/163 (18%)
Query: 45  IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVS 104
           ++H DL   NIL+ E     +SDFG+S+ + E +  V ++     + +MA E   + I +
Sbjct: 171 LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYT 230
Query: 105 AKCDVYSYGVLLMETFTRKR------PTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVR 158
            + DV+S+GVLL E  T         P + +F                        NL++
Sbjct: 231 TQSDVWSFGVLLWEIVTLGGNPYPGIPPERLF------------------------NLLK 266
Query: 159 EEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI 201
                    +C   +  L L C  + P KR    D +  L+K+
Sbjct: 267 TGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKM 309

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 30/78 (38%), Positives = 44/78 (56%), Gaps = 1/78 (1%)
Query: 45  IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFV-TQTMTMATIGYMAPEYGSEGIV 103
            +H DL   N+LL     A +SDFG+SK L   E++   QT     + + APE  +    
Sbjct: 491 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF 550
Query: 104 SAKCDVYSYGVLLMETFT 121
           S+K DV+S+GVL+ E F+
Sbjct: 551 SSKSDVWSFGVLMWEAFS 568

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 51/99 (51%), Gaps = 5/99 (5%)
Query: 23  LNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVT 82
           L +   + SA+EY    +     IH DL   N L+ EN +  V+DFG+S+L+  G+ +  
Sbjct: 115 LYMATQISSAMEYLEKKN----FIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTA 169
Query: 83  QTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT 121
                  I + APE  +    S K DV+++GVLL E  T
Sbjct: 170 PAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 208

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 41/163 (25%), Positives = 68/163 (41%), Gaps = 30/163 (18%)
Query: 45  IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVS 104
           ++H DL   NIL+ E     +SDFG+S+ + E +  V ++     + +MA E   + I +
Sbjct: 171 LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYT 230
Query: 105 AKCDVYSYGVLLMETFTRKR------PTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVR 158
            + DV+S+GVLL E  T         P + +F                        NL++
Sbjct: 231 TQSDVWSFGVLLWEIVTLGGNPYPGIPPERLF------------------------NLLK 266
Query: 159 EEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI 201
                    +C   +  L L C  + P KR    D +  L+K+
Sbjct: 267 TGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKM 309

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 27/81 (33%), Positives = 46/81 (56%)
Query: 41  SSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSE 100
           +S   IH DL   N+L+ EN V  ++DFG+++ +   +     T     + +MAPE   +
Sbjct: 174 ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNGRLPVKWMAPEALFD 233
Query: 101 GIVSAKCDVYSYGVLLMETFT 121
            + + + DV+S+GVL+ E FT
Sbjct: 234 RVYTHQSDVWSFGVLMWEIFT 254

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 27/81 (33%), Positives = 46/81 (56%)
Query: 41  SSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSE 100
           +S   IH DL   N+L+ EN V  ++DFG+++ +   +     T     + +MAPE   +
Sbjct: 174 ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNGRLPVKWMAPEALFD 233
Query: 101 GIVSAKCDVYSYGVLLMETFT 121
            + + + DV+S+GVL+ E FT
Sbjct: 234 RVYTHQSDVWSFGVLMWEIFT 254

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 51/93 (54%), Gaps = 2/93 (2%)
Query: 45  IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED-FVTQTMTMATIGYMAPEYGSEGIV 103
            +H DL   N+LL     A +SDFG+SK L   E+ +  QT     + + APE  +    
Sbjct: 132 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVKWYAPECINYYKF 191
Query: 104 SAKCDVYSYGVLLMETFTR-KRPTDEMFTGEMS 135
           S+K DV+S+GVL+ E F+  ++P   M   E++
Sbjct: 192 SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT 224

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 51/99 (51%), Gaps = 5/99 (5%)
Query: 23  LNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVT 82
           L +   + SA+EY    +     IH DL   N L+ EN +  V+DFG+S+L+  G+ +  
Sbjct: 116 LYMATQISSAMEYLEKKN----FIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTA 170
Query: 83  QTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT 121
                  I + APE  +    S K DV+++GVLL E  T
Sbjct: 171 PAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 209

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 28/81 (34%), Positives = 47/81 (58%)
Query: 41  SSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSE 100
           +S   IH DL   N+L+ E+ V  ++DFG+++ +   + +   T     + +MAPE   +
Sbjct: 167 ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD 226
Query: 101 GIVSAKCDVYSYGVLLMETFT 121
            I + + DV+S+GVLL E FT
Sbjct: 227 RIYTHQSDVWSFGVLLWEIFT 247

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 25/76 (32%), Positives = 47/76 (61%), Gaps = 1/76 (1%)
Query: 46  IHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSA 105
           IH DL+  N+L+ E+++  ++DFG+++++ E  ++  +      I + APE  + G  + 
Sbjct: 132 IHRDLRAANVLVSESLMCKIADFGLARVI-EDNEYTAREGAKFPIKWTAPEAINFGCFTI 190
Query: 106 KCDVYSYGVLLMETFT 121
           K DV+S+G+LL E  T
Sbjct: 191 KSDVWSFGILLYEIVT 206

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 52/106 (49%), Gaps = 7/106 (6%)
Query: 19  ILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILL---DENMVAHVSDFGISKLLG 75
           +L+ L++  D+    +Y    H     IH D+   N LL       VA + DFG+++ + 
Sbjct: 146 MLDLLHVARDIACGCQYLEENH----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY 201
Query: 76  EGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT 121
               +      M  + +M PE   EGI ++K D +S+GVLL E F+
Sbjct: 202 RASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 247

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 52/106 (49%), Gaps = 7/106 (6%)
Query: 19  ILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILL---DENMVAHVSDFGISKLLG 75
           +L+ L++  D+    +Y    H     IH D+   N LL       VA + DFG+++ + 
Sbjct: 131 MLDLLHVARDIACGCQYLEENH----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY 186
Query: 76  EGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT 121
               +      M  + +M PE   EGI ++K D +S+GVLL E F+
Sbjct: 187 RASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 232

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 52/106 (49%), Gaps = 7/106 (6%)
Query: 19  ILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILL---DENMVAHVSDFGISKLLG 75
           +L+ L++  D+    +Y    H     IH D+   N LL       VA + DFG+++ + 
Sbjct: 139 MLDLLHVARDIACGCQYLEENH----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY 194
Query: 76  EGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT 121
               +      M  + +M PE   EGI ++K D +S+GVLL E F+
Sbjct: 195 RASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 29/100 (29%), Positives = 55/100 (55%), Gaps = 4/100 (4%)
Query: 23  LNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVT 82
           L  M+D+   +EY     S+   +H DL   N +L ++M   V+DFG+SK +  G+ +  
Sbjct: 150 LKFMVDIALGMEY----LSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQ 205
Query: 83  QTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTR 122
             +    + ++A E  ++ + ++K DV+++GV + E  TR
Sbjct: 206 GRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATR 245

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 52/106 (49%), Gaps = 7/106 (6%)
Query: 19  ILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILL---DENMVAHVSDFGISKLLG 75
           +L+ L++  D+    +Y    H     IH D+   N LL       VA + DFG+++ + 
Sbjct: 156 MLDLLHVARDIACGCQYLEENH----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY 211
Query: 76  EGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT 121
               +      M  + +M PE   EGI ++K D +S+GVLL E F+
Sbjct: 212 RASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 257

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 52/106 (49%), Gaps = 7/106 (6%)
Query: 19  ILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILL---DENMVAHVSDFGISKLLG 75
           +L+ L++  D+    +Y    H     IH D+   N LL       VA + DFG+++ + 
Sbjct: 139 MLDLLHVARDIACGCQYLEENH----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY 194
Query: 76  EGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT 121
               +      M  + +M PE   EGI ++K D +S+GVLL E F+
Sbjct: 195 RASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 37/101 (36%), Positives = 54/101 (53%), Gaps = 8/101 (7%)
Query: 26  MIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTM 85
           + ++  AL++ H    S  II+ DLKP NILLDE     ++DFG+SK   E  D   +  
Sbjct: 133 LAELALALDHLH----SLGIIYRDLKPENILLDEEGHIKLTDFGLSK---ESIDHEKKAY 185
Query: 86  TM-ATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRP 125
           +   T+ YMAPE  +    +   D +S+GVL+ E  T   P
Sbjct: 186 SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 226

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 35/124 (28%), Positives = 64/124 (51%), Gaps = 4/124 (3%)
Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           M NGSL  +L + +    I   +N ++D+ + +            IH +L+  NIL+ + 
Sbjct: 85  MENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEERNYIHRNLRAANILVSDT 141
Query: 61  MVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETF 120
           +   ++DFG+++L+ E  ++  +      I + APE  + G  + K DV+S+G+LL E  
Sbjct: 142 LSCKIADFGLARLI-EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIV 200
Query: 121 TRKR 124
           T  R
Sbjct: 201 THGR 204

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 37/101 (36%), Positives = 54/101 (53%), Gaps = 8/101 (7%)
Query: 26  MIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTM 85
           + ++  AL++ H    S  II+ DLKP NILLDE     ++DFG+SK   E  D   +  
Sbjct: 132 LAELALALDHLH----SLGIIYRDLKPENILLDEEGHIKLTDFGLSK---ESIDHEKKAY 184
Query: 86  TM-ATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRP 125
           +   T+ YMAPE  +    +   D +S+GVL+ E  T   P
Sbjct: 185 SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 52/106 (49%), Gaps = 7/106 (6%)
Query: 19  ILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILL---DENMVAHVSDFGISKLLG 75
           +L+ L++  D+    +Y    H     IH D+   N LL       VA + DFG+++ + 
Sbjct: 140 MLDLLHVARDIACGCQYLEENH----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY 195
Query: 76  EGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT 121
               +      M  + +M PE   EGI ++K D +S+GVLL E F+
Sbjct: 196 RASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 53.9 bits (128), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 52/106 (49%), Gaps = 7/106 (6%)
Query: 19  ILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLD---ENMVAHVSDFGISKLLG 75
           +L+ L++  D+    +Y    H     IH D+   N LL       VA + DFG+++ + 
Sbjct: 166 MLDLLHVARDIACGCQYLEENH----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY 221
Query: 76  EGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT 121
               +      M  + +M PE   EGI ++K D +S+GVLL E F+
Sbjct: 222 RASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 267

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 53.9 bits (128), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 52/106 (49%), Gaps = 7/106 (6%)
Query: 19  ILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILL---DENMVAHVSDFGISKLLG 75
           +L+ L++  D+    +Y    H     IH D+   N LL       VA + DFG+++ + 
Sbjct: 140 MLDLLHVARDIACGCQYLEENH----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY 195
Query: 76  EGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT 121
               +      M  + +M PE   EGI ++K D +S+GVLL E F+
Sbjct: 196 RASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 53.9 bits (128), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 52/106 (49%), Gaps = 7/106 (6%)
Query: 19  ILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILL---DENMVAHVSDFGISKLLG 75
           +L+ L++  D+    +Y    H     IH D+   N LL       VA + DFG+++ + 
Sbjct: 154 MLDLLHVARDIACGCQYLEENH----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY 209
Query: 76  EGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT 121
               +      M  + +M PE   EGI ++K D +S+GVLL E F+
Sbjct: 210 RASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 53.9 bits (128), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 47/149 (31%), Positives = 68/149 (45%), Gaps = 21/149 (14%)
Query: 2   PNGSLEKWLYSYNYFFDILERLNIMIDVGSAL---EYPHHGHSSAPIIHCDLKPTNILLD 58
           PNGSL K+L  +   +    RL   +  G A    E P   H    I H DL   N+L+ 
Sbjct: 95  PNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVK 154
Query: 59  ENMVAHVSDFGIS------KLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVS-------- 104
            +    +SDFG+S      +L+  GE+       + TI YMAPE   EG V+        
Sbjct: 155 NDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEV-LEGAVNLRDXESAL 213
Query: 105 AKCDVYSYGVLLMETFTRKRPTDEMFTGE 133
            + D+Y+ G++  E F R     ++F GE
Sbjct: 214 KQVDMYALGLIYWEIFMR---CTDLFPGE 239

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 53.9 bits (128), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 52/106 (49%), Gaps = 7/106 (6%)
Query: 19  ILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILL---DENMVAHVSDFGISKLLG 75
           +L+ L++  D+    +Y    H     IH D+   N LL       VA + DFG+++ + 
Sbjct: 154 MLDLLHVARDIACGCQYLEENH----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY 209
Query: 76  EGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT 121
               +      M  + +M PE   EGI ++K D +S+GVLL E F+
Sbjct: 210 RASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 53.9 bits (128), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 52/106 (49%), Gaps = 7/106 (6%)
Query: 19  ILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILL---DENMVAHVSDFGISKLLG 75
           +L+ L++  D+    +Y    H     IH D+   N LL       VA + DFG+++ + 
Sbjct: 154 MLDLLHVARDIACGCQYLEENH----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY 209
Query: 76  EGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT 121
               +      M  + +M PE   EGI ++K D +S+GVLL E F+
Sbjct: 210 RASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 37/101 (36%), Positives = 54/101 (53%), Gaps = 8/101 (7%)
Query: 26  MIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTM 85
           + ++  AL++ H    S  II+ DLKP NILLDE     ++DFG+SK   E  D   +  
Sbjct: 132 LAELALALDHLH----SLGIIYRDLKPENILLDEEGHIKLTDFGLSK---ESIDHEKKAY 184
Query: 86  TM-ATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRP 125
           +   T+ YMAPE  +    +   D +S+GVL+ E  T   P
Sbjct: 185 SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 53.5 bits (127), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 69/148 (46%), Gaps = 23/148 (15%)
Query: 22  RLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILL---DEN--MVAHVSDFGISKLLGE 76
           +L +M+D+   +EY  +   + PI+H DL+  NI L   DEN  + A V+DF +S+    
Sbjct: 124 KLRLMLDIALGIEYMQN--QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ---- 177
Query: 77  GEDFVTQTMTMATIGYMAPEY--GSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTG-- 132
            +   + +  +    +MAPE     E   + K D YS+ ++L    T + P DE   G  
Sbjct: 178 -QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI 236
Query: 133 -------EMSLRRWVKESLPHGLTEVVD 153
                  E  LR  + E  P  L  V++
Sbjct: 237 KFINMIREEGLRPTIPEDCPPRLRNVIE 264

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 53.5 bits (127), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 52/106 (49%), Gaps = 7/106 (6%)
Query: 19  ILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILL---DENMVAHVSDFGISKLLG 75
           +L+ L++  D+    +Y    H     IH D+   N LL       VA + DFG+++ + 
Sbjct: 140 MLDLLHVARDIACGCQYLEENH----FIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIY 195
Query: 76  EGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT 121
               +      M  + +M PE   EGI ++K D +S+GVLL E F+
Sbjct: 196 RASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 53.5 bits (127), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 35/127 (27%), Positives = 61/127 (48%), Gaps = 6/127 (4%)
Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           M +G L  ++ +  +   + + +   + V   ++Y     +S   +H DL   N +LDE 
Sbjct: 114 MKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL----ASKKFVHRDLAARNCMLDEK 169
Query: 61  MVAHVSDFGISKLLGEGEDFVTQTMTMAT--IGYMAPEYGSEGIVSAKCDVYSYGVLLME 118
               V+DFG+++ + + E +     T A   + +MA E       + K DV+S+GVLL E
Sbjct: 170 FTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWE 229
Query: 119 TFTRKRP 125
             TR  P
Sbjct: 230 LMTRGAP 236

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 53.5 bits (127), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 35/127 (27%), Positives = 61/127 (48%), Gaps = 6/127 (4%)
Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           M +G L  ++ +  +   + + +   + V   ++Y     +S   +H DL   N +LDE 
Sbjct: 112 MKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL----ASKKFVHRDLAARNCMLDEK 167
Query: 61  MVAHVSDFGISKLLGEGEDFVTQTMTMAT--IGYMAPEYGSEGIVSAKCDVYSYGVLLME 118
               V+DFG+++ + + E +     T A   + +MA E       + K DV+S+GVLL E
Sbjct: 168 FTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWE 227
Query: 119 TFTRKRP 125
             TR  P
Sbjct: 228 LMTRGAP 234

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 53.5 bits (127), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 35/87 (40%), Positives = 49/87 (56%), Gaps = 9/87 (10%)
Query: 32  ALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIG 91
           ALEY H    S  II+ DLKP NILLD+N    ++DFG +K + +    VT  +   T  
Sbjct: 118 ALEYLH----SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD----VTYXLC-GTPD 168
Query: 92  YMAPEYGSEGIVSAKCDVYSYGVLLME 118
           Y+APE  S    +   D +S+G+L+ E
Sbjct: 169 YIAPEVVSTKPYNKSIDWWSFGILIYE 195

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 53.5 bits (127), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 35/127 (27%), Positives = 61/127 (48%), Gaps = 6/127 (4%)
Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           M +G L  ++ +  +   + + +   + V   ++Y     +S   +H DL   N +LDE 
Sbjct: 113 MKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL----ASKKFVHRDLAARNCMLDEK 168
Query: 61  MVAHVSDFGISKLLGEGEDFVTQTMTMAT--IGYMAPEYGSEGIVSAKCDVYSYGVLLME 118
               V+DFG+++ + + E +     T A   + +MA E       + K DV+S+GVLL E
Sbjct: 169 FTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWE 228
Query: 119 TFTRKRP 125
             TR  P
Sbjct: 229 LMTRGAP 235

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 53.5 bits (127), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 50/93 (53%), Gaps = 4/93 (4%)
Query: 29  VGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMA 88
           V   +EY     +S   IH DL   N+L+ E+ V  ++DFG+++ +   +     T    
Sbjct: 159 VARGMEY----LASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTTNGRL 214
Query: 89  TIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT 121
            + +MAPE   + I + + DV+S+GVLL E FT
Sbjct: 215 PVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 53.5 bits (127), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 35/127 (27%), Positives = 61/127 (48%), Gaps = 6/127 (4%)
Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           M +G L  ++ +  +   + + +   + V   ++Y     +S   +H DL   N +LDE 
Sbjct: 109 MKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL----ASKKFVHRDLAARNCMLDEK 164
Query: 61  MVAHVSDFGISKLLGEGEDFVTQTMTMAT--IGYMAPEYGSEGIVSAKCDVYSYGVLLME 118
               V+DFG+++ + + E +     T A   + +MA E       + K DV+S+GVLL E
Sbjct: 165 FTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWE 224
Query: 119 TFTRKRP 125
             TR  P
Sbjct: 225 LMTRGAP 231

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 53.1 bits (126), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 35/127 (27%), Positives = 61/127 (48%), Gaps = 6/127 (4%)
Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           M +G L  ++ +  +   + + +   + V   ++Y     +S   +H DL   N +LDE 
Sbjct: 106 MKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKY----LASKKFVHRDLAARNCMLDEK 161
Query: 61  MVAHVSDFGISKLLGEGEDFVTQTMTMAT--IGYMAPEYGSEGIVSAKCDVYSYGVLLME 118
               V+DFG+++ + + E +     T A   + +MA E       + K DV+S+GVLL E
Sbjct: 162 FTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWE 221
Query: 119 TFTRKRP 125
             TR  P
Sbjct: 222 LMTRGAP 228

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 53.1 bits (126), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 35/127 (27%), Positives = 61/127 (48%), Gaps = 6/127 (4%)
Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           M +G L  ++ +  +   + + +   + V   ++Y     +S   +H DL   N +LDE 
Sbjct: 114 MKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL----ASKKFVHRDLAARNCMLDEK 169
Query: 61  MVAHVSDFGISKLLGEGEDFVTQTMTMAT--IGYMAPEYGSEGIVSAKCDVYSYGVLLME 118
               V+DFG+++ + + E +     T A   + +MA E       + K DV+S+GVLL E
Sbjct: 170 FTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWE 229
Query: 119 TFTRKRP 125
             TR  P
Sbjct: 230 LMTRGAP 236

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 53.1 bits (126), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 35/127 (27%), Positives = 61/127 (48%), Gaps = 6/127 (4%)
Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           M +G L  ++ +  +   + + +   + V   ++Y     +S   +H DL   N +LDE 
Sbjct: 111 MKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKY----LASKKFVHRDLAARNCMLDEK 166
Query: 61  MVAHVSDFGISKLLGEGEDFVTQTMTMAT--IGYMAPEYGSEGIVSAKCDVYSYGVLLME 118
               V+DFG+++ + + E +     T A   + +MA E       + K DV+S+GVLL E
Sbjct: 167 FTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWE 226
Query: 119 TFTRKRP 125
             TR  P
Sbjct: 227 LMTRGAP 233

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 53.1 bits (126), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 33/106 (31%), Positives = 52/106 (49%), Gaps = 14/106 (13%)
Query: 23  LNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED--- 79
           L+I I +  A+E+ H    S  ++H DLKP+NI    + V  V DFG+   + + E+   
Sbjct: 167 LHIFIQIAEAVEFLH----SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQT 222
Query: 80  -------FVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLME 118
                  + T    + T  YM+PE       S K D++S G++L E
Sbjct: 223 VLTPMPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFE 268

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 53.1 bits (126), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 35/127 (27%), Positives = 61/127 (48%), Gaps = 6/127 (4%)
Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           M +G L  ++ +  +   + + +   + V   ++Y     +S   +H DL   N +LDE 
Sbjct: 133 MKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKY----LASKKFVHRDLAARNCMLDEK 188
Query: 61  MVAHVSDFGISKLLGEGEDFVTQTMTMAT--IGYMAPEYGSEGIVSAKCDVYSYGVLLME 118
               V+DFG+++ + + E +     T A   + +MA E       + K DV+S+GVLL E
Sbjct: 189 FTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWE 248
Query: 119 TFTRKRP 125
             TR  P
Sbjct: 249 LMTRGAP 255

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 53.1 bits (126), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 52/106 (49%), Gaps = 7/106 (6%)
Query: 19  ILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILL---DENMVAHVSDFGISKLLG 75
           +L+ L++  D+    +Y    H     IH D+   N LL       VA + DFG+++ + 
Sbjct: 157 MLDLLHVARDIACGCQYLEENH----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY 212
Query: 76  EGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT 121
               +      M  + +M PE   EGI ++K D +S+GVLL E F+
Sbjct: 213 RAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 258

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 53.1 bits (126), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 35/127 (27%), Positives = 61/127 (48%), Gaps = 6/127 (4%)
Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           M +G L  ++ +  +   + + +   + V   ++Y     +S   +H DL   N +LDE 
Sbjct: 132 MKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKY----LASKKFVHRDLAARNCMLDEK 187
Query: 61  MVAHVSDFGISKLLGEGEDFVTQTMTMAT--IGYMAPEYGSEGIVSAKCDVYSYGVLLME 118
               V+DFG+++ + + E +     T A   + +MA E       + K DV+S+GVLL E
Sbjct: 188 FTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWE 247
Query: 119 TFTRKRP 125
             TR  P
Sbjct: 248 LMTRGAP 254

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 53.1 bits (126), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 52/106 (49%), Gaps = 7/106 (6%)
Query: 19  ILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILL---DENMVAHVSDFGISKLLG 75
           +L+ L++  D+    +Y    H     IH D+   N LL       VA + DFG+++ + 
Sbjct: 180 MLDLLHVARDIACGCQYLEENH----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY 235
Query: 76  EGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT 121
               +      M  + +M PE   EGI ++K D +S+GVLL E F+
Sbjct: 236 RAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 53.1 bits (126), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 50/99 (50%), Gaps = 5/99 (5%)
Query: 23  LNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVT 82
           L +   + SA+EY    +     IH DL   N L+ EN +  V+DFG+S+L+  G+    
Sbjct: 112 LYMATQISSAMEYLEKKN----FIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTXTA 166
Query: 83  QTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT 121
                  I + APE  +    S K DV+++GVLL E  T
Sbjct: 167 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 205

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 53.1 bits (126), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 35/110 (31%), Positives = 60/110 (54%), Gaps = 8/110 (7%)
Query: 20  LERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED 79
           +E   +   + SA++Y H       ++H DLKP N+LLD +M A ++DFG+S ++ +GE 
Sbjct: 111 MEARRLFQQILSAVDYCH----RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE- 165
Query: 80  FVTQTMTMATIGYMAPEYGSEGIVSA-KCDVYSYGVLLMETFTRKRPTDE 128
           F+    +  +  Y APE  S  + +  + D++S GV+L        P D+
Sbjct: 166 FLRD--SCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDD 213

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 50/99 (50%), Gaps = 5/99 (5%)
Query: 23  LNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVT 82
           L +   + SA+EY    +     IH DL   N L+ EN +  V+DFG+S+L+  G+    
Sbjct: 112 LYMATQISSAMEYLEKKN----FIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTXTA 166
Query: 83  QTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT 121
                  I + APE  +    S K DV+++GVLL E  T
Sbjct: 167 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 205

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 50/99 (50%), Gaps = 5/99 (5%)
Query: 23  LNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVT 82
           L +   + SA+EY    +     IH DL   N L+ EN +  V+DFG+S+L+  G+    
Sbjct: 119 LYMATQISSAMEYLEKKN----FIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTXTA 173
Query: 83  QTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT 121
                  I + APE  +    S K DV+++GVLL E  T
Sbjct: 174 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 50/99 (50%), Gaps = 5/99 (5%)
Query: 23  LNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVT 82
           L +   + SA+EY    +     IH DL   N L+ EN +  V+DFG+S+L+  G+    
Sbjct: 115 LYMATQISSAMEYLEKKN----FIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTXTA 169
Query: 83  QTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT 121
                  I + APE  +    S K DV+++GVLL E  T
Sbjct: 170 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 208

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 51/99 (51%), Gaps = 5/99 (5%)
Query: 23  LNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVT 82
           L +   + SA+EY    +     IH +L   N L+ EN +  V+DFG+S+L+  G+ +  
Sbjct: 321 LYMATQISSAMEYLEKKN----FIHRNLAARNCLVGENHLVKVADFGLSRLM-TGDTYTA 375
Query: 83  QTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT 121
                  I + APE  +    S K DV+++GVLL E  T
Sbjct: 376 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 414

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 25/81 (30%), Positives = 43/81 (53%)
Query: 41  SSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSE 100
           +S   IH DL   NILL    +  + DFG+++ +    ++V +      + +MAPE    
Sbjct: 185 ASKNCIHRDLAARNILLTHGRITKICDFGLARHIKNDSNYVVKGNARLPVKWMAPESIFN 244
Query: 101 GIVSAKCDVYSYGVLLMETFT 121
            + + + DV+SYG+ L E F+
Sbjct: 245 CVYTFESDVWSYGIFLWELFS 265

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 29/85 (34%), Positives = 48/85 (56%), Gaps = 4/85 (4%)
Query: 45  IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVS 104
           ++H DLKP N+LLD +M A ++DFG+S ++ +GE       +  +  Y APE  S  + +
Sbjct: 137 VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFL---RXSCGSPNYAAPEVISGRLYA 193
Query: 105 A-KCDVYSYGVLLMETFTRKRPTDE 128
             + D++S GV+L        P D+
Sbjct: 194 GPEVDIWSSGVILYALLCGTLPFDD 218

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 40/123 (32%), Positives = 57/123 (46%), Gaps = 19/123 (15%)
Query: 37  HHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPE 96
           +H   +  IIH D+KP+NILLD +    + DFGIS   G+  D + +T       YMAPE
Sbjct: 139 NHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGIS---GQLVDSIAKTRDAGCRPYMAPE 195
Query: 97  Y----GSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVV 152
                 S      + DV+S G+ L           E+ TG     +W   S+   LT+VV
Sbjct: 196 RIDPSASRQGYDVRSDVWSLGITLY----------ELATGRFPYPKW--NSVFDQLTQVV 243
Query: 153 DAN 155
             +
Sbjct: 244 KGD 246

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 51/99 (51%), Gaps = 5/99 (5%)
Query: 23  LNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVT 82
           L +   + SA+EY    +     IH +L   N L+ EN +  V+DFG+S+L+  G+ +  
Sbjct: 360 LYMATQISSAMEYLEKKN----FIHRNLAARNCLVGENHLVKVADFGLSRLM-TGDTYTA 414
Query: 83  QTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT 121
                  I + APE  +    S K DV+++GVLL E  T
Sbjct: 415 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 453

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/127 (27%), Positives = 60/127 (47%), Gaps = 6/127 (4%)
Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           M +G L  ++ +  +   + + +   + V   ++Y     +S   +H DL   N +LDE 
Sbjct: 113 MKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKY----LASKKFVHRDLAARNCMLDEK 168
Query: 61  MVAHVSDFGISKLLGEGEDFVTQTMTMAT--IGYMAPEYGSEGIVSAKCDVYSYGVLLME 118
               V+DFG+++ + + E       T A   + +MA E       + K DV+S+GVLL E
Sbjct: 169 FTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWE 228
Query: 119 TFTRKRP 125
             TR  P
Sbjct: 229 LMTRGAP 235

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 25/81 (30%), Positives = 43/81 (53%)
Query: 41  SSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSE 100
           +S   IH DL   NILL    +  + DFG+++ +    ++V +      + +MAPE    
Sbjct: 178 ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN 237
Query: 101 GIVSAKCDVYSYGVLLMETFT 121
            + + + DV+SYG+ L E F+
Sbjct: 238 CVYTFESDVWSYGIFLWELFS 258

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 25/81 (30%), Positives = 43/81 (53%)
Query: 41  SSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSE 100
           +S   IH DL   NILL    +  + DFG+++ +    ++V +      + +MAPE    
Sbjct: 180 ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN 239
Query: 101 GIVSAKCDVYSYGVLLMETFT 121
            + + + DV+SYG+ L E F+
Sbjct: 240 CVYTFESDVWSYGIFLWELFS 260

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 31/112 (27%), Positives = 55/112 (49%), Gaps = 7/112 (6%)
Query: 17  FDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGE 76
           F++++ ++I       ++Y H    +  IIH DLK  NI L E++   + DFG++ +   
Sbjct: 128 FEMIKLIDIARQTAQGMDYLH----AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSR 183
Query: 77  GEDFVTQTMTMATIGYMAPEY---GSEGIVSAKCDVYSYGVLLMETFTRKRP 125
                       +I +MAPE      +   S + DVY++G++L E  T + P
Sbjct: 184 WSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 235

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 31/112 (27%), Positives = 55/112 (49%), Gaps = 7/112 (6%)
Query: 17  FDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGE 76
           F++++ ++I       ++Y H    +  IIH DLK  NI L E++   + DFG++ +   
Sbjct: 129 FEMIKLIDIARQTAQGMDYLH----AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSR 184
Query: 77  GEDFVTQTMTMATIGYMAPEY---GSEGIVSAKCDVYSYGVLLMETFTRKRP 125
                       +I +MAPE      +   S + DVY++G++L E  T + P
Sbjct: 185 WSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 236

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 25/81 (30%), Positives = 43/81 (53%)
Query: 41  SSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSE 100
           +S   IH DL   NILL    +  + DFG+++ +    ++V +      + +MAPE    
Sbjct: 185 ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN 244
Query: 101 GIVSAKCDVYSYGVLLMETFT 121
            + + + DV+SYG+ L E F+
Sbjct: 245 CVYTFESDVWSYGIFLWELFS 265

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 52/106 (49%), Gaps = 14/106 (13%)
Query: 23  LNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED--- 79
           L+I + +  A+E+ H    S  ++H DLKP+NI    + V  V DFG+   + + E+   
Sbjct: 121 LHIFLQIAEAVEFLH----SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQT 176
Query: 80  -------FVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLME 118
                  +   T  + T  YM+PE       S K D++S G++L E
Sbjct: 177 VLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFE 222

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 39/158 (24%), Positives = 69/158 (43%), Gaps = 20/158 (12%)
Query: 45  IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVS 104
            +H DL   N L+ + +V  + DFG+S+ +   + +     TM  I +M PE       +
Sbjct: 179 FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFT 238
Query: 105 AKCDVYSYGVLLMETFTR-KRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAF 163
            + DV+S+GV+L E FT  K+P             W + S     TE +D   + + +  
Sbjct: 239 TESDVWSFGVVLWEIFTYGKQP-------------WYQLS----NTEAIDC--ITQGREL 279
Query: 164 AAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI 201
                C   +  +   C    P +R ++ D  A+L+ +
Sbjct: 280 ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQAL 317

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 31/112 (27%), Positives = 55/112 (49%), Gaps = 7/112 (6%)
Query: 17  FDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGE 76
           F++++ ++I       ++Y H    +  IIH DLK  NI L E++   + DFG++ +   
Sbjct: 106 FEMIKLIDIARQTAQGMDYLH----AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSR 161
Query: 77  GEDFVTQTMTMATIGYMAPEY---GSEGIVSAKCDVYSYGVLLMETFTRKRP 125
                       +I +MAPE      +   S + DVY++G++L E  T + P
Sbjct: 162 WSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 213

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 25/81 (30%), Positives = 43/81 (53%)
Query: 41  SSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSE 100
           +S   IH DL   NILL    +  + DFG+++ +    ++V +      + +MAPE    
Sbjct: 162 ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN 221
Query: 101 GIVSAKCDVYSYGVLLMETFT 121
            + + + DV+SYG+ L E F+
Sbjct: 222 CVYTFESDVWSYGIFLWELFS 242

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/144 (30%), Positives = 66/144 (45%), Gaps = 12/144 (8%)
Query: 18  DILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEG 77
           DIL +  I + +  ALE   H HS   +IH D+KP+N+L++        DFGIS  L   
Sbjct: 136 DILGK--IAVSIVKALE---HLHSKLSVIHRDVKPSNVLINALGQVKXCDFGISGYL--- 187
Query: 78  EDFVTQTMTMATIGYMAPEYGSEGI----VSAKCDVYSYGVLLMETFTRKRPTDEMFTGE 133
            D V + +      Y APE  +  +     S K D++S G+  +E    + P D   T  
Sbjct: 188 VDDVAKDIDAGCKPYXAPERINPELNQKGYSVKSDIWSLGITXIELAILRFPYDSWGTPF 247
Query: 134 MSLRRWVKESLPHGLTEVVDANLV 157
             L++ V+E  P    +   A  V
Sbjct: 248 QQLKQVVEEPSPQLPADKFSAEFV 271

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 31/112 (27%), Positives = 55/112 (49%), Gaps = 7/112 (6%)
Query: 17  FDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGE 76
           F++++ ++I       ++Y H    +  IIH DLK  NI L E++   + DFG++ +   
Sbjct: 101 FEMIKLIDIARQTAQGMDYLH----AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSR 156
Query: 77  GEDFVTQTMTMATIGYMAPEY---GSEGIVSAKCDVYSYGVLLMETFTRKRP 125
                       +I +MAPE      +   S + DVY++G++L E  T + P
Sbjct: 157 WSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 208

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 31/112 (27%), Positives = 55/112 (49%), Gaps = 7/112 (6%)
Query: 17  FDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGE 76
           F++++ ++I       ++Y H    +  IIH DLK  NI L E++   + DFG++ +   
Sbjct: 101 FEMIKLIDIARQTAQGMDYLH----AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSR 156
Query: 77  GEDFVTQTMTMATIGYMAPEY---GSEGIVSAKCDVYSYGVLLMETFTRKRP 125
                       +I +MAPE      +   S + DVY++G++L E  T + P
Sbjct: 157 WSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 208

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 31/112 (27%), Positives = 55/112 (49%), Gaps = 7/112 (6%)
Query: 17  FDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGE 76
           F++++ ++I       ++Y H    +  IIH DLK  NI L E++   + DFG++ +   
Sbjct: 106 FEMIKLIDIARQTAQGMDYLH----AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSR 161
Query: 77  GEDFVTQTMTMATIGYMAPEY---GSEGIVSAKCDVYSYGVLLMETFTRKRP 125
                       +I +MAPE      +   S + DVY++G++L E  T + P
Sbjct: 162 WSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 213

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 31/112 (27%), Positives = 55/112 (49%), Gaps = 7/112 (6%)
Query: 17  FDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGE 76
           F++++ ++I       ++Y H    +  IIH DLK  NI L E++   + DFG++ +   
Sbjct: 103 FEMIKLIDIARQTAQGMDYLH----AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSR 158
Query: 77  GEDFVTQTMTMATIGYMAPEY---GSEGIVSAKCDVYSYGVLLMETFTRKRP 125
                       +I +MAPE      +   S + DVY++G++L E  T + P
Sbjct: 159 WSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 210

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 39/158 (24%), Positives = 69/158 (43%), Gaps = 20/158 (12%)
Query: 45  IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVS 104
            +H DL   N L+ + +V  + DFG+S+ +   + +     TM  I +M PE       +
Sbjct: 150 FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFT 209
Query: 105 AKCDVYSYGVLLMETFTR-KRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAF 163
            + DV+S+GV+L E FT  K+P             W + S     TE +D   + + +  
Sbjct: 210 TESDVWSFGVVLWEIFTYGKQP-------------WYQLS----NTEAIDC--ITQGREL 250
Query: 164 AAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI 201
                C   +  +   C    P +R ++ D  A+L+ +
Sbjct: 251 ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQAL 288

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 24/76 (31%), Positives = 47/76 (61%), Gaps = 1/76 (1%)
Query: 46  IHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSA 105
           IH DL+  N+L+ E+++  ++DFG+++++ E  ++  +      I + APE  + G  + 
Sbjct: 131 IHRDLRAANVLVSESLMCKIADFGLARVI-EDNEYTAREGAKFPIKWTAPEAINFGCFTI 189
Query: 106 KCDVYSYGVLLMETFT 121
           K +V+S+G+LL E  T
Sbjct: 190 KSNVWSFGILLYEIVT 205

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 39/158 (24%), Positives = 69/158 (43%), Gaps = 20/158 (12%)
Query: 45  IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVS 104
            +H DL   N L+ + +V  + DFG+S+ +   + +     TM  I +M PE       +
Sbjct: 156 FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFT 215
Query: 105 AKCDVYSYGVLLMETFTR-KRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAF 163
            + DV+S+GV+L E FT  K+P             W + S     TE +D   + + +  
Sbjct: 216 TESDVWSFGVVLWEIFTYGKQP-------------WYQLS----NTEAIDC--ITQGREL 256
Query: 164 AAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI 201
                C   +  +   C    P +R ++ D  A+L+ +
Sbjct: 257 ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQAL 294

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/162 (25%), Positives = 67/162 (41%), Gaps = 20/162 (12%)
Query: 41  SSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSE 100
           +S   +H DL   N L+ EN++  + DFG+S+ +   + +     TM  I +M PE    
Sbjct: 145 ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY 204
Query: 101 GIVSAKCDVYSYGVLLMETFTR-KRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVRE 159
              + + DV+S GV+L E FT  K+P  ++   E      V E +  G            
Sbjct: 205 RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE------VIECITQG------------ 246
Query: 160 EQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI 201
            +       C   + +L L C    P  R N+      L+ +
Sbjct: 247 -RVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNL 287

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 29/79 (36%), Positives = 45/79 (56%), Gaps = 11/79 (13%)
Query: 46  IHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSA 105
           IH DL+  NIL+  ++V  ++DFG++++   G  F         I + APE  + G  + 
Sbjct: 300 IHRDLRAANILVSASLVCKIADFGLARV---GAKF--------PIKWTAPEAINFGSFTI 348
Query: 106 KCDVYSYGVLLMETFTRKR 124
           K DV+S+G+LLME  T  R
Sbjct: 349 KSDVWSFGILLMEIVTYGR 367

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 50/100 (50%), Gaps = 9/100 (9%)
Query: 23  LNIMIDVGSALEYPHH----GHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGE 78
           L +M  +  AL+  H     GH+   ++H DLKP N+ LD      + DFG++++L    
Sbjct: 114 LRVMTQLTLALKECHRRSDGGHT---VLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT 170
Query: 79  DFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLME 118
            F      + T  YM+PE  +    + K D++S G LL E
Sbjct: 171 SFA--KTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYE 208

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 39/109 (35%), Positives = 52/109 (47%), Gaps = 25/109 (22%)
Query: 21  ERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF 80
           E  +IM  +  A+ + H  +    I+H DLKP NILLD+NM   +SDFG S  L  GE  
Sbjct: 201 ETRSIMRSLLEAVSFLHANN----IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKL 256
Query: 81  VTQTMTMATIGYMAPE------------YGSEGIVSAKCDVYSYGVLLM 117
                   T GY+APE            YG E       D+++ GV+L 
Sbjct: 257 RE---LCGTPGYLAPEILKCSMDETHPGYGKE------VDLWACGVILF 296

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 50/100 (50%), Gaps = 9/100 (9%)
Query: 23  LNIMIDVGSALEYPHH----GHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGE 78
           L +M  +  AL+  H     GH+   ++H DLKP N+ LD      + DFG++++L    
Sbjct: 114 LRVMTQLTLALKECHRRSDGGHT---VLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT 170
Query: 79  DFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLME 118
            F      + T  YM+PE  +    + K D++S G LL E
Sbjct: 171 SFAKA--FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYE 208

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 34/106 (32%), Positives = 50/106 (47%), Gaps = 8/106 (7%)
Query: 24  NIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQ 83
            I+ +V   LEY H        IH D+K  NILL E+    ++DFG+S  L  G D    
Sbjct: 125 TILREVLEGLEYLHKNGQ----IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRN 180
Query: 84  TMTMATIG---YMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKRP 125
            +    +G   +MAPE   +      K D++S+G+  +E  T   P
Sbjct: 181 KVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP 226

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 31/101 (30%), Positives = 50/101 (49%), Gaps = 4/101 (3%)
Query: 21  ERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF 80
           E+L I   V + + Y     S    +H DL   N L+ ENMV  ++DFG+S+ +   + +
Sbjct: 175 EQLCIARQVAAGMAY----LSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY 230
Query: 81  VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT 121
                    I +M PE       + + DV++YGV+L E F+
Sbjct: 231 KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 34/106 (32%), Positives = 50/106 (47%), Gaps = 8/106 (7%)
Query: 24  NIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQ 83
            I+ +V   LEY H        IH D+K  NILL E+    ++DFG+S  L  G D    
Sbjct: 120 TILREVLEGLEYLHKNGQ----IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRN 175
Query: 84  TMTMATIG---YMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKRP 125
            +    +G   +MAPE   +      K D++S+G+  +E  T   P
Sbjct: 176 KVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP 221

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 51.2 bits (121), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 48/87 (55%), Gaps = 2/87 (2%)
Query: 45  IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVT-QTMTMATIGYMAPEYGSEGIV 103
            +H DL   N+LL     A +SDFG+SK LG  + + T ++     + + APE  +    
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF 190
Query: 104 SAKCDVYSYGVLLMETFTR-KRPTDEM 129
           S++ DV+SYGV + E  +  ++P  +M
Sbjct: 191 SSRSDVWSYGVTMWEALSYGQKPYKKM 217

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 50.8 bits (120), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 31/112 (27%), Positives = 54/112 (48%), Gaps = 7/112 (6%)
Query: 17  FDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGE 76
           F++++ ++I       ++Y H    +  IIH DLK  NI L E++   + DFG++     
Sbjct: 129 FEMIKLIDIARQTAQGMDYLH----AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSR 184
Query: 77  GEDFVTQTMTMATIGYMAPEY---GSEGIVSAKCDVYSYGVLLMETFTRKRP 125
                       +I +MAPE      +   S + DVY++G++L E  T + P
Sbjct: 185 WSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 236

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 50.8 bits (120), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 31/112 (27%), Positives = 54/112 (48%), Gaps = 7/112 (6%)
Query: 17  FDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGE 76
           F++++ ++I       ++Y H    +  IIH DLK  NI L E++   + DFG++     
Sbjct: 121 FEMIKLIDIARQTAQGMDYLH----AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSR 176
Query: 77  GEDFVTQTMTMATIGYMAPEY---GSEGIVSAKCDVYSYGVLLMETFTRKRP 125
                       +I +MAPE      +   S + DVY++G++L E  T + P
Sbjct: 177 WSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 228

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 50.8 bits (120), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 33/117 (28%), Positives = 59/117 (50%), Gaps = 10/117 (8%)
Query: 4   GSLEKWLYSYN-YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMV 62
           G+LE+W+        D +  L +   +   ++Y H    S  +I+ DLKP+NI L +   
Sbjct: 105 GTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIH----SKKLINRDLKPSNIFLVDTKQ 160
Query: 63  AHVSDFG-ISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLME 118
             + DFG ++ L  +G+    +  +  T+ YM+PE  S      + D+Y+ G++L E
Sbjct: 161 VKIGDFGLVTSLKNDGK----RXRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAE 213

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 50.8 bits (120), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 31/112 (27%), Positives = 54/112 (48%), Gaps = 7/112 (6%)
Query: 17  FDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGE 76
           F++++ ++I       ++Y H    +  IIH DLK  NI L E++   + DFG++     
Sbjct: 101 FEMIKLIDIARQTAQGMDYLH----AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSR 156
Query: 77  GEDFVTQTMTMATIGYMAPEY---GSEGIVSAKCDVYSYGVLLMETFTRKRP 125
                       +I +MAPE      +   S + DVY++G++L E  T + P
Sbjct: 157 WSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 208

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 50.4 bits (119), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 29/74 (39%), Positives = 42/74 (56%), Gaps = 6/74 (8%)
Query: 45  IIHCDLKPTNILL---DENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEG 101
           I+H DLKP N+L    DE     +SDFG+SK+ G+G+     +    T GY+APE  ++ 
Sbjct: 141 IVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGD---VMSTACGTPGYVAPEVLAQK 197
Query: 102 IVSAKCDVYSYGVL 115
             S   D +S GV+
Sbjct: 198 PYSKAVDCWSIGVI 211

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 50.4 bits (119), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 50/184 (27%), Positives = 83/184 (45%), Gaps = 26/184 (14%)
Query: 24  NIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQ 83
           ++M  +   L++ H    S  ++H DLKP NIL+  +    ++DFG++++       +  
Sbjct: 124 DMMFQLLRGLDFLH----SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ---MAL 176
Query: 84  TMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVK-- 141
           T  + T+ Y APE   +   +   D++S G +  E F RK     +F G   + +  K  
Sbjct: 177 TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK----PLFRGSSDVDQLGKIL 232
Query: 142 --ESLPHGLTEVVDANLVREEQAFAAK----MDCIVSIM-----DLALDCCMESPGKRIN 190
               LP       D  L R  QAF +K    ++  V+ +     DL L C   +P KRI+
Sbjct: 233 DVIGLPGEEDWPRDVALPR--QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRIS 290
Query: 191 MTDA 194
              A
Sbjct: 291 AYSA 294

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 50.4 bits (119), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 34/127 (26%), Positives = 60/127 (47%), Gaps = 6/127 (4%)
Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           M +G L  ++ +  +   + + +   + V   +++     +S   +H DL   N +LDE 
Sbjct: 115 MKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL----ASKKFVHRDLAARNCMLDEK 170
Query: 61  MVAHVSDFGISK--LLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLME 118
               V+DFG+++  L  E +    +T     + +MA E       + K DV+S+GVLL E
Sbjct: 171 FTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWE 230
Query: 119 TFTRKRP 125
             TR  P
Sbjct: 231 LMTRGAP 237

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 50.1 bits (118), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 50/184 (27%), Positives = 83/184 (45%), Gaps = 26/184 (14%)
Query: 24  NIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQ 83
           ++M  +   L++ H    S  ++H DLKP NIL+  +    ++DFG++++       +  
Sbjct: 124 DMMFQLLRGLDFLH----SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ---MAL 176
Query: 84  TMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVK-- 141
           T  + T+ Y APE   +   +   D++S G +  E F RK     +F G   + +  K  
Sbjct: 177 TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK----PLFRGSSDVDQLGKIL 232
Query: 142 --ESLPHGLTEVVDANLVREEQAFAAK----MDCIVSIM-----DLALDCCMESPGKRIN 190
               LP       D  L R  QAF +K    ++  V+ +     DL L C   +P KRI+
Sbjct: 233 DVIGLPGEEDWPRDVALPR--QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRIS 290
Query: 191 MTDA 194
              A
Sbjct: 291 AYSA 294

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 50.1 bits (118), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 50/184 (27%), Positives = 83/184 (45%), Gaps = 26/184 (14%)
Query: 24  NIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQ 83
           ++M  +   L++ H    S  ++H DLKP NIL+  +    ++DFG++++       +  
Sbjct: 124 DMMFQLLRGLDFLH----SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ---MAL 176
Query: 84  TMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVK-- 141
           T  + T+ Y APE   +   +   D++S G +  E F RK     +F G   + +  K  
Sbjct: 177 TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK----PLFRGSSDVDQLGKIL 232
Query: 142 --ESLPHGLTEVVDANLVREEQAFAAK----MDCIVSIM-----DLALDCCMESPGKRIN 190
               LP       D  L R  QAF +K    ++  V+ +     DL L C   +P KRI+
Sbjct: 233 DVIGLPGEEDWPRDVALPR--QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRIS 290
Query: 191 MTDA 194
              A
Sbjct: 291 AYSA 294

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 50.1 bits (118), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 30/113 (26%), Positives = 56/113 (49%), Gaps = 6/113 (5%)
Query: 17  FDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGE 76
           FD  +   ++ ++   L+Y H    S   IH D+K  N+LL E     ++DFG++  L +
Sbjct: 117 FDEFQIATMLKEILKGLDYLH----SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD 172
Query: 77  GEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEM 129
            +  + +   + T  +MAPE   +    +K D++S G+  +E    + P  +M
Sbjct: 173 TQ--IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDM 223

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 35/127 (27%), Positives = 61/127 (48%), Gaps = 6/127 (4%)
Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           M +G L +++ S      + + ++  + V   +EY     +    +H DL   N +LDE+
Sbjct: 105 MCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEY----LAEQKFVHRDLAARNCMLDES 160
Query: 61  MVAHVSDFGISKLLGEGEDFVTQTMTMAT--IGYMAPEYGSEGIVSAKCDVYSYGVLLME 118
               V+DFG+++ + + E +  Q    A   + + A E       + K DV+S+GVLL E
Sbjct: 161 FTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWE 220
Query: 119 TFTRKRP 125
             TR  P
Sbjct: 221 LLTRGAP 227

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 29/84 (34%), Positives = 45/84 (53%), Gaps = 3/84 (3%)
Query: 45  IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVS 104
           I++ DLKP NILLD++    +SD G++  + EG+   T    + T+GYMAPE       +
Sbjct: 307 IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---TIKGRVGTVGYMAPEVVKNERYT 363
Query: 105 AKCDVYSYGVLLMETFTRKRPTDE 128
              D ++ G LL E    + P  +
Sbjct: 364 FSPDWWALGCLLYEMIAGQSPFQQ 387

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 29/84 (34%), Positives = 45/84 (53%), Gaps = 3/84 (3%)
Query: 45  IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVS 104
           I++ DLKP NILLD++    +SD G++  + EG+   T    + T+GYMAPE       +
Sbjct: 307 IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---TIKGRVGTVGYMAPEVVKNERYT 363
Query: 105 AKCDVYSYGVLLMETFTRKRPTDE 128
              D ++ G LL E    + P  +
Sbjct: 364 FSPDWWALGCLLYEMIAGQSPFQQ 387

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 34/124 (27%), Positives = 57/124 (45%), Gaps = 7/124 (5%)
Query: 5   SLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAH 64
           SL   L++    F++ + ++I       ++Y H    +  IIH DLK  NI L E+    
Sbjct: 93  SLYHHLHASETKFEMKKLIDIARQTARGMDYLH----AKSIIHRDLKSNNIFLHEDNTVK 148
Query: 65  VSDFGISKLLGEGEDFVTQTMTMATIGYMAPEY---GSEGIVSAKCDVYSYGVLLMETFT 121
           + DFG++ +               +I +MAPE          S + DVY++G++L E  T
Sbjct: 149 IGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMT 208
Query: 122 RKRP 125
            + P
Sbjct: 209 GQLP 212

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 35/127 (27%), Positives = 62/127 (48%), Gaps = 6/127 (4%)
Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           M +G L  ++ +  +   + + +   + V   +++     +S   +H DL   N +LDE 
Sbjct: 114 MKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL----ASKKFVHRDLAARNCMLDEK 169
Query: 61  MVAHVSDFGISKLLGEGE-DFV-TQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLME 118
               V+DFG+++ + + E D V  +T     + +MA E       + K DV+S+GVLL E
Sbjct: 170 FTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWE 229
Query: 119 TFTRKRP 125
             TR  P
Sbjct: 230 LMTRGAP 236

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 39/129 (30%), Positives = 57/129 (44%), Gaps = 17/129 (13%)
Query: 3   NGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMV 62
           NG+L   ++S N      E   +   +  AL Y H    S  IIH DLKP NI +DE+  
Sbjct: 99  NGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIH----SQGIIHRDLKPMNIFIDESRN 154
Query: 63  AHVSDFGISKLLGEGEDFV------------TQTMTMATIGYMAPE-YGSEGIVSAKCDV 109
             + DFG++K +    D +              T  + T  Y+A E     G  + K D+
Sbjct: 155 VKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDM 214
Query: 110 YSYGVLLME 118
           YS G++  E
Sbjct: 215 YSLGIIFFE 223

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 35/127 (27%), Positives = 62/127 (48%), Gaps = 6/127 (4%)
Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           M +G L  ++ +  +   + + +   + V   +++     +S   +H DL   N +LDE 
Sbjct: 112 MKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL----ASKKFVHRDLAARNCMLDEK 167
Query: 61  MVAHVSDFGISKLLGEGE-DFV-TQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLME 118
               V+DFG+++ + + E D V  +T     + +MA E       + K DV+S+GVLL E
Sbjct: 168 FTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWE 227
Query: 119 TFTRKRP 125
             TR  P
Sbjct: 228 LMTRGAP 234

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 35/127 (27%), Positives = 62/127 (48%), Gaps = 6/127 (4%)
Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           M +G L  ++ +  +   + + +   + V   +++     +S   +H DL   N +LDE 
Sbjct: 115 MKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL----ASKKFVHRDLAARNCMLDEK 170
Query: 61  MVAHVSDFGISKLLGEGE-DFV-TQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLME 118
               V+DFG+++ + + E D V  +T     + +MA E       + K DV+S+GVLL E
Sbjct: 171 FTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWE 230
Query: 119 TFTRKRP 125
             TR  P
Sbjct: 231 LMTRGAP 237

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 79/198 (39%), Gaps = 35/198 (17%)
Query: 4   GSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVA 63
           G+L   + S +  +   +R++   D+ S + Y H    S  IIH DL   N L+ EN   
Sbjct: 92  GTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH----SMNIIHRDLNSHNCLVRENKNV 147
Query: 64  HVSDFGISKLL------GEG------EDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYS 111
            V+DFG+++L+       EG       D   +   +    +MAPE  +      K DV+S
Sbjct: 148 VVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFS 207
Query: 112 YGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANL-VREEQAFAAKMDCI 170
           +G++L E   R                    + P  L   +D  L VR         +C 
Sbjct: 208 FGIVLCEIIGR------------------VNADPDYLPRTMDFGLNVRGFLDRYCPPNCP 249
Query: 171 VSIMDLALDCCMESPGKR 188
            S   + + CC   P KR
Sbjct: 250 PSFFPITVRCCDLDPEKR 267

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 34/95 (35%), Positives = 49/95 (51%), Gaps = 11/95 (11%)
Query: 31  SALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGE-GEDFVTQTMTMAT 89
             LEY H       I+H DLKP N+LLDEN V  ++DFG++K  G     +  Q +T   
Sbjct: 123 QGLEYLHQHW----ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVVTR-- 176
Query: 90  IGYMAPE--YGSEGIVSAKCDVYSYGVLLMETFTR 122
             Y APE  +G+  +     D+++ G +L E   R
Sbjct: 177 -WYRAPELLFGAR-MYGVGVDMWAVGCILAELLLR 209

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 35/127 (27%), Positives = 62/127 (48%), Gaps = 6/127 (4%)
Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           M +G L  ++ +  +   + + +   + V   +++     +S   +H DL   N +LDE 
Sbjct: 114 MKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL----ASKKFVHRDLAARNCMLDEK 169
Query: 61  MVAHVSDFGISKLLGEGE-DFV-TQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLME 118
               V+DFG+++ + + E D V  +T     + +MA E       + K DV+S+GVLL E
Sbjct: 170 FTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWE 229
Query: 119 TFTRKRP 125
             TR  P
Sbjct: 230 LMTRGAP 236

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 35/127 (27%), Positives = 62/127 (48%), Gaps = 6/127 (4%)
Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           M +G L  ++ +  +   + + +   + V   +++     +S   +H DL   N +LDE 
Sbjct: 173 MKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKF----LASKKFVHRDLAARNCMLDEK 228
Query: 61  MVAHVSDFGISKLLGEGE-DFV-TQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLME 118
               V+DFG+++ + + E D V  +T     + +MA E       + K DV+S+GVLL E
Sbjct: 229 FTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWE 288
Query: 119 TFTRKRP 125
             TR  P
Sbjct: 289 LMTRGAP 295

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 35/127 (27%), Positives = 62/127 (48%), Gaps = 6/127 (4%)
Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           M +G L  ++ +  +   + + +   + V   +++     +S   +H DL   N +LDE 
Sbjct: 119 MKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL----ASKKFVHRDLAARNCMLDEK 174
Query: 61  MVAHVSDFGISKLLGEGE-DFV-TQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLME 118
               V+DFG+++ + + E D V  +T     + +MA E       + K DV+S+GVLL E
Sbjct: 175 FTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWE 234
Query: 119 TFTRKRP 125
             TR  P
Sbjct: 235 LMTRGAP 241

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/134 (31%), Positives = 62/134 (46%), Gaps = 13/134 (9%)
Query: 19  ILERL--NIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGE 76
           I ER+   + + +  AL Y    H    +IH D+KP+NILLDE     + DFGIS   G 
Sbjct: 121 IPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGIS---GR 174
Query: 77  GEDFVTQTMTMATIGYMAPEY-----GSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFT 131
             D   +  +     YMAPE       ++     + DV+S G+ L+E  T + P     T
Sbjct: 175 LVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT 234
Query: 132 GEMSLRRWVKESLP 145
               L + ++E  P
Sbjct: 235 DFEVLTKVLQEEPP 248

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 36/112 (32%), Positives = 55/112 (49%), Gaps = 14/112 (12%)
Query: 29  VGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTM--T 86
           + S L    + H+   I H D+KP+NIL+D+N    +SDF      GE E  V + +  +
Sbjct: 157 IKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDF------GESEYMVDKKIKGS 210
Query: 87  MATIGYMAPEYGSE--GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSL 136
             T  +M PE+ S       AK D++S G+ L   F    P    F+ ++SL
Sbjct: 211 RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP----FSLKISL 258

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 36/122 (29%), Positives = 58/122 (47%), Gaps = 7/122 (5%)
Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           +P GSL  +L  ++    + + L     +   + Y H  H     IH DL   N+LLD +
Sbjct: 117 VPLGSLRDYLPRHS--IGLAQLLLFAQQICEGMAYLHAQH----YIHRDLAARNVLLDND 170
Query: 61  MVAHVSDFGISKLLGEG-EDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMET 119
            +  + DFG++K + EG E +  +    + + + APE   E       DV+S+GV L E 
Sbjct: 171 RLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYEL 230
Query: 120 FT 121
            T
Sbjct: 231 LT 232

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 35/103 (33%), Positives = 52/103 (50%), Gaps = 10/103 (9%)
Query: 16  FFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNIL---LDENMVAHVSDFGISK 72
           F+   +   ++  V  A++Y H       I+H DLKP N+L   LDE+    +SDFG+SK
Sbjct: 112 FYTERDASRLIFQVLDAVKYLH----DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK 167
Query: 73  LLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVL 115
           +   G    T      T GY+APE  ++   S   D +S GV+
Sbjct: 168 MEDPGSVLST---ACGTPGYVAPEVLAQKPYSKAVDCWSIGVI 207

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 35/103 (33%), Positives = 52/103 (50%), Gaps = 10/103 (9%)
Query: 16  FFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNIL---LDENMVAHVSDFGISK 72
           F+   +   ++  V  A++Y H       I+H DLKP N+L   LDE+    +SDFG+SK
Sbjct: 112 FYTERDASRLIFQVLDAVKYLH----DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK 167
Query: 73  LLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVL 115
           +   G    T      T GY+APE  ++   S   D +S GV+
Sbjct: 168 MEDPGSVLST---ACGTPGYVAPEVLAQKPYSKAVDCWSIGVI 207

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 35/103 (33%), Positives = 52/103 (50%), Gaps = 10/103 (9%)
Query: 16  FFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNIL---LDENMVAHVSDFGISK 72
           F+   +   ++  V  A++Y H       I+H DLKP N+L   LDE+    +SDFG+SK
Sbjct: 112 FYTERDASRLIFQVLDAVKYLH----DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK 167
Query: 73  LLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVL 115
           +   G    T      T GY+APE  ++   S   D +S GV+
Sbjct: 168 MEDPGSVLST---ACGTPGYVAPEVLAQKPYSKAVDCWSIGVI 207

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 48/87 (55%), Gaps = 2/87 (2%)
Query: 45  IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVT-QTMTMATIGYMAPEYGSEGIV 103
            +H +L   N+LL     A +SDFG+SK LG  + + T ++     + + APE  +    
Sbjct: 457 FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF 516
Query: 104 SAKCDVYSYGVLLMETFTR-KRPTDEM 129
           S++ DV+SYGV + E  +  ++P  +M
Sbjct: 517 SSRSDVWSYGVTMWEALSYGQKPYKKM 543

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 24/93 (25%), Positives = 47/93 (50%)
Query: 45  IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVS 104
            +H DL   N ++ E+    + DFG+++ + E + +      +  + +M+PE   +G+ +
Sbjct: 149 FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFT 208
Query: 105 AKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLR 137
              DV+S+GV+L E  T      +  + E  LR
Sbjct: 209 TYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 241

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 24/93 (25%), Positives = 47/93 (50%)
Query: 45  IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVS 104
            +H DL   N ++ E+    + DFG+++ + E + +      +  + +M+PE   +G+ +
Sbjct: 181 FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFT 240
Query: 105 AKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLR 137
              DV+S+GV+L E  T      +  + E  LR
Sbjct: 241 TYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 273

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 24/93 (25%), Positives = 47/93 (50%)
Query: 45  IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVS 104
            +H DL   N ++ E+    + DFG+++ + E + +      +  + +M+PE   +G+ +
Sbjct: 150 FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFT 209
Query: 105 AKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLR 137
              DV+S+GV+L E  T      +  + E  LR
Sbjct: 210 TYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 242

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 41/158 (25%), Positives = 66/158 (41%), Gaps = 5/158 (3%)
Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           MP G L  ++  +         LN  + +   + Y         ++H DL   N+L+   
Sbjct: 105 MPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR----LVHRDLAARNVLVKTP 160
Query: 61  MVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETF 120
               ++DFG++KLLG  E           I +MA E     I + + DV+SYGV + E  
Sbjct: 161 QHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 220
Query: 121 T-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV 157
           T   +P D +   E+S      E LP      +D  ++
Sbjct: 221 TFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMI 258

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 24/93 (25%), Positives = 47/93 (50%)
Query: 45  IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVS 104
            +H DL   N ++ E+    + DFG+++ + E + +      +  + +M+PE   +G+ +
Sbjct: 159 FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFT 218
Query: 105 AKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLR 137
              DV+S+GV+L E  T      +  + E  LR
Sbjct: 219 TYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 251

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 41/158 (25%), Positives = 66/158 (41%), Gaps = 5/158 (3%)
Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           MP G L  ++  +         LN  + +   + Y         ++H DL   N+L+   
Sbjct: 98  MPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR----LVHRDLAARNVLVKTP 153
Query: 61  MVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETF 120
               ++DFG++KLLG  E           I +MA E     I + + DV+SYGV + E  
Sbjct: 154 QHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 213
Query: 121 T-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV 157
           T   +P D +   E+S      E LP      +D  ++
Sbjct: 214 TFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMI 251

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 34/114 (29%), Positives = 53/114 (46%), Gaps = 1/114 (0%)
Query: 45  IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVS 104
           ++H DL   N+L+       ++DFG++KLLG  E           I +MA E     I +
Sbjct: 142 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 201
Query: 105 AKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV 157
            + DV+SYGV + E  T   +P D +   E+S      E LP      +D  ++
Sbjct: 202 HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMI 255

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 24/93 (25%), Positives = 47/93 (50%)
Query: 45  IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVS 104
            +H DL   N ++ E+    + DFG+++ + E + +      +  + +M+PE   +G+ +
Sbjct: 146 FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFT 205
Query: 105 AKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLR 137
              DV+S+GV+L E  T      +  + E  LR
Sbjct: 206 TYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 238

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 24/93 (25%), Positives = 47/93 (50%)
Query: 45  IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVS 104
            +H DL   N ++ E+    + DFG+++ + E + +      +  + +M+PE   +G+ +
Sbjct: 153 FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFT 212
Query: 105 AKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLR 137
              DV+S+GV+L E  T      +  + E  LR
Sbjct: 213 TYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 245

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 34/114 (29%), Positives = 53/114 (46%), Gaps = 1/114 (0%)
Query: 45  IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVS 104
           ++H DL   N+L+       ++DFG++KLLG  E           I +MA E     I +
Sbjct: 140 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 199
Query: 105 AKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV 157
            + DV+SYGV + E  T   +P D +   E+S      E LP      +D  ++
Sbjct: 200 HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMI 253

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 41/158 (25%), Positives = 66/158 (41%), Gaps = 5/158 (3%)
Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           MP G L  ++  +         LN  + +   + Y         ++H DL   N+L+   
Sbjct: 92  MPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR----LVHRDLAARNVLVKTP 147
Query: 61  MVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETF 120
               ++DFG++KLLG  E           I +MA E     I + + DV+SYGV + E  
Sbjct: 148 QHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 207
Query: 121 T-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV 157
           T   +P D +   E+S      E LP      +D  ++
Sbjct: 208 TFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMI 245

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 41/158 (25%), Positives = 66/158 (41%), Gaps = 5/158 (3%)
Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           MP G L  ++  +         LN  + +   + Y         ++H DL   N+L+   
Sbjct: 105 MPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR----LVHRDLAARNVLVKTP 160
Query: 61  MVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETF 120
               ++DFG++KLLG  E           I +MA E     I + + DV+SYGV + E  
Sbjct: 161 QHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 220
Query: 121 T-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV 157
           T   +P D +   E+S      E LP      +D  ++
Sbjct: 221 TFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMI 258

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 34/114 (29%), Positives = 53/114 (46%), Gaps = 1/114 (0%)
Query: 45  IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVS 104
           ++H DL   N+L+       ++DFG++KLLG  E           I +MA E     I +
Sbjct: 144 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 203
Query: 105 AKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV 157
            + DV+SYGV + E  T   +P D +   E+S      E LP      +D  ++
Sbjct: 204 HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMI 257

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 41/158 (25%), Positives = 66/158 (41%), Gaps = 5/158 (3%)
Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           MP G L  ++  +         LN  + +   + Y         ++H DL   N+L+   
Sbjct: 101 MPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR----LVHRDLAARNVLVKTP 156
Query: 61  MVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETF 120
               ++DFG++KLLG  E           I +MA E     I + + DV+SYGV + E  
Sbjct: 157 QHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 216
Query: 121 T-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV 157
           T   +P D +   E+S      E LP      +D  ++
Sbjct: 217 TFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMI 254

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 41/158 (25%), Positives = 66/158 (41%), Gaps = 5/158 (3%)
Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           MP G L  ++  +         LN  + +   + Y         ++H DL   N+L+   
Sbjct: 105 MPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR----LVHRDLAARNVLVKTP 160
Query: 61  MVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETF 120
               ++DFG++KLLG  E           I +MA E     I + + DV+SYGV + E  
Sbjct: 161 QHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 220
Query: 121 T-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV 157
           T   +P D +   E+S      E LP      +D  ++
Sbjct: 221 TFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMI 258

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 41/158 (25%), Positives = 66/158 (41%), Gaps = 5/158 (3%)
Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           MP G L  ++  +         LN  + +   + Y         ++H DL   N+L+   
Sbjct: 99  MPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR----LVHRDLAARNVLVKTP 154
Query: 61  MVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETF 120
               ++DFG++KLLG  E           I +MA E     I + + DV+SYGV + E  
Sbjct: 155 QHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 214
Query: 121 T-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV 157
           T   +P D +   E+S      E LP      +D  ++
Sbjct: 215 TFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMI 252

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 41/158 (25%), Positives = 66/158 (41%), Gaps = 5/158 (3%)
Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           MP G L  ++  +         LN  + +   + Y         ++H DL   N+L+   
Sbjct: 101 MPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR----LVHRDLAARNVLVKTP 156
Query: 61  MVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETF 120
               ++DFG++KLLG  E           I +MA E     I + + DV+SYGV + E  
Sbjct: 157 QHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 216
Query: 121 T-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV 157
           T   +P D +   E+S      E LP      +D  ++
Sbjct: 217 TFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMI 254

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 24/93 (25%), Positives = 47/93 (50%)
Query: 45  IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVS 104
            +H DL   N ++ E+    + DFG+++ + E + +      +  + +M+PE   +G+ +
Sbjct: 152 FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFT 211
Query: 105 AKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLR 137
              DV+S+GV+L E  T      +  + E  LR
Sbjct: 212 TYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 244

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 41/158 (25%), Positives = 66/158 (41%), Gaps = 5/158 (3%)
Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           MP G L  ++  +         LN  + +   + Y         ++H DL   N+L+   
Sbjct: 101 MPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR----LVHRDLAARNVLVKTP 156
Query: 61  MVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETF 120
               ++DFG++KLLG  E           I +MA E     I + + DV+SYGV + E  
Sbjct: 157 QHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 216
Query: 121 T-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV 157
           T   +P D +   E+S      E LP      +D  ++
Sbjct: 217 TFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMI 254

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 35/103 (33%), Positives = 52/103 (50%), Gaps = 10/103 (9%)
Query: 16  FFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNIL---LDENMVAHVSDFGISK 72
           F+   +   ++  V  A++Y H       I+H DLKP N+L   LDE+    +SDFG+SK
Sbjct: 112 FYTERDASRLIFQVLDAVKYLH----DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK 167
Query: 73  LLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVL 115
           +   G    T      T GY+APE  ++   S   D +S GV+
Sbjct: 168 MEDPGSVLST---ACGTPGYVAPEVLAQKPYSKAVDCWSIGVI 207

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 34/114 (29%), Positives = 53/114 (46%), Gaps = 1/114 (0%)
Query: 45  IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVS 104
           ++H DL   N+L+       ++DFG++KLLG  E           I +MA E     I +
Sbjct: 138 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 197
Query: 105 AKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV 157
            + DV+SYGV + E  T   +P D +   E+S      E LP      +D  ++
Sbjct: 198 HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMI 251

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 24/93 (25%), Positives = 47/93 (50%)
Query: 45  IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVS 104
            +H DL   N ++ E+    + DFG+++ + E + +      +  + +M+PE   +G+ +
Sbjct: 159 FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFT 218
Query: 105 AKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLR 137
              DV+S+GV+L E  T      +  + E  LR
Sbjct: 219 TYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 251

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 34/114 (29%), Positives = 53/114 (46%), Gaps = 1/114 (0%)
Query: 45  IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVS 104
           ++H DL   N+L+       ++DFG++KLLG  E           I +MA E     I +
Sbjct: 138 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 197
Query: 105 AKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV 157
            + DV+SYGV + E  T   +P D +   E+S      E LP      +D  ++
Sbjct: 198 HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMI 251

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 34/114 (29%), Positives = 53/114 (46%), Gaps = 1/114 (0%)
Query: 45  IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVS 104
           ++H DL   N+L+       ++DFG++KLLG  E           I +MA E     I +
Sbjct: 138 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 197
Query: 105 AKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV 157
            + DV+SYGV + E  T   +P D +   E+S      E LP      +D  ++
Sbjct: 198 HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMI 251

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 41/158 (25%), Positives = 66/158 (41%), Gaps = 5/158 (3%)
Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           MP G L  ++  +         LN  + +   + Y         ++H DL   N+L+   
Sbjct: 108 MPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR----LVHRDLAARNVLVKTP 163
Query: 61  MVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETF 120
               ++DFG++KLLG  E           I +MA E     I + + DV+SYGV + E  
Sbjct: 164 QHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 223
Query: 121 T-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV 157
           T   +P D +   E+S      E LP      +D  ++
Sbjct: 224 TFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMI 261

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 34/114 (29%), Positives = 53/114 (46%), Gaps = 1/114 (0%)
Query: 45  IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVS 104
           ++H DL   N+L+       ++DFG++KLLG  E           I +MA E     I +
Sbjct: 139 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 198
Query: 105 AKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV 157
            + DV+SYGV + E  T   +P D +   E+S      E LP      +D  ++
Sbjct: 199 HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMI 252

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 41/158 (25%), Positives = 66/158 (41%), Gaps = 5/158 (3%)
Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           MP G L  ++  +         LN  + +   + Y         ++H DL   N+L+   
Sbjct: 101 MPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR----LVHRDLAARNVLVKTP 156
Query: 61  MVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETF 120
               ++DFG++KLLG  E           I +MA E     I + + DV+SYGV + E  
Sbjct: 157 QHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 216
Query: 121 T-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV 157
           T   +P D +   E+S      E LP      +D  ++
Sbjct: 217 TFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMI 254

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 24/93 (25%), Positives = 47/93 (50%)
Query: 45  IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVS 104
            +H DL   N ++ E+    + DFG+++ + E + +      +  + +M+PE   +G+ +
Sbjct: 152 FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFT 211
Query: 105 AKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLR 137
              DV+S+GV+L E  T      +  + E  LR
Sbjct: 212 TYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 244

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 34/114 (29%), Positives = 53/114 (46%), Gaps = 1/114 (0%)
Query: 45  IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVS 104
           ++H DL   N+L+       ++DFG++KLLG  E           I +MA E     I +
Sbjct: 163 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 222
Query: 105 AKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV 157
            + DV+SYGV + E  T   +P D +   E+S      E LP      +D  ++
Sbjct: 223 HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMI 276

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 34/114 (29%), Positives = 53/114 (46%), Gaps = 1/114 (0%)
Query: 45  IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVS 104
           ++H DL   N+L+       ++DFG++KLLG  E           I +MA E     I +
Sbjct: 140 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 199
Query: 105 AKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV 157
            + DV+SYGV + E  T   +P D +   E+S      E LP      +D  ++
Sbjct: 200 HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMI 253

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/111 (34%), Positives = 54/111 (48%), Gaps = 15/111 (13%)
Query: 25  IMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDE---NMVAHVSDFGISKLLGEGEDFV 81
           +M  + +AL Y H  H    ++H DLKP NIL  +   +    + DFG+++L    E   
Sbjct: 129 LMKQMMNALAYFHSQH----VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH-- 182
Query: 82  TQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTG 132
             T    T  YMAPE      V+ KCD++S GV++    T   P    FTG
Sbjct: 183 -STNAAGTALYMAPEVFKRD-VTFKCDIWSAGVVMYFLLTGCLP----FTG 227

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 25/79 (31%), Positives = 41/79 (51%), Gaps = 3/79 (3%)
Query: 45  IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVS 104
           I+H DLKP NIL+       ++DFG++++       +  T  + T+ Y APE   +   +
Sbjct: 141 IVHRDLKPENILVTSGGTVKLADFGLARIYSYQ---MALTPVVVTLWYRAPEVLLQSTYA 197
Query: 105 AKCDVYSYGVLLMETFTRK 123
              D++S G +  E F RK
Sbjct: 198 TPVDMWSVGCIFAEMFRRK 216

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 34/114 (29%), Positives = 53/114 (46%), Gaps = 1/114 (0%)
Query: 45  IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVS 104
           ++H DL   N+L+       ++DFG++KLLG  E           I +MA E     I +
Sbjct: 138 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 197
Query: 105 AKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV 157
            + DV+SYGV + E  T   +P D +   E+S      E LP      +D  ++
Sbjct: 198 HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMI 251

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 41/158 (25%), Positives = 66/158 (41%), Gaps = 5/158 (3%)
Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           MP G L  ++  +         LN  + +   + Y         ++H DL   N+L+   
Sbjct: 132 MPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR----LVHRDLAARNVLVKTP 187
Query: 61  MVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETF 120
               ++DFG++KLLG  E           I +MA E     I + + DV+SYGV + E  
Sbjct: 188 QHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 247
Query: 121 T-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV 157
           T   +P D +   E+S      E LP      +D  ++
Sbjct: 248 TFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMI 285

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 34/114 (29%), Positives = 53/114 (46%), Gaps = 1/114 (0%)
Query: 45  IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVS 104
           ++H DL   N+L+       ++DFG++KLLG  E           I +MA E     I +
Sbjct: 135 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 194
Query: 105 AKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV 157
            + DV+SYGV + E  T   +P D +   E+S      E LP      +D  ++
Sbjct: 195 HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMI 248

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 34/124 (27%), Positives = 56/124 (45%), Gaps = 7/124 (5%)
Query: 5   SLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAH 64
           SL   L++    F++ + ++I       ++Y H    +  IIH DLK  NI L E+    
Sbjct: 105 SLYHHLHASETKFEMKKLIDIARQTARGMDYLH----AKSIIHRDLKSNNIFLHEDNTVK 160
Query: 65  VSDFGISKLLGEGEDFVTQTMTMATIGYMAPEY---GSEGIVSAKCDVYSYGVLLMETFT 121
           + DFG++                 +I +MAPE          S + DVY++G++L E  T
Sbjct: 161 IGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMT 220
Query: 122 RKRP 125
            + P
Sbjct: 221 GQLP 224

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 42/136 (30%), Positives = 62/136 (45%), Gaps = 11/136 (8%)
Query: 17  FDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGE 76
           FD       + ++ +AL Y H    S  +IH D+KP N+LL  N    ++DFG S     
Sbjct: 109 FDEQRTATYITELANALSYCH----SKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPS 164
Query: 77  GEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSL 136
                 +T    T+ Y+ PE     +   K D++S GVL  E F    P  E  T + + 
Sbjct: 165 SR----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYE-FLVGMPPFEAHTYQETY 219
Query: 137 RR--WVKESLPHGLTE 150
           RR   V+ + P  +TE
Sbjct: 220 RRISRVEFTFPDFVTE 235

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 34/124 (27%), Positives = 56/124 (45%), Gaps = 7/124 (5%)
Query: 5   SLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAH 64
           SL   L++    F++ + ++I       ++Y H    +  IIH DLK  NI L E+    
Sbjct: 105 SLYHHLHASETKFEMKKLIDIARQTARGMDYLH----AKSIIHRDLKSNNIFLHEDNTVK 160
Query: 65  VSDFGISKLLGEGEDFVTQTMTMATIGYMAPEY---GSEGIVSAKCDVYSYGVLLMETFT 121
           + DFG++                 +I +MAPE          S + DVY++G++L E  T
Sbjct: 161 IGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMT 220
Query: 122 RKRP 125
            + P
Sbjct: 221 GQLP 224

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 37/114 (32%), Positives = 55/114 (48%), Gaps = 10/114 (8%)
Query: 16  FFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNIL-LDEN---MVAHVSDFGIS 71
           FF   E   ++  +   +EY H    +  ++H DLKP+NIL +DE+       + DFG +
Sbjct: 112 FFSEREASAVLFTITKTVEYLH----AQGVVHRDLKPSNILYVDESGNPESIRICDFGFA 167
Query: 72  KLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRP 125
           K L   E+ +  T    T  ++APE        A CD++S GVLL    T   P
Sbjct: 168 KQL-RAENGLLXTPCY-TANFVAPEVLERQGYDAACDIWSLGVLLYTXLTGYTP 219

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 24/93 (25%), Positives = 46/93 (49%)
Query: 45  IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVS 104
            +H DL   N ++ E+    + DFG+++ + E +        +  + +M+PE   +G+ +
Sbjct: 153 FVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMSPESLKDGVFT 212
Query: 105 AKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLR 137
              DV+S+GV+L E  T      +  + E  LR
Sbjct: 213 TYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 245

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 24/93 (25%), Positives = 46/93 (49%)
Query: 45  IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVS 104
            +H DL   N ++ E+    + DFG+++ + E +        +  + +M+PE   +G+ +
Sbjct: 144 FVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMSPESLKDGVFT 203
Query: 105 AKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLR 137
              DV+S+GV+L E  T      +  + E  LR
Sbjct: 204 TYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 236

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 47.8 bits (112), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 29/106 (27%), Positives = 54/106 (50%), Gaps = 6/106 (5%)
Query: 24  NIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQ 83
            I+ ++   L+Y H    S   IH D+K  N+LL E+    ++DFG++  L + +  + +
Sbjct: 108 TILREILKGLDYLH----SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--IKR 161
Query: 84  TMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEM 129
              + T  +MAPE   +    +K D++S G+  +E    + P  E+
Sbjct: 162 NXFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL 207

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 47.8 bits (112), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 30/88 (34%), Positives = 47/88 (53%), Gaps = 9/88 (10%)
Query: 45  IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQ--------TMTMATIGYMAPE 96
           +IH DLKP+N+L++ N    V DFG+++++ E     ++        T  +AT  Y APE
Sbjct: 133 VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVATRWYRAPE 192
Query: 97  YG-SEGIVSAKCDVYSYGVLLMETFTRK 123
              +    S   DV+S G +L E F R+
Sbjct: 193 VMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 47.8 bits (112), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 29/106 (27%), Positives = 54/106 (50%), Gaps = 6/106 (5%)
Query: 24  NIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQ 83
            I+ ++   L+Y H    S   IH D+K  N+LL E+    ++DFG++  L + +  + +
Sbjct: 108 TILREILKGLDYLH----SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--IKR 161
Query: 84  TMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEM 129
              + T  +MAPE   +    +K D++S G+  +E    + P  E+
Sbjct: 162 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL 207

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 47.8 bits (112), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 29/105 (27%), Positives = 54/105 (51%), Gaps = 6/105 (5%)
Query: 25  IMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQT 84
           I+ ++   L+Y H    S   IH D+K  N+LL E+    ++DFG++  L + +  + + 
Sbjct: 124 ILREILKGLDYLH----SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--IKRN 177
Query: 85  MTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEM 129
             + T  +MAPE   +    +K D++S G+  +E    + P  E+
Sbjct: 178 XFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL 222

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 47.8 bits (112), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 36/144 (25%), Positives = 64/144 (44%), Gaps = 24/144 (16%)
Query: 3   NGSLEKWLYSYNY----FFDILER--------LNIMIDVGSALEYPH---HGHSSAPII- 46
           N S + WL ++ +     +D L+R        L + +     L + H    G    P I 
Sbjct: 76  NSSTQLWLITHYHEHGSLYDFLQRQTLEPHLALRLAVSAACGLAHLHVEIFGTQGKPAIA 135
Query: 47  HCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF--VTQTMTMATIGYMAPEYGSEGIVS 104
           H D K  N+L+  N+   ++D G++ +  +G D+  +     + T  YMAPE   E I +
Sbjct: 136 HRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRYMAPEVLDEQIRT 195
Query: 105 ------AKCDVYSYGVLLMETFTR 122
                    D++++G++L E   R
Sbjct: 196 DCFESYKWTDIWAFGLVLWEIARR 219

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 47.8 bits (112), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 35/92 (38%), Positives = 52/92 (56%), Gaps = 9/92 (9%)
Query: 28  DVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTM 87
           D+   +EY H+      IIH D+KP+N+L+ E+    ++DFG+S    +G D +    T+
Sbjct: 145 DLIKGIEYLHY----QKIIHRDIKPSNLLVGEDGHIKIADFGVSNEF-KGSDALLSN-TV 198
Query: 88  ATIGYMAPEYGSE--GIVSAKC-DVYSYGVLL 116
            T  +MAPE  SE   I S K  DV++ GV L
Sbjct: 199 GTPAFMAPESLSETRKIFSGKALDVWAMGVTL 230

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 47.8 bits (112), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 37/98 (37%), Positives = 52/98 (53%), Gaps = 12/98 (12%)
Query: 31  SALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMA-T 89
           S LE+ H  +    II+ DLKP N+LLD++    +SD G++  L  G+   T+T   A T
Sbjct: 300 SGLEHLHQRN----IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ---TKTKGYAGT 352
Query: 90  IGYMAPE--YGSEGIVSAKCDVYSYGVLLMETFTRKRP 125
            G+MAPE   G E   S   D ++ GV L E    + P
Sbjct: 353 PGFMAPELLLGEEYDFS--VDYFALGVTLYEMIAARGP 388

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 47.8 bits (112), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 36/106 (33%), Positives = 58/106 (54%), Gaps = 15/106 (14%)
Query: 33  LEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLL----GEGEDFVTQTMTMA 88
           L+Y H    SA +IH DLKP+N+L++EN    + DFG+++ L     E + F+T+   +A
Sbjct: 171 LKYMH----SAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTE--YVA 224
Query: 89  TIGYMAPEYG-SEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGE 133
           T  Y APE   S    +   D++S G +  E   R+    ++F G+
Sbjct: 225 TRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARR----QLFPGK 266

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 47.8 bits (112), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 37/98 (37%), Positives = 52/98 (53%), Gaps = 12/98 (12%)
Query: 31  SALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMA-T 89
           S LE+ H  +    II+ DLKP N+LLD++    +SD G++  L  G+   T+T   A T
Sbjct: 300 SGLEHLHQRN----IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ---TKTKGYAGT 352
Query: 90  IGYMAPE--YGSEGIVSAKCDVYSYGVLLMETFTRKRP 125
            G+MAPE   G E   S   D ++ GV L E    + P
Sbjct: 353 PGFMAPELLLGEEYDFS--VDYFALGVTLYEMIAARGP 388

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 37/98 (37%), Positives = 52/98 (53%), Gaps = 12/98 (12%)
Query: 31  SALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMA-T 89
           S LE+ H  +    II+ DLKP N+LLD++    +SD G++  L  G+   T+T   A T
Sbjct: 300 SGLEHLHQRN----IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ---TKTKGYAGT 352
Query: 90  IGYMAPE--YGSEGIVSAKCDVYSYGVLLMETFTRKRP 125
            G+MAPE   G E   S   D ++ GV L E    + P
Sbjct: 353 PGFMAPELLLGEEYDFS--VDYFALGVTLYEMIAARGP 388

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 33/95 (34%), Positives = 45/95 (47%), Gaps = 12/95 (12%)
Query: 38  HGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEY 97
           H H+   +IH D+K  NILL E  +  + DFG + ++     FV       T  +MAPE 
Sbjct: 171 HSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV------GTPYWMAPEV 221
Query: 98  ---GSEGIVSAKCDVYSYGVLLMETFTRKRPTDEM 129
                EG    K DV+S G+  +E   RK P   M
Sbjct: 222 ILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 256

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 49/94 (52%), Gaps = 11/94 (11%)
Query: 25  IMIDVGSALEYPHHGHSSAPIIHCDLKPTNILL---DENMVAHVSDFGISKLLGEGEDFV 81
           ++  V SA++Y H       I+H DLKP N+L    +EN    ++DFG+SK+   G    
Sbjct: 111 VIQQVLSAVKYLHEN----GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG---- 162
Query: 82  TQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVL 115
             +    T GY+APE  ++   S   D +S GV+
Sbjct: 163 IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVI 196

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 47.4 bits (111), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 37/114 (32%), Positives = 55/114 (48%), Gaps = 10/114 (8%)
Query: 16  FFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNIL-LDEN---MVAHVSDFGIS 71
           FF   E   ++  +   +EY H    +  ++H DLKP+NIL +DE+       + DFG +
Sbjct: 112 FFSEREASAVLFTITKTVEYLH----AQGVVHRDLKPSNILYVDESGNPESIRICDFGFA 167
Query: 72  KLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRP 125
           K L   E+ +  T    T  ++APE        A CD++S GVLL    T   P
Sbjct: 168 KQL-RAENGLLMTPCY-TANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTP 219

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 47.4 bits (111), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 33/97 (34%), Positives = 54/97 (55%), Gaps = 11/97 (11%)
Query: 42  SAPIIHCDLKPTNILLDENMVAHVSDFGISKLL----GEGEDFVTQTMTMATIGYMAPEY 97
           SA +IH DLKP+N+L++EN    + DFG+++ L     E + F+T+   +AT  Y APE 
Sbjct: 177 SAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTE--YVATRWYRAPEL 234
Query: 98  G-SEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGE 133
             S    +   D++S G +  E   R+    ++F G+
Sbjct: 235 MLSLHEYTQAIDLWSVGCIFGEMLARR----QLFPGK 267

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 47.4 bits (111), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 33/95 (34%), Positives = 45/95 (47%), Gaps = 12/95 (12%)
Query: 38  HGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEY 97
           H H+   +IH D+K  NILL E  +  + DFG + ++     FV       T  +MAPE 
Sbjct: 132 HSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV------GTPYWMAPEV 182
Query: 98  ---GSEGIVSAKCDVYSYGVLLMETFTRKRPTDEM 129
                EG    K DV+S G+  +E   RK P   M
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 217

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 47.4 bits (111), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 37/98 (37%), Positives = 52/98 (53%), Gaps = 12/98 (12%)
Query: 31  SALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMA-T 89
           S LE+ H  +    II+ DLKP N+LLD++    +SD G++  L  G+   T+T   A T
Sbjct: 300 SGLEHLHQRN----IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ---TKTKGYAGT 352
Query: 90  IGYMAPE--YGSEGIVSAKCDVYSYGVLLMETFTRKRP 125
            G+MAPE   G E   S   D ++ GV L E    + P
Sbjct: 353 PGFMAPELLLGEEYDFSV--DYFALGVTLYEMIAARGP 388

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 47.4 bits (111), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 29/106 (27%), Positives = 54/106 (50%), Gaps = 6/106 (5%)
Query: 24  NIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQ 83
            I+ ++   L+Y H    S   IH D+K  N+LL E+    ++DFG++  L + +  + +
Sbjct: 128 TILREILKGLDYLH----SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--IKR 181
Query: 84  TMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEM 129
              + T  +MAPE   +    +K D++S G+  +E    + P  E+
Sbjct: 182 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL 227

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 47.4 bits (111), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 41/113 (36%), Positives = 61/113 (53%), Gaps = 16/113 (14%)
Query: 32  ALEYPHHGHSSAPIIHCDLKPTNILL---DENMVAHVSDFGISKLLGEGEDFVTQTMTMA 88
           A++Y H       IIH DLKP N+LL   +E+ +  ++DFG SK+LGE    + +T+   
Sbjct: 265 AVQYLHENG----IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS--LMRTLC-G 317
Query: 89  TIGYMAPE----YGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLR 137
           T  Y+APE     G+ G   A  D +S GV+L    +   P  E  T ++SL+
Sbjct: 318 TPTYLAPEVLVSVGTAGYNRA-VDCWSLGVILFICLSGYPPFSEHRT-QVSLK 368

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 47.4 bits (111), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 30/88 (34%), Positives = 47/88 (53%), Gaps = 9/88 (10%)
Query: 45  IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQ--------TMTMATIGYMAPE 96
           +IH DLKP+N+L++ N    V DFG+++++ E     ++        T  +AT  Y APE
Sbjct: 133 VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVATRWYRAPE 192
Query: 97  YG-SEGIVSAKCDVYSYGVLLMETFTRK 123
              +    S   DV+S G +L E F R+
Sbjct: 193 VMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 47.4 bits (111), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 41/113 (36%), Positives = 61/113 (53%), Gaps = 16/113 (14%)
Query: 32  ALEYPHHGHSSAPIIHCDLKPTNILL---DENMVAHVSDFGISKLLGEGEDFVTQTMTMA 88
           A++Y H       IIH DLKP N+LL   +E+ +  ++DFG SK+LGE    + +T+   
Sbjct: 251 AVQYLHENG----IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS--LMRTLC-G 303
Query: 89  TIGYMAPE----YGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLR 137
           T  Y+APE     G+ G   A  D +S GV+L    +   P  E  T ++SL+
Sbjct: 304 TPTYLAPEVLVSVGTAGYNRA-VDCWSLGVILFICLSGYPPFSEHRT-QVSLK 354

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 24/93 (25%), Positives = 46/93 (49%)
Query: 45  IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVS 104
            +H DL   N  + E+    + DFG+++ + E + +      +  + +M+PE   +G+ +
Sbjct: 146 FVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFT 205
Query: 105 AKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLR 137
              DV+S+GV+L E  T      +  + E  LR
Sbjct: 206 TYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 238

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 41/113 (36%), Positives = 61/113 (53%), Gaps = 16/113 (14%)
Query: 32  ALEYPHHGHSSAPIIHCDLKPTNILL---DENMVAHVSDFGISKLLGEGEDFVTQTMTMA 88
           A++Y H       IIH DLKP N+LL   +E+ +  ++DFG SK+LGE    + +T+   
Sbjct: 126 AVQYLHENG----IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS--LMRTLC-G 178
Query: 89  TIGYMAPE----YGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLR 137
           T  Y+APE     G+ G   A  D +S GV+L    +   P  E  T ++SL+
Sbjct: 179 TPTYLAPEVLVSVGTAGYNRA-VDCWSLGVILFICLSGYPPFSEHRT-QVSLK 229

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 41/113 (36%), Positives = 61/113 (53%), Gaps = 16/113 (14%)
Query: 32  ALEYPHHGHSSAPIIHCDLKPTNILL---DENMVAHVSDFGISKLLGEGEDFVTQTMTMA 88
           A++Y H       IIH DLKP N+LL   +E+ +  ++DFG SK+LGE    + +T+   
Sbjct: 126 AVQYLHENG----IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS--LMRTLC-G 178
Query: 89  TIGYMAPE----YGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLR 137
           T  Y+APE     G+ G   A  D +S GV+L    +   P  E  T ++SL+
Sbjct: 179 TPTYLAPEVLVSVGTAGYNRA-VDCWSLGVILFICLSGYPPFSEHRT-QVSLK 229

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 47.0 bits (110), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 41/113 (36%), Positives = 61/113 (53%), Gaps = 16/113 (14%)
Query: 32  ALEYPHHGHSSAPIIHCDLKPTNILL---DENMVAHVSDFGISKLLGEGEDFVTQTMTMA 88
           A++Y H       IIH DLKP N+LL   +E+ +  ++DFG SK+LGE    + +T+   
Sbjct: 126 AVQYLHENG----IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS--LMRTLC-G 178
Query: 89  TIGYMAPE----YGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLR 137
           T  Y+APE     G+ G   A  D +S GV+L    +   P  E  T ++SL+
Sbjct: 179 TPTYLAPEVLVSVGTAGYNRA-VDCWSLGVILFICLSGYPPFSEHRT-QVSLK 229

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 47.0 bits (110), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 34/122 (27%), Positives = 58/122 (47%), Gaps = 7/122 (5%)
Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           +P GSL  +L  ++    + + L     +   + Y H  H     IH +L   N+LLD +
Sbjct: 100 VPLGSLRDYLPRHS--IGLAQLLLFAQQICEGMAYLHSQH----YIHRNLAARNVLLDND 153
Query: 61  MVAHVSDFGISKLLGEGEDFV-TQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMET 119
            +  + DFG++K + EG ++   +    + + + APE   E       DV+S+GV L E 
Sbjct: 154 RLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYEL 213
Query: 120 FT 121
            T
Sbjct: 214 LT 215

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 47.0 bits (110), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 46/100 (46%), Gaps = 17/100 (17%)
Query: 32  ALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFV---------- 81
           AL Y H    S  IIH DLKP NI +DE+    + DFG++K +    D +          
Sbjct: 128 ALSYIH----SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183
Query: 82  --TQTMTMATIGYMAPE-YGSEGIVSAKCDVYSYGVLLME 118
               T  + T  Y+A E     G  + K D+YS G++  E
Sbjct: 184 SDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFE 223

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 47.0 bits (110), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 44/129 (34%), Positives = 65/129 (50%), Gaps = 18/129 (13%)
Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDE- 59
           M  GS+   ++   +F + LE   ++ DV SAL++ H    +  I H DLKP NIL +  
Sbjct: 93  MRGGSILSHIHKRRHFNE-LEASVVVQDVASALDFLH----NKGIAHRDLKPENILCEHP 147
Query: 60  NMVAHVS--DFGIS---KLLGEGEDFVTQTM--TMATIGYMAPE----YGSEG-IVSAKC 107
           N V+ V   DFG+    KL G+     T  +     +  YMAPE    +  E  I   +C
Sbjct: 148 NQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRC 207
Query: 108 DVYSYGVLL 116
           D++S GV+L
Sbjct: 208 DLWSLGVIL 216

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 47.0 bits (110), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 41/113 (36%), Positives = 61/113 (53%), Gaps = 16/113 (14%)
Query: 32  ALEYPHHGHSSAPIIHCDLKPTNILL---DENMVAHVSDFGISKLLGEGEDFVTQTMTMA 88
           A++Y H       IIH DLKP N+LL   +E+ +  ++DFG SK+LGE    + +T+   
Sbjct: 132 AVQYLHENG----IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS--LMRTLC-G 184
Query: 89  TIGYMAPE----YGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLR 137
           T  Y+APE     G+ G   A  D +S GV+L    +   P  E  T ++SL+
Sbjct: 185 TPTYLAPEVLVSVGTAGYNRA-VDCWSLGVILFICLSGYPPFSEHRT-QVSLK 235

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 47.0 bits (110), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 41/113 (36%), Positives = 61/113 (53%), Gaps = 16/113 (14%)
Query: 32  ALEYPHHGHSSAPIIHCDLKPTNILL---DENMVAHVSDFGISKLLGEGEDFVTQTMTMA 88
           A++Y H       IIH DLKP N+LL   +E+ +  ++DFG SK+LGE    + +T+   
Sbjct: 125 AVQYLHENG----IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS--LMRTLC-G 177
Query: 89  TIGYMAPE----YGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLR 137
           T  Y+APE     G+ G   A  D +S GV+L    +   P  E  T ++SL+
Sbjct: 178 TPTYLAPEVLVSVGTAGYNRA-VDCWSLGVILFICLSGYPPFSEHRT-QVSLK 228

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 47.0 bits (110), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 34/122 (27%), Positives = 58/122 (47%), Gaps = 7/122 (5%)
Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           +P GSL  +L  ++    + + L     +   + Y H  H     IH +L   N+LLD +
Sbjct: 100 VPLGSLRDYLPRHS--IGLAQLLLFAQQICEGMAYLHAQH----YIHRNLAARNVLLDND 153
Query: 61  MVAHVSDFGISKLLGEGEDFV-TQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMET 119
            +  + DFG++K + EG ++   +    + + + APE   E       DV+S+GV L E 
Sbjct: 154 RLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYEL 213
Query: 120 FT 121
            T
Sbjct: 214 LT 215

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 46.6 bits (109), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 41/158 (25%), Positives = 65/158 (41%), Gaps = 5/158 (3%)
Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           MP G L  ++  +         LN  + +   + Y         ++H DL   N+L+   
Sbjct: 105 MPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR----LVHRDLAARNVLVKTP 160
Query: 61  MVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETF 120
               ++DFG +KLLG  E           I +MA E     I + + DV+SYGV + E  
Sbjct: 161 QHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 220
Query: 121 T-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV 157
           T   +P D +   E+S      E LP      +D  ++
Sbjct: 221 TFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMI 258

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 46.6 bits (109), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 41/158 (25%), Positives = 65/158 (41%), Gaps = 5/158 (3%)
Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           MP G L  ++  +         LN  + +   + Y         ++H DL   N+L+   
Sbjct: 100 MPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR----LVHRDLAARNVLVKTP 155
Query: 61  MVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETF 120
               ++DFG +KLLG  E           I +MA E     I + + DV+SYGV + E  
Sbjct: 156 QHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 215
Query: 121 T-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV 157
           T   +P D +   E+S      E LP      +D  ++
Sbjct: 216 TFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMI 253

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 46.6 bits (109), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 41/158 (25%), Positives = 65/158 (41%), Gaps = 5/158 (3%)
Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           MP G L  ++  +         LN  + +   + Y         ++H DL   N+L+   
Sbjct: 100 MPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR----LVHRDLAARNVLVKTP 155
Query: 61  MVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETF 120
               ++DFG +KLLG  E           I +MA E     I + + DV+SYGV + E  
Sbjct: 156 QHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 215
Query: 121 T-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV 157
           T   +P D +   E+S      E LP      +D  ++
Sbjct: 216 TFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMI 253

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 46.6 bits (109), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 41/158 (25%), Positives = 65/158 (41%), Gaps = 5/158 (3%)
Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           MP G L  ++  +         LN  + +   + Y         ++H DL   N+L+   
Sbjct: 100 MPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR----LVHRDLAARNVLVKTP 155
Query: 61  MVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETF 120
               ++DFG +KLLG  E           I +MA E     I + + DV+SYGV + E  
Sbjct: 156 QHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 215
Query: 121 T-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV 157
           T   +P D +   E+S      E LP      +D  ++
Sbjct: 216 TFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMI 253

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 46.6 bits (109), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 41/158 (25%), Positives = 65/158 (41%), Gaps = 5/158 (3%)
Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           MP G L  ++  +         LN  + +   + Y         ++H DL   N+L+   
Sbjct: 98  MPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR----LVHRDLAARNVLVKTP 153
Query: 61  MVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETF 120
               ++DFG +KLLG  E           I +MA E     I + + DV+SYGV + E  
Sbjct: 154 QHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 213
Query: 121 T-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV 157
           T   +P D +   E+S      E LP      +D  ++
Sbjct: 214 TFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMI 251

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 46.6 bits (109), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 34/114 (29%), Positives = 52/114 (45%), Gaps = 1/114 (0%)
Query: 45  IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVS 104
           ++H DL   N+L+       ++DFG +KLLG  E           I +MA E     I +
Sbjct: 142 LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 201
Query: 105 AKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV 157
            + DV+SYGV + E  T   +P D +   E+S      E LP      +D  ++
Sbjct: 202 HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMI 255

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 46.6 bits (109), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 27/79 (34%), Positives = 41/79 (51%), Gaps = 1/79 (1%)
Query: 47  HCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAK 106
           H D+KP NIL+  +  A++ DFGI+    + E       T+ T+ Y APE  SE   + +
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIASATTD-EKLTQLGNTVGTLYYXAPERFSESHATYR 215
Query: 107 CDVYSYGVLLMETFTRKRP 125
            D+Y+   +L E  T   P
Sbjct: 216 ADIYALTCVLYECLTGSPP 234

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 46.6 bits (109), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 37/117 (31%), Positives = 61/117 (52%), Gaps = 16/117 (13%)
Query: 25  IMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED---FV 81
            +  +   L+Y H    SA ++H DLKP+N+LL+      + DFG++++     D   F+
Sbjct: 129 FLYQILRGLKYIH----SANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFL 184
Query: 82  TQTMTMATIGYMAPE--YGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSL 136
           T+   +AT  Y APE    S+G   +  D++S G +L E  +  RP   +F G+  L
Sbjct: 185 TE--YVATRWYRAPEIMLNSKGYTKS-IDIWSVGCILAEMLS-NRP---IFPGKHYL 234

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/86 (33%), Positives = 46/86 (53%), Gaps = 8/86 (9%)
Query: 46  IHCDLKPTNILLDENMVAHVSDFGIS-KLLGEGEDFVTQTMTMATIGYMAPEY-----GS 99
           +H D+KP NIL+D N    ++DFG   KL+ +G   V  ++ + T  Y++PE      G 
Sbjct: 197 VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT--VQSSVAVGTPDYISPEILQAMEGG 254
Query: 100 EGIVSAKCDVYSYGVLLMETFTRKRP 125
           +G    +CD +S GV + E    + P
Sbjct: 255 KGRYGPECDWWSLGVCMYEMLYGETP 280

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 24/79 (30%), Positives = 40/79 (50%), Gaps = 3/79 (3%)
Query: 45  IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVS 104
           I+H DLKP NIL+       ++DFG++++       +     + T+ Y APE   +   +
Sbjct: 133 IVHRDLKPENILVTSGGTVKLADFGLARIYSYQ---MALAPVVVTLWYRAPEVLLQSTYA 189
Query: 105 AKCDVYSYGVLLMETFTRK 123
              D++S G +  E F RK
Sbjct: 190 TPVDMWSVGCIFAEMFRRK 208

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 31/88 (35%), Positives = 46/88 (52%), Gaps = 9/88 (10%)
Query: 45  IIHCDLKPTNILLDENMVAHVSDFGISKLLGE----GEDFVTQTMTM----ATIGYMAPE 96
           +IH DLKP+N+L++ N    V DFG+++++ E      +   Q   M    AT  Y APE
Sbjct: 133 VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPE 192
Query: 97  YG-SEGIVSAKCDVYSYGVLLMETFTRK 123
              +    S   DV+S G +L E F R+
Sbjct: 193 VMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 37/117 (31%), Positives = 61/117 (52%), Gaps = 16/117 (13%)
Query: 25  IMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED---FV 81
            +  +   L+Y H    SA ++H DLKP+N+LL+      + DFG++++     D   F+
Sbjct: 133 FLYQILRGLKYIH----SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFL 188
Query: 82  TQTMTMATIGYMAPE--YGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSL 136
           T+   +AT  Y APE    S+G   +  D++S G +L E  +  RP   +F G+  L
Sbjct: 189 TE--YVATRWYRAPEIMLNSKGYTKS-IDIWSVGCILAEMLS-NRP---IFPGKHYL 238

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 54/103 (52%), Gaps = 11/103 (10%)
Query: 17  FDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN---MVAHVSDFGISKL 73
           FD  +  NIM  + S + Y H  +    I+H D+KP NILL+     +   + DFG+S  
Sbjct: 143 FDECDAANIMKQILSGICYLHKHN----IVHRDIKPENILLENKNSLLNIKIVDFGLSSF 198
Query: 74  LGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLL 116
               +D+  +   + T  Y+APE   +   + KCDV+S GV++
Sbjct: 199 F--SKDYKLRD-RLGTAYYIAPEVLKKK-YNEKCDVWSCGVIM 237

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 37/117 (31%), Positives = 61/117 (52%), Gaps = 16/117 (13%)
Query: 25  IMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED---FV 81
            +  +   L+Y H    SA ++H DLKP+N+LL+      + DFG++++     D   F+
Sbjct: 129 FLYQILRGLKYIH----SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFL 184
Query: 82  TQTMTMATIGYMAPE--YGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSL 136
           T+   +AT  Y APE    S+G   +  D++S G +L E  +  RP   +F G+  L
Sbjct: 185 TE--YVATRWYRAPEIMLNSKGYTKS-IDIWSVGCILAEMLS-NRP---IFPGKHYL 234

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 37/117 (31%), Positives = 61/117 (52%), Gaps = 16/117 (13%)
Query: 25  IMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED---FV 81
            +  +   L+Y H    SA ++H DLKP+N+LL+      + DFG++++     D   F+
Sbjct: 133 FLYQILRGLKYIH----SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFL 188
Query: 82  TQTMTMATIGYMAPE--YGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSL 136
           T+   +AT  Y APE    S+G   +  D++S G +L E  +  RP   +F G+  L
Sbjct: 189 TE--YVATRWYRAPEIMLNSKGYTKS-IDIWSVGCILAEMLS-NRP---IFPGKHYL 238

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 37/117 (31%), Positives = 61/117 (52%), Gaps = 16/117 (13%)
Query: 25  IMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED---FV 81
            +  +   L+Y H    SA ++H DLKP+N+LL+      + DFG++++     D   F+
Sbjct: 129 FLYQILRGLKYIH----SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFL 184
Query: 82  TQTMTMATIGYMAPE--YGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSL 136
           T+   +AT  Y APE    S+G   +  D++S G +L E  +  RP   +F G+  L
Sbjct: 185 TE--YVATRWYRAPEIMLNSKGYTKS-IDIWSVGCILAEMLS-NRP---IFPGKHYL 234

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 28/84 (33%), Positives = 44/84 (52%), Gaps = 9/84 (10%)
Query: 45  IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQT--MTMATIGYMAPEYGSEGI 102
           +++ DLKP NILLDE+    +SD G++       DF  +    ++ T GYMAPE   +G+
Sbjct: 313 VVYRDLKPANILLDEHGHVRISDLGLAC------DFSKKKPHASVGTHGYMAPEVLQKGV 366
Query: 103 V-SAKCDVYSYGVLLMETFTRKRP 125
              +  D +S G +L +      P
Sbjct: 367 AYDSSADWFSLGCMLFKLLRGHSP 390

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 36/146 (24%), Positives = 60/146 (41%), Gaps = 2/146 (1%)
Query: 45  IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVS 104
           I H D+KP N+LLDE     +SDFG++ +               T+ Y+APE        
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFH 184
Query: 105 AK-CDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWV-KESLPHGLTEVVDANLVREEQA 162
           A+  DV+S G++L      + P D+          W  K++  +   ++  A L    + 
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWDQPSDSXQEYSDWKEKKTYLNPWKKIDSAPLALLHKI 244
Query: 163 FAAKMDCIVSIMDLALDCCMESPGKR 188
                   ++I D+  D     P K+
Sbjct: 245 LVENPSARITIPDIKKDRWYNKPLKK 270

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 37/117 (31%), Positives = 61/117 (52%), Gaps = 16/117 (13%)
Query: 25  IMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED---FV 81
            +  +   L+Y H    SA ++H DLKP+N+LL+      + DFG++++     D   F+
Sbjct: 149 FLYQILRGLKYIH----SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFL 204
Query: 82  TQTMTMATIGYMAPE--YGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSL 136
           T+   +AT  Y APE    S+G   +  D++S G +L E  +  RP   +F G+  L
Sbjct: 205 TE--YVATRWYRAPEIMLNSKGYTKS-IDIWSVGCILAEMLS-NRP---IFPGKHYL 254

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 28/84 (33%), Positives = 44/84 (52%), Gaps = 9/84 (10%)
Query: 45  IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQT--MTMATIGYMAPEYGSEGI 102
           +++ DLKP NILLDE+    +SD G++       DF  +    ++ T GYMAPE   +G+
Sbjct: 312 VVYRDLKPANILLDEHGHVRISDLGLAC------DFSKKKPHASVGTHGYMAPEVLQKGV 365
Query: 103 V-SAKCDVYSYGVLLMETFTRKRP 125
              +  D +S G +L +      P
Sbjct: 366 AYDSSADWFSLGCMLFKLLRGHSP 389

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/123 (35%), Positives = 58/123 (47%), Gaps = 16/123 (13%)
Query: 3   NGSLEKWLYSYNYFFDILERL--NIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           NGS+  +  S +  F   E+L  NIM  + SAL Y H    +  I H D+KP N L   N
Sbjct: 151 NGSIHGFRESLD--FVQREKLISNIMRQIFSALHYLH----NQGICHRDIKPENFLFSTN 204
Query: 61  MVAHVS--DFGISK---LLGEGEDFVTQTMTMATIGYMAPEY--GSEGIVSAKCDVYSYG 113
               +   DFG+SK    L  GE +   T    T  ++APE    +      KCD +S G
Sbjct: 205 KSFEIKLVDFGLSKEFYKLNNGE-YYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAG 263
Query: 114 VLL 116
           VLL
Sbjct: 264 VLL 266

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 43/88 (48%), Gaps = 5/88 (5%)
Query: 42  SAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPE----Y 97
           S   IH D+KP N+LLD++    ++DFG    + + E  V     + T  Y++PE     
Sbjct: 191 SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK-EGMVRCDTAVGTPDYISPEVLKSQ 249
Query: 98  GSEGIVSAKCDVYSYGVLLMETFTRKRP 125
           G +G    +CD +S GV L E      P
Sbjct: 250 GGDGYYGRECDWWSVGVFLYEMLVGDTP 277

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 43/88 (48%), Gaps = 5/88 (5%)
Query: 42  SAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPE----Y 97
           S   IH D+KP N+LLD++    ++DFG    + + E  V     + T  Y++PE     
Sbjct: 186 SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK-EGMVRCDTAVGTPDYISPEVLKSQ 244
Query: 98  GSEGIVSAKCDVYSYGVLLMETFTRKRP 125
           G +G    +CD +S GV L E      P
Sbjct: 245 GGDGYYGRECDWWSVGVFLYEMLVGDTP 272

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/131 (30%), Positives = 60/131 (45%), Gaps = 15/131 (11%)
Query: 1   MPNGSLEKWLYSYNYFFDILERLN--IMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLD 58
           MP G L   + +Y    D+ E+       +V  AL+  H    S  +IH D+KP N+LLD
Sbjct: 157 MPGGDLVNLMSNY----DVPEKWAKFYTAEVVLALDAIH----SMGLIHRDVKPDNMLLD 208
Query: 59  ENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPE----YGSEGIVSAKCDVYSYGV 114
           ++    ++DFG    + E    V     + T  Y++PE     G +G    +CD +S GV
Sbjct: 209 KHGHLKLADFGTCMKMDE-TGMVHCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGV 267
Query: 115 LLMETFTRKRP 125
            L E      P
Sbjct: 268 FLFEMLVGDTP 278

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 28/84 (33%), Positives = 44/84 (52%), Gaps = 9/84 (10%)
Query: 45  IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQT--MTMATIGYMAPEYGSEGI 102
           +++ DLKP NILLDE+    +SD G++       DF  +    ++ T GYMAPE   +G+
Sbjct: 313 VVYRDLKPANILLDEHGHVRISDLGLAC------DFSKKKPHASVGTHGYMAPEVLQKGV 366
Query: 103 V-SAKCDVYSYGVLLMETFTRKRP 125
              +  D +S G +L +      P
Sbjct: 367 AYDSSADWFSLGCMLFKLLRGHSP 390

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 28/84 (33%), Positives = 44/84 (52%), Gaps = 9/84 (10%)
Query: 45  IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQT--MTMATIGYMAPEYGSEGI 102
           +++ DLKP NILLDE+    +SD G++       DF  +    ++ T GYMAPE   +G+
Sbjct: 313 VVYRDLKPANILLDEHGHVRISDLGLAC------DFSKKKPHASVGTHGYMAPEVLQKGV 366
Query: 103 V-SAKCDVYSYGVLLMETFTRKRP 125
              +  D +S G +L +      P
Sbjct: 367 AYDSSADWFSLGCMLFKLLRGHSP 390

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 43/88 (48%), Gaps = 5/88 (5%)
Query: 42  SAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPE----Y 97
           S   IH D+KP N+LLD++    ++DFG    + + E  V     + T  Y++PE     
Sbjct: 191 SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK-EGMVRCDTAVGTPDYISPEVLKSQ 249
Query: 98  GSEGIVSAKCDVYSYGVLLMETFTRKRP 125
           G +G    +CD +S GV L E      P
Sbjct: 250 GGDGYYGRECDWWSVGVFLYEMLVGDTP 277

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 37/117 (31%), Positives = 61/117 (52%), Gaps = 16/117 (13%)
Query: 25  IMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED---FV 81
            +  +   L+Y H    SA ++H DLKP+N+LL+      + DFG++++     D   F+
Sbjct: 133 FLYQILRGLKYIH----SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFL 188
Query: 82  TQTMTMATIGYMAPE--YGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSL 136
           T+   +AT  Y APE    S+G   +  D++S G +L E  +  RP   +F G+  L
Sbjct: 189 TE--YVATRWYRAPEIMLNSKGYTKS-IDIWSVGCILAEMLS-NRP---IFPGKHYL 238

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 37/117 (31%), Positives = 61/117 (52%), Gaps = 16/117 (13%)
Query: 25  IMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED---FV 81
            +  +   L+Y H    SA ++H DLKP+N+LL+      + DFG++++     D   F+
Sbjct: 129 FLYQILRGLKYIH----SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFL 184
Query: 82  TQTMTMATIGYMAPE--YGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSL 136
           T+   +AT  Y APE    S+G   +  D++S G +L E  +  RP   +F G+  L
Sbjct: 185 TE--YVATRWYRAPEIMLNSKGYTKS-IDIWSVGCILAEMLS-NRP---IFPGKHYL 234

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 24/79 (30%), Positives = 40/79 (50%), Gaps = 3/79 (3%)
Query: 45  IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVS 104
           I+H DLKP NIL+       ++DFG++++       +     + T+ Y APE   +   +
Sbjct: 133 IVHRDLKPENILVTSGGTVKLADFGLARIYSYQ---MALDPVVVTLWYRAPEVLLQSTYA 189
Query: 105 AKCDVYSYGVLLMETFTRK 123
              D++S G +  E F RK
Sbjct: 190 TPVDMWSVGCIFAEMFRRK 208

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 37/117 (31%), Positives = 61/117 (52%), Gaps = 16/117 (13%)
Query: 25  IMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED---FV 81
            +  +   L+Y H    SA ++H DLKP+N+LL+      + DFG++++     D   F+
Sbjct: 133 FLYQILRGLKYIH----SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFL 188
Query: 82  TQTMTMATIGYMAPE--YGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSL 136
           T+   +AT  Y APE    S+G   +  D++S G +L E  +  RP   +F G+  L
Sbjct: 189 TE--YVATRWYRAPEIMLNSKGYTKS-IDIWSVGCILAEMLS-NRP---IFPGKHYL 238

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 37/117 (31%), Positives = 61/117 (52%), Gaps = 16/117 (13%)
Query: 25  IMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED---FV 81
            +  +   L+Y H    SA ++H DLKP+N+LL+      + DFG++++     D   F+
Sbjct: 127 FLYQILRGLKYIH----SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFL 182
Query: 82  TQTMTMATIGYMAPE--YGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSL 136
           T+   +AT  Y APE    S+G   +  D++S G +L E  +  RP   +F G+  L
Sbjct: 183 TE--YVATRWYRAPEIMLNSKGYTKS-IDIWSVGCILAEMLS-NRP---IFPGKHYL 232

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 37/117 (31%), Positives = 61/117 (52%), Gaps = 16/117 (13%)
Query: 25  IMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED---FV 81
            +  +   L+Y H    SA ++H DLKP+N+LL+      + DFG++++     D   F+
Sbjct: 134 FLYQILRGLKYIH----SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFL 189
Query: 82  TQTMTMATIGYMAPE--YGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSL 136
           T+   +AT  Y APE    S+G   +  D++S G +L E  +  RP   +F G+  L
Sbjct: 190 TE--YVATRWYRAPEIMLNSKGYTKS-IDIWSVGCILAEMLS-NRP---IFPGKHYL 239

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/105 (33%), Positives = 53/105 (50%), Gaps = 10/105 (9%)
Query: 16  FFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNIL-LDEN---MVAHVSDFGIS 71
           FF   E   ++  +G  +EY H    S  ++H DLKP+NIL +DE+       + DFG +
Sbjct: 117 FFSEREASFVLHTIGKTVEYLH----SQGVVHRDLKPSNILYVDESGNPECLRICDFGFA 172
Query: 72  KLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLL 116
           K L   E+ +  T    T  ++APE          CD++S G+LL
Sbjct: 173 KQL-RAENGLLMT-PCYTANFVAPEVLKRQGYDEGCDIWSLGILL 215

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 37/117 (31%), Positives = 61/117 (52%), Gaps = 16/117 (13%)
Query: 25  IMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED---FV 81
            +  +   L+Y H    SA ++H DLKP+N+LL+      + DFG++++     D   F+
Sbjct: 135 FLYQILRGLKYIH----SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFL 190
Query: 82  TQTMTMATIGYMAPE--YGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSL 136
           T+   +AT  Y APE    S+G   +  D++S G +L E  +  RP   +F G+  L
Sbjct: 191 TE--YVATRWYRAPEIMLNSKGYTKS-IDIWSVGCILAEMLS-NRP---IFPGKHYL 240

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 37/117 (31%), Positives = 61/117 (52%), Gaps = 16/117 (13%)
Query: 25  IMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED---FV 81
            +  +   L+Y H    SA ++H DLKP+N+LL+      + DFG++++     D   F+
Sbjct: 126 FLYQILRGLKYIH----SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFL 181
Query: 82  TQTMTMATIGYMAPE--YGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSL 136
           T+   +AT  Y APE    S+G   +  D++S G +L E  +  RP   +F G+  L
Sbjct: 182 TE--YVATRWYRAPEIMLNSKGYTKS-IDIWSVGCILAEMLS-NRP---IFPGKHYL 231

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 37/117 (31%), Positives = 61/117 (52%), Gaps = 16/117 (13%)
Query: 25  IMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED---FV 81
            +  +   L+Y H    SA ++H DLKP+N+LL+      + DFG++++     D   F+
Sbjct: 133 FLYQILRGLKYIH----SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFL 188
Query: 82  TQTMTMATIGYMAPE--YGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSL 136
           T+   +AT  Y APE    S+G   +  D++S G +L E  +  RP   +F G+  L
Sbjct: 189 TE--YVATRWYRAPEIMLNSKGYTKS-IDIWSVGCILAEMLS-NRP---IFPGKHYL 238

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 24/79 (30%), Positives = 39/79 (49%), Gaps = 3/79 (3%)
Query: 45  IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVS 104
           I+H DLKP NIL+       ++DFG++++             + T+ Y APE   +   +
Sbjct: 133 IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFP---VVVTLWYRAPEVLLQSTYA 189
Query: 105 AKCDVYSYGVLLMETFTRK 123
              D++S G +  E F RK
Sbjct: 190 TPVDMWSVGCIFAEMFRRK 208

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/117 (31%), Positives = 61/117 (52%), Gaps = 16/117 (13%)
Query: 25  IMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED---FV 81
            +  +   L+Y H    SA ++H DLKP+N+LL+      + DFG++++     D   F+
Sbjct: 131 FLYQILRGLKYIH----SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFL 186
Query: 82  TQTMTMATIGYMAPE--YGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSL 136
           T+   +AT  Y APE    S+G   +  D++S G +L E  +  RP   +F G+  L
Sbjct: 187 TE--YVATRWYRAPEIMLNSKGYTKS-IDIWSVGCILAEMLS-NRP---IFPGKHYL 236

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 45/100 (45%), Gaps = 17/100 (17%)
Query: 32  ALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFV---------- 81
           AL Y H    S  IIH +LKP NI +DE+    + DFG++K +    D +          
Sbjct: 128 ALSYIH----SQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183
Query: 82  --TQTMTMATIGYMAPE-YGSEGIVSAKCDVYSYGVLLME 118
               T  + T  Y+A E     G  + K D YS G++  E
Sbjct: 184 SDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFE 223

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/117 (31%), Positives = 61/117 (52%), Gaps = 16/117 (13%)
Query: 25  IMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED---FV 81
            +  +   L+Y H    SA ++H DLKP+N+LL+      + DFG++++     D   F+
Sbjct: 131 FLYQILRGLKYIH----SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFL 186
Query: 82  TQTMTMATIGYMAPE--YGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSL 136
           T+   +AT  Y APE    S+G   +  D++S G +L E  +  RP   +F G+  L
Sbjct: 187 TE--YVATRWYRAPEIMLNSKGYTKS-IDIWSVGCILAEMLS-NRP---IFPGKHYL 236

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/84 (36%), Positives = 42/84 (50%), Gaps = 21/84 (25%)
Query: 45  IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPE-------- 96
           I+H DLKP NILLD++M   ++DFG S  L  GE   +      T  Y+APE        
Sbjct: 145 IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRS---VCGTPSYLAPEIIECSMND 201
Query: 97  ----YGSEGIVSAKCDVYSYGVLL 116
               YG E       D++S GV++
Sbjct: 202 NHPGYGKE------VDMWSTGVIM 219

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/117 (31%), Positives = 61/117 (52%), Gaps = 16/117 (13%)
Query: 25  IMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED---FV 81
            +  +   L+Y H    SA ++H DLKP+N+LL+      + DFG++++     D   F+
Sbjct: 127 FLYQILRGLKYIH----SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFL 182
Query: 82  TQTMTMATIGYMAPE--YGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSL 136
           T+   +AT  Y APE    S+G   +  D++S G +L E  +  RP   +F G+  L
Sbjct: 183 TE--YVATRWYRAPEIMLNSKGYTKS-IDIWSVGCILAEMLS-NRP---IFPGKHYL 232

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/117 (31%), Positives = 61/117 (52%), Gaps = 16/117 (13%)
Query: 25  IMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED---FV 81
            +  +   L+Y H    SA ++H DLKP+N+LL+      + DFG++++     D   F+
Sbjct: 131 FLYQILRGLKYIH----SANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFL 186
Query: 82  TQTMTMATIGYMAPE--YGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSL 136
           T+   +AT  Y APE    S+G   +  D++S G +L E  +  RP   +F G+  L
Sbjct: 187 TE--YVATRWYRAPEIMLNSKGYTKS-IDIWSVGCILAEMLS-NRP---IFPGKHYL 236

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 35/105 (33%), Positives = 53/105 (50%), Gaps = 10/105 (9%)
Query: 16  FFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNIL-LDEN---MVAHVSDFGIS 71
           FF   E   ++  +G  +EY H    S  ++H DLKP+NIL +DE+       + DFG +
Sbjct: 117 FFSEREASFVLHTIGKTVEYLH----SQGVVHRDLKPSNILYVDESGNPECLRICDFGFA 172
Query: 72  KLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLL 116
           K L   E+ +  T    T  ++APE          CD++S G+LL
Sbjct: 173 KQL-RAENGLLMT-PCYTANFVAPEVLKRQGYDEGCDIWSLGILL 215

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/117 (31%), Positives = 61/117 (52%), Gaps = 16/117 (13%)
Query: 25  IMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED---FV 81
            +  +   L+Y H    SA ++H DLKP+N+LL+      + DFG++++     D   F+
Sbjct: 137 FLYQILRGLKYIH----SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFL 192
Query: 82  TQTMTMATIGYMAPE--YGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSL 136
           T+   +AT  Y APE    S+G   +  D++S G +L E  +  RP   +F G+  L
Sbjct: 193 TE--YVATRWYRAPEIMLNSKGYTKS-IDIWSVGCILAEMLS-NRP---IFPGKHYL 242

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/117 (31%), Positives = 61/117 (52%), Gaps = 16/117 (13%)
Query: 25  IMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED---FV 81
            +  +   L+Y H    SA ++H DLKP+N+LL+      + DFG++++     D   F+
Sbjct: 129 FLYQILRGLKYIH----SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFL 184
Query: 82  TQTMTMATIGYMAPE--YGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSL 136
           T+   +AT  Y APE    S+G   +  D++S G +L E  +  RP   +F G+  L
Sbjct: 185 TE--YVATRWYRAPEIMLNSKGYTKS-IDIWSVGCILAEMLS-NRP---IFPGKHYL 234

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/136 (30%), Positives = 61/136 (44%), Gaps = 11/136 (8%)
Query: 17  FDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGE 76
           FD       + ++ +AL Y H    S  +IH D+KP N+LL  N    ++DFG S     
Sbjct: 109 FDEQRTATYITELANALSYCH----SKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPS 164
Query: 77  GEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSL 136
                 +     T+ Y+ PE     +   K D++S GVL  E F    P  E  T + + 
Sbjct: 165 SR----RDTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYE-FLVGMPPFEAHTYQETY 219
Query: 137 RR--WVKESLPHGLTE 150
           RR   V+ + P  +TE
Sbjct: 220 RRISRVEFTFPDFVTE 235

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/117 (31%), Positives = 61/117 (52%), Gaps = 16/117 (13%)
Query: 25  IMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED---FV 81
            +  +   L+Y H    SA ++H DLKP+N+LL+      + DFG++++     D   F+
Sbjct: 149 FLYQILRGLKYIH----SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFL 204
Query: 82  TQTMTMATIGYMAPE--YGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSL 136
           T+   +AT  Y APE    S+G   +  D++S G +L E  +  RP   +F G+  L
Sbjct: 205 TE--YVATRWYRAPEIMLNSKGYTKS-IDIWSVGCILAEMLS-NRP---IFPGKHYL 254

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/124 (29%), Positives = 54/124 (43%), Gaps = 9/124 (7%)
Query: 2   PNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENM 61
           P G + K L   + F D       + ++ +AL Y H    S  +IH D+KP N+LL    
Sbjct: 96  PRGEVYKELQKLSKF-DEQRTATYITELANALSYCH----SKRVIHRDIKPENLLLGSAG 150
Query: 62  VAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT 121
              ++DFG S           +T    T+ Y+ PE     +   K D++S GVL  E   
Sbjct: 151 ELKIADFGWSVHAPSSR----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLV 206
Query: 122 RKRP 125
            K P
Sbjct: 207 GKPP 210

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 28/106 (26%), Positives = 52/106 (49%), Gaps = 6/106 (5%)
Query: 24  NIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQ 83
            I+ ++   L+Y H    S   IH D+K  N+LL E     ++DFG++  L + +  + +
Sbjct: 120 TILREILKGLDYLH----SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--IKR 173
Query: 84  TMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEM 129
              + T  +MAPE   +     K D++S G+  +E    + P  ++
Sbjct: 174 NXFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDL 219

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 48/95 (50%), Gaps = 8/95 (8%)
Query: 39  GHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYG 98
           GH  A I H D+K  N+LL  N+ A ++DFG++     G+        + T  YMAPE  
Sbjct: 147 GHKPA-ISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEV- 204
Query: 99  SEGIVS------AKCDVYSYGVLLMETFTRKRPTD 127
            EG ++       + D+Y+ G++L E  +R    D
Sbjct: 205 LEGAINFQRDAFLRIDMYAMGLVLWELASRCTAAD 239

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/188 (25%), Positives = 67/188 (35%), Gaps = 22/188 (11%)
Query: 2   PNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENM 61
           P GSL   L  +   F +       + V   + Y      S   IH DL   N+LL    
Sbjct: 93  PLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGY----LESKRFIHRDLAARNLLLATRD 148
Query: 62  VAHVSDFGISKLLGEGED-FVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETF 120
           +  + DFG+ + L + +D +V Q        + APE       S   D + +GV L E F
Sbjct: 149 LVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMF 208
Query: 121 TRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLALDC 180
           T  +       G   L +  KE             L R E       DC   I ++ + C
Sbjct: 209 TYGQEPWIGLNGSQILHKIDKEG----------ERLPRPE-------DCPQDIYNVMVQC 251
Query: 181 CMESPGKR 188
               P  R
Sbjct: 252 WAHKPEDR 259

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/188 (25%), Positives = 67/188 (35%), Gaps = 22/188 (11%)
Query: 2   PNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENM 61
           P GSL   L  +   F +       + V   + Y      S   IH DL   N+LL    
Sbjct: 93  PLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGY----LESKRFIHRDLAARNLLLATRD 148
Query: 62  VAHVSDFGISKLLGEGED-FVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETF 120
           +  + DFG+ + L + +D +V Q        + APE       S   D + +GV L E F
Sbjct: 149 LVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMF 208
Query: 121 TRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLALDC 180
           T  +       G   L +  KE             L R E       DC   I ++ + C
Sbjct: 209 TYGQEPWIGLNGSQILHKIDKEG----------ERLPRPE-------DCPQDIYNVMVQC 251
Query: 181 CMESPGKR 188
               P  R
Sbjct: 252 WAHKPEDR 259

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/188 (25%), Positives = 67/188 (35%), Gaps = 22/188 (11%)
Query: 2   PNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENM 61
           P GSL   L  +   F +       + V   + Y      S   IH DL   N+LL    
Sbjct: 97  PLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGY----LESKRFIHRDLAARNLLLATRD 152
Query: 62  VAHVSDFGISKLLGEGED-FVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETF 120
           +  + DFG+ + L + +D +V Q        + APE       S   D + +GV L E F
Sbjct: 153 LVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMF 212
Query: 121 TRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLALDC 180
           T  +       G   L +  KE             L R E       DC   I ++ + C
Sbjct: 213 TYGQEPWIGLNGSQILHKIDKEG----------ERLPRPE-------DCPQDIYNVMVQC 255
Query: 181 CMESPGKR 188
               P  R
Sbjct: 256 WAHKPEDR 263

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/188 (25%), Positives = 67/188 (35%), Gaps = 22/188 (11%)
Query: 2   PNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENM 61
           P GSL   L  +   F +       + V   + Y      S   IH DL   N+LL    
Sbjct: 103 PLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGY----LESKRFIHRDLAARNLLLATRD 158
Query: 62  VAHVSDFGISKLLGEGED-FVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETF 120
           +  + DFG+ + L + +D +V Q        + APE       S   D + +GV L E F
Sbjct: 159 LVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMF 218
Query: 121 TRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLALDC 180
           T  +       G   L +  KE             L R E       DC   I ++ + C
Sbjct: 219 TYGQEPWIGLNGSQILHKIDKEG----------ERLPRPE-------DCPQDIYNVMVQC 261
Query: 181 CMESPGKR 188
               P  R
Sbjct: 262 WAHKPEDR 269

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 33/95 (34%), Positives = 48/95 (50%), Gaps = 11/95 (11%)
Query: 25  IMIDVGSALEYPHHGHSSAPIIHCDLKPTNILL---DENMVAHVSDFGISKLLGEGEDFV 81
           I+  V S + Y H  +    I+H DLKP NILL   +++    + DFG+S    +     
Sbjct: 126 IIKQVFSGITYMHKHN----IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMK 181
Query: 82  TQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLL 116
            +   + T  Y+APE    G    KCDV+S GV+L
Sbjct: 182 DR---IGTAYYIAPEV-LRGTYDEKCDVWSAGVIL 212

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 33/109 (30%), Positives = 48/109 (44%), Gaps = 8/109 (7%)
Query: 17  FDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGE 76
           FD       + ++ +AL Y H    S  +IH D+KP N+LL       ++DFG S     
Sbjct: 108 FDEQRTATYITELANALSYCH----SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 163
Query: 77  GEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRP 125
                 +T    T+ Y+ PE     +   K D++S GVL  E    K P
Sbjct: 164 SR----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 27/87 (31%), Positives = 43/87 (49%), Gaps = 6/87 (6%)
Query: 38  HGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPE- 96
           H H    ++H DLKP N+L++      ++DFG+++    G    T T  + T+ Y APE 
Sbjct: 120 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEI 174
Query: 97  YGSEGIVSAKCDVYSYGVLLMETFTRK 123
                  S   D++S G +  E  TR+
Sbjct: 175 LLGXKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 33/109 (30%), Positives = 48/109 (44%), Gaps = 8/109 (7%)
Query: 17  FDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGE 76
           FD       + ++ +AL Y H    S  +IH D+KP N+LL       ++DFG S     
Sbjct: 110 FDEQRTATYITELANALSYCH----SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 165
Query: 77  GEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRP 125
                 +T    T+ Y+ PE     +   K D++S GVL  E    K P
Sbjct: 166 SR----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/122 (23%), Positives = 58/122 (47%), Gaps = 5/122 (4%)
Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           +P+GSL+++L       ++ ++L   + +   ++Y      S   +H DL   N+L++  
Sbjct: 107 LPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDY----LGSRQYVHRDLAARNVLVESE 162
Query: 61  MVAHVSDFGISKLL-GEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMET 119
               + DFG++K +  + E    +    + + + APE   +       DV+S+GV L E 
Sbjct: 163 HQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHEL 222
Query: 120 FT 121
            T
Sbjct: 223 LT 224

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 27/87 (31%), Positives = 43/87 (49%), Gaps = 6/87 (6%)
Query: 38  HGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPE- 96
           H H    ++H DLKP N+L++      ++DFG+++    G    T T  + T+ Y APE 
Sbjct: 127 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEI 181
Query: 97  YGSEGIVSAKCDVYSYGVLLMETFTRK 123
                  S   D++S G +  E  TR+
Sbjct: 182 LLGXKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 47/188 (25%), Positives = 67/188 (35%), Gaps = 22/188 (11%)
Query: 2   PNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENM 61
           P GSL   L  +   F +       + V   + Y      S   IH DL   N+LL    
Sbjct: 97  PLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGY----LESKRFIHRDLAARNLLLATRD 152
Query: 62  VAHVSDFGISKLLGEGED-FVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETF 120
           +  + DFG+ + L + +D +V Q        + APE       S   D + +GV L E F
Sbjct: 153 LVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMF 212
Query: 121 TRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLALDC 180
           T  +       G   L +  KE             L R E       DC   I ++ + C
Sbjct: 213 TYGQEPWIGLNGSQILHKIDKEG----------ERLPRPE-------DCPQDIYNVMVQC 255
Query: 181 CMESPGKR 188
               P  R
Sbjct: 256 WAHKPEDR 263

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 29/122 (23%), Positives = 58/122 (47%), Gaps = 5/122 (4%)
Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           +P+GSL+++L       ++ ++L   + +   ++Y      S   +H DL   N+L++  
Sbjct: 95  LPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDY----LGSRQYVHRDLAARNVLVESE 150
Query: 61  MVAHVSDFGISKLL-GEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMET 119
               + DFG++K +  + E    +    + + + APE   +       DV+S+GV L E 
Sbjct: 151 HQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHEL 210
Query: 120 FT 121
            T
Sbjct: 211 LT 212

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 31/84 (36%), Positives = 41/84 (48%), Gaps = 21/84 (25%)
Query: 45  IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPE-------- 96
           I+H DLKP NILLD++M   ++DFG S  L  GE          T  Y+APE        
Sbjct: 145 IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL---REVCGTPSYLAPEIIECSMND 201
Query: 97  ----YGSEGIVSAKCDVYSYGVLL 116
               YG E       D++S GV++
Sbjct: 202 NHPGYGKE------VDMWSTGVIM 219

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 42/137 (30%), Positives = 67/137 (48%), Gaps = 14/137 (10%)
Query: 1   MPNGSLEKWLYSYNYFFD-ILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDE 59
           M  GSL++ L       + IL +++I +  G  L Y    H    I+H D+KP+NIL++ 
Sbjct: 89  MDGGSLDQVLKKAGRIPEQILGKVSIAVIKG--LTYLREKHK---IMHRDVKPSNILVNS 143
Query: 60  NMVAHVSDFGIS-KLLGE-GEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLM 117
                + DFG+S +L+ E   +FV       T  YM+PE       S + D++S G+ L+
Sbjct: 144 RGEIKLCDFGVSGQLIDEMANEFV------GTRSYMSPERLQGTHYSVQSDIWSMGLSLV 197
Query: 118 ETFTRKRPTDEMFTGEM 134
           E    + P   M   E+
Sbjct: 198 EMAVGRYPRPPMAIFEL 214

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 33/109 (30%), Positives = 48/109 (44%), Gaps = 8/109 (7%)
Query: 17  FDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGE 76
           FD       + ++ +AL Y H    S  +IH D+KP N+LL       ++DFG S     
Sbjct: 105 FDEQRTATYITELANALSYCH----SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 160
Query: 77  GEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRP 125
                 +T    T+ Y+ PE     +   K D++S GVL  E    K P
Sbjct: 161 SR----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 33/103 (32%), Positives = 48/103 (46%), Gaps = 10/103 (9%)
Query: 17  FDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDE---NMVAHVSDFGISKL 73
           F   E   IM  +G A++Y H    S  I H D+KP N+L      N +  ++DFG +K 
Sbjct: 158 FTEREASEIMKSIGEAIQYLH----SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK- 212
Query: 74  LGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLL 116
             E     + T    T  Y+APE          CD++S GV++
Sbjct: 213 --ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 253

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 33/109 (30%), Positives = 48/109 (44%), Gaps = 8/109 (7%)
Query: 17  FDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGE 76
           FD       + ++ +AL Y H    S  +IH D+KP N+LL       ++DFG S     
Sbjct: 122 FDEQRTATYITELANALSYCH----SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 177
Query: 77  GEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRP 125
                 +T    T+ Y+ PE     +   K D++S GVL  E    K P
Sbjct: 178 SR----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 222

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 33/109 (30%), Positives = 48/109 (44%), Gaps = 8/109 (7%)
Query: 17  FDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGE 76
           FD       + ++ +AL Y H    S  +IH D+KP N+LL       ++DFG S     
Sbjct: 108 FDEQRTATYITELANALSYCH----SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 163
Query: 77  GEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRP 125
                 +T    T+ Y+ PE     +   K D++S GVL  E    K P
Sbjct: 164 SR----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 33/103 (32%), Positives = 48/103 (46%), Gaps = 10/103 (9%)
Query: 17  FDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDE---NMVAHVSDFGISKL 73
           F   E   IM  +G A++Y H    S  I H D+KP N+L      N +  ++DFG +K 
Sbjct: 120 FTEREASEIMKSIGEAIQYLH----SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK- 174
Query: 74  LGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLL 116
             E     + T    T  Y+APE          CD++S GV++
Sbjct: 175 --ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 215

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 52/103 (50%), Gaps = 11/103 (10%)
Query: 17  FDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILL---DENMVAHVSDFGISKL 73
           F   E   IM D+G+A+++ H    S  I H D+KP N+L    +++ V  ++DFG +K 
Sbjct: 106 FTEREAAEIMRDIGTAIQFLH----SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK- 160
Query: 74  LGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLL 116
             E      QT    T  Y+APE          CD++S GV++
Sbjct: 161 --ETTQNALQT-PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 200

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 27/85 (31%), Positives = 41/85 (48%), Gaps = 1/85 (1%)
Query: 45  IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVS 104
           I H D+KP N+LLDE     +SDFG++ +               T+ Y+APE        
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFH 184
Query: 105 AK-CDVYSYGVLLMETFTRKRPTDE 128
           A+  DV+S G++L      + P D+
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 48/96 (50%), Gaps = 11/96 (11%)
Query: 24  NIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILL---DENMVAHVSDFGISKLLGEGEDF 80
            I+  V S + Y H  +    I+H DLKP NILL   +++    + DFG+S    +    
Sbjct: 125 RIIKQVFSGITYMHKHN----IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM 180
Query: 81  VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLL 116
             +   + T  Y+APE    G    KCDV+S GV+L
Sbjct: 181 KDR---IGTAYYIAPEV-LRGTYDEKCDVWSAGVIL 212

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 33/103 (32%), Positives = 48/103 (46%), Gaps = 10/103 (9%)
Query: 17  FDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDE---NMVAHVSDFGISKL 73
           F   E   IM  +G A++Y H    S  I H D+KP N+L      N +  ++DFG +K 
Sbjct: 119 FTEREASEIMKSIGEAIQYLH----SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK- 173
Query: 74  LGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLL 116
             E     + T    T  Y+APE          CD++S GV++
Sbjct: 174 --ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 214

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 33/103 (32%), Positives = 48/103 (46%), Gaps = 10/103 (9%)
Query: 17  FDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDE---NMVAHVSDFGISKL 73
           F   E   IM  +G A++Y H    S  I H D+KP N+L      N +  ++DFG +K 
Sbjct: 164 FTEREASEIMKSIGEAIQYLH----SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK- 218
Query: 74  LGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLL 116
             E     + T    T  Y+APE          CD++S GV++
Sbjct: 219 --ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 259

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 31/84 (36%), Positives = 41/84 (48%), Gaps = 21/84 (25%)
Query: 45  IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPE-------- 96
           I+H DLKP NILLD++M   ++DFG S  L  GE          T  Y+APE        
Sbjct: 132 IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL---REVCGTPSYLAPEIIECSMND 188
Query: 97  ----YGSEGIVSAKCDVYSYGVLL 116
               YG E       D++S GV++
Sbjct: 189 NHPGYGKE------VDMWSTGVIM 206

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 33/109 (30%), Positives = 48/109 (44%), Gaps = 8/109 (7%)
Query: 17  FDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGE 76
           FD       + ++ +AL Y H    S  +IH D+KP N+LL       ++DFG S     
Sbjct: 131 FDEQRTATYITELANALSYCH----SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 186
Query: 77  GEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRP 125
                 +T    T+ Y+ PE     +   K D++S GVL  E    K P
Sbjct: 187 SR----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 231

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 33/103 (32%), Positives = 48/103 (46%), Gaps = 10/103 (9%)
Query: 17  FDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDE---NMVAHVSDFGISKL 73
           F   E   IM  +G A++Y H    S  I H D+KP N+L      N +  ++DFG +K 
Sbjct: 114 FTEREASEIMKSIGEAIQYLH----SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK- 168
Query: 74  LGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLL 116
             E     + T    T  Y+APE          CD++S GV++
Sbjct: 169 --ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 209

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 33/109 (30%), Positives = 48/109 (44%), Gaps = 8/109 (7%)
Query: 17  FDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGE 76
           FD       + ++ +AL Y H    S  +IH D+KP N+LL       ++DFG S     
Sbjct: 105 FDEQRTATYITELANALSYCH----SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 160
Query: 77  GEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRP 125
                 +T    T+ Y+ PE     +   K D++S GVL  E    K P
Sbjct: 161 SR----RTXLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 27/85 (31%), Positives = 41/85 (48%), Gaps = 1/85 (1%)
Query: 45  IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVS 104
           I H D+KP N+LLDE     +SDFG++ +               T+ Y+APE        
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFH 184
Query: 105 AK-CDVYSYGVLLMETFTRKRPTDE 128
           A+  DV+S G++L      + P D+
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 33/103 (32%), Positives = 48/103 (46%), Gaps = 10/103 (9%)
Query: 17  FDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDE---NMVAHVSDFGISKL 73
           F   E   IM  +G A++Y H    S  I H D+KP N+L      N +  ++DFG +K 
Sbjct: 113 FTEREASEIMKSIGEAIQYLH----SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK- 167
Query: 74  LGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLL 116
             E     + T    T  Y+APE          CD++S GV++
Sbjct: 168 --ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 208

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 48/96 (50%), Gaps = 11/96 (11%)
Query: 24  NIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILL---DENMVAHVSDFGISKLLGEGEDF 80
            I+  V S + Y H  +    I+H DLKP NILL   +++    + DFG+S    +    
Sbjct: 125 RIIKQVFSGITYMHKHN----IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM 180
Query: 81  VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLL 116
             +   + T  Y+APE    G    KCDV+S GV+L
Sbjct: 181 KDR---IGTAYYIAPEV-LRGTYDEKCDVWSAGVIL 212

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 27/85 (31%), Positives = 41/85 (48%), Gaps = 1/85 (1%)
Query: 45  IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVS 104
           I H D+KP N+LLDE     +SDFG++ +               T+ Y+APE        
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFH 185
Query: 105 AK-CDVYSYGVLLMETFTRKRPTDE 128
           A+  DV+S G++L      + P D+
Sbjct: 186 AEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 36/117 (30%), Positives = 61/117 (52%), Gaps = 6/117 (5%)
Query: 45  IIHCDLKPTNILLDENMVAHVSDFGI-SKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIV 103
           +IH DLK  N+ L+E++   + DFG+ +K+  +GE    + +   T  Y+APE  S+   
Sbjct: 160 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE---RKKVLCGTPNYIAPEVLSKKGH 216
Query: 104 SAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKE-SLPHGLTEVVDANLVRE 159
           S + DV+S G ++      K P +     E  LR    E S+P  +  V  A+L+++
Sbjct: 217 SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVA-ASLIQK 272

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 33/109 (30%), Positives = 48/109 (44%), Gaps = 8/109 (7%)
Query: 17  FDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGE 76
           FD       + ++ +AL Y H    S  +IH D+KP N+LL       ++DFG S     
Sbjct: 104 FDEQRTATYITELANALSYCH----SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 159
Query: 77  GEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRP 125
                 +T    T+ Y+ PE     +   K D++S GVL  E    K P
Sbjct: 160 SR----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 204

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 33/109 (30%), Positives = 48/109 (44%), Gaps = 8/109 (7%)
Query: 17  FDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGE 76
           FD       + ++ +AL Y H    S  +IH D+KP N+LL       ++DFG S     
Sbjct: 102 FDEQRTATYITELANALSYCH----SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 157
Query: 77  GEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRP 125
                 +T    T+ Y+ PE     +   K D++S GVL  E    K P
Sbjct: 158 SR----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 202

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 33/103 (32%), Positives = 48/103 (46%), Gaps = 10/103 (9%)
Query: 17  FDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDE---NMVAHVSDFGISKL 73
           F   E   IM  +G A++Y H    S  I H D+KP N+L      N +  ++DFG +K 
Sbjct: 118 FTEREASEIMKSIGEAIQYLH----SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK- 172
Query: 74  LGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLL 116
             E     + T    T  Y+APE          CD++S GV++
Sbjct: 173 --ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 213

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 33/103 (32%), Positives = 48/103 (46%), Gaps = 10/103 (9%)
Query: 17  FDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDE---NMVAHVSDFGISKL 73
           F   E   IM  +G A++Y H    S  I H D+KP N+L      N +  ++DFG +K 
Sbjct: 114 FTEREASEIMKSIGEAIQYLH----SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK- 168
Query: 74  LGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLL 116
             E     + T    T  Y+APE          CD++S GV++
Sbjct: 169 --ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 209

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 33/103 (32%), Positives = 48/103 (46%), Gaps = 10/103 (9%)
Query: 17  FDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDE---NMVAHVSDFGISKL 73
           F   E   IM  +G A++Y H    S  I H D+KP N+L      N +  ++DFG +K 
Sbjct: 112 FTEREASEIMKSIGEAIQYLH----SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK- 166
Query: 74  LGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLL 116
             E     + T    T  Y+APE          CD++S GV++
Sbjct: 167 --ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 207

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 33/103 (32%), Positives = 48/103 (46%), Gaps = 10/103 (9%)
Query: 17  FDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDE---NMVAHVSDFGISKL 73
           F   E   IM  +G A++Y H    S  I H D+KP N+L      N +  ++DFG +K 
Sbjct: 128 FTEREASEIMKSIGEAIQYLH----SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK- 182
Query: 74  LGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLL 116
             E     + T    T  Y+APE          CD++S GV++
Sbjct: 183 --ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 223

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 33/109 (30%), Positives = 48/109 (44%), Gaps = 8/109 (7%)
Query: 17  FDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGE 76
           FD       + ++ +AL Y H    S  +IH D+KP N+LL       ++DFG S     
Sbjct: 109 FDEQRTATYITELANALSYCH----SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 164
Query: 77  GEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRP 125
                 +T    T+ Y+ PE     +   K D++S GVL  E    K P
Sbjct: 165 SR----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 209

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 27/85 (31%), Positives = 41/85 (48%), Gaps = 1/85 (1%)
Query: 45  IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVS 104
           I H D+KP N+LLDE     +SDFG++ +               T+ Y+APE        
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFH 184
Query: 105 AK-CDVYSYGVLLMETFTRKRPTDE 128
           A+  DV+S G++L      + P D+
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 52/103 (50%), Gaps = 11/103 (10%)
Query: 17  FDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILL---DENMVAHVSDFGISKL 73
           F   E   IM D+G+A+++ H    S  I H D+KP N+L    +++ V  ++DFG +K 
Sbjct: 125 FTEREAAEIMRDIGTAIQFLH----SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK- 179
Query: 74  LGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLL 116
             E      QT    T  Y+APE          CD++S GV++
Sbjct: 180 --ETTQNALQT-PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 219

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 32/112 (28%), Positives = 53/112 (47%), Gaps = 19/112 (16%)
Query: 14  NYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKL 73
           +Y F +L+ L+             H H    ++H DLKP N+L++      ++DFG+++ 
Sbjct: 107 SYLFQLLQGLSFC-----------HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARA 152
Query: 74  LGEGEDFVTQTMTMATIGYMAPE--YGSEGIVSAKCDVYSYGVLLMETFTRK 123
              G    T T  + T+ Y APE   G +   S   D++S G +  E  TR+
Sbjct: 153 F--GVPVRTYTHEVVTLWYRAPEILLGCK-YYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 34/108 (31%), Positives = 50/108 (46%), Gaps = 8/108 (7%)
Query: 31  SALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATI 90
           SA++Y H  +    I+H DLK  N+LLD +M   ++DFG S     G    T      + 
Sbjct: 125 SAVQYCHQKY----IVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDT---FCGSP 177
Query: 91  GYMAPE-YGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLR 137
            Y APE +  +     + DV+S GV+L    +   P D     E+  R
Sbjct: 178 PYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRER 225

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 36/117 (30%), Positives = 61/117 (52%), Gaps = 6/117 (5%)
Query: 45  IIHCDLKPTNILLDENMVAHVSDFGI-SKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIV 103
           +IH DLK  N+ L+E++   + DFG+ +K+  +GE    + +   T  Y+APE  S+   
Sbjct: 162 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE---RKKVLCGTPNYIAPEVLSKKGH 218
Query: 104 SAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKE-SLPHGLTEVVDANLVRE 159
           S + DV+S G ++      K P +     E  LR    E S+P  +  V  A+L+++
Sbjct: 219 SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVA-ASLIQK 274

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 39/126 (30%), Positives = 63/126 (50%), Gaps = 10/126 (7%)
Query: 1   MPNGSLEKWLYSYNYFFD-ILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDE 59
           M  GSL++ L       + IL +++I +  G  L Y    H    I+H D+KP+NIL++ 
Sbjct: 96  MDGGSLDQVLKEAKRIPEEILGKVSIAVLRG--LAYLREKHQ---IMHRDVKPSNILVNS 150
Query: 60  NMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMET 119
                + DFG+S   G+  D +  +  + T  YMAPE       S + D++S G+ L+E 
Sbjct: 151 RGEIKLCDFGVS---GQLIDSMANSF-VGTRSYMAPERLQGTHYSVQSDIWSMGLSLVEL 206
Query: 120 FTRKRP 125
              + P
Sbjct: 207 AVGRYP 212

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 36/117 (30%), Positives = 61/117 (52%), Gaps = 6/117 (5%)
Query: 45  IIHCDLKPTNILLDENMVAHVSDFGI-SKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIV 103
           +IH DLK  N+ L+E++   + DFG+ +K+  +GE    + +   T  Y+APE  S+   
Sbjct: 136 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE---RKKVLCGTPNYIAPEVLSKKGH 192
Query: 104 SAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKE-SLPHGLTEVVDANLVRE 159
           S + DV+S G ++      K P +     E  LR    E S+P  +  V  A+L+++
Sbjct: 193 SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVA-ASLIQK 248

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 36/117 (30%), Positives = 61/117 (52%), Gaps = 16/117 (13%)
Query: 25  IMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED---FV 81
            +  +   L+Y H    SA ++H DLKP+N+L++      + DFG++++     D   F+
Sbjct: 149 FLYQILRGLKYIH----SANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFL 204
Query: 82  TQTMTMATIGYMAPE--YGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSL 136
           T+   +AT  Y APE    S+G   +  D++S G +L E  +  RP   +F G+  L
Sbjct: 205 TE--XVATRWYRAPEIMLNSKGYTKS-IDIWSVGCILAEMLS-NRP---IFPGKHYL 254

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 19/74 (25%), Positives = 40/74 (54%)
Query: 45  IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVS 104
            +H DL   N ++  +    + DFG+++ + E + +      +  + +MAPE   +G+ +
Sbjct: 151 FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFT 210
Query: 105 AKCDVYSYGVLLME 118
              D++S+GV+L E
Sbjct: 211 TSSDMWSFGVVLWE 224

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 34/122 (27%), Positives = 56/122 (45%), Gaps = 7/122 (5%)
Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           +P GSL  +L    +   + + L     +   + Y H  H     IH  L   N+LLD +
Sbjct: 94  VPLGSLRDYLP--RHCVGLAQLLLFAQQICEGMAYLHAQH----YIHRALAARNVLLDND 147
Query: 61  MVAHVSDFGISKLLGEGEDFV-TQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMET 119
            +  + DFG++K + EG ++   +    + + + APE   E       DV+S+GV L E 
Sbjct: 148 RLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKECKFYYASDVWSFGVTLYEL 207
Query: 120 FT 121
            T
Sbjct: 208 LT 209

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 33/109 (30%), Positives = 48/109 (44%), Gaps = 8/109 (7%)
Query: 17  FDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGE 76
           FD       + ++ +AL Y H    S  +IH D+KP N+LL       ++DFG S     
Sbjct: 106 FDEQRTATYITELANALSYCH----SKRVIHRDIKPENLLLGSAGELKIADFGWSCHAPS 161
Query: 77  GEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRP 125
                 +T    T+ Y+ PE     +   K D++S GVL  E    K P
Sbjct: 162 SR----RTTLSGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 206

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 45/88 (51%), Gaps = 8/88 (9%)
Query: 38  HGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPE- 96
           H H    ++H DLKP N+L++      ++DFG+++    G    T T  + T+ Y APE 
Sbjct: 119 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEI 173
Query: 97  -YGSEGIVSAKCDVYSYGVLLMETFTRK 123
             G +   S   D++S G +  E  TR+
Sbjct: 174 LLGCK-YYSTAVDIWSLGCIFAEMVTRR 200

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 34/122 (27%), Positives = 56/122 (45%), Gaps = 7/122 (5%)
Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           +P GSL  +L    +   + + L     +   + Y H  H     IH  L   N+LLD +
Sbjct: 95  VPLGSLRDYLP--RHCVGLAQLLLFAQQICEGMAYLHAQH----YIHRALAARNVLLDND 148
Query: 61  MVAHVSDFGISKLLGEGEDFV-TQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMET 119
            +  + DFG++K + EG ++   +    + + + APE   E       DV+S+GV L E 
Sbjct: 149 RLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKECKFYYASDVWSFGVTLYEL 208
Query: 120 FT 121
            T
Sbjct: 209 LT 210

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 45/88 (51%), Gaps = 8/88 (9%)
Query: 38  HGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPE- 96
           H H    ++H DLKP N+L++      ++DFG+++    G    T T  + T+ Y APE 
Sbjct: 120 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEI 174
Query: 97  -YGSEGIVSAKCDVYSYGVLLMETFTRK 123
             G +   S   D++S G +  E  TR+
Sbjct: 175 LLGCK-YYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 45/88 (51%), Gaps = 8/88 (9%)
Query: 38  HGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPE- 96
           H H    ++H DLKP N+L++      ++DFG+++    G    T T  + T+ Y APE 
Sbjct: 121 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEI 175
Query: 97  -YGSEGIVSAKCDVYSYGVLLMETFTRK 123
             G +   S   D++S G +  E  TR+
Sbjct: 176 LLGCK-YYSTAVDIWSLGCIFAEMVTRR 202

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 33/109 (30%), Positives = 47/109 (43%), Gaps = 8/109 (7%)
Query: 17  FDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGE 76
           FD       + ++ +AL Y H    S  +IH D+KP N+LL       ++DFG S     
Sbjct: 110 FDEQRTATYITELANALSYCH----SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 165
Query: 77  GEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRP 125
                 +T    T+ Y+ PE         K D++S GVL  E    K P
Sbjct: 166 SR----RTTLCGTLDYLPPEXIEGRXHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 45/88 (51%), Gaps = 8/88 (9%)
Query: 38  HGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPE- 96
           H H    ++H DLKP N+L++      ++DFG+++    G    T T  + T+ Y APE 
Sbjct: 119 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEI 173
Query: 97  -YGSEGIVSAKCDVYSYGVLLMETFTRK 123
             G +   S   D++S G +  E  TR+
Sbjct: 174 LLGCK-YYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 45/88 (51%), Gaps = 8/88 (9%)
Query: 38  HGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPE- 96
           H H    ++H DLKP N+L++      ++DFG+++    G    T T  + T+ Y APE 
Sbjct: 124 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEI 178
Query: 97  -YGSEGIVSAKCDVYSYGVLLMETFTRK 123
             G +   S   D++S G +  E  TR+
Sbjct: 179 LLGCK-YYSTAVDIWSLGCIFAEMVTRR 205

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 36/113 (31%), Positives = 54/113 (47%), Gaps = 5/113 (4%)
Query: 29  VGSALEYPHHGHSSAPIIHCDLKPTNILLDENMV-AHVSDFGISKLL---GEGEDFVTQT 84
           +G ALE   + HS   I+H D+K  N+LL  +   A + DFG +  L   G G+D +T  
Sbjct: 172 LGQALEGLEYLHSRR-ILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGD 230
Query: 85  MTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLR 137
               T  +MAPE        AK DV+S   +++       P  + F G + L+
Sbjct: 231 YIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHPWTQFFRGPLCLK 283

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 27/85 (31%), Positives = 41/85 (48%), Gaps = 1/85 (1%)
Query: 45  IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVS 104
           I H D+KP N+LLDE     +SDFG++ +               T+ Y+APE        
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185
Query: 105 AK-CDVYSYGVLLMETFTRKRPTDE 128
           A+  DV+S G++L      + P D+
Sbjct: 186 AEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 45/88 (51%), Gaps = 8/88 (9%)
Query: 38  HGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPE- 96
           H H    ++H DLKP N+L++      ++DFG+++    G    T T  + T+ Y APE 
Sbjct: 120 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEI 174
Query: 97  -YGSEGIVSAKCDVYSYGVLLMETFTRK 123
             G +   S   D++S G +  E  TR+
Sbjct: 175 LLGCK-YYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 45/88 (51%), Gaps = 8/88 (9%)
Query: 38  HGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPE- 96
           H H    ++H DLKP N+L++      ++DFG+++    G    T T  + T+ Y APE 
Sbjct: 119 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEI 173
Query: 97  -YGSEGIVSAKCDVYSYGVLLMETFTRK 123
             G +   S   D++S G +  E  TR+
Sbjct: 174 LLGCK-YYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 45/88 (51%), Gaps = 8/88 (9%)
Query: 38  HGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPE- 96
           H H    ++H DLKP N+L++      ++DFG+++    G    T T  + T+ Y APE 
Sbjct: 120 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEI 174
Query: 97  -YGSEGIVSAKCDVYSYGVLLMETFTRK 123
             G +   S   D++S G +  E  TR+
Sbjct: 175 LLGCK-YYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 19/74 (25%), Positives = 39/74 (52%)
Query: 45  IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVS 104
            +H DL   N ++  +    + DFG+++ + E +        +  + +MAPE   +G+ +
Sbjct: 148 FVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAPESLKDGVFT 207
Query: 105 AKCDVYSYGVLLME 118
              D++S+GV+L E
Sbjct: 208 TSSDMWSFGVVLWE 221

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 45/88 (51%), Gaps = 8/88 (9%)
Query: 38  HGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPE- 96
           H H    ++H DLKP N+L++      ++DFG+++    G    T T  + T+ Y APE 
Sbjct: 127 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEI 181
Query: 97  -YGSEGIVSAKCDVYSYGVLLMETFTRK 123
             G +   S   D++S G +  E  TR+
Sbjct: 182 LLGCK-YYSTAVDIWSLGCIFAEMVTRR 208

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 27/85 (31%), Positives = 41/85 (48%), Gaps = 1/85 (1%)
Query: 45  IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVS 104
           I H D+KP N+LLDE     +SDFG++ +               T+ Y+APE        
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 184
Query: 105 AK-CDVYSYGVLLMETFTRKRPTDE 128
           A+  DV+S G++L      + P D+
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 27/85 (31%), Positives = 41/85 (48%), Gaps = 1/85 (1%)
Query: 45  IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVS 104
           I H D+KP N+LLDE     +SDFG++ +               T+ Y+APE        
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 184
Query: 105 AK-CDVYSYGVLLMETFTRKRPTDE 128
           A+  DV+S G++L      + P D+
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 19/74 (25%), Positives = 39/74 (52%)
Query: 45  IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVS 104
            +H DL   N ++  +    + DFG+++ + E +        +  + +MAPE   +G+ +
Sbjct: 151 FVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAPESLKDGVFT 210
Query: 105 AKCDVYSYGVLLME 118
              D++S+GV+L E
Sbjct: 211 TSSDMWSFGVVLWE 224

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 27/85 (31%), Positives = 41/85 (48%), Gaps = 1/85 (1%)
Query: 45  IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVS 104
           I H D+KP N+LLDE     +SDFG++ +               T+ Y+APE        
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 184
Query: 105 AK-CDVYSYGVLLMETFTRKRPTDE 128
           A+  DV+S G++L      + P D+
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 27/85 (31%), Positives = 41/85 (48%), Gaps = 1/85 (1%)
Query: 45  IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVS 104
           I H D+KP N+LLDE     +SDFG++ +               T+ Y+APE        
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 184
Query: 105 AK-CDVYSYGVLLMETFTRKRPTDE 128
           A+  DV+S G++L      + P D+
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 27/85 (31%), Positives = 41/85 (48%), Gaps = 1/85 (1%)
Query: 45  IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVS 104
           I H D+KP N+LLDE     +SDFG++ +               T+ Y+APE        
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185
Query: 105 AK-CDVYSYGVLLMETFTRKRPTDE 128
           A+  DV+S G++L      + P D+
Sbjct: 186 AEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 27/85 (31%), Positives = 41/85 (48%), Gaps = 1/85 (1%)
Query: 45  IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVS 104
           I H D+KP N+LLDE     +SDFG++ +               T+ Y+APE        
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185
Query: 105 AK-CDVYSYGVLLMETFTRKRPTDE 128
           A+  DV+S G++L      + P D+
Sbjct: 186 AEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 27/85 (31%), Positives = 41/85 (48%), Gaps = 1/85 (1%)
Query: 45  IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVS 104
           I H D+KP N+LLDE     +SDFG++ +               T+ Y+APE        
Sbjct: 124 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 183
Query: 105 AK-CDVYSYGVLLMETFTRKRPTDE 128
           A+  DV+S G++L      + P D+
Sbjct: 184 AEPVDVWSCGIVLTAMLAGELPWDQ 208

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 27/85 (31%), Positives = 41/85 (48%), Gaps = 1/85 (1%)
Query: 45  IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVS 104
           I H D+KP N+LLDE     +SDFG++ +               T+ Y+APE        
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 184
Query: 105 AK-CDVYSYGVLLMETFTRKRPTDE 128
           A+  DV+S G++L      + P D+
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 19/74 (25%), Positives = 39/74 (52%)
Query: 45  IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVS 104
            +H DL   N ++  +    + DFG+++ + E +        +  + +MAPE   +G+ +
Sbjct: 151 FVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAPESLKDGVFT 210
Query: 105 AKCDVYSYGVLLME 118
              D++S+GV+L E
Sbjct: 211 TSSDMWSFGVVLWE 224

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 27/85 (31%), Positives = 41/85 (48%), Gaps = 1/85 (1%)
Query: 45  IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVS 104
           I H D+KP N+LLDE     +SDFG++ +               T+ Y+APE        
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 184
Query: 105 AK-CDVYSYGVLLMETFTRKRPTDE 128
           A+  DV+S G++L      + P D+
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 19/78 (24%), Positives = 42/78 (53%)
Query: 41  SSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSE 100
           ++   +H DL   N ++  +    + DFG+++ + E + +      +  + +MAPE   +
Sbjct: 146 NAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD 205
Query: 101 GIVSAKCDVYSYGVLLME 118
           G+ +   D++S+GV+L E
Sbjct: 206 GVFTTSSDMWSFGVVLWE 223

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 27/85 (31%), Positives = 41/85 (48%), Gaps = 1/85 (1%)
Query: 45  IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVS 104
           I H D+KP N+LLDE     +SDFG++ +               T+ Y+APE        
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 184
Query: 105 AK-CDVYSYGVLLMETFTRKRPTDE 128
           A+  DV+S G++L      + P D+
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 33/109 (30%), Positives = 48/109 (44%), Gaps = 8/109 (7%)
Query: 17  FDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGE 76
           FD       + ++ +AL Y H    S  +IH D+KP N+LL       ++DFG S     
Sbjct: 105 FDEQRTATYITELANALSYCH----SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 160
Query: 77  GEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRP 125
                 +T    T+ Y+ PE     +   K D++S GVL  E    K P
Sbjct: 161 SR----RTELCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 44.3 bits (103), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 45/88 (51%), Gaps = 8/88 (9%)
Query: 38  HGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPE- 96
           H H    ++H DLKP N+L++      ++DFG+++    G    T T  + T+ Y APE 
Sbjct: 119 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEI 173
Query: 97  -YGSEGIVSAKCDVYSYGVLLMETFTRK 123
             G +   S   D++S G +  E  TR+
Sbjct: 174 LLGCK-YYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 44.3 bits (103), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 32/96 (33%), Positives = 50/96 (52%), Gaps = 11/96 (11%)
Query: 25  IMIDVGSALEYPHHGHSSAPIIHCDLKPTNILL---DENMVAHVSDFGISKLLGEGEDFV 81
           I+  V S + Y H  +    I+H DLKP N+LL   +++ +  + DFG+S +    E+  
Sbjct: 141 IIKQVLSGVTYLHKHN----IVHRDLKPENLLLESKEKDALIKIVDFGLSAVF---ENQK 193
Query: 82  TQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLM 117
                + T  Y+APE   +     KCDV+S GV+L 
Sbjct: 194 KMKERLGTAYYIAPEVLRKK-YDEKCDVWSIGVILF 228

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 44.3 bits (103), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 40/137 (29%), Positives = 66/137 (48%), Gaps = 10/137 (7%)
Query: 1   MPNGSLEKWLYSYNYFFD-ILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDE 59
           M  GSL++ L       + IL +++I +  G  L Y    H    I+H D+KP+NIL++ 
Sbjct: 148 MDGGSLDQVLKKAGRIPEQILGKVSIAVIKG--LTYLREKHK---IMHRDVKPSNILVNS 202
Query: 60  NMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMET 119
                + DFG+S   G+  D +  +  + T  YM+PE       S + D++S G+ L+E 
Sbjct: 203 RGEIKLCDFGVS---GQLIDSMANSF-VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEM 258
Query: 120 FTRKRPTDEMFTGEMSL 136
              + P       E+ L
Sbjct: 259 AVGRYPIPPPDAKELEL 275

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 44.3 bits (103), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 27/85 (31%), Positives = 41/85 (48%), Gaps = 1/85 (1%)
Query: 45  IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVS 104
           I H D+KP N+LLDE     +SDFG++ +               T+ Y+APE        
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185
Query: 105 AK-CDVYSYGVLLMETFTRKRPTDE 128
           A+  DV+S G++L      + P D+
Sbjct: 186 AEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 44.3 bits (103), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 27/85 (31%), Positives = 41/85 (48%), Gaps = 1/85 (1%)
Query: 45  IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVS 104
           I H D+KP N+LLDE     +SDFG++ +               T+ Y+APE        
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185
Query: 105 AK-CDVYSYGVLLMETFTRKRPTDE 128
           A+  DV+S G++L      + P D+
Sbjct: 186 AEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 44.3 bits (103), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 27/85 (31%), Positives = 41/85 (48%), Gaps = 1/85 (1%)
Query: 45  IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVS 104
           I H D+KP N+LLDE     +SDFG++ +               T+ Y+APE        
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185
Query: 105 AK-CDVYSYGVLLMETFTRKRPTDE 128
           A+  DV+S G++L      + P D+
Sbjct: 186 AEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 44.3 bits (103), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 27/85 (31%), Positives = 41/85 (48%), Gaps = 1/85 (1%)
Query: 45  IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVS 104
           I H D+KP N+LLDE     +SDFG++ +               T+ Y+APE        
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185
Query: 105 AK-CDVYSYGVLLMETFTRKRPTDE 128
           A+  DV+S G++L      + P D+
Sbjct: 186 AEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 44.3 bits (103), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 33/103 (32%), Positives = 48/103 (46%), Gaps = 10/103 (9%)
Query: 17  FDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDE---NMVAHVSDFGISKL 73
           F   E   IM  +G A++Y H    S  I H D+KP N+L      N +  ++DFG +K 
Sbjct: 112 FTEREASEIMKSIGEAIQYLH----SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK- 166
Query: 74  LGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLL 116
             E     + T    T  Y+APE          CD++S GV++
Sbjct: 167 --ETTSHNSLTEPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 207

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 44.3 bits (103), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 71/168 (42%), Gaps = 37/168 (22%)
Query: 32  ALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMA--- 88
           ALE+ H       II+ D+K  NILLD N    ++DFG+SK      +FV      A   
Sbjct: 171 ALEHLH----KLGIIYRDIKLENILLDSNGHVVLTDFGLSK------EFVADETERAYDF 220
Query: 89  --TIGYMAPE--YGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFT--GEMSLRRWVKE 142
             TI YMAP+   G +       D +S GVL+ E  T   P    FT  GE + +  +  
Sbjct: 221 CGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP----FTVDGEKNSQAEISR 276
Query: 143 SLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRIN 190
                        +++ E  +  +M  +    DL     M+ P KR+ 
Sbjct: 277 ------------RILKSEPPYPQEMSALAK--DLIQRLLMKDPKKRLG 310

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 44.3 bits (103), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 33/109 (30%), Positives = 48/109 (44%), Gaps = 8/109 (7%)
Query: 17  FDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGE 76
           FD       + ++ +AL Y H    S  +IH D+KP N+LL       ++DFG S     
Sbjct: 110 FDEQRTATYITELANALSYCH----SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 165
Query: 77  GEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRP 125
                 +T    T+ Y+ PE     +   K D++S GVL  E    K P
Sbjct: 166 SR----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 44.3 bits (103), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 43/129 (33%), Positives = 64/129 (49%), Gaps = 18/129 (13%)
Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDE- 59
           M  GS+   ++   +F + LE   ++ DV SAL++ H    +  I H DLKP NIL +  
Sbjct: 93  MRGGSILSHIHKRRHFNE-LEASVVVQDVASALDFLH----NKGIAHRDLKPENILCEHP 147
Query: 60  NMVAHVS--DFGIS---KLLGEGEDFVTQTM--TMATIGYMAPE----YGSEG-IVSAKC 107
           N V+ V   DF +    KL G+     T  +     +  YMAPE    +  E  I   +C
Sbjct: 148 NQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRC 207
Query: 108 DVYSYGVLL 116
           D++S GV+L
Sbjct: 208 DLWSLGVIL 216

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 44.3 bits (103), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 36/117 (30%), Positives = 60/117 (51%), Gaps = 16/117 (13%)
Query: 25  IMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED---FV 81
            +  +   L+Y H    SA ++H DLKP+N+LL+      + DFG++++     D   F+
Sbjct: 133 FLYQILRGLKYIH----SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFL 188
Query: 82  TQTMTMATIGYMAPE--YGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSL 136
            +   +AT  Y APE    S+G   +  D++S G +L E  +  RP   +F G+  L
Sbjct: 189 XE--XVATRWYRAPEIMLNSKGYTKS-IDIWSVGCILAEMLS-NRP---IFPGKHYL 238

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 44.3 bits (103), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 36/117 (30%), Positives = 60/117 (51%), Gaps = 6/117 (5%)
Query: 45  IIHCDLKPTNILLDENMVAHVSDFGI-SKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIV 103
           +IH DLK  N+ L+E++   + DFG+ +K+  +GE    +     T  Y+APE  S+   
Sbjct: 138 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE---RKKTLCGTPNYIAPEVLSKKGH 194
Query: 104 SAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKE-SLPHGLTEVVDANLVRE 159
           S + DV+S G ++      K P +     E  LR    E S+P  +  V  A+L+++
Sbjct: 195 SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVA-ASLIQK 250

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 44.3 bits (103), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 27/85 (31%), Positives = 41/85 (48%), Gaps = 1/85 (1%)
Query: 45  IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVS 104
           I H D+KP N+LLDE     +SDFG++ +               T+ Y+APE        
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 184
Query: 105 AK-CDVYSYGVLLMETFTRKRPTDE 128
           A+  DV+S G++L      + P D+
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 44.3 bits (103), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 36/117 (30%), Positives = 60/117 (51%), Gaps = 16/117 (13%)
Query: 25  IMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED---FV 81
            +  +   L+Y H    SA ++H DLKP+N+LL+      + DFG++++     D   F+
Sbjct: 134 FLYQILRGLKYIH----SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFL 189
Query: 82  TQTMTMATIGYMAPE--YGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSL 136
            +   +AT  Y APE    S+G   +  D++S G +L E  +  RP   +F G+  L
Sbjct: 190 XE--XVATRWYRAPEIMLNSKGYTKS-IDIWSVGCILAEMLS-NRP---IFPGKHYL 239

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 44.3 bits (103), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 36/117 (30%), Positives = 60/117 (51%), Gaps = 6/117 (5%)
Query: 45  IIHCDLKPTNILLDENMVAHVSDFGI-SKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIV 103
           +IH DLK  N+ L+E++   + DFG+ +K+  +GE    +     T  Y+APE  S+   
Sbjct: 142 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE---RKKTLCGTPNYIAPEVLSKKGH 198
Query: 104 SAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKE-SLPHGLTEVVDANLVRE 159
           S + DV+S G ++      K P +     E  LR    E S+P  +  V  A+L+++
Sbjct: 199 SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVA-ASLIQK 254

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 44.3 bits (103), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 31/104 (29%), Positives = 49/104 (47%), Gaps = 14/104 (13%)
Query: 26  MIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTM 85
            + + SALE+ H    S  ++H D+KP N+ +    V  + D G+      G  F ++T 
Sbjct: 142 FVQLCSALEHMH----SRRVMHRDIKPANVFITATGVVKLGDLGL------GRFFSSKTT 191
Query: 86  T----MATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRP 125
                + T  YM+PE   E   + K D++S G LL E    + P
Sbjct: 192 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 235

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 44.3 bits (103), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 33/109 (30%), Positives = 48/109 (44%), Gaps = 8/109 (7%)
Query: 17  FDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGE 76
           FD       + ++ +AL Y H    S  +IH D+KP N+LL       ++DFG S     
Sbjct: 105 FDEQRTATYITELANALSYCH----SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 160
Query: 77  GEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRP 125
                 +T    T+ Y+ PE     +   K D++S GVL  E    K P
Sbjct: 161 SR----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 44.3 bits (103), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 33/109 (30%), Positives = 48/109 (44%), Gaps = 8/109 (7%)
Query: 17  FDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGE 76
           FD       + ++ +AL Y H    S  +IH D+KP N+LL       ++DFG S     
Sbjct: 105 FDEQRTATYITELANALSYCH----SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 160
Query: 77  GEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRP 125
                 +T    T+ Y+ PE     +   K D++S GVL  E    K P
Sbjct: 161 SR----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 44.3 bits (103), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 33/109 (30%), Positives = 48/109 (44%), Gaps = 8/109 (7%)
Query: 17  FDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGE 76
           FD       + ++ +AL Y H    S  +IH D+KP N+LL       ++DFG S     
Sbjct: 106 FDEQRTATYITELANALSYCH----SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 161
Query: 77  GEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRP 125
                 +T    T+ Y+ PE     +   K D++S GVL  E    K P
Sbjct: 162 SR----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 206

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 44.3 bits (103), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 36/117 (30%), Positives = 60/117 (51%), Gaps = 6/117 (5%)
Query: 45  IIHCDLKPTNILLDENMVAHVSDFGI-SKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIV 103
           +IH DLK  N+ L+E++   + DFG+ +K+  +GE    +     T  Y+APE  S+   
Sbjct: 138 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE---RKKTLCGTPNYIAPEVLSKKGH 194
Query: 104 SAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKE-SLPHGLTEVVDANLVRE 159
           S + DV+S G ++      K P +     E  LR    E S+P  +  V  A+L+++
Sbjct: 195 SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVA-ASLIQK 250

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 44.3 bits (103), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 35/126 (27%), Positives = 58/126 (46%), Gaps = 16/126 (12%)
Query: 13  YNYF----FDILERLNIMIDVGSALEYPH---HGHSSAPII-HCDLKPTNILLDENMVAH 64
           Y+Y      D +  L I++ + S L + H    G    P I H DLK  NIL+ +N    
Sbjct: 94  YDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCC 153
Query: 65  VSDFGISKLLGEGEDF--VTQTMTMATIGYMAPEYGSEGI------VSAKCDVYSYGVLL 116
           ++D G++ +  +  +   V     + T  YMAPE   E I         + D++++G++L
Sbjct: 154 IADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVL 213
Query: 117 METFTR 122
            E   R
Sbjct: 214 WEVARR 219

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 44.3 bits (103), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 35/137 (25%), Positives = 62/137 (45%), Gaps = 23/137 (16%)
Query: 23  LNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLD-------------ENMVAHVSDFG 69
           ++++  + S + + H    S  IIH DLKP NIL+              EN+   +SDFG
Sbjct: 136 ISLLRQIASGVAHLH----SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFG 191
Query: 70  ISKLLGEGEDFVTQTMT--MATIGYMAPEYGSEGI---VSAKCDVYSYGVLLMETFTR-K 123
           + K L  G+      +     T G+ APE   E     ++   D++S G +     ++ K
Sbjct: 192 LCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGK 251
Query: 124 RPTDEMFTGEMSLRRWV 140
            P  + ++ E ++ R +
Sbjct: 252 HPFGDKYSRESNIIRGI 268

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 43.9 bits (102), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 49/103 (47%), Gaps = 11/103 (10%)
Query: 17  FDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLD---ENMVAHVSDFGISKL 73
           F  ++   I+  V S + Y H       I+H DLKP N+LL+   ++    + DFG+S  
Sbjct: 123 FSEVDAARIIRQVLSGITYXHKN----KIVHRDLKPENLLLESKSKDANIRIIDFGLSTH 178
Query: 74  LGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLL 116
               E        + T  Y+APE    G    KCDV+S GV+L
Sbjct: 179 F---EASKKXKDKIGTAYYIAPEV-LHGTYDEKCDVWSTGVIL 217

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 43.9 bits (102), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 40/137 (29%), Positives = 66/137 (48%), Gaps = 10/137 (7%)
Query: 1   MPNGSLEKWLYSYNYFFD-ILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDE 59
           M  GSL++ L       + IL +++I +  G  L Y    H    I+H D+KP+NIL++ 
Sbjct: 113 MDGGSLDQVLKKAGRIPEQILGKVSIAVIKG--LTYLREKHK---IMHRDVKPSNILVNS 167
Query: 60  NMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMET 119
                + DFG+S   G+  D +  +  + T  YM+PE       S + D++S G+ L+E 
Sbjct: 168 RGEIKLCDFGVS---GQLIDSMANSF-VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEM 223
Query: 120 FTRKRPTDEMFTGEMSL 136
              + P       E+ L
Sbjct: 224 AVGRYPIPPPDAKELEL 240

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 43.9 bits (102), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 34/108 (31%), Positives = 49/108 (45%), Gaps = 8/108 (7%)
Query: 31  SALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATI 90
           SA++Y H       I+H DLK  N+LLD +M   ++DFG S     G    T      + 
Sbjct: 117 SAVQYCHQKF----IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT---FCGSP 169
Query: 91  GYMAPE-YGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLR 137
            Y APE +  +     + DV+S GV+L    +   P D     E+  R
Sbjct: 170 PYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRER 217

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 43.9 bits (102), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 35/137 (25%), Positives = 62/137 (45%), Gaps = 23/137 (16%)
Query: 23  LNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLD-------------ENMVAHVSDFG 69
           ++++  + S + + H    S  IIH DLKP NIL+              EN+   +SDFG
Sbjct: 136 ISLLRQIASGVAHLH----SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFG 191
Query: 70  ISKLLGEGEDFVTQTMT--MATIGYMAPEYGSEGI---VSAKCDVYSYGVLLMETFTR-K 123
           + K L  G+      +     T G+ APE   E     ++   D++S G +     ++ K
Sbjct: 192 LCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGK 251
Query: 124 RPTDEMFTGEMSLRRWV 140
            P  + ++ E ++ R +
Sbjct: 252 HPFGDKYSRESNIIRGI 268

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 43.9 bits (102), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 34/108 (31%), Positives = 49/108 (45%), Gaps = 8/108 (7%)
Query: 31  SALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATI 90
           SA++Y H       I+H DLK  N+LLD +M   ++DFG S     G    T      + 
Sbjct: 124 SAVQYCHQKF----IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT---FCGSP 176
Query: 91  GYMAPE-YGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLR 137
            Y APE +  +     + DV+S GV+L    +   P D     E+  R
Sbjct: 177 PYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRER 224

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 43.9 bits (102), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 35/126 (27%), Positives = 58/126 (46%), Gaps = 16/126 (12%)
Query: 13  YNYF----FDILERLNIMIDVGSALEYPH---HGHSSAPII-HCDLKPTNILLDENMVAH 64
           Y+Y      D +  L I++ + S L + H    G    P I H DLK  NIL+ +N    
Sbjct: 94  YDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCC 153
Query: 65  VSDFGISKLLGEGEDF--VTQTMTMATIGYMAPEYGSEGI------VSAKCDVYSYGVLL 116
           ++D G++ +  +  +   V     + T  YMAPE   E I         + D++++G++L
Sbjct: 154 IADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVL 213
Query: 117 METFTR 122
            E   R
Sbjct: 214 WEVARR 219

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 43.9 bits (102), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 38/126 (30%), Positives = 63/126 (50%), Gaps = 10/126 (7%)
Query: 1   MPNGSLEKWLYSYNYFFD-ILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDE 59
           M  GSL++ L       + IL +++I +  G  L Y    H    I+H D+KP+NIL++ 
Sbjct: 105 MDGGSLDQVLKKAGRIPEQILGKVSIAVIKG--LTYLREKHK---IMHRDVKPSNILVNS 159
Query: 60  NMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMET 119
                + DFG+S   G+  D +  +  + T  YM+PE       S + D++S G+ L+E 
Sbjct: 160 RGEIKLCDFGVS---GQLIDSMANSF-VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEM 215
Query: 120 FTRKRP 125
              + P
Sbjct: 216 AVGRYP 221

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 43.9 bits (102), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 47/188 (25%), Positives = 66/188 (35%), Gaps = 22/188 (11%)
Query: 2   PNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENM 61
           P GSL   L  +   F +       + V   + Y      S   IH DL   N+LL    
Sbjct: 93  PLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGY----LESKRFIHRDLAARNLLLATRD 148
Query: 62  VAHVSDFGISKLLGEGEDF-VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETF 120
           +  + DFG+ + L + +D  V Q        + APE       S   D + +GV L E F
Sbjct: 149 LVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMF 208
Query: 121 TRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLALDC 180
           T  +       G   L +  KE             L R E       DC   I ++ + C
Sbjct: 209 TYGQEPWIGLNGSQILHKIDKEG----------ERLPRPE-------DCPQDIYNVMVQC 251
Query: 181 CMESPGKR 188
               P  R
Sbjct: 252 WAHKPEDR 259

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 43.9 bits (102), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 36/124 (29%), Positives = 53/124 (42%), Gaps = 9/124 (7%)
Query: 2   PNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENM 61
           P G + K L   + F D       + ++ +AL Y H    S  +IH D+KP N+LL    
Sbjct: 96  PRGEVYKELQKLSKF-DEQRTATYITELANALSYCH----SKRVIHRDIKPENLLLGSAG 150
Query: 62  VAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT 121
              ++DFG S           +     T+ Y+ PE     +   K D++S GVL  E   
Sbjct: 151 ELKIADFGWSVHAPSSR----RXXLXGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLV 206
Query: 122 RKRP 125
            K P
Sbjct: 207 GKPP 210

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 43.9 bits (102), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 34/108 (31%), Positives = 49/108 (45%), Gaps = 8/108 (7%)
Query: 31  SALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATI 90
           SA++Y H       I+H DLK  N+LLD +M   ++DFG S     G    T      + 
Sbjct: 124 SAVQYCHQKF----IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT---FCGSP 176
Query: 91  GYMAPE-YGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLR 137
            Y APE +  +     + DV+S GV+L    +   P D     E+  R
Sbjct: 177 PYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRER 224

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 43.9 bits (102), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 34/108 (31%), Positives = 49/108 (45%), Gaps = 8/108 (7%)
Query: 31  SALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATI 90
           SA++Y H       I+H DLK  N+LLD +M   ++DFG S     G    T      + 
Sbjct: 124 SAVQYCHQKF----IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT---FCGSP 176
Query: 91  GYMAPE-YGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLR 137
            Y APE +  +     + DV+S GV+L    +   P D     E+  R
Sbjct: 177 PYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRER 224

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 43.9 bits (102), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 19/74 (25%), Positives = 39/74 (52%)
Query: 45  IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVS 104
            +H DL   N ++  +    + DFG+++ + E   +      +  + +MAPE   +G+ +
Sbjct: 151 FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLPVRWMAPESLKDGVFT 210
Query: 105 AKCDVYSYGVLLME 118
              D++S+GV+L E
Sbjct: 211 TSSDMWSFGVVLWE 224

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 43.9 bits (102), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 49/192 (25%), Positives = 85/192 (44%), Gaps = 18/192 (9%)
Query: 1   MPNGSLEKWLYSYNYFFD-ILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDE 59
           M  GSL++ L       + IL +++I +  G  L Y    H    I+H D+KP+NIL++ 
Sbjct: 86  MDGGSLDQVLKKAGRIPEQILGKVSIAVIKG--LTYLREKHK---IMHRDVKPSNILVNS 140
Query: 60  NMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMET 119
                + DFG+S   G+  D +  +  + T  YM+PE       S + D++S G+ L+E 
Sbjct: 141 RGEIKLCDFGVS---GQLIDSMANSF-VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEM 196
Query: 120 FTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLALD 179
              + P       E S         P  + E++D  +V E           +   D    
Sbjct: 197 AVGRYPIPPPDAKEDS-------RPPMAIFELLDY-IVNEPPPKLPSGVFSLEFQDFVNK 248
Query: 180 CCMESPGKRINM 191
           C +++P +R ++
Sbjct: 249 CLIKNPAERADL 260

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 43.9 bits (102), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 35/126 (27%), Positives = 58/126 (46%), Gaps = 16/126 (12%)
Query: 13  YNYF----FDILERLNIMIDVGSALEYPH---HGHSSAPII-HCDLKPTNILLDENMVAH 64
           Y+Y      D +  L I++ + S L + H    G    P I H DLK  NIL+ +N    
Sbjct: 123 YDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCC 182
Query: 65  VSDFGISKLLGEGEDF--VTQTMTMATIGYMAPEYGSEGI------VSAKCDVYSYGVLL 116
           ++D G++ +  +  +   V     + T  YMAPE   E I         + D++++G++L
Sbjct: 183 IADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVL 242
Query: 117 METFTR 122
            E   R
Sbjct: 243 WEVARR 248

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 43.9 bits (102), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 40/137 (29%), Positives = 66/137 (48%), Gaps = 10/137 (7%)
Query: 1   MPNGSLEKWLYSYNYFFD-ILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDE 59
           M  GSL++ L       + IL +++I +  G  L Y    H    I+H D+KP+NIL++ 
Sbjct: 86  MDGGSLDQVLKKAGRIPEQILGKVSIAVIKG--LTYLREKHK---IMHRDVKPSNILVNS 140
Query: 60  NMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMET 119
                + DFG+S   G+  D +  +  + T  YM+PE       S + D++S G+ L+E 
Sbjct: 141 RGEIKLCDFGVS---GQLIDSMANSF-VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEM 196
Query: 120 FTRKRPTDEMFTGEMSL 136
              + P       E+ L
Sbjct: 197 AVGRYPIPPPDAKELEL 213

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 43.9 bits (102), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 47/188 (25%), Positives = 66/188 (35%), Gaps = 22/188 (11%)
Query: 2   PNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENM 61
           P GSL   L  +   F +       + V   + Y      S   IH DL   N+LL    
Sbjct: 103 PLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGY----LESKRFIHRDLAARNLLLATRD 158
Query: 62  VAHVSDFGISKLLGEGEDF-VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETF 120
           +  + DFG+ + L + +D  V Q        + APE       S   D + +GV L E F
Sbjct: 159 LVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMF 218
Query: 121 TRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLALDC 180
           T  +       G   L +  KE             L R E       DC   I ++ + C
Sbjct: 219 TYGQEPWIGLNGSQILHKIDKEG----------ERLPRPE-------DCPQDIYNVMVQC 261
Query: 181 CMESPGKR 188
               P  R
Sbjct: 262 WAHKPEDR 269

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 43.9 bits (102), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 30/104 (28%), Positives = 51/104 (49%), Gaps = 9/104 (8%)
Query: 25  IMIDVGSALEYPHHGHSSAPIIHCDLKPTNILL---DENMVAHVSDFGISKLLGEGEDFV 81
           IM  + SA+ + H       ++H DLKP N+L    ++N+   + DFG ++L  +  D  
Sbjct: 111 IMRKLVSAVSHMH----DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARL--KPPDNQ 164
Query: 82  TQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRP 125
                  T+ Y APE  ++      CD++S GV+L    + + P
Sbjct: 165 PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVP 208

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 43.9 bits (102), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 34/108 (31%), Positives = 49/108 (45%), Gaps = 8/108 (7%)
Query: 31  SALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATI 90
           SA++Y H       I+H DLK  N+LLD +M   ++DFG S     G    T      + 
Sbjct: 122 SAVQYCHQKR----IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDT---FCGSP 174
Query: 91  GYMAPE-YGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLR 137
            Y APE +  +     + DV+S GV+L    +   P D     E+  R
Sbjct: 175 PYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRER 222

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 43.9 bits (102), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 40/137 (29%), Positives = 66/137 (48%), Gaps = 10/137 (7%)
Query: 1   MPNGSLEKWLYSYNYFFD-ILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDE 59
           M  GSL++ L       + IL +++I +  G  L Y    H    I+H D+KP+NIL++ 
Sbjct: 86  MDGGSLDQVLKKAGRIPEQILGKVSIAVIKG--LTYLREKHK---IMHRDVKPSNILVNS 140
Query: 60  NMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMET 119
                + DFG+S   G+  D +  +  + T  YM+PE       S + D++S G+ L+E 
Sbjct: 141 RGEIKLCDFGVS---GQLIDSMANSF-VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEM 196
Query: 120 FTRKRPTDEMFTGEMSL 136
              + P       E+ L
Sbjct: 197 AVGRYPIPPPDAKELEL 213

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 43.9 bits (102), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 40/137 (29%), Positives = 66/137 (48%), Gaps = 10/137 (7%)
Query: 1   MPNGSLEKWLYSYNYFFD-ILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDE 59
           M  GSL++ L       + IL +++I +  G  L Y    H    I+H D+KP+NIL++ 
Sbjct: 86  MDGGSLDQVLKKAGRIPEQILGKVSIAVIKG--LTYLREKHK---IMHRDVKPSNILVNS 140
Query: 60  NMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMET 119
                + DFG+S   G+  D +  +  + T  YM+PE       S + D++S G+ L+E 
Sbjct: 141 RGEIKLCDFGVS---GQLIDSMANSF-VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEM 196
Query: 120 FTRKRPTDEMFTGEMSL 136
              + P       E+ L
Sbjct: 197 AVGRYPIPPPDAKELEL 213

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 43.9 bits (102), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 40/137 (29%), Positives = 66/137 (48%), Gaps = 10/137 (7%)
Query: 1   MPNGSLEKWLYSYNYFFD-ILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDE 59
           M  GSL++ L       + IL +++I +  G  L Y    H    I+H D+KP+NIL++ 
Sbjct: 86  MDGGSLDQVLKKAGRIPEQILGKVSIAVIKG--LTYLREKHK---IMHRDVKPSNILVNS 140
Query: 60  NMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMET 119
                + DFG+S   G+  D +  +  + T  YM+PE       S + D++S G+ L+E 
Sbjct: 141 RGEIKLCDFGVS---GQLIDSMANSF-VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEM 196
Query: 120 FTRKRPTDEMFTGEMSL 136
              + P       E+ L
Sbjct: 197 AVGRYPIPPPDAKELEL 213

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 43.5 bits (101), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 33/103 (32%), Positives = 50/103 (48%), Gaps = 11/103 (10%)
Query: 17  FDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLD---ENMVAHVSDFGISKL 73
           F  ++   I+  V S + Y H       I+H DLKP N+LL+   ++    + DFG+S  
Sbjct: 123 FSEVDAARIIRQVLSGITYMHKN----KIVHRDLKPENLLLESKSKDANIRIIDFGLSTH 178
Query: 74  LGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLL 116
               +    +   + T  Y+APE    G    KCDV+S GV+L
Sbjct: 179 FEASKKMKDK---IGTAYYIAPEV-LHGTYDEKCDVWSTGVIL 217

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 43.5 bits (101), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 30/104 (28%), Positives = 51/104 (49%), Gaps = 12/104 (11%)
Query: 23  LNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVT 82
           L+  + +  AL++ H       I+H D+K  NI L ++    + DFGI+++L       T
Sbjct: 128 LDWFVQICLALKHVH----DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS-----T 178
Query: 83  QTMTMATIG---YMAPEYGSEGIVSAKCDVYSYGVLLMETFTRK 123
             +  A IG   Y++PE       + K D+++ G +L E  T K
Sbjct: 179 VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLK 222

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 43.5 bits (101), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 32/109 (29%), Positives = 48/109 (44%), Gaps = 8/109 (7%)
Query: 17  FDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGE 76
           FD       + ++ +AL Y H    S  +IH D+KP N+LL       +++FG S     
Sbjct: 107 FDEQRTATYITELANALSYCH----SKRVIHRDIKPENLLLGSAGELKIANFGWSVHAPS 162
Query: 77  GEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRP 125
                 +T    T+ Y+ PE     +   K D++S GVL  E    K P
Sbjct: 163 SR----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 207

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 43.5 bits (101), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 33/103 (32%), Positives = 50/103 (48%), Gaps = 11/103 (10%)
Query: 17  FDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLD---ENMVAHVSDFGISKL 73
           F  ++   I+  V S + Y H       I+H DLKP N+LL+   ++    + DFG+S  
Sbjct: 129 FSEVDAARIIRQVLSGITYMHKN----KIVHRDLKPENLLLESKSKDANIRIIDFGLSTH 184
Query: 74  LGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLL 116
               +    +   + T  Y+APE    G    KCDV+S GV+L
Sbjct: 185 FEASKKMKDK---IGTAYYIAPEV-LHGTYDEKCDVWSTGVIL 223

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 43.5 bits (101), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 32/125 (25%), Positives = 55/125 (44%), Gaps = 6/125 (4%)
Query: 3   NGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMV 62
           NG + ++L +    F   E  + M  + + + Y H    S  I+H DL  +N+LL  NM 
Sbjct: 95  NGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH----SHGILHRDLTLSNLLLTRNMN 150
Query: 63  AHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTR 122
             ++DFG++  L    +         T  Y++PE  +      + DV+S G +       
Sbjct: 151 IKIADFGLATQLKMPHE--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIG 208
Query: 123 KRPTD 127
           + P D
Sbjct: 209 RPPFD 213

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 43.5 bits (101), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 33/103 (32%), Positives = 50/103 (48%), Gaps = 11/103 (10%)
Query: 17  FDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLD---ENMVAHVSDFGISKL 73
           F  ++   I+  V S + Y H       I+H DLKP N+LL+   ++    + DFG+S  
Sbjct: 146 FSEVDAARIIRQVLSGITYMHKN----KIVHRDLKPENLLLESKSKDANIRIIDFGLSTH 201
Query: 74  LGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLL 116
               +    +   + T  Y+APE    G    KCDV+S GV+L
Sbjct: 202 FEASKKMKDK---IGTAYYIAPEV-LHGTYDEKCDVWSTGVIL 240

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 43.5 bits (101), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 35/111 (31%), Positives = 50/111 (45%), Gaps = 14/111 (12%)
Query: 31  SALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATI 90
           SA++Y H       I+H DLK  N+LLD +M   ++DFG S       +F       A  
Sbjct: 125 SAVQYCHQKR----IVHRDLKAENLLLDADMNIKIADFGFS------NEFTVGGKLDAFC 174
Query: 91  G---YMAPE-YGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLR 137
           G   Y APE +  +     + DV+S GV+L    +   P D     E+  R
Sbjct: 175 GAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRER 225

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 43.5 bits (101), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 31/85 (36%), Positives = 46/85 (54%), Gaps = 8/85 (9%)
Query: 38  HGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGE-GEDFVTQTMTMATIGYMAPE 96
           H H+   IIH D+KP NIL+ ++ V  + DFG ++ L   GE +  +   +AT  Y APE
Sbjct: 141 HSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDE---VATRWYRAPE 194
Query: 97  YGSEGIVSAKC-DVYSYGVLLMETF 120
                +   K  DV++ G L+ E F
Sbjct: 195 LLVGDVKYGKAVDVWAIGCLVTEMF 219

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 43.5 bits (101), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 33/103 (32%), Positives = 50/103 (48%), Gaps = 11/103 (10%)
Query: 17  FDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLD---ENMVAHVSDFGISKL 73
           F  ++   I+  V S + Y H       I+H DLKP N+LL+   ++    + DFG+S  
Sbjct: 147 FSEVDAARIIRQVLSGITYMHKN----KIVHRDLKPENLLLESKSKDANIRIIDFGLSTH 202
Query: 74  LGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLL 116
               +    +   + T  Y+APE    G    KCDV+S GV+L
Sbjct: 203 FEASKKMKDK---IGTAYYIAPEV-LHGTYDEKCDVWSTGVIL 241

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 43.5 bits (101), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 32/109 (29%), Positives = 47/109 (43%), Gaps = 8/109 (7%)
Query: 17  FDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGE 76
           FD       + ++ +AL Y H    S  +IH D+KP N+LL       ++DFG S     
Sbjct: 105 FDEQRTATYITELANALSYCH----SKKVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 160
Query: 77  GEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRP 125
                 +     T+ Y+ PE     +   K D++S GVL  E    K P
Sbjct: 161 SR----RAALCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 43.5 bits (101), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 36/97 (37%), Positives = 48/97 (49%), Gaps = 9/97 (9%)
Query: 38  HGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISK-LLGEGEDFVTQTMTMATIGYMAPE 96
           H H    II+ DLKP NI+L+      ++DFG+ K  + +G   VT T    TI YMAPE
Sbjct: 136 HLHQKG-IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT--VTHTFC-GTIEYMAPE 191
Query: 97  YGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGE 133
                  +   D +S G L+ +  T   P    FTGE
Sbjct: 192 ILMRSGHNRAVDWWSLGALMYDMLTGAPP----FTGE 224

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 43.5 bits (101), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 34/116 (29%), Positives = 56/116 (48%), Gaps = 5/116 (4%)
Query: 45  IIHCDLKPTNILLDENMVAHVSDFGI-SKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIV 103
           +IH DLK  N+ L+++M   + DFG+ +K+  +GE    +     T  Y+APE   +   
Sbjct: 163 VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGE---RKKTLCGTPNYIAPEVLCKKGH 219
Query: 104 SAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKE-SLPHGLTEVVDANLVR 158
           S + D++S G +L      K P +     E  +R    E S+P  +  V  A + R
Sbjct: 220 SFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRHINPVASALIRR 275

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 43.5 bits (101), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 34/116 (29%), Positives = 56/116 (48%), Gaps = 5/116 (4%)
Query: 45  IIHCDLKPTNILLDENMVAHVSDFGI-SKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIV 103
           +IH DLK  N+ L+++M   + DFG+ +K+  +GE    +     T  Y+APE   +   
Sbjct: 163 VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGE---RKKXLCGTPNYIAPEVLCKKGH 219
Query: 104 SAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKE-SLPHGLTEVVDANLVR 158
           S + D++S G +L      K P +     E  +R    E S+P  +  V  A + R
Sbjct: 220 SFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRHINPVASALIRR 275

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 43.1 bits (100), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 32/109 (29%), Positives = 47/109 (43%), Gaps = 8/109 (7%)
Query: 17  FDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGE 76
           FD       + ++ +AL Y H    S  +IH D+KP N+LL       ++DFG S     
Sbjct: 108 FDEQRTATYITELANALSYCH----SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 163
Query: 77  GEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRP 125
                 +     T+ Y+ PE     +   K D++S GVL  E    K P
Sbjct: 164 SR----RAALCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 43.1 bits (100), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 43/199 (21%), Positives = 75/199 (37%), Gaps = 25/199 (12%)
Query: 4   GSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVA 63
           G L  +L    Y  D+   +     + +AL Y      S   +H D+   N+L+  N   
Sbjct: 100 GELRSFLQVRKYSLDLASLILYAYQLSTALAY----LESKRFVHRDIAARNVLVSSNDCV 155
Query: 64  HVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRK 123
            + DFG+S+ + E   +   +     I +MAPE  +    ++  DV+ +GV + E     
Sbjct: 156 KLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHG 214
Query: 124 -RPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLALDCCM 182
            +P   +   ++  R    E LP                      +C  ++  L   C  
Sbjct: 215 VKPFQGVKNNDVIGRIENGERLP-------------------MPPNCPPTLYSLMTKCWA 255
Query: 183 ESPGKRINMTDAAAKLKKI 201
             P +R   T+  A+L  I
Sbjct: 256 YDPSRRPRFTELKAQLSTI 274

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 35/122 (28%), Positives = 59/122 (48%), Gaps = 13/122 (10%)
Query: 4   GSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLD----- 58
            +L++++   ++    LE + ++    S L + H    S  I+H DLKP NIL+      
Sbjct: 102 ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH----SLNIVHRDLKPHNILISMPNAH 157
Query: 59  ENMVAHVSDFGISKLLGEGE-DFVTQTMTMATIGYMAPEYGSEGIV---SAKCDVYSYGV 114
             + A +SDFG+ K L  G   F  ++    T G++APE  SE      +   D++S G 
Sbjct: 158 GKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGC 217
Query: 115 LL 116
           + 
Sbjct: 218 VF 219

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/109 (29%), Positives = 48/109 (44%), Gaps = 8/109 (7%)
Query: 17  FDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGE 76
           FD       + ++ +AL Y H    S  +IH D+KP N+LL       +++FG S     
Sbjct: 108 FDEQRTATYITELANALSYCH----SKRVIHRDIKPENLLLGSAGELKIANFGWSVHAPS 163
Query: 77  GEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRP 125
                 +T    T+ Y+ PE     +   K D++S GVL  E    K P
Sbjct: 164 SR----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/109 (29%), Positives = 47/109 (43%), Gaps = 8/109 (7%)
Query: 17  FDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGE 76
           FD       + ++ +AL Y H    S  +IH D+KP N+LL       ++DFG S     
Sbjct: 107 FDEQRTATYITELANALSYCH----SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 162
Query: 77  GEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRP 125
                 +     T+ Y+ PE     +   K D++S GVL  E    K P
Sbjct: 163 SR----RXXLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 207

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/95 (30%), Positives = 48/95 (50%), Gaps = 8/95 (8%)
Query: 39  GHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYG 98
           GH  + I H D K  N+LL  ++ A ++DFG++     G+        + T  YMAPE  
Sbjct: 139 GHKPS-IAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRYMAPEV- 196
Query: 99  SEGIVS------AKCDVYSYGVLLMETFTRKRPTD 127
            EG ++       + D+Y+ G++L E  +R +  D
Sbjct: 197 LEGAINFQRDAFLRIDMYAMGLVLWELVSRCKAAD 231

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/109 (29%), Positives = 47/109 (43%), Gaps = 8/109 (7%)
Query: 17  FDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGE 76
           FD       + ++ +AL Y H    S  +IH D+KP N+LL       ++DFG S     
Sbjct: 105 FDEQRTATYITELANALSYCH----SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 160
Query: 77  GEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRP 125
                 +     T+ Y+ PE     +   K D++S GVL  E    K P
Sbjct: 161 SR----RAALCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/199 (21%), Positives = 75/199 (37%), Gaps = 25/199 (12%)
Query: 4   GSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVA 63
           G L  +L    Y  D+   +     + +AL Y      S   +H D+   N+L+  N   
Sbjct: 92  GELRSFLQVRKYSLDLASLILYAYQLSTALAY----LESKRFVHRDIAARNVLVSSNDCV 147
Query: 64  HVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRK 123
            + DFG+S+ + E   +   +     I +MAPE  +    ++  DV+ +GV + E     
Sbjct: 148 KLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHG 206
Query: 124 -RPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLALDCCM 182
            +P   +   ++  R    E LP                      +C  ++  L   C  
Sbjct: 207 VKPFQGVKNNDVIGRIENGERLP-------------------MPPNCPPTLYSLMTKCWA 247
Query: 183 ESPGKRINMTDAAAKLKKI 201
             P +R   T+  A+L  I
Sbjct: 248 YDPSRRPRFTELKAQLSTI 266

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 31/104 (29%), Positives = 48/104 (46%), Gaps = 8/104 (7%)
Query: 38  HGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEY 97
           H HS+  IIH DLKP+NI++  +    + DFG+++  G        T  + T  Y APE 
Sbjct: 141 HLHSAG-IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTS---FMMTPYVVTRYYRAPEV 196
Query: 98  GSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVK 141
                     D++S G ++ E    K     +F G   + +W K
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQWNK 236

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 31/104 (29%), Positives = 48/104 (46%), Gaps = 8/104 (7%)
Query: 38  HGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEY 97
           H HS+  IIH DLKP+NI++  +    + DFG+++  G        T  + T  Y APE 
Sbjct: 134 HLHSAG-IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTS---FMMTPYVVTRYYRAPEV 189
Query: 98  GSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVK 141
                     D++S G ++ E    K     +F G   + +W K
Sbjct: 190 ILGMGYKENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQWNK 229

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/199 (21%), Positives = 75/199 (37%), Gaps = 25/199 (12%)
Query: 4   GSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVA 63
           G L  +L    Y  D+   +     + +AL Y      S   +H D+   N+L+  N   
Sbjct: 97  GELRSFLQVRKYSLDLASLILYAYQLSTALAY----LESKRFVHRDIAARNVLVSSNDCV 152
Query: 64  HVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRK 123
            + DFG+S+ + E   +   +     I +MAPE  +    ++  DV+ +GV + E     
Sbjct: 153 KLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHG 211
Query: 124 -RPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLALDCCM 182
            +P   +   ++  R    E LP                      +C  ++  L   C  
Sbjct: 212 VKPFQGVKNNDVIGRIENGERLP-------------------MPPNCPPTLYSLMTKCWA 252
Query: 183 ESPGKRINMTDAAAKLKKI 201
             P +R   T+  A+L  I
Sbjct: 253 YDPSRRPRFTELKAQLSTI 271

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 31/104 (29%), Positives = 48/104 (46%), Gaps = 8/104 (7%)
Query: 38  HGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEY 97
           H HS+  IIH DLKP+NI++  +    + DFG+++  G        T  + T  Y APE 
Sbjct: 141 HLHSAG-IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTS---FMMTPYVVTRYYRAPEV 196
Query: 98  GSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVK 141
                     D++S G ++ E    K     +F G   + +W K
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQWNK 236

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 18/74 (24%), Positives = 40/74 (54%)
Query: 45  IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVS 104
            +H +L   N ++  +    + DFG+++ + E + +      +  + +MAPE   +G+ +
Sbjct: 152 FVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFT 211
Query: 105 AKCDVYSYGVLLME 118
              D++S+GV+L E
Sbjct: 212 TSSDMWSFGVVLWE 225

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 18/74 (24%), Positives = 40/74 (54%)
Query: 45  IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVS 104
            +H +L   N ++  +    + DFG+++ + E + +      +  + +MAPE   +G+ +
Sbjct: 151 FVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFT 210
Query: 105 AKCDVYSYGVLLME 118
              D++S+GV+L E
Sbjct: 211 TSSDMWSFGVVLWE 224

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/199 (21%), Positives = 75/199 (37%), Gaps = 25/199 (12%)
Query: 4   GSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVA 63
           G L  +L    Y  D+   +     + +AL Y      S   +H D+   N+L+  N   
Sbjct: 123 GELRSFLQVRKYSLDLASLILYAYQLSTALAY----LESKRFVHRDIAARNVLVSSNDCV 178
Query: 64  HVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRK 123
            + DFG+S+ + E   +   +     I +MAPE  +    ++  DV+ +GV + E     
Sbjct: 179 KLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHG 237
Query: 124 -RPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLALDCCM 182
            +P   +   ++  R    E LP                      +C  ++  L   C  
Sbjct: 238 VKPFQGVKNNDVIGRIENGERLP-------------------MPPNCPPTLYSLMTKCWA 278
Query: 183 ESPGKRINMTDAAAKLKKI 201
             P +R   T+  A+L  I
Sbjct: 279 YDPSRRPRFTELKAQLSTI 297

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/199 (21%), Positives = 75/199 (37%), Gaps = 25/199 (12%)
Query: 4   GSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVA 63
           G L  +L    Y  D+   +     + +AL Y      S   +H D+   N+L+  N   
Sbjct: 98  GELRSFLQVRKYSLDLASLILYAYQLSTALAY----LESKRFVHRDIAARNVLVSSNDCV 153
Query: 64  HVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRK 123
            + DFG+S+ + E   +   +     I +MAPE  +    ++  DV+ +GV + E     
Sbjct: 154 KLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHG 212
Query: 124 -RPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLALDCCM 182
            +P   +   ++  R    E LP                      +C  ++  L   C  
Sbjct: 213 VKPFQGVKNNDVIGRIENGERLP-------------------MPPNCPPTLYSLMTKCWA 253
Query: 183 ESPGKRINMTDAAAKLKKI 201
             P +R   T+  A+L  I
Sbjct: 254 YDPSRRPRFTELKAQLSTI 272

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/111 (28%), Positives = 48/111 (43%), Gaps = 8/111 (7%)
Query: 17  FDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGE 76
           FD       + ++ +AL Y H    S  +IH D+KP N+LL       ++DFG S     
Sbjct: 108 FDEQRTATYITELANALSYCH----SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 163
Query: 77  GEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTD 127
                 +     T+ Y+ PE     +   K D++S GVL  E    K P +
Sbjct: 164 SR----RXXLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 33/122 (27%), Positives = 54/122 (44%), Gaps = 6/122 (4%)
Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEY-PHHGHSSAPIIHCDLKPTNILLDE 59
           +P GSL   +  +         LN  + +   + Y   HG     ++H +L   N+LL  
Sbjct: 114 LPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG-----MVHRNLAARNVLLKS 168
Query: 60  NMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMET 119
                V+DFG++ LL   +  +  +     I +MA E    G  + + DV+SYGV + E 
Sbjct: 169 PSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWEL 228
Query: 120 FT 121
            T
Sbjct: 229 MT 230

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/111 (28%), Positives = 48/111 (43%), Gaps = 8/111 (7%)
Query: 17  FDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGE 76
           FD       + ++ +AL Y H    S  +IH D+KP N+LL       ++DFG S     
Sbjct: 105 FDEQRTATYITELANALSYCH----SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 160
Query: 77  GEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTD 127
                 +     T+ Y+ PE     +   K D++S GVL  E    K P +
Sbjct: 161 SR----RXXLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/199 (21%), Positives = 75/199 (37%), Gaps = 25/199 (12%)
Query: 4   GSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVA 63
           G L  +L    Y  D+   +     + +AL Y      S   +H D+   N+L+  N   
Sbjct: 95  GELRSFLQVRKYSLDLASLILYAYQLSTALAY----LESKRFVHRDIAARNVLVSSNDCV 150
Query: 64  HVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRK 123
            + DFG+S+ + E   +   +     I +MAPE  +    ++  DV+ +GV + E     
Sbjct: 151 KLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHG 209
Query: 124 -RPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLALDCCM 182
            +P   +   ++  R    E LP                      +C  ++  L   C  
Sbjct: 210 VKPFQGVKNNDVIGRIENGERLP-------------------MPPNCPPTLYSLMTKCWA 250
Query: 183 ESPGKRINMTDAAAKLKKI 201
             P +R   T+  A+L  I
Sbjct: 251 YDPSRRPRFTELKAQLSTI 269

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/199 (21%), Positives = 75/199 (37%), Gaps = 25/199 (12%)
Query: 4   GSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVA 63
           G L  +L    Y  D+   +     + +AL Y      S   +H D+   N+L+  N   
Sbjct: 95  GELRSFLQVRKYSLDLASLILYAYQLSTALAY----LESKRFVHRDIAARNVLVSSNDCV 150
Query: 64  HVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRK 123
            + DFG+S+ + E   +   +     I +MAPE  +    ++  DV+ +GV + E     
Sbjct: 151 KLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHG 209
Query: 124 -RPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLALDCCM 182
            +P   +   ++  R    E LP                      +C  ++  L   C  
Sbjct: 210 VKPFQGVKNNDVIGRIENGERLP-------------------MPPNCPPTLYSLMTKCWA 250
Query: 183 ESPGKRINMTDAAAKLKKI 201
             P +R   T+  A+L  I
Sbjct: 251 YDPSRRPRFTELKAQLSTI 269

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/109 (29%), Positives = 47/109 (43%), Gaps = 8/109 (7%)
Query: 17  FDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGE 76
           FD       + ++ +AL Y H    S  +IH D+KP N+LL       ++DFG S     
Sbjct: 106 FDEQRTATYITELANALSYCH----SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 161
Query: 77  GEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRP 125
                 +     T+ Y+ PE     +   K D++S GVL  E    K P
Sbjct: 162 SR----RDTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 206

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 33/122 (27%), Positives = 54/122 (44%), Gaps = 6/122 (4%)
Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEY-PHHGHSSAPIIHCDLKPTNILLDE 59
           +P GSL   +  +         LN  + +   + Y   HG     ++H +L   N+LL  
Sbjct: 96  LPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG-----MVHRNLAARNVLLKS 150
Query: 60  NMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMET 119
                V+DFG++ LL   +  +  +     I +MA E    G  + + DV+SYGV + E 
Sbjct: 151 PSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWEL 210
Query: 120 FT 121
            T
Sbjct: 211 MT 212

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 48/104 (46%), Gaps = 8/104 (7%)
Query: 38  HGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEY 97
           H HS A IIH DLKP+NI++  +    + DFG+++  G        T  + T  Y APE 
Sbjct: 141 HLHS-AGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTS---FMMTPYVVTRYYRAPEV 196
Query: 98  GSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVK 141
                     D++S G ++ E    K     +F G   + +W K
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQWNK 236

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 39/158 (24%), Positives = 67/158 (42%), Gaps = 5/158 (3%)
Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           MP+G L ++++ +         LN  + +   + Y         ++H DL   N+L+   
Sbjct: 98  MPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR----LVHRDLAARNVLVKSP 153
Query: 61  MVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETF 120
               ++DFG+++LL   E           I +MA E       + + DV+SYGV + E  
Sbjct: 154 NHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELM 213
Query: 121 T-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV 157
           T   +P D + T E+       E LP      +D  +V
Sbjct: 214 TFGGKPYDGIPTREIPDLLEKGERLPQPPICTIDVYMV 251

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 46/88 (52%), Gaps = 8/88 (9%)
Query: 38  HGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEY 97
           H H    I+H DLKP N+L++ +    ++DFG+++    G    + T  + T+ Y AP+ 
Sbjct: 136 HQHR---ILHRDLKPQNLLINSDGALKLADFGLARAF--GIPVRSYTHEVVTLWYRAPDV 190
Query: 98  --GSEGIVSAKCDVYSYGVLLMETFTRK 123
             GS+   S   D++S G +  E  T K
Sbjct: 191 LMGSKK-YSTSVDIWSIGCIFAEMITGK 217

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 46/88 (52%), Gaps = 8/88 (9%)
Query: 38  HGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEY 97
           H H    I+H DLKP N+L++ +    ++DFG+++    G    + T  + T+ Y AP+ 
Sbjct: 136 HQHR---ILHRDLKPQNLLINSDGALKLADFGLARAF--GIPVRSYTHEVVTLWYRAPDV 190
Query: 98  --GSEGIVSAKCDVYSYGVLLMETFTRK 123
             GS+   S   D++S G +  E  T K
Sbjct: 191 LMGSKK-YSTSVDIWSIGCIFAEMITGK 217

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 46/99 (46%), Gaps = 13/99 (13%)
Query: 38  HGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTM---ATIGYMA 94
           H H    II+ DLKP NI+L+      ++DFG+ K     E     T+T     TI YMA
Sbjct: 136 HLHQKG-IIYRDLKPENIMLNHQGHVKLTDFGLCK-----ESIHDGTVTHXFCGTIEYMA 189
Query: 95  PEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGE 133
           PE       +   D +S G L+ +  T   P    FTGE
Sbjct: 190 PEILMRSGHNRAVDWWSLGALMYDMLTGAPP----FTGE 224

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 48/104 (46%), Gaps = 8/104 (7%)
Query: 38  HGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEY 97
           H HS A IIH DLKP+NI++  +    + DFG+++  G        T  + T  Y APE 
Sbjct: 141 HLHS-AGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTS---FMMTPYVVTRYYRAPEV 196
Query: 98  GSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVK 141
                     D++S G ++ E    K     +F G   + +W K
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQWNK 236

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 39/158 (24%), Positives = 67/158 (42%), Gaps = 5/158 (3%)
Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           MP+G L ++++ +         LN  + +   + Y         ++H DL   N+L+   
Sbjct: 121 MPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR----LVHRDLAARNVLVKSP 176
Query: 61  MVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETF 120
               ++DFG+++LL   E           I +MA E       + + DV+SYGV + E  
Sbjct: 177 NHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELM 236
Query: 121 T-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV 157
           T   +P D + T E+       E LP      +D  +V
Sbjct: 237 TFGGKPYDGIPTREIPDLLEKGERLPQPPICTIDVYMV 274

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 31/104 (29%), Positives = 48/104 (46%), Gaps = 8/104 (7%)
Query: 38  HGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEY 97
           H HS+  IIH DLKP+NI++  +    + DFG+++  G        T  + T  Y APE 
Sbjct: 134 HLHSAG-IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPYVVTRYYRAPEV 189
Query: 98  GSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVK 141
                     D++S G ++ E    K     +F G   + +W K
Sbjct: 190 ILGMGYKENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQWNK 229

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/190 (23%), Positives = 85/190 (44%), Gaps = 21/190 (11%)
Query: 1   MPNGSLEKWLYS-YNYFFDILERLNIMIDVGSALEYPHHGHSSAPII-HCDLKPTNILLD 58
           MP GSL   L+   N+  D  + +   +D+   + +    H+  P+I    L   ++++D
Sbjct: 91  MPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAF---LHTLEPLIPRHALNSRSVMID 147
Query: 59  ENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPE---YGSEGIVSAKCDVYSYGVL 115
           E+M A +S       + + +        M    ++APE      E       D++S+ VL
Sbjct: 148 EDMTARIS-------MADVKFSFQSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVL 200
Query: 116 LMETFTRKRPTDEMFTGEMSLR---RWVKESLPHGLTEVVDANL---VREEQAFAAKMDC 169
           L E  TR+ P  ++   E+ ++     ++ ++P G++  V   +   + E+ A   K D 
Sbjct: 201 LWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDM 260
Query: 170 IVSIMDLALD 179
           IV I++   D
Sbjct: 261 IVPILEKMQD 270

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 27/88 (30%), Positives = 44/88 (50%), Gaps = 8/88 (9%)
Query: 38  HGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPE- 96
           H H    ++H DLKP N+L++      ++DFG+++    G    T    + T+ Y APE 
Sbjct: 120 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEI 174
Query: 97  -YGSEGIVSAKCDVYSYGVLLMETFTRK 123
             G +   S   D++S G +  E  TR+
Sbjct: 175 LLGCK-YYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 31/104 (29%), Positives = 48/104 (46%), Gaps = 8/104 (7%)
Query: 38  HGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEY 97
           H HS+  IIH DLKP+NI++  +    + DFG+++  G        T  + T  Y APE 
Sbjct: 135 HLHSAG-IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPYVVTRYYRAPEV 190
Query: 98  GSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVK 141
                     D++S G ++ E    K     +F G   + +W K
Sbjct: 191 ILGMGYKENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQWNK 230

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 35/111 (31%), Positives = 50/111 (45%), Gaps = 14/111 (12%)
Query: 31  SALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATI 90
           SA++Y H       I+H DLK  N+LLD +M   ++DFG S       +F       A  
Sbjct: 124 SAVQYCHQKF----IVHRDLKAENLLLDADMNIKIADFGFS------NEFTFGNKLDAFC 173
Query: 91  G---YMAPE-YGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLR 137
           G   Y APE +  +     + DV+S GV+L    +   P D     E+  R
Sbjct: 174 GAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRER 224

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 27/88 (30%), Positives = 44/88 (50%), Gaps = 8/88 (9%)
Query: 38  HGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPE- 96
           H H    ++H DLKP N+L++      ++DFG+++    G    T    + T+ Y APE 
Sbjct: 122 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEI 176
Query: 97  -YGSEGIVSAKCDVYSYGVLLMETFTRK 123
             G +   S   D++S G +  E  TR+
Sbjct: 177 LLGCK-YYSTAVDIWSLGCIFAEMVTRR 203

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 27/88 (30%), Positives = 44/88 (50%), Gaps = 8/88 (9%)
Query: 38  HGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPE- 96
           H H    ++H DLKP N+L++      ++DFG+++    G    T    + T+ Y APE 
Sbjct: 123 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEI 177
Query: 97  -YGSEGIVSAKCDVYSYGVLLMETFTRK 123
             G +   S   D++S G +  E  TR+
Sbjct: 178 LLGCK-YYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 27/88 (30%), Positives = 44/88 (50%), Gaps = 8/88 (9%)
Query: 38  HGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPE- 96
           H H    ++H DLKP N+L++      ++DFG+++    G    T    + T+ Y APE 
Sbjct: 122 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEI 176
Query: 97  -YGSEGIVSAKCDVYSYGVLLMETFTRK 123
             G +   S   D++S G +  E  TR+
Sbjct: 177 LLGCK-YYSTAVDIWSLGCIFAEMVTRR 203

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 31/104 (29%), Positives = 48/104 (46%), Gaps = 8/104 (7%)
Query: 38  HGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEY 97
           H HS+  IIH DLKP+NI++  +    + DFG+++  G        T  + T  Y APE 
Sbjct: 135 HLHSAG-IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPYVVTRYYRAPEV 190
Query: 98  GSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVK 141
                     D++S G ++ E    K     +F G   + +W K
Sbjct: 191 ILGMGYKENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQWNK 230

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 27/88 (30%), Positives = 44/88 (50%), Gaps = 8/88 (9%)
Query: 38  HGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPE- 96
           H H    ++H DLKP N+L++      ++DFG+++    G    T    + T+ Y APE 
Sbjct: 124 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEI 178
Query: 97  -YGSEGIVSAKCDVYSYGVLLMETFTRK 123
             G +   S   D++S G +  E  TR+
Sbjct: 179 LLGCK-YYSTAVDIWSLGCIFAEMVTRR 205

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 31/104 (29%), Positives = 48/104 (46%), Gaps = 8/104 (7%)
Query: 38  HGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEY 97
           H HS+  IIH DLKP+NI++  +    + DFG+++  G        T  + T  Y APE 
Sbjct: 141 HLHSAG-IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPYVVTRYYRAPEV 196
Query: 98  GSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVK 141
                     D++S G ++ E    K     +F G   + +W K
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQWNK 236

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/88 (30%), Positives = 44/88 (50%), Gaps = 8/88 (9%)
Query: 38  HGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPE- 96
           H H    ++H DLKP N+L++      ++DFG+++    G    T    + T+ Y APE 
Sbjct: 119 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEI 173
Query: 97  -YGSEGIVSAKCDVYSYGVLLMETFTRK 123
             G +   S   D++S G +  E  TR+
Sbjct: 174 LLGCK-YYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/88 (30%), Positives = 44/88 (50%), Gaps = 8/88 (9%)
Query: 38  HGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPE- 96
           H H    ++H DLKP N+L++      ++DFG+++    G    T    + T+ Y APE 
Sbjct: 123 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEI 177
Query: 97  -YGSEGIVSAKCDVYSYGVLLMETFTRK 123
             G +   S   D++S G +  E  TR+
Sbjct: 178 LLGCK-YYSTAVDIWSLGCIFAEMVTRR 204

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/88 (30%), Positives = 44/88 (50%), Gaps = 8/88 (9%)
Query: 38  HGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPE- 96
           H H    ++H DLKP N+L++      ++DFG+++    G    T    + T+ Y APE 
Sbjct: 119 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEI 173
Query: 97  -YGSEGIVSAKCDVYSYGVLLMETFTRK 123
             G +   S   D++S G +  E  TR+
Sbjct: 174 LLGCK-YYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 31/104 (29%), Positives = 48/104 (46%), Gaps = 8/104 (7%)
Query: 38  HGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEY 97
           H HS+  IIH DLKP+NI++  +    + DFG+++  G        T  + T  Y APE 
Sbjct: 140 HLHSAG-IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPYVVTRYYRAPEV 195
Query: 98  GSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVK 141
                     D++S G ++ E    K     +F G   + +W K
Sbjct: 196 ILGMGYKENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQWNK 235

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/88 (30%), Positives = 44/88 (50%), Gaps = 8/88 (9%)
Query: 38  HGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPE- 96
           H H    ++H DLKP N+L++      ++DFG+++    G    T    + T+ Y APE 
Sbjct: 120 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEI 174
Query: 97  -YGSEGIVSAKCDVYSYGVLLMETFTRK 123
             G +   S   D++S G +  E  TR+
Sbjct: 175 LLGCK-YYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 31/104 (29%), Positives = 48/104 (46%), Gaps = 8/104 (7%)
Query: 38  HGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEY 97
           H HS+  IIH DLKP+NI++  +    + DFG+++  G        T  + T  Y APE 
Sbjct: 142 HLHSAG-IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPYVVTRYYRAPEV 197
Query: 98  GSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVK 141
                     D++S G ++ E    K     +F G   + +W K
Sbjct: 198 ILGMGYKENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQWNK 237

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/88 (30%), Positives = 44/88 (50%), Gaps = 8/88 (9%)
Query: 38  HGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPE- 96
           H H    ++H DLKP N+L++      ++DFG+++    G    T    + T+ Y APE 
Sbjct: 120 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEI 174
Query: 97  -YGSEGIVSAKCDVYSYGVLLMETFTRK 123
             G +   S   D++S G +  E  TR+
Sbjct: 175 LLGCK-YYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/88 (30%), Positives = 44/88 (50%), Gaps = 8/88 (9%)
Query: 38  HGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPE- 96
           H H    ++H DLKP N+L++      ++DFG+++    G    T    + T+ Y APE 
Sbjct: 121 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEI 175
Query: 97  -YGSEGIVSAKCDVYSYGVLLMETFTRK 123
             G +   S   D++S G +  E  TR+
Sbjct: 176 LLGCK-YYSTAVDIWSLGCIFAEMVTRR 202

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 31/104 (29%), Positives = 48/104 (46%), Gaps = 8/104 (7%)
Query: 38  HGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEY 97
           H HS+  IIH DLKP+NI++  +    + DFG+++  G        T  + T  Y APE 
Sbjct: 142 HLHSAG-IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPYVVTRYYRAPEV 197
Query: 98  GSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVK 141
                     D++S G ++ E    K     +F G   + +W K
Sbjct: 198 ILGMGYKENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQWNK 237

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/88 (30%), Positives = 44/88 (50%), Gaps = 8/88 (9%)
Query: 38  HGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPE- 96
           H H    ++H DLKP N+L++      ++DFG+++    G    T    + T+ Y APE 
Sbjct: 123 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEI 177
Query: 97  -YGSEGIVSAKCDVYSYGVLLMETFTRK 123
             G +   S   D++S G +  E  TR+
Sbjct: 178 LLGCK-YYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/88 (30%), Positives = 44/88 (50%), Gaps = 8/88 (9%)
Query: 38  HGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPE- 96
           H H    ++H DLKP N+L++      ++DFG+++    G    T    + T+ Y APE 
Sbjct: 122 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEI 176
Query: 97  -YGSEGIVSAKCDVYSYGVLLMETFTRK 123
             G +   S   D++S G +  E  TR+
Sbjct: 177 LLGCK-YYSTAVDIWSLGCIFAEMVTRR 203

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/88 (30%), Positives = 44/88 (50%), Gaps = 8/88 (9%)
Query: 38  HGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPE- 96
           H H    ++H DLKP N+L++      ++DFG+++    G    T    + T+ Y APE 
Sbjct: 123 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEI 177
Query: 97  -YGSEGIVSAKCDVYSYGVLLMETFTRK 123
             G +   S   D++S G +  E  TR+
Sbjct: 178 LLGCK-YYSTAVDIWSLGCIFAEMVTRR 204

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 31/104 (29%), Positives = 48/104 (46%), Gaps = 8/104 (7%)
Query: 38  HGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEY 97
           H HS+  IIH DLKP+NI++  +    + DFG+++  G        T  + T  Y APE 
Sbjct: 141 HLHSAG-IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPYVVTRYYRAPEV 196
Query: 98  GSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVK 141
                     D++S G ++ E    K     +F G   + +W K
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQWNK 236

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/88 (30%), Positives = 44/88 (50%), Gaps = 8/88 (9%)
Query: 38  HGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPE- 96
           H H    ++H DLKP N+L++      ++DFG+++    G    T    + T+ Y APE 
Sbjct: 123 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEI 177
Query: 97  -YGSEGIVSAKCDVYSYGVLLMETFTRK 123
             G +   S   D++S G +  E  TR+
Sbjct: 178 LLGCK-YYSTAVDIWSLGCIFAEMVTRR 204

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/88 (30%), Positives = 44/88 (50%), Gaps = 8/88 (9%)
Query: 38  HGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPE- 96
           H H    ++H DLKP N+L++      ++DFG+++    G    T    + T+ Y APE 
Sbjct: 120 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEI 174
Query: 97  -YGSEGIVSAKCDVYSYGVLLMETFTRK 123
             G +   S   D++S G +  E  TR+
Sbjct: 175 LLGCK-YYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 31/104 (29%), Positives = 48/104 (46%), Gaps = 8/104 (7%)
Query: 38  HGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEY 97
           H HS+  IIH DLKP+NI++  +    + DFG+++  G        T  + T  Y APE 
Sbjct: 179 HLHSAG-IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPYVVTRYYRAPEV 234
Query: 98  GSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVK 141
                     D++S G ++ E    K     +F G   + +W K
Sbjct: 235 ILGMGYKENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQWNK 274

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 49/97 (50%), Gaps = 6/97 (6%)
Query: 29  VGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMA 88
           V  AL Y H    +  +IH D+K  +ILL  +    +SDFG    + +  D   +   + 
Sbjct: 150 VLQALAYLH----AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISK--DVPKRKXLVG 203
Query: 89  TIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRP 125
           T  +MAPE  S  + + + D++S G++++E    + P
Sbjct: 204 TPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPP 240

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 48/104 (46%), Gaps = 8/104 (7%)
Query: 38  HGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEY 97
           H HS A IIH DLKP+NI++  +    + DFG+++  G        T  + T  Y APE 
Sbjct: 179 HLHS-AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPYVVTRYYRAPEV 234
Query: 98  GSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVK 141
                     D++S G ++ E    K     +F G   + +W K
Sbjct: 235 ILGMGYKENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQWNK 274

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/88 (30%), Positives = 44/88 (50%), Gaps = 8/88 (9%)
Query: 38  HGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPE- 96
           H H    ++H DLKP N+L++      ++DFG+++    G    T    + T+ Y APE 
Sbjct: 122 HSHR---VLHRDLKPENLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEI 176
Query: 97  -YGSEGIVSAKCDVYSYGVLLMETFTRK 123
             G +   S   D++S G +  E  TR+
Sbjct: 177 LLGCK-YYSTAVDIWSLGCIFAEMVTRR 203

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/88 (30%), Positives = 44/88 (50%), Gaps = 8/88 (9%)
Query: 38  HGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPE- 96
           H H    ++H DLKP N+L++      ++DFG+++    G    T    + T+ Y APE 
Sbjct: 121 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEI 175
Query: 97  -YGSEGIVSAKCDVYSYGVLLMETFTRK 123
             G +   S   D++S G +  E  TR+
Sbjct: 176 LLGCK-YYSTAVDIWSLGCIFAEMVTRR 202

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 34/116 (29%), Positives = 56/116 (48%), Gaps = 5/116 (4%)
Query: 45  IIHCDLKPTNILLDENMVAHVSDFGI-SKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIV 103
           +IH DLK  N+ L+++M   + DFG+ +K+  +GE    +     T  Y+APE   +   
Sbjct: 163 VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGE---RKKDLCGTPNYIAPEVLCKKGH 219
Query: 104 SAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKE-SLPHGLTEVVDANLVR 158
           S + D++S G +L      K P +     E  +R    E S+P  +  V  A + R
Sbjct: 220 SFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRHINPVASALIRR 275

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 44/88 (50%), Gaps = 11/88 (12%)
Query: 32  ALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTM-ATI 90
             EY H    S  +I+ DLKP N+L+D+     V+DFG +K +        +T T+  T 
Sbjct: 139 TFEYLH----SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK------GRTWTLCGTP 188
Query: 91  GYMAPEYGSEGIVSAKCDVYSYGVLLME 118
            Y+APE       +   D ++ GVL+ E
Sbjct: 189 EYLAPEIILSKGYNKAVDWWALGVLIYE 216

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/88 (30%), Positives = 44/88 (50%), Gaps = 8/88 (9%)
Query: 38  HGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPE- 96
           H H    ++H DLKP N+L++      ++DFG+++    G    T    + T+ Y APE 
Sbjct: 121 HSHR---VLHRDLKPENLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEI 175
Query: 97  -YGSEGIVSAKCDVYSYGVLLMETFTRK 123
             G +   S   D++S G +  E  TR+
Sbjct: 176 LLGCK-YYSTAVDIWSLGCIFAEMVTRR 202

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/88 (30%), Positives = 44/88 (50%), Gaps = 8/88 (9%)
Query: 38  HGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPE- 96
           H H    ++H DLKP N+L++      ++DFG+++    G    T    + T+ Y APE 
Sbjct: 123 HSHR---VLHRDLKPENLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEI 177
Query: 97  -YGSEGIVSAKCDVYSYGVLLMETFTRK 123
             G +   S   D++S G +  E  TR+
Sbjct: 178 LLGCK-YYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 34/116 (29%), Positives = 56/116 (48%), Gaps = 5/116 (4%)
Query: 45  IIHCDLKPTNILLDENMVAHVSDFGI-SKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIV 103
           +IH DLK  N+ L+++M   + DFG+ +K+  +GE    +     T  Y+APE   +   
Sbjct: 147 VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGE---RKKDLCGTPNYIAPEVLCKKGH 203
Query: 104 SAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKE-SLPHGLTEVVDANLVR 158
           S + D++S G +L      K P +     E  +R    E S+P  +  V  A + R
Sbjct: 204 SFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRHINPVASALIRR 259

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 31/104 (29%), Positives = 48/104 (46%), Gaps = 8/104 (7%)
Query: 38  HGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEY 97
           H HS+  IIH DLKP+NI++  +    + DFG+++  G        T  + T  Y APE 
Sbjct: 141 HLHSAG-IIHRDLKPSNIVVKSDATLKILDFGLARTAGTS---FMMTPYVVTRYYRAPEV 196
Query: 98  GSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVK 141
                     D++S GV++ E          +F G   + +W K
Sbjct: 197 ILGMGYKENVDIWSVGVIMGEMIK----GGVLFPGTDHIDQWNK 236

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 31/104 (29%), Positives = 48/104 (46%), Gaps = 8/104 (7%)
Query: 38  HGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEY 97
           H HS+  IIH DLKP+NI++  +    + DFG+++  G        T  + T  Y APE 
Sbjct: 141 HLHSAG-IIHRDLKPSNIVVKSDATLKILDFGLARTAGTS---FMMTPYVVTRYYRAPEV 196
Query: 98  GSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVK 141
                     D++S GV++ E          +F G   + +W K
Sbjct: 197 ILGMGYKENVDIWSVGVIMGEMIK----GGVLFPGTDHIDQWNK 236

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/88 (30%), Positives = 44/88 (50%), Gaps = 8/88 (9%)
Query: 38  HGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPE- 96
           H H    ++H DLKP N+L++      ++DFG+++    G    T    + T+ Y APE 
Sbjct: 121 HSHR---VLHRDLKPENLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEI 175
Query: 97  -YGSEGIVSAKCDVYSYGVLLMETFTRK 123
             G +   S   D++S G +  E  TR+
Sbjct: 176 LLGCK-YYSTAVDIWSLGCIFAEMVTRR 202

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 44/87 (50%), Gaps = 11/87 (12%)
Query: 33  LEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTM-ATIG 91
            EY H    S  +I+ DLKP N+L+D+     V+DFG +K +        +T T+  T  
Sbjct: 155 FEYLH----SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK------GRTWTLCGTPE 204
Query: 92  YMAPEYGSEGIVSAKCDVYSYGVLLME 118
           Y+APE       +   D ++ GVL+ E
Sbjct: 205 YLAPEIILSKGYNKAVDWWALGVLIYE 231

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 30/99 (30%), Positives = 50/99 (50%), Gaps = 7/99 (7%)
Query: 28  DVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEG-EDFVTQTMT 86
           ++ SAL+Y H   S   +++ DLK  N++LD++    ++DFG+ K   EG +D  T    
Sbjct: 259 EIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK---EGIKDGATMKTF 312
Query: 87  MATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRP 125
             T  Y+APE   +       D +  GV++ E    + P
Sbjct: 313 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 351

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 42.0 bits (97), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/88 (30%), Positives = 44/88 (50%), Gaps = 8/88 (9%)
Query: 38  HGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPE- 96
           H H    ++H DLKP N+L++      ++DFG+++    G    T    + T+ Y APE 
Sbjct: 120 HSHR---VLHRDLKPENLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEI 174
Query: 97  -YGSEGIVSAKCDVYSYGVLLMETFTRK 123
             G +   S   D++S G +  E  TR+
Sbjct: 175 LLGCK-YYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 42.0 bits (97), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 30/99 (30%), Positives = 50/99 (50%), Gaps = 7/99 (7%)
Query: 28  DVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEG-EDFVTQTMT 86
           ++ SAL+Y H   S   +++ DLK  N++LD++    ++DFG+ K   EG +D  T    
Sbjct: 256 EIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK---EGIKDGATMKTF 309
Query: 87  MATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRP 125
             T  Y+APE   +       D +  GV++ E    + P
Sbjct: 310 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 42.0 bits (97), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/95 (34%), Positives = 47/95 (49%), Gaps = 11/95 (11%)
Query: 25  IMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLD---ENMVAHVSDFGISKLLGEGEDFV 81
           IM  V S   Y H  +    I+H DLKP N+LL+    + +  + DFG+S     G    
Sbjct: 126 IMKQVLSGTTYLHKHN----IVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMK 181
Query: 82  TQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLL 116
            +   + T  Y+APE   +     KCDV+S GV+L
Sbjct: 182 ER---LGTAYYIAPEVLRKK-YDEKCDVWSCGVIL 212

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 42.0 bits (97), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/95 (34%), Positives = 47/95 (49%), Gaps = 11/95 (11%)
Query: 25  IMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLD---ENMVAHVSDFGISKLLGEGEDFV 81
           IM  V S   Y H  +    I+H DLKP N+LL+    + +  + DFG+S     G    
Sbjct: 109 IMKQVLSGTTYLHKHN----IVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMK 164
Query: 82  TQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLL 116
            +   + T  Y+APE   +     KCDV+S GV+L
Sbjct: 165 ER---LGTAYYIAPEVLRKK-YDEKCDVWSCGVIL 195

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 42.0 bits (97), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 29/86 (33%), Positives = 44/86 (51%), Gaps = 6/86 (6%)
Query: 42  SAPIIHCDLKPTNILLDENMVAHVSDFGISK--LLGEGEDFVTQTMTMATIGYMAPEYGS 99
           S  I++ DLK  NILLD++    ++DFG+ K  +LG+ +          T  Y+APE   
Sbjct: 136 SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK----TNXFCGTPDYIAPEILL 191
Query: 100 EGIVSAKCDVYSYGVLLMETFTRKRP 125
               +   D +S+GVLL E    + P
Sbjct: 192 GQKYNHSVDWWSFGVLLYEMLIGQSP 217

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 42.0 bits (97), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/108 (30%), Positives = 48/108 (44%), Gaps = 8/108 (7%)
Query: 31  SALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATI 90
           SA++Y H       I+H DLK  N+LLD +M   ++DFG S     G           + 
Sbjct: 124 SAVQYCHQKF----IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKL---DEFCGSP 176
Query: 91  GYMAPE-YGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLR 137
            Y APE +  +     + DV+S GV+L    +   P D     E+  R
Sbjct: 177 PYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRER 224

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 42.0 bits (97), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 29/83 (34%), Positives = 40/83 (48%), Gaps = 2/83 (2%)
Query: 45  IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVS 104
           II+ DLK  N++LD      ++DFG+ K      D VT      T  Y+APE  +     
Sbjct: 141 IIYRDLKLDNVMLDSEGHIKIADFGMCK--EHMMDGVTTREFCGTPDYIAPEIIAYQPYG 198
Query: 105 AKCDVYSYGVLLMETFTRKRPTD 127
              D ++YGVLL E    + P D
Sbjct: 199 KSVDWWAYGVLLYEMLAGQPPFD 221

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 42.0 bits (97), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 71/163 (43%), Gaps = 17/163 (10%)
Query: 2   PNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENM 61
           P G L K L   +  FD      IM ++  AL Y H       +IH D+KP N+LL    
Sbjct: 106 PRGELYKELQK-SCTFDEQRTATIMEELADALMYCH----GKKVIHRDIKPENLLLGLKG 160
Query: 62  VAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT 121
              ++DFG S           +TM   T+ Y+ PE     + + K D++  GVL  E   
Sbjct: 161 ELKIADFGWSV---HAPSLRRKTMC-GTLDYLPPEMIEGRMHNEKVDLWCIGVLCYELLV 216
Query: 122 RKRPTDEMFTGEMSLRRWVK------ESLPHGLTEVVDANLVR 158
              P +     E + RR VK       S+P G  +++ + L+R
Sbjct: 217 GNPPFESASHNE-TYRRIVKVDLKFPASVPTGAQDLI-SKLLR 257

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 42.0 bits (97), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 35/113 (30%), Positives = 53/113 (46%), Gaps = 5/113 (4%)
Query: 29  VGSALEYPHHGHSSAPIIHCDLKPTNILLDENMV-AHVSDFGISKLL---GEGEDFVTQT 84
           +G ALE   + HS   I+H D+K  N+LL  +   A + DFG +  L   G G+  +T  
Sbjct: 191 LGQALEGLEYLHSRR-ILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGD 249
Query: 85  MTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLR 137
               T  +MAPE        AK DV+S   +++       P  + F G + L+
Sbjct: 250 YIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHPWTQFFRGPLCLK 302

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 42.0 bits (97), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 44/87 (50%), Gaps = 11/87 (12%)
Query: 33  LEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMA-TIG 91
            EY H    S  +I+ DLKP N+L+D+     V+DFG +K +        +T  +A T  
Sbjct: 154 FEYLH----SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK------GRTWXLAGTPE 203
Query: 92  YMAPEYGSEGIVSAKCDVYSYGVLLME 118
           Y+APE       +   D ++ GVL+ E
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYE 230

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 42.0 bits (97), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 30/99 (30%), Positives = 49/99 (49%), Gaps = 8/99 (8%)
Query: 28  DVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEG-EDFVTQTMT 86
           ++ SALEY H    S  +++ D+K  N++LD++    ++DFG+ K   EG  D  T    
Sbjct: 113 EIVSALEYLH----SRDVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKXF 165
Query: 87  MATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRP 125
             T  Y+APE   +       D +  GV++ E    + P
Sbjct: 166 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 41/159 (25%), Positives = 73/159 (45%), Gaps = 22/159 (13%)
Query: 24  NIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQ 83
            + + V  AL Y H    +  +IH D+K  +ILL  +    +SDFG    +   ++   +
Sbjct: 145 TVCLSVLRALSYLH----NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQV--SKEVPKR 198
Query: 84  TMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLR--RWVK 141
              + T  +MAPE  S      + D++S G++++E    + P    +  E  L+  R ++
Sbjct: 199 KXLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPP----YFNEPPLQAMRRIR 254
Query: 142 ESLP------HGLTEV----VDANLVREEQAFAAKMDCI 170
           +SLP      H ++ V    +D  LVRE    A   + +
Sbjct: 255 DSLPPRVKDLHKVSSVLRGFLDLMLVREPSQRATAQELL 293

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 30/99 (30%), Positives = 50/99 (50%), Gaps = 7/99 (7%)
Query: 28  DVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEG-EDFVTQTMT 86
           ++ SAL+Y H   S   +++ DLK  N++LD++    ++DFG+ K   EG +D  T    
Sbjct: 116 EIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK---EGIKDGATMKXF 169
Query: 87  MATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRP 125
             T  Y+APE   +       D +  GV++ E    + P
Sbjct: 170 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 208

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 27/81 (33%), Positives = 44/81 (54%), Gaps = 5/81 (6%)
Query: 45  IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEY--GSEGI 102
           I+H DLKP N+L+++     + DFG+++  G   +  T +  + T+ Y AP+   GS   
Sbjct: 129 ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVN--TFSSEVVTLWYRAPDVLMGSR-T 185
Query: 103 VSAKCDVYSYGVLLMETFTRK 123
            S   D++S G +L E  T K
Sbjct: 186 YSTSIDIWSCGCILAEMITGK 206

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 30/99 (30%), Positives = 50/99 (50%), Gaps = 7/99 (7%)
Query: 28  DVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEG-EDFVTQTMT 86
           ++ SAL+Y H   S   +++ DLK  N++LD++    ++DFG+ K   EG +D  T    
Sbjct: 117 EIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK---EGIKDGATMKXF 170
Query: 87  MATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRP 125
             T  Y+APE   +       D +  GV++ E    + P
Sbjct: 171 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 209

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 35/141 (24%), Positives = 62/141 (43%), Gaps = 27/141 (19%)
Query: 23  LNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLD-------------ENMVAHVSDFG 69
           ++++  + S + + H    S  IIH DLKP NIL+              EN+   +SDFG
Sbjct: 118 ISLLRQIASGVAHLH----SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFG 173
Query: 70  ISKLLGEGEDFVTQTMT--MATIGYMAPEYGSEG-------IVSAKCDVYSYGVLLMETF 120
           + K L  G+      +     T G+ APE   E         ++   D++S G +     
Sbjct: 174 LCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYIL 233
Query: 121 TR-KRPTDEMFTGEMSLRRWV 140
           ++ K P  + ++ E ++ R +
Sbjct: 234 SKGKHPFGDKYSRESNIIRGI 254

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 30/99 (30%), Positives = 49/99 (49%), Gaps = 8/99 (8%)
Query: 28  DVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEG-EDFVTQTMT 86
           ++ SALEY H    S  +++ D+K  N++LD++    ++DFG+ K   EG  D  T    
Sbjct: 118 EIVSALEYLH----SRDVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKXF 170
Query: 87  MATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRP 125
             T  Y+APE   +       D +  GV++ E    + P
Sbjct: 171 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 209

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 31/104 (29%), Positives = 48/104 (46%), Gaps = 8/104 (7%)
Query: 38  HGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEY 97
           H HS+  IIH DLKP+NI++  +    + DFG+++  G        T  + T  Y APE 
Sbjct: 135 HLHSAG-IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPYVVTRYYRAPEV 190
Query: 98  GSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVK 141
                     D++S G ++ E    K     +F G   + +W K
Sbjct: 191 ILGMGYKENVDLWSVGCIMGEMVCHKI----LFPGRDYIDQWNK 230

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 32/109 (29%), Positives = 47/109 (43%), Gaps = 8/109 (7%)
Query: 17  FDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGE 76
           FD       + ++ +AL Y H    S  +IH D+KP N+LL       ++DFG S     
Sbjct: 131 FDEQRTATYITELANALSYCH----SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 186
Query: 77  GEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRP 125
                 +     T+ Y+ PE     +   K D++S GVL  E    K P
Sbjct: 187 SR----RDDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 231

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 30/99 (30%), Positives = 50/99 (50%), Gaps = 7/99 (7%)
Query: 28  DVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEG-EDFVTQTMT 86
           ++ SAL+Y H   S   +++ DLK  N++LD++    ++DFG+ K   EG +D  T    
Sbjct: 118 EIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK---EGIKDGATMKXF 171
Query: 87  MATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRP 125
             T  Y+APE   +       D +  GV++ E    + P
Sbjct: 172 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 210

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 31/104 (29%), Positives = 48/104 (46%), Gaps = 8/104 (7%)
Query: 38  HGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEY 97
           H HS+  IIH DLKP+NI++  +    + DFG+++  G        T  + T  Y APE 
Sbjct: 146 HLHSAG-IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPYVVTRYYRAPEV 201
Query: 98  GSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVK 141
                     D++S G ++ E    K     +F G   + +W K
Sbjct: 202 ILGMGYKENVDLWSVGCIMGEMVCHKI----LFPGRDYIDQWNK 241

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 32/102 (31%), Positives = 45/102 (44%), Gaps = 10/102 (9%)
Query: 17  FDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDE---NMVAHVSDFGISKL 73
           F   E   I   +G A++Y H    S  I H D+KP N+L      N +  ++DFG +K 
Sbjct: 158 FTEREASEIXKSIGEAIQYLH----SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK- 212
Query: 74  LGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVL 115
             E     + T    T  Y+APE          CD +S GV+
Sbjct: 213 --ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDXWSLGVI 252

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 30/77 (38%), Positives = 43/77 (55%), Gaps = 7/77 (9%)
Query: 45  IIHCDLKPTNILLD-ENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPE--YGSEG 101
           I H D+KP N+LLD +  V  + DFG +K L  GE  V+    + +  Y APE  +G+  
Sbjct: 177 ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICSRYYRAPELIFGATD 233
Query: 102 IVSAKCDVYSYGVLLME 118
             S+  DV+S G +L E
Sbjct: 234 YTSS-IDVWSAGCVLAE 249

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 27/95 (28%), Positives = 46/95 (48%), Gaps = 6/95 (6%)
Query: 31  SALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATI 90
            ALE+ H    S  +IH D+K  NILL  +    ++DFG    +   +    ++  + T 
Sbjct: 128 QALEFLH----SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSXMVGTP 181
Query: 91  GYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRP 125
            +MAPE  +      K D++S G++ +E    + P
Sbjct: 182 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 216

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 27/95 (28%), Positives = 46/95 (48%), Gaps = 6/95 (6%)
Query: 31  SALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATI 90
            ALE+ H    S  +IH D+K  NILL  +    ++DFG    +   +    ++  + T 
Sbjct: 127 QALEFLH----SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSXMVGTP 180
Query: 91  GYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRP 125
            +MAPE  +      K D++S G++ +E    + P
Sbjct: 181 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 32/109 (29%), Positives = 47/109 (43%), Gaps = 8/109 (7%)
Query: 17  FDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGE 76
           FD       + ++ +AL Y H    S  +IH D+KP N+LL       ++DFG S     
Sbjct: 108 FDEQRTATYITELANALSYCH----SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 163
Query: 77  GEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRP 125
                 +     T+ Y+ PE     +   K D++S GVL  E    K P
Sbjct: 164 SR----RDDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 30/93 (32%), Positives = 47/93 (50%), Gaps = 10/93 (10%)
Query: 32  ALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIG 91
            L+Y H    SA IIH DLKP+N+ ++E+    + DFG+++   E       T  +AT  
Sbjct: 143 GLKYIH----SAGIIHRDLKPSNVAVNEDSELRILDFGLARQADE-----EMTGYVATRW 193
Query: 92  YMAPEYGSEGI-VSAKCDVYSYGVLLMETFTRK 123
           Y APE     +  +   D++S G ++ E    K
Sbjct: 194 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 27/95 (28%), Positives = 46/95 (48%), Gaps = 6/95 (6%)
Query: 31  SALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATI 90
            ALE+ H    S  +IH D+K  NILL  +    ++DFG    +   +    ++  + T 
Sbjct: 127 QALEFLH----SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTP 180
Query: 91  GYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRP 125
            +MAPE  +      K D++S G++ +E    + P
Sbjct: 181 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 42/199 (21%), Positives = 75/199 (37%), Gaps = 25/199 (12%)
Query: 4   GSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVA 63
           G L  +L    +  D+   +     + +AL Y      S   +H D+   N+L+  N   
Sbjct: 475 GELRSFLQVRKFSLDLASLILYAYQLSTALAY----LESKRFVHRDIAARNVLVSSNDCV 530
Query: 64  HVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRK 123
            + DFG+S+ + E   +   +     I +MAPE  +    ++  DV+ +GV + E     
Sbjct: 531 KLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHG 589
Query: 124 -RPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLALDCCM 182
            +P   +   ++  R    E LP                      +C  ++  L   C  
Sbjct: 590 VKPFQGVKNNDVIGRIENGERLP-------------------MPPNCPPTLYSLMTKCWA 630
Query: 183 ESPGKRINMTDAAAKLKKI 201
             P +R   T+  A+L  I
Sbjct: 631 YDPSRRPRFTELKAQLSTI 649

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 30/93 (32%), Positives = 47/93 (50%), Gaps = 10/93 (10%)
Query: 32  ALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIG 91
            L+Y H    SA IIH DLKP+N+ ++E+    + DFG+++   E       T  +AT  
Sbjct: 143 GLKYIH----SAGIIHRDLKPSNVAVNEDSELRILDFGLARQADE-----EMTGYVATRW 193
Query: 92  YMAPEYGSEGI-VSAKCDVYSYGVLLMETFTRK 123
           Y APE     +  +   D++S G ++ E    K
Sbjct: 194 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 35/141 (24%), Positives = 62/141 (43%), Gaps = 27/141 (19%)
Query: 23  LNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLD-------------ENMVAHVSDFG 69
           ++++  + S + + H    S  IIH DLKP NIL+              EN+   +SDFG
Sbjct: 118 ISLLRQIASGVAHLH----SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFG 173
Query: 70  ISKLLGEGEDFVTQTMT--MATIGYMAPEYGSEG-------IVSAKCDVYSYGVLLMETF 120
           + K L  G+      +     T G+ APE   E         ++   D++S G +     
Sbjct: 174 LCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYIL 233
Query: 121 TR-KRPTDEMFTGEMSLRRWV 140
           ++ K P  + ++ E ++ R +
Sbjct: 234 SKGKHPFGDKYSRESNIIRGI 254

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 30/99 (30%), Positives = 49/99 (49%), Gaps = 8/99 (8%)
Query: 28  DVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEG-EDFVTQTMT 86
           ++ SALEY H    S  +++ D+K  N++LD++    ++DFG+ K   EG  D  T    
Sbjct: 113 EIVSALEYLH----SRDVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTF 165
Query: 87  MATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRP 125
             T  Y+APE   +       D +  GV++ E    + P
Sbjct: 166 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 30/77 (38%), Positives = 43/77 (55%), Gaps = 7/77 (9%)
Query: 45  IIHCDLKPTNILLD-ENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPE--YGSEG 101
           I H D+KP N+LLD +  V  + DFG +K L  GE  V+    + +  Y APE  +G+  
Sbjct: 155 ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICSRYYRAPELIFGATD 211
Query: 102 IVSAKCDVYSYGVLLME 118
             S+  DV+S G +L E
Sbjct: 212 YTSS-IDVWSAGCVLAE 227

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 30/99 (30%), Positives = 49/99 (49%), Gaps = 8/99 (8%)
Query: 28  DVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEG-EDFVTQTMT 86
           ++ SALEY H    S  +++ D+K  N++LD++    ++DFG+ K   EG  D  T    
Sbjct: 113 EIVSALEYLH----SRDVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKXF 165
Query: 87  MATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRP 125
             T  Y+APE   +       D +  GV++ E    + P
Sbjct: 166 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 43/88 (48%), Gaps = 11/88 (12%)
Query: 32  ALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTM-ATI 90
             EY H    S  +I+ DLKP N+L+DE     V+DFG +K +        +T  +  T 
Sbjct: 140 TFEYLH----SLDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVK------GRTWXLCGTP 189
Query: 91  GYMAPEYGSEGIVSAKCDVYSYGVLLME 118
            Y+APE       +   D ++ GVL+ E
Sbjct: 190 EYLAPEIILSKGYNKAVDWWALGVLIYE 217

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 30/77 (38%), Positives = 43/77 (55%), Gaps = 7/77 (9%)
Query: 45  IIHCDLKPTNILLD-ENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPE--YGSEG 101
           I H D+KP N+LLD +  V  + DFG +K L  GE  V+    + +  Y APE  +G+  
Sbjct: 151 ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICSRYYRAPELIFGATD 207
Query: 102 IVSAKCDVYSYGVLLME 118
             S+  DV+S G +L E
Sbjct: 208 YTSS-IDVWSAGCVLAE 223

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 30/93 (32%), Positives = 47/93 (50%), Gaps = 10/93 (10%)
Query: 32  ALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIG 91
            L+Y H    SA IIH DLKP+N+ ++E+    + DFG+++   E       T  +AT  
Sbjct: 135 GLKYIH----SAGIIHRDLKPSNVAVNEDCELRILDFGLARQADE-----EMTGYVATRW 185
Query: 92  YMAPEYGSEGI-VSAKCDVYSYGVLLMETFTRK 123
           Y APE     +  +   D++S G ++ E    K
Sbjct: 186 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 218

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 29/86 (33%), Positives = 44/86 (51%), Gaps = 6/86 (6%)
Query: 42  SAPIIHCDLKPTNILLDENMVAHVSDFGISK--LLGEGEDFVTQTMTMATIGYMAPEYGS 99
           S  I++ DLK  NILLD++    ++DFG+ K  +LG+ +          T  Y+APE   
Sbjct: 137 SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK----TNEFCGTPDYIAPEILL 192
Query: 100 EGIVSAKCDVYSYGVLLMETFTRKRP 125
               +   D +S+GVLL E    + P
Sbjct: 193 GQKYNHSVDWWSFGVLLYEMLIGQSP 218

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 30/77 (38%), Positives = 43/77 (55%), Gaps = 7/77 (9%)
Query: 45  IIHCDLKPTNILLD-ENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPE--YGSEG 101
           I H D+KP N+LLD +  V  + DFG +K L  GE  V+    + +  Y APE  +G+  
Sbjct: 162 ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICSRYYRAPELIFGATD 218
Query: 102 IVSAKCDVYSYGVLLME 118
             S+  DV+S G +L E
Sbjct: 219 YTSS-IDVWSAGCVLAE 234

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 31/104 (29%), Positives = 50/104 (48%), Gaps = 8/104 (7%)
Query: 38  HGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEY 97
           H HS+  IIH DLKP+NI++  +    + DFG+++  G    F+ +   + T  Y APE 
Sbjct: 141 HLHSAG-IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMEP-EVVTRYYRAPEV 196
Query: 98  GSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVK 141
                     D++S G ++ E    K     +F G   + +W K
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMVCHKI----LFPGRDYIDQWNK 236

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 41.2 bits (95), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 35/96 (36%), Positives = 50/96 (52%), Gaps = 11/96 (11%)
Query: 26  MIDVGSALEYPHHGHSSAPIIHCDLKPTNILLD-ENMVAHVSDFGISKLLGEGEDFVTQT 84
           M  +  +L Y H    S  I H D+KP N+LLD +  V  + DFG +K L  GE  V+  
Sbjct: 128 MYQLFRSLAYIH----SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS-- 181
Query: 85  MTMATIGYMAPE--YGSEGIVSAKCDVYSYGVLLME 118
             + +  Y APE  +G+    S+  DV+S G +L E
Sbjct: 182 -XICSRYYRAPELIFGATDYTSS-IDVWSAGCVLAE 215

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 41.2 bits (95), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 45/99 (45%), Gaps = 7/99 (7%)
Query: 41  SSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSE 100
            S  II+ DLK  N++LD      ++DFG+ K      D VT      T  Y+APE  + 
Sbjct: 138 QSKGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKXFCGTPDYIAPEIIAY 195
Query: 101 GIVSAKCDVYSYGVLLMETFTRKRP-----TDEMFTGEM 134
                  D +++GVLL E    + P      DE+F   M
Sbjct: 196 QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM 234

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 41.2 bits (95), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 35/96 (36%), Positives = 50/96 (52%), Gaps = 11/96 (11%)
Query: 26  MIDVGSALEYPHHGHSSAPIIHCDLKPTNILLD-ENMVAHVSDFGISKLLGEGEDFVTQT 84
           M  +  +L Y H    S  I H D+KP N+LLD +  V  + DFG +K L  GE  V+  
Sbjct: 128 MYQLFRSLAYIH----SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS-- 181
Query: 85  MTMATIGYMAPE--YGSEGIVSAKCDVYSYGVLLME 118
             + +  Y APE  +G+    S+  DV+S G +L E
Sbjct: 182 -XICSRYYRAPELIFGATDYTSS-IDVWSAGCVLAE 215

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 41.2 bits (95), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 35/96 (36%), Positives = 50/96 (52%), Gaps = 11/96 (11%)
Query: 26  MIDVGSALEYPHHGHSSAPIIHCDLKPTNILLD-ENMVAHVSDFGISKLLGEGEDFVTQT 84
           M  +  +L Y H    S  I H D+KP N+LLD +  V  + DFG +K L  GE  V+  
Sbjct: 129 MYQLFRSLAYIH----SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS-- 182
Query: 85  MTMATIGYMAPE--YGSEGIVSAKCDVYSYGVLLME 118
             + +  Y APE  +G+    S+  DV+S G +L E
Sbjct: 183 -XICSRYYRAPELIFGATDYTSS-IDVWSAGCVLAE 216

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 41.2 bits (95), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 36/108 (33%), Positives = 49/108 (45%), Gaps = 8/108 (7%)
Query: 28  DVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTM 87
           ++ SAL Y H    S  I++ DLKP NILLD      ++DFG+ K   E  +  + T T 
Sbjct: 147 EIASALGYLH----SLNIVYRDLKPENILLDSQGHIVLTDFGLCK---ENIEHNSTTSTF 199
Query: 88  -ATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEM 134
             T  Y+APE   +       D +  G +L E      P     T EM
Sbjct: 200 CGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM 247

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 41.2 bits (95), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 30/99 (30%), Positives = 49/99 (49%), Gaps = 8/99 (8%)
Query: 28  DVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEG-EDFVTQTMT 86
           ++ SALEY H    S  +++ D+K  N++LD++    ++DFG+ K   EG  D  T    
Sbjct: 113 EIVSALEYLH----SRDVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKXF 165
Query: 87  MATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRP 125
             T  Y+APE   +       D +  GV++ E    + P
Sbjct: 166 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 41.2 bits (95), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 30/77 (38%), Positives = 43/77 (55%), Gaps = 7/77 (9%)
Query: 45  IIHCDLKPTNILLD-ENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPE--YGSEG 101
           I H D+KP N+LLD +  V  + DFG +K L  GE  V+    + +  Y APE  +G+  
Sbjct: 155 ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICSRYYRAPELIFGATD 211
Query: 102 IVSAKCDVYSYGVLLME 118
             S+  DV+S G +L E
Sbjct: 212 YTSS-IDVWSAGCVLAE 227

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 41.2 bits (95), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 27/85 (31%), Positives = 42/85 (49%), Gaps = 6/85 (7%)
Query: 46  IHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEY-----GSE 100
           +H D+KP N+LLD N    ++DFG S L    +  V  ++ + T  Y++PE         
Sbjct: 197 VHRDIKPDNVLLDVNGHIRLADFG-SCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDGM 255
Query: 101 GIVSAKCDVYSYGVLLMETFTRKRP 125
           G    +CD +S GV + E    + P
Sbjct: 256 GKYGPECDWWSLGVCMYEMLYGETP 280

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 41.2 bits (95), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 27/85 (31%), Positives = 42/85 (49%), Gaps = 6/85 (7%)
Query: 46  IHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEY-----GSE 100
           +H D+KP N+LLD N    ++DFG S L    +  V  ++ + T  Y++PE         
Sbjct: 213 VHRDIKPDNVLLDVNGHIRLADFG-SCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDGM 271
Query: 101 GIVSAKCDVYSYGVLLMETFTRKRP 125
           G    +CD +S GV + E    + P
Sbjct: 272 GKYGPECDWWSLGVCMYEMLYGETP 296

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 41.2 bits (95), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 30/99 (30%), Positives = 49/99 (49%), Gaps = 8/99 (8%)
Query: 28  DVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEG-EDFVTQTMT 86
           ++ SALEY H    S  +++ D+K  N++LD++    ++DFG+ K   EG  D  T    
Sbjct: 113 EIVSALEYLH----SRDVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTF 165
Query: 87  MATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRP 125
             T  Y+APE   +       D +  GV++ E    + P
Sbjct: 166 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 41.2 bits (95), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 50/98 (51%), Gaps = 10/98 (10%)
Query: 25  IMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQT 84
           ++  +   L+Y H    SA IIH DLKP+N+ ++E+    + DFG+++   +       T
Sbjct: 130 LIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMT 180
Query: 85  MTMATIGYMAPEYGSEGI-VSAKCDVYSYGVLLMETFT 121
             +AT  Y APE     +  +   D++S G ++ E  T
Sbjct: 181 GYVATRWYRAPEIMLNAMHYNQTVDIWSVGCIMAELLT 218

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 41.2 bits (95), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 35/96 (36%), Positives = 50/96 (52%), Gaps = 11/96 (11%)
Query: 26  MIDVGSALEYPHHGHSSAPIIHCDLKPTNILLD-ENMVAHVSDFGISKLLGEGEDFVTQT 84
           M  +  +L Y H    S  I H D+KP N+LLD +  V  + DFG +K L  GE  V+  
Sbjct: 128 MYQLFRSLAYIH----SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS-- 181
Query: 85  MTMATIGYMAPE--YGSEGIVSAKCDVYSYGVLLME 118
             + +  Y APE  +G+    S+  DV+S G +L E
Sbjct: 182 -XICSRYYRAPELIFGATDYTSS-IDVWSAGCVLAE 215

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 41.2 bits (95), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 30/99 (30%), Positives = 49/99 (49%), Gaps = 8/99 (8%)
Query: 28  DVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEG-EDFVTQTMT 86
           ++ SALEY H    S  +++ D+K  N++LD++    ++DFG+ K   EG  D  T    
Sbjct: 116 EIVSALEYLH----SRDVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTF 168
Query: 87  MATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRP 125
             T  Y+APE   +       D +  GV++ E    + P
Sbjct: 169 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 207

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 41.2 bits (95), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 50/98 (51%), Gaps = 10/98 (10%)
Query: 25  IMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQT 84
           ++  +   L+Y H    SA IIH DLKP+N+ ++E+    + DFG+++   +       T
Sbjct: 130 LIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDXELKILDFGLARHTDD-----EMT 180
Query: 85  MTMATIGYMAPEYGSEGI-VSAKCDVYSYGVLLMETFT 121
             +AT  Y APE     +  +   D++S G ++ E  T
Sbjct: 181 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 41.2 bits (95), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 50/98 (51%), Gaps = 10/98 (10%)
Query: 25  IMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQT 84
           ++  +   L+Y H    SA IIH DLKP+N+ ++E+    + DFG+++   +       T
Sbjct: 137 LIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD-----EMT 187
Query: 85  MTMATIGYMAPEYGSEGI-VSAKCDVYSYGVLLMETFT 121
             +AT  Y APE     +  +   D++S G ++ E  T
Sbjct: 188 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 225

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 41.2 bits (95), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 43/87 (49%), Gaps = 11/87 (12%)
Query: 33  LEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTM-ATIG 91
            EY H    S  +I+ DLKP N+L+D+     V+DFG +K +         T T+  T  
Sbjct: 175 FEYLH----SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGA------TWTLCGTPE 224
Query: 92  YMAPEYGSEGIVSAKCDVYSYGVLLME 118
           Y+APE       +   D ++ GVL+ E
Sbjct: 225 YLAPEIILSKGYNKAVDWWALGVLIYE 251

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 41.2 bits (95), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 33/113 (29%), Positives = 53/113 (46%), Gaps = 5/113 (4%)
Query: 29  VGSALEYPHHGHSSAPIIHCDLKPTNILLD-ENMVAHVSDFGISKLL---GEGEDFVTQT 84
           +G ALE   + H+   I+H D+K  N+LL  +   A + DFG +  L   G G+  +T  
Sbjct: 156 LGQALEGLEYLHTRR-ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGD 214
Query: 85  MTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLR 137
               T  +MAPE        AK D++S   +++       P  + F G + L+
Sbjct: 215 YIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLK 267

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 41.2 bits (95), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 33/113 (29%), Positives = 53/113 (46%), Gaps = 5/113 (4%)
Query: 29  VGSALEYPHHGHSSAPIIHCDLKPTNILLD-ENMVAHVSDFGISKLL---GEGEDFVTQT 84
           +G ALE   + H+   I+H D+K  N+LL  +   A + DFG +  L   G G+  +T  
Sbjct: 170 LGQALEGLEYLHTRR-ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGD 228
Query: 85  MTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLR 137
               T  +MAPE        AK D++S   +++       P  + F G + L+
Sbjct: 229 YIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLK 281

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 41.2 bits (95), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 50/98 (51%), Gaps = 10/98 (10%)
Query: 25  IMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQT 84
           ++  +   L+Y H    SA IIH DLKP+N+ ++E+    + DFG+++   +       T
Sbjct: 135 LIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDXELKILDFGLARHTDD-----EMT 185
Query: 85  MTMATIGYMAPEYGSEGI-VSAKCDVYSYGVLLMETFT 121
             +AT  Y APE     +  +   D++S G ++ E  T
Sbjct: 186 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 223

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 41.2 bits (95), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 50/98 (51%), Gaps = 10/98 (10%)
Query: 25  IMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQT 84
           ++  +   L+Y H    SA IIH DLKP+N+ ++E+    + DFG+++   +       T
Sbjct: 137 LIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD-----EMT 187
Query: 85  MTMATIGYMAPEYGSEGI-VSAKCDVYSYGVLLMETFT 121
             +AT  Y APE     +  +   D++S G ++ E  T
Sbjct: 188 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 225

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 41.2 bits (95), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 33/113 (29%), Positives = 53/113 (46%), Gaps = 5/113 (4%)
Query: 29  VGSALEYPHHGHSSAPIIHCDLKPTNILLD-ENMVAHVSDFGISKLL---GEGEDFVTQT 84
           +G ALE   + H+   I+H D+K  N+LL  +   A + DFG +  L   G G+  +T  
Sbjct: 172 LGQALEGLEYLHTRR-ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGD 230
Query: 85  MTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLR 137
               T  +MAPE        AK D++S   +++       P  + F G + L+
Sbjct: 231 YIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLK 283

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 41.2 bits (95), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 50/98 (51%), Gaps = 10/98 (10%)
Query: 25  IMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQT 84
           ++  +   L+Y H    SA IIH DLKP+N+ ++E+    + DFG+++   +       T
Sbjct: 137 LIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD-----EMT 187
Query: 85  MTMATIGYMAPEYGSEGI-VSAKCDVYSYGVLLMETFT 121
             +AT  Y APE     +  +   D++S G ++ E  T
Sbjct: 188 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 225

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 41.2 bits (95), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 35/96 (36%), Positives = 50/96 (52%), Gaps = 11/96 (11%)
Query: 26  MIDVGSALEYPHHGHSSAPIIHCDLKPTNILLD-ENMVAHVSDFGISKLLGEGEDFVTQT 84
           M  +  +L Y H    S  I H D+KP N+LLD +  V  + DFG +K L  GE  V+  
Sbjct: 132 MYQLFRSLAYIH----SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS-- 185
Query: 85  MTMATIGYMAPE--YGSEGIVSAKCDVYSYGVLLME 118
             + +  Y APE  +G+    S+  DV+S G +L E
Sbjct: 186 -XICSRYYRAPELIFGATDYTSS-IDVWSAGCVLAE 219

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 41.2 bits (95), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 50/98 (51%), Gaps = 10/98 (10%)
Query: 25  IMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQT 84
           ++  +   L+Y H    SA IIH DLKP+N+ ++E+    + DFG+++   +       T
Sbjct: 135 LIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDXELKILDFGLARHTDD-----EMT 185
Query: 85  MTMATIGYMAPEYGSEGI-VSAKCDVYSYGVLLMETFT 121
             +AT  Y APE     +  +   D++S G ++ E  T
Sbjct: 186 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 223

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 41.2 bits (95), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 50/98 (51%), Gaps = 10/98 (10%)
Query: 25  IMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQT 84
           ++  +   L+Y H    SA IIH DLKP+N+ ++E+    + DFG+++   +       T
Sbjct: 141 LIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDXELKILDFGLARHTDD-----EMT 191
Query: 85  MTMATIGYMAPEYGSEGI-VSAKCDVYSYGVLLMETFT 121
             +AT  Y APE     +  +   D++S G ++ E  T
Sbjct: 192 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 229

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 41.2 bits (95), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 30/77 (38%), Positives = 43/77 (55%), Gaps = 7/77 (9%)
Query: 45  IIHCDLKPTNILLD-ENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPE--YGSEG 101
           I H D+KP N+LLD +  V  + DFG +K L  GE  V+    + +  Y APE  +G+  
Sbjct: 171 ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYRAPELIFGATD 227
Query: 102 IVSAKCDVYSYGVLLME 118
             S+  DV+S G +L E
Sbjct: 228 YTSS-IDVWSAGCVLAE 243

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 41.2 bits (95), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 30/77 (38%), Positives = 43/77 (55%), Gaps = 7/77 (9%)
Query: 45  IIHCDLKPTNILLD-ENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPE--YGSEG 101
           I H D+KP N+LLD +  V  + DFG +K L  GE  V+    + +  Y APE  +G+  
Sbjct: 143 ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICSRYYRAPELIFGATD 199
Query: 102 IVSAKCDVYSYGVLLME 118
             S+  DV+S G +L E
Sbjct: 200 YTSS-IDVWSAGCVLAE 215

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 41.2 bits (95), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 30/77 (38%), Positives = 43/77 (55%), Gaps = 7/77 (9%)
Query: 45  IIHCDLKPTNILLD-ENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPE--YGSEG 101
           I H D+KP N+LLD +  V  + DFG +K L  GE  V+    + +  Y APE  +G+  
Sbjct: 179 ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYRAPELIFGATD 235
Query: 102 IVSAKCDVYSYGVLLME 118
             S+  DV+S G +L E
Sbjct: 236 YTSS-IDVWSAGCVLAE 251

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 41.2 bits (95), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 30/77 (38%), Positives = 43/77 (55%), Gaps = 7/77 (9%)
Query: 45  IIHCDLKPTNILLD-ENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPE--YGSEG 101
           I H D+KP N+LLD +  V  + DFG +K L  GE  V+    + +  Y APE  +G+  
Sbjct: 177 ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYRAPELIFGATD 233
Query: 102 IVSAKCDVYSYGVLLME 118
             S+  DV+S G +L E
Sbjct: 234 YTSS-IDVWSAGCVLAE 249

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 41.2 bits (95), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 50/98 (51%), Gaps = 10/98 (10%)
Query: 25  IMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQT 84
           ++  +   L+Y H    SA IIH DLKP+N+ ++E+    + DFG+++   +       T
Sbjct: 130 LIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMT 180
Query: 85  MTMATIGYMAPEYGSEGI-VSAKCDVYSYGVLLMETFT 121
             +AT  Y APE     +  +   D++S G ++ E  T
Sbjct: 181 GXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 41.2 bits (95), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 35/126 (27%), Positives = 50/126 (39%), Gaps = 9/126 (7%)
Query: 2   PNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENM 61
           P G L K L  +  F D       M ++  AL Y H       +IH D+KP N+L+    
Sbjct: 98  PRGELYKELQKHGRF-DEQRSATFMEELADALHYCH----ERKVIHRDIKPENLLMGYKG 152
Query: 62  VAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT 121
              ++DFG S         + +     T+ Y+ PE         K D++  GVL  E   
Sbjct: 153 ELKIADFGWSVHAPS----LRRRXMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLV 208
Query: 122 RKRPTD 127
              P D
Sbjct: 209 GMPPFD 214

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 41.2 bits (95), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 35/126 (27%), Positives = 50/126 (39%), Gaps = 9/126 (7%)
Query: 2   PNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENM 61
           P G L K L  +  F D       M ++  AL Y H       +IH D+KP N+L+    
Sbjct: 97  PRGELYKELQKHGRF-DEQRSATFMEELADALHYCH----ERKVIHRDIKPENLLMGYKG 151
Query: 62  VAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT 121
              ++DFG S         + +     T+ Y+ PE         K D++  GVL  E   
Sbjct: 152 ELKIADFGWSVHAPS----LRRRXMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLV 207
Query: 122 RKRPTD 127
              P D
Sbjct: 208 GMPPFD 213

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 41.2 bits (95), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 28/86 (32%), Positives = 43/86 (50%), Gaps = 9/86 (10%)
Query: 33  LEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGY 92
            EY H    S  +I+ DLKP N+L+D+     V+DFG +K + +G  +        T  Y
Sbjct: 154 FEYLH----SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGRTW----XLXGTPEY 204
Query: 93  MAPEYGSEGIVSAKCDVYSYGVLLME 118
           +APE       +   D ++ GVL+ E
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYE 230

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 41.2 bits (95), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 30/77 (38%), Positives = 43/77 (55%), Gaps = 7/77 (9%)
Query: 45  IIHCDLKPTNILLD-ENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPE--YGSEG 101
           I H D+KP N+LLD +  V  + DFG +K L  GE  V+    + +  Y APE  +G+  
Sbjct: 181 ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYRAPELIFGATD 237
Query: 102 IVSAKCDVYSYGVLLME 118
             S+  DV+S G +L E
Sbjct: 238 YTSS-IDVWSAGCVLAE 253

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 41.2 bits (95), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 45/99 (45%), Gaps = 7/99 (7%)
Query: 41  SSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSE 100
            S  II+ DLK  N++LD      ++DFG+ K      D VT      T  Y+APE  + 
Sbjct: 459 QSKGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKXFCGTPDYIAPEIIAY 516
Query: 101 GIVSAKCDVYSYGVLLMETFTRKRP-----TDEMFTGEM 134
                  D +++GVLL E    + P      DE+F   M
Sbjct: 517 QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM 555

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 40.8 bits (94), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 27/95 (28%), Positives = 46/95 (48%), Gaps = 6/95 (6%)
Query: 31  SALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATI 90
            ALE+ H    S  +IH D+K  NILL  +    ++DFG    +   +    ++  + T 
Sbjct: 127 QALEFLH----SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSEMVGTP 180
Query: 91  GYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRP 125
            +MAPE  +      K D++S G++ +E    + P
Sbjct: 181 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 40.8 bits (94), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 30/77 (38%), Positives = 43/77 (55%), Gaps = 7/77 (9%)
Query: 45  IIHCDLKPTNILLD-ENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPE--YGSEG 101
           I H D+KP N+LLD +  V  + DFG +K L  GE  V+    + +  Y APE  +G+  
Sbjct: 148 ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYRAPELIFGATD 204
Query: 102 IVSAKCDVYSYGVLLME 118
             S+  DV+S G +L E
Sbjct: 205 YTSS-IDVWSAGCVLAE 220

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 40.8 bits (94), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 35/96 (36%), Positives = 50/96 (52%), Gaps = 11/96 (11%)
Query: 26  MIDVGSALEYPHHGHSSAPIIHCDLKPTNILLD-ENMVAHVSDFGISKLLGEGEDFVTQT 84
           M  +  +L Y H    S  I H D+KP N+LLD +  V  + DFG +K L  GE  V+  
Sbjct: 128 MYQLFRSLAYIH----SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY- 182
Query: 85  MTMATIGYMAPE--YGSEGIVSAKCDVYSYGVLLME 118
             + +  Y APE  +G+    S+  DV+S G +L E
Sbjct: 183 --ICSRYYRAPELIFGATDYTSS-IDVWSAGCVLAE 215

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 40.8 bits (94), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 30/77 (38%), Positives = 43/77 (55%), Gaps = 7/77 (9%)
Query: 45  IIHCDLKPTNILLD-ENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPE--YGSEG 101
           I H D+KP N+LLD +  V  + DFG +K L  GE  V+    + +  Y APE  +G+  
Sbjct: 222 ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYRAPELIFGATD 278
Query: 102 IVSAKCDVYSYGVLLME 118
             S+  DV+S G +L E
Sbjct: 279 YTSS-IDVWSAGCVLAE 294

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 40.8 bits (94), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 30/77 (38%), Positives = 43/77 (55%), Gaps = 7/77 (9%)
Query: 45  IIHCDLKPTNILLD-ENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPE--YGSEG 101
           I H D+KP N+LLD +  V  + DFG +K L  GE  V+    + +  Y APE  +G+  
Sbjct: 156 ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYRAPELIFGATD 212
Query: 102 IVSAKCDVYSYGVLLME 118
             S+  DV+S G +L E
Sbjct: 213 YTSS-IDVWSAGCVLAE 228

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 40.8 bits (94), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 36/127 (28%), Positives = 56/127 (44%), Gaps = 19/127 (14%)
Query: 26  MIDVGSALEYPHHGHSSAPIIHCDLKPTNILL---DENMVAHVSDFGISKLLGEGEDFVT 82
           M  +  AL Y H  +    IIH D+KP N+LL   + +    + DFG++  LGE    + 
Sbjct: 136 MRQILEALRYCHDNN----IIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESG--LV 189
Query: 83  QTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRP----TDEMFTG------ 132
               + T  +MAPE           DV+  GV+L    +   P     + +F G      
Sbjct: 190 AGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKY 249
Query: 133 EMSLRRW 139
           +M+ R+W
Sbjct: 250 KMNPRQW 256

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 40.8 bits (94), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 26/93 (27%), Positives = 48/93 (51%), Gaps = 8/93 (8%)
Query: 42  SAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPE--YGS 99
           S  ++H DLKP N+L++ N    ++DFG+++  G        +  + T+ Y  P+  +G+
Sbjct: 119 SRNVLHRDLKPQNLLINRNGELKLADFGLARAFGIP--VRCYSAEVVTLWYRPPDVLFGA 176
Query: 100 EGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTG 132
           + + S   D++S G +  E     RP   +F G
Sbjct: 177 K-LYSTSIDMWSAGCIFAELANAARP---LFPG 205

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 40.8 bits (94), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 50/98 (51%), Gaps = 10/98 (10%)
Query: 25  IMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQT 84
           ++  +   L+Y H    SA IIH DLKP+N+ ++E+    + DFG+++   +       T
Sbjct: 136 LIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDSELKILDFGLARHTDD-----EMT 186
Query: 85  MTMATIGYMAPEYGSEGI-VSAKCDVYSYGVLLMETFT 121
             +AT  Y APE     +  +   D++S G ++ E  T
Sbjct: 187 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 224

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 40.8 bits (94), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 50/98 (51%), Gaps = 10/98 (10%)
Query: 25  IMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQT 84
           ++  +   L+Y H    SA IIH DLKP+N+ ++E+    + DFG+++   +       T
Sbjct: 132 LIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDSELKILDFGLARHTDD-----EMT 182
Query: 85  MTMATIGYMAPEYGSEGI-VSAKCDVYSYGVLLMETFT 121
             +AT  Y APE     +  +   D++S G ++ E  T
Sbjct: 183 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 220

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 40.8 bits (94), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 35/96 (36%), Positives = 50/96 (52%), Gaps = 11/96 (11%)
Query: 26  MIDVGSALEYPHHGHSSAPIIHCDLKPTNILLD-ENMVAHVSDFGISKLLGEGEDFVTQT 84
           M  +  +L Y H    S  I H D+KP N+LLD +  V  + DFG +K L  GE  V+  
Sbjct: 128 MYQLFRSLAYIH----SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY- 182
Query: 85  MTMATIGYMAPE--YGSEGIVSAKCDVYSYGVLLME 118
             + +  Y APE  +G+    S+  DV+S G +L E
Sbjct: 183 --ICSRYYRAPELIFGATDYTSS-IDVWSAGCVLAE 215

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 40.8 bits (94), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 50/98 (51%), Gaps = 10/98 (10%)
Query: 25  IMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQT 84
           ++  +   L+Y H    SA IIH DLKP+N+ ++E+    + DFG+++   +       T
Sbjct: 141 LIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMT 191
Query: 85  MTMATIGYMAPEYGSEGI-VSAKCDVYSYGVLLMETFT 121
             +AT  Y APE     +  +   D++S G ++ E  T
Sbjct: 192 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 229

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 40.8 bits (94), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 50/98 (51%), Gaps = 10/98 (10%)
Query: 25  IMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQT 84
           ++  +   L+Y H    SA IIH DLKP+N+ ++E+    + DFG+++   +       T
Sbjct: 130 LIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMT 180
Query: 85  MTMATIGYMAPEYGSEGI-VSAKCDVYSYGVLLMETFT 121
             +AT  Y APE     +  +   D++S G ++ E  T
Sbjct: 181 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 40.8 bits (94), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 31/104 (29%), Positives = 50/104 (48%), Gaps = 8/104 (7%)
Query: 38  HGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEY 97
           H HS+  IIH DLKP+NI++  +    + DFG+++  G    F+ +   + T  Y APE 
Sbjct: 141 HLHSAG-IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMEP-EVVTRYYRAPEV 196
Query: 98  GSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVK 141
                     D++S G ++ E    K     +F G   + +W K
Sbjct: 197 ILGMGYKENVDLWSVGCIMGEMVCHKI----LFPGRDYIDQWNK 236

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 40.8 bits (94), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 50/98 (51%), Gaps = 10/98 (10%)
Query: 25  IMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQT 84
           ++  +   L+Y H    SA IIH DLKP+N+ ++E+    + DFG+++   +       T
Sbjct: 126 LIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMT 176
Query: 85  MTMATIGYMAPEYGSEGI-VSAKCDVYSYGVLLMETFT 121
             +AT  Y APE     +  +   D++S G ++ E  T
Sbjct: 177 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 214

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 40.8 bits (94), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 50/98 (51%), Gaps = 10/98 (10%)
Query: 25  IMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQT 84
           ++  +   L+Y H    SA IIH DLKP+N+ ++E+    + DFG+++   +       T
Sbjct: 135 LIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMT 185
Query: 85  MTMATIGYMAPEYGSEGI-VSAKCDVYSYGVLLMETFT 121
             +AT  Y APE     +  +   D++S G ++ E  T
Sbjct: 186 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 223

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 40.8 bits (94), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 50/98 (51%), Gaps = 10/98 (10%)
Query: 25  IMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQT 84
           ++  +   L+Y H    SA IIH DLKP+N+ ++E+    + DFG+++   +       T
Sbjct: 129 LIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMT 179
Query: 85  MTMATIGYMAPEYGSEGI-VSAKCDVYSYGVLLMETFT 121
             +AT  Y APE     +  +   D++S G ++ E  T
Sbjct: 180 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 217

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 40.8 bits (94), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 50/98 (51%), Gaps = 10/98 (10%)
Query: 25  IMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQT 84
           ++  +   L+Y H    SA IIH DLKP+N+ ++E+    + DFG+++   +       T
Sbjct: 130 LIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMT 180
Query: 85  MTMATIGYMAPEYGSEGI-VSAKCDVYSYGVLLMETFT 121
             +AT  Y APE     +  +   D++S G ++ E  T
Sbjct: 181 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 40.8 bits (94), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 30/77 (38%), Positives = 43/77 (55%), Gaps = 7/77 (9%)
Query: 45  IIHCDLKPTNILLD-ENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPE--YGSEG 101
           I H D+KP N+LLD +  V  + DFG +K L  GE  V+    + +  Y APE  +G+  
Sbjct: 143 ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYRAPELIFGATD 199
Query: 102 IVSAKCDVYSYGVLLME 118
             S+  DV+S G +L E
Sbjct: 200 YTSS-IDVWSAGCVLAE 215

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 40.4 bits (93), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 78/196 (39%), Gaps = 25/196 (12%)
Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           +  G L   + + +Y     E +N M      L++ H  HS   I+H D+KP NI+ +  
Sbjct: 130 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE-HS---IVHLDIKPENIMCETK 185
Query: 61  MVAHVS--DFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLME 118
             + V   DFG++  L   E      +T AT  + APE      V    D+++ GVL   
Sbjct: 186 KASSVKIIDFGLATKLNPDE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYV 242
Query: 119 TFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLAL 178
             +   P    F GE  L           L  V   +   +E AF++         D   
Sbjct: 243 LLSGLSP----FAGEDDLE---------TLQNVKRCDWEFDEDAFSS---VSPEAKDFIK 286
Query: 179 DCCMESPGKRINMTDA 194
           +   + P KR+ + DA
Sbjct: 287 NLLQKEPRKRLTVHDA 302

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 40.4 bits (93), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 50/98 (51%), Gaps = 10/98 (10%)
Query: 25  IMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQT 84
           ++  +   L+Y H    SA IIH DLKP+N+ ++E+    + DFG+++   +       T
Sbjct: 127 LIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMT 177
Query: 85  MTMATIGYMAPEYGSEGI-VSAKCDVYSYGVLLMETFT 121
             +AT  Y APE     +  +   D++S G ++ E  T
Sbjct: 178 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 215

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 40.4 bits (93), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 50/98 (51%), Gaps = 10/98 (10%)
Query: 25  IMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQT 84
           ++  +   L+Y H    SA IIH DLKP+N+ ++E+    + DFG+++   +       T
Sbjct: 130 LIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMT 180
Query: 85  MTMATIGYMAPEYGSEGI-VSAKCDVYSYGVLLMETFT 121
             +AT  Y APE     +  +   D++S G ++ E  T
Sbjct: 181 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 40.4 bits (93), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 50/98 (51%), Gaps = 10/98 (10%)
Query: 25  IMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQT 84
           ++  +   L+Y H    SA IIH DLKP+N+ ++E+    + DFG+++   +       T
Sbjct: 132 LIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMT 182
Query: 85  MTMATIGYMAPEYGSEGI-VSAKCDVYSYGVLLMETFT 121
             +AT  Y APE     +  +   D++S G ++ E  T
Sbjct: 183 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 220

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 40.4 bits (93), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 50/98 (51%), Gaps = 10/98 (10%)
Query: 25  IMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQT 84
           ++  +   L+Y H    SA IIH DLKP+N+ ++E+    + DFG+++   +       T
Sbjct: 130 LIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMT 180
Query: 85  MTMATIGYMAPEYGSEGI-VSAKCDVYSYGVLLMETFT 121
             +AT  Y APE     +  +   D++S G ++ E  T
Sbjct: 181 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 40.4 bits (93), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 50/98 (51%), Gaps = 10/98 (10%)
Query: 25  IMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQT 84
           ++  +   L+Y H    SA IIH DLKP+N+ ++E+    + DFG+++   +       T
Sbjct: 127 LIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMT 177
Query: 85  MTMATIGYMAPEYGSEGI-VSAKCDVYSYGVLLMETFT 121
             +AT  Y APE     +  +   D++S G ++ E  T
Sbjct: 178 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 215

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 40.4 bits (93), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 50/98 (51%), Gaps = 10/98 (10%)
Query: 25  IMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQT 84
           ++  +   L+Y H    SA IIH DLKP+N+ ++E+    + DFG+++   +       T
Sbjct: 130 LIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMT 180
Query: 85  MTMATIGYMAPEYGSEGI-VSAKCDVYSYGVLLMETFT 121
             +AT  Y APE     +  +   D++S G ++ E  T
Sbjct: 181 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 40.4 bits (93), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 50/98 (51%), Gaps = 10/98 (10%)
Query: 25  IMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQT 84
           ++  +   L+Y H    SA IIH DLKP+N+ ++E+    + DFG+++   +       T
Sbjct: 137 LIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMT 187
Query: 85  MTMATIGYMAPEYGSEGI-VSAKCDVYSYGVLLMETFT 121
             +AT  Y APE     +  +   D++S G ++ E  T
Sbjct: 188 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 225

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 40.4 bits (93), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 50/98 (51%), Gaps = 10/98 (10%)
Query: 25  IMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQT 84
           ++  +   L+Y H    SA IIH DLKP+N+ ++E+    + DFG+++   +       T
Sbjct: 136 LIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMT 186
Query: 85  MTMATIGYMAPEYGSEGI-VSAKCDVYSYGVLLMETFT 121
             +AT  Y APE     +  +   D++S G ++ E  T
Sbjct: 187 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 224

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 40.4 bits (93), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 50/98 (51%), Gaps = 10/98 (10%)
Query: 25  IMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQT 84
           ++  +   L+Y H    SA IIH DLKP+N+ ++E+    + DFG+++   +       T
Sbjct: 130 LIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMT 180
Query: 85  MTMATIGYMAPEYGSEGI-VSAKCDVYSYGVLLMETFT 121
             +AT  Y APE     +  +   D++S G ++ E  T
Sbjct: 181 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 40.4 bits (93), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 50/98 (51%), Gaps = 10/98 (10%)
Query: 25  IMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQT 84
           ++  +   L+Y H    SA IIH DLKP+N+ ++E+    + DFG+++   +       T
Sbjct: 130 LIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMT 180
Query: 85  MTMATIGYMAPEYGSEGI-VSAKCDVYSYGVLLMETFT 121
             +AT  Y APE     +  +   D++S G ++ E  T
Sbjct: 181 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 40.4 bits (93), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 50/98 (51%), Gaps = 10/98 (10%)
Query: 25  IMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQT 84
           ++  +   L+Y H    SA IIH DLKP+N+ ++E+    + DFG+++   +       T
Sbjct: 142 LIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMT 192
Query: 85  MTMATIGYMAPEYGSEGI-VSAKCDVYSYGVLLMETFT 121
             +AT  Y APE     +  +   D++S G ++ E  T
Sbjct: 193 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 230

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 40.4 bits (93), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 50/98 (51%), Gaps = 10/98 (10%)
Query: 25  IMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQT 84
           ++  +   L+Y H    SA IIH DLKP+N+ ++E+    + DFG+++   +       T
Sbjct: 136 LIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMT 186
Query: 85  MTMATIGYMAPEYGSEGI-VSAKCDVYSYGVLLMETFT 121
             +AT  Y APE     +  +   D++S G ++ E  T
Sbjct: 187 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 224

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 40.4 bits (93), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 50/98 (51%), Gaps = 10/98 (10%)
Query: 25  IMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQT 84
           ++  +   L+Y H    SA IIH DLKP+N+ ++E+    + DFG+++   +       T
Sbjct: 135 LIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMT 185
Query: 85  MTMATIGYMAPEYGSEGI-VSAKCDVYSYGVLLMETFT 121
             +AT  Y APE     +  +   D++S G ++ E  T
Sbjct: 186 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 223

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 40.4 bits (93), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 50/98 (51%), Gaps = 10/98 (10%)
Query: 25  IMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQT 84
           ++  +   L+Y H    SA IIH DLKP+N+ ++E+    + DFG+++   +       T
Sbjct: 132 LIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMT 182
Query: 85  MTMATIGYMAPEYGSEGI-VSAKCDVYSYGVLLMETFT 121
             +AT  Y APE     +  +   D++S G ++ E  T
Sbjct: 183 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 220

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 40.4 bits (93), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 50/98 (51%), Gaps = 10/98 (10%)
Query: 25  IMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQT 84
           ++  +   L+Y H    SA IIH DLKP+N+ ++E+    + DFG+++   +       T
Sbjct: 142 LIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMT 192
Query: 85  MTMATIGYMAPEYGSEGI-VSAKCDVYSYGVLLMETFT 121
             +AT  Y APE     +  +   D++S G ++ E  T
Sbjct: 193 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 230

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 40.4 bits (93), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 23/64 (35%), Positives = 33/64 (51%), Gaps = 2/64 (3%)
Query: 33  LEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGY 92
           LE  H  H    I+H DLKP N L+ + M+  + DFGI+  +      V +   + T+ Y
Sbjct: 137 LEAVHTIHQHG-IVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDXXXVVKDSQVGTVNY 194
Query: 93  MAPE 96
           M PE
Sbjct: 195 MPPE 198

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 40.4 bits (93), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 50/98 (51%), Gaps = 10/98 (10%)
Query: 25  IMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQT 84
           ++  +   L+Y H    SA IIH DLKP+N+ ++E+    + DFG+++   +       T
Sbjct: 142 LIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMT 192
Query: 85  MTMATIGYMAPEYGSEGI-VSAKCDVYSYGVLLMETFT 121
             +AT  Y APE     +  +   D++S G ++ E  T
Sbjct: 193 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 230

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 40.4 bits (93), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 34/111 (30%), Positives = 49/111 (44%), Gaps = 14/111 (12%)
Query: 31  SALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATI 90
           SA++Y H       I+H DLK  N+LLD +    ++DFG S       +F       A  
Sbjct: 124 SAVQYCHQKF----IVHRDLKAENLLLDADXNIKIADFGFS------NEFTFGNKLDAFC 173
Query: 91  G---YMAPE-YGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLR 137
           G   Y APE +  +     + DV+S GV+L    +   P D     E+  R
Sbjct: 174 GAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRER 224

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 40.4 bits (93), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 50/98 (51%), Gaps = 10/98 (10%)
Query: 25  IMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQT 84
           ++  +   L+Y H    SA IIH DLKP+N+ ++E+    + DFG+++   +       T
Sbjct: 130 LIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMT 180
Query: 85  MTMATIGYMAPEYGSEGI-VSAKCDVYSYGVLLMETFT 121
             +AT  Y APE     +  +   D++S G ++ E  T
Sbjct: 181 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 40.4 bits (93), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 50/98 (51%), Gaps = 10/98 (10%)
Query: 25  IMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQT 84
           ++  +   L+Y H    SA IIH DLKP+N+ ++E+    + DFG+++   +       T
Sbjct: 140 LIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMT 190
Query: 85  MTMATIGYMAPEYGSEGI-VSAKCDVYSYGVLLMETFT 121
             +AT  Y APE     +  +   D++S G ++ E  T
Sbjct: 191 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 228

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 40.4 bits (93), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 50/98 (51%), Gaps = 10/98 (10%)
Query: 25  IMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQT 84
           ++  +   L+Y H    SA IIH DLKP+N+ ++E+    + DFG+++   +       T
Sbjct: 128 LIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMT 178
Query: 85  MTMATIGYMAPEYGSEGI-VSAKCDVYSYGVLLMETFT 121
             +AT  Y APE     +  +   D++S G ++ E  T
Sbjct: 179 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 216

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 40.4 bits (93), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 50/98 (51%), Gaps = 10/98 (10%)
Query: 25  IMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQT 84
           ++  +   L+Y H    SA IIH DLKP+N+ ++E+    + DFG+++   +       T
Sbjct: 126 LIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMT 176
Query: 85  MTMATIGYMAPEYGSEGI-VSAKCDVYSYGVLLMETFT 121
             +AT  Y APE     +  +   D++S G ++ E  T
Sbjct: 177 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 214

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 40.4 bits (93), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 50/98 (51%), Gaps = 10/98 (10%)
Query: 25  IMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQT 84
           ++  +   L+Y H    SA IIH DLKP+N+ ++E+    + DFG+++   +       T
Sbjct: 130 LIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMT 180
Query: 85  MTMATIGYMAPEYGSEGI-VSAKCDVYSYGVLLMETFT 121
             +AT  Y APE     +  +   D++S G ++ E  T
Sbjct: 181 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 40.4 bits (93), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 50/98 (51%), Gaps = 10/98 (10%)
Query: 25  IMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQT 84
           ++  +   L+Y H    SA IIH DLKP+N+ ++E+    + DFG+++   +       T
Sbjct: 149 LIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMT 199
Query: 85  MTMATIGYMAPEYGSEGI-VSAKCDVYSYGVLLMETFT 121
             +AT  Y APE     +  +   D++S G ++ E  T
Sbjct: 200 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 237

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 40.4 bits (93), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 50/98 (51%), Gaps = 10/98 (10%)
Query: 25  IMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQT 84
           ++  +   L+Y H    SA IIH DLKP+N+ ++E+    + DFG+++   +       T
Sbjct: 136 LIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMT 186
Query: 85  MTMATIGYMAPEYGSEGI-VSAKCDVYSYGVLLMETFT 121
             +AT  Y APE     +  +   D++S G ++ E  T
Sbjct: 187 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 224

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 40.4 bits (93), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 50/98 (51%), Gaps = 10/98 (10%)
Query: 25  IMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQT 84
           ++  +   L+Y H    SA IIH DLKP+N+ ++E+    + DFG+++   +       T
Sbjct: 150 LIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMT 200
Query: 85  MTMATIGYMAPEYGSEGI-VSAKCDVYSYGVLLMETFT 121
             +AT  Y APE     +  +   D++S G ++ E  T
Sbjct: 201 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 238

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 40.4 bits (93), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 50/98 (51%), Gaps = 10/98 (10%)
Query: 25  IMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQT 84
           ++  +   L+Y H    SA IIH DLKP+N+ ++E+    + DFG+++   +       T
Sbjct: 126 LIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMT 176
Query: 85  MTMATIGYMAPEYGSEGI-VSAKCDVYSYGVLLMETFT 121
             +AT  Y APE     +  +   D++S G ++ E  T
Sbjct: 177 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 214

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 40.4 bits (93), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 50/98 (51%), Gaps = 10/98 (10%)
Query: 25  IMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQT 84
           ++  +   L+Y H    SA IIH DLKP+N+ ++E+    + DFG+++   +       T
Sbjct: 132 LIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMT 182
Query: 85  MTMATIGYMAPEYGSEGI-VSAKCDVYSYGVLLMETFT 121
             +AT  Y APE     +  +   D++S G ++ E  T
Sbjct: 183 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 220

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 40.4 bits (93), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 50/98 (51%), Gaps = 10/98 (10%)
Query: 25  IMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQT 84
           ++  +   L+Y H    SA IIH DLKP+N+ ++E+    + DFG+++   +       T
Sbjct: 150 LIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMT 200
Query: 85  MTMATIGYMAPEYGSEGI-VSAKCDVYSYGVLLMETFT 121
             +AT  Y APE     +  +   D++S G ++ E  T
Sbjct: 201 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 238

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 40.4 bits (93), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 50/98 (51%), Gaps = 10/98 (10%)
Query: 25  IMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQT 84
           ++  +   L+Y H    SA IIH DLKP+N+ ++E+    + DFG+++   +       T
Sbjct: 149 LIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMT 199
Query: 85  MTMATIGYMAPEYGSEGI-VSAKCDVYSYGVLLMETFT 121
             +AT  Y APE     +  +   D++S G ++ E  T
Sbjct: 200 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 237

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 40.4 bits (93), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 43/88 (48%), Gaps = 11/88 (12%)
Query: 32  ALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTM-ATI 90
             EY H    S  +I+ DLKP N+L+D+     V+DFG +K +        +T  +  T 
Sbjct: 148 TFEYLH----SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK------GRTWXLCGTP 197
Query: 91  GYMAPEYGSEGIVSAKCDVYSYGVLLME 118
            Y+APE       +   D ++ GVL+ E
Sbjct: 198 EYLAPEIILSKGYNKAVDWWALGVLIYE 225

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 40.4 bits (93), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 28/92 (30%), Positives = 43/92 (46%), Gaps = 10/92 (10%)
Query: 45  IIHCDLKPTNILLDENMV---AHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEG 101
           I+H DLKP NILL          + DFG+S+ +G   +       M T  Y+APE  +  
Sbjct: 152 IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACEL---REIMGTPEYLAPEILNYD 208
Query: 102 IVSAKCDVYSYGVLLMETFTRKRPTDEMFTGE 133
            ++   D+++ G++     T   P    F GE
Sbjct: 209 PITTATDMWNIGIIAYMLLTHTSP----FVGE 236

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 40.4 bits (93), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 50/98 (51%), Gaps = 10/98 (10%)
Query: 25  IMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQT 84
           ++  +   L+Y H    SA IIH DLKP+N+ ++E+    + DFG+++   +       T
Sbjct: 153 LIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMT 203
Query: 85  MTMATIGYMAPEYGSEGI-VSAKCDVYSYGVLLMETFT 121
             +AT  Y APE     +  +   D++S G ++ E  T
Sbjct: 204 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 241

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 40.4 bits (93), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 43/87 (49%), Gaps = 11/87 (12%)
Query: 33  LEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTM-ATIG 91
            EY H    S  +I+ DLKP N+L+D+     V+DFG +K +        +T  +  T  
Sbjct: 154 FEYLH----SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK------GRTWXLCGTPE 203
Query: 92  YMAPEYGSEGIVSAKCDVYSYGVLLME 118
           Y+APE       +   D ++ GVL+ E
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYE 230

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 40.4 bits (93), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 43/87 (49%), Gaps = 11/87 (12%)
Query: 33  LEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTM-ATIG 91
            EY H    S  +I+ DLKP N+L+D+     V+DFG +K +        +T  +  T  
Sbjct: 154 FEYLH----SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK------GRTWXLCGTPE 203
Query: 92  YMAPEYGSEGIVSAKCDVYSYGVLLME 118
           Y+APE       +   D ++ GVL+ E
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYE 230

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 40.4 bits (93), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 43/87 (49%), Gaps = 11/87 (12%)
Query: 33  LEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTM-ATIG 91
            EY H    S  +I+ DLKP N+L+D+     V+DFG +K +        +T  +  T  
Sbjct: 154 FEYLH----SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK------GRTWXLCGTPE 203
Query: 92  YMAPEYGSEGIVSAKCDVYSYGVLLME 118
           Y+APE       +   D ++ GVL+ E
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYE 230

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 40.4 bits (93), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 43/87 (49%), Gaps = 11/87 (12%)
Query: 33  LEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTM-ATIG 91
            EY H    S  +I+ DLKP N+L+D+     V+DFG +K +        +T  +  T  
Sbjct: 154 FEYLH----SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK------GRTWXLCGTPE 203
Query: 92  YMAPEYGSEGIVSAKCDVYSYGVLLME 118
           Y+APE       +   D ++ GVL+ E
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYE 230

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 40.4 bits (93), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 43/87 (49%), Gaps = 11/87 (12%)
Query: 33  LEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTM-ATIG 91
            EY H    S  +I+ DLKP N+L+D+     V+DFG +K +        +T  +  T  
Sbjct: 154 FEYLH----SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK------GRTWXLCGTPE 203
Query: 92  YMAPEYGSEGIVSAKCDVYSYGVLLME 118
           Y+APE       +   D ++ GVL+ E
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYE 230

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 40.4 bits (93), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 28/86 (32%), Positives = 43/86 (50%), Gaps = 9/86 (10%)
Query: 33  LEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGY 92
            EY H    S  +I+ DLKP N+L+D+     V+DFG +K + +G  +        T  Y
Sbjct: 154 FEYLH----SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGRTW----XLCGTPEY 204
Query: 93  MAPEYGSEGIVSAKCDVYSYGVLLME 118
           +APE       +   D ++ GVL+ E
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYE 230

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 40.4 bits (93), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 30/82 (36%), Positives = 40/82 (48%), Gaps = 4/82 (4%)
Query: 45  IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGE-DFVTQTMTMATIGYMAPEYGSEGIV 103
           II+ DLK  N+LLD      ++DFG+ K   EG  + VT      T  Y+APE   E + 
Sbjct: 145 IIYRDLKLDNVLLDHEGHCKLADFGMCK---EGICNGVTTATFCGTPDYIAPEILQEMLY 201
Query: 104 SAKCDVYSYGVLLMETFTRKRP 125
               D ++ GVLL E      P
Sbjct: 202 GPAVDWWAMGVLLYEMLCGHAP 223

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 40.4 bits (93), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 44/94 (46%), Gaps = 6/94 (6%)
Query: 32  ALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIG 91
            LEY H        IH D+K  NILL+    A ++DFG++  L   +    +   + T  
Sbjct: 137 GLEYLHFMRK----IHRDIKAGNILLNTEGHAKLADFGVAGQL--TDXMAKRNXVIGTPF 190
Query: 92  YMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRP 125
           +MAPE   E   +   D++S G+  +E    K P
Sbjct: 191 WMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPP 224

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 40.4 bits (93), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 43/87 (49%), Gaps = 11/87 (12%)
Query: 33  LEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTM-ATIG 91
            EY H    S  +I+ DLKP N+L+D+     V+DFG +K +        +T  +  T  
Sbjct: 154 FEYLH----SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK------GRTWXLCGTPE 203
Query: 92  YMAPEYGSEGIVSAKCDVYSYGVLLME 118
           Y+APE       +   D ++ GVL+ E
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYE 230

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 40.4 bits (93), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 43/88 (48%), Gaps = 11/88 (12%)
Query: 32  ALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTM-ATI 90
             EY H    S  +I+ DLKP N+L+D+     V+DFG +K +        +T  +  T 
Sbjct: 146 TFEYLH----SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK------GRTWXLCGTP 195
Query: 91  GYMAPEYGSEGIVSAKCDVYSYGVLLME 118
            Y+APE       +   D ++ GVL+ E
Sbjct: 196 EYLAPEIILSKGYNKAVDWWALGVLIYE 223

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 40.4 bits (93), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 28/86 (32%), Positives = 43/86 (50%), Gaps = 9/86 (10%)
Query: 33  LEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGY 92
            EY H    S  +I+ DLKP N+L+D+     V+DFG +K + +G  +        T  Y
Sbjct: 155 FEYLH----SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGRTW----XLCGTPEY 205
Query: 93  MAPEYGSEGIVSAKCDVYSYGVLLME 118
           +APE       +   D ++ GVL+ E
Sbjct: 206 LAPEIILSKGYNKAVDWWALGVLIYE 231

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 40.4 bits (93), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 43/87 (49%), Gaps = 11/87 (12%)
Query: 33  LEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTM-ATIG 91
            EY H    S  +I+ DLKP N+L+D+     V+DFG +K +        +T  +  T  
Sbjct: 154 FEYLH----SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK------GRTWXLCGTPE 203
Query: 92  YMAPEYGSEGIVSAKCDVYSYGVLLME 118
           Y+APE       +   D ++ GVL+ E
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYE 230

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 40.4 bits (93), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 30/104 (28%), Positives = 47/104 (45%), Gaps = 8/104 (7%)
Query: 38  HGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEY 97
           H HS+  IIH DLKP+NI++  +    + DFG+++  G        T  + T  Y APE 
Sbjct: 141 HLHSAG-IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPEVVTRYYRAPEV 196
Query: 98  GSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVK 141
                     D++S G ++ E          +F G   + +W K
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMIK----GGVLFPGTDHIDQWNK 236

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 40.4 bits (93), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 43/87 (49%), Gaps = 11/87 (12%)
Query: 33  LEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTM-ATIG 91
            EY H    S  +I+ DLKP N+L+D+     V+DFG +K +        +T  +  T  
Sbjct: 154 FEYLH----SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK------GRTWXLCGTPE 203
Query: 92  YMAPEYGSEGIVSAKCDVYSYGVLLME 118
           Y+APE       +   D ++ GVL+ E
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYE 230

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 40.4 bits (93), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 43/87 (49%), Gaps = 11/87 (12%)
Query: 33  LEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTM-ATIG 91
            EY H    S  +I+ DLKP N+L+D+     V+DFG +K +        +T  +  T  
Sbjct: 154 FEYLH----SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK------GRTWXLCGTPE 203
Query: 92  YMAPEYGSEGIVSAKCDVYSYGVLLME 118
           Y+APE       +   D ++ GVL+ E
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYE 230

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 40.4 bits (93), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 43/87 (49%), Gaps = 11/87 (12%)
Query: 33  LEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTM-ATIG 91
            EY H    S  +I+ DLKP N+L+D+     V+DFG +K +        +T  +  T  
Sbjct: 155 FEYLH----SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK------GRTWXLCGTPE 204
Query: 92  YMAPEYGSEGIVSAKCDVYSYGVLLME 118
           Y+APE       +   D ++ GVL+ E
Sbjct: 205 YLAPEIILSKGYNKAVDWWALGVLIYE 231

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 40.4 bits (93), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 43/87 (49%), Gaps = 11/87 (12%)
Query: 33  LEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTM-ATIG 91
            EY H    S  +I+ DLKP N+L+D+     V+DFG +K +        +T  +  T  
Sbjct: 154 FEYLH----SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK------GRTWXLCGTPE 203
Query: 92  YMAPEYGSEGIVSAKCDVYSYGVLLME 118
           Y+APE       +   D ++ GVL+ E
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYE 230

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 40.0 bits (92), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 43/87 (49%), Gaps = 11/87 (12%)
Query: 33  LEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTM-ATIG 91
            EY H    S  +I+ DLKP N+L+D+     V+DFG +K +        +T  +  T  
Sbjct: 154 FEYLH----SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK------GRTWXLCGTPE 203
Query: 92  YMAPEYGSEGIVSAKCDVYSYGVLLME 118
           Y+APE       +   D ++ GVL+ E
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYE 230

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 40.0 bits (92), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 28/86 (32%), Positives = 43/86 (50%), Gaps = 9/86 (10%)
Query: 33  LEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGY 92
            EY H    S  +I+ DLKP N+L+D+     V+DFG +K + +G  +        T  Y
Sbjct: 154 FEYLH----SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGRTW----XLCGTPEY 204
Query: 93  MAPEYGSEGIVSAKCDVYSYGVLLME 118
           +APE       +   D ++ GVL+ E
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYE 230

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 40.0 bits (92), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 43/87 (49%), Gaps = 11/87 (12%)
Query: 33  LEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTM-ATIG 91
            EY H    S  +I+ DLKP N+L+D+     V+DFG +K +        +T  +  T  
Sbjct: 154 FEYLH----SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK------GRTWXLCGTPE 203
Query: 92  YMAPEYGSEGIVSAKCDVYSYGVLLME 118
           Y+APE       +   D ++ GVL+ E
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYE 230

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 40.0 bits (92), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 28/86 (32%), Positives = 43/86 (50%), Gaps = 9/86 (10%)
Query: 33  LEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGY 92
            EY H    S  +I+ DLKP N+L+D+     V+DFG +K + +G  +        T  Y
Sbjct: 154 FEYLH----SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGRTW----XLCGTPEY 204
Query: 93  MAPEYGSEGIVSAKCDVYSYGVLLME 118
           +APE       +   D ++ GVL+ E
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYE 230

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 40.0 bits (92), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 43/87 (49%), Gaps = 11/87 (12%)
Query: 33  LEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTM-ATIG 91
            EY H    S  +I+ DLKP N+L+D+     V+DFG +K +        +T  +  T  
Sbjct: 154 FEYLH----SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK------GRTWXLCGTPE 203
Query: 92  YMAPEYGSEGIVSAKCDVYSYGVLLME 118
           Y+APE       +   D ++ GVL+ E
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYE 230

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 40.0 bits (92), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 43/87 (49%), Gaps = 11/87 (12%)
Query: 33  LEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTM-ATIG 91
            EY H    S  +I+ DLKP N+L+D+     V+DFG +K +        +T  +  T  
Sbjct: 154 FEYLH----SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK------GRTWXLCGTPE 203
Query: 92  YMAPEYGSEGIVSAKCDVYSYGVLLME 118
           Y+APE       +   D ++ GVL+ E
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYE 230

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 40.0 bits (92), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 43/87 (49%), Gaps = 11/87 (12%)
Query: 33  LEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTM-ATIG 91
            EY H    S  +I+ DLKP N+L+D+     V+DFG +K +        +T  +  T  
Sbjct: 154 FEYLH----SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK------GRTWXLCGTPE 203
Query: 92  YMAPEYGSEGIVSAKCDVYSYGVLLME 118
           Y+APE       +   D ++ GVL+ E
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYE 230

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 40.0 bits (92), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 43/87 (49%), Gaps = 11/87 (12%)
Query: 33  LEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTM-ATIG 91
            EY H    S  +I+ DLKP N+L+D+     V+DFG +K +        +T  +  T  
Sbjct: 155 FEYLH----SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK------GRTWXLCGTPE 204
Query: 92  YMAPEYGSEGIVSAKCDVYSYGVLLME 118
           Y+APE       +   D ++ GVL+ E
Sbjct: 205 YLAPEIILSKGYNKAVDWWALGVLIYE 231

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 40.0 bits (92), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 43/87 (49%), Gaps = 11/87 (12%)
Query: 33  LEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTM-ATIG 91
            EY H    S  +I+ DLKP N+L+D+     V+DFG +K +        +T  +  T  
Sbjct: 155 FEYLH----SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK------GRTWXLCGTPE 204
Query: 92  YMAPEYGSEGIVSAKCDVYSYGVLLME 118
           Y+APE       +   D ++ GVL+ E
Sbjct: 205 YLAPEIILSKGYNKAVDWWALGVLIYE 231

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 40.0 bits (92), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 43/87 (49%), Gaps = 11/87 (12%)
Query: 33  LEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTM-ATIG 91
            EY H    S  +I+ DLKP N+L+D+     V+DFG +K +        +T  +  T  
Sbjct: 155 FEYLH----SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK------GRTWXLCGTPE 204
Query: 92  YMAPEYGSEGIVSAKCDVYSYGVLLME 118
           Y+APE       +   D ++ GVL+ E
Sbjct: 205 YLAPEIILSKGYNKAVDWWALGVLIYE 231

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 40.0 bits (92), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 30/104 (28%), Positives = 47/104 (45%), Gaps = 8/104 (7%)
Query: 38  HGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEY 97
           H HS+  IIH DLKP+NI++  +    + DFG+++  G        T  + T  Y APE 
Sbjct: 141 HLHSAG-IIHRDLKPSNIVVKSDATLKILDFGLARTAGTS---FMMTPYVVTRYYRAPEV 196
Query: 98  GSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVK 141
                     D++S G ++ E          +F G   + +W K
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMIK----GGVLFPGTDHIDQWNK 236

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 40.0 bits (92), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 43/87 (49%), Gaps = 11/87 (12%)
Query: 33  LEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTM-ATIG 91
            EY H    S  +I+ DLKP N+L+D+     V+DFG +K +        +T  +  T  
Sbjct: 155 FEYLH----SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK------GRTWXLCGTPE 204
Query: 92  YMAPEYGSEGIVSAKCDVYSYGVLLME 118
           Y+APE       +   D ++ GVL+ E
Sbjct: 205 YLAPEIILSKGYNKAVDWWALGVLIYE 231

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 40.0 bits (92), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 43/88 (48%), Gaps = 11/88 (12%)
Query: 32  ALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTM-ATI 90
             EY H    S  +I+ DLKP N+L+D+     V+DFG +K +        +T  +  T 
Sbjct: 146 TFEYLH----SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK------GRTWXLCGTP 195
Query: 91  GYMAPEYGSEGIVSAKCDVYSYGVLLME 118
            Y+APE       +   D ++ GVL+ E
Sbjct: 196 EYLAPEIILSKGYNKAVDWWALGVLIYE 223

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 40.0 bits (92), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 23/64 (35%), Positives = 33/64 (51%), Gaps = 2/64 (3%)
Query: 33  LEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGY 92
           LE  H  H    I+H DLKP N L+ + M+  + DFGI+  +      V +   + T+ Y
Sbjct: 117 LEAVHTIHQHG-IVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDTTSVVKDSQVGTVNY 174
Query: 93  MAPE 96
           M PE
Sbjct: 175 MPPE 178

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 40.0 bits (92), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 23/64 (35%), Positives = 33/64 (51%), Gaps = 2/64 (3%)
Query: 33  LEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGY 92
           LE  H  H    I+H DLKP N L+ + M+  + DFGI+  +      V +   + T+ Y
Sbjct: 121 LEAVHTIHQHG-IVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDTTSVVKDSQVGTVNY 178
Query: 93  MAPE 96
           M PE
Sbjct: 179 MPPE 182

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 40.0 bits (92), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 28/86 (32%), Positives = 43/86 (50%), Gaps = 9/86 (10%)
Query: 33  LEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGY 92
            EY H    S  +I+ DLKP N+L+D+     V+DFG +K + +G  +        T  Y
Sbjct: 175 FEYLH----SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGRTW----XLCGTPEY 225
Query: 93  MAPEYGSEGIVSAKCDVYSYGVLLME 118
           +APE       +   D ++ GVL+ E
Sbjct: 226 LAPEIILSKGYNKAVDWWALGVLIYE 251

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 40.0 bits (92), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 23/64 (35%), Positives = 33/64 (51%), Gaps = 2/64 (3%)
Query: 33  LEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGY 92
           LE  H  H    I+H DLKP N L+ + M+  + DFGI+  +      V +   + T+ Y
Sbjct: 137 LEAVHTIHQHG-IVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDTTSVVKDSQVGTVNY 194
Query: 93  MAPE 96
           M PE
Sbjct: 195 MPPE 198

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 40.0 bits (92), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 23/64 (35%), Positives = 33/64 (51%), Gaps = 2/64 (3%)
Query: 33  LEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGY 92
           LE  H  H    I+H DLKP N L+ + M+  + DFGI+  +      V +   + T+ Y
Sbjct: 118 LEAVHTIHQHG-IVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDTTSVVKDSQVGTVNY 175
Query: 93  MAPE 96
           M PE
Sbjct: 176 MPPE 179

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 40.0 bits (92), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 30/104 (28%), Positives = 47/104 (45%), Gaps = 8/104 (7%)
Query: 38  HGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEY 97
           H HS+  IIH DLKP+NI++  +    + DFG+++  G        T  + T  Y APE 
Sbjct: 141 HLHSAG-IIHRDLKPSNIVVKSDATLKILDFGLARTAGTS---FMMTPYVVTRYYRAPEV 196
Query: 98  GSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVK 141
                     D++S G ++ E          +F G   + +W K
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMIK----GGVLFPGTDHIDQWNK 236

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 40.0 bits (92), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 28/86 (32%), Positives = 43/86 (50%), Gaps = 9/86 (10%)
Query: 33  LEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGY 92
            EY H    S  +I+ DLKP N+L+D+     V+DFG +K + +G  +        T  Y
Sbjct: 175 FEYLH----SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGRTW----XLCGTPEY 225
Query: 93  MAPEYGSEGIVSAKCDVYSYGVLLME 118
           +APE       +   D ++ GVL+ E
Sbjct: 226 LAPEIILSKGYNKAVDWWALGVLIYE 251

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 40.0 bits (92), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 31/115 (26%), Positives = 50/115 (43%), Gaps = 22/115 (19%)
Query: 17  FDILERLNI-------------MIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVA 63
            DI ER+N              +  V  AL++ H    S  I H D++P NI+      +
Sbjct: 86  LDIFERINTSAFELNEREIVSYVHQVCEALQFLH----SHNIGHFDIRPENIIYQTRRSS 141
Query: 64  HVS--DFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLL 116
            +   +FG ++ L  G++F    +      Y APE     +VS   D++S G L+
Sbjct: 142 TIKIIEFGQARQLKPGDNF---RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLV 193

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 40.0 bits (92), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 23/64 (35%), Positives = 33/64 (51%), Gaps = 2/64 (3%)
Query: 33  LEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGY 92
           LE  H  H    I+H DLKP N L+ + M+  + DFGI+  +      V +   + T+ Y
Sbjct: 165 LEAVHTIHQHG-IVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDTTSVVKDSQVGTVNY 222
Query: 93  MAPE 96
           M PE
Sbjct: 223 MPPE 226

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 40.0 bits (92), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 23/64 (35%), Positives = 33/64 (51%), Gaps = 2/64 (3%)
Query: 33  LEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGY 92
           LE  H  H    I+H DLKP N L+ + M+  + DFGI+  +      V +   + T+ Y
Sbjct: 165 LEAVHTIHQHG-IVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDTTSVVKDSQVGTVNY 222
Query: 93  MAPE 96
           M PE
Sbjct: 223 MPPE 226

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 40.0 bits (92), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 30/104 (28%), Positives = 47/104 (45%), Gaps = 8/104 (7%)
Query: 38  HGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEY 97
           H HS+  IIH DLKP+NI++  +    + DFG+++  G        T  + T  Y APE 
Sbjct: 141 HLHSAG-IIHRDLKPSNIVVKSDATLKILDFGLARTAGTS---FMMTPYVVTRYYRAPEV 196
Query: 98  GSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVK 141
                     D++S G ++ E          +F G   + +W K
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMIK----GGVLFPGTDHIDQWNK 236

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	202
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-51
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	4e-51
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	8e-46
3soc_A	322	Activin receptor type-2A; structural genomics cons	8e-40
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	7e-37
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	3e-36
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	5e-36
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	1e-35
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	4e-34
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	4e-33
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	1e-32
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	6e-32
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	2e-31
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	8e-31
3q4u_A	301	Activin receptor type-1; structural genomics conso	5e-30
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	6e-30
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	1e-27
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	4e-27
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	2e-26
3ork_A	311	Serine/threonine protein kinase; structural genomi	3e-26
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	1e-24
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	9e-24
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	9e-22
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	4e-21
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	5e-21
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	1e-20
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	1e-20
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	2e-20
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	2e-20
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	2e-20
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	2e-20
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	3e-20
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	4e-20
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	4e-20
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	5e-20
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	6e-20
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	6e-20
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	7e-20
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	8e-20
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	8e-20
2a19_B	284	Interferon-induced, double-stranded RNA-activated	1e-19
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	1e-19
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	1e-19
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	2e-19
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	2e-19
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	2e-19
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	3e-19
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	3e-19
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	3e-19
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	3e-19
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	4e-19
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	4e-19
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	7e-19
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	7e-19
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	8e-19
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	9e-19
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	1e-18
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	1e-18
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	1e-18
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	2e-18
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	2e-18
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	2e-18
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	3e-18
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	4e-18
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	7e-18
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	8e-18
3pls_A	298	Macrophage-stimulating protein receptor; protein k	1e-17
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	2e-17
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	2e-17
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	6e-17
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	1e-16
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	1e-16
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	1e-16
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	1e-16
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	3e-16
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	3e-16
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	4e-16
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	4e-16
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	5e-16
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	6e-16
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	2e-15
3an0_A	340	Dual specificity mitogen-activated protein kinase;	2e-15
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	3e-15
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	3e-15
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	3e-15
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	4e-15
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	4e-15
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	4e-15
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	5e-15
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	7e-15
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	8e-15
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	9e-15
3aln_A	327	Dual specificity mitogen-activated protein kinase;	1e-14
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	1e-14
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	1e-14
2dyl_A	318	Dual specificity mitogen-activated protein kinase	2e-14
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	2e-14
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	2e-14
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	2e-14
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	3e-14
3fme_A	290	Dual specificity mitogen-activated protein kinase;	3e-14
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	3e-14
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	4e-14
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	4e-14
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	4e-14
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	5e-14
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	6e-14
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	7e-14
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	9e-14
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	1e-13
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	1e-13
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-13
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	2e-13
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	2e-13
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	2e-13
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	2e-13
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	3e-13
4aoj_A	329	High affinity nerve growth factor receptor; transf	3e-13
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	3e-13
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	3e-13
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	3e-13
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	4e-13
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	4e-13
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	4e-13
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	5e-13
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	6e-13
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	8e-13
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	8e-13
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	8e-13
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	9e-13
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	1e-12
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	1e-12
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	1e-12
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	1e-12
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	1e-12
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	2e-12
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	2e-12
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	3e-12
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	3e-12
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	3e-12
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	3e-12
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	3e-12
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	5e-12
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	7e-12
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	9e-12
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	1e-11
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	2e-11
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	2e-11
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	2e-11
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	2e-11
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	2e-11
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	3e-11
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	3e-11
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	3e-11
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	4e-11
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	4e-11
3bhy_A	283	Death-associated protein kinase 3; death associate	4e-11
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	5e-11
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	5e-11
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	6e-11
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	9e-11
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	1e-10
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	1e-10
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	1e-10
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	1e-10
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	2e-10
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	2e-10
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	2e-10
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	2e-10
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	3e-10
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	3e-10
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	3e-10
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	4e-10
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	4e-10
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	5e-10
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	6e-10
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	7e-10
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	1e-09
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	1e-09
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	1e-09
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	1e-09
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	1e-09
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	2e-09
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	2e-09
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	2e-09
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	3e-09
3uqc_A	286	Probable conserved transmembrane protein; structur	3e-09
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	4e-09
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	4e-09
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	5e-09
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	6e-09
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	1e-08
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	1e-08
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	2e-08
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	2e-08
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	3e-08
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	3e-08
3o0g_A	292	Cell division protein kinase 5; kinase activator c	4e-08
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	8e-08
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	8e-08
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	8e-08
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	9e-08
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	1e-07
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	1e-07
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	1e-07
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	2e-07
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	3e-07
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	6e-07
3niz_A	311	Rhodanese family protein; structural genomics, str	6e-07
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	6e-07
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	9e-07
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	1e-06
3rp9_A	458	Mitogen-activated protein kinase; structural genom	1e-06
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	2e-06
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	2e-06
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	6e-06
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	9e-06
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	1e-05
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	1e-05
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	1e-05
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	1e-05
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	1e-05
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	1e-05
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	1e-05
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	2e-05
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	2e-05
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	2e-05
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	1e-04
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	2e-04
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	2e-04
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	3e-04
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	5e-04
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	6e-04

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  167 bits (426), Expect = 1e-51
 Identities = 68/205 (33%), Positives = 102/205 (49%), Gaps = 16/205 (7%)

Query: 1   MPNGSLEKWLYSYNYFFDIL---ERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILL 57
           M NG+L++ LY  +     +   +RL I I     L Y H       IIH D+K  NILL
Sbjct: 117 MENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR----AIIHRDVKSINILL 172

Query: 58  DENMVAHVSDFGISKL-LGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLL 116
           DEN V  ++DFGISK      +  ++ T+   T+GY+ PEY  +G ++ K DVYS+GV+L
Sbjct: 173 DENFVPKITDFGISKKGTELDQTHLS-TVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVL 231

Query: 117 METFTRKRPTDEMF-TGEMSLRRWVKESLPHG-LTEVVDANLVREEQAFAAKMDCIVSIM 174
            E    +    +      ++L  W  ES  +G L ++VD NL  +      + + +    
Sbjct: 232 FEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADK-----IRPESLRKFG 286

Query: 175 DLALDCCMESPGKRINMTDAAAKLK 199
           D A+ C   S   R +M D   KL+
Sbjct: 287 DTAVKCLALSSEDRPSMGDVLWKLE 311

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  166 bits (423), Expect = 4e-51
 Identities = 71/206 (34%), Positives = 99/206 (48%), Gaps = 14/206 (6%)

Query: 1   MPNGSLEKWLYSYNYFFDILE---RLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILL 57
           M NGS+   L         L+   R  I +     L Y H  H    IIH D+K  NILL
Sbjct: 109 MANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHD-HCDPKIIHRDVKAANILL 167

Query: 58  DENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLM 117
           DE   A V DFG++KL+   +  VT T    TIG++APEY S G  S K DV+ YGV+L+
Sbjct: 168 DEEFEAVVGDFGLAKLMDYKDTHVT-TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLL 226

Query: 118 ETFTRKRPTDEMFTGE---MSLRRWVKESLPHG-LTEVVDANLVREEQAFAAKMDCIVSI 173
           E  T +R  D         + L  WVK  L    L  +VD +L  +      +++ ++ +
Sbjct: 227 ELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDL--QGNYKDEEVEQLIQV 284

Query: 174 MDLALDCCMESPGKRINMTDAAAKLK 199
              AL C   SP +R  M++    L+
Sbjct: 285 ---ALLCTQSSPMERPKMSEVVRMLE 307

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  152 bits (386), Expect = 8e-46
 Identities = 55/206 (26%), Positives = 85/206 (41%), Gaps = 18/206 (8%)

Query: 1   MPNGSLEKWLYSYNYFFDILE---RLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILL 57
           MPNGSL   L   +     L    R  I     + + + H        IH D+K  NILL
Sbjct: 112 MPNGSLLDRLSCLDGT-PPLSWHMRCKIAQGAANGINFLHEN----HHIHRDIKSANILL 166

Query: 58  DENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLM 117
           DE   A +SDFG+++   +    V  +  + T  YMAPE    G ++ K D+YS+GV+L+
Sbjct: 167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLL 225

Query: 118 ETFTRKRPTDEMFTGEMSLRRWVKESL--PHGLTEVVDANLVREEQAFAAKMDCIVSIMD 175
           E  T     DE       L    +E       + + +D  +   +      M        
Sbjct: 226 EIITGLPAVDEHR-EPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAM------YS 278

Query: 176 LALDCCMESPGKRINMTDAAAKLKKI 201
           +A  C  E   KR ++      L+++
Sbjct: 279 VASQCLHEKKNKRPDIKKVQQLLQEM 304

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  137 bits (347), Expect = 8e-40
 Identities = 45/215 (20%), Positives = 76/215 (35%), Gaps = 16/215 (7%)

Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPH------HGHSSAPIIHCDLKPTN 54
              GSL  +L          E  +I   +   L Y H             I H D+K  N
Sbjct: 104 HEKGSLSDFLK--ANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKN 161

Query: 55  ILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGI-----VSAKCDV 109
           +LL  N+ A ++DFG++     G+        + T  YMAPE     I        + D+
Sbjct: 162 VLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDM 221

Query: 110 YSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLP--HGLTEVVDANLVREE-QAFAAK 166
           Y+ G++L E  +R    D      M          P    + EVV     R   + +  K
Sbjct: 222 YAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQK 281

Query: 167 MDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI 201
              +  + +   +C       R++      ++ ++
Sbjct: 282 HAGMAMLCETIEECWDHDAEARLSAGCVGERITQM 316

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  128 bits (325), Expect = 7e-37
 Identities = 47/215 (21%), Positives = 85/215 (39%), Gaps = 44/215 (20%)

Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDE- 59
           +P G L   L    +      +L +M+D+   +EY  +   + PI+H DL+  NI L   
Sbjct: 103 VPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQN--QNPPIVHRDLRSPNIFLQSL 160

Query: 60  ----NMVAHVSDFGISKLLGEGEDFVTQTMTMA--TIGYMAPE--YGSEGIVSAKCDVYS 111
                + A V+DFG+S+           +++       +MAPE     E   + K D YS
Sbjct: 161 DENAPVCAKVADFGLSQ-------QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYS 213

Query: 112 YGVLLMETFTRKRPTDEMFTGEMSLRRWVKE-----SLPHGLTEVVDANLVREEQAFAAK 166
           + ++L    T + P DE   G++     ++E     ++P                     
Sbjct: 214 FAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPE-------------------- 253

Query: 167 MDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI 201
            DC   + ++   C    P KR + +    +L ++
Sbjct: 254 -DCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  127 bits (321), Expect = 3e-36
 Identities = 41/204 (20%), Positives = 81/204 (39%), Gaps = 21/204 (10%)

Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
               SL   L++    F++ + ++I       ++Y H    +  IIH DLK  NI L E+
Sbjct: 101 CEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH----AKSIIHRDLKSNNIFLHED 156

Query: 61  MVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPE---YGSEGIVSAKCDVYSYGVLLM 117
               + DFG++                 +I +MAPE          S + DVY++G++L 
Sbjct: 157 NTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLY 216

Query: 118 ETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLA 177
           E  T + P   +   +  +             E+V    +  + +     +C   +  L 
Sbjct: 217 ELMTGQLPYSNINNRDQII-------------EMVGRGSLSPDLSKVRS-NCPKRMKRLM 262

Query: 178 LDCCMESPGKRINMTDAAAKLKKI 201
            +C  +   +R +     A+++++
Sbjct: 263 AECLKKKRDERPSFPRILAEIEEL 286

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  127 bits (320), Expect = 5e-36
 Identities = 47/211 (22%), Positives = 76/211 (36%), Gaps = 38/211 (18%)

Query: 1   MPNGSLEKWLYSYN--YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLD 58
              GSL   L+      ++     ++  +     + Y H       +IH DLKP N+LL 
Sbjct: 81  AEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHS-MQPKALIHRDLKPPNLLLV 139

Query: 59  ENM-VAHVSDFGISKLLGEGEDFVTQTMTMA--TIGYMAPEYGSEGIVSAKCDVYSYGVL 115
               V  + DFG +         +   MT    +  +MAPE       S KCDV+S+G++
Sbjct: 140 AGGTVLKICDFGTAC-------DIQTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGII 192

Query: 116 LMETFTRKRPTDEMFTGEMSLRRWVKE----SLPHGLTEVVDANLVREEQAFAAKMDCIV 171
           L E  TR++P DE+      +   V       L                       +   
Sbjct: 193 LWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIK---------------------NLPK 231

Query: 172 SIMDLALDCCMESPGKRINMTDAAAKLKKIK 202
            I  L   C  + P +R +M +    +  + 
Sbjct: 232 PIESLMTRCWSKDPSQRPSMEEIVKIMTHLM 262

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  122 bits (307), Expect = 4e-34
 Identities = 42/131 (32%), Positives = 68/131 (51%), Gaps = 6/131 (4%)

Query: 1   MPNGSLEKWLYSYN--YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLD 58
           +  GSL + L+        D   RL++  DV   + Y H+   + PI+H +LK  N+L+D
Sbjct: 116 LSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN--RNPPIVHRNLKSPNLLVD 173

Query: 59  ENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLME 118
           +     V DFG+S+L  +   F++      T  +MAPE   +   + K DVYS+GV+L E
Sbjct: 174 KKYTVKVCDFGLSRL--KASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWE 231

Query: 119 TFTRKRPTDEM 129
             T ++P   +
Sbjct: 232 LATLQQPWGNL 242

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  119 bits (301), Expect = 4e-33
 Identities = 46/214 (21%), Positives = 81/214 (37%), Gaps = 33/214 (15%)

Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           +  G+L   + S +  +   +R++   D+ S + Y H    S  IIH DL   N L+ EN
Sbjct: 89  IKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH----SMNIIHRDLNSHNCLVREN 144

Query: 61  MVAHVSDFGISKLLGEGE------------DFVTQTMTMATIGYMAPEYGSEGIVSAKCD 108
               V+DFG+++L+ + +            D   +   +    +MAPE  +      K D
Sbjct: 145 KNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVD 204

Query: 109 VYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMD 168
           V+S+G++L E   R     +                      +     VR         +
Sbjct: 205 VFSFGIVLCEIIGRVNADPDY-----------------LPRTMDFGLNVRGFLDRYCPPN 247

Query: 169 CIVSIMDLALDCCMESPGKRINMTDAAAKLKKIK 202
           C  S   + + CC   P KR +       L+ ++
Sbjct: 248 CPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLR 281

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  117 bits (295), Expect = 1e-32
 Identities = 31/133 (23%), Positives = 54/133 (40%), Gaps = 13/133 (9%)

Query: 1   MPNGSLEKWLYS-YNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDE 59
           MP GSL   L+   N+  D  + +   +D+   + + H       I    L   ++++DE
Sbjct: 91  MPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT--LEPLIPRHALNSRSVMIDE 148

Query: 60  NMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPE---YGSEGIVSAKCDVYSYGVLL 116
           +M A +S   +                M    ++APE      E       D++S+ VLL
Sbjct: 149 DMTARISMADVKF-------SFQSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLL 201

Query: 117 METFTRKRPTDEM 129
            E  TR+ P  ++
Sbjct: 202 WELVTREVPFADL 214

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  116 bits (293), Expect = 6e-32
 Identities = 35/214 (16%), Positives = 69/214 (32%), Gaps = 35/214 (16%)

Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
               +L   +       D+ +   I  ++   + Y H    +  I+H DLK  N+  D  
Sbjct: 111 CKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH----AKGILHKDLKSKNVFYDNG 166

Query: 61  MVAHVSDFGISKLLGEGEDFVTQTMTMA---TIGYMAPE---------YGSEGIVSAKCD 108
            V  ++DFG+  + G  +    +         + ++APE            +   S   D
Sbjct: 167 KV-VITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSD 225

Query: 109 VYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMD 168
           V++ G +  E   R+ P        +                 +   +        +++ 
Sbjct: 226 VFALGTIWYELHAREWPFKTQPAEAII--------------WQMGTGMKPNL----SQIG 267

Query: 169 CIVSIMDLALDCCMESPGKRINMTDAAAKLKKIK 202
               I D+ L C      +R   T     L+K+ 
Sbjct: 268 MGKEISDILLFCWAFEQEERPTFTKLMDMLEKLP 301

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  115 bits (291), Expect = 2e-31
 Identities = 44/219 (20%), Positives = 74/219 (33%), Gaps = 22/219 (10%)

Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPH----HGHSSAPIIHCDLKPTNIL 56
             NGSL  +L S     D    L +     S L + H           I H DLK  NIL
Sbjct: 117 HENGSLYDYLKSTT--LDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNIL 174

Query: 57  LDENMVAHVSDFGISKLLGEGEDFVTQTMTMA--TIGYMAPE--YGSEGIVSA----KCD 108
           + +N    ++D G++       + V         T  YM PE    S            D
Sbjct: 175 VKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMAD 234

Query: 109 VYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQ-----AF 163
           +YS+G++L E   R      +   ++    +          E +   +  ++        
Sbjct: 235 MYSFGLILWEVARRCVSGGIVEEYQLP---YHDLVPSDPSYEDMREIVCIKKLRPSFPNR 291

Query: 164 AAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKIK 202
            +  +C+  +  L  +C   +P  R+        L K+ 
Sbjct: 292 WSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMS 330

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  112 bits (283), Expect = 8e-31
 Identities = 50/210 (23%), Positives = 76/210 (36%), Gaps = 35/210 (16%)

Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDE- 59
              G L + L            +N  + +   + Y H   +  PIIH DLK +NIL+ + 
Sbjct: 88  ARGGPLNRVLSGKR--IPPDILVNWAVQIARGMNYLHD-EAIVPIIHRDLKSSNILILQK 144

Query: 60  -------NMVAHVSDFGISKLLGEGEDFVTQTMTMA-TIGYMAPEYGSEGIVSAKCDVYS 111
                  N +  ++DFG+++         T  M+ A    +MAPE     + S   DV+S
Sbjct: 145 VENGDLSNKILKITDFGLAREWHR-----TTKMSAAGAYAWMAPEVIRASMFSKGSDVWS 199

Query: 112 YGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIV 171
           YGVLL E  T + P   +    ++               V    L            C  
Sbjct: 200 YGVLLWELLTGEVPFRGIDGLAVAY-------------GVAMNKL-ALPIP----STCPE 241

Query: 172 SIMDLALDCCMESPGKRINMTDAAAKLKKI 201
               L  DC    P  R + T+   +L  I
Sbjct: 242 PFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  111 bits (279), Expect = 5e-30
 Identities = 42/218 (19%), Positives = 78/218 (35%), Gaps = 22/218 (10%)

Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPH----HGHSSAPIIHCDLKPTNIL 56
              GSL  +L       D +  L I++ + S L + H           I H DLK  NIL
Sbjct: 88  HEMGSLYDYLQLTT--LDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNIL 145

Query: 57  LDENMVAHVSDFGISKLLGEGEDFVTQTMTMA--TIGYMAPE------YGSEGIVSAKCD 108
           + +N    ++D G++ +  +  + +         T  YMAPE               + D
Sbjct: 146 VKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVD 205

Query: 109 VYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQ-----AF 163
           ++++G++L E   R      +   +     +          E +   +  ++Q       
Sbjct: 206 IWAFGLVLWEVARRMVSNGIVEDYKPP---FYDVVPNDPSFEDMRKVVCVDQQRPNIPNR 262

Query: 164 AAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI 201
                 + S+  L  +C  ++P  R+        L KI
Sbjct: 263 WFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  111 bits (280), Expect = 6e-30
 Identities = 50/225 (22%), Positives = 84/225 (37%), Gaps = 26/225 (11%)

Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPH-----HGHSSAPIIHCDLKPTNI 55
            PNGSL K+L  +    D +    +   V   L Y H       H    I H DL   N+
Sbjct: 94  YPNGSLXKYLSLHT--SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNV 151

Query: 56  LLDENMVAHVSDFGISKLLGEGEDFVTQTMTMA------TIGYMAPEYGSEGI------- 102
           L+  +    +SDFG+S  L             A      TI YMAPE     +       
Sbjct: 152 LVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXES 211

Query: 103 VSAKCDVYSYGVLLMETFTRK---RPTDEMFTGEMSLRRWVKESLP-HGLTEVVDANLVR 158
              + D+Y+ G++  E F R     P + +   +M+ +  V        +  +V     R
Sbjct: 212 ALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQR 271

Query: 159 EE--QAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI 201
            +  +A+      + S+ +   DC  +    R+    A  ++ ++
Sbjct: 272 PKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAEL 316

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  104 bits (261), Expect = 4e-27
 Identities = 38/216 (17%), Positives = 70/216 (32%), Gaps = 16/216 (7%)

Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPH----HGHSSAPIIHCDLKPTNIL 56
             +GSL  +L  Y     +   + + +   S L + H           I H DLK  NIL
Sbjct: 122 HEHGSLFDYLNRYT--VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNIL 179

Query: 57  LDENMVAHVSDFGISKLLGEGEDFVTQTMTMA--TIGYMAPE------YGSEGIVSAKCD 108
           + +N    ++D G++       D +         T  YMAPE               + D
Sbjct: 180 VKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRAD 239

Query: 109 VYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKE--SLPHGLTEVVDANLVREEQAFAAK 166
           +Y+ G++  E   R          ++     V    S+      V +  L          
Sbjct: 240 IYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQS 299

Query: 167 MDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKIK 202
            + +  +  +  +C   +   R+        L ++ 
Sbjct: 300 CEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 335

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  101 bits (255), Expect = 2e-26
 Identities = 36/112 (32%), Positives = 58/112 (51%), Gaps = 11/112 (9%)

Query: 23  LNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVT 82
           + I+  +GSAL+  H         H D+KP NIL+  +  A++ DFGI+    + +  +T
Sbjct: 137 VAIVRQIGSALDAAHAAG----ATHRDVKPENILVSADDFAYLVDFGIASATTDEK--LT 190

Query: 83  QT-MTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGE 133
           Q   T+ T+ YMAPE  SE   + + D+Y+   +L E  T   P    + G+
Sbjct: 191 QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPP----YQGD 238

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  101 bits (254), Expect = 3e-26
 Identities = 39/112 (34%), Positives = 58/112 (51%), Gaps = 9/112 (8%)

Query: 23  LNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVT 82
           + ++ D   AL + H       IIH D+KP NI++       V DFGI++ + +  + VT
Sbjct: 119 IEVIADACQALNFSHQNG----IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVT 174

Query: 83  QT-MTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGE 133
           QT   + T  Y++PE      V A+ DVYS G +L E  T + P    FTG+
Sbjct: 175 QTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP----FTGD 222

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 96.9 bits (242), Expect = 1e-24
 Identities = 36/112 (32%), Positives = 54/112 (48%), Gaps = 11/112 (9%)

Query: 23  LNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVT 82
           +N    +   +++ H       I+H D+KP NIL+D N    + DFGI+K L E    +T
Sbjct: 114 INFTNQILDGIKHAHDMR----IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS--LT 167

Query: 83  QT-MTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGE 133
           QT   + T+ Y +PE           D+YS G++L E    + P    F GE
Sbjct: 168 QTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPP----FNGE 215

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 95.8 bits (239), Expect = 9e-24
 Identities = 46/210 (21%), Positives = 84/210 (40%), Gaps = 38/210 (18%)

Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           +  G    +L +      +   L ++ D  + +EY      S   IH DL   N L+ E 
Sbjct: 194 VQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE----SKCCIHRDLAARNCLVTEK 249

Query: 61  MVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETF 120
            V  +SDFG+S+   +G    +  +    + + APE  + G  S++ DV+S+G+LL ETF
Sbjct: 250 NVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETF 309

Query: 121 TR-KRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDC-------IVS 172
           +    P   +   +       +E +  G                  ++ C       +  
Sbjct: 310 SLGASPYPNLSNQQ------TREFVEKGG-----------------RLPCPELCPDAVFR 346

Query: 173 IMDLALDCCMESPGKRINMTDAAAKLKKIK 202
           +M     C    PG+R + +    +L+ I+
Sbjct: 347 LM---EQCWAYEPGQRPSFSTIYQELQSIR 373

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 91.5 bits (227), Expect = 9e-22
 Identities = 25/112 (22%), Positives = 41/112 (36%), Gaps = 18/112 (16%)

Query: 23  LNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVT 82
           +  ++++  AL Y H    S  +++ DLKP NI+L E  +  + D G    +        
Sbjct: 185 IAYLLEILPALSYLH----SIGLVYNDLKPENIMLTEEQLK-LIDLGAVSRI-------N 232

Query: 83  QT-MTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGE 133
                  T G+ APE       +   D+Y+ G  L               G 
Sbjct: 233 SFGYLYGTPGFQAPEI-VRTGPTVATDIYTVGRTLAALTLDLPT----RNGR 279

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 87.3 bits (217), Expect = 4e-21
 Identities = 34/131 (25%), Positives = 59/131 (45%), Gaps = 6/131 (4%)

Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
              G L K+L        +     ++  V   ++Y          +H DL   N+LL   
Sbjct: 91  AGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKY----LEEKNFVHRDLAARNVLLVNR 146

Query: 61  MVAHVSDFGISKLLGEGED-FVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMET 119
             A +SDFG+SK LG  +  +  ++     + + APE  +    S++ DV+SYGV + E 
Sbjct: 147 HYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEA 206

Query: 120 FTR-KRPTDEM 129
            +  ++P  +M
Sbjct: 207 LSYGQKPYKKM 217

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 87.4 bits (217), Expect = 5e-21
 Identities = 35/202 (17%), Positives = 80/202 (39%), Gaps = 9/202 (4%)

Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           +P+GSL+++L       ++ ++L   + +   ++Y          +H DL   N+L++  
Sbjct: 107 LPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ----YVHRDLAARNVLVESE 162

Query: 61  MVAHVSDFGISKLLGEGEDF-VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMET 119
               + DFG++K +   +++   +    + + + APE   +       DV+S+GV L E 
Sbjct: 163 HQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHEL 222

Query: 120 FTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLALD 179
            T            + +       +    T +V+   ++E +      +C   +  L   
Sbjct: 223 LTYCDSDSSPMALFLKMIGPTHGQMTV--TRLVN--TLKEGKRLPCPPNCPDEVYQLMRK 278

Query: 180 CCMESPGKRINMTDAAAKLKKI 201
           C    P  R +  +     + +
Sbjct: 279 CWEFQPSNRTSFQNLIEGFEAL 300

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 88.0 bits (218), Expect = 1e-20
 Identities = 51/203 (25%), Positives = 86/203 (42%), Gaps = 26/203 (12%)

Query: 1   MPNGSLEKWLYSYN-YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDE 59
           M  GSL  +L      +  + + +++   + S + Y          +H DL+  NIL+ E
Sbjct: 343 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV----ERMNYVHRDLRAANILVGE 398

Query: 60  NMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMET 119
           N+V  V+DFG+++L+ E  ++  +      I + APE    G  + K DV+S+G+LL E 
Sbjct: 399 NLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTEL 457

Query: 120 FTR-KRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLAL 178
            T+ + P   M   E      V + +  G          R         +C  S+ DL  
Sbjct: 458 TTKGRVPYPGMVNRE------VLDQVERG---------YRMP----CPPECPESLHDLMC 498

Query: 179 DCCMESPGKRINMTDAAAKLKKI 201
            C  + P +R       A L+  
Sbjct: 499 QCWRKEPEERPTFEYLQAFLEDY 521

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 87.7 bits (217), Expect = 1e-20
 Identities = 33/131 (25%), Positives = 59/131 (45%), Gaps = 6/131 (4%)

Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
              G L K+L        +     ++  V   ++Y          +H +L   N+LL   
Sbjct: 417 AGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKY----LEEKNFVHRNLAARNVLLVNR 472

Query: 61  MVAHVSDFGISKLLGEGED-FVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMET 119
             A +SDFG+SK LG  +  +  ++     + + APE  +    S++ DV+SYGV + E 
Sbjct: 473 HYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEA 532

Query: 120 FTR-KRPTDEM 129
            +  ++P  +M
Sbjct: 533 LSYGQKPYKKM 543

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 87.0 bits (215), Expect = 2e-20
 Identities = 23/139 (16%), Positives = 49/139 (35%), Gaps = 28/139 (20%)

Query: 21  ERLNIMIDVGSALEYPH-HGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED 79
            RL + + V   L   H +G     ++H  L+P +I+LD+     ++ F      G    
Sbjct: 212 ARLQLTLQVIRLLASLHHYG-----LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-- 264

Query: 80  FVTQTMTMATIGYMAPEY----------GSEGIVSAKCDVYSYGVLLMETFTRKRPTDEM 129
                ++    G+  PE               +++   D ++ G+ +   +    P    
Sbjct: 265 ----AVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP---- 316

Query: 130 FTGE--MSLRRWVKESLPH 146
            T +  +    W+  S  +
Sbjct: 317 NTDDAALGGSEWIFRSCKN 335

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 85.4 bits (212), Expect = 2e-20
 Identities = 47/205 (22%), Positives = 87/205 (42%), Gaps = 14/205 (6%)

Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           +P GSL  +L  +    D ++ L     +   +EY          IH DL   NIL++  
Sbjct: 95  LPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR----YIHRDLATRNILVENE 150

Query: 61  MVAHVSDFGISKLLGEGEDF-VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMET 119
               + DFG++K+L + ++F   +    + I + APE  +E   S   DV+S+GV+L E 
Sbjct: 151 NRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 210

Query: 120 FTRKRPTDEMFTGEMSLRRWVKESLPHG---LTEVVDANLVREEQAFAAKMDCIVSIMDL 176
           FT    +       M +      +   G   +  +++  L++          C   I  +
Sbjct: 211 FTYIEKSKSPPAEFMRM----IGNDKQGQMIVFHLIE--LLKNNGRLPRPDGCPDEIYMI 264

Query: 177 ALDCCMESPGKRINMTDAAAKLKKI 201
             +C   +  +R +  D A ++ +I
Sbjct: 265 MTECWNNNVNQRPSFRDLALRVDQI 289

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 85.7 bits (213), Expect = 2e-20
 Identities = 35/130 (26%), Positives = 56/130 (43%), Gaps = 5/130 (3%)

Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           MP G L  ++  +         LN  + +   + Y         ++H DL   N+L+   
Sbjct: 98  MPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY----LEDRRLVHRDLAARNVLVKTP 153

Query: 61  MVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETF 120
               ++DFG++KLLG  E           I +MA E     I + + DV+SYGV + E  
Sbjct: 154 QHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 213

Query: 121 TR-KRPTDEM 129
           T   +P D +
Sbjct: 214 TFGSKPYDGI 223

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 86.7 bits (215), Expect = 2e-20
 Identities = 51/203 (25%), Positives = 86/203 (42%), Gaps = 26/203 (12%)

Query: 1   MPNGSLEKWLYSYN-YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDE 59
           M  GSL  +L      +  + + +++   + S + Y          +H DL+  NIL+ E
Sbjct: 260 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV----ERMNYVHRDLRAANILVGE 315

Query: 60  NMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMET 119
           N+V  V+DFG+++L+ E  ++  +      I + APE    G  + K DV+S+G+LL E 
Sbjct: 316 NLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTEL 374

Query: 120 FTR-KRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLAL 178
            T+ + P   M   E      V + +  G          R         +C  S+ DL  
Sbjct: 375 TTKGRVPYPGMVNRE------VLDQVERG---------YRMP----CPPECPESLHDLMC 415

Query: 179 DCCMESPGKRINMTDAAAKLKKI 201
            C  + P +R       A L+  
Sbjct: 416 QCWRKEPEERPTFEYLQAFLEDY 438

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 85.7 bits (212), Expect = 3e-20
 Identities = 37/140 (26%), Positives = 58/140 (41%), Gaps = 16/140 (11%)

Query: 2   PNGSLEKWLYSYNY--FFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDE 59
              +L+ W+         +    L+I I +  A+E+ H    S  ++H DLKP+NI    
Sbjct: 144 RKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLH----SKGLMHRDLKPSNIFFTM 199

Query: 60  NMVAHVSDFGISKLLGEGEDFVTQTMTMA----------TIGYMAPEYGSEGIVSAKCDV 109
           + V  V DFG+   + + E+  T    M           T  YM+PE       S K D+
Sbjct: 200 DDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDI 259

Query: 110 YSYGVLLMETFTRKRPTDEM 129
           +S G++L E         E 
Sbjct: 260 FSLGLILFELLYSFSTQMER 279

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 86.4 bits (214), Expect = 4e-20
 Identities = 38/122 (31%), Positives = 58/122 (47%), Gaps = 6/122 (4%)

Query: 1   MPNGSLEKWLYSYN-YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDE 59
           M  G+L  +L   N      +  L +   + SA+EY          IH +L   N L+ E
Sbjct: 298 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEY----LEKKNFIHRNLAARNCLVGE 353

Query: 60  NMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMET 119
           N +  V+DFG+S+L+  G+ +         I + APE  +    S K DV+++GVLL E 
Sbjct: 354 NHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 412

Query: 120 FT 121
            T
Sbjct: 413 AT 414

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 85.5 bits (212), Expect = 4e-20
 Identities = 53/203 (26%), Positives = 92/203 (45%), Gaps = 25/203 (12%)

Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           M NGSL+ +L  ++  F +++ + ++  + S ++Y     S    +H DL   NIL++ N
Sbjct: 128 MENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKY----LSDMGYVHRDLAARNILINSN 183

Query: 61  MVAHVSDFGISKLLGEGEDFV-TQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMET 119
           +V  VSDFG+ ++L +  +   T       I + +PE  +    ++  DV+SYG++L E 
Sbjct: 184 LVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEV 243

Query: 120 FTR-KRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLAL 178
            +  +RP  EM                    +V+ A  V E       MDC  ++  L L
Sbjct: 244 MSYGERPYWEM-----------------SNQDVIKA--VDEGYRLPPPMDCPAALYQLML 284

Query: 179 DCCMESPGKRINMTDAAAKLKKI 201
           DC  +    R       + L K+
Sbjct: 285 DCWQKDRNNRPKFEQIVSILDKL 307

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 84.2 bits (209), Expect = 5e-20
 Identities = 42/190 (22%), Positives = 69/190 (36%), Gaps = 24/190 (12%)

Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
            P GSL   L  +   F +       + V   + Y      S   IH DL   N+LL   
Sbjct: 102 APLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGY----LESKRFIHRDLAARNLLLATR 157

Query: 61  MVAHVSDFGISKLLGEGED-FVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMET 119
            +  + DFG+ + L + +D +V Q        + APE       S   D + +GV L E 
Sbjct: 158 DLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEM 217

Query: 120 FTR-KRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLAL 178
           FT  + P   +                   ++++   + +E +      DC   I ++ +
Sbjct: 218 FTYGQEPWIGL-----------------NGSQILHK-IDKEGERLPRPEDCPQDIYNVMV 259

Query: 179 DCCMESPGKR 188
            C    P  R
Sbjct: 260 QCWAHKPEDR 269

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score = 85.6 bits (212), Expect = 6e-20
 Identities = 32/131 (24%), Positives = 59/131 (45%), Gaps = 13/131 (9%)

Query: 4   GSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDE---- 59
            +L++++   ++    LE + ++    S L + H    S  I+H DLKP NIL+      
Sbjct: 102 ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH----SLNIVHRDLKPHNILISMPNAH 157

Query: 60  -NMVAHVSDFGISKLLGEGEDFVTQTMTMA-TIGYMAPEY---GSEGIVSAKCDVYSYGV 114
             + A +SDFG+ K L  G    ++   +  T G++APE      +   +   D++S G 
Sbjct: 158 GKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGC 217

Query: 115 LLMETFTRKRP 125
           +     +    
Sbjct: 218 VFYYVISEGSH 228

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 84.2 bits (209), Expect = 6e-20
 Identities = 39/131 (29%), Positives = 62/131 (47%), Gaps = 7/131 (5%)

Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
              G L K+L   N        + ++  V   ++Y       +  +H DL   N+LL   
Sbjct: 99  AELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKY----LEESNFVHRDLAARNVLLVTQ 153

Query: 61  MVAHVSDFGISKLLGEGEDF-VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMET 119
             A +SDFG+SK L   E++   QT     + + APE  +    S+K DV+S+GVL+ E 
Sbjct: 154 HYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEA 213

Query: 120 FTR-KRPTDEM 129
           F+  ++P   M
Sbjct: 214 FSYGQKPYRGM 224

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 84.3 bits (209), Expect = 7e-20
 Identities = 46/205 (22%), Positives = 88/205 (42%), Gaps = 14/205 (6%)

Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           +P GSL  +L  +    D ++ L     +   +EY      +   IH DL   NIL++  
Sbjct: 126 LPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEY----LGTKRYIHRDLATRNILVENE 181

Query: 61  MVAHVSDFGISKLLGEGEDF-VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMET 119
               + DFG++K+L + +++   +    + I + APE  +E   S   DV+S+GV+L E 
Sbjct: 182 NRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 241

Query: 120 FTRKRPTDEMFTGEMSLRRWVKESLPHG---LTEVVDANLVREEQAFAAKMDCIVSIMDL 176
           FT    +       M +      +   G   +  +++  L++          C   I  +
Sbjct: 242 FTYIEKSKSPPAEFMRM----IGNDKQGQMIVFHLIE--LLKNNGRLPRPDGCPDEIYMI 295

Query: 177 ALDCCMESPGKRINMTDAAAKLKKI 201
             +C   +  +R +  D A ++ +I
Sbjct: 296 MTECWNNNVNQRPSFRDLALRVDQI 320

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score = 83.5 bits (207), Expect = 8e-20
 Identities = 33/110 (30%), Positives = 48/110 (43%), Gaps = 15/110 (13%)

Query: 23  LNIMIDVGSALEYPHHGHSSA-PIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFV 81
           L +M  +  AL+  H        ++H DLKP N+ LD      + DFG++++L     F 
Sbjct: 114 LRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF- 172

Query: 82  TQTMTMATIGYMAPE------YGSEGIVSAKCDVYSYGVLLMETFTRKRP 125
            +T    T  YM+PE      Y        K D++S G LL E      P
Sbjct: 173 AKTFV-GTPYYMSPEQMNRMSYNE------KSDIWSLGCLLYELCALMPP 215

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 85.7 bits (212), Expect = 8e-20
 Identities = 28/121 (23%), Positives = 51/121 (42%), Gaps = 5/121 (4%)

Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
              G L  +L    +  D+   +     + +AL Y      S   +H D+   N+L+  N
Sbjct: 472 CTLGELRSFLQVRKFSLDLASLILYAYQLSTALAY----LESKRFVHRDIAARNVLVSSN 527

Query: 61  MVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETF 120
               + DFG+S+ + E   +   +     I +MAPE  +    ++  DV+ +GV + E  
Sbjct: 528 DCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 586

Query: 121 T 121
            
Sbjct: 587 M 587

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score = 83.1 bits (206), Expect = 1e-19
 Identities = 32/129 (24%), Positives = 53/129 (41%), Gaps = 8/129 (6%)

Query: 2   PNGSLEKWLYSYN-YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
             G+LE+W+        D +  L +   +   ++Y H       +I+ DLKP+NI L + 
Sbjct: 103 DKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK----LINRDLKPSNIFLVDT 158

Query: 61  MVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETF 120
               + DFG+   L              T+ YM+PE  S      + D+Y+ G++L E  
Sbjct: 159 KQVKIGDFGLVTSLKNDGKRTRSK---GTLRYMSPEQISSQDYGKEVDLYALGLILAELL 215

Query: 121 TRKRPTDEM 129
                  E 
Sbjct: 216 HVCDTAFET 224

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 83.5 bits (207), Expect = 1e-19
 Identities = 53/203 (26%), Positives = 88/203 (43%), Gaps = 11/203 (5%)

Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           +P+G L  +L  +    D    L     +   +EY          +H DL   NIL++  
Sbjct: 108 LPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR----CVHRDLAARNILVESE 163

Query: 61  MVAHVSDFGISKLLGEGED-FVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMET 119
               ++DFG++KLL   +D +V +    + I + APE  S+ I S + DV+S+GV+L E 
Sbjct: 164 AHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYEL 223

Query: 120 FTR-KRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLAL 178
           FT   +           LR    E     L+ +++  L+ E Q   A   C   + +L  
Sbjct: 224 FTYCDKS---CSPSAEFLRMMGCERDVPALSRLLE--LLEEGQRLPAPPACPAEVHELMK 278

Query: 179 DCCMESPGKRINMTDAAAKLKKI 201
            C   SP  R + +    +L  +
Sbjct: 279 LCWAPSPQDRPSFSALGPQLDML 301

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score = 84.0 bits (208), Expect = 1e-19
 Identities = 40/135 (29%), Positives = 58/135 (42%), Gaps = 19/135 (14%)

Query: 3   NGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPH-HGHSSAPIIHCDLKPTNILLDENM 61
           N  L  WL       D  ER +   ++  A+   H HG     I+H DLKP N L+ + M
Sbjct: 92  NIDLNSWLKKKKSI-DPWERKSYWKNMLEAVHTIHQHG-----IVHSDLKPANFLIVDGM 145

Query: 62  VAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPE-----------YGSEGIVSAKCDVY 110
           +  + DFGI+  +      V +   + T+ YM PE             S+  +S K DV+
Sbjct: 146 L-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVW 204

Query: 111 SYGVLLMETFTRKRP 125
           S G +L      K P
Sbjct: 205 SLGCILYYMTYGKTP 219

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 83.5 bits (207), Expect = 2e-19
 Identities = 44/131 (33%), Positives = 72/131 (54%), Gaps = 6/131 (4%)

Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           M NGSL+ +L +++  F I++ + ++  VG+ + Y     S    +H DL   N+L+D N
Sbjct: 132 MENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRY----LSDLGYVHRDLAARNVLVDSN 187

Query: 61  MVAHVSDFGISKLLGEGEDFV-TQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMET 119
           +V  VSDFG+S++L +  D   T T     I + APE  +    S+  DV+S+GV++ E 
Sbjct: 188 LVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEV 247

Query: 120 FTR-KRPTDEM 129
               +RP   M
Sbjct: 248 LAYGERPYWNM 258

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score = 83.2 bits (206), Expect = 2e-19
 Identities = 37/130 (28%), Positives = 54/130 (41%), Gaps = 17/130 (13%)

Query: 2   PNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENM 61
            NG+L   ++S N      E   +   +  AL Y H       IIH DLKP NI +DE+ 
Sbjct: 98  ENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQG----IIHRDLKPMNIFIDESR 153

Query: 62  VAHVSDFGISKLLGEGEDFVTQTMTMA------------TIGYMAPE-YGSEGIVSAKCD 108
              + DFG++K +    D +                   T  Y+A E     G  + K D
Sbjct: 154 NVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKID 213

Query: 109 VYSYGVLLME 118
           +YS G++  E
Sbjct: 214 MYSLGIIFFE 223

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 82.2 bits (204), Expect = 2e-19
 Identities = 50/202 (24%), Positives = 82/202 (40%), Gaps = 25/202 (12%)

Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           M +G L  +L +    F     L + +DV   + Y       A +IH DL   N L+ EN
Sbjct: 85  MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAY----LEEACVIHRDLAARNCLVGEN 140

Query: 61  MVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETF 120
            V  VSDFG+++ +   + + + T T   + + +PE  S    S+K DV+S+GVL+ E F
Sbjct: 141 QVIKVSDFGMTRFV-LDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVF 199

Query: 121 TR-KRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLALD 179
           +  K P +                     +EVV+   +               +  +   
Sbjct: 200 SEGKIPYENR-----------------SNSEVVED--ISTGFRLYKPRLASTHVYQIMNH 240

Query: 180 CCMESPGKRINMTDAAAKLKKI 201
           C  E P  R   +    +L +I
Sbjct: 241 CWRERPEDRPAFSRLLRQLAEI 262

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 82.8 bits (205), Expect = 3e-19
 Identities = 35/130 (26%), Positives = 56/130 (43%), Gaps = 5/130 (3%)

Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           MP G L  ++  +         LN  + +   + Y         ++H DL   N+L+   
Sbjct: 98  MPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY----LEDRRLVHRDLAARNVLVKTP 153

Query: 61  MVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETF 120
               ++DFG++KLLG  E           I +MA E     I + + DV+SYGV + E  
Sbjct: 154 QHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 213

Query: 121 TR-KRPTDEM 129
           T   +P D +
Sbjct: 214 TFGSKPYDGI 223

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score = 83.3 bits (206), Expect = 3e-19
 Identities = 39/135 (28%), Positives = 57/135 (42%), Gaps = 19/135 (14%)

Query: 3   NGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPH-HGHSSAPIIHCDLKPTNILLDENM 61
           N  L  WL       D  ER +   ++  A+   H HG     I+H DLKP N L+ + M
Sbjct: 139 NIDLNSWLKKKKSI-DPWERKSYWKNMLEAVHTIHQHG-----IVHSDLKPANFLIVDGM 192

Query: 62  VAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPE-----------YGSEGIVSAKCDVY 110
           +  + DFGI+  +      V +   +  + YM PE             S+  +S K DV+
Sbjct: 193 L-KLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVW 251

Query: 111 SYGVLLMETFTRKRP 125
           S G +L      K P
Sbjct: 252 SLGCILYYMTYGKTP 266

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 83.6 bits (207), Expect = 3e-19
 Identities = 33/122 (27%), Positives = 61/122 (50%), Gaps = 6/122 (4%)

Query: 1   MPNGSLEKWLYSYNY-FFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDE 59
           M  GSL  +L S       + + ++    +   + +          IH DL+  NIL+  
Sbjct: 264 MAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI----EQRNYIHRDLRAANILVSA 319

Query: 60  NMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMET 119
           ++V  ++DFG+++++ E  ++  +      I + APE  + G  + K DV+S+G+LLME 
Sbjct: 320 SLVCKIADFGLARVI-EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEI 378

Query: 120 FT 121
            T
Sbjct: 379 VT 380

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 82.8 bits (205), Expect = 3e-19
 Identities = 42/189 (22%), Positives = 69/189 (36%), Gaps = 24/189 (12%)

Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           +P GSL   +  +         LN  + +   + Y         ++H +L   N+LL   
Sbjct: 96  LPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYY----LEEHGMVHRNLAARNVLLKSP 151

Query: 61  MVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETF 120
               V+DFG++ LL   +  +  +     I +MA E    G  + + DV+SYGV + E  
Sbjct: 152 SQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELM 211

Query: 121 TR-KRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLALD 179
           T    P   +   E      V + L  G          R  Q       C + +  + + 
Sbjct: 212 TFGAEPYAGLRLAE------VPDLLEKGE---------RLAQP----QICTIDVYMVMVK 252

Query: 180 CCMESPGKR 188
           C M     R
Sbjct: 253 CWMIDENIR 261

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 83.1 bits (205), Expect = 4e-19
 Identities = 23/144 (15%), Positives = 48/144 (33%), Gaps = 27/144 (18%)

Query: 16  FFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLG 75
                 RL + + V   L   HH      ++H  L+P +I+LD+     ++ F      G
Sbjct: 202 SLVHHARLQLTLQVIRLLASLHHYG----LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 257

Query: 76  EGEDFVTQTMTMATIGYMAPEY-----------GSEGIVSAKCDVYSYGVLLMETFTRKR 124
                        + G+  PE                +++   D ++ G+++   +    
Sbjct: 258 ARVVSSV------SRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADL 311

Query: 125 PTDEMFTGE--MSLRRWVKESLPH 146
           P     T +  +    W+  S  +
Sbjct: 312 P----ITKDAALGGSEWIFRSCKN 331

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score = 82.4 bits (204), Expect = 4e-19
 Identities = 30/127 (23%), Positives = 48/127 (37%), Gaps = 18/127 (14%)

Query: 4   GSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVA 63
            SL++   ++       +    + D   AL + H       ++H D+KP NI L      
Sbjct: 141 PSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQG----LVHLDVKPANIFLGPRGRC 196

Query: 64  HVSDFGISKLLGEGEDFVTQTMTMATIGYMAPE-----YGSEGIVSAKCDVYSYGVLLME 118
            + DFG+   LG       +        YMAPE     YG+        DV+S G+ ++E
Sbjct: 197 KLGDFGLLVELGTAG--AGEVQE-GDPRYMAPELLQGSYGT------AADVFSLGLTILE 247

Query: 119 TFTRKRP 125
                  
Sbjct: 248 VACNMEL 254

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score = 81.6 bits (202), Expect = 7e-19
 Identities = 40/135 (29%), Positives = 58/135 (42%), Gaps = 19/135 (14%)

Query: 3   NGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPH-HGHSSAPIIHCDLKPTNILLDENM 61
           N  L  WL       D  ER +   ++  A+   H HG     I+H DLKP N L+ + M
Sbjct: 111 NIDLNSWLKKKKSI-DPWERKSYWKNMLEAVHTIHQHG-----IVHSDLKPANFLIVDGM 164

Query: 62  VAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPE-----------YGSEGIVSAKCDVY 110
           +  + DFGI+  +      V +   + T+ YM PE             S+  +S K DV+
Sbjct: 165 L-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVW 223

Query: 111 SYGVLLMETFTRKRP 125
           S G +L      K P
Sbjct: 224 SLGCILYYMTYGKTP 238

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 81.1 bits (201), Expect = 7e-19
 Identities = 30/130 (23%), Positives = 54/130 (41%), Gaps = 6/130 (4%)

Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
              G L  +L    Y  D+   +     + +AL Y      S   +H D+   N+L+  N
Sbjct: 97  CTLGELRSFLQVRKYSLDLASLILYAYQLSTALAY----LESKRFVHRDIAARNVLVSSN 152

Query: 61  MVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETF 120
               + DFG+S+ + E   +   +     I +MAPE  +    ++  DV+ +GV + E  
Sbjct: 153 DCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 211

Query: 121 TR-KRPTDEM 129
               +P   +
Sbjct: 212 MHGVKPFQGV 221

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 81.6 bits (202), Expect = 8e-19
 Identities = 52/203 (25%), Positives = 95/203 (46%), Gaps = 25/203 (12%)

Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           M NG+L+K+L   +  F +L+ + ++  + + ++Y     ++   +H DL   NIL++ N
Sbjct: 128 MENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKY----LANMNYVHRDLAARNILVNSN 183

Query: 61  MVAHVSDFGISKLLGEGEDFVTQTM-TMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMET 119
           +V  VSDFG+S++L +  +    T      I + APE  S    ++  DV+S+G+++ E 
Sbjct: 184 LVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEV 243

Query: 120 FTR-KRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLAL 178
            T  +RP  E+                    EV+ A  + +       MDC  +I  L +
Sbjct: 244 MTYGERPYWEL-----------------SNHEVMKA--INDGFRLPTPMDCPSAIYQLMM 284

Query: 179 DCCMESPGKRINMTDAAAKLKKI 201
            C  +   +R    D  + L K+
Sbjct: 285 QCWQQERARRPKFADIVSILDKL 307

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 80.7 bits (200), Expect = 9e-19
 Identities = 37/130 (28%), Positives = 64/130 (49%), Gaps = 6/130 (4%)

Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           + NG L  +L S+    +  + L +  DV   + +      S   IH DL   N L+D +
Sbjct: 85  ISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAF----LESHQFIHRDLAARNCLVDRD 140

Query: 61  MVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETF 120
           +   VSDFG+++ +   + +V+   T   + + APE       S+K DV+++G+L+ E F
Sbjct: 141 LCVKVSDFGMTRYV-LDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVF 199

Query: 121 TR-KRPTDEM 129
           +  K P D  
Sbjct: 200 SLGKMPYDLY 209

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 80.3 bits (199), Expect = 1e-18
 Identities = 36/130 (27%), Positives = 64/130 (49%), Gaps = 6/130 (4%)

Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           M NG L  +L    + F   + L +  DV  A+EY      S   +H DL   N L+++ 
Sbjct: 101 MANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEY----LESKQFLHRDLAARNCLVNDQ 156

Query: 61  MVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETF 120
            V  VSDFG+S+ +   +++ +   +   + +  PE       S+K D++++GVL+ E +
Sbjct: 157 GVVKVSDFGLSRYV-LDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIY 215

Query: 121 TR-KRPTDEM 129
           +  K P +  
Sbjct: 216 SLGKMPYERF 225

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 81.6 bits (202), Expect = 1e-18
 Identities = 42/122 (34%), Positives = 58/122 (47%), Gaps = 10/122 (8%)

Query: 1   MPNGSLEKWLYSYN-YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDE 59
           M  GSL  +L S           L   +DV  A+EY          +H DL   N+L+ E
Sbjct: 269 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY----LEGNNFVHRDLAARNVLVSE 324

Query: 60  NMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMET 119
           + VA VSDFG++K     E   TQ      + + APE   E   S K DV+S+G+LL E 
Sbjct: 325 DNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEI 379

Query: 120 FT 121
           ++
Sbjct: 380 YS 381

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 80.3 bits (199), Expect = 1e-18
 Identities = 31/130 (23%), Positives = 57/130 (43%), Gaps = 6/130 (4%)

Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
            P G L  +L        +L  +   + +  A+ Y      S   +H D+   NIL+   
Sbjct: 94  YPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAY----LESINCVHRDIAVRNILVASP 149

Query: 61  MVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETF 120
               + DFG+S+ + E ED+   ++T   I +M+PE  +    +   DV+ + V + E  
Sbjct: 150 ECVKLGDFGLSRYI-EDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEIL 208

Query: 121 TR-KRPTDEM 129
           +  K+P   +
Sbjct: 209 SFGKQPFFWL 218

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score = 81.2 bits (200), Expect = 2e-18
 Identities = 21/193 (10%), Positives = 51/193 (26%), Gaps = 22/193 (11%)

Query: 4   GSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVA 63
            S   ++Y +     IL    +   +               ++H    P N+ +  +   
Sbjct: 178 FSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG----LVHGHFTPDNLFIMPDGRL 233

Query: 64  HVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEY--GSEGIVSAKCDVYSYGVLLMETFT 121
            + D      +G          +   + Y   E+   S    +   + +  G+ +   + 
Sbjct: 234 MLGDVSALWKVGT-----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWC 288

Query: 122 RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLALDCC 181
              P   +  G     +     +P             +  AF +       +  L     
Sbjct: 289 LFLPFGLVTPGIKGSWKRPSLRVPG-----------TDSLAFGSCTPLPDFVKTLIGRFL 337

Query: 182 MESPGKRINMTDA 194
                +R+   +A
Sbjct: 338 NFDRRRRLLPLEA 350

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score = 80.1 bits (198), Expect = 2e-18
 Identities = 33/129 (25%), Positives = 55/129 (42%), Gaps = 16/129 (12%)

Query: 2   PNGSLEKWL--YSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDE 59
              +L+ W+         +    L+I + +  A+E+ H       ++H DLKP+NI    
Sbjct: 98  RKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG----LMHRDLKPSNIFFTM 153

Query: 60  NMVAHVSDFGISKLLGEGEDFVTQTMTMATIG----------YMAPEYGSEGIVSAKCDV 109
           + V  V DFG+   + + E+  T    M              YM+PE       S K D+
Sbjct: 154 DDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDI 213

Query: 110 YSYGVLLME 118
           +S G++L E
Sbjct: 214 FSLGLILFE 222

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score = 80.5 bits (199), Expect = 2e-18
 Identities = 28/109 (25%), Positives = 50/109 (45%), Gaps = 18/109 (16%)

Query: 23  LNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVT 82
           L+  + +  AL++ H       I+H D+K  NI L ++    + DFGI+++L    +   
Sbjct: 128 LDWFVQICLALKHVHDRK----ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVEL-A 182

Query: 83  QTMTMATIGYMAPE------YGSEGIVSAKCDVYSYGVLLMETFTRKRP 125
           +     T  Y++PE      Y +      K D+++ G +L E  T K  
Sbjct: 183 RACI-GTPYYLSPEICENKPYNN------KSDIWALGCVLYELCTLKHA 224

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 80.1 bits (198), Expect = 3e-18
 Identities = 44/202 (21%), Positives = 79/202 (39%), Gaps = 11/202 (5%)

Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           +P GSL  +L  ++    + + L     +   + Y H  H     IH DL   N+LLD +
Sbjct: 117 VPLGSLRDYLPRHS--IGLAQLLLFAQQICEGMAYLHAQH----YIHRDLAARNVLLDND 170

Query: 61  MVAHVSDFGISKLLGEGEDF-VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMET 119
            +  + DFG++K + EG ++   +    + + + APE   E       DV+S+GV L E 
Sbjct: 171 RLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYEL 230

Query: 120 FTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLALD 179
            T    +    T  + L    +  +      + +  L+   +       C   +  L  +
Sbjct: 231 LTHCDSSQSPPTKFLELIGIAQGQMTV--LRLTE--LLERGERLPRPDKCPAEVYHLMKN 286

Query: 180 CCMESPGKRINMTDAAAKLKKI 201
           C       R    +    LK +
Sbjct: 287 CWETEASFRPTFENLIPILKTV 308

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 78.8 bits (195), Expect = 4e-18
 Identities = 34/122 (27%), Positives = 62/122 (50%), Gaps = 6/122 (4%)

Query: 1   MPNGSLEKWLYSYN-YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDE 59
           M NGSL  +L + +     I + L++   +   + +          IH DL+  NIL+ +
Sbjct: 89  MENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAF----IEERNYIHRDLRAANILVSD 144

Query: 60  NMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMET 119
            +   ++DFG+++L+ E  ++  +      I + APE  + G  + K DV+S+G+LL E 
Sbjct: 145 TLSCKIADFGLARLI-EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEI 203

Query: 120 FT 121
            T
Sbjct: 204 VT 205

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score = 78.9 bits (195), Expect = 7e-18
 Identities = 29/127 (22%), Positives = 50/127 (39%), Gaps = 9/127 (7%)

Query: 2   PNGSLEKWLYSY---NYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLD 58
             G L + +  +                + + SALE+ H       ++H D+KP N+ + 
Sbjct: 115 DAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR----VMHRDIKPANVFIT 170

Query: 59  ENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLME 118
              V  + D G+ +           ++   T  YM+PE   E   + K D++S G LL E
Sbjct: 171 ATGVVKLGDLGLGRFFSSKTTA-AHSLV-GTPYYMSPERIHENGYNFKSDIWSLGCLLYE 228

Query: 119 TFTRKRP 125
               + P
Sbjct: 229 MAALQSP 235

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 79.0 bits (195), Expect = 8e-18
 Identities = 33/124 (26%), Positives = 59/124 (47%), Gaps = 6/124 (4%)

Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           M +G L  ++ +  +   + + +   + V   +++     +S   +H DL   N +LDE 
Sbjct: 173 MKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKF----LASKKFVHRDLAARNCMLDEK 228

Query: 61  MVAHVSDFGISKLLGEGEDFVTQTMTMAT--IGYMAPEYGSEGIVSAKCDVYSYGVLLME 118
               V+DFG+++ + + E       T A   + +MA E       + K DV+S+GVLL E
Sbjct: 229 FTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWE 288

Query: 119 TFTR 122
             TR
Sbjct: 289 LMTR 292

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 78.1 bits (193), Expect = 1e-17
 Identities = 34/124 (27%), Positives = 60/124 (48%), Gaps = 6/124 (4%)

Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           M +G L +++ S      + + ++  + V   +EY     +    +H DL   N +LDE+
Sbjct: 105 MCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEY----LAEQKFVHRDLAARNCMLDES 160

Query: 61  MVAHVSDFGISKLLGEGEDFVTQTMTMAT--IGYMAPEYGSEGIVSAKCDVYSYGVLLME 118
               V+DFG+++ + + E +  Q    A   + + A E       + K DV+S+GVLL E
Sbjct: 161 FTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWE 220

Query: 119 TFTR 122
             TR
Sbjct: 221 LLTR 224

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 77.3 bits (191), Expect = 2e-17
 Identities = 39/123 (31%), Positives = 58/123 (47%), Gaps = 6/123 (4%)

Query: 1   MPNGSLEKWLYSYN-YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDE 59
           M  G+L  +L   N      +  L +   + SA+EY          IH DL   N L+ E
Sbjct: 91  MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEY----LEKKNFIHRDLAARNCLVGE 146

Query: 60  NMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMET 119
           N +  V+DFG+S+L+  G+ +         I + APE  +    S K DV+++GVLL E 
Sbjct: 147 NHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 205

Query: 120 FTR 122
            T 
Sbjct: 206 ATY 208

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 77.3 bits (191), Expect = 2e-17
 Identities = 34/124 (27%), Positives = 60/124 (48%), Gaps = 6/124 (4%)

Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           M +G L  ++ +  +   + + +   + V   ++Y     +S   +H DL   N +LDE 
Sbjct: 109 MKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKY----LASKKFVHRDLAARNCMLDEK 164

Query: 61  MVAHVSDFGISKLLGEGEDFVTQTMTMAT--IGYMAPEYGSEGIVSAKCDVYSYGVLLME 118
               V+DFG+++ + + E +     T A   + +MA E       + K DV+S+GVLL E
Sbjct: 165 FTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWE 224

Query: 119 TFTR 122
             TR
Sbjct: 225 LMTR 228

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 77.0 bits (190), Expect = 6e-17
 Identities = 39/106 (36%), Positives = 53/106 (50%), Gaps = 22/106 (20%)

Query: 29  VGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMA 88
           +  AL+Y  +      IIH D+KP NILLDE+   H++DF I+ +L       TQ  TMA
Sbjct: 124 LVMALDYLQNQR----IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE----TQITTMA 175

Query: 89  -TIGYMAPEYGSEGIVSAKC--------DVYSYGVLLMETFTRKRP 125
            T  YMAPE     + S++         D +S GV   E    +RP
Sbjct: 176 GTKPYMAPE-----MFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score = 75.5 bits (186), Expect = 1e-16
 Identities = 39/160 (24%), Positives = 64/160 (40%), Gaps = 15/160 (9%)

Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLD-E 59
           M +G+L+ +L  +      + R +    +   L++ H    + PIIH DLK  NI +   
Sbjct: 111 MTSGTLKTYLKRFKVMKIKVLR-SWCRQILKGLQFLHT--RTPPIIHRDLKCDNIFITGP 167

Query: 60  NMVAHVSDFGISKLLGEGEDFVTQTMTMATIG---YMAPEYGSEGIVSAKCDVYSYGVLL 116
                + D G++ L          +   A IG   +MAPE   E       DVY++G+ +
Sbjct: 168 TGSVKIGDLGLATLK-------RASFAKAVIGTPEFMAPEMYEEK-YDESVDVYAFGMCM 219

Query: 117 METFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANL 156
           +E  T + P  E        RR      P    +V    +
Sbjct: 220 LEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEV 259

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score = 75.0 bits (185), Expect = 1e-16
 Identities = 39/131 (29%), Positives = 55/131 (41%), Gaps = 13/131 (9%)

Query: 1   MPNGSLEKWLYSYNYFFDILERL--NIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLD 58
           +P GSL   L S        E+        +   L+Y H       I+H D+K  N+L++
Sbjct: 101 VPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ----IVHRDIKGDNVLIN 156

Query: 59  -ENMVAHVSDFGISKLLGEGEDFVTQTMTMA-TIGYMAPE--YGSEGIVSAKCDVYSYGV 114
             + V  +SDFG SK L         T T   T+ YMAPE             D++S G 
Sbjct: 157 TYSGVLKISDFGTSKRL---AGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGC 213

Query: 115 LLMETFTRKRP 125
            ++E  T K P
Sbjct: 214 TIIEMATGKPP 224

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 75.4 bits (186), Expect = 1e-16
 Identities = 33/127 (25%), Positives = 61/127 (48%), Gaps = 9/127 (7%)

Query: 1   MPNGSLEKWL-----YSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNI 55
           M +G L  +L         +   +   +  M+D+   +EY     SS   IH DL   N 
Sbjct: 113 MKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEY----LSSRNFIHRDLAARNC 168

Query: 56  LLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVL 115
           +L E+M   V+DFG+S+ +  G+ +     +   + ++A E  ++ + +   DV+++GV 
Sbjct: 169 MLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVT 228

Query: 116 LMETFTR 122
           + E  TR
Sbjct: 229 MWEIMTR 235

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score = 76.0 bits (187), Expect = 1e-16
 Identities = 34/152 (22%), Positives = 62/152 (40%), Gaps = 34/152 (22%)

Query: 3   NGSLEKWLYSYNYFFDILERL------NIMIDVGSALEYPH-HGHSSAPIIHCDLKPTNI 55
           N +L+  + S N   + L+        +++  + S + + H        IIH DLKP NI
Sbjct: 92  NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK-----IIHRDLKPQNI 146

Query: 56  LLD-------------ENMVAHVSDFGISKLLGEGEDFVTQTMTMA--TIGYMAPE---- 96
           L+              EN+   +SDFG+ K L  G+      +     T G+ APE    
Sbjct: 147 LVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEE 206

Query: 97  ---YGSEGIVSAKCDVYSYGVLLMETFTRKRP 125
                ++  ++   D++S G +     ++ + 
Sbjct: 207 SNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH 238

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 74.2 bits (183), Expect = 3e-16
 Identities = 33/127 (25%), Positives = 62/127 (48%), Gaps = 9/127 (7%)

Query: 1   MPNGSLEKWL-----YSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNI 55
           M  G L  +L      +      +   L  M+D+   +EY     S+   +H DL   N 
Sbjct: 123 MKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEY----LSNRNFLHRDLAARNC 178

Query: 56  LLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVL 115
           +L ++M   V+DFG+SK +  G+ +    +    + ++A E  ++ + ++K DV+++GV 
Sbjct: 179 MLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVT 238

Query: 116 LMETFTR 122
           + E  TR
Sbjct: 239 MWEIATR 245

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 74.6 bits (183), Expect = 3e-16
 Identities = 31/99 (31%), Positives = 52/99 (52%), Gaps = 4/99 (4%)

Query: 23  LNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVT 82
           +     V   +E+     +S   IH DL   NILL E  V  + DFG+++ + +  D+V 
Sbjct: 196 ICYSFQVAKGMEFL----ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 251

Query: 83  QTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT 121
           +      + +MAPE   + + + + DV+S+GVLL E F+
Sbjct: 252 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 73.4 bits (181), Expect = 4e-16
 Identities = 42/122 (34%), Positives = 58/122 (47%), Gaps = 10/122 (8%)

Query: 1   MPNGSLEKWLYSYN-YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDE 59
           M  GSL  +L S           L   +DV  A+EY          +H DL   N+L+ E
Sbjct: 97  MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY----LEGNNFVHRDLAARNVLVSE 152

Query: 60  NMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMET 119
           + VA VSDFG++K     E   TQ      + + APE   E   S K DV+S+G+LL E 
Sbjct: 153 DNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEI 207

Query: 120 FT 121
           ++
Sbjct: 208 YS 209

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score = 74.1 bits (182), Expect = 4e-16
 Identities = 44/188 (23%), Positives = 70/188 (37%), Gaps = 14/188 (7%)

Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           M  GSL++ +              + I V   L Y    H    I+H D+KP+NIL++  
Sbjct: 113 MDGGSLDQ-VLKKAGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSR 168

Query: 61  MVAHVSDFGISKLLGEGEDFVTQTMTMATIG---YMAPEYGSEGIVSAKCDVYSYGVLLM 117
               + DFG+S  L         +M  + +G   YM+PE       S + D++S G+ L+
Sbjct: 169 GEIKLCDFGVSGQL-------IDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLV 221

Query: 118 ETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLA 177
           E    + P       E+ L    +       T        R    F       ++I +L 
Sbjct: 222 EMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELL 281

Query: 178 LDCCMESP 185
                E P
Sbjct: 282 DYIVNEPP 289

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score = 74.0 bits (182), Expect = 5e-16
 Identities = 29/129 (22%), Positives = 48/129 (37%), Gaps = 9/129 (6%)

Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           +  GSL + +       +       +      LEY H    +  I+H D+K  N+LL  +
Sbjct: 132 LEGGSLGQLIKQMGCLPEDRAL-YYLGQALEGLEYLH----TRRILHGDVKADNVLLSSD 186

Query: 61  -MVAHVSDFGISKLLGEGEDFVTQTMTMATIG---YMAPEYGSEGIVSAKCDVYSYGVLL 116
              A + DFG +  L       +        G   +MAPE        AK D++S   ++
Sbjct: 187 GSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMM 246

Query: 117 METFTRKRP 125
           +       P
Sbjct: 247 LHMLNGCHP 255

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score = 73.5 bits (181), Expect = 6e-16
 Identities = 37/151 (24%), Positives = 56/151 (37%), Gaps = 19/151 (12%)

Query: 2   PNGSLEKWLYSY---NYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLD 58
             G+L   +        F    + L +++ +   LE  H    +    H DLKPTNILL 
Sbjct: 113 KRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH----AKGYAHRDLKPTNILLG 168

Query: 59  ENMVAHVSDFGISKLLGEGEDFVTQTMTMA-------TIGYMAPE----YGSEGIVSAKC 107
           +     + D G         +   Q +T+        TI Y APE         I   + 
Sbjct: 169 DEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVI-DERT 227

Query: 108 DVYSYGVLLMETFTRKRPTDEMFTGEMSLRR 138
           DV+S G +L      + P D +F    S+  
Sbjct: 228 DVWSLGCVLYAMMFGEGPYDMVFQKGDSVAL 258

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score = 72.6 bits (178), Expect = 2e-15
 Identities = 35/139 (25%), Positives = 59/139 (42%), Gaps = 23/139 (16%)

Query: 2   PNGSLEKWLYSYNYFFDILER--LNIMIDVGSALEYPH-HGHSSAPIIHCDLKPTNILL- 57
           P GSL   L   +  + + E   L ++ DV   + +   +G     I+H ++KP NI+  
Sbjct: 92  PCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG-----IVHRNIKPGNIMRV 146

Query: 58  ---DENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIV--------SAK 106
              D   V  ++DFG ++ L + E FV+      T  Y+ P+     ++         A 
Sbjct: 147 IGEDGQSVYKLTDFGAARELEDDEQFVSL---YGTEEYLHPDMYERAVLRKDHQKKYGAT 203

Query: 107 CDVYSYGVLLMETFTRKRP 125
            D++S GV      T   P
Sbjct: 204 VDLWSIGVTFYHAATGSLP 222

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score = 72.8 bits (178), Expect = 3e-15
 Identities = 40/130 (30%), Positives = 60/130 (46%), Gaps = 12/130 (9%)

Query: 1   MPNGSLEKWLYSYNYFFDILER--LNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLD 58
              G L K+L  +     + E     ++ D+ SAL Y H       IIH DLKP NI+L 
Sbjct: 100 CEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR----IIHRDLKPENIVLQ 155

Query: 59  ---ENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVL 115
              + ++  + D G +K L +GE        + T+ Y+APE   +   +   D +S+G L
Sbjct: 156 PGPQRLIHKIIDLGYAKELDQGELCTEF---VGTLQYLAPELLEQKKYTVTVDYWSFGTL 212

Query: 116 LMETFTRKRP 125
             E  T  RP
Sbjct: 213 AFECITGFRP 222

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 71.5 bits (176), Expect = 3e-15
 Identities = 34/106 (32%), Positives = 46/106 (43%), Gaps = 27/106 (25%)

Query: 24  NIMIDVGSALEYPH-HGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVT 82
            IM  +   +   H        I+H DLKP NILLD++M   ++DFG S  L  GE    
Sbjct: 128 KIMRALLEVICALHKLN-----IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRE 182

Query: 83  QTMTMATIGYMAPE------------YGSEGIVSAKCDVYSYGVLL 116
                 T  Y+APE            YG E       D++S GV++
Sbjct: 183 ---VCGTPSYLAPEIIECSMNDNHPGYGKE------VDMWSTGVIM 219

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score = 71.7 bits (176), Expect = 3e-15
 Identities = 34/139 (24%), Positives = 57/139 (41%), Gaps = 21/139 (15%)

Query: 1   MPNGSLEKWLYSYNYFFDILER--LNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILL- 57
            P GSL   L   +  + + E   L ++ DV   + +         I+H ++KP NI+  
Sbjct: 91  CPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG----IVHRNIKPGNIMRV 146

Query: 58  ---DENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIV--------SAK 106
              D   V  ++DFG ++ L + E FV+      T  Y+ P+     ++         A 
Sbjct: 147 IGEDGQSVYKLTDFGAARELEDDEQFVSL---YGTEEYLHPDMYERAVLRKDHQKKYGAT 203

Query: 107 CDVYSYGVLLMETFTRKRP 125
            D++S GV      T   P
Sbjct: 204 VDLWSIGVTFYHAATGSLP 222

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score = 71.7 bits (176), Expect = 4e-15
 Identities = 33/128 (25%), Positives = 47/128 (36%), Gaps = 19/128 (14%)

Query: 23  LNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVT 82
           L I      A+++ H      PIIH DLK  N+LL       + DFG +  +    D+  
Sbjct: 139 LKIFYQTCRAVQHMHR--QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSW 196

Query: 83  QTMTMA----------TIGYMAPE---YGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEM 129
                A          T  Y  PE     S   +  K D+++ G +L     R+ P    
Sbjct: 197 SAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP---- 252

Query: 130 FTGEMSLR 137
           F     LR
Sbjct: 253 FEDGAKLR 260

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 71.6 bits (176), Expect = 4e-15
 Identities = 26/131 (19%), Positives = 58/131 (44%), Gaps = 13/131 (9%)

Query: 1   MPNGSLEKWL---------YSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLK 51
           M  G L+ +L                 + + + +  ++   + Y     ++   +H DL 
Sbjct: 110 MTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAY----LNANKFVHRDLA 165

Query: 52  PTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYS 111
             N ++ E+    + DFG+++ + E + +      +  + +M+PE   +G+ +   DV+S
Sbjct: 166 ARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWS 225

Query: 112 YGVLLMETFTR 122
           +GV+L E  T 
Sbjct: 226 FGVVLWEIATL 236

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 71.5 bits (176), Expect = 4e-15
 Identities = 31/134 (23%), Positives = 57/134 (42%), Gaps = 17/134 (12%)

Query: 1   MPNGSLEKWL-------------YSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIH 47
              G L  +L                N      + L+    V   + +     +S   IH
Sbjct: 132 CCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFL----ASKNCIH 187

Query: 48  CDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKC 107
            D+   N+LL    VA + DFG+++ +    +++ +      + +MAPE   + + + + 
Sbjct: 188 RDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQS 247

Query: 108 DVYSYGVLLMETFT 121
           DV+SYG+LL E F+
Sbjct: 248 DVWSYGILLWEIFS 261

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 71.2 bits (175), Expect = 5e-15
 Identities = 40/136 (29%), Positives = 66/136 (48%), Gaps = 19/136 (13%)

Query: 1   MPNGSLEKWL---------YSYNYFFDILERLN------IMIDVGSALEYPHHGHSSAPI 45
              G+L ++L         YSYN   +  E+L+          V   +EY     +S   
Sbjct: 157 ASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL----ASKKC 212

Query: 46  IHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSA 105
           IH DL   N+L+ E+ V  ++DFG+++ +   + +   T     + +MAPE   + I + 
Sbjct: 213 IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTH 272

Query: 106 KCDVYSYGVLLMETFT 121
           + DV+S+GVLL E FT
Sbjct: 273 QSDVWSFGVLLWEIFT 288

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 70.4 bits (173), Expect = 7e-15
 Identities = 32/138 (23%), Positives = 55/138 (39%), Gaps = 21/138 (15%)

Query: 1   MPNGSLEKWL-------YSYNYFFDILER----------LNIMIDVGSALEYPHHGHSSA 43
              G L  +L               I+E           L+    V   + +     +S 
Sbjct: 109 CCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL----ASK 164

Query: 44  PIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIV 103
             IH DL   NILL    +  + DFG+++ +    ++V +      + +MAPE     + 
Sbjct: 165 NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVY 224

Query: 104 SAKCDVYSYGVLLMETFT 121
           + + DV+SYG+ L E F+
Sbjct: 225 TFESDVWSYGIFLWELFS 242

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 70.4 bits (173), Expect = 8e-15
 Identities = 36/130 (27%), Positives = 58/130 (44%), Gaps = 13/130 (10%)

Query: 1   MPNGSLEKWL------YSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTN 54
           M  G L+ +L       S      +L+ L++  D+    +Y          IH D+   N
Sbjct: 115 MAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY----LEENHFIHRDIAARN 170

Query: 55  ILLD---ENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYS 111
            LL       VA + DFG+++ +     +      M  + +M PE   EGI ++K D +S
Sbjct: 171 CLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWS 230

Query: 112 YGVLLMETFT 121
           +GVLL E F+
Sbjct: 231 FGVLLWEIFS 240

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 70.4 bits (173), Expect = 9e-15
 Identities = 36/136 (26%), Positives = 60/136 (44%), Gaps = 19/136 (13%)

Query: 1   MPNGSLEKWL---------------YSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPI 45
              G+L  +L                 Y  F  +   +     V   +E+     +S   
Sbjct: 114 CKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL----ASRKC 169

Query: 46  IHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSA 105
           IH DL   NILL E  V  + DFG+++ + +  D+V +      + +MAPE   + + + 
Sbjct: 170 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI 229

Query: 106 KCDVYSYGVLLMETFT 121
           + DV+S+GVLL E F+
Sbjct: 230 QSDVWSFGVLLWEIFS 245

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 70.0 bits (172), Expect = 1e-14
 Identities = 34/98 (34%), Positives = 46/98 (46%), Gaps = 10/98 (10%)

Query: 25  IMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQT 84
           I +    AL +         IIH D+KP+NILLD +    + DFGIS   G+  D + +T
Sbjct: 130 ITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGIS---GQLVDSIAKT 183

Query: 85  MTMATIGYMAPE----YGSEGIVSAKCDVYSYGVLLME 118
                  YMAPE      S      + DV+S G+ L E
Sbjct: 184 RDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYE 221

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 70.1 bits (172), Expect = 1e-14
 Identities = 36/130 (27%), Positives = 58/130 (44%), Gaps = 13/130 (10%)

Query: 1   MPNGSLEKWL------YSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTN 54
           M  G L+ +L       S      +L+ L++  D+    +Y          IH D+   N
Sbjct: 156 MAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY----LEENHFIHRDIAARN 211

Query: 55  ILLD---ENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYS 111
            LL       VA + DFG+++ +     +      M  + +M PE   EGI ++K D +S
Sbjct: 212 CLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWS 271

Query: 112 YGVLLMETFT 121
           +GVLL E F+
Sbjct: 272 FGVLLWEIFS 281

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 69.8 bits (171), Expect = 1e-14
 Identities = 35/125 (28%), Positives = 56/125 (44%), Gaps = 16/125 (12%)

Query: 1   MPNGSLEKWLYSYNYF-------FDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPT 53
           M N S+ K+   +            I     I+  V ++  Y H+  +   I H D+KP+
Sbjct: 125 MENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPS 181

Query: 54  NILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPE--YGSEGIVSAKCDVYS 111
           NIL+D+N    +SDFG S+ +    D   +  +  T  +M PE          AK D++S
Sbjct: 182 NILMDKNGRVKLSDFGESEYM---VDKKIKG-SRGTYEFMPPEFFSNESSYNGAKVDIWS 237

Query: 112 YGVLL 116
            G+ L
Sbjct: 238 LGICL 242

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 69.7 bits (171), Expect = 2e-14
 Identities = 33/99 (33%), Positives = 48/99 (48%), Gaps = 11/99 (11%)

Query: 25  IMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQT 84
           + + +  AL Y    H    +IH D+KP+NILLDE     + DFGIS   G   D   + 
Sbjct: 129 MTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGIS---GRLVDDKAKD 182

Query: 85  MTMATIGYMAPE-----YGSEGIVSAKCDVYSYGVLLME 118
            +     YMAPE       ++     + DV+S G+ L+E
Sbjct: 183 RSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVE 221

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 69.7 bits (171), Expect = 2e-14
 Identities = 35/100 (35%), Positives = 50/100 (50%), Gaps = 15/100 (15%)

Query: 24  NIMIDVGSALEYPH-HGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVT 82
           +IM  +  A+ + H +      I+H DLKP NILLD+NM   +SDFG S  L  GE    
Sbjct: 204 SIMRSLLEAVSFLHANN-----IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRE 258

Query: 83  QTMTMATIGYMAPE------YGSEGIVSAKCDVYSYGVLL 116
                 T GY+APE        +      + D+++ GV+L
Sbjct: 259 ---LCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 69.7 bits (171), Expect = 2e-14
 Identities = 34/136 (25%), Positives = 64/136 (47%), Gaps = 19/136 (13%)

Query: 1   MPNGSLEKWL-------YSYNYFFDILER--------LNIMIDVGSALEYPHHGHSSAPI 45
              G+L ++L         Y+Y  + +          ++    +   +EY     +S   
Sbjct: 169 ASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL----ASQKC 224

Query: 46  IHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSA 105
           IH DL   N+L+ EN V  ++DFG+++ +   + +   T     + +MAPE   + + + 
Sbjct: 225 IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTH 284

Query: 106 KCDVYSYGVLLMETFT 121
           + DV+S+GVL+ E FT
Sbjct: 285 QSDVWSFGVLMWEIFT 300

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 69.2 bits (170), Expect = 2e-14
 Identities = 36/136 (26%), Positives = 64/136 (47%), Gaps = 19/136 (13%)

Query: 1   MPNGSLEKWL---------YSYNYFFDILERLN------IMIDVGSALEYPHHGHSSAPI 45
              G+L ++L         YSY+      E++           +   +EY     +S   
Sbjct: 123 ASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL----ASQKC 178

Query: 46  IHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSA 105
           IH DL   N+L+ EN V  ++DFG+++ +   + +   T     + +MAPE   + + + 
Sbjct: 179 IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTH 238

Query: 106 KCDVYSYGVLLMETFT 121
           + DV+S+GVL+ E FT
Sbjct: 239 QSDVWSFGVLMWEIFT 254

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 68.8 bits (169), Expect = 3e-14
 Identities = 41/136 (30%), Positives = 62/136 (45%), Gaps = 22/136 (16%)

Query: 1   MPNGSLEKWL---------------YSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPI 45
            P+G+L  +L                S        + L+   DV   ++Y     S    
Sbjct: 108 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL----SQKQF 163

Query: 46  IHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSA 105
           IH DL   NIL+ EN VA ++DFG+S+     E +V +TM    + +MA E  +  + + 
Sbjct: 164 IHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLPVRWMAIESLNYSVYTT 220

Query: 106 KCDVYSYGVLLMETFT 121
             DV+SYGVLL E  +
Sbjct: 221 NSDVWSYGVLLWEIVS 236

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 68.4 bits (168), Expect = 3e-14
 Identities = 36/129 (27%), Positives = 57/129 (44%), Gaps = 27/129 (20%)

Query: 4   GSLEKWLYSYNYFFDILERLN------IMIDVGSALEYPHHGHSSAPIIHCDLKPTNILL 57
            SL+K    Y    D  + +       I + +  ALE+ H   S   +IH D+KP+N+L+
Sbjct: 90  TSLDK---FYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLI 143

Query: 58  DENMVAHVSDFGISKLLGEGEDFVTQTMTMAT-IG---YMAPE----YGSEGIVSAKCDV 109
           +      + DFGIS  L          +      G   YMAPE      ++   S K D+
Sbjct: 144 NALGQVKMCDFGISGYL-------VDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDI 196

Query: 110 YSYGVLLME 118
           +S G+ ++E
Sbjct: 197 WSLGITMIE 205

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 68.4 bits (168), Expect = 3e-14
 Identities = 30/136 (22%), Positives = 62/136 (45%), Gaps = 19/136 (13%)

Query: 1   MPNGSLEKWL---------------YSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPI 45
             +G L ++L                +     +  + ++++  + + +EY     SS  +
Sbjct: 94  CSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEY----LSSHHV 149

Query: 46  IHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSA 105
           +H DL   N+L+ + +   +SD G+ + +   + +     ++  I +MAPE    G  S 
Sbjct: 150 VHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSI 209

Query: 106 KCDVYSYGVLLMETFT 121
             D++SYGV+L E F+
Sbjct: 210 DSDIWSYGVVLWEVFS 225

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 68.4 bits (168), Expect = 4e-14
 Identities = 37/136 (27%), Positives = 61/136 (44%), Gaps = 19/136 (13%)

Query: 1   MPNGSLEKWLYSYNYFFDILER---------------LNIMIDVGSALEYPHHGHSSAPI 45
           M +G L K+L ++     IL                 L+I   + S + Y     +S   
Sbjct: 99  MKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVY----LASQHF 154

Query: 46  IHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSA 105
           +H DL   N L+  N++  + DFG+S+ +   + +     TM  I +M PE       + 
Sbjct: 155 VHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTT 214

Query: 106 KCDVYSYGVLLMETFT 121
           + DV+S+GV+L E FT
Sbjct: 215 ESDVWSFGVILWEIFT 230

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 69.0 bits (169), Expect = 4e-14
 Identities = 32/101 (31%), Positives = 47/101 (46%), Gaps = 21/101 (20%)

Query: 24  NIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILL---DENMVAHVSDFGISKLLGEGEDF 80
           NIM  + S + Y H       I+H D+KP NILL   +  +   + DFG+S    +    
Sbjct: 150 NIMKQILSGICYLH----KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKL 205

Query: 81  VTQTMTMATIGYMAPE-----YGSEGIVSAKCDVYSYGVLL 116
             +   + T  Y+APE     Y        KCDV+S GV++
Sbjct: 206 RDR---LGTAYYIAPEVLKKKYNE------KCDVWSCGVIM 237

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 68.1 bits (167), Expect = 4e-14
 Identities = 27/132 (20%), Positives = 51/132 (38%), Gaps = 23/132 (17%)

Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLD-- 58
           +  GSL+ +L       +IL +L +   + +A+ +         +IH ++   NILL   
Sbjct: 94  VKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHF----LEENTLIHGNVCAKNILLIRE 149

Query: 59  ------ENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPE---YGSEGIVSAKCDV 109
                       +SD GIS  +   +      +    I ++ PE         ++   D 
Sbjct: 150 EDRKTGNPPFIKLSDPGISITVLPKD------ILQERIPWVPPECIENP--KNLNLATDK 201

Query: 110 YSYGVLLMETFT 121
           +S+G  L E  +
Sbjct: 202 WSFGTTLWEICS 213

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 68.1 bits (167), Expect = 5e-14
 Identities = 30/99 (30%), Positives = 49/99 (49%), Gaps = 4/99 (4%)

Query: 23  LNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVT 82
           L     V   +E+          +H DL   N+L+    V  + DFG+++ +    ++V 
Sbjct: 175 LCFAYQVAKGMEFL----EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVV 230

Query: 83  QTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT 121
           +      + +MAPE   EGI + K DV+SYG+LL E F+
Sbjct: 231 RGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 68.0 bits (167), Expect = 6e-14
 Identities = 28/99 (28%), Positives = 52/99 (52%), Gaps = 4/99 (4%)

Query: 23  LNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVT 82
           ++    +   ++Y     +   ++H DL   NIL+ E     +SDFG+S+ + E + +V 
Sbjct: 153 ISFAWQISQGMQYL----AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVK 208

Query: 83  QTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT 121
           ++     + +MA E   + I + + DV+S+GVLL E  T
Sbjct: 209 RSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 67.9 bits (166), Expect = 7e-14
 Identities = 35/100 (35%), Positives = 48/100 (48%), Gaps = 12/100 (12%)

Query: 24  NIMIDVGSALEYPH-HGHSSAPIIHCDLKPTNILL--DENMVAHVSDFGISKLLGEGEDF 80
           NIM  + SAL Y H  G     I H D+KP N L   +++    + DFG+SK   +  + 
Sbjct: 172 NIMRQIFSALHYLHNQG-----ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNG 226

Query: 81  VTQTMTMA--TIGYMAPE--YGSEGIVSAKCDVYSYGVLL 116
               MT    T  ++APE    +      KCD +S GVLL
Sbjct: 227 EYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 67.7 bits (166), Expect = 9e-14
 Identities = 29/119 (24%), Positives = 53/119 (44%), Gaps = 32/119 (26%)

Query: 16  FFDILER--------LNIMIDVGSALEYPH-HGHSSAPIIHCDLKPTNILL---DENMVA 63
           F DI+ R         + +  +  ++ Y H +G     I+H +LKP N+LL    +    
Sbjct: 116 FEDIVAREFYSEADASHCIQQILESIAYCHSNG-----IVHRNLKPENLLLASKAKGAAV 170

Query: 64  HVSDFGISKLLGEGEDFVTQTMTMATIGYMAPE------YGSEGIVSAKCDVYSYGVLL 116
            ++DFG++  + + E +        T GY++PE      Y          D+++ GV+L
Sbjct: 171 KLADFGLAIEVNDSEAWHG---FAGTPGYLSPEVLKKDPYSKP------VDIWACGVIL 220

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 67.0 bits (164), Expect = 1e-13
 Identities = 30/99 (30%), Positives = 48/99 (48%), Gaps = 4/99 (4%)

Query: 23  LNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVT 82
           L I   V + + Y     S    +H DL   N L+ ENMV  ++DFG+S+ +   + +  
Sbjct: 177 LCIARQVAAGMAY----LSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKA 232

Query: 83  QTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT 121
                  I +M PE       + + DV++YGV+L E F+
Sbjct: 233 DGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score = 66.5 bits (163), Expect = 1e-13
 Identities = 27/90 (30%), Positives = 39/90 (43%), Gaps = 12/90 (13%)

Query: 31  SALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTM--TMA 88
           +AL Y H       +IH D+KP N+LL       ++DFG S             +  T+ 
Sbjct: 120 NALSYCHSKR----VIHRDIKPENLLLGSAGELKIADFGWSVHA---PSSRRTDLCGTLD 172

Query: 89  TIGYMAPEYGSEGIVSAKCDVYSYGVLLME 118
              Y+ PE     +   K D++S GVL  E
Sbjct: 173 ---YLPPEMIEGRMHDEKVDLWSLGVLCYE 199

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 67.0 bits (164), Expect = 1e-13
 Identities = 30/103 (29%), Positives = 47/103 (45%), Gaps = 24/103 (23%)

Query: 24  NIMIDVGSALEYPH-HGHSSAPIIHCDLKPTNILL---DENMVAHVSDFGISKLLGEGED 79
           + +  +  A+ Y H +G     I+H DLKP N+L      +    ++DFG+SK++     
Sbjct: 152 DAVKQILEAVAYLHENG-----IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL 206

Query: 80  FVTQTMTMATIGYMAPE------YGSEGIVSAKCDVYSYGVLL 116
             T      T GY APE      YG E       D++S G++ 
Sbjct: 207 MKT---VCGTPGYCAPEILRGCAYGPE------VDMWSVGIIT 240

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 66.5 bits (163), Expect = 2e-13
 Identities = 31/102 (30%), Positives = 45/102 (44%), Gaps = 23/102 (22%)

Query: 24  NIMIDVGSALEYPH-HGHSSAPIIHCDLKPTNILL---DENMVAHVSDFGISKLLGEGED 79
            IM DV SA+ Y H        + H DLKP N L      +    + DFG++     G+ 
Sbjct: 110 RIMKDVLSAVAYCHKLN-----VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM 164

Query: 80  FVTQTMTMATIGYMAPE-----YGSEGIVSAKCDVYSYGVLL 116
             T    + T  Y++P+     YG E      CD +S GV++
Sbjct: 165 MRT---KVGTPYYVSPQVLEGLYGPE------CDEWSAGVMM 197

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 67.0 bits (164), Expect = 2e-13
 Identities = 33/101 (32%), Positives = 47/101 (46%), Gaps = 21/101 (20%)

Query: 24  NIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILL---DENMVAHVSDFGISKLLGEGEDF 80
            I+  V S + Y H       I+H DLKP NILL   +++    + DFG+S    +    
Sbjct: 125 RIIKQVFSGITYMH----KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM 180

Query: 81  VTQTMTMATIGYMAPE-----YGSEGIVSAKCDVYSYGVLL 116
             +   + T  Y+APE     Y        KCDV+S GV+L
Sbjct: 181 KDR---IGTAYYIAPEVLRGTYDE------KCDVWSAGVIL 212

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 66.5 bits (163), Expect = 2e-13
 Identities = 35/106 (33%), Positives = 49/106 (46%), Gaps = 27/106 (25%)

Query: 24  NIMIDVGSALEYPH-HGHSSAPIIHCDLKPTNILL---DENMVAHVSDFGISKLLGEGED 79
                +  A++Y H +G     IIH DLKP N+LL   +E+ +  ++DFG SK+LGE   
Sbjct: 118 LYFYQMLLAVQYLHENG-----IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL 172

Query: 80  FVTQTMTMATIGYMAPE---------YGSEGIVSAKCDVYSYGVLL 116
             T      T  Y+APE         Y          D +S GV+L
Sbjct: 173 MRT---LCGTPTYLAPEVLVSVGTAGYNRA------VDCWSLGVIL 209

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 67.1 bits (164), Expect = 2e-13
 Identities = 30/104 (28%), Positives = 44/104 (42%), Gaps = 26/104 (25%)

Query: 24  NIMIDVGSALEYPH-HGHSSAPIIHCDLKPTNILL---DENMVAHVSDFGISKLLGEGED 79
            IM  +G A++Y H        I H D+KP N+L      N +  ++DFG +K       
Sbjct: 165 EIMKSIGEAIQYLHSIN-----IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS 219

Query: 80  FVTQTMTMA-TIGYMAPE------YGSEGIVSAKCDVYSYGVLL 116
                 T   T  Y+APE      Y         CD++S GV++
Sbjct: 220 L----TTPCYTPYYVAPEVLGPEKYDKS------CDMWSLGVIM 253

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 66.6 bits (163), Expect = 3e-13
 Identities = 35/118 (29%), Positives = 53/118 (44%), Gaps = 25/118 (21%)

Query: 24  NIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILL---DENMVAHVSDFGISKLLGEGEDF 80
            I+  V S + Y H       I+H DLKP N+LL   +++ +  + DFG+S +    +  
Sbjct: 140 VIIKQVLSGVTYLH----KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKM 195

Query: 81  VTQTMTMATIGYMAPE-----YGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGE 133
             +   + T  Y+APE     Y        KCDV+S GV+L        P    F G+
Sbjct: 196 KER---LGTAYYIAPEVLRKKYDE------KCDVWSIGVILFILLAGYPP----FGGQ 240

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 66.2 bits (162), Expect = 3e-13
 Identities = 34/135 (25%), Positives = 59/135 (43%), Gaps = 18/135 (13%)

Query: 1   MPNGSLEKWLYSYNYFFDILER--------------LNIMIDVGSALEYPHHGHSSAPII 46
           M +G L ++L S+     +L                L +   V + + Y     +    +
Sbjct: 125 MRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVY----LAGLHFV 180

Query: 47  HCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAK 106
           H DL   N L+ + +V  + DFG+S+ +   + +     TM  I +M PE       + +
Sbjct: 181 HRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTE 240

Query: 107 CDVYSYGVLLMETFT 121
            DV+S+GV+L E FT
Sbjct: 241 SDVWSFGVVLWEIFT 255

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 66.6 bits (163), Expect = 3e-13
 Identities = 32/101 (31%), Positives = 45/101 (44%), Gaps = 21/101 (20%)

Query: 24  NIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILL---DENMVAHVSDFGISKLLGEGEDF 80
            I+  V S + Y H       I+H DLKP N+LL    ++    + DFG+S      +  
Sbjct: 130 RIIRQVLSGITYMH----KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM 185

Query: 81  VTQTMTMATIGYMAPE-----YGSEGIVSAKCDVYSYGVLL 116
             +     T  Y+APE     Y        KCDV+S GV+L
Sbjct: 186 KDKI---GTAYYIAPEVLHGTYDE------KCDVWSTGVIL 217

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 65.8 bits (161), Expect = 3e-13
 Identities = 32/92 (34%), Positives = 50/92 (54%), Gaps = 9/92 (9%)

Query: 28  DVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTM 87
           D+   +EY H+      IIH D+KP+N+L+ E+    ++DFG+S    +G D +    T+
Sbjct: 145 DLIKGIEYLHYQK----IIHRDIKPSNLLVGEDGHIKIADFGVSNEF-KGSDALLSN-TV 198

Query: 88  ATIGYMAPE--YGSEGIVS-AKCDVYSYGVLL 116
            T  +MAPE    +  I S    DV++ GV L
Sbjct: 199 GTPAFMAPESLSETRKIFSGKALDVWAMGVTL 230

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 66.3 bits (162), Expect = 3e-13
 Identities = 35/106 (33%), Positives = 49/106 (46%), Gaps = 27/106 (25%)

Query: 24  NIMIDVGSALEYPH-HGHSSAPIIHCDLKPTNILL---DENMVAHVSDFGISKLLGEGED 79
                +  A++Y H +G     IIH DLKP N+LL   +E+ +  ++DFG SK+LGE   
Sbjct: 243 LYFYQMLLAVQYLHENG-----IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL 297

Query: 80  FVTQTMTMATIGYMAPE---------YGSEGIVSAKCDVYSYGVLL 116
             T      T  Y+APE         Y          D +S GV+L
Sbjct: 298 MRT---LCGTPTYLAPEVLVSVGTAGYNRA------VDCWSLGVIL 334

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 65.3 bits (160), Expect = 4e-13
 Identities = 27/90 (30%), Positives = 38/90 (42%), Gaps = 12/90 (13%)

Query: 31  SALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTM--TMA 88
            AL Y H       +IH D+KP N+L+       ++DFG S           +TM  T+ 
Sbjct: 125 DALHYCHERK----VIHRDIKPENLLMGYKGELKIADFGWSVHA---PSLRRRTMCGTLD 177

Query: 89  TIGYMAPEYGSEGIVSAKCDVYSYGVLLME 118
              Y+ PE         K D++  GVL  E
Sbjct: 178 ---YLPPEMIEGKTHDEKVDLWCAGVLCYE 204

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 65.3 bits (160), Expect = 4e-13
 Identities = 33/102 (32%), Positives = 47/102 (46%), Gaps = 23/102 (22%)

Query: 24  NIMIDVGSALEYPH-HGHSSAPIIHCDLKPTNILL---DENMVAHVSDFGISKLLGEGED 79
            I+  V S + Y H H      I+H DLKP NILL   +++    + DFG+S    +   
Sbjct: 125 RIIKQVFSGITYMHKHN-----IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK 179

Query: 80  FVTQTMTMATIGYMAPE-----YGSEGIVSAKCDVYSYGVLL 116
                  + T  Y+APE     Y  +      CDV+S GV+L
Sbjct: 180 MKD---RIGTAYYIAPEVLRGTYDEK------CDVWSAGVIL 212

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 65.3 bits (160), Expect = 4e-13
 Identities = 29/102 (28%), Positives = 44/102 (43%), Gaps = 23/102 (22%)

Query: 24  NIMIDVGSALEYPH-HGHSSAPIIHCDLKPTNILL---DENMVAHVSDFGISKLLGEGED 79
            +M  + +AL Y H        ++H DLKP NIL      +    + DFG+++L    E 
Sbjct: 128 ELMKQMMNALAYFHSQH-----VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH 182

Query: 80  FVTQTMTMATIGYMAPE-----YGSEGIVSAKCDVYSYGVLL 116
                    T  YMAPE        +      CD++S GV++
Sbjct: 183 STN---AAGTALYMAPEVFKRDVTFK------CDIWSAGVVM 215

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score = 64.9 bits (159), Expect = 5e-13
 Identities = 30/116 (25%), Positives = 53/116 (45%), Gaps = 8/116 (6%)

Query: 2   PNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENM 61
            NG + ++L +    F   E  + M  + + + Y H       I+H DL  +N+LL  NM
Sbjct: 94  HNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG----ILHRDLTLSNLLLTRNM 149

Query: 62  VAHVSDFGISKLLGEGEDFVTQTMTM-ATIGYMAPEYGSEGIVSAKCDVYSYGVLL 116
              ++DFG++  L    +      T+  T  Y++PE  +      + DV+S G + 
Sbjct: 150 NIKIADFGLATQLKMPHEKH---YTLCGTPNYISPEIATRSAHGLESDVWSLGCMF 202

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 64.9 bits (159), Expect = 6e-13
 Identities = 29/119 (24%), Positives = 53/119 (44%), Gaps = 32/119 (26%)

Query: 16  FFDILER--------LNIMIDVGSALEYPH-HGHSSAPIIHCDLKPTNILL---DENMVA 63
           F DI+ R         + +  +  ++ Y H +G     I+H +LKP N+LL    +    
Sbjct: 93  FEDIVAREFYSEADASHCIQQILESIAYCHSNG-----IVHRNLKPENLLLASKAKGAAV 147

Query: 64  HVSDFGISKLLGEGEDFVTQTMTMATIGYMAPE------YGSEGIVSAKCDVYSYGVLL 116
            ++DFG++  + + E +        T GY++PE      Y          D+++ GV+L
Sbjct: 148 KLADFGLAIEVNDSEAWHG---FAGTPGYLSPEVLKKDPYSKP------VDIWACGVIL 197

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 64.7 bits (158), Expect = 8e-13
 Identities = 28/87 (32%), Positives = 40/87 (45%), Gaps = 8/87 (9%)

Query: 31  SALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATI 90
           SA+ Y         IIH D+K  NI++ E+    + DFG +  L  G+ F T      TI
Sbjct: 141 SAVGYLRLKD----IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYT---FCGTI 193

Query: 91  GYMAPE-YGSEGIVSAKCDVYSYGVLL 116
            Y APE          + +++S GV L
Sbjct: 194 EYCAPEVLMGNPYRGPELEMWSLGVTL 220

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 64.6 bits (158), Expect = 8e-13
 Identities = 31/104 (29%), Positives = 49/104 (47%), Gaps = 25/104 (24%)

Query: 24  NIMIDVGSALEYPH-HGHSSAPIIHCDLKPTNILL---DENMVAHVSDFGISKLL-GEGE 78
            IM  + SA+ + H  G     ++H DLKP N+L    ++N+   + DFG ++L   + +
Sbjct: 110 YIMRKLVSAVSHMHDVG-----VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ 164

Query: 79  DFVTQTMTMATIGYMAPE------YGSEGIVSAKCDVYSYGVLL 116
              T      T+ Y APE      Y         CD++S GV+L
Sbjct: 165 PLKT---PCFTLHYAAPELLNQNGYDES------CDLWSLGVIL 199

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 64.6 bits (158), Expect = 8e-13
 Identities = 33/107 (30%), Positives = 47/107 (43%), Gaps = 19/107 (17%)

Query: 24  NIMIDVGSALEYPH-HGHSSAPIIHCDLKPTNILL---DENMVAHVSDFGISKLLGEGED 79
            ++ DV SAL++ H  G     I H DLKP NIL    ++     + DF +   +    D
Sbjct: 115 VVVQDVASALDFLHNKG-----IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGD 169

Query: 80  FV-TQTMTMATI----GYMAPE-----YGSEGIVSAKCDVYSYGVLL 116
                T  + T      YMAPE          I   +CD++S GV+L
Sbjct: 170 CSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 64.6 bits (158), Expect = 9e-13
 Identities = 31/94 (32%), Positives = 49/94 (52%), Gaps = 16/94 (17%)

Query: 31  SALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTM-AT 89
           SALEY H       IIH DLKP NILL+E+M   ++DFG +K+L           +   T
Sbjct: 141 SALEYLHGKG----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR-ANSFVGT 195

Query: 90  IGYMAPEYGSEGIVSAK-----CDVYSYGVLLME 118
             Y++PE     +++ K      D+++ G ++ +
Sbjct: 196 AQYVSPE-----LLTEKSACKSSDLWALGCIIYQ 224

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 64.1 bits (157), Expect = 1e-12
 Identities = 34/104 (32%), Positives = 49/104 (47%), Gaps = 27/104 (25%)

Query: 24  NIMIDVGSALEYPH-HGHSSAPIIHCDLKPTNILL---DENMVAHVSDFGISKLLGEGED 79
            ++  V SA++Y H +G     I+H DLKP N+L    +EN    ++DFG+SK+   G  
Sbjct: 110 LVIQQVLSAVKYLHENG-----IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG-- 162

Query: 80  FVTQTMTMA-TIGYMAPE------YGSEGIVSAKCDVYSYGVLL 116
                 T   T GY+APE      Y          D +S GV+ 
Sbjct: 163 ---IMSTACGTPGYVAPEVLAQKPYSKA------VDCWSIGVIT 197

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 64.4 bits (157), Expect = 1e-12
 Identities = 32/110 (29%), Positives = 47/110 (42%), Gaps = 24/110 (21%)

Query: 31  SALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHV--SDFGISKLLGEGEDFVTQTMTMA 88
            A++  H        +H D+KP NIL+D N   H+  +DFG    L E     +    + 
Sbjct: 186 IAIDSVH----QLHYVHRDIKPDNILMDMN--GHIRLADFGSCLKLMEDGTVQSSVA-VG 238

Query: 89  TIGYMAPE-----YGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGE 133
           T  Y++PE      G +G    +CD +S GV +           EM  GE
Sbjct: 239 TPDYISPEILQAMEGGKGRYGPECDWWSLGVCMY----------EMLYGE 278

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 64.5 bits (157), Expect = 1e-12
 Identities = 31/117 (26%), Positives = 47/117 (40%), Gaps = 33/117 (28%)

Query: 31  SALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHV--SDFGISKLLGEGEDFVTQTMTMA 88
             LE+ H    +  +++ DLKP NILLDE+   HV  SD G++    +      +     
Sbjct: 303 LGLEHMH----NRFVVYRDLKPANILLDEH--GHVRISDLGLACDFSKK-----KPHASV 351

Query: 89  -TIGYMAPEYGSEGIVSAK------CDVYSYGVLLMETFTRKRP--------TDEMF 130
            T GYMAPE     ++          D +S G +L +      P          E+ 
Sbjct: 352 GTHGYMAPE-----VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID 403

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 64.3 bits (157), Expect = 1e-12
 Identities = 31/104 (29%), Positives = 50/104 (48%), Gaps = 27/104 (25%)

Query: 24  NIMIDVGSALEYPH-HGHSSAPIIHCDLKPTNILL---DENMVAHVSDFGISKLLGEGED 79
            IM D+G+A+++ H H      I H D+KP N+L    +++ V  ++DFG +K   +   
Sbjct: 132 EIMRDIGTAIQFLHSHN-----IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA- 185

Query: 80  FVTQTMTMA-TIGYMAPE------YGSEGIVSAKCDVYSYGVLL 116
                 T   T  Y+APE      Y         CD++S GV++
Sbjct: 186 ----LQTPCYTPYYVAPEVLGPEKYDKS------CDMWSLGVIM 219

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 64.4 bits (157), Expect = 1e-12
 Identities = 36/140 (25%), Positives = 53/140 (37%), Gaps = 38/140 (27%)

Query: 29  VGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHV--SDFGISKLLGEGEDFVTQTMT 86
           +   LE  H       I++ DLKP NILLD++   H+  SD G++  + EG+        
Sbjct: 295 ICCGLEDLH----RERIVYRDLKPENILLDDH--GHIRISDLGLAVHVPEGQ----TIKG 344

Query: 87  MA-TIGYMAPE------YGSEGIVSAKCDVYSYGVLLMETFT---------RKRPTDEMF 130
              T+GYMAPE      Y          D ++ G LL E            +K   +E+ 
Sbjct: 345 RVGTVGYMAPEVVKNERYTFS------PDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE 398

Query: 131 TGEMSLRRWVKESLPHGLTE 150
                    V E      + 
Sbjct: 399 RLVKE----VPEEYSERFSP 414

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 63.9 bits (156), Expect = 2e-12
 Identities = 33/124 (26%), Positives = 49/124 (39%), Gaps = 37/124 (29%)

Query: 16  FFDILERLN------------IMIDVGSALEYPH-HGHSSAPIIHCDLKPTNILL---DE 59
            F+I++R +             M  +  AL Y H +      IIH D+KP  +LL   + 
Sbjct: 114 CFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN-----IIHRDVKPHCVLLASKEN 168

Query: 60  NMVAHVSDFGISKLLGEGEDFVTQTMTMA-TIGYMAPE------YGSEGIVSAKCDVYSY 112
           +    +  FG++  LGE             T  +MAPE      YG         DV+  
Sbjct: 169 SAPVKLGGFGVAIQLGESGLVAG---GRVGTPHFMAPEVVKREPYGKP------VDVWGC 219

Query: 113 GVLL 116
           GV+L
Sbjct: 220 GVIL 223

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score = 63.9 bits (156), Expect = 2e-12
 Identities = 24/87 (27%), Positives = 42/87 (48%), Gaps = 8/87 (9%)

Query: 31  SALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTM-AT 89
              +Y H       +IH DLK  N+ L+E++   + DFG++  +    +       +  T
Sbjct: 152 LGCQYLHRNR----VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK---KVLCGT 204

Query: 90  IGYMAPEYGSEGIVSAKCDVYSYGVLL 116
             Y+APE  S+   S + DV+S G ++
Sbjct: 205 PNYIAPEVLSKKGHSFEVDVWSIGCIM 231

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 63.4 bits (155), Expect = 3e-12
 Identities = 25/97 (25%), Positives = 45/97 (46%), Gaps = 12/97 (12%)

Query: 24  NIMIDVGSALEYPH-HGHSSAPIIHCDLKPTNILL---DENMVAHVSDFGISKLLGEGED 79
            ++  +   + Y H +      I+H DLKP NILL          + DFG+S+ +G   +
Sbjct: 135 RLIKQILEGVYYLHQNN-----IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE 189

Query: 80  FVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLL 116
                  M T  Y+APE  +   ++   D+++ G++ 
Sbjct: 190 LRE---IMGTPEYLAPEILNYDPITTATDMWNIGIIA 223

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 63.5 bits (154), Expect = 3e-12
 Identities = 21/137 (15%), Positives = 38/137 (27%), Gaps = 15/137 (10%)

Query: 17  FDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAH-----------V 65
                 ++  + +   +E  H       IIH D+KP N +L    +             +
Sbjct: 169 MPQGLVISFAMRMLYMIEQVH----DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLAL 224

Query: 66  SDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRP 125
            D G S  +         T    T G+   E  S    + + D +     +         
Sbjct: 225 IDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM 284

Query: 126 TDEMFTGEMSLRRWVKE 142
             +   GE       + 
Sbjct: 285 KVKNEGGECKPEGLFRR 301

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 63.6 bits (155), Expect = 3e-12
 Identities = 36/118 (30%), Positives = 50/118 (42%), Gaps = 33/118 (27%)

Query: 31  SALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHV--SDFGISKLLGEGEDFVTQTMTMA 88
           S LE+ H       II+ DLKP N+LLD++   +V  SD G++  L  G+    +T   A
Sbjct: 300 SGLEHLH----QRNIIYRDLKPENVLLDDD--GNVRISDLGLAVELKAGQT---KTKGYA 350

Query: 89  -TIGYMAPE------YGSEGIVSAKCDVYSYGVLLMETFT---------RKRPTDEMF 130
            T G+MAPE      Y          D ++ GV L E             K    E+ 
Sbjct: 351 GTPGFMAPELLLGEEYDFS------VDYFALGVTLYEMIAARGPFRARGEKVENKELK 402

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score = 63.0 bits (154), Expect = 3e-12
 Identities = 24/87 (27%), Positives = 42/87 (48%), Gaps = 8/87 (9%)

Query: 31  SALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTM-AT 89
              +Y H       +IH DLK  N+ L+E++   + DFG++  +    +       +  T
Sbjct: 126 LGCQYLHRNR----VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK---KVLCGT 178

Query: 90  IGYMAPEYGSEGIVSAKCDVYSYGVLL 116
             Y+APE  S+   S + DV+S G ++
Sbjct: 179 PNYIAPEVLSKKGHSFEVDVWSIGCIM 205

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 63.2 bits (154), Expect = 3e-12
 Identities = 33/109 (30%), Positives = 48/109 (44%), Gaps = 23/109 (21%)

Query: 31  SALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHV--SDFGISKLLGEGEDFVTQTMTMA 88
            AL+  H    S   IH D+KP N+LLD++   H+  +DFG    + +       T    
Sbjct: 179 LALDAIH----SMGFIHRDVKPDNMLLDKS--GHLKLADFGTCMKMNKEGMVRCDTAV-G 231

Query: 89  TIGYMAPE----YGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGE 133
           T  Y++PE     G +G    +CD +S GV L           EM  G+
Sbjct: 232 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLY----------EMLVGD 270

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 62.7 bits (153), Expect = 5e-12
 Identities = 29/120 (24%), Positives = 52/120 (43%), Gaps = 33/120 (27%)

Query: 16  FFDILER--------LNIMIDVGSALEYPH-HGHSSAPIIHCDLKPTNILL---DENMVA 63
           F DI+ R         + +  +  A+ + H  G     ++H +LKP N+LL    +    
Sbjct: 98  FEDIVAREYYSEADASHCIQQILEAVLHCHQMG-----VVHRNLKPENLLLASKLKGAAV 152

Query: 64  HVSDFGISKLLGEGEDFVTQTMTMA-TIGYMAPE------YGSEGIVSAKCDVYSYGVLL 116
            ++DFG++  +   +         A T GY++PE      YG         D+++ GV+L
Sbjct: 153 KLADFGLAIEVEGEQQAWF---GFAGTPGYLSPEVLRKDPYGKP------VDLWACGVIL 203

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 62.3 bits (152), Expect = 7e-12
 Identities = 31/105 (29%), Positives = 45/105 (42%), Gaps = 26/105 (24%)

Query: 24  NIMIDVGSALEYPH-HGHSSAPIIHCDLKPTNILL----DENMVAHVSDFGISKLLGEGE 78
            ++  +   +EY H  G     ++H DLKP+NIL            + DFG +K L    
Sbjct: 120 AVLFTITKTVEYLHAQG-----VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN 174

Query: 79  DFVTQTMTMA-TIGYMAPE------YGSEGIVSAKCDVYSYGVLL 116
                 MT   T  ++APE      Y +       CD++S GVLL
Sbjct: 175 GL---LMTPCYTANFVAPEVLERQGYDAA------CDIWSLGVLL 210

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 61.9 bits (151), Expect = 9e-12
 Identities = 40/115 (34%), Positives = 49/115 (42%), Gaps = 24/115 (20%)

Query: 31  SALEYPH-HGHSSAPIIHCDLKPTNILLDENMVAHV--SDFGISKLLGEGEDFVTQTMTM 87
            ALE+ H  G     II+ D+K  NILLD N   HV  +DFG+SK     E         
Sbjct: 170 LALEHLHKLG-----IIYRDIKLENILLDSN--GHVVLTDFGLSKEFVADETERAYDFC- 221

Query: 88  ATIGYMAPE---YGSEGIVSAKCDVYSYGVLLME---------TFTRKRPTDEMF 130
            TI YMAP+    G  G   A  D +S GVL+ E             K    E+ 
Sbjct: 222 GTIEYMAPDIVRGGDSGHDKA-VDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS 275

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 61.4 bits (150), Expect = 1e-11
 Identities = 40/114 (35%), Positives = 55/114 (48%), Gaps = 29/114 (25%)

Query: 31  SALEYPH-HGHSSAPIIHCDLKPTNILLDENMVAHV--SDFGISKLLGEGEDFVTQTMTM 87
            AL++ H  G     II+ DLKP NILLDE    H+  +DFG+SK   E  D   +  + 
Sbjct: 137 LALDHLHSLG-----IIYRDLKPENILLDEE--GHIKLTDFGLSK---ESIDHEKKAYSF 186

Query: 88  -ATIGYMAPEYGSEGIVSAK-----CDVYSYGVLLMETFTRKRP-----TDEMF 130
             T+ YMAPE     +V+ +      D +S+GVL+ E  T   P       E  
Sbjct: 187 CGTVEYMAPE-----VVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETM 235

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 61.3 bits (149), Expect = 2e-11
 Identities = 29/106 (27%), Positives = 50/106 (47%), Gaps = 12/106 (11%)

Query: 31  SALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTM-AT 89
           SAL+Y H   +   +++ DLK  N++LD++    ++DFG+ K   EG        T   T
Sbjct: 259 SALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCK---EGIKDGATMKTFCGT 312

Query: 90  IGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRP-----TDEMF 130
             Y+APE   +       D +  GV++ E    + P      +++F
Sbjct: 313 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF 358

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 60.6 bits (148), Expect = 2e-11
 Identities = 37/114 (32%), Positives = 48/114 (42%), Gaps = 29/114 (25%)

Query: 31  SALEYPH-HGHSSAPIIHCDLKPTNILLDENMVAHV--SDFGISKLLGEGEDFVTQTMTM 87
            AL + H  G     II+ DLKP NI+L+     HV  +DFG+ K   E     T T T 
Sbjct: 132 MALGHLHQKG-----IIYRDLKPENIMLNHQ--GHVKLTDFGLCK---ESIHDGTVTHTF 181

Query: 88  A-TIGYMAPEYGSEGIVSAK-----CDVYSYGVLLMETFTRKRP-----TDEMF 130
             TI YMAPE     I+         D +S G L+ +  T   P       +  
Sbjct: 182 CGTIEYMAPE-----ILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTI 230

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 60.8 bits (148), Expect = 2e-11
 Identities = 24/97 (24%), Positives = 43/97 (44%), Gaps = 11/97 (11%)

Query: 24  NIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILL----DENMVAHVSDFGISKLLGEGED 79
           + +  +   + Y H       I H DLKP NI+L           + DFG++  + +G +
Sbjct: 119 SFIKQILDGVNYLHTKK----IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE 174

Query: 80  FVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLL 116
           F        T  ++APE  +   +  + D++S GV+ 
Sbjct: 175 FKN---IFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 60.7 bits (148), Expect = 2e-11
 Identities = 26/89 (29%), Positives = 39/89 (43%), Gaps = 8/89 (8%)

Query: 31  SALEYPH-HGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMAT 89
             LEY H  G     I+H D+KP N+LL       +S  G+++ L       T   +  +
Sbjct: 120 DGLEYLHSQG-----IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGS 174

Query: 90  IGYMAPE--YGSEGIVSAKCDVYSYGVLL 116
             +  PE   G +     K D++S GV L
Sbjct: 175 PAFQPPEIANGLDTFSGFKVDIWSAGVTL 203

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 60.3 bits (147), Expect = 2e-11
 Identities = 24/97 (24%), Positives = 43/97 (44%), Gaps = 11/97 (11%)

Query: 24  NIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILL----DENMVAHVSDFGISKLLGEGED 79
           + +  +   + Y H       I H DLKP NI+L           + DFG++  + +G +
Sbjct: 119 SFIKQILDGVNYLHTKK----IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE 174

Query: 80  FVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLL 116
           F        T  ++APE  +   +  + D++S GV+ 
Sbjct: 175 FKN---IFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 60.5 bits (147), Expect = 3e-11
 Identities = 29/96 (30%), Positives = 43/96 (44%), Gaps = 11/96 (11%)

Query: 24  NIMIDVGSALEYPH-HGHSSAPIIHCDLKPTNILLDENMVAHV--SDFGISKLLGEGEDF 80
           N M      L++ H H      I+H D+KP NI+ +    + V   DFG++  L   E  
Sbjct: 153 NYMRQACEGLKHMHEHS-----IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV 207

Query: 81  VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLL 116
               +T AT  + APE      V    D+++ GVL 
Sbjct: 208 ---KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLG 240

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 60.5 bits (147), Expect = 3e-11
 Identities = 32/120 (26%), Positives = 46/120 (38%), Gaps = 33/120 (27%)

Query: 31  SALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHV--SDFGISKLLGEGEDFVTQTMTMA 88
            A++  H        +H D+KP NILLD     H+  +DFG    L       +    + 
Sbjct: 173 MAIDSVH----RLGYVHRDIKPDNILLDRC--GHIRLADFGSCLKLRADGTVRSLVA-VG 225

Query: 89  TIGYMAPE-------------YGSEGIVSAKCDVYSYGVLLMETFTRKRP-----TDEMF 130
           T  Y++PE             YG E      CD ++ GV   E F  + P     T E +
Sbjct: 226 TPDYLSPEILQAVGGGPGTGSYGPE------CDWWALGVFAYEMFYGQTPFYADSTAETY 279

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 60.6 bits (147), Expect = 3e-11
 Identities = 26/96 (27%), Positives = 38/96 (39%), Gaps = 11/96 (11%)

Query: 24  NIMIDVGSALEYPH-HGHSSAPIIHCDLKPTNILLDENMVAHV--SDFGISKLLGEGEDF 80
             M  V   L + H +       +H DLKP NI+        +   DFG++  L   +  
Sbjct: 259 EYMRQVCKGLCHMHENN-----YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV 313

Query: 81  VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLL 116
               +T  T  + APE      V    D++S GVL 
Sbjct: 314 ---KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLS 346

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score = 59.6 bits (145), Expect = 4e-11
 Identities = 24/141 (17%), Positives = 49/141 (34%), Gaps = 21/141 (14%)

Query: 2   PNGSLEKWLYSYNYFFDIL---ERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLD 58
             GSL   +             E  ++++ VG  L Y H       ++H D+KP+NI + 
Sbjct: 94  NGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS----LVHMDIKPSNIFIS 149

Query: 59  ENMVAHVSDFGISKLLGEGE-------DF--VTQ-TMTMATIG---YMAPEYGSEGIV-S 104
              + + +     +             D   VT+ +      G   ++A E   E     
Sbjct: 150 RTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEEGDSRFLANEVLQENYTHL 209

Query: 105 AKCDVYSYGVLLMETFTRKRP 125
            K D+++  + ++     +  
Sbjct: 210 PKADIFALALTVVCAAGAEPL 230

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 60.0 bits (146), Expect = 4e-11
 Identities = 24/98 (24%), Positives = 42/98 (42%), Gaps = 13/98 (13%)

Query: 24  NIMIDVGSALEYPH-HGHSSAPIIHCDLKPTNILL----DENMVAHVSDFGISKLLGEGE 78
             +  + + + Y H        I H DLKP NI+L           + DFG++  +  G 
Sbjct: 118 EFLKQILNGVYYLHSLQ-----IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN 172

Query: 79  DFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLL 116
           +F        T  ++APE  +   +  + D++S GV+ 
Sbjct: 173 EFKN---IFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 207

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 59.5 bits (145), Expect = 4e-11
 Identities = 26/98 (26%), Positives = 42/98 (42%), Gaps = 13/98 (13%)

Query: 24  NIMIDVGSALEYPH-HGHSSAPIIHCDLKPTNILL----DENMVAHVSDFGISKLLGEGE 78
             +  +   + Y H        I H DLKP NI+L      N    + DFGI+  +  G 
Sbjct: 112 QFLKQILDGVHYLHSKR-----IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN 166

Query: 79  DFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLL 116
           +F        T  ++APE  +   +  + D++S GV+ 
Sbjct: 167 EFKN---IFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 201

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 60.0 bits (146), Expect = 5e-11
 Identities = 37/115 (32%), Positives = 52/115 (45%), Gaps = 27/115 (23%)

Query: 29  VGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHV--SDFGISKLLGEGEDFVTQTMT 86
           + SAL Y H    S  I++ DLKP NILLD     H+  +DFG+ K   E  +  + T T
Sbjct: 148 IASALGYLH----SLNIVYRDLKPENILLDSQ--GHIVLTDFGLCK---ENIEHNSTTST 198

Query: 87  M-ATIGYMAPEYGSEGIVSAK-----CDVYSYGVLLMETFTRKRP-----TDEMF 130
              T  Y+APE     ++  +      D +  G +L E      P     T EM+
Sbjct: 199 FCGTPEYLAPE-----VLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMY 248

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 59.7 bits (145), Expect = 5e-11
 Identities = 26/97 (26%), Positives = 41/97 (42%), Gaps = 13/97 (13%)

Query: 24  NIMIDVGSALEYPH-HGHSSAPIIHCDLKPTNILL---DENMVAHVSDFGISKLLGEGED 79
             M  +   + + H        I+H DLKP NIL    D   +  + DFG+++     E 
Sbjct: 191 LFMKQICEGIRHMHQMY-----ILHLDLKPENILCVNRDAKQIK-IIDFGLARRYKPREK 244

Query: 80  FVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLL 116
                    T  ++APE  +   VS   D++S GV+ 
Sbjct: 245 LKV---NFGTPEFLAPEVVNYDFVSFPTDMWSVGVIA 278

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 59.6 bits (145), Expect = 6e-11
 Identities = 26/96 (27%), Positives = 45/96 (46%), Gaps = 11/96 (11%)

Query: 24  NIMIDVGSALEYPH-HGHSSAPIIHCDLKPTNILL--DENMVAHVSDFGISKLLGEGEDF 80
           + +  V  AL++ H H      I H D++P NI+     +    + +FG ++ L  G++F
Sbjct: 106 SYVHQVCEALQFLHSHN-----IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF 160

Query: 81  VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLL 116
               +      Y APE     +VS   D++S G L+
Sbjct: 161 ---RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLV 193

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 58.9 bits (143), Expect = 9e-11
 Identities = 27/94 (28%), Positives = 44/94 (46%), Gaps = 11/94 (11%)

Query: 32  ALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMT--MAT 89
            +++ H    SA IIH DLKP+NI++  +    + DFG+++  G      +  MT  + T
Sbjct: 139 GIKHLH----SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-----SFMMTPYVVT 189

Query: 90  IGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRK 123
             Y APE           D++S G ++ E     
Sbjct: 190 RYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 58.8 bits (143), Expect = 1e-10
 Identities = 33/116 (28%), Positives = 52/116 (44%), Gaps = 29/116 (25%)

Query: 29  VGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHV--SDFGISKLLGEGEDFVTQTMT 86
           + SALEY H    S  +++ D+K  N++LD++   H+  +DFG+ K   EG        T
Sbjct: 114 IVSALEYLH----SRDVVYRDIKLENLMLDKD--GHIKITDFGLCK---EGISDGATMKT 164

Query: 87  M-ATIGYMAPE------YGSEGIVSAKCDVYSYGVLLMETFTRKRP-----TDEMF 130
              T  Y+APE      YG         D +  GV++ E    + P      + +F
Sbjct: 165 FCGTPEYLAPEVLEDNDYGRA------VDWWGLGVVMYEMMCGRLPFYNQDHERLF 214

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 58.4 bits (142), Expect = 1e-10
 Identities = 34/115 (29%), Positives = 51/115 (44%), Gaps = 27/115 (23%)

Query: 29  VGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHV--SDFGISKLLGEGEDFVTQTMT 86
           +   L +      S  II+ DLK  N++LD     H+  +DFG+ K   E       T T
Sbjct: 130 IAIGLFFLQ----SKGIIYRDLKLDNVMLDSE--GHIKIADFGMCK---ENIWDGVTTKT 180

Query: 87  M-ATIGYMAPEYGSEGIVSAK-----CDVYSYGVLLMETFTRKRP-----TDEMF 130
              T  Y+APE     I++ +      D +++GVLL E    + P      DE+F
Sbjct: 181 FCGTPDYIAPE-----IIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELF 230

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 58.0 bits (141), Expect = 1e-10
 Identities = 31/87 (35%), Positives = 49/87 (56%), Gaps = 8/87 (9%)

Query: 31  SALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATI 90
           SA++Y H       ++H DLKP N+LLD +M A ++DFG+S ++ +GE   T   +  + 
Sbjct: 122 SAVDYCHRHM----VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT---SCGSP 174

Query: 91  GYMAPE-YGSEGIVSAKCDVYSYGVLL 116
            Y APE          + D++S GV+L
Sbjct: 175 NYAAPEVISGRLYAGPEVDIWSCGVIL 201

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 58.5 bits (141), Expect = 2e-10
 Identities = 35/116 (30%), Positives = 49/116 (42%), Gaps = 29/116 (25%)

Query: 29  VGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHV--SDFGISKLLGEGEDFVTQTMT 86
           +   L +      S  II+ DLK  N++LD     H+  +DFG+ K   E       T T
Sbjct: 451 IAIGLFFLQ----SKGIIYRDLKLDNVMLDSE--GHIKIADFGMCK---ENIWDGVTTKT 501

Query: 87  MA-TIGYMAPE------YGSEGIVSAKCDVYSYGVLLMETFTRKRP-----TDEMF 130
              T  Y+APE      YG         D +++GVLL E    + P      DE+F
Sbjct: 502 FCGTPDYIAPEIIAYQPYGKS------VDWWAFGVLLYEMLAGQAPFEGEDEDELF 551

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 57.9 bits (141), Expect = 2e-10
 Identities = 38/98 (38%), Positives = 52/98 (53%), Gaps = 25/98 (25%)

Query: 29  VGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHV--SDFGISKLLGEGEDFVTQTMT 86
           V  ALEY H       II+ DLKP NILLD+N   H+  +DFG +K + +       T T
Sbjct: 115 VCLALEYLHSKD----IIYRDLKPENILLDKN--GHIKITDFGFAKYVPD------VTYT 162

Query: 87  M-ATIGYMAPEYGSEGIVSAK-----CDVYSYGVLLME 118
           +  T  Y+APE     +VS K      D +S+G+L+ E
Sbjct: 163 LCGTPDYIAPE-----VVSTKPYNKSIDWWSFGILIYE 195

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 58.0 bits (141), Expect = 2e-10
 Identities = 38/116 (32%), Positives = 49/116 (42%), Gaps = 29/116 (25%)

Query: 29  VGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHV--SDFGISKLLGEGEDFVTQTMT 86
           + SAL + H       II+ DLK  N+LLD     H   +DFG+ K   EG      T T
Sbjct: 133 IISALMFLH----DKGIIYRDLKLDNVLLDHE--GHCKLADFGMCK---EGICNGVTTAT 183

Query: 87  M-ATIGYMAPE------YGSEGIVSAKCDVYSYGVLLMETFTRKRP-----TDEMF 130
              T  Y+APE      YG         D ++ GVLL E      P      D++F
Sbjct: 184 FCGTPDYIAPEILQEMLYGPA------VDWWAMGVLLYEMLCGHAPFEAENEDDLF 233

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 57.7 bits (140), Expect = 2e-10
 Identities = 29/87 (33%), Positives = 41/87 (47%), Gaps = 8/87 (9%)

Query: 31  SALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATI 90
           SA++Y H       I+H DLK  N+LLD +M   ++DFG S     G             
Sbjct: 125 SAVQYCHQKR----IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDA---FCGAP 177

Query: 91  GYMAPE-YGSEGIVSAKCDVYSYGVLL 116
            Y APE +  +     + DV+S GV+L
Sbjct: 178 PYAAPELFQGKKYDGPEVDVWSLGVIL 204

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 57.9 bits (140), Expect = 3e-10
 Identities = 31/90 (34%), Positives = 48/90 (53%), Gaps = 14/90 (15%)

Query: 31  SALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATI 90
           S ++Y H       ++H DLKP N+LLD +M A ++DFG+S ++ +GE   T      + 
Sbjct: 127 SGVDYCHRHM----VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT------SC 176

Query: 91  G---YMAPE-YGSEGIVSAKCDVYSYGVLL 116
           G   Y APE          + D++S GV+L
Sbjct: 177 GSPNYAAPEVISGRLYAGPEVDIWSSGVIL 206

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 57.3 bits (139), Expect = 3e-10
 Identities = 30/87 (34%), Positives = 48/87 (55%), Gaps = 8/87 (9%)

Query: 31  SALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATI 90
            A+EY H       I+H DLKP N+LLD+N+   ++DFG+S ++ +G    T   +  + 
Sbjct: 119 CAIEYCHRHK----IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKT---SCGSP 171

Query: 91  GYMAPE-YGSEGIVSAKCDVYSYGVLL 116
            Y APE    +     + DV+S G++L
Sbjct: 172 NYAAPEVINGKLYAGPEVDVWSCGIVL 198

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 57.2 bits (139), Expect = 3e-10
 Identities = 35/111 (31%), Positives = 53/111 (47%), Gaps = 19/111 (17%)

Query: 29  VGSALEYPH-HGHSSAPIIHCDLKPTNILLDENMVAHV--SDFGISKLLGEGEDFVTQTM 85
           +   L++ H  G     I++ DLK  NILLD++   H+  +DFG+ K   E      +T 
Sbjct: 127 IILGLQFLHSKG-----IVYRDLKLDNILLDKD--GHIKIADFGMCK---ENMLGDAKTN 176

Query: 86  TM-ATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRP-----TDEMF 130
           T   T  Y+APE       +   D +S+GVLL E    + P      +E+F
Sbjct: 177 TFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF 227

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 56.9 bits (138), Expect = 4e-10
 Identities = 29/95 (30%), Positives = 51/95 (53%), Gaps = 8/95 (8%)

Query: 32  ALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMT--MAT 89
            L+Y H    SA ++H DLKP+N+LL+      + DFG++++  + +   T  +T  +AT
Sbjct: 140 GLKYIH----SANVLHRDLKPSNLLLNTTCDLKICDFGLARVA-DPDHDHTGFLTEYVAT 194

Query: 90  IGYMAPEY-GSEGIVSAKCDVYSYGVLLMETFTRK 123
             Y APE   +    +   D++S G +L E  + +
Sbjct: 195 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 56.4 bits (137), Expect = 4e-10
 Identities = 29/112 (25%), Positives = 46/112 (41%), Gaps = 5/112 (4%)

Query: 31  SALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATI 90
           + + Y H       I H D+KP N+LLDE     +SDFG++ +               T+
Sbjct: 116 AGVVYLHGIG----ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 171

Query: 91  GYMAPE-YGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVK 141
            Y+APE        +   DV+S G++L      + P D+          W +
Sbjct: 172 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE 223

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 56.6 bits (137), Expect = 5e-10
 Identities = 30/113 (26%), Positives = 47/113 (41%), Gaps = 7/113 (6%)

Query: 31  SALEYPH-HGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMAT 89
           + + Y H  G     I H D+KP N+LLDE     +SDFG++ +               T
Sbjct: 116 AGVVYLHGIG-----ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170

Query: 90  IGYMAPE-YGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVK 141
           + Y+APE        +   DV+S G++L      + P D+          W +
Sbjct: 171 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE 223

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 56.6 bits (137), Expect = 6e-10
 Identities = 26/90 (28%), Positives = 46/90 (51%), Gaps = 12/90 (13%)

Query: 32  ALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIG 91
           AL Y H       +IH D+K  +ILL  +    +SDFG    +      V +  ++  +G
Sbjct: 153 ALAYLHAQG----VIHRDIKSDSILLTLDGRVKLSDFGFCAQI---SKDVPKRKSL--VG 203

Query: 92  ---YMAPEYGSEGIVSAKCDVYSYGVLLME 118
              +MAPE  S  + + + D++S G++++E
Sbjct: 204 TPYWMAPEVISRSLYATEVDIWSLGIMVIE 233

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 56.5 bits (137), Expect = 7e-10
 Identities = 29/96 (30%), Positives = 46/96 (47%), Gaps = 21/96 (21%)

Query: 29  VGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTM- 87
           +    EY H       +I+ DLKP N+L+D+     V+DFG +K +        +T T+ 
Sbjct: 150 IVLTFEYLHSLD----LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG------RTWTLC 199

Query: 88  ATIGYMAPEYGSEGIVSAK-----CDVYSYGVLLME 118
            T   +APE     I+ +K      D ++ GVL+ E
Sbjct: 200 GTPEALAPE-----IILSKGYNKAVDWWALGVLIYE 230

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 55.8 bits (135), Expect = 1e-09
 Identities = 29/89 (32%), Positives = 37/89 (41%), Gaps = 10/89 (11%)

Query: 31  SALEYPHHGHSSAPIIHCDLKPTNILLDENMVAH--VSDFGISKLLGEGEDFVTQTMTMA 88
           S + Y H       I H DLK  N LLD +      + DFG SK         +   T+ 
Sbjct: 127 SGVSYCHSMQ----ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS---TVG 179

Query: 89  TIGYMAPE-YGSEGIVSAKCDVYSYGVLL 116
           T  Y+APE    +       DV+S GV L
Sbjct: 180 TPAYIAPEVLLRQEYDGKIADVWSCGVTL 208

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 55.7 bits (135), Expect = 1e-09
 Identities = 33/99 (33%), Positives = 44/99 (44%), Gaps = 24/99 (24%)

Query: 29  VGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHV--SDFGISKLLGEGEDFVTQTMT 86
           +  AL Y H       II+ DLK  N+LLD     H+  +D+G+ K   EG      T T
Sbjct: 119 ISLALNYLH----ERGIIYRDLKLDNVLLDSE--GHIKLTDYGMCK---EGLRPGDTTST 169

Query: 87  M-ATIGYMAPE------YGSEGIVSAKCDVYSYGVLLME 118
              T  Y+APE      YG         D ++ GVL+ E
Sbjct: 170 FCGTPNYIAPEILRGEDYGFS------VDWWALGVLMFE 202

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 56.0 bits (135), Expect = 1e-09
 Identities = 29/98 (29%), Positives = 47/98 (47%), Gaps = 19/98 (19%)

Query: 32  ALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMT--MAT 89
            +++ H    SA IIH DLKP+NI++  +    + DFG+++  G      +  MT  + T
Sbjct: 176 GIKHLH----SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-----SFMMTPYVVT 226

Query: 90  IGYMAPEYGSEGIVSAKC----DVYSYGVLLMETFTRK 123
             Y APE     I+        D++S G ++ E    K
Sbjct: 227 RYYRAPEV----ILGMGYKENVDIWSVGCIMGEMVRHK 260

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 55.8 bits (135), Expect = 1e-09
 Identities = 33/99 (33%), Positives = 44/99 (44%), Gaps = 24/99 (24%)

Query: 29  VGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHV--SDFGISKLLGEGEDFVTQTMT 86
           +  AL Y H       II+ DLK  N+LLD     H+  +D+G+ K   EG      T T
Sbjct: 162 ISLALNYLH----ERGIIYRDLKLDNVLLDSE--GHIKLTDYGMCK---EGLRPGDTTST 212

Query: 87  M-ATIGYMAPE------YGSEGIVSAKCDVYSYGVLLME 118
              T  Y+APE      YG         D ++ GVL+ E
Sbjct: 213 FCGTPNYIAPEILRGEDYGFS------VDWWALGVLMFE 245

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 55.4 bits (134), Expect = 1e-09
 Identities = 27/88 (30%), Positives = 43/88 (48%), Gaps = 8/88 (9%)

Query: 32  ALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMA-TI 90
           ALE+ H       +IH D+K  NILL  +    ++DFG    +       ++  TM  T 
Sbjct: 128 ALEFLHSNQ----VIHRDIKSDNILLGMDGSVKLTDFGFCAQI---TPEQSKRSTMVGTP 180

Query: 91  GYMAPEYGSEGIVSAKCDVYSYGVLLME 118
            +MAPE  +      K D++S G++ +E
Sbjct: 181 YWMAPEVVTRKAYGPKVDIWSLGIMAIE 208

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 55.4 bits (134), Expect = 2e-09
 Identities = 34/140 (24%), Positives = 52/140 (37%), Gaps = 34/140 (24%)

Query: 32  ALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMT--MAT 89
            L   H     A ++H DL P NILL +N    + DF +++     ED      T  +  
Sbjct: 146 GLHVLH----EAGVVHRDLHPGNILLADNNDITICDFNLAR-----EDTADANKTHYVTH 196

Query: 90  IGYMAPEY-GSEGIVSAKCDVYSYGVLLMETFTRK--------------------RPTDE 128
             Y APE        +   D++S G ++ E F RK                     P  E
Sbjct: 197 RWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIE 256

Query: 129 --MFTGEMSLRRWVKESLPH 146
             +     S R +++ SL +
Sbjct: 257 DVVMFSSPSARDYLRNSLSN 276

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 55.0 bits (133), Expect = 2e-09
 Identities = 26/102 (25%), Positives = 50/102 (49%), Gaps = 21/102 (20%)

Query: 32  ALEYPHHGHSSAPIIHCDLKPTNILLD-ENMVAHVSDFGISKLLGEGEDFVTQTMT--MA 88
            L+Y H    SA ++H DLKP N+ ++ E++V  + DFG+++++          ++  + 
Sbjct: 132 GLKYIH----SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYS-HKGHLSEGLV 186

Query: 89  TIGYMAPE-------YGSEGIVSAKCDVYSYGVLLMETFTRK 123
           T  Y +P        Y ++ I     D+++ G +  E  T K
Sbjct: 187 TKWYRSPRLLLSPNNY-TKAI-----DMWAAGCIFAEMLTGK 222

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 54.9 bits (133), Expect = 2e-09
 Identities = 33/107 (30%), Positives = 53/107 (49%), Gaps = 25/107 (23%)

Query: 32  ALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQT------M 85
           A++  H     + +IH DLKP+N+L++ N    V DFG+++++ E     ++       M
Sbjct: 124 AVKVLH----GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM 179

Query: 86  T--MATIGYMAPE-------YGSEGIVSAKCDVYSYGVLLMETFTRK 123
              +AT  Y APE       Y S  +     DV+S G +L E F R+
Sbjct: 180 VEFVATRWYRAPEVMLTSAKY-SRAM-----DVWSCGCILAELFLRR 220

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 54.6 bits (132), Expect = 3e-09
 Identities = 30/95 (31%), Positives = 48/95 (50%), Gaps = 14/95 (14%)

Query: 32  ALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMT--MAT 89
            L+Y H    SA IIH DLKP+N+ ++E+    + DFG+++            MT  +AT
Sbjct: 144 GLKYIH----SADIIHRDLKPSNLAVNEDCELKILDFGLARH-------TADEMTGYVAT 192

Query: 90  IGYMAPE-YGSEGIVSAKCDVYSYGVLLMETFTRK 123
             Y APE   +    +   D++S G ++ E  T +
Sbjct: 193 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 54.0 bits (130), Expect = 3e-09
 Identities = 19/152 (12%), Positives = 37/152 (24%), Gaps = 47/152 (30%)

Query: 21  ERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF 80
             +  M  + +A +  H     A +      P+ +         VS  G   L       
Sbjct: 130 GAIRAMQSLAAAADAAHR----AGVALSIDHPSRVR--------VSIDGDVVL------- 170

Query: 81  VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLR--- 137
                  A    M          + + D+   G  L      + P  E       L    
Sbjct: 171 -------AYPATMPD-------ANPQDDIRGIGASLYALLVNRWPLPEA-GVRSGLAPAE 215

Query: 138 ----------RWVKESLPHGLTEVVDANLVRE 159
                       +   +P  ++ V   ++  +
Sbjct: 216 RDTAGQPIEPADIDRDIPFQISAVAARSVQGD 247

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 54.3 bits (131), Expect = 4e-09
 Identities = 29/95 (30%), Positives = 45/95 (47%), Gaps = 14/95 (14%)

Query: 32  ALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMT--MAT 89
            L Y H    +A IIH DLKP N+ ++E+    + DFG+++            MT  + T
Sbjct: 140 GLRYIH----AAGIIHRDLKPGNLAVNEDCELKILDFGLARQ-------ADSEMTGYVVT 188

Query: 90  IGYMAPEY-GSEGIVSAKCDVYSYGVLLMETFTRK 123
             Y APE   +    +   D++S G ++ E  T K
Sbjct: 189 RWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 54.2 bits (131), Expect = 4e-09
 Identities = 29/95 (30%), Positives = 46/95 (48%), Gaps = 14/95 (14%)

Query: 32  ALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMT--MAT 89
            L+Y H    SA ++H DLKP N+ ++E+    + DFG+++            MT  + T
Sbjct: 138 GLKYIH----SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA-------EMTGYVVT 186

Query: 90  IGYMAPE-YGSEGIVSAKCDVYSYGVLLMETFTRK 123
             Y APE   S    +   D++S G ++ E  T K
Sbjct: 187 RWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 53.9 bits (130), Expect = 5e-09
 Identities = 28/99 (28%), Positives = 47/99 (47%), Gaps = 16/99 (16%)

Query: 25  IMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQT 84
           I+ ++   L+Y H        IH D+K  N+LL E+    ++DFG++  L       T T
Sbjct: 124 ILREILKGLDYLHSEK----KIHRDIKAANVLLSEHGEVKLADFGVAGQL-------TDT 172

Query: 85  MTMAT--IG---YMAPEYGSEGIVSAKCDVYSYGVLLME 118
                  +G   +MAPE   +    +K D++S G+  +E
Sbjct: 173 QIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIE 211

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 53.5 bits (129), Expect = 6e-09
 Identities = 31/92 (33%), Positives = 43/92 (46%), Gaps = 16/92 (17%)

Query: 32  ALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMAT-- 89
            LEY H        IH D+K  NILL+    A ++DFG++  L       T TM      
Sbjct: 137 GLEYLHFMR----KIHRDIKAGNILLNTEGHAKLADFGVAGQL-------TDTMAKRNTV 185

Query: 90  IG---YMAPEYGSEGIVSAKCDVYSYGVLLME 118
           IG   +MAPE   E   +   D++S G+  +E
Sbjct: 186 IGTPFWMAPEVIQEIGYNCVADIWSLGITAIE 217

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 52.3 bits (126), Expect = 1e-08
 Identities = 33/104 (31%), Positives = 48/104 (46%), Gaps = 20/104 (19%)

Query: 25  IMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQT 84
           I+ +V   LEY H        IH D+K  NILL E+    ++DFG+S  L  G D     
Sbjct: 126 ILREVLEGLEYLHKNG----QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNK 181

Query: 85  MTMATIG---YMAPE-------YGSEGIVSAKCDVYSYGVLLME 118
           +    +G   +MAPE       Y        K D++S+G+  +E
Sbjct: 182 VRKTFVGTPCWMAPEVMEQVRGYDF------KADIWSFGITAIE 219

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 52.3 bits (126), Expect = 1e-08
 Identities = 26/90 (28%), Positives = 40/90 (44%), Gaps = 14/90 (15%)

Query: 31  SALEYPHHGHSSAPIIHCDLKPTNILLD-ENMVAHVSDFGISKLLGEG--EDFVTQTMTM 87
           +A+++ H       ++H D+K  NIL+D     A + DFG   LL +    DF       
Sbjct: 150 AAIQHCHSRG----VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFD------ 199

Query: 88  ATIGYMAPEY-GSEGIVSAKCDVYSYGVLL 116
            T  Y  PE+       +    V+S G+LL
Sbjct: 200 GTRVYSPPEWISRHQYHALPATVWSLGILL 229

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 52.3 bits (126), Expect = 2e-08
 Identities = 29/102 (28%), Positives = 46/102 (45%), Gaps = 21/102 (20%)

Query: 32  ALEYPHHGHSSAPIIHCDLKPTNILLD-ENMVAHVSDFGISKLLGEGEDFVTQTMT--MA 88
           AL+Y H    S  I+H D+KP N+++D E+    + D+G    L E      Q     +A
Sbjct: 142 ALDYCH----SMGIMHRDVKPHNVMIDHEHRKLRLIDWG----LAEFYH-PGQEYNVRVA 192

Query: 89  TIGYMAPEYGSEGIVSAKC-----DVYSYGVLLMETFTRKRP 125
           +  +  PE     +V  +      D++S G +L     RK P
Sbjct: 193 SRYFKGPEL----LVDYQMYDYSLDMWSLGCMLASMIFRKEP 230

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 51.9 bits (125), Expect = 2e-08
 Identities = 24/95 (25%), Positives = 44/95 (46%), Gaps = 9/95 (9%)

Query: 32  ALEYPHHGHSSAPIIHCDLKPTNILLD-ENMVAHVSDFGISKLLGEGEDFVTQTMTMATI 90
           ++   H    S  + H D+KP N+L++  +    + DFG +K L   E  V     + + 
Sbjct: 141 SIGCLHL--PSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVA---YICSR 195

Query: 91  GYMAPE--YGSEGIVSAKCDVYSYGVLLMETFTRK 123
            Y APE  +G++   +   D++S G +  E    +
Sbjct: 196 YYRAPELIFGNQH-YTTAVDIWSVGCIFAEMMLGE 229

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 51.8 bits (124), Expect = 3e-08
 Identities = 22/101 (21%), Positives = 43/101 (42%), Gaps = 11/101 (10%)

Query: 25  IMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED--FVT 82
           I+  V  AL+Y HH       +H  +K ++IL+  +   ++S    +  +        V 
Sbjct: 133 ILQGVLKALDYIHHMG----YVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVV 188

Query: 83  QTMTMATIG---YMAPEYGSEGIV--SAKCDVYSYGVLLME 118
                 ++    +++PE   + +    AK D+YS G+   E
Sbjct: 189 HDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACE 229

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 51.6 bits (124), Expect = 3e-08
 Identities = 26/90 (28%), Positives = 38/90 (42%), Gaps = 14/90 (15%)

Query: 31  SALEYPHHGHSSAPIIHCDLKPTNILLDEN-MVAHVSDFGISKLLGEG--EDFVTQTMTM 87
            A+ + H+      ++H D+K  NIL+D N     + DFG   LL +    DF       
Sbjct: 160 EAVRHCHNCG----VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD------ 209

Query: 88  ATIGYMAPEY-GSEGIVSAKCDVYSYGVLL 116
            T  Y  PE+            V+S G+LL
Sbjct: 210 GTRVYSPPEWIRYHRYHGRSAAVWSLGILL 239

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 51.0 bits (123), Expect = 4e-08
 Identities = 31/132 (23%), Positives = 62/132 (46%), Gaps = 16/132 (12%)

Query: 6   LEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHV 65
           L+K+  S N   D     + +  +   L + H  +    ++H DLKP N+L++ N    +
Sbjct: 87  LKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN----VLHRDLKPQNLLINRNGELKL 142

Query: 66  SDFGISKLLGEGEDFVTQTMT--MATIGYMAPE--YGSEGIVSAKCDVYSYGVLLMETFT 121
           ++FG+++  G       +  +  + T+ Y  P+  +G++ + S   D++S G +  E   
Sbjct: 143 ANFGLARAFG----IPVRCYSAEVVTLWYRPPDVLFGAK-LYSTSIDMWSAGCIFAELAN 197

Query: 122 RKRPTDEMFTGE 133
             RP   +F G 
Sbjct: 198 AGRP---LFPGN 206

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 50.5 bits (121), Expect = 8e-08
 Identities = 30/107 (28%), Positives = 49/107 (45%), Gaps = 19/107 (17%)

Query: 32  ALEYPHHGHSSAPIIHCDLKPTNILLD-ENMVAHVSDFGISKLLGEGEDFVTQTMT--MA 88
           A+ + H    S  I H D+KP N+L++ ++    + DFG +K L   E          + 
Sbjct: 153 AVGFIH----SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP-----SVAYIC 203

Query: 89  TIGYMAPE--YGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGE 133
           +  Y APE   G+    +   D++S G +  E    K P   +F+GE
Sbjct: 204 SRFYRAPELMLGATE-YTPSIDLWSIGCVFGELILGK-P---LFSGE 245

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 50.5 bits (121), Expect = 8e-08
 Identities = 33/118 (27%), Positives = 48/118 (40%), Gaps = 36/118 (30%)

Query: 32  ALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFG-----------------ISKLL 74
            ++Y H    S  ++H D+KP+NILL+      V+DFG                      
Sbjct: 121 VIKYLH----SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINEN 176

Query: 75  GEGEDFVTQTMT--MATIGYMAPE-------YGSEGIVSAKCDVYSYGVLLMETFTRK 123
            E  D     +T  +AT  Y APE       Y ++GI     D++S G +L E    K
Sbjct: 177 TENFDDDQPILTDYVATRWYRAPEILLGSTKY-TKGI-----DMWSLGCILGEILCGK 228

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 50.3 bits (121), Expect = 8e-08
 Identities = 47/224 (20%), Positives = 82/224 (36%), Gaps = 59/224 (26%)

Query: 6   LEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHV 65
           L   L +    F + E   +M  + + L Y H       I+H D+K  N+L+  + V  +
Sbjct: 110 LAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK----ILHRDMKAANVLITRDGVLKL 165

Query: 66  SDFGISKLLGEGEDFVTQTMT--MATIGYMAPE-------YGSEGIVSAKCDVYSYGVLL 116
           +DFG+++     ++      T  + T+ Y  PE       YG         D++  G ++
Sbjct: 166 ADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPP------IDLWGAGCIM 219

Query: 117 METFTRK--------------------RPTDEMFTGEMSLRRWVKESLPHG----LTEVV 152
            E +TR                       T E++    +   + K  L  G    + + +
Sbjct: 220 AEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRL 279

Query: 153 DANLVREEQAF--AAKMDCIVSIMDLALDCCMESPGKRINMTDA 194
               VR+  A     K+        L LD     P +RI+  DA
Sbjct: 280 -KAYVRDPYALDLIDKL--------LVLD-----PAQRIDSDDA 309

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 50.1 bits (120), Expect = 9e-08
 Identities = 29/104 (27%), Positives = 45/104 (43%), Gaps = 21/104 (20%)

Query: 25  IMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQT 84
           I  ++   L + H       +IH D+K  N+LL EN    + DFG+S  L        +T
Sbjct: 134 ICREILRGLSHLHQHK----VIHRDIKGQNVLLTENAEVKLVDFGVSAQL-------DRT 182

Query: 85  MTMAT--IG---YMAPE-----YGSEGIVSAKCDVYSYGVLLME 118
           +      IG   +MAPE        +     K D++S G+  +E
Sbjct: 183 VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIE 226

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 49.6 bits (119), Expect = 1e-07
 Identities = 28/104 (26%), Positives = 44/104 (42%), Gaps = 21/104 (20%)

Query: 25  IMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQT 84
           +   +  AL + H       IIH DLK  N+L+       ++DFG+S           +T
Sbjct: 122 VCRQMLEALNFLHSKR----IIHRDLKAGNVLMTLEGDIRLADFGVSAKN-------LKT 170

Query: 85  MTMAT--IG---YMAPE-----YGSEGIVSAKCDVYSYGVLLME 118
           +      IG   +MAPE        +     K D++S G+ L+E
Sbjct: 171 LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIE 214

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 49.7 bits (119), Expect = 1e-07
 Identities = 23/106 (21%), Positives = 38/106 (35%), Gaps = 27/106 (25%)

Query: 40  HSSAPIIHCDLKPTNILLDENMVAH------VSDFGISKLLGEGEDFVTQTMTMATIGYM 93
           H    IIH D+KP N+L++            ++D G +      E +     T     Y 
Sbjct: 148 HRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW--YDEHYTNSIQTRE---YR 202

Query: 94  APE------YGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGE 133
           +PE      +G         D++S   L+ E  T       +F  +
Sbjct: 203 SPEVLLGAPWG------CGADIWSTACLIFELITGDF----LFEPD 238

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 49.7 bits (119), Expect = 1e-07
 Identities = 31/97 (31%), Positives = 43/97 (44%), Gaps = 13/97 (13%)

Query: 25  IMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQT 84
           +       L Y H    S  +IH D+K  NILL E  +  + DFG + ++     FV   
Sbjct: 159 VTHGALQGLAYLH----SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV--- 211

Query: 85  MTMATIGYMAPE---YGSEGIVSAKCDVYSYGVLLME 118
               T  +MAPE      EG    K DV+S G+  +E
Sbjct: 212 ---GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE 245

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 49.3 bits (118), Expect = 2e-07
 Identities = 30/95 (31%), Positives = 40/95 (42%), Gaps = 15/95 (15%)

Query: 31  SALEYPHHGHSSAPIIHCDLKPTNILLDENMVAH--VSDFGISKLLGEGEDFVTQTMT-- 86
             L+  H       IIHCDLKP NILL +   +   V DFG S        +  Q +   
Sbjct: 211 QCLDALH----KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSC-------YEHQRVYTY 259

Query: 87  MATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT 121
           + +  Y APE           D++S G +L E  T
Sbjct: 260 IQSRFYRAPEVILGARYGMPIDMWSLGCILAELLT 294

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 48.5 bits (116), Expect = 3e-07
 Identities = 33/100 (33%), Positives = 47/100 (47%), Gaps = 21/100 (21%)

Query: 32  ALEYPHHGHSSAPIIHCDLKPTNILLDENM-VAHVSDFGISKLLGEGEDFVTQTMTMATI 90
           +L Y H    S  I H D+KP N+LLD +  V  + DFG +K L  GE  V+    + + 
Sbjct: 168 SLAYIH----SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSR 220

Query: 91  GYMAPE-------YGSEGIVSAKCDVYSYGVLLMETFTRK 123
            Y APE       Y      ++  DV+S G +L E    +
Sbjct: 221 YYRAPELIFGATDY------TSSIDVWSAGCVLAELLLGQ 254

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 47.7 bits (114), Expect = 6e-07
 Identities = 26/98 (26%), Positives = 39/98 (39%), Gaps = 35/98 (35%)

Query: 24  NIMIDVGSALEYPH-HGHSSAPIIHCDLKPTNILL---DENMVAHVSDFGISK-LLGEGE 78
            IM  +G A++Y H        I H D+KP N+L      N +  ++DFG +K   GE  
Sbjct: 121 EIMKSIGEAIQYLHSIN-----IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTGEK- 174

Query: 79  DFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLL 116
                             Y         CD++S GV++
Sbjct: 175 ------------------YDKS------CDMWSLGVIM 188

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 47.5 bits (114), Expect = 6e-07
 Identities = 30/122 (24%), Positives = 55/122 (45%), Gaps = 13/122 (10%)

Query: 6   LEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHV 65
           L+K L          +    +  +   + + H       I+H DLKP N+L++ +    +
Sbjct: 105 LKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR----ILHRDLKPQNLLINSDGALKL 160

Query: 66  SDFGISKLLGEGEDFVTQTMT--MATIGYMAPE--YGSEGIVSAKCDVYSYGVLLMETFT 121
           +DFG+++  G       ++ T  + T+ Y AP+   GS+   S   D++S G +  E  T
Sbjct: 161 ADFGLARAFG----IPVRSYTHEVVTLWYRAPDVLMGSK-KYSTSVDIWSIGCIFAEMIT 215

Query: 122 RK 123
            K
Sbjct: 216 GK 217

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 47.6 bits (114), Expect = 6e-07
 Identities = 28/122 (22%), Positives = 54/122 (44%), Gaps = 13/122 (10%)

Query: 6   LEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHV 65
           L+++L       ++      +  +   L Y H       ++H DLKP N+L++E     +
Sbjct: 86  LKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK----VLHRDLKPQNLLINERGELKL 141

Query: 66  SDFGISKLLGEGEDFVTQTMT--MATIGYMAPE--YGSEGIVSAKCDVYSYGVLLMETFT 121
           +DFG+++         T+T    + T+ Y  P+   GS    S + D++  G +  E  T
Sbjct: 142 ADFGLARAKSIP----TKTYDNEVVTLWYRPPDILLGST-DYSTQIDMWGVGCIFYEMAT 196

Query: 122 RK 123
            +
Sbjct: 197 GR 198

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 47.4 bits (113), Expect = 9e-07
 Identities = 31/98 (31%), Positives = 41/98 (41%), Gaps = 21/98 (21%)

Query: 32  ALEYPHHGHSSAPIIHCDLKPTNILL--DENMVAHVSDFGISKLLGEGEDFVTQTMTMAT 89
           AL +         IIHCDLKP NILL   +     + DFG S  LG+      Q+     
Sbjct: 169 ALLFLATPE--LSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRF--- 223

Query: 90  IGYMAPE------YGSEGIVSAKCDVYSYGVLLMETFT 121
             Y +PE      Y          D++S G +L+E  T
Sbjct: 224 --YRSPEVLLGMPYDL------AIDMWSLGCILVEMHT 253

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 46.7 bits (112), Expect = 1e-06
 Identities = 28/122 (22%), Positives = 55/122 (45%), Gaps = 13/122 (10%)

Query: 6   LEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHV 65
           L+K L       + +   + ++ + + + Y H       ++H DLKP N+L++      +
Sbjct: 86  LKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR----VLHRDLKPQNLLINREGELKI 141

Query: 66  SDFGISKLLGEGEDFVTQTMT--MATIGYMAPE--YGSEGIVSAKCDVYSYGVLLMETFT 121
           +DFG+++  G       +  T  + T+ Y AP+   GS+   S   D++S G +  E   
Sbjct: 142 ADFGLARAFG----IPVRKYTHEIVTLWYRAPDVLMGSK-KYSTTIDIWSVGCIFAEMVN 196

Query: 122 RK 123
             
Sbjct: 197 GT 198

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 46.7 bits (111), Expect = 1e-06
 Identities = 19/69 (27%), Positives = 32/69 (46%), Gaps = 4/69 (5%)

Query: 32  ALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIG 91
            ++Y H    SA I+H DLKP N L++++    V DFG+++ +   E+  +Q        
Sbjct: 168 GVKYVH----SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPRED 223

Query: 92  YMAPEYGSE 100
            M       
Sbjct: 224 DMNLVTFPH 232

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 46.7 bits (111), Expect = 2e-06
 Identities = 16/70 (22%), Positives = 27/70 (38%), Gaps = 4/70 (5%)

Query: 32  ALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIG 91
              + H     + IIH DLKP N LL+++    V DFG+++ +   +D            
Sbjct: 141 GENFIH----ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEE 196

Query: 92  YMAPEYGSEG 101
                   + 
Sbjct: 197 PGPHNKNLKK 206

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 46.2 bits (110), Expect = 2e-06
 Identities = 31/100 (31%), Positives = 46/100 (46%), Gaps = 21/100 (21%)

Query: 32  ALEYPHHGHSSAPIIHCDLKPTNILLDENM-VAHVSDFGISKLLGEGEDFVTQTMTMATI 90
           +L Y H    S  I H D+KP N+LLD    V  + DFG +K+L  GE  V+    + + 
Sbjct: 153 SLAYIH----SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSY---ICSR 205

Query: 91  GYMAPE-------YGSEGIVSAKCDVYSYGVLLMETFTRK 123
            Y APE       Y      +   D++S G ++ E    +
Sbjct: 206 YYRAPELIFGATNY------TTNIDIWSTGCVMAELMQGQ 239

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 44.9 bits (107), Expect = 6e-06
 Identities = 39/195 (20%), Positives = 67/195 (34%), Gaps = 53/195 (27%)

Query: 31  SALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMT--MA 88
             L + H       I+H DLKP N+L+++     + DFG+++  G        T +  + 
Sbjct: 119 QGLAFCHENK----ILHRDLKPQNLLINKRGQLKLGDFGLARAFG----IPVNTFSSEVV 170

Query: 89  TIGYMAPE--YGSEGIVSAKCDVYSYGVLLMETFTRK--------------------RPT 126
           T+ Y AP+   GS    S   D++S G +L E  T K                     P 
Sbjct: 171 TLWYRAPDVLMGSR-TYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPN 229

Query: 127 DEMFTG-------EMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLALD 179
           + ++           ++++     L   L       L      F   +        L L+
Sbjct: 230 ESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGL--------LQLN 281

Query: 180 CCMESPGKRINMTDA 194
                P  R++   A
Sbjct: 282 -----PDMRLSAKQA 291

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 44.1 bits (105), Expect = 9e-06
 Identities = 37/122 (30%), Positives = 55/122 (45%), Gaps = 13/122 (10%)

Query: 6   LEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHV 65
           LE  +   +           M+     LEY H       I+H DLKP N+LLDEN V  +
Sbjct: 98  LEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW----ILHRDLKPNNLLLDENGVLKL 153

Query: 66  SDFGISKLLGEGEDFVTQTMT--MATIGYMAPE--YGSEGIVSAKCDVYSYGVLLMETFT 121
           +DFG++K  G       +  T  + T  Y APE  +G+  +     D+++ G +L E   
Sbjct: 154 ADFGLAKSFGSP----NRAYTHQVVTRWYRAPELLFGAR-MYGVGVDMWAVGCILAELLL 208

Query: 122 RK 123
           R 
Sbjct: 209 RV 210

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 44.2 bits (105), Expect = 1e-05
 Identities = 22/98 (22%), Positives = 38/98 (38%), Gaps = 28/98 (28%)

Query: 45  IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED------------FVTQTMTMATI-- 90
           + H DLKP NIL  ++      +  I +      +            +  +  +  T+  
Sbjct: 139 LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHS--TLVS 196

Query: 91  --GYMAPEYGSEGIV-----SAKCDVYSYGVLLMETFT 121
              Y APE     ++     S  CDV+S G +L+E + 
Sbjct: 197 TRHYRAPE-----VILALGWSQPCDVWSIGCILIEYYL 229

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 44.1 bits (105), Expect = 1e-05
 Identities = 27/97 (27%), Positives = 46/97 (47%), Gaps = 15/97 (15%)

Query: 31  SALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMT--MA 88
             L++ H       ++H DLKP NIL+  +    ++DFG++++           +T  + 
Sbjct: 131 RGLDFLHSHR----VVHRDLKPQNILVTSSGQIKLADFGLARIYS-----FQMALTSVVV 181

Query: 89  TIGYMAPE--YGSEGIVSAKCDVYSYGVLLMETFTRK 123
           T+ Y APE    S    +   D++S G +  E F RK
Sbjct: 182 TLWYRAPEVLLQSS--YATPVDLWSVGCIFAEMFRRK 216

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 44.2 bits (105), Expect = 1e-05
 Identities = 26/109 (23%), Positives = 41/109 (37%), Gaps = 28/109 (25%)

Query: 32  ALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED------------ 79
           AL + H       + H DLKP NIL   +    + +   S      ++            
Sbjct: 135 ALRFLHENQ----LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSAT 190

Query: 80  FVTQTMT--MATIGYMAPEYGSEGIV-----SAKCDVYSYGVLLMETFT 121
           F  +  T  +AT  Y  PE     ++     +  CDV+S G +L E + 
Sbjct: 191 FDHEHHTTIVATRHYRPPE-----VILELGWAQPCDVWSIGCILFEYYR 234

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 43.8 bits (104), Expect = 1e-05
 Identities = 24/102 (23%), Positives = 42/102 (41%), Gaps = 18/102 (17%)

Query: 31  SALEYPHHGHSSAPIIHCDLKPTNILLDENMVAH-----VSDFGISKLLGEGEDFVTQTM 85
           + + + H        +H DLKP N+LL  +  +      + DFG+++  G       +  
Sbjct: 143 NGVNFCHSRR----CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG----IPIRQF 194

Query: 86  T--MATIGYMAPE--YGSEGIVSAKCDVYSYGVLLMETFTRK 123
           T  + T+ Y  PE   GS    S   D++S   +  E   + 
Sbjct: 195 THEIITLWYRPPEILLGSR-HYSTSVDIWSIACIWAEMLMKT 235

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 43.7 bits (104), Expect = 1e-05
 Identities = 30/127 (23%), Positives = 49/127 (38%), Gaps = 23/127 (18%)

Query: 6   LEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHV 65
           +   L  Y          +I      A+ + H        IH D+KP NIL+ ++ V  +
Sbjct: 88  VLHELDRYQRGVPEHLVKSITWQTLQAVNFCH----KHNCIHRDVKPENILITKHSVIKL 143

Query: 66  SDFGISKLLGEGEDFVTQTMT--MATIGYMAPE-------YGSEGIVSAKCDVYSYGVLL 116
            DFG ++LL       +      +AT  Y +PE       YG   +     DV++ G + 
Sbjct: 144 CDFGFARLLTGP----SDYYDDEVATRWYRSPELLVGDTQYGP-PV-----DVWAIGCVF 193

Query: 117 METFTRK 123
            E  +  
Sbjct: 194 AELLSGV 200

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 43.7 bits (104), Expect = 1e-05
 Identities = 28/97 (28%), Positives = 45/97 (46%), Gaps = 15/97 (15%)

Query: 31  SALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMT--MA 88
             L++ H       I+H DLKP NIL+       ++DFG++++           +T  + 
Sbjct: 131 RGLDFLHANC----IVHRDLKPENILVTSGGTVKLADFGLARIYS-----YQMALTPVVV 181

Query: 89  TIGYMAPE--YGSEGIVSAKCDVYSYGVLLMETFTRK 123
           T+ Y APE    S    +   D++S G +  E F RK
Sbjct: 182 TLWYRAPEVLLQST--YATPVDMWSVGCIFAEMFRRK 216

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 43.6 bits (103), Expect = 2e-05
 Identities = 20/71 (28%), Positives = 34/71 (47%), Gaps = 9/71 (12%)

Query: 5   SLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILL---DENM 61
            L+K +   N  F     L + I +   LEY H        +H D+K  N+LL   + + 
Sbjct: 137 DLQK-ISGQNGTFKKSTVLQLGIRMLDVLEYIHENE----YVHGDIKAANLLLGYKNPDQ 191

Query: 62  VAHVSDFGISK 72
           V +++D+G+S 
Sbjct: 192 V-YLADYGLSY 201

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 43.4 bits (103), Expect = 2e-05
 Identities = 31/125 (24%), Positives = 53/125 (42%), Gaps = 19/125 (15%)

Query: 6   LEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHV 65
           +   L  +    D       +  + + + + H  +    IIH D+KP NIL+ ++ V  +
Sbjct: 110 ILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHN----IIHRDIKPENILVSQSGVVKL 165

Query: 66  SDFGISKLLGEGEDFVTQTMTMATIGYMAPE-------YGSEGIVSAKCDVYSYGVLLME 118
            DFG ++ L    +       +AT  Y APE       YG   +     DV++ G L+ E
Sbjct: 166 CDFGFARTLAAPGEVYDD--EVATRWYRAPELLVGDVKYGK-AV-----DVWAIGCLVTE 217

Query: 119 TFTRK 123
            F  +
Sbjct: 218 MFMGE 222

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 43.1 bits (102), Expect = 2e-05
 Identities = 23/104 (22%), Positives = 35/104 (33%), Gaps = 34/104 (32%)

Query: 45  IIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED------------------FVTQTMT 86
           + H DLKP NILLD+               G+                     F +    
Sbjct: 158 LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHG 217

Query: 87  MATI----GYMAPEYGSEGIV-----SAKCDVYSYGVLLMETFT 121
             +I     Y APE     ++         D++S+G +L E +T
Sbjct: 218 --SIINTRQYRAPE-----VILNLGWDVSSDMWSFGCVLAELYT 254

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 41.3 bits (97), Expect = 1e-04
 Identities = 17/71 (23%), Positives = 33/71 (46%), Gaps = 8/71 (11%)

Query: 5   SLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILL---DENM 61
            L+K   +    F     L + + +   LEY H        +H D+K +N+LL   + + 
Sbjct: 137 DLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHE----YVHGDIKASNLLLNYKNPDQ 192

Query: 62  VAHVSDFGISK 72
           V ++ D+G++ 
Sbjct: 193 V-YLVDYGLAY 202

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 40.5 bits (95), Expect = 2e-04
 Identities = 11/53 (20%), Positives = 24/53 (45%), Gaps = 8/53 (15%)

Query: 23  LNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILL---DENMVAHVSDFGISK 72
           L +   +  ALE+ H        +H ++   NI +   D++ V  ++ +G + 
Sbjct: 162 LQVACRLLDALEFLHENE----YVHGNVTAENIFVDPEDQSQV-TLAGYGFAF 209

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 40.4 bits (95), Expect = 2e-04
 Identities = 18/74 (24%), Positives = 32/74 (43%), Gaps = 11/74 (14%)

Query: 5   SLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILL------D 58
           SLE  L      F +         + + ++  H       +++ D+KP N L+      +
Sbjct: 91  SLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH----EKSLVYRDIKPDNFLIGRPNSKN 146

Query: 59  ENMVAHVSDFGISK 72
            NM+ +V DFG+ K
Sbjct: 147 ANMI-YVVDFGMVK 159

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 39.3 bits (92), Expect = 3e-04
 Identities = 22/74 (29%), Positives = 36/74 (48%), Gaps = 11/74 (14%)

Query: 5   SLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILL------D 58
           SLE      +  F +   L I I + S +EY H    S  +I+ D+KP N L+       
Sbjct: 90  SLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVH----SKNLIYRDVKPENFLIGRPGNKT 145

Query: 59  ENMVAHVSDFGISK 72
           + ++ H+ DF ++K
Sbjct: 146 QQVI-HIIDFALAK 158

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 39.4 bits (92), Expect = 5e-04
 Identities = 23/105 (21%), Positives = 38/105 (36%), Gaps = 22/105 (20%)

Query: 31  SALEYPHHGHSSAPIIHCDLKPTNILLDENMVAH----VSDFGISKLLGE-GEDFVTQTM 85
             + Y H       ++H DLKP NIL+           ++D G ++L     +       
Sbjct: 139 DGIHYLHANW----VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP 194

Query: 86  TMATIGYMAPE-------YGSEGIVSAKCDVYSYGVLLMETFTRK 123
            + T  Y APE       Y          D+++ G +  E  T +
Sbjct: 195 VVVTFWYRAPELLLGARHYTKA------IDIWAIGCIFAELLTSE 233

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 38.7 bits (89), Expect = 6e-04
 Identities = 11/68 (16%), Positives = 22/68 (32%), Gaps = 6/68 (8%)

Query: 5   SLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAH 64
            LE+          +    +I+  + ++L             H DL   N+LL +  +  
Sbjct: 149 DLEQMRTK---LSSLATAKSILHQLTASLAVAEASLR---FEHRDLHWGNVLLKKTSLKK 202

Query: 65  VSDFGISK 72
           +      K
Sbjct: 203 LHYTLNGK 210

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	202
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	99.98
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	99.98
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	99.98
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	99.98
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	99.98
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	99.98
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	99.98
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	99.98
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	99.98
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	99.98
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	99.98
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	99.98
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	99.98
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	99.98
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	99.98
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	99.98
2a19_B	284	Interferon-induced, double-stranded RNA-activated	99.98
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	99.98
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	99.98
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	99.98
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	99.98
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	99.98
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	99.98
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	99.98
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	99.98
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	99.98
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	99.98
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	99.98
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	99.98
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	99.98
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	99.98
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	99.98
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	99.98
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	99.98
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	99.98
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	99.97
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	99.97
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	99.97
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	99.97
3rp9_A	458	Mitogen-activated protein kinase; structural genom	99.97
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	99.97
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	99.97
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	99.97
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	99.97
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	99.97
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	99.97
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	99.97
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	99.97
3fme_A	290	Dual specificity mitogen-activated protein kinase;	99.97
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	99.97
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	99.97
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	99.97
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	99.97
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	99.97
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	99.97
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	99.97
3bhy_A	283	Death-associated protein kinase 3; death associate	99.97
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	99.97
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	99.97
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	99.97
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	99.97
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	99.97
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	99.97
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	99.97
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	99.97
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	99.97
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	99.97
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	99.97
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	99.97
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	99.97
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	99.97
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	99.97
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	99.97
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	99.97
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	99.97
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	99.97
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	99.97
3an0_A	340	Dual specificity mitogen-activated protein kinase;	99.97
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	99.97
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	99.97
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	99.97
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	99.97
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	99.97
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	99.97
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	99.97
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	99.97
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	99.97
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	99.97
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	99.97
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	99.97
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	99.97
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	99.97
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	99.97
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	99.97
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	99.97
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	99.97
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	99.97
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	99.97
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	99.97
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	99.97
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	99.97
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	99.97
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	99.97
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	99.97
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	99.97
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	99.97
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	99.97
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	99.97
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	99.97
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	99.96
2dyl_A	318	Dual specificity mitogen-activated protein kinase	99.96
3aln_A	327	Dual specificity mitogen-activated protein kinase;	99.96
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	99.96
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	99.96
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	99.96
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	99.96
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	99.95
3uqc_A	286	Probable conserved transmembrane protein; structur	99.95
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	99.93
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.86
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.67
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.32
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.06
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	98.55
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	98.0
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	97.61
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	97.49
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	97.38
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	96.51
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	96.03
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	95.82
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	94.93
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	94.86
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	94.52
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	93.96
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	93.94
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	93.7
3ats_A	357	Putative uncharacterized protein; hypothetical pro	93.19
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	92.4
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	92.35
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	92.08
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	91.83
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	90.83
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	90.82
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	90.0
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	89.46
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	89.13
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	88.63
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	87.2
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	86.66
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	85.09
3mes_A	424	Choline kinase; malaria, structural genomics, stru	82.85
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	80.66

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=9.2e-46  Score=281.66  Aligned_cols=182  Identities=23%  Similarity=0.364  Sum_probs=140.1

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |+||||.++|......+++.+++.++.|++.||.|||    +.+|+||||||+|||++.++.+||+|||+++........
T Consensus       113 ~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH----~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~  188 (307)
T 3omv_A          113 CEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLH----AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGS  188 (307)
T ss_dssp             CSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHH----HTTCBCSCCCSSSEEEETTEEEEECCCSSCBC-------
T ss_pred             CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCccCCccCHHHEEECCCCcEEEeeccCceecccCCcc
Confidence            7899999999877667999999999999999999999    899999999999999999999999999999865433222


Q ss_pred             ccccCCCCCccccCCCCCCC---CCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhC-CCChhhhhhhhh
Q 037267           81 VTQTMTMATIGYMAPEYGSE---GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESL-PHGLTEVVDANL  156 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~---~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  156 (202)
                      .......||+.|+|||++.+   ..++.++|||||||++|||++|..||........ +...+.... .+...       
T Consensus       189 ~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~-~~~~~~~~~~~p~~~-------  260 (307)
T 3omv_A          189 QQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQ-IIFMVGRGYASPDLS-------  260 (307)
T ss_dssp             -----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH-HHHHHHTTCCCCCST-------
T ss_pred             eeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHH-HHHHHhcCCCCCCcc-------
Confidence            22334579999999997643   4588999999999999999999999976543221 111121111 11100       


Q ss_pred             hhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          157 VREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                             ..+..+++++.+|+.+||+.||++|||+.|+++.|+.|
T Consensus       261 -------~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l  298 (307)
T 3omv_A          261 -------KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELL  298 (307)
T ss_dssp             -------TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHH
T ss_pred             -------cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence                   11234677799999999999999999999999998865

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=8.8e-45  Score=277.00  Aligned_cols=178  Identities=22%  Similarity=0.406  Sum_probs=144.8

Q ss_pred             CCCCcHHHHHhhcC---------------CCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEE
Q 037267            1 MPNGSLEKWLYSYN---------------YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHV   65 (202)
Q Consensus         1 ~~~gsL~~~l~~~~---------------~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l   65 (202)
                      |+||||.++|....               ..+++.+++.++.|++.||.|||    +.+|+||||||.|||++.++.+||
T Consensus       111 ~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH----~~~iiHRDLK~~NILl~~~~~~Ki  186 (308)
T 4gt4_A          111 CSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS----SHHVVHKDLATRNVLVYDKLNVKI  186 (308)
T ss_dssp             CSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEECGGGCEEE
T ss_pred             CCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH----hCCCCCCCccccceEECCCCCEEE
Confidence            68999999997432               35899999999999999999999    899999999999999999999999


Q ss_pred             cccccceeccCCCccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhC
Q 037267           66 SDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESL  144 (202)
Q Consensus        66 ~d~g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~  144 (202)
                      +|||+++...............||+.|+|||.+.+..++.++|||||||++||+++ |..||......+  +...+....
T Consensus       187 ~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~--~~~~i~~~~  264 (308)
T 4gt4_A          187 SDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD--VVEMIRNRQ  264 (308)
T ss_dssp             CCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH--HHHHHHTTC
T ss_pred             CCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcCC
Confidence            99999987654332222334568999999999888899999999999999999998 899997654322  222222111


Q ss_pred             CCChhhhhhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          145 PHGLTEVVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                                       ..+.+..|+.++.+||.+||+.||++|||+.||++.|+++
T Consensus       265 -----------------~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~  304 (308)
T 4gt4_A          265 -----------------VLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW  304 (308)
T ss_dssp             -----------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             -----------------CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence                             0112345778899999999999999999999999999875

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=2.4e-44  Score=276.95  Aligned_cols=178  Identities=24%  Similarity=0.395  Sum_probs=136.9

Q ss_pred             CCCCcHHHHHhhcC--------------CCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEc
Q 037267            1 MPNGSLEKWLYSYN--------------YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVS   66 (202)
Q Consensus         1 ~~~gsL~~~l~~~~--------------~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~   66 (202)
                      |+||||.++|++..              ..+++.+++.++.|++.||.|||    +.+|+||||||.|||++.++.+||+
T Consensus       125 ~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH----~~~iiHRDLKp~NILl~~~~~~Ki~  200 (329)
T 4aoj_A          125 MRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA----GLHFVHRDLATRNCLVGQGLVVKIG  200 (329)
T ss_dssp             CTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEEETTTEEEEC
T ss_pred             CCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh----cCCeecccccHhhEEECCCCcEEEc
Confidence            68999999998642              35899999999999999999999    8999999999999999999999999


Q ss_pred             ccccceeccCCCccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhCC
Q 037267           67 DFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLP  145 (202)
Q Consensus        67 d~g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~  145 (202)
                      |||+++...............||+.|+|||++.+..++.++|+|||||++||+++ |+.||......+  +...+.... 
T Consensus       201 DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~--~~~~i~~g~-  277 (329)
T 4aoj_A          201 DFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE--AIDCITQGR-  277 (329)
T ss_dssp             CCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHH--HHHHHHHTC-
T ss_pred             ccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHH--HHHHHHcCC-
Confidence            9999987654333222334568999999999999999999999999999999998 899997654322  111121111 


Q ss_pred             CChhhhhhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          146 HGLTEVVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                                      ..+.+..+++++.+|+.+||+.||++|||+.||++.|+.+
T Consensus       278 ----------------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l  317 (329)
T 4aoj_A          278 ----------------ELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQAL  317 (329)
T ss_dssp             ----------------CCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHH
T ss_pred             ----------------CCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence                            0112235677899999999999999999999999999875

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=4.1e-45  Score=277.77  Aligned_cols=178  Identities=26%  Similarity=0.410  Sum_probs=144.3

Q ss_pred             CCCCcHHHHHhhcC------------CCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEccc
Q 037267            1 MPNGSLEKWLYSYN------------YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDF   68 (202)
Q Consensus         1 ~~~gsL~~~l~~~~------------~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~   68 (202)
                      |+||||.++|++..            ..+++.+++.++.|+++||.|||    +++|+||||||+|||++.++.+||+||
T Consensus        97 ~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH----~~~iiHRDlKp~NILl~~~~~~Ki~DF  172 (299)
T 4asz_A           97 MKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLA----SQHFVHRDLATRNCLVGENLLVKIGDF  172 (299)
T ss_dssp             CTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEECGGGCEEECCC
T ss_pred             CCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH----hCCcccCccCHhhEEECCCCcEEECCc
Confidence            68999999998642            35999999999999999999999    899999999999999999999999999


Q ss_pred             ccceeccCCCccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhCCCC
Q 037267           69 GISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHG  147 (202)
Q Consensus        69 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~  147 (202)
                      |+++...............+|+.|+|||.+.+..++.++|+|||||++||+++ |+.||......+  +...+..+.   
T Consensus       173 Gla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~--~~~~i~~~~---  247 (299)
T 4asz_A          173 GMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE--VIECITQGR---  247 (299)
T ss_dssp             SCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH--HHHHHHHTC---
T ss_pred             ccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHHHcCC---
Confidence            99986554333222233458899999999988899999999999999999998 899997754322  111121111   


Q ss_pred             hhhhhhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          148 LTEVVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                                    ..+.+..+++++.+|+.+||+.||++|||+.++.+.|+++
T Consensus       248 --------------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~  287 (299)
T 4asz_A          248 --------------VLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNL  287 (299)
T ss_dssp             --------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --------------CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence                          0112235677899999999999999999999999999875

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=3.5e-44  Score=278.17  Aligned_cols=179  Identities=27%  Similarity=0.401  Sum_probs=145.3

Q ss_pred             CCCCcHHHHHhhcC---------------CCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEE
Q 037267            1 MPNGSLEKWLYSYN---------------YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHV   65 (202)
Q Consensus         1 ~~~gsL~~~l~~~~---------------~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l   65 (202)
                      |+||||.++|++..               ..+++..++.++.||+.||.|||    +++|+||||||.|||++.++.+||
T Consensus       151 ~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH----~~~iiHRDLK~~NILl~~~~~vKi  226 (353)
T 4ase_A          151 CKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA----SRKCIHRDLAARNILLSEKNVVKI  226 (353)
T ss_dssp             CTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEECGGGCEEE
T ss_pred             CCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHh----hCCeecCccCccceeeCCCCCEEE
Confidence            78999999998532               34899999999999999999999    899999999999999999999999


Q ss_pred             cccccceeccCCCccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhC
Q 037267           66 SDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESL  144 (202)
Q Consensus        66 ~d~g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~  144 (202)
                      +|||+++...............+|+.|+|||++.+..++.++|||||||++||+++ |..||......... ...+..+.
T Consensus       227 ~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~-~~~i~~g~  305 (353)
T 4ase_A          227 CDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF-CRRLKEGT  305 (353)
T ss_dssp             CCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH-HHHHHHTC
T ss_pred             CcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHH-HHHHHcCC
Confidence            99999987655443333444568899999999988999999999999999999998 89999775433321 11222111


Q ss_pred             CCChhhhhhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          145 PHGLTEVVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                      .                 .+.+..+++++.++|.+||+.||++|||++|+++.|+.+
T Consensus       306 ~-----------------~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~l  345 (353)
T 4ase_A          306 R-----------------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  345 (353)
T ss_dssp             C-----------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             C-----------------CCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence            0                 111234667799999999999999999999999998764

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=3.2e-43  Score=270.22  Aligned_cols=178  Identities=22%  Similarity=0.249  Sum_probs=139.6

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCC-ceEEcccccceeccCCCc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENM-VAHVSDFGISKLLGEGED   79 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~-~~~l~d~g~~~~~~~~~~   79 (202)
                      |+||||.++|++.+ .+++.++..++.|++.||.|||    +++|+||||||+|||++.++ .+||+|||+++.......
T Consensus       132 ~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH----~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~  206 (336)
T 4g3f_A          132 LEGGSLGQLIKQMG-CLPEDRALYYLGQALEGLEYLH----TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL  206 (336)
T ss_dssp             CTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----TTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred             cCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence            68999999998755 4999999999999999999999    89999999999999999887 599999999987654322


Q ss_pred             c---ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhh
Q 037267           80 F---VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANL  156 (202)
Q Consensus        80 ~---~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (202)
                      .   .......||+.|+|||++.+..++.++|+||+||++|+|++|..||.........  ..+....+           
T Consensus       207 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~--~~i~~~~~-----------  273 (336)
T 4g3f_A          207 GKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLC--LKIASEPP-----------  273 (336)
T ss_dssp             -------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCH--HHHHHSCC-----------
T ss_pred             ccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHH--HHHHcCCC-----------
Confidence            1   1123346999999999999999999999999999999999999999765433321  11111100           


Q ss_pred             hhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhh
Q 037267          157 VREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKK  200 (202)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~  200 (202)
                          .....+..+++++.+++.+||.+||++|||+.|+++.|..
T Consensus       274 ----~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~  313 (336)
T 4g3f_A          274 ----PIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGK  313 (336)
T ss_dssp             ----GGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ----CchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence                0001123466779999999999999999999999987754

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=5.1e-42  Score=261.78  Aligned_cols=191  Identities=19%  Similarity=0.277  Sum_probs=137.3

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCC----CCCCeeecCCCCCceeeCCCCceEEcccccceeccC
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGH----SSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGE   76 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~----~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~   76 (202)
                      |+||||.++|+..+  +++..+++++.|++.||.|||+..    ...+|+||||||+|||++.++.+||+|||+++....
T Consensus        83 ~~~gsL~~~l~~~~--l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~  160 (303)
T 3hmm_A           83 HEHGSLFDYLNRYT--VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS  160 (303)
T ss_dssp             CTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEET
T ss_pred             CCCCcHHHHHHhCC--CCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccC
Confidence            68999999998643  899999999999999999999310    012999999999999999999999999999987654


Q ss_pred             CCccc--cccCCCCCccccCCCCCCCC------CcCcchhhhhHHHHHHHHHhCCCCCCcccccch----------hhHH
Q 037267           77 GEDFV--TQTMTMATIGYMAPEYGSEG------IVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEM----------SLRR  138 (202)
Q Consensus        77 ~~~~~--~~~~~~~~~~~~~pe~~~~~------~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~----------~~~~  138 (202)
                      .....  ......||+.|+|||++.+.      .++.++|||||||++|||++|..||........          ....
T Consensus       161 ~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~  240 (303)
T 3hmm_A          161 ATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE  240 (303)
T ss_dssp             TTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHH
T ss_pred             CCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHHH
Confidence            43221  12234699999999987653      467789999999999999999877654322211          1111


Q ss_pred             HHHHhCCCChhhhhhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          139 WVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       139 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                      .............+..        ...+..++..+.+|+.+||+.||++|||+.||++.|++|
T Consensus       241 ~~~~~~~~~~rp~~p~--------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l  295 (303)
T 3hmm_A          241 MRKVVCEQKLRPNIPN--------RWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL  295 (303)
T ss_dssp             HHHHHTTSCCCCCCCG--------GGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHhcccCCCCCCc--------cccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence            1111111111100000        011224567789999999999999999999999999876

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=7.6e-42  Score=258.34  Aligned_cols=169  Identities=22%  Similarity=0.358  Sum_probs=132.4

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCC--eeecCCCCCceeeC-CCCceEEcccccceeccCC
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAP--IIHCDLKPTNILLD-ENMVAHVSDFGISKLLGEG   77 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~--i~h~dlk~~nil~~-~~~~~~l~d~g~~~~~~~~   77 (202)
                      |+||||.+++.+.. .+++..+..++.||+.||.|||    +++  |+||||||+|||++ .++.+||+|||+++.....
T Consensus       111 ~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~ylH----~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~  185 (290)
T 3fpq_A          111 MTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLH----TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS  185 (290)
T ss_dssp             CCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----TSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred             CCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCCC
Confidence            68999999998654 4899999999999999999999    777  99999999999998 4789999999999754322


Q ss_pred             CccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhh
Q 037267           78 EDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV  157 (202)
Q Consensus        78 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (202)
                      .    .....||+.|+|||++.+ .++.++||||+||++|+|++|..||........ +...+.....+           
T Consensus       186 ~----~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~-~~~~i~~~~~~-----------  248 (290)
T 3fpq_A          186 F----AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ-IYRRVTSGVKP-----------  248 (290)
T ss_dssp             S----BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH-HHHHHTTTCCC-----------
T ss_pred             c----cCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHH-HHHHHHcCCCC-----------
Confidence            1    223579999999998765 699999999999999999999999975432221 11111111100           


Q ss_pred             hhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          158 REEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                           ...+..+++++.+|+.+||..||++|||++|+++
T Consensus       249 -----~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          249 -----ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             -----GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             -----CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                 0011234456899999999999999999999975

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=2.9e-42  Score=265.71  Aligned_cols=171  Identities=20%  Similarity=0.257  Sum_probs=138.5

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |+||+|.+++.+.  .+++.++..++.||+.||.|||    +++|+||||||+|||++.++.+||+|||+++........
T Consensus       153 ~~gg~L~~~l~~~--~l~e~~~~~~~~qi~~aL~ylH----~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~  226 (346)
T 4fih_A          153 LEGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVLH----AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR  226 (346)
T ss_dssp             CTTEEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC
T ss_pred             CCCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH----HCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCc
Confidence            6899999999763  4899999999999999999999    899999999999999999999999999999876543321


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhH
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREE  160 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (202)
                        .....||+.|+|||++.+..|+.++||||+||++|+|++|..||......  .....+....+...            
T Consensus       227 --~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~--~~~~~i~~~~~~~~------------  290 (346)
T 4fih_A          227 --RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL--KAMKMIRDNLPPRL------------  290 (346)
T ss_dssp             --BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHHHHHSSCCCC------------
T ss_pred             --ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH--HHHHHHHcCCCCCC------------
Confidence              23457999999999999889999999999999999999999999763221  11222222221111            


Q ss_pred             HHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          161 QAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       161 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                         ..+..+++++.+|+.+||..||++|||++|+++
T Consensus       291 ---~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~  323 (346)
T 4fih_A          291 ---KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  323 (346)
T ss_dssp             ---SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ---CccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence               011235567899999999999999999999875

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=3.3e-42  Score=261.87  Aligned_cols=170  Identities=25%  Similarity=0.319  Sum_probs=138.0

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |+||+|.+++++.+ .+++.++..++.||+.||.|||    +++|+||||||+|||++.++.+||+|||+++........
T Consensus       114 ~~gG~L~~~i~~~~-~l~e~~~~~~~~qi~~al~ylH----~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~  188 (311)
T 4aw0_A          114 AKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLH----GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ  188 (311)
T ss_dssp             CTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTC
T ss_pred             CCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCc
Confidence            68999999998755 4999999999999999999999    899999999999999999999999999999987544332


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhH
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREE  160 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (202)
                      .......||+.|+|||++.+..++.++|+||+||++|+|++|..||.......  +...+.....               
T Consensus       189 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~--~~~~i~~~~~---------------  251 (311)
T 4aw0_A          189 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGL--IFAKIIKLEY---------------  251 (311)
T ss_dssp             CCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHTCC---------------
T ss_pred             ccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHcCCC---------------
Confidence            23345679999999999988899999999999999999999999997533211  1111111110               


Q ss_pred             HHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHH
Q 037267          161 QAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAA  195 (202)
Q Consensus       161 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~  195 (202)
                         ..+..+++++.+|+.+||.+||++|||+.|++
T Consensus       252 ---~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~  283 (311)
T 4aw0_A          252 ---DFPEKFFPKARDLVEKLLVLDATKRLGCEEME  283 (311)
T ss_dssp             ---CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred             ---CCCcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence               01123456689999999999999999999863

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=2.9e-41  Score=266.08  Aligned_cols=171  Identities=20%  Similarity=0.264  Sum_probs=138.3

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |+||+|.++++..  .+++.++..++.||+.||.|||    +++|+||||||+|||++.++.+||+|||++........ 
T Consensus       230 ~~gG~L~~~i~~~--~l~e~~~~~~~~qil~aL~ylH----~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~-  302 (423)
T 4fie_A          230 LEGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVLH----AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-  302 (423)
T ss_dssp             CTTEEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC-
T ss_pred             CCCCcHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHH----HCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCc-
Confidence            6899999999753  3899999999999999999999    89999999999999999999999999999987654332 


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhH
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREE  160 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (202)
                       ......||+.|+|||++.+..|+.++||||+||++|+|++|..||.+....  .....+....+....           
T Consensus       303 -~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~--~~~~~i~~~~~~~~~-----------  368 (423)
T 4fie_A          303 -RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL--KAMKMIRDNLPPRLK-----------  368 (423)
T ss_dssp             -CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHHHHHSCCCCCS-----------
T ss_pred             -cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH--HHHHHHHcCCCCCCc-----------
Confidence             123457999999999999999999999999999999999999999753221  122222222211110           


Q ss_pred             HHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          161 QAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       161 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                          ....+++++.+|+.+||..||++|||+.|+++
T Consensus       369 ----~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~  400 (423)
T 4fie_A          369 ----NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  400 (423)
T ss_dssp             ----CTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ----ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence                11234567899999999999999999999875

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=2.1e-41  Score=261.26  Aligned_cols=171  Identities=21%  Similarity=0.327  Sum_probs=137.1

Q ss_pred             CCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCc
Q 037267            1 MPNGSLEKWLYSYN-YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED   79 (202)
Q Consensus         1 ~~~gsL~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~   79 (202)
                      |+||||.++|.... ..+++.+++.++.||+.||.|||    +.+|+||||||+|||++.++.+||+|||+++.......
T Consensus       105 ~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH----~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~  180 (350)
T 4b9d_A          105 CEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH----DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE  180 (350)
T ss_dssp             CTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH----HTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHH
T ss_pred             CCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHH----HCCeeeccCCHHHEEECCCCCEEEcccccceeecCCcc
Confidence            68999999998544 45799999999999999999999    89999999999999999999999999999987543211


Q ss_pred             cccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhh
Q 037267           80 FVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVRE  159 (202)
Q Consensus        80 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (202)
                        ......||+.|+|||++.+..|+.++||||+||++|+|++|..||....... .+........+              
T Consensus       181 --~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~-~~~~i~~~~~~--------------  243 (350)
T 4b9d_A          181 --LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKN-LVLKIISGSFP--------------  243 (350)
T ss_dssp             --HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHTCCC--------------
T ss_pred             --cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH-HHHHHHcCCCC--------------
Confidence              1223469999999999999999999999999999999999999997643221 11111111111              


Q ss_pred             HHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          160 EQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       160 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                          +.+..++.++.+|+.+||..||++|||++|+++
T Consensus       244 ----~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  276 (350)
T 4b9d_A          244 ----PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE  276 (350)
T ss_dssp             ----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ----CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                011235667899999999999999999999975

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=2.2e-41  Score=257.13  Aligned_cols=164  Identities=27%  Similarity=0.273  Sum_probs=131.1

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |+||||.+++.+.. .+++.++..++.|++.||.|||    +.+|+||||||+|||++.++.+||+|||+++....... 
T Consensus       108 ~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH----~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~-  181 (304)
T 3ubd_A          108 LRGGDLFTRLSKEV-MFTEEDVKFYLAELALALDHLH----SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK-  181 (304)
T ss_dssp             CTTCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH----HTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-----C-
T ss_pred             CCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCCcCCCCCHHHeEEcCCCCEEecccccceeccCCCc-
Confidence            68999999998755 4999999999999999999999    89999999999999999999999999999986543322 


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhH
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREE  160 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (202)
                       ......||+.|+|||++.+..++.++|+||+||++|+|++|..||.......  ....+.....               
T Consensus       182 -~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~--~~~~i~~~~~---------------  243 (304)
T 3ubd_A          182 -KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE--TMTMILKAKL---------------  243 (304)
T ss_dssp             -CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHCCC---------------
T ss_pred             -cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHH--HHHHHHcCCC---------------
Confidence             1234579999999999988899999999999999999999999997643221  1111111110               


Q ss_pred             HHHHHhHHHHHHHHHHHhhhcCCCCCCCCCH
Q 037267          161 QAFAAKMDCIVSIMDLALDCCMESPGKRINM  191 (202)
Q Consensus       161 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~  191 (202)
                         ..+..+++++.+|+.+||++||++|||+
T Consensus       244 ---~~p~~~s~~~~~li~~~L~~dP~~R~ta  271 (304)
T 3ubd_A          244 ---GMPQFLSPEAQSLLRMLFKRNPANRLGA  271 (304)
T ss_dssp             ---CCCTTSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred             ---CCCCcCCHHHHHHHHHHcccCHHHCCCC
Confidence               0112356678999999999999999985

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=8.3e-40  Score=245.32  Aligned_cols=166  Identities=25%  Similarity=0.362  Sum_probs=125.9

Q ss_pred             CCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcccc
Q 037267            3 NGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVT   82 (202)
Q Consensus         3 ~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~   82 (202)
                      +|+|.+++.+.. .+++.++..++.|++.||.|||    +++|+||||||+|||++.++.+||+|||+++.......   
T Consensus        96 ~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~ylH----~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~---  167 (275)
T 3hyh_A           96 GNELFDYIVQRD-KMSEQEARRFFQQIISAVEYCH----RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNF---  167 (275)
T ss_dssp             CEEHHHHHHHSC-SCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCTTTEEECTTCCEEECCSSCC-----------
T ss_pred             CCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCcccccCChHHeEECCCCCEEEeecCCCeecCCCCc---
Confidence            789999998755 4999999999999999999999    89999999999999999999999999999987554322   


Q ss_pred             ccCCCCCccccCCCCCCCCCc-CcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhHH
Q 037267           83 QTMTMATIGYMAPEYGSEGIV-SAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQ  161 (202)
Q Consensus        83 ~~~~~~~~~~~~pe~~~~~~~-~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (202)
                      .....||+.|+|||++.+..+ +.++|+||+||++|+|++|..||......  .+...+......               
T Consensus       168 ~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~--~~~~~i~~~~~~---------------  230 (275)
T 3hyh_A          168 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIP--VLFKNISNGVYT---------------  230 (275)
T ss_dssp             -------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHTCCC---------------
T ss_pred             cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHH--HHHHHHHcCCCC---------------
Confidence            233579999999999888776 57899999999999999999999753211  111111111110               


Q ss_pred             HHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          162 AFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       162 ~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                         .+..+++++.+|+.+||+.||++|||++|+++
T Consensus       231 ---~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~  262 (275)
T 3hyh_A          231 ---LPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ  262 (275)
T ss_dssp             ---CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             ---CCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence               11234566899999999999999999999986

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=2.6e-39  Score=246.12  Aligned_cols=171  Identities=23%  Similarity=0.305  Sum_probs=123.8

Q ss_pred             CCCCcHHHHHhhcCC--CCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCC
Q 037267            1 MPNGSLEKWLYSYNY--FFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGE   78 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~--~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~   78 (202)
                      |+||+|.+++.....  ..++..++.++.|+++||.|||    +++|+||||||+|||++.++.+||+|||+++......
T Consensus        97 ~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH----~~~IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~  172 (299)
T 4g31_A           97 CRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLH----SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDE  172 (299)
T ss_dssp             CCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECTTCCEEECCCCCC-------
T ss_pred             CCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHH----HCcCccccCcHHHeEECCCCcEEEccCccceecCCCc
Confidence            689999999986442  3566778999999999999999    8999999999999999999999999999998764332


Q ss_pred             cc----------ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCCh
Q 037267           79 DF----------VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGL  148 (202)
Q Consensus        79 ~~----------~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  148 (202)
                      ..          .......||+.|+|||++.+..++.++||||+||++|+|++   ||.........+... ...     
T Consensus       173 ~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~~~-~~~-----  243 (299)
T 4g31_A          173 EEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLTDV-RNL-----  243 (299)
T ss_dssp             -------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHH-HTT-----
T ss_pred             cccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHHHH-hcC-----
Confidence            11          11223469999999999999999999999999999999995   764321111001000 000     


Q ss_pred             hhhhhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          149 TEVVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                              ..    .+.....++.+.+|+.+||+.||++|||+.|+++
T Consensus       244 --------~~----p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  279 (299)
T 4g31_A          244 --------KF----PPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE  279 (299)
T ss_dssp             --------CC----CHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             --------CC----CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence                    00    0112234455789999999999999999999986

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=5e-38  Score=244.79  Aligned_cols=188  Identities=19%  Similarity=0.209  Sum_probs=132.1

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCC-CceEEcccccceeccCCCc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN-MVAHVSDFGISKLLGEGED   79 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~-~~~~l~d~g~~~~~~~~~~   79 (202)
                      |+||+|.+++.    .+++.++..++.|++.||.|||    +.+|+||||||+|||++.+ +.+||+|||+++.......
T Consensus       102 ~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH----~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~  173 (361)
T 4f9c_A          102 LEHESFLDILN----SLSFQEVREYMLNLFKALKRIH----QFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKI  173 (361)
T ss_dssp             CCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSC
T ss_pred             CCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHH----HCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCccc
Confidence            68999999994    3899999999999999999999    8999999999999999876 7999999999986543221


Q ss_pred             cc--------------------------cccCCCCCccccCCCCCCCC-CcCcchhhhhHHHHHHHHHhCCCCCCccccc
Q 037267           80 FV--------------------------TQTMTMATIGYMAPEYGSEG-IVSAKCDVYSYGVLLMETFTRKRPTDEMFTG  132 (202)
Q Consensus        80 ~~--------------------------~~~~~~~~~~~~~pe~~~~~-~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~  132 (202)
                      ..                          ......||+.|+|||++.+. .++.++|+||+||++|+|++|+.||....+.
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~  253 (361)
T 4f9c_A          174 ELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDD  253 (361)
T ss_dssp             GGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSH
T ss_pred             cccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCH
Confidence            00                          01234699999999987765 4889999999999999999999999754433


Q ss_pred             chhhHHHHHH---------------------hCCCChhhhhhhhhhh--------------hHHHHHHhHHHHHHHHHHH
Q 037267          133 EMSLRRWVKE---------------------SLPHGLTEVVDANLVR--------------EEQAFAAKMDCIVSIMDLA  177 (202)
Q Consensus       133 ~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~l~  177 (202)
                      ...+......                     ..+.............              ...........++++.||+
T Consensus       254 ~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl  333 (361)
T 4f9c_A          254 LTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLL  333 (361)
T ss_dssp             HHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHHH
T ss_pred             HHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHHH
Confidence            2222111100                     0000000000000000              0000112234567789999


Q ss_pred             hhhcCCCCCCCCCHHHHHH
Q 037267          178 LDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       178 ~~cl~~~p~~Rps~~~~~~  196 (202)
                      .+||..||++|||+.|+++
T Consensus       334 ~~lL~~dP~~R~ta~eaL~  352 (361)
T 4f9c_A          334 DKLLDLNPASRITAEEALL  352 (361)
T ss_dssp             HHHTCSCTTTSCCHHHHHT
T ss_pred             HHHCcCChhHCcCHHHHhc
Confidence            9999999999999999885

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.8e-37  Score=244.19  Aligned_cols=189  Identities=22%  Similarity=0.189  Sum_probs=133.2

Q ss_pred             CCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc--
Q 037267            3 NGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF--   80 (202)
Q Consensus         3 ~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~--   80 (202)
                      +|+|.+++.+.. .+++.++..++.||+.||.|||    +.+|+||||||+|||++.++.+|++|||+++........  
T Consensus       142 ~g~L~~~i~~~~-~l~~~~~~~~~~qil~al~ylH----~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~~~~~  216 (398)
T 4b99_A          142 ESDLHQIIHSSQ-PLTLEHVRYFLYQLLRGLKYMH----SAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQ  216 (398)
T ss_dssp             SEEHHHHHTSSS-CCCHHHHHHHHHHHHHHHHHHH----HTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC-------C
T ss_pred             CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCcCcCCCcCccccccCCCCCEEEeecceeeecccCccccc
Confidence            578999997644 5999999999999999999999    899999999999999999999999999999876433211  


Q ss_pred             ccccCCCCCccccCCCCCCCC-CcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCCh--hhhhh----
Q 037267           81 VTQTMTMATIGYMAPEYGSEG-IVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGL--TEVVD----  153 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~-~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~----  153 (202)
                      .......||+.|+|||++.+. .++.++||||+||++|+|++|..||.+.........-....+.+...  .....    
T Consensus       217 ~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~  296 (398)
T 4b99_A          217 YFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVR  296 (398)
T ss_dssp             CCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-----CHH
T ss_pred             cccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhh
Confidence            123346799999999987765 46889999999999999999999997643322111111111111100  00000    


Q ss_pred             hhhh----hhH-HHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          154 ANLV----REE-QAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       154 ~~~~----~~~-~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                      ....    ... .........+.++.+|+.+||..||++|||+.|+++
T Consensus       297 ~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  344 (398)
T 4b99_A          297 AYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR  344 (398)
T ss_dssp             HHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             hhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            0000    000 000111234567899999999999999999999875

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=1.3e-36  Score=250.15  Aligned_cols=168  Identities=22%  Similarity=0.268  Sum_probs=134.8

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |+||+|.++|.+.+ .+++..+..++.||+.||.|||    +.+|+||||||+|||++.+|.+||+|||++.......  
T Consensus       274 ~~GGdL~~~l~~~~-~l~E~~a~~y~~qIl~aL~yLH----~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~~--  346 (689)
T 3v5w_A          274 MNGGDLHYHLSQHG-VFSEADMRFYAAEIILGLEHMH----NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--  346 (689)
T ss_dssp             CCSCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH----TTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCC--
T ss_pred             CCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCccccCCchHHeEEeCCCCEEecccceeeecCCCC--
Confidence            68999999998755 4999999999999999999999    9999999999999999999999999999998765433  


Q ss_pred             ccccCCCCCccccCCCCCC-CCCcCcchhhhhHHHHHHHHHhCCCCCCcccccch-hhHHHHHHhCCCChhhhhhhhhhh
Q 037267           81 VTQTMTMATIGYMAPEYGS-EGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEM-SLRRWVKESLPHGLTEVVDANLVR  158 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~-~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  158 (202)
                        ..+..||+.|+|||++. +..|+.++|+||+||++|+|++|..||........ .+...+.....             
T Consensus       347 --~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~-------------  411 (689)
T 3v5w_A          347 --PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV-------------  411 (689)
T ss_dssp             --CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCC-------------
T ss_pred             --CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCC-------------
Confidence              23457999999999875 45789999999999999999999999976433221 11111111100             


Q ss_pred             hHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCC-----HHHHH
Q 037267          159 EEQAFAAKMDCIVSIMDLALDCCMESPGKRIN-----MTDAA  195 (202)
Q Consensus       159 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps-----~~~~~  195 (202)
                           ..+..+++++.+|+.+||.+||++|++     ++|++
T Consensus       412 -----~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~  448 (689)
T 3v5w_A          412 -----ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVK  448 (689)
T ss_dssp             -----CCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHT
T ss_pred             -----CCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHh
Confidence                 011235667899999999999999998     56664

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=3.8e-37  Score=236.95  Aligned_cols=194  Identities=21%  Similarity=0.264  Sum_probs=141.3

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCC----------CeeecCCCCCceeeCCCCceEEccccc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSA----------PIIHCDLKPTNILLDENMVAHVSDFGI   70 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~----------~i~h~dlk~~nil~~~~~~~~l~d~g~   70 (202)
                      |++|||.++++...  +++..+..++.|++.||.|||    +.          +|+||||||+||+++.++.+||+|||+
T Consensus       104 ~~~g~L~~~l~~~~--~~~~~~~~i~~qi~~al~~LH----~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~  177 (322)
T 3soc_A          104 HEKGSLSDFLKANV--VSWNELCHIAETMARGLAYLH----EDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGL  177 (322)
T ss_dssp             CTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHT----CCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             CCCCCHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHH----hhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCc
Confidence            57899999998643  899999999999999999999    78          999999999999999999999999999


Q ss_pred             ceeccCCCccccccCCCCCccccCCCCCCC-----CCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCC
Q 037267           71 SKLLGEGEDFVTQTMTMATIGYMAPEYGSE-----GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLP  145 (202)
Q Consensus        71 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-----~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~  145 (202)
                      +................+++.|+|||.+.+     ..++.++|+||+||++|++++|..||.................. 
T Consensus       178 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~-  256 (322)
T 3soc_A          178 ALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQH-  256 (322)
T ss_dssp             CEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSS-
T ss_pred             ccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccC-
Confidence            987665433322333568999999998765     34566789999999999999999999765432211110000000 


Q ss_pred             CChhhhhhhhhh----hhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          146 HGLTEVVDANLV----REEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       146 ~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                      ............    ...........++.++.+++.+||+.||++|||+.++++.|++|
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l  316 (322)
T 3soc_A          257 PSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQM  316 (322)
T ss_dssp             CCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            000000000000    00000011234567799999999999999999999999999876

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=9.9e-36  Score=226.56  Aligned_cols=192  Identities=23%  Similarity=0.330  Sum_probs=142.7

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCC----CCCCeeecCCCCCceeeCCCCceEEcccccceeccC
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGH----SSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGE   76 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~----~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~   76 (202)
                      |++|+|.++++..  .+++..++.++.|++.||.|||...    .+.+|+||||||+||+++.++.+||+|||++.....
T Consensus        88 ~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  165 (301)
T 3q4u_A           88 HEMGSLYDYLQLT--TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQ  165 (301)
T ss_dssp             CTTCBHHHHHTTC--CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEET
T ss_pred             ccCCCHHHHHhhc--ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCeeeccc
Confidence            5789999999643  4899999999999999999999311    046899999999999999999999999999987654


Q ss_pred             CCccc--cccCCCCCccccCCCCCCCC------CcCcchhhhhHHHHHHHHHhC----------CCCCCcccccchhhHH
Q 037267           77 GEDFV--TQTMTMATIGYMAPEYGSEG------IVSAKCDVYSYGVLLMETFTR----------KRPTDEMFTGEMSLRR  138 (202)
Q Consensus        77 ~~~~~--~~~~~~~~~~~~~pe~~~~~------~~~~~~di~s~G~~~~~~~~g----------~~p~~~~~~~~~~~~~  138 (202)
                      .....  ......+++.|+|||.+.+.      .++.++|+||+|+++|++++|          ..||............
T Consensus       166 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~~~  245 (301)
T 3q4u_A          166 STNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFED  245 (301)
T ss_dssp             TTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHH
T ss_pred             ccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcchhh
Confidence            43221  12234689999999987765      455789999999999999999          7788765444433333


Q ss_pred             HHHHhCCCChhhhhhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhcC
Q 037267          139 WVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKIK  202 (202)
Q Consensus       139 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l~  202 (202)
                      .................        .....++.++.+++.+||+.||++|||+.++++.|++|+
T Consensus       246 ~~~~~~~~~~~~~~~~~--------~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~  301 (301)
T 3q4u_A          246 MRKVVCVDQQRPNIPNR--------WFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKID  301 (301)
T ss_dssp             HHHHHTTSCCCCCCCGG--------GGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHC
T ss_pred             hhHHHhccCCCCCCChh--------hccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhccC
Confidence            22211111111111000        012346678999999999999999999999999999874

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=1.3e-35  Score=225.69  Aligned_cols=182  Identities=14%  Similarity=0.066  Sum_probs=141.8

Q ss_pred             CCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCc-----eEEcccccceeccCC
Q 037267            3 NGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMV-----AHVSDFGISKLLGEG   77 (202)
Q Consensus         3 ~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~-----~~l~d~g~~~~~~~~   77 (202)
                      +|||.+++...+..+++..+..++.|++.||.|||    +.+|+||||||+||+++.++.     ++|+|||++......
T Consensus        89 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~  164 (298)
T 1csn_A           89 GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH----EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP  164 (298)
T ss_dssp             CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH----TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCT
T ss_pred             CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH----hCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccccc
Confidence            89999999876666999999999999999999999    899999999999999987765     999999999876543


Q ss_pred             Ccc-----ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchh-hHHHHHHhCCCChhhh
Q 037267           78 EDF-----VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMS-LRRWVKESLPHGLTEV  151 (202)
Q Consensus        78 ~~~-----~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~  151 (202)
                      ...     .......+++.|+|||.+.+..++.++|+||+|+++|++++|..||......... ....+.          
T Consensus       165 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~----------  234 (298)
T 1csn_A          165 VTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIG----------  234 (298)
T ss_dssp             TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHH----------
T ss_pred             cccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHH----------
Confidence            221     1123346899999999988888999999999999999999999999875432211 000000          


Q ss_pred             hhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          152 VDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                       ......  ........++.++.+++.+||+.||++|||+.++++.|+++
T Consensus       235 -~~~~~~--~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~  281 (298)
T 1csn_A          235 -EKKQST--PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV  281 (298)
T ss_dssp             -HHHHHS--CHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred             -hhccCc--cHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHH
Confidence             000000  00111224667899999999999999999999999999865

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=9.3e-37  Score=250.33  Aligned_cols=173  Identities=23%  Similarity=0.210  Sum_probs=137.8

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCC--CceEEcccccceeccCCC
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN--MVAHVSDFGISKLLGEGE   78 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~--~~~~l~d~g~~~~~~~~~   78 (202)
                      |+||+|.++|......+++.++..++.||+.||.|||    +++|+||||||+|||++.+  +.+||+|||+++......
T Consensus       236 ~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH----~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~  311 (573)
T 3uto_A          236 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH----ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ  311 (573)
T ss_dssp             CCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS
T ss_pred             cCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH----HCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCC
Confidence            6899999999866666999999999999999999999    8999999999999999854  789999999999876543


Q ss_pred             ccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhh
Q 037267           79 DFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVR  158 (202)
Q Consensus        79 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (202)
                      ..   ....||+.|+|||++.+..++.++||||+||++|+|++|..||.......  ....+........          
T Consensus       312 ~~---~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~--~~~~i~~~~~~~~----------  376 (573)
T 3uto_A          312 SV---KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE--TLRNVKSCDWNMD----------  376 (573)
T ss_dssp             EE---EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH--HHHHHHTTCCCCC----------
T ss_pred             ce---eeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH--HHHHHHhCCCCCC----------
Confidence            22   23469999999999999999999999999999999999999997643222  1111111100000          


Q ss_pred             hHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          159 EEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       159 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                          ......++.++.+|+.+||..||++|||+.|+++
T Consensus       377 ----~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~  410 (573)
T 3uto_A          377 ----DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE  410 (573)
T ss_dssp             ----SGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ----cccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                0111235566899999999999999999999986

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=8.4e-36  Score=233.02  Aligned_cols=186  Identities=15%  Similarity=0.151  Sum_probs=142.6

Q ss_pred             CCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeC--CCCceEEcccccceeccCCCcc
Q 037267            3 NGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLD--ENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         3 ~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~--~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      ||+|.+++......+++..++.++.|++.||.|||    +.+|+||||||+||+++  .++.+||+|||++.........
T Consensus       135 g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH----~~~iiHrDlkp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~  210 (364)
T 3op5_A          135 GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIH----EHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVH  210 (364)
T ss_dssp             EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEEESSCTTCEEECCCTTCEESSGGGCC
T ss_pred             CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH----HCCeEEecCCHHHEEEecCCCCeEEEEECCcceecccCCcc
Confidence            78999999877667999999999999999999999    89999999999999999  8899999999999876533211


Q ss_pred             c-----cccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhh
Q 037267           81 V-----TQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDAN  155 (202)
Q Consensus        81 ~-----~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (202)
                      .     ......+|+.|+|||.+.+..++.++|+||+|+++|++++|..||............ .............+..
T Consensus       211 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~~-~~~~~~~~~~~~~~~~  289 (364)
T 3op5_A          211 KAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRD-SKIRYRENIASLMDKC  289 (364)
T ss_dssp             CCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHH-HHHHHHHCHHHHHHHH
T ss_pred             cccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHHHHHH-HHHHhhhhHHHHHHHh
Confidence            1     112334899999999988888999999999999999999999999864333221111 1111111111111111


Q ss_pred             hhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          156 LVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                      .        ....++.++.+++..||..||++||++.++++.|+.+
T Consensus       290 ~--------~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~  327 (364)
T 3op5_A          290 F--------PAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQG  327 (364)
T ss_dssp             S--------CTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred             c--------ccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Confidence            0        0123477899999999999999999999999998764

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=3.5e-36  Score=228.20  Aligned_cols=184  Identities=23%  Similarity=0.366  Sum_probs=132.5

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |++|+|.+++......+++..++.++.|++.||.|||    +.+++||||||+||+++.++.++|+|||++.........
T Consensus       101 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH----~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  176 (289)
T 3og7_A          101 CEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH----AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGS  176 (289)
T ss_dssp             CCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEEETTTEEEECCCC-----------
T ss_pred             cCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH----hCCcccccCccceEEECCCCCEEEccceecccccccccc
Confidence            5789999999876667999999999999999999999    899999999999999999999999999998765432222


Q ss_pred             ccccCCCCCccccCCCCCC---CCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhh
Q 037267           81 VTQTMTMATIGYMAPEYGS---EGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV  157 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~---~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (202)
                      .......+++.|+|||.+.   +..++.++|+||+|+++|++++|..||.........................      
T Consensus       177 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------  250 (289)
T 3og7_A          177 HQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKV------  250 (289)
T ss_dssp             -------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSS------
T ss_pred             ccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhc------
Confidence            2223345899999999765   5567889999999999999999999997754333222211111111111110      


Q ss_pred             hhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhcC
Q 037267          158 REEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKIK  202 (202)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l~  202 (202)
                              ...++.++.+++.+||+.||++|||+.++++.|+++.
T Consensus       251 --------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~  287 (289)
T 3og7_A          251 --------RSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA  287 (289)
T ss_dssp             --------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             --------cccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence                    1235567899999999999999999999999998763

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=2.8e-36  Score=236.25  Aligned_cols=178  Identities=25%  Similarity=0.416  Sum_probs=141.7

Q ss_pred             CCCCcHHHHHhhcC---------------CCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEE
Q 037267            1 MPNGSLEKWLYSYN---------------YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHV   65 (202)
Q Consensus         1 ~~~gsL~~~l~~~~---------------~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l   65 (202)
                      |++|+|.+++....               ..+++..++.++.|++.||.|||    +.+|+||||||+||+++.++.+||
T Consensus       169 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH----~~~ivHrDlkp~NIll~~~~~~kl  244 (370)
T 2psq_A          169 ASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA----SQKCIHRDLAARNVLVTENNVMKI  244 (370)
T ss_dssp             CTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCCGGGEEECTTCCEEE
T ss_pred             CCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHH----hCCeeccccchhhEEECCCCCEEE
Confidence            57899999998643               24899999999999999999999    899999999999999999999999


Q ss_pred             cccccceeccCCCccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhC
Q 037267           66 SDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESL  144 (202)
Q Consensus        66 ~d~g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~  144 (202)
                      +|||++................+++.|+|||.+.+..++.++|+||+||++|++++ |..||.......  +...+....
T Consensus       245 ~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~--~~~~~~~~~  322 (370)
T 2psq_A          245 ADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--LFKLLKEGH  322 (370)
T ss_dssp             CCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--HHHHHHTTC
T ss_pred             ccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHHhcCC
Confidence            99999987654433222333456788999998888889999999999999999998 999997643222  111111111


Q ss_pred             CCChhhhhhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          145 PHGLTEVVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                      .                 ...+..++.++.+++.+||+.||++|||+.|+++.|+++
T Consensus       323 ~-----------------~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~i  362 (370)
T 2psq_A          323 R-----------------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI  362 (370)
T ss_dssp             C-----------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             C-----------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            0                 011224566789999999999999999999999999875

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=9.6e-36  Score=227.82  Aligned_cols=180  Identities=25%  Similarity=0.406  Sum_probs=141.5

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |++|||.+++......+++..+..++.|++.||.|||    +.+++||||||+||+++.++.+||+|||++.........
T Consensus        89 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH----~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  164 (310)
T 3s95_A           89 IKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH----SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQ  164 (310)
T ss_dssp             CTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSTTSEEECTTSCEEECCCTTCEECC-----
T ss_pred             cCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH----hCCccCCCCCcCeEEECCCCCEEEeecccceeccccccc
Confidence            5799999999986667999999999999999999999    899999999999999999999999999999876433221


Q ss_pred             c------------cccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCCh
Q 037267           81 V------------TQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGL  148 (202)
Q Consensus        81 ~------------~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  148 (202)
                      .            ......|++.|+|||.+.+..++.++|+||+|+++|++++|..||...............       
T Consensus       165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~-------  237 (310)
T 3s95_A          165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVR-------  237 (310)
T ss_dssp             ---------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHH-------
T ss_pred             ccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhh-------
Confidence            1            011346899999999998888999999999999999999999998764433221110000       


Q ss_pred             hhhhhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          149 TEVVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                       ...         ....+..++.++.+++.+||+.||++|||+.++++.|+.+
T Consensus       238 -~~~---------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l  280 (310)
T 3s95_A          238 -GFL---------DRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETL  280 (310)
T ss_dssp             -HHH---------HHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -ccc---------cccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence             000         0011234556689999999999999999999999999876

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.6e-35  Score=225.28  Aligned_cols=187  Identities=25%  Similarity=0.357  Sum_probs=138.6

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCC--------CeeecCCCCCceeeCCCCceEEcccccce
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSA--------PIIHCDLKPTNILLDENMVAHVSDFGISK   72 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~--------~i~h~dlk~~nil~~~~~~~~l~d~g~~~   72 (202)
                      |++|+|.++++..  .+++..++.++.|++.||.|||    +.        +|+||||||+||+++.++.+||+|||++.
T Consensus       117 ~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH----~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~  190 (337)
T 3mdy_A          117 HENGSLYDYLKST--TLDAKSMLKLAYSSVSGLCHLH----TEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  190 (337)
T ss_dssp             CTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHH----SCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             cCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHH----HhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCce
Confidence            5789999999764  4899999999999999999999    77        99999999999999999999999999997


Q ss_pred             eccCCCccc--cccCCCCCccccCCCCCCCCCcCcc------hhhhhHHHHHHHHHhC----------CCCCCcccccch
Q 037267           73 LLGEGEDFV--TQTMTMATIGYMAPEYGSEGIVSAK------CDVYSYGVLLMETFTR----------KRPTDEMFTGEM  134 (202)
Q Consensus        73 ~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~------~di~s~G~~~~~~~~g----------~~p~~~~~~~~~  134 (202)
                      .........  ......+++.|+|||.+.+...+..      +|+||+||++|++++|          ..||........
T Consensus       191 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~  270 (337)
T 3mdy_A          191 KFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDP  270 (337)
T ss_dssp             ECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred             eeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCC
Confidence            654432211  1223468999999998776655554      8999999999999999          666655443333


Q ss_pred             hhHHHHHHhCCCChhhhhhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          135 SLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       135 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                      .....................        .....++.++.+++.+||+.||++|||+.++++.|+++
T Consensus       271 ~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l  329 (337)
T 3mdy_A          271 SYEDMREIVCIKKLRPSFPNR--------WSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKM  329 (337)
T ss_dssp             CHHHHHHHHTTSCCCCCCCGG--------GGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             chhhhHHHHhhhccCcccccc--------chhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHH
Confidence            222222211111111111100        11235778899999999999999999999999999876

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=8.8e-37  Score=235.37  Aligned_cols=178  Identities=23%  Similarity=0.374  Sum_probs=141.0

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |++|+|.+++......+++..++.++.|++.||.|||    +.+|+||||||+||+++.++.+||+|||++.........
T Consensus        98 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH----~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  173 (327)
T 3poz_A           98 MPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE----DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE  173 (327)
T ss_dssp             CTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC-
T ss_pred             cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh----hCCeeCCCCChheEEECCCCCEEEccCcceeEccCCccc
Confidence            5799999999987777999999999999999999999    899999999999999999999999999999876544332


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhh
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVRE  159 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (202)
                      .......++..|+|||.+.+..++.++|+||+|+++|++++ |..||.......  ....+.....              
T Consensus       174 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~~~~~~~~--------------  237 (327)
T 3poz_A          174 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISSILEKGER--------------  237 (327)
T ss_dssp             ------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHHHHHTTCC--------------
T ss_pred             ccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH--HHHHHHcCCC--------------
Confidence            22333456788999998888889999999999999999999 999997654322  1111111110              


Q ss_pred             HHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          160 EQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       160 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                         .+.+..++.++.+++.+||+.||++|||+.++++.|+.+
T Consensus       238 ---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~  276 (327)
T 3poz_A          238 ---LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM  276 (327)
T ss_dssp             ---CCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHH
T ss_pred             ---CCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence               001123455689999999999999999999999998764

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=3.3e-35  Score=223.06  Aligned_cols=181  Identities=18%  Similarity=0.146  Sum_probs=141.9

Q ss_pred             CCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceee---CCCCceEEcccccceeccCCCc
Q 037267            3 NGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILL---DENMVAHVSDFGISKLLGEGED   79 (202)
Q Consensus         3 ~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~---~~~~~~~l~d~g~~~~~~~~~~   79 (202)
                      +|+|.+++......+++..+..++.|++.||.|||    +.+|+||||||+||++   +.++.+||+|||++........
T Consensus        88 ~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH----~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~  163 (296)
T 4hgt_A           88 GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH----SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART  163 (296)
T ss_dssp             CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred             CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCccc
Confidence            89999999866666999999999999999999999    8999999999999999   7888999999999987654322


Q ss_pred             c-----ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccch--hhHHHHHHhCCCChhhhh
Q 037267           80 F-----VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEM--SLRRWVKESLPHGLTEVV  152 (202)
Q Consensus        80 ~-----~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~  152 (202)
                      .     .......+++.|+|||...+..++.++|+||+|+++|++++|..||........  .......           
T Consensus       164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-----------  232 (296)
T 4hgt_A          164 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE-----------  232 (296)
T ss_dssp             CCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHH-----------
T ss_pred             CccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhc-----------
Confidence            1     112235689999999998888899999999999999999999999987543221  1111100           


Q ss_pred             hhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          153 DANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                       .......  ......++.++.+++.+||+.||++|||+.++++.|+++
T Consensus       233 -~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~  278 (296)
T 4hgt_A          233 -KKMSTPI--EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL  278 (296)
T ss_dssp             -HHHHSCH--HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred             -ccccchh--hhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHH
Confidence             0000000  011123467799999999999999999999999999865

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=9.7e-37  Score=239.39  Aligned_cols=178  Identities=26%  Similarity=0.408  Sum_probs=140.9

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |++|+|.++++.....+++..+..++.|++.||.|||    +.+++||||||+||+++.++.+||+|||++.........
T Consensus       194 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH----~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~  269 (377)
T 3cbl_A          194 VQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE----SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYA  269 (377)
T ss_dssp             CTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEE
T ss_pred             CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCcee
Confidence            5799999999876666999999999999999999999    899999999999999999999999999999865433211


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhh
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVRE  159 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (202)
                      .......++..|+|||.+.+..++.++|+||+|+++|++++ |..||.......  ....+.....              
T Consensus       270 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~--~~~~~~~~~~--------------  333 (377)
T 3cbl_A          270 ASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ--TREFVEKGGR--------------  333 (377)
T ss_dssp             CCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHH--HHHHHHTTCC--------------
T ss_pred             ecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcCCC--------------
Confidence            11112234667999998887888999999999999999998 999997653222  1111111110              


Q ss_pred             HHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          160 EQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       160 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                         .+.+..++.++.+++.+||+.||++|||+.++++.|+.+
T Consensus       334 ---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  372 (377)
T 3cbl_A          334 ---LPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI  372 (377)
T ss_dssp             ---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence               011223566789999999999999999999999999876

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=4.7e-36  Score=231.76  Aligned_cols=195  Identities=23%  Similarity=0.296  Sum_probs=137.0

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCC---------CeeecCCCCCceeeCCCCceEEcccccc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSA---------PIIHCDLKPTNILLDENMVAHVSDFGIS   71 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~---------~i~h~dlk~~nil~~~~~~~~l~d~g~~   71 (202)
                      |++|||.+++....  .++..+..++.|++.||.|||    +.         +|+||||||+||+++.++.+||+|||++
T Consensus        94 ~~~g~L~~~l~~~~--~~~~~~~~i~~qi~~~L~~LH----~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a  167 (336)
T 3g2f_A           94 YPNGSLXKYLSLHT--SDWVSSCRLAHSVTRGLAYLH----TELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLS  167 (336)
T ss_dssp             CTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHH----CCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTTC
T ss_pred             CCCCcHHHHHhhcc--cchhHHHHHHHHHHHHHHHHH----hhhccccccccceeecccccceEEEcCCCcEEEeeccce
Confidence            57999999997654  589999999999999999999    77         9999999999999999999999999999


Q ss_pred             eeccCCCcc------ccccCCCCCccccCCCCCCC-------CCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHH
Q 037267           72 KLLGEGEDF------VTQTMTMATIGYMAPEYGSE-------GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRR  138 (202)
Q Consensus        72 ~~~~~~~~~------~~~~~~~~~~~~~~pe~~~~-------~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~  138 (202)
                      .........      .......+++.|+|||.+.+       ..++.++|+||+||++|++++|..||............
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~  247 (336)
T 3g2f_A          168 MRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMA  247 (336)
T ss_dssp             EECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCT
T ss_pred             eecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHh
Confidence            876543211      11223468999999998766       35567899999999999999998776543322111110


Q ss_pred             HHH-HhCCCChhhhh---hhhhhhh--HHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          139 WVK-ESLPHGLTEVV---DANLVRE--EQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       139 ~~~-~~~~~~~~~~~---~~~~~~~--~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                      +.. ....+......   .......  .........++.++.+++.+||..||++|||+.|+++.|+++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~l  316 (336)
T 3g2f_A          248 FQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAEL  316 (336)
T ss_dssp             THHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             hhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHH
Confidence            000 00000100000   0000000  000011224667799999999999999999999999999875

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=1.3e-36  Score=230.98  Aligned_cols=192  Identities=24%  Similarity=0.369  Sum_probs=138.4

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |++|||.+++......+++..+..++.|++.||.|||    +.+|+||||||+||+++.++.++|+|||++.........
T Consensus        95 ~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  170 (295)
T 3ugc_A           95 LPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG----TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEF  170 (295)
T ss_dssp             CTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEEEETTEEEECCCCSCC--------
T ss_pred             CCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHh----cCCcccCCCCHhhEEEcCCCeEEEccCcccccccCCcce
Confidence            5799999999877666999999999999999999999    899999999999999999999999999999876543221


Q ss_pred             -ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhh--hhh
Q 037267           81 -VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDA--NLV  157 (202)
Q Consensus        81 -~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~  157 (202)
                       .......++..|+|||.+.+..++.++|+||+|+++|++++|..||.......   .......  .........  ...
T Consensus       171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~---~~~~~~~--~~~~~~~~~~~~~~  245 (295)
T 3ugc_A          171 FKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEF---MRMIGND--KQGQMIVFHLIELL  245 (295)
T ss_dssp             -----CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHH---HHHHCTT--CCTHHHHHHHHHHH
T ss_pred             eeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHH---HhhhcCc--cccchhHHHHHHHH
Confidence             11222346677999998888889999999999999999999999886532111   0000000  000000000  000


Q ss_pred             hhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          158 REEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                      ......+.+..++.++.+++.+||+.||++|||+.|+++.|+++
T Consensus       246 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l  289 (295)
T 3ugc_A          246 KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI  289 (295)
T ss_dssp             HTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             hccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence            00001122345677899999999999999999999999999876

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.5e-36  Score=232.86  Aligned_cols=178  Identities=23%  Similarity=0.367  Sum_probs=135.6

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      +++|+|.+++......+++..++.++.|++.||.|||    +.+|+||||||+||+++.++.++|+|||++.........
T Consensus        98 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH----~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~~  173 (327)
T 3lzb_A           98 MPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE----DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE  173 (327)
T ss_dssp             CSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEEEETTEEEECCTTC----------
T ss_pred             cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh----hCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccCcccc
Confidence            5789999999987777999999999999999999999    899999999999999999999999999999876543332


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhh
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVRE  159 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (202)
                      .......++..|+|||.+.+..++.++|+||+|+++|++++ |..||.......  +...+.....              
T Consensus       174 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~--~~~~~~~~~~--------------  237 (327)
T 3lzb_A          174 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISSILEKGER--------------  237 (327)
T ss_dssp             ------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHHHHHTTCC--------------
T ss_pred             ccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH--HHHHHHcCCC--------------
Confidence            22233456778999998888889999999999999999999 999997654332  1111111110              


Q ss_pred             HHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          160 EQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       160 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                         .+.+..++.++.+++.+||..||++|||+.|+++.|+++
T Consensus       238 ---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~  276 (327)
T 3lzb_A          238 ---LPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKM  276 (327)
T ss_dssp             ---CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence               011123455689999999999999999999999999865

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=3.7e-35  Score=222.12  Aligned_cols=175  Identities=26%  Similarity=0.410  Sum_probs=139.5

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCC--eeecCCCCCceeeCCCCc-----eEEccccccee
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAP--IIHCDLKPTNILLDENMV-----AHVSDFGISKL   73 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~--i~h~dlk~~nil~~~~~~-----~~l~d~g~~~~   73 (202)
                      |++|+|.+++......+++..+..++.|++.||.|||    +.+  ++||||||+||+++.++.     ++|+|||++..
T Consensus       103 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH----~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~  178 (287)
T 4f0f_A          103 VPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ----NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ  178 (287)
T ss_dssp             CTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH----TSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTCBC
T ss_pred             cCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHH----hCCCCeecCCCCcceEEEeccCCCCceeEEeCCCCcccc
Confidence            5789999999877767999999999999999999999    888  999999999999987766     99999999875


Q ss_pred             ccCCCccccccCCCCCccccCCCCC--CCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHh-CCCChhh
Q 037267           74 LGEGEDFVTQTMTMATIGYMAPEYG--SEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKES-LPHGLTE  150 (202)
Q Consensus        74 ~~~~~~~~~~~~~~~~~~~~~pe~~--~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~  150 (202)
                      ....     .....+++.|+|||.+  ....++.++|+||+|+++|++++|..||................. ....   
T Consensus       179 ~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~---  250 (287)
T 4f0f_A          179 SVHS-----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPT---  250 (287)
T ss_dssp             CSSC-----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCCC---
T ss_pred             cccc-----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCCCC---
Confidence            4332     2234688999999987  345678899999999999999999999976554433222222111 1100   


Q ss_pred             hhhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          151 VVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                                    .+..++.++.+++.+||+.||++|||+.++++.|++|
T Consensus       251 --------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          251 --------------IPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             --------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             --------------CCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence                          1123556689999999999999999999999999875

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=1.1e-34  Score=220.18  Aligned_cols=181  Identities=18%  Similarity=0.146  Sum_probs=141.6

Q ss_pred             CCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeC---CCCceEEcccccceeccCCCc
Q 037267            3 NGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLD---ENMVAHVSDFGISKLLGEGED   79 (202)
Q Consensus         3 ~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~---~~~~~~l~d~g~~~~~~~~~~   79 (202)
                      +|||.+++......+++..+..++.|++.||.|||    +.+++||||||+||+++   .++.+||+|||++........
T Consensus        88 ~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~  163 (296)
T 3uzp_A           88 GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH----SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART  163 (296)
T ss_dssp             CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred             CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH----hCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccccc
Confidence            89999999866667999999999999999999999    89999999999999994   788999999999987654332


Q ss_pred             cc-----cccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccch--hhHHHHHHhCCCChhhhh
Q 037267           80 FV-----TQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEM--SLRRWVKESLPHGLTEVV  152 (202)
Q Consensus        80 ~~-----~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~  152 (202)
                      ..     ......+++.|+|||...+..++.++|+||+|+++|++++|..||........  .+.....           
T Consensus       164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-----------  232 (296)
T 3uzp_A          164 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE-----------  232 (296)
T ss_dssp             CCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHH-----------
T ss_pred             ccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcc-----------
Confidence            11     12334689999999998888899999999999999999999999986533221  1111111           


Q ss_pred             hhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          153 DANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                       .......  ......++.++.+++.+||+.||++|||+.++++.|+++
T Consensus       233 -~~~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~  278 (296)
T 3uzp_A          233 -KKMSTPI--EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL  278 (296)
T ss_dssp             -HHHHSCH--HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred             -cccCCch--HHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHH
Confidence             0000000  011134567799999999999999999999999999865

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=1.9e-35  Score=227.64  Aligned_cols=178  Identities=22%  Similarity=0.323  Sum_probs=139.8

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |++|+|.+++......+++..++.++.|++.||.|||    +.+|+||||||+||+++.++.++|+|||++.........
T Consensus        96 ~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~  171 (325)
T 3kex_A           96 LPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE----EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQ  171 (325)
T ss_dssp             CTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHH----HTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCTTC
T ss_pred             CCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHH----hCCCCCCccchheEEECCCCeEEECCCCcccccCccccc
Confidence            5789999999876566899999999999999999999    899999999999999999999999999999876544332


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhh
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVRE  159 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (202)
                      .......++..|+|||.+.+..++.++|+||+|+++|++++ |..||.......  ....+......             
T Consensus       172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~~~~~~~~~-------------  236 (325)
T 3kex_A          172 LLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE--VPDLLEKGERL-------------  236 (325)
T ss_dssp             CC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH--HHHHHHTTCBC-------------
T ss_pred             ccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH--HHHHHHcCCCC-------------
Confidence            22333457778999998888889999999999999999999 999997643222  11111111100             


Q ss_pred             HHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          160 EQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       160 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                          ..+..++.++.+++.+||..||++|||+.++++.|+.+
T Consensus       237 ----~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~  274 (325)
T 3kex_A          237 ----AQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRM  274 (325)
T ss_dssp             ----CCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHH
T ss_pred             ----CCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence                00112344578999999999999999999999999865

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=6e-36  Score=229.11  Aligned_cols=177  Identities=26%  Similarity=0.369  Sum_probs=131.6

Q ss_pred             CCCCcHHHHHhhcCC--CCCHHHHHHHHHHHHHhhhcccCCCCCCC--eeecCCCCCceeeCCCCceEEcccccceeccC
Q 037267            1 MPNGSLEKWLYSYNY--FFDILERLNIMIDVGSALEYPHHGHSSAP--IIHCDLKPTNILLDENMVAHVSDFGISKLLGE   76 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~--~l~~~~~~~~~~~l~~~l~~lH~~~~~~~--i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~   76 (202)
                      |++|+|.+++.....  .+++..++.++.|++.||.|||    +.+  |+||||||+||+++.++.+||+|||++.....
T Consensus       116 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH----~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~  191 (309)
T 3p86_A          116 LSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH----NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS  191 (309)
T ss_dssp             CTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHH----TSSSCCCCTTCCGGGEEECTTCCEEECCCC-------
T ss_pred             CCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH----cCCCCEECCCCChhhEEEeCCCcEEECCCCCCccccc
Confidence            578999999986442  3899999999999999999999    888  99999999999999999999999999975443


Q ss_pred             CCccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhh
Q 037267           77 GEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANL  156 (202)
Q Consensus        77 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (202)
                      ...  ......+++.|+|||.+.+..++.++|+||+|+++|++++|..||........  ...+.....           
T Consensus       192 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~--~~~~~~~~~-----------  256 (309)
T 3p86_A          192 TFL--SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQV--VAAVGFKCK-----------  256 (309)
T ss_dssp             ------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHH--HHHHHHSCC-----------
T ss_pred             ccc--ccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHhcCC-----------
Confidence            221  12234689999999998888899999999999999999999999976432221  111100000           


Q ss_pred             hhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          157 VREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                           ....+..++.++.+++.+||..||++|||+.++++.|+.+
T Consensus       257 -----~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~  296 (309)
T 3p86_A          257 -----RLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPL  296 (309)
T ss_dssp             -----CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -----CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence                 0011123556689999999999999999999999999764

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=1.8e-35  Score=230.43  Aligned_cols=163  Identities=27%  Similarity=0.406  Sum_probs=129.3

Q ss_pred             CCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCccccccCCCCCccccCCC
Q 037267           17 FDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPE   96 (202)
Q Consensus        17 l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~pe   96 (202)
                      +++..++.++.|++.||.|||    +.+|+||||||+||+++.++.++|+|||++................+++.|+|||
T Consensus       190 l~~~~~~~~~~ql~~aL~~LH----~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE  265 (359)
T 3vhe_A          190 LTLEHLICYSFQVAKGMEFLA----SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE  265 (359)
T ss_dssp             BCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGGCCHH
T ss_pred             cCHHHHHHHHHHHHHHHHHHH----HCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCceeEChh
Confidence            899999999999999999999    8999999999999999999999999999998765443333333445788899999


Q ss_pred             CCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhHHHHHHhHHHHHHHHH
Q 037267           97 YGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMD  175 (202)
Q Consensus        97 ~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  175 (202)
                      .+.+..++.++|+||+|+++|++++ |..||............. ......                 ..+..+++++.+
T Consensus       266 ~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~-~~~~~~-----------------~~~~~~~~~l~~  327 (359)
T 3vhe_A          266 TIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL-KEGTRM-----------------RAPDYTTPEMYQ  327 (359)
T ss_dssp             HHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHH-HHTCCC-----------------CCCTTCCHHHHH
T ss_pred             hhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHH-HcCCCC-----------------CCCCCCCHHHHH
Confidence            8888888999999999999999998 999997654333222211 111100                 011224556899


Q ss_pred             HHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          176 LALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       176 l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                      ++.+||+.||++|||+.|+++.|+++
T Consensus       328 li~~~l~~dP~~Rps~~ell~~L~~~  353 (359)
T 3vhe_A          328 TMLDCWHGEPSQRPTFSELVEHLGNL  353 (359)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHccCChhhCCCHHHHHHHHHHH
Confidence            99999999999999999999999875

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=6.3e-36  Score=230.47  Aligned_cols=178  Identities=30%  Similarity=0.495  Sum_probs=139.3

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |++|+|.++++.....+++..++.++.|++.||.|||    +.+|+||||||+||+++.++.++|+|||++.........
T Consensus       132 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH----~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  207 (325)
T 3kul_A          132 MENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLS----DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDA  207 (325)
T ss_dssp             CTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECTTCCEEECCCSSCEECC----C
T ss_pred             CCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH----HCCeeCCCCCcceEEECCCCCEEECCCCcccccccCccc
Confidence            5789999999876667999999999999999999999    899999999999999999999999999999876543221


Q ss_pred             c-cccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhh
Q 037267           81 V-TQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVR  158 (202)
Q Consensus        81 ~-~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (202)
                      . ......++..|+|||.+.+..++.++|+||+|+++|++++ |..||.......  ....+.....             
T Consensus       208 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~--~~~~~~~~~~-------------  272 (325)
T 3kul_A          208 AYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD--VISSVEEGYR-------------  272 (325)
T ss_dssp             CEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH--HHHHHHTTCC-------------
T ss_pred             eeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHH--HHHHHHcCCC-------------
Confidence            1 1222345678999999888888999999999999999998 999997643322  1111111100             


Q ss_pred             hHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          159 EEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       159 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                          .+.+..++.++.+++..||..||++|||+.++++.|+.+
T Consensus       273 ----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l  311 (325)
T 3kul_A          273 ----LPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDAL  311 (325)
T ss_dssp             ----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----CCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence                011224566789999999999999999999999999875

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=1.7e-35  Score=229.74  Aligned_cols=185  Identities=17%  Similarity=0.168  Sum_probs=140.2

Q ss_pred             CCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCC--ceEEcccccceeccCCCcc
Q 037267            3 NGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENM--VAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         3 ~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~--~~~l~d~g~~~~~~~~~~~   80 (202)
                      +|||.+++.... .+++..++.++.|++.||.|||    +.+|+||||||+||+++.++  .+||+|||++.........
T Consensus       135 ~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH----~~~ivH~Dlkp~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~  209 (345)
T 2v62_A          135 GIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIH----ENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNH  209 (345)
T ss_dssp             EEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEEESSSTTSEEECCCTTCEESSGGGCC
T ss_pred             CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----hCCeeCCCcCHHHEEEccCCCCcEEEEeCCCceeccccccc
Confidence            789999998655 5999999999999999999999    89999999999999998777  9999999999876432211


Q ss_pred             -----ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhh
Q 037267           81 -----VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDAN  155 (202)
Q Consensus        81 -----~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (202)
                           .......++..|+|||.+.+..++.++|+||+|+++|++++|..||..................         ..
T Consensus       210 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~---------~~  280 (345)
T 2v62_A          210 KQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAKTNLL---------DE  280 (345)
T ss_dssp             CCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHHHHHHH---------HT
T ss_pred             ccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHHHHHhhc---------cc
Confidence                 1113346899999999988888899999999999999999999999654333222221111110         00


Q ss_pred             hhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          156 LVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                      .............++.++.+++..||..||++|||+.++++.|+++
T Consensus       281 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~  326 (345)
T 2v62_A          281 LPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPH  326 (345)
T ss_dssp             TTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTT
T ss_pred             ccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhcc
Confidence            0000000000114566799999999999999999999999999875

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=1.1e-34  Score=223.77  Aligned_cols=181  Identities=18%  Similarity=0.139  Sum_probs=140.4

Q ss_pred             CCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCc-----eEEcccccceeccCC
Q 037267            3 NGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMV-----AHVSDFGISKLLGEG   77 (202)
Q Consensus         3 ~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~-----~~l~d~g~~~~~~~~   77 (202)
                      +|||.+++......+++..++.++.|++.||.|||    +.+|+||||||+||+++.++.     ++|+|||++......
T Consensus        88 ~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH----~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~  163 (330)
T 2izr_A           88 GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVH----SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDP  163 (330)
T ss_dssp             CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCT
T ss_pred             CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH----hCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecC
Confidence            89999999876667999999999999999999999    899999999999999998887     999999999876543


Q ss_pred             Cccc-----cccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhH-HHHHHhCCCChhhh
Q 037267           78 EDFV-----TQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLR-RWVKESLPHGLTEV  151 (202)
Q Consensus        78 ~~~~-----~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~  151 (202)
                      ....     ......||+.|+|||.+.+..++.++|+||+|+++|++++|..||........... ..+.          
T Consensus       164 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~----------  233 (330)
T 2izr_A          164 ETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIG----------  233 (330)
T ss_dssp             TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHH----------
T ss_pred             CCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHH----------
Confidence            2211     12345689999999998888899999999999999999999999987543321110 0000          


Q ss_pred             hhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          152 VDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                       ........  ......++ ++.+++..||+.||.+||+++++++.|+.+
T Consensus       234 -~~~~~~~~--~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~  279 (330)
T 2izr_A          234 -DTKRATPI--EVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDL  279 (330)
T ss_dssp             -HHHHHSCH--HHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred             -hhhccCCH--HHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHH
Confidence             00000000  00011234 799999999999999999999999998754

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=6e-35  Score=224.46  Aligned_cols=192  Identities=36%  Similarity=0.545  Sum_probs=144.6

Q ss_pred             CCCCcHHHHHhhcC---CCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCC
Q 037267            1 MPNGSLEKWLYSYN---YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEG   77 (202)
Q Consensus         1 ~~~gsL~~~l~~~~---~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~   77 (202)
                      |++|+|.+++....   ..+++..++.++.|++.||.|||    +.+++||||||+||+++.++.+|++|||++......
T Consensus       117 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH----~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  192 (321)
T 2qkw_B          117 MENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH----TRAIIHRDVKSINILLDENFVPKITDFGISKKGTEL  192 (321)
T ss_dssp             CTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCCSTTEEECTTCCEEECCCTTCEECSSS
T ss_pred             CCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhc----CCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence            57899999997543   24899999999999999999999    899999999999999999999999999999875433


Q ss_pred             CccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccch-hhHHHHHH-hCCCChhhhhhhh
Q 037267           78 EDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEM-SLRRWVKE-SLPHGLTEVVDAN  155 (202)
Q Consensus        78 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~  155 (202)
                      ..........+++.|+|||.+.+..++.++|+||+|+++|++++|..||........ ....+... .........++..
T Consensus       193 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (321)
T 2qkw_B          193 DQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPN  272 (321)
T ss_dssp             SCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSS
T ss_pred             cccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChh
Confidence            222122234578899999988778889999999999999999999999976544332 12222111 1111111111111


Q ss_pred             hhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          156 LVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                      ...     .....++..+.+++.+||+.||++|||+.|+++.|+.+
T Consensus       273 ~~~-----~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~  313 (321)
T 2qkw_B          273 LAD-----KIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA  313 (321)
T ss_dssp             CTT-----CSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             hcc-----ccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence            111     11235677899999999999999999999999999864

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=1.4e-34  Score=220.37  Aligned_cols=171  Identities=21%  Similarity=0.249  Sum_probs=135.9

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |++|+|.+++...  .+++..+..++.|++.||.|||    +.+|+||||||+||+++.++.+||+|||++........ 
T Consensus        99 ~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-  171 (297)
T 3fxz_A           99 LAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH----SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-  171 (297)
T ss_dssp             CTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred             CCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH----hCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc-
Confidence            5799999999864  3899999999999999999999    89999999999999999999999999999987654332 


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhH
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREE  160 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (202)
                       ......+++.|+|||.+.+..++.++|+||+|+++|++++|..||......... ........+..             
T Consensus       172 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~-~~~~~~~~~~~-------------  236 (297)
T 3fxz_A          172 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL-YLIATNGTPEL-------------  236 (297)
T ss_dssp             -CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH-HHHHHHCSCCC-------------
T ss_pred             -ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHhCCCCCC-------------
Confidence             123356899999999988888999999999999999999999999764322211 11111111000             


Q ss_pred             HHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          161 QAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       161 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                         ..+..++..+.+++.+||+.||++|||+.|+++
T Consensus       237 ---~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  269 (297)
T 3fxz_A          237 ---QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ  269 (297)
T ss_dssp             ---SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ---CCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence               011234566899999999999999999999975

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=1.3e-35  Score=222.63  Aligned_cols=178  Identities=25%  Similarity=0.357  Sum_probs=141.4

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |++|+|.+++......+++..+..++.|++.||.|||    +.+++||||||+||+++.++.++++|||++.........
T Consensus        85 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~  160 (268)
T 3sxs_A           85 ISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLE----SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV  160 (268)
T ss_dssp             CTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH----HTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE
T ss_pred             cCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCcCcceEEECCCCCEEEccCccceecchhhhh
Confidence            5789999999876666999999999999999999999    899999999999999999999999999999876554322


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhh
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVRE  159 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (202)
                      . .....+++.|+|||...+..++.++|+||+|+++|++++ |..||..........  .+......             
T Consensus       161 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~--~~~~~~~~-------------  224 (268)
T 3sxs_A          161 S-SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVL--KVSQGHRL-------------  224 (268)
T ss_dssp             E-CCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH--HHHTTCCC-------------
T ss_pred             c-ccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHH--HHHcCCCC-------------
Confidence            2 222345678999998888888999999999999999998 999997643322111  11111000             


Q ss_pred             HHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhcC
Q 037267          160 EQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKIK  202 (202)
Q Consensus       160 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l~  202 (202)
                          ..+..++.++.+++.+||+.||++|||+.++++.|+.++
T Consensus       225 ----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~  263 (268)
T 3sxs_A          225 ----YRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLR  263 (268)
T ss_dssp             ----CCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGC
T ss_pred             ----CCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence                001123456889999999999999999999999999874

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=2e-35  Score=232.28  Aligned_cols=178  Identities=26%  Similarity=0.403  Sum_probs=141.3

Q ss_pred             CCCCcHHHHHhhcC---------------CCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEE
Q 037267            1 MPNGSLEKWLYSYN---------------YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHV   65 (202)
Q Consensus         1 ~~~gsL~~~l~~~~---------------~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l   65 (202)
                      |++|||.+++....               ..+++..++.++.|++.||.|||    +.+|+||||||+||+++.++.+||
T Consensus       157 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH----~~~ivH~Dlkp~NIll~~~~~~kL  232 (382)
T 3tt0_A          157 ASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA----SKKCIHRDLAARNVLVTEDNVMKI  232 (382)
T ss_dssp             CTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEECTTCCEEE
T ss_pred             cCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHH----hCCEecCCCCcceEEEcCCCcEEE
Confidence            57899999998643               24899999999999999999999    899999999999999999999999


Q ss_pred             cccccceeccCCCccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhC
Q 037267           66 SDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESL  144 (202)
Q Consensus        66 ~d~g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~  144 (202)
                      +|||++................+++.|+|||.+.+..++.++|+||+|+++|++++ |..||.......  +...+....
T Consensus       233 ~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~--~~~~~~~~~  310 (382)
T 3tt0_A          233 ADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE--LFKLLKEGH  310 (382)
T ss_dssp             CSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--HHHHHHTTC
T ss_pred             cccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcCC
Confidence            99999987654332222333456788999998888889999999999999999999 999997543221  111111111


Q ss_pred             CCChhhhhhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          145 PHGLTEVVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                      ..                 ..+..++.++.+++.+||+.||++|||+.|+++.|+++
T Consensus       311 ~~-----------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~  350 (382)
T 3tt0_A          311 RM-----------------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI  350 (382)
T ss_dssp             CC-----------------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CC-----------------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            00                 01123556789999999999999999999999999875

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=5.7e-34  Score=217.53  Aligned_cols=190  Identities=27%  Similarity=0.412  Sum_probs=144.3

Q ss_pred             CCCCcHHHHHhhc--CCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCC
Q 037267            1 MPNGSLEKWLYSY--NYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGE   78 (202)
Q Consensus         1 ~~~gsL~~~l~~~--~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~   78 (202)
                      |++|+|.+++...  ...+++..+..++.|++.||.|||    +.+++|+||||+||+++.++.++++|||++.......
T Consensus       112 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH----~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~  187 (307)
T 2nru_A          112 MPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH----ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFA  187 (307)
T ss_dssp             CTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCS
T ss_pred             cCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh----cCCeecCCCCHHHEEEcCCCcEEEeeccccccccccc
Confidence            5789999999743  345899999999999999999999    8999999999999999999999999999998765433


Q ss_pred             ccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhH--HHHHHhCCCChhhhhhhhh
Q 037267           79 DFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLR--RWVKESLPHGLTEVVDANL  156 (202)
Q Consensus        79 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~  156 (202)
                      .........+++.|+|||...+ .++.++|+||+|+++|++++|..||...........  .... .........+....
T Consensus       188 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~  265 (307)
T 2nru_A          188 QTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIE-DEEKTIEDYIDKKM  265 (307)
T ss_dssp             SCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHH-TTSCCHHHHSCSSC
T ss_pred             ccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhh-hhhhhhhhhccccc
Confidence            2222233468999999997765 478899999999999999999999987544332111  1111 11111222222111


Q ss_pred             hhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhcC
Q 037267          157 VREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKIK  202 (202)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l~  202 (202)
                      .      ..+..++..+.+++.+||+.||++|||+.++++.|++++
T Consensus       266 ~------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~  305 (307)
T 2nru_A          266 N------DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT  305 (307)
T ss_dssp             S------CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred             c------ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence            1      112456778999999999999999999999999999874

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.9e-35  Score=225.97  Aligned_cols=179  Identities=22%  Similarity=0.338  Sum_probs=140.7

Q ss_pred             CCCCcHHHHHhhcCC----------------------CCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeC
Q 037267            1 MPNGSLEKWLYSYNY----------------------FFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLD   58 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~----------------------~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~   58 (202)
                      |++|+|.+++.....                      .+++..++.++.|++.||.|||    +.+|+||||||+||+++
T Consensus       131 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH----~~~ivH~Dikp~NIll~  206 (344)
T 1rjb_A          131 CCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE----FKSCVHRDLAARNVLVT  206 (344)
T ss_dssp             CTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH----HTTEEETTCSGGGEEEE
T ss_pred             CCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCChhhEEEc
Confidence            578999999986532                      3789999999999999999999    89999999999999999


Q ss_pred             CCCceEEcccccceeccCCCccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhH
Q 037267           59 ENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLR  137 (202)
Q Consensus        59 ~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~  137 (202)
                      .++.++|+|||++................+++.|+|||.+.+..++.++|+||+|+++|++++ |..||........ +.
T Consensus       207 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~-~~  285 (344)
T 1rjb_A          207 HGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDAN-FY  285 (344)
T ss_dssp             TTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH-HH
T ss_pred             CCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcHHH-HH
Confidence            999999999999986654433222333456788999998877888999999999999999998 9999976543321 11


Q ss_pred             HHHHHhCCCChhhhhhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          138 RWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       138 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                      ..+......                 ..+..++.++.+++.+||..||.+|||+.++++.|+.+
T Consensus       286 ~~~~~~~~~-----------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~  332 (344)
T 1rjb_A          286 KLIQNGFKM-----------------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQ  332 (344)
T ss_dssp             HHHHTTCCC-----------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHhcCCCC-----------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence            222211110                 01123456689999999999999999999999999865

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=1.9e-34  Score=222.00  Aligned_cols=190  Identities=37%  Similarity=0.523  Sum_probs=144.9

Q ss_pred             CCCCcHHHHHhhcC---CCCCHHHHHHHHHHHHHhhhcccCCCCCC---CeeecCCCCCceeeCCCCceEEcccccceec
Q 037267            1 MPNGSLEKWLYSYN---YFFDILERLNIMIDVGSALEYPHHGHSSA---PIIHCDLKPTNILLDENMVAHVSDFGISKLL   74 (202)
Q Consensus         1 ~~~gsL~~~l~~~~---~~l~~~~~~~~~~~l~~~l~~lH~~~~~~---~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~   74 (202)
                      |++|+|.+++....   ..+++..+..++.|++.||.|||    +.   +|+||||||+||+++.++.++|+|||++...
T Consensus       109 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH----~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~  184 (326)
T 3uim_A          109 MANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLH----DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM  184 (326)
T ss_dssp             CTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHH----HSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred             ccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH----hCCCCCeEeCCCchhhEEECCCCCEEeccCcccccc
Confidence            57899999998643   24899999999999999999999    77   9999999999999999999999999999876


Q ss_pred             cCCCccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCccc---ccchhhHHHHHHhCCCC-hhh
Q 037267           75 GEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMF---TGEMSLRRWVKESLPHG-LTE  150 (202)
Q Consensus        75 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~---~~~~~~~~~~~~~~~~~-~~~  150 (202)
                      ....... .....+++.|+|||.+.+..++.++|+||+|+++|++++|..||....   ........+........ ...
T Consensus       185 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (326)
T 3uim_A          185 DYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEA  263 (326)
T ss_dssp             CSSSSCE-ECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTT
T ss_pred             Ccccccc-cccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhhh
Confidence            5433221 223458999999998888888999999999999999999999996422   12222333332222211 111


Q ss_pred             hhhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhh
Q 037267          151 VVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKK  200 (202)
Q Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~  200 (202)
                      ........     ......+..+.+++.+||+.||++|||+.++++.|+.
T Consensus       264 ~~~~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~  308 (326)
T 3uim_A          264 LVDVDLQG-----NYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG  308 (326)
T ss_dssp             SSCTTCTT-----SCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred             hcChhhcc-----ccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence            11111111     1224567789999999999999999999999999975

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=1.3e-34  Score=221.50  Aligned_cols=179  Identities=23%  Similarity=0.360  Sum_probs=141.2

Q ss_pred             CCCCcHHHHHhhcCC-----------------CCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCce
Q 037267            1 MPNGSLEKWLYSYNY-----------------FFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVA   63 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~-----------------~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~   63 (202)
                      |++|+|.+++.....                 .+++..++.++.|++.||.|||    +.+++||||||+||+++.++.+
T Consensus       109 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dlkp~Nil~~~~~~~  184 (313)
T 1t46_A          109 CCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA----SKNCIHRDLAARNILLTHGRIT  184 (313)
T ss_dssp             CTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEEETTTEE
T ss_pred             CCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCccceEEEcCCCCE
Confidence            578999999986542                 4899999999999999999999    8999999999999999999999


Q ss_pred             EEcccccceeccCCCccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHH
Q 037267           64 HVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKE  142 (202)
Q Consensus        64 ~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~  142 (202)
                      +++|||++................+++.|+|||.+.+..++.++|+||+|+++|++++ |..||........ .......
T Consensus       185 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-~~~~~~~  263 (313)
T 1t46_A          185 KICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK-FYKMIKE  263 (313)
T ss_dssp             EECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH-HHHHHHH
T ss_pred             EEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH-HHHHhcc
Confidence            9999999987655433222333456778999998877888999999999999999998 9999976543322 1111111


Q ss_pred             hCCCChhhhhhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          143 SLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                      .....                 .+..++.++.+++.+||..||++|||+.++++.|+++
T Consensus       264 ~~~~~-----------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~  305 (313)
T 1t46_A          264 GFRML-----------------SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ  305 (313)
T ss_dssp             TCCCC-----------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCC-----------------CcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence            11100                 0123456689999999999999999999999999864

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=3.6e-34  Score=230.82  Aligned_cols=183  Identities=16%  Similarity=0.150  Sum_probs=142.9

Q ss_pred             CCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceee---CCCCceEEcccccceeccCCCc
Q 037267            3 NGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILL---DENMVAHVSDFGISKLLGEGED   79 (202)
Q Consensus         3 ~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~---~~~~~~~l~d~g~~~~~~~~~~   79 (202)
                      +|+|.+++......+++..++.++.||+.||.|||    +.+|+||||||+|||+   +.++.+||+|||++........
T Consensus        86 g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH----~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~  161 (483)
T 3sv0_A           86 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH----SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST  161 (483)
T ss_dssp             CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred             CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH----HCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCcc
Confidence            89999999866667999999999999999999999    8999999999999999   5788999999999987654432


Q ss_pred             c-----ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhh
Q 037267           80 F-----VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDA  154 (202)
Q Consensus        80 ~-----~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (202)
                      .     .......++..|++||.+.+..++.++|+|||||++|+|++|..||.............          .+...
T Consensus       162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~----------~i~~~  231 (483)
T 3sv0_A          162 HQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYE----------KISEK  231 (483)
T ss_dssp             CCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHH----------HHHHH
T ss_pred             ccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHH----------HHhhc
Confidence            1     11224568999999999988889999999999999999999999998754432111100          00000


Q ss_pred             hhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          155 NLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                      .....  .......++.++.+++..||..||++||++.+|++.|+.+
T Consensus       232 ~~~~~--~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l  276 (483)
T 3sv0_A          232 KVATS--IEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL  276 (483)
T ss_dssp             HHHSC--HHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred             ccccc--HHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence            00000  0111234567899999999999999999999999998765

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=2.3e-35  Score=226.86  Aligned_cols=178  Identities=24%  Similarity=0.452  Sum_probs=132.2

Q ss_pred             CCCCcHHHHHhhcC-----CCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceecc
Q 037267            1 MPNGSLEKWLYSYN-----YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLG   75 (202)
Q Consensus         1 ~~~gsL~~~l~~~~-----~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~   75 (202)
                      |++|+|.+++....     ..+++..++.++.|++.||.|||    +.+++||||||+||+++.++.++|+|||++....
T Consensus       113 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH----~~~ivH~Dikp~NIli~~~~~~kl~Dfg~a~~~~  188 (323)
T 3qup_A          113 MKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLS----SRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIY  188 (323)
T ss_dssp             CTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred             ccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHH----cCCcccCCCCcceEEEcCCCCEEEeecccccccc
Confidence            57899999997432     25899999999999999999999    8999999999999999999999999999998765


Q ss_pred             CCCccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhCCCChhhhhhh
Q 037267           76 EGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDA  154 (202)
Q Consensus        76 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (202)
                      ............+++.|+|||.+.+..++.++|+||+|+++|++++ |..||........  ...+.....         
T Consensus       189 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~--~~~~~~~~~---------  257 (323)
T 3qup_A          189 SGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEI--YNYLIGGNR---------  257 (323)
T ss_dssp             ------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH--HHHHHTTCC---------
T ss_pred             ccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHH--HHHHhcCCC---------
Confidence            4433222223346778999998888888999999999999999999 8999976543321  111111100         


Q ss_pred             hhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          155 NLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                              ...+..++.++.+++.+||+.||++|||+.++++.|+++
T Consensus       258 --------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~  296 (323)
T 3qup_A          258 --------LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENI  296 (323)
T ss_dssp             --------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence                    001123456689999999999999999999999999875

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=4.3e-35  Score=224.28  Aligned_cols=178  Identities=25%  Similarity=0.393  Sum_probs=141.5

Q ss_pred             CCCCcHHHHHhhcC-----------------------CCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceee
Q 037267            1 MPNGSLEKWLYSYN-----------------------YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILL   57 (202)
Q Consensus         1 ~~~gsL~~~l~~~~-----------------------~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~   57 (202)
                      |++|+|.+++....                       ..+++..++.++.|++.||.|||    +.+++||||||+||++
T Consensus       108 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~ivH~dikp~NIli  183 (314)
T 2ivs_A          108 AKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA----EMKLVHRDLAARNILV  183 (314)
T ss_dssp             CTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEE
T ss_pred             cCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH----HCCCcccccchheEEE
Confidence            57899999998643                       23899999999999999999999    8999999999999999


Q ss_pred             CCCCceEEcccccceeccCCCccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhh
Q 037267           58 DENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSL  136 (202)
Q Consensus        58 ~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~  136 (202)
                      +.++.++|+|||++................+++.|+|||...+..++.++|+||+|+++|++++ |..||.......  .
T Consensus       184 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--~  261 (314)
T 2ivs_A          184 AEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPER--L  261 (314)
T ss_dssp             ETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--H
T ss_pred             cCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--H
Confidence            9999999999999987655433333333456788999998888888999999999999999999 999997644322  1


Q ss_pred             HHHHHHhCCCChhhhhhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          137 RRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       137 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                      ...+......                 ..+..++.++.+++.+||+.||++|||+.++++.|+++
T Consensus       262 ~~~~~~~~~~-----------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~  309 (314)
T 2ivs_A          262 FNLLKTGHRM-----------------ERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKM  309 (314)
T ss_dssp             HHHHHTTCCC-----------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHhhcCCcC-----------------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            1122111100                 01123556789999999999999999999999999875

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=3.6e-35  Score=223.63  Aligned_cols=190  Identities=19%  Similarity=0.347  Sum_probs=141.8

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |++|||.+++......+++..+..++.|++.||.|||    +.+|+|+||||+||+++.++.++|+|||++.........
T Consensus       107 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  182 (302)
T 4e5w_A          107 LPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG----SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEY  182 (302)
T ss_dssp             CTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCCE
T ss_pred             CCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhh----cCCcccCCCchheEEEcCCCCEEECcccccccccCCCcc
Confidence            5789999999776667999999999999999999999    899999999999999999999999999999876554322


Q ss_pred             -ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhh---hhhhh
Q 037267           81 -VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEV---VDANL  156 (202)
Q Consensus        81 -~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~  156 (202)
                       .......++..|+|||.+.+..++.++|+||+|+++|++++|..|+......      ......+......   .....
T Consensus       183 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~~~~~~~~~~~~  256 (302)
T 4e5w_A          183 YTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMAL------FLKMIGPTHGQMTVTRLVNTL  256 (302)
T ss_dssp             EECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH------HHHHHCSCCGGGHHHHHHHHH
T ss_pred             eeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhH------HhhccCCcccccCHHHHHHHH
Confidence             1223345778899999888888889999999999999999999886432111      0000000000000   00000


Q ss_pred             hhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          157 VREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                      . .....+.+..+++++.+++.+||+.||++|||+.++++.|+++
T Consensus       257 ~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  300 (302)
T 4e5w_A          257 K-EGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL  300 (302)
T ss_dssp             H-TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             h-ccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence            0 0000111234567799999999999999999999999999875

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=1.9e-35  Score=223.26  Aligned_cols=177  Identities=21%  Similarity=0.378  Sum_probs=130.9

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |++|+|.+++......+++..+..++.|++.||.|||    +.+++||||||+||+++.++.++|+|||++.........
T Consensus        97 ~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  172 (281)
T 1mp8_A           97 CTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE----SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY  172 (281)
T ss_dssp             CTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEEEETTEEEECC-------------
T ss_pred             CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----hCCeecccccHHHEEECCCCCEEECccccccccCccccc
Confidence            5789999999876667999999999999999999999    899999999999999999999999999999876543221


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhh
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVRE  159 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (202)
                       ......+++.|+|||.+.+..++.++|+||+|+++|++++ |..||........  ...+......             
T Consensus       173 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~--~~~i~~~~~~-------------  236 (281)
T 1mp8_A          173 -KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV--IGRIENGERL-------------  236 (281)
T ss_dssp             -------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH--HHHHHTTCCC-------------
T ss_pred             -ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHH--HHHHHcCCCC-------------
Confidence             1122346778999998877788999999999999999996 9999976543321  1111111100             


Q ss_pred             HHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          160 EQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       160 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                          +.+..++.++.+++.+||+.||++|||+.++++.|+++
T Consensus       237 ----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~  274 (281)
T 1mp8_A          237 ----PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI  274 (281)
T ss_dssp             ----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence                01123566789999999999999999999999999875

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=1e-34  Score=222.42  Aligned_cols=179  Identities=27%  Similarity=0.386  Sum_probs=140.8

Q ss_pred             CCCCcHHHHHhhcCCC---------------CCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEE
Q 037267            1 MPNGSLEKWLYSYNYF---------------FDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHV   65 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~---------------l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l   65 (202)
                      |++|+|.+++......               +++..+..++.|++.||.|||    +.+++||||||+||+++.++.+++
T Consensus       114 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH----~~~i~H~dikp~Nil~~~~~~~kl  189 (316)
T 2xir_A          114 CKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA----SRKCIHRDLAARNILLSEKNVVKI  189 (316)
T ss_dssp             CTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEECGGGCEEE
T ss_pred             CCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHH----hCCcccccCccceEEECCCCCEEE
Confidence            5789999999865432               899999999999999999999    899999999999999999999999


Q ss_pred             cccccceeccCCCccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhC
Q 037267           66 SDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESL  144 (202)
Q Consensus        66 ~d~g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~  144 (202)
                      +|||++................+++.|+|||.+.+..++.++|+||+|+++|++++ |..||............. ....
T Consensus       190 ~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~-~~~~  268 (316)
T 2xir_A          190 CDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL-KEGT  268 (316)
T ss_dssp             CCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHH-HHTC
T ss_pred             CCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHHHHh-ccCc
Confidence            99999987654433222333456788999998888888999999999999999998 999997654333222111 1111


Q ss_pred             CCChhhhhhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          145 PHGLTEVVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                      ...                 .+..++.++.+++.+||+.||++|||+.++++.|+.+
T Consensus       269 ~~~-----------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~  308 (316)
T 2xir_A          269 RMR-----------------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  308 (316)
T ss_dssp             CCC-----------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             cCC-----------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            000                 0112445689999999999999999999999999875

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.4e-35  Score=230.23  Aligned_cols=178  Identities=21%  Similarity=0.335  Sum_probs=131.4

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |++|+|.++++.....+++..+..++.|++.||.|||    +.+|+||||||+||+++.++.+||+|||+++........
T Consensus       173 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH----~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~  248 (373)
T 3c1x_A          173 MKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA----SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD  248 (373)
T ss_dssp             CTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEECTTCCEEECCC------------
T ss_pred             CCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH----HCCEecCccchheEEECCCCCEEEeeccccccccccccc
Confidence            5789999999877667899999999999999999999    899999999999999999999999999999865433211


Q ss_pred             c--cccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhh
Q 037267           81 V--TQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV  157 (202)
Q Consensus        81 ~--~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (202)
                      .  ......+++.|+|||.+.+..++.++|+||+|+++|++++ |..||........  ...+......           
T Consensus       249 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~--~~~~~~~~~~-----------  315 (373)
T 3c1x_A          249 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI--TVYLLQGRRL-----------  315 (373)
T ss_dssp             ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCH--HHHHHTTCCC-----------
T ss_pred             cccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHH--HHHHHcCCCC-----------
Confidence            1  1122346778999998888888999999999999999999 6777765433221  1111111100           


Q ss_pred             hhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          158 REEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                            ..+..++..+.+++.+||..||++|||+.++++.|+++
T Consensus       316 ------~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i  353 (373)
T 3c1x_A          316 ------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI  353 (373)
T ss_dssp             ------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence                  01123556689999999999999999999999999865

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1.8e-35  Score=228.96  Aligned_cols=178  Identities=26%  Similarity=0.409  Sum_probs=139.3

Q ss_pred             CCCCcHHHHHhhcC-----------------------CCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceee
Q 037267            1 MPNGSLEKWLYSYN-----------------------YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILL   57 (202)
Q Consensus         1 ~~~gsL~~~l~~~~-----------------------~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~   57 (202)
                      |++|+|.+++....                       ..+++..++.++.|++.||.|||    +.+|+||||||+||++
T Consensus       132 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH----~~~ivH~Dlkp~NIl~  207 (343)
T 1luf_A          132 MAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS----ERKFVHRDLATRNCLV  207 (343)
T ss_dssp             CTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEE
T ss_pred             CCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCcceEEE
Confidence            57899999998642                       45899999999999999999999    8999999999999999


Q ss_pred             CCCCceEEcccccceeccCCCccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhh
Q 037267           58 DENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSL  136 (202)
Q Consensus        58 ~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~  136 (202)
                      +.++.++|+|||++................+++.|+|||.+.+..++.++|+||+|+++|++++ |..||.......  .
T Consensus       208 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--~  285 (343)
T 1luf_A          208 GENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE--V  285 (343)
T ss_dssp             CGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH--H
T ss_pred             CCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCChHH--H
Confidence            9999999999999976543322222233457888999998877788999999999999999999 999997643221  1


Q ss_pred             HHHHHHhCCCChhhhhhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          137 RRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       137 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                      ...+......                 ..+..++.++.+++.+||+.||++|||+.++++.|+++
T Consensus       286 ~~~~~~~~~~-----------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~  333 (343)
T 1luf_A          286 IYYVRDGNIL-----------------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM  333 (343)
T ss_dssp             HHHHHTTCCC-----------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred             HHHHhCCCcC-----------------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHH
Confidence            1111111100                 01123556789999999999999999999999999876

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.2e-34  Score=217.28  Aligned_cols=179  Identities=22%  Similarity=0.332  Sum_probs=138.8

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      +++|+|.+++......+++..+..++.|++.||.|||    +.+++||||||+||+++.++.++++|||++.........
T Consensus       105 ~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH----~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~  180 (298)
T 3pls_A          105 MCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLA----EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYY  180 (298)
T ss_dssp             CTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGG
T ss_pred             ccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCccc
Confidence            4689999999876667899999999999999999999    899999999999999999999999999999765432211


Q ss_pred             --ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhh
Q 037267           81 --VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVR  158 (202)
Q Consensus        81 --~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (202)
                        .......++..|.|||...+..++.++|+||+|+++|++++|..|+........ ....+......            
T Consensus       181 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~-~~~~~~~~~~~------------  247 (298)
T 3pls_A          181 SVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD-LTHFLAQGRRL------------  247 (298)
T ss_dssp             CSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGG-HHHHHHTTCCC------------
T ss_pred             ccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHH-HHHHhhcCCCC------------
Confidence              112234567889999998888899999999999999999996665443322221 12222111100            


Q ss_pred             hHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          159 EEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       159 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                           ..+..++.++.+++.+||+.||++|||+.++++.|+++
T Consensus       248 -----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~  285 (298)
T 3pls_A          248 -----PQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQI  285 (298)
T ss_dssp             -----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -----CCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence                 01123455689999999999999999999999999875

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=1.4e-34  Score=222.77  Aligned_cols=174  Identities=21%  Similarity=0.278  Sum_probs=136.4

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |++|+|.+++.... .+++..+..++.|++.||.|||    +.+|+||||||+||+++.++.+||+|||++.........
T Consensus        87 ~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH----~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  161 (323)
T 3tki_A           87 CSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLH----GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE  161 (323)
T ss_dssp             CTTEEGGGGSBTTT-BCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred             CCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcc
Confidence            57899999997543 4899999999999999999999    899999999999999999999999999999865433322


Q ss_pred             ccccCCCCCccccCCCCCCCCCc-CcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhh
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIV-SAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVRE  159 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~-~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (202)
                      .......+++.|+|||.+.+..+ +.++|+||+|+++|++++|..||............+......              
T Consensus       162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~--------------  227 (323)
T 3tki_A          162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY--------------  227 (323)
T ss_dssp             CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTT--------------
T ss_pred             cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhccccc--------------
Confidence            22234568999999998776665 678999999999999999999997755443333322211110              


Q ss_pred             HHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          160 EQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       160 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                         ......++.++.+++.+||..||++|||+.|+++
T Consensus       228 ---~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~  261 (323)
T 3tki_A          228 ---LNPWKKIDSAPLALLHKILVENPSARITIPDIKK  261 (323)
T ss_dssp             ---STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ---CCccccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence               0001234556889999999999999999999874

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=2.6e-35  Score=230.92  Aligned_cols=178  Identities=28%  Similarity=0.498  Sum_probs=129.9

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |++|||.+++......+++..++.++.|++.||.|||    +.+|+||||||+||+++.++.+||+|||++.........
T Consensus       128 ~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH----~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  203 (373)
T 2qol_A          128 MENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS----DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEA  203 (373)
T ss_dssp             CTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEECTTCCEEECCC------------
T ss_pred             CCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH----HCCeeCCCCCcceEEEcCCCCEEECcCccccccccCCcc
Confidence            5799999999877667999999999999999999999    899999999999999999999999999999876543211


Q ss_pred             c-cccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhh
Q 037267           81 V-TQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVR  158 (202)
Q Consensus        81 ~-~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (202)
                      . ......++..|+|||.+.+..++.++|+||+|+++|++++ |..||.......  ....+....              
T Consensus       204 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~--~~~~i~~~~--------------  267 (373)
T 2qol_A          204 AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD--VIKAVDEGY--------------  267 (373)
T ss_dssp             ----------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHH--HHHHHHTTE--------------
T ss_pred             ceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcCC--------------
Confidence            1 1111234678999998888889999999999999999997 999996643221  111111110              


Q ss_pred             hHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          159 EEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       159 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                         ..+.+..++.++.+++.+||+.||++||++.++++.|+++
T Consensus       268 ---~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~  307 (373)
T 2qol_A          268 ---RLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL  307 (373)
T ss_dssp             ---ECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---CCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHH
Confidence               0011224566789999999999999999999999999865

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=7.5e-35  Score=233.48  Aligned_cols=173  Identities=28%  Similarity=0.409  Sum_probs=138.7

Q ss_pred             CCCCcHHHHHhhcCC-CCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCc
Q 037267            1 MPNGSLEKWLYSYNY-FFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED   79 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~-~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~   79 (202)
                      |++|+|.++++.... .+++..++.++.|++.||.|||    +.+++||||||.||+++.++.+||+|||+++...... 
T Consensus       269 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH----~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-  343 (450)
T 1k9a_A          269 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE----GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-  343 (450)
T ss_dssp             CTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCCGGGEEECTTSCEEECCCTTCEECC----
T ss_pred             cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH----hCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc-
Confidence            579999999986543 4799999999999999999999    8999999999999999999999999999998643221 


Q ss_pred             cccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhh
Q 037267           80 FVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVR  158 (202)
Q Consensus        80 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (202)
                          ....++..|+|||.+.+..++.++|+||+|+++|++++ |..||........  ...+....              
T Consensus       344 ----~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~--~~~i~~~~--------------  403 (450)
T 1k9a_A          344 ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV--VPRVEKGY--------------  403 (450)
T ss_dssp             -------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTH--HHHHHTTC--------------
T ss_pred             ----cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH--HHHHHcCC--------------
Confidence                12246788999999888889999999999999999998 9999976543321  11111111              


Q ss_pred             hHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          159 EEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       159 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                         ..+.+..++.++.++|.+||+.||++|||+.++++.|+.+
T Consensus       404 ---~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i  443 (450)
T 1k9a_A          404 ---KMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHI  443 (450)
T ss_dssp             ---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence               0111234667799999999999999999999999999875

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-34  Score=222.30  Aligned_cols=173  Identities=19%  Similarity=0.281  Sum_probs=137.4

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCC--CCceEEcccccceeccCCC
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDE--NMVAHVSDFGISKLLGEGE   78 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~--~~~~~l~d~g~~~~~~~~~   78 (202)
                      |+||+|.+++......+++..+..++.|++.||.|||    +.+|+||||||+||+++.  ++.++++|||++.......
T Consensus        83 ~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH----~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~  158 (321)
T 1tki_A           83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH----SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD  158 (321)
T ss_dssp             CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred             CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC
Confidence            5789999999876667999999999999999999999    899999999999999986  7899999999998765433


Q ss_pred             ccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhh
Q 037267           79 DFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVR  158 (202)
Q Consensus        79 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (202)
                      ..   ....+++.|+|||.+.+..++.++|+||+|+++|++++|..||.......  ....+.......           
T Consensus       159 ~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--~~~~i~~~~~~~-----------  222 (321)
T 1tki_A          159 NF---RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ--IIENIMNAEYTF-----------  222 (321)
T ss_dssp             EE---EEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH--HHHHHHHTCCCC-----------
T ss_pred             cc---ccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHH--HHHHHHcCCCCC-----------
Confidence            21   22357899999999888888999999999999999999999997643221  111111111000           


Q ss_pred             hHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          159 EEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       159 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                         .......++.++.+++.+||..||++|||+.|+++
T Consensus       223 ---~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~  257 (321)
T 1tki_A          223 ---DEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             ---CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ---ChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence               01112345667899999999999999999999986

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=9.9e-36  Score=232.90  Aligned_cols=178  Identities=24%  Similarity=0.393  Sum_probs=137.8

Q ss_pred             CCCCcHHHHHhhcC------CCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCC---ceEEcccccc
Q 037267            1 MPNGSLEKWLYSYN------YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENM---VAHVSDFGIS   71 (202)
Q Consensus         1 ~~~gsL~~~l~~~~------~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~---~~~l~d~g~~   71 (202)
                      |++|+|.+++....      ..+++..++.++.|++.||.|||    +.+|+||||||+||+++.++   .+||+|||++
T Consensus       156 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH----~~~ivHrDlkp~NIll~~~~~~~~~kL~DFG~a  231 (367)
T 3l9p_A          156 MAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE----ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA  231 (367)
T ss_dssp             CTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEESCSSTTCCEEECCCHHH
T ss_pred             CCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHH----hCCeeCCCCChhhEEEecCCCCceEEECCCccc
Confidence            57899999998643      34899999999999999999999    89999999999999999554   5999999999


Q ss_pred             eeccCCCccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhCCCChhh
Q 037267           72 KLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTE  150 (202)
Q Consensus        72 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  150 (202)
                      ................+++.|+|||.+.+..++.++|+||+||++|++++ |..||.......  ....+.....     
T Consensus       232 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~--~~~~i~~~~~-----  304 (367)
T 3l9p_A          232 RDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE--VLEFVTSGGR-----  304 (367)
T ss_dssp             HHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--HHHHHHTTCC-----
T ss_pred             cccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcCCC-----
Confidence            75433222222233457889999998888889999999999999999998 999997643221  1111111110     


Q ss_pred             hhhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          151 VVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                                  ...+..++..+.+++.+||+.||++|||+.++++.|+.+
T Consensus       305 ------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~  343 (367)
T 3l9p_A          305 ------------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC  343 (367)
T ss_dssp             ------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ------------CCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence                        001123556689999999999999999999999999764

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=3.6e-34  Score=217.83  Aligned_cols=178  Identities=22%  Similarity=0.360  Sum_probs=137.1

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |++|||.+++......+++..+..++.|++.||.|||    +.+++||||||+||+++.++.++++|||++.........
T Consensus       109 ~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH----~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~  184 (298)
T 3f66_A          109 MKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA----SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYY  184 (298)
T ss_dssp             CTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGGC
T ss_pred             CCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH----hCCccCCCCchheEEECCCCCEEECcccccccccccchh
Confidence            5789999999876667899999999999999999999    899999999999999999999999999999865433211


Q ss_pred             --ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhh
Q 037267           81 --VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV  157 (202)
Q Consensus        81 --~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (202)
                        .......+++.|+|||...+..++.++|+||+|+++|++++ |..||.......  ...........           
T Consensus       185 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~--~~~~~~~~~~~-----------  251 (298)
T 3f66_A          185 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD--ITVYLLQGRRL-----------  251 (298)
T ss_dssp             BC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT--HHHHHHTTCCC-----------
T ss_pred             ccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH--HHHHHhcCCCC-----------
Confidence              11223456778999998888888999999999999999999 555554433222  11111111100           


Q ss_pred             hhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          158 REEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                            ..+..++..+.+++.+||+.||++|||+.++++.|+++
T Consensus       252 ------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~  289 (298)
T 3f66_A          252 ------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI  289 (298)
T ss_dssp             ------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence                  00112445689999999999999999999999999875

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=9e-34  Score=216.75  Aligned_cols=178  Identities=25%  Similarity=0.378  Sum_probs=133.0

Q ss_pred             CCCCcHHHHHhhcCC--CCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCc-eEEcccccceeccCC
Q 037267            1 MPNGSLEKWLYSYNY--FFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMV-AHVSDFGISKLLGEG   77 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~--~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~-~~l~d~g~~~~~~~~   77 (202)
                      |++|+|.+++.....  .++...++.++.|++.||.|||+.+ ..+|+||||||+||+++.++. +||+|||++......
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~-~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~  159 (307)
T 2eva_A           81 AEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ-PKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH  159 (307)
T ss_dssp             CTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCS-SSCCCCCCCSGGGEEEETTTTEEEECCCCC-------
T ss_pred             CCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCC-CCCeecCCCChhHEEEeCCCCEEEEcccccccccccc
Confidence            578999999986543  4789999999999999999999321 189999999999999988776 799999998754332


Q ss_pred             CccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhh
Q 037267           78 EDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV  157 (202)
Q Consensus        78 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (202)
                      .     ....+++.|+|||.+.+..++.++|+||+|+++|++++|..||....................           
T Consensus       160 ~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-----------  223 (307)
T 2eva_A          160 M-----TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRP-----------  223 (307)
T ss_dssp             ----------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCC-----------
T ss_pred             c-----ccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCC-----------
Confidence            1     123588999999998888899999999999999999999999976543322221111111100           


Q ss_pred             hhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          158 REEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                            +....++..+.+++.+||+.||++|||+.++++.|+.+
T Consensus       224 ------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~  261 (307)
T 2eva_A          224 ------PLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHL  261 (307)
T ss_dssp             ------CCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ------CcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence                  00123455689999999999999999999999999865

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=1.2e-33  Score=223.45  Aligned_cols=175  Identities=22%  Similarity=0.285  Sum_probs=131.3

Q ss_pred             CCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCC---CCceEEcccccceeccC
Q 037267            1 MPNGSLEKWLYSYN-YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDE---NMVAHVSDFGISKLLGE   76 (202)
Q Consensus         1 ~~~gsL~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~---~~~~~l~d~g~~~~~~~   76 (202)
                      |+||+|.+++.... ..+++..+..++.|++.||.|||    +.+|+||||||+||+++.   ++.+||+|||++.....
T Consensus       141 ~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH----~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~  216 (400)
T 1nxk_A          141 LDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH----SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS  216 (400)
T ss_dssp             CCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC-
T ss_pred             CCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH----HCCccccCcCcceEEEecCCCCccEEEEecccccccCC
Confidence            57899999998653 35999999999999999999999    899999999999999997   78899999999987543


Q ss_pred             CCccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccch--hhHHHHHHhCCCChhhhhhh
Q 037267           77 GEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEM--SLRRWVKESLPHGLTEVVDA  154 (202)
Q Consensus        77 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~  154 (202)
                      ...   .....+|+.|+|||++.+..++.++|+||+||++|++++|..||........  .....+........      
T Consensus       217 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~------  287 (400)
T 1nxk_A          217 HNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP------  287 (400)
T ss_dssp             -------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCC------
T ss_pred             CCc---cccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCC------
Confidence            221   2234679999999999888999999999999999999999999976543221  11111111110000      


Q ss_pred             hhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          155 NLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                              .+....++.++.+|+.+||..||++|||+.|+++
T Consensus       288 --------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~  321 (400)
T 1nxk_A          288 --------NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  321 (400)
T ss_dssp             --------TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             --------CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence                    0011235667899999999999999999999986

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=8e-35  Score=219.75  Aligned_cols=177  Identities=20%  Similarity=0.315  Sum_probs=137.9

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      +++|+|.+++......+++..+..++.|++.||.|||    +.+++|+||||+||+++.++.++++|||++.........
T Consensus        94 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  169 (281)
T 3cc6_A           94 YPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE----SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYY  169 (281)
T ss_dssp             CTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC------
T ss_pred             CCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCccceEEECCCCcEEeCccCCCccccccccc
Confidence            5789999999876667999999999999999999999    899999999999999999999999999998765443221


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhh
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVRE  159 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (202)
                       ......++..|+|||...+..++.++|+||+|+++|++++ |..||........  ...+......             
T Consensus       170 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~--~~~~~~~~~~-------------  233 (281)
T 3cc6_A          170 -KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDV--IGVLEKGDRL-------------  233 (281)
T ss_dssp             ----CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGH--HHHHHHTCCC-------------
T ss_pred             -ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHH--HHHHhcCCCC-------------
Confidence             1222346778999998877788999999999999999998 9999975433221  1111111100             


Q ss_pred             HHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          160 EQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       160 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                          +.+..+++.+.+++.+||..||++|||+.++++.|+.+
T Consensus       234 ----~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~  271 (281)
T 3cc6_A          234 ----PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV  271 (281)
T ss_dssp             ----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----CCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHH
Confidence                01123456689999999999999999999999999865

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=5.5e-34  Score=221.78  Aligned_cols=186  Identities=11%  Similarity=0.102  Sum_probs=140.5

Q ss_pred             CCcHHHHHhhc-CCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCC--ceEEcccccceeccCCCc
Q 037267            3 NGSLEKWLYSY-NYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENM--VAHVSDFGISKLLGEGED   79 (202)
Q Consensus         3 ~gsL~~~l~~~-~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~--~~~l~d~g~~~~~~~~~~   79 (202)
                      +|||.+++... ...+++..++.++.|++.||.|||    +.+|+||||||+||+++.++  .++|+|||++........
T Consensus       141 ~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH----~~~ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~  216 (352)
T 2jii_A          141 GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLH----ENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGK  216 (352)
T ss_dssp             CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH----HTTCBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGC
T ss_pred             CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHH----hCCccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCc
Confidence            89999999865 245999999999999999999999    89999999999999999988  899999999976543221


Q ss_pred             cc-----cccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhh
Q 037267           80 FV-----TQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDA  154 (202)
Q Consensus        80 ~~-----~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (202)
                      ..     ......+++.|+|||.+.+..++.++|+||+|+++|++++|..||.........+......... ........
T Consensus       217 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~  295 (352)
T 2jii_A          217 HVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVD-KPGPFVGP  295 (352)
T ss_dssp             CCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHH-SCCCEECT
T ss_pred             cccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcCHHHHHHHHHhccC-Chhhhhhh
Confidence            11     1123468899999999888889999999999999999999999998754333222222111000 00000000


Q ss_pred             hhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          155 NLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                      .        .....++.++.+++.+||..||++|||+.++++.|+++
T Consensus       296 ~--------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~  334 (352)
T 2jii_A          296 C--------GHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEAL  334 (352)
T ss_dssp             T--------SCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred             c--------cccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHH
Confidence            0        00012356689999999999999999999999999865

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.9e-34  Score=223.69  Aligned_cols=173  Identities=25%  Similarity=0.335  Sum_probs=126.6

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      +.+|+|.+++.... .+++.++..++.|++.||.|||    +.+|+||||||+||+++ ++.+||+|||++.........
T Consensus        90 ~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH----~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~  163 (343)
T 3dbq_A           90 CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIH----QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS  163 (343)
T ss_dssp             CCSEEHHHHHHHSC-CCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC------
T ss_pred             CCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCcceEEEE-CCcEEEeecccccccCccccc
Confidence            46899999998754 4899999999999999999999    89999999999999997 578999999999876543332


Q ss_pred             ccccCCCCCccccCCCCCCC-----------CCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChh
Q 037267           81 VTQTMTMATIGYMAPEYGSE-----------GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLT  149 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~-----------~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  149 (202)
                      .......|++.|+|||.+.+           ..++.++|+||+||++|++++|..||.........+..........   
T Consensus       164 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~---  240 (343)
T 3dbq_A          164 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI---  240 (343)
T ss_dssp             ------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCC---
T ss_pred             ccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCccc---
Confidence            22334568999999997643           5678899999999999999999999976433222111111111000   


Q ss_pred             hhhhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          150 EVVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                                    ..+...+.++.+++.+||..||++|||+.|+++
T Consensus       241 --------------~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~  273 (343)
T 3dbq_A          241 --------------EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA  273 (343)
T ss_dssp             --------------CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             --------------CCcccCCHHHHHHHHHHcCCChhHCCCHHHHHh
Confidence                          001112345889999999999999999999975

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=1.6e-33  Score=217.93  Aligned_cols=191  Identities=20%  Similarity=0.323  Sum_probs=141.3

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCC----CCCCeeecCCCCCceeeCCCCceEEcccccceeccC
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGH----SSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGE   76 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~----~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~   76 (202)
                      |++|+|.+++.+.  .+++..++.++.|++.||.|||...    .+.+|+||||||+||+++.++.++|+|||++.....
T Consensus       122 ~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~  199 (342)
T 1b6c_B          122 HEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS  199 (342)
T ss_dssp             CTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCTTCEEEET
T ss_pred             cCCCcHHHHHhcc--CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECCCceeccc
Confidence            5789999999864  4899999999999999999999310    036899999999999999999999999999987654


Q ss_pred             CCccc--cccCCCCCccccCCCCCCCC------CcCcchhhhhHHHHHHHHHhC----------CCCCCcccccchhhHH
Q 037267           77 GEDFV--TQTMTMATIGYMAPEYGSEG------IVSAKCDVYSYGVLLMETFTR----------KRPTDEMFTGEMSLRR  138 (202)
Q Consensus        77 ~~~~~--~~~~~~~~~~~~~pe~~~~~------~~~~~~di~s~G~~~~~~~~g----------~~p~~~~~~~~~~~~~  138 (202)
                      .....  ......+++.|+|||.+.+.      .++.++|+||+|+++|++++|          ..||............
T Consensus       200 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~  279 (342)
T 1b6c_B          200 ATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE  279 (342)
T ss_dssp             TTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHH
T ss_pred             cccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCcccHHH
Confidence            43221  12334689999999987654      234689999999999999999          7788765444333333


Q ss_pred             HHHHhCCCChhhhhhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          139 WVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       139 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                      +.................        ....++..+.+++.+||+.||++|||+.++++.|+++
T Consensus       280 ~~~~~~~~~~~~~~~~~~--------~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i  334 (342)
T 1b6c_B          280 MRKVVCEQKLRPNIPNRW--------QSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL  334 (342)
T ss_dssp             HHHHHTTSCCCCCCCGGG--------GTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHhCCCCcccc--------cchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence            332222111111111100        1234667799999999999999999999999999876

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=2e-34  Score=222.52  Aligned_cols=179  Identities=22%  Similarity=0.349  Sum_probs=139.5

Q ss_pred             CCCCcHHHHHhhc-------------CCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcc
Q 037267            1 MPNGSLEKWLYSY-------------NYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSD   67 (202)
Q Consensus         1 ~~~gsL~~~l~~~-------------~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d   67 (202)
                      |++|+|.+++...             ...+++..++.++.|++.||.|||    +.+|+||||||+||+++.++.++|+|
T Consensus       132 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~ivH~Dlkp~NIl~~~~~~~kl~D  207 (333)
T 2i1m_A          132 CCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA----SKNCIHRDVAARNVLLTNGHVAKIGD  207 (333)
T ss_dssp             CTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGCEEEGGGEEEBCC
T ss_pred             CCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHh----cCCcccCCcccceEEECCCCeEEECc
Confidence            5789999999753             235799999999999999999999    89999999999999999999999999


Q ss_pred             cccceeccCCCccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhCCC
Q 037267           68 FGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPH  146 (202)
Q Consensus        68 ~g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~  146 (202)
                      ||++................++..|+|||.+.+..++.++|+||+|+++|++++ |..||........ ...........
T Consensus       208 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~-~~~~~~~~~~~  286 (333)
T 2i1m_A          208 FGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK-FYKLVKDGYQM  286 (333)
T ss_dssp             CGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH-HHHHHHHTCCC
T ss_pred             cccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH-HHHHHhcCCCC
Confidence            999986554332222233446778999998877788999999999999999998 8999976543321 11222211110


Q ss_pred             ChhhhhhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          147 GLTEVVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                      .                 .+..++.++.+++.+||+.||.+|||+.++++.|+++
T Consensus       287 ~-----------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~  324 (333)
T 2i1m_A          287 A-----------------QPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQ  324 (333)
T ss_dssp             C-----------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             C-----------------CCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence            0                 0112345689999999999999999999999999864

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=1.6e-34  Score=219.66  Aligned_cols=180  Identities=22%  Similarity=0.390  Sum_probs=135.7

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |+||+|.+++.... .+++..+..++.|++.||.|||    +.+++||||||+||+++.++.++|+|||++.........
T Consensus        93 ~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  167 (294)
T 4eqm_A           93 IEGPTLSEYIESHG-PLSVDTAINFTNQILDGIKHAH----DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLT  167 (294)
T ss_dssp             CCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC------
T ss_pred             CCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEEECCCCCEEEEeCCCcccccccccc
Confidence            57899999998654 4899999999999999999999    899999999999999999999999999998765433211


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhH
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREE  160 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (202)
                       ......+++.|+|||.+.+..++.++|+||+|+++|++++|..||........... ......+              .
T Consensus       168 -~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~-~~~~~~~--------------~  231 (294)
T 4eqm_A          168 -QTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIK-HIQDSVP--------------N  231 (294)
T ss_dssp             --------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHH-HHSSCCC--------------C
T ss_pred             -ccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHH-HhhccCC--------------C
Confidence             12234589999999988888889999999999999999999999976432221111 0000000              0


Q ss_pred             HHHHHhHHHHHHHHHHHhhhcCCCCCCCC-CHHHHHHHHhhc
Q 037267          161 QAFAAKMDCIVSIMDLALDCCMESPGKRI-NMTDAAAKLKKI  201 (202)
Q Consensus       161 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rp-s~~~~~~~l~~l  201 (202)
                      ........++..+.+++.+||..||++|| ++.++.+.|+.+
T Consensus       232 ~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~  273 (294)
T 4eqm_A          232 VTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSV  273 (294)
T ss_dssp             HHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTS
T ss_pred             cchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHH
Confidence            00111234566789999999999999999 899999998765

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=2e-34  Score=220.71  Aligned_cols=178  Identities=23%  Similarity=0.402  Sum_probs=133.0

Q ss_pred             CCCCcHHHHHhh-----cCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceecc
Q 037267            1 MPNGSLEKWLYS-----YNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLG   75 (202)
Q Consensus         1 ~~~gsL~~~l~~-----~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~   75 (202)
                      |++|+|.+++..     ....+++..++.++.|++.||.|||    +.+|+||||||+||+++.++.++|+|||++....
T Consensus       123 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH----~~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~  198 (313)
T 3brb_A          123 MKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS----NRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIY  198 (313)
T ss_dssp             CTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHH----TTTCCCCCCSGGGEEECTTSCEEECSCSCC----
T ss_pred             ccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCCcceEEEcCCCcEEEeecCcceecc
Confidence            578999999953     2345999999999999999999999    8999999999999999999999999999998665


Q ss_pred             CCCccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhCCCChhhhhhh
Q 037267           76 EGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDA  154 (202)
Q Consensus        76 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (202)
                      ............+++.|+|||...+..++.++|+||+|+++|++++ |..||........  ...+......        
T Consensus       199 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~--~~~~~~~~~~--------  268 (313)
T 3brb_A          199 SGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEM--YDYLLHGHRL--------  268 (313)
T ss_dssp             ------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH--HHHHHTTCCC--------
T ss_pred             cccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHH--HHHHHcCCCC--------
Confidence            4332222233456788999998888888999999999999999999 8889876433221  1111111100        


Q ss_pred             hhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          155 NLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                               ..+..++.++.+++.+||..||++|||+.++++.|+++
T Consensus       269 ---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l  306 (313)
T 3brb_A          269 ---------KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKL  306 (313)
T ss_dssp             ---------CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---------CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence                     01123456689999999999999999999999999875

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.9e-34  Score=215.38  Aligned_cols=177  Identities=27%  Similarity=0.385  Sum_probs=139.5

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |++|+|.+++......+++..+..++.|++.||.|||    +.+++||||||+||+++.++.++++|||++.........
T Consensus        87 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH----~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  162 (269)
T 4hcu_A           87 MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE----EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT  162 (269)
T ss_dssp             CTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred             CCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHH----hCCeecCCcchheEEEcCCCCEEeccccccccccccccc
Confidence            5789999999877777999999999999999999999    899999999999999999999999999999765432211


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhh
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVRE  159 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (202)
                       ......++..|+|||.+.+..++.++|+||+|+++|++++ |..||.......  ....+......             
T Consensus       163 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~--~~~~~~~~~~~-------------  226 (269)
T 4hcu_A          163 -SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE--VVEDISTGFRL-------------  226 (269)
T ss_dssp             -STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHHHHTTCCC-------------
T ss_pred             -cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHH--HHHHHhcCccC-------------
Confidence             1222345778999998887888999999999999999999 999997643221  11111111100             


Q ss_pred             HHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          160 EQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       160 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                          ..+...+..+.+++.+||+.||++|||+.++++.|+++
T Consensus       227 ----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l  264 (269)
T 4hcu_A          227 ----YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI  264 (269)
T ss_dssp             ----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----CCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHH
Confidence                00112345689999999999999999999999999876

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=1.2e-34  Score=223.55  Aligned_cols=168  Identities=25%  Similarity=0.285  Sum_probs=133.5

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |+||+|.+++..... +++..+..++.|++.||.|||    +.+|+||||||+||+++.++.+||+|||++........ 
T Consensus        96 ~~~~~L~~~l~~~~~-l~~~~~~~~~~qi~~al~~lH----~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~-  169 (328)
T 3fe3_A           96 ASGGEVFDYLVAHGR-MKEKEARSKFRQIVSAVQYCH----QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK-  169 (328)
T ss_dssp             CTTCBHHHHHHHHCC-CCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCG-
T ss_pred             CCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH----HCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCCc-
Confidence            579999999986544 899999999999999999999    89999999999999999999999999999976554332 


Q ss_pred             ccccCCCCCccccCCCCCCCCCcC-cchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhh
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVS-AKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVRE  159 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~-~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (202)
                        .....+++.|+|||.+.+..+. .++|+||+||++|++++|..||.......  ....+.....              
T Consensus       170 --~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~~~~i~~~~~--------------  231 (328)
T 3fe3_A          170 --LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE--LRERVLRGKY--------------  231 (328)
T ss_dssp             --GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHCCC--------------
T ss_pred             --cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHH--HHHHHHhCCC--------------
Confidence              2335689999999988777664 78999999999999999999997643211  1111111100              


Q ss_pred             HHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          160 EQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       160 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                          ..+..++.++.+++.+||..||++|||+.|+++
T Consensus       232 ----~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~  264 (328)
T 3fe3_A          232 ----RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMK  264 (328)
T ss_dssp             ----CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred             ----CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence                001124556889999999999999999999875

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=4.3e-34  Score=225.26  Aligned_cols=173  Identities=24%  Similarity=0.330  Sum_probs=127.7

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |.+|+|.+++.... .+++..+..++.|++.||.|||    +.+|+||||||+||+++ ++.+||+|||++.........
T Consensus       137 ~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH----~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~  210 (390)
T 2zmd_A          137 CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIH----QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS  210 (390)
T ss_dssp             CCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHH----TTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC------
T ss_pred             cCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCcc
Confidence            46899999998755 5899999999999999999999    89999999999999995 578999999999876543322


Q ss_pred             ccccCCCCCccccCCCCCCC-----------CCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChh
Q 037267           81 VTQTMTMATIGYMAPEYGSE-----------GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLT  149 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~-----------~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  149 (202)
                      .......|++.|+|||++.+           ..++.++|+||+||++|++++|..||.........+...........  
T Consensus       211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~--  288 (390)
T 2zmd_A          211 VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE--  288 (390)
T ss_dssp             ---CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCC--
T ss_pred             ccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCC--
Confidence            22334568999999997643           35788999999999999999999999764322211211111110000  


Q ss_pred             hhhhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          150 EVVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                                     .+...+.++.+++.+||..||++|||+.|+++
T Consensus       289 ---------------~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~  320 (390)
T 2zmd_A          289 ---------------FPDIPEKDLQDVLKCCLKRDPKQRISIPELLA  320 (390)
T ss_dssp             ---------------CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ---------------CCccchHHHHHHHHHHcccChhhCCCHHHHhh
Confidence                           01112345889999999999999999999974

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9e-35  Score=220.15  Aligned_cols=178  Identities=22%  Similarity=0.389  Sum_probs=142.0

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |++|+|.+++......+++..+..++.|++.||.|||    +.+++|+||||+||+++.++.++|+|||++.........
T Consensus        91 ~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~  166 (287)
T 1u59_A           91 AGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE----EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY  166 (287)
T ss_dssp             CTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCE
T ss_pred             CCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHH----HCCEeeCCCchheEEEcCCCCEEECcccceeeeccCcce
Confidence            5789999999876667999999999999999999999    899999999999999999999999999999876543322


Q ss_pred             c-cccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhh
Q 037267           81 V-TQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVR  158 (202)
Q Consensus        81 ~-~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (202)
                      . ......+++.|+|||.+.+..++.++|+||+|+++|++++ |..||.......  ....+......            
T Consensus       167 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~~i~~~~~~------------  232 (287)
T 1u59_A          167 YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE--VMAFIEQGKRM------------  232 (287)
T ss_dssp             ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH--HHHHHHTTCCC------------
T ss_pred             eeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH--HHHHHhcCCcC------------
Confidence            1 1223346788999998877788999999999999999998 999997644322  11111111100            


Q ss_pred             hHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          159 EEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       159 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                           ..+..++.++.+++.+||..||++|||+.++++.|+++
T Consensus       233 -----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~  270 (287)
T 1u59_A          233 -----ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC  270 (287)
T ss_dssp             -----CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -----CCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence                 01123566799999999999999999999999999865

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=7.9e-35  Score=241.05  Aligned_cols=178  Identities=22%  Similarity=0.392  Sum_probs=138.7

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |++|+|.+++......+++..++.++.|++.||.|||    +.+|+||||||+||+++.++.+||+|||+++........
T Consensus       417 ~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH----~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~  492 (613)
T 2ozo_A          417 AGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE----EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSY  492 (613)
T ss_dssp             CTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-----
T ss_pred             CCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH----HCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCce
Confidence            6799999999876667999999999999999999999    899999999999999999999999999999865433211


Q ss_pred             -ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhh
Q 037267           81 -VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVR  158 (202)
Q Consensus        81 -~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (202)
                       .......+++.|+|||.+.+..++.++|+||||+++|++++ |..||......+  ....+.....             
T Consensus       493 ~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~--~~~~i~~~~~-------------  557 (613)
T 2ozo_A          493 YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE--VMAFIEQGKR-------------  557 (613)
T ss_dssp             ---------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH--HHHHHHTTCC-------------
T ss_pred             eeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH--HHHHHHcCCC-------------
Confidence             11222335678999998888889999999999999999998 999997754322  1122211110             


Q ss_pred             hHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          159 EEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       159 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                          ...+..++.++.++|..||..||++||++.++++.|+.+
T Consensus       558 ----~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~  596 (613)
T 2ozo_A          558 ----MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC  596 (613)
T ss_dssp             ----CCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHH
T ss_pred             ----CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence                011234667799999999999999999999999999864

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=3.4e-35  Score=226.39  Aligned_cols=193  Identities=26%  Similarity=0.371  Sum_probs=142.8

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |++|+|.+++......+++..++.++.|++.||.|||    +.+++|+||||+||+++.++.++|+|||++.........
T Consensus       108 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH----~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~  183 (327)
T 3lxl_A          108 LPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG----SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDY  183 (327)
T ss_dssp             CTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEEEETTEEEECCGGGCEECCTTCSE
T ss_pred             cCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH----hCCccCCCCChhhEEECCCCCEEEcccccceecccCCcc
Confidence            5799999999876556999999999999999999999    899999999999999999999999999999876544322


Q ss_pred             -ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhh
Q 037267           81 -VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVRE  159 (202)
Q Consensus        81 -~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (202)
                       .......++..|+|||.+.+..++.++|+||+|+++|++++|..||............  ............... . .
T Consensus       184 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~--~~~~~~~~~~~~~~~-~-~  259 (327)
T 3lxl_A          184 YVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMG--CERDVPALSRLLELL-E-E  259 (327)
T ss_dssp             EECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC------CCHHHHHHHHH-H-T
T ss_pred             ceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcc--cccccccHHHHHHHh-h-c
Confidence             1223345778899999888888899999999999999999999998653221100000  000000000000000 0 0


Q ss_pred             HHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          160 EQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       160 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                      ....+.+..+++++.+++.+||..||++|||+.++++.|+.+
T Consensus       260 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~  301 (327)
T 3lxl_A          260 GQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDML  301 (327)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC
T ss_pred             ccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            000111234667799999999999999999999999999875

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=9e-34  Score=221.22  Aligned_cols=172  Identities=19%  Similarity=0.223  Sum_probs=135.4

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCC----ceEEcccccceeccC
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENM----VAHVSDFGISKLLGE   76 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~----~~~l~d~g~~~~~~~   76 (202)
                      |+||+|.+++.... .+++..+..++.|++.||.|||    +.+|+||||||+||+++.++    .+||+|||++.....
T Consensus        97 ~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH----~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~  171 (361)
T 2yab_A           97 VSGGELFDFLAQKE-SLSEEEATSFIKQILDGVNYLH----TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED  171 (361)
T ss_dssp             CCSCBHHHHHTTCS-CCBHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECCT
T ss_pred             CCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcCC
Confidence            57999999997644 5899999999999999999999    89999999999999998776    799999999987654


Q ss_pred             CCccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhh
Q 037267           77 GEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANL  156 (202)
Q Consensus        77 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (202)
                      ...   .....|++.|+|||.+.+..++.++|+||+|+++|++++|..||.......  ....+......          
T Consensus       172 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~--~~~~i~~~~~~----------  236 (361)
T 2yab_A          172 GVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE--TLANITAVSYD----------  236 (361)
T ss_dssp             TCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH--HHHHHHTTCCC----------
T ss_pred             CCc---cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhcCCC----------
Confidence            322   223468999999999888889999999999999999999999997643221  11111111000          


Q ss_pred             hhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          157 VREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                       .   ........+.++.+++.+||..||++|||+.|+++
T Consensus       237 -~---~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          237 -F---DEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             -C---CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             -C---CchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence             0   01112345667899999999999999999999874

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=1e-34  Score=223.66  Aligned_cols=193  Identities=23%  Similarity=0.349  Sum_probs=141.5

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |++|||.+++......+++..++.++.|++.||.|||    +.+++|+||||+||+++.++.++|+|||++.........
T Consensus       126 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH----~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~~~  201 (326)
T 2w1i_A          126 LPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG----TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEY  201 (326)
T ss_dssp             CTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHH----HTTEECSCCCGGGEEEEETTEEEECCCTTCEECCSSCSE
T ss_pred             CCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH----hCCEeccCCCcceEEEcCCCcEEEecCcchhhccccccc
Confidence            4789999999987667999999999999999999999    899999999999999999999999999999876544322


Q ss_pred             c-cccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCCh-hhhhhhhhhh
Q 037267           81 V-TQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGL-TEVVDANLVR  158 (202)
Q Consensus        81 ~-~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  158 (202)
                      . ......++..|+|||.+.+..++.++|+||+|+++|++++|..||......   +............ ...+...+..
T Consensus       202 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~  278 (326)
T 2w1i_A          202 YKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE---FMRMIGNDKQGQMIVFHLIELLKN  278 (326)
T ss_dssp             EECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHH---HHHHHCTTCCTHHHHHHHHHHHHT
T ss_pred             cccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHH---HHHhhccccchhhhHHHHHHHhhc
Confidence            1 122234677899999888878899999999999999999999887542111   0000000000000 0000000000


Q ss_pred             hHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          159 EEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       159 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                       ....+.+..++.++.+++.+||..||++|||+.++++.|+++
T Consensus       279 -~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l  320 (326)
T 2w1i_A          279 -NGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI  320 (326)
T ss_dssp             -TCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             -CCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence             000111234667799999999999999999999999999876

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=3.6e-35  Score=235.62  Aligned_cols=177  Identities=24%  Similarity=0.412  Sum_probs=139.9

Q ss_pred             CCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCc
Q 037267            1 MPNGSLEKWLYSYN-YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED   79 (202)
Q Consensus         1 ~~~gsL~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~   79 (202)
                      |++|+|.++++... ..+++..++.++.|++.||.|||    +.+|+||||||+||+++.++.+||+|||+++.......
T Consensus       264 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH----~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~  339 (454)
T 1qcf_A          264 MAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE----QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY  339 (454)
T ss_dssp             CTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHH----HTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHH
T ss_pred             cCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH----hCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCce
Confidence            57999999998543 25899999999999999999999    89999999999999999999999999999976543211


Q ss_pred             cccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhh
Q 037267           80 FVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVR  158 (202)
Q Consensus        80 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (202)
                       .......++..|+|||.+.+..++.++|+||+|+++|++++ |..||......+  ....+.....             
T Consensus       340 -~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~--~~~~i~~~~~-------------  403 (454)
T 1qcf_A          340 -TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE--VIRALERGYR-------------  403 (454)
T ss_dssp             -HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--HHHHHHHTCC-------------
T ss_pred             -eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcCCC-------------
Confidence             11222345778999998887889999999999999999999 999997653222  1111111110             


Q ss_pred             hHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          159 EEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       159 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                          .+.+..++.++.+++.+||+.||++|||+.++++.|+.+
T Consensus       404 ----~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~  442 (454)
T 1qcf_A          404 ----MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF  442 (454)
T ss_dssp             ----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             ----CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence                011234667799999999999999999999999999875

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=1.5e-33  Score=217.79  Aligned_cols=178  Identities=25%  Similarity=0.410  Sum_probs=140.5

Q ss_pred             CCCCcHHHHHhhcCC---------------CCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEE
Q 037267            1 MPNGSLEKWLYSYNY---------------FFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHV   65 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~---------------~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l   65 (202)
                      |++|+|.+++.....               .+++..++.++.|++.||.|||    +.+|+||||||+||+++.++.+||
T Consensus       123 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH----~~~ivH~Dlkp~NIll~~~~~~kL  198 (334)
T 2pvf_A          123 ASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA----SQKCIHRDLAARNVLVTENNVMKI  198 (334)
T ss_dssp             CTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECTTCCEEE
T ss_pred             CCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH----hCCeeCCCCccceEEEcCCCCEEE
Confidence            578999999986432               3899999999999999999999    899999999999999999999999


Q ss_pred             cccccceeccCCCccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhC
Q 037267           66 SDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESL  144 (202)
Q Consensus        66 ~d~g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~  144 (202)
                      +|||++................+++.|+|||.+.+..++.++|+||+|+++|++++ |..||.......  +...+....
T Consensus       199 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~~~~~~~  276 (334)
T 2pvf_A          199 ADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--LFKLLKEGH  276 (334)
T ss_dssp             CCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--HHHHHHHTC
T ss_pred             ccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHH--HHHHHhcCC
Confidence            99999987654433222333456788999998877888999999999999999999 999997643221  111111111


Q ss_pred             CCChhhhhhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          145 PHGLTEVVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                      ..                 ..+..++.++.+++.+||..||.+|||+.++++.|+++
T Consensus       277 ~~-----------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l  316 (334)
T 2pvf_A          277 RM-----------------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI  316 (334)
T ss_dssp             CC-----------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CC-----------------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            00                 01123556689999999999999999999999999875

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=9.7e-34  Score=221.36  Aligned_cols=172  Identities=16%  Similarity=0.058  Sum_probs=135.5

Q ss_pred             CCCCcHHHHHhh----cCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCC-----------CCceEE
Q 037267            1 MPNGSLEKWLYS----YNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDE-----------NMVAHV   65 (202)
Q Consensus         1 ~~~gsL~~~l~~----~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~-----------~~~~~l   65 (202)
                      |+||||.+++..    ....+++..++.++.|++.||.|||    +.+|+||||||+||+++.           ++.+||
T Consensus       149 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH----~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~kl  224 (365)
T 3e7e_A          149 YSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH----DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLAL  224 (365)
T ss_dssp             CCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHH----TTTEECCCCSGGGEEECGGGTCC------CTTEEE
T ss_pred             cCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHh----hCCeecCCCCHHHEEecccccCccccccccCCEEE
Confidence            579999999974    3446999999999999999999999    899999999999999988           899999


Q ss_pred             cccccceeccCCCccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCC
Q 037267           66 SDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLP  145 (202)
Q Consensus        66 ~d~g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~  145 (202)
                      +|||++................||+.|+|||++.+..++.++|+||+||++|+|++|..||...........        
T Consensus       225 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~--------  296 (365)
T 3e7e_A          225 IDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPE--------  296 (365)
T ss_dssp             CCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEEEC--------
T ss_pred             eeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCceeec--------
Confidence            999999865432222223445689999999999888899999999999999999999999865433221110        


Q ss_pred             CChhhhhhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCC-CHHHHHHHHhh
Q 037267          146 HGLTEVVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRI-NMTDAAAKLKK  200 (202)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rp-s~~~~~~~l~~  200 (202)
                          ......            ...+.+.+++..|+..+|.+|+ ++.++.+.|+.
T Consensus       297 ----~~~~~~------------~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~  336 (365)
T 3e7e_A          297 ----GLFRRL------------PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKK  336 (365)
T ss_dssp             ----SCCTTC------------SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHH
T ss_pred             ----hhcccc------------CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHH
Confidence                000000            0133467899999999999995 67777777764

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=1.1e-33  Score=212.09  Aligned_cols=173  Identities=23%  Similarity=0.317  Sum_probs=135.0

Q ss_pred             CCCCcHHHHHhhcCC-CCCHHHHHHHHHHHHHhhhcccCCCCCCC--eeecCCCCCceeeCCCCceEEcccccceeccCC
Q 037267            1 MPNGSLEKWLYSYNY-FFDILERLNIMIDVGSALEYPHHGHSSAP--IIHCDLKPTNILLDENMVAHVSDFGISKLLGEG   77 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~-~l~~~~~~~~~~~l~~~l~~lH~~~~~~~--i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~   77 (202)
                      |++|||.+++..... .+++..+..++.|++.||.|||    +.+  ++||||||+||+++.++.+++.||+++..... 
T Consensus        91 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~-  165 (271)
T 3kmu_A           91 MPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH----TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS-  165 (271)
T ss_dssp             CTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHT----TSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC-
T ss_pred             cCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh----cCCCceecCCCccceEEEcCCcceeEEeccceeeecc-
Confidence            578999999986543 5899999999999999999999    888  99999999999999999999998887644222 


Q ss_pred             CccccccCCCCCccccCCCCCCCCCcCc---chhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhh
Q 037267           78 EDFVTQTMTMATIGYMAPEYGSEGIVSA---KCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDA  154 (202)
Q Consensus        78 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~---~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (202)
                            ....+++.|+|||.+.+..++.   ++|+||+|+++|++++|..||.......... .........        
T Consensus       166 ------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~-~~~~~~~~~--------  230 (271)
T 3kmu_A          166 ------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGM-KVALEGLRP--------  230 (271)
T ss_dssp             ------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHH-HHHHSCCCC--------
T ss_pred             ------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHH-HHHhcCCCC--------
Confidence                  2235789999999877655444   7999999999999999999997643322111 111111100        


Q ss_pred             hhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhcC
Q 037267          155 NLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKIK  202 (202)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l~  202 (202)
                               ..+..++.++.+++.+||+.||++|||+.++++.|++++
T Consensus       231 ---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~  269 (271)
T 3kmu_A          231 ---------TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ  269 (271)
T ss_dssp             ---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred             ---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence                     011234566899999999999999999999999999874

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=7e-35  Score=220.85  Aligned_cols=179  Identities=23%  Similarity=0.328  Sum_probs=138.7

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      +++|+|.+++......+++..+..++.|++.||.|||    +.+++|+||||+||+++.++.++++|||++.........
T Consensus       102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~  177 (291)
T 1u46_A          102 APLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE----SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH  177 (291)
T ss_dssp             CTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHH----HTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCE
T ss_pred             ccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHH----hCCcccCCCchheEEEcCCCCEEEccccccccccccccc
Confidence            4789999999876666899999999999999999999    899999999999999999999999999999876543322


Q ss_pred             c-cccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhh
Q 037267           81 V-TQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVR  158 (202)
Q Consensus        81 ~-~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (202)
                      . ......++..|+|||...+..++.++|+||+|+++|++++ |..||.......  ....+.....             
T Consensus       178 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~~~~~~~~~-------------  242 (291)
T 1u46_A          178 YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ--ILHKIDKEGE-------------  242 (291)
T ss_dssp             EEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHHHHTSCC-------------
T ss_pred             hhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHH--HHHHHHccCC-------------
Confidence            1 1223346778999998887788899999999999999999 999997643221  1111110000             


Q ss_pred             hHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          159 EEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       159 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                         ..+.+..++.++.+++.+||..||++|||+.++++.|+++
T Consensus       243 ---~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~  282 (291)
T 1u46_A          243 ---RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  282 (291)
T ss_dssp             ---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---CCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHh
Confidence               0001123556789999999999999999999999999875

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.2e-33  Score=217.85  Aligned_cols=172  Identities=22%  Similarity=0.243  Sum_probs=134.9

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCC----ceEEcccccceeccC
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENM----VAHVSDFGISKLLGE   76 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~----~~~l~d~g~~~~~~~   76 (202)
                      |++|+|.+++.... .+++..+..++.|++.||.|||    +.+|+||||||+||+++.++    .+||+|||++.....
T Consensus        96 ~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH----~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~  170 (326)
T 2y0a_A           96 VAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLH----SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF  170 (326)
T ss_dssp             CCSCBHHHHHTTSS-CCBHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECCT
T ss_pred             CCCCCHHHHHHhcC-CcCHHHHHHHHHHHHHHHHHHH----HCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECCC
Confidence            57999999997644 5899999999999999999999    89999999999999999877    799999999987654


Q ss_pred             CCccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhh
Q 037267           77 GEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANL  156 (202)
Q Consensus        77 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (202)
                      ...   .....+++.|+|||.+.+..++.++|+||+|+++|++++|..||........ +. .+.......         
T Consensus       171 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~-~~~~~~~~~---------  236 (326)
T 2y0a_A          171 GNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET-LA-NVSAVNYEF---------  236 (326)
T ss_dssp             TSC---CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH-HH-HHHHTCCCC---------
T ss_pred             CCc---cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH-HH-HHHhcCCCc---------
Confidence            322   1234689999999998888899999999999999999999999965432111 11 111110000         


Q ss_pred             hhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          157 VREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                           .......++..+.+++.+||..||++|||+.|+++
T Consensus       237 -----~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  271 (326)
T 2y0a_A          237 -----EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  271 (326)
T ss_dssp             -----CHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             -----CccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence                 01112235567899999999999999999999986

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=9.4e-34  Score=217.97  Aligned_cols=171  Identities=20%  Similarity=0.282  Sum_probs=135.0

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |++|+|.+++...  .+++..+..++.|++.||.|||    +.+|+||||||+||+++.++.++++|||++.........
T Consensus       124 ~~~~~L~~~l~~~--~l~~~~~~~i~~qi~~~L~~LH----~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  197 (321)
T 2c30_A          124 LQGGALTDIVSQV--RLNEEQIATVCEAVLQALAYLH----AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK  197 (321)
T ss_dssp             CCSCBHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC
T ss_pred             CCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCccc
Confidence            5799999999753  4899999999999999999999    899999999999999999999999999999876543221


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhH
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREE  160 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (202)
                        .....+++.|+|||.+.+..++.++|+||+|+++|++++|..||.......  ....+....+....           
T Consensus       198 --~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~-----------  262 (321)
T 2c30_A          198 --RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQ--AMKRLRDSPPPKLK-----------  262 (321)
T ss_dssp             --BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHHHHHHSSCCCCT-----------
T ss_pred             --cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHhcCCCCCcC-----------
Confidence              233468999999999888889999999999999999999999997543211  11111111111100           


Q ss_pred             HHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          161 QAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       161 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                          ....++.++.+++.+||..||++|||+.++++
T Consensus       263 ----~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  294 (321)
T 2c30_A          263 ----NSHKVSPVLRDFLERMLVRDPQERATAQELLD  294 (321)
T ss_dssp             ----TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ----ccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                01124556889999999999999999999986

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.1e-34  Score=222.57  Aligned_cols=178  Identities=28%  Similarity=0.507  Sum_probs=134.1

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |++|+|.+++......+++..++.++.|++.||.|||    +.+++||||||+||+++.++.++|+|||++.........
T Consensus       128 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH----~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~  203 (333)
T 1mqb_A          128 MENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA----NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA  203 (333)
T ss_dssp             CTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEECTTCCEEECCCCC----------
T ss_pred             CCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH----hCCeeCCCCChheEEECCCCcEEECCCCcchhhcccccc
Confidence            5789999999876667999999999999999999999    899999999999999999999999999999875433211


Q ss_pred             c-cccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhh
Q 037267           81 V-TQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVR  158 (202)
Q Consensus        81 ~-~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (202)
                      . ......++..|+|||.+.+..++.++|+||+|+++|++++ |..||.......  ....+.....             
T Consensus       204 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~--~~~~~~~~~~-------------  268 (333)
T 1mqb_A          204 TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE--VMKAINDGFR-------------  268 (333)
T ss_dssp             -------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHHHHTTCC-------------
T ss_pred             ccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHH--HHHHHHCCCc-------------
Confidence            1 1122345778999998888888999999999999999998 999996543221  1111111110             


Q ss_pred             hHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          159 EEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       159 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                          .+.+..++.++.+++.+||+.||++||++.++++.|+++
T Consensus       269 ----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~  307 (333)
T 1mqb_A          269 ----LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL  307 (333)
T ss_dssp             ----CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             ----CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence                001123556689999999999999999999999999864

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=3e-33  Score=214.23  Aligned_cols=188  Identities=21%  Similarity=0.215  Sum_probs=136.9

Q ss_pred             CCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcccc
Q 037267            3 NGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVT   82 (202)
Q Consensus         3 ~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~   82 (202)
                      .|+|.+++......+++..+..++.|++.||.|||    +.+|+||||||+||+++.++.+||+|||++.........  
T Consensus       102 ~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH----~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~--  175 (311)
T 3niz_A          102 EKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH----QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRS--  175 (311)
T ss_dssp             SEEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC---
T ss_pred             CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCchHhEEECCCCCEEEccCcCceecCCCccc--
Confidence            46899999876667999999999999999999999    899999999999999999999999999999876533221  


Q ss_pred             ccCCCCCccccCCCCCCC-CCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhC--CCChhhhhhhhhh--
Q 037267           83 QTMTMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESL--PHGLTEVVDANLV--  157 (202)
Q Consensus        83 ~~~~~~~~~~~~pe~~~~-~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~--  157 (202)
                      .....+++.|+|||.+.+ ..++.++|+||+||++|++++|..||..................  +..+.........  
T Consensus       176 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  255 (311)
T 3niz_A          176 YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQ  255 (311)
T ss_dssp             --CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHS
T ss_pred             ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhh
Confidence            223467899999998765 46789999999999999999999999875544322221111111  1111111000000  


Q ss_pred             ------hhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          158 ------REEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       158 ------~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                            ...........++.++.+++.+||..||++|||+.|+++
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  300 (311)
T 3niz_A          256 RTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN  300 (311)
T ss_dssp             CCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             cccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence                  000001122335567899999999999999999999986

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=1.4e-33  Score=218.26  Aligned_cols=169  Identities=21%  Similarity=0.196  Sum_probs=133.9

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |+||+|.+++.... .+++..+..++.|++.||.|||    +.+|+||||||+||+++.++.+||+|||++........ 
T Consensus        87 ~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH----~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~-  160 (337)
T 1o6l_A           87 ANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLH----SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-  160 (337)
T ss_dssp             CTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH----HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC-
T ss_pred             CCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCCC-
Confidence            57999999998654 4899999999999999999999    89999999999999999999999999999976432221 


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhH
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREE  160 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (202)
                       ......||+.|+|||.+.+..++.++|+||+|+++|+|++|..||.......  ....+.....               
T Consensus       161 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--~~~~i~~~~~---------------  222 (337)
T 1o6l_A          161 -TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER--LFELILMEEI---------------  222 (337)
T ss_dssp             -CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHCCC---------------
T ss_pred             -cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHH--HHHHHHcCCC---------------
Confidence             1223468999999999988889999999999999999999999996533211  1111111100               


Q ss_pred             HHHHHhHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHH
Q 037267          161 QAFAAKMDCIVSIMDLALDCCMESPGKRI-----NMTDAAA  196 (202)
Q Consensus       161 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rp-----s~~~~~~  196 (202)
                         ..+..++.++.+++.+||..||++||     ++.|+++
T Consensus       223 ---~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~  260 (337)
T 1o6l_A          223 ---RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             ---CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             ---CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence               00123456689999999999999999     8888864

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=4.9e-33  Score=222.34  Aligned_cols=173  Identities=19%  Similarity=0.216  Sum_probs=135.3

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeC---CCCceEEcccccceeccCC
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLD---ENMVAHVSDFGISKLLGEG   77 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~---~~~~~~l~d~g~~~~~~~~   77 (202)
                      |+||+|.+++.... .+++..+..++.|++.||.|||    +.+|+||||||+||+++   .++.+||+|||++......
T Consensus        92 ~~gg~L~~~i~~~~-~~~e~~~~~i~~qil~aL~~lH----~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~  166 (444)
T 3soa_A           92 VTGGELFEDIVARE-YYSEADASHCIQQILEAVLHCH----QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE  166 (444)
T ss_dssp             CBCCBHHHHHHHCS-CCCHHHHHHHHHHHHHHHHHHH----HTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTT
T ss_pred             CCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCC
Confidence            57899999998755 4899999999999999999999    89999999999999998   4678999999999766543


Q ss_pred             CccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhh
Q 037267           78 EDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV  157 (202)
Q Consensus        78 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (202)
                      ...  .....|++.|+|||.+.+..++.++|+||+||++|++++|..||.......  ....+........         
T Consensus       167 ~~~--~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~--~~~~i~~~~~~~~---------  233 (444)
T 3soa_A          167 QQA--WFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHR--LYQQIKAGAYDFP---------  233 (444)
T ss_dssp             CCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHTCCCCC---------
T ss_pred             Cce--eecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHH--HHHHHHhCCCCCC---------
Confidence            221  223468999999999888889999999999999999999999996543211  1111111110000         


Q ss_pred             hhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          158 REEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                           .+....+++++.+++.+||..||++|||+.|+++
T Consensus       234 -----~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~  267 (444)
T 3soa_A          234 -----SPEWDTVTPEAKDLINKMLTINPSKRITAAEALK  267 (444)
T ss_dssp             -----TTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             -----ccccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence                 0011234566899999999999999999999985

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.6e-33  Score=216.31  Aligned_cols=192  Identities=20%  Similarity=0.207  Sum_probs=140.4

Q ss_pred             CCCCcHHHHHhhcCC--CCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceee----CCCCceEEcccccceec
Q 037267            1 MPNGSLEKWLYSYNY--FFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILL----DENMVAHVSDFGISKLL   74 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~--~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~----~~~~~~~l~d~g~~~~~   74 (202)
                      |++|+|.+++.....  .+++..++.++.|++.||.|||    +.+|+||||||+||++    +.++.+||+|||++...
T Consensus        91 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH----~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~  166 (319)
T 4euu_A           91 CPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR----ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL  166 (319)
T ss_dssp             CTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEEC
T ss_pred             CCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH----HCCEecCCCCHHHEEEeccCCCCceEEEccCCCceec
Confidence            578999999986432  3899999999999999999999    8999999999999999    77788999999999876


Q ss_pred             cCCCccccccCCCCCccccCCCCCC--------CCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchh--hHHHHHHhC
Q 037267           75 GEGEDFVTQTMTMATIGYMAPEYGS--------EGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMS--LRRWVKESL  144 (202)
Q Consensus        75 ~~~~~~~~~~~~~~~~~~~~pe~~~--------~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~--~~~~~~~~~  144 (202)
                      ......   ....+++.|+|||.+.        +..++.++|+||+||++|++++|..||.........  ....+....
T Consensus       167 ~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  243 (319)
T 4euu_A          167 EDDEQF---VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK  243 (319)
T ss_dssp             CTTCCB---CCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHC
T ss_pred             CCCCce---eecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCC
Confidence            544321   2346899999999754        467889999999999999999999999764433221  112222222


Q ss_pred             CCChhhhhhh----hhh---hhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHh
Q 037267          145 PHGLTEVVDA----NLV---REEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLK  199 (202)
Q Consensus       145 ~~~~~~~~~~----~~~---~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~  199 (202)
                      +.........    ...   ............+..+.+++.+||+.||++|||++|+++..+
T Consensus       244 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~  305 (319)
T 4euu_A          244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS  305 (319)
T ss_dssp             CTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred             CcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence            2111000000    000   000001123456777999999999999999999999998765

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=7e-35  Score=223.89  Aligned_cols=190  Identities=24%  Similarity=0.372  Sum_probs=139.9

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |++|+|.+++....  +++..++.++.|++.||.|||    +.+|+|+||||+||+++.++.++|+|||++.........
T Consensus       117 ~~~~~L~~~l~~~~--~~~~~~~~i~~~l~~~l~~LH----~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~  190 (318)
T 3lxp_A          117 VPLGSLRDYLPRHS--IGLAQLLLFAQQICEGMAYLH----AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEY  190 (318)
T ss_dssp             CTTCBHHHHGGGSC--CCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTTCSE
T ss_pred             ccCCcHHHHHhhCC--CCHHHHHHHHHHHHHHHHHHH----hCCccCCCCchheEEEcCCCCEEECCccccccccccccc
Confidence            57899999998644  899999999999999999999    899999999999999999999999999999876554322


Q ss_pred             c-cccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhh-hhhhhh
Q 037267           81 V-TQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVV-DANLVR  158 (202)
Q Consensus        81 ~-~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~  158 (202)
                      . ......++..|+|||.+.+..++.++|+||+|+++|++++|..||............     ......... ......
T Consensus       191 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~  265 (318)
T 3lxp_A          191 YRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIG-----IAQGQMTVLRLTELLE  265 (318)
T ss_dssp             EEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHC-----SCCHHHHHHHHHHHHH
T ss_pred             cccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhc-----ccccchhHHHHHHHHh
Confidence            1 122345778899999888888889999999999999999999998653221110000     000000000 000000


Q ss_pred             hHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          159 EEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       159 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                      .....+.+..++.++.+++.+||+.||++|||+.++++.|+.+
T Consensus       266 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l  308 (318)
T 3lxp_A          266 RGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTV  308 (318)
T ss_dssp             TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             cccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence            0000112234667799999999999999999999999999875

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=1.7e-33  Score=213.56  Aligned_cols=177  Identities=25%  Similarity=0.383  Sum_probs=139.0

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      +++|+|.+++.... .+++..+..++.|++.||.|||    +.+++|+||||+||+++.++.++|+|||++.........
T Consensus        99 ~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH----~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  173 (291)
T 1xbb_A           99 AELGPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLE----ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY  173 (291)
T ss_dssp             CTTEEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE
T ss_pred             CCCCCHHHHHHhCc-CCCHHHHHHHHHHHHHHHHHHH----hCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCc
Confidence            47899999998754 4899999999999999999999    899999999999999999999999999999876544322


Q ss_pred             c-cccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhh
Q 037267           81 V-TQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVR  158 (202)
Q Consensus        81 ~-~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (202)
                      . ......++..|+|||.+.+..++.++|+||+|+++|++++ |..||.......  ....+......            
T Consensus       174 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~~~~~~~~~~------------  239 (291)
T 1xbb_A          174 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE--VTAMLEKGERM------------  239 (291)
T ss_dssp             EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHHHHHTTCCC------------
T ss_pred             ccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH--HHHHHHcCCCC------------
Confidence            1 1222345688999998877788899999999999999999 999997643221  11111111100            


Q ss_pred             hHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          159 EEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       159 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                           ..+..++.++.+++.+||+.||++|||+.++++.|+++
T Consensus       240 -----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~  277 (291)
T 1xbb_A          240 -----GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY  277 (291)
T ss_dssp             -----CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             -----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence                 01123556789999999999999999999999999875

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=7.4e-34  Score=214.60  Aligned_cols=177  Identities=24%  Similarity=0.360  Sum_probs=139.0

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |++|+|.+++......+++..+..++.|++.||.|||    +.+++||||||+||+++.++.++|+|||++.........
T Consensus       101 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~  176 (283)
T 3gen_A          101 MANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE----SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT  176 (283)
T ss_dssp             CTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHH
T ss_pred             cCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH----HCCccCCCCccceEEEcCCCCEEEccccccccccccccc
Confidence            5789999999875556999999999999999999999    899999999999999999999999999999765432211


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhh
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVRE  159 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (202)
                       ......+++.|+|||...+..++.++|+||+|+++|++++ |..||.......  ....+.......            
T Consensus       177 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~--~~~~~~~~~~~~------------  241 (283)
T 3gen_A          177 -SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE--TAEHIAQGLRLY------------  241 (283)
T ss_dssp             -STTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH--HHHHHHTTCCCC------------
T ss_pred             -cccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhH--HHHHHhcccCCC------------
Confidence             1222345778999998887888999999999999999998 999997644322  111111111000            


Q ss_pred             HHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          160 EQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       160 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                           .+..++..+.+++.+||+.||++|||+.++++.|+.+
T Consensus       242 -----~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~  278 (283)
T 3gen_A          242 -----RPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV  278 (283)
T ss_dssp             -----CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -----CCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence                 0112345688999999999999999999999999865

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=1.8e-34  Score=221.70  Aligned_cols=178  Identities=21%  Similarity=0.390  Sum_probs=138.8

Q ss_pred             CCCCcHHHHHhhcC---------CCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccc
Q 037267            1 MPNGSLEKWLYSYN---------YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGIS   71 (202)
Q Consensus         1 ~~~gsL~~~l~~~~---------~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~   71 (202)
                      |++|+|.+++....         ..+++..++.++.|++.||.|||    +.+|+||||||+||+++.++.++|+|||++
T Consensus       110 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~i~H~dikp~NIli~~~~~~kl~Dfg~~  185 (322)
T 1p4o_A          110 MTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN----ANKFVHRDLAARNCMVAEDFTVKIGDFGMT  185 (322)
T ss_dssp             CTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH----HTTCBCSCCSGGGEEECTTCCEEECCTTCC
T ss_pred             CCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHH----HCCCccCCCccceEEEcCCCeEEECcCccc
Confidence            57899999997532         34789999999999999999999    899999999999999999999999999998


Q ss_pred             eeccCCCccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhCCCChhh
Q 037267           72 KLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTE  150 (202)
Q Consensus        72 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  150 (202)
                      ................+++.|+|||.+.+..++.++|+||+|+++|++++ |..||.......  ....+.....     
T Consensus       186 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~~~~~~~~~~-----  258 (322)
T 1p4o_A          186 RDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ--VLRFVMEGGL-----  258 (322)
T ss_dssp             CGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH--HHHHHHTTCC-----
T ss_pred             cccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHH--HHHHHHcCCc-----
Confidence            76544332222333456788999998888888999999999999999999 888987643221  1111111100     


Q ss_pred             hhhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          151 VVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                                  ...+..++..+.+++.+||..||++|||+.|+++.|+++
T Consensus       259 ------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~  297 (322)
T 1p4o_A          259 ------------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE  297 (322)
T ss_dssp             ------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred             ------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHh
Confidence                        001123556689999999999999999999999999864

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=2.6e-34  Score=232.80  Aligned_cols=177  Identities=24%  Similarity=0.367  Sum_probs=141.0

Q ss_pred             CCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCc
Q 037267            1 MPNGSLEKWLYSYN-YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED   79 (202)
Q Consensus         1 ~~~gsL~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~   79 (202)
                      |++|+|.++++... ..+++..++.++.|++.||.|||    +.+|+||||||.||+++.++.+||+|||+++.......
T Consensus       298 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH----~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~  373 (495)
T 1opk_A          298 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE----KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTY  373 (495)
T ss_dssp             CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCE
T ss_pred             cCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCChhhEEECCCCcEEEeecccceeccCCce
Confidence            57899999998643 45899999999999999999999    89999999999999999999999999999987644322


Q ss_pred             cccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhh
Q 037267           80 FVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVR  158 (202)
Q Consensus        80 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (202)
                       .......++..|+|||.+.+..++.++|+||||+++|++++ |..||.......  ....+.....             
T Consensus       374 -~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~--~~~~~~~~~~-------------  437 (495)
T 1opk_A          374 -TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--VYELLEKDYR-------------  437 (495)
T ss_dssp             -ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--HHHHHHTTCC-------------
T ss_pred             -eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcCCC-------------
Confidence             11222345678999998888889999999999999999998 999997654322  1111111110             


Q ss_pred             hHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          159 EEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       159 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                          ...+..++.++.+++.+||+.||++|||+.++++.|+.+
T Consensus       438 ----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~  476 (495)
T 1opk_A          438 ----MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM  476 (495)
T ss_dssp             ----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             ----CCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence                011234567799999999999999999999999999875

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=1.1e-33  Score=222.93  Aligned_cols=173  Identities=20%  Similarity=0.223  Sum_probs=130.4

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |+||+|.+++.... .+++..+..++.|++.||.|||    +.+|+||||||+||+++.++.+||+|||+++....... 
T Consensus       135 ~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH----~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~-  208 (396)
T 4dc2_A          135 VNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYLH----ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-  208 (396)
T ss_dssp             CTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC-
T ss_pred             CCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCEEeccCCHHHEEECCCCCEEEeecceeeecccCCC-
Confidence            57999999998754 4899999999999999999999    89999999999999999999999999999975332221 


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhH
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREE  160 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (202)
                       ......||+.|+|||++.+..++.++|+||+||++|+|++|..||...........         .........+....
T Consensus       209 -~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~---------~~~~~~~~~i~~~~  278 (396)
T 4dc2_A          209 -TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ---------NTEDYLFQVILEKQ  278 (396)
T ss_dssp             -CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC---------------CCHHHHHHHHHHCC
T ss_pred             -ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccch---------hhHHHHHHHHhccc
Confidence             12345689999999999998999999999999999999999999965322111000         00000000000000


Q ss_pred             HHHHHhHHHHHHHHHHHhhhcCCCCCCCCCH
Q 037267          161 QAFAAKMDCIVSIMDLALDCCMESPGKRINM  191 (202)
Q Consensus       161 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~  191 (202)
                        ...+..++.++.+++.+||..||++||++
T Consensus       279 --~~~p~~~s~~~~~li~~lL~~dP~~R~~~  307 (396)
T 4dc2_A          279 --IRIPRSLSVKAASVLKSFLNKDPKERLGC  307 (396)
T ss_dssp             --CCCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred             --cCCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence              00112355668999999999999999996

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=1.9e-33  Score=221.38  Aligned_cols=191  Identities=17%  Similarity=0.198  Sum_probs=133.6

Q ss_pred             CCCCcHHHHHhhc-CCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCc
Q 037267            1 MPNGSLEKWLYSY-NYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED   79 (202)
Q Consensus         1 ~~~gsL~~~l~~~-~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~   79 (202)
                      |++|+|.+++... ...+++..+..++.|++.||.|||    +.+|+||||||+||+++.++.++++|||.+........
T Consensus       108 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH----~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~  183 (389)
T 3gni_B          108 MAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIH----HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQ  183 (389)
T ss_dssp             CTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTCCEEECCGGGCEECEETTE
T ss_pred             cCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEEcCCCCEEEcccccceeeccccc
Confidence            5799999999865 245899999999999999999999    89999999999999999999999999999875432211


Q ss_pred             c-----ccccCCCCCccccCCCCCCC--CCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChh---
Q 037267           80 F-----VTQTMTMATIGYMAPEYGSE--GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLT---  149 (202)
Q Consensus        80 ~-----~~~~~~~~~~~~~~pe~~~~--~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---  149 (202)
                      .     .......++..|+|||.+.+  ..++.++|+||+||++|++++|..||............. ....+....   
T Consensus       184 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~-~~~~~~~~~~~~  262 (389)
T 3gni_B          184 RQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKL-NGTVPCLLDTST  262 (389)
T ss_dssp             ECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC--------------
T ss_pred             cccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHh-cCCCCccccccc
Confidence            1     01122367889999998776  578899999999999999999999997654333221111 100000000   


Q ss_pred             --------------------hhh----hhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          150 --------------------EVV----DANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       150 --------------------~~~----~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                                          ...    ...........+.+..++.++.+|+.+||+.||++|||+.|+++
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~  333 (389)
T 3gni_B          263 IPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLN  333 (389)
T ss_dssp             -------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             cccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence                                000    00000000011233456778999999999999999999999974

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=1.5e-34  Score=217.02  Aligned_cols=173  Identities=26%  Similarity=0.383  Sum_probs=129.6

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCC---eeecCCCCCceeeCC--------CCceEEcccc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAP---IIHCDLKPTNILLDE--------NMVAHVSDFG   69 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~---i~h~dlk~~nil~~~--------~~~~~l~d~g   69 (202)
                      |++|+|.+++..  ..+++..+..++.|++.||.|||    +.+   ++||||||+||+++.        ++.++++|||
T Consensus        88 ~~~~~L~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH----~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg  161 (271)
T 3dtc_A           88 ARGGPLNRVLSG--KRIPPDILVNWAVQIARGMNYLH----DEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG  161 (271)
T ss_dssp             CTTEEHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHH----HSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCC
T ss_pred             CCCCCHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHH----hCCCCceeecCCchHHEEEecccccccccCcceEEccCC
Confidence            578999999964  34899999999999999999999    777   999999999999985        6789999999


Q ss_pred             cceeccCCCccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChh
Q 037267           70 ISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLT  149 (202)
Q Consensus        70 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  149 (202)
                      .+........    ....+++.|+|||...+..++.++|+||+|+++|++++|..||........... .......    
T Consensus       162 ~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~-~~~~~~~----  232 (271)
T 3dtc_A          162 LAREWHRTTK----MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYG-VAMNKLA----  232 (271)
T ss_dssp             C-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHH-HHTSCCC----
T ss_pred             cccccccccc----cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHh-hhcCCCC----
Confidence            9976543322    124588999999988888889999999999999999999999976432221111 0000000    


Q ss_pred             hhhhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          150 EVVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                                   .+.+..++.++.+++.+||+.||++|||+.|+++.|++|
T Consensus       233 -------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          233 -------------LPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             -------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             -------------CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence                         001123456689999999999999999999999999875

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=1.8e-33  Score=215.39  Aligned_cols=166  Identities=19%  Similarity=0.186  Sum_probs=130.0

Q ss_pred             CCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCccc
Q 037267            2 PNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFV   81 (202)
Q Consensus         2 ~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~~   81 (202)
                      .+|+|.+++...+..+++..+..++.|++.||.|||    +.+|+||||||+||+++.++.+||+|||++........  
T Consensus       139 ~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH----~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~--  212 (311)
T 3p1a_A          139 CGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLH----SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGA--  212 (311)
T ss_dssp             CCCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECGGGCEEECCCTTCEECC------
T ss_pred             cCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCEecCCCCHHHEEECCCCCEEEccceeeeecccCCC--
Confidence            378999999877767999999999999999999999    89999999999999999999999999999887644322  


Q ss_pred             cccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhHH
Q 037267           82 TQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQ  161 (202)
Q Consensus        82 ~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (202)
                       .....|++.|+|||.+.+ .++.++|+||+|+++|++++|..|+.....    ......            ..     .
T Consensus       213 -~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~----~~~~~~------------~~-----~  269 (311)
T 3p1a_A          213 -GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG----WQQLRQ------------GY-----L  269 (311)
T ss_dssp             ---CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH----HHHHTT------------TC-----C
T ss_pred             -CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH----HHHHhc------------cC-----C
Confidence             223458999999998776 689999999999999999999766543211    111100            00     0


Q ss_pred             HHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          162 AFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       162 ~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                      ....+..++.++.+++.+||+.||++|||+.|+++
T Consensus       270 ~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          270 PPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLA  304 (311)
T ss_dssp             CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence            01112345677999999999999999999999975

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=6.6e-35  Score=228.46  Aligned_cols=173  Identities=11%  Similarity=0.087  Sum_probs=128.6

Q ss_pred             CcHHHHHhhcCCCCCHHHH------HHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCC
Q 037267            4 GSLEKWLYSYNYFFDILER------LNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEG   77 (202)
Q Consensus         4 gsL~~~l~~~~~~l~~~~~------~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~   77 (202)
                      |||.+++...+..++...+      ..++.|++.||.|||    +.+|+||||||+||+++.++.+||+|||++......
T Consensus       172 ~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH----~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~  247 (371)
T 3q60_A          172 VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ----SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR  247 (371)
T ss_dssp             EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHH----HTTEEETTCSGGGEEECTTSCEEECCGGGEEETTCE
T ss_pred             CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHH----HCCCccCcCCHHHEEECCCCCEEEEecceeeecCCC
Confidence            8999999865444555566      788899999999999    899999999999999999999999999999875432


Q ss_pred             CccccccCCCCCccccCCCCCCC--CCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhh
Q 037267           78 EDFVTQTMTMATIGYMAPEYGSE--GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDAN  155 (202)
Q Consensus        78 ~~~~~~~~~~~~~~~~~pe~~~~--~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (202)
                      .     ....+++.|+|||.+.+  ..++.++|+||+||++|++++|..||..............      .........
T Consensus       248 ~-----~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~------~~~~~~~~~  316 (371)
T 3q60_A          248 G-----PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRP------SLRVPGTDS  316 (371)
T ss_dssp             E-----EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCTTCCCBC------CTTSCCCCS
T ss_pred             c-----cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCcccccchhhh------hhhhccccc
Confidence            1     12346699999998876  6789999999999999999999999987543221100000      000000000


Q ss_pred             hhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          156 LVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                           ...+....++.++.+++.+||+.||++|||+.++++
T Consensus       317 -----~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  352 (371)
T 3q60_A          317 -----LAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME  352 (371)
T ss_dssp             -----CCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred             -----cchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                 000011234567899999999999999999999864

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=1.1e-33  Score=216.09  Aligned_cols=187  Identities=21%  Similarity=0.230  Sum_probs=136.3

Q ss_pred             CCcHHHHHhhcCC-CCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCccc
Q 037267            3 NGSLEKWLYSYNY-FFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFV   81 (202)
Q Consensus         3 ~gsL~~~l~~~~~-~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~~   81 (202)
                      +|+|.+++..... .+++..+..++.|++.||.|||    +.+|+||||||+||+++.++.+||+|||++........  
T Consensus       102 ~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH----~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~--  175 (308)
T 3g33_A          102 DQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLH----ANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA--  175 (308)
T ss_dssp             CCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCTTTEEECTTSCEEECSCSCTTTSTTCCC--
T ss_pred             hcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEEEcCCCCEEEeeCccccccCCCcc--
Confidence            5799999986543 4899999999999999999999    89999999999999999999999999999976543322  


Q ss_pred             cccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCC--hhh---hhhhhh
Q 037267           82 TQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHG--LTE---VVDANL  156 (202)
Q Consensus        82 ~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~---~~~~~~  156 (202)
                       .....+++.|+|||.+.+..++.++|+||+||++|++++|..||..................+..  +..   ......
T Consensus       176 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  254 (308)
T 3g33_A          176 -LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAF  254 (308)
T ss_dssp             -SGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCSSCSSCGGGS
T ss_pred             -cCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccchhhcccccc
Confidence             12345799999999888888999999999999999999999999764433221111111111100  000   000000


Q ss_pred             h--hhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          157 V--REEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       157 ~--~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                      .  ...........++.++.+++.+||+.||++|||+.|+++
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  296 (308)
T 3g33_A          255 PPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ  296 (308)
T ss_dssp             CCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence            0  000011122345677899999999999999999999875

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=1.2e-34  Score=232.40  Aligned_cols=177  Identities=28%  Similarity=0.452  Sum_probs=135.3

Q ss_pred             CCCCcHHHHHhhc-CCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCc
Q 037267            1 MPNGSLEKWLYSY-NYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED   79 (202)
Q Consensus         1 ~~~gsL~~~l~~~-~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~   79 (202)
                      |++|||.+++... ...+++..++.++.|++.||.|||    +.+|+||||||.||+++.++.+||+|||++........
T Consensus       260 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH----~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  335 (452)
T 1fmk_A          260 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE----RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY  335 (452)
T ss_dssp             CTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred             hcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH----hCCeeCCCCChhhEEECCCCCEEECCCccceecCCCce
Confidence            5789999999853 345899999999999999999999    89999999999999999999999999999986543221


Q ss_pred             cccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhh
Q 037267           80 FVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVR  158 (202)
Q Consensus        80 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (202)
                      . ......++..|+|||.+.+..++.++|+||+|+++|++++ |..||......+  ....+....              
T Consensus       336 ~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~--~~~~i~~~~--------------  398 (452)
T 1fmk_A          336 T-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--VLDQVERGY--------------  398 (452)
T ss_dssp             --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHHHHHTTC--------------
T ss_pred             e-cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcCC--------------
Confidence            1 1222346778999998887889999999999999999999 999997643222  111111111              


Q ss_pred             hHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          159 EEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       159 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                         ..+.+..++..+.+++.+||+.||++|||+.++++.|+.+
T Consensus       399 ---~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~  438 (452)
T 1fmk_A          399 ---RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  438 (452)
T ss_dssp             ---CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTT
T ss_pred             ---CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence               0011234667799999999999999999999999999875

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=1.4e-32  Score=215.88  Aligned_cols=170  Identities=26%  Similarity=0.318  Sum_probs=132.8

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |+||+|.+++.... .+++..+..++.|++.||.|||    +.+|+||||||+||+++.++.++|+|||++........ 
T Consensus        97 ~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH----~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~-  170 (384)
T 4fr4_A           97 LLGGDLRYHLQQNV-HFKEETVKLFICELVMALDYLQ----NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ-  170 (384)
T ss_dssp             CTTEEHHHHHHTTC-CCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTCC-
T ss_pred             CCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCceeccCcHHHeEECCCCCEEEeccceeeeccCCCc-
Confidence            57999999998644 4999999999999999999999    89999999999999999999999999999987654322 


Q ss_pred             ccccCCCCCccccCCCCCCC---CCcCcchhhhhHHHHHHHHHhCCCCCCcccccchh-hHHHHHHhCCCChhhhhhhhh
Q 037267           81 VTQTMTMATIGYMAPEYGSE---GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMS-LRRWVKESLPHGLTEVVDANL  156 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~---~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  156 (202)
                        .....||+.|+|||++.+   ..++.++|+||+||++|+|++|..||......... ....+.....           
T Consensus       171 --~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~-----------  237 (384)
T 4fr4_A          171 --ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVV-----------  237 (384)
T ss_dssp             --BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCC-----------
T ss_pred             --eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhccc-----------
Confidence              233568999999998763   45888999999999999999999999754332211 1111111100           


Q ss_pred             hhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCC-HHHHHH
Q 037267          157 VREEQAFAAKMDCIVSIMDLALDCCMESPGKRIN-MTDAAA  196 (202)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps-~~~~~~  196 (202)
                             ..+..++.++.+++.+||..||++||+ +.++++
T Consensus       238 -------~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          238 -------TYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             -------CCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             -------CCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence                   011234566899999999999999998 666653

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=1.4e-34  Score=240.25  Aligned_cols=177  Identities=25%  Similarity=0.387  Sum_probs=137.6

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |++|+|.+++.... .+++..++.++.||+.||.|||    +.+|+||||||+||+++.++.+||+|||+++........
T Consensus       451 ~~~g~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~yLH----~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~  525 (635)
T 4fl3_A          451 AELGPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLE----ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY  525 (635)
T ss_dssp             CTTEEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC----
T ss_pred             cCCCCHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHHH----HCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccc
Confidence            57999999997644 4899999999999999999999    899999999999999999999999999999876543321


Q ss_pred             -ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhh
Q 037267           81 -VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVR  158 (202)
Q Consensus        81 -~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (202)
                       .......++..|+|||.+.+..++.++|+||+|+++|++++ |..||.......  ....+.....             
T Consensus       526 ~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~--~~~~i~~~~~-------------  590 (635)
T 4fl3_A          526 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE--VTAMLEKGER-------------  590 (635)
T ss_dssp             ---------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHHHHHTTCC-------------
T ss_pred             cccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcCCC-------------
Confidence             11222346778999999888889999999999999999998 999997654322  1111111110             


Q ss_pred             hHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          159 EEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       159 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                          ...+..++.++.++|..||+.||++|||+.++++.|+.+
T Consensus       591 ----~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~  629 (635)
T 4fl3_A          591 ----MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY  629 (635)
T ss_dssp             ----CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             ----CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence                011224667799999999999999999999999999865

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=3.8e-33  Score=209.81  Aligned_cols=174  Identities=21%  Similarity=0.282  Sum_probs=135.3

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |++|+|.+++... ..+++..+..++.|++.||.|||    +.+++|+||||+||+++.++.++++|||.+.........
T Consensus        87 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~  161 (276)
T 2yex_A           87 CSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLH----GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE  161 (276)
T ss_dssp             CTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred             cCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHH----hCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcch
Confidence            4688999999754 34899999999999999999999    899999999999999999999999999999865433221


Q ss_pred             ccccCCCCCccccCCCCCCCCCc-CcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhh
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIV-SAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVRE  159 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~-~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (202)
                      .......+++.|+|||...+..+ +.++|+||+|+++|++++|..||............+......              
T Consensus       162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--------------  227 (276)
T 2yex_A          162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY--------------  227 (276)
T ss_dssp             CCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTT--------------
T ss_pred             hcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccc--------------
Confidence            12233468899999998877664 678999999999999999999997755443333322211100              


Q ss_pred             HHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          160 EQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       160 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                         .......+..+.+++.+||+.||++|||+.|+++
T Consensus       228 ---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          228 ---LNPWKKIDSAPLALLHKILVENPSARITIPDIKK  261 (276)
T ss_dssp             ---STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ---cCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence               0001234556889999999999999999999875

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=2.7e-33  Score=214.72  Aligned_cols=181  Identities=23%  Similarity=0.251  Sum_probs=137.5

Q ss_pred             CCCCcHHHHHhh---cCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCC
Q 037267            1 MPNGSLEKWLYS---YNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEG   77 (202)
Q Consensus         1 ~~~gsL~~~l~~---~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~   77 (202)
                      |++|+|.+++..   ....+++..++.++.|++.||.|||    +.+++||||||+||+++.++.++++|||.+......
T Consensus       112 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH----~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~  187 (317)
T 2buj_A          112 FKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH----AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIH  187 (317)
T ss_dssp             CTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEECTTSCEEECCCSSCEESCEE
T ss_pred             CCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCCHHHEEEcCCCCEEEEecCcchhcccc
Confidence            578999999985   3456999999999999999999999    899999999999999999999999999998764321


Q ss_pred             Cccc-------cccCCCCCccccCCCCCCCCC---cCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCC
Q 037267           78 EDFV-------TQTMTMATIGYMAPEYGSEGI---VSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHG  147 (202)
Q Consensus        78 ~~~~-------~~~~~~~~~~~~~pe~~~~~~---~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~  147 (202)
                      ....       ......+++.|+|||.+.+..   ++.++|+||+|+++|++++|..||...................  
T Consensus       188 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~--  265 (317)
T 2buj_A          188 VEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLS--  265 (317)
T ss_dssp             EESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHCC----
T ss_pred             cccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhccCC--
Confidence            1100       011234688999999876543   6889999999999999999999996533222111111111000  


Q ss_pred             hhhhhhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhcC
Q 037267          148 LTEVVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKIK  202 (202)
Q Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l~  202 (202)
                                     .+....++.++.+++.+||..||++|||+.++++.|++++
T Consensus       266 ---------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~  305 (317)
T 2buj_A          266 ---------------IPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ  305 (317)
T ss_dssp             ---------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred             ---------------CCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence                           0011234566899999999999999999999999998764

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.7e-33  Score=210.75  Aligned_cols=177  Identities=27%  Similarity=0.386  Sum_probs=138.9

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      +++|+|.+++.+....+++..+..++.|++.||.|||    +.+++|+||||+||+++.++.++++|||++........ 
T Consensus        85 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~-  159 (267)
T 3t9t_A           85 MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE----EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-  159 (267)
T ss_dssp             CTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH-
T ss_pred             CCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCchheEEECCCCCEEEcccccccccccccc-
Confidence            4689999999877667899999999999999999999    89999999999999999999999999999876543211 


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhh
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVRE  159 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (202)
                      .......++..|+|||...+..++.++|+||+|+++|++++ |..||.......  ....+.......            
T Consensus       160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~~~i~~~~~~~------------  225 (267)
T 3t9t_A          160 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE--VVEDISTGFRLY------------  225 (267)
T ss_dssp             HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHHHHTTCCCC------------
T ss_pred             cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHH--HHHHHhcCCcCC------------
Confidence            11222346778999998877788999999999999999999 899987643221  111111111000            


Q ss_pred             HHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          160 EQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       160 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                           .+..++..+.+++.+||+.||++|||+.++++.|+++
T Consensus       226 -----~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l  262 (267)
T 3t9t_A          226 -----KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI  262 (267)
T ss_dssp             -----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -----CCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence                 0112345688999999999999999999999999876

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1.1e-33  Score=217.84  Aligned_cols=177  Identities=23%  Similarity=0.293  Sum_probs=116.9

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCC---ceEEcccccceeccCC
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENM---VAHVSDFGISKLLGEG   77 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~---~~~l~d~g~~~~~~~~   77 (202)
                      |++|+|.+++.... .+++..+..++.|++.||.|||    +.+|+||||||+||+++.++   .++|+|||++......
T Consensus        88 ~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH----~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~  162 (325)
T 3kn6_A           88 LNGGELFERIKKKK-HFSETEASYIMRKLVSAVSHMH----DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD  162 (325)
T ss_dssp             CCSCBHHHHHHHCS-CCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-
T ss_pred             cCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCC
Confidence            57899999998754 4999999999999999999999    89999999999999997655   7999999999865443


Q ss_pred             CccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccc--hhhHHHHHHhCCCChhhhhhhh
Q 037267           78 EDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGE--MSLRRWVKESLPHGLTEVVDAN  155 (202)
Q Consensus        78 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  155 (202)
                      ...  .....+++.|+|||.+.+..++.++|+||+|+++|++++|..||.......  ...........        ...
T Consensus       163 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~--------~~~  232 (325)
T 3kn6_A          163 NQP--LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIK--------KGD  232 (325)
T ss_dssp             -----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHT--------TTC
T ss_pred             CCc--ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHH--------cCC
Confidence            221  223457899999999988889999999999999999999999997643321  01111111110        000


Q ss_pred             hhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHH
Q 037267          156 LVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAA  195 (202)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~  195 (202)
                      ..   ........++.++.+++.+||..||++|||+.|++
T Consensus       233 ~~---~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell  269 (325)
T 3kn6_A          233 FS---FEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLR  269 (325)
T ss_dssp             CC---CCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTST
T ss_pred             CC---CCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHh
Confidence            00   00111234667799999999999999999999876

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=4.9e-34  Score=218.50  Aligned_cols=174  Identities=23%  Similarity=0.360  Sum_probs=126.8

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |+||+|.+++.... .+++..+..++.|++.||.|||    +.+|+||||||+||+++.++.+||+|||++.........
T Consensus        98 ~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH----~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~  172 (311)
T 3ork_A           98 VDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSH----QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNS  172 (311)
T ss_dssp             CCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEEETTSCEEECCCSCC---------
T ss_pred             CCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCCCcCCCCHHHEEEcCCCCEEEeeccCcccccccccc
Confidence            56899999998654 4899999999999999999999    899999999999999999999999999999865543221


Q ss_pred             c-cccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhh
Q 037267           81 V-TQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVRE  159 (202)
Q Consensus        81 ~-~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (202)
                      . ......+++.|+|||.+.+..++.++|+||+|+++|++++|..||........... ......               
T Consensus       173 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~-~~~~~~---------------  236 (311)
T 3ork_A          173 VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQ-HVREDP---------------  236 (311)
T ss_dssp             ---------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH-HHHCCC---------------
T ss_pred             cccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHH-HhcCCC---------------
Confidence            1 12234589999999998888899999999999999999999999976432221111 110000               


Q ss_pred             HHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHH
Q 037267          160 EQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAA  195 (202)
Q Consensus       160 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~  195 (202)
                      .........++.++.+++.+||+.||++||++.+++
T Consensus       237 ~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l  272 (311)
T 3ork_A          237 IPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEM  272 (311)
T ss_dssp             CCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHH
T ss_pred             CCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHH
Confidence            000111223566789999999999999999766554

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=4.4e-33  Score=219.30  Aligned_cols=187  Identities=24%  Similarity=0.298  Sum_probs=131.5

Q ss_pred             CCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCc---
Q 037267            3 NGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED---   79 (202)
Q Consensus         3 ~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~---   79 (202)
                      +|+|.++++..  .++...+..++.|++.||.|||    +.+|+||||||+||+++.++.+||+|||+++.......   
T Consensus        94 ~~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH----~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~  167 (388)
T 3oz6_A           94 ETDLHAVIRAN--ILEPVHKQYVVYQLIKVIKYLH----SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTN  167 (388)
T ss_dssp             SEEHHHHHHHT--CCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCCCC
T ss_pred             CcCHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH----hCCEEeCCCCHHHeEEcCCCCEEecCCcccccccccccccc
Confidence            47899999863  4899999999999999999999    89999999999999999999999999999986543110   


Q ss_pred             ----------------cccccCCCCCccccCCCCCCC-CCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHH
Q 037267           80 ----------------FVTQTMTMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKE  142 (202)
Q Consensus        80 ----------------~~~~~~~~~~~~~~~pe~~~~-~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~  142 (202)
                                      ........+|+.|+|||.+.+ ..++.++|+||+||++|++++|..||........ +......
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~-~~~i~~~  246 (388)
T 3oz6_A          168 NIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQ-LERIIGV  246 (388)
T ss_dssp             CGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHH
T ss_pred             cccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHh
Confidence                            011223468999999998766 5789999999999999999999999976443221 1111111


Q ss_pred             -hCCCC----------hhhhhhhhhh-------h-----hHH-----HHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHH
Q 037267          143 -SLPHG----------LTEVVDANLV-------R-----EEQ-----AFAAKMDCIVSIMDLALDCCMESPGKRINMTDA  194 (202)
Q Consensus       143 -~~~~~----------~~~~~~~~~~-------~-----~~~-----~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~  194 (202)
                       ..+..          ..........       .     ..+     .......+++++.+|+.+||..||++|||+.|+
T Consensus       247 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e~  326 (388)
T 3oz6_A          247 IDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDA  326 (388)
T ss_dssp             HCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred             cCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHHHH
Confidence             11100          0000000000       0     000     000011456779999999999999999999998


Q ss_pred             HH
Q 037267          195 AA  196 (202)
Q Consensus       195 ~~  196 (202)
                      ++
T Consensus       327 l~  328 (388)
T 3oz6_A          327 LK  328 (388)
T ss_dssp             TT
T ss_pred             hC
Confidence            74

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=5.6e-33  Score=213.39  Aligned_cols=166  Identities=27%  Similarity=0.260  Sum_probs=133.2

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |+||+|.+++.... .+++..+..++.|++.||.|||    +.+|+||||||+||+++.++.+||+|||++.......  
T Consensus        88 ~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH----~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~~--  160 (318)
T 1fot_A           88 IEGGELFSLLRKSQ-RFPNPVAKFYAAEVCLALEYLH----SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT--  160 (318)
T ss_dssp             CCSCBHHHHHHHTS-SCCHHHHHHHHHHHHHHHHHHH----TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSCB--
T ss_pred             CCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCccccCCChheEEEcCCCCEEEeecCcceecCCcc--
Confidence            57899999998654 4899999999999999999999    8999999999999999999999999999998754321  


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhH
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREE  160 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (202)
                         ....|++.|+|||.+.+..++.++|+||+||++|++++|..||.......  ....+.....           .   
T Consensus       161 ---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~~~~i~~~~~-----------~---  221 (318)
T 1fot_A          161 ---YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK--TYEKILNAEL-----------R---  221 (318)
T ss_dssp             ---CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH--HHHHHHHCCC-----------C---
T ss_pred             ---ccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH--HHHHHHhCCC-----------C---
Confidence               23468999999999888889999999999999999999999997643211  1111111100           0   


Q ss_pred             HHHHHhHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHH
Q 037267          161 QAFAAKMDCIVSIMDLALDCCMESPGKRI-----NMTDAAA  196 (202)
Q Consensus       161 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rp-----s~~~~~~  196 (202)
                          .+...+.++.+++.+||..||++||     ++.++++
T Consensus       222 ----~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~  258 (318)
T 1fot_A          222 ----FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  258 (318)
T ss_dssp             ----CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             ----CCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence                0112455689999999999999999     7888763

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=7e-34  Score=221.25  Aligned_cols=164  Identities=24%  Similarity=0.219  Sum_probs=127.3

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |+||+|.+++.... .+++..+..++.|++.||.|||    +.+|+||||||+||+++.++.+||+|||++........ 
T Consensus       106 ~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH----~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~~-  179 (353)
T 3txo_A          106 VNGGDLMFHIQKSR-RFDEARARFYAAEIISALMFLH----DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGV-  179 (353)
T ss_dssp             CCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC----
T ss_pred             CCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCCcccCCCHHHEEECCCCCEEEccccceeecccCCc-
Confidence            57999999998754 4899999999999999999999    89999999999999999999999999999975332221 


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhH
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREE  160 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (202)
                       ......||+.|+|||++.+..++.++|+||+||++|+|++|..||.......  ....+.....           .   
T Consensus       180 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~--~~~~i~~~~~-----------~---  242 (353)
T 3txo_A          180 -TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD--LFEAILNDEV-----------V---  242 (353)
T ss_dssp             -------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHCCC-----------C---
T ss_pred             -cccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHH--HHHHHHcCCC-----------C---
Confidence             1233468999999998888888999999999999999999999997643221  1111111100           0   


Q ss_pred             HHHHHhHHHHHHHHHHHhhhcCCCCCCCCCH
Q 037267          161 QAFAAKMDCIVSIMDLALDCCMESPGKRINM  191 (202)
Q Consensus       161 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~  191 (202)
                          .+...+.++.+++.+||..||++||++
T Consensus       243 ----~p~~~~~~~~~li~~lL~~dP~~R~~~  269 (353)
T 3txo_A          243 ----YPTWLHEDATGILKSFMTKNPTMRLGS  269 (353)
T ss_dssp             ----CCTTSCHHHHHHHHHHTCSSGGGSTTS
T ss_pred             ----CCCCCCHHHHHHHHHHhhhCHHHccCC
Confidence                011244568899999999999999998

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=2.6e-33  Score=218.02  Aligned_cols=164  Identities=23%  Similarity=0.241  Sum_probs=130.1

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |+||+|.+++.... .+++..+..++.|++.||.|||    +.+|+||||||+||+++.++.+||+|||++........ 
T Consensus       103 ~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH----~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~-  176 (353)
T 2i0e_A          103 VNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQ----SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV-  176 (353)
T ss_dssp             CCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC-
T ss_pred             CCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccCCc-
Confidence            57999999998654 4899999999999999999999    89999999999999999999999999999976432221 


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhH
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREE  160 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (202)
                       ......||+.|+|||.+.+..++.++|+||+||++|+|++|..||.......  ....+.....           .   
T Consensus       177 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~--~~~~i~~~~~-----------~---  239 (353)
T 2i0e_A          177 -TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE--LFQSIMEHNV-----------A---  239 (353)
T ss_dssp             -CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHCCC-----------C---
T ss_pred             -ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHH--HHHHHHhCCC-----------C---
Confidence             1233568999999999888889999999999999999999999997643211  1111111100           0   


Q ss_pred             HHHHHhHHHHHHHHHHHhhhcCCCCCCCCCH
Q 037267          161 QAFAAKMDCIVSIMDLALDCCMESPGKRINM  191 (202)
Q Consensus       161 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~  191 (202)
                          .+...+.++.+++.+||..||++||++
T Consensus       240 ----~p~~~s~~~~~li~~lL~~dP~~R~~~  266 (353)
T 2i0e_A          240 ----YPKSMSKEAVAICKGLMTKHPGKRLGC  266 (353)
T ss_dssp             ----CCTTSCHHHHHHHHHHTCSCTTSCTTC
T ss_pred             ----CCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence                012345668999999999999999963

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=6.1e-33  Score=218.34  Aligned_cols=173  Identities=25%  Similarity=0.268  Sum_probs=135.2

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCC--CCceEEcccccceeccCCC
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDE--NMVAHVSDFGISKLLGEGE   78 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~--~~~~~l~d~g~~~~~~~~~   78 (202)
                      |+||+|.+++......+++..+..++.|++.||.|||    +.+|+||||||+||+++.  .+.+||+|||++.......
T Consensus       130 ~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH----~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~  205 (387)
T 1kob_A          130 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH----EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE  205 (387)
T ss_dssp             CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred             CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH----hCCeeecccchHHeEEecCCCCceEEEecccceecCCCc
Confidence            5799999999876667999999999999999999999    899999999999999974  5679999999998765433


Q ss_pred             ccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhh
Q 037267           79 DFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVR  158 (202)
Q Consensus        79 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (202)
                      ..   ....+++.|+|||.+.+..++.++|+||+||++|++++|..||....... .+. .+.........         
T Consensus       206 ~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~-~~~-~i~~~~~~~~~---------  271 (387)
T 1kob_A          206 IV---KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE-TLQ-NVKRCDWEFDE---------  271 (387)
T ss_dssp             CE---EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH-HHH-HHHHCCCCCCS---------
T ss_pred             ce---eeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHH-HHH-HHHhCCCCCCc---------
Confidence            21   12358999999999888889999999999999999999999997643211 111 11111000000         


Q ss_pred             hHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          159 EEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       159 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                           .....++.++.+++.+||..||++|||+.|+++
T Consensus       272 -----~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  304 (387)
T 1kob_A          272 -----DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE  304 (387)
T ss_dssp             -----STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             -----cccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence                 001234566899999999999999999999985

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=9.9e-33  Score=214.71  Aligned_cols=173  Identities=23%  Similarity=0.231  Sum_probs=133.9

Q ss_pred             CCCCcHHHHHhhc---CCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCc---eEEcccccceec
Q 037267            1 MPNGSLEKWLYSY---NYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMV---AHVSDFGISKLL   74 (202)
Q Consensus         1 ~~~gsL~~~l~~~---~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~---~~l~d~g~~~~~   74 (202)
                      |+||+|.+++...   ...+++..+..++.|++.||.|||    +.+|+||||||+||+++.++.   +|++|||++...
T Consensus       108 ~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH----~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~  183 (351)
T 3c0i_A          108 MDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH----DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL  183 (351)
T ss_dssp             CSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEEC
T ss_pred             CCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH----HCCceeccCChHHeEEecCCCCCcEEEecCcceeEe
Confidence            5789999988643   335899999999999999999999    899999999999999986554   999999999876


Q ss_pred             cCCCccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhh
Q 037267           75 GEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDA  154 (202)
Q Consensus        75 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (202)
                      ......  .....+++.|+|||.+.+..++.++|+||+||++|++++|..||.....   .....+.....         
T Consensus       184 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~i~~~~~---------  249 (351)
T 3c0i_A          184 GESGLV--AGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE---RLFEGIIKGKY---------  249 (351)
T ss_dssp             CTTSCB--CCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH---HHHHHHHHTCC---------
T ss_pred             cCCCee--ecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH---HHHHHHHcCCC---------
Confidence            543321  2334689999999998888899999999999999999999999976321   11111111100         


Q ss_pred             hhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          155 NLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                        ...   ......++.++.+++.+||..||++|||+.++++
T Consensus       250 --~~~---~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          250 --KMN---PRQWSHISESAKDLVRRMLMLDPAERITVYEALN  286 (351)
T ss_dssp             --CCC---HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             --CCC---ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence              000   0111235667899999999999999999999975

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=2.9e-33  Score=217.57  Aligned_cols=173  Identities=21%  Similarity=0.290  Sum_probs=127.0

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCC---CCceEEcccccceeccCC
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDE---NMVAHVSDFGISKLLGEG   77 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~---~~~~~l~d~g~~~~~~~~   77 (202)
                      |++|+|.+++.... .+++..+..++.|++.||.|||    +.+|+||||||+||+++.   ++.+||+|||++......
T Consensus       130 ~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~L~~LH----~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~  204 (349)
T 2w4o_A          130 VTGGELFDRIVEKG-YYSERDAADAVKQILEAVAYLH----ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ  204 (349)
T ss_dssp             CCSCBHHHHHTTCS-SCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEESSSSTTCCEEECCCC--------
T ss_pred             CCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcc
Confidence            57899999997644 4899999999999999999999    899999999999999975   889999999998765432


Q ss_pred             CccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhh
Q 037267           78 EDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV  157 (202)
Q Consensus        78 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (202)
                      ..   .....+++.|+|||.+.+..++.++|+||+||++|++++|..||.........+........ ....        
T Consensus       205 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~-~~~~--------  272 (349)
T 2w4o_A          205 VL---MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEY-YFIS--------  272 (349)
T ss_dssp             -----------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCC-CCCT--------
T ss_pred             cc---cccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCC-ccCC--------
Confidence            21   12345899999999988888999999999999999999999999764433222221111110 0000        


Q ss_pred             hhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          158 REEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                            +....++.++.+++.+||..||++|||+.|+++
T Consensus       273 ------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  305 (349)
T 2w4o_A          273 ------PWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ  305 (349)
T ss_dssp             ------TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ------chhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                  011234566899999999999999999999985

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=9.4e-33  Score=215.64  Aligned_cols=172  Identities=22%  Similarity=0.260  Sum_probs=133.8

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCC---CceEEcccccceeccCC
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN---MVAHVSDFGISKLLGEG   77 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~---~~~~l~d~g~~~~~~~~   77 (202)
                      |+||+|.+++.... .+++..+..++.|++.||.|||    +.+|+||||||+||+++.+   +.+||+|||++......
T Consensus       110 ~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH----~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~  184 (362)
T 2bdw_A          110 VTGGELFEDIVARE-FYSEADASHCIQQILESIAYCH----SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS  184 (362)
T ss_dssp             CCSCBHHHHHTTCS-CCCHHHHHHHHHHHHHHHHHHH----HTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC
T ss_pred             CCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCC
Confidence            57899999997644 4899999999999999999999    8999999999999999864   45999999999876543


Q ss_pred             CccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhh
Q 037267           78 EDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV  157 (202)
Q Consensus        78 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (202)
                      ..   .....+++.|+|||.+.+..++.++|+||+||++|++++|..||.......  ....+........         
T Consensus       185 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~--~~~~i~~~~~~~~---------  250 (362)
T 2bdw_A          185 EA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR--LYAQIKAGAYDYP---------  250 (362)
T ss_dssp             CS---CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHTCCCCC---------
T ss_pred             cc---cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHhCCCCCC---------
Confidence            22   223468999999999888889999999999999999999999997543211  1111211110000         


Q ss_pred             hhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          158 REEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                           .+....++.++.+++.+||..||++|||+.++++
T Consensus       251 -----~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  284 (362)
T 2bdw_A          251 -----SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK  284 (362)
T ss_dssp             -----TTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             -----cccccCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence                 0011234566899999999999999999999874

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=6.6e-34  Score=219.18  Aligned_cols=175  Identities=28%  Similarity=0.417  Sum_probs=135.4

Q ss_pred             CCCCcHHHHHhhcC---------------CCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEE
Q 037267            1 MPNGSLEKWLYSYN---------------YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHV   65 (202)
Q Consensus         1 ~~~gsL~~~l~~~~---------------~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l   65 (202)
                      |++|+|.+++....               ..+++..++.++.|++.||.|||    +.+|+||||||+||+++.++.++|
T Consensus       108 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH----~~~ivH~dlkp~NIl~~~~~~~kL  183 (327)
T 1fvr_A          108 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS----QKQFIHRDLAARNILVGENYVAKI  183 (327)
T ss_dssp             CTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECGGGCEEE
T ss_pred             CCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH----hCCccCCCCccceEEEcCCCeEEE
Confidence            57899999998643               35899999999999999999999    899999999999999999999999


Q ss_pred             cccccceeccCCCccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhC
Q 037267           66 SDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESL  144 (202)
Q Consensus        66 ~d~g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~  144 (202)
                      +|||++.......   ......++..|+|||.+.+..++.++|+||+|+++|++++ |..||.......  ....+....
T Consensus       184 ~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~--~~~~~~~~~  258 (327)
T 1fvr_A          184 ADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE--LYEKLPQGY  258 (327)
T ss_dssp             CCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHHGGGTC
T ss_pred             cccCcCccccccc---cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHH--HHHHhhcCC
Confidence            9999987432211   1122346778999998877788999999999999999998 999997643221  111111000


Q ss_pred             CCChhhhhhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          145 PHGLTEVVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                      .                 ...+..++.++.+++.+||..||++|||+.++++.|+.+
T Consensus       259 ~-----------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~  298 (327)
T 1fvr_A          259 R-----------------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  298 (327)
T ss_dssp             C-----------------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             C-----------------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            0                 001123456689999999999999999999999999764

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=4.6e-33  Score=212.87  Aligned_cols=179  Identities=22%  Similarity=0.269  Sum_probs=129.6

Q ss_pred             CCCCcHHHHHhh---cCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCC
Q 037267            1 MPNGSLEKWLYS---YNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEG   77 (202)
Q Consensus         1 ~~~gsL~~~l~~---~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~   77 (202)
                      +++|+|.+++..   ....+++..+..++.|++.||.|||    +.+++|+||||+||+++.++.++|+|||++......
T Consensus       114 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH----~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~  189 (310)
T 2wqm_A          114 ADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH----SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK  189 (310)
T ss_dssp             CCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECTTSCEEECCC---------
T ss_pred             CCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHh----hCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecCC
Confidence            468899999974   3456899999999999999999999    899999999999999999999999999998765432


Q ss_pred             CccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhh
Q 037267           78 EDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV  157 (202)
Q Consensus        78 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (202)
                      ...  .....+++.|+|||.+.+..++.++|+||+|+++|++++|..||.............+.......   .      
T Consensus       190 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~------  258 (310)
T 2wqm_A          190 TTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPP---L------  258 (310)
T ss_dssp             -----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCC---C------
T ss_pred             Ccc--ccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCC---C------
Confidence            211  12235788999999888888899999999999999999999999654322222221111110000   0      


Q ss_pred             hhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          158 REEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                             ....++.++.+++.+||+.||++|||+.++++.|+++
T Consensus       259 -------~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l  295 (310)
T 2wqm_A          259 -------PSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRM  295 (310)
T ss_dssp             -------CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -------cccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence                   0123456689999999999999999999999999876

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=5.1e-34  Score=215.09  Aligned_cols=177  Identities=25%  Similarity=0.402  Sum_probs=139.0

Q ss_pred             CCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCc
Q 037267            1 MPNGSLEKWLYSYN-YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED   79 (202)
Q Consensus         1 ~~~gsL~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~   79 (202)
                      |++|||.+++.... ..+++..+..++.|++.||.|||    +.+++|+||||+||+++.++.++|+|||.+........
T Consensus        89 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  164 (279)
T 1qpc_A           89 MENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE----ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY  164 (279)
T ss_dssp             CTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred             CCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH----HCCeeccCCCHhhEEEcCCCCEEECCCcccccccCccc
Confidence            57899999997543 25899999999999999999999    89999999999999999999999999999987654332


Q ss_pred             cccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhh
Q 037267           80 FVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVR  158 (202)
Q Consensus        80 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (202)
                      . ......++..|+|||...+..++.++|+||+|+++|++++ |..||.......  ....+......            
T Consensus       165 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~~~~~~~~~~~------------  229 (279)
T 1qpc_A          165 T-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE--VIQNLERGYRM------------  229 (279)
T ss_dssp             E-CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHHHHHTTCCC------------
T ss_pred             c-cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHH--HHHHHhcccCC------------
Confidence            1 1222346778999998877788999999999999999999 899987643221  11111111100            


Q ss_pred             hHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          159 EEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       159 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                           ..+..++.++.+++.+||..||++|||+.++++.|+.+
T Consensus       230 -----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~  267 (279)
T 1qpc_A          230 -----VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF  267 (279)
T ss_dssp             -----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -----CCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence                 01123456789999999999999999999999999864

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.3e-33  Score=214.89  Aligned_cols=170  Identities=24%  Similarity=0.272  Sum_probs=130.0

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |++|+|.+++..  ..+++..+..++.|++.||.|||    +.+|+||||||+||+++.++.+||+|||++.........
T Consensus       120 ~~~~~l~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH----~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  193 (298)
T 2zv2_A          120 VNQGPVMEVPTL--KPLSEDQARFYFQDLIKGIEYLH----YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDAL  193 (298)
T ss_dssp             CTTCBSCCSSCS--SCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEECTTSCEEECCCTTCEECSSSSCE
T ss_pred             CCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHH----HCCeeccCCCHHHEEECCCCCEEEecCCCcccccccccc
Confidence            467888886643  35899999999999999999999    899999999999999999999999999999876543321


Q ss_pred             ccccCCCCCccccCCCCCCCCC---cCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhh
Q 037267           81 VTQTMTMATIGYMAPEYGSEGI---VSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV  157 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~---~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (202)
                        .....+++.|+|||.+.+..   ++.++|+||+|+++|++++|..||.......  ....+......           
T Consensus       194 --~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--~~~~~~~~~~~-----------  258 (298)
T 2zv2_A          194 --LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMC--LHSKIKSQALE-----------  258 (298)
T ss_dssp             --ECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHCCCC-----------
T ss_pred             --ccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHH--HHHHHhcccCC-----------
Confidence              22346899999999887654   3678999999999999999999996532111  11111111000           


Q ss_pred             hhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          158 REEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                           .+....++.++.+++.+||+.||++|||+.|+++
T Consensus       259 -----~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          259 -----FPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             -----CCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             -----CCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence                 0001134566899999999999999999999864

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=1e-33  Score=219.61  Aligned_cols=168  Identities=26%  Similarity=0.307  Sum_probs=132.9

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |+||+|.+++.+.. .+++..+..++.|++.||.|||    +.+|+||||||+||+++.++.+||+|||++........ 
T Consensus       100 ~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH----~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~-  173 (345)
T 1xjd_A          100 LNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLH----SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA-  173 (345)
T ss_dssp             CTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC-
T ss_pred             CCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccCCC-
Confidence            57999999998654 4899999999999999999999    89999999999999999999999999999975432221 


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhH
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREE  160 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (202)
                       ......||+.|+|||.+.+..++.++|+||+||++|++++|..||.......  ....+....+.              
T Consensus       174 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--~~~~i~~~~~~--------------  236 (345)
T 1xjd_A          174 -KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE--LFHSIRMDNPF--------------  236 (345)
T ss_dssp             -CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHCCCC--------------
T ss_pred             -cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHH--HHHHHHhCCCC--------------
Confidence             1233568999999999888889999999999999999999999997543221  11111111100              


Q ss_pred             HHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHH-HHH
Q 037267          161 QAFAAKMDCIVSIMDLALDCCMESPGKRINMT-DAA  195 (202)
Q Consensus       161 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~-~~~  195 (202)
                          .+..++.++.+++.+||..||++||++. +++
T Consensus       237 ----~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~  268 (345)
T 1xjd_A          237 ----YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR  268 (345)
T ss_dssp             ----CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             ----CCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence                0112455689999999999999999987 554

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=6.4e-34  Score=215.48  Aligned_cols=171  Identities=19%  Similarity=0.283  Sum_probs=131.3

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCc--------eEEcccccce
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMV--------AHVSDFGISK   72 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~--------~~l~d~g~~~   72 (202)
                      |++|+|.+++......+++..+..++.|++.||.|||    +.+|+||||||+||+++.++.        ++++|||++.
T Consensus        94 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH----~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~~~  169 (289)
T 4fvq_A           94 VKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLE----ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISI  169 (289)
T ss_dssp             CTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEEEECCBGGGTBCCEEEECCCCSCT
T ss_pred             CCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHh----hCCeECCCcCcceEEEecCCcccccccceeeeccCcccc
Confidence            5789999999876666999999999999999999999    899999999999999988776        9999999986


Q ss_pred             eccCCCccccccCCCCCccccCCCCCCC-CCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhh
Q 037267           73 LLGEGEDFVTQTMTMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEV  151 (202)
Q Consensus        73 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (202)
                      ......      ...++..|+|||.+.+ ..++.++|+||+|+++|++++|..|+........... ......  .    
T Consensus       170 ~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~-~~~~~~--~----  236 (289)
T 4fvq_A          170 TVLPKD------ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQ-FYEDRH--Q----  236 (289)
T ss_dssp             TTSCHH------HHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH-HHHTTC--C----
T ss_pred             cccCcc------ccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHH-HhhccC--C----
Confidence            543221      1236778999998776 6688899999999999999996554433222111111 111000  0    


Q ss_pred             hhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          152 VDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                                   .+...+.++.+++.+||+.||++|||+.++++.|+++
T Consensus       237 -------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l  273 (289)
T 4fvq_A          237 -------------LPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSL  273 (289)
T ss_dssp             -------------CCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTC
T ss_pred             -------------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence                         0011234478999999999999999999999999876

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=1.2e-32  Score=208.61  Aligned_cols=169  Identities=23%  Similarity=0.359  Sum_probs=130.9

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCC--eeecCCCCCceeeC-CCCceEEcccccceeccCC
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAP--IIHCDLKPTNILLD-ENMVAHVSDFGISKLLGEG   77 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~--i~h~dlk~~nil~~-~~~~~~l~d~g~~~~~~~~   77 (202)
                      |++|+|.+++.... .+++..+..++.|++.||.|||    +.+  ++|+||||+||+++ .++.++|+|||++......
T Consensus       111 ~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH----~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~  185 (290)
T 1t4h_A          111 MTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLH----TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS  185 (290)
T ss_dssp             CCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred             cCCCCHHHHHHHcc-CCCHHHHHHHHHHHHHHHHHHH----cCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccccccc
Confidence            57899999998654 4899999999999999999999    778  99999999999998 7889999999998654332


Q ss_pred             CccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhh
Q 037267           78 EDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV  157 (202)
Q Consensus        78 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (202)
                      .    .....+++.|+|||.+.+ .++.++|+||+|+++|++++|..||..................+            
T Consensus       186 ~----~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~------------  248 (290)
T 1t4h_A          186 F----AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP------------  248 (290)
T ss_dssp             S----BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC------------
T ss_pred             c----cccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCc------------
Confidence            2    122458899999998764 58899999999999999999999997643322211111110000            


Q ss_pred             hhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          158 REEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                           ...+...++++.+++.+||..||++|||+.|+++
T Consensus       249 -----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  282 (290)
T 1t4h_A          249 -----ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             -----GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             -----cccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence                 0011123456899999999999999999999985

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=3.4e-34  Score=216.02  Aligned_cols=173  Identities=27%  Similarity=0.403  Sum_probs=132.0

Q ss_pred             CCCCcHHHHHhhcCC-CCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCc
Q 037267            1 MPNGSLEKWLYSYNY-FFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED   79 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~-~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~   79 (202)
                      |++|||.+++..... .+++..+..++.|++.||.|||    +.+++|+||||+||+++.++.++++|||++....... 
T Consensus        97 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-  171 (278)
T 1byg_A           97 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE----GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-  171 (278)
T ss_dssp             CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred             CCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH----hCCccccCCCcceEEEeCCCcEEEeeccccccccccc-
Confidence            468899999986432 3799999999999999999999    8999999999999999999999999999987644322 


Q ss_pred             cccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhh
Q 037267           80 FVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVR  158 (202)
Q Consensus        80 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (202)
                          ....++..|+|||...+..++.++|+||+|+++|++++ |..||.......  ....+.....             
T Consensus       172 ----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~--~~~~~~~~~~-------------  232 (278)
T 1byg_A          172 ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VVPRVEKGYK-------------  232 (278)
T ss_dssp             --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG--HHHHHTTTCC-------------
T ss_pred             ----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHhcCCC-------------
Confidence                12346788999998877788999999999999999998 999997643222  1111111100             


Q ss_pred             hHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          159 EEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       159 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                          ...+..+++.+.+++.+||+.||++|||+.++++.|+++
T Consensus       233 ----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i  271 (278)
T 1byg_A          233 ----MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI  271 (278)
T ss_dssp             ----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----CCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHH
Confidence                001123556789999999999999999999999999876

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=99.98  E-value=3.5e-33  Score=211.90  Aligned_cols=188  Identities=20%  Similarity=0.206  Sum_probs=134.0

Q ss_pred             CCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcccc
Q 037267            3 NGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVT   82 (202)
Q Consensus         3 ~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~   82 (202)
                      +|+|.+++...+..+++..+..++.|++.||.|||    +.+|+||||||+||+++.++.+||+|||++........  .
T Consensus        84 ~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH----~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~  157 (292)
T 3o0g_A           84 DQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH----SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR--C  157 (292)
T ss_dssp             SEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCS--C
T ss_pred             CCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEEcCCCCEEEeecccceecCCccc--c
Confidence            46777777766667999999999999999999999    89999999999999999999999999999987653322  1


Q ss_pred             ccCCCCCccccCCCCCCCCC-cCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCC---Chhhhhhhhh--
Q 037267           83 QTMTMATIGYMAPEYGSEGI-VSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPH---GLTEVVDANL--  156 (202)
Q Consensus        83 ~~~~~~~~~~~~pe~~~~~~-~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~--  156 (202)
                      .....+++.|+|||.+.+.. ++.++|+||+|+++|++++|..||.........+..........   .+........  
T Consensus       158 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  237 (292)
T 3o0g_A          158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK  237 (292)
T ss_dssp             CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCC
T ss_pred             ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccccc
Confidence            23346789999999876655 78999999999999999998888654433332222222211110   0000000000  


Q ss_pred             -----hhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          157 -----VREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       157 -----~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                           .............+.++.+++.+||+.||++|||++|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             CCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence                 0000000111235566899999999999999999999975

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=99.98  E-value=5.8e-33  Score=217.61  Aligned_cols=173  Identities=21%  Similarity=0.244  Sum_probs=136.2

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceee--CCCCceEEcccccceeccCCC
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILL--DENMVAHVSDFGISKLLGEGE   78 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~--~~~~~~~l~d~g~~~~~~~~~   78 (202)
                      |++|+|.+++......+++..+..++.|++.||.|||    +.+|+||||||+||++  +.++.+||+|||++.......
T Consensus       168 ~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH----~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~  243 (373)
T 2x4f_A          168 VDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMH----QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE  243 (373)
T ss_dssp             CTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC
T ss_pred             CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc
Confidence            5789999999876666999999999999999999999    8999999999999999  567889999999998765433


Q ss_pred             ccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhh
Q 037267           79 DFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVR  158 (202)
Q Consensus        79 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (202)
                      .   .....+++.|+|||.+.+..++.++|+||+||++|++++|..||....... .+......... ..          
T Consensus       244 ~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-~~~~i~~~~~~-~~----------  308 (373)
T 2x4f_A          244 K---LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAE-TLNNILACRWD-LE----------  308 (373)
T ss_dssp             B---CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHHTCCC-SC----------
T ss_pred             c---cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhccCC-CC----------
Confidence            2   223458999999999888888999999999999999999999997643221 11111111100 00          


Q ss_pred             hHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          159 EEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       159 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                          ......++.++.+++.+||..||++|||+.|+++
T Consensus       309 ----~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~  342 (373)
T 2x4f_A          309 ----DEEFQDISEEAKEFISKLLIKEKSWRISASEALK  342 (373)
T ss_dssp             ----SGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ----hhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                0001234567899999999999999999999986

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=99.98  E-value=1.7e-32  Score=212.86  Aligned_cols=173  Identities=20%  Similarity=0.222  Sum_probs=129.6

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |+||+|.+++.+.. .+++..+..++.|++.||.|||    +.+|+||||||+||+++.++.+||+|||++........ 
T Consensus        92 ~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH----~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~~-  165 (345)
T 3a8x_A           92 VNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYLH----ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-  165 (345)
T ss_dssp             CCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----HTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTTC-
T ss_pred             CCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCceecCCCHHHEEECCCCCEEEEeccccccccCCCC-
Confidence            57999999998654 4899999999999999999999    89999999999999999999999999999976432221 


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhH
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREE  160 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (202)
                       ......|++.|+|||.+.+..++.++|+||+||++|+|++|..||............         ........+....
T Consensus       166 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~---------~~~~~~~~i~~~~  235 (345)
T 3a8x_A          166 -TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN---------TEDYLFQVILEKQ  235 (345)
T ss_dssp             -CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC----------------CHHHHHHHHHHCC
T ss_pred             -cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccc---------cHHHHHHHHHcCC
Confidence             123356899999999988888999999999999999999999999753221110000         0000000000000


Q ss_pred             HHHHHhHHHHHHHHHHHhhhcCCCCCCCCCH
Q 037267          161 QAFAAKMDCIVSIMDLALDCCMESPGKRINM  191 (202)
Q Consensus       161 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~  191 (202)
                        ...+...+.++.+++.+||..||++||++
T Consensus       236 --~~~p~~~s~~~~~li~~lL~~dP~~R~~~  264 (345)
T 3a8x_A          236 --IRIPRSLSVKAASVLKSFLNKDPKERLGC  264 (345)
T ss_dssp             --CCCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred             --CCCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence              00112345668999999999999999996

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=99.98  E-value=9.5e-33  Score=215.25  Aligned_cols=183  Identities=21%  Similarity=0.173  Sum_probs=133.1

Q ss_pred             CCcHHHHHhhcC-CCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCC----------------------
Q 037267            3 NGSLEKWLYSYN-YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDE----------------------   59 (202)
Q Consensus         3 ~gsL~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~----------------------   59 (202)
                      +|+|.+++.... ..+++..+..++.|++.||.|||    +.+|+||||||+||+++.                      
T Consensus       119 ~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH----~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~  194 (360)
T 3llt_A          119 GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLR----KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIY  194 (360)
T ss_dssp             CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEE
T ss_pred             CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH----HCCeeeCCCCcccEEEccccccccccchhccccccccccc
Confidence            899999998654 35899999999999999999999    899999999999999975                      


Q ss_pred             ---CCceEEcccccceeccCCCccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhh
Q 037267           60 ---NMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSL  136 (202)
Q Consensus        60 ---~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~  136 (202)
                         ++.+||+|||++.......     ....+++.|+|||.+.+..++.++|+||+||++|++++|..||........ .
T Consensus       195 ~~~~~~~kl~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~  268 (360)
T 3llt_A          195 RTKSTGIKLIDFGCATFKSDYH-----GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEH-L  268 (360)
T ss_dssp             EESCCCEEECCCTTCEETTSCC-----CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH-H
T ss_pred             ccCCCCEEEEeccCceecCCCC-----cCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCcHHHH-H
Confidence               7889999999998644322     234689999999998888899999999999999999999999976432221 1


Q ss_pred             HHHHHHhCCCChhhhhhhhhh--------------------hhHH--------HHHHhHHHHHHHHHHHhhhcCCCCCCC
Q 037267          137 RRWVKESLPHGLTEVVDANLV--------------------REEQ--------AFAAKMDCIVSIMDLALDCCMESPGKR  188 (202)
Q Consensus       137 ~~~~~~~~~~~~~~~~~~~~~--------------------~~~~--------~~~~~~~~~~~~~~l~~~cl~~~p~~R  188 (202)
                       ..+.......-.........                    ....        .........+.+.+++.+||+.||++|
T Consensus       269 -~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R  347 (360)
T 3llt_A          269 -AMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLR  347 (360)
T ss_dssp             -HHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGS
T ss_pred             -HHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhC
Confidence             11111111000000000000                    0000        000111223568899999999999999


Q ss_pred             CCHHHHHH
Q 037267          189 INMTDAAA  196 (202)
Q Consensus       189 ps~~~~~~  196 (202)
                      ||+.|+++
T Consensus       348 pta~elL~  355 (360)
T 3llt_A          348 PSPAELLK  355 (360)
T ss_dssp             CCHHHHTT
T ss_pred             CCHHHHhc
Confidence            99999874

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=99.98  E-value=9.4e-33  Score=212.61  Aligned_cols=171  Identities=26%  Similarity=0.302  Sum_probs=129.9

Q ss_pred             CCCCcHHHHHhhcCC--CCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCC
Q 037267            1 MPNGSLEKWLYSYNY--FFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGE   78 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~--~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~   78 (202)
                      |++|+|.+++.....  ..++..++.++.|++.||.|||    +.+|+||||||+||+++.++.+||+|||++.......
T Consensus       143 ~~~~~L~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH----~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~  218 (332)
T 3qd2_B          143 CRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLH----SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDE  218 (332)
T ss_dssp             CCSSCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC-
T ss_pred             cCCCCHHHHHhcccCccchhhHHHHHHHHHHHHHHHHHH----hCCeeecCCCcccEEEeCCCCEEEeecCcccccccch
Confidence            578999999986442  3567789999999999999999    8999999999999999999999999999998765432


Q ss_pred             cc----------ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCCh
Q 037267           79 DF----------VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGL  148 (202)
Q Consensus        79 ~~----------~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  148 (202)
                      ..          .......+++.|+|||.+.+..++.++|+||+|+++|++++|..|+....    .........     
T Consensus       219 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~----~~~~~~~~~-----  289 (332)
T 3qd2_B          219 EEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERV----RIITDVRNL-----  289 (332)
T ss_dssp             -------------CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHH----HHHHHHHTT-----
T ss_pred             hhccccccccccccccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHH----HHHHHhhcc-----
Confidence            11          11233468999999999888889999999999999999999876642210    000000000     


Q ss_pred             hhhhhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          149 TEVVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                                  .........++++.+++.+||+.||++|||+.|+++
T Consensus       290 ------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~  325 (332)
T 3qd2_B          290 ------------KFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIE  325 (332)
T ss_dssp             ------------CCCHHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred             ------------CCCcccccCChhHHHHHHHHccCCCCcCCCHHHHhh
Confidence                        000112344566789999999999999999999986

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=99.98  E-value=1.2e-32  Score=211.74  Aligned_cols=172  Identities=19%  Similarity=0.219  Sum_probs=134.8

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCC----ceEEcccccceeccC
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENM----VAHVSDFGISKLLGE   76 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~----~~~l~d~g~~~~~~~   76 (202)
                      |++|+|.+++.... .+++..+..++.|++.||.|||    +.+++||||||+||+++.++    .++++|||++.....
T Consensus        97 ~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH----~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~  171 (321)
T 2a2a_A           97 VSGGELFDFLAQKE-SLSEEEATSFIKQILDGVNYLH----TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED  171 (321)
T ss_dssp             CCSCBHHHHHHTCS-CEEHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECCT
T ss_pred             CCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCChHHEEEecCCCCcCCEEEccCccceecCc
Confidence            57899999998644 4899999999999999999999    89999999999999999877    799999999987654


Q ss_pred             CCccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhh
Q 037267           77 GEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANL  156 (202)
Q Consensus        77 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (202)
                      ...   .....+++.|+|||.+.+..++.++|+||+|+++|++++|..||.......  ....+.......         
T Consensus       172 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~i~~~~~~~---------  237 (321)
T 2a2a_A          172 GVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE--TLANITSVSYDF---------  237 (321)
T ss_dssp             TCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH--HHHHHHTTCCCC---------
T ss_pred             ccc---ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHhccccc---------
Confidence            322   123458999999999888889999999999999999999999996543221  111111110000         


Q ss_pred             hhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          157 VREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                           ........+..+.+++.+||..||++|||+.|+++
T Consensus       238 -----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~  272 (321)
T 2a2a_A          238 -----DEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR  272 (321)
T ss_dssp             -----CHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred             -----ChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence                 00111235566899999999999999999999985

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=99.98  E-value=1.4e-33  Score=220.19  Aligned_cols=174  Identities=24%  Similarity=0.255  Sum_probs=122.9

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCc--eEEcccccceeccCCC
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMV--AHVSDFGISKLLGEGE   78 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~--~~l~d~g~~~~~~~~~   78 (202)
                      |++|+|.+++.... .+++..+..++.|++.||.|||    +.+|+||||||+||+++.++.  +||+|||++.......
T Consensus        98 ~~~~~L~~~l~~~~-~~~~~~~~~i~~ql~~~L~~LH----~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~  172 (361)
T 3uc3_A           98 ASGGELYERICNAG-RFSEDEARFFFQQLLSGVSYCH----SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS  172 (361)
T ss_dssp             CCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----HTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred             CCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccC
Confidence            57999999997654 4899999999999999999999    899999999999999987665  9999999987533222


Q ss_pred             ccccccCCCCCccccCCCCCCCCCcCcc-hhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhh
Q 037267           79 DFVTQTMTMATIGYMAPEYGSEGIVSAK-CDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV  157 (202)
Q Consensus        79 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~-~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (202)
                      .   .....+++.|+|||.+.+..++.+ +|+||+||++|++++|..||........... .......        ..  
T Consensus       173 ~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~-~~~~~~~--------~~--  238 (361)
T 3uc3_A          173 Q---PKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRK-TIQRILS--------VK--  238 (361)
T ss_dssp             -----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHH-HHHHHHT--------TC--
T ss_pred             C---CCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHH-HHHHHhc--------CC--
Confidence            1   223468999999998777766555 8999999999999999999976543322111 1111000        00  


Q ss_pred             hhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          158 REEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                         ...+....++.++.+|+.+||..||++|||+.|+++
T Consensus       239 ---~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~  274 (361)
T 3uc3_A          239 ---YSIPDDIRISPECCHLISRIFVADPATRISIPEIKT  274 (361)
T ss_dssp             ---CCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             ---CCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence               000011124556889999999999999999999875

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=99.98  E-value=4.2e-33  Score=213.19  Aligned_cols=178  Identities=24%  Similarity=0.293  Sum_probs=129.3

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |++++|.+++.... .+++..+..++.|++.||.|||    +.+|+|+||||+||+++.++.++|+|||++.........
T Consensus       116 ~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH----~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~  190 (309)
T 2h34_A          116 INGVDLAAMLRRQG-PLAPPRAVAIVRQIGSALDAAH----AAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLT  190 (309)
T ss_dssp             CCCEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEECTTSCEEECSCCC----------
T ss_pred             cCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCcCCcCCCChHHEEEcCCCCEEEecCccCccccccccc
Confidence            46889999998654 4899999999999999999999    899999999999999999999999999998765443211


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhH
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREE  160 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (202)
                       ......+++.|+|||.+.+..++.++|+||+|+++|++++|..||......  .....+....+. .            
T Consensus       191 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~-~------------  254 (309)
T 2h34_A          191 -QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS--VMGAHINQAIPR-P------------  254 (309)
T ss_dssp             -------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH--HHHHHHHSCCCC-G------------
T ss_pred             -cccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH--HHHHHhccCCCC-c------------
Confidence             122345889999999998888899999999999999999999999764321  111111111100 0            


Q ss_pred             HHHHHhHHHHHHHHHHHhhhcCCCCCCCC-CHHHHHHHHhhc
Q 037267          161 QAFAAKMDCIVSIMDLALDCCMESPGKRI-NMTDAAAKLKKI  201 (202)
Q Consensus       161 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rp-s~~~~~~~l~~l  201 (202)
                        ...+..++.++.+++.+||..||++|| |+.++++.|+++
T Consensus       255 --~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~  294 (309)
T 2h34_A          255 --STVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAA  294 (309)
T ss_dssp             --GGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHT
T ss_pred             --cccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHH
Confidence              001123556689999999999999999 999999999764

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=99.98  E-value=2.4e-33  Score=224.52  Aligned_cols=169  Identities=21%  Similarity=0.189  Sum_probs=133.3

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCC-CCeeecCCCCCceeeCCCCceEEcccccceeccCCCc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSS-APIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED   79 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~-~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~   79 (202)
                      |++|+|.+++.... .+++..+..++.|++.||.|||    + .+|+||||||+||+++.++.+||+|||++........
T Consensus       230 ~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH----~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~  304 (446)
T 4ejn_A          230 ANGGELFFHLSRER-VFSEDRARFYGAEIVSALDYLH----SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA  304 (446)
T ss_dssp             CSSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH----HHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC---
T ss_pred             CCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHh----hcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCCCc
Confidence            57999999998654 4899999999999999999999    7 8999999999999999999999999999875433221


Q ss_pred             cccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhh
Q 037267           80 FVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVRE  159 (202)
Q Consensus        80 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (202)
                        ......||+.|+|||++.+..++.++|+||+||++|++++|..||.......  ....+.....              
T Consensus       305 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--~~~~i~~~~~--------------  366 (446)
T 4ejn_A          305 --TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK--LFELILMEEI--------------  366 (446)
T ss_dssp             ----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHCCC--------------
T ss_pred             --ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH--HHHHHHhCCC--------------
Confidence              1233568999999999888889999999999999999999999996643221  1111111100              


Q ss_pred             HHHHHHhHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHH
Q 037267          160 EQAFAAKMDCIVSIMDLALDCCMESPGKRI-----NMTDAAA  196 (202)
Q Consensus       160 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rp-----s~~~~~~  196 (202)
                          ..+..+++++.+++.+||..||++||     ++.|+++
T Consensus       367 ----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~  404 (446)
T 4ejn_A          367 ----RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ  404 (446)
T ss_dssp             ----CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             ----CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence                00122456689999999999999999     9999874

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=99.98  E-value=4.7e-33  Score=215.22  Aligned_cols=166  Identities=24%  Similarity=0.375  Sum_probs=131.4

Q ss_pred             CCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcccc
Q 037267            3 NGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVT   82 (202)
Q Consensus         3 ~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~   82 (202)
                      +|+|.+++.... .+++..+..++.|++.||.|||    +.+|+||||||+||+++.++.+||+|||++........   
T Consensus        92 ~g~l~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH----~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~---  163 (336)
T 3h4j_B           92 GGELFDYIVEKK-RMTEDEGRRFFQQIICAIEYCH----RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF---  163 (336)
T ss_dssp             CEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH----HHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBT---
T ss_pred             CCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCcc---
Confidence            789999997654 4899999999999999999999    89999999999999999999999999999986554332   


Q ss_pred             ccCCCCCccccCCCCCCCCCc-CcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhHH
Q 037267           83 QTMTMATIGYMAPEYGSEGIV-SAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQ  161 (202)
Q Consensus        83 ~~~~~~~~~~~~pe~~~~~~~-~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (202)
                      .....|++.|+|||.+.+..+ +.++|+||+|+++|++++|..||.........             ..+. ....    
T Consensus       164 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~-------------~~i~-~~~~----  225 (336)
T 3h4j_B          164 LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF-------------KKVN-SCVY----  225 (336)
T ss_dssp             TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB-------------CCCC-SSCC----
T ss_pred             cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH-------------HHHH-cCCC----
Confidence            223468999999999888776 67899999999999999999999764322110             0000 0000    


Q ss_pred             HHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          162 AFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       162 ~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                        ..+..++.++.+++.+||..||++|||+.|+++
T Consensus       226 --~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~  258 (336)
T 3h4j_B          226 --VMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR  258 (336)
T ss_dssp             --CCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred             --CCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence              001224556889999999999999999999864

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=99.98  E-value=3.3e-33  Score=218.86  Aligned_cols=169  Identities=27%  Similarity=0.237  Sum_probs=132.3

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |+||+|.+++.+.. .+++..+..++.|++.||.|||    +.+|+||||||+||+++.++.+||+|||+++....... 
T Consensus       121 ~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH----~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~~-  194 (373)
T 2r5t_A          121 INGGELFYHLQRER-CFLEPRARFYAAEIASALGYLH----SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNS-  194 (373)
T ss_dssp             CCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCCC-
T ss_pred             CCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCceecCCCHHHEEECCCCCEEEeeCccccccccCCC-
Confidence            57999999998654 4899999999999999999999    89999999999999999999999999999875432221 


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhH
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREE  160 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (202)
                       ......||+.|+|||++.+..++.++|+||+||++|+|++|..||.......  ....+....           ..   
T Consensus       195 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~--~~~~i~~~~-----------~~---  257 (373)
T 2r5t_A          195 -TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE--MYDNILNKP-----------LQ---  257 (373)
T ss_dssp             -CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHH--HHHHHHHSC-----------CC---
T ss_pred             -ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH--HHHHHHhcc-----------cC---
Confidence             1233568999999999888889999999999999999999999997643221  111111110           00   


Q ss_pred             HHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          161 QAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       161 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                          .+..++.++.+++.+||..||++||++.+.++
T Consensus       258 ----~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~  289 (373)
T 2r5t_A          258 ----LKPNITNSARHLLEGLLQKDRTKRLGAKDDFM  289 (373)
T ss_dssp             ----CCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHH
T ss_pred             ----CCCCCCHHHHHHHHHHcccCHHhCCCCCCCHH
Confidence                01124556899999999999999999864433

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=99.98  E-value=7.9e-34  Score=214.87  Aligned_cols=177  Identities=25%  Similarity=0.362  Sum_probs=139.4

Q ss_pred             CCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCc
Q 037267            1 MPNGSLEKWLYSYN-YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED   79 (202)
Q Consensus         1 ~~~gsL~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~   79 (202)
                      |++|+|.+++...+ ..+++..+..++.|++.||.|||    +.+++|+||||+||+++.++.++|+|||++........
T Consensus        91 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH----~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  166 (288)
T 3kfa_A           91 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE----KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY  166 (288)
T ss_dssp             CTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHH----HHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSS
T ss_pred             CCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHH----HCCccCCCCCcceEEEcCCCCEEEccCccceeccCCcc
Confidence            56899999998643 45899999999999999999999    89999999999999999999999999999976554332


Q ss_pred             cccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhh
Q 037267           80 FVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVR  158 (202)
Q Consensus        80 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (202)
                      . ......+++.|+|||...+..++.++|+||+|+++|++++ |..||.......  ....+......            
T Consensus       167 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~--~~~~~~~~~~~------------  231 (288)
T 3kfa_A          167 T-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--VYELLEKDYRM------------  231 (288)
T ss_dssp             E-EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--HHHHHHTTCCC------------
T ss_pred             c-cccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHhccCCC------------
Confidence            1 1222345778999998888888999999999999999999 999987643222  11111111100            


Q ss_pred             hHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          159 EEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       159 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                           ..+..++.++.+++.+||..||++|||+.++++.|+.+
T Consensus       232 -----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~  269 (288)
T 3kfa_A          232 -----ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM  269 (288)
T ss_dssp             -----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -----CCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHH
Confidence                 01123456689999999999999999999999999764

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=99.98  E-value=5.7e-33  Score=215.94  Aligned_cols=166  Identities=21%  Similarity=0.185  Sum_probs=133.5

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |+||+|.+++.+.. .+++..+..++.|++.||.|||    +.+|+||||||+||+++.++.+||+|||++.......  
T Consensus       123 ~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH----~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~~--  195 (350)
T 1rdq_E          123 VAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLH----SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT--  195 (350)
T ss_dssp             CTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB--
T ss_pred             CCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCcccccCccceEEECCCCCEEEcccccceeccCCc--
Confidence            57999999998654 4899999999999999999999    8999999999999999999999999999998754322  


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhH
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREE  160 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (202)
                         ....|++.|+|||.+.+..++.++|+||+||++|++++|..||.......  ....+.....               
T Consensus       196 ---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--~~~~i~~~~~---------------  255 (350)
T 1rdq_E          196 ---WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ--IYEKIVSGKV---------------  255 (350)
T ss_dssp             ---CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHCCC---------------
T ss_pred             ---ccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHH--HHHHHHcCCC---------------
Confidence               23468999999999888889999999999999999999999997542211  1111111110               


Q ss_pred             HHHHHhHHHHHHHHHHHhhhcCCCCCCCCC-----HHHHHH
Q 037267          161 QAFAAKMDCIVSIMDLALDCCMESPGKRIN-----MTDAAA  196 (202)
Q Consensus       161 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps-----~~~~~~  196 (202)
                         ..+..++.++.+++.+||..||++||+     +.++++
T Consensus       256 ---~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~  293 (350)
T 1rdq_E          256 ---RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             ---CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             ---CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence               001234566899999999999999998     777753

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=99.98  E-value=9.8e-33  Score=222.11  Aligned_cols=168  Identities=26%  Similarity=0.385  Sum_probs=134.0

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |+||+|.+++.... .+++..+..++.|++.||.|||    +.+|+||||||+||+++.++.+||+|||++........ 
T Consensus        98 ~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH----~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~-  171 (476)
T 2y94_A           98 VSGGELFDYICKNG-RLDEKESRRLFQQILSGVDYCH----RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF-  171 (476)
T ss_dssp             CSSEEHHHHTTSSS-SCCHHHHHHHHHHHHHHHHHHH----TTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTCC-
T ss_pred             CCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCCCcccccHHHEEEecCCCeEEEeccchhhcccccc-
Confidence            57999999997644 4999999999999999999999    89999999999999999999999999999987654332 


Q ss_pred             ccccCCCCCccccCCCCCCCCCc-CcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhh
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIV-SAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVRE  159 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~-~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (202)
                        .....|++.|+|||.+.+..+ +.++|+||+||++|++++|..||.......  ....+.....              
T Consensus       172 --~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~--~~~~i~~~~~--------------  233 (476)
T 2y94_A          172 --LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPT--LFKKICDGIF--------------  233 (476)
T ss_dssp             --BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHH--HHHHHHTTCC--------------
T ss_pred             --ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHH--HHHHHhcCCc--------------
Confidence              223468999999998877665 678999999999999999999997543211  1111111110              


Q ss_pred             HHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          160 EQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       160 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                          ..+..++.++.+++.+||..||++|||+.|+++
T Consensus       234 ----~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~  266 (476)
T 2y94_A          234 ----YTPQYLNPSVISLLKHMLQVDPMKRATIKDIRE  266 (476)
T ss_dssp             ----CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ----CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence                001124456899999999999999999999986

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=99.98  E-value=3e-33  Score=222.96  Aligned_cols=176  Identities=20%  Similarity=0.243  Sum_probs=134.8

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |+||+|.+++.+....+++..+..++.|++.||.|||    +.+|+||||||+|||++.++.+||+|||++.........
T Consensus       156 ~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH----~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~  231 (437)
T 4aw2_A          156 YVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVH----QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV  231 (437)
T ss_dssp             CTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCE
T ss_pred             CCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHH----hCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCCc
Confidence            5799999999876566999999999999999999999    899999999999999999999999999999876543322


Q ss_pred             ccccCCCCCccccCCCCCC-----CCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhh
Q 037267           81 VTQTMTMATIGYMAPEYGS-----EGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDAN  155 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~-----~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (202)
                       ......||+.|+|||++.     ...++.++|+||+||++|+|++|..||......+. ........          ..
T Consensus       232 -~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~-~~~i~~~~----------~~  299 (437)
T 4aw2_A          232 -QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET-YGKIMNHK----------ER  299 (437)
T ss_dssp             -ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HHHHHTHH----------HH
T ss_pred             -ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHH-HHhhhhcc----------cc
Confidence             123356899999999875     45688999999999999999999999976432221 11000000          00


Q ss_pred             hhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCC--CCCHHHHHH
Q 037267          156 LVREEQAFAAKMDCIVSIMDLALDCCMESPGK--RINMTDAAA  196 (202)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~--Rps~~~~~~  196 (202)
                      ....    .....+++++.+|+.+||..+|++  ||++.|+++
T Consensus       300 ~~~p----~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~  338 (437)
T 4aw2_A          300 FQFP----TQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKK  338 (437)
T ss_dssp             CCCC----SSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred             ccCC----cccccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence            0000    000124566899999999988888  999999874

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=99.98  E-value=7.7e-33  Score=208.50  Aligned_cols=170  Identities=21%  Similarity=0.317  Sum_probs=115.3

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |++|+|.+++......+++..+..++.|++.||.|||    +.+++|+||||+||+++.++.++++|||.+.........
T Consensus        93 ~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~  168 (278)
T 3cok_A           93 CHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH----SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEK  168 (278)
T ss_dssp             CTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHH----HTTEECSSCCGGGEEECTTCCEEECCCTTCEECC-----
T ss_pred             CCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCCc
Confidence            4689999999876667999999999999999999999    899999999999999999999999999999875532211


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhH
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREE  160 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (202)
                        .....+++.|+|||...+..++.++|+||+|+++|++++|..||........     .........            
T Consensus       169 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-----~~~~~~~~~------------  229 (278)
T 3cok_A          169 --HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT-----LNKVVLADY------------  229 (278)
T ss_dssp             -------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC----------CCSSCC------------
T ss_pred             --ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH-----HHHHhhccc------------
Confidence              1224578899999998888889999999999999999999999976432211     000000000            


Q ss_pred             HHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          161 QAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       161 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                         ..+..++.++.+++.+||..||++|||+.++++
T Consensus       230 ---~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          230 ---EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             ---CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             ---CCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence               001124456889999999999999999999875

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=99.98  E-value=1.1e-32  Score=207.95  Aligned_cols=171  Identities=23%  Similarity=0.330  Sum_probs=136.5

Q ss_pred             CCCCcHHHHHhhc-CCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCc
Q 037267            1 MPNGSLEKWLYSY-NYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED   79 (202)
Q Consensus         1 ~~~gsL~~~l~~~-~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~   79 (202)
                      |++|+|.+++... ...+++..+..++.|++.||.|||    +.+|+|+||||+||+++.++.++|+|||++........
T Consensus       102 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  177 (284)
T 2a19_B          102 CDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIH----SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK  177 (284)
T ss_dssp             CCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEEEETTEEEECCCTTCEESSCCSC
T ss_pred             cCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH----hCCeeeccCCHHHEEEcCCCCEEECcchhheecccccc
Confidence            5789999999754 345899999999999999999999    89999999999999999999999999999987654332


Q ss_pred             cccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhh
Q 037267           80 FVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVRE  159 (202)
Q Consensus        80 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (202)
                         .....+++.|+|||...+..++.++|+||+|+++|++++|..|+....    ..........               
T Consensus       178 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~----~~~~~~~~~~---------------  235 (284)
T 2a19_B          178 ---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS----KFFTDLRDGI---------------  235 (284)
T ss_dssp             ---CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH----HHHHHHHTTC---------------
T ss_pred             ---ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH----HHHHHhhccc---------------
Confidence               223458899999998888888999999999999999999998864211    0000000000               


Q ss_pred             HHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhcC
Q 037267          160 EQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKIK  202 (202)
Q Consensus       160 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l~  202 (202)
                           .+..++.++.+++.+||+.||++|||+.|+++.|..++
T Consensus       236 -----~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~  273 (284)
T 2a19_B          236 -----ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK  273 (284)
T ss_dssp             -----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred             -----ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence                 01123455789999999999999999999999998764

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=99.98  E-value=9.6e-33  Score=230.63  Aligned_cols=164  Identities=23%  Similarity=0.248  Sum_probs=132.1

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |+||+|.+++.... .+++..++.++.||+.||.|||    +.+|+||||||+|||++.++.+||+|||++........ 
T Consensus       424 ~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH----~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~-  497 (674)
T 3pfq_A          424 VNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQ----SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV-  497 (674)
T ss_dssp             CCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----HTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCTTC-
T ss_pred             cCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----hCCeEeccCChhhEEEcCCCcEEEeecceeeccccCCc-
Confidence            57999999998755 4899999999999999999999    89999999999999999999999999999986433222 


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhH
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREE  160 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (202)
                       ......||+.|+|||++.+..++.++|+||+|+++|+|++|..||......+  +...+....           ..   
T Consensus       498 -~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~--~~~~i~~~~-----------~~---  560 (674)
T 3pfq_A          498 -TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE--LFQSIMEHN-----------VA---  560 (674)
T ss_dssp             -CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHSSC-----------CC---
T ss_pred             -ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHH--HHHHHHhCC-----------CC---
Confidence             1234568999999999988899999999999999999999999997643221  111111110           00   


Q ss_pred             HHHHHhHHHHHHHHHHHhhhcCCCCCCCCCH
Q 037267          161 QAFAAKMDCIVSIMDLALDCCMESPGKRINM  191 (202)
Q Consensus       161 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~  191 (202)
                          .+...+.++.+|+.+||.+||++||++
T Consensus       561 ----~p~~~s~~~~~li~~lL~~dP~~R~~~  587 (674)
T 3pfq_A          561 ----YPKSMSKEAVAICKGLMTKHPGKRLGC  587 (674)
T ss_dssp             ----CCTTSCHHHHHHHHHHSCSSSTTCTTC
T ss_pred             ----CCccCCHHHHHHHHHHccCCHHHCCCC
Confidence                112355668999999999999999997

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=99.98  E-value=7.6e-33  Score=212.31  Aligned_cols=179  Identities=20%  Similarity=0.252  Sum_probs=131.8

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCc-
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED-   79 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~-   79 (202)
                      |++|+|.+++......+++..+..++.|++.||.|||    +.+++||||||+||+++ ++.++++|||++........ 
T Consensus       111 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH----~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~  185 (319)
T 2y4i_B          111 CKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH----AKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAG  185 (319)
T ss_dssp             CCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHH----HTTCCCCCCCSTTEEEC---CCEECCCSCCC--------
T ss_pred             ccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----hCCccccCCChhhEEEe-CCCEEEeecCCcccccccccc
Confidence            5789999999876667999999999999999999999    89999999999999998 67899999999875432111 


Q ss_pred             --cccccCCCCCccccCCCCCCC---------CCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCCh
Q 037267           80 --FVTQTMTMATIGYMAPEYGSE---------GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGL  148 (202)
Q Consensus        80 --~~~~~~~~~~~~~~~pe~~~~---------~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  148 (202)
                        ........+++.|+|||.+.+         ..++.++|+||+|+++|++++|..||........  ...+........
T Consensus       186 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~~~~~~~~~~~  263 (319)
T 2y4i_B          186 RREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAI--IWQMGTGMKPNL  263 (319)
T ss_dssp             --CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHH--HHHHHTTCCCCC
T ss_pred             ccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHhccCCCCCC
Confidence              111222357889999997653         3468899999999999999999999976432221  111111110000


Q ss_pred             hhhhhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhcC
Q 037267          149 TEVVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKIK  202 (202)
Q Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l~  202 (202)
                      .                ...++.++.+++.+||..||++|||+.++++.|+++.
T Consensus       264 ~----------------~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~  301 (319)
T 2y4i_B          264 S----------------QIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLP  301 (319)
T ss_dssp             C----------------CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-
T ss_pred             C----------------cCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence            0                0123445889999999999999999999999998763

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=99.98  E-value=9.9e-33  Score=213.97  Aligned_cols=175  Identities=23%  Similarity=0.293  Sum_probs=132.5

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCC----CceEEcccccceeccC
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN----MVAHVSDFGISKLLGE   76 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~----~~~~l~d~g~~~~~~~   76 (202)
                      |+||+|.+++.... .+++..+..++.|++.||.|||    +.+|+||||||+||++...    +.+||+|||++.....
T Consensus        98 ~~gg~L~~~i~~~~-~~~~~~~~~~~~qi~~al~~lH----~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~  172 (342)
T 2qr7_A           98 MKGGELLDKILRQK-FFSEREASAVLFTITKTVEYLH----AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA  172 (342)
T ss_dssp             CCSCBHHHHHHTCT-TCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBC
T ss_pred             CCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcC
Confidence            57999999998654 4899999999999999999999    8999999999999998532    3599999999987654


Q ss_pred             CCccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccc-hhhHHHHHHhCCCChhhhhhhh
Q 037267           77 GEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGE-MSLRRWVKESLPHGLTEVVDAN  155 (202)
Q Consensus        77 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  155 (202)
                      ....  .....+++.|+|||.+.+..++.++|+||+||++|++++|..||....... ..+...+.........      
T Consensus       173 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~------  244 (342)
T 2qr7_A          173 ENGL--LMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSG------  244 (342)
T ss_dssp             TTCC--BCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCS------
T ss_pred             CCCc--eeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCc------
Confidence            3221  223467999999998877778889999999999999999999997532211 1111111111100000      


Q ss_pred             hhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          156 LVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                              .....++.++.+++.+||..||++|||+.++++
T Consensus       245 --------~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~  277 (342)
T 2qr7_A          245 --------GYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR  277 (342)
T ss_dssp             --------TTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             --------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence                    001234566899999999999999999999874

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=99.98  E-value=1.1e-32  Score=219.58  Aligned_cols=120  Identities=26%  Similarity=0.237  Sum_probs=104.6

Q ss_pred             CCcHHHHHhhcC-CCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCc--eEEcccccceeccCCCc
Q 037267            3 NGSLEKWLYSYN-YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMV--AHVSDFGISKLLGEGED   79 (202)
Q Consensus         3 ~gsL~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~--~~l~d~g~~~~~~~~~~   79 (202)
                      +|+|.+++.... ..+++..+..++.|++.||.|||    +.+|+||||||+||+++.++.  +||+|||++....... 
T Consensus       182 ~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH----~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~~~-  256 (429)
T 3kvw_A          182 SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH----KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRV-  256 (429)
T ss_dssp             CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH----HHTEECSCCSGGGEEESSTTSCCEEECCCTTCEETTCCC-
T ss_pred             CCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHeEEccCCCcceEEeecccceecCCcc-
Confidence            579999998654 35899999999999999999999    899999999999999998877  9999999997644322 


Q ss_pred             cccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccc
Q 037267           80 FVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFT  131 (202)
Q Consensus        80 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~  131 (202)
                          ....+++.|+|||++.+..++.++|+||+||++|++++|..||.....
T Consensus       257 ----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~  304 (429)
T 3kvw_A          257 ----YTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDE  304 (429)
T ss_dssp             ----CSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             ----cccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCH
Confidence                234688999999998888899999999999999999999999976543

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=99.98  E-value=5.2e-34  Score=232.98  Aligned_cols=177  Identities=28%  Similarity=0.471  Sum_probs=139.3

Q ss_pred             CCCCcHHHHHhhc-CCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCc
Q 037267            1 MPNGSLEKWLYSY-NYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED   79 (202)
Q Consensus         1 ~~~gsL~~~l~~~-~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~   79 (202)
                      |++|+|.++++.. ...+++..++.++.|++.||.|||    +++|+||||||.||+++.++.+||+|||++....... 
T Consensus       343 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH----~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-  417 (535)
T 2h8h_A          343 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE----RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-  417 (535)
T ss_dssp             CTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH-
T ss_pred             hcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH----hCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCc-
Confidence            5789999999853 345899999999999999999999    8999999999999999999999999999997654321 


Q ss_pred             cccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhh
Q 037267           80 FVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVR  158 (202)
Q Consensus        80 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (202)
                      ........++..|+|||.+.+..++.++|+||||+++|++++ |..||......+  ....+.....             
T Consensus       418 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~--~~~~i~~~~~-------------  482 (535)
T 2h8h_A          418 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--VLDQVERGYR-------------  482 (535)
T ss_dssp             HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHH--HHHHHHTTCC-------------
T ss_pred             eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcCCC-------------
Confidence            111222346778999998887889999999999999999999 899997643222  1111111110             


Q ss_pred             hHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          159 EEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       159 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                          .+.+..++.++.++|.+||+.||++|||+.++++.|+.+
T Consensus       483 ----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~  521 (535)
T 2h8h_A          483 ----MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  521 (535)
T ss_dssp             ----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             ----CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence                011224667799999999999999999999999999875

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=99.98  E-value=4.3e-33  Score=214.92  Aligned_cols=174  Identities=21%  Similarity=0.258  Sum_probs=119.1

Q ss_pred             CCCcHHHHHhh--cCCCCCHHHHHHHHHHHHHhhhcccCCCCCCC--eeecCCCCCceeeCCCCceEEcccccceeccCC
Q 037267            2 PNGSLEKWLYS--YNYFFDILERLNIMIDVGSALEYPHHGHSSAP--IIHCDLKPTNILLDENMVAHVSDFGISKLLGEG   77 (202)
Q Consensus         2 ~~gsL~~~l~~--~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~--i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~   77 (202)
                      .+|+|.+++..  ....+++..++.++.|++.||.|||    +.+  |+||||||+||+++.++.++|+|||++......
T Consensus       116 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH----~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~  191 (337)
T 3ll6_A          116 CKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH----RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHY  191 (337)
T ss_dssp             CSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHH----TSSSCCBCCCCCGGGCEECTTSCEEBCCCTTCBCCSSC
T ss_pred             cCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH----hCCCCEEEccCCcccEEECCCCCEEEecCccceecccc
Confidence            36899999875  3446999999999999999999999    888  999999999999999999999999999876543


Q ss_pred             Cccc----------cccCCCCCccccCCCCC---CCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhC
Q 037267           78 EDFV----------TQTMTMATIGYMAPEYG---SEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESL  144 (202)
Q Consensus        78 ~~~~----------~~~~~~~~~~~~~pe~~---~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~  144 (202)
                      ....          ......+++.|+|||.+   .+..++.++|+||+|+++|++++|..||.......     ......
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-----~~~~~~  266 (337)
T 3ll6_A          192 PDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR-----IVNGKY  266 (337)
T ss_dssp             C-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------------C
T ss_pred             CcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH-----hhcCcc
Confidence            2211          01123578899999987   56678889999999999999999999996532211     011000


Q ss_pred             CCChhhhhhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          145 PHGLTEVVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                      ..                 +....++..+.+++.+||+.||++|||+.|+++.|+.+
T Consensus       267 ~~-----------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~  306 (337)
T 3ll6_A          267 SI-----------------PPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEI  306 (337)
T ss_dssp             CC-----------------CTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             cC-----------------CcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            00                 00011223478999999999999999999999999865

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=99.98  E-value=3.1e-33  Score=211.83  Aligned_cols=188  Identities=20%  Similarity=0.254  Sum_probs=131.2

Q ss_pred             CCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcccc
Q 037267            3 NGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVT   82 (202)
Q Consensus         3 ~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~   82 (202)
                      .|+|.+++......+++..+..++.|++.||.|||    +.+|+||||||+||+++.++.+||+|||++........  .
T Consensus        83 ~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~  156 (288)
T 1ob3_A           83 DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH----DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR--K  156 (288)
T ss_dssp             SEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred             CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHEEEcCCCCEEEeECccccccCcccc--c
Confidence            46899999876667999999999999999999999    89999999999999999999999999999876543221  1


Q ss_pred             ccCCCCCccccCCCCCCC-CCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCC--CChhhhhh-----h
Q 037267           83 QTMTMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLP--HGLTEVVD-----A  154 (202)
Q Consensus        83 ~~~~~~~~~~~~pe~~~~-~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~-----~  154 (202)
                      .....+++.|+|||.+.+ ..++.++|+||+||++|++++|..||..................+  ..+.....     .
T Consensus       157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (288)
T 1ob3_A          157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP  236 (288)
T ss_dssp             -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred             cccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccccccc
Confidence            223457899999998765 357899999999999999999999997654322211111111110  00000000     0


Q ss_pred             hhh--hhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          155 NLV--REEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       155 ~~~--~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                      ...  ............+.++.+++.+||+.||++|||+.|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             TCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            000  000000001234567899999999999999999999875

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=99.98  E-value=5.2e-33  Score=215.02  Aligned_cols=161  Identities=24%  Similarity=0.269  Sum_probs=130.5

Q ss_pred             CCC-cHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            2 PNG-SLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         2 ~~g-sL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      .+| +|.+++.... .+++..+..++.|++.||.|||    +.+|+||||||+||+++.++.+||+|||++.........
T Consensus       112 ~~g~~l~~~~~~~~-~l~~~~~~~i~~qi~~~L~~LH----~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~  186 (335)
T 3dls_A          112 GSGLDLFAFIDRHP-RLDEPLASYIFRQLVSAVGYLR----LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLF  186 (335)
T ss_dssp             TTSCBHHHHHHTCC-CCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTCCB
T ss_pred             CCCccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----hCCeEEeccCHHHEEEcCCCcEEEeecccceECCCCCce
Confidence            345 9999998654 4899999999999999999999    899999999999999999999999999999876543321


Q ss_pred             ccccCCCCCccccCCCCCCCCCc-CcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhh
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIV-SAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVRE  159 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~-~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (202)
                         ....+++.|+|||.+.+..+ +.++|+||+|+++|++++|..||........                   ....  
T Consensus       187 ---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-------------------~~~~--  242 (335)
T 3dls_A          187 ---YTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVE-------------------AAIH--  242 (335)
T ss_dssp             ---CEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGTT-------------------TCCC--
T ss_pred             ---eccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHHh-------------------hccC--
Confidence               22458999999998877776 7789999999999999999999965321110                   0000  


Q ss_pred             HHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          160 EQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       160 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                           .+..++.++.+++.+||..||++|||+.++++
T Consensus       243 -----~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  274 (335)
T 3dls_A          243 -----PPYLVSKELMSLVSGLLQPVPERRTTLEKLVT  274 (335)
T ss_dssp             -----CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -----CCcccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                 01124456899999999999999999999986

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=99.98  E-value=1.1e-32  Score=212.15  Aligned_cols=188  Identities=19%  Similarity=0.212  Sum_probs=132.6

Q ss_pred             CCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcccc
Q 037267            3 NGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVT   82 (202)
Q Consensus         3 ~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~   82 (202)
                      .|+|.+++......+++..+..++.|++.||.|||    +.+|+||||||+||+++.++.++|+|||++........  .
T Consensus        83 ~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH----~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~--~  156 (324)
T 3mtl_A           83 DKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH----RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK--T  156 (324)
T ss_dssp             SEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH----HTTEEESSCCGGGEEECTTCCEEECSSSEEECC--------
T ss_pred             ccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCccCCCcCHHHEEECCCCCEEEccCcccccccCCcc--c
Confidence            47999999877777999999999999999999999    89999999999999999999999999999976543222  1


Q ss_pred             ccCCCCCccccCCCCCCC-CCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCC--CChhhhhhhhhh--
Q 037267           83 QTMTMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLP--HGLTEVVDANLV--  157 (202)
Q Consensus        83 ~~~~~~~~~~~~pe~~~~-~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~--  157 (202)
                      .....+++.|+|||.+.+ ..++.++|+||+|+++|++++|..||..................+  ..+.........  
T Consensus       157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  236 (324)
T 3mtl_A          157 YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKT  236 (324)
T ss_dssp             ------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHH
T ss_pred             cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcc
Confidence            223457899999997765 567899999999999999999999997754332211111111111  111111100000  


Q ss_pred             ------hhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          158 ------REEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       158 ------~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                            ...........++.++.+++.+||+.||++|||+.|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  281 (324)
T 3mtl_A          237 YNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK  281 (324)
T ss_dssp             TCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             cccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence                  000011222345677899999999999999999999975

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=99.98  E-value=2.9e-33  Score=220.95  Aligned_cols=194  Identities=21%  Similarity=0.202  Sum_probs=140.7

Q ss_pred             CCCCcHHHHHhhcC--CCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceee----CCCCceEEcccccceec
Q 037267            1 MPNGSLEKWLYSYN--YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILL----DENMVAHVSDFGISKLL   74 (202)
Q Consensus         1 ~~~gsL~~~l~~~~--~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~----~~~~~~~l~d~g~~~~~   74 (202)
                      |++|+|.+++....  ..+++..++.++.|++.||.|||    +.+|+||||||+||++    +.++.+||+|||++...
T Consensus        91 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH----~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~  166 (396)
T 4eut_A           91 CPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR----ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL  166 (396)
T ss_dssp             CTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEEC
T ss_pred             CCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH----HCCEEECCcCHHHEEEeecCCCceeEEEecCCCceEc
Confidence            57899999998543  23899999999999999999999    8999999999999999    77788999999999876


Q ss_pred             cCCCccccccCCCCCccccCCCCCCC--------CCcCcchhhhhHHHHHHHHHhCCCCCCcccccchh--hHHHHHHhC
Q 037267           75 GEGEDFVTQTMTMATIGYMAPEYGSE--------GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMS--LRRWVKESL  144 (202)
Q Consensus        75 ~~~~~~~~~~~~~~~~~~~~pe~~~~--------~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~--~~~~~~~~~  144 (202)
                      .....   .....+++.|+|||.+.+        ..++.++|+||+||++|++++|..||.........  ....+....
T Consensus       167 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~  243 (396)
T 4eut_A          167 EDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK  243 (396)
T ss_dssp             CCGGG---SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSC
T ss_pred             cCCCc---cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCC
Confidence            54322   223468999999997643        45678899999999999999999999765433221  111122222


Q ss_pred             CCChhhhhhhhhh-------hhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          145 PHGLTEVVDANLV-------REEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       145 ~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                      +............       ............+..+.+++.+||..||++|||+.++++.++.+
T Consensus       244 p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~i  307 (396)
T 4eut_A          244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI  307 (396)
T ss_dssp             CTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred             CcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHH
Confidence            2111000000000       00000112245677799999999999999999999999988764

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=99.98  E-value=1.3e-32  Score=218.69  Aligned_cols=173  Identities=25%  Similarity=0.282  Sum_probs=127.7

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCC---CceEEcccccceeccCC
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN---MVAHVSDFGISKLLGEG   77 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~---~~~~l~d~g~~~~~~~~   77 (202)
                      |++|+|.+++.... .+++..+..++.|++.||.|||    +.+|+||||||+||+++.+   ..+||+|||++......
T Consensus       221 ~~~g~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH----~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~  295 (419)
T 3i6u_A          221 MEGGELFDKVVGNK-RLKEATCKLYFYQMLLAVQYLH----ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET  295 (419)
T ss_dssp             CTTCBGGGGTSSSC-CCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSCC--
T ss_pred             CCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH----HCCccccCCChHhEEEecCCCcceEEEeecccceecCCC
Confidence            57999999997644 4899999999999999999999    8999999999999999754   45999999999875433


Q ss_pred             CccccccCCCCCccccCCCCCCC---CCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhh
Q 037267           78 EDFVTQTMTMATIGYMAPEYGSE---GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDA  154 (202)
Q Consensus        78 ~~~~~~~~~~~~~~~~~pe~~~~---~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (202)
                      ..   .....+++.|+|||.+.+   ..++.++|+||+|+++|++++|..||........ +...+........      
T Consensus       296 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~-~~~~i~~~~~~~~------  365 (419)
T 3i6u_A          296 SL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS-LKDQITSGKYNFI------  365 (419)
T ss_dssp             ------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC-HHHHHHTTCCCCC------
T ss_pred             cc---ccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH-HHHHHhcCCCCCC------
Confidence            21   123468999999998753   5678899999999999999999999976433221 2222211111000      


Q ss_pred             hhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          155 NLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                              ......++.++.+++.+||+.||++|||+.|+++
T Consensus       366 --------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  399 (419)
T 3i6u_A          366 --------PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR  399 (419)
T ss_dssp             --------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             --------chhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence                    1112235667899999999999999999999885

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=99.98  E-value=1.2e-32  Score=216.91  Aligned_cols=185  Identities=21%  Similarity=0.208  Sum_probs=134.0

Q ss_pred             CCcHHHHHhhcC-CCCCHHHHHHHHHHHHHhhhcccCCCCCC-CeeecCCCCCceeeCCCC-------------------
Q 037267            3 NGSLEKWLYSYN-YFFDILERLNIMIDVGSALEYPHHGHSSA-PIIHCDLKPTNILLDENM-------------------   61 (202)
Q Consensus         3 ~gsL~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~~~~-~i~h~dlk~~nil~~~~~-------------------   61 (202)
                      +|+|.+++.... ..+++..+..++.|++.||.|||    ++ +|+||||||+||+++.++                   
T Consensus       128 ~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH----~~~givHrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~  203 (397)
T 1wak_A          128 GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLH----TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAP  203 (397)
T ss_dssp             CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH----HTTCEECCCCSGGGEEECCCHHHHHHHHHHHC--------
T ss_pred             CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH----HhCCEecCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCC
Confidence            677777776543 46999999999999999999999    77 999999999999999775                   


Q ss_pred             ------------------------------ceEEcccccceeccCCCccccccCCCCCccccCCCCCCCCCcCcchhhhh
Q 037267           62 ------------------------------VAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYS  111 (202)
Q Consensus        62 ------------------------------~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s  111 (202)
                                                    .++|+|||++......     .....+|+.|+|||.+.+..++.++|+||
T Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Diws  278 (397)
T 1wak_A          204 PPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEVLIGSGYNTPADIWS  278 (397)
T ss_dssp             -------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHHHHTSCCCTHHHHHH
T ss_pred             CCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCChhhcCCCCCcHHHHHH
Confidence                                          7999999999876432     12346899999999988888999999999


Q ss_pred             HHHHHHHHHhCCCCCCcccccchhhH----HHHHHhCCCChhhhh-hhhhh-----------------------hhHHHH
Q 037267          112 YGVLLMETFTRKRPTDEMFTGEMSLR----RWVKESLPHGLTEVV-DANLV-----------------------REEQAF  163 (202)
Q Consensus       112 ~G~~~~~~~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~~-~~~~~-----------------------~~~~~~  163 (202)
                      +||++|++++|..||...........    ..+.......-.... .....                       ......
T Consensus       279 lG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  358 (397)
T 1wak_A          279 TACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKY  358 (397)
T ss_dssp             HHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTS
T ss_pred             HHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchhHhhhhhc
Confidence            99999999999999986544322110    111110000000000 00000                       000001


Q ss_pred             HHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          164 AAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       164 ~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                      ..+...+.++.+|+.+||..||++|||++|+++
T Consensus       359 ~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  391 (397)
T 1wak_A          359 EWSQEEAAGFTDFLLPMLELIPEKRATAAECLR  391 (397)
T ss_dssp             CCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred             ccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence            123566778999999999999999999999985

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=99.98  E-value=7.5e-33  Score=219.25  Aligned_cols=175  Identities=21%  Similarity=0.237  Sum_probs=133.0

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |+||+|.+++.+.+..+++..+..++.|++.||.|||    +.+|+||||||+||+++.++.+||+|||++.........
T Consensus       143 ~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH----~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~~  218 (412)
T 2vd5_A          143 YVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVH----RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTV  218 (412)
T ss_dssp             CCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCE
T ss_pred             CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCeeecccCHHHeeecCCCCEEEeechhheeccCCCcc
Confidence            5799999999876656999999999999999999999    899999999999999999999999999999876543321


Q ss_pred             ccccCCCCCccccCCCCCC-------CCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhh
Q 037267           81 VTQTMTMATIGYMAPEYGS-------EGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVD  153 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~-------~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (202)
                       ......||+.|+|||++.       ...++.++|+||+||++|+|++|..||........ ... +           ..
T Consensus       219 -~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~-~~~-i-----------~~  284 (412)
T 2vd5_A          219 -RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAET-YGK-I-----------VH  284 (412)
T ss_dssp             -ECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HHH-H-----------HT
T ss_pred             -ccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHH-HHH-H-----------Hh
Confidence             122356899999999765       35688999999999999999999999976432211 010 0           00


Q ss_pred             hhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCC---CCHHHHHH
Q 037267          154 ANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKR---INMTDAAA  196 (202)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~R---ps~~~~~~  196 (202)
                      .....  ........++.++.+++.+||. +|++|   |+++|+++
T Consensus       285 ~~~~~--~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~  327 (412)
T 2vd5_A          285 YKEHL--SLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT  327 (412)
T ss_dssp             HHHHC--CCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred             cccCc--CCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence            00000  0000112456779999999999 99998   58888763

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=99.98  E-value=1.6e-33  Score=234.61  Aligned_cols=177  Identities=21%  Similarity=0.381  Sum_probs=138.2

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |++|+|.+++......+++..++.++.|++.||.|||    +.+|+||||||+||+++.++.+||+|||++.........
T Consensus       472 ~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH----~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~~~  547 (656)
T 2j0j_A          472 CTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE----SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY  547 (656)
T ss_dssp             CTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC----
T ss_pred             CCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH----hCCccccccchHhEEEeCCCCEEEEecCCCeecCCCcce
Confidence            5789999999876667999999999999999999999    899999999999999999999999999999876443221


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhh
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVRE  159 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (202)
                       ......+++.|+|||.+.+..++.++|+||+|+++|++++ |..||.......  ....+.....              
T Consensus       548 -~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~--~~~~i~~~~~--------------  610 (656)
T 2j0j_A          548 -KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND--VIGRIENGER--------------  610 (656)
T ss_dssp             -------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHHHHHTCC--------------
T ss_pred             -eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHH--HHHHHHcCCC--------------
Confidence             1222346778999998887888999999999999999997 999997643222  1111111110              


Q ss_pred             HHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          160 EQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       160 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                         .+.+..++..+.+++.+||..||++|||+.++++.|+.+
T Consensus       611 ---~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~i  649 (656)
T 2j0j_A          611 ---LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI  649 (656)
T ss_dssp             ---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---CCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence               011123566789999999999999999999999999875

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=99.98  E-value=1.7e-32  Score=211.27  Aligned_cols=185  Identities=19%  Similarity=0.242  Sum_probs=133.2

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCC-ceEEcccccceeccCCCc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENM-VAHVSDFGISKLLGEGED   79 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~-~~~l~d~g~~~~~~~~~~   79 (202)
                      |++++|.+++..    ++...+..++.|++.||.|||    +.+|+||||||+||+++.++ .++|+|||++........
T Consensus       115 ~~~~~l~~~~~~----~~~~~~~~~~~qi~~~l~~lH----~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~  186 (330)
T 3nsz_A          115 VNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCH----SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE  186 (330)
T ss_dssp             CCCCCHHHHGGG----CCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCC
T ss_pred             cCchhHHHHHHh----CCHHHHHHHHHHHHHHHHHHH----hCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCc
Confidence            578999999853    789999999999999999999    89999999999999999766 899999999987654332


Q ss_pred             cccccCCCCCccccCCCCCCC-CCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhh
Q 037267           80 FVTQTMTMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVR  158 (202)
Q Consensus        80 ~~~~~~~~~~~~~~~pe~~~~-~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (202)
                         .....++..|+|||.+.+ ..++.++|+||+||++|++++|..||.........+.......-.....+.+......
T Consensus       187 ---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  263 (330)
T 3nsz_A          187 ---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE  263 (330)
T ss_dssp             ---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred             ---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccc
Confidence               223467889999998766 5688999999999999999999999965443322222211111000000000000000


Q ss_pred             ------------------hHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          159 ------------------EEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       159 ------------------~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                                        ..........++.++.+++.+||..||++|||++|+++
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~  319 (330)
T 3nsz_A          264 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  319 (330)
T ss_dssp             CCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             cccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                              00000011225677999999999999999999999986

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=99.98  E-value=7.3e-33  Score=208.81  Aligned_cols=167  Identities=25%  Similarity=0.305  Sum_probs=130.2

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      +++|+|.+++.... .+++..+..++.|++.||.|||    +.+++|+||||+||+++.++.++|+|||++.......  
T Consensus        91 ~~~~~l~~~l~~~~-~~~~~~~~~~~~qi~~~l~~LH----~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~--  163 (279)
T 3fdn_A           91 APLGTVYRELQKLS-KFDEQRTATYITELANALSYCH----SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR--  163 (279)
T ss_dssp             CTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----TTTCEECCCCGGGEEECTTSCEEECSCCEESCC------
T ss_pred             CCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----hCCEecccCChHhEEEcCCCCEEEEeccccccCCccc--
Confidence            46899999998654 4899999999999999999999    8999999999999999999999999999886543322  


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhH
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREE  160 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (202)
                        .....+++.|+|||.+.+..++.++|+||+|+++|++++|..||........  ...+.....               
T Consensus       164 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~~~~---------------  224 (279)
T 3fdn_A          164 --RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET--YKRISRVEF---------------  224 (279)
T ss_dssp             ------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH--HHHHHHTCC---------------
T ss_pred             --ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHH--HHHHHhCCC---------------
Confidence              2234678999999998888889999999999999999999999975432111  111111000               


Q ss_pred             HHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          161 QAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       161 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                         ..+..++..+.+++.+||+.||++|||+.|+++
T Consensus       225 ---~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~  257 (279)
T 3fdn_A          225 ---TFPDFVTEGARDLISRLLKHNPSQRPMLREVLE  257 (279)
T ss_dssp             ---CCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             ---CCCCcCCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence               011224556889999999999999999999985

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=99.98  E-value=1.9e-32  Score=206.25  Aligned_cols=171  Identities=23%  Similarity=0.263  Sum_probs=133.0

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceee---CCCCceEEcccccceeccCC
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILL---DENMVAHVSDFGISKLLGEG   77 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~---~~~~~~~l~d~g~~~~~~~~   77 (202)
                      |++|+|.+++.... .+++..+..++.|++.||.|||    +.+++|+||||+||++   +.++.++++|||++......
T Consensus        88 ~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lH----~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~  162 (277)
T 3f3z_A           88 CTGGELFERVVHKR-VFRESDAARIMKDVLSAVAYCH----KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG  162 (277)
T ss_dssp             CCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT
T ss_pred             cCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc
Confidence            57899999998654 4899999999999999999999    8999999999999999   77889999999999876543


Q ss_pred             CccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhh
Q 037267           78 EDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV  157 (202)
Q Consensus        78 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (202)
                      ..   .....+++.|+|||.+.+. ++.++|+||+|+++|++++|..||........  ...+.......          
T Consensus       163 ~~---~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~--~~~~~~~~~~~----------  226 (277)
T 3f3z_A          163 KM---MRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEV--MLKIREGTFTF----------  226 (277)
T ss_dssp             SC---BCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHCCCCC----------
T ss_pred             cc---hhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHH--HHHHHhCCCCC----------
Confidence            32   2234688999999987654 88999999999999999999999976432221  11111110000          


Q ss_pred             hhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          158 REEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                          .......++.++.+++.+||+.||++|||+.++++
T Consensus       227 ----~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  261 (277)
T 3f3z_A          227 ----PEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE  261 (277)
T ss_dssp             ----CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             ----CchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                00111235667899999999999999999999874

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=99.98  E-value=9.4e-33  Score=212.73  Aligned_cols=178  Identities=24%  Similarity=0.395  Sum_probs=135.5

Q ss_pred             CCCCcHHHHHhhcC------CCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCC---CCceEEcccccc
Q 037267            1 MPNGSLEKWLYSYN------YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDE---NMVAHVSDFGIS   71 (202)
Q Consensus         1 ~~~gsL~~~l~~~~------~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~---~~~~~l~d~g~~   71 (202)
                      |++|+|.+++....      ..+++..++.++.|++.||.|||    +.+++||||||+||+++.   +..++|+|||++
T Consensus       115 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH----~~~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~  190 (327)
T 2yfx_A          115 MAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE----ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA  190 (327)
T ss_dssp             CTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEESCSSTTCCEEECCCHHH
T ss_pred             CCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHh----hCCeecCcCCHhHEEEecCCCcceEEECccccc
Confidence            47899999998653      34899999999999999999999    899999999999999984   446999999998


Q ss_pred             eeccCCCccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhCCCChhh
Q 037267           72 KLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTE  150 (202)
Q Consensus        72 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  150 (202)
                      ................+++.|+|||.+.+..++.++|+||+|+++|++++ |..||.......  ....+......    
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~~~~~~~~~----  264 (327)
T 2yfx_A          191 RDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE--VLEFVTSGGRM----  264 (327)
T ss_dssp             HHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--HHHHHHTTCCC----
T ss_pred             cccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHH--HHHHHhcCCCC----
Confidence            75543332222233457889999998877788999999999999999998 999986543221  11111111100    


Q ss_pred             hhhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          151 VVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                                   ..+..++..+.+++.+||..||++|||+.++++.|+.+
T Consensus       265 -------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~  302 (327)
T 2yfx_A          265 -------------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC  302 (327)
T ss_dssp             -------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -------------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence                         01123456689999999999999999999999998764

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=99.97  E-value=3.6e-32  Score=208.15  Aligned_cols=173  Identities=24%  Similarity=0.267  Sum_probs=135.9

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |++|+|.+++......+++..+..++.|++.||.|||    +.+++|+||||+||+++.++.++|+|||.+........ 
T Consensus       106 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH----~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~-  180 (314)
T 3com_A          106 CGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLH----FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA-  180 (314)
T ss_dssp             CTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS-
T ss_pred             CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----hCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc-
Confidence            4688999999865666999999999999999999999    89999999999999999999999999999987654322 


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhH
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREE  160 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (202)
                       ......+++.|+|||.+.+..++.++|+||+|+++|++++|..||.........  .......+...            
T Consensus       181 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~--~~~~~~~~~~~------------  245 (314)
T 3com_A          181 -KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAI--FMIPTNPPPTF------------  245 (314)
T ss_dssp             -CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHH--HHHHHSCCCCC------------
T ss_pred             -ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHH--HHHhcCCCccc------------
Confidence             122346889999999988888899999999999999999999999764322111  01111110000            


Q ss_pred             HHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          161 QAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       161 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                         ..+..++..+.+++.+||..||++|||+.++++
T Consensus       246 ---~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          246 ---RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             ---SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             ---CCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence               001224556899999999999999999999975

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=99.97  E-value=1.5e-32  Score=210.35  Aligned_cols=173  Identities=25%  Similarity=0.336  Sum_probs=125.8

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      +.+|+|.+++.... .+++..+..++.|++.||.|||    +.+++||||||+||+++. +.++|+|||++.........
T Consensus       109 ~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH----~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~~  182 (313)
T 3cek_A          109 CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIH----QHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTS  182 (313)
T ss_dssp             CCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEEET-TEEEECCCSSSCC-------
T ss_pred             cCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCceecCCCcccEEEEC-CeEEEeeccccccccCcccc
Confidence            46889999998654 5899999999999999999999    899999999999999964 88999999999865543322


Q ss_pred             ccccCCCCCccccCCCCCCC-----------CCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChh
Q 037267           81 VTQTMTMATIGYMAPEYGSE-----------GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLT  149 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~-----------~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  149 (202)
                      .......+++.|+|||.+.+           ..++.++|+||+|+++|++++|..||.........+..........   
T Consensus       183 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~---  259 (313)
T 3cek_A          183 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI---  259 (313)
T ss_dssp             -------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCC---
T ss_pred             ccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhccccc---
Confidence            22223468999999997654           4678899999999999999999999976433222111111100000   


Q ss_pred             hhhhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          150 EVVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                                    ..+..++.++.+++.+||..||++|||+.|+++
T Consensus       260 --------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  292 (313)
T 3cek_A          260 --------------EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA  292 (313)
T ss_dssp             --------------CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             --------------CCcccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence                          001112455889999999999999999999985

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=99.97  E-value=1.7e-32  Score=210.11  Aligned_cols=188  Identities=22%  Similarity=0.280  Sum_probs=128.6

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCc---eEEcccccceeccCC
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMV---AHVSDFGISKLLGEG   77 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~---~~l~d~g~~~~~~~~   77 (202)
                      |++|+|.+++.... .+++..+..++.|++.||.|||    +.+|+||||||+||+++.++.   +||+|||++......
T Consensus        93 ~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH----~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~  167 (316)
T 2ac3_A           93 MRGGSILSHIHKRR-HFNELEASVVVQDVASALDFLH----NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLN  167 (316)
T ss_dssp             CTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-----
T ss_pred             CCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH----hCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccC
Confidence            57899999998654 4899999999999999999999    899999999999999997765   999999998765422


Q ss_pred             Ccc-----ccccCCCCCccccCCCCCCC-----CCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCC
Q 037267           78 EDF-----VTQTMTMATIGYMAPEYGSE-----GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHG  147 (202)
Q Consensus        78 ~~~-----~~~~~~~~~~~~~~pe~~~~-----~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~  147 (202)
                      ...     .......+++.|+|||.+.+     ..++.++|+||+||++|++++|..||.........+...   .....
T Consensus       168 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~---~~~~~  244 (316)
T 2ac3_A          168 GDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRG---EACPA  244 (316)
T ss_dssp             --------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC-------CCHH
T ss_pred             CccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccccccc---ccchh
Confidence            111     01122358999999997654     457889999999999999999999998654332110000   00000


Q ss_pred             hhhhhhhhhhhhH--HHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          148 LTEVVDANLVREE--QAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       148 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                      ........+....  ........++.++.+++.+||..||++|||+.|+++
T Consensus       245 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  295 (316)
T 2ac3_A          245 CQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ  295 (316)
T ss_dssp             HHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence            0000000000000  000111235667899999999999999999999986

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=99.97  E-value=1.5e-32  Score=207.43  Aligned_cols=172  Identities=22%  Similarity=0.257  Sum_probs=133.8

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCc---eEEcccccceeccCC
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMV---AHVSDFGISKLLGEG   77 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~---~~l~d~g~~~~~~~~   77 (202)
                      |++|+|.+++.... .+++..+..++.|++.||.|||    +.+++||||||+||+++.++.   ++++|||.+......
T Consensus        87 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~  161 (284)
T 3kk8_A           87 VTGGELFEDIVARE-FYSEADASHCIQQILESIAYCH----SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS  161 (284)
T ss_dssp             CCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS
T ss_pred             CCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC
Confidence            57899999998654 4899999999999999999999    899999999999999986554   999999999876543


Q ss_pred             CccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhh
Q 037267           78 EDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV  157 (202)
Q Consensus        78 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (202)
                      ..   .....+++.|+|||.+.+..++.++|+||+|+++|++++|..||.......  ....+........         
T Consensus       162 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~---------  227 (284)
T 3kk8_A          162 EA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR--LYAQIKAGAYDYP---------  227 (284)
T ss_dssp             CB---CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHTCCCCC---------
T ss_pred             cc---ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhH--HHHHHHhccccCC---------
Confidence            32   123468999999999888889999999999999999999999996643221  1111111110000         


Q ss_pred             hhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          158 REEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                           .+....+++++.+++.+||+.||++|||+.|+++
T Consensus       228 -----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (284)
T 3kk8_A          228 -----SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK  261 (284)
T ss_dssp             -----TTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -----chhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence                 0001234566899999999999999999999975

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=99.97  E-value=3.9e-32  Score=218.17  Aligned_cols=116  Identities=26%  Similarity=0.384  Sum_probs=95.3

Q ss_pred             CCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc-
Q 037267            2 PNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF-   80 (202)
Q Consensus         2 ~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~-   80 (202)
                      .+|+|.+++... ..+++..+..++.||+.||.|||    +.+|+||||||+|||++.++.+||+|||+++........ 
T Consensus       139 ~~~~L~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH----~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~  213 (458)
T 3rp9_A          139 ADSDFKKLFRTP-VYLTELHIKTLLYNLLVGVKYVH----SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGN  213 (458)
T ss_dssp             CSEEHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHHH----HTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCTTCC
T ss_pred             cccchhhhcccC-CCCCHHHHHHHHHHHHHHHHHHH----hCCcCCCCCChhhEEECCCCCEeecccccchhccCccccc
Confidence            478999999764 35999999999999999999999    899999999999999999999999999999875432110 


Q ss_pred             ------------------------ccccCCCCCccccCCCCC-CCCCcCcchhhhhHHHHHHHHHhC
Q 037267           81 ------------------------VTQTMTMATIGYMAPEYG-SEGIVSAKCDVYSYGVLLMETFTR  122 (202)
Q Consensus        81 ------------------------~~~~~~~~~~~~~~pe~~-~~~~~~~~~di~s~G~~~~~~~~g  122 (202)
                                              .......+|+.|+|||++ .+..++.++|+||+||++|+|++|
T Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg  280 (458)
T 3rp9_A          214 SQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM  280 (458)
T ss_dssp             CCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred             cccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence                                    012234679999999964 566789999999999999999984

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=99.97  E-value=1.7e-32  Score=210.59  Aligned_cols=187  Identities=22%  Similarity=0.275  Sum_probs=132.8

Q ss_pred             CCcHHHHHhhcC-----CCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCC
Q 037267            3 NGSLEKWLYSYN-----YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEG   77 (202)
Q Consensus         3 ~gsL~~~l~~~~-----~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~   77 (202)
                      .|+|.+++....     ..+++..+..++.|++.||.|||    +.+|+||||||+||+++.++.+||+|||++......
T Consensus        86 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH----~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  161 (317)
T 2pmi_A           86 DNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH----ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIP  161 (317)
T ss_dssp             CCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEECTTCCEEECCCSSCEETTSC
T ss_pred             CCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHH----HCCeeeCCCChHHeEEcCCCCEEECcCccceecCCC
Confidence            379999987432     35899999999999999999999    899999999999999999999999999999876533


Q ss_pred             CccccccCCCCCccccCCCCCCC-CCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHH-hCCC--Chhhhhh
Q 037267           78 EDFVTQTMTMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKE-SLPH--GLTEVVD  153 (202)
Q Consensus        78 ~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~-~~~~--~~~~~~~  153 (202)
                      ...  .....+++.|+|||.+.+ ..++.++|+||+||++|++++|..||........ ....... ..+.  .+.....
T Consensus       162 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~  238 (317)
T 2pmi_A          162 VNT--FSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQ-LKLIFDIMGTPNESLWPSVTK  238 (317)
T ss_dssp             CCC--CCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCSCCTTTCGGGGG
T ss_pred             ccc--CCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCChhHhhhhhh
Confidence            221  223467899999998765 4578999999999999999999999976543221 1111110 1100  0000000


Q ss_pred             -----hhhh----hh-HH--HHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          154 -----ANLV----RE-EQ--AFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       154 -----~~~~----~~-~~--~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                           ....    .. ..  ........+.++.+++.+||..||++|||+.|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~  293 (317)
T 2pmi_A          239 LPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH  293 (317)
T ss_dssp             CTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence                 0000    00 00  00001134567899999999999999999999874

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=99.97  E-value=4e-32  Score=209.56  Aligned_cols=185  Identities=22%  Similarity=0.233  Sum_probs=134.5

Q ss_pred             CCcHHHHHhhcC-CCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCC-------------------CCc
Q 037267            3 NGSLEKWLYSYN-YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDE-------------------NMV   62 (202)
Q Consensus         3 ~gsL~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~-------------------~~~   62 (202)
                      +++|.+++.... ..+++..+..++.|++.||.|||    +.+|+||||||+||+++.                   ++.
T Consensus       100 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~  175 (339)
T 1z57_A          100 GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLH----SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPD  175 (339)
T ss_dssp             CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEESCCCEEEEEC----CEEEEESCCC
T ss_pred             CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHH----HCCCcCCCCCHHHEEEeccccccccCCccccccccccCCC
Confidence            789999998654 35899999999999999999999    899999999999999987                   567


Q ss_pred             eEEcccccceeccCCCccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhH-HHHH
Q 037267           63 AHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLR-RWVK  141 (202)
Q Consensus        63 ~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~-~~~~  141 (202)
                      ++++|||++.......     ....+++.|+|||.+.+..++.++|+||+|+++|++++|..||........... ....
T Consensus       176 ~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~  250 (339)
T 1z57_A          176 IKVVDFGSATYDDEHH-----STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERIL  250 (339)
T ss_dssp             EEECCCSSCEETTSCC-----CSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHHHHH
T ss_pred             ceEeeCcccccCcccc-----ccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Confidence            9999999998744322     234689999999998888899999999999999999999999976543221110 1111


Q ss_pred             HhCCCChhhhhhh-----------------------hhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          142 ESLPHGLTEVVDA-----------------------NLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       142 ~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                      ...+..+......                       ..............+++++.+++.+||..||++|||+.|+++
T Consensus       251 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  328 (339)
T 1z57_A          251 GPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALK  328 (339)
T ss_dssp             CSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             CCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHhc
Confidence            1111100000000                       000000000112345678999999999999999999999974

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=99.97  E-value=5.8e-32  Score=212.54  Aligned_cols=121  Identities=26%  Similarity=0.262  Sum_probs=103.9

Q ss_pred             CCcHHHHHhhcC-CCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeC--CCCceEEcccccceeccCCCc
Q 037267            3 NGSLEKWLYSYN-YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLD--ENMVAHVSDFGISKLLGEGED   79 (202)
Q Consensus         3 ~gsL~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~--~~~~~~l~d~g~~~~~~~~~~   79 (202)
                      +|+|.+++.... ..+++..+..++.|++.||.|||..  ..+|+||||||+||+++  .++.+||+|||++....... 
T Consensus       139 ~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~--~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~~~~-  215 (382)
T 2vx3_A          139 SYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP--ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRI-  215 (382)
T ss_dssp             CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST--TTCEECCCCSGGGEEESSTTSCCEEECCCTTCEETTCCC-
T ss_pred             CCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC--CCCEEcCCCCcccEEEecCCCCcEEEEeccCceeccccc-
Confidence            579999998654 4589999999999999999999931  36899999999999995  47789999999998764322 


Q ss_pred             cccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCccc
Q 037267           80 FVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMF  130 (202)
Q Consensus        80 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~  130 (202)
                          ....+++.|+|||.+.+..++.++|+||+||++|++++|..||....
T Consensus       216 ----~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~  262 (382)
T 2vx3_A          216 ----YQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN  262 (382)
T ss_dssp             ----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             ----ccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence                23468899999999888889999999999999999999999998654

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=99.97  E-value=1.5e-32  Score=211.83  Aligned_cols=169  Identities=22%  Similarity=0.208  Sum_probs=128.8

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |+||+|.+++.... .+++..+..++.|++.||.|||    +.+|+||||||+||+++.++.+||+|||++........ 
T Consensus       103 ~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH----~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-  176 (327)
T 3a62_A          103 LSGGELFMQLEREG-IFMEDTACFYLAEISMALGHLH----QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT-  176 (327)
T ss_dssp             CTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCTTTEEECTTSCEEECCCSCC---------
T ss_pred             CCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHH----hCCEEcccCCHHHeEECCCCcEEEEeCCcccccccCCc-
Confidence            57899999998654 4899999999999999999999    89999999999999999999999999999875432221 


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhH
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREE  160 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (202)
                       ......|++.|+|||.+.+..++.++|+||+|+++|++++|..||........ .. .+.....               
T Consensus       177 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~-~i~~~~~---------------  238 (327)
T 3a62_A          177 -VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKT-ID-KILKCKL---------------  238 (327)
T ss_dssp             ---CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HH-HHHHTCC---------------
T ss_pred             -cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHH-HH-HHHhCCC---------------
Confidence             12234689999999998888889999999999999999999999976432211 11 1111100               


Q ss_pred             HHHHHhHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHH
Q 037267          161 QAFAAKMDCIVSIMDLALDCCMESPGKRI-----NMTDAAA  196 (202)
Q Consensus       161 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rp-----s~~~~~~  196 (202)
                         ..+..++.++.+++.+||..||++||     ++.++++
T Consensus       239 ---~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~  276 (327)
T 3a62_A          239 ---NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA  276 (327)
T ss_dssp             ---CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred             ---CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence               00112455689999999999999999     6677764

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=99.97  E-value=1.8e-33  Score=220.79  Aligned_cols=160  Identities=14%  Similarity=0.142  Sum_probs=124.6

Q ss_pred             CCcHHHHHhhcCC------CCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccC
Q 037267            3 NGSLEKWLYSYNY------FFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGE   76 (202)
Q Consensus         3 ~gsL~~~l~~~~~------~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~   76 (202)
                      +|||.+++.....      .+++..+..++.|++.||.|||    +.+|+||||||+||+++.++.+||+|||++.....
T Consensus       183 ~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH----~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~  258 (377)
T 3byv_A          183 QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH----HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA  258 (377)
T ss_dssp             SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHH----HTTEECSCCCGGGEEECTTCCEEECCGGGCEETTC
T ss_pred             CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEEcCCCCEEEEechhheecCC
Confidence            6899999985432      2335888899999999999999    89999999999999999999999999999986432


Q ss_pred             CCccccccCCCCCccccCCCCCCCC-----------CcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCC
Q 037267           77 GEDFVTQTMTMATIGYMAPEYGSEG-----------IVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLP  145 (202)
Q Consensus        77 ~~~~~~~~~~~~~~~~~~pe~~~~~-----------~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~  145 (202)
                      .     .....| +.|+|||.+.+.           .++.++|+||+||++|++++|..||........           
T Consensus       259 ~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~-----------  321 (377)
T 3byv_A          259 R-----VVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGG-----------  321 (377)
T ss_dssp             E-----EECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC------CC-----------
T ss_pred             c-----ccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCCCCCcccccccc-----------
Confidence            1     223456 899999988776           789999999999999999999999965432211           


Q ss_pred             CChhhhhhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          146 HGLTEVVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                        ...+...           ...++.++.+++.+||..||++|||+.|+++
T Consensus       322 --~~~~~~~-----------~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  359 (377)
T 3byv_A          322 --SEWIFRS-----------CKNIPQPVRALLEGFLRYPKEDRLLPLQAME  359 (377)
T ss_dssp             --SGGGGSS-----------CCCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred             --hhhhhhh-----------ccCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence              0000000           0134566899999999999999999999985

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=99.97  E-value=2.5e-33  Score=222.44  Aligned_cols=161  Identities=16%  Similarity=0.154  Sum_probs=126.9

Q ss_pred             CCCcHHHHHh------hcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceecc
Q 037267            2 PNGSLEKWLY------SYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLG   75 (202)
Q Consensus         2 ~~gsL~~~l~------~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~   75 (202)
                      .+|+|.++++      ..+..+++..++.++.|++.||.|||    +.+|+||||||+||+++.++.+||+|||++....
T Consensus       187 ~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH----~~~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~  262 (413)
T 3dzo_A          187 MQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH----HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG  262 (413)
T ss_dssp             CSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH----HTTEECSCCCGGGEEECTTCCEEECCGGGCEETT
T ss_pred             hcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHH----hCCcccCCcccceEEEecCCeEEEEeccceeecC
Confidence            5688999985      22335788899999999999999999    8999999999999999999999999999987654


Q ss_pred             CCCccccccCCCCCccccCCCCC----------CCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCC
Q 037267           76 EGEDFVTQTMTMATIGYMAPEYG----------SEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLP  145 (202)
Q Consensus        76 ~~~~~~~~~~~~~~~~~~~pe~~----------~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~  145 (202)
                      ..     .....| +.|+|||.+          .+..++.++|+||+||++|++++|..||.........          
T Consensus       263 ~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~----------  326 (413)
T 3dzo_A          263 AS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGS----------  326 (413)
T ss_dssp             EE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCS----------
T ss_pred             Cc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhhH----------
Confidence            32     223456 899999987          5556888999999999999999999999764322210          


Q ss_pred             CChhhhhhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          146 HGLTEVVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                         .......           ..+++++.+++.+||..||++||++.++++
T Consensus       327 ---~~~~~~~-----------~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~  363 (413)
T 3dzo_A          327 ---EWIFRSC-----------KNIPQPVRALLEGFLRYPKEDRLLPLQAME  363 (413)
T ss_dssp             ---GGGGSSC-----------CCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             ---HHHHhhc-----------ccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence               0010000           123456899999999999999999887753

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=99.97  E-value=4.6e-32  Score=217.96  Aligned_cols=183  Identities=22%  Similarity=0.223  Sum_probs=127.0

Q ss_pred             CCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcccc
Q 037267            3 NGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVT   82 (202)
Q Consensus         3 ~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~   82 (202)
                      +|+|.+.+..   .+++..+..++.|++.||.|||    +.+|+||||||+||+++.++.+||+|||+++.......   
T Consensus       150 ~~~l~~~~~~---~l~~~~~~~~~~qil~aL~~lH----~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~---  219 (464)
T 3ttj_A          150 DANLCQVIQM---ELDHERMSYLLYQMLCGIKHLH----SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---  219 (464)
T ss_dssp             SEEHHHHHTS---CCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECTTSCEEECCCCCC-----CCC---
T ss_pred             CCCHHHHHhh---cCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCCCcc---
Confidence            3567777753   3899999999999999999999    89999999999999999999999999999987554321   


Q ss_pred             ccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHH-hCCC--Ch-------hhhh
Q 037267           83 QTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKE-SLPH--GL-------TEVV  152 (202)
Q Consensus        83 ~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~-~~~~--~~-------~~~~  152 (202)
                      .....+|+.|+|||++.+..++.++|+||+||++|+|++|..||.+...... +...+.. +.+.  .+       ...+
T Consensus       220 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~-~~~i~~~lg~p~~~~~~~~~~~~~~~~  298 (464)
T 3ttj_A          220 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ-WNKVIEQLGTPCPEFMKKLQPTVRNYV  298 (464)
T ss_dssp             C----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHHCSCCHHHHTTSCHHHHHHH
T ss_pred             cCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcCCCCHHHHHHcchhhhhHh
Confidence            2234689999999998888999999999999999999999999976432221 1111110 0000  00       0000


Q ss_pred             h----------hhhhhhH---HHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          153 D----------ANLVREE---QAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       153 ~----------~~~~~~~---~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                      .          +......   .........+.++.+|+.+||..||++|||++|+++
T Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  355 (464)
T 3ttj_A          299 ENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  355 (464)
T ss_dssp             TTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            0          0000000   000112334677999999999999999999999875

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=99.97  E-value=4.2e-32  Score=212.20  Aligned_cols=172  Identities=28%  Similarity=0.324  Sum_probs=133.2

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |+||+|.+++.... .+++..+..++.|++.||.|||    +.+++|+|+||.||+++.++.++++|||++........ 
T Consensus       182 ~~g~~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH----~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~~~~-  255 (365)
T 2y7j_A          182 MRKGELFDYLTEKV-ALSEKETRSIMRSLLEAVSFLH----ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK-  255 (365)
T ss_dssp             CTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCC-
T ss_pred             CCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEECCCCCEEEEecCcccccCCCcc-
Confidence            57899999998644 4899999999999999999999    89999999999999999999999999999987654332 


Q ss_pred             ccccCCCCCccccCCCCCC------CCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhh
Q 037267           81 VTQTMTMATIGYMAPEYGS------EGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDA  154 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~------~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (202)
                        .....+++.|+|||++.      ...++.++|+||+|+++|++++|..||.......  ....+.......       
T Consensus       256 --~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~--~~~~i~~~~~~~-------  324 (365)
T 2y7j_A          256 --LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQIL--MLRMIMEGQYQF-------  324 (365)
T ss_dssp             --BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHTCCCC-------
T ss_pred             --cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHH--HHHHHHhCCCCC-------
Confidence              22346899999999754      2357889999999999999999999996532111  111111111000       


Q ss_pred             hhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          155 NLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                             ..+....++.++.+++.+||..||++|||+.++++
T Consensus       325 -------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~  359 (365)
T 2y7j_A          325 -------SSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ  359 (365)
T ss_dssp             -------CHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             -------CCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence                   01111234566899999999999999999999986

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=99.97  E-value=2e-32  Score=207.20  Aligned_cols=170  Identities=25%  Similarity=0.310  Sum_probs=123.4

Q ss_pred             CCcHHHHHhh---cCCCCCHHHHHHHHHHHHHhhhcccCCCCCC-CeeecCCCCCceeeCCCCceEEcccccceeccCCC
Q 037267            3 NGSLEKWLYS---YNYFFDILERLNIMIDVGSALEYPHHGHSSA-PIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGE   78 (202)
Q Consensus         3 ~gsL~~~l~~---~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~-~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~   78 (202)
                      +|+|.+++..   ....+++..+..++.|++.||.|||    +. +++||||||+||+++.++.++|+|||++.......
T Consensus        89 ~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  164 (290)
T 3fme_A           89 DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH----SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDV  164 (290)
T ss_dssp             SEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH----HHSCCCCCCCSGGGCEECTTCCEEBCCC----------
T ss_pred             ccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh----hcCCeecCCCCHHHEEECCCCCEEEeecCCcccccccc
Confidence            4688888764   3456999999999999999999999    77 99999999999999999999999999997654432


Q ss_pred             ccccccCCCCCccccCCCCC----CCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhh
Q 037267           79 DFVTQTMTMATIGYMAPEYG----SEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDA  154 (202)
Q Consensus        79 ~~~~~~~~~~~~~~~~pe~~----~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (202)
                      .   .....+++.|+|||.+    .+..++.++|+||+|+++|++++|..||..................+...      
T Consensus       165 ~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~------  235 (290)
T 3fme_A          165 A---KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLP------  235 (290)
T ss_dssp             --------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCC------
T ss_pred             c---ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcc------
Confidence            2   2223588999999984    55678889999999999999999999997644333333322222111110      


Q ss_pred             hhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          155 NLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                                 ...++.++.+++.+||+.||++|||+.|+++
T Consensus       236 -----------~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          236 -----------ADKFSAEFVDFTSQCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             -----------TTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             -----------cccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence                       1124556899999999999999999999976

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=6.9e-32  Score=211.13  Aligned_cols=182  Identities=20%  Similarity=0.231  Sum_probs=132.5

Q ss_pred             CCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcccc
Q 037267            3 NGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVT   82 (202)
Q Consensus         3 ~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~   82 (202)
                      +++|.+++...  .+++..+..++.|++.||.|||    +.+|+||||||+||+++.++.+||+|||+++.....     
T Consensus       113 ~~~L~~~~~~~--~l~~~~~~~~~~qi~~~L~~LH----~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~-----  181 (367)
T 1cm8_A          113 GTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIH----AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE-----  181 (367)
T ss_dssp             SEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSS-----
T ss_pred             CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH----HCCccccCcCHHHEEEcCCCCEEEEeeecccccccc-----
Confidence            78999999863  4899999999999999999999    899999999999999999999999999999875432     


Q ss_pred             ccCCCCCccccCCCCCCC-CCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHH-HhCCCC-hhhhhhhhhhh-
Q 037267           83 QTMTMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVK-ESLPHG-LTEVVDANLVR-  158 (202)
Q Consensus        83 ~~~~~~~~~~~~pe~~~~-~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~-~~~~~~~~~~~-  158 (202)
                      .....+++.|+|||.+.+ ..++.++|+||+||++|++++|..||........ +..... .+.+.. ....+...... 
T Consensus       182 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-l~~i~~~~g~~~~~~~~~~~~~~~~~  260 (367)
T 1cm8_A          182 MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ-LKEIMKVTGTPPAEFVQRLQSDEAKN  260 (367)
T ss_dssp             CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHHCCCCHHHHHTCSCHHHHH
T ss_pred             cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcCCCCHHHHHHhhhHHHHH
Confidence            123467999999997665 5788999999999999999999999976432221 111111 111100 00000000000 


Q ss_pred             ---------hHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          159 ---------EEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       159 ---------~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                               ...........++++.+|+.+||..||++|||+.|+++
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~  307 (367)
T 1cm8_A          261 YMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA  307 (367)
T ss_dssp             HHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence                     00000011234667899999999999999999999986

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=99.97  E-value=4.6e-32  Score=211.84  Aligned_cols=188  Identities=21%  Similarity=0.203  Sum_probs=133.6

Q ss_pred             CCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCccc
Q 037267            2 PNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFV   81 (202)
Q Consensus         2 ~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~~   81 (202)
                      .+|+|.+++...  .+++..+..++.|++.||.|||    +.+|+||||||+||+++.++.++|+|||++..........
T Consensus       112 ~~~~L~~~l~~~--~~~~~~~~~i~~qi~~aL~~LH----~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~  185 (364)
T 3qyz_A          112 METDLYKLLKTQ--HLSNDHICYFLYQILRGLKYIH----SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT  185 (364)
T ss_dssp             CSEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBC
T ss_pred             cCcCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCChHhEEECCCCCEEEEeCcceEecCCCCCcc
Confidence            357999999764  3899999999999999999999    8999999999999999999999999999998765332211


Q ss_pred             -cccCCCCCccccCCCCCC-CCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhh---hhhh
Q 037267           82 -TQTMTMATIGYMAPEYGS-EGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVV---DANL  156 (202)
Q Consensus        82 -~~~~~~~~~~~~~pe~~~-~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~  156 (202)
                       ......+++.|+|||.+. +..++.++|+||+||++|++++|..||......... .......-.+......   ....
T Consensus       186 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~-~~i~~~~~~~~~~~~~~~~~~~~  264 (364)
T 3qyz_A          186 GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQL-NHILGILGSPSQEDLNCIINLKA  264 (364)
T ss_dssp             CTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHH-HHHHHHHCSCCHHHHHTCCCHHH
T ss_pred             ccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHH-HHHHHHhCCCCHHHHHHhhhhhH
Confidence             123346899999999644 445789999999999999999999999765433321 1111111000000000   0000


Q ss_pred             h---------hhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          157 V---------REEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       157 ~---------~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                      .         ...........++.++.+++.+||..||++|||+.|+++
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  313 (364)
T 3qyz_A          265 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  313 (364)
T ss_dssp             HHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            0         000001111235667899999999999999999999975

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=99.97  E-value=1.7e-32  Score=209.67  Aligned_cols=189  Identities=19%  Similarity=0.152  Sum_probs=129.8

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |++++|.+++.... .+++..+..++.|++.||.|||    +.+++||||||+||+++.++.++|+|||++.........
T Consensus        84 ~~~~~l~~~~~~~~-~~~~~~~~~i~~~l~~~l~~lH----~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  158 (311)
T 4agu_A           84 CDHTVLHELDRYQR-GVPEHLVKSITWQTLQAVNFCH----KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDY  158 (311)
T ss_dssp             CSEEHHHHHHHTSS-CCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred             CCCchHHHHHhhhc-CCCHHHHHHHHHHHHHHHHHHH----HCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccc
Confidence            56788988887544 4899999999999999999999    899999999999999999999999999999876533221


Q ss_pred             ccccCCCCCccccCCCCCCC-CCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHH-HHhCCCChhhhhhhhh--
Q 037267           81 VTQTMTMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWV-KESLPHGLTEVVDANL--  156 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~-~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~--  156 (202)
                        .....+++.|+|||.+.+ ..++.++|+||+|+++|++++|..||.............. .....+..........  
T Consensus       159 --~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (311)
T 4agu_A          159 --YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYF  236 (311)
T ss_dssp             ---------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGG
T ss_pred             --cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccc
Confidence              223467889999997765 5678899999999999999999999976543322111000 0000000000000000  


Q ss_pred             -----h---hhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          157 -----V---REEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       157 -----~---~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                           .   ...........++.++.+++.+||..||++|||+.|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  284 (311)
T 4agu_A          237 SGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH  284 (311)
T ss_dssp             TTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred             ccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence                 0   000001111245667899999999999999999999974

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=99.97  E-value=1.4e-32  Score=217.64  Aligned_cols=173  Identities=22%  Similarity=0.244  Sum_probs=133.2

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |+||+|.+++...  .+++..+..++.|++.||.|||    +.+|+||||||+||+++.++.+||+|||++.........
T Consensus       151 ~~gg~L~~~l~~~--~~~e~~~~~~~~qi~~aL~~LH----~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~  224 (410)
T 3v8s_A          151 MPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIH----SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV  224 (410)
T ss_dssp             CTTEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSEE
T ss_pred             CCCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH----HCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCCcc
Confidence            5799999999764  3899999999999999999999    899999999999999999999999999999876543321


Q ss_pred             ccccCCCCCccccCCCCCCCCC----cCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhh
Q 037267           81 VTQTMTMATIGYMAPEYGSEGI----VSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANL  156 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~----~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (202)
                       ......||+.|+|||++.+..    ++.++|+||+||++|+|++|..||........ .. .+.           ....
T Consensus       225 -~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~-~~-~i~-----------~~~~  290 (410)
T 3v8s_A          225 -RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT-YS-KIM-----------NHKN  290 (410)
T ss_dssp             -ECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HH-HHH-----------THHH
T ss_pred             -cccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhH-HH-HHH-----------hccc
Confidence             223457999999999776544    78899999999999999999999975432111 11 110           0000


Q ss_pred             hhhHHHHHHhHHHHHHHHHHHhhhcCCCCCC--CCCHHHHHH
Q 037267          157 VREEQAFAAKMDCIVSIMDLALDCCMESPGK--RINMTDAAA  196 (202)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~--Rps~~~~~~  196 (202)
                         ....+....++.++.+|+.+||..+|.+  ||++.|+++
T Consensus       291 ---~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~  329 (410)
T 3v8s_A          291 ---SLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKR  329 (410)
T ss_dssp             ---HCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred             ---cccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence               0000111235567899999999999988  999999874

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=99.97  E-value=1.2e-31  Score=208.45  Aligned_cols=190  Identities=21%  Similarity=0.212  Sum_probs=134.9

Q ss_pred             CCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc--
Q 037267            3 NGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF--   80 (202)
Q Consensus         3 ~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~--   80 (202)
                      .|+|.+.+......+++..+..++.|++.||.|||    +.+|+||||||+||+++.++.++|+|||++.........  
T Consensus       107 ~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH----~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~  182 (351)
T 3mi9_A          107 EHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH----RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQP  182 (351)
T ss_dssp             SEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCCCSSSSC
T ss_pred             CCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH----HCCeeCCCCCHHHEEEcCCCCEEEccchhcccccccccccc
Confidence            46888888876666999999999999999999999    899999999999999999999999999999876532211  


Q ss_pred             ccccCCCCCccccCCCCCCC-CCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHH-HHHhCCCCh-hhhhhhhhh
Q 037267           81 VTQTMTMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRW-VKESLPHGL-TEVVDANLV  157 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~-~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~-~~~~~~~~~  157 (202)
                      .......+++.|+|||.+.+ ..++.++|+||+||++|++++|..||............. .....+... .........
T Consensus       183 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  262 (351)
T 3mi9_A          183 NRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELY  262 (351)
T ss_dssp             CCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCGGG
T ss_pred             cccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccccccchhh
Confidence            11233467999999997765 457899999999999999999999998654322111111 111111111 110000000


Q ss_pred             ----------hhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          158 ----------REEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       158 ----------~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                                ............++++.+|+.+||..||++|||++|+++
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  311 (351)
T 3mi9_A          263 EKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  311 (351)
T ss_dssp             TSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence                      000001111223566899999999999999999999875

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=99.97  E-value=4.3e-32  Score=212.26  Aligned_cols=185  Identities=19%  Similarity=0.213  Sum_probs=131.0

Q ss_pred             CCcHHHHHhhcC-CCCCHHHHHHHHHHHHHhhhcccCCCCCC-CeeecCCCCCceeeC------CCCceEEcccccceec
Q 037267            3 NGSLEKWLYSYN-YFFDILERLNIMIDVGSALEYPHHGHSSA-PIIHCDLKPTNILLD------ENMVAHVSDFGISKLL   74 (202)
Q Consensus         3 ~gsL~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~~~~-~i~h~dlk~~nil~~------~~~~~~l~d~g~~~~~   74 (202)
                      +++|.+++.... ..+++..+..++.|++.||.|||    +. +|+||||||+||+++      ..+.++|+|||++...
T Consensus       113 ~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH----~~~~ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~  188 (373)
T 1q8y_A          113 GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMH----RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWY  188 (373)
T ss_dssp             CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH----HTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEET
T ss_pred             CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHH----hcCCEEecCCChHHeEEeccCCCcCcceEEEccccccccc
Confidence            789999998643 35899999999999999999999    77 999999999999994      4457999999999876


Q ss_pred             cCCCccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccch-----hhHHHHHHh--CCCC
Q 037267           75 GEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEM-----SLRRWVKES--LPHG  147 (202)
Q Consensus        75 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~-----~~~~~~~~~--~~~~  147 (202)
                      ....     ....+++.|+|||.+.+..++.++|+||+|+++|++++|..||........     .+.......  .+..
T Consensus       189 ~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~  263 (373)
T 1q8y_A          189 DEHY-----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSY  263 (373)
T ss_dssp             TBCC-----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHH
T ss_pred             CCCC-----CCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHhcCCCCHH
Confidence            4322     224689999999998888899999999999999999999999986432211     111111100  0000


Q ss_pred             hhh-----------------hhhhhh----hhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          148 LTE-----------------VVDANL----VREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       148 ~~~-----------------~~~~~~----~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                      ...                 ......    .........+..++.++.+|+.+||..||++|||+.|+++
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  333 (373)
T 1q8y_A          264 LLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVN  333 (373)
T ss_dssp             HHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHT
T ss_pred             HHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhh
Confidence            000                 000000    0000001123567788999999999999999999999985

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=99.97  E-value=4.3e-32  Score=213.39  Aligned_cols=186  Identities=22%  Similarity=0.175  Sum_probs=133.8

Q ss_pred             CCcHHHHHhh---cCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeC-CCCceEEcccccceeccCCC
Q 037267            3 NGSLEKWLYS---YNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLD-ENMVAHVSDFGISKLLGEGE   78 (202)
Q Consensus         3 ~gsL~~~l~~---~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~-~~~~~~l~d~g~~~~~~~~~   78 (202)
                      .|+|.+.+..   .+..+++..+..++.|++.||.|||    +.+|+||||||+||+++ .++.+||+|||++.......
T Consensus       121 ~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH----~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~  196 (383)
T 3eb0_A          121 PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH----SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE  196 (383)
T ss_dssp             SEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH----TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS
T ss_pred             CccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC
Confidence            3677777763   3456999999999999999999999    89999999999999997 68899999999998765433


Q ss_pred             ccccccCCCCCccccCCCCCCCC-CcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhh----
Q 037267           79 DFVTQTMTMATIGYMAPEYGSEG-IVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVD----  153 (202)
Q Consensus        79 ~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~----  153 (202)
                      .   .....+++.|+|||.+.+. .++.++|+||+||++|++++|..||......+. +...+...-.+.......    
T Consensus       197 ~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~~~i~~~~g~p~~~~~~~~~~~  272 (383)
T 3eb0_A          197 P---SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQ-LVRIIQIMGTPTKEQMIRMNPH  272 (383)
T ss_dssp             C---CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHHCCCCHHHHHHHCTT
T ss_pred             C---CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCCHHHHHHhCcc
Confidence            2   2234678899999977664 489999999999999999999999976443322 111111111111111000    


Q ss_pred             ------hhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          154 ------ANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       154 ------~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                            +......+....+..++.++.+|+.+||..||++|||+.|+++
T Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  321 (383)
T 3eb0_A          273 YTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMA  321 (383)
T ss_dssp             C--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             cccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence                  0000111111223346677999999999999999999999974

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=99.97  E-value=4.1e-32  Score=204.97  Aligned_cols=172  Identities=20%  Similarity=0.237  Sum_probs=131.8

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCC----ceEEcccccceeccC
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENM----VAHVSDFGISKLLGE   76 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~----~~~l~d~g~~~~~~~   76 (202)
                      |++++|.+++.... .+++..+..++.|++.||.|||    +.+++|+||||+||+++.++    .++++|||.+.....
T Consensus        90 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~  164 (283)
T 3bhy_A           90 VSGGELFDFLAEKE-SLTEDEATQFLKQILDGVHYLH----SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA  164 (283)
T ss_dssp             CCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC-
T ss_pred             cCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----hCCccCCCCChHHEEEecCCCCCCceEEEecccceeccC
Confidence            46899999997644 4899999999999999999999    89999999999999998776    799999999987654


Q ss_pred             CCccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhh
Q 037267           77 GEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANL  156 (202)
Q Consensus        77 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (202)
                      ...   .....+++.|+|||.+.+..++.++|+||+|+++|++++|..||.......  ....+......          
T Consensus       165 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~~~----------  229 (283)
T 3bhy_A          165 GNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQE--TLTNISAVNYD----------  229 (283)
T ss_dssp             ----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH--HHHHHHTTCCC----------
T ss_pred             CCc---ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHH--HHHHhHhcccC----------
Confidence            322   122357899999999888888999999999999999999999997643211  11111100000          


Q ss_pred             hhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          157 VREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                          .........+..+.+++.+||..||++|||+.++++
T Consensus       230 ----~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  265 (283)
T 3bhy_A          230 ----FDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE  265 (283)
T ss_dssp             ----CCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ----CcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence                001112235566899999999999999999999986

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=99.97  E-value=8.5e-32  Score=209.01  Aligned_cols=185  Identities=23%  Similarity=0.264  Sum_probs=132.9

Q ss_pred             CCcHHHHHhhcC-CCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceee-------------------CCCCc
Q 037267            3 NGSLEKWLYSYN-YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILL-------------------DENMV   62 (202)
Q Consensus         3 ~gsL~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~-------------------~~~~~   62 (202)
                      +|+|.+++.... ..+++..+..++.|++.||.|||    +.+|+||||||+||++                   +.++.
T Consensus       105 ~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH----~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~  180 (355)
T 2eu9_A          105 GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLH----ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTS  180 (355)
T ss_dssp             CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH----TTTEECCCCCGGGEEESCCCEEEEECCC-CCCEEEESCCC
T ss_pred             CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEEEecccccccccccccccccccCCCc
Confidence            678888887544 46999999999999999999999    8999999999999999                   56788


Q ss_pred             eEEcccccceeccCCCccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhH-HHHH
Q 037267           63 AHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLR-RWVK  141 (202)
Q Consensus        63 ~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~-~~~~  141 (202)
                      ++|+|||++.......     ....+++.|+|||.+.+..++.++|+||+|+++|++++|..||........... ....
T Consensus       181 ~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~  255 (355)
T 2eu9_A          181 IRVADFGSATFDHEHH-----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKIL  255 (355)
T ss_dssp             EEECCCTTCEETTSCC-----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred             EEEeecCccccccccc-----cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHc
Confidence            9999999998744322     234689999999998888899999999999999999999999976543221111 0111


Q ss_pred             HhCCCChhhhhhh------------hhhhh-----------HHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          142 ESLPHGLTEVVDA------------NLVRE-----------EQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       142 ~~~~~~~~~~~~~------------~~~~~-----------~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                      ...+..+......            .....           ..........+.++.+|+.+||..||++|||+.|+++
T Consensus       256 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~  333 (355)
T 2eu9_A          256 GPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALL  333 (355)
T ss_dssp             CCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             CCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            1111110000000            00000           0000011234567999999999999999999999973

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=7.4e-32  Score=210.07  Aligned_cols=172  Identities=28%  Similarity=0.268  Sum_probs=131.4

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |++|+|.+++.... .+++..+..++.|++.||.|||    +.+|+||||||+||+++.++.+||+|||++.........
T Consensus       141 ~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH----~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~  215 (355)
T 1vzo_A          141 INGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLH----KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE  215 (355)
T ss_dssp             CCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGGG
T ss_pred             CCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEEECCCCcEEEeeCCCCeecccCCCC
Confidence            57899999998654 4899999999999999999999    899999999999999999999999999999875433221


Q ss_pred             ccccCCCCCccccCCCCCCC--CCcCcchhhhhHHHHHHHHHhCCCCCCcccccchh--hHHHHHHhCCCChhhhhhhhh
Q 037267           81 VTQTMTMATIGYMAPEYGSE--GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMS--LRRWVKESLPHGLTEVVDANL  156 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~--~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~  156 (202)
                       ......+++.|+|||.+.+  ..++.++|+||+||++|++++|..||.........  +...+....+           
T Consensus       216 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~-----------  283 (355)
T 1vzo_A          216 -RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP-----------  283 (355)
T ss_dssp             -GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCC-----------
T ss_pred             -cccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCC-----------
Confidence             1223468999999998765  34678999999999999999999999754322211  1111111100           


Q ss_pred             hhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHH
Q 037267          157 VREEQAFAAKMDCIVSIMDLALDCCMESPGKRI-----NMTDAAA  196 (202)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rp-----s~~~~~~  196 (202)
                             ..+..++..+.+++.+||..||++||     ++.++++
T Consensus       284 -------~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~  321 (355)
T 1vzo_A          284 -------PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  321 (355)
T ss_dssp             -------CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             -------CCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHc
Confidence                   01123455688999999999999999     8888875

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=99.97  E-value=6e-33  Score=216.44  Aligned_cols=186  Identities=24%  Similarity=0.286  Sum_probs=133.0

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCC-CeeecCCCCCceeeCCCCceEEcccccceeccCCCc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSA-PIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED   79 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~-~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~   79 (202)
                      |++|+|.+++.... .+++..+..++.|++.||.|||    +. +|+||||||+||+++.++.++|+|||++....... 
T Consensus       113 ~~~~~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lh----~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-  186 (360)
T 3eqc_A          113 MDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLR----EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-  186 (360)
T ss_dssp             CTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----HHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHC-
T ss_pred             CCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HhCCEEcCCccHHHEEECCCCCEEEEECCCCccccccc-
Confidence            57899999998654 4899999999999999999999    65 89999999999999999999999999986543221 


Q ss_pred             cccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHH-HHHhC--------------
Q 037267           80 FVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRW-VKESL--------------  144 (202)
Q Consensus        80 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~-~~~~~--------------  144 (202)
                         .....+++.|+|||.+.+..++.++|+||+|+++|++++|..||............. .....              
T Consensus       187 ---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (360)
T 3eqc_A          187 ---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP  263 (360)
T ss_dssp             -------CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC--------------------
T ss_pred             ---ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCc
Confidence               123468899999999888889999999999999999999999997644322111000 00000              


Q ss_pred             ----------CCChhhhhhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          145 ----------PHGLTEVVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       145 ----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                                +.......+....... .......++.++.+++.+||..||++|||+.|+++
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  324 (360)
T 3eqc_A          264 LNKFGMDSRPPMAIFELLDYIVNEPP-PKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  324 (360)
T ss_dssp             ----------CCCHHHHHHHHHHSCC-CCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             ccccccCCCCcccchhhhhHHhccCC-CCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence                      0000000000000000 00011224667999999999999999999999875

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=99.97  E-value=2.7e-32  Score=206.17  Aligned_cols=167  Identities=25%  Similarity=0.270  Sum_probs=133.3

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |++|+|.+++.... .+++..+..++.|++.||.|||    +.+++|+||||+||+++.++.++++|||++.......  
T Consensus        96 ~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~--  168 (284)
T 2vgo_A           96 APRGELYKELQKHG-RFDEQRSATFMEELADALHYCH----ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR--  168 (284)
T ss_dssp             CTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----TTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC--
T ss_pred             CCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCceecCCCHHHEEEcCCCCEEEecccccccCcccc--
Confidence            46899999998654 4899999999999999999999    8999999999999999999999999999987654322  


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhH
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREE  160 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (202)
                        .....+++.|+|||.+.+..++.++|+||+|+++|++++|..||........  ...+.....               
T Consensus       169 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~~~~~---------------  229 (284)
T 2vgo_A          169 --RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTET--HRRIVNVDL---------------  229 (284)
T ss_dssp             --BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH--HHHHHTTCC---------------
T ss_pred             --cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHH--HHHHhcccc---------------
Confidence              2234688999999998888889999999999999999999999975432211  111110000               


Q ss_pred             HHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          161 QAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       161 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                         ..+...+.++.+++.+||..||++|||+.++++
T Consensus       230 ---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  262 (284)
T 2vgo_A          230 ---KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVME  262 (284)
T ss_dssp             ---CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ---CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence               001124456889999999999999999999975

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=99.97  E-value=3.8e-32  Score=216.80  Aligned_cols=121  Identities=25%  Similarity=0.351  Sum_probs=98.1

Q ss_pred             CCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc-
Q 037267            2 PNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF-   80 (202)
Q Consensus         2 ~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~-   80 (202)
                      .+|+|.++++.. ..+++..+..++.||+.||.|||    +.+|+||||||+||+++.++.+||+|||+++........ 
T Consensus       112 ~~~~L~~~~~~~-~~l~~~~~~~i~~qil~aL~~LH----~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  186 (432)
T 3n9x_A          112 ADSDLKKLFKTP-IFLTEEHIKTILYNLLLGENFIH----ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTN  186 (432)
T ss_dssp             CSEEHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEECTTCCEEECCCTTCEEC-------
T ss_pred             CCcCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH----HCCCCCCCCCHHHeEECCCCCEEEccCCCccccccccccc
Confidence            457999999764 45899999999999999999999    899999999999999999999999999999876433211 


Q ss_pred             -------------------ccccCCCCCccccCCCCC-CCCCcCcchhhhhHHHHHHHHHhCCCCCC
Q 037267           81 -------------------VTQTMTMATIGYMAPEYG-SEGIVSAKCDVYSYGVLLMETFTRKRPTD  127 (202)
Q Consensus        81 -------------------~~~~~~~~~~~~~~pe~~-~~~~~~~~~di~s~G~~~~~~~~g~~p~~  127 (202)
                                         .......+|+.|+|||.+ .+..++.++|+||+||++|+|++|..||.
T Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~  253 (432)
T 3n9x_A          187 IVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI  253 (432)
T ss_dssp             ------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred             ccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence                               012345689999999974 56678999999999999999998665554

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=99.97  E-value=4.3e-32  Score=209.93  Aligned_cols=174  Identities=24%  Similarity=0.288  Sum_probs=114.3

Q ss_pred             CCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCC---CCceEEcccccceeccC
Q 037267            1 MPNGSLEKWLYSYN-YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDE---NMVAHVSDFGISKLLGE   76 (202)
Q Consensus         1 ~~~gsL~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~---~~~~~l~d~g~~~~~~~   76 (202)
                      |+||+|.+++.... ..+++..+..++.|++.||.|||    +.+++||||||+||+++.   ++.++|+|||++.....
T Consensus       108 ~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH----~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~  183 (336)
T 3fhr_A          108 MEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH----SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ  183 (336)
T ss_dssp             CTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC--
T ss_pred             cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEEEecCCCceEEEeccccceeccc
Confidence            57899999998654 36999999999999999999999    899999999999999985   45599999999986543


Q ss_pred             CCccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhH--HHHHHhCCCChhhhhhh
Q 037267           77 GEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLR--RWVKESLPHGLTEVVDA  154 (202)
Q Consensus        77 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~  154 (202)
                      ..    .....+++.|+|||.+.+..++.++|+||+|+++|++++|..||...........  ..+....    ...   
T Consensus       184 ~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~----~~~---  252 (336)
T 3fhr_A          184 NA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQ----YGF---  252 (336)
T ss_dssp             ------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------------CC---
T ss_pred             cc----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccc----ccc---
Confidence            22    1224578999999999888899999999999999999999999976443221100  0000000    000   


Q ss_pred             hhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          155 NLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                             ..+....++.++.+++.+||..||++|||+.|+++
T Consensus       253 -------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  287 (336)
T 3fhr_A          253 -------PNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN  287 (336)
T ss_dssp             -------CTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             -------CchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence                   00011235667899999999999999999999986

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=99.97  E-value=6.6e-33  Score=213.69  Aligned_cols=173  Identities=20%  Similarity=0.226  Sum_probs=131.4

Q ss_pred             CCCCcHHHHHhhc-CCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCC---CCceEEcccccceeccC
Q 037267            1 MPNGSLEKWLYSY-NYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDE---NMVAHVSDFGISKLLGE   76 (202)
Q Consensus         1 ~~~gsL~~~l~~~-~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~---~~~~~l~d~g~~~~~~~   76 (202)
                      |++|+|.+++... ...+++..+..++.|++.||.|||    +.+|+||||||+||+++.   ++.++|+|||++.....
T Consensus       111 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH----~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~  186 (327)
T 3lm5_A          111 AAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH----QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGH  186 (327)
T ss_dssp             CTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC--
T ss_pred             cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH----HCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCC
Confidence            5789999998643 346899999999999999999999    899999999999999987   78999999999987654


Q ss_pred             CCccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhh
Q 037267           77 GEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANL  156 (202)
Q Consensus        77 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (202)
                      ...   .....+++.|+|||.+.+..++.++|+||+|+++|++++|..||..........  .+........        
T Consensus       187 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~--~i~~~~~~~~--------  253 (327)
T 3lm5_A          187 ACE---LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYL--NISQVNVDYS--------  253 (327)
T ss_dssp             ----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH--HHHHTCCCCC--------
T ss_pred             ccc---cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHH--HHHhcccccC--------
Confidence            322   122468999999999888889999999999999999999999997643322111  1111100000        


Q ss_pred             hhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          157 VREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                            ......++..+.+++.+||..||++|||+.++++
T Consensus       254 ------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~  287 (327)
T 3lm5_A          254 ------EETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS  287 (327)
T ss_dssp             ------TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             ------chhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence                  0011234566899999999999999999999875

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=99.97  E-value=4.5e-32  Score=219.30  Aligned_cols=171  Identities=25%  Similarity=0.286  Sum_probs=131.3

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeC---CCCceEEcccccceeccCC
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLD---ENMVAHVSDFGISKLLGEG   77 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~---~~~~~~l~d~g~~~~~~~~   77 (202)
                      |++|+|.+++.... .+++..+..++.|++.||.|||    +.+|+||||||+||+++   .++.+||+|||++......
T Consensus       103 ~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~al~~lH----~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~  177 (486)
T 3mwu_A          103 YTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMH----KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN  177 (486)
T ss_dssp             CCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC
T ss_pred             CCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC
Confidence            57999999997654 4899999999999999999999    89999999999999995   4567999999999765433


Q ss_pred             CccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhh
Q 037267           78 EDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV  157 (202)
Q Consensus        78 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (202)
                      ..   .....+++.|+|||.+.+ .++.++|+||+||++|++++|..||.......  ....+........         
T Consensus       178 ~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--~~~~i~~~~~~~~---------  242 (486)
T 3mwu_A          178 TK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD--ILKRVETGKYAFD---------  242 (486)
T ss_dssp             -------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHTCCCSC---------
T ss_pred             Cc---cCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhCCCCCC---------
Confidence            22   223468999999998766 58899999999999999999999997643221  1111111110000         


Q ss_pred             hhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          158 REEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                           .+....++.++.+++.+||..||++|||+.++++
T Consensus       243 -----~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~  276 (486)
T 3mwu_A          243 -----LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (486)
T ss_dssp             -----SGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             -----CcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence                 0111235567899999999999999999999986

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=99.97  E-value=2e-31  Score=203.32  Aligned_cols=171  Identities=26%  Similarity=0.310  Sum_probs=133.1

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceee---CCCCceEEcccccceeccCC
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILL---DENMVAHVSDFGISKLLGEG   77 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~---~~~~~~~l~d~g~~~~~~~~   77 (202)
                      |++|+|.+++.... .+++..+..++.|++.||.|||    +.+++|+||||+||++   +.++.++++|||++......
T Consensus        88 ~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~  162 (304)
T 2jam_A           88 VSGGELFDRILERG-VYTEKDASLVIQQVLSAVKYLH----ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG  162 (304)
T ss_dssp             CCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH----HTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB
T ss_pred             CCCccHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC
Confidence            57899999997654 4899999999999999999999    8999999999999999   67889999999998754332


Q ss_pred             CccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhh
Q 037267           78 EDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV  157 (202)
Q Consensus        78 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (202)
                      .    .....+++.|+|||.+.+..++.++|+||+|+++|++++|..||.......  ....+.........        
T Consensus       163 ~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~i~~~~~~~~~--------  228 (304)
T 2jam_A          163 I----MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESK--LFEKIKEGYYEFES--------  228 (304)
T ss_dssp             T----THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHHHHHHCCCCCCT--------
T ss_pred             c----cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHcCCCCCCc--------
Confidence            1    112347889999999988889999999999999999999999997643221  11111111100000        


Q ss_pred             hhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          158 REEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                            +....++.++.+++.+||..||++|||+.++++
T Consensus       229 ------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (304)
T 2jam_A          229 ------PFWDDISESAKDFICHLLEKDPNERYTCEKALS  261 (304)
T ss_dssp             ------TTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             ------cccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence                  001234566899999999999999999999975

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=99.97  E-value=1.2e-31  Score=219.18  Aligned_cols=171  Identities=26%  Similarity=0.347  Sum_probs=135.7

Q ss_pred             CCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCc
Q 037267            1 MPNGSLEKWLYSYN-YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED   79 (202)
Q Consensus         1 ~~~gsL~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~   79 (202)
                      |+||+|.+++.... ..+++..+..++.||+.||.|||    +.+|+||||||+||+++.++.+||+|||++........
T Consensus       266 ~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH----~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~~  341 (576)
T 2acx_A          266 MNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH----RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT  341 (576)
T ss_dssp             CCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCC
T ss_pred             CCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH----HCCEeccCCchheEEEeCCCCeEEEecccceecccCcc
Confidence            57999999998654 34899999999999999999999    89999999999999999999999999999987654332


Q ss_pred             cccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccch--hhHHHHHHhCCCChhhhhhhhhh
Q 037267           80 FVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEM--SLRRWVKESLPHGLTEVVDANLV  157 (202)
Q Consensus        80 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  157 (202)
                         .....||+.|+|||++.+..++.++|+||+||++|+|++|..||........  .+...+... +..          
T Consensus       342 ---~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~-~~~----------  407 (576)
T 2acx_A          342 ---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV-PEE----------  407 (576)
T ss_dssp             ---EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHC-CCC----------
T ss_pred             ---ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcc-ccc----------
Confidence               1234689999999998888899999999999999999999999976433211  111111111 000          


Q ss_pred             hhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHH
Q 037267          158 REEQAFAAKMDCIVSIMDLALDCCMESPGKRI-----NMTDAAA  196 (202)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rp-----s~~~~~~  196 (202)
                             .+..++.++.+|+.+||..||++||     ++.|+++
T Consensus       408 -------~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~  444 (576)
T 2acx_A          408 -------YSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE  444 (576)
T ss_dssp             -------CCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred             -------CCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence                   0123456689999999999999999     6777763

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=3.2e-32  Score=211.35  Aligned_cols=187  Identities=25%  Similarity=0.274  Sum_probs=134.7

Q ss_pred             CCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcccc
Q 037267            3 NGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVT   82 (202)
Q Consensus         3 ~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~   82 (202)
                      .|+|.+++......+++..+..++.|++.||.|||    +.+|+||||||+||+++.++.+||+|||++........  .
T Consensus        95 ~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~--~  168 (346)
T 1ua2_A           95 ETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH----QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR--A  168 (346)
T ss_dssp             SEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC--C
T ss_pred             CCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHH----HCCEECCCCCHHHEEEcCCCCEEEEecccceeccCCcc--c
Confidence            46899999876667899999999999999999999    89999999999999999999999999999986543322  1


Q ss_pred             ccCCCCCccccCCCCCCCC-CcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHH-hCCC--Chhhhh---hh-
Q 037267           83 QTMTMATIGYMAPEYGSEG-IVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKE-SLPH--GLTEVV---DA-  154 (202)
Q Consensus        83 ~~~~~~~~~~~~pe~~~~~-~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~-~~~~--~~~~~~---~~-  154 (202)
                      .....+++.|+|||.+.+. .++.++|+||+||++|++++|..||........ +...... ..+.  .+....   +. 
T Consensus       169 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~~  247 (346)
T 1ua2_A          169 YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ-LTRIFETLGTPTEEQWPDMCSLPDYV  247 (346)
T ss_dssp             CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHHCCCCTTTSSSTTSSTTCC
T ss_pred             CCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH-HHHHHHHcCCCChhhhhhhccCcccc
Confidence            2234679999999987654 478899999999999999999999876433221 1111111 1110  000000   00 


Q ss_pred             --hhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          155 --NLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       155 --~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                        ..............++.++.+++.+||..||++|||+.|+++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  291 (346)
T 1ua2_A          248 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  291 (346)
T ss_dssp             CCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             cccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc
Confidence              000000001112345567999999999999999999999975

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=99.97  E-value=2.2e-32  Score=212.17  Aligned_cols=186  Identities=24%  Similarity=0.292  Sum_probs=134.3

Q ss_pred             CCCCcHHHH------Hhhc-CCCCCHHHHHHHHHHHHHhhhcccCCCCC-CCeeecCCCCCceeeCCCCceEEcccccce
Q 037267            1 MPNGSLEKW------LYSY-NYFFDILERLNIMIDVGSALEYPHHGHSS-APIIHCDLKPTNILLDENMVAHVSDFGISK   72 (202)
Q Consensus         1 ~~~gsL~~~------l~~~-~~~l~~~~~~~~~~~l~~~l~~lH~~~~~-~~i~h~dlk~~nil~~~~~~~~l~d~g~~~   72 (202)
                      |++|||.++      +... ...+++..+..++.|++.||.|||    + .+++|+||||+||+++.++.++|+|||.+.
T Consensus       125 ~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~  200 (348)
T 2pml_X          125 MENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIH----NEKNICHRDVKPSNILMDKNGRVKLSDFGESE  200 (348)
T ss_dssp             CTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHH----HTSCEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             cCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHh----ccCCEeecCCChHhEEEcCCCcEEEecccccc
Confidence            568899998      6542 446999999999999999999999    7 999999999999999999999999999998


Q ss_pred             eccCCCccccccCCCCCccccCCCCCCCC-CcCc-chhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhC--CCCh
Q 037267           73 LLGEGEDFVTQTMTMATIGYMAPEYGSEG-IVSA-KCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESL--PHGL  148 (202)
Q Consensus        73 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~-~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~  148 (202)
                      .....    ......++..|+|||...+. .++. ++|+||+|+++|++++|..||..................  +...
T Consensus       201 ~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~  276 (348)
T 2pml_X          201 YMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDR  276 (348)
T ss_dssp             ECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHHHTSCCCCCCCSS
T ss_pred             ccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCcCCccch
Confidence            76443    12334688999999988776 5655 899999999999999999999765432221111111100  0000


Q ss_pred             hhhhhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          149 TEVVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                      .......  ...........++.++.+++.+||..||++|||+.|+++
T Consensus       277 ~~~~~~~--~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~  322 (348)
T 2pml_X          277 NHFLYPL--TNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK  322 (348)
T ss_dssp             SSSTTTT--CC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             hhhhccc--cccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            0000000  000001112345677899999999999999999999986

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=99.97  E-value=2.6e-32  Score=210.56  Aligned_cols=187  Identities=20%  Similarity=0.220  Sum_probs=128.3

Q ss_pred             CCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeC-----CCCceEEcccccceeccCC
Q 037267            3 NGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLD-----ENMVAHVSDFGISKLLGEG   77 (202)
Q Consensus         3 ~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~-----~~~~~~l~d~g~~~~~~~~   77 (202)
                      .|+|.+++..... +++..+..++.|++.||.|||    +.+|+||||||+||+++     ..+.+||+|||++......
T Consensus       116 ~~~L~~~~~~~~~-~~~~~~~~i~~ql~~~l~~LH----~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~  190 (329)
T 3gbz_A          116 ENDLKKYMDKNPD-VSMRVIKSFLYQLINGVNFCH----SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIP  190 (329)
T ss_dssp             SEEHHHHHHHCTT-CCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC--
T ss_pred             CCCHHHHHhhcCC-CCHHHHHHHHHHHHHHHHHHH----hCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCCc
Confidence            4699999987554 899999999999999999999    89999999999999994     4556999999999765433


Q ss_pred             CccccccCCCCCccccCCCCCCCC-CcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCCh--hhhh--
Q 037267           78 EDFVTQTMTMATIGYMAPEYGSEG-IVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGL--TEVV--  152 (202)
Q Consensus        78 ~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~--  152 (202)
                      ...  .....+++.|+|||.+.+. .++.++|+||+||++|++++|..||..................+...  ....  
T Consensus       191 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  268 (329)
T 3gbz_A          191 IRQ--FTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTAL  268 (329)
T ss_dssp             -----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred             ccc--cCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhh
Confidence            221  2234578999999987664 47999999999999999999999997654332221111111111100  0000  


Q ss_pred             -h-----hhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          153 -D-----ANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       153 -~-----~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                       .     ...............++.++.+++.+||..||++|||+.|+++
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          269 PDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             TTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence             0     0000000111122335677899999999999999999999986

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=99.97  E-value=1.9e-31  Score=217.22  Aligned_cols=167  Identities=25%  Similarity=0.294  Sum_probs=132.3

Q ss_pred             CCCCcHHHHHhhcC---CCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCC
Q 037267            1 MPNGSLEKWLYSYN---YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEG   77 (202)
Q Consensus         1 ~~~gsL~~~l~~~~---~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~   77 (202)
                      |+||+|.+++....   ..+++..+..++.||+.||.|||    +.+|+||||||+||+++.++.+||+|||++......
T Consensus       267 ~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH----~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~  342 (543)
T 3c4z_A          267 MNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH----QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAG  342 (543)
T ss_dssp             CTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             ccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHH----HcCCcccCCChHHEEEeCCCCEEEeecceeeeccCC
Confidence            57999999998542   35999999999999999999999    899999999999999999999999999999876543


Q ss_pred             CccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccc--hhhHHHHHHhCCCChhhhhhhh
Q 037267           78 EDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGE--MSLRRWVKESLPHGLTEVVDAN  155 (202)
Q Consensus        78 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  155 (202)
                      ...  .....||+.|+|||++.+..++.++|+||+||++|+|++|..||.......  ..+...+.....          
T Consensus       343 ~~~--~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~----------  410 (543)
T 3c4z_A          343 QTK--TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAV----------  410 (543)
T ss_dssp             CCC--BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCC----------
T ss_pred             Ccc--cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhccc----------
Confidence            321  223468999999999888889999999999999999999999997643221  111111111100          


Q ss_pred             hhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCH
Q 037267          156 LVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINM  191 (202)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~  191 (202)
                              ..+..++.++.+++.+||..||++||++
T Consensus       411 --------~~p~~~s~~~~~li~~lL~~dP~~R~~~  438 (543)
T 3c4z_A          411 --------TYPDKFSPASKDFCEALLQKDPEKRLGF  438 (543)
T ss_dssp             --------CCCTTSCHHHHHHHHHHSCSSGGGSCCC
T ss_pred             --------CCCcccCHHHHHHHHHhccCCHhHCCCC
Confidence                    0112345668999999999999999975

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=99.97  E-value=6.1e-32  Score=204.50  Aligned_cols=171  Identities=26%  Similarity=0.297  Sum_probs=126.1

Q ss_pred             CCCCcHHHHHhhc---CCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceee---CCCCceEEcccccceec
Q 037267            1 MPNGSLEKWLYSY---NYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILL---DENMVAHVSDFGISKLL   74 (202)
Q Consensus         1 ~~~gsL~~~l~~~---~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~---~~~~~~~l~d~g~~~~~   74 (202)
                      |++|+|.+++...   ...+++..+..++.|++.||.|||    +.+|+||||||+||++   +.++.++|+|||++...
T Consensus       102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH----~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~  177 (285)
T 3is5_A          102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH----SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF  177 (285)
T ss_dssp             CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred             CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHH----hCCEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence            5789999999643   356999999999999999999999    8999999999999999   45678999999999765


Q ss_pred             cCCCccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhh
Q 037267           75 GEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDA  154 (202)
Q Consensus        75 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (202)
                      .....   .....+++.|+|||.+. ..++.++|+||+|+++|++++|..||........  ........+....     
T Consensus       178 ~~~~~---~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~--~~~~~~~~~~~~~-----  246 (285)
T 3is5_A          178 KSDEH---STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEV--QQKATYKEPNYAV-----  246 (285)
T ss_dssp             ------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHCCCCCCC-----
T ss_pred             CCccc---CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHH--HhhhccCCccccc-----
Confidence            43321   22345889999999865 4578899999999999999999999976432221  1111110000000     


Q ss_pred             hhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          155 NLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                                .....++++.+++.+||+.||++|||+.|+++
T Consensus       247 ----------~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          247 ----------ECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             ------------CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             ----------ccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                      00113456889999999999999999999985

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=99.97  E-value=2.3e-32  Score=211.85  Aligned_cols=160  Identities=25%  Similarity=0.250  Sum_probs=118.2

Q ss_pred             CCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCC--ceEEcccccceeccCCCc--cccccCCCCCccc
Q 037267           17 FDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENM--VAHVSDFGISKLLGEGED--FVTQTMTMATIGY   92 (202)
Q Consensus        17 l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~--~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~~   92 (202)
                      +++..+..++.|++.||.|||    +.+|+||||||+||+++.++  .+||+|||++........  ........+++.|
T Consensus       165 ~~~~~~~~i~~qi~~~l~~LH----~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y  240 (345)
T 3hko_A          165 QREKLISNIMRQIFSALHYLH----NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYF  240 (345)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGG
T ss_pred             ccHHHHHHHHHHHHHHHHHHH----HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccc
Confidence            467788999999999999999    89999999999999998766  899999999987543221  1112334689999


Q ss_pred             cCCCCCCC--CCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhHHHHHHhHHHH
Q 037267           93 MAPEYGSE--GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCI  170 (202)
Q Consensus        93 ~~pe~~~~--~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (202)
                      +|||.+.+  ..++.++|+||+|+++|++++|..||........ ............               .+....++
T Consensus       241 ~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~---------------~~~~~~~~  304 (345)
T 3hko_A          241 VAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADT-ISQVLNKKLCFE---------------NPNYNVLS  304 (345)
T ss_dssp             CCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHCCCCTT---------------SGGGGGSC
T ss_pred             cCchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHH-HHHHHhcccccC---------------CcccccCC
Confidence            99997654  5688899999999999999999999976543221 111111110000               00112345


Q ss_pred             HHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          171 VSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       171 ~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                      +++.+++.+||..||++|||+.++++
T Consensus       305 ~~~~~li~~~l~~~p~~Rps~~~~l~  330 (345)
T 3hko_A          305 PLARDLLSNLLNRNVDERFDAMRALQ  330 (345)
T ss_dssp             HHHHHHHHHHSCSCTTTSCCHHHHHH
T ss_pred             HHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            66899999999999999999999986

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=99.97  E-value=4.5e-32  Score=210.75  Aligned_cols=166  Identities=25%  Similarity=0.272  Sum_probs=130.6

Q ss_pred             CCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcccc
Q 037267            3 NGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVT   82 (202)
Q Consensus         3 ~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~   82 (202)
                      .|+|.+++......+++..+..++.|++.||.|||    +.+|+||||||+||+++.++.+||+|||++......     
T Consensus       137 ~g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH----~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~-----  207 (348)
T 1u5q_A          137 LGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH----SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-----  207 (348)
T ss_dssp             SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH----HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-----
T ss_pred             CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH----hCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC-----
Confidence            47899999766667999999999999999999999    899999999999999999999999999998765432     


Q ss_pred             ccCCCCCccccCCCCC---CCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhh
Q 037267           83 QTMTMATIGYMAPEYG---SEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVRE  159 (202)
Q Consensus        83 ~~~~~~~~~~~~pe~~---~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (202)
                       ....+++.|+|||.+   ....++.++|+||+|+++|++++|..||........ .........+..            
T Consensus       208 -~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~-~~~~~~~~~~~~------------  273 (348)
T 1u5q_A          208 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-LYHIAQNESPAL------------  273 (348)
T ss_dssp             -CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-HHHHHHSCCCCC------------
T ss_pred             -CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHhcCCCCC------------
Confidence             234689999999976   356788899999999999999999999976432211 111111111000            


Q ss_pred             HHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          160 EQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       160 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                           ....++..+.+++.+||+.||++|||+.++++
T Consensus       274 -----~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~  305 (348)
T 1u5q_A          274 -----QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  305 (348)
T ss_dssp             -----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             -----CCCCCCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence                 01124556889999999999999999999874

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=99.97  E-value=1.9e-32  Score=211.38  Aligned_cols=189  Identities=22%  Similarity=0.225  Sum_probs=129.7

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |++++|.+++.... .+++..+..++.|++.||.|||    +.+++||||||+||+++.++.++|+|||++.........
T Consensus       106 ~~~~~l~~~~~~~~-~~~~~~~~~~~~qi~~~l~~LH----~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  180 (331)
T 4aaa_A          106 VDHTILDDLELFPN-GLDYQVVQKYLFQIINGIGFCH----SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV  180 (331)
T ss_dssp             CSEEHHHHHHHSTT-CCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECTTSCEEECCCTTC---------
T ss_pred             CCcchHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHH----HCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCccc
Confidence            46778888766433 4899999999999999999999    899999999999999999999999999999765433221


Q ss_pred             ccccCCCCCccccCCCCCCCC-CcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHh-CCCChhhhhh-----
Q 037267           81 VTQTMTMATIGYMAPEYGSEG-IVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKES-LPHGLTEVVD-----  153 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~-~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~-----  153 (202)
                        .....+++.|+|||.+.+. .++.++|+||+|+++|++++|..||................. ..+.......     
T Consensus       181 --~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (331)
T 4aaa_A          181 --YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVF  258 (331)
T ss_dssp             -----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGG
T ss_pred             --cCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcccc
Confidence              2234578999999987664 678899999999999999999999976543322111111000 0000000000     


Q ss_pred             -----hhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          154 -----ANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       154 -----~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                           +..............++.++.+++.+||+.||++|||+.|+++
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  306 (331)
T 4aaa_A          259 AGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH  306 (331)
T ss_dssp             TTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             ccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence                 0000000111122345777999999999999999999998874

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=99.97  E-value=9.2e-32  Score=218.39  Aligned_cols=171  Identities=25%  Similarity=0.303  Sum_probs=133.6

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCC---ceEEcccccceeccCC
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENM---VAHVSDFGISKLLGEG   77 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~---~~~l~d~g~~~~~~~~   77 (202)
                      |+||+|.+++.... .+++..+..++.|++.||.|||    +.+|+||||||+||+++.++   .+||+|||++......
T Consensus       128 ~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH----~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~  202 (504)
T 3q5i_A          128 YEGGELFEQIINRH-KFDECDAANIMKQILSGICYLH----KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKD  202 (504)
T ss_dssp             CTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEESSTTCCSSEEECCCTTCEECCTT
T ss_pred             CCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeEeCCCcHHHEEEecCCCCccEEEEECCCCEEcCCC
Confidence            67999999998654 4899999999999999999999    89999999999999998765   6999999999876543


Q ss_pred             CccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhh
Q 037267           78 EDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV  157 (202)
Q Consensus        78 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (202)
                      ..   .....+++.|+|||.+.+ .++.++|+||+||++|++++|..||.......  ....+......           
T Consensus       203 ~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--~~~~i~~~~~~-----------  265 (504)
T 3q5i_A          203 YK---LRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQD--IIKKVEKGKYY-----------  265 (504)
T ss_dssp             SC---BCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHCCCC-----------
T ss_pred             Cc---cccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHcCCCC-----------
Confidence            22   223468999999998764 68899999999999999999999997643221  11111111000           


Q ss_pred             hhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          158 REEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                         ...+....++.++.+++.+||..||++|||+.|+++
T Consensus       266 ---~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~  301 (504)
T 3q5i_A          266 ---FDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN  301 (504)
T ss_dssp             ---CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ---CCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence               001112345677999999999999999999999874

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=99.97  E-value=2.9e-32  Score=206.98  Aligned_cols=169  Identities=20%  Similarity=0.222  Sum_probs=133.7

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |++++|.+++.... .+++..+..++.|++.||.|||    +.+++|+||||+||+++.++.++++|||.+.........
T Consensus        97 ~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH----~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~  171 (294)
T 2rku_A           97 CRRRSLLELHKRRK-ALTEPEARYYLRQIVLGCQYLH----RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER  171 (294)
T ss_dssp             CTTCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred             CCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCccccCCChHhEEEcCCCCEEEEeccCceecccCccc
Confidence            57899999997644 4899999999999999999999    899999999999999999999999999999876533221


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhH
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREE  160 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (202)
                        .....+++.|+|||...+..++.++|+||+|+++|++++|..||........  ...+.....               
T Consensus       172 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~--~~~~~~~~~---------------  232 (294)
T 2rku_A          172 --KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET--YLRIKKNEY---------------  232 (294)
T ss_dssp             --BCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH--HHHHHTTCC---------------
T ss_pred             --cccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHhhccC---------------
Confidence              2234578899999988888889999999999999999999999976432211  001110000               


Q ss_pred             HHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          161 QAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       161 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                         ..+..++..+.+++.+||+.||++|||+.|+++
T Consensus       233 ---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  265 (294)
T 2rku_A          233 ---SIPKHINPVAASLIQKMLQTDPTARPTINELLN  265 (294)
T ss_dssp             ---CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             ---CCccccCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence               001124456889999999999999999999875

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=99.97  E-value=2e-31  Score=203.14  Aligned_cols=169  Identities=22%  Similarity=0.307  Sum_probs=134.3

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |++|+|.+++..  ..+++..+..++.|++.||.|||    +.+++|+||||+||+++.++.++|+|||.+........ 
T Consensus       102 ~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~-  174 (303)
T 3a7i_A          102 LGGGSALDLLEP--GPLDETQIATILREILKGLDYLH----SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-  174 (303)
T ss_dssp             CTTEEHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC-
T ss_pred             CCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH----HCCCccCCCChheEEECCCCCEEEeecccceecCcccc-
Confidence            578999999975  34899999999999999999999    89999999999999999999999999999987654322 


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhH
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREE  160 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (202)
                       ......+++.|+|||.+.+..++.++|+||+|+++|++++|..||.......  ....+....+..             
T Consensus       175 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~-------------  238 (303)
T 3a7i_A          175 -KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMK--VLFLIPKNNPPT-------------  238 (303)
T ss_dssp             -CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHHHHHHSCCCC-------------
T ss_pred             -ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHH--HHHHhhcCCCCC-------------
Confidence             1233468899999999888888999999999999999999999997643221  111111111100             


Q ss_pred             HHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          161 QAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       161 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                          ....++..+.+++.+||..||++|||+.++++
T Consensus       239 ----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  270 (303)
T 3a7i_A          239 ----LEGNYSKPLKEFVEACLNKEPSFRPTAKELLK  270 (303)
T ss_dssp             ----CCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             ----CccccCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence                01124456899999999999999999999975

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=99.97  E-value=2.5e-32  Score=211.11  Aligned_cols=169  Identities=20%  Similarity=0.225  Sum_probs=133.7

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |++++|.+++.... .+++..+..++.|++.||.|||    +.+|+||||||+||+++.++.++|+|||++.........
T Consensus       123 ~~~~~L~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH----~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~  197 (335)
T 2owb_A          123 CRRRSLLELHKRRK-ALTEPEARYYLRQIVLGCQYLH----RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER  197 (335)
T ss_dssp             CTTCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred             CCCCCHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH----HCCCEecCCCchhEEEcCCCCEEEeeccCceecccCccc
Confidence            56899999997644 4899999999999999999999    899999999999999999999999999999876533221


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhH
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREE  160 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (202)
                        .....++..|+|||.+.+..++.++|+||+|+++|++++|..||........ .. .+.....               
T Consensus       198 --~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~-~~~~~~~---------------  258 (335)
T 2owb_A          198 --KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET-YL-RIKKNEY---------------  258 (335)
T ss_dssp             --BCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HH-HHHHTCC---------------
T ss_pred             --ccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHH-HH-HHhcCCC---------------
Confidence              2234588999999988888889999999999999999999999975432211 11 1111000               


Q ss_pred             HHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          161 QAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       161 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                         ..+..++.++.+++.+||+.||++|||+.|+++
T Consensus       259 ---~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  291 (335)
T 2owb_A          259 ---SIPKHINPVAASLIQKMLQTDPTARPTINELLN  291 (335)
T ss_dssp             ---CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             ---CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence               001124456889999999999999999999875

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=99.97  E-value=1.1e-31  Score=206.39  Aligned_cols=173  Identities=25%  Similarity=0.275  Sum_probs=132.1

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCc---eEEcccccceeccCC
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMV---AHVSDFGISKLLGEG   77 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~---~~l~d~g~~~~~~~~   77 (202)
                      |++|+|.+++.... .+++..+..++.|++.||.|||    +.+++||||||+||+++.++.   ++|+|||++......
T Consensus        96 ~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH----~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~  170 (322)
T 2ycf_A           96 MEGGELFDKVVGNK-RLKEATCKLYFYQMLLAVQYLH----ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET  170 (322)
T ss_dssp             CTTEETHHHHSTTC-CCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEECCCC
T ss_pred             CCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH----HCCeeccCCCHHHEEEecCCCCCeEEEccCccceecccc
Confidence            57899999997644 5899999999999999999999    899999999999999986554   999999999876443


Q ss_pred             CccccccCCCCCccccCCCCC---CCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhh
Q 037267           78 EDFVTQTMTMATIGYMAPEYG---SEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDA  154 (202)
Q Consensus        78 ~~~~~~~~~~~~~~~~~pe~~---~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (202)
                      ..   .....+++.|+|||.+   ....++.++|+||+|+++|++++|..||........ +...+........      
T Consensus       171 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~------  240 (322)
T 2ycf_A          171 SL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS-LKDQITSGKYNFI------  240 (322)
T ss_dssp             HH---HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC-HHHHHHHTCCCCC------
T ss_pred             cc---cccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH-HHHHHHhCccccC------
Confidence            21   1123578999999974   345678899999999999999999999976443322 2222211111000      


Q ss_pred             hhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          155 NLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                              ......++.++.+++.+||..||++|||+.++++
T Consensus       241 --------~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          241 --------PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             --------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             --------chhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence                    0111235667899999999999999999999874

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=99.97  E-value=1.3e-31  Score=203.23  Aligned_cols=173  Identities=25%  Similarity=0.286  Sum_probs=130.4

Q ss_pred             CCCCcHHHHHhhcC--CCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCC-CCceEEcccccceeccCC
Q 037267            1 MPNGSLEKWLYSYN--YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDE-NMVAHVSDFGISKLLGEG   77 (202)
Q Consensus         1 ~~~gsL~~~l~~~~--~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~-~~~~~l~d~g~~~~~~~~   77 (202)
                      |++|+|.+++....  ..+++..+..++.|++.||.|||    +.+++|+||||+||+++. ++.++|+|||.+......
T Consensus       101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~  176 (295)
T 2clq_A          101 VPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH----DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI  176 (295)
T ss_dssp             CSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-
T ss_pred             CCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHH----hCCEEccCCChhhEEEECCCCCEEEeecccccccCCC
Confidence            46899999998653  24678999999999999999999    899999999999999987 889999999999875432


Q ss_pred             CccccccCCCCCccccCCCCCCCCC--cCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhh
Q 037267           78 EDFVTQTMTMATIGYMAPEYGSEGI--VSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDAN  155 (202)
Q Consensus        78 ~~~~~~~~~~~~~~~~~pe~~~~~~--~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (202)
                      ..  ......+++.|+|||...+..  ++.++|+||+|+++|++++|..||....................         
T Consensus       177 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~---------  245 (295)
T 2clq_A          177 NP--CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHP---------  245 (295)
T ss_dssp             ------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCC---------
T ss_pred             CC--cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccc---------
Confidence            21  122346889999999875543  67899999999999999999999965432221111110000000         


Q ss_pred             hhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          156 LVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                              ..+..++.++.+++.+||..||++|||+.++++
T Consensus       246 --------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          246 --------EIPESMSAEAKAFILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             --------CCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred             --------cccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence                    011234566899999999999999999999874

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=99.97  E-value=9.2e-33  Score=210.33  Aligned_cols=173  Identities=22%  Similarity=0.245  Sum_probs=130.6

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |++|+|.+++......+++..+..++.|++.||.|||    +.+++|+||||+||+++.++.++++|||++.......  
T Consensus        98 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--  171 (302)
T 2j7t_A           98 CPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH----SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL--  171 (302)
T ss_dssp             CTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH--
T ss_pred             CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHh----cCCcccCCCCHHHEEECCCCCEEEEECCCCccccccc--
Confidence            5789999999876666999999999999999999999    8999999999999999999999999999875422110  


Q ss_pred             ccccCCCCCccccCCCCC-----CCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhh
Q 037267           81 VTQTMTMATIGYMAPEYG-----SEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDAN  155 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~-----~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (202)
                      .......+++.|+|||.+     .+..++.++|+||+|+++|++++|..||........ .........+..        
T Consensus       172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~--------  242 (302)
T 2j7t_A          172 QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV-LLKIAKSDPPTL--------  242 (302)
T ss_dssp             HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-HHHHHHSCCCCC--------
T ss_pred             cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHH-HHHHhccCCccc--------
Confidence            011224578999999976     456788899999999999999999999976432211 111111100000        


Q ss_pred             hhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          156 LVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                              ..+..++.++.+++.+||..||++|||+.++++
T Consensus       243 --------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          243 --------LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             --------SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred             --------CCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence                    011234556899999999999999999999874

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=99.97  E-value=8.4e-32  Score=218.13  Aligned_cols=171  Identities=25%  Similarity=0.307  Sum_probs=132.2

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCC---CCceEEcccccceeccCC
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDE---NMVAHVSDFGISKLLGEG   77 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~---~~~~~l~d~g~~~~~~~~   77 (202)
                      |++|+|.+++.... .+++..+..++.|++.||.|||    +.+|+||||||+||+++.   ++.+||+|||++......
T Consensus       118 ~~~g~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH----~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~  192 (494)
T 3lij_A          118 YKGGELFDEIIHRM-KFNEVDAAVIIKQVLSGVTYLH----KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ  192 (494)
T ss_dssp             CCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT
T ss_pred             CCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC
Confidence            67999999997654 4899999999999999999999    899999999999999975   455999999999876543


Q ss_pred             CccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhh
Q 037267           78 EDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV  157 (202)
Q Consensus        78 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (202)
                      ..   .....+++.|+|||.+. ..++.++|+||+||++|++++|..||.......  ....+........         
T Consensus       193 ~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--~~~~i~~~~~~~~---------  257 (494)
T 3lij_A          193 KK---MKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQE--ILRKVEKGKYTFD---------  257 (494)
T ss_dssp             BC---BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHTCCCCC---------
T ss_pred             cc---ccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhCCCCCC---------
Confidence            32   22346899999999875 468999999999999999999999997643221  1111111110000         


Q ss_pred             hhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          158 REEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                           .+....++.++.+++.+||..||++|||+.++++
T Consensus       258 -----~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  291 (494)
T 3lij_A          258 -----SPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALE  291 (494)
T ss_dssp             -----SGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             -----chhcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence                 0011234566899999999999999999999874

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=99.97  E-value=1e-31  Score=213.57  Aligned_cols=185  Identities=21%  Similarity=0.176  Sum_probs=130.0

Q ss_pred             CcHHHHHh---hcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCC-CceEEcccccceeccCCCc
Q 037267            4 GSLEKWLY---SYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN-MVAHVSDFGISKLLGEGED   79 (202)
Q Consensus         4 gsL~~~l~---~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~-~~~~l~d~g~~~~~~~~~~   79 (202)
                      ++|.+.+.   .....+++..+..++.|++.||.|||    +.+|+||||||+||+++.+ +.+||+|||+++.......
T Consensus       137 ~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH----~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~~~  212 (420)
T 1j1b_A          137 ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH----SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP  212 (420)
T ss_dssp             EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH----TTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCC
T ss_pred             ccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH----HCCccccCCChhhEEEeCCCCeEEeccchhhhhcccCCC
Confidence            46666654   23456999999999999999999999    8999999999999999955 6789999999987654322


Q ss_pred             cccccCCCCCccccCCCCCCCC-CcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhh------
Q 037267           80 FVTQTMTMATIGYMAPEYGSEG-IVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVV------  152 (202)
Q Consensus        80 ~~~~~~~~~~~~~~~pe~~~~~-~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~------  152 (202)
                         .....+++.|+|||.+.+. .++.++|+||+||++|+|++|..||......+. +...+...-.+....+.      
T Consensus       213 ---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~-l~~i~~~lg~p~~~~~~~~~~~~  288 (420)
T 1j1b_A          213 ---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ-LVEIIKVLGTPTREQIREMNPNY  288 (420)
T ss_dssp             ---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHHCSCCHHHHHHHCSCC
T ss_pred             ---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCCHHHHHhhChhh
Confidence               2234689999999987654 688999999999999999999999976432221 11111111000000000      


Q ss_pred             ----hhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          153 ----DANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       153 ----~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                          .+......+........+.++.+|+.+||..||++|||+.|+++
T Consensus       289 ~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~  336 (420)
T 1j1b_A          289 TEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  336 (420)
T ss_dssp             CCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence                00000001111111234567999999999999999999999874

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=99.97  E-value=6.6e-32  Score=213.05  Aligned_cols=175  Identities=22%  Similarity=0.216  Sum_probs=126.1

Q ss_pred             CCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeC-CCCceEEcccccceeccCCCccccccCCCCCccc
Q 037267           14 NYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLD-ENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGY   92 (202)
Q Consensus        14 ~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~-~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~   92 (202)
                      ...+++..+..++.|++.||.|||    +.+|+||||||+||+++ .++.+||+|||+++.......   .....+++.|
T Consensus       135 ~~~~~~~~~~~~~~qi~~aL~~LH----~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~~---~~~~~~t~~y  207 (394)
T 4e7w_A          135 KQTMPMLLIKLYMYQLLRSLAYIH----SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEP---NVSYICSRYY  207 (394)
T ss_dssp             TSCCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCC---CCSSCSCGGG
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHH----HCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCCC---CcccccCcCc
Confidence            446899999999999999999999    89999999999999999 789999999999987644332   2234678999


Q ss_pred             cCCCCCCCC-CcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhh--h--------hhhhhHH
Q 037267           93 MAPEYGSEG-IVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVD--A--------NLVREEQ  161 (202)
Q Consensus        93 ~~pe~~~~~-~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~--------~~~~~~~  161 (202)
                      +|||.+.+. .++.++|+||+||++|++++|..||........ +...+...-.+....+..  .        .......
T Consensus       208 ~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~-l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~  286 (394)
T 4e7w_A          208 RAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQ-LVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPF  286 (394)
T ss_dssp             CCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCH
T ss_pred             cCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCCHHHHHhhChhhhhhccccccCCcH
Confidence            999977654 589999999999999999999999976543221 111111110001000000  0        0000001


Q ss_pred             HHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          162 AFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       162 ~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                      ........++++.+|+.+||..||++|||+.|+++
T Consensus       287 ~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  321 (394)
T 4e7w_A          287 SKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC  321 (394)
T ss_dssp             HHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence            11112235667999999999999999999999975

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=99.97  E-value=2.5e-32  Score=220.68  Aligned_cols=171  Identities=26%  Similarity=0.325  Sum_probs=132.9

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceee---CCCCceEEcccccceeccCC
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILL---DENMVAHVSDFGISKLLGEG   77 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~---~~~~~~~l~d~g~~~~~~~~   77 (202)
                      |++|+|.+++.... .+++..+..++.|++.||.|||    +.+|+||||||+||++   +.++.+||+|||++......
T Consensus       108 ~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH----~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~  182 (484)
T 3nyv_A          108 YTGGELFDEIISRK-RFSEVDAARIIRQVLSGITYMH----KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS  182 (484)
T ss_dssp             CCSCBHHHHHHTCS-CCBHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCC
T ss_pred             CCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccc
Confidence            57999999998654 4899999999999999999999    8999999999999999   46788999999999876543


Q ss_pred             CccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhh
Q 037267           78 EDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV  157 (202)
Q Consensus        78 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (202)
                      ...   ....+++.|+|||.+.+ .++.++|+||+||++|++++|..||.......  ....+........         
T Consensus       183 ~~~---~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--~~~~i~~~~~~~~---------  247 (484)
T 3nyv_A          183 KKM---KDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYD--ILKKVEKGKYTFE---------  247 (484)
T ss_dssp             CSH---HHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHCCCCCC---------
T ss_pred             ccc---ccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHcCCCCCC---------
Confidence            321   22358999999998765 68899999999999999999999997643221  1111111110000         


Q ss_pred             hhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          158 REEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                           .+....+++++.+++.+||..||++|||+.|+++
T Consensus       248 -----~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  281 (484)
T 3nyv_A          248 -----LPQWKKVSESAKDLIRKMLTYVPSMRISARDALD  281 (484)
T ss_dssp             -----SGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -----CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence                 0111235567899999999999999999999875

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=99.97  E-value=4.3e-32  Score=212.23  Aligned_cols=182  Identities=22%  Similarity=0.215  Sum_probs=119.7

Q ss_pred             CCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCccc
Q 037267            2 PNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFV   81 (202)
Q Consensus         2 ~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~~   81 (202)
                      .+++|.+++..  ..+++..+..++.|++.||.|||    +.+|+||||||+||+++.++.+||+|||+++.....    
T Consensus       116 ~~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH----~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~----  185 (367)
T 2fst_X          116 MGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE----  185 (367)
T ss_dssp             CCEECC-------CCCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECTTCCEEECC--------------
T ss_pred             cCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH----HCCeeeCCCCHhhEEECCCCCEEEeecccccccccc----
Confidence            36889898875  34899999999999999999999    899999999999999999999999999999765432    


Q ss_pred             cccCCCCCccccCCCCCCC-CCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhh-----
Q 037267           82 TQTMTMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDAN-----  155 (202)
Q Consensus        82 ~~~~~~~~~~~~~pe~~~~-~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----  155 (202)
                       .....+++.|+|||.+.+ ..++.++|+||+||++|++++|..||........ +.... ..............     
T Consensus       186 -~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-l~~i~-~~~g~p~~~~~~~~~~~~~  262 (367)
T 2fst_X          186 -MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ-LKLIL-RLVGTPGAELLKKISSESA  262 (367)
T ss_dssp             ------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHH-HHHCSCCHHHHTTCCCHHH
T ss_pred             -CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHH-HHhCCCCHHHHHHhhhHHH
Confidence             123468999999998766 6788999999999999999999999976443221 11111 11000000000000     


Q ss_pred             ------hh--hhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          156 ------LV--REEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       156 ------~~--~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                            ..  ............++++.+|+.+||..||++|||+.|+++
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~  311 (367)
T 2fst_X          263 RNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  311 (367)
T ss_dssp             HHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence                  00  000001111234567899999999999999999999975

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=99.97  E-value=3e-32  Score=207.37  Aligned_cols=182  Identities=25%  Similarity=0.302  Sum_probs=130.2

Q ss_pred             CCCCcHHHHHhh-------cCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEccccccee
Q 037267            1 MPNGSLEKWLYS-------YNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKL   73 (202)
Q Consensus         1 ~~~gsL~~~l~~-------~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~   73 (202)
                      |++|+|.+++..       ....+++..+..++.|++.||.|||    +.+++|+||||+||+++.++.++|+|||++..
T Consensus        95 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~  170 (303)
T 2vwi_A           95 LSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH----KNGQIHRDVKAGNILLGEDGSVQIADFGVSAF  170 (303)
T ss_dssp             CTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCSGGGEEECTTCCEEECCCHHHHH
T ss_pred             ccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHH----hCCCCCCCCChhhEEEcCCCCEEEEeccchhe
Confidence            478999999974       2345899999999999999999999    89999999999999999999999999999876


Q ss_pred             ccCCCcc---ccccCCCCCccccCCCCCCC-CCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChh
Q 037267           74 LGEGEDF---VTQTMTMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLT  149 (202)
Q Consensus        74 ~~~~~~~---~~~~~~~~~~~~~~pe~~~~-~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  149 (202)
                      .......   .......+++.|+|||...+ ..++.++|+||+|+++|++++|..||...........  .....+....
T Consensus       171 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~--~~~~~~~~~~  248 (303)
T 2vwi_A          171 LATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLML--TLQNDPPSLE  248 (303)
T ss_dssp             CC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHH--HHTSSCCCTT
T ss_pred             eccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHH--HhccCCCccc
Confidence            5432211   11223458899999997654 4578899999999999999999999976543322111  1111111100


Q ss_pred             hhhhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          150 EVVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                      ....        .......++.++.+++.+||..||++|||+.++++
T Consensus       249 ~~~~--------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          249 TGVQ--------DKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR  287 (303)
T ss_dssp             C-------------CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             cccc--------cchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence            0000        00001234456899999999999999999999985

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=99.97  E-value=1.4e-31  Score=208.86  Aligned_cols=186  Identities=22%  Similarity=0.205  Sum_probs=128.5

Q ss_pred             CCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcccc
Q 037267            3 NGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVT   82 (202)
Q Consensus         3 ~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~   82 (202)
                      +|+|.+++......+++..+..++.|++.||.|||    +.+|+||||||+||+++.++.++|+|||++........   
T Consensus       117 ~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~---  189 (362)
T 3pg1_A          117 RTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLH----EAGVVHRDLHPGNILLADNNDITICDFNLAREDTADAN---  189 (362)
T ss_dssp             SEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECTTCCEEECCTTC------------
T ss_pred             CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH----HCcCEecCCChHHEEEcCCCCEEEEecCcccccccccc---
Confidence            47899999876667999999999999999999999    89999999999999999999999999999975443221   


Q ss_pred             ccCCCCCccccCCCCCCC-CCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhh--------
Q 037267           83 QTMTMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVD--------  153 (202)
Q Consensus        83 ~~~~~~~~~~~~pe~~~~-~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------  153 (202)
                      .....+++.|+|||.+.+ ..++.++|+||+||++|++++|..||........ ..................        
T Consensus       190 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~~  268 (362)
T 3pg1_A          190 KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQ-LNKIVEVVGTPKIEDVVMFSSPSARD  268 (362)
T ss_dssp             ------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCCCHHHHHHTSCHHHHH
T ss_pred             cceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHcCCCChHHhhhccchhhhH
Confidence            223457889999997766 5688999999999999999999999976432221 111111111111111000        


Q ss_pred             ---hhhhh--hHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          154 ---ANLVR--EEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       154 ---~~~~~--~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                         .....  ...........++.+.+++.+||..||++|||+.|+++
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  316 (362)
T 3pg1_A          269 YLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR  316 (362)
T ss_dssp             HTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence               00000  00011222345667899999999999999999999975

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=99.97  E-value=1.2e-31  Score=206.25  Aligned_cols=172  Identities=20%  Similarity=0.236  Sum_probs=126.0

Q ss_pred             CCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCc
Q 037267            1 MPNGSLEKWLYSYN-YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED   79 (202)
Q Consensus         1 ~~~gsL~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~   79 (202)
                      |++|+|.+++.... ..+++..+..++.|++.||.|||    +.+++|+||||.||+++.++.++|+|||++........
T Consensus       109 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~  184 (326)
T 2x7f_A          109 CGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH----QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG  184 (326)
T ss_dssp             CTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCSGGGEEECTTCCEEECCCTTTC-------
T ss_pred             CCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH----HCCccccCCcHHHEEEcCCCCEEEeeCcCceecCcCcc
Confidence            46889999998643 45899999999999999999999    89999999999999999999999999999876543211


Q ss_pred             cccccCCCCCccccCCCCCC-----CCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhh
Q 037267           80 FVTQTMTMATIGYMAPEYGS-----EGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDA  154 (202)
Q Consensus        80 ~~~~~~~~~~~~~~~pe~~~-----~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (202)
                        ......+++.|+|||.+.     +..++.++|+||+|+++|++++|..||........ .. .+........      
T Consensus       185 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~-~~~~~~~~~~------  254 (326)
T 2x7f_A          185 --RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA-LF-LIPRNPAPRL------  254 (326)
T ss_dssp             --------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH-HH-HHHHSCCCCC------
T ss_pred             --ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH-HH-HhhcCccccC------
Confidence              122345889999999765     45678899999999999999999999965432211 11 1111100000      


Q ss_pred             hhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          155 NLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                                ....++..+.+++.+||..||++|||+.++++
T Consensus       255 ----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  286 (326)
T 2x7f_A          255 ----------KSKKWSKKFQSFIESCLVKNHSQRPATEQLMK  286 (326)
T ss_dssp             ----------SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             ----------CccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence                      01123456899999999999999999999986

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=99.97  E-value=5.3e-32  Score=204.44  Aligned_cols=164  Identities=18%  Similarity=0.265  Sum_probs=126.2

Q ss_pred             CCCCcHHHHHhhcC---CCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCC-----------------
Q 037267            1 MPNGSLEKWLYSYN---YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN-----------------   60 (202)
Q Consensus         1 ~~~gsL~~~l~~~~---~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~-----------------   60 (202)
                      |++|||.+++....   ..+++..+..++.|++.||.|||    +.+|+||||||+||+++.+                 
T Consensus        93 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH----~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~  168 (289)
T 1x8b_A           93 CNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH----SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWAS  168 (289)
T ss_dssp             CTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEEC-------------------
T ss_pred             cCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHH----hCCEeecCCCHHHEEEcCCCCCcccccccccccccC
Confidence            57899999998542   45899999999999999999999    8999999999999999844                 


Q ss_pred             --CceEEcccccceeccCCCccccccCCCCCccccCCCCCCCC-CcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhH
Q 037267           61 --MVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEG-IVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLR  137 (202)
Q Consensus        61 --~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~  137 (202)
                        ..++++|||.+.......      ...+++.|+|||.+.+. .++.++|+||+|+++|++++|..++....    ...
T Consensus       169 ~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~----~~~  238 (289)
T 1x8b_A          169 NKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD----QWH  238 (289)
T ss_dssp             -CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH----HHH
T ss_pred             CceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh----HHH
Confidence              478999999998765432      23488999999987665 56678999999999999999987764321    111


Q ss_pred             HHHHHhCCCChhhhhhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          138 RWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       138 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                      .......+                  ..+..++.++.+++.+||+.||++|||+.++++
T Consensus       239 ~~~~~~~~------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  279 (289)
T 1x8b_A          239 EIRQGRLP------------------RIPQVLSQEFTELLKVMIHPDPERRPSAMALVK  279 (289)
T ss_dssp             HHHTTCCC------------------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHcCCCC------------------CCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence            11111110                  001124556899999999999999999999875

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=99.97  E-value=5e-31  Score=198.33  Aligned_cols=168  Identities=26%  Similarity=0.391  Sum_probs=125.2

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |++++|.+++.... .+++..+..++.|++.||.|||    +.+++|+||||+||+++.++.++++|||++........ 
T Consensus        93 ~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-  166 (276)
T 2h6d_A           93 VSGGELFDYICKHG-RVEEMEARRLFQQILSAVDYCH----RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF-  166 (276)
T ss_dssp             CCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH----HHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC----
T ss_pred             cCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH----HCCCccCCCChhhEEECCCCCEEEeecccccccCCCcc-
Confidence            46899999998654 4899999999999999999999    89999999999999999999999999999876544321 


Q ss_pred             ccccCCCCCccccCCCCCCCCCc-CcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhh
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIV-SAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVRE  159 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~-~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (202)
                        .....+++.|+|||...+..+ +.++|+||+|+++|++++|..||.......  ....+......             
T Consensus       167 --~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~~~~~~~~~~~-------------  229 (276)
T 2h6d_A          167 --LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPT--LFKKIRGGVFY-------------  229 (276)
T ss_dssp             ------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHCCCC-------------
T ss_pred             --eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH--HHHHhhcCccc-------------
Confidence              122357889999998877654 578999999999999999999996532211  11111111100             


Q ss_pred             HHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          160 EQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       160 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                           .+..++.++.+++.+||+.||++|||+.++++
T Consensus       230 -----~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~  261 (276)
T 2h6d_A          230 -----IPEYLNRSVATLLMHMLQVDPLKRATIKDIRE  261 (276)
T ss_dssp             -----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -----CchhcCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence                 01123456889999999999999999999986

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=99.97  E-value=1.8e-31  Score=205.22  Aligned_cols=186  Identities=24%  Similarity=0.284  Sum_probs=134.7

Q ss_pred             CCcHHHHHhhcC-CCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCccc
Q 037267            3 NGSLEKWLYSYN-YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFV   81 (202)
Q Consensus         3 ~gsL~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~~   81 (202)
                      +|+|.+++.... ..+++..+..++.|++.||.|||    +.+++|+||||+||+++.++.++|+|||++.......   
T Consensus       102 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~---  174 (326)
T 1blx_A          102 DQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH----SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM---  174 (326)
T ss_dssp             SCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECTTCCEEECSCCSCCCCCGGG---
T ss_pred             CCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH----HCCceeccCCHHHeEEcCCCCEEEecCcccccccCCC---
Confidence            479999998654 34899999999999999999999    8999999999999999999999999999987654322   


Q ss_pred             cccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHH-hCCCC--hhhhh---hhh
Q 037267           82 TQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKE-SLPHG--LTEVV---DAN  155 (202)
Q Consensus        82 ~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~--~~~~~---~~~  155 (202)
                      ......++..|+|||.+.+..++.++|+||+|+++|++++|..||........ +...... ..+..  +....   ...
T Consensus       175 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~~  253 (326)
T 1blx_A          175 ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ-LGKILDVIGLPGEEDWPRDVALPRQA  253 (326)
T ss_dssp             GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCCCGGGSCTTCSSCGGG
T ss_pred             CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHH-HHHHHHHcCCCCcccCccccccchhh
Confidence            12334678999999988888899999999999999999999999976543221 1111111 11100  00000   000


Q ss_pred             hh--hhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          156 LV--REEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       156 ~~--~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                      ..  ...........++..+.+++.+||..||++|||+.|+++
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  296 (326)
T 1blx_A          254 FHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  296 (326)
T ss_dssp             SCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            00  000000111235567899999999999999999999984

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=99.97  E-value=4.9e-32  Score=204.14  Aligned_cols=173  Identities=22%  Similarity=0.284  Sum_probs=132.1

Q ss_pred             CCCCcHHHHHhhc---CCCCCHHHHHHHHHHHHHhhhcccCCCCCCC-----eeecCCCCCceeeCCCCceEEcccccce
Q 037267            1 MPNGSLEKWLYSY---NYFFDILERLNIMIDVGSALEYPHHGHSSAP-----IIHCDLKPTNILLDENMVAHVSDFGISK   72 (202)
Q Consensus         1 ~~~gsL~~~l~~~---~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~-----i~h~dlk~~nil~~~~~~~~l~d~g~~~   72 (202)
                      |++|+|.+++...   ...+++..+..++.|++.||.|||    +.+     ++|+||||+||+++.++.++|+|||.+.
T Consensus        89 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH----~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~  164 (279)
T 2w5a_A           89 CEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH----RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  164 (279)
T ss_dssp             CTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH----HHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred             CCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHh----cccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence            4689999999753   234899999999999999999999    777     9999999999999999999999999987


Q ss_pred             eccCCCccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhh
Q 037267           73 LLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVV  152 (202)
Q Consensus        73 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  152 (202)
                      ........  .....++..|+|||...+..++.++|+||+|+++|++++|..||.......  ....+.......     
T Consensus       165 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~i~~~~~~~-----  235 (279)
T 2w5a_A          165 ILNHDTSF--AKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE--LAGKIREGKFRR-----  235 (279)
T ss_dssp             HC---CHH--HHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHTCCCC-----
T ss_pred             eecccccc--ccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHH--HHHHHhhccccc-----
Confidence            65433211  112357889999998888888999999999999999999999997643211  111111111100     


Q ss_pred             hhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 037267          153 DANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKL  198 (202)
Q Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l  198 (202)
                                  .+..++.++.+++.+||+.||++|||+.|+++.+
T Consensus       236 ------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~  269 (279)
T 2w5a_A          236 ------------IPYRYSDELNEIITRMLNLKDYHRPSVEEILENP  269 (279)
T ss_dssp             ------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred             ------------CCcccCHHHHHHHHHHcCCCcccCCCHHHHHhCh
Confidence                        0113456689999999999999999999998754

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=99.97  E-value=8.8e-31  Score=205.11  Aligned_cols=182  Identities=21%  Similarity=0.183  Sum_probs=124.3

Q ss_pred             CCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcccc
Q 037267            3 NGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVT   82 (202)
Q Consensus         3 ~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~   82 (202)
                      .|+|.+++..   .+++..+..++.|++.||.|||    +.+|+||||||+||+++.++.+||+|||++........   
T Consensus       113 ~~~l~~~~~~---~~~~~~~~~i~~qi~~al~~lH----~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~---  182 (371)
T 2xrw_A          113 DANLCQVIQM---ELDHERMSYLLYQMLCGIKHLH----SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---  182 (371)
T ss_dssp             SEEHHHHHHS---CCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEECTTSCEEECCCCC------------
T ss_pred             CCCHHHHHhh---ccCHHHHHHHHHHHHHHHHHHH----HCCeecccCCHHHEEEcCCCCEEEEEeecccccccccc---
Confidence            4678888852   3899999999999999999999    89999999999999999999999999999976543221   


Q ss_pred             ccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhh---hhhh---
Q 037267           83 QTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVV---DANL---  156 (202)
Q Consensus        83 ~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~---  156 (202)
                      .....+++.|+|||.+.+..++.++|+||+||++|++++|..||........ +.. +............   ....   
T Consensus       183 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~-i~~~~~~~~~~~~~~~~~~~~~~  260 (371)
T 2xrw_A          183 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQ-WNK-VIEQLGTPCPEFMKKLQPTVRTY  260 (371)
T ss_dssp             -------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHH-HHC-CCCCCHHHHTTSCHHHHHH
T ss_pred             cCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHH-HHHHhCCCCHHHHHHhhhHHHHH
Confidence            1234688999999998888899999999999999999999999976432211 111 1100000000000   0000   


Q ss_pred             ---------------hh---hHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          157 ---------------VR---EEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       157 ---------------~~---~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                                     ..   ...........+.++.+|+.+||..||++|||+.|+++
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  318 (371)
T 2xrw_A          261 VENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ  318 (371)
T ss_dssp             HHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence                           00   00001122345778999999999999999999999975

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=99.97  E-value=2.6e-31  Score=206.52  Aligned_cols=188  Identities=22%  Similarity=0.208  Sum_probs=131.8

Q ss_pred             CCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCccc-
Q 037267            3 NGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFV-   81 (202)
Q Consensus         3 ~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~~-   81 (202)
                      +|+|.+++...  .+++..+..++.|++.||.|||    +.+++||||||+||+++.++.++|+|||++.......... 
T Consensus        97 ~~~L~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH----~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~  170 (353)
T 2b9h_A           97 QTDLHRVISTQ--MLSDDHIQYFIYQTLRAVKVLH----GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNS  170 (353)
T ss_dssp             SEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCCGGGEEECTTCCEEECCCTTCEECC-------
T ss_pred             CccHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHeEEcCCCcEEEEeccccccccccccccc
Confidence            47899999763  4899999999999999999999    8999999999999999999999999999998765322111 


Q ss_pred             -------cccCCCCCccccCCCCCC-CCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChh---h
Q 037267           82 -------TQTMTMATIGYMAPEYGS-EGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLT---E  150 (202)
Q Consensus        82 -------~~~~~~~~~~~~~pe~~~-~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---~  150 (202)
                             ......+++.|+|||.+. +..++.++|+||+||++|++++|..||..................+....   .
T Consensus       171 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (353)
T 2b9h_A          171 EPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRC  250 (353)
T ss_dssp             ---------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTTTTT
T ss_pred             CccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhccccc
Confidence                   111235789999999654 36788899999999999999999999976543221111111111111000   0


Q ss_pred             hhhhhhh---------hhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          151 VVDANLV---------REEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       151 ~~~~~~~---------~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                      .......         ...........++.++.+++.+||..||++|||+.|+++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (353)
T 2b9h_A          251 IESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE  305 (353)
T ss_dssp             CCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            0000000         000001112346677899999999999999999999985

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=99.97  E-value=1.1e-30  Score=198.44  Aligned_cols=172  Identities=27%  Similarity=0.274  Sum_probs=132.8

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |++|+|.+++.... .+++..+..++.|++.||.|||    +.+++|+||||+||+++.++.++++|||++........ 
T Consensus       106 ~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~-  179 (298)
T 1phk_A          106 MKKGELFDYLTEKV-TLSEKETRKIMRALLEVICALH----KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK-  179 (298)
T ss_dssp             CTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCC-
T ss_pred             cCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCcceEEEcCCCcEEEecccchhhcCCCcc-
Confidence            47899999998644 4899999999999999999999    89999999999999999999999999999987654332 


Q ss_pred             ccccCCCCCccccCCCCCC------CCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhh
Q 037267           81 VTQTMTMATIGYMAPEYGS------EGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDA  154 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~------~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (202)
                        .....+++.|+|||.+.      ...++.++|+||+|+++|++++|..||.......  ....+........      
T Consensus       180 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~~------  249 (298)
T 1phk_A          180 --LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML--MLRMIMSGNYQFG------  249 (298)
T ss_dssp             --BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHTCCCCC------
T ss_pred             --cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHH--HHHHHhcCCcccC------
Confidence              22345789999999753      4567889999999999999999999996543211  1111111110000      


Q ss_pred             hhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          155 NLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                              .+....++.++.+++.+||..||++|||+.++++
T Consensus       250 --------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          250 --------SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             --------TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             --------cccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence                    0011234566899999999999999999999974

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=99.97  E-value=9.3e-32  Score=204.48  Aligned_cols=174  Identities=25%  Similarity=0.265  Sum_probs=124.6

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCc-
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED-   79 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~-   79 (202)
                      |++|+|.+++...+..+++..+..++.|++.||.|||    +.+++|+||||+||+++.++.++++|||++........ 
T Consensus        97 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH----~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~  172 (303)
T 1zy4_A           97 CENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIH----SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDI  172 (303)
T ss_dssp             CCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEECTTSCEEECCCCCCSCTTC----
T ss_pred             CCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHH----hCCeecccCCHHhEEEcCCCCEEEeeCcchhhcccccch
Confidence            5789999999876666899999999999999999999    89999999999999999999999999999876542210 


Q ss_pred             -----------cccccCCCCCccccCCCCCCCC-CcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCC
Q 037267           80 -----------FVTQTMTMATIGYMAPEYGSEG-IVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHG  147 (202)
Q Consensus        80 -----------~~~~~~~~~~~~~~~pe~~~~~-~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~  147 (202)
                                 ........+++.|+|||.+.+. .++.++|+||+|+++|++++   ||............ +..... .
T Consensus       173 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~~~-~~~~~~-~  247 (303)
T 1zy4_A          173 LKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILKK-LRSVSI-E  247 (303)
T ss_dssp             ---------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHH-HHSTTC-C
T ss_pred             hccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHHHh-cccccc-c
Confidence                       0111234578899999987654 67889999999999999998   55432211111111 110000 0


Q ss_pred             hhhhhhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          148 LTEVVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                      ..             ...+...+..+.+++.+||+.||++|||+.++++
T Consensus       248 ~~-------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  283 (303)
T 1zy4_A          248 FP-------------PDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN  283 (303)
T ss_dssp             CC-------------TTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cC-------------ccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence            00             0011234455889999999999999999999986

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=99.97  E-value=2.2e-31  Score=210.69  Aligned_cols=190  Identities=18%  Similarity=0.188  Sum_probs=123.4

Q ss_pred             CCcHHHHHhhcC--------CCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceee----CCCCceEEccccc
Q 037267            3 NGSLEKWLYSYN--------YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILL----DENMVAHVSDFGI   70 (202)
Q Consensus         3 ~gsL~~~l~~~~--------~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~----~~~~~~~l~d~g~   70 (202)
                      +|+|.+++....        ..+++..+..++.||+.||.|||    +.+|+||||||+||++    +.++.+||+|||+
T Consensus       103 ~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH----~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~  178 (405)
T 3rgf_A          103 EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH----ANWVLHRDLKPANILVMGEGPERGRVKIADMGF  178 (405)
T ss_dssp             SEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECCSSTTTTCEEECCTTC
T ss_pred             CCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH----hCCEeCCCcCHHHeEEecCCCCCCcEEEEECCC
Confidence            568888876321        24899999999999999999999    8999999999999999    6778999999999


Q ss_pred             ceeccCCCcc-ccccCCCCCccccCCCCCCC-CCcCcchhhhhHHHHHHHHHhCCCCCCcccccc--------hhhHHHH
Q 037267           71 SKLLGEGEDF-VTQTMTMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGE--------MSLRRWV  140 (202)
Q Consensus        71 ~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~-~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~--------~~~~~~~  140 (202)
                      +......... .......+|+.|+|||.+.+ ..++.++|+||+||++|+|++|..||.......        ..+...+
T Consensus       179 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~  258 (405)
T 3rgf_A          179 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF  258 (405)
T ss_dssp             CC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHH
T ss_pred             ceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHH
Confidence            9876532211 12233468999999998776 458899999999999999999999997543321        1111111


Q ss_pred             HH-hCCC--Chhhhhhh---h-----hhhh--------HHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          141 KE-SLPH--GLTEVVDA---N-----LVRE--------EQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       141 ~~-~~~~--~~~~~~~~---~-----~~~~--------~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                      .. +.+.  .+......   .     ....        ..........+.++.+|+.+||..||++|||+.|+++
T Consensus       259 ~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~  333 (405)
T 3rgf_A          259 NVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ  333 (405)
T ss_dssp             HHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            11 1110  01111000   0     0000        0000000011456889999999999999999999975

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=99.97  E-value=3.4e-31  Score=211.15  Aligned_cols=173  Identities=23%  Similarity=0.309  Sum_probs=122.4

Q ss_pred             CCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCC-----CCceEEcccccceeccCC
Q 037267            3 NGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDE-----NMVAHVSDFGISKLLGEG   77 (202)
Q Consensus         3 ~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~-----~~~~~l~d~g~~~~~~~~   77 (202)
                      +|+|.+++......++...+..++.|++.||.|||    +.+|+||||||+||+++.     ...++|+|||++......
T Consensus       101 ~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH----~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~  176 (432)
T 3p23_A          101 AATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH----SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVG  176 (432)
T ss_dssp             SEEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHH----HTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC---
T ss_pred             CCCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHH----HCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCC
Confidence            57999999876655666678899999999999999    899999999999999953     235789999999876543


Q ss_pred             Ccc-ccccCCCCCccccCCCCCC---CCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhCCCChhhhh
Q 037267           78 EDF-VTQTMTMATIGYMAPEYGS---EGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVV  152 (202)
Q Consensus        78 ~~~-~~~~~~~~~~~~~~pe~~~---~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  152 (202)
                      ... .......||+.|+|||.+.   +..++.++|+||+||++|++++ |..||.........   ..   .........
T Consensus       177 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~---~~---~~~~~~~~~  250 (432)
T 3p23_A          177 RHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQAN---IL---LGACSLDCL  250 (432)
T ss_dssp             ---------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHH---HH---TTCCCCTTS
T ss_pred             CcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHH---HH---hccCCcccc
Confidence            211 1223356899999999876   3556778999999999999999 89998543222110   00   000000000


Q ss_pred             hhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          153 DANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                      .           .....+..+.+++.+||+.||++|||+.++++
T Consensus       251 ~-----------~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          251 H-----------PEKHEDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             C-----------TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             C-----------ccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence            0           01123445789999999999999999999983

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=99.97  E-value=5.6e-31  Score=200.70  Aligned_cols=169  Identities=23%  Similarity=0.240  Sum_probs=128.9

Q ss_pred             CcHHHHHhhc-CCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcccc
Q 037267            4 GSLEKWLYSY-NYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVT   82 (202)
Q Consensus         4 gsL~~~l~~~-~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~   82 (202)
                      ++|.+++... ...+++..+..++.|++.||.|||    +.+++||||||+||+++.++.++++|||.+...........
T Consensus        92 ~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH----~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~  167 (305)
T 2wtk_C           92 CGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLH----SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDT  167 (305)
T ss_dssp             EEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCSSCE
T ss_pred             CCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHH----HCCeeecCCCcccEEEcCCCcEEeeccccccccCccccccc
Confidence            4477777653 346899999999999999999999    89999999999999999999999999999987653322222


Q ss_pred             ccCCCCCccccCCCCCCCCC--cCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhH
Q 037267           83 QTMTMATIGYMAPEYGSEGI--VSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREE  160 (202)
Q Consensus        83 ~~~~~~~~~~~~pe~~~~~~--~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (202)
                      .....++..|+|||...+..  ++.++|+||+|+++|++++|..||.......  ....+.....               
T Consensus       168 ~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~i~~~~~---------------  230 (305)
T 2wtk_C          168 CRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYK--LFENIGKGSY---------------  230 (305)
T ss_dssp             ECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHCCC---------------
T ss_pred             cccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHH--HHHHHhcCCC---------------
Confidence            23346889999999876543  4678999999999999999999997532111  1111111100               


Q ss_pred             HHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          161 QAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       161 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                         ..+..++..+.+++.+||..||++|||+.|+++
T Consensus       231 ---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  263 (305)
T 2wtk_C          231 ---AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQ  263 (305)
T ss_dssp             ---CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             ---CCCCccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence               011234566889999999999999999999985

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=99.97  E-value=8.3e-31  Score=205.25  Aligned_cols=182  Identities=20%  Similarity=0.200  Sum_probs=127.3

Q ss_pred             CCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcccc
Q 037267            3 NGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVT   82 (202)
Q Consensus         3 ~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~   82 (202)
                      +|+|.+++.   ..+++..+..++.|++.||.|||    +.+|+||||||+||+++.++.++|+|||++......     
T Consensus       130 ~~~l~~~~~---~~~~~~~~~~i~~qi~~aL~~LH----~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~-----  197 (371)
T 4exu_A          130 QTDLQKIMG---MEFSEEKIQYLVYQMLKGLKYIH----SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE-----  197 (371)
T ss_dssp             CEEHHHHTT---SCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEECTTCCEEECSTTCC-----------
T ss_pred             cccHHHHhh---cCCCHHHHHHHHHHHHHHHHHHH----HCCCcCCCcCHHHeEECCCCCEEEEecCcccccccC-----
Confidence            467887774   23899999999999999999999    899999999999999999999999999999765432     


Q ss_pred             ccCCCCCccccCCCCCCC-CCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCC-hhhhhhhh-----
Q 037267           83 QTMTMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHG-LTEVVDAN-----  155 (202)
Q Consensus        83 ~~~~~~~~~~~~pe~~~~-~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~-----  155 (202)
                      .....+++.|+|||.+.+ ..++.++|+||+|+++|++++|..||..................+.. ........     
T Consensus       198 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  277 (371)
T 4exu_A          198 MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSY  277 (371)
T ss_dssp             --CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHH
T ss_pred             cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhh
Confidence            123467899999997766 67889999999999999999999999764432211111111111100 00000000     


Q ss_pred             ---hhh--hHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          156 ---LVR--EEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       156 ---~~~--~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                         ...  ..........++.++.+|+.+||..||++|||+.|+++
T Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  323 (371)
T 4exu_A          278 IQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  323 (371)
T ss_dssp             HHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             hhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence               000  00001122345677999999999999999999999975

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=99.97  E-value=7.9e-32  Score=207.10  Aligned_cols=159  Identities=19%  Similarity=0.208  Sum_probs=127.4

Q ss_pred             CCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeC-CCCceEEcccccceeccCCCccc
Q 037267            3 NGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLD-ENMVAHVSDFGISKLLGEGEDFV   81 (202)
Q Consensus         3 ~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~-~~~~~~l~d~g~~~~~~~~~~~~   81 (202)
                      +++|.+++.... .+++..+..++.|++.||.|||    +.+|+||||||+||+++ .++.+||+|||++.......   
T Consensus       133 ~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH----~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~~~~---  204 (320)
T 3a99_A          133 VQDLFDFITERG-ALQEELARSFFWQVLEAVRHCH----NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---  204 (320)
T ss_dssp             EEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCSSC---
T ss_pred             CccHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH----HCCcEeCCCCHHHEEEeCCCCCEEEeeCcccccccccc---
Confidence            389999998644 4899999999999999999999    89999999999999999 78899999999998765432   


Q ss_pred             cccCCCCCccccCCCCCCCCCc-CcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhH
Q 037267           82 TQTMTMATIGYMAPEYGSEGIV-SAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREE  160 (202)
Q Consensus        82 ~~~~~~~~~~~~~pe~~~~~~~-~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (202)
                       .....+++.|+|||.+.+..+ +.++|+||+|+++|++++|..||.....       ......            .   
T Consensus       205 -~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-------~~~~~~------------~---  261 (320)
T 3a99_A          205 -YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-------IIRGQV------------F---  261 (320)
T ss_dssp             -BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-------HHHCCC------------C---
T ss_pred             -ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh-------hhcccc------------c---
Confidence             123458899999997766554 6778999999999999999999965211       000000            0   


Q ss_pred             HHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          161 QAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       161 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                          ....++.++.+++.+||..||++|||+.++++
T Consensus       262 ----~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  293 (320)
T 3a99_A          262 ----FRQRVSSECQHLIRWCLALRPSDRPTFEEIQN  293 (320)
T ss_dssp             ----CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ----ccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                01124456889999999999999999999986

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=99.97  E-value=1.7e-31  Score=213.09  Aligned_cols=175  Identities=25%  Similarity=0.334  Sum_probs=121.3

Q ss_pred             CCcHHHHHhhcCCC------CCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCC-------------Cce
Q 037267            3 NGSLEKWLYSYNYF------FDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN-------------MVA   63 (202)
Q Consensus         3 ~gsL~~~l~~~~~~------l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~-------------~~~   63 (202)
                      +|||.+++......      .++..++.++.|++.||.|||    +.+|+||||||+||+++.+             +.+
T Consensus        92 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH----~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~  167 (434)
T 2rio_A           92 NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH----SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRI  167 (434)
T ss_dssp             SEEHHHHHHTC------------CCHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred             CCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHH----HCCccccCCChHhEEEecCcccccccccCCCceEE
Confidence            57999999864321      123346789999999999999    8999999999999999754             479


Q ss_pred             EEcccccceeccCCCccc--cccCCCCCccccCCCCCCC-------CCcCcchhhhhHHHHHHHHHh-CCCCCCcccccc
Q 037267           64 HVSDFGISKLLGEGEDFV--TQTMTMATIGYMAPEYGSE-------GIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGE  133 (202)
Q Consensus        64 ~l~d~g~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~-------~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~  133 (202)
                      ||+|||++..........  ......|++.|+|||++.+       ..++.++|+||+||++|++++ |..||.......
T Consensus       168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~  247 (434)
T 2rio_A          168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE  247 (434)
T ss_dssp             EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH
T ss_pred             EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH
Confidence            999999998765432211  1223468999999997654       567889999999999999998 999996543222


Q ss_pred             hhhHHHHHHhCCCChhhhhhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          134 MSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       134 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                      .   ..........  ..  .        ......++.++.+++.+||+.||++|||+.++++
T Consensus       248 ~---~i~~~~~~~~--~~--~--------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          248 S---NIIRGIFSLD--EM--K--------CLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             H---HHHHTCCCCC--CC--T--------TCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             H---HHhcCCCCcc--cc--c--------ccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence            1   1111111000  00  0        0011245677999999999999999999999975

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=99.97  E-value=1.8e-30  Score=202.22  Aligned_cols=188  Identities=16%  Similarity=0.145  Sum_probs=129.9

Q ss_pred             CCcHHHHHhh---cCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCC-CCceEEcccccceeccCCC
Q 037267            3 NGSLEKWLYS---YNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDE-NMVAHVSDFGISKLLGEGE   78 (202)
Q Consensus         3 ~gsL~~~l~~---~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~-~~~~~l~d~g~~~~~~~~~   78 (202)
                      .|+|.+.+..   ....+++..+..++.|++.||.|||..  +.+|+||||||+||+++. ++.+||+|||++.......
T Consensus       109 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~--~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~~~  186 (360)
T 3e3p_A          109 PDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLP--SVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSE  186 (360)
T ss_dssp             SCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTST--TTCCBCSCCCGGGEEEETTTTEEEECCCTTCBCCCTTS
T ss_pred             cccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCC--CCCeecCcCCHHHEEEeCCCCcEEEeeCCCceecCCCC
Confidence            3556555542   344589999999999999999999942  579999999999999996 8999999999998765433


Q ss_pred             ccccccCCCCCccccCCCCCCCC-CcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhh--hhhh-
Q 037267           79 DFVTQTMTMATIGYMAPEYGSEG-IVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTE--VVDA-  154 (202)
Q Consensus        79 ~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~-  154 (202)
                      .   .....+++.|+|||.+.+. .++.++|+||+|+++|++++|..||........ +..............  .... 
T Consensus       187 ~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  262 (360)
T 3e3p_A          187 P---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQ-LHEIVRVLGCPSREVLRKLNPS  262 (360)
T ss_dssp             C---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHHCCCCHHHHHHHCTT
T ss_pred             C---cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHH-HHHHHHHcCCCCHHHHHhcccc
Confidence            2   2234578999999977554 478999999999999999999999976433221 111111110000000  0000 


Q ss_pred             ----------hhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          155 ----------NLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       155 ----------~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                                ...............+.++.+++.+||+.||++|||+.|+++
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  314 (360)
T 3e3p_A          263 HTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC  314 (360)
T ss_dssp             CCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             hhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence                      000000000111225677999999999999999999999875

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=99.97  E-value=2e-31  Score=203.92  Aligned_cols=161  Identities=22%  Similarity=0.258  Sum_probs=129.1

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeC-CCCceEEcccccceeccCCCc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLD-ENMVAHVSDFGISKLLGEGED   79 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~-~~~~~~l~d~g~~~~~~~~~~   79 (202)
                      +++++|.+++.... .+++..+..++.|++.||.|||    +.+++||||||+||+++ .++.++|+|||++....... 
T Consensus       121 ~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~~~~~~~~-  194 (312)
T 2iwi_A          121 LPAQDLFDYITEKG-PLGEGPSRCFFGQVVAAIQHCH----SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEP-  194 (312)
T ss_dssp             SSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH----HHTEECCCCSGGGEEEETTTTEEEECCCSSCEECCSSC-
T ss_pred             CCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeeecCCChhhEEEeCCCCeEEEEEcchhhhcccCc-
Confidence            36899999998644 4899999999999999999999    89999999999999999 88999999999998765432 


Q ss_pred             cccccCCCCCccccCCCCCCCCCc-CcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhh
Q 037267           80 FVTQTMTMATIGYMAPEYGSEGIV-SAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVR  158 (202)
Q Consensus        80 ~~~~~~~~~~~~~~~pe~~~~~~~-~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (202)
                         .....++..|+|||...+..+ +.++|+||+|+++|++++|..||.....       ......            . 
T Consensus       195 ---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-------~~~~~~------------~-  251 (312)
T 2iwi_A          195 ---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE-------ILEAEL------------H-  251 (312)
T ss_dssp             ---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-------HHHTCC------------C-
T ss_pred             ---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH-------Hhhhcc------------C-
Confidence               123458899999997765555 4489999999999999999999964211       000000            0 


Q ss_pred             hHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          159 EEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       159 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                            .+..++.++.+++.+||..||++|||+.|+++
T Consensus       252 ------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~  283 (312)
T 2iwi_A          252 ------FPAHVSPDCCALIRRCLAPKPSSRPSLEEILL  283 (312)
T ss_dssp             ------CCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             ------CcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                  01124456889999999999999999999986

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=99.96  E-value=1.8e-30  Score=198.89  Aligned_cols=186  Identities=20%  Similarity=0.228  Sum_probs=129.9

Q ss_pred             CCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeC-CCCceEEcccccceeccCCCcc-
Q 037267            3 NGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLD-ENMVAHVSDFGISKLLGEGEDF-   80 (202)
Q Consensus         3 ~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~-~~~~~~l~d~g~~~~~~~~~~~-   80 (202)
                      +|+|.+++..  ..+++..+..++.|++.||.|||    +.+++||||||+||+++ .++.+||+|||++......... 
T Consensus       105 ~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~  178 (320)
T 2i6l_A          105 ETDLANVLEQ--GPLLEEHARLFMYQLLRGLKYIH----SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHK  178 (320)
T ss_dssp             SEEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHH----HTTCBCCCCSGGGEEEETTTTEEEECCCTTCBCC-------
T ss_pred             CCCHHHHhhc--CCccHHHHHHHHHHHHHHHHHHH----hCCEecCCCCHHHEEEcCCCCeEEEccCccccccCCCcccc
Confidence            4799999975  34899999999999999999999    89999999999999997 5679999999999865432111 


Q ss_pred             ccccCCCCCccccCCCCCCC-CCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhh-----
Q 037267           81 VTQTMTMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDA-----  154 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~-~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----  154 (202)
                      .......++..|+|||...+ ..++.++|+||+|+++|++++|..||.......  ....+....+.........     
T Consensus       179 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  256 (320)
T 2i6l_A          179 GHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELE--QMQLILESIPVVHEEDRQELLSVI  256 (320)
T ss_dssp             -CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHSCCCCHHHHHHHHTTS
T ss_pred             cccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHhcCCCchhhhhhhhhcC
Confidence            11122346888999996544 568889999999999999999999997654322  1111222221111110000     


Q ss_pred             ------hhhhh-HHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          155 ------NLVRE-EQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       155 ------~~~~~-~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                            ..... .........++.++.+++.+||+.||++|||+.|+++
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (320)
T 2i6l_A          257 PVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS  305 (320)
T ss_dssp             CHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             cccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence                  00000 0001112346778999999999999999999999975

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=99.96  E-value=1.2e-30  Score=199.81  Aligned_cols=171  Identities=26%  Similarity=0.272  Sum_probs=120.5

Q ss_pred             CCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCC-CeeecCCCCCceeeCCCCceEEcccccceeccCCCccc
Q 037267            3 NGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSA-PIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFV   81 (202)
Q Consensus         3 ~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~-~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~~   81 (202)
                      ++.+..+.......+++..+..++.|++.||.|||    +. +++|+||||+||+++.++.++|+|||++........  
T Consensus       107 ~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH----~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~--  180 (318)
T 2dyl_A          107 GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLK----EKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKA--  180 (318)
T ss_dssp             SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH----HHHCCCCCCCCGGGEEECTTSCEEECCCTTC----------
T ss_pred             CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH----hhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCcc--
Confidence            44555555544556899999999999999999999    74 999999999999999999999999999876543221  


Q ss_pred             cccCCCCCccccCCCCCC-----CCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhh
Q 037267           82 TQTMTMATIGYMAPEYGS-----EGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANL  156 (202)
Q Consensus        82 ~~~~~~~~~~~~~pe~~~-----~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (202)
                       .....+++.|+|||.+.     +..++.++|+||+|+++|++++|..||.........+........ ...        
T Consensus       181 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~-~~~--------  250 (318)
T 2dyl_A          181 -KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEP-PLL--------  250 (318)
T ss_dssp             -------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCC-CCC--------
T ss_pred             -ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCC-CCC--------
Confidence             12235789999999863     456788999999999999999999999764332222222111111 000        


Q ss_pred             hhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          157 VREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                             +....++.++.+++.+||..||.+|||+.++++
T Consensus       251 -------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (318)
T 2dyl_A          251 -------PGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE  283 (318)
T ss_dssp             -------CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             -------CccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence                   000124456899999999999999999999875

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=99.96  E-value=6.5e-31  Score=202.39  Aligned_cols=173  Identities=27%  Similarity=0.276  Sum_probs=111.0

Q ss_pred             CCcHHHHHhh----cCCCCCHHHHHHHHHHHHHhhhcccCCCCCC-CeeecCCCCCceeeCCCCceEEcccccceeccCC
Q 037267            3 NGSLEKWLYS----YNYFFDILERLNIMIDVGSALEYPHHGHSSA-PIIHCDLKPTNILLDENMVAHVSDFGISKLLGEG   77 (202)
Q Consensus         3 ~gsL~~~l~~----~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~-~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~   77 (202)
                      .|+|.+++..    ....+++..+..++.|++.||.|||    +. +++||||||+||+++.++.+||+|||++......
T Consensus       104 ~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH----~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  179 (327)
T 3aln_A          104 STSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK----ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDS  179 (327)
T ss_dssp             SEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHH----HHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC----
T ss_pred             CCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHh----ccCCEeECCCCHHHEEEcCCCCEEEccCCCceecccc
Confidence            4678888763    2445899999999999999999999    77 9999999999999999999999999999765433


Q ss_pred             CccccccCCCCCccccCCCCC----CCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhh
Q 037267           78 EDFVTQTMTMATIGYMAPEYG----SEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVD  153 (202)
Q Consensus        78 ~~~~~~~~~~~~~~~~~pe~~----~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (202)
                      ..   .....+++.|+|||.+    .+..++.++|+||+|+++|++++|..||................ .+...     
T Consensus       180 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~-----  250 (327)
T 3aln_A          180 IA---KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKG-DPPQL-----  250 (327)
T ss_dssp             -----------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCS-CCCCC-----
T ss_pred             cc---cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcC-CCCCC-----
Confidence            21   1223588899999987    45568889999999999999999999997643211111000000 00000     


Q ss_pred             hhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          154 ANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                         ..     .....++.++.+++.+||..||++|||+.++++
T Consensus       251 ---~~-----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  285 (327)
T 3aln_A          251 ---SN-----SEEREFSPSFINFVNLCLTKDESKRPKYKELLK  285 (327)
T ss_dssp             ---CC-----CSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             ---CC-----cccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence               00     000124556899999999999999999999865

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=99.96  E-value=5.2e-30  Score=193.99  Aligned_cols=171  Identities=25%  Similarity=0.287  Sum_probs=129.6

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCC---CceEEcccccceeccCC
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN---MVAHVSDFGISKLLGEG   77 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~---~~~~l~d~g~~~~~~~~   77 (202)
                      |++++|.+++.... .+++..+..++.|++.||.|||    +.+++|+||||+||+++.+   +.++++|||++......
T Consensus       103 ~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH----~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~  177 (287)
T 2wei_A          103 YTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMH----KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN  177 (287)
T ss_dssp             CCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCC
T ss_pred             cCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCC
Confidence            47899999997654 4899999999999999999999    8999999999999999754   46999999998765433


Q ss_pred             CccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhh
Q 037267           78 EDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV  157 (202)
Q Consensus        78 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (202)
                      ...   ....+++.|+|||.+.+ .++.++|+||+|+++|++++|..||.......  ....+........         
T Consensus       178 ~~~---~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~~---------  242 (287)
T 2wei_A          178 TKM---KDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD--ILKRVETGKYAFD---------  242 (287)
T ss_dssp             SSC---SCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHCCCCCC---------
T ss_pred             Ccc---ccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHH--HHHHHHcCCCCCC---------
Confidence            211   12246788999998765 47889999999999999999999997643221  1111111110000         


Q ss_pred             hhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          158 REEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                           .+....++.++.+++.+||..||++|||+.++++
T Consensus       243 -----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  276 (287)
T 2wei_A          243 -----LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (287)
T ss_dssp             -----SGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -----chhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence                 0011234566899999999999999999999987

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=99.96  E-value=2e-30  Score=201.67  Aligned_cols=181  Identities=22%  Similarity=0.231  Sum_probs=125.7

Q ss_pred             CCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcccc
Q 037267            3 NGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVT   82 (202)
Q Consensus         3 ~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~   82 (202)
                      +|+|.+++..   .+++..+..++.|++.||.|||    +.+++||||||+||+++.++.++|+|||++......     
T Consensus       112 ~~~l~~~~~~---~~~~~~~~~i~~qi~~al~~LH----~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~-----  179 (353)
T 3coi_A          112 QTDLQKIMGL---KFSEEKIQYLVYQMLKGLKYIH----SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE-----  179 (353)
T ss_dssp             SEEGGGTTTS---CCCHHHHHHHHHHHHHHHHHHH----HTTCCCSSCCGGGEEECTTCCEEECSTTCTTC---------
T ss_pred             cCCHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEeECCCCcEEEeecccccCCCCC-----
Confidence            3577776642   3899999999999999999999    899999999999999999999999999998764322     


Q ss_pred             ccCCCCCccccCCCCCCC-CCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHH-HhCCCC-h-hhhhhhh---
Q 037267           83 QTMTMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVK-ESLPHG-L-TEVVDAN---  155 (202)
Q Consensus        83 ~~~~~~~~~~~~pe~~~~-~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~-~-~~~~~~~---  155 (202)
                      .....+++.|+|||.+.+ ..++.++|+||+|+++|++++|..||........ +..... .+.+.. . .......   
T Consensus       180 ~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~~  258 (353)
T 3coi_A          180 MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ-LTQILKVTGVPGTEFVQKLNDKAAKS  258 (353)
T ss_dssp             ----CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHH-HHHHHHHHCBCCHHHHTTCSCHHHHH
T ss_pred             ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCCHHHHHHHhhHHHHH
Confidence            122457899999997665 5688899999999999999999999976432221 111111 011000 0 0000000   


Q ss_pred             ----hhh--hHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          156 ----LVR--EEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       156 ----~~~--~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                          ...  ..........++.++.+++.+||..||++|||+.++++
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  305 (353)
T 3coi_A          259 YIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  305 (353)
T ss_dssp             HHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence                000  00000011235677999999999999999999999974

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=99.96  E-value=1.7e-29  Score=192.31  Aligned_cols=156  Identities=23%  Similarity=0.323  Sum_probs=116.7

Q ss_pred             CCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCC---CCceEEcccccceeccC
Q 037267            1 MPNGSLEKWLYSYN-YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDE---NMVAHVSDFGISKLLGE   76 (202)
Q Consensus         1 ~~~gsL~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~---~~~~~l~d~g~~~~~~~   76 (202)
                      |++|+|.+++.... ..+++..+..++.|++.||.|||    +.+++||||||+||+++.   ++.++++|||++.... 
T Consensus        97 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~-  171 (299)
T 3m2w_A           97 LDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH----SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT-  171 (299)
T ss_dssp             CCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT-
T ss_pred             cCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCCHHHEEEecCCCCCcEEEeccccccccc-
Confidence            57899999998654 36999999999999999999999    899999999999999997   7889999999886532 


Q ss_pred             CCccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhh
Q 037267           77 GEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANL  156 (202)
Q Consensus        77 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (202)
                                             +..++.++|+||+||++|++++|..||.........          ......+....
T Consensus       172 -----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~----------~~~~~~~~~~~  218 (299)
T 3m2w_A          172 -----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS----------PGMKTRIRMGQ  218 (299)
T ss_dssp             -----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-----------------CCSCCSSCTTC
T ss_pred             -----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh----------HHHHHHHhhcc
Confidence                                   134677899999999999999999999754322100          00000000000


Q ss_pred             hhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          157 VREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                      .  ....+....++.++.+++.+||+.||++|||+.|+++
T Consensus       219 ~--~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~  256 (299)
T 3m2w_A          219 Y--EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  256 (299)
T ss_dssp             C--SSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             c--cCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            0  0001112345677999999999999999999999986

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=99.96  E-value=3.7e-30  Score=212.78  Aligned_cols=187  Identities=23%  Similarity=0.219  Sum_probs=129.0

Q ss_pred             CCCCcHHHHHhhcCC--CCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCc---eEEcccccceecc
Q 037267            1 MPNGSLEKWLYSYNY--FFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMV---AHVSDFGISKLLG   75 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~--~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~---~~l~d~g~~~~~~   75 (202)
                      |+||||.+++.....  .+++..+..++.|++.||.|||    +.+|+||||||+||+++.++.   ++++|||.+....
T Consensus       100 ~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLH----s~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~~  175 (676)
T 3qa8_A          100 CEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH----ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD  175 (676)
T ss_dssp             CSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHH----HTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCCBTT
T ss_pred             CCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH----HCCCccCCCCHHHeEeecCCCceeEEEcccccccccc
Confidence            579999999986442  5899999999999999999999    899999999999999986654   8999999998765


Q ss_pred             CCCccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCC-CChhhhhhh
Q 037267           76 EGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLP-HGLTEVVDA  154 (202)
Q Consensus        76 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  154 (202)
                      ....   .....+++.|+|||.+.+..++.++|+||+|+++|++++|..||................... .........
T Consensus       176 ~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~g  252 (676)
T 3qa8_A          176 QGEL---CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTG  252 (676)
T ss_dssp             SCCC---CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCCSS
T ss_pred             cccc---cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhhcc
Confidence            4332   223468999999999998899999999999999999999999996532111000000000000 000000000


Q ss_pred             hhhhh---HHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHH
Q 037267          155 NLVRE---EQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDA  194 (202)
Q Consensus       155 ~~~~~---~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~  194 (202)
                      .....   ..........+..+.+++.+||..||++|||+.++
T Consensus       253 ~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~el  295 (676)
T 3qa8_A          253 AVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQN  295 (676)
T ss_dssp             SCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTC
T ss_pred             ccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHH
Confidence            00000   00000112356779999999999999999999873

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=99.95  E-value=1.7e-28  Score=205.67  Aligned_cols=159  Identities=22%  Similarity=0.309  Sum_probs=122.1

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |+|++|.+++..   .+++..++.++.|++.||.|||    +.+|+||||||+||+++.+ .+||+|||++......   
T Consensus       166 ~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH----~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~---  234 (681)
T 2pzi_A          166 VGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLH----SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF---  234 (681)
T ss_dssp             CCCEECC----C---CCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECSS-CEEECCCTTCEETTCC---
T ss_pred             CCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHH----HCCCeecccChHHeEEeCC-cEEEEecccchhcccC---
Confidence            578999998864   5899999999999999999999    8999999999999999975 8999999999876543   


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhH
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREE  160 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (202)
                         ....||+.|+|||.+.+. ++.++|+||+|+++|++++|..||........          +.           .. 
T Consensus       235 ---~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~----------~~-----------~~-  288 (681)
T 2pzi_A          235 ---GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDGL----------PE-----------DD-  288 (681)
T ss_dssp             ---SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSSC----------CT-----------TC-
T ss_pred             ---CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcccccccc----------cc-----------cc-
Confidence               234689999999987654 37899999999999999999888765321110          00           00 


Q ss_pred             HHHHHhHHHHHHHHHHHhhhcCCCCCCCCC-HHHHHHHHhh
Q 037267          161 QAFAAKMDCIVSIMDLALDCCMESPGKRIN-MTDAAAKLKK  200 (202)
Q Consensus       161 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps-~~~~~~~l~~  200 (202)
                          .....+..+.+++.+||+.||++||+ +.++...|..
T Consensus       289 ----~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~  325 (681)
T 2pzi_A          289 ----PVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG  325 (681)
T ss_dssp             ----HHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             ----cccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence                01123456889999999999999995 6666665543

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=99.95  E-value=7e-28  Score=182.45  Aligned_cols=151  Identities=13%  Similarity=0.060  Sum_probs=112.9

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |+|++|.++++..   ....++..++.|++.||.|||    +.+|+||||||+||+++.++.+++++++           
T Consensus       113 ~~g~~L~~~l~~~---~~~~~~~~i~~ql~~aL~~lH----~~givH~Dikp~NIll~~~g~~kl~~~~-----------  174 (286)
T 3uqc_A          113 IRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAH----RAGVALSIDHPSRVRVSIDGDVVLAYPA-----------  174 (286)
T ss_dssp             CCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCSGGGEEEETTSCEEECSCC-----------
T ss_pred             cCCCCHHHHHhcC---CChHHHHHHHHHHHHHHHHHH----HCCCccCCCCcccEEEcCCCCEEEEecc-----------
Confidence            5789999999642   356678999999999999999    8999999999999999999999987432           


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhH
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREE  160 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (202)
                                 |++       .++.++|+||+||++|++++|..||.............          .......   .
T Consensus       175 -----------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~----------~~~~~~~---~  223 (286)
T 3uqc_A          175 -----------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE----------RDTAGQP---I  223 (286)
T ss_dssp             -----------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECC----------BCTTSCB---C
T ss_pred             -----------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHH----------HHhccCC---C
Confidence                       112       25788999999999999999999998654322100000          0000000   0


Q ss_pred             HHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          161 QAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       161 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                      ........++.++.+++.+||+.||++| |+.|+++.|+++
T Consensus       224 ~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~  263 (286)
T 3uqc_A          224 EPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQA  263 (286)
T ss_dssp             CHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHH
T ss_pred             ChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHH
Confidence            0011123466779999999999999999 999999999864

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=99.93  E-value=8.2e-27  Score=180.20  Aligned_cols=165  Identities=15%  Similarity=0.100  Sum_probs=119.3

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCC-------------------
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENM-------------------   61 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~-------------------   61 (202)
                      |++|++.+.+.+  ..+++..+..++.|++.||.|||+   +.+|+||||||+|||++.++                   
T Consensus       144 ~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~aL~~lH~---~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~  218 (336)
T 2vuw_A          144 EFGGIDLEQMRT--KLSSLATAKSILHQLTASLAVAEA---SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCG  218 (336)
T ss_dssp             ECCCEETGGGTT--TCCCHHHHHHHHHHHHHHHHHHHH---HHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTT
T ss_pred             cCCCccHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHH---hCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCC
Confidence            467877666654  348999999999999999999993   47899999999999999876                   


Q ss_pred             -ceEEcccccceeccCCCccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHH-HHHHHhCCCCCCcccccchhhHHH
Q 037267           62 -VAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVL-LMETFTRKRPTDEMFTGEMSLRRW  139 (202)
Q Consensus        62 -~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~-~~~~~~g~~p~~~~~~~~~~~~~~  139 (202)
                       .+||+|||+++.....       ...||+.|+|||.+.+.. +.++||||+++. .+++++|..||.............
T Consensus       219 ~~vkL~DFG~a~~~~~~-------~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~  290 (336)
T 2vuw_A          219 LQVSIIDYTLSRLERDG-------IVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKM  290 (336)
T ss_dssp             EEEEECCCTTCBEEETT-------EEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHH
T ss_pred             ceEEEeeccccEecCCC-------cEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhh
Confidence             8999999999875532       236899999999988766 889999998776 667788988874311000000000


Q ss_pred             HHHhCCCChhhhhhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHH
Q 037267          140 VKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAA  195 (202)
Q Consensus       140 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~  195 (202)
                      .. ..           .............+++++.+|+.+||.+|     |+.|++
T Consensus       291 ~~-~~-----------~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l  329 (336)
T 2vuw_A          291 LK-QM-----------TFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLL  329 (336)
T ss_dssp             HH-TC-----------CCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHH
T ss_pred             hh-hh-----------ccCcccchhhhhhcCHHHHHHHHHHhccC-----CHHHHH
Confidence            00 00           00000011223467888999999999987     999887

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.86  E-value=1.7e-23  Score=171.78  Aligned_cols=112  Identities=19%  Similarity=0.090  Sum_probs=76.8

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |+||+|.++|.... .++..   .++.||++||.|+|    +.||+||||||+|||++.++.+||+|||+++........
T Consensus       324 v~G~~L~d~i~~~~-~l~~~---~I~~QIl~AL~ylH----~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~  395 (569)
T 4azs_A          324 LPGRLLSDMLAAGE-EIDRE---KILGSLLRSLAALE----KQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSW  395 (569)
T ss_dssp             CCSEEHHHHHHTTC-CCCHH---HHHHHHHHHHHHHH----HTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---CC
T ss_pred             CCCCcHHHHHHhCC-CCCHH---HHHHHHHHHHHHHH----HCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCcc
Confidence            68999999998654 46664   58899999999999    999999999999999999999999999999875543221


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCC
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRK  123 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~  123 (202)
                        .....||+.|++||++.+. +..++|+||+|++++.+.++.
T Consensus       396 --~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~  435 (569)
T 4azs_A          396 --PTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPW  435 (569)
T ss_dssp             --SHHHHHHHHHHHHHHC------------------CCCCTTH
T ss_pred             --ccCceechhhccHHHhCCC-CCCcccccccccchhhhcccc
Confidence              2234689999999988764 566789999999877665544

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.67  E-value=1.7e-18  Score=141.46  Aligned_cols=111  Identities=20%  Similarity=0.239  Sum_probs=90.1

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |+||||.+++..         +..++.|++.||.|||    +.+|+||||||+||+++.  .+||+|||+++........
T Consensus       421 ~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH----~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~  485 (540)
T 3en9_A          421 INGKLAKDVIED---------NLDIAYKIGEIVGKLH----KNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDK  485 (540)
T ss_dssp             CCSEEHHHHSTT---------CTHHHHHHHHHHHHHH----HTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHH
T ss_pred             CCCCCHHHHHHH---------HHHHHHHHHHHHHHHH----HCcCccCCCCHHHEEECC--eEEEEECccCEECCCcccc
Confidence            578999999975         5689999999999999    899999999999999999  9999999999986543221


Q ss_pred             c-----cccCCCCCccccCCCCCCC--CCcCcchhhhhHHHHHHHHHhCCCCC
Q 037267           81 V-----TQTMTMATIGYMAPEYGSE--GIVSAKCDVYSYGVLLMETFTRKRPT  126 (202)
Q Consensus        81 ~-----~~~~~~~~~~~~~pe~~~~--~~~~~~~di~s~G~~~~~~~~g~~p~  126 (202)
                      .     ......||+.|+|||++..  ..|+...|+|+..+-..+-+.++.+|
T Consensus       486 ~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          486 AVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             HHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             ccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            1     1123468999999998765  45777889999888877777666554

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.32  E-value=4e-13  Score=101.19  Aligned_cols=60  Identities=17%  Similarity=0.109  Sum_probs=52.1

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEccccccee
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKL   73 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~   73 (202)
                      |+||+|.+ +..       .....++.|++.||.|||    +.+|+||||||.||+++ ++.++|+|||++..
T Consensus       182 ~~g~~L~~-l~~-------~~~~~i~~qi~~~l~~lH----~~giiHrDlkp~NILl~-~~~vkl~DFG~a~~  241 (282)
T 1zar_A          182 IDAKELYR-VRV-------ENPDEVLDMILEEVAKFY----HRGIVHGDLSQYNVLVS-EEGIWIIDFPQSVE  241 (282)
T ss_dssp             CCCEEGGG-CCC-------SCHHHHHHHHHHHHHHHH----HTTEECSCCSTTSEEEE-TTEEEECCCTTCEE
T ss_pred             cCCCcHHH-cch-------hhHHHHHHHHHHHHHHHH----HCCCEeCCCCHHHEEEE-CCcEEEEECCCCeE
Confidence            57889988 531       224579999999999999    89999999999999999 99999999999864

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.06  E-value=2.9e-11  Score=89.78  Aligned_cols=61  Identities=23%  Similarity=0.240  Sum_probs=50.8

Q ss_pred             cHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceec
Q 037267            5 SLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLL   74 (202)
Q Consensus         5 sL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~   74 (202)
                      +|.++...    .++..+..++.|++.+|.|||.   +.+|+||||||.|||++.  .++|+|||++...
T Consensus       159 ~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~---~~givHrDlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          159 TLVELGRE----LKELDVEGIFNDVVENVKRLYQ---EAELVHADLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             BHHHHGGG----GGGSCHHHHHHHHHHHHHHHHH---TSCEECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred             cHHHHhhc----cChHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence            67766542    2345678999999999999994   579999999999999998  8999999998753

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=98.55  E-value=3.4e-08  Score=77.08  Aligned_cols=49  Identities=18%  Similarity=0.200  Sum_probs=42.8

Q ss_pred             HHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCC----------ceEEccccccee
Q 037267           21 ERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENM----------VAHVSDFGISKL   73 (202)
Q Consensus        21 ~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~----------~~~l~d~g~~~~   73 (202)
                      ....++.|++.+|.+||    ..|||||||||.|||++.++          .+.|+||+-+..
T Consensus       206 ~~~~l~~qll~~l~~lH----~~gIVHrDLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~  264 (397)
T 4gyi_A          206 DPASLYADLIALILRLA----KHGLIHGDFNEFNILIREEKDAEDPSSITLTPIIIXFPQMVS  264 (397)
T ss_dssp             CHHHHHHHHHHHHHHHH----HTTEECSCCSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHHHHH----HCCCcCCCCCHHHEEEeCCCCcccccccccceEEEEeCCccc
Confidence            45678999999999999    89999999999999998766          388999987654

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=98.00  E-value=6.7e-05  Score=53.57  Aligned_cols=103  Identities=13%  Similarity=0.053  Sum_probs=65.9

Q ss_pred             CcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCccccc
Q 037267            4 GSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQ   83 (202)
Q Consensus         4 gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~   83 (202)
                      =||.+.|+..+.++++.+++.++.|.+.+|.-+-.   .+.-..+=..+..|++..+|.+.+.+ ..+.           
T Consensus        33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~---~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-----------   97 (229)
T 2yle_A           33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAAR---RRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-----------   97 (229)
T ss_dssp             EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred             ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhh---cccCCceecCCcceEEecCCceeccc-cccc-----------
Confidence            37999999888889999999999999999876510   11111223456788888898887653 1110           


Q ss_pred             cCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCC
Q 037267           84 TMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRP  125 (202)
Q Consensus        84 ~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p  125 (202)
                         .....+.+||... ...+.+.-|||+|+++|.-+--..|
T Consensus        98 ---~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~  135 (229)
T 2yle_A           98 ---AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK  135 (229)
T ss_dssp             ------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             ---ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence               0122345677542 2345677899999999998764443

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=97.61  E-value=3e-05  Score=57.08  Aligned_cols=31  Identities=29%  Similarity=0.363  Sum_probs=25.8

Q ss_pred             CCeeecCCCCCceeeCCCCceEEccccccee
Q 037267           43 APIIHCDLKPTNILLDENMVAHVSDFGISKL   73 (202)
Q Consensus        43 ~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~   73 (202)
                      ..++|+|+++.||+++....+.|+||+.+..
T Consensus       183 ~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          183 LVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             EEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             ceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence            4599999999999998766667999987643

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=97.49  E-value=8.6e-05  Score=54.29  Aligned_cols=30  Identities=20%  Similarity=0.254  Sum_probs=25.7

Q ss_pred             CeeecCCCCCceeeCCCCceEEccccccee
Q 037267           44 PIIHCDLKPTNILLDENMVAHVSDFGISKL   73 (202)
Q Consensus        44 ~i~h~dlk~~nil~~~~~~~~l~d~g~~~~   73 (202)
                      .++|+|++|.||+++.++.++++||+.+..
T Consensus       185 ~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          185 VVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             EEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             EEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence            499999999999998776677999997644

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=97.38  E-value=0.00015  Score=55.90  Aligned_cols=57  Identities=23%  Similarity=0.311  Sum_probs=45.9

Q ss_pred             CCHHHHHHHHHHHHHhhhcccCCCC------------------------------------------------------C
Q 037267           17 FDILERLNIMIDVGSALEYPHHGHS------------------------------------------------------S   42 (202)
Q Consensus        17 l~~~~~~~~~~~l~~~l~~lH~~~~------------------------------------------------------~   42 (202)
                      ++..++..++.+++..|..||....                                                      .
T Consensus       136 l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~  215 (359)
T 3dxp_A          136 MSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDADL  215 (359)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSC
T ss_pred             CCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCC
Confidence            5677888889999999999995210                                                      1


Q ss_pred             CCeeecCCCCCceeeCCCC--ceEEccccccee
Q 037267           43 APIIHCDLKPTNILLDENM--VAHVSDFGISKL   73 (202)
Q Consensus        43 ~~i~h~dlk~~nil~~~~~--~~~l~d~g~~~~   73 (202)
                      ..++|+|+++.||+++.++  .+.++||+.+..
T Consensus       216 ~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          216 TSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             CEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             ceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence            5799999999999999764  368999998875

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=96.51  E-value=0.002  Score=48.40  Aligned_cols=32  Identities=31%  Similarity=0.561  Sum_probs=27.4

Q ss_pred             CCeeecCCCCCceeeCC--CCceEEcccccceec
Q 037267           43 APIIHCDLKPTNILLDE--NMVAHVSDFGISKLL   74 (202)
Q Consensus        43 ~~i~h~dlk~~nil~~~--~~~~~l~d~g~~~~~   74 (202)
                      ..++|+|+++.||+++.  ...+.++||+.+..-
T Consensus       191 ~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~  224 (304)
T 3sg8_A          191 PCLIHNDFSSDHILFDTEKNTICGIIDFGDAAIS  224 (304)
T ss_dssp             CEEECSCCCGGGEEEETTTTEEEEECCCTTCEEE
T ss_pred             ceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccC
Confidence            46899999999999997  566789999988753

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=95.82  E-value=0.0098  Score=45.09  Aligned_cols=32  Identities=31%  Similarity=0.335  Sum_probs=28.0

Q ss_pred             CCCeeecCCCCCceeeCCCCceEEccccccee
Q 037267           42 SAPIIHCDLKPTNILLDENMVAHVSDFGISKL   73 (202)
Q Consensus        42 ~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~   73 (202)
                      ...++|+|+.+.||+++.++.+.++||+.+..
T Consensus       221 ~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          221 SPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             SCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             cCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence            57899999999999998778899999987643

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=94.93  E-value=0.033  Score=43.83  Aligned_cols=32  Identities=22%  Similarity=0.318  Sum_probs=28.2

Q ss_pred             CCCeeecCCCCCceeeCCCCceEEcccccceec
Q 037267           42 SAPIIHCDLKPTNILLDENMVAHVSDFGISKLL   74 (202)
Q Consensus        42 ~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~   74 (202)
                      ...++|+|+++.||+++.++ +.++||+.+..-
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G  262 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYG  262 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEE
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccccC
Confidence            67899999999999998776 999999888653

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=94.86  E-value=0.031  Score=41.97  Aligned_cols=32  Identities=28%  Similarity=0.513  Sum_probs=26.2

Q ss_pred             CCCeeecCCCCCceeeCC---CCc-eEEccccccee
Q 037267           42 SAPIIHCDLKPTNILLDE---NMV-AHVSDFGISKL   73 (202)
Q Consensus        42 ~~~i~h~dlk~~nil~~~---~~~-~~l~d~g~~~~   73 (202)
                      ...++|+|+.+.|++++.   ++. ..|+||+.+..
T Consensus       189 ~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          189 TPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             CCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             CCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence            457899999999999987   344 58999987754

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=94.52  E-value=0.033  Score=40.77  Aligned_cols=32  Identities=22%  Similarity=0.387  Sum_probs=27.1

Q ss_pred             CCCeeecCCCCCceeeCCCCceEEccccccee
Q 037267           42 SAPIIHCDLKPTNILLDENMVAHVSDFGISKL   73 (202)
Q Consensus        42 ~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~   73 (202)
                      ...++|+|+.+.||+++..+.+.|+||+.+..
T Consensus       192 ~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          192 DSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             CEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             CcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence            44689999999999999887778999987654

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=93.94  E-value=0.023  Score=42.82  Aligned_cols=32  Identities=25%  Similarity=0.333  Sum_probs=26.9

Q ss_pred             CCCeeecCCCCCceeeCCCCceEEccccccee
Q 037267           42 SAPIIHCDLKPTNILLDENMVAHVSDFGISKL   73 (202)
Q Consensus        42 ~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~   73 (202)
                      ..+++|+|+.+.||+++.+..+.++||+.+..
T Consensus       186 ~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          186 PAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             CEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             CcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence            45799999999999999876668999987643

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=93.70  E-value=0.095  Score=39.64  Aligned_cols=33  Identities=27%  Similarity=0.286  Sum_probs=28.2

Q ss_pred             CCCeeecCCCCCceeeCCC----CceEEcccccceec
Q 037267           42 SAPIIHCDLKPTNILLDEN----MVAHVSDFGISKLL   74 (202)
Q Consensus        42 ~~~i~h~dlk~~nil~~~~----~~~~l~d~g~~~~~   74 (202)
                      ...++|+|+.+.||+++.+    +.+.++||+.+..-
T Consensus       182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence            5689999999999999864    67899999987653

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=93.19  E-value=0.041  Score=42.07  Aligned_cols=32  Identities=19%  Similarity=0.266  Sum_probs=26.8

Q ss_pred             CCCeeecCCCCCceeeCCCCceEEccccccee
Q 037267           42 SAPIIHCDLKPTNILLDENMVAHVSDFGISKL   73 (202)
Q Consensus        42 ~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~   73 (202)
                      ...++|+|+.+.||+++....+.|+||+.+..
T Consensus       221 ~~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~~  252 (357)
T 3ats_A          221 EPVLLWGDARVGNVLYRDFQPVAVLDWEMVAL  252 (357)
T ss_dssp             CCEEECSSCSGGGEEEETTEEEEECCGGGCEE
T ss_pred             CceEEeCCCCCCeEEEeCCcEEEEEccccccc
Confidence            35799999999999999655578999987754

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=92.40  E-value=0.14  Score=39.10  Aligned_cols=32  Identities=19%  Similarity=0.312  Sum_probs=28.1

Q ss_pred             CCCeeecCCCCCceeeCCCCceEEccccccee
Q 037267           42 SAPIIHCDLKPTNILLDENMVAHVSDFGISKL   73 (202)
Q Consensus        42 ~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~   73 (202)
                      ...++|+|+.+.|++++.++.+.++||+.+..
T Consensus       205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            46799999999999999878899999987765

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=92.35  E-value=0.14  Score=38.45  Aligned_cols=30  Identities=20%  Similarity=0.205  Sum_probs=25.8

Q ss_pred             CCCeeecCCCCCceeeCCCCceEEccccccee
Q 037267           42 SAPIIHCDLKPTNILLDENMVAHVSDFGISKL   73 (202)
Q Consensus        42 ~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~   73 (202)
                      ...++|+|+++.||+++ + .+.++||+.+..
T Consensus       194 ~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          194 TVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             CCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             CeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence            56789999999999999 4 789999987654

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=92.08  E-value=0.24  Score=39.58  Aligned_cols=17  Identities=35%  Similarity=0.649  Sum_probs=15.4

Q ss_pred             CCCeeecCCCCCceeeC
Q 037267           42 SAPIIHCDLKPTNILLD   58 (202)
Q Consensus        42 ~~~i~h~dlk~~nil~~   58 (202)
                      ...++|+|+.+.||+++
T Consensus       289 ~~v~cHnDl~~gNIL~~  305 (458)
T 2qg7_A          289 PIVLCHCDLLSSNIINT  305 (458)
T ss_dssp             CEEEECSCCCGGGEEEC
T ss_pred             CeeEEecCCCCCcEEee
Confidence            45799999999999998

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=91.83  E-value=0.27  Score=36.55  Aligned_cols=31  Identities=26%  Similarity=0.359  Sum_probs=26.0

Q ss_pred             CCCeeecCCCCCceeeCCCCceEEccccccee
Q 037267           42 SAPIIHCDLKPTNILLDENMVAHVSDFGISKL   73 (202)
Q Consensus        42 ~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~   73 (202)
                      ...++|+|+.+.|++ ..++.+.++||..+..
T Consensus       172 ~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          172 PLAACHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             CCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             CceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence            567999999999999 5566789999988764

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=90.83  E-value=0.26  Score=38.93  Aligned_cols=32  Identities=28%  Similarity=0.346  Sum_probs=25.2

Q ss_pred             CCCeeecCCCCCceeeCCC----------------------------CceEEccccccee
Q 037267           42 SAPIIHCDLKPTNILLDEN----------------------------MVAHVSDFGISKL   73 (202)
Q Consensus        42 ~~~i~h~dlk~~nil~~~~----------------------------~~~~l~d~g~~~~   73 (202)
                      ...++|+|+.+.||+++.+                            +.+.++||..+..
T Consensus       248 ~~v~~H~Dl~~gNiL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lIDfEya~~  307 (429)
T 1nw1_A          248 PVTFCHNDLQEGNILLPKASSGNIRMPSLSDETQALGNSLSAFNPADPRLVLIDFEYASY  307 (429)
T ss_dssp             CEEEECSCCCGGGEEEEC------------------------------CCEECCCTTCEE
T ss_pred             CeEEEeCCCCCCeEEeeCCccccccccccccccccccccccccccCCCeEEEEecccCCc
Confidence            4579999999999999875                            5678888877654

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=90.82  E-value=0.14  Score=39.30  Aligned_cols=31  Identities=26%  Similarity=0.370  Sum_probs=25.5

Q ss_pred             CCCeeecCCCCCceeeCCCCceEEccccccee
Q 037267           42 SAPIIHCDLKPTNILLDENMVAHVSDFGISKL   73 (202)
Q Consensus        42 ~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~   73 (202)
                      ...++|+|+.+.||+++.+. +.++||..+..
T Consensus       211 ~~~l~HgDl~~~Nil~~~~~-~~lID~e~a~~  241 (369)
T 3c5i_A          211 TIVFCHNDLQENNIINTNKC-LRLIDFEYSGF  241 (369)
T ss_dssp             CEEEECSCCCGGGEEECC-C-EEECCCTTCEE
T ss_pred             CeEEEeCCCCcccEEecCCc-EEEEEecCCCC
Confidence            45799999999999998655 78999987754

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=90.00  E-value=0.59  Score=33.30  Aligned_cols=82  Identities=13%  Similarity=0.179  Sum_probs=57.7

Q ss_pred             CCHHHHHHHHHHHHHhhh-cccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCccccccCCCCCccccCC
Q 037267           17 FDILERLNIMIDVGSALE-YPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAP   95 (202)
Q Consensus        17 l~~~~~~~~~~~l~~~l~-~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~p   95 (202)
                      ++..++++++.+|+.-.. +++      .-+|--+.|+|++++.++.+++.-.|+-..+                   +|
T Consensus        82 ~~~~eKlrll~nl~~L~~~~~~------~r~tf~l~P~NL~f~~~~~p~i~hRGi~~~l-------------------pP  136 (219)
T 4ano_A           82 TTLLSRIRAAIHLVSKVKHHSA------RRLIFIVCPENLMFNRALEPFFLHVGVKESL-------------------PP  136 (219)
T ss_dssp             SCHHHHHHHHHHHHHHHSSCCS------SSEECCCCGGGEEECTTCCEEESCCEETTTB-------------------SS
T ss_pred             cCHHHHHHHHHHHHHHHHHhhh------CceeEEEeCceEEEeCCCcEEEEEcCCcccC-------------------CC
Confidence            788999999999999777 555      3467778999999999999999877753221                   22


Q ss_pred             CCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCc
Q 037267           96 EYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDE  128 (202)
Q Consensus        96 e~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~  128 (202)
                      .     ..+...-.-.+=|++..++.++..|+.
T Consensus       137 ~-----e~~ee~fl~qyKali~all~~K~~Fe~  164 (219)
T 4ano_A          137 D-----EWDDERLLREVKATVLALTEGEYRFDE  164 (219)
T ss_dssp             C-----SCCHHHHHHHHHHHHHHHTTCSSCHHH
T ss_pred             C-----CCCHHHHHHHHHHHHHHHHcCCCCHHH
Confidence            1     112222234567777788888766654

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=89.13  E-value=0.23  Score=38.49  Aligned_cols=31  Identities=26%  Similarity=0.336  Sum_probs=26.3

Q ss_pred             CCCeeecCCCCCceeeCCCCceEEccccccee
Q 037267           42 SAPIIHCDLKPTNILLDENMVAHVSDFGISKL   73 (202)
Q Consensus        42 ~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~   73 (202)
                      ...++|+|+.+.||+++.+ .++++||..+..
T Consensus       226 ~~~L~HGDl~~~Nil~~~~-~~~lID~e~a~~  256 (397)
T 2olc_A          226 AETLIHGDLHTGSIFASEH-ETKVIDPEFAFY  256 (397)
T ss_dssp             CCEEECSCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred             CCceeeCCCCcCcEEEeCC-CeEEEeCccccc
Confidence            5689999999999999865 488999987764

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=88.63  E-value=0.26  Score=38.34  Aligned_cols=32  Identities=28%  Similarity=0.313  Sum_probs=27.5

Q ss_pred             CCCeeecCCCCCceeeCCC----CceEEccccccee
Q 037267           42 SAPIIHCDLKPTNILLDEN----MVAHVSDFGISKL   73 (202)
Q Consensus        42 ~~~i~h~dlk~~nil~~~~----~~~~l~d~g~~~~   73 (202)
                      ...++|+|+.+.||+++.+    +.+.++||..+..
T Consensus       219 ~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          219 PVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             CEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             CcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            5689999999999999876    6889999987754

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=87.20  E-value=0.38  Score=37.52  Aligned_cols=31  Identities=32%  Similarity=0.361  Sum_probs=25.5

Q ss_pred             CCeeecCCCCCceee------CCCCceEEccccccee
Q 037267           43 APIIHCDLKPTNILL------DENMVAHVSDFGISKL   73 (202)
Q Consensus        43 ~~i~h~dlk~~nil~------~~~~~~~l~d~g~~~~   73 (202)
                      ..++|+|+.+.||++      +.+..+.++||..+..
T Consensus       244 ~vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          244 VVFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            357899999999999      3456789999988764

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=85.09  E-value=1.3  Score=31.40  Aligned_cols=84  Identities=18%  Similarity=0.291  Sum_probs=60.0

Q ss_pred             CCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCccccccCCCCCccccCCC
Q 037267           17 FDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPE   96 (202)
Q Consensus        17 l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~pe   96 (202)
                      ++...+++++.+|+.-..+++      .-+|--+.|+|++++.++.+++.-.|+...+                   +|.
T Consensus        78 ~~~~eKlr~l~ni~~l~~~~~------~r~tf~L~P~NL~f~~~~~p~i~~RGik~~l-------------------~P~  132 (215)
T 4ann_A           78 FTKNEKLRYLLNIKNLEEVNR------TRYTFVLAPDELFFTRDGLPIAKTRGLQNVV-------------------DPL  132 (215)
T ss_dssp             SCHHHHHHHHHHGGGGGGGGG------SSEECCCSGGGEEECTTSCEEESCCEETTTB-------------------SCC
T ss_pred             cCHHHHHHHHHHHHHHHHHhc------CceEEEEecceEEEcCCCCEEEEEccCccCC-------------------CCC
Confidence            688899999999999886666      2467788999999999999999877653221                   121


Q ss_pred             CCCCCCcCcchhhhhHHHHHHHHHhCCCCCCccc
Q 037267           97 YGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMF  130 (202)
Q Consensus        97 ~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~  130 (202)
                           ..+...-.-.+=|++..+++++..|+...
T Consensus       133 -----~~~ee~fL~qyKAliiall~~K~~Fe~l~  161 (215)
T 4ann_A          133 -----PVSEAEFLTRYKALVICAFNEKQSFDALV  161 (215)
T ss_dssp             -----CCCHHHHHHHHHHHHHHHHCTTCCHHHHH
T ss_pred             -----CCCHHHHHHHHHHHHHHHHcCCCCHHHHH
Confidence                 11222234457778888888888876543

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=82.85  E-value=0.68  Score=36.53  Aligned_cols=31  Identities=26%  Similarity=0.367  Sum_probs=27.2

Q ss_pred             CCCeeecCCCCCceeeCCCCceEEccccccee
Q 037267           42 SAPIIHCDLKPTNILLDENMVAHVSDFGISKL   73 (202)
Q Consensus        42 ~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~   73 (202)
                      ...++|+|+.+.|++ +.++.+.++||..+..
T Consensus       261 ~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~  291 (424)
T 3mes_A          261 SLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI  291 (424)
T ss_dssp             CEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             CceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence            457999999999999 7778899999988764

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=80.66  E-value=1.8  Score=31.73  Aligned_cols=25  Identities=32%  Similarity=0.358  Sum_probs=20.6

Q ss_pred             CCCeeecCCCCCceeeCCCCceEEcc
Q 037267           42 SAPIIHCDLKPTNILLDENMVAHVSD   67 (202)
Q Consensus        42 ~~~i~h~dlk~~nil~~~~~~~~l~d   67 (202)
                      ...++|+|+.+.|++++.++. .++|
T Consensus       187 ~p~LvHGDlw~gNvl~~~~g~-~~iD  211 (288)
T 3f7w_A          187 PPARIHGDLWNGNVLWQDDGA-VVID  211 (288)
T ss_dssp             CCEEECSCCSGGGEEEETTEE-EECS
T ss_pred             CCeeeecCCCCCcEEEcCCCe-EEEe
Confidence            457999999999999998874 4555

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	202
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	2e-44
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	2e-35
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	2e-34
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	8e-34
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	1e-33
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	1e-32
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	2e-32
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	6e-32
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	7e-32
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	7e-32
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	9e-32
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	2e-31
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	3e-31
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	1e-30
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	1e-30
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	1e-30
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-30
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	2e-30
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	4e-30
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	1e-29
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	2e-29
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	8e-29
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	9e-29
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	3e-28
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	3e-28
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	5e-28
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	1e-27
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	7e-27
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	1e-26
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	2e-25
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	2e-25
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	2e-24
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	3e-24
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	7e-24
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	4e-23
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	6e-23
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	2e-22
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	1e-21
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	4e-21
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	4e-21
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	4e-21
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	5e-21
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	8e-19
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	1e-18
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	2e-18
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	6e-18
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	6e-18
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	7e-18
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	8e-18
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	9e-18
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	2e-17
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	3e-17
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	6e-17
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	8e-17
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	2e-16
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	3e-16
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	6e-14
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	7e-14
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	2e-13
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	1e-12
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	3e-12
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	5e-10
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	5e-06

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (370), Expect = 2e-44
 Identities = 42/205 (20%), Positives = 81/205 (39%), Gaps = 21/205 (10%)

Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
               SL   L+     F++++ ++I       ++Y H       IIH DLK  NI L E+
Sbjct: 85  CEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA----KSIIHRDLKSNNIFLHED 140

Query: 61  MVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEY---GSEGIVSAKCDVYSYGVLLM 117
           +   + DFG++ +               +I +MAPE      +   S + DVY++G++L 
Sbjct: 141 LTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLY 200

Query: 118 ETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLA 177
           E  T + P   +   +  +    +  L   L++V                +C  ++  L 
Sbjct: 201 ELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRS--------------NCPKAMKRLM 246

Query: 178 LDCCMESPGKRINMTDAAAKLKKIK 202
            +C  +   +R       A ++ + 
Sbjct: 247 AECLKKKRDERPLFPQILASIELLA 271

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (311), Expect = 2e-35
 Identities = 39/216 (18%), Positives = 73/216 (33%), Gaps = 16/216 (7%)

Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHG----HSSAPIIHCDLKPTNIL 56
             +GSL  +L  Y    +    + + +   S L + H           I H DLK  NIL
Sbjct: 83  HEHGSLFDYLNRYTVTVE--GMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNIL 140

Query: 57  LDENMVAHVSDFGISKLLGEGEDFVTQTMT--MATIGYMAPEYGSEGI------VSAKCD 108
           + +N    ++D G++       D +       + T  YMAPE   + I         + D
Sbjct: 141 VKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRAD 200

Query: 109 VYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKE--SLPHGLTEVVDANLVREEQAFAAK 166
           +Y+ G++  E   R          ++     V    S+      V +  L          
Sbjct: 201 IYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQS 260

Query: 167 MDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKIK 202
            + +  +  +  +C   +   R+        L ++ 
Sbjct: 261 CEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (304), Expect = 2e-34
 Identities = 41/203 (20%), Positives = 75/203 (36%), Gaps = 25/203 (12%)

Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
              G L K+L        +     ++  V   ++Y          +H DL   N+LL   
Sbjct: 90  AGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE----KNFVHRDLAARNVLLVNR 145

Query: 61  MVAHVSDFGISKLLGEGEDFVTQTMTMA-TIGYMAPEYGSEGIVSAKCDVYSYGVLLMET 119
             A +SDFG+SK LG  + + T        + + APE  +    S++ DV+SYGV + E 
Sbjct: 146 HYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEA 205

Query: 120 FTR-KRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLAL 178
            +  ++P  +M   E+                      + + +      +C   +  L  
Sbjct: 206 LSYGQKPYKKMKGPEV-------------------MAFIEQGKRMECPPECPPELYALMS 246

Query: 179 DCCMESPGKRINMTDAAAKLKKI 201
           DC +     R +      +++  
Sbjct: 247 DCWIYKWEDRPDFLTVEQRMRAC 269

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  119 bits (300), Expect = 8e-34
 Identities = 47/204 (23%), Positives = 84/204 (41%), Gaps = 25/204 (12%)

Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           M NGSL+ +L   +  F +++ + ++  + + ++Y    +     +H DL   NIL++ N
Sbjct: 109 MENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMN----YVHRDLAARNILVNSN 164

Query: 61  MVAHVSDFGISKLLGEGEDFVTQTMT---MATIGYMAPEYGSEGIVSAKCDVYSYGVLLM 117
           +V  VSDFG+S+ L +     T T        I + APE       ++  DV+SYG+++ 
Sbjct: 165 LVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMW 224

Query: 118 ETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLA 177
           E  +                          +T     N + ++      MDC  ++  L 
Sbjct: 225 EVMSYGERPYW------------------DMTNQDVINAIEQDYRLPPPMDCPSALHQLM 266

Query: 178 LDCCMESPGKRINMTDAAAKLKKI 201
           LDC  +    R         L K+
Sbjct: 267 LDCWQKDRNHRPKFGQIVNTLDKM 290

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (298), Expect = 1e-33
 Identities = 38/198 (19%), Positives = 66/198 (33%), Gaps = 25/198 (12%)

Query: 1   MPNGSLEKWLYSY---NYFFDILERLNIMIDVGSALEYPH-HGHSSAPIIHCDLKPTNIL 56
              G L   +        + D    L +M  +  AL+  H        ++H DLKP N+ 
Sbjct: 87  CEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVF 146

Query: 57  LDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLL 116
           LD      + DFG++++L     F    +   T  YM+PE  +    + K D++S G LL
Sbjct: 147 LDGKQNVKLGDFGLARILNHDTSFAKAFVG--TPYYMSPEQMNRMSYNEKSDIWSLGCLL 204

Query: 117 METFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDL 176
            E      P       +  L   ++E     +       L                  ++
Sbjct: 205 YELCALMPPFTAF--SQKELAGKIREGKFRRIPYRYSDELN-----------------EI 245

Query: 177 ALDCCMESPGKRINMTDA 194
                      R ++ + 
Sbjct: 246 ITRMLNLKDYHRPSVEEI 263

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (290), Expect = 1e-32
 Identities = 51/203 (25%), Positives = 78/203 (38%), Gaps = 28/203 (13%)

Query: 1   MPNGSLEKWLYSYNY-FFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDE 59
           M  GSL  +L S           L   +DV  A+EY          +H DL   N+L+ E
Sbjct: 83  MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE----GNNFVHRDLAARNVLVSE 138

Query: 60  NMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMET 119
           + VA VSDFG++K         TQ      + + APE   E   S K DV+S+G+LL E 
Sbjct: 139 DNVAKVSDFGLTKEASS-----TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEI 193

Query: 120 FTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLALD 179
           ++  R        +  + R                  V +     A   C  ++ ++  +
Sbjct: 194 YSFGRVPYPRIPLKDVVPR------------------VEKGYKMDAPDGCPPAVYEVMKN 235

Query: 180 CCMESPGKRINMTDAAAKLKKIK 202
           C       R +      +L+ IK
Sbjct: 236 CWHLDAAMRPSFLQLREQLEHIK 258

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (292), Expect = 2e-32
 Identities = 37/203 (18%), Positives = 77/203 (37%), Gaps = 24/203 (11%)

Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           M +G L  ++ +  +   + + +   + V   +++          +H DL   N +LDE 
Sbjct: 111 MKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS----KKFVHRDLAARNCMLDEK 166

Query: 61  MVAHVSDFGISKLLGEGEDFVTQTMT--MATIGYMAPEYGSEGIVSAKCDVYSYGVLLME 118
               V+DFG+++ + + E       T     + +MA E       + K DV+S+GVLL E
Sbjct: 167 FTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWE 226

Query: 119 TFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLAL 178
             TR  P       +++                     + + +       C   + ++ L
Sbjct: 227 LMTRGAP----PYPDVNTFDITVY--------------LLQGRRLLQPEYCPDPLYEVML 268

Query: 179 DCCMESPGKRINMTDAAAKLKKI 201
            C       R + ++  +++  I
Sbjct: 269 KCWHPKAEMRPSFSELVSRISAI 291

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (287), Expect = 6e-32
 Identities = 46/202 (22%), Positives = 89/202 (44%), Gaps = 23/202 (11%)

Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           M NG+L+K+L   +  F +L+ + ++  + + ++Y      +   +H DL   NIL++ N
Sbjct: 91  MENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA----NMNYVHRDLAARNILVNSN 146

Query: 61  MVAHVSDFGISKLLGEGEDFV-TQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMET 119
           +V  VSDFG+S++L +  +   T +     I + APE  S    ++  DV+S+G+++ E 
Sbjct: 147 LVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEV 206

Query: 120 FTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLALD 179
            T         +    ++                   + +       MDC  +I  L + 
Sbjct: 207 MTYGERPYWELSNHEVMK------------------AINDGFRLPTPMDCPSAIYQLMMQ 248

Query: 180 CCMESPGKRINMTDAAAKLKKI 201
           C  +   +R    D  + L K+
Sbjct: 249 CWQQERARRPKFADIVSILDKL 270

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  114 bits (287), Expect = 7e-32
 Identities = 43/224 (19%), Positives = 77/224 (34%), Gaps = 45/224 (20%)

Query: 1   MPNGSLEKWLYSYNYF-----------------------FDILERLNIMIDVGSALEYPH 37
           M  G L ++L S +                             E+L I   V + + Y  
Sbjct: 98  MAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS 157

Query: 38  HGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEY 97
                   +H DL   N L+ ENMV  ++DFG+S+ +   + +         I +M PE 
Sbjct: 158 ER----KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPES 213

Query: 98  GSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV 157
                 + + DV++YGV+L E F+           E  +      ++             
Sbjct: 214 IFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNIL------------ 261

Query: 158 REEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI 201
                 A   +C + + +L   C  + P  R +       L+++
Sbjct: 262 ------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 299

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (286), Expect = 7e-32
 Identities = 50/202 (24%), Positives = 81/202 (40%), Gaps = 24/202 (11%)

Query: 1   MPNGSLEKWLYSYNYFFDIL-ERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDE 59
           M  GSL  +L      +  L + +++   + S + Y    +     +H DL+  NIL+ E
Sbjct: 93  MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN----YVHRDLRAANILVGE 148

Query: 60  NMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMET 119
           N+V  V+DFG+++L+ + E    Q      I + APE    G  + K DV+S+G+LL E 
Sbjct: 149 NLVCKVADFGLARLIEDNEYTARQGA-KFPIKWTAPEAALYGRFTIKSDVWSFGILLTEL 207

Query: 120 FTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLALD 179
            T+ R           L +                  V          +C  S+ DL   
Sbjct: 208 TTKGRVPYPGMVNREVLDQ------------------VERGYRMPCPPECPESLHDLMCQ 249

Query: 180 CCMESPGKRINMTDAAAKLKKI 201
           C  + P +R       A L+  
Sbjct: 250 CWRKEPEERPTFEYLQAFLEDY 271

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (284), Expect = 9e-32
 Identities = 43/201 (21%), Positives = 77/201 (38%), Gaps = 23/201 (11%)

Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           M +G L  +L +    F     L + +DV   + Y         +IH DL   N L+ EN
Sbjct: 82  MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC----VIHRDLAARNCLVGEN 137

Query: 61  MVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETF 120
            V  VSDFG+++ + + +   +       + + +PE  S    S+K DV+S+GVL+ E F
Sbjct: 138 QVIKVSDFGMTRFVLDDQYTSSTGT-KFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVF 196

Query: 121 TRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLALDC 180
           +  +   E  +    +   +          +   ++                   +   C
Sbjct: 197 SEGKIPYENRS-NSEVVEDISTGFRLYKPRLASTHVY-----------------QIMNHC 238

Query: 181 CMESPGKRINMTDAAAKLKKI 201
             E P  R   +    +L +I
Sbjct: 239 WKERPEDRPAFSRLLRQLAEI 259

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (286), Expect = 2e-31
 Identities = 47/218 (21%), Positives = 75/218 (34%), Gaps = 32/218 (14%)

Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           M  GSL++ L              + I V   L Y    H    I+H D+KP+NIL++  
Sbjct: 86  MDGGSLDQVLKKAGRI-PEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSR 141

Query: 61  MVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETF 120
               + DFG+S  L +          + T  YM+PE       S + D++S G+ L+E  
Sbjct: 142 GEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMA 197

Query: 121 TRKRPTDEMFTGEMSL----------RRWVKESLPHGLTEVVDANLVREEQAFAAKMDCI 170
             + P       E+ L                    G          R   A    +D I
Sbjct: 198 VGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYI 257

Query: 171 VS--------------IMDLALDCCMESPGKRINMTDA 194
           V+                D    C +++P +R ++   
Sbjct: 258 VNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQL 295

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  112 bits (282), Expect = 3e-31
 Identities = 45/202 (22%), Positives = 80/202 (39%), Gaps = 24/202 (11%)

Query: 1   MPNGSLEKWLYSYNYF-FDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDE 59
           M NGSL  +L + +     I + L++   +   + +          IH DL+  NIL+ +
Sbjct: 89  MENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE----ERNYIHRDLRAANILVSD 144

Query: 60  NMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMET 119
            +   ++DFG+++L+ + E           I + APE  + G  + K DV+S+G+LL E 
Sbjct: 145 TLSCKIADFGLARLIEDNEYTAR-EGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEI 203

Query: 120 FTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLALD 179
            T  R      T    ++   +              +VR +       +C   +  L   
Sbjct: 204 VTHGRIPYPGMTNPEVIQNLER-----------GYRMVRPD-------NCPEELYQLMRL 245

Query: 180 CCMESPGKRINMTDAAAKLKKI 201
           C  E P  R       + L+  
Sbjct: 246 CWKERPEDRPTFDYLRSVLEDF 267

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  112 bits (280), Expect = 1e-30
 Identities = 40/221 (18%), Positives = 70/221 (31%), Gaps = 43/221 (19%)

Query: 1   MPNGSLEKWLYSYNYFF----------------------DILERLNIMIDVGSALEYPHH 38
              G L  +L S    F                         + L     V   +E+   
Sbjct: 123 CCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE- 181

Query: 39  GHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYG 98
                  +H DL   N+L+    V  + DFG+++ +    ++V +      + +MAPE  
Sbjct: 182 ---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESL 238

Query: 99  SEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVR 158
            EGI + K DV+SYG+LL E F+           + +  + ++                 
Sbjct: 239 FEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFK------------- 285

Query: 159 EEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLK 199
                         I  +   C      KR +  +  + L 
Sbjct: 286 ----MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (277), Expect = 1e-30
 Identities = 40/195 (20%), Positives = 70/195 (35%), Gaps = 26/195 (13%)

Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILL-DE 59
           M +G+L+ +L  +     I    +    +   L++ H      PIIH DLK  NI +   
Sbjct: 94  MTSGTLKTYLKRFKVM-KIKVLRSWCRQILKGLQFLHTRTP--PIIHRDLKCDNIFITGP 150

Query: 60  NMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMET 119
                + D G++ L             + T  +MAPE   E       DVY++G+ ++E 
Sbjct: 151 TGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAPEMYEEK-YDESVDVYAFGMCMLEM 205

Query: 120 FTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLALD 179
            T + P  E        RR      P    +V    +                  ++   
Sbjct: 206 ATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVK-----------------EIIEG 248

Query: 180 CCMESPGKRINMTDA 194
           C  ++  +R ++ D 
Sbjct: 249 CIRQNKDERYSIKDL 263

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (276), Expect = 1e-30
 Identities = 40/201 (19%), Positives = 77/201 (38%), Gaps = 23/201 (11%)

Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           M NG L  +L    + F   + L +  DV  A+EY          +H DL   N L+++ 
Sbjct: 81  MANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES----KQFLHRDLAARNCLVNDQ 136

Query: 61  MVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETF 120
            V  VSDFG+S+ + +  ++ +   +   + +  PE       S+K D++++GVL+ E +
Sbjct: 137 GVVKVSDFGLSRYVLDD-EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIY 195

Query: 121 TRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLALDC 180
           +  +   E FT        + + L      +    +                   +   C
Sbjct: 196 SLGKMPYERFT-NSETAEHIAQGLRLYRPHLASEKVY-----------------TIMYSC 237

Query: 181 CMESPGKRINMTDAAAKLKKI 201
             E   +R       + +  +
Sbjct: 238 WHEKADERPTFKILLSNILDV 258

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (279), Expect = 2e-30
 Identities = 39/202 (19%), Positives = 72/202 (35%), Gaps = 22/202 (10%)

Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           MP G L  ++  +         LN  + +   + Y         ++H DL   N+L+   
Sbjct: 92  MPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED----RRLVHRDLAARNVLVKTP 147

Query: 61  MVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETF 120
               ++DFG++KLLG  E           I +MA E     I + + DV+SYGV + E  
Sbjct: 148 QHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 207

Query: 121 TRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLALDC 180
           T                         G+     ++++ + +       C + +  + + C
Sbjct: 208 TFGSK------------------PYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKC 249

Query: 181 CMESPGKRINMTDAAAKLKKIK 202
            M     R    +   +  K+ 
Sbjct: 250 WMIDADSRPKFRELIIEFSKMA 271

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (276), Expect = 2e-30
 Identities = 41/202 (20%), Positives = 72/202 (35%), Gaps = 24/202 (11%)

Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
              G L K+L    +       + ++  V   ++Y    +     +H DL   N+LL   
Sbjct: 89  AELGPLNKYLQQNRHV-KDKNIIELVHQVSMGMKYLEESN----FVHRDLAARNVLLVTQ 143

Query: 61  MVAHVSDFGISKLLGEGEDFVTQTMTMA-TIGYMAPEYGSEGIVSAKCDVYSYGVLLMET 119
             A +SDFG+SK L   E++          + + APE  +    S+K DV+S+GVL+ E 
Sbjct: 144 HYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEA 203

Query: 120 FTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLALD 179
           F+  +                      G+       ++ + +       C   + DL   
Sbjct: 204 FSYGQK------------------PYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNL 245

Query: 180 CCMESPGKRINMTDAAAKLKKI 201
           C       R        +L+  
Sbjct: 246 CWTYDVENRPGFAAVELRLRNY 267

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (276), Expect = 4e-30
 Identities = 38/218 (17%), Positives = 70/218 (32%), Gaps = 38/218 (17%)

Query: 1   MPNGSLEKWLYSY-----------------NYFFDILERLNIMIDVGSALEYPHHGHSSA 43
              G L  +L                        D+ + L+    V   + +    +   
Sbjct: 109 CCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--- 165

Query: 44  PIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIV 103
             IH DL   NILL    +  + DFG+++ +    ++V +      + +MAPE     + 
Sbjct: 166 -CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVY 224

Query: 104 SAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAF 163
           + + DV+SYG+ L E F+           +    + +KE                     
Sbjct: 225 TFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFR-----------------M 267

Query: 164 AAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI 201
            +       + D+   C    P KR         ++K 
Sbjct: 268 LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  109 bits (272), Expect = 1e-29
 Identities = 49/216 (22%), Positives = 80/216 (37%), Gaps = 40/216 (18%)

Query: 1   MPNGSLEKWLYSYNYF---------------FDILERLNIMIDVGSALEYPHHGHSSAPI 45
            P+G+L  +L                         + L+   DV   ++Y          
Sbjct: 93  APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS----QKQF 148

Query: 46  IHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSA 105
           IH DL   NIL+ EN VA ++DFG+S+     E +V +TM    + +MA E  +  + + 
Sbjct: 149 IHRDLAARNILVGENYVAKIADFGLSRG---QEVYVKKTMGRLPVRWMAIESLNYSVYTT 205

Query: 106 KCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAA 165
             DV+SYGVLL E  +                         G+T       + +      
Sbjct: 206 NSDVWSYGVLLWEIVSLGGTPYC------------------GMTCAELYEKLPQGYRLEK 247

Query: 166 KMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI 201
            ++C   + DL   C  E P +R +       L ++
Sbjct: 248 PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 283

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  108 bits (271), Expect = 2e-29
 Identities = 46/202 (22%), Positives = 76/202 (37%), Gaps = 24/202 (11%)

Query: 1   MPNGSLEKWLYSYNYF-FDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDE 59
           M  G+L  +L   N      +  L +   + SA+EY          IH DL   N L+ E
Sbjct: 95  MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE----KKNFIHRDLAARNCLVGE 150

Query: 60  NMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMET 119
           N +  V+DFG+S+L+  G+ +         I + APE  +    S K DV+++GVLL E 
Sbjct: 151 NHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 209

Query: 120 FTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLALD 179
            T                         G+       L+ ++        C   + +L   
Sbjct: 210 ATYGMSPYP------------------GIDLSQVYELLEKDYRMERPEGCPEKVYELMRA 251

Query: 180 CCMESPGKRINMTDAAAKLKKI 201
           C   +P  R +  +     + +
Sbjct: 252 CWQWNPSDRPSFAEIHQAFETM 273

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  106 bits (265), Expect = 8e-29
 Identities = 45/195 (23%), Positives = 71/195 (36%), Gaps = 31/195 (15%)

Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
            P G++ + L   + F D       + ++ +AL Y H    S  +IH D+KP N+LL   
Sbjct: 88  APLGTVYRELQKLSKF-DEQRTATYITELANALSYCH----SKRVIHRDIKPENLLLGSA 142

Query: 61  MVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETF 120
               ++DFG S                 T+ Y+ PE     +   K D++S GVL  E  
Sbjct: 143 GELKIADFGWSVHAPSSRRT----TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFL 198

Query: 121 TRKRPTDEMFTGEMSLR-RWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLALD 179
             K P +     E   R   V+ + P  +TE                        DL   
Sbjct: 199 VGKPPFEANTYQETYKRISRVEFTFPDFVTE---------------------GARDLISR 237

Query: 180 CCMESPGKRINMTDA 194
               +P +R  + + 
Sbjct: 238 LLKHNPSQRPMLREV 252

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  106 bits (265), Expect = 9e-29
 Identities = 45/203 (22%), Positives = 67/203 (33%), Gaps = 22/203 (10%)

Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
            P GSL   L  +   F +       + V   + Y      S   IH DL   N+LL   
Sbjct: 92  APLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE----SKRFIHRDLAARNLLLATR 147

Query: 61  MVAHVSDFGISKLLGEGED-FVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMET 119
            +  + DFG+ + L + +D +V Q        + APE       S   D + +GV L E 
Sbjct: 148 DLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEM 207

Query: 120 FTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLALD 179
           FT  +       G   L +  KE                         DC   I ++ + 
Sbjct: 208 FTYGQEPWIGLNGSQILHKIDKEGER-----------------LPRPEDCPQDIYNVMVQ 250

Query: 180 CCMESPGKRINMTDAAAKLKKIK 202
           C    P  R         L + +
Sbjct: 251 CWAHKPEDRPTFVALRDFLLEAQ 273

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  105 bits (263), Expect = 3e-28
 Identities = 39/199 (19%), Positives = 64/199 (32%), Gaps = 28/199 (14%)

Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
              G+++  +          +   +      AL Y H       IIH DLK  NIL   +
Sbjct: 91  CAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH----DNKIIHRDLKAGNILFTLD 146

Query: 61  MVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEY-----GSEGIVSAKCDVYSYGVL 115
               ++DFG+S           +   + T  +MAPE        +     K DV+S G+ 
Sbjct: 147 GDIKLADFGVSAKNTRTIQ--RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGIT 204

Query: 116 LMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMD 175
           L+E    + P  E+    + L +  K   P                  A       +  D
Sbjct: 205 LIEMAEIEPPHHELNPMRV-LLKIAKSEPPT----------------LAQPSRWSSNFKD 247

Query: 176 LALDCCMESPGKRINMTDA 194
               C  ++   R   +  
Sbjct: 248 FLKKCLEKNVDARWTTSQL 266

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  105 bits (263), Expect = 3e-28
 Identities = 41/197 (20%), Positives = 61/197 (30%), Gaps = 32/197 (16%)

Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
               + +     +      +E   +       L Y H    S  +IH D+K  NILL E 
Sbjct: 97  CLGSASDLLEV-HKKPLQEVEIAAVTHGALQGLAYLH----SHNMIHRDVKAGNILLSEP 151

Query: 61  MVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEY---GSEGIVSAKCDVYSYGVLLM 117
            +  + DFG + ++     FV       T  +MAPE      EG    K DV+S G+  +
Sbjct: 152 GLVKLGDFGSASIMAPANSFV------GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCI 205

Query: 118 ETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLA 177
           E   RK P   M      L    +   P   +                         +  
Sbjct: 206 ELAERKPPLFNMNAMSA-LYHIAQNESPALQSGHWSEYFR-----------------NFV 247

Query: 178 LDCCMESPGKRINMTDA 194
             C  + P  R      
Sbjct: 248 DSCLQKIPQDRPTSEVL 264

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  104 bits (260), Expect = 5e-28
 Identities = 47/216 (21%), Positives = 77/216 (35%), Gaps = 36/216 (16%)

Query: 1   MPNGSLEKWLYS---------------YNYFFDILERLNIMIDVGSALEYPHHGHSSAPI 45
              G+L  +L S               Y  F  +   +     V   +E+      S   
Sbjct: 100 CKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA----SRKC 155

Query: 46  IHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSA 105
           IH DL   NILL E  V  + DFG+++ + +  D+V +      + +MAPE   + + + 
Sbjct: 156 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI 215

Query: 106 KCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAA 165
           + DV+S+GVLL E F+           +    R +KE                      A
Sbjct: 216 QSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR-----------------MRA 258

Query: 166 KMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI 201
                  +    LDC    P +R   ++    L  +
Sbjct: 259 PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  103 bits (257), Expect = 1e-27
 Identities = 38/201 (18%), Positives = 69/201 (34%), Gaps = 23/201 (11%)

Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
              G L  +L    Y  D+   +     + +AL Y      S   +H D+   N+L+  N
Sbjct: 89  CTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE----SKRFVHRDIAARNVLVSSN 144

Query: 61  MVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETF 120
               + DFG+S+ + +   +      +  I +MAPE  +    ++  DV+ +GV + E  
Sbjct: 145 DCVKLGDFGLSRYMEDSTYYKASKGKL-PIKWMAPESINFRRFTSASDVWMFGVCMWEIL 203

Query: 121 TRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLALDC 180
                  +       + R                             +C  ++  L   C
Sbjct: 204 MHGVKPFQGVKNNDVIGRIENGERLP------------------MPPNCPPTLYSLMTKC 245

Query: 181 CMESPGKRINMTDAAAKLKKI 201
               P +R   T+  A+L  I
Sbjct: 246 WAYDPSRRPRFTELKAQLSTI 266

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  101 bits (252), Expect = 7e-27
 Identities = 38/195 (19%), Positives = 67/195 (34%), Gaps = 23/195 (11%)

Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
              G L   +   +      +       + + + Y H       I H D+KP N+LLDE 
Sbjct: 85  CSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIG----ITHRDIKPENLLLDER 139

Query: 61  MVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEY-GSEGIVSAKCDVYSYGVLLMET 119
               +SDFG++ +               T+ Y+APE        +   DV+S G++L   
Sbjct: 140 DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAM 199

Query: 120 FTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLALD 179
              + P D+          W ++       + +D+  +                  L   
Sbjct: 200 LAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL-----------------ALLHK 242

Query: 180 CCMESPGKRINMTDA 194
             +E+P  RI + D 
Sbjct: 243 ILVENPSARITIPDI 257

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  101 bits (252), Expect = 1e-26
 Identities = 44/216 (20%), Positives = 78/216 (36%), Gaps = 37/216 (17%)

Query: 1   MPNGSLEKWLYSYNYF---------------FDILERLNIMIDVGSALEYPHHGHSSAPI 45
              G+L ++L +                       + ++    V   +EY      S   
Sbjct: 101 ASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA----SKKC 156

Query: 46  IHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSA 105
           IH DL   N+L+ E+ V  ++DFG+++ +   + +   T     + +MAPE   + I + 
Sbjct: 157 IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTH 216

Query: 106 KCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAA 165
           + DV+S+GVLL E FT                         G+       L++E      
Sbjct: 217 QSDVWSFGVLLWEIFTLGGSPYP------------------GVPVEELFKLLKEGHRMDK 258

Query: 166 KMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI 201
             +C   +  +  DC    P +R         L +I
Sbjct: 259 PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score = 99.0 bits (246), Expect = 2e-25
 Identities = 40/196 (20%), Positives = 66/196 (33%), Gaps = 25/196 (12%)

Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILL--D 58
           M  G L + +   +      E +  M  V   L + H  +     +H DLKP NI+    
Sbjct: 105 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN----YVHLDLKPENIMFTTK 160

Query: 59  ENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLME 118
            +    + DFG++  L   +       T  T  + APE      V    D++S GVL   
Sbjct: 161 RSNELKLIDFGLTAHLDPKQSVKV---TTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYI 217

Query: 119 TFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLAL 178
             +   P             +  E+    L  V   +   ++ AF+          D   
Sbjct: 218 LLSGLSP-------------FGGENDDETLRNVKSCDWNMDDSAFS---GISEDGKDFIR 261

Query: 179 DCCMESPGKRINMTDA 194
              +  P  R+ +  A
Sbjct: 262 KLLLADPNTRMTIHQA 277

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 98.0 bits (243), Expect = 2e-25
 Identities = 37/211 (17%), Positives = 82/211 (38%), Gaps = 31/211 (14%)

Query: 1   MPNGSLEKWLYSYNYF---------FDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLK 51
           M  G L+ +L S               + + + +  ++   + Y +    +   +H DL 
Sbjct: 105 MTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN----ANKFVHRDLA 160

Query: 52  PTNILLDENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYS 111
             N ++ E+    + DFG+++ + E + +      +  + +M+PE   +G+ +   DV+S
Sbjct: 161 ARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWS 220

Query: 112 YGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIV 171
           +GV+L E  T      +  + E  LR  ++  L                       +C  
Sbjct: 221 FGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLD------------------KPDNCPD 262

Query: 172 SIMDLALDCCMESPGKRINMTDAAAKLKKIK 202
            + +L   C   +P  R +  +  + +K+  
Sbjct: 263 MLFELMRMCWQYNPKMRPSFLEIISSIKEEM 293

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 95.1 bits (236), Expect = 2e-24
 Identities = 37/194 (19%), Positives = 64/194 (32%), Gaps = 25/194 (12%)

Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           +  GSL   +       D  +   +  +   ALE+ H    S  +IH D+K  NILL  +
Sbjct: 99  LAGGSLTDVVT--ETCMDEGQIAAVCRECLQALEFLH----SNQVIHRDIKSDNILLGMD 152

Query: 61  MVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETF 120
               ++DFG    +   +    ++  + T  +MAPE  +      K D++S G++ +E  
Sbjct: 153 GSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMI 210

Query: 121 TRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLALDC 180
             + P         +L        P                             D    C
Sbjct: 211 EGEPPYLNE-NPLRALYLIATNGTPE----------------LQNPEKLSAIFRDFLNRC 253

Query: 181 CMESPGKRINMTDA 194
                 KR +  + 
Sbjct: 254 LDMDVEKRGSAKEL 267

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 94.7 bits (235), Expect = 3e-24
 Identities = 38/125 (30%), Positives = 58/125 (46%), Gaps = 5/125 (4%)

Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
             NG L K++     F D         ++ SALEY H       IIH DLKP NILL+E+
Sbjct: 90  AKNGELLKYIRKIGSF-DETCTRFYTAEIVSALEYLH----GKGIIHRDLKPENILLNED 144

Query: 61  MVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETF 120
           M   ++DFG +K+L            + T  Y++PE  +E       D+++ G ++ +  
Sbjct: 145 MHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 204

Query: 121 TRKRP 125
               P
Sbjct: 205 AGLPP 209

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score = 94.7 bits (235), Expect = 7e-24
 Identities = 45/196 (22%), Positives = 73/196 (37%), Gaps = 25/196 (12%)

Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           +  G L   + + +Y     E +N M      L++ H       I+H D+KP NI+ +  
Sbjct: 108 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH----EHSIVHLDIKPENIMCETK 163

Query: 61  MVAHV--SDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLME 118
             + V   DFG++  L   E      +T AT  + APE      V    D+++ GVL   
Sbjct: 164 KASSVKIIDFGLATKLNPDE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYV 220

Query: 119 TFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLAL 178
             +   P             +  E     L  V   +   +E AF+          D   
Sbjct: 221 LLSGLSP-------------FAGEDDLETLQNVKRCDWEFDEDAFS---SVSPEAKDFIK 264

Query: 179 DCCMESPGKRINMTDA 194
           +   + P KR+ + DA
Sbjct: 265 NLLQKEPRKRLTVHDA 280

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 92.4 bits (229), Expect = 4e-23
 Identities = 37/196 (18%), Positives = 81/196 (41%), Gaps = 25/196 (12%)

Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           +    + + + +  +  +  E ++ +  V  AL++ H    S  I H D++P NI+    
Sbjct: 83  ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH----SHNIGHFDIRPENIIYQTR 138

Query: 61  MVAHV--SDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLME 118
             + +   +FG ++ L  G++F    +      Y APE     +VS   D++S G L+  
Sbjct: 139 RSSTIKIIEFGQARQLKPGDNF---RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYV 195

Query: 119 TFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLAL 178
             +   P             ++ E+    +  +++A    +E+AF    +  +  MD   
Sbjct: 196 LLSGINP-------------FLAETNQQIIENIMNAEYTFDEEAFK---EISIEAMDFVD 239

Query: 179 DCCMESPGKRINMTDA 194
              ++    R+  ++A
Sbjct: 240 RLLVKERKSRMTASEA 255

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score = 91.0 bits (225), Expect = 6e-23
 Identities = 44/203 (21%), Positives = 80/203 (39%), Gaps = 23/203 (11%)

Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           +   +L   +++          + ++ D   AL + H       IIH D+KP NI++   
Sbjct: 93  VDGVTLRDIVHTEGPM-TPKRAIEVIADACQALNFSH----QNGIIHRDVKPANIMISAT 147

Query: 61  MVAHVSDFGISKLLGEGEDFVTQTMTMA-TIGYMAPEYGSEGIVSAKCDVYSYGVLLMET 119
               V DFGI++ + +  + VTQT  +  T  Y++PE      V A+ DVYS G +L E 
Sbjct: 148 NAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEV 207

Query: 120 FTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLALD 179
            T + P        ++ +   ++ +P                  A        +  + L 
Sbjct: 208 LTGEPPFTGDSPVSVAYQHVREDPIP----------------PSARHEGLSADLDAVVLK 251

Query: 180 CCMESPGKRI-NMTDAAAKLKKI 201
              ++P  R     +  A L ++
Sbjct: 252 ALAKNPENRYQTAAEMRADLVRV 274

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 89.9 bits (222), Expect = 2e-22
 Identities = 43/201 (21%), Positives = 76/201 (37%), Gaps = 14/201 (6%)

Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           +                      ++M  +   L++ H    S  ++H DLKP NIL+  +
Sbjct: 97  VDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH----SHRVVHRDLKPQNILVTSS 152

Query: 61  MVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETF 120
               ++DFG++++       +  T  + T+ Y APE   +   +   D++S G +  E F
Sbjct: 153 GQIKLADFGLARIY---SFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF 209

Query: 121 TRKRP------TDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVS-I 173
            RK         D++      +    +E  P  +     A   +  Q     +  I    
Sbjct: 210 RRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELG 269

Query: 174 MDLALDCCMESPGKRINMTDA 194
            DL L C   +P KRI+   A
Sbjct: 270 KDLLLKCLTFNPAKRISAYSA 290

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 88.2 bits (218), Expect = 1e-21
 Identities = 43/203 (21%), Positives = 70/203 (34%), Gaps = 33/203 (16%)

Query: 1   MPNGSLEKWLYSY-NYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLD- 58
           +  G L   +    +  F   E   IM  +G A++Y H    S  I H D+KP N+L   
Sbjct: 91  LDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH----SINIAHRDVKPENLLYTS 146

Query: 59  --ENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLL 116
              N +  ++DFG +K         T      T  Y+APE          CD++S GV++
Sbjct: 147 KRPNAILKLTDFGFAKETTSHNSLTT---PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 203

Query: 117 METFTRKRP-----TDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIV 171
                   P        +  G  +  R  +   P+     V   +               
Sbjct: 204 YILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVK-------------- 249

Query: 172 SIMDLALDCCMESPGKRINMTDA 194
               L  +     P +R+ +T+ 
Sbjct: 250 ---MLIRNLLKTEPTQRMTITEF 269

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 86.7 bits (214), Expect = 4e-21
 Identities = 40/164 (24%), Positives = 67/164 (40%), Gaps = 12/164 (7%)

Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           +  G L   + S  + FD+        ++   L++ H       I++ DLK  NILLD++
Sbjct: 85  LNGGDLMYHIQS-CHKFDLSRATFYAAEIILGLQFLHSKG----IVYRDLKLDNILLDKD 139

Query: 61  MVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETF 120
               ++DFG+ K    G+          T  Y+APE       +   D +S+GVLL E  
Sbjct: 140 GHIKIADFGMCKENMLGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEML 197

Query: 121 TRKRP-----TDEMFTGEMSLRRWVKESLPHGLTEVVDANLVRE 159
             + P      +E+F        +    L     +++    VRE
Sbjct: 198 IGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVRE 241

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 86.7 bits (214), Expect = 4e-21
 Identities = 39/134 (29%), Positives = 56/134 (41%), Gaps = 9/134 (6%)

Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
              G     L   +  F          +V  ALEY H    S  II+ DLKP NILLD+N
Sbjct: 85  YIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLH----SKDIIYRDLKPENILLDKN 140

Query: 61  MVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETF 120
               ++DFG +K + +            T  Y+APE  S    +   D +S+G+L+ E  
Sbjct: 141 GHIKITDFGFAKYVPD-----VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEML 195

Query: 121 TRKRPTDEMFTGEM 134
               P  +  T + 
Sbjct: 196 AGYTPFYDSNTMKT 209

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 87.1 bits (215), Expect = 4e-21
 Identities = 40/198 (20%), Positives = 73/198 (36%), Gaps = 27/198 (13%)

Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           M  G L   L  +  F +  +      ++   LE+ H+      +++ DLKP NILLDE+
Sbjct: 89  MNGGDLHYHLSQHGVFSE-ADMRFYAAEIILGLEHMHNRF----VVYRDLKPANILLDEH 143

Query: 61  MVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGI-VSAKCDVYSYGVLLMET 119
               +SD G++    + +       ++ T GYMAPE   +G+   +  D +S G +L + 
Sbjct: 144 GHVRISDLGLACDFSKKKP----HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKL 199

Query: 120 FTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLALD 179
                P  +  T +      +  ++   L +     L                   L   
Sbjct: 200 LRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELR-----------------SLLEG 242

Query: 180 CCMESPGKRINMTDAAAK 197
                  +R+      A+
Sbjct: 243 LLQRDVNRRLGCLGRGAQ 260

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score = 85.9 bits (212), Expect = 5e-21
 Identities = 43/197 (21%), Positives = 66/197 (33%), Gaps = 24/197 (12%)

Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           M  G L  +L          E   IM  +   +   H       I+H DLKP NILLD++
Sbjct: 92  MKKGELFDYLTE-KVTLSEKETRKIMRALLEVICALH----KLNIVHRDLKPENILLDDD 146

Query: 61  MVAHVSDFGISKLLGEGEDFVTQTMT---MATIGYMAPEYGSEGIVSAKCDVYSYGVLLM 117
           M   ++DFG S  L  GE       T   +A          +      + D++S GV++ 
Sbjct: 147 MNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMY 206

Query: 118 ETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLA 177
                  P             +        L  ++  N       +    D   ++ DL 
Sbjct: 207 TLLAGSPP-------------FWHRKQMLMLRMIMSGNYQFGSPEWD---DYSDTVKDLV 250

Query: 178 LDCCMESPGKRINMTDA 194
               +  P KR    +A
Sbjct: 251 SRFLVVQPQKRYTAEEA 267

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 80.1 bits (197), Expect = 8e-19
 Identities = 46/199 (23%), Positives = 75/199 (37%), Gaps = 31/199 (15%)

Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILL--- 57
           +  G L   +     F+   +   ++  V  A++Y H       I+H DLKP N+L    
Sbjct: 89  VSGGELFDRIVEKG-FYTERDASRLIFQVLDAVKYLHDLG----IVHRDLKPENLLYYSL 143

Query: 58  DENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLM 117
           DE+    +SDFG+SK+   G      +    T GY+APE  ++   S   D +S GV+  
Sbjct: 144 DEDSKIMISDFGLSKMEDPGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAY 200

Query: 118 ETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVS--IMD 175
                  P    F  E   + + +              +++ E  F +     +S    D
Sbjct: 201 ILLCGYPP----FYDENDAKLFEQ--------------ILKAEYEFDSPYWDDISDSAKD 242

Query: 176 LALDCCMESPGKRINMTDA 194
                  + P KR     A
Sbjct: 243 FIRHLMEKDPEKRFTCEQA 261

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 79.5 bits (195), Expect = 1e-18
 Identities = 47/201 (23%), Positives = 72/201 (35%), Gaps = 15/201 (7%)

Query: 3   NGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMV 62
              LE  +   +           M+     LEY H       I+H DLKP N+LLDEN V
Sbjct: 83  ETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW----ILHRDLKPNNLLLDENGV 138

Query: 63  AHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPE-YGSEGIVSAKCDVYSYGVLLMETFT 121
             ++DFG++K    G      T  + T  Y APE      +     D+++ G +L E   
Sbjct: 139 LKLADFGLAKSF--GSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLL 196

Query: 122 RKRP------TDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVS--I 173
           R          D++     +L    +E  P   +                 +       +
Sbjct: 197 RVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDL 256

Query: 174 MDLALDCCMESPGKRINMTDA 194
           +DL     + +P  RI  T A
Sbjct: 257 LDLIQGLFLFNPCARITATQA 277

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 79.0 bits (194), Expect = 2e-18
 Identities = 30/149 (20%), Positives = 50/149 (33%), Gaps = 13/149 (8%)

Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
                      +           +    V  A+ +      +  ++H D+K  NIL+D N
Sbjct: 91  PEPVQDLFDFITERGALQEELARSFFWQVLEAVRH----CHNCGVLHRDIKDENILIDLN 146

Query: 61  -MVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEY-GSEGIVSAKCDVYSYGVLLME 118
                + DFG   LL +       T    T  Y  PE+            V+S G+LL +
Sbjct: 147 RGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYD 202

Query: 119 TFTRKRP---TDEMFTGEMSLRRWVKESL 144
                 P    +E+  G++  R+ V    
Sbjct: 203 MVCGDIPFEHDEEIIRGQVFFRQRVSSEC 231

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 77.5 bits (190), Expect = 6e-18
 Identities = 26/211 (12%), Positives = 56/211 (26%), Gaps = 26/211 (12%)

Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           +   SLE  L      F +         + + ++  H       +++ D+KP N L+   
Sbjct: 82  LLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS----LVYRDIKPDNFLIGRP 137

Query: 61  MVAH-----VSDFGISKLLGEGED-----FVTQTMTMATIGYMAPEYGSEGIVSAKCDVY 110
              +     V DFG+ K   +        +  +     T  YM+         S + D+ 
Sbjct: 138 NSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLE 197

Query: 111 SYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCI 170
           + G + M              G +  +     +       + +       +   A     
Sbjct: 198 ALGHVFM----------YFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCA--GFP 245

Query: 171 VSIMDLALDCCMESPGKRINMTDAAAKLKKI 201
                        +     +         K+
Sbjct: 246 EEFYKYMHYARNLAFDATPDYDYLQGLFSKV 276

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 77.6 bits (190), Expect = 6e-18
 Identities = 32/211 (15%), Positives = 61/211 (28%), Gaps = 28/211 (13%)

Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNIL---L 57
           +   SLE      +  F +   L +   + S +EY H    S   IH D+KP N L    
Sbjct: 84  LLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH----SKNFIHRDVKPDNFLMGLG 139

Query: 58  DENMVAHVSDFGISKLLGEGEDFVTQTMTMA-----TIGYMAPEYGSEGIVSAKCDVYSY 112
            +  + ++ DFG++K   +                 T  Y +         S + D+ S 
Sbjct: 140 KKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESL 199

Query: 113 GVLLMETFTRKRPTDEMFTGE--MSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCI 170
           G +LM       P   +          R  ++ +   +  +                   
Sbjct: 200 GYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCK--------------GYP 245

Query: 171 VSIMDLALDCCMESPGKRINMTDAAAKLKKI 201
                    C       + + +      + +
Sbjct: 246 SEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 77.6 bits (190), Expect = 7e-18
 Identities = 37/204 (18%), Positives = 68/204 (33%), Gaps = 16/204 (7%)

Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           +     +    S      +    + +  +   L + H    S  ++H DLKP N+L++  
Sbjct: 83  LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH----SHRVLHRDLKPQNLLINTE 138

Query: 61  MVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPE-YGSEGIVSAKCDVYSYGVLLMET 119
               ++DFG+++  G      T  +    + Y APE        S   D++S G +  E 
Sbjct: 139 GAIKLADFGLARAFGVPVRTYTHEVVT--LWYRAPEILLGCKYYSTAVDIWSLGCIFAEM 196

Query: 120 FTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVS------- 172
            TR+         +   R +     P  +      ++   + +F        S       
Sbjct: 197 VTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLD 256

Query: 173 --IMDLALDCCMESPGKRINMTDA 194
                L        P KRI+   A
Sbjct: 257 EDGRSLLSQMLHYDPNKRISAKAA 280

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 77.3 bits (189), Expect = 8e-18
 Identities = 37/197 (18%), Positives = 75/197 (38%), Gaps = 17/197 (8%)

Query: 9   WLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDF 68
           +  S N   D     + +  +   L + H  +    ++H DLKP N+L++ N    +++F
Sbjct: 90  YFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN----VLHRDLKPQNLLINRNGELKLANF 145

Query: 69  GISKLLGEGEDFVTQTMTMATIGYMAPE-YGSEGIVSAKCDVYSYGVLLMETFTRKRP-- 125
           G+++  G        +  + T+ Y  P+      + S   D++S G +  E     RP  
Sbjct: 146 GLARAFGIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF 203

Query: 126 ----TDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLALD-- 179
                D+       L     E     +T++ D        A  + ++ +  +     D  
Sbjct: 204 PGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLL 263

Query: 180 --CCMESPGKRINMTDA 194
                 +P +RI+  +A
Sbjct: 264 QNLLKCNPVQRISAEEA 280

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 77.6 bits (190), Expect = 9e-18
 Identities = 42/209 (20%), Positives = 69/209 (33%), Gaps = 19/209 (9%)

Query: 1   MPNGSLEKWLYSY--NYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLD 58
           +    +   LY                +  +   L+Y H    SA ++H DLKP+N+LL+
Sbjct: 88  LVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH----SANVLHRDLKPSNLLLN 143

Query: 59  ENMVAHVSDFGISKLLGEGED-FVTQTMTMATIGYMAPEYGSEGIV-SAKCDVYSYGVLL 116
                 + DFG++++     D     T  +AT  Y APE        +   D++S G +L
Sbjct: 144 TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCIL 203

Query: 117 METFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSI--- 173
            E  + +         +           P         NL       +      V     
Sbjct: 204 AEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRL 263

Query: 174 --------MDLALDCCMESPGKRINMTDA 194
                   +DL       +P KRI +  A
Sbjct: 264 FPNADSKALDLLDKMLTFNPHKRIEVEQA 292

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score = 76.1 bits (186), Expect = 2e-17
 Identities = 37/204 (18%), Positives = 72/204 (35%), Gaps = 16/204 (7%)

Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
             +  L+K L       + +   + ++ + + + Y H       ++H DLKP N+L++  
Sbjct: 81  HLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH----DRRVLHRDLKPQNLLINRE 136

Query: 61  MVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPE-YGSEGIVSAKCDVYSYGVLLMET 119
               ++DFG+++  G        T  + T+ Y AP+        S   D++S G +  E 
Sbjct: 137 GELKIADFGLARAFGIPVR--KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEM 194

Query: 120 FTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKM---------DCI 170
                    +   +  +R +     P+         L + +  F                
Sbjct: 195 VNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLD 254

Query: 171 VSIMDLALDCCMESPGKRINMTDA 194
            S +DL        P +RI    A
Sbjct: 255 ESGIDLLSKMLKLDPNQRITAKQA 278

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 76.1 bits (186), Expect = 3e-17
 Identities = 40/209 (19%), Positives = 76/209 (36%), Gaps = 20/209 (9%)

Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
             +             F + E   +M  + + L Y H       I+H D+K  N+L+  +
Sbjct: 99  CEHDLAGLLSN-VLVKFTLSEIKRVMQMLLNGLYYIHRNK----ILHRDMKAANVLITRD 153

Query: 61  MVAHVSDFGISKLLGEGEDFVTQTMT--MATIGYMAPE-YGSEGIVSAKCDVYSYGVLLM 117
            V  ++DFG+++     ++      T  + T+ Y  PE    E       D++  G ++ 
Sbjct: 154 GVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMA 213

Query: 118 ETFTRKRP-TDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVS---- 172
           E +TR           +++L   +  S+   +   VD   + E+          V     
Sbjct: 214 EMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLK 273

Query: 173 -------IMDLALDCCMESPGKRINMTDA 194
                   +DL     +  P +RI+  DA
Sbjct: 274 AYVRDPYALDLIDKLLVLDPAQRIDSDDA 302

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 75.6 bits (185), Expect = 6e-17
 Identities = 30/125 (24%), Positives = 45/125 (36%), Gaps = 10/125 (8%)

Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           +  G +   L     F            +    EY H    S  +I+ DLKP N+L+D+ 
Sbjct: 123 VAGGEMFSHLRRIGRF-SEPHARFYAAQIVLTFEYLH----SLDLIYRDLKPENLLIDQQ 177

Query: 61  MVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETF 120
               V+DFG +K                T   +APE       +   D ++ GVL+ E  
Sbjct: 178 GYIQVTDFGFAK-----RVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMA 232

Query: 121 TRKRP 125
               P
Sbjct: 233 AGYPP 237

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 74.8 bits (183), Expect = 8e-17
 Identities = 31/125 (24%), Positives = 50/125 (40%), Gaps = 7/125 (5%)

Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
              G L   L      F          ++ SALEY H    S  +++ D+K  N++LD++
Sbjct: 87  ANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLH----SRDVVYRDIKLENLMLDKD 141

Query: 61  MVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETF 120
               ++DFG+ K         T      T  Y+APE   +       D +  GV++ E  
Sbjct: 142 GHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM 199

Query: 121 TRKRP 125
             + P
Sbjct: 200 CGRLP 204

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 73.3 bits (179), Expect = 2e-16
 Identities = 41/198 (20%), Positives = 77/198 (38%), Gaps = 28/198 (14%)

Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           +  G L  +L       +  E    +  + + + Y H    S  I H DLKP NI+L + 
Sbjct: 95  VAGGELFDFLAEKESLTEE-EATEFLKQILNGVYYLH----SLQIAHFDLKPENIMLLDR 149

Query: 61  MVA----HVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLL 116
            V      + DFG++  +  G +F        T  ++APE  +   +  + D++S GV+ 
Sbjct: 150 NVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 206

Query: 117 METFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDL 176
               +   P             ++ ++    L  V   N   E++ F+   +      D 
Sbjct: 207 YILLSGASP-------------FLGDTKQETLANVSAVNYEFEDEYFS---NTSALAKDF 250

Query: 177 ALDCCMESPGKRINMTDA 194
                ++ P KR+ + D+
Sbjct: 251 IRRLLVKDPKKRMTIQDS 268

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 73.3 bits (179), Expect = 3e-16
 Identities = 36/206 (17%), Positives = 66/206 (32%), Gaps = 18/206 (8%)

Query: 1   MPNGSLEKWLY--SYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLD 58
           +P        +         ++     M  +  +L Y H    S  I H D+KP N+LLD
Sbjct: 101 VPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH----SFGICHRDIKPQNLLLD 156

Query: 59  -ENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLM 117
            +  V  + DFG +K L  GE     +   +               ++  DV+S G +L 
Sbjct: 157 PDTAVLKLCDFGSAKQLVRGEPN--VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLA 214

Query: 118 ETFTRKRP------TDEMFTGEMSLRRWVKESLPHGLTEVVDANLVR-EEQAFAAKMDCI 170
           E    +         D++      L    +E +        +    + +   +       
Sbjct: 215 ELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPR 274

Query: 171 VS--IMDLALDCCMESPGKRINMTDA 194
                + L       +P  R+   +A
Sbjct: 275 TPPEAIALCSRLLEYTPTARLTPLEA 300

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score = 66.8 bits (162), Expect = 6e-14
 Identities = 27/127 (21%), Positives = 56/127 (44%), Gaps = 13/127 (10%)

Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLD-E 59
           + N   ++   +        +    M ++  AL+Y H       I+H D+KP N+++D E
Sbjct: 114 VNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCHSMG----IMHRDVKPHNVMIDHE 165

Query: 60  NMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLME 118
           +    + D+G+++    G+      + +A+  +  PE   +  +     D++S G +L  
Sbjct: 166 HRKLRLIDWGLAEFYHPGQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLAS 222

Query: 119 TFTRKRP 125
              RK P
Sbjct: 223 MIFRKEP 229

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 66.4 bits (161), Expect = 7e-14
 Identities = 40/127 (31%), Positives = 54/127 (42%), Gaps = 8/127 (6%)

Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDEN 60
           +  G L   L      F   E    + ++  ALE+ H       II+ D+K  NILLD N
Sbjct: 111 INGGELFTHLSQ-RERFTEHEVQIYVGEIVLALEHLHKLG----IIYRDIKLENILLDSN 165

Query: 61  MVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPE--YGSEGIVSAKCDVYSYGVLLME 118
               ++DFG+SK     E          TI YMAP+   G +       D +S GVL+ E
Sbjct: 166 GHVVLTDFGLSKEFVADETERAY-DFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYE 224

Query: 119 TFTRKRP 125
             T   P
Sbjct: 225 LLTGASP 231

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 65.4 bits (158), Expect = 2e-13
 Identities = 25/126 (19%), Positives = 45/126 (35%), Gaps = 4/126 (3%)

Query: 1   MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLD-E 59
           +    L       +    ++    I   +   L+Y H       IIH D+KP N+L++  
Sbjct: 106 LGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIV 162

Query: 60  NMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMET 119
           +   ++    I+ L          T ++ T  Y +PE           D++S   L+ E 
Sbjct: 163 DSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFEL 222

Query: 120 FTRKRP 125
            T    
Sbjct: 223 ITGDFL 228

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 63.3 bits (153), Expect = 1e-12
 Identities = 36/190 (18%), Positives = 66/190 (34%), Gaps = 21/190 (11%)

Query: 17  FDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGE 76
                   ++  +   L Y H       IIH DLKP N+ ++E+    + DFG+++    
Sbjct: 118 LGEDRIQFLVYQMLKGLRYIHAAG----IIHRDLKPGNLAVNEDCELKILDFGLARQADS 173

Query: 77  GEDFVTQTMTMATIGYMAPE-YGSEGIVSAKCDVYSYGVLLMETFTRKRP---------T 126
                  T  + T  Y APE   +    +   D++S G ++ E  T K            
Sbjct: 174 -----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQL 228

Query: 127 DEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVS--IMDLALDCCMES 184
            E+     +      + L     +     L   E+   A +    S   ++L     +  
Sbjct: 229 KEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLD 288

Query: 185 PGKRINMTDA 194
             +R+   +A
Sbjct: 289 AEQRVTAGEA 298

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 61.9 bits (149), Expect = 3e-12
 Identities = 38/208 (18%), Positives = 66/208 (31%), Gaps = 29/208 (13%)

Query: 9   WLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDF 68
                    D      ++  +   +++ H       IIH DLKP+NI++  +    + DF
Sbjct: 108 LCQVIQMELDHERMSYLLYQMLCGIKHLHSAG----IIHRDLKPSNIVVKSDCTLKILDF 163

Query: 69  GISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRP--- 125
           G+++  G        T  + T  Y APE           D++S G ++ E    K     
Sbjct: 164 GLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG 220

Query: 126 -----------------TDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFAAKMD 168
                              E         R   E+ P                   ++ +
Sbjct: 221 RDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHN 280

Query: 169 CIVS--IMDLALDCCMESPGKRINMTDA 194
            + +    DL     +  P KRI++ DA
Sbjct: 281 KLKASQARDLLSKMLVIDPAKRISVDDA 308

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 55.7 bits (133), Expect = 5e-10
 Identities = 34/189 (17%), Positives = 65/189 (34%), Gaps = 19/189 (10%)

Query: 17  FDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGE 76
                   ++  +   L+Y H       IIH DLKP+N+ ++E+    + DFG+++    
Sbjct: 118 LTDDHVQFLIYQILRGLKYIHSAD----IIHRDLKPSNLAVNEDCELKILDFGLARHT-- 171

Query: 77  GEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRP---TDEMFTGE 133
             D                   +    +   D++S G ++ E  T +     TD +   +
Sbjct: 172 --DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLK 229

Query: 134 MSLRRWVK--ESLPHGLTEVVDANLVREEQAFAAK--MDCIVSIMDLALD----CCMESP 185
           + LR        L   ++     N ++           +  +    LA+D      +   
Sbjct: 230 LILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDS 289

Query: 186 GKRINMTDA 194
            KRI    A
Sbjct: 290 DKRITAAQA 298

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 42.8 bits (100), Expect = 5e-06
 Identities = 15/71 (21%), Positives = 28/71 (39%), Gaps = 5/71 (7%)

Query: 6   LEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHV 65
           +E       Y   +     ++  +   +   +H      I+H DL   N+L+ E  +  +
Sbjct: 89  MELIDAKELYRVRVENPDEVLDMILEEVAKFYHRG----IVHGDLSQYNVLVSEEGI-WI 143

Query: 66  SDFGISKLLGE 76
            DF  S  +GE
Sbjct: 144 IDFPQSVEVGE 154

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	202
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	99.97
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	99.96
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.26
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	95.63
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	94.5
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	94.32
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	90.61
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	90.44
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	82.58

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-44  Score=268.75  Aligned_cols=182  Identities=23%  Similarity=0.367  Sum_probs=140.0

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |+||||.+++...+..+++..++.++.|++.||.|||    +++|+||||||+|||++.++.+||+|||+++........
T Consensus        85 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH----~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~  160 (276)
T d1uwha_          85 CEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH----AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS  160 (276)
T ss_dssp             CCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEEETTSSEEECCCCCSCC-------
T ss_pred             CCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHh----cCCEeccccCHHHEEEcCCCCEEEccccceeeccccCCc
Confidence            6899999999876667999999999999999999999    899999999999999999999999999999876543322


Q ss_pred             ccccCCCCCccccCCCCCCC---CCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhC-CCChhhhhhhhh
Q 037267           81 VTQTMTMATIGYMAPEYGSE---GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESL-PHGLTEVVDANL  156 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~---~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  156 (202)
                      .......||+.|+|||++.+   ..++.++|||||||++||+++|..||........ +...+.... ++...       
T Consensus       161 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~-~~~~~~~~~~~p~~~-------  232 (276)
T d1uwha_         161 HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ-IIFMVGRGYLSPDLS-------  232 (276)
T ss_dssp             -----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH-HHHHHHHTSCCCCGG-------
T ss_pred             ccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHH-HHHHHhcCCCCCcch-------
Confidence            22334568999999997654   3478899999999999999999999976543322 222222211 11111       


Q ss_pred             hhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          157 VREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                             ..+..+++++.+++.+||+.||++|||++|+++.|+.+
T Consensus       233 -------~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l  270 (276)
T d1uwha_         233 -------KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELL  270 (276)
T ss_dssp             -------GSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -------hccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence                   11234667799999999999999999999999999876

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-42  Score=264.76  Aligned_cols=177  Identities=23%  Similarity=0.364  Sum_probs=142.2

Q ss_pred             CCCCcHHHHHhhcC----------------------CCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeC
Q 037267            1 MPNGSLEKWLYSYN----------------------YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLD   58 (202)
Q Consensus         1 ~~~gsL~~~l~~~~----------------------~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~   58 (202)
                      |+||||.++|++..                      ..+++..++.++.|++.||.|||    +.+|+||||||+||+++
T Consensus       123 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH----~~~IiHRDlKp~Nill~  198 (325)
T d1rjba_         123 CCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE----FKSCVHRDLAARNVLVT  198 (325)
T ss_dssp             CTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH----HTTEEETTCSGGGEEEE
T ss_pred             CCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHH----hCCeeeccCchhccccc
Confidence            68999999997542                      24899999999999999999999    89999999999999999


Q ss_pred             CCCceEEcccccceeccCCCccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhH
Q 037267           59 ENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLR  137 (202)
Q Consensus        59 ~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~  137 (202)
                      .++.+||+|||+++...............+|+.|+|||.+.+..++.++||||+||++|||++ |..||....... .+.
T Consensus       199 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~-~~~  277 (325)
T d1rjba_         199 HGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA-NFY  277 (325)
T ss_dssp             TTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH-HHH
T ss_pred             cCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHHH-HHH
Confidence            999999999999987655443333334557899999999888899999999999999999997 899997644332 222


Q ss_pred             HHHHHhCCCChhhhhhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHh
Q 037267          138 RWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLK  199 (202)
Q Consensus       138 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~  199 (202)
                      ..+.....                 .+.+..+++++.+|+.+||+.||++|||++||++.|.
T Consensus       278 ~~~~~~~~-----------------~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         278 KLIQNGFK-----------------MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             HHHHTTCC-----------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHhcCCC-----------------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            22222111                 1112345677999999999999999999999999986

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.5e-42  Score=254.46  Aligned_cols=174  Identities=21%  Similarity=0.278  Sum_probs=137.4

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |+||||.+++.+.. .+++.++..++.|+++||.|||    +.+|+||||||+|||++.++.+||+|||+++........
T Consensus        85 ~~gg~L~~~l~~~~-~l~e~~~~~i~~qi~~al~ylH----~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~  159 (271)
T d1nvra_          85 CSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLH----GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE  159 (271)
T ss_dssp             CTTEEGGGGSBTTT-BCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred             cCCCcHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH----HcCCccCcccHHHEEECCCCCEEEccchhheeeccCCcc
Confidence            68999999997543 5999999999999999999999    899999999999999999999999999999876543322


Q ss_pred             ccccCCCCCccccCCCCCCCCCc-CcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhh
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIV-SAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVRE  159 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~-~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (202)
                      .......||+.|+|||++.+..+ +.++|+||+||++|+|++|..||...................              
T Consensus       160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~--------------  225 (271)
T d1nvra_         160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY--------------  225 (271)
T ss_dssp             CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTT--------------
T ss_pred             ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC--------------
Confidence            22344579999999998877765 567999999999999999999997654333222222111100              


Q ss_pred             HHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          160 EQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       160 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                         ......+++++.+|+.+||+.||++|||++|+++
T Consensus       226 ---~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         226 ---LNPWKKIDSAPLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             ---STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ---CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence               0011234566889999999999999999999875

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-42  Score=259.61  Aligned_cols=177  Identities=23%  Similarity=0.399  Sum_probs=144.7

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |+||||.+++......+++.+++.++.|++.||.|||    +++|+||||||+||+++.++.+||+|||+++........
T Consensus        90 ~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH----~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~  165 (285)
T d1u59a_          90 AGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE----EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY  165 (285)
T ss_dssp             CTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCE
T ss_pred             CCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHH----hCCeecCcCchhheeeccCCceeeccchhhhcccccccc
Confidence            6899999999876667999999999999999999999    899999999999999999999999999999987654332


Q ss_pred             c-cccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhh
Q 037267           81 V-TQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVR  158 (202)
Q Consensus        81 ~-~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (202)
                      . ......+|+.|+|||.+.+..++.++|||||||++||+++ |..||......+  +...+..+..             
T Consensus       166 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~--~~~~i~~~~~-------------  230 (285)
T d1u59a_         166 YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE--VMAFIEQGKR-------------  230 (285)
T ss_dssp             ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH--HHHHHHTTCC-------------
T ss_pred             cccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHH--HHHHHHcCCC-------------
Confidence            2 2333457889999999888889999999999999999998 899997654322  2222222110             


Q ss_pred             hHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhh
Q 037267          159 EEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKK  200 (202)
Q Consensus       159 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~  200 (202)
                          .+.+..+++++.+|+.+||+.||++|||+.++.+.|+.
T Consensus       231 ----~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~  268 (285)
T d1u59a_         231 ----MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA  268 (285)
T ss_dssp             ----CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred             ----CCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence                11123466779999999999999999999999999875

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.1e-42  Score=260.73  Aligned_cols=178  Identities=26%  Similarity=0.466  Sum_probs=133.6

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |+||+|.+++......+++.+++.++.|++.||.|||    +++|+||||||+|||++.++.+||+|||+++........
T Consensus       109 ~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH----~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~  184 (299)
T d1jpaa_         109 MENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA----DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSD  184 (299)
T ss_dssp             CTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEECTTCCEEECCC------------
T ss_pred             cCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHh----hCCCccCccccceEEECCCCcEEECCcccceEccCCCCc
Confidence            6899999999877767999999999999999999999    899999999999999999999999999999876543221


Q ss_pred             c---cccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhCCCChhhhhhhhh
Q 037267           81 V---TQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANL  156 (202)
Q Consensus        81 ~---~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (202)
                      .   ......+|+.|+|||.+.+..++.++|||||||++||+++ |..||.......  +...+....            
T Consensus       185 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~--~~~~i~~~~------------  250 (299)
T d1jpaa_         185 PTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD--VINAIEQDY------------  250 (299)
T ss_dssp             -----------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHHHHTTC------------
T ss_pred             ceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHH--HHHHHHcCC------------
Confidence            1   1122346889999999888889999999999999999998 899997653321  111121111            


Q ss_pred             hhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          157 VREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                           ..+.+..++.++.+|+.+||+.||++|||+.|+++.|+++
T Consensus       251 -----~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~  290 (299)
T d1jpaa_         251 -----RLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM  290 (299)
T ss_dssp             -----CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             -----CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence                 0111234667799999999999999999999999999764

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-42  Score=254.97  Aligned_cols=178  Identities=26%  Similarity=0.356  Sum_probs=132.0

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |++|+|.+++......+++..++.++.|++.||.|||    +.+|+||||||+||+++.++.+||+|||+++........
T Consensus        82 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH----~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~  157 (263)
T d1sm2a_          82 MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE----EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT  157 (263)
T ss_dssp             CTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH----HTTCCCTTCSGGGEEECGGGCEEECSCC-----------
T ss_pred             cCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhh----ccceeecccchhheeecCCCCeEecccchheeccCCCce
Confidence            6899999999877777999999999999999999999    899999999999999999999999999999876543322


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhH
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREE  160 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (202)
                      . .....+|..|+|||.+.+..++.++|+||||+++||++++..|+....... .+...+......              
T Consensus       158 ~-~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~-~~~~~i~~~~~~--------------  221 (263)
T d1sm2a_         158 S-STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS-EVVEDISTGFRL--------------  221 (263)
T ss_dssp             --------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHH-HHHHHHHHTCCC--------------
T ss_pred             e-ecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHH-HHHHHHHhcCCC--------------
Confidence            1 223457899999999998899999999999999999999544443322211 111222221110              


Q ss_pred             HHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          161 QAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       161 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                         ..+..+++++.+++.+||+.||++|||++|+++.|+++
T Consensus       222 ---~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i  259 (263)
T d1sm2a_         222 ---YKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI  259 (263)
T ss_dssp             ---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---CCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence               11223566789999999999999999999999999876

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-41  Score=255.48  Aligned_cols=179  Identities=27%  Similarity=0.401  Sum_probs=136.4

Q ss_pred             CCCCcHHHHHhhcC---------------CCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEE
Q 037267            1 MPNGSLEKWLYSYN---------------YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHV   65 (202)
Q Consensus         1 ~~~gsL~~~l~~~~---------------~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l   65 (202)
                      |++|||.++++...               ..+++.+++.++.|+++||.|||    +++|+||||||+|||++.++.+||
T Consensus       100 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH----~~~ivHrDlKp~NILl~~~~~~Kl  175 (299)
T d1ywna1         100 CKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA----SRKCIHRDLAARNILLSEKNVVKI  175 (299)
T ss_dssp             CTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEECGGGCEEE
T ss_pred             cCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHH----hCCCcCCcCCccceeECCCCcEEE
Confidence            68999999997532               24899999999999999999999    899999999999999999999999


Q ss_pred             cccccceeccCCCccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCC-CCCCcccccchhhHHHHHHhC
Q 037267           66 SDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRK-RPTDEMFTGEMSLRRWVKESL  144 (202)
Q Consensus        66 ~d~g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~-~p~~~~~~~~~~~~~~~~~~~  144 (202)
                      +|||+++...............||+.|+|||.+.+..++.++||||+||++|+|++|. .||........ +...+..+.
T Consensus       176 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~-~~~~~~~~~  254 (299)
T d1ywna1         176 CDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-FCRRLKEGT  254 (299)
T ss_dssp             CC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH-HHHHHHHTC
T ss_pred             ccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHH-HHHHHhcCC
Confidence            9999998765443333334456899999999988888999999999999999999865 56765433322 222222221


Q ss_pred             CCChhhhhhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          145 PHGLTEVVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                      ..                 +.+..+++++.+++.+||+.||++|||++|+++.|+++
T Consensus       255 ~~-----------------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i  294 (299)
T d1ywna1         255 RM-----------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  294 (299)
T ss_dssp             CC-----------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CC-----------------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            11                 11223556789999999999999999999999999865

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.8e-42  Score=255.92  Aligned_cols=176  Identities=26%  Similarity=0.392  Sum_probs=140.9

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |++|||.++++... .+++..++.++.||+.||.|||    +++|+||||||+||+++.++.+|++|||+++........
T Consensus        89 ~~~g~L~~~l~~~~-~l~~~~~~~i~~qi~~gl~ylH----~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~  163 (277)
T d1xbba_          89 AELGPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLE----ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY  163 (277)
T ss_dssp             CTTEEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE
T ss_pred             CCCCcHHHHHhhcc-CCCHHHHHHHHHHHHHHHhhHH----hCCcccCCCcchhhcccccCcccccchhhhhhccccccc
Confidence            68999999998654 4899999999999999999999    899999999999999999999999999999876544322


Q ss_pred             c-cccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhh
Q 037267           81 V-TQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVR  158 (202)
Q Consensus        81 ~-~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (202)
                      . ......+|+.|+|||.+.+..++.++||||||+++||+++ |..||.......  +...+..+..             
T Consensus       164 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~--~~~~i~~~~~-------------  228 (277)
T d1xbba_         164 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE--VTAMLEKGER-------------  228 (277)
T ss_dssp             EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHHHHHTTCC-------------
T ss_pred             cccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHH--HHHHHHcCCC-------------
Confidence            2 2233468899999999888889999999999999999997 899997653221  2222221110             


Q ss_pred             hHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhh
Q 037267          159 EEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKK  200 (202)
Q Consensus       159 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~  200 (202)
                          .+.+..++.++.+|+.+||+.||++|||++++.+.|+.
T Consensus       229 ----~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~  266 (277)
T d1xbba_         229 ----MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN  266 (277)
T ss_dssp             ----CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             ----CCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence                11123466779999999999999999999999998875

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-40  Score=247.92  Aligned_cols=171  Identities=22%  Similarity=0.271  Sum_probs=137.2

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |+||+|.+++.+.  .+++.++..++.|++.||.|||    +.+|+||||||+|||++.++.+||+|||++........ 
T Consensus        99 ~~gg~L~~~~~~~--~l~~~~~~~i~~qi~~aL~yLH----~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~-  171 (293)
T d1yhwa1          99 LAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH----SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-  171 (293)
T ss_dssp             CTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred             cCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHH----HCCCcccCCcHHHeEECCCCcEeeccchhheeeccccc-
Confidence            6899999998753  4899999999999999999999    89999999999999999999999999999987654332 


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhH
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREE  160 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (202)
                       ......||+.|+|||.+.+..++.++|+||+||++|+|++|..||........ +........+.              
T Consensus       172 -~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-~~~~~~~~~~~--------------  235 (293)
T d1yhwa1         172 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-LYLIATNGTPE--------------  235 (293)
T ss_dssp             -CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-HHHHHHHCSCC--------------
T ss_pred             -cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHH-HHHHHhCCCCC--------------
Confidence             22345699999999999998899999999999999999999999975432221 11111111110              


Q ss_pred             HHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          161 QAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       161 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                        ...+..+++++.+++.+||+.||++|||+.|+++
T Consensus       236 --~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         236 --LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             --CSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             --CCCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence              0111235667899999999999999999999875

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-40  Score=245.28  Aligned_cols=169  Identities=22%  Similarity=0.352  Sum_probs=132.2

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCC--eeecCCCCCceeeC-CCCceEEcccccceeccCC
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAP--IIHCDLKPTNILLD-ENMVAHVSDFGISKLLGEG   77 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~--i~h~dlk~~nil~~-~~~~~~l~d~g~~~~~~~~   77 (202)
                      |++|||.+++.+.. .+++..+..++.|+++||.|||    +.+  |+||||||+|||++ .++.+||+|||+++.....
T Consensus        94 ~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~gl~yLH----~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~  168 (270)
T d1t4ha_          94 MTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLH----TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS  168 (270)
T ss_dssp             CCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred             CCCCcHHHHHhccc-cccHHHHHHHHHHHHHHHHHHH----HCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC
Confidence            68999999998654 4899999999999999999999    777  99999999999996 5789999999999754332


Q ss_pred             CccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhh
Q 037267           78 EDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV  157 (202)
Q Consensus        78 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (202)
                      .    .....||+.|+|||++.+ .++.++||||+||++|+|++|..||........... .+.....+           
T Consensus       169 ~----~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~-~i~~~~~~-----------  231 (270)
T d1t4ha_         169 F----AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYR-RVTSGVKP-----------  231 (270)
T ss_dssp             S----BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHH-HHTTTCCC-----------
T ss_pred             c----cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHH-HHHcCCCC-----------
Confidence            2    223468999999998765 589999999999999999999999975432221111 11111100           


Q ss_pred             hhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          158 REEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                           ...+..+++++.+++.+||+.||++|||++|+++
T Consensus       232 -----~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         232 -----ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             -----GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             -----cccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence                 0111234556889999999999999999999975

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-41  Score=249.51  Aligned_cols=167  Identities=25%  Similarity=0.307  Sum_probs=136.0

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |++|+|.+++..... +++..+..++.|++.||.|||    +.+|+||||||+||+++.++.+||+|||++........ 
T Consensus        88 ~~~g~L~~~l~~~~~-l~e~~~~~i~~qi~~al~~lH----~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~~-  161 (263)
T d2j4za1          88 APLGTVYRELQKLSK-FDEQRTATYITELANALSYCH----SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR-  161 (263)
T ss_dssp             CTTCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCCC-
T ss_pred             cCCCcHHHHHhhcCC-CCHHHHHHHHHHHHHHHHHHH----HCCeeeeeeccccceecCCCCEeecccceeeecCCCcc-
Confidence            689999999986554 899999999999999999999    89999999999999999999999999999976543321 


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhH
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREE  160 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (202)
                         ....||+.|+|||++.+..++.++|+||+||++|+|++|+.||.......  ....+.....               
T Consensus       162 ---~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~--~~~~i~~~~~---------------  221 (263)
T d2j4za1         162 ---TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE--TYKRISRVEF---------------  221 (263)
T ss_dssp             ---EETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH--HHHHHHTTCC---------------
T ss_pred             ---cccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHH--HHHHHHcCCC---------------
Confidence               23468999999999999889999999999999999999999997543221  1111111100               


Q ss_pred             HHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          161 QAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       161 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                         ..+..+++++.+++.+||+.||++|||+.|+++
T Consensus       222 ---~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         222 ---TFPDFVTEGARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             ---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ---CCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence               011235567899999999999999999999986

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-41  Score=252.81  Aligned_cols=173  Identities=23%  Similarity=0.260  Sum_probs=135.9

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |+||+|.+++.+....+++.++..++.|++.||.|||    +.+|+||||||+||+++.++.+||+|||++.......  
T Consensus        91 ~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH----~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~--  164 (288)
T d2jfla1          91 CAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH----DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--  164 (288)
T ss_dssp             CTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH--
T ss_pred             CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCEEEeecChhheeECCCCCEEEEechhhhccCCCc--
Confidence            6899999998866666999999999999999999999    8999999999999999999999999999997643221  


Q ss_pred             ccccCCCCCccccCCCCCC-----CCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhh
Q 037267           81 VTQTMTMATIGYMAPEYGS-----EGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDAN  155 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~-----~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (202)
                      .......||+.|+|||++.     +..++.++|+||+||++|+|++|..||........ +..... ..+..        
T Consensus       165 ~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~-~~~i~~-~~~~~--------  234 (288)
T d2jfla1         165 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV-LLKIAK-SEPPT--------  234 (288)
T ss_dssp             HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH-HHHHHH-SCCCC--------
T ss_pred             ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHH-HHHHHc-CCCCC--------
Confidence            1123457899999999753     45678899999999999999999999976543221 111111 11000        


Q ss_pred             hhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          156 LVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                             ...+..+++++.+|+.+||+.||++|||++|+++
T Consensus       235 -------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         235 -------LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             -------CSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -------CCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                   0111235667899999999999999999999975

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-40  Score=247.54  Aligned_cols=179  Identities=26%  Similarity=0.464  Sum_probs=134.7

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |.+|+|.+++......+++..++.++.|++.||.|||    +.+|+||||||+|||++.++.+||+|||+++........
T Consensus        91 ~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH----~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~  166 (283)
T d1mqba_          91 MENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA----NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA  166 (283)
T ss_dssp             CTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEECTTCCEEECCCCC----------
T ss_pred             cccCcchhhhhcccccccHHHHHHHHHHHHHhhhhcc----ccccccCccccceEEECCCCeEEEcccchhhcccCCCcc
Confidence            5789999999877777999999999999999999999    899999999999999999999999999999876543221


Q ss_pred             c-cccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhh
Q 037267           81 V-TQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVRE  159 (202)
Q Consensus        81 ~-~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (202)
                      . ......+|+.|+|||.+.+..++.++|||||||++||+++|..|+........ +...+.....              
T Consensus       167 ~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~-~~~~i~~~~~--------------  231 (283)
T d1mqba_         167 TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE-VMKAINDGFR--------------  231 (283)
T ss_dssp             -------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-HHHHHHTTCC--------------
T ss_pred             ceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHH-HHHHHhccCC--------------
Confidence            1 12234578899999998888999999999999999999997666544322221 1222221110              


Q ss_pred             HHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          160 EQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       160 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                         .+.+..++.++.+|+.+||+.||++|||+.|+++.|+++
T Consensus       232 ---~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l  270 (283)
T d1mqba_         232 ---LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL  270 (283)
T ss_dssp             ---CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             ---CCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHH
Confidence               111234566789999999999999999999999999764

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-40  Score=247.02  Aligned_cols=178  Identities=24%  Similarity=0.384  Sum_probs=139.5

Q ss_pred             CCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCc
Q 037267            1 MPNGSLEKWLYSYN-YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED   79 (202)
Q Consensus         1 ~~~gsL~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~   79 (202)
                      |++|+|.+++.... ..+++..++.++.|++.||.|||    +.+|+||||||+||+++.++.+||+|||+++.......
T Consensus        89 ~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH----~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~  164 (272)
T d1qpca_          89 MENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE----ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY  164 (272)
T ss_dssp             CTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred             CCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH----hCCcccCccchhheeeecccceeeccccceEEccCCcc
Confidence            68999999887433 35899999999999999999999    89999999999999999999999999999988765432


Q ss_pred             cccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhh
Q 037267           80 FVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVRE  159 (202)
Q Consensus        80 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (202)
                      . ......+++.|+|||.+.+..++.++|||||||++||+++|..|+........ ....+.....              
T Consensus       165 ~-~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~-~~~~i~~~~~--------------  228 (272)
T d1qpca_         165 T-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE-VIQNLERGYR--------------  228 (272)
T ss_dssp             E-CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-HHHHHHTTCC--------------
T ss_pred             c-cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHH-HHHHHHhcCC--------------
Confidence            2 22334678899999998888899999999999999999996665543322211 1111211110              


Q ss_pred             HHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          160 EQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       160 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                         ...+..+++++.+|+.+||+.||++|||++++++.|+.+
T Consensus       229 ---~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~  267 (272)
T d1qpca_         229 ---MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF  267 (272)
T ss_dssp             ---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---CCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhh
Confidence               011224566789999999999999999999999988753

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-41  Score=255.72  Aligned_cols=178  Identities=23%  Similarity=0.374  Sum_probs=141.7

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |++|+|.+++......+++..++.++.|++.||.|||    +++|+||||||+||+++.++.+||+|||+++........
T Consensus        92 ~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH----~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~~  167 (317)
T d1xkka_          92 MPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE----DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE  167 (317)
T ss_dssp             CTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC-
T ss_pred             ccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHH----HcCcccCcchhhcceeCCCCCeEeeccccceeccccccc
Confidence            5789999999987778999999999999999999999    899999999999999999999999999999876544333


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhh
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVRE  159 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (202)
                      .......+|+.|+|||.+.+..++.++|+|||||++||+++ |..||.......  +...+..+..              
T Consensus       168 ~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~--~~~~i~~~~~--------------  231 (317)
T d1xkka_         168 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISSILEKGER--------------  231 (317)
T ss_dssp             -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG--HHHHHHHTCC--------------
T ss_pred             ccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH--HHHHHHcCCC--------------
Confidence            22333457899999999888889999999999999999998 788887654322  2222222110              


Q ss_pred             HHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          160 EQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       160 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                         .+.+..+++++.+|+.+||+.||++|||+.|+++.|+.+
T Consensus       232 ---~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~  270 (317)
T d1xkka_         232 ---LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM  270 (317)
T ss_dssp             ---CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---CCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence               111234667799999999999999999999999988754

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=5.5e-40  Score=246.98  Aligned_cols=178  Identities=24%  Similarity=0.332  Sum_probs=140.3

Q ss_pred             CCCCcHHHHHhhc-CCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCc
Q 037267            1 MPNGSLEKWLYSY-NYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED   79 (202)
Q Consensus         1 ~~~gsL~~~l~~~-~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~   79 (202)
                      |++|+|.+++... ...+++..++.++.|+++||.|||    +.+|+||||||+|||++.++.+||+|||+++.......
T Consensus        95 ~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH----~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~  170 (287)
T d1opja_          95 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE----KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY  170 (287)
T ss_dssp             CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSS
T ss_pred             ccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHH----HCCcccCccccCeEEECCCCcEEEccccceeecCCCCc
Confidence            6899999999754 456999999999999999999999    89999999999999999999999999999987654332


Q ss_pred             cccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhh
Q 037267           80 FVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVRE  159 (202)
Q Consensus        80 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (202)
                      . ......+++.|+|||.+.+..++.++|+||+||++|++++|..||....... .....+.....              
T Consensus       171 ~-~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~-~~~~~i~~~~~--------------  234 (287)
T d1opja_         171 T-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-QVYELLEKDYR--------------  234 (287)
T ss_dssp             E-EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-HHHHHHHTTCC--------------
T ss_pred             e-eeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHH-HHHHHHhcCCC--------------
Confidence            2 1222347889999999888889999999999999999999777664432221 11122221110              


Q ss_pred             HHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          160 EQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       160 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                         .+.+..+++++.+|+.+||+.||++|||++|+++.|+.+
T Consensus       235 ---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~  273 (287)
T d1opja_         235 ---MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM  273 (287)
T ss_dssp             ---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred             ---CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence               111234566799999999999999999999999999865

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-40  Score=248.60  Aligned_cols=180  Identities=23%  Similarity=0.339  Sum_probs=141.4

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |++|+|.+++......+++..++.++.|++.||.|||    +++|+||||||+||+++.++.+|++|||+++........
T Consensus        92 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH----~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~~~  167 (273)
T d1u46a_          92 APLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE----SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH  167 (273)
T ss_dssp             CTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHH----HTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCE
T ss_pred             ecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhh----hCCEeeeeecHHHhccccccceeeccchhhhhcccCCCc
Confidence            6799999999877767999999999999999999999    899999999999999999999999999999976544332


Q ss_pred             c-cccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhh
Q 037267           81 V-TQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVR  158 (202)
Q Consensus        81 ~-~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (202)
                      . ......++..|+|||.+.+..++.++|+||||+++|||++ |..||......+.  ...+...               
T Consensus       168 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~--~~~i~~~---------------  230 (273)
T d1u46a_         168 YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI--LHKIDKE---------------  230 (273)
T ss_dssp             EEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH--HHHHHTS---------------
T ss_pred             ceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHH--HHHHHhC---------------
Confidence            2 1223346788999999888889999999999999999998 8999976432221  1111100               


Q ss_pred             hHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhcC
Q 037267          159 EEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKIK  202 (202)
Q Consensus       159 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l~  202 (202)
                       ....+.+..++.++.+|+.+||+.||++|||++++++.|.+.+
T Consensus       231 -~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~~  273 (273)
T d1u46a_         231 -GERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ  273 (273)
T ss_dssp             -CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred             -CCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcC
Confidence             0001112345567899999999999999999999999998754

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-40  Score=244.95  Aligned_cols=177  Identities=24%  Similarity=0.371  Sum_probs=143.4

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |++|+|.+++......+++..+.+++.|+++||.|||    +++|+||||||+||+++.++.+||+|||+++........
T Consensus        81 ~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH----~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~  156 (258)
T d1k2pa_          81 MANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE----SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT  156 (258)
T ss_dssp             CTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH----HTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC
T ss_pred             cCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHh----hcCcccccccceeEEEcCCCcEEECcchhheeccCCCce
Confidence            5799999998876667899999999999999999999    899999999999999999999999999999865543322


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhh
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVRE  159 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (202)
                       ......+|..|+|||.+.+..++.++||||+|+++||+++ |..||......+  ....+.....              
T Consensus       157 -~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~--~~~~i~~~~~--------------  219 (258)
T d1k2pa_         157 -SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE--TAEHIAQGLR--------------  219 (258)
T ss_dssp             -CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH--HHHHHHTTCC--------------
T ss_pred             -eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH--HHHHHHhCCC--------------
Confidence             2333568899999999888889999999999999999998 899997764332  1111211110              


Q ss_pred             HHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          160 EQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       160 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                         .+.+..+++++.+++.+||+.||++|||++++++.|..|
T Consensus       220 ---~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di  258 (258)
T d1k2pa_         220 ---LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV  258 (258)
T ss_dssp             ---CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred             ---CCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence               111234556799999999999999999999999998754

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=8.6e-40  Score=247.69  Aligned_cols=179  Identities=26%  Similarity=0.409  Sum_probs=139.8

Q ss_pred             CCCCcHHHHHhhcC-----------------------CCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceee
Q 037267            1 MPNGSLEKWLYSYN-----------------------YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILL   57 (202)
Q Consensus         1 ~~~gsL~~~l~~~~-----------------------~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~   57 (202)
                      |++|||.+++....                       ..+++..++.++.|++.||.|||    +.+++||||||+|||+
T Consensus        98 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH----~~~ivHrDlKp~NILl  173 (301)
T d1lufa_          98 MAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS----ERKFVHRDLATRNCLV  173 (301)
T ss_dssp             CTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEE
T ss_pred             cCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcc----cCCeEeeEEcccceEE
Confidence            57999999997432                       24889999999999999999999    8999999999999999


Q ss_pred             CCCCceEEcccccceeccCCCccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCC-CCCCcccccchhh
Q 037267           58 DENMVAHVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRK-RPTDEMFTGEMSL  136 (202)
Q Consensus        58 ~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~-~p~~~~~~~~~~~  136 (202)
                      +.++.+||+|||+++...........+...+++.|+|||.+.+..++.++|+|||||++||+++|. .||......+  +
T Consensus       174 d~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e--~  251 (301)
T d1lufa_         174 GENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE--V  251 (301)
T ss_dssp             CGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH--H
T ss_pred             CCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCHHH--H
Confidence            999999999999998654433322333456788999999988889999999999999999999986 4665543222  1


Q ss_pred             HHHHHHhCCCChhhhhhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhcC
Q 037267          137 RRWVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKIK  202 (202)
Q Consensus       137 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l~  202 (202)
                      ...+.....                 .+.+..+++++.+|+.+||+.||++|||+.||++.|++++
T Consensus       252 ~~~v~~~~~-----------------~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~  300 (301)
T d1lufa_         252 IYYVRDGNI-----------------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC  300 (301)
T ss_dssp             HHHHHTTCC-----------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             HHHHHcCCC-----------------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            111211110                 1112345667899999999999999999999999999874

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-40  Score=251.56  Aligned_cols=186  Identities=24%  Similarity=0.296  Sum_probs=134.6

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCC-CCeeecCCCCCceeeCCCCceEEcccccceeccCCCc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSS-APIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED   79 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~-~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~   79 (202)
                      |+||||.+++.+.. .+++..+..++.|++.||.|||    + .+|+||||||+|||++.++.+||+|||++....... 
T Consensus        86 ~~gg~L~~~l~~~~-~l~~~~~~~~~~qil~aL~yLH----~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~-  159 (322)
T d1s9ja_          86 MDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLR----EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-  159 (322)
T ss_dssp             CTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----HHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHT-
T ss_pred             CCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHH----HhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCCc-
Confidence            68999999998655 4899999999999999999999    6 489999999999999999999999999998654321 


Q ss_pred             cccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHH--HHHhC---C---------
Q 037267           80 FVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRW--VKESL---P---------  145 (202)
Q Consensus        80 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~--~~~~~---~---------  145 (202)
                         .....||+.|+|||++.+..++.++||||+||++|+|++|+.||.............  .....   +         
T Consensus       160 ---~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (322)
T d1s9ja_         160 ---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP  236 (322)
T ss_dssp             ---C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------------
T ss_pred             ---cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccc
Confidence               223579999999999999899999999999999999999999997644322111100  00000   0         


Q ss_pred             -----------CChhhhhhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          146 -----------HGLTEVVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       146 -----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                                 ....+.......... ........+.++.+++.+||..||++|||++|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~  297 (322)
T d1s9ja_         237 LSSYGMDSRPPMAIFELLDYIVNEPP-PKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  297 (322)
T ss_dssp             ---------CCCCHHHHHHHHHTSCC-CCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccccccccccchhHHHHHhhhhccCC-ccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence                       000000000000000 00001124567899999999999999999999976

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-40  Score=247.77  Aligned_cols=177  Identities=21%  Similarity=0.386  Sum_probs=133.2

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |++|+|.+++......+++..++.++.|+++||.|||    +.+++||||||+||+++.++.+|++|||+++........
T Consensus        89 ~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH----~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~~  164 (273)
T d1mp8a_          89 CTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE----SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY  164 (273)
T ss_dssp             CTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEEEETTEEEECC-------------
T ss_pred             ccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhc----ccCeeccccchhheeecCCCcEEEccchhheeccCCcce
Confidence            6899999998877777999999999999999999999    899999999999999999999999999999875543222


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhh
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVRE  159 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (202)
                       ......+|+.|+|||.+.+..++.++|+||+||++||+++ |..||......+  +...+.....              
T Consensus       165 -~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~--~~~~i~~~~~--------------  227 (273)
T d1mp8a_         165 -KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND--VIGRIENGER--------------  227 (273)
T ss_dssp             -------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHHHHHTTCC--------------
T ss_pred             -eccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH--HHHHHHcCCC--------------
Confidence             2223457889999999888889999999999999999987 888987654332  1111221110              


Q ss_pred             HHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          160 EQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       160 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                         .+.+..+++++.+|+.+||+.||++|||+.|+++.|+++
T Consensus       228 ---~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i  266 (273)
T d1mp8a_         228 ---LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI  266 (273)
T ss_dssp             ---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence               011234667799999999999999999999999999865

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-40  Score=247.97  Aligned_cols=170  Identities=25%  Similarity=0.302  Sum_probs=133.1

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |+||+|.+++.... .+++..+..++.|++.||.|||    +.+|+||||||+||+++.++.+|++|||+++........
T Consensus        90 ~~gg~L~~~~~~~~-~l~e~~~~~~~~qi~~al~ylH----~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~  164 (288)
T d1uu3a_          90 AKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLH----GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ  164 (288)
T ss_dssp             CTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred             cCCCCHHHhhhccC-CCCHHHHHHHHHHHHHHHHhhc----cccEEcCcCCccccccCCCceEEecccccceecccCCcc
Confidence            68999999998655 4999999999999999999999    899999999999999999999999999999876544332


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhH
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREE  160 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (202)
                      .......||+.|+|||++.+..++.++||||+||++|+|++|..||.......  ....+.....               
T Consensus       165 ~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~--~~~~i~~~~~---------------  227 (288)
T d1uu3a_         165 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL--IFQKIIKLEY---------------  227 (288)
T ss_dssp             -----CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHTTCC---------------
T ss_pred             cccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHH--HHHHHHcCCC---------------
Confidence            22334569999999999988899999999999999999999999997542211  1111111100               


Q ss_pred             HHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHH
Q 037267          161 QAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAA  195 (202)
Q Consensus       161 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~  195 (202)
                         ..+..+++++.+|+.+||..||++|||++|++
T Consensus       228 ---~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~  259 (288)
T d1uu3a_         228 ---DFPEKFFPKARDLVEKLLVLDATKRLGCEEME  259 (288)
T ss_dssp             ---CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGT
T ss_pred             ---CCCccCCHHHHHHHHHHccCCHhHCcCHHHHc
Confidence               01123456689999999999999999999864

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-39  Score=242.95  Aligned_cols=175  Identities=22%  Similarity=0.286  Sum_probs=126.0

Q ss_pred             CCCCcHHHHHhh---cCCCCCHHHHHHHHHHHHHhhhcccCCC-CCCCeeecCCCCCceeeCCCCceEEcccccceeccC
Q 037267            1 MPNGSLEKWLYS---YNYFFDILERLNIMIDVGSALEYPHHGH-SSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGE   76 (202)
Q Consensus         1 ~~~gsL~~~l~~---~~~~l~~~~~~~~~~~l~~~l~~lH~~~-~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~   76 (202)
                      |+||||.+++.+   .+..+++..++.++.|++.||.|||+.. ...+|+||||||+||+++.++.+||+|||+++....
T Consensus        87 ~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~  166 (269)
T d2java1          87 CEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH  166 (269)
T ss_dssp             CTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC--
T ss_pred             CCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeeccc
Confidence            689999999974   2456999999999999999999999310 012499999999999999999999999999987654


Q ss_pred             CCccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhh
Q 037267           77 GEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANL  156 (202)
Q Consensus        77 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (202)
                      ....  .....||+.|+|||.+.+..++.++||||+||++|+|++|..||.......  +...+......          
T Consensus       167 ~~~~--~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~--~~~~i~~~~~~----------  232 (269)
T d2java1         167 DTSF--AKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE--LAGKIREGKFR----------  232 (269)
T ss_dssp             -----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHTCCC----------
T ss_pred             CCCc--cccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHH--HHHHHHcCCCC----------
Confidence            3221  223568999999999988899999999999999999999999997643221  11111111100          


Q ss_pred             hhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          157 VREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                             ..+..+++++.+|+.+||+.||++|||++|+++
T Consensus       233 -------~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         233 -------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             -------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence                   011235567899999999999999999999874

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1e-38  Score=241.95  Aligned_cols=172  Identities=25%  Similarity=0.282  Sum_probs=125.5

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeC---CCCceEEcccccceeccCC
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLD---ENMVAHVSDFGISKLLGEG   77 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~---~~~~~~l~d~g~~~~~~~~   77 (202)
                      |+||||.+++...+ .+++..+..++.|++.||.|||    +.+|+||||||+||++.   .++.+|++|||+++.....
T Consensus        89 ~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~al~ylH----~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~  163 (307)
T d1a06a_          89 VSGGELFDRIVEKG-FYTERDASRLIFQVLDAVKYLH----DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG  163 (307)
T ss_dssp             CCSCBHHHHHHTCS-CCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEESSSSTTCCEEECCC---------
T ss_pred             cCCCcHHHhhhccc-CCCHHHHHHHHHHHHHHHHhhh----hceeeeEEecccceeecccCCCceEEEeccceeEEccCC
Confidence            68999999997644 4999999999999999999999    89999999999999995   5788999999999865433


Q ss_pred             CccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhh
Q 037267           78 EDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV  157 (202)
Q Consensus        78 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (202)
                      ..   .....||+.|+|||.+.+..++.++|+||+||++|+|++|..||.......  ....+........         
T Consensus       164 ~~---~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~--~~~~i~~~~~~~~---------  229 (307)
T d1a06a_         164 SV---LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK--LFEQILKAEYEFD---------  229 (307)
T ss_dssp             ------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHTTCCCCC---------
T ss_pred             Ce---eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHH--HHHHHhccCCCCC---------
Confidence            22   223468999999999988899999999999999999999999997643221  1111111110000         


Q ss_pred             hhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          158 REEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                           .+....+++++.+|+.+||..||++|||++|+++
T Consensus       230 -----~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  263 (307)
T d1a06a_         230 -----SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ  263 (307)
T ss_dssp             -----TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             -----CccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence                 0111235567899999999999999999999986

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-38  Score=243.94  Aligned_cols=177  Identities=23%  Similarity=0.290  Sum_probs=136.8

Q ss_pred             CCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCC---CCceEEcccccceeccC
Q 037267            1 MPNGSLEKWLYSYN-YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDE---NMVAHVSDFGISKLLGE   76 (202)
Q Consensus         1 ~~~gsL~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~---~~~~~l~d~g~~~~~~~   76 (202)
                      |+||||.++|.+.+ ..+++.++..++.|++.||.|||    +.+|+||||||+||+++.   .+.+|++|||+++....
T Consensus        91 ~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH----~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~  166 (335)
T d2ozaa1          91 LDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH----SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS  166 (335)
T ss_dssp             CCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCC
T ss_pred             CCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHH----HcCCccccccccccccccccccccccccccceeeeccC
Confidence            68999999998643 46999999999999999999999    899999999999999985   45799999999987654


Q ss_pred             CCccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhh
Q 037267           77 GEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANL  156 (202)
Q Consensus        77 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (202)
                      ...   .....||+.|+|||++.+..++.++|+||+||++|+|++|..||........ ..... ..........     
T Consensus       167 ~~~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~-~~~~~-~~i~~~~~~~-----  236 (335)
T d2ozaa1         167 HNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-SPGMK-TRIRMGQYEF-----  236 (335)
T ss_dssp             CCC---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC----------CCCSCSSSC-----
T ss_pred             CCc---cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHH-HHHHH-HHHhcCCCCC-----
Confidence            432   2335689999999999999999999999999999999999999976432221 00000 0000000000     


Q ss_pred             hhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          157 VREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                           ..+....+++++.+|+.+||..||++|||+.|+++
T Consensus       237 -----~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  271 (335)
T d2ozaa1         237 -----PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  271 (335)
T ss_dssp             -----CTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             -----CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence                 00112356778999999999999999999999976

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-38  Score=240.80  Aligned_cols=178  Identities=26%  Similarity=0.403  Sum_probs=142.6

Q ss_pred             CCCCcHHHHHhhcC---------------CCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEE
Q 037267            1 MPNGSLEKWLYSYN---------------YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHV   65 (202)
Q Consensus         1 ~~~gsL~~~l~~~~---------------~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l   65 (202)
                      |++|+|.++|+...               ..+++.+++.++.|++.||.|||    +.+|+||||||+|||++.++.+||
T Consensus       101 ~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH----~~~ivHrDiKp~NiLl~~~~~~kl  176 (299)
T d1fgka_         101 ASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA----SKKCIHRDLAARNVLVTEDNVMKI  176 (299)
T ss_dssp             CTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEECTTCCEEE
T ss_pred             cCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhh----hCCEEeeeecccceeecCCCCeEe
Confidence            68999999997542               34899999999999999999999    899999999999999999999999


Q ss_pred             cccccceeccCCCccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhC
Q 037267           66 SDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESL  144 (202)
Q Consensus        66 ~d~g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~  144 (202)
                      +|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||.......  ....+....
T Consensus       177 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~--~~~~i~~~~  254 (299)
T d1fgka_         177 ADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE--LFKLLKEGH  254 (299)
T ss_dssp             CSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--HHHHHHTTC
T ss_pred             ccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHH--HHHHHHcCC
Confidence            99999987655443323334567889999998888899999999999999999998 688886543221  222222221


Q ss_pred             CCChhhhhhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          145 PHGLTEVVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                      ..                 +.+..+++++.+|+.+||+.||++|||+.||++.|++|
T Consensus       255 ~~-----------------~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i  294 (299)
T d1fgka_         255 RM-----------------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI  294 (299)
T ss_dssp             CC-----------------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CC-----------------CCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence            11                 11123556689999999999999999999999999875

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-38  Score=241.11  Aligned_cols=179  Identities=21%  Similarity=0.321  Sum_probs=141.6

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |++|+|.+++......+++..++.++.|++.||.|||    +.+|+||||||+|||++.++.+||+|||+++........
T Consensus       111 ~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH----~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~  186 (311)
T d1r0pa_         111 MKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA----SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD  186 (311)
T ss_dssp             CTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred             eecCchhhhhccccccchHHHHHHHHHHHHHhhhhhc----ccCcccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence            6899999999977777889999999999999999999    899999999999999999999999999999876544322


Q ss_pred             c--cccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhh
Q 037267           81 V--TQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVR  158 (202)
Q Consensus        81 ~--~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (202)
                      .  ......+|+.|+|||......++.++||||||+++||+++|..||........ +...+..+...            
T Consensus       187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~-~~~~i~~g~~~------------  253 (311)
T d1r0pa_         187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-ITVYLLQGRRL------------  253 (311)
T ss_dssp             CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------CHHHHHTTCCC------------
T ss_pred             cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHH-HHHHHHcCCCC------------
Confidence            1  12234678999999988888899999999999999999998888765432221 22222221110            


Q ss_pred             hHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          159 EEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       159 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                           ..+..+++++.+|+.+||+.||++|||+.||++.|+++
T Consensus       254 -----~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i  291 (311)
T d1r0pa_         254 -----LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI  291 (311)
T ss_dssp             -----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -----CCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence                 11123566789999999999999999999999999875

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=3.5e-38  Score=242.87  Aligned_cols=173  Identities=24%  Similarity=0.225  Sum_probs=136.6

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeC--CCCceEEcccccceeccCCC
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLD--ENMVAHVSDFGISKLLGEGE   78 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~--~~~~~~l~d~g~~~~~~~~~   78 (202)
                      |+||+|.+++.+....+++..+..++.||+.||.|||    +.+|+||||||+||+++  .++.+||+|||++.......
T Consensus       105 ~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH----~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~  180 (350)
T d1koaa2         105 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH----ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ  180 (350)
T ss_dssp             CCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS
T ss_pred             CCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH----hcCCeeeeechhHeeeccCCCCeEEEeecchheeccccc
Confidence            6899999999766666999999999999999999999    89999999999999996  46789999999998765443


Q ss_pred             ccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhh
Q 037267           79 DFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVR  158 (202)
Q Consensus        79 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (202)
                      .   .....||+.|+|||++.+..++.++||||+||++|+|++|..||......+ .+. .+........          
T Consensus       181 ~---~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~-~~~-~i~~~~~~~~----------  245 (350)
T d1koaa2         181 S---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE-TLR-NVKSCDWNMD----------  245 (350)
T ss_dssp             C---EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHH-HHHHTCCCSC----------
T ss_pred             c---cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHH-HHH-HHHhCCCCCC----------
Confidence            2   223468999999999988889999999999999999999999997543221 111 1111110000          


Q ss_pred             hHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          159 EEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       159 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                          ......+++++.+|+.+||..||++|||++|+++
T Consensus       246 ----~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  279 (350)
T d1koaa2         246 ----DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE  279 (350)
T ss_dssp             ----CGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             ----cccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                0011234566899999999999999999999986

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2e-39  Score=246.07  Aligned_cols=167  Identities=23%  Similarity=0.232  Sum_probs=131.1

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |++|+|..++... ..+++.++..++.|++.||.|||    +.+|+||||||+|||++.++.+||+|||++......   
T Consensus        97 ~~~g~l~~~~~~~-~~l~e~~~~~i~~qi~~aL~yLH----~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~---  168 (309)
T d1u5ra_          97 CLGSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLH----SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---  168 (309)
T ss_dssp             CSEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHH----HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB---
T ss_pred             cCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHH----hCCEeccCCCcceEEECCCCCEEEeecccccccCCC---
Confidence            5788887776654 45999999999999999999999    899999999999999999999999999999765432   


Q ss_pred             ccccCCCCCccccCCCCCCC---CCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhh
Q 037267           81 VTQTMTMATIGYMAPEYGSE---GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV  157 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~---~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (202)
                         ....||+.|+|||++.+   ..++.++||||+||++|+|++|..||........ +........+..          
T Consensus       169 ---~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~-~~~i~~~~~~~~----------  234 (309)
T d1u5ra_         169 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-LYHIAQNESPAL----------  234 (309)
T ss_dssp             ---CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-HHHHHHSCCCCC----------
T ss_pred             ---CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHH-HHHHHhCCCCCC----------
Confidence               23468999999997653   4588899999999999999999999976432211 111111111100          


Q ss_pred             hhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          158 REEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                             .+..+++++.+|+.+||..||++|||++|+++
T Consensus       235 -------~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         235 -------QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             -------SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             -------CCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence                   01234567899999999999999999999875

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-38  Score=239.46  Aligned_cols=179  Identities=22%  Similarity=0.345  Sum_probs=142.3

Q ss_pred             CCCCcHHHHHhhcC-----------------CCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCce
Q 037267            1 MPNGSLEKWLYSYN-----------------YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVA   63 (202)
Q Consensus         1 ~~~gsL~~~l~~~~-----------------~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~   63 (202)
                      |+||+|.++++...                 ..+++..+..++.|++.||.|||    +.+++||||||+||+++.++.+
T Consensus       109 ~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH----~~~ivHrDLKp~NIl~~~~~~~  184 (311)
T d1t46a_         109 CCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA----SKNCIHRDLAARNILLTHGRIT  184 (311)
T ss_dssp             CTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEEETTTEE
T ss_pred             CCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH----hCCeeecccccccccccccCcc
Confidence            68999999997532                 25899999999999999999999    8999999999999999999999


Q ss_pred             EEcccccceeccCCCccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHh
Q 037267           64 HVSDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKES  143 (202)
Q Consensus        64 ~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~  143 (202)
                      +++|||.++...............+++.|+|||.+.+..++.++||||||+++|+|+++..|+.........+...+...
T Consensus       185 ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~i~~~  264 (311)
T d1t46a_         185 KICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEG  264 (311)
T ss_dssp             EECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHT
T ss_pred             cccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcC
Confidence            99999999876654443334445689999999988888899999999999999999985555443333333333333333


Q ss_pred             CCCChhhhhhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhh
Q 037267          144 LPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKK  200 (202)
Q Consensus       144 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~  200 (202)
                      ....                 .+..++.++.+|+.+||+.||++|||++++++.|++
T Consensus       265 ~~~~-----------------~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~  304 (311)
T d1t46a_         265 FRML-----------------SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK  304 (311)
T ss_dssp             CCCC-----------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCCC-----------------CcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence            2111                 112345668999999999999999999999999975

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=1.2e-38  Score=238.76  Aligned_cols=180  Identities=23%  Similarity=0.364  Sum_probs=134.4

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |+||+|.+++.... .+++.+++.++.|++.||.|||    +.+|+||||||+||+++.++..+++|||.+.........
T Consensus        93 ~~g~~L~~~~~~~~-~l~~~~~~~i~~qi~~al~~lH----~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~~~  167 (277)
T d1o6ya_          93 VDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSH----QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNS  167 (277)
T ss_dssp             CCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEEETTSCEEECCCTTCEECC-----
T ss_pred             CCCCEehhhhcccC-CCCHHHHHHHHHHHHHHHHHHH----hCCccCccccCcccccCccccceeehhhhhhhhcccccc
Confidence            67999999998655 4899999999999999999999    899999999999999999999999999998765433221


Q ss_pred             -ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhh
Q 037267           81 -VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVRE  159 (202)
Q Consensus        81 -~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (202)
                       .......||+.|+|||.+.+..++.++||||+||++|+|++|..||......+.... ... ..+...           
T Consensus       168 ~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~-~~~-~~~~~~-----------  234 (277)
T d1o6ya_         168 VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQ-HVR-EDPIPP-----------  234 (277)
T ss_dssp             -----------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH-HHH-CCCCCG-----------
T ss_pred             ccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHH-HHh-cCCCCC-----------
Confidence             123335689999999999888899999999999999999999999976432221111 111 000000           


Q ss_pred             HHHHHHhHHHHHHHHHHHhhhcCCCCCCCC-CHHHHHHHHhhc
Q 037267          160 EQAFAAKMDCIVSIMDLALDCCMESPGKRI-NMTDAAAKLKKI  201 (202)
Q Consensus       160 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rp-s~~~~~~~l~~l  201 (202)
                         ......+++++.+++.+||+.||++|| |++++++.|.++
T Consensus       235 ---~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~  274 (277)
T d1o6ya_         235 ---SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV  274 (277)
T ss_dssp             ---GGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             ---chhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence               001123566789999999999999999 899999998765

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=2.4e-38  Score=244.00  Aligned_cols=173  Identities=24%  Similarity=0.254  Sum_probs=137.9

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeC--CCCceEEcccccceeccCCC
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLD--ENMVAHVSDFGISKLLGEGE   78 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~--~~~~~~l~d~g~~~~~~~~~   78 (202)
                      |+||+|.+++.+....+++.++..++.||+.||.|||    +.+|+||||||+|||++  .++.+||+|||++.......
T Consensus       108 ~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH----~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~  183 (352)
T d1koba_         108 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH----EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE  183 (352)
T ss_dssp             CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred             CCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCeeecccccccccccccCCCeEEEeecccceecCCCC
Confidence            6899999999876667999999999999999999999    89999999999999998  67899999999998876543


Q ss_pred             ccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhh
Q 037267           79 DFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVR  158 (202)
Q Consensus        79 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (202)
                      ..   ....+++.|+|||++.+..++.++||||+||++|+|++|..||.......  ....+.........         
T Consensus       184 ~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~--~~~~i~~~~~~~~~---------  249 (352)
T d1koba_         184 IV---KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE--TLQNVKRCDWEFDE---------  249 (352)
T ss_dssp             CE---EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH--HHHHHHHCCCCCCS---------
T ss_pred             ce---eeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhCCCCCCc---------
Confidence            22   23468999999999999999999999999999999999999997643222  11111111100000         


Q ss_pred             hHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          159 EEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       159 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                           .....+++++.+|+.+||..||.+|||+.|+++
T Consensus       250 -----~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  282 (352)
T d1koba_         250 -----DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE  282 (352)
T ss_dssp             -----STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             -----ccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                 001234566899999999999999999999975

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-37  Score=235.14  Aligned_cols=191  Identities=19%  Similarity=0.281  Sum_probs=138.0

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCC----CCCCCeeecCCCCCceeeCCCCceEEcccccceeccC
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHG----HSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGE   76 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~----~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~   76 (202)
                      |++|||.++|++.  .+++..++.++.|++.||.|+|+.    ..+++|+||||||+|||++.++.+||+|||++.....
T Consensus        83 ~~~g~L~~~l~~~--~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~  160 (303)
T d1vjya_          83 HEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS  160 (303)
T ss_dssp             CTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEET
T ss_pred             ccCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccC
Confidence            6799999999864  389999999999999999999941    0036999999999999999999999999999987655


Q ss_pred             CCccc--cccCCCCCccccCCCCCCCC------CcCcchhhhhHHHHHHHHHhCCCCCCcccccchhh----------HH
Q 037267           77 GEDFV--TQTMTMATIGYMAPEYGSEG------IVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSL----------RR  138 (202)
Q Consensus        77 ~~~~~--~~~~~~~~~~~~~pe~~~~~------~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~----------~~  138 (202)
                      .....  ......||+.|+|||++.+.      .++.++|+|||||++||+++|..||..........          ..
T Consensus       161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (303)
T d1vjya_         161 ATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE  240 (303)
T ss_dssp             TTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHH
T ss_pred             CCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHHH
Confidence            43221  12345689999999986654      25678999999999999999998875433222111          11


Q ss_pred             HHHHhCCCChhhhhhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          139 WVKESLPHGLTEVVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       139 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                      ...........    +...    .......+...+.+|+.+||..||++|||+.||++.|+++
T Consensus       241 ~~~~~~~~~~~----p~~~----~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i  295 (303)
T d1vjya_         241 MRKVVCEQKLR----PNIP----NRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL  295 (303)
T ss_dssp             HHHHHTTSCCC----CCCC----GGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHhccccC----CCCC----cccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence            11111100000    0000    0111234556789999999999999999999999999876

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-38  Score=241.89  Aligned_cols=169  Identities=21%  Similarity=0.190  Sum_probs=135.9

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |+||+|.+++..... +++..+..++.|++.||.|||    +.+|+||||||+|||++.++.+||+|||+++....... 
T Consensus        87 ~~gg~L~~~~~~~~~-~~e~~~~~~~~qil~al~ylH----~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~-  160 (337)
T d1o6la_          87 ANGGELFFHLSRERV-FTEERARFYGAEIVSALEYLH----SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-  160 (337)
T ss_dssp             CTTCBHHHHHHHHSC-CCHHHHHHHHHHHHHHHHHHH----HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC-
T ss_pred             cCCCchhhhhhcccC-CcHHHHHHHHHHHhhhhhhhh----hcCccccccCHHHeEecCCCCEEEeecccccccccCCc-
Confidence            689999999987554 899999999999999999999    89999999999999999999999999999986543322 


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhH
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREE  160 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (202)
                       ......||+.|+|||++.+..++.++|+||+||++|+|++|..||.......  +...+.....               
T Consensus       161 -~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~--~~~~i~~~~~---------------  222 (337)
T d1o6la_         161 -TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER--LFELILMEEI---------------  222 (337)
T ss_dssp             -CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHCCC---------------
T ss_pred             -ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHH--HHHHHhcCCC---------------
Confidence             1233568999999999999999999999999999999999999997643221  1111111110               


Q ss_pred             HHHHHhHHHHHHHHHHHhhhcCCCCCCCCC-----HHHHHH
Q 037267          161 QAFAAKMDCIVSIMDLALDCCMESPGKRIN-----MTDAAA  196 (202)
Q Consensus       161 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps-----~~~~~~  196 (202)
                         ..+..+++++.+|+.+||.+||++|++     +.|+++
T Consensus       223 ---~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         223 ---RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             ---CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             ---CCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence               011235667899999999999999995     777764

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=9.5e-38  Score=241.70  Aligned_cols=170  Identities=22%  Similarity=0.266  Sum_probs=134.3

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |+||+|.++|.+.. .+++..+..++.||+.||.|||    +.+|+||||||+|||++.++.+||+|||++........ 
T Consensus        89 ~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~aL~ylH----~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~~~-  162 (364)
T d1omwa3          89 MNGGDLHYHLSQHG-VFSEADMRFYAAEIILGLEHMH----NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-  162 (364)
T ss_dssp             CCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSSCC-
T ss_pred             cCCCcHHHHHHhcc-cccHHHHHHHHHHHHHHHHHHH----HCCccceeeccceeEEcCCCcEEEeeeceeeecCCCcc-
Confidence            68999999998654 4899999999999999999999    89999999999999999999999999999987654332 


Q ss_pred             ccccCCCCCccccCCCCCC-CCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhh
Q 037267           81 VTQTMTMATIGYMAPEYGS-EGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVRE  159 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~-~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (202)
                         ....||+.|+|||++. +..++.++|+||+||++|+|++|..||.........  ..........            
T Consensus       163 ---~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~--~~~~~~~~~~------------  225 (364)
T d1omwa3         163 ---HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH--EIDRMTLTMA------------  225 (364)
T ss_dssp             ---CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHH--HHHHHSSSCC------------
T ss_pred             ---cccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHhcccCC------------
Confidence               2346899999999875 456899999999999999999999999765433211  1111110000            


Q ss_pred             HHHHHHhHHHHHHHHHHHhhhcCCCCCCCCC-----HHHHHH
Q 037267          160 EQAFAAKMDCIVSIMDLALDCCMESPGKRIN-----MTDAAA  196 (202)
Q Consensus       160 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps-----~~~~~~  196 (202)
                         ...+..+++++.+|+.+||..||++|||     ++|+++
T Consensus       226 ---~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         226 ---VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             ---CCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             ---CCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence               0011235566899999999999999999     677763

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-38  Score=238.27  Aligned_cols=178  Identities=26%  Similarity=0.419  Sum_probs=134.6

Q ss_pred             CCCCcHHHHHhhc-CCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCc
Q 037267            1 MPNGSLEKWLYSY-NYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED   79 (202)
Q Consensus         1 ~~~gsL~~~l~~~-~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~   79 (202)
                      |++|+|.+++... ...+++.+++.++.|++.||.|||    +.+|+||||||+||+++.++.+||+|||+++.......
T Consensus        93 ~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH----~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~  168 (285)
T d1fmka3          93 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE----RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY  168 (285)
T ss_dssp             CTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred             cCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHh----hhheecccccceEEEECCCCcEEEcccchhhhccCCCc
Confidence            6899999998754 345999999999999999999999    89999999999999999999999999999986544332


Q ss_pred             cccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhh
Q 037267           80 FVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVRE  159 (202)
Q Consensus        80 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (202)
                      . ......+++.|+|||.+.+..++.++||||+||++||+++|..||......... ...+.....              
T Consensus       169 ~-~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~-~~~i~~~~~--------------  232 (285)
T d1fmka3         169 T-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV-LDQVERGYR--------------  232 (285)
T ss_dssp             --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH-HHHHHTTCC--------------
T ss_pred             e-eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHH-HHHHHhcCC--------------
Confidence            2 223345889999999988888999999999999999999976665543322211 122221111              


Q ss_pred             HHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          160 EQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       160 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                         .+.+..+++++.+++.+||+.||++|||+++|++.|+.+
T Consensus       233 ---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~  271 (285)
T d1fmka3         233 ---MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  271 (285)
T ss_dssp             ---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTT
T ss_pred             ---CCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhh
Confidence               011234566789999999999999999999999988753

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-39  Score=240.14  Aligned_cols=174  Identities=28%  Similarity=0.407  Sum_probs=133.9

Q ss_pred             CCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCc
Q 037267            1 MPNGSLEKWLYSYN-YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGED   79 (202)
Q Consensus         1 ~~~gsL~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~   79 (202)
                      |++|||.++|.+.. ..+++..+++++.|++.||.|||    +.+|+||||||+||+++.++.+|++|||+++...... 
T Consensus        83 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH----~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~-  157 (262)
T d1byga_          83 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE----GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-  157 (262)
T ss_dssp             CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred             cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccc----cCceeccccchHhheecCCCCEeecccccceecCCCC-
Confidence            68999999997543 35899999999999999999999    8999999999999999999999999999998654322 


Q ss_pred             cccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHh-CCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhh
Q 037267           80 FVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVR  158 (202)
Q Consensus        80 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (202)
                          ....++..|+|||.+.+..++.++||||||+++||+++ |..||.......  +...+.....             
T Consensus       158 ----~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~--~~~~i~~~~~-------------  218 (262)
T d1byga_         158 ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VVPRVEKGYK-------------  218 (262)
T ss_dssp             --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG--HHHHHTTTCC-------------
T ss_pred             ----ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH--HHHHHHcCCC-------------
Confidence                22356889999998888889999999999999999998 677776543222  2222211110             


Q ss_pred             hHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhcC
Q 037267          159 EEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKIK  202 (202)
Q Consensus       159 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l~  202 (202)
                          .+.+..+++++.+|+.+||+.||++|||+.++++.|++++
T Consensus       219 ----~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~  258 (262)
T d1byga_         219 ----MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK  258 (262)
T ss_dssp             ----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ----CCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence                0112235567899999999999999999999999998864

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-38  Score=236.69  Aligned_cols=172  Identities=21%  Similarity=0.235  Sum_probs=136.3

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCC----ceEEcccccceeccC
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENM----VAHVSDFGISKLLGE   76 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~----~~~l~d~g~~~~~~~   76 (202)
                      |+||||.+++.... .+++..+..++.|++.||.|||    +.+|+||||||+||+++.++    .+|++|||++.....
T Consensus        95 ~~gg~L~~~i~~~~-~l~~~~~~~~~~qi~~al~yLH----~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~  169 (293)
T d1jksa_          95 VAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLH----SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF  169 (293)
T ss_dssp             CCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTT
T ss_pred             CCCccccchhcccc-ccchhHHHHHHHHHHHHHHhhh----hcceeecccccceEEEecCCCcccceEecchhhhhhcCC
Confidence            68999999998654 4999999999999999999999    89999999999999998766    489999999987654


Q ss_pred             CCccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhh
Q 037267           77 GEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANL  156 (202)
Q Consensus        77 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (202)
                      ...   .....+++.|+|||.+.+..++.++|+||+||++|+|++|..||......+  ....+......          
T Consensus       170 ~~~---~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~--~~~~i~~~~~~----------  234 (293)
T d1jksa_         170 GNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE--TLANVSAVNYE----------  234 (293)
T ss_dssp             SCB---CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHTTCCC----------
T ss_pred             Ccc---ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHH--HHHHHHhcCCC----------
Confidence            332   223468899999999988889999999999999999999999997643221  11111111000          


Q ss_pred             hhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          157 VREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                          .....+..++.++.+|+.+||..||++|||++|+++
T Consensus       235 ----~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         235 ----FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             ----CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ----CCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                001122345677899999999999999999999975

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=9.5e-38  Score=240.55  Aligned_cols=166  Identities=21%  Similarity=0.185  Sum_probs=134.9

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |+||+|.+++.+.. .+++..+..++.||+.||.|||    +.+|+||||||+|||++.++.+||+|||+++......  
T Consensus       123 ~~~g~l~~~l~~~~-~l~e~~~~~i~~qi~~aL~yLH----~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~--  195 (350)
T d1rdqe_         123 VAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLH----SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT--  195 (350)
T ss_dssp             CTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB--
T ss_pred             ccccchhhhHhhcC-CCCHHHHHHHHHHHHHHHHHHH----hCCEecCcCCHHHcccCCCCCEEeeeceeeeeccccc--
Confidence            57999999998655 4899999999999999999999    8999999999999999999999999999998765322  


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhH
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREE  160 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (202)
                         ....||+.|+|||++.+..++.++|+||+||++|+|++|..||.......  ....+.....               
T Consensus       196 ---~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~--~~~~i~~~~~---------------  255 (350)
T d1rdqe_         196 ---WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ--IYEKIVSGKV---------------  255 (350)
T ss_dssp             ---CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHCCC---------------
T ss_pred             ---ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHH--HHHHHhcCCC---------------
Confidence               23468999999999999999999999999999999999999997532111  1111111110               


Q ss_pred             HHHHHhHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHH
Q 037267          161 QAFAAKMDCIVSIMDLALDCCMESPGKRI-----NMTDAAA  196 (202)
Q Consensus       161 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rp-----s~~~~~~  196 (202)
                         ..+..+++++.+++.+||..||.+|+     |++++++
T Consensus       256 ---~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         256 ---RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             ---CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             ---CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence               01123556789999999999999995     8998875

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-37  Score=236.44  Aligned_cols=175  Identities=28%  Similarity=0.414  Sum_probs=136.6

Q ss_pred             CCCCcHHHHHhhc---------------CCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEE
Q 037267            1 MPNGSLEKWLYSY---------------NYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHV   65 (202)
Q Consensus         1 ~~~gsL~~~l~~~---------------~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l   65 (202)
                      |+||+|.++|+..               ...+++..+.+++.|++.||.|||    +.+|+||||||+|||++.++.+||
T Consensus        93 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH----~~~iiHrDlkp~NIL~~~~~~~kl  168 (309)
T d1fvra_          93 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS----QKQFIHRDLAARNILVGENYVAKI  168 (309)
T ss_dssp             CTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECGGGCEEE
T ss_pred             cCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhh----cCCccccccccceEEEcCCCceEE
Confidence            6899999999753               246999999999999999999999    899999999999999999999999


Q ss_pred             cccccceeccCCCccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCC-CCCcccccchhhHHHHHHhC
Q 037267           66 SDFGISKLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKR-PTDEMFTGEMSLRRWVKESL  144 (202)
Q Consensus        66 ~d~g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~-p~~~~~~~~~~~~~~~~~~~  144 (202)
                      +|||+++.......   .....+|..|+|||.+.+..++.++|+||||+++|+|++|.. ||.......  +...+....
T Consensus       169 ~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~--~~~~i~~~~  243 (309)
T d1fvra_         169 ADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE--LYEKLPQGY  243 (309)
T ss_dssp             CCTTCEESSCEECC---C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHHGGGTC
T ss_pred             cccccccccccccc---ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHH--HHHHHHhcC
Confidence            99999975443221   223357889999999888899999999999999999999765 565432111  111111110


Q ss_pred             CCChhhhhhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          145 PHGLTEVVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                                       ..+.+..+++++.+|+.+||+.||++|||+.|+++.|+++
T Consensus       244 -----------------~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i  283 (309)
T d1fvra_         244 -----------------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  283 (309)
T ss_dssp             -----------------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -----------------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence                             0111234667799999999999999999999999999765

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=3.3e-37  Score=230.52  Aligned_cols=172  Identities=27%  Similarity=0.283  Sum_probs=134.8

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |+||||.++++... .+++.+++.++.||+.||.|||    +.+|+||||||+||+++.++.+||+|||++........ 
T Consensus        92 ~~~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~~lH----~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~-  165 (277)
T d1phka_          92 MKKGELFDYLTEKV-TLSEKETRKIMRALLEVICALH----KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK-  165 (277)
T ss_dssp             CTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCC-
T ss_pred             CCCchHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HcCCcccccccceEEEcCCCCeEEccchheeEccCCCc-
Confidence            68999999998655 5999999999999999999999    89999999999999999999999999999987654332 


Q ss_pred             ccccCCCCCccccCCCCCC------CCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhh
Q 037267           81 VTQTMTMATIGYMAPEYGS------EGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDA  154 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~------~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (202)
                        .....||+.|.+||...      ...++.++|+||+||++|+|++|+.||.......  ....+.......       
T Consensus       166 --~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~--~~~~i~~~~~~~-------  234 (277)
T d1phka_         166 --LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML--MLRMIMSGNYQF-------  234 (277)
T ss_dssp             --BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHTCCCC-------
T ss_pred             --eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHH--HHHHHHhCCCCC-------
Confidence              23356899999999653      3346788999999999999999999997643221  111111111000       


Q ss_pred             hhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          155 NLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                             ..+....+++++.+|+.+||+.||++|||++|+++
T Consensus       235 -------~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~  269 (277)
T d1phka_         235 -------GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  269 (277)
T ss_dssp             -------CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             -------CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence                   00112245677999999999999999999999875

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-37  Score=234.95  Aligned_cols=188  Identities=21%  Similarity=0.209  Sum_probs=135.5

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |.+|++..........+++..+..++.|++.||.|||    +++|+||||||+|||++.++.+|++|||++.......  
T Consensus        97 ~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH----~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~~~~~~--  170 (305)
T d1blxa_          97 VDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH----SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM--  170 (305)
T ss_dssp             CSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECTTCCEEECSCCSCCCCCGGG--
T ss_pred             ccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHH----hCCEEecCCCccEEEEcCCCCeeecchhhhhhhcccc--
Confidence            4566666666555667999999999999999999999    8999999999999999999999999999987644322  


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhh------hh
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVV------DA  154 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~  154 (202)
                       ......||+.|+|||++.+..++.++||||+||++|+|++|..||......+. +.........+......      ..
T Consensus       171 -~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~  248 (305)
T d1blxa_         171 -ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ-LGKILDVIGLPGEEDWPRDVALPRQ  248 (305)
T ss_dssp             -GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCCCGGGSCTTCSSCGG
T ss_pred             -cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHH-HHHHHHhhCCCchhcccccccchhh
Confidence             23345789999999999899999999999999999999999999976533221 11111110000000000      00


Q ss_pred             hhh--hhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          155 NLV--REEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       155 ~~~--~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                      ...  ............++.+.+|+.+||+.||++|||++|+++
T Consensus       249 ~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~  292 (305)
T d1blxa_         249 AFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  292 (305)
T ss_dssp             GSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            000  000000111234566889999999999999999999975

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-37  Score=234.64  Aligned_cols=178  Identities=21%  Similarity=0.393  Sum_probs=140.7

Q ss_pred             CCCCcHHHHHhhcC---------CCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccc
Q 037267            1 MPNGSLEKWLYSYN---------YFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGIS   71 (202)
Q Consensus         1 ~~~gsL~~~l~~~~---------~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~   71 (202)
                      |++|||.+++....         ..+++..+.+++.|+++||.|||    +++|+||||||+|||++.++.+||+|||++
T Consensus       105 ~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH----~~~ivHrDlk~~NiLld~~~~~Kl~DFGla  180 (308)
T d1p4oa_         105 MTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN----ANKFVHRDLAARNCMVAEDFTVKIGDFGMT  180 (308)
T ss_dssp             CTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH----HTTCBCSCCSGGGEEECTTCCEEECCTTCC
T ss_pred             cCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHh----hCCeeeceEcCCceeecCCceEEEeecccc
Confidence            68999999987431         24789999999999999999999    899999999999999999999999999999


Q ss_pred             eeccCCCccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCC-CCCCcccccchhhHHHHHHhCCCChhh
Q 037267           72 KLLGEGEDFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRK-RPTDEMFTGEMSLRRWVKESLPHGLTE  150 (202)
Q Consensus        72 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~  150 (202)
                      +...............+++.|++||.+.+..++.++|+||||+++|||++|. .||....... .+. .+....      
T Consensus       181 ~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~-~~~-~i~~~~------  252 (308)
T d1p4oa_         181 RDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ-VLR-FVMEGG------  252 (308)
T ss_dssp             CGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH-HHH-HHHTTC------
T ss_pred             eeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHH-HHH-HHHhCC------
Confidence            8765544433344456889999999988888999999999999999999985 6665432221 111 111110      


Q ss_pred             hhhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          151 VVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                                 ..+.+..+++++.+++.+||+.+|++|||+.+|++.|++.
T Consensus       253 -----------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~  292 (308)
T d1p4oa_         253 -----------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE  292 (308)
T ss_dssp             -----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred             -----------CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence                       0111234566799999999999999999999999999864

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=6.4e-37  Score=232.94  Aligned_cols=166  Identities=27%  Similarity=0.265  Sum_probs=134.3

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |+||+|.+++..... +++..+..++.|++.||.|||    +++|+||||||+|||++.++.+||+|||+++......  
T Consensus        86 ~~gg~l~~~~~~~~~-~~~~~~~~~~~qi~~al~~lH----~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~--  158 (316)
T d1fota_          86 IEGGELFSLLRKSQR-FPNPVAKFYAAEVCLALEYLH----SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT--  158 (316)
T ss_dssp             CCSCBHHHHHHHTSS-CCHHHHHHHHHHHHHHHHHHH----TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSCB--
T ss_pred             cCCcccccccccccc-ccccHHHHHHHHHHHhhhhhc----cCcEEccccCchheeEcCCCCEEEecCccceEecccc--
Confidence            689999999986554 899999999999999999999    9999999999999999999999999999998765432  


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhH
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREE  160 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (202)
                         ....||+.|+|||++.+..++.++|+||+||++|+|++|..||.......  ....+.....               
T Consensus       159 ---~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~--~~~~i~~~~~---------------  218 (316)
T d1fota_         159 ---YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK--TYEKILNAEL---------------  218 (316)
T ss_dssp             ---CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH--HHHHHHHCCC---------------
T ss_pred             ---ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHH--HHHHHHcCCC---------------
Confidence               23568999999999999899999999999999999999999997643221  1111111100               


Q ss_pred             HHHHHhHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHH
Q 037267          161 QAFAAKMDCIVSIMDLALDCCMESPGKRI-----NMTDAAA  196 (202)
Q Consensus       161 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rp-----s~~~~~~  196 (202)
                         ..+..+++++.+++.+||..||++|+     |++++++
T Consensus       219 ---~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~  256 (316)
T d1fota_         219 ---RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  256 (316)
T ss_dssp             ---CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             ---CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence               00123456689999999999999996     8888874

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.1e-36  Score=230.47  Aligned_cols=184  Identities=17%  Similarity=0.124  Sum_probs=139.3

Q ss_pred             CCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCC---CCceEEcccccceeccCCC
Q 037267            2 PNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDE---NMVAHVSDFGISKLLGEGE   78 (202)
Q Consensus         2 ~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~---~~~~~l~d~g~~~~~~~~~   78 (202)
                      .+|+|.+.+......+++..+..++.|++.||.|||    +.+|+||||||+||++..   +..++++|||+++......
T Consensus        85 ~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~  160 (299)
T d1ckia_          85 LGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH----SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR  160 (299)
T ss_dssp             CCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTT
T ss_pred             cCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHH----HCCeeeccCCHhhccccccCCCceeeeeccCcceeccccc
Confidence            478888888776667999999999999999999999    899999999999999863   4579999999999875443


Q ss_pred             cc-----ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhh
Q 037267           79 DF-----VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVD  153 (202)
Q Consensus        79 ~~-----~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (202)
                      ..     .......||+.|+|||...+..++.++|+||+||++|++++|..||..............          ...
T Consensus       161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~----------~~~  230 (299)
T d1ckia_         161 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYER----------ISE  230 (299)
T ss_dssp             TCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHH----------HHH
T ss_pred             cccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHH----------hhc
Confidence            21     122345689999999998888899999999999999999999999977543332111100          000


Q ss_pred             hhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhhc
Q 037267          154 ANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKKI  201 (202)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~l  201 (202)
                      ......  .......+++++.+++..||+.+|++||+++++.+.|+.+
T Consensus       231 ~~~~~~--~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~  276 (299)
T d1ckia_         231 KKMSTP--IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL  276 (299)
T ss_dssp             HHHHSC--HHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred             ccCCCC--hhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence            000000  0111235677899999999999999999999998888753

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-37  Score=233.79  Aligned_cols=173  Identities=18%  Similarity=0.267  Sum_probs=136.6

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCC--CCceEEcccccceeccCCC
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDE--NMVAHVSDFGISKLLGEGE   78 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~--~~~~~l~d~g~~~~~~~~~   78 (202)
                      |+||+|.+++...+..+++.++..++.||+.||.|||    +++|+||||||+||+++.  ...++++|||++.......
T Consensus        83 ~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH----~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~  158 (321)
T d1tkia_          83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH----SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD  158 (321)
T ss_dssp             CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred             CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HcCCCcccccccceeecCCCceEEEEcccchhhccccCC
Confidence            6899999999876667999999999999999999999    899999999999999984  4578999999998765433


Q ss_pred             ccccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhh
Q 037267           79 DFVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVR  158 (202)
Q Consensus        79 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (202)
                      .   .....+++.|++||...+..++.++|+||+||++|+|++|..||.......  ....+.....           ..
T Consensus       159 ~---~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~--~~~~i~~~~~-----------~~  222 (321)
T d1tkia_         159 N---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ--IIENIMNAEY-----------TF  222 (321)
T ss_dssp             E---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH--HHHHHHHTCC-----------CC
T ss_pred             c---ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhCCC-----------CC
Confidence            2   122457899999999888889999999999999999999999997643221  1111111110           00


Q ss_pred             hHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          159 EEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       159 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                         .......+++++.+|+.+||..||++|||+.|+++
T Consensus       223 ---~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  257 (321)
T d1tkia_         223 ---DEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             ---CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ---ChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence               01112235667899999999999999999999986

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-36  Score=232.67  Aligned_cols=189  Identities=22%  Similarity=0.205  Sum_probs=136.2

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      +.+|||.+++...  .+++..++.++.|++.||.|||    +.+|+||||||+|||++.++.+||+|||++.........
T Consensus        92 ~~~g~L~~~l~~~--~l~~~~i~~i~~qil~al~yLH----~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~  165 (345)
T d1pmea_          92 LMGADLYKLLKTQ--HLSNDHICYFLYQILRGLKYIH----SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH  165 (345)
T ss_dssp             CCCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCB
T ss_pred             ecCCchhhhhhcC--CCCHHHHHHHHHHHHHHHHHHH----HCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCCcc
Confidence            4689999999764  4899999999999999999999    899999999999999999999999999999876543222


Q ss_pred             c-cccCCCCCccccCCCCC-CCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhh-
Q 037267           81 V-TQTMTMATIGYMAPEYG-SEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV-  157 (202)
Q Consensus        81 ~-~~~~~~~~~~~~~pe~~-~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  157 (202)
                      . ......+++.|+|||.+ .+..++.++|+||+||++|+|++|..||..................+ ........... 
T Consensus       166 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  244 (345)
T d1pmea_         166 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP-SQEDLNCIINLK  244 (345)
T ss_dssp             CCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSC-CHHHHHTCCCHH
T ss_pred             ceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCC-Chhhhhhhhhhh
Confidence            1 12335689999999986 44567889999999999999999999997654322211111111111 11100000000 


Q ss_pred             h-----------hHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          158 R-----------EEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       158 ~-----------~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                      .           ...........+.++.+|+.+||..||++|||+.|+++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~  294 (345)
T d1pmea_         245 ARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  294 (345)
T ss_dssp             HHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0           00000111234557899999999999999999999985

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-37  Score=236.92  Aligned_cols=168  Identities=26%  Similarity=0.305  Sum_probs=135.1

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |+||+|.+++..... +++.++..++.||+.||.|||    +++|+||||||+|||++.++.+|++|||+++....... 
T Consensus        85 ~~~g~L~~~i~~~~~-~~e~~~~~~~~qi~~al~ylH----~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~-  158 (320)
T d1xjda_          85 LNGGDLMYHIQSCHK-FDLSRATFYAAEIILGLQFLH----SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA-  158 (320)
T ss_dssp             CTTCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHH----HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC-
T ss_pred             cCCCcHHHHhhccCC-CCHHHHHHHHHHHHHHHHHHH----hCCeeeccCcccceeecCCCceeccccchhhhcccccc-
Confidence            689999999986554 899999999999999999999    89999999999999999999999999999986543322 


Q ss_pred             ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhH
Q 037267           81 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREE  160 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (202)
                       ......||+.|+|||++.+..++.++|+||+||++|+|++|..||.+.....  +...+....+               
T Consensus       159 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~--~~~~i~~~~~---------------  220 (320)
T d1xjda_         159 -KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE--LFHSIRMDNP---------------  220 (320)
T ss_dssp             -CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHCCC---------------
T ss_pred             -cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHH--HHHHHHcCCC---------------
Confidence             1233468999999999999999999999999999999999999997643221  1111111111               


Q ss_pred             HHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHH-HHH
Q 037267          161 QAFAAKMDCIVSIMDLALDCCMESPGKRINMT-DAA  195 (202)
Q Consensus       161 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~-~~~  195 (202)
                         ..+..+++++.+|+.+||..||++|||+. +++
T Consensus       221 ---~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~  253 (320)
T d1xjda_         221 ---FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR  253 (320)
T ss_dssp             ---CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             ---CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHH
Confidence               01123556689999999999999999985 664

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-36  Score=229.94  Aligned_cols=188  Identities=24%  Similarity=0.235  Sum_probs=131.4

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |++|++..+. .....+++..+..++.|++.||.|||    +.+|+||||||+||+++.++.+||+|||++.........
T Consensus        82 ~~~~~~~~~~-~~~~~l~~~~~~~~~~qil~aL~~lH----~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~  156 (299)
T d1ua2a_          82 METDLEVIIK-DNSLVLTPSHIKAYMLMTLQGLEYLH----QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA  156 (299)
T ss_dssp             CSEEHHHHHT-TCCSSCCSSHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC
T ss_pred             hcchHHhhhh-hcccCCCHHHHHHHHHHHHHHHHHhh----ccceecccCCcceEEecCCCccccccCccccccCCCccc
Confidence            3455555554 44556899999999999999999999    899999999999999999999999999999765543221


Q ss_pred             ccccCCCCCccccCCCCCCC-CCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHH-hCCCC--hhhhhhh--
Q 037267           81 VTQTMTMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKE-SLPHG--LTEVVDA--  154 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~-~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~--  154 (202)
                        .....+|+.|+|||.+.+ ..++.++||||+||++|+|++|..||......+. +...... +.+..  +......  
T Consensus       157 --~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~-l~~i~~~~~~~~~~~~~~~~~~~~  233 (299)
T d1ua2a_         157 --YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ-LTRIFETLGTPTEEQWPDMCSLPD  233 (299)
T ss_dssp             --CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHHCCCCTTTSSSTTSSTT
T ss_pred             --ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHH-HHHHHHhcCCCChhhccchhccch
Confidence              223468999999997654 4578999999999999999999999976433221 1111111 00000  0000000  


Q ss_pred             --h--hhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          155 --N--LVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       155 --~--~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                        .  ..............++++.+|+.+||..||++|||+.|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~  279 (299)
T d1ua2a_         234 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  279 (299)
T ss_dssp             CCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             hhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence              0  00000001112234567899999999999999999999985

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=3.2e-35  Score=221.61  Aligned_cols=182  Identities=14%  Similarity=0.072  Sum_probs=140.8

Q ss_pred             CCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCC-----CCceEEcccccceeccC
Q 037267            2 PNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDE-----NMVAHVSDFGISKLLGE   76 (202)
Q Consensus         2 ~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~-----~~~~~l~d~g~~~~~~~   76 (202)
                      .+|+|.+++......++..++..++.|++.||.|||    +.+|+||||||+||+++.     ++.++++|||+++....
T Consensus        83 ~~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH----~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~  158 (293)
T d1csna_          83 LGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH----EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD  158 (293)
T ss_dssp             CCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH----TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred             cCCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHH----HCCceeccCCccceeecCcccccCCceEEcccceeEEccc
Confidence            479999999877767999999999999999999999    999999999999999974     56799999999998654


Q ss_pred             CCcc-----ccccCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhH-HHHHHhCCCChhh
Q 037267           77 GEDF-----VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLR-RWVKESLPHGLTE  150 (202)
Q Consensus        77 ~~~~-----~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~  150 (202)
                      ....     .......||+.|+|||.+.+..++.++|+||+|+++|++++|..||........... ..+..        
T Consensus       159 ~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~--------  230 (293)
T d1csna_         159 PVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGE--------  230 (293)
T ss_dssp             TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHH--------
T ss_pred             CccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHh--------
Confidence            3221     112345699999999998888899999999999999999999999976543322111 11100        


Q ss_pred             hhhhhhhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhh
Q 037267          151 VVDANLVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAAKLKK  200 (202)
Q Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~~l~~  200 (202)
                         ......  .......+++++.+++..||..+|++||+++.+.+.|+.
T Consensus       231 ---~~~~~~--~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~  275 (293)
T d1csna_         231 ---KKQSTP--LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSK  275 (293)
T ss_dssp             ---HHHHSC--HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred             ---ccCCCC--hHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHH
Confidence               000000  011123466789999999999999999999888877764

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.9e-36  Score=225.21  Aligned_cols=188  Identities=22%  Similarity=0.222  Sum_probs=132.8

Q ss_pred             CCcHHHHHh-hcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCccc
Q 037267            3 NGSLEKWLY-SYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFV   81 (202)
Q Consensus         3 ~gsL~~~l~-~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~~   81 (202)
                      +|++.+++. .....+++..+..++.|++.||.|||    +.+|+||||||+||+++.++.+|++|||.+......... 
T Consensus        84 ~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH----~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~-  158 (298)
T d1gz8a_          84 HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH----SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-  158 (298)
T ss_dssp             SEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBC-
T ss_pred             CCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhh----cCCEEccccCchheeecccCcceeccCCcceeccCCccc-
Confidence            455556654 44556999999999999999999999    899999999999999999999999999999876543322 


Q ss_pred             cccCCCCCccccCCCCCCCCC-cCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCCh--hhhh---hhh
Q 037267           82 TQTMTMATIGYMAPEYGSEGI-VSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGL--TEVV---DAN  155 (202)
Q Consensus        82 ~~~~~~~~~~~~~pe~~~~~~-~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~---~~~  155 (202)
                       .....+++.|+|||...... ++.++|+||+||++|+|++|+.||..................+...  ....   ...
T Consensus       159 -~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  237 (298)
T d1gz8a_         159 -YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK  237 (298)
T ss_dssp             -TTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred             -ceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccc
Confidence             23346899999999755544 5788999999999999999999997654322211111111111110  0000   000


Q ss_pred             h----hhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          156 L----VREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       156 ~----~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                      .    .............+.++.+|+.+||..||++|||+.|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~  282 (298)
T d1gz8a_         238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA  282 (298)
T ss_dssp             TTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence            0    0000011122345567899999999999999999999986

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-36  Score=225.92  Aligned_cols=159  Identities=19%  Similarity=0.186  Sum_probs=127.0

Q ss_pred             CCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCC-CCceEEcccccceeccCCCccc
Q 037267            3 NGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDE-NMVAHVSDFGISKLLGEGEDFV   81 (202)
Q Consensus         3 ~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~-~~~~~l~d~g~~~~~~~~~~~~   81 (202)
                      ++++.+++.... .+++.++..++.|++.||.|||    +.+|+||||||+||+++. ++.+|++|||++.......   
T Consensus        94 ~~~l~~~~~~~~-~l~e~~~~~~~~qi~~al~~lH----~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~~~---  165 (273)
T d1xwsa_          94 VQDLFDFITERG-ALQEELARSFFWQVLEAVRHCH----NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---  165 (273)
T ss_dssp             EEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCSSC---
T ss_pred             cchHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH----HCCCccccCcccceEEecCCCeEEECccccceeccccc---
Confidence            468888887644 4899999999999999999999    899999999999999985 5789999999998754332   


Q ss_pred             cccCCCCCccccCCCCCCCCCc-CcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhhhH
Q 037267           82 TQTMTMATIGYMAPEYGSEGIV-SAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREE  160 (202)
Q Consensus        82 ~~~~~~~~~~~~~pe~~~~~~~-~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (202)
                       .....||+.|+|||.+.+..+ +.++|+||+||++|+|++|..||.....        +.....           .   
T Consensus       166 -~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~--------i~~~~~-----------~---  222 (273)
T d1xwsa_         166 -YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE--------IIRGQV-----------F---  222 (273)
T ss_dssp             -BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH--------HHHCCC-----------C---
T ss_pred             -ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH--------Hhhccc-----------C---
Confidence             234568999999998776655 5678999999999999999999965210        000000           0   


Q ss_pred             HHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          161 QAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       161 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                          .+..+++++.+++.+||..||++|||+.|+++
T Consensus       223 ----~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  254 (273)
T d1xwsa_         223 ----FRQRVSSECQHLIRWCLALRPSDRPTFEEIQN  254 (273)
T ss_dssp             ----CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ----CCCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence                01124566899999999999999999999986

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=2e-35  Score=222.09  Aligned_cols=188  Identities=19%  Similarity=0.232  Sum_probs=128.4

Q ss_pred             CCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcccc
Q 037267            3 NGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVT   82 (202)
Q Consensus         3 ~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~   82 (202)
                      +|++.+.+......+++..+..++.|++.||.|||    +.+|+||||||+||+++.++.+|++|||.+.........  
T Consensus        83 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH----~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~--  156 (286)
T d1ob3a_          83 DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH----DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK--  156 (286)
T ss_dssp             SEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred             hhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhc----cCcEEecCCCCceeeEcCCCCEEecccccceecccCccc--
Confidence            44555555555566999999999999999999999    899999999999999999999999999999876543321  


Q ss_pred             ccCCCCCccccCCCCCCCC-CcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCC--Chhhhhhhhh---
Q 037267           83 QTMTMATIGYMAPEYGSEG-IVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPH--GLTEVVDANL---  156 (202)
Q Consensus        83 ~~~~~~~~~~~~pe~~~~~-~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~---  156 (202)
                      .....+++.|.+||.+.+. .++.++|+||+||++|++++|+.||......+...........+.  .+........   
T Consensus       157 ~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  236 (286)
T d1ob3a_         157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP  236 (286)
T ss_dssp             -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred             cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhccc
Confidence            2234578899999976554 568899999999999999999999976543222111111111110  0000000000   


Q ss_pred             ----hhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          157 ----VREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       157 ----~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                          .............++++.+++.+||+.||++|||++|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             TCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                0000000111234566899999999999999999999973

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-34  Score=219.17  Aligned_cols=190  Identities=20%  Similarity=0.202  Sum_probs=129.6

Q ss_pred             CCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc-
Q 037267            2 PNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF-   80 (202)
Q Consensus         2 ~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~-   80 (202)
                      +++++. ........++...+..++.|++.||.|||    +.+|+||||||+||+++.++.+|++|||++......... 
T Consensus       100 ~~~~~~-~~~~~~~~~~~~~~~~i~~qil~~l~~lH----~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~~~~~~~  174 (318)
T d3blha1         100 EHDLAG-LLSNVLVKFTLSEIKRVMQMLLNGLYYIH----RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQ  174 (318)
T ss_dssp             CEEHHH-HHTCTTCCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEECTTSCEEECCCTTCEECCC-----
T ss_pred             CCCccc-hhhhcccccccHHHHHHHHHHHHHHHHhc----cCCEEecCcCchheeecCCCcEEeeecceeeecccccccc
Confidence            334444 44444456899999999999999999999    899999999999999999999999999999876543221 


Q ss_pred             -ccccCCCCCccccCCCCCCCC-CcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHH-HHHHhCCCCh-hhhhhhh-
Q 037267           81 -VTQTMTMATIGYMAPEYGSEG-IVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRR-WVKESLPHGL-TEVVDAN-  155 (202)
Q Consensus        81 -~~~~~~~~~~~~~~pe~~~~~-~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~-~~~~~~~-  155 (202)
                       .......+|+.|+|||.+.+. .++.++|+||+||++|+|++|+.||............ ......+... ....... 
T Consensus       175 ~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  254 (318)
T d3blha1         175 PNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYEL  254 (318)
T ss_dssp             CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC--
T ss_pred             cccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccccchhhh
Confidence             112334689999999976654 6789999999999999999999999764332211110 0111111110 0000000 


Q ss_pred             ---h------hhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          156 ---L------VREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       156 ---~------~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                         .      ..............+++.+|+.+||..||++|||+.|+++
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~  304 (318)
T d3blha1         255 YEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  304 (318)
T ss_dssp             -----CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             hhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence               0      0000001112334567889999999999999999999975

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.6e-35  Score=224.05  Aligned_cols=176  Identities=22%  Similarity=0.202  Sum_probs=124.2

Q ss_pred             cCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCC-ceEEcccccceeccCCCccccccCCCCCcc
Q 037267           13 YNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENM-VAHVSDFGISKLLGEGEDFVTQTMTMATIG   91 (202)
Q Consensus        13 ~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~-~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~   91 (202)
                      ....+++.++..++.|++.||.|||    +++|+||||||+|||++.++ .+||+|||++........   .....+++.
T Consensus       115 ~~~~l~~~~~~~i~~qil~aL~yLH----~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~  187 (350)
T d1q5ka_         115 AKQTLPVIYVKLYMYQLFRSLAYIH----SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSYICSRY  187 (350)
T ss_dssp             TTCCCCHHHHHHHHHHHHHHHHHHH----TTTEECCCCCGGGEEECTTTCCEEECCCTTCEECCTTSC---CCSCCSCTT
T ss_pred             ccCCCCHHHHHHHHHHHHHHHHHHH----hcCCcccCCCcceEEEecCCCceeEecccchhhccCCcc---ccccccccc
Confidence            3446999999999999999999999    99999999999999999765 889999999987654432   223468899


Q ss_pred             ccCCCCCCC-CCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhh----------hhhhhhH
Q 037267           92 YMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVD----------ANLVREE  160 (202)
Q Consensus        92 ~~~pe~~~~-~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~  160 (202)
                      |.|||.+.+ ..++.++||||+||++|++++|..||......+. +.......-.........          .......
T Consensus       188 y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~-l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (350)
T d1q5ka_         188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ-LVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHP  266 (350)
T ss_dssp             SCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHH-HHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCC
T ss_pred             ccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHH-HHHHHHHhCCChHHhhhhhccchhhccccccccCc
Confidence            999996554 5689999999999999999999999976443221 111111000000000000          0000000


Q ss_pred             HHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          161 QAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       161 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                      .........++++.+|+.+||..||++|||+.|+++
T Consensus       267 ~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  302 (350)
T d1q5ka_         267 WTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  302 (350)
T ss_dssp             GGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            000011234566899999999999999999999985

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-34  Score=220.09  Aligned_cols=174  Identities=26%  Similarity=0.213  Sum_probs=132.8

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |.+|+|.+++..... +++..+..++.|++.||.|+|    +.+|+||||||+||+++.++.++|+|||++.........
T Consensus       111 ~~~~~L~~~i~~~~~-~~e~~~~~~~~Qi~~al~~lH----~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~~~~~  185 (322)
T d1vzoa_         111 INGGELFTHLSQRER-FTEHEVQIYVGEIVLALEHLH----KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE  185 (322)
T ss_dssp             CCSCBHHHHHHHHSC-CCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGGG
T ss_pred             ccccHHHHHHHhccc-ccHHHHHHHHHHHHHHHHHhh----cCCEEeccCCccceeecCCCCEEEeeccchhhhcccccc
Confidence            579999999987654 789999999999999999999    899999999999999999999999999999876543322


Q ss_pred             ccccCCCCCccccCCCCCCCC--CcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhhhhhh
Q 037267           81 VTQTMTMATIGYMAPEYGSEG--IVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVR  158 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~--~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (202)
                      . .....+++.|.+||...+.  .++.++||||+||++|+|++|..||...........-.....             ..
T Consensus       186 ~-~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~-------------~~  251 (322)
T d1vzoa_         186 R-AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL-------------KS  251 (322)
T ss_dssp             G-GCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHH-------------HC
T ss_pred             c-ccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcc-------------cC
Confidence            2 2334688999999976543  467789999999999999999999976543332111111000             00


Q ss_pred             hHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCC-----HHHHHH
Q 037267          159 EEQAFAAKMDCIVSIMDLALDCCMESPGKRIN-----MTDAAA  196 (202)
Q Consensus       159 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps-----~~~~~~  196 (202)
                         ..+.+..+++++.+++.+||++||++|||     ++|+++
T Consensus       252 ---~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         252 ---EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             ---CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             ---CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence               00112346677999999999999999995     778874

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-33  Score=217.81  Aligned_cols=183  Identities=19%  Similarity=0.186  Sum_probs=130.6

Q ss_pred             CCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcccc
Q 037267            3 NGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVT   82 (202)
Q Consensus         3 ~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~   82 (202)
                      +++|..+++..  .+++..+..++.|++.||.|||    +.+|+||||||+|||++.++.+|++|||++.......    
T Consensus       106 ~~~l~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH----~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~~~----  175 (346)
T d1cm8a_         106 GTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIH----AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEM----  175 (346)
T ss_dssp             SEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSSC----
T ss_pred             cccHHHHHHhc--cccHHHHHHHHHHHHHHHHHHH----hCCCcccccCcchhhcccccccccccccceeccCCcc----
Confidence            56777777643  4899999999999999999999    8999999999999999999999999999998765432    


Q ss_pred             ccCCCCCccccCCCCCCC-CCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCC-hhhhhhhhhh---
Q 037267           83 QTMTMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHG-LTEVVDANLV---  157 (202)
Q Consensus        83 ~~~~~~~~~~~~pe~~~~-~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~---  157 (202)
                       ....+++.|+|||.+.+ ..++.++|+||+||++|+|++|..||..................++. ..........   
T Consensus       176 -~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (346)
T d1cm8a_         176 -TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNY  254 (346)
T ss_dssp             -CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHH
T ss_pred             -ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhhhh
Confidence             23568999999997655 45688999999999999999999999765332211111111111100 0000000000   


Q ss_pred             -----h--hHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          158 -----R--EEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       158 -----~--~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                           .  ...........++++.+|+.+||..||++|||+.|+++
T Consensus       255 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~  300 (346)
T d1cm8a_         255 MKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA  300 (346)
T ss_dssp             HHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             hccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence                 0  00000011234566889999999999999999999986

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.4e-34  Score=214.31  Aligned_cols=189  Identities=17%  Similarity=0.161  Sum_probs=133.4

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      +.+++|..++... ..+++..+..++.|++.||+|||    +.+|+||||||+||+++.++.+|++|||.+.........
T Consensus        83 ~~~~~l~~~~~~~-~~~~~~~~~~~~~q~~~aL~~lH----~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~  157 (292)
T d1unla_          83 CDQDLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCH----SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC  157 (292)
T ss_dssp             CSEEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSC
T ss_pred             ccccccccccccc-cccchhHHHHHHHHHHHHHHHhh----cCCEeeecccCcccccccCCceeeeecchhhcccCCCcc
Confidence            4577777777654 45899999999999999999999    899999999999999999999999999999886654332


Q ss_pred             ccccCCCCCccccCCCCCCCCC-cCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCC---hhhhhhhh-
Q 037267           81 VTQTMTMATIGYMAPEYGSEGI-VSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHG---LTEVVDAN-  155 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~~-~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~-  155 (202)
                        .....++..|.|||.+.+.. ++.++|+||+||++|+|++|..||.........+...........   ........ 
T Consensus       158 --~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (292)
T d1unla_         158 --YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD  235 (292)
T ss_dssp             --CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTT
T ss_pred             --ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccc
Confidence              22235677889999766554 588999999999999999999997654333322222221111110   00000000 


Q ss_pred             ------hhhhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          156 ------LVREEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       156 ------~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                            ..............++.+.+|+.+||+.||++||||+|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~  282 (292)
T d1unla_         236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             ccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                  00000001112234556889999999999999999999986

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=5e-34  Score=218.30  Aligned_cols=185  Identities=17%  Similarity=0.204  Sum_probs=130.3

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCC-ceEEcccccceeccCCCc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENM-VAHVSDFGISKLLGEGED   79 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~-~~~l~d~g~~~~~~~~~~   79 (202)
                      |++|+|.++.    ..+++..+..++.||+.||.|||    +.+|+||||||+|||++.++ .++++|||++........
T Consensus       114 ~~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH----~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~  185 (328)
T d3bqca1         114 VNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCH----SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE  185 (328)
T ss_dssp             CCSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCC
T ss_pred             cCCCcHHHHh----cCCCHHHHHHHHHHHHHHHHHHh----hcccccccccccceEEcCCCCeeeecccccceeccCCCc
Confidence            5778887654    34899999999999999999999    89999999999999998654 689999999987654432


Q ss_pred             cccccCCCCCccccCCCCCCCC-CcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHH------------HHhCCC
Q 037267           80 FVTQTMTMATIGYMAPEYGSEG-IVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWV------------KESLPH  146 (202)
Q Consensus        80 ~~~~~~~~~~~~~~~pe~~~~~-~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~------------~~~~~~  146 (202)
                         .....+|+.|+|||...+. .++.++|+||+||++|++++|..||..............            ......
T Consensus       186 ---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~  262 (328)
T d3bqca1         186 ---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE  262 (328)
T ss_dssp             ---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred             ---ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccc
Confidence               2334688999999976654 478999999999999999999999976443221111110            000000


Q ss_pred             Ch---hhhhhhhhh---hhHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          147 GL---TEVVDANLV---REEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       147 ~~---~~~~~~~~~---~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                      ..   .........   ...........+++++.+|+.+||..||++|||++|+++
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         263 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             CCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            00   000000000   000000112335667899999999999999999999986

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.4e-34  Score=218.37  Aligned_cols=183  Identities=22%  Similarity=0.211  Sum_probs=129.2

Q ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCcc
Q 037267            1 MPNGSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDF   80 (202)
Q Consensus         1 ~~~gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~   80 (202)
                      |.+|+|.+++...  .+++.++..++.|++.||.|||    +++|+||||||+||+++.++.++++|||.+......   
T Consensus       104 ~~gg~L~~~~~~~--~l~e~~~~~i~~qil~aL~~LH----~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~~---  174 (348)
T d2gfsa1         104 LMGADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---  174 (348)
T ss_dssp             CCSEEHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECTTCCEEECCC----CCTGG---
T ss_pred             ecCCchhhhcccc--cccHHHHHHHHHHHHHHHHHHH----hCCCcccccCCccccccccccccccccchhcccCcc---
Confidence            4689999999653  4899999999999999999999    899999999999999999999999999998764322   


Q ss_pred             ccccCCCCCccccCCCCCCCC-CcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCChhhhhhh-----
Q 037267           81 VTQTMTMATIGYMAPEYGSEG-IVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDA-----  154 (202)
Q Consensus        81 ~~~~~~~~~~~~~~pe~~~~~-~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----  154 (202)
                        .....+++.|+|||...+. .++.++|+||+||++|+|++|..||..................+  .......     
T Consensus       175 --~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~--~~~~~~~~~~~~  250 (348)
T d2gfsa1         175 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP--GAELLKKISSES  250 (348)
T ss_dssp             --GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC--CHHHHTTCCCHH
T ss_pred             --cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC--ChHHhhhccchh
Confidence              2334678899999975554 46789999999999999999999997643222111111111110  0000000     


Q ss_pred             ------hhhh--hHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          155 ------NLVR--EEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       155 ------~~~~--~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                            ....  ...........++++.+|+.+||..||++|||+.|+++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~  300 (348)
T d2gfsa1         251 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  300 (348)
T ss_dssp             HHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence                  0000  00001112345667899999999999999999999986

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=8.9e-32  Score=207.73  Aligned_cols=182  Identities=21%  Similarity=0.185  Sum_probs=123.1

Q ss_pred             CcHHHHHhhcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceeccCCCccccc
Q 037267            4 GSLEKWLYSYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLGEGEDFVTQ   83 (202)
Q Consensus         4 gsL~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~   83 (202)
                      |++.+.+.   ..+++..+..++.|++.||.|||    +.||+||||||+||+++.++.++++|||+++.......   .
T Consensus       106 ~~l~~~~~---~~~~~~~i~~~~~qil~gl~~LH----~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~~~---~  175 (355)
T d2b1pa1         106 ANLCQVIQ---MELDHERMSYLLYQMLCGIKHLH----SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---M  175 (355)
T ss_dssp             EEHHHHHT---SCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEECTTCCEEECCCCC-------------
T ss_pred             hHHHHhhh---cCCCHHHHHHHHHHHHHHHHHhh----hcccccccCCccccccccccceeeechhhhhccccccc---c
Confidence            44555553   24899999999999999999999    89999999999999999999999999999876554322   2


Q ss_pred             cCCCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccchhhHHHHHHhCCCC----------hhhhhh
Q 037267           84 TMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHG----------LTEVVD  153 (202)
Q Consensus        84 ~~~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~  153 (202)
                      ....+|+.|+|||.+.+..++.++|+||+||+++++++|+.||......... ...........          ......
T Consensus       176 ~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~-~~i~~~~~~~~~~~~~~~~~~~~~~~~  254 (355)
T d2b1pa1         176 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQW-NKVIEQLGTPCPEFMKKLQPTVRNYVE  254 (355)
T ss_dssp             -----CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-HHHHHHHCCCCHHHHTTSCHHHHHHHH
T ss_pred             ccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHH-HHHHHhccCCCHHHHHHhhhhHHHHhh
Confidence            3346889999999998889999999999999999999999999754322111 11110000000          000000


Q ss_pred             ----------hhhhh---hHHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          154 ----------ANLVR---EEQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       154 ----------~~~~~---~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                                .....   ...........+.++.+|+.+||..||++||||+|+++
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~  310 (355)
T d2b1pa1         255 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  310 (355)
T ss_dssp             TSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             cCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence                      00000   00001233456778999999999999999999999974

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.96  E-value=1e-30  Score=202.24  Aligned_cols=177  Identities=19%  Similarity=0.188  Sum_probs=122.2

Q ss_pred             hcCCCCCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCC------ceEEcccccceeccCCCccccccC
Q 037267           12 SYNYFFDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENM------VAHVSDFGISKLLGEGEDFVTQTM   85 (202)
Q Consensus        12 ~~~~~l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~------~~~l~d~g~~~~~~~~~~~~~~~~   85 (202)
                      .....+++..+..++.|++.||.|||+   ..+|+||||||+|||++.++      .++++|||.+.......     ..
T Consensus       117 ~~~~~~~~~~i~~i~~qil~al~~lh~---~~~IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~~~-----~~  188 (362)
T d1q8ya_         117 YEHRGIPLIYVKQISKQLLLGLDYMHR---RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY-----TN  188 (362)
T ss_dssp             TTTSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBCC-----CS
T ss_pred             ccccCCcHHHHHHHHHHHHHHHHHHhh---hcCcccccCChhHeeeeccCcccccceeeEeeccccccccccc-----cc
Confidence            334568999999999999999999993   38999999999999998654      48999999998654332     23


Q ss_pred             CCCCccccCCCCCCCCCcCcchhhhhHHHHHHHHHhCCCCCCcccccch-----hhHHHHHHh--CCCChh---------
Q 037267           86 TMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEM-----SLRRWVKES--LPHGLT---------  149 (202)
Q Consensus        86 ~~~~~~~~~pe~~~~~~~~~~~di~s~G~~~~~~~~g~~p~~~~~~~~~-----~~~~~~~~~--~~~~~~---------  149 (202)
                      ..+++.|+|||...+..++.++|+||+||+++++++|..||........     .....+...  .+....         
T Consensus       189 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~  268 (362)
T d1q8ya_         189 SIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTF  268 (362)
T ss_dssp             CCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHH
T ss_pred             ccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccc
Confidence            4689999999988888899999999999999999999999975332111     111111000  000000         


Q ss_pred             --------hhhhhhhhhh----HHHHHHhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 037267          150 --------EVVDANLVRE----EQAFAAKMDCIVSIMDLALDCCMESPGKRINMTDAAA  196 (202)
Q Consensus       150 --------~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~~~~  196 (202)
                              ..........    ..........++++.+|+.+||..||++|||++|+++
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~  327 (362)
T d1q8ya_         269 FNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVN  327 (362)
T ss_dssp             BCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHT
T ss_pred             cccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence                    0000000000    0011123456778999999999999999999999975

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.26  E-value=8.4e-13  Score=92.07  Aligned_cols=54  Identities=20%  Similarity=0.203  Sum_probs=47.4

Q ss_pred             CCHHHHHHHHHHHHHhhhcccCCCCCCCeeecCCCCCceeeCCCCceEEcccccceecc
Q 037267           17 FDILERLNIMIDVGSALEYPHHGHSSAPIIHCDLKPTNILLDENMVAHVSDFGISKLLG   75 (202)
Q Consensus        17 l~~~~~~~~~~~l~~~l~~lH~~~~~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~~~   75 (202)
                      ++...+..++.|++.+|.|||    +.+|+||||||+|||++.+ .++++|||.+....
T Consensus       100 l~~~~~~~i~~ql~~~l~~lH----~~giiHrDiKP~NILv~~~-~~~liDFG~a~~~~  153 (191)
T d1zara2         100 VRVENPDEVLDMILEEVAKFY----HRGIVHGDLSQYNVLVSEE-GIWIIDFPQSVEVG  153 (191)
T ss_dssp             CCCSCHHHHHHHHHHHHHHHH----HTTEECSCCSTTSEEEETT-EEEECCCTTCEETT
T ss_pred             hhhHHHHHHHHHHHHHHHHHh----hCCEEEccCChhheeeeCC-CEEEEECCCcccCC
Confidence            555667889999999999999    8999999999999999965 48899999987654

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=95.63  E-value=0.0044  Score=44.95  Aligned_cols=32  Identities=25%  Similarity=0.333  Sum_probs=28.4

Q ss_pred             CCCeeecCCCCCceeeCCCCceEEccccccee
Q 037267           42 SAPIIHCDLKPTNILLDENMVAHVSDFGISKL   73 (202)
Q Consensus        42 ~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~   73 (202)
                      ..+++|+|+.++|++++.+....++||+.+..
T Consensus       182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~  213 (316)
T d2ppqa1         182 PAGVIHADLFQDNVFFLGDELSGLIDFYFACN  213 (316)
T ss_dssp             CEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             ccccccCCcchhhhhcccccceeEeccccccc
Confidence            57899999999999999988889999987643

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=94.50  E-value=0.014  Score=40.61  Aligned_cols=32  Identities=19%  Similarity=0.231  Sum_probs=26.8

Q ss_pred             CCCeeecCCCCCceeeCCCCceEEccccccee
Q 037267           42 SAPIIHCDLKPTNILLDENMVAHVSDFGISKL   73 (202)
Q Consensus        42 ~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~   73 (202)
                      ...++|+|+.+.||+++.+..+.|+||+.+..
T Consensus       174 ~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~  205 (255)
T d1nd4a_         174 DLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  205 (255)
T ss_dssp             CEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             CceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence            45689999999999999877778999987643

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=94.32  E-value=0.013  Score=40.99  Aligned_cols=32  Identities=28%  Similarity=0.353  Sum_probs=26.7

Q ss_pred             CCCeeecCCCCCceeeCCCCceEEccccccee
Q 037267           42 SAPIIHCDLKPTNILLDENMVAHVSDFGISKL   73 (202)
Q Consensus        42 ~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~   73 (202)
                      ...++|+|+.+.||+++.++...++||+.+..
T Consensus       182 ~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         182 ELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             CEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             CcEEEEeeccCcceeecCCceEEEeechhccc
Confidence            34589999999999999877778999987643

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=90.61  E-value=0.17  Score=36.49  Aligned_cols=30  Identities=20%  Similarity=0.252  Sum_probs=24.3

Q ss_pred             CCCeeecCCCCCceeeCCCCceEEccccccee
Q 037267           42 SAPIIHCDLKPTNILLDENMVAHVSDFGISKL   73 (202)
Q Consensus        42 ~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~   73 (202)
                      ..+++|+|+.+.||+++.+  ..++||+-+..
T Consensus       191 p~~liHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         191 TVLRLHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             CCEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             CceeecCCCCcccEEEeCC--ceEEechhccc
Confidence            4679999999999999743  45899987754

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=90.44  E-value=0.073  Score=39.67  Aligned_cols=31  Identities=26%  Similarity=0.335  Sum_probs=26.2

Q ss_pred             CCCeeecCCCCCceeeCCCCceEEccccccee
Q 037267           42 SAPIIHCDLKPTNILLDENMVAHVSDFGISKL   73 (202)
Q Consensus        42 ~~~i~h~dlk~~nil~~~~~~~~l~d~g~~~~   73 (202)
                      ...++|+|+.+.||+++.+. ++|+||..+..
T Consensus       222 ~~~LiHGDl~~gNIlv~~~~-~~vID~E~a~~  252 (392)
T d2pula1         222 AETLIHGDLHTGSIFASEHE-TKVIDPEFAFY  252 (392)
T ss_dssp             CCEEECSCCCGGGEEECSSC-EEECCCTTCEE
T ss_pred             CcceeccCCcCCceeEcCCc-eEEechhhccc
Confidence            44799999999999998764 79999988764

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=82.58  E-value=0.29  Score=36.23  Aligned_cols=16  Identities=44%  Similarity=0.607  Sum_probs=13.8

Q ss_pred             CeeecCCCCCceeeCC
Q 037267           44 PIIHCDLKPTNILLDE   59 (202)
Q Consensus        44 ~i~h~dlk~~nil~~~   59 (202)
                      .++|.|+.+.||++..
T Consensus       219 v~CHnDL~~~NiL~~~  234 (395)
T d1nw1a_         219 TFCHNDLQEGNILLPK  234 (395)
T ss_dssp             EEECSCCCGGGEEEEC
T ss_pred             eEEecCCCcccEeecc
Confidence            4689999999999854